PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Cheng, Q; Jiang, B; Xi, J; Li, ZY; Liu, JF; Wang, JY				Cheng, Quan; Jiang, Bing; Xi, Jian; Li, Zhen Yan; Liu, Jin Fang; Wang, Jun Yu			The relation between persistent coma and brain ischemia after severe brain injury	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						severe head injury; persistent coma; SPECT; brain ischemia; thalamic; relationship	VEGETATIVE STATE; HEAD-INJURY	Aim: To investigate the relation between brain ischemia and persistent vegetative state after severe traumatic brain injury. Methods: The 66 patients with severe brain injury were divided into two groups: The persistent coma group (coma duration >= 10 d) included 51 patients who had an admission Glasgow Coma Scale (GCS) of 5-8 and were unconscious for more than 10 d. There were 15 patients in the control group, their admission GCS was 5-8, and were unconscious for less than 10 d. The brain areas, including frontal, parietal, temporal, occipital lobes and thalamus, were measured by Single Photon Emission Computed Tomogrophy (SPECT). Results: In the first SPECT scan, multiple areas of cerebral ischemia were documented in all patients in both groups, whereas bilateral thalamic ischemia were presented in all patients in the persistent coma group and were absented in the control group. In the second SPECT scan taken during the period of analepsia, with an indication that unilateral thalamic ischemia were persisted in 28 of 41 patients in persistent coma group(28/41,68.29%). Conclusion: Persistent coma after severe brain injury is associated with bilateral thalamic ischemia.	[Cheng, Quan; Jiang, Bing; Xi, Jian; Li, Zhen Yan; Liu, Jin Fang; Wang, Jun Yu] Cent S Univ, Xiangya Hosp, Dept Neurosurg, Changsha 410008, Hunan, Peoples R China		Wang, JY (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurosurg, Changsha 410008, Hunan, Peoples R China.	junyu_wang2011@163.com	CHENG, QUAN/AAJ-6264-2021	Cheng, Quan/0000-0003-2401-5349	National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [30370512]	The study was supported by a grant from National Natural Science Foundation of China (NSFC) (30370512).	Danze F, 1989, J NEUROSURG REV, V12, P477; Graham DI, 2005, NEUROPSYCHOL REHABIL, V15, P198, DOI 10.1080/09602010443000452; Hlatky Roman, 2003, Neurosurg Focus, V14, pe2; Laureys S, 2002, ACTA NEUROL BELG, V102, P176; Lull N, 2010, BRAIN INJURY, V24, P1098, DOI 10.3109/02699052.2010.494592; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Wang J., 1999, B HUNAN MED U, V24, P189	11	3	6	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.	DEC	2013	123	12					832	836		10.3109/00207454.2013.794421			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	255RV	WOS:000327258400002	23627555				2022-02-06	
J	Ell, SW				Ell, Shawn W.			Targeted training of the decision rule benefits rule-guided behavior in Parkinson's disease	COGNITIVE AFFECTIVE & BEHAVIORAL NEUROSCIENCE			English	Article						Basal ganglia; Concept learning; Memory; Prefrontal cortex; Selective attention; Striatum	CATEGORY LEARNING-DEFICITS; TRAUMATIC BRAIN-INJURY; COGNITIVE REHABILITATION; WORKING-MEMORY; CATEGORIZATION; SYSTEMS; ATTENTION; IMPACT; MODEL; REINFORCEMENT	The impact of Parkinson's disease (PD) on rule-guided behavior has received considerable attention in cognitive neuroscience. The majority of research has used PD as a model of dysfunction in frontostriatal networks, but very few attempts have been made to investigate the possibility of adapting common experimental techniques in an effort to identify the conditions that are most likely to facilitate successful performance. The present study investigated a targeted training paradigm designed to facilitate rule learning and application using rule-based categorization as a model task. Participants received targeted training in which there was no selective-attention demand (i.e., stimuli varied along a single, relevant dimension) or nontargeted training in which there was selective-attention demand (i.e., stimuli varied along a relevant dimension as well as an irrelevant dimension). Following training, all participants were tested on a rule-based task with selective-attention demand. During the test phase, PD patients who received targeted training performed similarly to control participants and outperformed patients who did not receive targeted training. As a preliminary test of the generalizability of the benefit of targeted training, a subset of the PD patients were tested on the Wisconsin card sorting task (WCST). PD patients who received targeted training outperformed PD patients who did not receive targeted training on several WCST performance measures. These data further characterize the contribution of frontostriatal circuitry to rule-guided behavior. Importantly, these data also suggest that PD patient impairment, on selective-attention-demanding tasks of rule-guided behavior, is not inevitable and highlight the potential benefit of targeted training.	Univ Maine, Dept Psychol, Grad Sch Biomed Sci, Orono, ME 04469 USA		Ell, SW (corresponding author), Univ Maine, Dept Psychol, Grad Sch Biomed Sci, 5742 Little Hall,Room 301, Orono, ME 04469 USA.	shawn.ell@umit.maine.edu			Maine Institute for Human Genetics and Health	This research was supported in part by a grant from the Maine Institute for Human Genetics and Health. Thanks to the patients and their caregivers for their participation and ongoing commitment to research. Thanks to Dr. Ed Drasby, Dr. William Stamey, and the Maine Parkinson's Disease Association for their assistance in the recruitment and/or assessment of the patients. Thanks to Dr. Barch, three anonymous reviewers, and Steve Hutchinson for their helpful comments on an earlier draft of the manuscript. Thanks to Lacey Favreau, Rena Lolar, and Monica Zilioli for assistance with data collection. Correspondence concerning this article should be addressed to Shawn W. Ell, Psychology Department, University of Maine, 5742 Little Hall, Room 301, Orono, ME 04469-5742 (email: shawn.ell@umit.maine.edu).	ANDERSON JR, 1991, PSYCHOL REV, V98, P409, DOI 10.1037/0033-295X.98.3.409; Ashby EG, 2005, ANNU REV PSYCHOL, V56, P149, DOI 10.1146/annurev.psych.56.091103.070217; Ashby F. G., 1992, MULTIDIMENSIONAL MOD; Ashby F.G., 1992, MULTIVARIATE PROBABI, P1; Ashby F. G., 1998, MEASUREMENT JUDGMENT, P251; Ashby FG, 2001, TRENDS COGN SCI, V5, P204, DOI 10.1016/S1364-6613(00)01624-7; ASHBY FG, 1988, J EXP PSYCHOL LEARN, V14, P33, DOI 10.1037/0278-7393.14.1.33; Ashby FG, 2005, J COGNITIVE NEUROSCI, V17, P1728, DOI 10.1162/089892905774589271; ASHBY FG, 1994, J MATH PSYCHOL, V38, P423, DOI 10.1006/jmps.1994.1032; Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; ASHBY FG, 1986, PSYCHOL REV, V93, P154, DOI 10.1037/0033-295X.93.2.154; Ashby FG, 1999, PSYCHON B REV, V6, P363, DOI 10.3758/BF03210826; Ashby FG, 2003, NEUROPSYCHOLOGY, V17, P115, DOI 10.1037/0894-4105.17.1.115; Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; Badre D, 2012, CEREB CORTEX, V22, P527, DOI 10.1093/cercor/bhr117; Badre D, 2010, NEURON, V66, P315, DOI 10.1016/j.neuron.2010.03.025; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Braun DA, 2009, CURR BIOL, V19, P352, DOI 10.1016/j.cub.2009.01.036; Bunge S. A., 2007, NEUROSCIENCE RULE GU; Bunge Silvia A., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P564; Chudasama Y, 2006, BIOL PSYCHOL, V73, P19, DOI 10.1016/j.biopsycho.2006.01.005; Constantinidou F, 2005, J HEAD TRAUMA REHAB, V20, P143, DOI 10.1097/00001199-200503000-00003; Constantinidou F, 2008, J HEAD TRAUMA REHAB, V23, P312, DOI 10.1097/01.HTR.0000336844.99079.2c; Cools R, 2010, BRAIN, V133, P225, DOI 10.1093/brain/awp301; DeGutis J, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.044.2009; Delis DC., 2001, DELIS KAPLAN EXECUTI; Disbrow EA, 2012, BRAIN RES, V1452, P151, DOI 10.1016/j.brainres.2012.02.073; Djamshidian A, 2011, NEUROPSYCHOLOGIA, V49, P2483, DOI 10.1016/j.neuropsychologia.2011.04.026; Ell S. W., 2010, SAN DIEG ANN M SOC N; Ell SW, 2006, PERCEPT PSYCHOPHYS, V68, P1013, DOI 10.3758/BF03193362; Ell SW, 2012, ATTEN PERCEPT PSYCHO, V74, P466, DOI 10.3758/s13414-011-0238-z; Ell SW, 2010, NEUROPSYCHOLOGIA, V48, P2974, DOI 10.1016/j.neuropsychologia.2010.06.006; Ell SW, 2009, ATTEN PERCEPT PSYCHO, V71, P1263, DOI 10.3758/APP.71.6.1263; Fahn S, 1987, RECENT DEV PARKINSON, V2, P153; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Filoteo JV, 2007, NEUROPSYCHOLOGIA, V45, P305, DOI 10.1016/j.neuropsychologia.2006.06.034; Filoteo JV, 2005, J INT NEUROPSYCH SOC, V11, P503, DOI 10.1017/S1355617705050617; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Green D.M., 1966, SOCIETY; HARLOW HF, 1949, PSYCHOL REV, V56, P51, DOI 10.1037/h0062474; Hart T, 2008, NEUROPSYCHOL REHABIL, V18, P1, DOI 10.1080/09602010601082359; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Helie S, 2012, NEUROPSYCHOLOGIA, V50, P2290, DOI 10.1016/j.neuropsychologia.2012.05.033; Hindle JV, 2013, MOVEMENT DISORD, V28, P1034, DOI 10.1002/mds.25377; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Horowitz TS, 2006, NEUROPSYCHOLOGIA, V44, P1962, DOI 10.1016/j.neuropsychologia.2006.01.037; Jaeggi SM, 2011, P NATL ACAD SCI USA, V108, P10081, DOI 10.1073/pnas.1103228108; Kehagia AA, 2010, LANCET NEUROLOGY; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; Kennedy MRT, 2006, NEUROPSYCHOL REV, V16, P151, DOI 10.1007/s11065-006-9012-8; Lee, 1993, ADV PSYCHOL, V99, P369, DOI DOI 10.1016/S0166-4115(08)62778-8; Lewis SJG, 2005, NEUROPSYCHOLOGIA, V43, P823, DOI 10.1016/j.neuropsychologia.2004.10.001; Love BC, 2004, PSYCHOL REV, V111, P309, DOI 10.1037/0033-295X.111.2.309; Maddox W. T., 1992, MULTIDIMENSIONAL MOD, P147; MADDOX WT, 1993, PERCEPT PSYCHOPHYS, V53, P49, DOI 10.3758/BF03211715; Maddox WT, 2004, BEHAV PROCESS, V66, P309, DOI 10.1016/j.beproc.2004.03.011; Maddox WT, 2002, MEM COGNITION, V30, P325, DOI 10.3758/BF03194934; Maddox WT, 1996, NEUROPSYCHOLOGY, V10, P197, DOI 10.1037/0894-4105.10.2.197; Minda JP, 2001, J EXP PSYCHOL LEARN, V27, P775, DOI 10.1037//0278-7393.27.3.775; Monchi O, 2007, BRAIN, V130, P233, DOI 10.1093/brain/awl326; Nelson H.E., 1982, NATL ADULT READING T; NOSOFSKY RM, 1986, J EXP PSYCHOL GEN, V115, P39, DOI 10.1037/0096-3445.115.1.39; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pothos EM, 2002, COGNITIVE SCI, V26, P303, DOI 10.1016/S0364-0213(02)00064-2; Price AL, 2006, NEUROPSYCHOLOGY, V20, P249, DOI 10.1037/0894-4105.20.2.249; Price A, 2009, NEUROPSYCHOLOGIA, V47, P1213, DOI 10.1016/j.neuropsychologia.2009.01.031; Redick TS, 2013, J EXP PSYCHOL GEN, V142, P359, DOI 10.1037/a0029082; Rosenthal R., 2000, CONSRASTS EFFECT SIZ; Sammer G, 2006, J NEUROL SCI, V248, P115, DOI 10.1016/j.jns.2006.05.028; Schieshser D. M., ARCH CLIN NEUROPSYCH; Schutz LE, 2007, BRAIN INJURY, V21, P545, DOI 10.1080/02699050701426923; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seger CA, 2010, ANNU REV NEUROSCI, V33, P203, DOI 10.1146/annurev.neuro.051508.135546; Sinforiani E, 2004, ARCH GERONTOL GERIAT, P387; Slabosz A, 2006, NEUROPSYCHOLOGY, V20, P578, DOI 10.1037/0894-4105.20.5.578; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TERRACE HS, 1964, SCIENCE, V144, P78, DOI 10.1126/science.144.3614.78; TOWNSEND JT, 1992, BEHAV BRAIN SCI, V15, P458, DOI 10.1017/S0140525X00069685; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wickens T.D, 1982, MODELS BEHAV STOCHAS; Wilson B. A., 1994, NEUROPSYCHOL REHABIL, V4, P207; Woods SP, 2003, J INT NEUROPSYCH SOC, V9, P17, DOI 10.1017/S1355617703910022; [No title captured]	88	3	4	0	17	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1530-7026	1531-135X		COGN AFFECT BEHAV NE	Cogn. Affect. Behav. Neurosci.	DEC	2013	13	4					830	846		10.3758/s13415-013-0176-4			17	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	270TQ	WOS:000328342000013	23743576	Green Submitted			2022-02-06	
J	Greene, M				Greene, Mark			Saving a life but losing the patient	THEORETICAL MEDICINE AND BIOETHICS			English	Article						Identity; Survival; Replacement; Indeterminacy; Life-saving; Brain injury; Persons; Personal concern; Metamorphosis	TRAUMATIC BRAIN-INJURY; PERSONAL IDENTITY; ALZHEIMERS	Gregor Samsa awakes to find himself transformed into a gigantic bug. The creature's inchoate flailing leads Gregor's sister to conclude that Gregor is no more, having been replaced by a brute beast lacking any vestige of human understanding. Sadly, real cases of brain injury and disease can lead to psychological metamorphoses so profound that we cannot easily think that the survivor is the person we knew. I argue that there can be cases in which statements like, "It's just not Gregor anymore," are not merely figures of speech. With this in mind, I consider three possible results of saving a biological life: (1) ordinary cases where saving the life will save the person, with strong duties to save the life; (2) cases where the intervention needed to save the life will replace the person, with strong duties not to save the life; (3) cases in which it is indeterminate whether the person will be saved or replaced. How should we think about indeterminate cases? Impersonal ethical considerations miss the point, while standard person-affecting considerations are inapplicable. I suggest turning attention away from survival towards a richer focus on what I call "personal concern." I show how considerations of personal concern, unlike those of self-interest, need not be tied to survival and how this allows personal concern to provide a basis for ethically substantive discussion of cases where saving a life might result in losing the patient.	Univ Delaware, Dept Philosophy, Newark, DE 19716 USA		Greene, M (corresponding author), Univ Delaware, Dept Philosophy, 24 Kent Way, Newark, DE 19716 USA.	mkgreene@udel.edu		Greene, Mark/0000-0001-9512-4943			Bourget David, 2009, PHILPAPERS SURVEYS P; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Frontczak-Baniewicz M, 2011, FOLIA NEUROPATHOL, V49, P204; Greene M, 2008, ETHICS, V118, P633, DOI 10.1086/589530; Hayes J, 2009, J AGING STUD, V23, P48, DOI 10.1016/j.jaging.2007.09.002; Hinton WL, 1999, CULT MED PSYCHIAT, V23, P453, DOI 10.1023/A:1005516002792; Kafka F., 1996, METAMORPHOSIS; LOFTUS EF, 1995, PSYCHIAT ANN, V25, P720, DOI 10.3928/0048-5713-19951201-07; Mathews DJH, 2008, NEUROLOGY, V71, P288, DOI 10.1212/01.wnl.0000316436.13659.80; McMahan Jeff, 2003, ETHICS KILLING PROBL, V1; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Northoff G, 1996, J MED ETHICS, V22, P174, DOI 10.1136/jme.22.3.174; ORONA CJ, 1990, SOC SCI MED, V30, P1247, DOI 10.1016/0277-9536(90)90265-T; PARFIT D, 1971, PHILOS REV, V80, P3, DOI 10.2307/2184309; Parfit D., 1984, REASONS PERSONS; Parfit Derek, 2009, MY PHILOS VIEWS PHIL; Payne I, 2001, MUSIC TIMES, V142, P33, DOI 10.2307/1004680; Perry J., 1976, IDENTITIES PERSONS, P67; Tooley Michael., 1972, PHILOS PUBLIC AFF, V2, P37; WHITING J, 1986, PHILOS REV, V95, P547, DOI 10.2307/2185050	20	3	3	0	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1386-7415	1573-1200		THEOR MED BIOETH	Theor. Med. Bioeth.	DEC	2013	34	6					479	498		10.1007/s11017-013-9273-1			20	Ethics; Social Issues; Social Sciences, Biomedical	Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Social Sciences - Other Topics; Social Issues; Biomedical Social Sciences	269CB	WOS:000328217000003	24293085				2022-02-06	
J	Jang, SG; Pyun, SB				Jang, Seung-Gul; Pyun, Sung-Bom			Diffusion Tensor Tractography in Two Cases of Kernohan-Woltman Notch Phenomenon	ANNALS OF REHABILITATION MEDICINE-ARM			English	Article						Traumatic brain injury; Hemiplegia; Diffusion tractography; Pyramidal tract		Kernohan-Woltman notch phenomenon (KWP) is an ipsilateral motor weakness due to compression of the contralateral cerebral peduncle. We report two cases of KWP following traumatic brain injury. In case 1, ipsilateral hemiplegia was noted after right subdural hemorrhage. Although magnetic resonance imaging showed no abnormal signal changes on cerebral peduncle, diffusion tensor tractography (DTT) revealed interruption of corticospinal tract (CST) at lower level of the midbrain level. In case 2, there was abnormal signal change of the right cerebral peduncle contralateral to the primary lesion and we could not reconstruct right CST. Case 1 showed unsatisfactory motor recovery even after 15 months, and follow-up DTT showed no change. In case 2, follow-up DTT was not performed, but her ipsilateral hemiparesis had almost disappeared during the 15 months. DTT would be useful in detecting ipsilateral hemiparesis due to KWP and the clinical course may differ according to the lesion characteristics.	[Jang, Seung-Gul; Pyun, Sung-Bom] Korea Univ, Coll Med, Anam Hosp, Dept Phys Med & Rehabil, 73 Inchon Ro, Seoul 136705, South Korea		Pyun, SB (corresponding author), Korea Univ, Coll Med, Anam Hosp, Dept Phys Med & Rehabil, 73 Inchon Ro, Seoul 136705, South Korea.	rmpyun@korea.ac.kr			Korea University Grant	This study was supported by a Korea University Grant.	Cho HK, 2011, BRAIN INJURY, V25, P1005, DOI 10.3109/02699052.2011.605095; Choi GS, 2012, ARCH NEUROL-CHICAGO, V69, P363, DOI 10.1001/archneurol.2011.1930; COHEN AR, 1990, NEUROSURGERY, V27, P205, DOI 10.1227/00006123-199008000-00005; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Kernohan JW, 1929, ARCH NEURO PSYCHIATR, V21, P274, DOI 10.1001/archneurpsyc.1929.02210200030004; Kole MK, 2000, NEUROLOGY, V55, P1751; Yoo WK, 2008, J NEUROL NEUROSUR PS, V79, P1295, DOI 10.1136/jnnp.2007.138131; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P543, DOI 10.1016/S0003-9993(97)90174-X	9	3	3	0	1	KOREAN ACAD REHABILITATION MEDICINE	SEOUL	5F, YOUNGHAN BLDG, 742-22 BANPO-DONG, SEOCHO-GU, SEOUL, 137-040, SOUTH KOREA	2234-0645	2234-0653		ANN REHABIL MED-ARM	Ann. Rehabil. Med.-ARM	DEC	2013	37	6					879	885		10.5535/arm.2013.37.6.879			7	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	VC6DA	WOS:000433882200015	24466524	Green Published, Green Submitted, gold			2022-02-06	
J	Tornese, EB; Nabar, MJMY				Tornese, Elba Beatriz; Mazzoglio y Nabar, Martin Javier			Morphometry of the Corpus Callosum and Mammillary Bodies in Alcoholism using Magnetic Resonance	INTERNATIONAL JOURNAL OF MORPHOLOGY			Spanish	Article						Morphometry; Corpus callosum; Mammillary bodies; Alcoholism	WHITE-MATTER; SEX-DIFFERENCES; MRI; CHILDREN; DISRUPTION; ABSTINENT; ATROPHY; CORTEX; GRAY; MEN	Brain morphological abnormalities in individuals with severe chronic alcoholism explains the severe neurocognitive disorders, namely neuropsychiatric and anterograde amnesia, due to the neurotoxic nature and nutritional deficits generated. The objective of the present study was to describe in alcohol dependent subjects, the morphology of the corpus callosum and mammillary bodies and volume ratio in other brain areas. We used morphological and morphometric magnetic resonance imaging to study the brains of 26 men, ages 29-51 years diagnosed with alcohol dependence type disorder (DSM IV). Exclusion criteria were: liver diseases, autoimmune and central neurological disorders, as well as a neurological history not related to consumption, prior traumatic brain injury or brain surgery. Volumes were quantified by (ROI method) for the following: prefrontal cortex, hippocampus, amygdaloid body, thalamus and mammillary bodies, and the two-dimensional morphometry of corpus callosum regions (Witelson and Clarke methods). The procedure was subject to statistical tests and current legal ethical standards. Our results showed all patients dependent volumes were lower. In accordance with severity, significant volume reduction was recorded in prefrontal cortex, mammillary body, left hippocampus and thalamus, followed by the right amygdaloid body. The most affected area of the corpus callosum was the anterior third. Correlations were determined between the involvement of the mammillary bodies and the corpus callosum with subcortical structures. The relation of the corpus callosum and mammillary bodies correlated with the involvement of the hippocampus, amygdala and thalamus body, and are closely related to the amount of time and consumption of alcohol. These morphometric changes are indicative of severe cognitive and behavioral impairment.	[Tornese, Elba Beatriz] Univ Buenos Aires, Med UBA, Jefa Serv Hosp Neuropsiquitri Dr Braulio M, Fac Med, Buenos Aires, DF, Argentina; [Mazzoglio y Nabar, Martin Javier] Univ Buenos Aires, Med UBA, Fac Med, III Catedra Anat & III Catedra Farmacol, Buenos Aires, DF, Argentina		Nabar, MJMY (corresponding author), Univ Nacl Buenos Aires Paraguay, Fac Med, 2055,4o Piso, RA-1121 Buenos Aires, DF, Argentina.	mazzoglioynabar@hotmail.com					ABOITIZ F, 1992, BRAIN, V115, P1521, DOI 10.1093/brain/115.5.1521; ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Bilir E, 1998, NEURORADIOLOGY, V40, P138, DOI 10.1007/s002340050554; CLARKE S, 1989, J COMP NEUROL, V280, P213, DOI 10.1002/cne.902800205; DELACOSTE MC, 1985, J NEUROPATH EXP NEUR, V44, P578, DOI 10.1097/00005072-198511000-00004; Estruch R, 1997, J NEUROL SCI, V146, P145, DOI 10.1016/S0022-510X(96)00298-5; Fein G, 2002, DRUG ALCOHOL DEPEN, V68, P87, DOI 10.1016/S0376-8716(02)00110-2; Gazdzinski S, 2005, DRUG ALCOHOL DEPEN, V78, P263, DOI 10.1016/j.drugalcdep.2004.11.004; Giedd JN, 1996, DEV BRAIN RES, V91, P274; Hommer D, 1996, ARCH NEUROL-CHICAGO, V53, P359, DOI 10.1001/archneur.1996.00550040099019; Hommer DW, 2001, AM J PSYCHIAT, V158, P198, DOI 10.1176/appi.ajp.158.2.198; IAI M, 1994, ACTA PAEDIATR, V83, P1086, DOI 10.1111/j.1651-2227.1994.tb12991.x; LAISSY JP, 1993, AM J NEURORADIOL, V14, P145; LAMANTIA AS, 1990, J COMP NEUROL, V291, P520, DOI 10.1002/cne.902910404; Pfefferbaum A, 2000, ALCOHOL CLIN EXP RES, V24, P1214, DOI 10.1111/j.1530-0277.2000.tb02086.x; Pfefferbaum A, 2001, AM J PSYCHIAT, V158, P188, DOI 10.1176/appi.ajp.158.2.188; PFEFFERBAUM A, 1992, ALCOHOL CLIN EXP RES, V16, P1078, DOI 10.1111/j.1530-0277.1992.tb00702.x; Pfefferbaum A, 1998, ARCH GEN PSYCHIAT, V55, P905, DOI 10.1001/archpsyc.55.10.905; Pfefferbaum A, 1996, ALCOHOL CLIN EXP RES, V20, P752, DOI 10.1111/j.1530-0277.1996.tb01682.x; Pfefferbaum A, 2002, NEUROIMAGE, V15, P708, DOI 10.1006/nimg.2001.1018; PFEFFERBAUM A, 1995, ALCOHOL CLIN EXP RES, V19, P1177, DOI 10.1111/j.1530-0277.1995.tb01598.x; Pfefferbaum A, 1997, ALCOHOL CLIN EXP RES, V21, P521, DOI 10.1111/j.1530-0277.1997.tb03798.x; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; ROSEN GD, 1990, NEUROBIOLOGY HIGHER, P215; Sullivan E. V., 2003, AM J PSYCHIAT, V160, P11106; Sullivan EV, 1996, ALCOHOL CLIN EXP RES, V20, P348, DOI 10.1111/j.1530-0277.1996.tb01651.x; Verger K, 2001, BRAIN INJURY, V15, P211; WIBLE CG, 1995, ARCH GEN PSYCHIAT, V52, P279; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Zaidel Eran, 1995, Biological Research, V28, P27; [No title captured]	31	3	3	0	12	SOC CHILENA ANATOMIA	TEMUCO	CASILLA 54-D, TEMUCO, 00000, CHILE	0717-9502	0717-9367		INT J MORPHOL	Int. J. Morphol.	DEC	2013	31	4					1233	1242		10.4067/S0717-95022013000400015			10	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	AC1VX	WOS:000332286400015		gold, Green Published, Green Submitted			2022-02-06	
J	Zhu, JJ; Chen, HY				Zhu, Jianjun; Chen, Hsinyi			Clinical Utility of Cancellation on the WISC-IV	JOURNAL OF PSYCHOEDUCATIONAL ASSESSMENT			English	Article						cancellation; clinical diagnosis; WISC-IV	PROCESSING SPEED; WORKING-MEMORY; VISUOSPATIAL NEGLECT; FLUID INTELLIGENCE; SPATIAL NEGLECT; CHILDREN; PERFORMANCE; DISORDER; EDITION; SCALE	This study examined empirical evidence for clinical utility of the Wechsler Intelligence Scale for Children, fourth edition (WISC-IV) cancellation subtest by comparing data from 597 clinical and 597 matched control children. The results of dependent t and sequential logistic regression analyses demonstrated that (a) children with intellectual disabilities, motor impairments, head injuries, Autistic/Aszperger's disorder, ADHD and learning disabilities, and mathematics disorder showed significant deficits on the cancellation subtest; (b) children with intellectual disabilities and Asperger's disorder benefited when stimuli were randomly aligned, but children with ADHD benefited from structured conditions; (c) beyond the full-scaled IQ (FSIQ) and General Ability Index (GAI)-Cognitive Proficiency Index (CPI) discrepancy scores, the cancellation subtest added unique diagnostic power to identify children with reading disorders, mild intellectual disabilities, closed head injuries, and motor impairments. These results suggest the utility of the cancellation subtest in clinical assessment.	[Zhu, Jianjun] Pearson, San Antonio, TX USA; [Chen, Hsinyi] Natl Taiwan Normal Univ, Taipei 106, Taiwan		Chen, HY (corresponding author), Natl Taiwan Normal Univ, Dept Special Educ, Taipei 106, Taiwan.	hsinyi@ntnu.edu.tw					Allen DN, 2010, PSYCHOL ASSESSMENT, V22, P57, DOI 10.1037/a0016056; Borremans E., 2009, EUROPEAN J ADAPTED P, V2, P21, DOI DOI 10.5507/euj.2009.002; Calhoun SL, 2005, PSYCHOL SCHOOLS, V42, P333, DOI 10.1002/pits.20067; Carroll J.B., 1993, HUMAN COGNITIVE ABIL, DOI DOI 10.1017/CBO9780511571312; Chen HY, 2010, PERS INDIV DIFFER, V49, P677, DOI 10.1016/j.paid.2010.06.004; Ferber S, 2001, J CLIN EXP NEUROPSYC, V23, P599, DOI 10.1076/jcen.23.5.599.1243; Flanagan D.P., 2004, ESSENTIALS WISC 4 AS; Fry AF, 2000, BIOL PSYCHOL, V54, P1, DOI 10.1016/S0301-0511(00)00051-X; Fry AF, 1996, PSYCHOL SCI, V7, P237, DOI 10.1111/j.1467-9280.1996.tb00366.x; Glutting JJ, 2006, J SPEC EDUC, V40, P103, DOI 10.1177/00224669060400020101; HALLIGAN PW, 1989, LANCET, V2, P908; Harrison P.L., 2005, CONT INTELLECTUAL AS, P69; Henderson SE, 2002, ADAPT PHYS ACT Q, V19, P12, DOI 10.1123/apaq.19.1.11; Kail R, 2000, J SCHOOL PSYCHOL, V38, P51, DOI 10.1016/S0022-4405(99)00036-9; Kail RV, 2007, PSYCHOL SCI, V18, P312, DOI 10.1111/j.1467-9280.2007.01895.x; Kaufman AS, 2002, ASSESSING ADOLESCENT; Keith TZ, 2006, SCHOOL PSYCHOL REV, V35, P108; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lynn R., 2006, IQ GLOBAL INEQUALITY; Manly T, 2009, NEUROPSYCHOLOGY, V23, P519, DOI 10.1037/a0015413; Mather N., 2001, WOODCOCK JOHNSON 3 T; Menard S, 2000, AM STAT, V54, P17, DOI 10.2307/2685605; Miller D. C, 2008, WISC 4 CLIN ASSESSME, P445; Mintz J, 2008, PSYCHODYN PRACT, V14, P169, DOI 10.1080/14753630801961743; Nettelbeck T, 2010, PERS INDIV DIFFER, V48, P379, DOI 10.1016/j.paid.2009.10.032; Panaoura A., 2006, ED PSYCHOL, V26, P643; Pesta BJ, 2010, INTELLIGENCE, V38, P160, DOI 10.1016/j.intell.2009.09.006; Polirstok S. R., 2006, J EARLY INTENSIVE BE, V3, P187; Prifitera A., 2008, WISC 4 CLIN ASSESSME; Raiford SE, 2005, 4 WISC 4; Saklofske DH, 2012, CAN J BEHAV SCI, V44, P117, DOI 10.1037/a0026734; Saklofske DH, 2010, CAN J SCH PSYCHOL, V25, P277, DOI 10.1177/0829573510380539; Samuelsson H, 1996, CLIN NEUROPSYCHOL, V10, P15, DOI 10.1080/13854049608406659; Sattler J. M., 2004, ASSESSMENT CHILDREN; Spicer J., 2005, MAKING SENSE MULTIVA; Taylor HG, 2009, DEV DISABIL RES REV, V15, P52, DOI 10.1002/ddrr.51; Vanier M, 1990, NEUROPSYCHOLOGY, V4, P87, DOI 10.1037/0894-4105.4.2.87; Walcott CM, 2004, J CLIN CHILD ADOLESC, V33, P772, DOI 10.1207/s15374424jccp3304_12; Watkins MW, 2007, APPL NEUROPSYCHOL, V14, P13, DOI 10.1080/09084280701280353; Wechsler D, 2003, WECHSLER INTELLIGENC; Weiss L. G., 2005, WISC 4 CLIN USE INTE, P71, DOI [10.1016/B978-012564931-5/50004-9, DOI 10.1016/B978-012564931-5/50004-9]; Weiss L. G., 2008, WISC 4 CLIN ASSESSME, P3; Weiss L. G., J PSYCHOEDUCATIONAL; Weiss LG, 2006, WISC 4 ADV CLIN INTE, P1; Wolman BB., 1985, HDB INTELLIGENCE THE, P899; Young S, 2010, J CHILD PSYCHOL PSYC, V51, P116, DOI 10.1111/j.1469-7610.2009.02191.x; Zhu J., 2009, 117 ANN CONV AM PSYC; [No title captured]	48	3	3	1	20	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0734-2829	1557-5144		J PSYCHOEDUC ASSESS	J. Psychoeduc. Assess.	DEC	2013	31	6					527	537		10.1177/0734282913480865			11	Psychology, Educational	Social Science Citation Index (SSCI)	Psychology	251AF	WOS:000326897900001					2022-02-06	
J	Beaudeux, JL; Laribi, S				Beaudeux, Jean-Louis; Laribi, Said			S100B protein serum level as a biomarker of minor head injury	ANNALES DE BIOLOGIE CLINIQUE			French	Article						S100B protein; central nervous system; head injury; immunometric assay	NEURON-SPECIFIC ENOLASE; REFERENCE VALUES; MANAGEMENT; MARKER; ADULTS	S100B is a small protein selectively synthesized by cerebral astroglial cells. S100B participates physiologically in the regulation of intracellular free calcium levels, and exerts a neurotrophic activity on cerebral cells. The interest of S100B protein in clinical biology results from its physiological presence in biological fluids (cerebrospinal fluid, blood, urine) and from significant increased levels when an acute brain injury occurred, from vascular (intracranial hemorrhage, ischemic stroke) or traumatic (traumatic brain injury) origins. Thus, elevated plasma concentrations of S100B were significantly increased in patients with a minor, moderate and of course severe traumatic brain injury. By contrast, serum S100B levels remained unchanged in patients with negative craniocerebral tomography results, confirming the diagnostic value of this biomarker. A prognostic value of the biomarker in the context of minor head injury is also reported.	[Beaudeux, Jean-Louis] Hop Univ Necker Enfants Malad, APHP, Serv Biochim Gen, Paris, France; [Laribi, Said] Hop Lariboisiere, APHP, Serv Accueil Urgences, F-75475 Paris, France		Beaudeux, JL (corresponding author), Hop Univ Necker Enfants Malad, APHP, Serv Biochim Gen, Paris, France.	jean-louis.beaudeux@nck.aphp.fr	Laribi, Said/S-3693-2016; Laribi, Said/D-5229-2014	Laribi, Said/0000-0003-4648-4672; 			Amiri M, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00065; Astrand Ramona, 2013, Methods Mol Biol, V963, P373, DOI 10.1007/978-1-62703-230-8_23; Astrand R, 2011, CLIN CHIM ACTA, V412, P2190, DOI 10.1016/j.cca.2011.08.009; Beaudeux JL, 2000, CLIN CHEM, V46, P989; Beaudeux JL, 2002, IMMUNOANAL BIOL SPEC, V17, P280; Beaudeux JL, 2009, ANN PHARM FR, V3, P187; Beaudeux JL, 2011, 5 C SOC FRANC MED UR; Ben Abdesselam O, 2003, CLIN CHEM, V49, P836, DOI 10.1373/49.5.836; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Bouvier D, 2009, ANN BIOL CLIN-PARIS, V67, P425, DOI 10.1684/abc.2009.0347; Bouvier D, 2012, CLIN CHEM, V58, P1116, DOI 10.1373/clinchem.2011.180828; Bouvier D, 2011, CLIN BIOCHEM, V44, P927, DOI 10.1016/j.clinbiochem.2011.05.004; Calcagnile O, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-13; Chaves ML, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-6; Foerch C, 2007, STROKE, V38, P2491, DOI 10.1161/STROKEAHA.106.480111; Gonzalez-Garcia S, 2012, J ROY COLL PHYS EDIN, V42, P199, DOI 10.4997/JRCPE.2012.302; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Nash DL, 2008, NEUROCRIT CARE, V8, P301, DOI 10.1007/s12028-007-9019-x; Stroick M, 2006, CURR MED CHEM, V13, P3053, DOI 10.2174/092986706778521751; Townend W, 2006, INJURY, V37, P1098, DOI 10.1016/j.injury.2006.07.014; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Unden J, 2004, SCAND J INFECT DIS, V36, P10, DOI 10.1080/00365540310017294; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Weiss N, 2006, ANESTHESIOLOGY, V104, P658, DOI 10.1097/00000542-200604000-00008; Wiesmann M, 1998, CLIN CHEM, V44, P1056; Ziani S, 2010, ANN BIOL CLIN-PARIS, V68, P33, DOI 10.1684/abc.2010.0399; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	30	3	6	1	6	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE	0003-3898	1950-6112		ANN BIOL CLIN-PARIS	Ann. Biol. Clin.	NOV	2013	71			1			71	78		10.1684/abc.2013.0901			8	Medical Laboratory Technology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology; Research & Experimental Medicine	V40IM	WOS:000209472300009	24235330				2022-02-06	
J	Bisht, A; Garg, K; Agarwal, D; Singh, PK; Satyarthee, GD; Gupta, D; Sinha, S; Kakkar, A; Suri, V; Lalwani, S; Kale, SS; Sharma, BS				Bisht, Ajay; Garg, Kanwaljeet; Agarwal, Deepak; Singh, Pankaj Kumar; Satyarthee, Guru Dutt; Gupta, Deepak; Sinha, Sumit; Kakkar, Aanchal; Suri, Vaishali; Lalwani, Sanjeev; Kale, Shashank Sarad; Sharma, Bhawani Shankar			Histological changes in thalamus in short term survivors following traumatic brain injury: An autopsy study	NEUROLOGY INDIA			English	Article						Axonal retraction balls; neurofilament protein; thalamus; traumatic brain injury	ROAD TRAFFIC ACCIDENT; AXONAL INJURY; VEGETATIVE STATE; HEAD-INJURY; BETA-APP; DAMAGE; IMMUNOHISTOCHEMISTRY; NEUROPATHOLOGY; VICTIMS; MARKERS	Background: Severe traumatic brain injury (TBI) is a major cause of morbidity and mortality. Reduction of thalamic volumes were seen in upto 80% of patients who survived for more than 3 months after TBI. However, the same may not be true in patients who died earlier following TBI. Aims: To to study the thalamus for evidence of any injury in short term survivors of TBI (<5 days) using immunohistochemistry to look for evidence of acute thalamic injury. Materials and Methods: A cross sectional prospective study was done in which autopsy specimens of short term survivors of TBI (<5 days) were studied for histopathological changes. Results: A total of 16 patients with a mean age of 37.8 years were included in the study. CT scan revealed acute subdural haematoma in 10, contusions in 4 patients, extradural haematoma and depressed fracture in 1 each, and diffuse axonal injury in 1 patient. Seven patients required surgery in the form of a decompressive hemicraniectomy. The histopathological analysis of the bilateral thalami showed evidence of congestion of the cerebral capillaries in 8 patients. Axonal retraction balls were seen in 8 patients, myelin breakdown products were seen in 14 patients and axonal swelling was seen in 14 patients. Conclusions: Thalamic injury is universal in the setting of severe TBI in patients who have decreased survival and may be a significant factor for the poor outcome in these patients.	[Bisht, Ajay; Garg, Kanwaljeet; Agarwal, Deepak; Singh, Pankaj Kumar; Satyarthee, Guru Dutt; Gupta, Deepak; Sinha, Sumit; Kale, Shashank Sarad; Sharma, Bhawani Shankar] All India Inst Med Sci, Dept Neurosurg, New Delhi, India; [Kakkar, Aanchal; Suri, Vaishali] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India; [Lalwani, Sanjeev] Jai Prakash Narayan Apex Trauma Ctr, Dept Forens Med, New Delhi, India		Singh, PK (corresponding author), All India Inst Med Sci, Dept Neurosurg, Cardioneuro Ctr, Room 720, New Delhi, India.	drpankajsingh11@gmail.com	Garg, Kanwaljeet/AAS-7965-2021				Adams JH, 1999, J CLIN PATHOL, V52, P804, DOI 10.1136/jcp.52.11.804; Adams JH, 2001, J NEUROL NEUROSUR PS, V71, P521, DOI 10.1136/jnnp.71.4.521; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; Blumbergs PC, 2011, YOUMANS NEUROLOGICAL, P3288; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Bullock M, 2011, YOUMANS WINN NEUROLO, P3267; Conti AC, 1998, J NEUROSCI, V18, P5663; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Fernandez-Espejo D, 2010, J NEUROTRAUM, V27, P1187, DOI 10.1089/neu.2010.1297; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; Graham DI, 2004, FORENSIC SCI INT, V146, P89, DOI 10.1016/S0379-0738(03)00274-3; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Gusmao SS, 2002, ARQ NEURO-PSIQUIAT, V60, P801, DOI 10.1590/S0004-282X2002000500022; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Maxwell WL, 2006, J NEUROPATH EXP NEUR, V65, P478, DOI 10.1097/01.jnen.0000229241.28619.75; Maxwell WL, 2004, BRAIN, V127, P2470, DOI 10.1093/brain/awh294; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; Niess C, 2002, ACTA NEUROPATHOL, V104, P79, DOI 10.1007/s00401-002-0525-9; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Petzold A, 2011, BRAIN, V134, P464, DOI 10.1093/brain/awq360; Pittella JEH, 2003, J FORENSIC SCI, V48, P626; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; STRICH SJ, 1961, LANCET, V2, P443; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Uzan M, 2003, J NEUROL NEUROSUR PS, V74, P33, DOI 10.1136/jnnp.74.1.33; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	38	3	5	0	5	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	NOV-DEC	2013	61	6					599	605		10.4103/0028-3886.125256			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AB3OS	WOS:000331700700007	24441326				2022-02-06	
J	Diamandis, T; Gonzales-Portillo, C; Gonzales-Portillo, GS; Staples, M; Borlongan, MC; Hernandez, D; Acosta, S; Borlongan, CV				Diamandis, Theo; Gonzales-Portillo, Chiara; Gonzales-Portillo, Gabriel S.; Staples, Meaghan; Borlongan, Mia C.; Hernandez, Diana; Acosta, Sandra; Borlongan, Cesar V.			Diabetes insipidus contributes to traumatic brain injury pathology via CD36 neuroinflammation	MEDICAL HYPOTHESES			English	Article							INFLAMMATION; EXPRESSION; BINDING; TARGET; ATHEROSCLEROSIS; HYPOPITUITARISM; ANGIOGENESIS; DYSFUNCTION; ACTIVATION; PEPTIDE	Each year, over one million people in the United States are affected by traumatic brain injury (TBI). Symptoms of both acute and chronic neuroinflammation follow TBI, coinciding with a robust immune response and activation of the brain's endogenous repair mechanisms. TBI can lead to endocrine failure as a result of damage to the thalamic region of the brain, evidenced by excessive thirst and polyuria often accompanying TBI. These symptoms indicate the presence of diabetes insipidus (DI), a disruption of water homeostasis due to antidiuretic hormone deficiency. This deficiency accompanies a mechanical or neuroinflammatory damage to the thalamic region during TBI, evidenced by increased expression of inflammatory microglial marker MHCII in this brain region. Excessive thirst and urinations, which are typical DI symptoms, in our chronic TBI rats also suggest a close connection between TBI and DI. We seek to bridge this gap between TBI and DI through investigation of the Cluster of Differentiation 36 (CD36) receptor. This receptor is associated with Low-Density Lipoprotein (LDL) deregulation, pro-inflammatory events, and innate immunity regulation. We posit that CD36 exacerbates TBI through immune activation and subsequent neuroinflammation. Indeed, scientific evidence already supports pathological interaction of CD36 in other neurological disorders including stroke and Alzheimer's disease. We propose that DI contributes to TBI pathology via CD36 neuroinflammation. Use of CD36 as a biomarker may provide insights into treatment and disease pathology of TBI and DI. This unexplored avenue of research holds potential for a better understanding and treatment of TBI and DI. (C) 2013 Elsevier Ltd. All rights reserved.	[Diamandis, Theo; Gonzales-Portillo, Chiara; Gonzales-Portillo, Gabriel S.; Staples, Meaghan; Borlongan, Mia C.; Hernandez, Diana; Acosta, Sandra; Borlongan, Cesar V.] Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA		Borlongan, CV (corresponding author), Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA.	cborlong@health.usf.edu	Borlongan, Cesar/I-5696-2012; Gonzales-Portillo, Chiara/Q-3937-2017	Borlongan, Cesar/0000-0002-2966-9782; Gonzales-Portillo, Chiara/0000-0001-9012-4573; Borlongan, Mia/0000-0003-3223-8374	James and Esther King Foundation for Biomedical Research [1KG01-33966]; DOD TATRCUnited States Department of Defense [W81XWH-11-1-0634]; NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO1 1R01NS071956-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS071956] Funding Source: NIH RePORTER	CVB is supported by James and Esther King Foundation for Biomedical Research Program 1KG01-33966, DOD TATRC W81XWH-11-1-0634, and NIH NINDS RO1 1R01NS071956-01.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Assinger A, 2010, ATHEROSCLEROSIS, V213, P129, DOI 10.1016/j.atherosclerosis.2010.07.018; Assinger A, 2010, ATHEROSCLEROSIS, V212, P153, DOI 10.1016/j.atherosclerosis.2010.05.010; Baranova IN, 2010, J BIOL CHEM, V285, P8492, DOI 10.1074/jbc.M109.007526; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2004, J NEUROTRAUM, V21, P865; Chiurchitiu V, 2011, PEPTIDES, V32, P80, DOI 10.1016/j.peptides.2010.09.024; Cho SH, 2012, CURR PHARM DESIGN, V18, P3721, DOI 10.2174/138161212802002760; Cho S, 2009, J NEUROCHEM, V109, P126, DOI 10.1111/j.1471-4159.2009.05801.x; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; Faul M, 2010, TRAUMATIC BRAIN INJU; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Glynn N, 2013, CLIN ENDOCRINOL, V78, P17, DOI 10.1111/cen.12010; Greco T, 2013, J NEUROTRAUMA; Griffin E, 2001, NAT MED, V7, P840, DOI 10.1038/89969; GRIFFIN JM, 1976, J TRAUMA, V16, P979, DOI 10.1097/00005373-197612000-00007; Hannon MJ, 2012, J CLIN ENDOCR METAB, V97, P1423, DOI 10.1210/jc.2011-3201; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P166, DOI 10.1097/00004647-200302000-00004; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Kaneko Y, 2012, CELL MED, V4, P55, DOI 10.3727/215517912X639306; Kennedy DJ, 2009, ARTERIOSCL THROM VAS, V29, P1481, DOI 10.1161/ATVBAHA.109.191940; Kim E, 2012, ANN NEUROL, V71, P753, DOI 10.1002/ana.23569; Kouadir M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030756; Makaryus AN, 2006, CLEV CLIN J MED, V73, P65, DOI 10.3949/ccjm.73.1.65; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; Nihashi T, 2001, ACTA NEUROCHIR, V143, P287, DOI 10.1007/s007010170109; Pilitsis JG, 2003, BRAIN RES, V985, P198, DOI 10.1016/S0006-8993(03)03044-0; Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/NCC:5:1:61; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Silverstein RL, 2000, CURR OPIN LIPIDOL, V11, P483, DOI 10.1097/00041433-200010000-00006; Sima AV, 2010, J CELL MOL MED, V14, P2790, DOI 10.1111/j.1582-4934.2009.00933.x; Tisdall M, 2006, J NEUROSURG ANESTH, V18, P57, DOI 10.1097/01.ana.0000191280.05170.0f; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Tsagarakis S, 2005, Pituitary, V8, P251, DOI 10.1007/s11102-006-6049-x; Uno M, 2003, J NEUROL NEUROSUR PS, V74, P312, DOI 10.1136/jnnp.74.3.312; Verdier Y, 2004, J PEPT SCI, V10, P229, DOI 10.1002/psc.573; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	44	3	3	0	5	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	NOV	2013	81	5					936	939		10.1016/j.mehy.2013.08.022			4	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	257DI	WOS:000327363400049	24021616	Green Accepted			2022-02-06	
J	Hux, K; Dymacek, R; Childers, C				Hux, Karen; Dymacek, Rose; Childers, Carrie			Possible brain injury events and symptoms in elementary school children	BRAIN INJURY			English	Article						Assessment; children; concussion; mild brain injury	HEAD-INJURY; FUNCTIONAL RECOVERY; EARLY-CHILDHOOD; UNITED-STATES; BIRTH COHORT; YOUNG-ADULTS; TBI; STUDENTS; ADOLESCENTS; PREDICTORS	Primary objective: The purpose of this study was to determine the prevalence of potential mild brain injury incidents accompanied by behavioural changes in a non-clinical population of elementary school-aged children. The researchers also examined data regarding the occurrence of possible brain injuries among regular vs special education students. Research design: Survey study. Methods and procedures: The researchers distributed questionnaires through which parents or guardians of 692 first-to-fifth grade students provided information about possible brain injury incidents and associated behavioural changes. Main outcomes and results: Findings suggest that as many as one-third of children experience one or more incidents potentially resulting in brain injury before completing elementary school. Despite this, only 7.66% of the sample received positive screen results because of behavioural changes associated with a potential incident. None of the 53 children with positive screens were receiving special education services through the traumatic brain injury category of IDEA at the time of the screening. Positive screens were more common among students verified for special education than those enrolled in regular education. Specifically, 25.40% of positive screen results were for children identified with a disability warranting special education services; in contrast, only 5.90% of regular education students received positive screen results.	[Hux, Karen; Childers, Carrie] Univ Nebraska, Dept Special Educ & Commun Disorders, Lincoln, NE 68583 USA; [Dymacek, Rose] Nebraska Dept Educ, Lincoln, NE USA		Hux, K (corresponding author), Univ Nebraska, Barkley Mem Ctr 351, Lincoln, NE 68583 USA.	khux1@unl.edu	Hux, Karen/AAQ-2078-2020		Department of Health and Human Services (DHHS), Health Resources and Services Administration, Maternal and Child Health Bureau [H21MCO6758]	This work was supported in part by TBI Partnership Implementation Grant #H21MCO6758 from the Department of Health and Human Services (DHHS), Health Resources and Services Administration, Maternal and Child Health Bureau. The contents are the sole responsibility of the authors and do not necessarily represent the official views of DHHS.	Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Cantor JB, 2004, ARCH PHYS MED REHAB, V85, pS54, DOI 10.1016/j.apmr.2003.08.113; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Chapman S.B., 2006, BRAIN INJ PROF, V3, P10; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P257, DOI 10.1023/A:1022602400621; Deidrick KKM, 2005, PREV SCH FAIL, V49, P23, DOI 10.3200/PSFL.49.4.23-33; DePompei R, 2008, J HEAD TRAUMA REHAB, V23, P191, DOI 10.1097/01.HTR.0000327251.16010.3b; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Faul M, 2010, TRAUMATIC BRAIN INJU; Fry J., 2012, ESPN TAKES STAND CON; Gamino JF, 2009, TOP LANG DISORD, V29, P224, DOI 10.1097/TLD.0b013e3181b531da; Glang A, 2004, NEUROREHABILITATION, V19, P219; Glang A, 2008, NEUROREHABILITATION, V23, P477; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Laforce R, 2001, PERCEPT MOTOR SKILL, V93, P281, DOI 10.2466/PMS.93.5.281-288; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA, 2007, TRAUMATIC BRAIN INJU; McCrory P, 2008, S AFR J SPORTS MED, V21, P36; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; National Conference of State Legislatures, 2012, TRAUM BRAIN INJ LEG; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Schutz LE, 2010, INT J SPEC EDUC, V25, P55; Semrud-Clikeman M, 2010, APPL NEUROPSYCHOL, V17, P116, DOI 10.1080/09084281003708985; Snyder T. D., 2010, 2011015 NCES US DEP; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; U. S. Census Bureau, 2010, STAT COUNT QUICKF; Weinbaum W., 2012, ADAM GREENBERG GET 2; Winqvist S, 2007, NEUROEPIDEMIOLOGY, V29, P136, DOI 10.1159/000110741; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007; Zwerdling D, 2012, REACHING WAR ZONES T	38	3	3	1	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2013	27	12					1348	1355		10.3109/02699052.2013.823657			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	235UF	WOS:000325745500003	23923996				2022-02-06	
J	Parchani, A; El-Menyar, A; Al-Thani, H; Tuma, M; Zarour, A; Abdulrahman, H; Peralta, R; Asim, M; Latifi, R				Parchani, Ashok; El-Menyar, Ayman; Al-Thani, Hassan; Tuma, Mazin; Zarour, Ahmad; Abdulrahman, Husham; Peralta, Ruben; Asim, Mohammad; Latifi, Rifat			Recreational-related head injuries in Qatar	BRAIN INJURY			English	Article						All-terrain vehicle; head injury; sports; recreational activities	TERRAIN-VEHICLE INJURIES; TRAUMATIC BRAIN-INJURIES; UNITED-STATES; SPORTS; POPULATION; EPIDEMIOLOGY; PATTERNS; CHILDREN; HELMETS	Background: The incidence of recreation related-injuries (RRI) among the physically active population is increasing. This study aimed to analyse frequency and characteristics of RRI in Qatar. Methods: A retrospective chart review was conducted for all patients with head injuries who sustained a RRI and were admitted to the trauma unit between 2008-2011. Patients' demographics, injuries, complications and mortality were analysed. Results: Of 1665 cases of head injury, 107 (6.4%) had RRI. The majority of cases were males with mean age of 27 +/- 12, injury severity score of 14 +/- 8 and head abbreviated injury score of 3.2 +/- 0.9. Mechanisms of injury included All-Terrain Vehicle, Jet-skiing, football and water-boat. Patients sustained RRI mainly had contusion followed by subarachnoid haemorrhage, subdural and epidural haematoma. Upper extremities and the chest were the most frequently associated injuries. Severe head injuries were observed in 18% of patients with Glasgow Coma Score <8. Median length of stay was 4 (1-67) days. The incidence of RRI was highest amongst Asians (66%) and nationals (23%). The overall mortality among patients with RRI was 7%. Conclusion: RRI causes significant morbidity and mortality. An urgent need is recommended for legislative amendment and public awareness for safety regulations during recreational activities involving potential risk of trauma.	[Parchani, Ashok; El-Menyar, Ayman; Al-Thani, Hassan; Tuma, Mazin; Zarour, Ahmad; Abdulrahman, Husham; Peralta, Ruben; Asim, Mohammad; Latifi, Rifat] Hamad Gen Hosp, Sect Trauma Surg, Doha, Qatar; [Parchani, Ashok; El-Menyar, Ayman; Tuma, Mazin; Latifi, Rifat] Weill Cornell Med Coll, Doha, Qatar; [Latifi, Rifat] Univ Arizona, Dept Surg, Tucson, AZ USA		Parchani, A (corresponding author), Hamad Gen Hosp, Sect Trauma Surg, Dept Surg, Doha, Qatar.	traumaresearch@hmc.org.qa	El-Menyar, Ayman/F-6734-2015	El-Menyar, Ayman/0000-0003-2584-953X; Latifi, Rifat/0000-0003-1091-3682			ALANI M, 2012, J EMERGENCY MED TRAU, P1, DOI DOI 10.5339/JEMTAC.2012.1; Anson K, 2009, NEW ZEAL MED J, V122, P11; Bowman SM, 2009, INJURY PREV, V15, P3, DOI 10.1136/ip.2008.019372; Brandenburg Mark A, 2005, J Okla State Med Assoc, V98, P194; *COMM PA DEP CONS, 2009, SUMM PENNS ALL TERR; Conidi FX, 2012, HEADACHE, V52, P15, DOI 10.1111/j.1526-4610.2012.02138.x; Cvijanovich NZ, 2001, PEDIATRICS, V108, P631, DOI 10.1542/peds.108.3.631; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Hall AJ, 2009, AM J PREV MED, V36, P311, DOI 10.1016/j.amepre.2008.11.019; Harris AW, 2012, J SCI MED SPORT, V15, P298, DOI 10.1016/j.jsams.2011.12.005; Harris AW, 2012, CLIN J SPORT MED, V22, P91, DOI 10.1097/JSM.0b013e31823776cb; Helmkamp JC, 2001, AM J PUBLIC HEALTH, V91, P1792, DOI 10.2105/AJPH.91.11.1792; Hernandez-Tejedor Alberto, 2008, Cir Esp, V83, P320; Keenan HT, 2004, PEDIATRICS, V113, pE330, DOI 10.1542/peds.113.4.e330; Lam LT, 2005, J SCI MED SPORT, V8, P433, DOI 10.1016/S1440-2440(05)80058-1; Lister DG, 1998, J PEDIATR SURG, V33, P1081, DOI 10.1016/S0022-3468(98)90535-8; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Moroney P, 2003, INJURY, V34, P203, DOI 10.1016/S0020-1383(02)00317-0; Pelletier JS, 2012, CAN J SURG, V55, P249, DOI 10.1503/cjs.036210; RODGERS GB, 1990, ACCIDENT ANAL PREV, V22, P47, DOI 10.1016/0001-4575(90)90006-7; Rodgers GB, 1999, ACCIDENT ANAL PREV, V31, P409, DOI 10.1016/S0001-4575(98)00080-3; Russell A, 1998, PEDIATR EMERG CARE, V14, P31, DOI 10.1097/00006565-199802000-00009; Su W, 2006, J PEDIATR SURG, V41, P931, DOI 10.1016/j.jpedsurg.2006.01.011; Thepyasuwan N, 2009, AM SURGEON, V75, P1004	25	3	3	0	7	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2013	27	12					1450	1453		10.3109/02699052.2013.823664			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	235UF	WOS:000325745500017	23924056				2022-02-06	
J	Poston, WSC; Haddock, CK; Jahnke, SA; Jitnarin, N				Poston, Walker S. C.; Haddock, Christopher K.; Jahnke, Sara A.; Jitnarin, Nattinee			What Do Veterans Service Organizations' Web Sites Say About Tobacco Control?	AMERICAN JOURNAL OF HEALTH PROMOTION			English	Article						Tobacco Control; Veterans; Smoking; Content Analysis; Military; Prevention Research	POSTTRAUMATIC-STRESS-DISORDER; CIGARETTE-SMOKING; CONTROL POLICY; AIR-FORCE; MILITARY; PREVALENCE; MESSAGES; PERSONNEL; ARMY; PAIN	Purpose. Little is known about veterans service organizations (VSOs) and their perspectives on veterans smoking or military tobacco control. Veterans have high smoking rates and many started smoking in the military, where a culture promoting use exists. Design. A qualitative content analysis of VSO Web sites was conducted to classify health topics and identify tobacco-related information. Setting. Web sites were coded by trained raters from January to June of 2011. Data were entered, cleaned, and analyzed from July 2011 to January 2012. Subjects. Twenty-four active VSO Web sites meeting inclusion criteria were rated independently. Measures. A comprehensive form was used to code 15 veteran-relevant health topics across multiple content areas/domains within the Web sites. Raters achieved 94.5% interrater agreement over nearly 5000 data points. Analysis. Health content was coded as present or not within multiple VSO Web site areas/domains. The frequency of coverage by each VSO Web site and the number of VSO Web sites that mentioned a health topic in different Web site areas/domains were tabulated. Results. A total of 277 health topics were addressed, with the top five being insurance/Tricare/Veterans Administration issues (28.2%), posttraumatic stress disorder (PTSD; 15.5%), disability/amputation/wounds (13.4%), Agent Orange (10.5%), and traumatic brain injury (9.0%). Tobacco was mentioned four times (1.4%) across all 24 VSO Web sites, and smoking cessation was never addressed. Conclusion. VSO Web sites provide little information on tobacco-related topics and none offered information about smoking cessation. Given the high rates of tobacco use among veterans and active-duty service members, and the interaction between smoking and PTSD symptoms and treatment outcomes, VSOs should consider making tobacco control and smoking cessation higher-priority health issues on their Web sites.	[Poston, Walker S. C.; Haddock, Christopher K.; Jahnke, Sara A.; Jitnarin, Nattinee] Natl Dev & Res Inst Inc, Inst Biobehav Hlth Res, Leawood, KS USA		Poston, WSC (corresponding author), NDRI Natl Dev & Res Inst Inc, NDRI MA, Inst Biobehav Hlth Res, 1920 West 143rd St,Suite 120, Leawood, KS 66224 USA.	carlosposton@hopehri.com			NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01 CA157014, R01CA157014] Funding Source: Medline; NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01 DA036509] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA157014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA036509] Funding Source: NIH RePORTER		AMVETS, 2011, 2011 NATIONAL CONSTI; Arvey SR, 2008, MIL MED, V173, P985, DOI 10.7205/MILMED.173.10.985; Bastian LA, 2010, J GEN INTERN MED, V25, P102, DOI 10.1007/s11606-009-1224-1; Brancu Mira, 2011, N C Med J, V72, P54; Bray R.M., 2009, 2008 DEPARTMENT OF D; Brown DW, 2010, J GEN INTERN MED, V25, P147, DOI 10.1007/s11606-009-1160-0; Calhoun PS, 2011, PSYCHOPHARMACOLOGY, V215, P379, DOI 10.1007/s00213-010-2144-9; Callaghan PM, 2011, AMERICAN LEGION MAGA; Cho AH, 2010, TELEMED J E-HEALTH, V16, P595, DOI 10.1089/tmj.2009.0164; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Dept of Veterans Affairs, 2011, 2010 SURVEY OF VETER; FEIGELMAN W, 1994, PREV MED, V23, P235, DOI 10.1006/pmed.1994.1032; Freeman B, 2007, TOB CONTROL, V16, P207, DOI 10.1136/tc.2007.020024; Fu SS, 2007, NICOTINE TOB RES, V9, P1071, DOI 10.1080/14622200701488418; Gizlice Z, 2002, NORTH CAROLINA SPECI, V133; Goldberg Kenneth C, 2008, N C Med J, V69, P31; Gradus JL., EPIDEMIOLOGY OF PTSD; Haddock CK, 2008, NICOTINE TOB RES, V10, P1191, DOI 10.1080/14622200802163126; Haddock CK, 2009, AM J HEALTH PROMOT, V23, P241, DOI 10.4278/ajhp.070919100; Haddock CK, 2005, AM J PUBLIC HEALTH, V95, P1458, DOI 10.2105/AJPH.2004.048454; Harris JE, 1997, REPORT COMMISSIONED; Hoffman KM, 2008, NICOTINE TOB RES, V10, P653, DOI 10.1080/14622200801978730; Hoffman KM, 2011, J PUBLIC HEALTH POL, V32, P334, DOI 10.1057/jphp.2011.6; Hong T, 2002, J HEALTH COMMUN, V7, P273, DOI 10.1080/10810730290088148; Institute of Medicine (IOM), 2009, COMBATING TOBACCO US; Jahnke SA, 2011, MIL MED, V176, P1382, DOI 10.7205/MILMED-D-11-00164; Jahnke SA, 2011, JAMA-J AM MED ASSOC, V306, P2456, DOI 10.1001/jama.2011.1774; Jain A, 2004, PROCEEDINGS OF THE 2, P97; Jenssen BP, 2009, PEDIATRICS, V124, pE180, DOI 10.1542/peds.2008-3838; Joseph AM, 2005, MIL MED, V170, P874, DOI 10.7205/MILMED.170.10.874; KLEVENS RM, 1995, AM J PREV MED, V11, P245, DOI 10.1016/S0749-3797(18)30453-7; Leedahl SN, 2011, J GERONTOL SOC WORK, V54, P712, DOI 10.1080/01634372.2011.594149; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; McFall M, 2012, JAMA-J AM MED ASSOC, V304, P2485; McInnes D Keith, 2010, Inform Prim Care, V18, P59; McKinney WP, 1997, PUBLIC HEALTH REP, V112, P212; Mosack KE, 2012, CHRONIC ILLN, V8, P252, DOI 10.1177/1742395312437978; National Center for Veterans Analysis and Statistics, 2010, VETERAN POPULATION P; Nelson JP, 2009, MIL MED, V174, P162, DOI 10.7205/MILMED-D-01-2008; Offen N, 2010, AM J PUBLIC HEALTH, V100, P1166, DOI 10.2105/AJPH.2009.179846; Poston WSC, 2008, MIL MED, V173, P441, DOI 10.7205/MILMED.173.5.441; Poston WSC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-731; Ribisl KM, 2003, HEALTH EDUC BEHAV, V30, P64, DOI 10.1177/1090198102239259; Ribisl KM, 2003, TOB CONTROL, V12, pi49; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Smith EA, 2007, TOB CONTROL, V16, P38, DOI 10.1136/tc.2006.017350; Tedrow LM, 2011, PAPER PRESENTED AT P; VFW, 2008, VFW DEMANDS ACCOUNTA; Yu W, 2003, MED CARE RES REV, V60, p146S, DOI 10.1177/1077558703257000	50	3	3	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0890-1171	2168-6602		AM J HEALTH PROMOT	Am. J. Health Promot.	NOV-DEC	2013	28	2					88	96		10.4278/ajhp.120905-QUAL-426			9	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	268UP	WOS:000328196400011	23631454	Green Accepted			2022-02-06	
J	Ricard, C; Casez, P; Gstalder, H; Mawazini, S; Gauthier, V; Fontanel, A; Aveque, C; Despierre, F; Thelot, B; Courtois, X				Ricard, Cecile; Casez, Pierre; Gstalder, Helene; Mawazini, Suzanne; Gauthier, Vincent; Fontanel, Anne; Aveque, Catherine; Despierre, Francois; Thelot, Bertrand; Courtois, Xavier			Six-month outcome of 795 patients admitted to Annecy hospital emergency department for mild traumatic brain injury	SANTE PUBLIQUE			French	Article						Traumatic brain injuries; Anxiety disorder; Behavioural disorders; Sleep disorders	MINOR HEAD-INJURY; EPIDEMIOLOGY; GENDER	Introduction: Mild traumatic brain injuries (mTBI) are common, but their outcomes are not very well known. A prospective study was conducted in Annecy hospital, France (CHRA), to assess the incidence of disorders 6 months after the injury and to identify risk factors for persistent disorders. Method: All patients admitted to the emergency department after a mild brain injury between February 2006 and July 2007 were included. They were contacted by telephone 6 months later to detect (by questionnaire) the presence of persistent disorders. Patients reporting disorders were referred to the local brain injury centre for a follow-up check-up. Results: Ninety three of the 795 patients contacted reported disorders: memory disorders (80%), sleep disorders (79%), headaches (65%), irritability (64%), speech disorders (64%) and concentration disorders (62%). Disorders at 6 months were independently associated with age, female gender, presence of headache at the initial examination and CT scan performed in the emergency department. Discussion: The disorders reported in this study were consistent with the results of previous studies. As these disorders are usually nonspecific, a case-control study or an exposed-unexposed study would be necessary to determine whether or not these disorders are linked to mTBI.	[Ricard, Cecile; Casez, Pierre; Gstalder, Helene; Mawazini, Suzanne; Gauthier, Vincent; Fontanel, Anne; Courtois, Xavier] Ctr Hosp Annecy Genevois, F-74374 Pringy, France; [Aveque, Catherine] Med Phys & Readaptat Fonct Ctr Hosp Rumilly, Rumilly, France; [Despierre, Francois] Ctr Ressources Personnes Cerebrolesees 74, Seynod, France; [Thelot, Bertrand] Inst Veille Sanit DMCT, Unite Traumatismes, St Maurice, France		Ricard, C (corresponding author), Ctr Hosp Annecy Genevois, 1 Ave Hop, F-74374 Pringy, France.	cricard@ch-annecy.fr					Barrash J., 1997, J INT NEUROPSYCH SOC, V3, P27; Bayen E, 2011, ANN PHYS REHABIL MED, P72; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Brooks DN, 1994, EVALUATION TRAUMATIS; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Buck PW, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/625621; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Groupe SOMFER FEDMER, 2011, AD APR TRAUM CRAN GR; Hours M, 2010, ACCIDENT ANAL PREV, V42, P412, DOI 10.1016/j.aap.2009.09.002; Jehle E, 2012, ANN FR MED URGENCE, V2, P199, DOI 10.1007/s13341-012-0202-4; Kosakevitch-Ricbourg L, 2006, Rev Stomatol Chir Maxillofac, V107, P201, DOI 10.1016/S0035-1768(06)77041-3; Lannsjo M, 2012, EUR J NEUROL; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Masson F, 1997, J CLIN EPIDEMIOL, V50, P595, DOI 10.1016/S0895-4356(97)00012-7; Masson F, 1996, ARCH PEDIATR, V3, P9; Olff M, 2007, PSYCHOL BULL, V133, P183, DOI 10.1037/0033-2909.133.2.183; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Punamaki RL, 2005, AM J PSYCHIAT, V162, P545, DOI 10.1176/appi.ajp.162.3.545; Ricbourg B, 2006, Rev Stomatol Chir Maxillofac, V107, P206, DOI 10.1016/S0035-1768(06)77042-5; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Schnyder U, 2001, AM J PSYCHIAT, V158, P594, DOI 10.1176/appi.ajp.158.4.594; Soury S., 2005, Annales de Readaptation et de Medecine Physique, V48, P61, DOI 10.1016/j.annrmp.2004.08.007; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Tazopoulou E, 2005, ACTA NEUROPSYCHOL, V1, P13; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; Zare MA, 2012, INT J NEUROSCI; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	28	3	3	1	4	SOC FRANCAISE SANTE PUBLIQUE	VANDOEUVRE-LES-NANCY CEDEX	2 RUE DU DOYEN JACQUES PARISOT, BP 7, VANDOEUVRE-LES-NANCY CEDEX, 54501, FRANCE	0995-3914	2104-3841		SANTE PUBLIQUE	Sante Publique	NOV-DEC	2013	25	6					711	718		10.3917/spub.136.0711			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	AA2EQ	WOS:000330908300002	24451416				2022-02-06	
J	Topcu, I; Vatansever, S; Bayram, E; Var, A; Cetin, I; Civi, M				Topcu, Ismet; Vatansever, Seda; Bayram, Eda; Var, Ahmet; Cetin, Ismail; Civi, Melek			The Effects of Lornoxicam on Neuroprotection Following Diffuse Traumatic Brain Injury in Rats	TURKISH NEUROSURGERY			English	Article						Traumatic brain injury; Lornoxicam; Apoptosis; Neuroprotection; Rats	DNA FRAGMENTATION; CELL-DEATH; CYCLOOXYGENASE-2; APOPTOSIS; ISCHEMIA; NEURONS; INFLAMMATION; MANAGEMENT; MELOXICAM; PROFILE	AIM: In this study, the effects of lornoxicam on the prevention of secondary brain injury via the apoptotic pathway were studied in a rat model of head injury. MATERIAL and METHODS: Thirty adult male Wistar albino rats were anesthetized, and experimental closed head trauma was induced by allowing a 450 g weight to fall two meters onto a metallic disk fixed to the intact skull. After head injury, the rats were randomly divided into two groups: Group I (n=15) rats were administered 2 mL saline intraperitoneally (controls); Group II (n=15) rats were administered 2 mL 1.3 mg kg(-1) lornoxicam intraperitoneally. Brain tissue samples were divided into two pieces by interhemispheric incision for biochemical and histological analysis. RESULTS: TUNEL positivity was seen in neuroglia cells of the brain cortex in both groups. While the immunoreactivities of caspase 8,9 and Fast Fas ligand were similar in both groups, the immunoreactivity of caspase 3 was greater in Group I than Group II. MDA was significantly lower in Group II than in Group I (p<0.05).The decrease in SOD level was higher in Group I than Group II. CONCLUSION: Lornoxicam did not prevent apoptosis in this rat model of brain trauma but causes a decrease.	[Topcu, Ismet; Bayram, Eda; Cetin, Ismail; Civi, Melek] Celal Bayar Univ, Fac Med, Dept Anesthesiol & Intens Care, Manisa, Turkey; [Vatansever, Seda] Celal Bayar Univ, Fac Med, Dept Histol & Embryol, Manisa, Turkey; [Var, Ahmet] Celal Bayar Univ, Fac Med, Dept Biochem, Manisa, Turkey		Topcu, I (corresponding author), Celal Bayar Univ, Fac Med, Dept Anesthesiol & Intens Care, Manisa, Turkey.	topcuismet@yahoo.com					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Agha AM, 1999, PHARMACOL RES, V40, P385, DOI 10.1006/phrs.1999.0522; Balfour JA, 1996, DRUGS, V51, P639, DOI 10.2165/00003495-199651040-00008; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Candelario-Jalil E, 2002, BRAIN RES, V927, P212, DOI 10.1016/S0006-8993(01)03358-3; ELLIS E F, 1989, Journal of Neurotrauma, V6, P31, DOI 10.1089/neu.1989.6.31; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Hakan T, 2010, NEUROL RES, V32, P629, DOI 10.1179/016164109X12464612122731; Hausmann R, 2004, INT J LEGAL MED, V118, P32, DOI 10.1007/s00414-003-0413-4; Hickey RW, 2007, PEDIATR RES, V62, P271, DOI 10.1203/PDR.0b013e3180db2902; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kontos H A, 1980, Adv Exp Med Biol, V131, P243; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; LINNIK MD, 1995, MOL BRAIN RES, V32, P116, DOI 10.1016/0169-328X(95)00069-5; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Lu J, 2005, ACT NEUR S, V95, P281; MACMANUS JP, 1993, NEUROSCI LETT, V164, P89, DOI 10.1016/0304-3940(93)90864-H; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Okura T, 1996, J IMMUNOL, V157, P4277; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; PICKARD JD, 1993, J NEUROL NEUROSUR PS, V56, P845, DOI 10.1136/jnnp.56.8.845; Pratico D, 2002, J NEUROCHEM, V80, P894, DOI 10.1046/j.0022-3042.2002.00777.x; Radhofer-Welte S, 2000, DRUG TODAY, V36, P55, DOI 10.1358/dot.2000.36.1.566627; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Scali C, 2003, NEUROSCIENCE, V117, P909, DOI 10.1016/S0306-4522(02)00839-4; SCHWARTZMAN RA, 1993, ENDOCR REV, V14, P133, DOI 10.1210/er.14.2.133; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Strauss KI, 2008, BRAIN BEHAV IMMUN, V22, P285, DOI 10.1016/j.bbi.2007.09.011; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; SUN Y, 1988, CLIN CHEM, V34, P497; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Topcu I, 2007, ACTA HISTOCHEM, V109, P322, DOI 10.1016/j.acthis.2006.10.007; Ustun ME, 2001, INTENS CARE MED, V27, P264, DOI 10.1007/s001340000780; VANE JR, 1995, INFLAMM RES, V44, P1, DOI 10.1007/BF01630479	39	3	3	0	0	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	NOV	2013	23	6					764	771		10.5137/1019-5149.JTN.7749-13.0			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	288FZ	WOS:000329598700011	24310460	Bronze			2022-02-06	
J	Trinidad, KJ; Schmidt, JD; Register-Mihalik, JK; Groff, D; Goto, S; Guskiewicz, KM				Trinidad, Katrina J.; Schmidt, Julianne D.; Register-Mihalik, Johna K.; Groff, Diane; Goto, Shiho; Guskiewicz, Kevin M.			Predicting Clinical Concussion Measures at Baseline Based on Motivation and Academic Profile	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						Sensory Organization Test; CNS Vital Signs; baseline clinical concussion measures; Dot Counting Test	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; SPORT-RELATED CONCUSSION; AFRICAN-AMERICAN; STATEMENT; SCORES; IMPACT; SCHOOL	Objective:The purpose of this study was to predict baseline neurocognitive and postural control performance using a measure of motivation, high school grade point average (hsGPA), and Scholastic Aptitude Test (SAT) score.Design:Cross-sectional.Setting:Clinical research center.Participants:Eighty-eight National Collegiate Athletic Association Division I incoming student-athletes (freshman and transfers).Interventions:Participants completed baseline clinical concussion measures, including a neurocognitive test battery (CNS Vital Signs), a balance assessment [Sensory Organization Test (SOT)], and motivation testing (Rey Dot Counting). Participants granted permission to access hsGPA and SAT total score.Main Outcome Measures:Standard scores for each CNS Vital Signs domain and SOT composite score.Results:Baseline motivation, hsGPA, and SAT explained a small percentage of the variance of complex attention (11%), processing speed (12%), and composite SOT score (20%).Conclusions:Motivation, hsGPA, and total SAT score do not explain a significant amount of the variance in neurocognitive and postural control measures but may still be valuable to consider when interpreting neurocognitive and postural control measures.	[Trinidad, Katrina J.] Dunn Phys Therapy, Cary, NC USA; [Schmidt, Julianne D.; Groff, Diane; Goto, Shiho; Guskiewicz, Kevin M.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Register-Mihalik, Johna K.] WakeMed Hlth & Hosp, Emergency Serv Inst, Clin Res Unit, Raleigh, NC USA		Guskiewicz, KM (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 209 Fetzer Hall,CB 8700, Chapel Hill, NC 27599 USA.	gus@email.unc.edu		Guskiewicz, Kevin/0000-0002-8682-2130; Register-Mihalik, Johna/0000-0002-4229-4743			Alla S, 2011, BRIT J SPORT MED, V45, P132, DOI 10.1136/bjsm.2010.074088; Baddeley A.D., 2007, COMMUNICATION 0913; Baddeley A.D., 1986, WORKING MEMORY; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Boone KB, 2002, ARCH CLIN NEUROPSYCH, V17, P625, DOI 10.1016/S0887-6177(01)00166-4; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Doyle AE, 2009, PSYCHOL MED, V39, P1253, DOI 10.1017/S0033291708004832; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Goel N, 2009, SEMIN NEUROL, V29, P320, DOI 10.1055/s-0029-1237117; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Guskiewicz KM, 2006, BRIT J SPORT MED, V40, P6, DOI 10.1136/bjsm.2005.021683; HAMID MA, 1991, ACTA OTO-LARYNGOL, P596; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; SARNACKI RE, 1979, REV EDUC RES, V49, P252, DOI 10.3102/00346543049002252; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; St Clair-Thompson HL, 2006, Q J EXP PSYCHOL, V59, P745, DOI 10.1080/17470210500162854; Thorndike EL, 1951, ED MEASUREMENT; Whalstrom M, 1968, EDUC PSYCHOL MEAS, V28, P413	28	3	3	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2013	23	6					462	469		10.1097/JSM.0b013e318295e425			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	248VJ	WOS:000326732800009	24071664				2022-02-06	
J	Zhao, W; Wang, Y; Shi, W; Chen, Y; Cai, G; Chen, JL; Qian, M; Xu, W				Zhao, Wei; Wang, Yong; Shi, Wei; Chen, Yang; Cai, Gang; Chen, Jialei; Qian, Ming; Xu, Wei			The Expression of FBP1 after Traumatic Brain Injury and Its Role in Astrocyte Proliferation	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Traumatic brain injury; FBP1; Astrocytes; Proliferation; Rats	FAR UPSTREAM ELEMENT; SPINAL-CORD-INJURY; C-MYC EXPRESSION; CELL-CYCLE; GLIAL PROLIFERATION; PROTEIN EXPRESSION; BINDING-PROTEIN; NEURONAL DEATH; SCAR FORMATION; RAT	Far upstream element binding protein 1 (FBP1) has been identified as an upstream gene of p27(kip1) (p27), which is a key regulator of mammalian cell cycle regulation and neurogenesis. To elucidate the expression and function of FBP1 in central nervous system lesion and repair, we performed a traumatic brain injury (TBI) model in adult rats. We observed that FBP1 protein level significantly reduced at day 3 after injury, and the downregulation of FBP1 was predominant in astrocytes, which were largely proliferated after injury. Furthermore, in vitro, overexpression of FBP1 was concomitant with the up-regulation of p27 and reduction of PCNA in LPS-induced astrocyte proliferation. These results suggest that a decreased level of FBP1 in brain is involved in the proliferation of glial cells after TBI.	[Zhao, Wei; Wang, Yong; Shi, Wei; Chen, Yang; Cai, Gang; Chen, Jialei; Qian, Ming; Xu, Wei] Nantong Univ, Affiliated Hosp 2, Dept Neurosurg, Nantong 226001, Jiangsu, Peoples R China		Xu, W (corresponding author), Nantong Univ, Affiliated Hosp 2, Dept Neurosurg, Nantong 226001, Jiangsu, Peoples R China.	xuweineurosurgery@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171139, 812713681]	This work was supported by the National Natural Science Foundation of China (grants numbers 81171139 and 812713681).	AVIGAN MI, 1990, J BIOL CHEM, V265, P18538; Benton RL, 2003, NEUROCHEM RES, V28, P1693, DOI 10.1023/A:1026013106016; Boonstra J, 2003, J CELL BIOCHEM, V90, P244, DOI 10.1002/jcb.10617; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Chen X, 2012, J MOL NEUROSCI, V47, P158, DOI 10.1007/s12031-011-9704-2; Chung HJ, 2005, MOL CELLS, V20, P157; Chung HJ, 2006, MOL CELL BIOL, V26, P6584, DOI 10.1128/MCB.00754-06; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; Fillies T, 2007, ONCOL REP, V17, P355; Go HS, 2009, NEUROIMMUNOMODULAT, V16, P365, DOI 10.1159/000228911; He LS, 2000, EMBO J, V19, P1034, DOI 10.1093/emboj/19.5.1034; Kato H, 2003, BRAIN RES BULL, V60, P215, DOI 10.1016/S0361-9230(03)00036-4; Konigsmark B.W., 1970, CONT RES METHODS NEU, P315, DOI DOI 10.1007/978-3-642-85986-1_14; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Liu JH, 2006, EMBO J, V25, P2119, DOI 10.1038/sj.emboj.7601101; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; MORRIS GF, 1989, J BIOL CHEM, V264, P13856; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Pelengaris S, 2003, ARCH BIOCHEM BIOPHYS, V416, P129, DOI 10.1016/S0003-9861(03)00294-7; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Sgambato A, 2000, J CELL PHYSIOL, V183, P18, DOI 10.1002/(SICI)1097-4652(200004)183:1<18::AID-JCP3>3.0.CO;2-S; Tehranian R, 2008, J NEUROTRAUM, V25, P755, DOI 10.1089/neu.2007.0441; Tian DS, 2006, J NEUROSCI RES, V84, P1053, DOI 10.1002/jnr.20999; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198; Wang XJ, 1998, NEUROSCI LETT, V252, P191, DOI 10.1016/S0304-3940(98)00598-9; Wu XJ, 2012, J MOL NEUROSCI, V46, P184, DOI 10.1007/s12031-011-9572-9; Zhao W, 2011, J MOL HISTOL, V42, P195, DOI 10.1007/s10735-011-9324-8; Zheng YH, 2011, INT J BIOCHEM CELL B, V43, P1641, DOI 10.1016/j.biocel.2011.08.001; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	37	3	4	1	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	NOV	2013	51	3					687	694		10.1007/s12031-013-0049-x			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	235IH	WOS:000325710500007	23797733				2022-02-06	
J	Cheng, CW; Weng, YM; Lin, CC; Kuo, CI; Lin, CC				Cheng, Chien-Wei; Weng, Yi-Ming; Lin, Chih-Chuan; Kuo, Ching-I; Lin, Chi-Chun			The effects of post-intubation hypertension in severe traumatic brain injury	SIGNA VITAE			English	Article						endotracheal intubation; hemodynamics; blood pressure; mean arterial pressure; intracranial hemorrhage	CEREBROVASCULAR PRESSURE-REACTIVITY; CEREBRAL PERFUSION-PRESSURE; SYSTOLIC BLOOD-PRESSURE; ENDOTRACHEAL INTUBATION; MANAGEMENT; PREDICTORS; HEMORRHAGE	Introduction. The effect of post-intubation hypertension in severe traumatic brain injury (TBI) patients remains uncertain. We aimed to determine the relationship between post-intubation hypertension (mean arterial pressure (MAP) > 110mmHg) and outcomes in severe TBI. Methods. In this retrospective cohort study, adults who presented with isolated TBI and a MAP >= 70mmHg were assessed. Data were retrieved from our institutional trauma registry and the admission list of our neurosurgical intensive care unit (ICU). Results. We enrolled 126 patients, 81 of whom had a MAP <= 110 mmHg after intubation and were assigned to group 1; 45 patients who had a MAP > 110 mmHg were assigned to group 2. Only age (P = 0.008), heart rate (HR; P = 0.036), and MAP before intubation (P < 0.001) were significantly different between groups. We found no significant intergroup differences in mortality (35.8 vs. 35.6%, P = 1.000) or in the motor function of survivors at discharge (P = 0.333). The length of ventilator-dependent (median: 2.0 vs. 5.0 days; P = 0.003) and ICU stays (median: 4.5 vs. 10.0 days; P = 0.005) were significantly longer in group 2. Post-intubation hypertension remained significantly associated with longer ICU stay (>= 7 days) and poor neurologic outcome (motor < 4 at discharge) after adjusting for other variables (post-intubation MAP > 110 mmHg, P < 0.034, OR 3.119, 95% CI 1.087-8.953). Conclusion. Post-intubation hypertension was associated with longer ventilator-dependent and ICU stays in patients with severe TBI.	[Lin, Chih-Chuan] Chang Gung Mem Hosp, Dept Emergency Med, Tao Yuan, Taiwan; Chang Gung Univ, Coll Med, Dept Emergency Med, Chang Gung Mem Hosp, Tao Yuan, Taiwan		Lin, CC (corresponding author), Chang Gung Mem Hosp, Dept Emergency Med, 5 Fushing St, Tao Yuan, Taiwan.	bearuncle@adm.cgmh.org.tw; wengym33@gmail.com					Asfar S N, 1990, Acta Anaesthesiol Belg, V41, P17; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Broderick J, 2007, CIRCULATION, V116, pE391, DOI 10.1161/CIRCULATIONAHA.107.183689; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Czosnyka M, 1998, ACT NEUR S, V71, P74; FORBES AM, 1970, BRIT J ANAESTH, V42, P618, DOI 10.1093/bja/42.7.618; Franschman G, 2011, J TRAUMA, V71, P826, DOI 10.1097/TA.0b013e31820cebf0; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Kayhan Z, 2005, EUR J ANAESTH, V22, P780, DOI 10.1017/S0265021505001298; Kiboi JG, 2011, WORLD NEUROSURG, V75, P586, DOI 10.1016/j.wneu.2010.05.041; Klemenc-Ketis Z, 2011, ULUS TRAVMA ACIL CER, V17, P509, DOI 10.5505/tjtes.2011.35336; Kuzak Nick, 2006, CJEM, V8, P80; Ley EJ, 2011, J TRAUMA, V71, P1689, DOI 10.1097/TA.0b013e31823cc5df; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Shutter LA, 2008, ANN EMERG MED, V51, pS37, DOI 10.1016/j.annemergmed.2007.11.013; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Steiner T, 2006, CEREBROVASC DIS, V22, P294, DOI 10.1159/000094831; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Walia S, 2002, INJURY, V33, P339, DOI 10.1016/S0020-1383(02)00053-0; Zafar SN, 2011, J TRAUMA, V71, P1179, DOI 10.1097/TA.0b013e3182140d38	25	3	3	0	0	PHARMAMED MADO LTD	ZAGREB	ZATISJE 8 G, ZAGREB, 10000, CROATIA	1334-5605			SIGNA VITAE	Signa Vitae	OCT	2013	8	2					24	29		10.22514/SV82.102013.4			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	235VN	WOS:000325749100004		Green Published			2022-02-06	
J	Lamontagne, ME				Lamontagne, Marie-Eve			Exploration of the integration of care for persons with a traumatic brain injury using social network analysis methodology	INTERNATIONAL JOURNAL OF INTEGRATED CARE			English	Article						traumatic brain injury; brain injury; health care system; community network; social network analysis; social network; evaluation	ORGANIZATIONS; CENTRALITY	Introduction: Integration is a popular strategy to increase the quality of care within systems of care. However, there is no common language, approach or tool allowing for a valid description, comparison and evaluation of integrated care. Social network analysis could be a viable methodology to provide an objective picture of integrated networks. Goal of the article: To illustrate social network analysis use in the context of systems of care for traumatic brain injury. Method: We surveyed members of a network using a validated questionnaire to determine the links between them. We determined the density, centrality, multiplexity, and quality of the links reported. Results: The network was described as moderately dense (0.6), the most prevalent link was knowledge, and four organisation members of a consortium were central to the network. Social network analysis allowed us to create a graphic representation of the network. Conclusion: Social network analysis is a useful methodology to objectively characterise integrated networks.	Univ Laval, Dept Rehabil, Quebec City, PQ G1V 0A6, Canada		Lamontagne, ME (corresponding author), Univ Laval, Dept Rehabil, 2325 Rue Univ, Quebec City, PQ G1V 0A6, Canada.	marie-eve.lamontagne@fmed.ulaval.ca		Lamontagne, Marie-Eve/0000-0002-3301-7429			Ahgren B, 2005, INT J INTEGR CARE, V5, pE3; Ahgren B, 2005, INT J INTEGR CARE, V5, pe09; Ahgren Bengt, 2005, Int J Integr Care, V5, pe09; Berry FS, 2004, PUBLIC ADMIN REV, V64, P539, DOI 10.1111/j.1540-6210.2004.00402.x; Borgatti S., 2002, UCINET 6 WINDOWS SOF; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Borgatti SP, 2003, J MANAGE, V29, P991, DOI 10.1016/S0149-2063(03)00087-4; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; Brass DJ, 2004, ACAD MANAGE J, V47, P795, DOI 10.2307/20159624; Browne G, 2007, INDEXING COMPANION, P1, DOI 10.1017/CBO9781139168595; BROWNE G, 2004, INT J INTEGR CARE, V4, P1, DOI DOI 10.5334/IJIC.98; Contandriopoulos AP, 2001, REV TRANSDISCIP SANT, V8, P38; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 2008, SOCIAL NETWORK ANAL; Gittell JH, 2004, J MANAGE STUD, V41, P127, DOI 10.1111/j.1467-6486.2004.00424.x; Goodwin N, 2010, INT J INTEGR CARE, V10, pe76, DOI DOI 10.5334/IJIC.647; Hawe P, 2004, J EPIDEMIOL COMMUN H, V58, P971, DOI 10.1136/jech.2003.014530; Knoke D., 2008, SOCIAL NETWORK ANAL; Laumann E. O., 1983, RES METHODS SOCIAL N, DOI DOI 10.4324/9781315128511; Lemieux-Charles L, 2005, GERONTOLOGIST, V45, P456, DOI 10.1093/geront/45.4.456; MARSDEN PV, 1990, ANNU REV SOCIOL, V16, P435, DOI 10.1146/annurev.so.16.080190.002251; Meltzer D, 2010, SOC SCI MED, V71, P1119, DOI 10.1016/j.socscimed.2010.05.012; Milward HB, 1998, PUBLIC ADMIN, V76, P387, DOI 10.1111/1467-9299.00106; Provan KG, 2007, J MANAGE, V33, P479, DOI 10.1177/0149206307302554; Provan Keith G, 2004, Health Promot Pract, V5, P174, DOI 10.1177/1524839903259303; Provan KG, 2005, PUBLIC ADMIN REV, V65, P603, DOI 10.1111/j.1540-6210.2005.00487.x; PROVAN KG, 1995, ADMIN SCI QUART, V40, P1, DOI 10.2307/2393698; Provan KG, 2001, PUBLIC ADMIN REV, V61, P414, DOI 10.1111/0033-3352.00045; Provan KG, 1998, ACAD MANAGE J, V41, P453, DOI 10.2307/257084; Stein K. V., 2009, INT J INTEGR CARE, V9, P1; Yin RK, 2003, CASE STUDY RES DESIG	31	3	3	4	13	UBIQUITY PRESS LTD	LONDON	2N, 6 OSBORNE ST, LONDON, E1 6TD, ENGLAND	1568-4156			INT J INTEGR CARE	Int. J. Integr. Care	OCT-DEC	2013	13								114746				11	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	262ET	WOS:000327717800003	24250281	Green Published, Green Submitted, gold			2022-02-06	
J	Mao, H; Liu, J; Shi, W; Huang, QF; Xu, XD; Ni, LC; Zou, FH; Shi, JL; Li, DB; Liu, YH; Chen, J				Mao, Hui; Liu, Jiao; Shi, Wei; Huang, Qingfeng; Xu, Xide; Ni, Lanchun; Zou, Feihui; Shi, Jinlong; Li, Debao; Liu, Yonghua; Chen, Jian			The Expression Patterns of Septin-9 After Traumatic Brain Injury in Rat Brain	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Septin-9; Traumatic brain injury; Apoptosis; Rat	ACUTE MYELOID-LEUKEMIA; CELL-DEATH MECHANISMS; MAMMALIAN SEPTINS; DIVISION CYCLE; GENE; PROTEIN; EPIDEMIOLOGY; APOPTOSIS; CANCER; CORTEX	Septins are a novel group of GTPases, which are first identified in yeast and more recently found in a wide range of animal cells. Septin-9, a novel septin family member, is expressed ubiquitously and involved in an increasing number of signaling cascades. However, information regarding its distribution and possible function in the central nervous system (CNS) is limited. In this study, western blot analysis and immunohistochemistry showed a significant upregulation of Septin-9 in the ipsilateral peritrauma cortex compared with the sham group. Immunofluorescent labeling indicated that Septin-9 was localized strikingly in the cytoplasm of neurons, but not astrocytes and oligodendrocytes. The co-localization of Septin-9 and active caspase-3 was also examined in the ipsilateral cortex. In addition, the expression patterns of active caspase-3 were parallel with that of Septin-9. Quantitative real-time RT-PCR also was used to detect Seption-9 mRNA level. Based on our data, we speculated that traumatic brain injury may be a stimulus to induce the Septin-9 expression, and Septin-9 might play an important role in the pathophysiology process in the CNS after traumatic brain injury. Taken together, this is the first description of Septin-9 expression changes during the central nervous system lesion and repair, but further studies are needed to understand the cell signaling pathway which can direct the exact role of Septin-9 following traumatic brain injury.	[Mao, Hui; Shi, Wei; Huang, Qingfeng; Xu, Xide; Ni, Lanchun; Zou, Feihui; Shi, Jinlong; Li, Debao; Chen, Jian] Nantong Univ, Affiliated Hosp, Dept Neurosurg, Nantong 226001, Jiangsu, Peoples R China; [Liu, Yonghua] Nantong Univ, Coll Med, Dept Microbiol & Immunol, Nantong 226001, Jiangsu, Peoples R China; [Liu, Jiao] Nantong Univ, Dept Publ Hlth, Nantong 226001, Jiangsu, Peoples R China		Chen, J (corresponding author), Nantong Univ, Affiliated Hosp, Dept Neurosurg, Nantong 226001, Jiangsu, Peoples R China.	maohui198616@hotmail.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81070992]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the Natural Science Foundation of China (81070992) and funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Borgens RB, 2012, Q REV BIOL, V87, P89, DOI DOI 10.1086/665457; Burrows JF, 2003, J PATHOL, V201, P581, DOI 10.1002/path.1484; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Engidawork E, 2003, NEUROSCIENCE, V122, P145, DOI 10.1016/S0306-4522(03)00605-5; Field CM, 1999, TRENDS CELL BIOL, V9, P387, DOI 10.1016/S0962-8924(99)01632-3; Gottfried Y, 2004, EMBO J, V23, P1627, DOI 10.1038/sj.emboj.7600155; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; HARTWELL LH, 1973, GENETICS, V74, P267; Heegaard W, 2007, EMERG MED CLIN N AM, V25, P655, DOI 10.1016/j.emc.2007.07.001; Kartmann B, 2001, J CELL SCI, V114, P839; Kuhlenbaumer G, 2005, NAT GENET, V37, P1044, DOI 10.1038/ng1649; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larisch S, 2000, NAT CELL BIOL, V2, P915, DOI 10.1038/35046566; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; Liu ZQ, 2011, J MOL HISTOL, V42, P265, DOI 10.1007/s10735-011-9330-x; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; LOGAN A, 1992, J NEUROSCI, V12, P3828; Macara IG, 2002, MOL BIOL CELL, V13, P4111, DOI 10.1091/mbc.E02-07-0438; Megonigal MD, 1998, P NATL ACAD SCI USA, V95, P6413, DOI 10.1073/pnas.95.11.6413; Montagna C, 2003, CANCER RES, V63, P2179; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Osaka M, 1999, P NATL ACAD SCI USA, V96, P6428, DOI 10.1073/pnas.96.11.6428; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Russell SEH, 2005, BRIT J CANCER, V93, P499, DOI 10.1038/sj.bjc.6602753; Scott M, 2005, ONCOGENE, V24, P4688, DOI 10.1038/sj.onc.1208574; Shi W, 2011, NEUROCHEM RES, V36, P375, DOI 10.1007/s11064-010-0332-y; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Versele M, 2005, TRENDS CELL BIOL, V15, P414, DOI 10.1016/j.tcb.2005.06.007; Xu T, 2012, J MOL HISTOL, V43, P335, DOI 10.1007/s10735-012-9408-0; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3	31	3	3	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696			J MOL NEUROSCI	J. Mol. Neurosci.	OCT	2013	51	2					558	566		10.1007/s12031-013-0024-6			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	221DG	WOS:000324637200041	23700216				2022-02-06	
J	Rech, RR; da Silva, MC; Langohr, IM; Marques, MG; Pescador, CA; Silva, GS; Dutra, MC; Brum, JS; Kramer, B; Bordin, LC; Silva, VS				Rech, Raquel R.; da Silva, Marcia C.; Langohr, Ingeborg M.; Marques, Mariana G.; Pescador, Caroline A.; Silva, Gustavo S.; Dutra, Mauricio C.; Brum, Juliana S.; Kramer, Beatris; Bordin, Luiz C.; Silva, Virginia S.			Not everything is an important lesion: Anatomical structures, non-lesions, artifacts, lesions without clinical significance, and postmortem findings in domestic and feral pigs (Sus scrofa)	PESQUISA VETERINARIA BRASILEIRA			Portuguese	Article						Necropsy; non-lesions; gross pathology; swine; wild boar; Sus scrofa	AFRICAN-SWINE-FEVER; ABORTED FETUSES; CARPAL GLANDS; BOARS; INGESTION; BRAZIL	The interpretation of the changes observed at necropsy is an important step for the success of the final diagnosis. This article aims to describe and illustrate the anatomical structures, non-lesions, artifacts, lesions without clinical significance and postmortem changes observed in domestic and wild pigs. Moreover, the article also recommends collection techniques of organs or structures for the diagnosis of diseases affecting this species. The main anatomical structures and non-lesions described are marginal lingual papillae, pars oesophagea of the stomach, torus pyloricus, and well demarcated lobular pattern of the liver (gastrointestinal system); tonsils of the soft palate, gastric lymphoid tissue, Peyer's patches of the small intestine, marginal folds of the spleen (hematopoietic system); prominent mediastinum testis and placental areolae (reproductive system); pulmonary atelectasis and periople (fetus); and carpal glands (integumentary system). The discussed artifacts related to euthanasia are petechiae on the surface of the lung and kidney, false anemia due to exsanguination, subdural hemorrhage due to cerebral concussion, pseudoinfarcts of the spleen, and cerebriform appearance of the small intestine. Lesions without clinical significance described are renal cysts, lymph nodes with iron pigment, papillomas and hemangiomas on the scrotum, osseous metaplasia in the mesentery, and hyperemia of the gastric mucosa. Commonly found postmortem changes are livor mortis, pale muscles, pseudomelanosis, and serosanguinous fluid in the thoracic and abdominal cavities of fetuses.	[Rech, Raquel R.; Marques, Mariana G.; Kramer, Beatris; Bordin, Luiz C.; Silva, Virginia S.] Embrapa Suinos & Aves, BR-89700000 Concordia, SC, Brazil; [da Silva, Marcia C.] Ctr Diagnost Sanidade Anim CEDISA, BR-89700000 Concordia, SC, Brazil; [Langohr, Ingeborg M.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Pescador, Caroline A.; Silva, Gustavo S.] Univ Fed Mato Grosso, Lab Patol Vet, BR-78069900 Cuiaba, MT, Brazil; [Dutra, Mauricio C.] Dept Med Vet Prevent & Saude Anim, Programa Posgrad Epidemiol Expt, BR-05508270 Sao Paulo, Brazil; [Brum, Juliana S.] Univ Fed Santa Maria, Ctr Ciencias Rurais, Area Concentracao Patol Vet, Programa Posgrad Med Vet, BR-97105900 Santa Maria, RS, Brazil		Rech, RR (corresponding author), Embrapa Suinos & Aves, BR-153 Km 110, BR-89700000 Concordia, SC, Brazil.	raquel.rech@embrapa.br	Marques, Mariana Groke/F-8713-2012; Rech, Raquel R/L-9071-2019; Langohr, Ingeborg/H-5570-2019	Marques, Mariana Groke/0000-0002-3110-1280; Rech, Raquel R/0000-0003-3768-0743; Langohr, Ingeborg/0000-0001-7366-4391; de Sousa e Silva, Gustavo/0000-0001-5884-8803			Alberton G.C., 2012, AN 7 SINS PORT AL RS, P263; Alstine Van, 2012, DIS SWINE, P348; AVMA, 2013, GUID EUTH AN; Bal H S, 1972, Zentralbl Veterinarmed C, V1, P289; Cardenas H., 2001, J ANIM SCI, V80, pE36; Carlson A., 2012, DIS SWINE, V1, P821; Casteignau A, 2006, J VET MED A, V53, P323, DOI 10.1111/j.1439-0442.2006.00830.x; Casteleyn C, 2011, CLIN DEV IMMUNOL, P1, DOI 10.1155/2011/472460; Caswell J.L., 2007, JUBB KENNEDY PALMERS, P523; Clark SG, 2003, THERIOGENOLOGY, V60, P1011, DOI 10.1016/S0093-691X(03)00127-4; Correa AMR, 2006, PESQUI VET BRASIL, V26, P9, DOI 10.1590/S0100-736X2006000100003; DOIGE C, 1975, CAN J COMP MED, V39, P7; Doster A. R., 1995, Swine Health and Production, V3, P256; Drolet R, 2012, DIS SWINE, P363; Fernandez P.J., 2010, ATLAS TRANSBOUNDARY; Frappier B.L., 2006, DELLMANNS TXB VET HI, P170; Fukui K, 2012, ARCH DERMATOL RES, V304, P599, DOI 10.1007/s00403-012-1226-4; Gabriel C, 2011, EMERG INFECT DIS, V17, P2342, DOI 10.3201/eid1712.110430; Getty R., 1981, ANATOMIA ANIMAIS DOM, V2, P1139; Guillamon M.H., 2010, GUIA DIAGNOSTICO NEC; Heise-Pavlov S, 2005, J ZOOL, V266, P73, DOI 10.1017/S0952836905006655; Herenda D., 1994, FAO MANUAL MEAT INSP; King J, 2005, THE NECROPSY BOOK; Knox RV, 2005, DOMEST ANIM ENDOCRIN, V29, P385, DOI 10.1016/j.domaniend.2005.02.025; Langohr IM, 2010, VET PATHOL, V47, P140, DOI 10.1177/0300985809352793; Lanteri G, 2009, VET PATHOL, V46, P329, DOI 10.1354/vp.46-2-329; LONG GG, 1986, VET CLIN N AM-FOOD A, V2, P147, DOI 10.1016/S0749-0720(15)31276-7; Maldonado J, 2005, VET J, V169, P454, DOI 10.1016/j.tvjl.2004.05.007; Muller M., 2011, PATHOLOGIC BASIS VET, P539; Nascimento E.F., 2008, PATOLOGIA REPROD ANI, P15; National Pork Board, 2009, EUT GRANJ REC PROD; Oliveira FN, 2005, PESQUISA VET BRASIL, V25, P135, DOI 10.1590/S0100-736X2005000300003; Pescador CA, 2010, PESQUI VET BRASIL, V30, P1058, DOI 10.1590/S0100-736X2010001200010; Romero CH, 2003, J WILDLIFE DIS, V39, P567, DOI 10.7589/0090-3558-39.3.567; ROTHKOTTER HJ, 1990, SCAND J IMMUNOL, V31, P191, DOI 10.1111/j.1365-3083.1990.tb02759.x; Salles MWS, 2011, J VET DIAGN INVEST, V23, P367, DOI 10.1177/104063871102300231; Sanford S. E., 1994, Swine Health and Production, V2, P17; Schlafer D.H., 2007, JUBB KENNEDY PALMERS, V3, P329; Schneider C, 1996, ANAT HISTOL EMBRYOL, V25, P95, DOI 10.1111/j.1439-0264.1996.tb00064.x; Segales J, 2012, VIRUS RES, V164, P10, DOI 10.1016/j.virusres.2011.10.007; Senger P.L., 2003, PATHWAYS PREGNANCY P, P304; Sims LD., 1996, PATHOLOGY PIG DIAGNO; Sobestiansky J., 2012, DOENCAS SUINOS DOENCAS SUINOS; Soede NM, 2011, ANIM REPROD SCI, V124, P251, DOI 10.1016/j.anireprosci.2011.02.025; Summers BA, 1995, VET NEUROPATHOLOGY, P156; Teankum K, 2008, J COMP PATHOL, V139, P177, DOI 10.1016/j.jcpa.2008.06.005; Tokarnia CH, 2004, PESQUI VET BRASIL, V24, P223, DOI 10.1590/S0100-736X2004000400010; Van Alstine WG, 2003, J VET DIAGN INVEST, V15, P289, DOI 10.1177/104063870301500313; Yaeger M.J., 2012, KIRKBRIDES DIAGNOSIS, P89; Youngquest R.S., 2007, CURRENT THERAPY LARG, P717; Zimmerman JJ, 2012, DIS SWINE, P199	51	3	3	0	17	REVISTA PESQUISA VETERINARIA BRASILEIRA	RIO JANEIRO	EMBRAPA-SAUDE ANIMAL, KM47 SEROPEDICA, 23851-970 RIO JANEIRO, BRAZIL	0100-736X	1678-5150		PESQUI VET BRASIL	Pesqui. Vet. Bras.	OCT	2013	33	10					1237	1255		10.1590/S0100-736X2013001000010			19	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	286UP	WOS:000329494600010		gold			2022-02-06	
J	Ahlander, AC; Persson, M; Emanuelson, I				Ahlander, Anne-Christine; Persson, Marika; Emanuelson, Ingrid			FIFTEEN-YEAR FOLLOW-UP OF UPPER LIMB FUNCTION IN CHILDREN WITH MODERATE TO SEVERE TRAUMATIC BRAIN INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article						long-term follow-up; upper limb function; traumatic brain injury	HAND FUNCTION-TEST; INTERRATER RELIABILITY; MOTOR; GRIP; PRESCHOOLERS; ADOLESCENTS; RECOVERY; COHORT	Objective: To describe the impaired fine-motor skills in patients with traumatic brain injury acquired in childhood. Design: A total of 165 patients with traumatic brain injury, aged 0-17 years, injured during the period 1987-1991, were identified. Fifteen years post-injury a questionnaire was sent to the patients. Twenty-six of the subjects had upper limb problems, 15 of whom agreed to participate and 12 attended an evaluation. Methods: The Sollerman test was administered. This test consists of 20 activities, of which 7 hand-grips were used (pulp-pinch, lateral pinch, tripod pinch, 5-finger pinch, diagonal, transverse and spherical volar grip). Each sub-test was scored from 0 to 4 points. Each task must be performed within 20 s. The maximum score was 80. Bimanual fine motor skills were classified by Bimanual Fine Motor Function (BFMF). BFMF consists of 5 levels of function of each hand. Level I is normal function, level II-V means subnormal function in an increasing grade. Co-ordination, spasticity, 2PD and stereognosis were also measured. Results: All patients had subnormal results on the Sollerman test. Fifty-eight percent had abnormal scores on the BFMF test. Conclusion: The Sollerman test seemed to be reliable at picking up hand motor problems, as all subjects who reported such problems scored subnormally. This is in contrast to the BFMF test findings, where only 60% of our group scored subnormally.	[Ahlander, Anne-Christine; Persson, Marika] Queen Silvia Childrens Hosp, Gothenburg, Sweden; [Emanuelson, Ingrid] Univ Gothenburg, Dept Paediat, Inst Clin Sci, Gothenburg, Sweden		Emanuelson, I (corresponding author), Naverlursgatan 38, SE-42144 Vastra Frolunda, Sweden.	ingrid.emanuelson@vgregion.se					Beckung E, 2002, DEV MED CHILD NEUROL, V44, P309; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Brogardh C, 2007, DISABIL REHABIL, V29, P145, DOI 10.1080/09638280600747603; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Golge M, 2004, ARCH PHYS MED REHAB, V85, P1435, DOI 10.1016/j.apmr.2003.11.029; Horneman G, 2005, INT J REHABIL RES, V28, P245, DOI 10.1097/00004356-200509000-00007; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Lagerstrom C, 1998, SCAND J REHABIL MED, V30, P113; MOBERG E, 1990, SCAND J REHABIL MED, V22, P127; NORDENSKIOLD UM, 1993, SCAND J RHEUMATOL, V22, P14, DOI 10.3109/03009749309095105; O'Flaherty SJ, 2000, ARCH PHYS MED REHAB, V81, P723, DOI 10.1016/S0003-9993(00)90100-X; Rosen B, 1998, J Hand Ther, V11, P251; Rosen B, 2000, BRIT J HAND THERAPY, V5, P114; SOLLERMAN C, 1995, SCAND J PLAST RECONS, V29, P167, DOI 10.3109/02844319509034334; Wallen MA, 2001, ARCH PHYS MED REHAB, V82, P642, DOI 10.1053/apmr.2001.22620	20	3	3	0	5	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	SEP	2013	45	8					815	819		10.2340/16501977-1203			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	243ZS	WOS:000326357500018	24002319	Green Submitted, gold			2022-02-06	
J	Halldorsson, JG; Arnkelsson, GB; Tomasson, K; Flekkoy, KM; Magnadottir, HB; Arnarson, EO				Halldorsson, Jonas G.; Arnkelsson, Gudmundur B.; Tomasson, Kristinn; Flekkoy, Kjell M.; Magnadottir, Hulda Bra; Arnarson, Eirikur Orn			Long-term outcome of medically confirmed and self-reported early traumatic brain injury in two nationwide samples	BRAIN INJURY			English	Article						Adolescents; children; longitudinal; nationwide; outcome; prognosis; traumatic brain injury; young adults	POST-CONCUSSIVE SYMPTOMS; PEDIATRIC HEAD-INJURY; PSYCHOSOCIAL OUTCOMES; SUBJECTIVE EXPERIENCE; EARLY-CHILDHOOD; UNITED-STATES; FOLLOW-UP; CHILDREN; MILD; SCALE	Primary objectives: To assess long-term effects of early traumatic brain injury (TBI) on mental health, cognition, behaviour and adjustment and to identify prognostic factors. Methods and procedures: A 1-year nationwide cohort of all 0-19 year old Icelandic children and adolescents diagnosed with TBI in 1992-1993 (n = 550) received a questionnaire with clinical outcome scales and questions on TBI and socio-economic status (SES) by mail similar to 16 years postinjury. A control group (n = 1232), newly selected from the National Registry, received the same questionnaire. Non-respondents answered a shorter version by telephone. Overall participation was 67%. Main outcomes and results: Medically confirmed and self-reported TBI was reflected in worse outcome. Force of impact, number and severity of TBIs predicted poorer results. Parental SES and demographic factors had limited effects. Not reporting early, medically confirmed TBI did not exclude cognitive sequelae. In self-reported disability, absence of evaluation for compensation was not linked to outcome. Conclusions: Clinical outcome was consistent with late complaints attributed to early TBI. TBI-related variables had greater prognostic value than other factors. Self-reporting of TBI sustained very early in life needs supplementary information from parents and medical records. More consistency in compensation evaluations following paediatric TBI is indicated.	[Halldorsson, Jonas G.; Arnarson, Eirikur Orn] Univ Iceland, Fac Med, Reykjavik, Iceland; [Halldorsson, Jonas G.; Arnarson, Eirikur Orn] Landspitali Univ Hosp, Psychol Serv, IS-108 Reykjavik, Iceland; [Arnkelsson, Gudmundur B.] Univ Iceland, Dept Psychol, Reykjavik, Iceland; [Tomasson, Kristinn] Adm Occupat Safety & Hlth, Reykjavik, Iceland; [Flekkoy, Kjell M.] Univ Oslo, Oslo, Norway; [Magnadottir, Hulda Bra] Upper Valley Neurol & Neurosurg, Lebanon, NH USA		Halldorsson, JG (corresponding author), Landspitali Univ Hosp, Psychol Serv, IS-108 Reykjavik, Iceland.	jonasgh@landspitali.is	Arnarson, Eirikur O/N-7731-2014; Arnarson, Eirikur Orn/AAE-4476-2021	Arnarson, Eirikur O/0000-0002-6816-148X; Arnarson, Eirikur Orn/0000-0002-6816-148X	University of Iceland Doctoral Fund; Landspitali University Hospital Science Fund; Margret Bjorgolfsdottir Memorial Fund; Olafia Jonsdottir Memorial Fund; Helga Jonsdotti; Sigurlidi Kristjansson Memorial Fund; Alcan Iceland Community Fund	The study was funded in part with grants from the University of Iceland Doctoral Fund, the Landspitali University Hospital Science Fund, the Margret Bjorgolfsdottir Memorial Fund, the Olafia Jonsdottir Memorial Fund, the Helga Jonsdottir and Sigurlidi Kristjansson Memorial Fund and the Alcan Iceland Community Fund. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	[Anonymous], 2006, SPSS WIND 15 0 0; ARNARSON EO, 1995, ACTA PAEDIATR, V84, P96, DOI 10.1111/j.1651-2227.1995.tb13496.x; Bailey BM, 2011, J TRAUMA, V72, P263; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; Chevignard MP, 2010, CURR OPIN NEUROL, V23, P695, DOI 10.1097/WCO.0b013e328340296f; Cordon IM, 2004, DEV REV, V24, P101, DOI 10.1016/j.dr.2003.09.003; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; Dillman DA, 2006, MAIL INTERNET SURVEY; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goldberg D., 1972, DETECTION PSYCHIAT I; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Greenes DS, 1998, ANN EMERG MED, V32, P680, DOI 10.1016/S0196-0644(98)70067-8; Greenspan AI, 2000, BRAIN INJURY, V14, P417; Halldorsson JG, 2012, BRAIN INJURY, V26, P1, DOI 10.3109/02699052.2011.635359; Halldorsson Jonas G, 2008, Neuropsychiatr Dis Treat, V4, P405; Halldorsson Jonas G, 2007, Neuropsychiatr Dis Treat, V3, P935; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Hessen E, 2006, SCAND J PSYCHOL, V47, P245, DOI 10.1111/j.1467-9450.2006.00514.x; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; JENNETT B, 1975, LANCET, V1, P480; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; Locker D, 2007, DENT TRAUMATOL, V23, P291, DOI 10.1111/j.1600-9657.2006.00457.x; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Martin C, 2001, BRAIN INJURY, V15, P947, DOI 10.1080/02699050110065655; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; Peterson C, 2005, LAW HUMAN BEHAV, V29, P527, DOI 10.1007/s10979-005-6833-6; Peterson C, 1999, DEV PSYCHOL, V35, P1493, DOI 10.1037/0012-1649.35.6.1493; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; R Development Core Team, 2010, R LANG ENV STAT COMP; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; SCHNURR RF, 1995, CLIN J PAIN, V11, P103, DOI 10.1097/00002508-199506000-00004; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Shevlin M, 2005, PSYCHOL ASSESSMENT, V17, P231, DOI 10.1037/1040-3590.17.2.231; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Sosin DM, 1996, BRAIN INJURY, V10, P47; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Stout JC, 2003, ASSESSMENT, V10, P79, DOI 10.1177/1073191102250339; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	68	3	3	2	15	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2013	27	10					1106	1118		10.3109/02699052.2013.765599			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	204KW	WOS:000323365200002	23885641				2022-02-06	
J	Helbok, R; Claassen, J				Helbok, Raimund; Claassen, Jan			Multimodal invasive monitoring in status epilepticus: What is the evidence it has a place?	EPILEPSIA			English	Article						Electrographic seizures; Status epilepticus; Multimodality monitoring; Continuous EEG monitoring; Brain metabolism	TRAUMATIC BRAIN-INJURY; SUBCUTANEOUS EXTRACELLULAR FLUID; CORTICAL SPREADING DEPRESSION; SUBDURAL CEREBROSPINAL-FLUID; ELECTROGRAPHIC SEIZURES; TISSUE HYPOXIA; MICRODIALYSIS; DEPOLARIZATIONS; EPILEPSY; PRESSURE	The underlying pathophysiology of status epilepticus (SE) remains mostly invisible to the clinician in the intensive care unit (ICU) setting. In animal studies associated hemodynamic and brain neurochemical changes have been well described. In the last decade, bedside invasive neuromonitoring techniques allow the assessments of changes in focal and global cerebral physiology associated with ictal activity on the tissue level in humans. Recent studies demonstrate that laboratory research insufficiently replicates the complexity of the human condition. Herein we summarize the current knowledge gained from human studies integrating cortical electrographic and brain tissue metabolic and hemodynamic information into the current pathophysiologic concept of SE in humans. With increasing experience gained by the use of extended neuromonitoring, we are more and more able to understand associated hemodynamic and brain neurochemical changes in patients with SE. In the future, this information can potentially provide integrated pathophysiologic end points into SE treatment concepts.	[Helbok, Raimund] Med Univ Innsbruck, Dept Neurol, Div Neurocrit Care, A-6020 Innsbruck, Austria; [Claassen, Jan] Columbia Univ, Coll Phys & Surg, Dept Neurol, Div Crit Care Neurol, New York, NY USA		Helbok, R (corresponding author), Med Univ Innsbruck, Dept Neurol, Anichstr 35, A-6020 Innsbruck, Austria.	raimund.helbok@uki.at	Claassen, Jan/AAA-5451-2020; Helbok, Raimund/AAA-8361-2021				Bahar S, 2006, NEUROREPORT, V17, P499, DOI 10.1097/01.wnr.0000209010.78599.f5; Balosso S, 2009, NEUROSCIENCE, V161, P293, DOI 10.1016/j.neuroscience.2009.03.005; Bhatia R, 2006, NEUROSURGERY, V58, P313, DOI 10.1227/01.NEU.0000208963.42378.83; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Claassen J, 2013, ANN NEUROL; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Drenckhahn C, 2012, BRAIN, V135, P853, DOI 10.1093/brain/aws010; DURING MJ, 1993, LANCET, V341, P1607; DYMOND AM, 1976, BRAIN RES, V102, P191, DOI 10.1016/0006-8993(76)90587-4; Fabricius M, 2008, CLIN NEUROPHYSIOL, V119, P1973, DOI 10.1016/j.clinph.2008.05.025; Geneslaw AS, 2011, J CEREBR BLOOD F MET, V31, P1394, DOI 10.1038/jcbfm.2011.16; Hammarlund-Udenaes M, 2000, ADV DRUG DELIVER REV, V45, P283, DOI 10.1016/S0169-409X(00)00109-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Helbok R, 2012, CRIT CARE, V16, DOI 10.1186/cc11880; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Ko SB, 2011, ARCH NEUROL-CHICAGO, V68, P1323, DOI 10.1001/archneurol.2011.240; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Lindberger M, 2002, PHARMACOL TOXICOL, V91, P158, DOI 10.1034/j.1600-0773.2002.910402.x; Lindberger M, 2001, EPILEPSIA, V42, P256, DOI 10.1046/j.1528-1157.2001.26600.x; Nandi P, 2009, ANAL CHIM ACTA, V651, P1, DOI 10.1016/j.aca.2009.07.064; Oddo M, 2009, CRIT CARE MED, V37, P2051, DOI 10.1097/CCM.0b013e3181a00604; Pan JW, 2012, ACTA NEUROL SCAND, V126, P411, DOI 10.1111/j.1600-0404.2012.01665.x; Pan JW, 2008, EPILEPSIA, V49, P31, DOI 10.1111/j.1528-1167.2008.01508.x; Park S, 2011, NEUROCRIT CARE, V15, P469, DOI 10.1007/s12028-011-9540-9; Rambeck B, 2006, EPILEPSIA, V47, P681, DOI 10.1111/j.1528-1167.2006.00504.x; Roche-Labarbe N, 2008, EPILEPSIA, V49, P1871, DOI 10.1111/j.1528-1167.2008.01711.x; Roy CS, 1890, J PHYSL, V11, P117; Salek-Haddadi A, 2006, BRAIN RES, V1088, P148, DOI 10.1016/j.brainres.2006.02.098; Sarrafzadeh A, 2010, NEUROCRIT CARE, V13, P339, DOI 10.1007/s12028-010-9432-4; Schiefecker AJ, 2012, SEIZURE, V22, P236; Schwartz Theodore H, 2007, Epilepsy Curr, V7, P91, DOI 10.1111/j.1535-7511.2007.00183.x; Tisdall M, 2006, BRIT J NEUROSURG, V20, P285, DOI 10.1080/02688690600999786; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Wei YH, 2009, CURR PHARM BIOTECHNO, V10, P631, DOI 10.2174/138920109789069288; Zhao MR, 2011, J NEUROSCI, V31, P13292, DOI 10.1523/JNEUROSCI.2597-11.2011	39	3	3	5	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580			EPILEPSIA	Epilepsia	SEP	2013	54			6	SI		57	60		10.1111/epi.12279			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	210JA	WOS:000323826600017	24001075				2022-02-06	
J	Inamasu, J; Nakatsukasa, M; Hirose, Y				Inamasu, Joji; Nakatsukasa, Masashi; Hirose, Yuichi			Computed Tomography Evaluation of the Brain and Upper Cervical Spine in Patients With Traumatic Cardiac Arrest Who Achieved Return of Spontaneous Circulation	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						computed tomography; return of spontaneous circulation; traumatic brain injury; traumatic cardiac arrest; upper cervical spine injury	COMATOSE PATIENTS; SURVIVAL; PREDICTORS; INJURIES; HEAD	The outcomes of patients with traumatic cardiac arrest (TCA) have been dismal. However, imaging modalities are improving rapidly and are expected to play a role in treatment of patients with TCA. In this retrospective study, whether obtaining computed tomography (CT) immediately after resuscitation had any clinical value was evaluated. Among 145 patients with TCA admitted to our institution during 4 years, hemodynamically stable return of spontaneous circulation (ROSC) was achieved in 38 (26%). Brain and cervical spine CT was obtained prospectively, and the frequency and type of traumatic brain injury (TBI)/upper cervical spine injury (UCSI) were investigated. CT was performed uneventfully in all patients with an average door-to-CT time of 51.5 +/- 18.6 min. Twenty (53%) had CT evidence of TBI. However, no patients underwent brain surgery because of lack of return of brainstem functions. Among the 18 patients without TBI, CT signs of hypoxia were present in 15 patients (39%), and CT was considered intact in 3 patients (8%). None of the 35 patients with abnormal CT findings survived, and the presence of such findings predicted fatality with high sensitivity and specificity. While 13 of the 38 patients (34%) had CT evidence of UCSI, concomitant TBI and USCI were uncommon. None of the 13 patients with UCSI underwent spine surgery because of lack of return of brainstem functions, and the presence of USCI might also be associated with fatality. Although obtaining CT was useful in the prognostication of TCA patients with ROSC, it did not have much impact in therapeutic decision making.	[Inamasu, Joji; Hirose, Yuichi] Fujita Hlth Univ Hosp, Dept Neurosurg, Toyoake, Aichi 4701131, Japan; [Inamasu, Joji; Nakatsukasa, Masashi] Saiseikai Utsunomiya Hosp, Dept Neurosurg, Utsunomiya, Tochigi, Japan		Inamasu, J (corresponding author), Fujita Hlth Univ Hosp, Dept Neurosurg, 1-98 Kutsukake, Toyoake, Aichi 4701131, Japan.	inamasu@fujita-hu.ac.jp	Inamasu, Joji/R-7314-2019; Hirose, Yuichi/P-1731-2019	Hirose, Yuichi/0000-0002-1305-1830			ALKER GJ, 1975, RADIOLOGY, V114, P611; Amantini A, 2008, EUR J ANAESTH, V25, P196, DOI 10.1017/S0265021507003183; Busch M, 2006, ACTA ANAESTH SCAND, V50, P754, DOI 10.1111/j.1399-6576.2006.01030.x; Cera SM, 2003, AM SURGEON, V69, P140; Cocchi MN, 2010, INTERN EMERG MED, V5, P533, DOI 10.1007/s11739-010-0403-8; Dreiangel N, 2010, SPINE J, V10, P704, DOI 10.1016/j.spinee.2010.05.015; Holly LT, 2002, J NEUROSURG, V96, P285, DOI 10.3171/spi.2002.96.3.0285; Huber-Wagner S, 2007, RESUSCITATION, V75, P276, DOI 10.1016/j.resuscitation.2007.04.018; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Inamasu J, 2010, RESUSCITATION, V81, P534, DOI 10.1016/j.resuscitation.2010.01.012; Inamasu J, 2009, RESUSCITATION, V80, P977, DOI 10.1016/j.resuscitation.2009.05.010; Kleweno CP, 2008, SPINE, V33, pE659, DOI 10.1097/BRS.0b013e318182272a; Martin SK, 2002, J TRAUMA, V53, P876, DOI 10.1097/00005373-200211000-00011; Matsumoto H, 2009, RESUSCITATION, V80, P1270, DOI 10.1016/j.resuscitation.2009.08.010; Naples R, 2009, AM J EMERG MED, V27, P63, DOI 10.1016/j.ajem.2008.01.014; Pickens JJ, 2005, J TRAUMA, V58, P951, DOI 10.1097/01.TA.0000162174.06448.5A; Provenzale J, 2007, EMERG RADIOL, V14, P1, DOI 10.1007/s10140-007-0587-z; ROSEMURGY AS, 1993, J TRAUMA, V35, P468, DOI 10.1097/00005373-199309000-00022; Rosemurgy AS, 1993, J TRAUMA, V35, P473; Shimazaki Shuji, 2003, Nihon Geka Gakkai Zasshi, V104, P290; Tian HL, 2009, J TRAUMA, V67, P1305, DOI 10.1097/TA.0b013e31819db57c; Torbey MT, 2000, STROKE, V31, P2163, DOI 10.1161/01.STR.31.9.2163; Walter S, 2012, LANCET NEUROL, V11, P397, DOI 10.1016/S1474-4422(12)70057-1	23	3	4	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	SEP	2013	53	9					585	589					5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	295EX	WOS:000330100500003	24067768				2022-02-06	
J	Manna, I; Labate, A; Mumoli, L; Ferlazzo, E; Aguglia, U; Quattrone, A; Gambardella, A				Manna, Ida; Labate, Angelo; Mumoli, Laura; Ferlazzo, Edoardo; Aguglia, Umberto; Quattrone, Aldo; Gambardella, Antonio			Failure to confirm association of a polymorphism in KCNMB4 gene with mesial temporal lobe epilepsy	EPILEPSY RESEARCH			English	Article						KCNMB4; Candidate gene; Single nucleotide polymorphism; Association studies; Genetic susceptibility; Mesial temporal lobe epilepsy	HIPPOCAMPAL; SCLEROSIS	A recent study has implicated a tagging single nucleotide polymorphism (SNP) rs398702 located 3' of KCNMB4 (encoding calcium-activated potassium channel, subfamily M subunit beta 4) as a possible susceptibility allele for mesial temporal lobe epilepsy (mTLE). Such a finding warrants a further well-powered study in additional carefully phenotyped cohorts. Here we examined the role of the SNP (rs398702) in a cohort of 332 patients (182 women and 150 men; mean +/- SD age: 47.06 +/- 18.12) who had diagnoses of mTLE. None of the patients had a mass lesion, malformations of cortical development, or traumatic brain injury. Brain MRI study revealed hippocampal sclerosis (Hs) in 86/332 (26%) patients. Most patients (254/332, 76%) patients had drug-responsive mTLE. We also enrolled 335 healthy controls (164 women and 171 men; mean +/- SD age: 48.20 +/- 21.90), matched for age, sex and ethnicity. All patients and controls were Caucasian and were born in Italy. The genotype distribution of the SNP rs398702 in patients and controls was within Hardy-Weinberg equilibrium (p > 0.05). There was no statistically significant difference in the genotype or allelic frequencies between patients and controls (p = 0.878 and p = 0.666 respectively). Moreover, such a variant did not influence the main clinical characteristics of mTLE, the presence of Hs or responsiveness to antiepileptic drugs. In conclusion, our data suggest that the rs398702 variant in the KCNMB4 gene is unlikely to influence significantly the risk of developing mTLE or its severity. They further highlight the importance of replication to confirm the validity of association study results. (C) 2013 Published by Elsevier B.V.	[Manna, Ida; Aguglia, Umberto; Quattrone, Aldo; Gambardella, Antonio] CNR, Inst Neurol Sci, Cosenza, Italy; [Labate, Angelo; Mumoli, Laura; Ferlazzo, Edoardo; Aguglia, Umberto; Quattrone, Aldo; Gambardella, Antonio] Magna Graecia Univ Catanzaro, Inst Neurol, I-88100 Catanzaro, Italy; [Ferlazzo, Edoardo; Aguglia, Umberto] Osped Riuniti Reggio Calabria, Epilepsy Ctr, Reggio Di Calabria, Italy		Gambardella, A (corresponding author), Magna Graecia Univ Catanzaro, Cattedra & UO Neurol, Campus Univ Germaneto, I-88100 Catanzaro, Italy.	a.gambardella@unicz.it	QUATTRONE, Aldo/A-6734-2016; Aguglia, Umberto/AAB-9898-2019; Ferlazzo, Edoardo/F-9566-2018; Gambardella, Antonio/F-5295-2012	QUATTRONE, Aldo/0000-0003-2001-957X; Aguglia, Umberto/0000-0002-4574-2951; Gambardella, Antonio/0000-0001-7384-3074; MANNA, IDA/0000-0002-4777-7138; Labate, Angelo/0000-0002-8827-7324			Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Cavalleri GL, 2007, LANCET NEUROL, V6, P970, DOI 10.1016/S1474-4422(07)70247-8; Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7; Engel J, 1996, NEW ENGL J MED, V334, P647, DOI 10.1056/NEJM199603073341008; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gambardella A, 2003, NEUROLOGY, V60, P560, DOI 10.1212/01.WNL.0000046520.79877.D8; Gambardella A, 2009, EPILEPSIA, V50, P55, DOI 10.1111/j.1528-1167.2009.02123.x; JACKSON GD, 1994, NEUROLOGY, V44, P42, DOI 10.1212/WNL.44.1.42; Konig IR, 2011, BRIEF BIOINFORM, V12, P253, DOI 10.1093/bib/bbq074; Labate A, 2008, NEUROLOGY, V71, P1094, DOI 10.1212/01.wnl.0000326898.05099.04; Labate A, 2006, NEUROLOGY, V66, P562, DOI 10.1212/01.wnl.0000198208.59347.96; Petrik D, 2011, EUR J NEUROSCI, V34, P695, DOI 10.1111/j.1460-9568.2011.07799.x; Tan NCK, 2004, EPILEPSIA, V45, P1429, DOI 10.1111/j.0013-9580.2004.22904.x	13	3	3	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	SEP	2013	106	1-2					284	287		10.1016/j.eplepsyres.2013.03.014			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	221NM	WOS:000324665600033	23623847				2022-02-06	
J	Fernandes, RNR; Silva, M				Ribeiro Fernandes, Raimundo Nonato; Silva, Marlene			Epidemiology of traumatic brain injury in Brazil	BRAZILIAN NEUROSURGERY-ARQUIVOS BRASILEIROS DE NEUROCIRURGIA			English	Article						Craniocerebral trauma; hospitalization; morbidity; mortality; hospital mortality		Objective: To describe the estimates of morbidity and nosocomial mortality for traumatic brain injury (TBI), along with its causes. Methods: This is a descriptive series of hospitalizations in public Brazilian hospitals, with patients with age among 14 and 69 years, during the period of 2001 to 2007. It was selected the total number of hospitalizations for TBI and others diagnoses. It was estimated prevalence rates, and the coefficients of nosocomial mortality and lethality of TBI and the external causes of TBI for each year of jurisdiction. Results: The hospitalizations for TBI concentrated among men (81.50%) aged between 14-34 years (53.00%). The median time of inpatient care was three days, with a total of 52,087 deaths. Falls (35.00%), and traffic accidents (31.00%) were the causes that most contributed to TBI. After exclusion of non-specified lesions, the most frequent diagnoses were the diffuse lesions (36.3%). The prevalence rate and nosocomial lethality remained elevated. Conclusion: It is necessary to establish preventive measures for TBI. The estimates of morbidity and lethality remain high.	Hosp Portugues, Inst Cardio Pulm, Salvador, BA, Brazil; Univ Fed Bahia UFBA, Salvador, BA, Brazil		Fernandes, RNR (corresponding author), Ave Sete Setembro,2284-1201, BR-40080001 Salvador, BA, Brazil.	raimundofernandes1@gmail.com					Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Aryan HE, 2005, BRAIN INJURY, V19, P505, DOI 10.1080/02699050400005143; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Datasus, SIST INF HOSP; de Faria JWV, 2008, ARQ NEURO-PSIQUIAT, V66, P69, DOI 10.1590/S0004-282X2008000100016; FARAGE LUCIANO, 2002, Rev. Assoc. Med. Bras., V48, P163, DOI 10.1590/S0104-42302002000200037; Faul M, 2010, TRAUMATIC BRAIN INJU; Gawryszewski Vilma Pinheiro, 2004, Cad. Saúde Pública, V20, P995, DOI 10.1590/S0102-311X2004000400014; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Instituto Brasileiro de Geografia e Estatistica. (IBGE), RES UN CENS 2000; Koizumi MS, 2000, ARQ NEURO-PSIQUIAT, V58, P81, DOI 10.1590/S0004-282X2000000100013; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Melo JRT, 2004, ARQ NEURO-PSIQUIAT, V62, P711, DOI 10.1590/S0004-282X2004000400027; Mesquita Filho M, 2007, REV BRAS EPIDEMIOL, V10, P679; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; Solmaz I, 2009, TURK NEUROSURG, V19, P216; Souza ER, 2006, CIENC SAUDE COLETIVA, V11, P1211, DOI [DOI 10.1590/S1413-81232006000500011, 10.1590/S1413-81232006000500011]; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tennant A, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-21; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; 2000, REV SAUDE PUBLICA, V34, P427	26	3	4	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0103-5355	2359-5922		BRAZ NEUROSURG	Braz. Neurosurg.	SEP	2013	32	3					136	142					7	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	VC6RD	WOS:000434525400002					2022-02-06	
J	Ta'eed, G; Skilbeck, CE; Slatyer, M				Ta'eed, Gillian; Skilbeck, Clive E.; Slatyer, Mark			Which Factors Determine Who is Referred for Community Rehabilitation Following Traumatic Brain Injury?	BRAIN IMPAIRMENT			English	Article						TBI; rehabilitation; community; referral; population-based sample	RANDOMIZED CONTROLLED-TRIAL; FUNCTIONAL INDEPENDENCE MEASURE; DISABILITY RATING-SCALE; MINOR HEAD-INJURY; DEPRESSION SCALE; HOSPITAL ANXIETY; SOUTH-AUSTRALIA; MILD; SYMPTOMS; CONCUSSION	Primary objective: To investigate which variables predict referral for rehabilitation in the participants of the Tasmanian Neurotrauma Register (TNTR), a large (N = 1226) prospective population-based study of adult traumatic brain injury (TBI) in southern Tasmania. Method: Over a 3-year period, only 54 TBI patients were referred by hospital or local health services for public community rehabilitation, with 121 referred by TNTR research assistants. A further 247 accessed private rehabilitation and 804 received no rehabilitation. These four groups were compared on a range of variables to identify which factors determine referral. Results: Those referred by hospital or community services and those receiving private rehabilitation had more severe TBI (p < .001), greater disability (p < .001) and were more likely to have been hospitalised post-injury (p < .001). The TNTR-referred group reported more post-concussion symptoms (PCS; p < .001), anxiety (p < .001) and depression (p < .001). TNTR-referral was more likely (p < .001) following assault, compared with other causes of injury. Sixteen per cent of those not referred for rehabilitation had suffered moderate or severe TBI. Conclusions: These results indicate that no recognised pathway existed for non-hospitalised TBI patients to access public rehabilitation, even if they were reporting high levels of PCS and psychological distress. Furthermore, routine follow-up to assess rehabilitation needs was not occurring in Tasmania, even for some with moderate and severe TBI.	[Ta'eed, Gillian; Skilbeck, Clive E.; Slatyer, Mark] Univ Tasmania, Sch Psychol, Hobart, Tas 7001, Australia; [Skilbeck, Clive E.; Slatyer, Mark] Royal Hobart Hosp, Tasmanian Neurotrauma Register, Hobart, Tas, Australia		Ta'eed, G (corresponding author), Univ Tasmania, Sch Psychol, Hobart, Tas 7001, Australia.	gillian.taeed@utas.edu.au					Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; BADCOCK KA, 1988, COMMUNITY HEALTH ST, V12, P428; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; British Society of Rehabilitation Medicine Royal College of Physicians, 2003, REH FOLL ACQ BRAIN I; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; FIFE D, 1987, AM J PUBLIC HEALTH, V77, P810, DOI 10.2105/AJPH.77.7.810; Gerhart KA, 2003, J TRAUMA, V55, P1045, DOI 10.1097/01.TA.0000044353.69681.96; Ghaffar O, 2006, J PSYCHOSOM RES, V61, P153, DOI 10.1016/j.jpsychores.2005.07.018; Goleburn G, 2001, J CLIN GEROPSYCHOL, V7, P161, DOI DOI 10.1023/A:1011335027445; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Graham SK, 2008, AUST HEALTH REV, V32, P392, DOI 10.1071/AH080392; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; GRONWALL D, 1975, LANCET, V2, P995; Helps Y., 2008, HOSP SEPARATIONS DUE; Hillier SL, 1997, BRAIN INJURY, V11, P649; *HLTH DEP VICT, 1991, SUMM REP HEAD INJ IM; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LOWDON IMR, 1989, INJURY, V20, P193, DOI 10.1016/0020-1383(89)90109-5; Marosszeky NEV, 1997, PTA PROTOCOL GUIDELI; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; Nelson H.E., 1982, NATL ADULT READING T; O'Callaghan AM, 2009, AUST J RURAL HEALTH, V17, P119, DOI 10.1111/j.1440-1584.2009.01054.x; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Sosin DM, 1996, BRAIN INJURY, V10, P47; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Turner-Stokes L, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1016/S0079-6123(09)17707-5; Vanderploeg RD, 2003, J HEAD TRAUMA REHAB, V18, P148, DOI 10.1097/00001199-200303000-00006; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Wechsler D, 1996, WECHSLER ADULT INTEL; Wenden FJ, 1998, CLIN REHABIL, V12, P53, DOI 10.1191/026921598675567949; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	59	3	3	0	7	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	SEP	2013	14	2					222	234		10.1017/BrImp.2013.21			13	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	222VU	WOS:000324760900002					2022-02-06	
J	Gardner, A; Poehling, KA; Miller, CD; Tooze, JA; Petty, J				Gardner, Alison; Poehling, Katherine A.; Miller, Chadwick D.; Tooze, Janet A.; Petty, John			Isolated Head Injury Is a Cause of Shock in Pediatric Trauma Patients	PEDIATRIC EMERGENCY CARE			English	Article						injury; craniocerebral trauma; shock	BRAIN-INJURY; RESUSCITATION; HYPOTENSION; FAMILY; IMPACT; CHILDHOOD	Objectives: Current trauma resuscitation protocols from the American College of Surgeons, Committee on Trauma, recommend intravascular volume expansion to treat shock after major trauma, assuming that hemorrhage is present. However, this assumption may not be correct. The purpose of this study was to identify the proportion of children with severe shock after trauma presenting with isolated head injury versus hemorrhagic injury. Methods: A retrospective review of all pediatric trauma patients (aged 0-15 years) was conducted over a 5-year period. Severe shock was defined as the presence of both an elevated blood lactate level and low blood pressure for age. Traumatic injuries were classified as hemorrhagic injuries, head injuries, combined hemorrhagic and head injuries, or other injuries, by analyzing International Classification of Diseases, Ninth Revision diagnostic codes. Results: A total of 31 (5%) of 680 pediatric trauma patients presented with severe shock. Among these 31 pediatric trauma patients, 9 (29%) had isolated head injury. Isolated head injury among children with shock was most frequently observed among children younger than 5 years (50%), and a decreased trend was noted with increasing age (23% for children 5-11 years and 0% for children 12-15 years [P = 0.03, Cochran-Armitage exact trend test]). Conclusions: Isolated head injury was observed in 29% of children 0 to 15 years of age with severe shock after trauma and in 50% of children younger than 5 years. Head injury is an important cause of severe shock in pediatric trauma, particularly among young children.	[Gardner, Alison; Poehling, Katherine A.] Wake Forest Hlth Sci, Dept Gen Surg, Dept Pediat, Winston Salem, NC USA; [Gardner, Alison; Miller, Chadwick D.] Wake Forest Hlth Sci, Dept Gen Surg, Dept Emergency Med, Winston Salem, NC USA; [Poehling, Katherine A.] Wake Forest Hlth Sci, Dept Gen Surg, Dept Epidemiol, Winston Salem, NC USA; [Tooze, Janet A.] Wake Forest Hlth Sci, Dept Gen Surg, Div Publ Hlth Sci, Dept Biostat Sci, Winston Salem, NC USA; [Petty, John] Wake Forest Hlth Sci, Dept Gen Surg, Pediat Surg Sect, Winston Salem, NC USA		Gardner, A (corresponding author), Wake Forest Sch Med, Dept Pediat & Emergency Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	agardner@wakehealth.edu			Childress Institute for Pediatric Trauma	This study was supported in part by a career development award from The Childress Institute for Pediatric Trauma.	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; [Anonymous], 2008, ADV TRAUM LIF SUPP D, P55; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; Feinstein AJ, 2005, J AM COLL SURGEONS, V201, P536, DOI 10.1016/j.jamcollsurg.2005.05.031; Fulton R L, 1993, J Invest Surg, V6, P117, DOI 10.3109/08941939309141603; Gilchrist Julie, 2012, Morbidity and Mortality Weekly Report, V61, P270; Kochanek KD, 2012, PEDIATRICS, V129, P338, DOI 10.1542/peds.2011-3435; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lavery RF, 2000, J AM COLL SURGEONS, V190, P656, DOI 10.1016/S1072-7515(00)00271-4; Mahoney EJ, 2003, J TRAUMA, V55, P1065, DOI 10.1097/01.TA.0000100381.89107.93; Montgomery V, 2002, J TRAUMA, V52, P1121, DOI 10.1097/00005373-200206000-00016; Osberg JS, 1997, BRAIN INJURY, V11, P11; Partrick DA, 2002, AM J SURG, V184, P555, DOI 10.1016/S0002-9610(02)01052-8; Porter JM, 1998, J TRAUMA, V44, P908, DOI 10.1097/00005373-199805000-00028; Sanui M, 2006, CRIT CARE MED, V34, P433, DOI 10.1097/01.CCM.0000196206.83534.39; Scott KK, 2002, SURG CLIN N AM, V82, P419, DOI 10.1016/S0039-6109(02)00013-0; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006	21	3	3	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	AUG	2013	29	8					879	883		10.1097/PEC.0b013e31829ec0ee			5	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	300NL	WOS:000330470500001	23903673				2022-02-06	
J	Holland, JM; Lisman, R; Currier, JM				Holland, Jason M.; Lisman, Ross; Currier, Joseph M.			Mild Traumatic Brain Injury, Meaning Made of Trauma, and Posttraumatic Stress: A Preliminary Test of a Novel Hypothesis	REHABILITATION PSYCHOLOGY			English	Article							DISORDER SYMPTOMS; AFGHANISTAN; IRAQ; DEPLOYMENT; OUTCOMES; HEALTH; SENSE; GRIEF	Objective: Research has demonstrated that a substantial number of veterans returning from Iraq and Afghanistan with mild traumatic brain injury (mTBI) also contend with symptoms of posttraumatic stress disorder (PTSD). One possible contributing factor for the development and/or exacerbation of PTSD symptoms among individuals with mTBI could involve challenges processing trauma and integrating their memories into existing global meaning systems. The goal of this study was to provide a preliminary examination of whether meaning made of trauma could account for the association between mTBI and PTSD (i.e., reexperiencing, avoidance, and hyperarousal symptoms). Method: The sample was comprised of 162 Iraq and/or Afghanistan veterans who presented for health care services at a Department of Veterans Affairs hospital. These veterans completed a two-level evaluation for mTBI as well as a self-report questionnaire assessing demographic and military background factors, meaning made of trauma, and PTSD symptomatology. Results: Drawing on structural equation modeling, results indicated that probable mTBI was indirectly associated with the three domains of PTSD symptomatology via veterans' meaning made of trauma. Conclusions: Although the cross-sectional nature of this study limits the conclusions that can be drawn, these results offer support for difficulties with meaning-making as a contributing factor for risk of PTSD among veterans with mTBI.	[Holland, Jason M.] Univ Nevada, Dept Psychol, Las Vegas, NV 89154 USA; [Lisman, Ross] Fuller Theol Seminary, Dept Clin Psychol, Pasadena, CA USA; [Currier, Joseph M.] Memphis Vet Adm Med Ctr, Memphis, TN USA; [Currier, Joseph M.] Univ S Alabama, Dept Psychol, Mobile, AL 36688 USA		Holland, JM (corresponding author), Univ Nevada, Dept Psychol, 4505 S Maryland Pkwy,Box 455030, Las Vegas, NV 89154 USA.	jason.holland@unlv.edu	Kiel, Steffen/C-3150-2009	Kiel, Steffen/0000-0001-6281-100X			American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Browne MW, 1993, TESTING STRUCTURAL E, P1136; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Currier JM, 2006, DEATH STUD, V30, P403, DOI 10.1080/07481180600614351; Currier JM, 2012, J TRAUMA STRESS, V25, P102, DOI 10.1002/jts.21655; Currier JM, 2011, J TRAUMA STRESS, V24, P691, DOI 10.1002/jts.20691; Dalgleish T, 2004, PSYCHOL BULL, V130, P228, DOI 10.1037/0033-2909.130.2.228; Ehlers A, 2004, MEMORY, V12, P403, DOI 10.1080/09658210444000025; Epston, 1990, NARRATIVE MEANS THER; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holland JM, 2011, J PSYCHOPATHOL BEHAV, V33, P254, DOI 10.1007/s10862-010-9214-5; Holland JM, 2010, INT J STRESS MANAGE, V17, P325, DOI 10.1037/a0020892; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Maestas KL, 2011, REHABIL PSYCHOL, V56, P366, DOI 10.1037/a0025447; Mansfield AJ, 2010, J TRAUMA STRESS, V23, P91, DOI 10.1002/jts.20492; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; Neimeyer Robert A, 2002, J Palliat Med, V5, P935, DOI 10.1089/10966210260499177; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Park CL, 2012, PSYCHOL TRAUMA-US, V4, P66, DOI 10.1037/a0018792; Park CL, 2010, PSYCHOL BULL, V136, P257, DOI 10.1037/a0018301; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Toblin RL, 2012, J AFFECT DISORDERS, V136, P469, DOI 10.1016/j.jad.2011.10.048; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Weathers F.W., 1993, ANN CONV INT SOC TRA; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	35	3	3	0	7	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2013	58	3					280	286		10.1037/a0033399			7	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	204ZB	WOS:000323408700007	23815305				2022-02-06	
J	Kane, SF; Saperstein, AK; Bunt, CW; Stephens, MB				Kane, Shawn F.; Saperstein, Adam K.; Bunt, Christopher W.; Stephens, Mark B.			When war follows combat veterans home	JOURNAL OF FAMILY PRACTICE			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; US MILITARY; ALCOHOL-USE; IRAQ; CARE; AFGHANISTAN; DIAGNOSIS; SERVICE		[Kane, Shawn F.; Saperstein, Adam K.; Bunt, Christopher W.; Stephens, Mark B.] Uniformed Serv Univ Hlth Sci, Dept Family Med, Bethesda, MD 20814 USA		Kane, SF (corresponding author), USASOC, 2929 Desert Storm Dr, Ft Bragg, NC 28310 USA.	shawn.kane@us.army.mil	Stephens, Mark/A-2679-2015	kane, Shawn/0000-0002-9110-5224; Bunt, Christopher/0000-0002-5130-6902			Adler AB, 2008, J TRAUMA STRESS, V21, P301, DOI 10.1002/jts.20336; Alexander Walter, 2012, P T, V37, P32; American Academy of Family Physicians, JOIN FORC; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Bohnert ASB, 2012, MIL MED, V177, P198, DOI 10.7205/MILMED-D-11-00270; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Center for Substance Abuse Treatment, 2004, TREATM IMPR PROT TIP, V40; Department of Veterans Affairs, 2008, REP BLUE RIBB WORK G; Department of Veterans Affairs Department of Defense, 2009, CLIN PRACT GUID MAN; Department of Veterans Affairs/Department of Defense, 2010, CLIN PRACT GUID MAN; Eaton KM, 2006, SUICIDE LIFE-THREAT, V36, P182, DOI 10.1521/suli.2006.36.2.182; Erbes CR, 2011, J REHABIL RES DEV, V48, P1159, DOI 10.1682/JRRD.2010.11.0212; ESPINOZA JM, 2010, J PSYCHOL ISSUES ORG, V1, P6; Farrell M, 1998, ADDICT BEHAV, V23, P909, DOI 10.1016/S0306-4603(98)00075-6; Fontana A, 2008, J NERV MENT DIS, V196, P513, DOI 10.1097/NMD.0b013e31817cf6e6; Gadermann AM, 2012, MIL MED, V177, P47, DOI 10.7205/MILMED-D-12-00103; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Greenberg J, 2012, MIL MED, V177, P60, DOI 10.7205/MILMED-D-12-00102; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Hermann BA, 2012, MIL MED, V177, P1; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2012, JAMA-J AM MED ASSOC, V308, P671, DOI 10.1001/jama.2012.9955; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jaffe G. (, 2012, WASH POST; Jonas DE, 2012, ANN INTERN MED, V157, P645, DOI 10.7326/0003-4819-157-9-201211060-00544; Kinn J.T., 2011, DEP DEFENSE SUICIDE; Kotwal RS, 2011, ARCH SURG-CHICAGO, V146, P1349, DOI 10.1001/archsurg.2011.213; Lew HL, 2005, AM J PHYS MED REHAB, V84, P393, DOI 10.1097/01.phm.0000163703.91647.a7; Marshall KR, 2012, MIL MED, V177, P67, DOI 10.7205/MILMED-D-12-00110; Miller M, 2012, AM J PUBLIC HEALTH, V102, pS20, DOI 10.2105/AJPH.2011.300572; Mirza Raul A, 2012, MSMR, V19, P10; Mossadegh S, 2012, J TRAUMA ACUTE CARE, V73, pS24, DOI 10.1097/TA.0b013e3182625f82; OBrien CP, 1996, ALCOHOL, V13, P35, DOI 10.1016/0741-8329(95)02038-1; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Perrone M., 2012, BOSTON          0725; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Praveen KT, 2012, AM FAM PHYSICIAN, V86, P565; Quinlan JD, 2010, AM FAM PHYSICIAN, V82, P43; Seal KH, 2012, JAMA-J AM MED ASSOC, V307, P940, DOI 10.1001/jama.2012.234; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Stecker T, 2010, PSYCHOSOMATICS, V51, P503, DOI 10.1176/appi.psy.51.6.503; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Toombs JD, 2005, AM FAM PHYSICIAN, V71, P1353; United States Census Bureau, 2013, SEX AG VET STAT CIV; United States Department of Health and Human Services Substance Abuse and Mental Health Services Administration, BUPR THER; Uomoto JM, 2012, J HEAD TRAUMA REHAB, V27, P241, DOI 10.1097/HTR.0b013e31825ee26a; van Dam D, 2012, CLIN PSYCHOL REV, V32, P202, DOI 10.1016/j.cpr.2012.01.004; VOLPICELLI JR, 1992, ARCH GEN PSYCHIAT, V49, P876; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warner CH, 2011, AM J PSYCHIAT, V168, P378, DOI 10.1176/appi.ajp.2010.10091303; Wessely S, 2005, BRIT J PSYCHIAT, V186, P459, DOI 10.1192/bjp.186.6.459; Wisco BE, 2012, MIL MED, V177, P7, DOI 10.7205/MILMED-D-12-00111	56	3	3	0	3	DOWDEN HEALTH MEDIA	MONTVALE	110 SUMMIT AVE, MONTVALE, NJ 07645-1712 USA	0094-3509			J FAM PRACTICE	J. Fam. Pract.	AUG	2013	62	8					399	407					9	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	218WW	WOS:000324464300003	24143332				2022-02-06	
J	Semmler, A; Prost, JC; Smulders, Y; Smith, D; Blom, H; Bigler, L; Linnebank, M				Semmler, Alexander; Prost, Jean-Christophe; Smulders, Yvo; Smith, Desiree; Blom, Henk; Bigler, Laurent; Linnebank, Michael			Methylation metabolism in sepsis and systemic inflammatory response syndrome	SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION			English	Article						Sepsis; methylation metabolism; DNA methylation; folate; vitamin B12; S-adenosylmethionine	TANDEM MASS-SPECTROMETRY; S-ADENOSYLHOMOCYSTEINE; PLASMA HOMOCYSTEINE; ADENOSYLMETHIONINE	We have recently shown that sepsis leads to alterations of methylation metabolism in a rodent model. In this study we analyzed methylation metabolism and DNA methylation in human sepsis. Patients treated in one of the Intensive Care Units (ICU) at the University Hospital Bonn diagnosed with sepsis or systemic inflammatory response syndrome (n = 12) and patients who were treated due to traumatic brain injury, or stroke without clinical or laboratory signs of sepsis or major inflammation (n = 22) were included. Blood samples were taken two times a week, until ICU treatment was discontinued. Deproteinized plasma was used for simultaneous determination of the ubiquitous methyl-group donor S-adenosylmethionine (SAM) and its demethylated residue, S-adenosylhomocysteine (SAH), by using stable isotope dilution tandem mass spectrometry. Homocysteine (Hcys), hydrolyzation product of SAH, was determined by fully automated particle-enhanced immunonephelometry, and global DNA-methylation was measured by liquid chromatography tandem mass spectrometry. SAM (p < 0.001) and SAH (p < 0.001) plasma levels were higher in septic patients suggesting an increased cellular release of SAM and SAH in septic patients. The SAM/SAH ratio was decreased in septic patients (p = 0.002). There were no differences in homocysteine plasma levels (p = 0.32) or global leukocyte DNA methylation between septic and non-septic patients (p = 0.21) suggesting that sepsis-induced changes in methylation metabolism do not affect homocysteine plasma levels or the availability of SAM-derived methyl groups for DNA methylation. Sepsis and systemic inflammatory response syndrome induce considerable changes of methylation metabolism without apparent functional consequences on homocysteine plasma levels or DNA methylation. Further studies may explore the clinical relevance of the observed changes.	[Semmler, Alexander; Linnebank, Michael] Univ Zurich, Dept Neurol, CH-8091 Zurich, Switzerland; [Prost, Jean-Christophe; Bigler, Laurent] Univ Zurich, Inst Organ Chem, CH-8091 Zurich, Switzerland; [Smulders, Yvo; Smith, Desiree; Blom, Henk] Vrije Univ Amsterdam, Med Ctr, Dept Internal Med, Amsterdam, Netherlands; [Smulders, Yvo; Smith, Desiree] Inst Cardiovasc Res ICaR VU, Amsterdam, Netherlands		Semmler, A (corresponding author), Univ Zurich, Dept Neurol, Frauenklin Str 26, CH-8091 Zurich, Switzerland.	alexander.semmler@usz.ch	Smulders, YM/AAG-7506-2021; Bigler, Laurent/AAP-3799-2020	Bigler, Laurent/0000-0003-3548-3594; Blom, Henk/0000-0001-5202-9241; Smith, Desiree/0000-0003-2053-3392; Prost, Jean-Christophe/0000-0002-8820-706X			Garcia-Alvarez F, 2000, Int J Surg Investig, V2, P9; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Ko K, 2008, LAB INVEST, V88, P1121, DOI 10.1038/labinvest.2008.69; Kok RM, 2007, CLIN CHEM LAB MED, V45, P903, DOI 10.1515/CCLM.2007.137; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Melnyk S, 2000, CLIN CHEM, V46, P265; Semmler A, 2008, CLIN CHEM LAB MED, V46, P1398, DOI 10.1515/CCLM.2008.277; Struys EA, 2000, CLIN CHEM, V46, P1650; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200	10	3	3	1	5	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0036-5513			SCAND J CLIN LAB INV	Scand. J. Clin. Lab. Invest.	AUG	2013	73	5					368	372		10.3109/00365513.2013.785587			5	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	200YE	WOS:000323106700002	23566119				2022-02-06	
J	Valitchka, L; Turkstra, LS				Valitchka, Lindsey; Turkstra, Lyn S.			Communicating with Inpatients with Memory Impairments	SEMINARS IN SPEECH AND LANGUAGE			English	Article						Communication; memory; posttraumatic amnesia; inpatient rehabilitation; cognitive rehabilitation	CLOSED-HEAD-INJURY; POSTTRAUMATIC AMNESIA; SURVIVORS	Many patients with acquired brain injury have acute impairments in declarative memory, the memory system responsible for learning facts and remembering events, whereas implicit memory for skills, habits, and emotional associations remains intact. The combination of impaired declarative memory and preserved implicit memory has implications for communicating with patients in inpatient rehabilitation, not only in therapy sessions but also in nontherapy interactions with rehabilitation staff. The aim of this study was to describe communication patterns among inpatients with declarative memory impairments and rehabilitation staff members during the early stage postinjury. Participants were five adults with acquired brain injury and declarative memory impairments. Each participant was observed for a full inpatient rehabilitation day. Results showed that staff and visitors frequently asked participants declarative questions to which answers were not verifiable (e.g., questions about preinjury events). Answers that could be verified often were incorrect but were accepted by staff as correct. Results suggest that acute rehabilitation staff may need training in communicating with patients with declarative memory impairments. We suggest strategies to create a more supportive communication environment for inpatients with memory impairment.	[Valitchka, Lindsey; Turkstra, Lyn S.] Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI 53706 USA		Turkstra, LS (corresponding author), Univ Wisconsin, Dept Commun Sci & Disorders, 1975 Willow Dr, Madison, WI 53706 USA.	lsturkstra@wisc.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921	Emma Allen Fellowship Award from the University of Wisconsin-Madison Department of Communicative Sciences and Disorders	This study was supported in part by the Emma Allen Fellowship Award from the University of Wisconsin-Madison Department of Communicative Sciences and Disorders. The authors would like to thank the staff at the two rehabilitation hospitals at which data were collected. The study was conducted in partial fulfillment of requirements for an M. S. degree, and the first author would like to thank the members of her thesis committee, Dr. Michelle Ciucci and Ms. Dana Longstreth, for their support.	Brush JA, 1998, THERAPY TECHNIQUE IM; COHEN NJ, 1985, ANN NY ACAD SCI, V444, P54, DOI 10.1111/j.1749-6632.1985.tb37579.x; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Mecklinger A, 1998, BRAIN, V121, P1919, DOI 10.1093/brain/121.10.1919; Myers CE, 2008, NEUROPSYCHOLOGY, V22, P681, DOI 10.1037/0894-4105.22.5.681; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Novak T., 2000, ORIENTATION LOG; Randolph C., 2001, REPEATABLE BATTERY A; SCHACTER DL, 1992, P NATL ACAD SCI USA, V89, P11113, DOI 10.1073/pnas.89.23.11113; Sohlberg M. M., 2011, OPTIMIZING INSTRUCTI; Turkstra LS, 2013, J HEAD TRAUMA REHAB, V28, P332, DOI 10.1097/HTR.0b013e31828b4f3f; Vidoni Eric D, 2007, J Neurol Phys Ther, V31, P145	13	3	3	0	3	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0734-0478	1098-9056		SEMIN SPEECH LANG	Semin. Speech Lang.	AUG	2013	34	3					142	153		10.1055/s-0033-1358371			12	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	242IF	WOS:000326231800003	24166189				2022-02-06	
J	Zasler, ND; Ameis, A; Riddick-Grisham, SN				Zasler, Nathan D.; Ameis, Arthur; Riddick-Grisham, Susan N.			Life Care Planning After Traumatic Brain Injury	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury (TBI); Life care planning; Physiatry; Medicolegal		A life care plan is a detailed and comprehensive analysis of impairments, realistic needs, and associated costs relevant to providing a lifetime of care to patients. Physicians have a central role in advising life care planners. Within an expertly prepared life care plan, issues must correspond directly with proposed goods and services. A life care plan must clearly cite all relevant caregiver sources and rely on scientific evidence. The central tenets of a life care plan and the ethical and professional roles that physicians may play in the context of traumatic brain injury and a life care plan are reviewed in this article.	[Zasler, Nathan D.] Concuss Care Ctr Virginia Ltd, Richmond, VA 23233 USA; [Zasler, Nathan D.] Tree Life Serv Inc, Richmond, VA 23233 USA; [Ameis, Arthur] Arthur Ameis Med Profess Corp, Toronto, ON M3H 1T2, Canada; [Ameis, Arthur] Univ Montreal, Fac Med, Certificat Program Insurance Med & MedicoLegal Ex, Montreal, PQ H3T 1J4, Canada; [Riddick-Grisham, Susan N.] Care Planner Network, Richmond, VA 23221 USA; [Riddick-Grisham, Susan N.] Life Care Manager, Richmond, VA 23221 USA; [Riddick-Grisham, Susan N.] Fdn Life Care Planning Res, Oviedo, FL 32764 USA; [Riddick-Grisham, Susan N.] Sarah Jane Brain Project, New York, NY 10023 USA; [Riddick-Grisham, Susan N.] Int Assoc Rehabil Profess, Glenview, IL 60025 USA		Zasler, ND (corresponding author), Concuss Care Ctr Virginia Ltd, 3721 Westerre Pkwy, Richmond, VA 23233 USA.	nzasler@cccv-ltd.com		Ameis, Arthur/0000-0003-4880-5150			Deutsch PM, 2003, GUIDE REHABILITATION, P5; Fagel BG, 2011, FORUM MAGAZINE, V41, P20; Kreuscher WC, 2010, J LIFE CARE PLAN, V9, P3; Marini I, 2010, J LIFE CARE PLAN, V4, P173; Patterson RM, 2010, J LIFE CARE PLAN, V9, P19; Reavis N, INT ACAD LIFE CARE P; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Thomas RL, 1996, INSIDE LIFE CARE PLA, V1, P3; Washington AD, 2010, PRODUCTS GEN LIA SPR, P4; Weed RO, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1437; Wehman Paul, 1993, Brain Injury, V7, P31, DOI 10.3109/02699059309008154; Zasler ND, 2009, PROG BRAIN RES, V177, P111, DOI 10.1016/S0079-6123(09)17709-9; Zasler ND, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1; Zasler ND, 1994, NARPPS J, V9, P57	14	3	3	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651			PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	AUG	2013	24	3					445	+		10.1016/j.pmr.2013.03.009			22	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	214QG	WOS:000324149800005	23910485				2022-02-06	
J	Chibbaro, S; Tigan, L; Marsella, M; George, B; Galzio, R; Kehrli, P; Vicaut, E; Diemidio, P				Chibbaro, Salvatore; Tigan, L.; Marsella, M.; George, B.; Galzio, R.; Kehrli, P.; Vicaut, E.; Diemidio, P.			The "Skull Flap" a new conceived device for decompressive craniectomy/cranioplasty: Feasibility study on cadaver specimen	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						Cranioplasty; decompressive craniectomy; new device and technique; skull flap	SEVERE HEAD-INJURY; MIDDLE CEREBRAL-ARTERY; PROSPECTIVE MULTICENTER; EARLY CRANIOPLASTY; BLOOD-FLOW; CRANIECTOMY; BRAIN; MANAGEMENT; INFARCTION	Background: Decompressive craniectomy (DC) is a procedure that is currently performed with increasing frequency. The reason is that its indications have become much broader. This procedure may be associated with the relevant morbidity in the postoperative stage due to the creation of a large bone defect. On the other hand, cranioplasty is associated too with some of the common complications related to any reconstructive head surgery. The authors present a newly developed device: The "Skull Flap" (SF). This new device allows the surgeon to complete a DC, yet providing at the same time a cranial reconstruction that will not require the patient to undergo a second reconstructive procedure. Materials and Methods: Different size and location craniectomies were carried out on four human cadaveric heads; the bone flaps were then repositioned in a more elevated position with respect to the skull edges. The flaps were placed at a distance of 12 and 15 mm from the skull edges using the SF system. Crash tests were conducted on each flap while in open and closed positions to assess its reliability and efficacy. Results: SF was shown to be a strong fixation device that allows satisfactory brain decompression by keeping the original bone flap away from the swollen brain; at the same time, in a later stage, it allows cranial reconstruction in a simple way. Conclusion: The SF device was shown to be very easy to use, adaptable, and practical to apply; thus, allowing both satisfactory brain decompression as well as bone flap repositioning at a later time after the brain swelling has subsided.	[Chibbaro, Salvatore; Tigan, L.; Kehrli, P.; Diemidio, P.] Strasbourg Univ Hosp, Dept Neurosurg, 1 Av Moliere, F-67100 Strasbourg, France; [George, B.] Lariboisiere Univ Hosp, Paris, France; [Vicaut, E.] Lariboisiere Hosp Fernand Widal, Clin Res Unit, Paris, France; [Marsella, M.] Univ Arizona, Med Ctr, Private Neurosurgeon, Tucson, AZ USA; [Galzio, R.] LAquila Univ, Dept Neurosurg, Laquila, Italy		Chibbaro, S (corresponding author), Strasbourg Univ Hosp, Dept Neurosurg, 1 Av Moliere, F-67100 Strasbourg, France.	schibbaro@hotmail.com	Chibbaro, Salvatore/AAI-6368-2020	Galzio, Renato/0000-0003-1933-1355; chibbaro, salvatore/0000-0003-1318-1245			Adeleye A Olufemi, 2011, Surg Neurol Int, V2, P150, DOI 10.4103/2152-7806.86227; Arikan F, 2010, NEUROCIRUGIA, V21, P452; Bostrom S, 2005, ACTA NEUROCHIR, V147, P279, DOI 10.1007/s00701-004-0480-4; Chibbaro S, 2013, REV NEUROL-FRANCE, V169, P240, DOI 10.1016/j.neurol.2012.06.016; Chibbaro S, 2012, INDIAN J NEUROSURG, V1, P17; Chibbaro S, 2007, SURG NEUROL, V68, P632, DOI 10.1016/j.surneu.2006.12.046; Chibbaro S, 2011, WORLD NEUROSURG, V75, P558, DOI 10.1016/j.wneu.2010.10.020; DeWitt D S, 1995, New Horiz, V3, P376; Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4; Ferro JM, 2011, STROKE, V42, P2825, DOI 10.1161/STROKEAHA.111.615393; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Jennett B., 1991, NIMODIPINE PHARM CLI, P225; Kawaguchi T, 2003, NEUROL MED-CHIR, V43, P320, DOI 10.2176/nmc.43.320; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Peethambaran AK, 2012, NEUROL INDIA, V60, P672, DOI 10.4103/0028-3886.105221; Sakamoto S, 2006, CLIN NEUROL NEUROSUR, V108, P583, DOI 10.1016/j.clineuro.2005.03.012; Salvatore C, 2008, J NEUROSURG, V108, P74, DOI 10.3171/JNS/2008/108/01/0074; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Theaudin M, 2010, STROKE, V41, P727, DOI 10.1161/STROKEAHA.109.572909; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; Winkler PA., 2000, NEUROSURG FOCUS, V8, DOI [10.3171/foc.2000.8.1.1920, DOI 10.3171/FOC.2000.8.1.1920, DOI 10.3171/INS.2000.93.1.0053]; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43	26	3	3	0	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	JUL-SEP	2013	4	3					283	287		10.4103/0976-3147.118779			5	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3W4E	WOS:000218648300010	24250160	Green Published, gold			2022-02-06	
J	Denys, P; Soler, JM; Giuliano, F				Denys, P.; Soler, J-M; Giuliano, F.			Sexuality of men with neurologic disorders	PROGRES EN UROLOGIE			French	Article						Spinal cord injured men; Sexuality; Anejaculation; Erectile dysfunction; Stroke; Parkinson's disease	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; CAUDA-EQUINA LESIONS; CONUS MEDULLARIS LESIONS; PARKINSONS-DISEASE; STROKE PATIENTS; ERECTILE DYSFUNCTION; MULTIPLE-SCLEROSIS; CARDIOVASCULAR-DISEASE; IMPROVES EJACULATION	Introduction. - Neurological disorders affecting the brain, the spinal cord or the peripheral nervous system are frequently responsible for sexual disorders. Their impact can be major and could rank first in the concerns of patients with neurological handicap, particularly those who are paraplegic. Methods. - Medical literature was reviewed and combined with expert opinion of the authors. Results. - Sexual dysfunction can vary depending on the site of the lesion, its complete or incompleteness for the spinal cord, its natural history, the age of onset. Value of the data present in the literature varies depending on the pathology. Many neurological patients are on medication and an iatrogenic factor is not to be excluded when managing and understanding the physiopathology of sexual dysfunction. Clinical trials evaluating the efficacy of pharmacological treatments are often specific to one pathology. This means that extrapolating to other neurological disorders is difficult and could even be dangerous in the presence of orthostatic hypotension. Due to the vicinity of the spinal centers controlling bladder, sphincteric, anorectal and sexual functions the symptomatology is often mixed associating urinary, sexual and fecal disorders. The treatment of urinary incontinence and management of anorectal disorders should precede the treatment for sexual complaints. The existence of a sexual disorder can be of great help in the neurological diagnosis in certain contexts (extrapyramidal syndromes). We report the data from the literature concerning male sexual disorders in cases of acquired brain lesions (stroke, cranial trauma), extrapyramidal symptoms, medullar lesions, multiple sclerosis, peripheral lesions of the cauda equina or more distal. Conclusion. - Sexual dysfunction must be part of the overall management of neurological patients. (C) 2013 Elsevier Masson SAS. All rights reserved.	[Denys, P.; Giuliano, F.] Univ Versailles St Quentin En Yvelines, Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, F-92380 Garches, France; [Soler, J-M] Ctr Bouffart Vercelli, F-66290 Cerbere, France		Giuliano, F (corresponding author), Univ Versailles St Quentin En Yvelines, Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, 104 Blvd R Poincare, F-92380 Garches, France.	francois.giuliano@uvsq.fr	Denys, Pierre/AAM-1638-2020	DENYS, Pierre/0000-0002-4831-6499			Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; BOND MR, 1976, ACTA NEUROCHIR, V34, P57, DOI 10.1007/BF01405863; Bronner G, 2004, J SEX MARITAL THER, V30, P95, DOI 10.1080/00926230490258893; BROWN RG, 1990, J NEUROL NEUROSUR PS, V53, P480, DOI 10.1136/jnnp.53.6.480; COMARR AE, 1971, J UROLOGY, V106, P375, DOI 10.1016/S0022-5347(17)61293-X; de Chazeron I, 2011, MOVEMENT DISORD, V26, P2127, DOI 10.1002/mds.23845; FORMISANO R, 1995, ACTA NEUROL SCAND, V91, P54; Freedman D, 2000, SOC SCI MED, V50, P1757, DOI 10.1016/S0277-9536(99)00417-7; Giuliano F, 2006, NEUROLOGY, V66, P210, DOI 10.1212/01.wnl.0000194260.43583.32; Giuliano F, 2008, SPINE, V33, P709, DOI 10.1097/BRS.0b013e3181695040; Goscinski I, 1997, J Neurosurg Sci, V41, P269; Hohl A, 2009, ARQ BRAS ENDOCRINOL, V53, P908, DOI 10.1590/S0004-27302009000800003; Korpelainen JT, 1999, STROKE, V30, P715, DOI 10.1161/01.STR.30.4.715; Korpelainen JT, 1998, ACTA NEUROL SCAND, V98, P400, DOI 10.1111/j.1600-0404.1998.tb07321.x; Kreuter M, 2011, SPINAL CORD, V49, P154, DOI 10.1038/sc.2010.51; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; LIPE H, 1990, NEUROLOGY, V40, P1347, DOI 10.1212/WNL.40.9.1347; Lundberg P O, 1981, Int Rehabil Med, V3, P32; McCall-Hosenfeld JS, 2008, AM J MED, V121, P295, DOI 10.1016/j.amjmed.2007.11.013; Pezzella FR, 2003, NEUROL SCI, V24, P205, DOI 10.1007/s10072-003-0132-0; Podnar S, 2007, EUR J NEUROL, V14, P48, DOI 10.1111/j.1468-1331.2006.01542.x; Podnar S, 2002, J NEUROL NEUROSUR PS, V73, P715, DOI 10.1136/jnnp.73.6.715; Podnar S, 2007, MUSCLE NERVE, V35, P529, DOI 10.1002/mus.20696; Quintard B., 2002, Annales de Readaptation et de Medecine Physique, V45, P456, DOI 10.1016/S0168-6054(02)00296-9; Reitz A, 2004, INT J IMPOT RES, V16, P167, DOI 10.1038/sj.ijir.3901193; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; Sipski ML, 2006, PROG BRAIN RES, V152, P441, DOI 10.1016/S0079-6123(05)52030-2; Soler JM, 2007, J UROLOGY, V178, P2082, DOI 10.1016/j.juro.2007.07.047; Song H, 2011, NEUROREHABILITATION, V28, P143, DOI 10.3233/NRE-2011-0642; SONKSEN J, 1992, SEMIN NEUROL, V12, P106, DOI 10.1055/s-2008-1041163; Tamam Y, 2008, EUR J NEUROL, V15, P660, DOI 10.1111/j.1468-1331.2008.02184.x; Thompson HS, 2009, J CLIN NURS, V18, P1803, DOI 10.1111/j.1365-2702.2008.02694.x; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P2996, DOI 10.1001/jama.294.23.2996; Tzortzis V, 2008, MULT SCLER J, V14, P561, DOI 10.1177/13524585080140040901; Weintraub D., 2009, PARKINSONISM RELA S3, V15, P5110; WERMUTH L, 1995, ACTA NEUROL SCAND, V91, P453; Zivadinov R, 1999, MULT SCLER J, V5, P428, DOI 10.1177/135245859900500i610; Zorzon M, 1999, MULT SCLER J, V5, P418, DOI 10.1191/135245899678846456	39	3	3	1	23	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	1166-7087			PROG UROL	Prog. Urol.	JUL	2013	23	9					712	717		10.1016/j.purol.2013.01.009			6	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	186PU	WOS:000322057400018	23830265				2022-02-06	
J	Dyer, BA; White, WA; Lee, D; Elkins, L; Slayton, DJ				Dyer, Brett A.; White, William A., Jr.; Lee, Doohee; Elkins, Laurie; Slayton, Donna J.			The Relationship Between Arterial Carbon Dioxide Tension and End-Tidal Carbon Dioxide Tension in Intubated Adults With Traumatic Brain Injuries Who Required Emergency Craniotomies	CRITICAL CARE NURSING QUARTERLY			English	Article						arterial partial pressure of dissolved carbon dioxide (PaCO2); arterial to end-tidal carbon dioxide partial pressure gradient (Pa-etCO(2)); craniotomy; end-tidal carbon dioxide (PetCO(2)); traumatic brain injury		Anesthetic management of patients who have suffered traumatic brain injuries can be challenging. We investigated the relationship between arterial to end-tidal carbon dioxide partial pressure gradients (Pa-etCO(2)) and 3 predictor variables: (1) injury severity score, (2) use of positive end-expiratory pressure, and (3) presence of rib fractures. Using a convenient sampling method, we sampled 56 patients who arrived to the operating room intubated after traumatic brain injuries between 2005 and 2011. Two groups were compared retrospectively: those with Pa-etCO(2) greater than 10 mm Hg (case group) (n = 37) and those with Pa-etCO2 gradients of 10 mm Hg or less (control group) (n = 19). Descriptive and inferential statistics were employed to identify any differences between the groups. Stepwise regression was also performed. Cross tabulation analysis revealed that injury severity score of 30 or more was a predictor of Pa-etCO(2) gradient. Stepwise regression analysis revealed the presence of rib fracture and body mass index to be significant predictors of Pa-etCO(2) gradient (P < .011). This study identified coexisting conditions in which the patients' Pa-etCO(2) gradients were large. Results showed that injury severity score of 30 or more, the presence of rib fractures, and higher body mass index were statistically significant predictors of Pa-etCO(2) gradients greater than 10 mm Hg. These observations should be considered when evaluating PetCO(2) in conjunction with arterial blood gas analysis to determine optimal ventilation status of these patients.	[Dyer, Brett A.] River Cities Anesthesia Inc, Huntington, WV USA; [Dyer, Brett A.] St Marys Hosp, Huntington, WV USA; [Lee, Doohee] Marshall Univ, Dept Management Mkt, MIS, S Charleston, WV USA; [White, William A., Jr.; Slayton, Donna J.] Charleston Area Med Ctr, Dept Anesthesiol, Charleston, WV USA; [Elkins, Laurie] Charleston Area Med Ctr, Gen Div, Charleston, WV 25301 USA		Lee, D (corresponding author), Marshall Univ, 100 Angus E Peyton Dr, S Charleston, WV 25303 USA.	leed@marshall.edu					[Anonymous], BMI AD; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; Barquist EA, 2003, J TRAUMA, V55, P896; Greenberg SB, 2009, CLIN ANESTH, P697; HESS D, 1992, J CLIN MONITOR, V8, P111, DOI 10.1007/BF01617428; Hiller J, 2010, ANAESTH INTENS CARE, V38, P302, DOI 10.1177/0310057X1003800212; IBM, 2010, IBM SPSS STAT WIND V; Kerr ME, 1996, CRIT CARE MED, V24, P785, DOI 10.1097/00003246-199605000-00010; Khan Fauzia Anis, 2007, J Pak Med Assoc, V57, P446; Lee SW, 2009, J TRAUMA, V67, P526, DOI 10.1097/TA.0b013e3181866432; McSwain SD, 2010, RESP CARE, V55, P288; RUSSELL GB, 1995, ANESTH ANALG, V81, P806, DOI 10.1097/00000539-199510000-00025; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; Tyburski JG, 2003, J TRAUMA, V55, P892, DOI 10.1097/01.TA.0000097827.51916.7E	14	3	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0887-9303	1550-5111		CRIT CARE NURS Q	Crit. Care Nurs. Q.	JUL-SEP	2013	36	3					310	315		10.1097/CNQ.0b013e318294ea8f			6	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V2A5T	WOS:000217404400006	23736670				2022-02-06	
J	Kaya, H; Sogut, O; Gokdemir, MT; Albayrak, L; Taskin, A				Kaya, H.; Sogut, O.; Gokdemir, M. T.; Albayrak, L.; Taskin, A.			The role of oxidative status in initial evaluation of paediatric patients with graded traumatic brain injury	HONG KONG JOURNAL OF EMERGENCY MEDICINE			English	Article						Children; craniocerebral trauma; oxidative stress; patient acuity	LIPID-PEROXIDATION; FREE-RADICALS; HEAD TRAUMA; STRESS; INFANTS	Introduction: The purposes of this study were (a) to investigate the oxidative and antioxidative status in paediatric patients with varying severity of traumatic brain injury (TBI) during the early post-traumatic period; (b) to correlate injury severity with the oxidative and antioxidative status of patients; and (c) to identify early predictors of outcome in patients with TBI. Methods: Fifty-two consecutive paediatric patients with isolated TBI and 31 age- and sex-matched healthy controls were enrolled. Patients were divided into two groups based on their Glasgow Coma Scale (GCS) scores recorded upon admission to the emergency department within the first 24 hours after injury. Twenty-three patients with moderate to severe TBI and 29 patients with mild TBI (GCS scores of >13) were included. The primary outcome variable was hospital mortality. Plasma total oxidant status (TOS), total antioxidant status (TAS), and the oxidative stress index (OSI) were assessed as predictors of early oxidative changes in serum using a novel automated measurement method. Results: Compared to patients with mild TBI, TOS and OSI values were markedly elevated in patients with moderate to severe TBI. However, TAS levels did not show significant changes in either group of patients. Both GCS scores and Revised Trauma Scores were negatively correlated with the TOS and OSI, but neither was significantly correlated with the TAS. The TOS and OSI were significantly higher in non-survivors than in survivors. However, there was no significant difference in TAS levels between survivors and non-survivors. Conclusion: Paediatric patients with isolated TBI are exposed to extensive oxidative stress, which varies with injury severity.	[Sogut, O.] Bezmialem Vakif Univ, Fac Med, Dept Emergency Med, Istanbul, Turkey; [Kaya, H.; Gokdemir, M. T.; Albayrak, L.] Harran Univ, Fac Med, Dept Emergency Med, Sanliurfa, Turkey; [Taskin, A.] Harran Univ, Fac Med, Dept Biochem, Sanliurfa, Turkey		Sogut, O (corresponding author), Bezmialem Vakif Univ, Fac Med, Dept Emergency Med, Istanbul, Turkey.	osogut@bezmialem.edu.tr	ALBAYRAK, LEVENT/T-1029-2019; Taskin, Abdullah/ABF-5740-2020; Kaya, Halil/ABH-5489-2020	ALBAYRAK, LEVENT/0000-0002-4288-8170; Kaya, Halil/0000-0003-2005-6100			Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Eghwrudjakpor P O, 2010, Niger J Med, V19, P14; Erel O, 2004, CLIN BIOCHEM, V37, P112, DOI 10.1016/j.clinbiochem.2003.10.014; Erel O, 2005, CLIN BIOCHEM, V38, P1103, DOI 10.1016/j.clinbiochem.2005.08.008; Facchinetti F, 1998, CELL MOL NEUROBIOL, V18, P667, DOI 10.1023/A:1020221919154; Hohl A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.007; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; Nayak C, 2007, CLIN CHEM LAB MED, V45, P629, DOI 10.1515/CCLM.2007.123; Nayak CD, 2008, NEUROL INDIA, V56, P31, DOI 10.4103/0028-3886.39309; Rael LT, 2007, BIOCHEM BIOPH RES CO, V361, P561, DOI 10.1016/j.bbrc.2007.07.078; ROSS D, 1988, PHARMACOL THERAPEUT, V37, P231, DOI 10.1016/0163-7258(88)90027-7; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Shao CX, 2006, FREE RADICAL BIO MED, V41, P77, DOI 10.1016/j.freeradbiomed.2006.03.007; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Stein SC, 2006, J TRAUMA, V61, P558, DOI 10.1097/01.ta.0000233766.60315.5e; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Toklu HZ, 2009, FREE RADICAL RES, V43, P658, DOI 10.1080/10715760902988843; Vagnozzi R, 1997, EXP BRAIN RES, V117, P411, DOI 10.1007/s002210050235	24	3	3	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1024-9079	2309-5407		HONG KONG J EMERG ME	Hong Kong J. Emerg. Med.	JUL	2013	20	4					225	233		10.1177/102490791302000406			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	210AU	WOS:000323802500006					2022-02-06	
J	Marshall, SA; Kalanuria, A; Markandaya, M; Nyquist, PA				Marshall, Scott A.; Kalanuria, Atul; Markandaya, Manjunath; Nyquist, Paul A.			Management of Intracerebral Pressure in the Neurosciences Critical Care Unit	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Acquired brain injury; Intracranial pressure; Intracranial hypertension; ICP; Neuromonitoring	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; ASSOCIATION/AMERICAN STROKE ASSOCIATION; REFRACTORY INTRACRANIAL HYPERTENSION; SEX STEROID-HORMONES; BLOOD-FLOW; DECOMPRESSIVE CRANIECTOMY; THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA	Management of intracranial pressure in neurocritical care remains a potentially valuable target for improvements in therapy and patient outcomes. Surrogate markers of increased intracranial pressure, invasive monitors, and standard therapy, as well as promising new approaches to improve cerebral compliance are discussed, and a current review of the literature addressing this metric in neuroscience critical care is provided.	[Marshall, Scott A.] San Antonio Mil Med Ctr, Dept Med, Ft Sam Houston, TX 78234 USA; [Kalanuria, Atul; Nyquist, Paul A.] Johns Hopkins Sch Med, Dept Anesthesia Crit Care Med, Baltimore, MD 21290 USA; [Kalanuria, Atul; Nyquist, Paul A.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21290 USA; [Kalanuria, Atul; Nyquist, Paul A.] Johns Hopkins Sch Med, Dept Neurosurg, Baltimore, MD 21290 USA; [Markandaya, Manjunath] Univ Maryland, Div Surg Trauma Crit Care, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Markandaya, Manjunath] Univ Maryland, Div Neurosci Crit Care, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Markandaya, Manjunath] Univ Maryland, Div Pulm Crit Care Med, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA		Marshall, SA (corresponding author), San Antonio Mil Med Ctr, Dept Med, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.	Scott.A.Marshall1.mil@mail.mil					Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Alberti A, 2011, INTERN EMERG MED, V6, P119, DOI 10.1007/s11739-011-0675-7; Amini A, 2013, AM J EMERG MED, V31, P236, DOI 10.1016/j.ajem.2012.06.025; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; Bar-Joseph G, 2009, J NEUROSURG-PEDIATR, V4, P40, DOI 10.3171/2009.1.PEDS08319; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Birch AA, 2006, NEUROCRIT CARE, V5, P51, DOI 10.1385/NCC:5:1:51; Brandi G, 2010, ACTA NEUROCHIR, V152, P965, DOI 10.1007/s00701-010-0643-4; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS21; Brazis PW., 2007, LOCALIZATION CLIN NE, V6th ed; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Carhuaporna JR, 2003, J NEUROSURG ANESTH, V15, P313, DOI 10.1097/00008506-200310000-00004; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; de Riva N, 2012, NEUROCRIT CARE, V17, P58, DOI 10.1007/s12028-012-9672-6; Delhaye C, 2012, J AM COLL CARDIOL, V59, P197, DOI 10.1016/j.jacc.2011.06.077; Dennis CM, 2010, J NEUROSCI NURS, V42, P217, DOI 10.1097/JNN.0b013e3181e26c20; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Diringer MN, 2004, NEUROCRIT CARE, V1, P219, DOI 10.1385/NCC:1:2:219; Diringer MN, 2004, CRIT CARE MED, V32, P559, DOI 10.1097/01.CCM.0000108868.97433.3F; Dorfman JD, 2011, NEUROCRIT CARE, V15, P516, DOI 10.1007/s12028-011-9549-0; Douds GL, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/479865; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Farahvar A, 2011, CURR OPIN ANESTHESIO, V24, P209, DOI 10.1097/ACO.0b013e328344016d; Fletcher JJ, 2010, NEUROCRIT CARE, V13, P47, DOI 10.1007/s12028-010-9345-2; Fudickar A, 2006, CURR OPIN ANESTHESIO, V19, P404, DOI 10.1097/01.aco.0000236140.08228.f1; Fung C, 2012, STROKE, V43, P3207, DOI 10.1161/STROKEAHA.112.666537; Geocadin R, 2004, TRAUMATIC BRAIN INJU; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Habashi NM, 2005, CRIT CARE MED S3, V33, pS228; Hartman BJ, 2009, PEDIATR CRIT CARE ME, V10, P19; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hudetz JA, 2010, J CARDIOTHOR VASC AN, V24, P131, DOI 10.1053/j.jvca.2009.05.008; Jalan R, 2004, GASTROENTEROLOGY, V127, P1338, DOI 10.1053/j.gastro.2004.08.005; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jia X., 2008, RESUSCITATION, V90, P1042; Joseph DK, 2004, J TRAUMA, V57, P687, DOI 10.1097/01.TA.0000140645.84897.F2; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Karnchanapandh Krissanee, 2012, Acta Neurochir Suppl, V114, P339, DOI 10.1007/978-3-7091-0956-4_65; Kellie George, 1824, Trans Med Chir Soc Edinb, V1, P84; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; Ko SB, 2012, CURR ATHEROSCLER REP, V14, P307, DOI 10.1007/s11883-012-0251-2; Kocaeli H, 2008, ACTA NEUROCHIR, V150, P1263, DOI 10.1007/s00701-008-0153-9; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; Le Roux P, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-012-0331-2; Lee K, 2012, NEUROLCU BOOK; Lee SW, 2009, J TRAUMA, V67, P526, DOI 10.1097/TA.0b013e3181866432; Ling GSF, 2008, NEUROL CLIN, V26, P409, DOI 10.1016/j.ncl.2008.02.001; Linsler S., 2012, ACTA NEUROCHIR WIEN; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; Marik PE, 2012, NEUROCRIT CARE, V17, P219, DOI 10.1007/s12028-012-9739-4; Marion D W, 1995, New Horiz, V3, P439; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marko NF, 2012, AM J RESP CRIT CARE, V185, P467, DOI 10.1164/rccm.201109-1698ED; Marshall GT, 2010, J TRAUMA, V69, P275, DOI 10.1097/TA.0b013e3181de74c7; MARSHALL LF, 1978, J NEUROSURG, V48, P169, DOI 10.3171/jns.1978.48.2.0169; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; MENDELOW AD, 1985, J NEUROSURG, V63, P43, DOI 10.3171/jns.1985.63.1.0043; MICHELSON AD, 1994, THROMB HAEMOSTASIS, V71, P633; Monro A., 1783, OBSERVATIONS STRUCTU; Moon SW, 2007, RESUSCITATION, V72, P219, DOI 10.1016/j.resuscitation.2006.06.034; Moore EM, 2011, INJURY, V42, P843, DOI 10.1016/j.injury.2011.03.027; Moretti R, 2009, NEUROCRIT CARE, V11, P406, DOI 10.1007/s12028-009-9250-8; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Mossad EB, 2007, SEMIN CARDIOTHORAC V, V11, P34, DOI 10.1177/1089253206297413; Muehlschlegel S, 2009, ARCH NEUROL-CHICAGO, V66, P670, DOI 10.1001/archneurol.2009.33; Nimkoff L, 1997, J CRIT CARE, V12, P132, DOI 10.1016/S0883-9441(97)90042-3; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; Oh HS, 2012, INT J NURS PRACT, V18, P295, DOI 10.1111/j.1440-172X.2012.02039.x; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Prasad K, 2010, ACTA NEUROL SCAND, V122, P404, DOI 10.1111/j.1600-0404.2010.01326.x; Qureshi AI, 2008, NEUROLOGY, V70, P990, DOI 10.1212/01.wnl.0000311290.86780.78; Rahme R, 2010, NEUROSURGERY, V67, pE214, DOI 10.1227/01.NEU.0000370015.94386.1F; Rajajee V, 2012, CRIT CARE, V16, DOI [10.1186/cc11336, 10.1186/CC11336]; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Raslan Ahmed, 2007, Neurosurg Focus, V22, pE12; Razumovsky A, 2013, ACTA NEUROCHIR SUPPL, V115, P87, DOI 10.1007/978-3-7091-1192-5_19; Razumovsky A, 2011, NEUROSURGERY, V68, pE289, DOI 10.1227/NEU.0b013e3181ff35ae; Rincon F, 2013, NEUROCRIT CARE, V18, P45, DOI 10.1007/s12028-012-9779-9; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; Rockswold GL, 2009, NEUROSURGERY, V65, P1035, DOI 10.1227/01.NEU.0000359533.16214.04; Romner B, 2013, NEUROCRIT CARE; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Scalea TM, 2007, J TRAUMA, V62, P647, DOI 10.1097/TA.0b013e31802ee542; Schedler Pam, 2002, J Neurosci Nurs, V34, P158; Schmittner MD, 2007, J NEUROSURG ANESTH, V19, P257, DOI 10.1097/ANA.0b013e31811f3feb; Schreckinger M, 2009, NEUROCRIT CARE, V11, P427, DOI 10.1007/s12028-009-9256-2; SCHULTEAMESCH J, 1978, ACTA NEUROCHIR, V45, P15, DOI 10.1007/BF01774380; Schwab S, 1999, NERVENARZT, V70, P539, DOI 10.1007/s001150050477; SCHWEDLER M, 1982, CAN ANAESTH SOC J, V29, P222, DOI 10.1007/BF03007120; Seinfeld Joshua, 2007, Neurosurgery, V61, pE175; Server A, 2001, ACTA RADIOL, V42, P254; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Stevenson LW, 2005, JAMA-J AM MED ASSOC, V294, P1625; Stiver SI, 2009, J NEUROSURG, V110, P1242, DOI 10.3171/2008.8.JNS08314; Stiver SI, 2008, NEUROSURG FOCUS S3, V33, pS228; Suehiro E, 2011, WORLD NEUROSURG, V75, P563, DOI 10.1016/j.wneu.2010.09.013; TEASDALE G, 1974, LANCET, V2, P81; Timofeev I, 2008, ACTA NEUROCHIR SUPPL, V102, P99, DOI 10.1007/978-3-211-85578-2_20; VALERI CR, 1987, ANN SURG, V205, P175, DOI 10.1097/00000658-198702000-00012; Verschuren F, 2004, CHEST, V125, P841, DOI 10.1378/chest.125.3.841; Vilela MD, 2008, SURG NEUROL, V69, P293, DOI 10.1016/j.surneu.2007.01.027; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Watts DD, 1998, J TRAUMA, V44, P846, DOI 10.1097/00005373-199805000-00017; WINER JW, 1991, NEUROSURGERY, V29, P739, DOI 10.1227/00006123-199111000-00016; Woda RP, 1996, J NEUROSURG ANESTH, V8, P286, DOI 10.1097/00008506-199610000-00005; Zweifel C, 2012, NEUROSURGERY, V71, P853, DOI 10.1227/NEU.0b013e3182675b42	119	3	3	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	JUL	2013	24	3					361	+		10.1016/j.nec.2013.03.004			14	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	191NY	WOS:000322421100006	23809031				2022-02-06	
J	Gonzalez, AEM; Lozano, MDJ; Gonzalez, AG; Gil, MDJ; Crespo, FDP; Piqueras, JA				Martinez Gonzalez, Agustin Ernesto; Jimenez Lozano, Maria Dolores; Gilar Gonzalez, Angeles; Jimenez Gil, Maria Dolores; Perez Crespo, Francisco de Asis; Antonio Piqueras, Jose			Integral intervention in a brain injury case after four years without any treatment	CUADERNOS DE NEUROPSICOLOGIA-PANAMERICAN JOURNAL OF NEUROPSYCHOLOGY			Spanish	Article						Traumatic brain injury; Organic personality disorder; Neuropsychological Rehabilitation; Family Cognitive-Behavioral Therapy; Clinical case	THERAPY PROGRAM; FAMILY	Over the last decades neuroscientific studies have showed the capacity of the human brain for neurogenesis and cognitive improvement following neuropsychological rehabilitation. This study evaluates the cognitive processes after two years of neuropsychological rehabilitation and speech therapy in a case with traumatic brain injury and organic personality disorder. The results show an improvement of cognitive processes such as attention, short and long term verbal and nonverbal memory, and viso-perceptive ability as well as some aspects of executive function and verbal fluency. Conclusions: This study obtained encouraging results with an integral and ecological intervention after four years without any intervention on the patient. Future studies should include a larger sample of subjects with similar cognitive impairment and brain injuries.	[Martinez Gonzalez, Agustin Ernesto; Jimenez Lozano, Maria Dolores; Gilar Gonzalez, Angeles; Jimenez Gil, Maria Dolores] Asociac Padres Jumillanos Ninos Deficientes ASPAJ, Murcia, Spain; [Martinez Gonzalez, Agustin Ernesto] Univ Alicante, Dept Psicol Evolut & Didact, Alicante, Spain; [Perez Crespo, Francisco de Asis] Serv Murciano Salud Serv Area V Murcia, Murcia, Spain; [Antonio Piqueras, Jose] Univ Miguel Hernandez, Elche, Spain		Gonzalez, AEM (corresponding author), Asociac Padres Jumillanos Ninos Deficientes ASPAJ, Murcia, Spain.	agustin.emartinez@ua.es	Lozano, Maria D/ABD-9613-2020; Piqueras, Jose A/C-6011-2011; MARTINEZ-GONZALEZ, AGUSTIN ERNESTO/Z-1311-2019	Lozano, Maria D/0000-0002-6796-9380; Piqueras, Jose A/0000-0002-3604-5441; MARTINEZ-GONZALEZ, AGUSTIN ERNESTO/0000-0002-9576-7348			American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT, VIV; [Anonymous], COGN 1 0 COGN REH SO; Arvedson J, 2010, AM J SPEECH-LANG PAT, V19, P321, DOI 10.1044/1058-0360(2010/09-0067); Barat M., 2010, LEARNING PROCESSES R, P149; Bascunana H, 2000, REV NEUROLOGIA, V30, P1044, DOI 10.33588/rn.3011.99480; Bausela E, 2008, CUADERNOS NEUROPSICO, V2, P136; Bolognini N, 2013, NEUROSCI BIOBEHAV R, V37, P269, DOI 10.1016/j.neubiorev.2012.12.006; Buller PI, 2010, CUAD NEUROPSICOL, V4, P63; Buller PI, 2008, CUAD NEUROPSICOL, V2, P10; Busigny T, 2010, NEUROPSYCHOLOGIA, V48, P4057, DOI 10.1016/j.neuropsychologia.2010.09.017; Cacho J, 1999, REV NEUROLOGIA, V28, P648, DOI 10.33588/rn.2807.98501; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Couillet J, 2010, NEUROPSYCHOL REHABIL, V20, P321, DOI 10.1080/09602010903467746; de Norena D, 2010, REV NEUROLOGIA, V51, P687, DOI 10.33588/rn.5111.2009652; Dehghan L., 2008, MODERN REHABILITATIO, V1, P3; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; GENTILINI M, 1989, MILD HEAD INJURY, P163; Gonzalez A., 2004, ANALES PSICOLOGIA, V20, P303; Gonzalez-Palau F., 2012, CUADERNOS NEUROPSICO, V6, P84; Goodglass J, 1986, TEST DIAGNOSTICO AFA; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Hahn V., 1992, INT J OROFACIAL MYOL, V18, P21; HENLEY NM, 1969, J VERB LEARN VERB BE, V8, P176, DOI 10.1016/S0022-5371(69)80058-7; Horton Jr A. M., 1984, CLIN BEHAV NEUROPSYC; Hotting K., NEUROSCIENCE BIOBEH; Kaplan E., 2001, BOSTON NAMING TEST; Khan-Bourne N, 2003, NEUROPSYCHOL REHABIL, V13, P89, DOI 10.1080/09602010244000318; Kreutzer JS, 2002, J HEAD TRAUMA REHAB, V17, P349, DOI 10.1097/00001199-200208000-00008; Lazarus C., 2011, EVIDENCE BASED SYSTE; Leon-Carrion J, 2001, REV NEUROLOGIA, V33, P377, DOI 10.33588/rn.3304.2000196; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lobo A, 1979, Actas Luso Esp Neurol Psiquiatr Cienc Afines, V7, P189; Luria-Christense A, 1979, LURIAS NEUROPSYCHOLO; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Oddy M, 2003, NEUROPSYCHOL REHABIL, V13, P259, DOI 10.1080/09602010244000345; Orient-Lopez F, 2004, REV NEUROLOGIA, V39, P901, DOI 10.33588/rn.3910.2004302; Orient-Lopez F, 2002, REV NEUROLOGIA, V35, P362, DOI 10.33588/rn.3504.2001457; Osterrieth PA, 1994, ARCH PSYCHOL, V30, P286; Park Denise C, 2013, Dialogues Clin Neurosci, V15, P109; Pelegrin-Valero C, 2001, REV NEUROLOGIA, V32, P681, DOI 10.33588/rn.3207.2000180; Pena-Casanova J., 2009, ARCH CLIN NEUROPSYCH, P1; PENACASANOVA J, 2009, ARCH CLIN NEUROPSYCH, V5, P1; Perea-Bartolome MV, 2002, REV NEUROLOGIA, V35, P607, DOI 10.33588/rn.3507.2001011; Rajeswaran J, 2013, ELSEV INSIGHT, P33, DOI 10.1016/B978-0-12-416046-0.00003-1; Reijnders J, 2013, AGEING RES REV, V12, P263, DOI 10.1016/j.arr.2012.07.003; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Ruff R., 1989, MILD HEAD INJURY, P152; Salas-Riquelme Ch, 2012, UADERNOS NEUROPSICO, V6, P59; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Sohlberg M., 2001, COGNITIVE REHABILITA; TEASDALE G, 1974, LANCET, V2, P81; Topolovec-Vranic J, 2010, BRAIN INJURY, V24, P762, DOI 10.3109/02699051003709599; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Varada V., 2013, INT J SCI ENG RES, V4, P1; Wechsler D., 1958, MEASUREMENT APPRAISA; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020; Ylvisaker M., 1998, COLLABORATIVE BRAIN	61	3	4	0	1	NEUROPSICOLOGIA CL	RANCAGUA	NEUROPSICOLOGIA CL, RANCAGUA, 00000, CHILE	0718-4123			CUAD NEUROPSICOL	Cuad. Neuropsicol.	JUL	2013	7	1					87	103		10.7714/cnsp/7.1.205			17	Psychology, Biological	Emerging Sources Citation Index (ESCI)	Psychology	V30YM	WOS:000215597900006					2022-02-06	
J	Pouliquen, U; Etcharry-Bouyx, F; Pinon, K; Patureau, F; Petit, A; Lambert, A; Richard, I				Pouliquen, U.; Etcharry-Bouyx, F.; Pinon, K.; Patureau, F.; Petit, A.; Lambert, A.; Richard, I.			Post-acute assessment programme for patients with traumatic brain injury: Measuring the gap between patients' expectations on entering and end of programme recommendations	BRAIN INJURY			English	Article						Return to work; traumatic brain injury; vocational rehabilitation	REHABILITATION; LIFE	Objective: To compare the expectations of patients with brain injury (TBI) entering a post-acute programme to the recommendations made at the end. Design: Retrospective study (1997 and 2009). Intervention: This 12-week post-acute programme included ecological multidisciplinary assessment of physical and cognitive disabilities, independence in activities of daily living and work abilities. Recommendations made at the conclusion of the programme included advice regarding the ability to work in an unsheltered or a sheltered environment and possible social activities. Results: Two hundred and forty patients participated. The main objective of 95.8% was return-to-work: 93.7% expected a normal work environment, 2.1% considered a sheltered environment and 4% entered the programme with the aim of improving social abilities and integration in the community. The recommendations included return-to-work in 68.3% of cases, in an unsheltered environment in 44.2% and in a sheltered environment in 24.1% and advice for contact with social services in order to achieve better social integration in 31.7%. There was a discrepancy between expectations and recommendations in half of the cases. Conclusion: The discrepancy between patients' expectations and recommendations is in part due to the cognitive disorders; long-term rehabilitation programmes should focus on this issue.	[Pouliquen, U.; Pinon, K.; Petit, A.; Richard, I.] LUNAM Univ, Angers, France; [Pouliquen, U.; Pinon, K.; Petit, A.; Richard, I.] Univ Angers France, Angers, France; [Etcharry-Bouyx, F.] LUNAM Univ, Dept Neurol, Angers, France; [Pinon, K.; Patureau, F.; Lambert, A.] UEROS Arceau Anjou, Angers, France		Richard, I (corresponding author), Univ Angers, LEEST EA INVS 4336, Rue Haute Reculee, F-49000 Angers 02, France.	isabelle.richard@univ-angers.fr	richard, isabelle/J-9371-2015; PETIT, Audrey/J-9098-2015				Aegerter P, 2008, REV EPID SANTE PUB S, p5S; Alaoui P., 1998, Annales de Readaptation et de Medecine Physique, V41, P171, DOI 10.1016/S0168-6054(98)80001-9; [Anonymous], 2004280 DHOSSDO01DGS; Asloun S, 2007, J CLIN EXPT IN PRESS; Avesani R, 2005, BRAIN INJURY, V19, P933, DOI 10.1080/02699050400002371; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Chevignard MP, 2008, NEUROPSYCHOL REHABIL, V18, P461, DOI 10.1080/09602010701643472; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Fugl-Meye KS., 1991, CLIN REHABIL, V5, P25, DOI [10.1177/026921559100500105, DOI 10.1177/026921559100500105]; Le Gall C, 2006, ANN READAPTATION MED, V50, P5; Le Thiec F., 1999, Annales de Readaptation et de Medecine Physique, V42, P1, DOI 10.1016/S0168-6054(99)80030-0; Lezak MD., 1993, J HEAD TRAUMA REHAB, V1, P24; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Majdan M, 2011, BRAIN INJURY, V25, P797, DOI 10.3109/02699052.2011.581642; Mathe JF, 2005, ANN FR ANESTH, V24, P688, DOI 10.1016/j.annfar.2005.03.029; Oppenheim-Gluckman H., 2003, Annales de Readaptation et de Medecine Physique, V46, P41, DOI 10.1016/S0168-6054(02)00352-5; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Quintard B., 2002, Annales de Readaptation et de Medecine Physique, V45, P456, DOI 10.1016/S0168-6054(02)00296-9; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Soury S., 2005, Annales de Readaptation et de Medecine Physique, V48, P61, DOI 10.1016/j.annrmp.2004.08.007; TEASDALE TW, 1993, BRAIN INJURY, V7, P535, DOI 10.3109/02699059309008181; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; William C, 2006, ARCH PHYS MED REHAB, V87, P1576	26	3	3	0	11	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUL	2013	27	7-8					789	792		10.3109/02699052.2013.794960			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	169UO	WOS:000320806200003	23782304	Green Submitted			2022-02-06	
J	Lasierra, JLF; Fuentes, CG; Vazquez, DT; Fernandez, MC; Aznarez, SB; Lopez, EA				Flordelis Lasierra, J. L.; Garcia Fuentes, C.; Toral Vazquez, D.; Chico Fernandez, M.; Bermejo Aznarez, S.; Alted Lopez, E.			Contralateral extraaxial hematomas after urgent neurosurgery of a mass lesion in patients with traumatic brain injury	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Delayed post-traumatic extracerebral hematomas; Contralateral acute epi- or subdural hematoma; Bilateral acute epidural hematoma; Alternating delayed intracranial hematomas; Traumatic brain injury	ACUTE SUBDURAL-HEMATOMA; ACUTE EPIDURAL HEMATOMA; DECOMPRESSIVE SURGERY; EXTRADURAL HEMATOMA; EVACUATION	The development of a contralateral extraaxial hematoma has repeatedly been described in small series and descriptive studies. However, the evidence available to date is limited. To evaluate the incidence and risk factors leading to the development of a contralateral extraaxial hematoma and to describe the characteristics of cases. A retrospective cohort study with prospective data collection was undertaken. All patients admitted to an intensive care unit (ICU) from 2006 to 2010 were studied. The inclusion criteria were as follows: severe trauma [Injury Severity Score (ISS a parts per thousand yen 16)], neurosurgery (NeuroSx) in the first 24 h. The following were excluded: subacute/chronic subdural hematomas, first bilateral NeuroSx. Cases were those who required immediate contralateral NeuroSx after the first NeuroSx due to the occurrence of a new extraaxial injury or significant growth of a previous one. Controls were those patients those who did not require second NeuroSx or who required reoperation due to ipsilateral lesions. The variables considered were: demographics, neurological assessment, traumatic injuries and severity, image and surgical findings, clinical course, and outcome. Statistics analysis comprised descriptive, inferential, and multivariate analysis by logistic regression. A total of 120 patients were included, among which there were 11 cases (incidence 9.2 %). The cases showed a significantly higher frequency of coma or severe traumatic brain injury (TBI) at admission, contralateral injury and contralateral skull fracture in the preoperative computed tomography (CT) scan, as well as decompressive craniectomy. There were no significant differences in the severity scores, clinical course, or outcomes. The presence of contralateral fracture was identified as an independent risk factor [relative risk (RR) 47.9, 95 % confidence interval (CI) 5.2-443]. Contralateral extraaxial hematoma is a rare entity, although it has a high mortality rate. Therefore, it requires a high index of suspicion, especially in patients with severe TBI, with minimal contralateral injury and mainly with contralateral skull fracture on the initial CT scan.	[Flordelis Lasierra, J. L.; Garcia Fuentes, C.; Toral Vazquez, D.; Chico Fernandez, M.; Bermejo Aznarez, S.; Alted Lopez, E.] Hosp Univ 12 Octubre, Trauma Intens Care Unit, Intens Care Med Serv, Madrid, Spain		Lasierra, JLF (corresponding author), Paseo Las Acacias 30,Block 4,Floor 8th A, Madrid 28005, Spain.	makalyconru@hotmail.com; cgarciaf.hdoc@salud.madrid.org; dtoral.hdoc@salud.madrid.org; murgchico@yahoo.es; sbermejo.hdoc@salud.madrid.org; ealted.hdoc@salud.madrid.org		Flordelis Lasierra, Jose Luis/0000-0001-6219-5083; Flordelis Lasierra, Jose Luis/0000-0001-6941-7574			Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; BAN M, 1991, Neurologia Medico-Chirurgica, V31, P927, DOI 10.2176/nmc.31.927; BOROVICH B, 1985, J NEUROSURG, V63, P30, DOI 10.3171/jns.1985.63.1.0030; Brain Trauma Foundation, 2007, GUID MAN SEV TRAUM B; Cohen JE, 2004, NEUROL RES, V26, P763, DOI 10.1179/016164104225015930; FEUERMAN T, 1988, NEUROSURGERY, V23, P480, DOI 10.1227/00006123-198810000-00013; Huang APH, 2011, J TRAUMA, V70, P1578, DOI 10.1097/TA.0b013e3182178c71; JENNETT B, 1975, LANCET, V1, P480; Jeon SW, 2011, J KOREAN NEUROSURG S, V49, P355, DOI 10.3340/jkns.2011.49.6.355; KOGA H, 1985, SURG NEUROL, V24, P272, DOI 10.1016/0090-3019(85)90037-0; KOULOURIS S, 1980, NEUROSURGERY, V7, P608, DOI 10.1227/00006123-198012000-00014; Lang JK, 1999, SURG NEUROL, V52, P630, DOI 10.1016/S0090-3019(99)00144-5; LESOIN F, 1984, NEURORADIOLOGY, V26, P515, DOI 10.1007/BF00342691; Matsuno A, 2003, SURG NEUROL, V60, P23, DOI 10.1016/S0090-3019(03)00023-5; MEGURO K, 1987, NEUROSURGERY, V20, P326, DOI 10.1227/00006123-198702000-00023; Mohindra S, 2005, BRIT J NEUROSURG, V19, P490, DOI 10.1080/02688690500495216; PETERSEN OF, 1984, NEURORADIOLOGY, V26, P363, DOI 10.1007/BF00327488; PIEPMEIER JM, 1982, J TRAUMA, V22, P455, DOI 10.1097/00005373-198206000-00003; REALE F, 1985, SURG NEUROL, V24, P260, DOI 10.1016/0090-3019(85)90034-5; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Su TM, 2008, J TRAUMA, V65, P1298, DOI 10.1097/TA.0b013e31815885d9; THIBODEAU M, 1987, J CAN ASSOC RADIOL, V38, P52	22	3	3	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933			EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	JUN	2013	39	3					277	283		10.1007/s00068-013-0268-4			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	159MR	WOS:000320050000009	26815234				2022-02-06	
J	Friedman, DE; Islam, S; Ettinger, AB				Friedman, David E.; Islam, Shahidul; Ettinger, Alan B.			Health-related quality of life among people with epilepsy with mild seizure-related head injuries	EPILEPSY & BEHAVIOR			English	Article						Seizure; Epilepsy; Head injury; Quality of life	TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; POSTCONCUSSION-LIKE SYMPTOMS; POST-CONCUSSION SYNDROME; AXONAL INJURY; DEPRESSION; MODERATE; COMORBIDITIES; PERFORMANCE; POPULATION	Seizure-related head injury (SRHI) is an under-recognized condition frequently experienced by people with epilepsy (PWE). The purpose of this study is to investigate the potential impact of SRHI on health-related quality of life (HRQOL) among PWE receiving care in a tertiary epilepsy center. Consecutive adult PWE receiving care at the Baylor Comprehensive Epilepsy Center (BCEC) were recruited for the study. After their informed consent was obtained, patients were administered the QOLIE-31 to measure HRQOL and the NDDI-E to screen for depression. Simple linear regression was used to identify clinical variables associated with HRQOL and that included SRHI obtained systematically at each clinic visit. Data were also compared between the SRHI and non-SRHI groups. Participants included 172 subjects. Recurrent mild SRHI occurred in 50 (29%) subjects. Factors with a negative effect on HRQOL included depression (slope = -19.99 [95% CI -25.16, -14.81]; p < .0001), recurrent SRHI (-17.02 [-22.35, -11.69]; p < .0001), past SRHI (-13.46 [-18.43, -8.48]; p < .0001), and seizure frequency (-0.17 [-0.26, -0.07]; p = 0.001) on univariate analysis. With stepwise multiple regression, depression and recurrent SRHI significantly impacted HRQOL with slopes (95% CI; p-value) of (-17.53 [-22.34, -12.73]; p < .0001) and (-14.03 [-18.78, -9.28]; p < .0001), respectively. Patient-derived HRQOL is negatively associated with depression and recurrent SRHI, independently. There has been a justifiable increased awareness of the potential effects of head injuries among healthy individuals. Our data suggest that head injuries can certainly be detrimental among PWE, and greater efforts should be made to recognize and formulate prevention strategies for SRHI. (C) 2013 Elsevier Inc. All rights reserved.	[Friedman, David E.] Winthrop Univ Hosp, Dept Neurosci, Mineola, NY 11501 USA; [Islam, Shahidul] Winthrop Univ Hosp, Dept Hlth Outcomes Res, Mineola, NY 11501 USA; [Ettinger, Alan B.] Neurol Surg PC, Lake Success, NY USA		Friedman, DE (corresponding author), Winthrop Univ Hosp, Dept Neurosci, 200 Old Country Rd, Mineola, NY 11501 USA.	defriedman@winthrop.org		Islam, Shahidul/0000-0002-9385-101X			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Beghi E, 2002, EPILEPSIA, V43, P1076, DOI 10.1046/j.1528-1157.2002.18701.x; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; BOHNEN NI, 1995, BRAIN INJURY, V9, P27, DOI 10.3109/02699059509004568; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Boylan LS, 2004, NEUROLOGY, V62, P258, DOI 10.1212/01.WNL.0000103282.62353.85; Buck D, 1997, EPILEPSIA, V38, P439, DOI 10.1111/j.1528-1157.1997.tb01733.x; Carroll LJ, 2003, J CLIN EPIDEMIOL, V56, P651, DOI 10.1016/S0895-4356(03)00118-5; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; COLLINGS JA, 1990, EPILEPSIA, V31, P418, DOI 10.1111/j.1528-1157.1990.tb05497.x; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Cramer JA, 2003, EPILEPSY BEHAV, V4, P515, DOI 10.1016/j.yebeh.2003.07.009; Cramer JA, 1998, EPILEPSIA, V39, P81, DOI 10.1111/j.1528-1157.1998.tb01278.x; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Ettinger A, 2004, NEUROLOGY, V63, P1008, DOI 10.1212/01.WNL.0000138430.11829.61; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; Friedman DE, 2010, EPILEPSY BEHAV, V19, P400, DOI 10.1016/j.yebeh.2010.07.029; Friedman DE, 2010, EPILEPSIA, V51, P43, DOI 10.1111/j.1528-1167.2009.02170.x; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Gilliam F, 1997, EPILEPSIA, V38, P233, DOI 10.1111/j.1528-1157.1997.tb01102.x; Gilliam FG, 2006, LANCET NEUROL, V5, P399, DOI 10.1016/S1474-4422(06)70415-X; Gilliam FG, 2005, EPILEPTIC DISORD, V7, pS27; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Harden CL, 2007, EPILEPSY BEHAV, V11, P208, DOI 10.1016/j.yebeh.2007.05.002; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Loring DW, 2004, EPILEPSY BEHAV, V5, P976, DOI 10.1016/j.yebeh.2004.08.019; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Martin R, 2005, EPILEPSY BEHAV, V7, P297, DOI 10.1016/j.yebeh.2005.05.003; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Neufeld MY, 1999, EPILEPSY RES, V34, P123, DOI 10.1016/S0920-1211(98)00105-3; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Ottman R, 2011, EPILEPSIA, V52, P308, DOI 10.1111/j.1528-1167.2010.02927.x; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Seligman MEP., 1975, HELPLESSNESS DEPRESS; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Teasdale TW, 2003, J NEUROL NEUROSUR PS, V74, P933, DOI 10.1136/jnnp.74.7.933; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Zhang SR, 2009, J REHABIL MED, V41, P1062, DOI 10.2340/16501977-0462	52	3	3	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	JUN	2013	27	3					492	496		10.1016/j.yebeh.2013.02.009			5	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	139WL	WOS:000318615600012	23611829				2022-02-06	
J	Guseva, MV; Kamenskii, AA; Gusev, VB				Guseva, M. V.; Kamenskii, A. A.; Gusev, V. B.			Optimization of Choline Administration Regimen for Correction of Cognitive Functions in Rats after Brain Injury	BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE			English	Article						mathematical model; traumatic brain injury; cognitive functions; nicotinic receptors; choline		Choline diet promotes improvement of the brain cognitive functions in rats with moderate-to-severe traumatic brain injury. In previous studies, the rats received choline being standart (0.2%) or choline-supplemented (2%) diet for 2 weeks prior to and 2 weeks after experimental brain injury. To the end of the experiments (in 4 weeks), the post-traumatic disturbances in the cognitive functions were observed in both groups, although they were less pronounced than in the rats kept on the choline-supplemented diet. Based on original mathematical model, this paper proposes a method to calculate the most efficient use of choline to correct the brain cognitive functions. In addition to evaluating the cognitive functions, the study assessed expression of alpha 7 nicotinic acetylcholine receptors, the amount of consumed food and water, and the dynamics of body weight.	[Guseva, M. V.; Kamenskii, A. A.] Moscow MV Lomonosov State Univ, Fac Biol, Dept Human & Anim Physiol, Moscow, Russia; [Gusev, V. B.] Russian Acad Sci, VA Trapeznikov Inst Control Sci, Lab Self Dev Syst, Moscow, Russia		Gusev, VB (corresponding author), Russian Acad Sci, VA Trapeznikov Inst Control Sci, Lab Self Dev Syst, Moscow, Russia.	gusvbr@mail.ru		Dubovaya, Tatiana/0000-0001-7936-180X			Guseva MV, 2006, PHARMACOL BIOCHEM BE, V84, P26, DOI 10.1016/j.pbb.2006.04.002; Guseva MV, 2012, B EXP BIOL MED+, V154, P7, DOI 10.1007/s10517-012-1861-y; Guseva M. V., 2012, B EXP BIOL MED, P49; Guseva MV, 2008, J NEUROTRAUM, V25, P975, DOI 10.1089/neu.2008.0516; Starkstein SE, 2005, INT PSYCHOGERIATR, V17, pS93, DOI 10.1017/S1041610205001973	5	3	4	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0007-4888			B EXP BIOL MED+	Bull. Exp. Biol. Med.	JUN	2013	155	2					197	199					3	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	189HT	WOS:000322258800007	24130988				2022-02-06	
J	Haffejee, S; Ntsiea, V; Mudzi, W				Haffejee, Sameera; Ntsiea, Veronica; Mudzi, Witness			Factors That Influence Functional Mobility Outcomes of Patients After Traumatic Brain Injury	HONG KONG JOURNAL OF OCCUPATIONAL THERAPY			English	Article						functional mobility; Glasgow Coma Scale; modified Mini Mental State Examination; Rivermead Mobility Index; traumatic brain injury	REHABILITATION; STROKE	Objective/Background: The consequences of traumatic brain injury (TBI) include physical, cognitive, psychological, behavioural, and emotional deficits. Prognostic factors such as age, mechanism of injury, and severity of injury assist in determining the outcome of the patient. It is believed that predictors of recovery assist both the patient as well as family members in determining the potential outcomes for the patient. The objective of this study was to identify factors that influence functional mobility outcome of patients after TBI. Methods: This was a cross-sectional study. Participants were assessed predischarge. The Glasgow Coma Scale on admission was noted to establish the severity of the TBI. The Rivermead Mobility Index was used to establish the functional mobility outcome. Results: The sample consisted of 60 participants of which 56 (93%) were mates. The average age of the participants in the study was 28 +/- 8.5 years. More than 50% of the participants were unable to walk outside and 37% were able to climb a flight of stairs without help at the time of discharge from the hospital. Younger age (p < .001), male gender (p = .001), Grade 12 education (p = .001), being self employed (p <.001), having bowel and bladder continence (p < .001), not smoking and drinking (p < .001), and having occupational therapy sessions (p = .002) had a positive impact on function after TBI. Conclusion: Previous studies have identified a multitude of factors and this study has served to confirm factors that have a positive impact on physical function after TBI within this study group. Copyright (C) 2013, Elsevier (Singapore) Pte. Ltd. All rights reserved.	[Haffejee, Sameera; Ntsiea, Veronica; Mudzi, Witness] Univ Witwatersrand, Physiotherapy Dept, Johannesburg, South Africa		Ntsiea, V (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Physiotherapy Dept, 7 York Rd, ZA-2193 Parktown, South Africa.		Mudzi, Witness/U-9086-2017; Mudzi, Witness/AAD-6229-2019; Ntsiea, Mokgobadibe/Q-7858-2017	Mudzi, Witness/0000-0003-4818-5318; Mudzi, Witness/0000-0003-4818-5318; Ntsiea, Mokgobadibe/0000-0003-4208-5498			Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Dickinson K, 2000, BMJ-BRIT MED J, V320, P1308, DOI 10.1136/bmj.320.7245.1308; Elhan AH, 2005, J REHABIL MED, V37, P306, DOI 10.1080/16501970510037573; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faul M, 2010, TRAUMATIC BRAIN INJU; Finch M, 1997, BRAIN INJURY, V11, P713, DOI 10.1080/026990597123089; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; Hillier SL, 1997, BRAIN INJURY, V11, P661; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jeon IC, 2008, J KOREAN NEUROSURG S, V44, P295, DOI 10.3340/jkns.2008.44.5.295; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Meyerhof D., 2005, CHRONIC DRINKING SMO; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Nunally J. C., 1978, PSYCHOMETRIC THEORY, P420; Patel M, 2001, STROKE, V32, P122, DOI 10.1161/01.STR.32.1.122; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Teasell RW, 2005, STROKE, V36, P215, DOI 10.1161/01.STR.0000153061.02375.04; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Williams G, 2004, AM J PHYS MED REHAB, V83, P910, DOI 10.1097/01.PHM.0000146503.25221.1D	23	3	3	0	9	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1569-1861	1876-4398		HONG KONG J OCCUP TH	Hong Kong J. Occup. Ther.	JUN	2013	23	1					39	44		10.1016/j.hkjot.2013.08.001			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	226SN	WOS:000325056400007		gold			2022-02-06	
J	Leung, J; Harvey, LA; Moseley, AM				Leung, Joan; Harvey, Lisa A.; Moseley, Anne M.			An Intensive Programme of Passive Stretch and Motor Training to Manage Severe Knee Contractures after Traumatic Brain Injury: A Case Report	PHYSIOTHERAPY CANADA			English	Article							RANDOMIZED CONTROLLED-TRIAL; SPINAL-CORD INJURIES; WRIST CONTRACTURE; ANKLE MOBILITY; JOINT MOBILITY; STROKE; SPASTICITY; PEOPLE; ADULTS; RELIABILITY		[Leung, Joan; Harvey, Lisa A.] Royal Rehabil Ctr Sydney, Ryde, NSW 2112, Australia; [Leung, Joan; Moseley, Anne M.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Harvey, Lisa A.] Univ Sydney, Rehabil Studies Unit, Sydney Med Sch Northern, Sydney, NSW 2006, Australia; [Moseley, Anne M.] George Inst Global Hlth, Sydney, NSW, Australia		Leung, J (corresponding author), Royal Rehabil Ctr Sydney, Brain Injury Unit, 59 Charles St, Ryde, NSW 2112, Australia.	joan.leung@royalrehab.com.au	Leung, Joan/AAC-8623-2019	Leung, Joan/0000-0003-0888-558X; Harvey, Lisa A/0000-0002-4365-0236			Ada L, 2006, DISABIL REHABIL, V28, P891, DOI 10.1080/09638280500535165; Ada L, 2005, ARCH PHYS MED REHAB, V86, P230, DOI 10.1016/j.apmr.2004.02.031; Ben M, 2005, AUST J PHYSIOTHER, V51, P251, DOI 10.1016/S0004-9514(05)70006-4; BOOTH BJ, 1983, PHYS THER, V63, P1960, DOI 10.1093/ptj/63.12.1960; Carr JH., 2010, NEUROLOGICAL REHABIL, V2nd; Cibere J, 2004, ARTHRITIS RHEUM, V50, P458, DOI 10.1002/art.20025; Dean CM, 2000, AUST J PHYSIOTHER, V46, P35, DOI 10.1016/S0004-9514(14)60312-3; Fergusson D, 2007, CLIN ORTHOP RELAT R, P22, DOI 10.1097/01.BLO.0b013e3180308456; Gustafsson L, 2006, CLIN REHABIL, V20, P277, DOI 10.1191/0269215506cr944oa; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Harvey LA, 2009, SPINAL CORD, V47, P62, DOI 10.1038/sc.2008.71; Harvey LA, 2000, ARCH PHYS MED REHAB, V81, P1340, DOI 10.1053/apmr.2000.9168; Harvey LA, 2003, AUST J PHYSIOTHER, V49, P176, DOI 10.1016/S0004-9514(14)60237-3; Harvey L, 2006, AUST J PHYSIOTHER, V52, P251, DOI 10.1016/S0004-9514(06)70004-6; Hislop H.J., 2007, DANIELS WORTHINGHAMS; Horsley SA, 2007, AUST J PHYSIOTHER, V53, P239, DOI 10.1016/S0004-9514(07)70004-1; Katalinic Owen M., 2010, COCHRANE DATABASE SY, V9; Kwah LK, 2012, J PHYSIOTHER, V58, P41, DOI 10.1016/S1836-9553(12)70071-1; Lannin NA, 2003, ARCH PHYS MED REHAB, V84, P297, DOI 10.1053/apmr.2003.50031; Lannin NA, 2007, STROKE, V38, P111, DOI 10.1161/01.STR.0000251722.77088.12; Mortenson PA, 2003, PHYS THER, V83, P648, DOI 10.1093/ptj/83.7.648; Moseley AM, 2008, CLIN REHABIL, V22, P406, DOI 10.1177/0269215507083795; ODwyer NJ, 1996, BRAIN, V119, P1737, DOI 10.1093/brain/119.5.1737; Pandyan AD, 2003, CLIN REHABIL, V17, P88, DOI 10.1191/0269215503cr587oa; Singer BJ, 2004, ARCH PHYS MED REHAB, V85, P1465, DOI 10.1016/j.apmr.2003.08.103; TURNERSTOKES L, 2003, REHABILITATION FOLLO; Turton AJ, 2005, CLIN REHABIL, V19, P600, DOI 10.1191/0269215505cr891oa; Verplancke D, 2005, CLIN REHABIL, V19, P117, DOI 10.1191/0269215505cr827oa; Waninge A, 2011, RES DEV DISABIL, V32, P613, DOI 10.1016/j.ridd.2010.12.013; ZABLOTNY C, 1987, J HEAD TRAUMA REHAB, V2, P46; Zoltan Denes, 2009, Orvosi Hetilap, V150, P165, DOI 10.1556/OH.2009.28357	31	3	3	0	1	UNIV TORONTO PRESS INC	TORONTO	JOURNALS DIVISION, 5201 DUFFERIN ST, DOWNSVIEW, TORONTO, ON M3H 5T8, CANADA	0300-0508	1708-8313		PHYSIOTHER CAN	Physiother. Can.	SUM	2013	65	3					223	228		10.3138/ptc.2012-29			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	297BB	WOS:000330229000005	24403690	Green Published			2022-02-06	
J	Leon-Takahashi, AM; Gomez-Pedraza, A; Cruz-Rodriguez, A; Ruiz-Molina, JM; Padilla-Rosciano, A; Herrera-Gomez, A				Mitsuo Leon-Takahashi, Alberto; Gomez-Pedraza, Antonio; Cruz-Rodriguez, Antonio; Manuel Ruiz-Molina, Juan; Padilla-Rosciano, Alejandro; Herrera-Gomez, Angel			Use of Glutaraldehyde-Preserved Bovine Pericardium Patch in Vascular Repair of Portal Vein in a Patient with Pancreatic Cancer	INDIAN JOURNAL OF SURGERY			English	Article						Glutaraldehyde-preserved bovine pericardium patch; Pancreatic cancer; Portal vein injury		Advanced-stage gastrointestinal tumors are aggressive and frequently invade blood vessels. Advances in endovascular surgery can repair blood vessels that may be infiltrated by a tumor. Currently there are many materials to do this, as the use of prostheses or implants and patches. In Mexico, the bovine pericardium preserved with glutaraldehyde has been used to treat incisional, inguinal, and diaphragmatic hernias and repair vascular defects with good results, low cost, and no allergic reaction from the patient. We report the case of a 47-year-old man, with a history of smoking and alcoholism, diagnosed with pancreatic adenocarcinoma. The tumor, with the use of endoscopic ultrasound, showed direct contact with the portal vein without invading the confluence of the mesenteric vein. During exploratory laparotomy, a tumor attached to the head of the pancreas of 4 cmx4 cm was found, with tumor invasion of 1 cmx2 cm on the outer sidewall of the portal vein. We performed pylorus-preserving pancreatoduodenectomy and tumor resection of the portal vein wall with placement of glutaraldehyde-preserved bovine pericardium patch to repair it. The intraoperative and immediate postoperative period arose without complications. The patient was discharged with good result and is currently under surveillance. We report this case to show a successful result using glutaraldehyde-preserved bovine pericardium to close vascular defects after resection of the tumor secondary to vascular invasion.	[Mitsuo Leon-Takahashi, Alberto; Gomez-Pedraza, Antonio; Cruz-Rodriguez, Antonio; Manuel Ruiz-Molina, Juan; Padilla-Rosciano, Alejandro; Herrera-Gomez, Angel] Natl Canc Inst, Div Gastroenterol, Mexico City, DF, Mexico		Leon-Takahashi, AM (corresponding author), San Fernando Ave 22 Sect 16, Mexico City 14080, DF, Mexico.	takabeto18@hotmail.com		HERRERA GOMEZ, ANGEL/0000-0002-7885-1599			Santibanez-Salgado JA, 2010, EUR CELLS MATER, V19, P158, DOI 10.22203/eCM.v019a16; Boin IDSF, 2003, HEPATO-GASTROENTEROL, V50, P839; Fukuda Saburo, 2007, Arch Surg, V142, P172; Hellstrom WJG, 2000, J UROLOGY, V163, P1445, DOI 10.1016/S0022-5347(05)67639-2; IONESCU MI, 1977, J THORAC CARDIOV SUR, V73, P31; Taschieri AM, 1999, HEPATO-GASTROENTEROL, V46, P492; [No title captured]	7	3	4	0	5	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0972-2068	0973-9793		INDIAN J SURG	Indian J. Surg	JUN	2013	75			1			S247	S249		10.1007/s12262-012-0655-9			3	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	296YL	WOS:000330221200087	24426580	Green Published			2022-02-06	
J	Ozsoy, KM; Menekse, G; Okten, AI; Guzel, A				Ozsoy, Kerem Mazhar; Menekse, Guner; Okten, Ali Ihsan; Guzel, Aslan			Cerebrospinal fluid fistula due to penetrating trauma	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						Cerebrospinal fluid leak; Fistula; Penetrating injury		Penetrating spinal injury with CSF (cerebrospinal fluid) leakage, without neurological deficit is extremely rare. Most of these CSF leakages spontaneously stops and do not threat life. CSF fistula due to penetrating trauma treated with conservatively in the first step. In the failure of conservative treatment surgery is necessary. Penetrating-cutting insults to the spinal cord are generally caused by back attack to the cervical and thoracic area and usually they are with incomplete cord injury. Most of these cases are caused by knife. In the present study a case with lumbar CSF leakage caused by knife injury treated with surgery without neurological deficit presented. Copyright (C) 2013, Neurotrauma Society of India. All rights reserved.	[Ozsoy, Kerem Mazhar; Menekse, Guner; Okten, Ali Ihsan] Adana Numune Training & Res Hosp, Dept Neurosurg, Adana, Turkey; [Guzel, Aslan] Adana Numune Training & Res Hosp, Dept Neurosurg, Neurosurg, Adana, Turkey		Menekse, G (corresponding author), Adana Numune Egitim & Arastirma Hastanesi, Norosirurji Klin, Adana, Turkey.	gunerbc@yahoo.com					Alkan A, 2002, NEURORADIOLOGY, V44, P64, DOI 10.1007/s002340100646; Dogan S, 2008, TURK NEUROSURG, V18, P298; Heary RF, 1996, ORTHOP CLIN N AM, V27, P69; ISU T, 1985, SURG NEUROL, V23, P255, DOI 10.1016/0090-3019(85)90091-6; Jacobsohn M, 2007, NEUROSURGERY, V61, P1262, DOI 10.1227/01.neu.0000306105.76259.63; Jallo GI, 1997, SURG NEUROL, V47, P328, DOI 10.1016/S0090-3019(96)00458-2; Kulkarni AV, 2000, J EMERG MED, V18, P209, DOI 10.1016/S0736-4679(99)00196-1; LEBLANC HJ, 1969, J NEUROSURG, V31, P683, DOI 10.3171/jns.1969.31.6.0683; LIPSCHITZ R, 1962, LANCET, V2, P169, DOI 10.1016/S0140-6736(62)90054-5; Manzone P, 2001, J SPINAL DISORD, V14, P264, DOI 10.1097/00002517-200106000-00014; Moyed S, 1999, AM J ROENTGENOL, V173, P1387, DOI 10.2214/ajr.173.5.10541126; PEACOCK WJ, 1977, S AFR MED J, V51, P961; Rahamimov N, 2010, J ORTHOP TRAUMATOL, V11, P57, DOI 10.1007/s10195-009-0070-6; Rubin G, 2001, SPINE, V26, P444, DOI 10.1097/00007632-200102150-00023; Secer M, 2011, ULUS TRAVMA ACIL CER, V17, P189, DOI 10.5505/tjtes.2011.16023; Shahlaie K, 2006, J NEUROSURG-SPINE, V4, P400, DOI 10.3171/spi.2006.4.5.400; Splavski B, 1996, INJURY, V27, P699, DOI 10.1016/S0020-1383(96)00130-1; THAKUR RC, 1991, ACTA NEUROCHIR, V113, P144, DOI 10.1007/BF01403200; VELMAHOS GC, 1995, J TRAUMA, V38, P334, DOI 10.1097/00005373-199503000-00004	19	3	3	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	JUN	2013	10	1					52	54		10.1016/j.ijnt.2013.04.002			3	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M4K	WOS:000218388900013					2022-02-06	
J	Kaipio, ML; Cheour, M; Ohman, J; Salonen, O; Naatanen, R				Kaipio, Marja-Liisa; Cheour, Marie; Ohman, Juha; Salonen, Oili; Naatanen, Risto			Mismatch negativity abnormality in traumatic brain injury without macroscopic lesions on conventional MRI	NEUROREPORT			English	Article						distractibility; involuntary attention; mismatch negativity; MRI; P3a; traumatic axonal injury; traumatic brain injury	EVENT-RELATED POTENTIALS; CLOSED-HEAD INJURY; COGNITIVE IMPAIRMENT; DISTRACTIBILITY; MMN; ATTENTION; HUMANS	Traumatic brain injury (TBI) causes damage through complex pathophysiological mechanisms. Deficits related to traumatic axonal injury persist in a subset of patients with no macroscopic lesions on conventional MRI. We examined two event-related brain potentials, mismatch negativity (MMN) and P3a, to identify possible electrophysiological anomalies in this subset of TBI patients in comparison with TBI patients with focal abnormalities on MRI/computed tomography and healthy controls. Each group consisted of 10 individuals. A passive oddball paradigm, in which the individuals were instructed to ignore auditory stimuli while watching a silent movie, consisted of non-native speech sounds presented in a random order. Patients with no discernible lesions on conventional MRI showed a significantly augmented amplitude of the brain's involuntary change-detection response MMN, relative to that of the two other groups. In patients with focal neuroradiological abnormalities, this MMN anomaly was not found, whereas the subsequent orientation-related P3a response was significantly enlarged when compared with that of the controls. The present findings demonstrate that MMN is indicative of a functional abnormality in the mechanisms of involuntary attention in chronic TBI patients with normal conventional MRI findings, indexing their increased distractibility associated with the traumatically-induced loss of neural integrity. NeuroReport 24:440-444 (C) 2013 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Kaipio, Marja-Liisa; Cheour, Marie; Naatanen, Risto] Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, FI-00014 Helsinki, Finland; [Salonen, Oili] Helsinki Univ Hosp, Dept Radiol, Helsinki, Finland; [Ohman, Juha] Tampere Univ Hosp, Dept Neurosurg, Tampere, Finland; [Naatanen, Risto] Univ Tartu, Dept Psychol, EE-50090 Tartu, Estonia; [Naatanen, Risto] Aarhus Univ, Ctr Integrat Neurosci CFIN, Aarhus, Denmark		Kaipio, ML (corresponding author), Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, POB 9, FI-00014 Helsinki, Finland.	marja-liisa.kaipio@helsinki.fi		Ohman, Juha/0000-0002-6592-1367	Academy of FinlandAcademy of FinlandEuropean Commission	The authors thank Professors Kimmo Alho and Istvan Winkler and Dr Rita Ceponiene for their constructive comments during the preparation of this report. They also thank Dr Anna Shestakova, Mr Jorma Arkkila, and Mr Teemu Peltonen for technical assistance. This research was supported by The Academy of Finland.	Alain C, 1998, BRAIN RES, V812, P23, DOI 10.1016/S0006-8993(98)00851-8; ALHO K, 1995, EAR HEARING, V16, P38, DOI 10.1097/00003446-199502000-00004; Alku P, 1999, CLIN NEUROPHYSIOL, V110, P1329, DOI 10.1016/S1388-2457(99)00088-7; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Duncan CC, 2011, INT J PSYCHOPHYSIOL, V82, P24, DOI 10.1016/j.ijpsycho.2011.02.013; Elting JW, 2008, BRAIN INJURY, V22, P870, DOI 10.1080/02699050802403581; Escera C, 2000, AUDIOL NEURO-OTOL, V5, P151, DOI 10.1159/000013877; Fischer C, 2006, CRIT CARE MED, V34, P1520, DOI 10.1097/01.CCM.0000215823.36344.99; Gosselin N, 2012, NEUROSURG FOCUS, V33, P1, DOI DOI 10.3171/2012.10.F0CUS12253; Johnson V. E., 2012, EXP NEUROL, DOI [10.1016/j.expneurol.2012.01.013, DOI 10.1016/J.EXPNEUR0L.2012.01.013.[]; Kaipio ML, 1999, NEUROREPORT, V10, P2125, DOI 10.1097/00001756-199907130-00024; Kaipio ML, 2000, NEUROREPORT, V11, P1463; Kaipio ML, 2001, NEUROREPORT, V12, P1517, DOI 10.1097/00001756-200105250-00043; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Knight RT, 1998, J CLIN NEUROPHYSIOL, V15, P3, DOI 10.1097/00004691-199801000-00003; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 2000, AUDIOL NEURO-OTOL, V5, P105, DOI 10.1159/000013874; Naatanen R, 2011, PSYCHOPHYSIOLOGY, V48, P4, DOI 10.1111/j.1469-8986.2010.01114.x; Rule RR, 2002, COGN AFFECT BEHAV NE, V2, P264, DOI 10.3758/CABN.2.3.264; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382	24	3	3	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0959-4965			NEUROREPORT	Neuroreport	MAY 29	2013	24	8					440	444		10.1097/WNR.0b013e32836164b4			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	138XQ	WOS:000318545500009	23604169				2022-02-06	
J	Kota, S; Kelsey, KM; Rigoni, JB; Molfese, DL				Kota, Srinivas; Kelsey, Kathleen M.; Rigoni, Joseph B.; Molfese, Dennis L.			Feasibility of using event-related potentials as a sideline measure of neurocognitive dysfunction during sporting events	NEUROREPORT			English	Article						concussion; event-related potentials; oddball; P3b; sport	CONCUSSION	This study recorded brain event-related potentials (ERPs) during an attention task under two conditions: (a) immediately after strenuous exercise and (b) immediately after an extended rest period. The goal was to examine the effect of different physiological states on the electrophysiological data. As expected, a larger P3b ERP component was observed in response to attended infrequent events. Strenuous exercise did not differentially alter the amplitude or latency of the brain response during an attention task. This study reports a novel application of ERPs as a potential additional measure of the neurocognitive state that can be assessed on the sideline of a sporting event. NeuroReport 24:437-439 (C) 2013 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Kota, Srinivas; Kelsey, Kathleen M.; Rigoni, Joseph B.; Molfese, Dennis L.] Univ Nebraska, Dept Psychol, Dev Neurosci Lab, Lincoln, NE 68588 USA		Molfese, DL (corresponding author), Univ Nebraska, Dept Psychol, Dev Neurosci Lab, 321 Burnett Hall, Lincoln, NE 68588 USA.	dlmolfese@mac.com	Kota, Srinivas/L-7946-2019	Kota, Srinivas/0000-0001-7870-4903; Earnest, Kathleen/0000-0002-6911-4335	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01EB007684, R43HD062072]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R43HD062072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB007684] Funding Source: NIH RePORTER	This work was supported in part by grants from NIH R01EB007684 and NIH R43HD062072. The authors thank Cathryn Cortesa, Anna Davidson, and Sara Mason for assisting in data collection.	Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Faul M, 2010, TRAUMATIC BRAIN INJU; Hudac CM, 2012, EYE BRAIN, V4, P1, DOI 10.2147/EB.S27290; Mofese DL, 2008, DEV NEUROPSYCHOL, V33, P682; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6	8	3	3	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0959-4965			NEUROREPORT	Neuroreport	MAY 29	2013	24	8					437	439		10.1097/WNR.0b013e3283616512			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	138XQ	WOS:000318545500008	23591362				2022-02-06	
J	Hertle, D; Werhahn, L; Beynon, C; Zweckberger, K; Vienenkotter, B; Jung, CS; Unterberg, A; Kiening, K; Sakowitz, O				Hertle, D.; Werhahn, L.; Beynon, C.; Zweckberger, K.; Vienenkoetter, B.; Jung, C. S.; Unterberg, A.; Kiening, K.; Sakowitz, O.			Depression of neuronal activity by sedatives is associated with adverse effects after brain injury	BRAIN RESEARCH			English	Article						Traumatic brain injury; TBI; Neuronal death; Isoflurane; Midazolam; Sedation	CELL-SURVIVAL; ACUTE STROKE; ISOFLURANE; ANESTHESIA; APOPTOSIS; ISCHEMIA; SEVOFLURANE; RATS; CLOMETHIAZOLE; HALOTHANE	Analgesics and sedatives are frequently used in the treatment of acute brain injury and subsequent brain swelling. Most agents act on specific receptors to modulate neuronal activity, which is normally involved in feedback loops that direct system building and maintenance. We investigated the neurodegenerative effects of midazolam and isoflurane in a rat model of controlled cortical impact injury (CCII). Two hours prior to CCII, four experimental groups were treated with different agents including a minimum alveolar concentration (MAC 1.0) of isoflurane. For additional sedation, isoflurane MAC 1.67, midazolam alone, or midazolam in combination with flumazenil was used. Blood pressure and blood gas analysis were monitored to investigate systemic side effects. Two days after treatment, relative apoptotic cell counts were determined by the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) method. With isoflurane and midazolam, electroencephalographic (EEG) recordings revealed a decrease in amplitude size and altered frequency distribution. Treatment using deep sedation with isoflurane MAC 1.67 or midazolam increased relative apoptotic cell count by 14.8% (95% CI 3.6 to 26.1, p<0.01) and 18.0% (95% CI 6.8 to 29.3, p<0.01), respectively. Co-treatment with flumazenil reversed the neurodegenerative effect of midazolam by -13.2% (95% CI -24.5 to 2.0, p<0.05). Functional neurological outcome was worse after isoflurane MAC 1.67 (18.8 score points; p<0.01) and midazolam (21.4 score points, p<0.001). Flumazenil antagonized the neurodegenerative effects of midazolam. In conclusion, neuronal survival and functional recovery are reduced by sedative use in a rat model of acute brain injury. (C) 2013 Elsevier B.V. All rights reserved.	[Hertle, D.; Werhahn, L.; Beynon, C.; Zweckberger, K.; Vienenkoetter, B.; Jung, C. S.; Unterberg, A.; Kiening, K.; Sakowitz, O.] Univ Heidelberg Hosp, Dept Neurosurg, D-69120 Heidelberg, Germany		Hertle, D (corresponding author), Univ Heidelberg Hosp, Dept Neurosurg, INF 400, D-69120 Heidelberg, Germany.	daniel.hertle@med.uni-heidelberg.de		Sakowitz, Oliver/0000-0003-3248-6335			Alkire MT, 1999, ANESTHESIOLOGY, V90, P701, DOI 10.1097/00000542-199903000-00011; Bauer S, 2007, NAT REV NEUROSCI, V8, P221, DOI 10.1038/nrn2054; Bechstein M, 2012, EXP NEUROL, V236, P141, DOI 10.1016/j.expneurol.2012.04.009; Belousov A.B., 2012, NEURONAL GAP JUNCTIO, DOI DOI 10.1016/J.TINS.2012.11.001; CATSICAS M, 1992, J NEUROSCI, V12, P4642; Chaulk D, 2003, EXP NEUROL, V182, P476, DOI 10.1016/S0014-4886(03)00121-3; Culley DJ, 2007, ANESTH ANALG, V105, P83, DOI 10.1213/01.ANE.0000266491.53318.20; Culley DJ, 2003, ANESTH ANALG, V96, P1004, DOI 10.1213/01.ANE.0000052712.67573.12; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dong YL, 2009, ARCH NEUROL-CHICAGO, V66, P620, DOI 10.1001/archneurol.2009.48; DRUMMOND JC, 1995, NEUROSURGERY, V37, P742, DOI 10.1227/00006123-199510000-00019; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hardingham GE, 2011, ANTIOXID REDOX SIGN, V14, P1421, DOI 10.1089/ars.2010.3573; Hertle D, 2008, CELL TISSUE RES, V334, P7, DOI 10.1007/s00441-008-0651-3; Hertle Daniel, 2012, Acta Neurochir Suppl, V114, P383, DOI 10.1007/978-3-7091-0956-4_74; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; Kawaguchi Masahiko, 2005, J Anesth, V19, P150, DOI 10.1007/s00540-005-0305-5; Kitano H, 2007, J CEREBR BLOOD F MET, V27, P1108, DOI 10.1038/sj.jcbfm.9600410; Kroppenstedt SN, 2002, J NEUROTRAUM, V19, P1421, DOI 10.1089/089771502320914651; Kvolik S, 2005, LIFE SCI, V77, P2369, DOI 10.1016/j.lfs.2004.12.052; Lodder J, 2006, CEREBROVASC DIS, V21, P120, DOI 10.1159/000090210; Loop T, 2005, ANESTHESIOLOGY, V102, P1147, DOI 10.1097/00000542-200506000-00014; Lyden P, 2002, STROKE, V33, P122, DOI 10.1161/hs0102.101478; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nangunoori R., 2011, NEUROCRIT CARE, V16; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; NEHLS DG, 1987, ANESTHESIOLOGY, V66, P453, DOI 10.1097/00000542-198704000-00002; Ochalski PG, 2010, J NEUROTRAUM, V27, P647, DOI 10.1089/neu.2009.1142; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Rampil IJ, 1998, ANESTHESIOLOGY, V89, P980, DOI 10.1097/00000542-199810000-00023; Rasband W.S, 1997, IMAGEJ US; Roberts DJ, 2011, CRIT CARE MED, V39, P2743, DOI 10.1097/CCM.0b013e318228236f; Rothstein S, 2008, NEUROSCIENCE, V152, P959, DOI 10.1016/j.neuroscience.2008.01.027; Sarissky M, 2005, NEOPLASMA, V52, P352; SCHURR A, 1986, BRAIN RES, V374, P244, DOI 10.1016/0006-8993(86)90418-X; Sherrard RM, 1998, CLIN EXP PHARMACOL P, V25, P487, DOI 10.1111/j.1440-1681.1998.tb02241.x; Shulman RG, 2009, P NATL ACAD SCI USA, V106, P11096, DOI 10.1073/pnas.0903941106; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Stover JF, 2004, ACTA NEUROCHIR, V146, P819, DOI 10.1007/s00701-004-0281-9; Stover John F, 2003, Med Sci Monit, V9, pBR382; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Wallenborn J, 2004, EUR J ANAESTH, V21, P30, DOI 10.1097/00003643-200406002-00111; Wei HF, 2005, BRAIN RES, V1037, P139, DOI 10.1016/j.brainres.2005.01.009; Xie ZC, 2006, ANESTHESIOLOGY, V104, P988, DOI 10.1097/00000542-200605000-00015; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zweckberger K, 2010, NEUROSCI LETT, V470, P150, DOI 10.1016/j.neulet.2009.12.075	52	3	3	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 13	2013	1510						1	9		10.1016/j.brainres.2013.03.009			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149FO	WOS:000319304600001	23524191				2022-02-06	
J	Khadrawy, YA; AboulEzz, HS; Ahmed, NA; Mohammed, HS				Khadrawy, Yasser A.; AboulEzz, Heba S.; Ahmed, Nawal A.; Mohammed, Haitham S.			The Anticonvulant Effect of Cooling in Comparison to alpha-Lipoic Acid: A Neurochemical Study	NEUROCHEMICAL RESEARCH			English	Article						Brain cooling; alpha-Lipoic acid; Hippocampus; Epilepsy; Oxidative stress	TRAUMATIC BRAIN-INJURY; PILOCARPINE-INDUCED SEIZURES; CELL MEMBRANE-FUNCTION; NITRIC-OXIDE; STATUS EPILEPTICUS; MODERATE HYPOTHERMIA; KAINIC ACID; LIPID-PEROXIDATION; OXIDATIVE STRESS; ATPASE ACTIVITY	Brain cooling has pronounced effects on seizures and epileptic activity. The aim of the present study is to evaluate the anticonvulsant effect of brain cooling on the oxidative stress and changes in Na+, K+-ATPase and acetylcholinesterase (AchE) activities during status epilepticus induced by pilocarpine in the hippocampus of adult male rat in comparison with alpha-lipoic acid. Rats were divided into four groups: control, rats treated with pilocarpine for induction of status epilepticus, rats treated for 3 consecutive days with alpha-lipoic acid before pilocarpine and rats subjected to whole body cooling for 30 min before pilocarpine. The present findings indicated that pilocarine-induced status epilepticus was accompanied by a state of oxidative stress as clear from the significant increase in lipid peroxidation (MDA) and superoxide dismutase (SOD) and significant decrease in reduced glutathione and nitric oxide (NO) levels and the activities of catalase, AchE and Na+, K+-ATPase. Pretreatment with alpha-lipoic acid ameliorated the state of oxidative stress and restored AchE to nearly control activity. However, Na+, K+-ATPase activity showed a significant decrease. Rats exposed to cooling for 30 min before the induction of status epilepticus revealed significant increases in MDA and NO levels and SOD activity. AchE returned to control value while the significant decrease in Na+, K+-ATPase persisted. The present data suggest that cooling may have an anticonvulsant effect which may be mediated by the elevated NO level. However, brain cooling may have drastic unwanted insults such as oxidative stress and the decrease in Na+, K+-ATPase activity.	[Khadrawy, Yasser A.] Natl Res Ctr, Dept Med Physiol, Div Med, Giza, Egypt; [AboulEzz, Heba S.; Ahmed, Nawal A.] Cairo Univ, Fac Sci, Dept Zool, Giza, Egypt; [Mohammed, Haitham S.] Cairo Univ, Fac Sci, Dept Biophys, Giza, Egypt		Khadrawy, YA (corresponding author), Natl Res Ctr, Dept Med Physiol, Div Med, El Bohouth St,PO 12622, Giza, Egypt.	yaserask@yahoo.com	mohammed, haitham/AAY-2237-2021; Sharaf, Haitham/AAU-7472-2021	Sharaf, Haitham/0000-0002-6055-9514; Ashry Khadrawy, Yasser/0000-0003-2562-535X; Aboul Ezz, Heba/0000-0003-1923-6155; , Heba/0000-0001-8689-1198			Aihara H, 2001, BRAIN RES, V893, P36, DOI 10.1016/S0006-8993(00)03285-6; ANDERSON WR, 1994, EPILEPSY RES, V17, P221, DOI 10.1016/0920-1211(94)90052-3; [Anonymous], 1993, EPILEPSIA, V34, P592; Bacher A, 1998, ANESTHESIOLOGY, V88, P403, DOI 10.1097/00000542-199802000-00019; Barros DO, 2007, NEUROSCI LETT, V416, P227, DOI 10.1016/j.neulet.2007.01.057; Berthon D, 1996, COMP BIOCHEM PHYS B, V114, P327, DOI 10.1016/0305-0491(96)00044-2; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Biagas Katherine V., 1998, Current Opinion in Pediatrics, V10, P271, DOI 10.1097/00008480-199806000-00009; BOWLER K, 1974, J NEUROCHEM, V23, P611, DOI 10.1111/j.1471-4159.1974.tb06068.x; BUCHAN A, 1990, J NEUROSCI, V10, P311; BUISSON A, 1993, NEUROREPORT, V4, P444, DOI 10.1097/00001756-199304000-00027; CALABRESI P, 1995, EUR J NEUROSCI, V7, P1674, DOI 10.1111/j.1460-9568.1995.tb00689.x; Chatzipanteli K, 1999, J NEUROCHEM, V72, P2047, DOI 10.1046/j.1471-4159.1999.0722047.x; Circu ML, 2008, FREE RADICAL RES, V42, P689, DOI 10.1080/10715760802317663; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; CORBETT D, 1990, BRAIN RES, V514, P300, DOI 10.1016/0006-8993(90)91424-F; Corry JJ, 2008, NEUROCRIT CARE, V9, P189, DOI 10.1007/s12028-008-9092-9; Czuczwar SJ, 1999, EUR J PHARMACOL, V366, P137, DOI 10.1016/S0014-2999(98)00927-3; Dal-Pizzol F, 2000, NEUROSCI LETT, V291, P179, DOI 10.1016/S0304-3940(00)01409-9; DAWSON TM, 1992, ANN NEUROL, V32, P297, DOI 10.1002/ana.410320302; de Freitas RM, 2003, ARQ NEURO-PSIQUIAT, V61, P430, DOI 10.1590/S0004-282X2003000300019; Santos IMD, 2010, CELL MOL NEUROBIOL, V30, P569, DOI 10.1007/s10571-009-9481-4; DESARRO G, 1993, EUR J PHARMACOL, V230, P151, DOI 10.1016/0014-2999(93)90797-L; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DONALDSON J, 1971, CAN J BIOCHEM CELL B, V49, P1217, DOI 10.1139/o71-175; DOUGLAS KT, 1987, ADV ENZYMOL RAMB, V59, P103; Duysen EG, 2002, DEV BRAIN RES, V137, P43, DOI 10.1016/S0165-3806(02)00367-X; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Fernandes MJS, 1996, NEUROCHEM INT, V28, P497, DOI 10.1016/0197-0186(95)00153-0; Frantseva MV, 2000, EUR J NEUROSCI, V12, P1431, DOI 10.1046/j.1460-9568.2000.00016.x; Freitas RM, 2009, NEUROSCI LETT, V455, P140, DOI 10.1016/j.neulet.2009.03.065; Freitas R.M., 2010, CELL MOL NEUROBIOL, V30, P381; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GORUN V, 1978, ANAL BIOCHEM, V86, P324, DOI 10.1016/0003-2697(78)90350-0; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; GRISAR T, 1992, EPILEPSY RES, V12, P141, DOI 10.1016/0920-1211(92)90034-Q; Gunn AJ, 1998, EARLY HUM DEV, V53, P19, DOI 10.1016/S0378-3782(98)00033-4; Gupta AK, 2002, BRIT J ANAESTH, V88, P188, DOI 10.1093/bja/88.2.188; Guven H, 2002, J TRAUMA, V53, P66, DOI 10.1097/00005373-200207000-00014; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HANDELMAN GJ, 1994, BIOCHEM PHARMACOL, V47, P1725, DOI 10.1016/0006-2952(94)90298-4; HEALES SJR, 1995, NEUROCHEM RES, V20, P31; Hill MW, 2000, EPILEPSIA, V41, P1241, DOI 10.1111/j.1528-1157.2000.tb04601.x; Horiguchi T, 2003, J NEUROTRAUM, V20, P511, DOI 10.1089/089771503765355577; IWAI T, 1993, LIFE SCI, V52, P1031, DOI 10.1016/0024-3205(93)90195-9; Javedan SP, 2002, EPILEPSIA, V43, P574, DOI 10.1046/j.1528-1157.2002.40101.x; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; JOPE RS, 1987, J NEUROCHEM, V49, P944, DOI 10.1111/j.1471-4159.1987.tb00985.x; Karkar KM, 2002, EPILEPSIA, V43, P932, DOI 10.1046/j.1528-1157.2002.03902.x; Katz LM, 2004, BRAIN RES, V1017, P85, DOI 10.1016/j.brainres.2004.05.020; Lees GJ, 1996, BRAIN RES, V714, P145, DOI 10.1016/0006-8993(95)01518-3; Liebregts MT, 2002, ANN NEUROL, V52, P318, DOI 10.1002/ana.10285; Liu JZ, 2010, SEIZURE-EUR J EPILEP, V19, P165, DOI 10.1016/j.seizure.2010.01.010; MACINTYRE PE, 1987, ANESTH ANALG, V66, P751; Maeda T, 1999, BRAIN RES, V818, P228, DOI 10.1016/S0006-8993(98)01269-4; MAGGIO R, 1995, BRAIN RES, V679, P184, DOI 10.1016/0006-8993(95)00217-E; MANZONI O, 1992, NEURON, V8, P653, DOI 10.1016/0896-6273(92)90087-T; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Matzen J, 2008, SEIZURE-EUR J EPILEP, V17, P76, DOI 10.1016/j.seizure.2007.07.008; Milatovic D, 2002, BRAIN RES, V957, P330, DOI 10.1016/S0006-8993(02)03669-7; MONTGOMERY H, 1961, ANALYST, V86, P414; Motamedi GK, 2012, NEUROTHERAPEUTICS, V9, P199, DOI 10.1007/s13311-011-0078-5; Motamedia GK, 2006, EPILEPSY RES, V70, P200, DOI 10.1016/j.eplepsyres.2006.05.001; NEUMAR RW, 1995, RESUSCITATION, V29, P249, DOI 10.1016/0300-9572(94)00827-3; NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3; OMMAYA AK, 1963, J NEUROSURG, V20, P8, DOI 10.3171/jns.1963.20.1.0008; ORMANDY GC, 1989, EXP NEUROL, V106, P172, DOI 10.1016/0014-4886(89)90091-5; Park WS, 2001, NEUROCHEM RES, V26, P369, DOI 10.1023/A:1010947030587; Park WS, 2001, J KOREAN MED SCI, V16, P335, DOI 10.3346/jkms.2001.16.3.335; Patel MN, 2002, FREE RADICAL RES, V36, P1139, DOI 10.1080/1071576021000016391; Polderman KH, 2001, INTENS CARE MED, V30, P556; RAPPORT RL, 1975, ARCH NEUROL-CHICAGO, V32, P549, DOI 10.1001/archneur.1975.00490500069008; RUIZLARREA MB, 1994, STEROIDS, V59, P383; SAPOLSKY RM, 1985, SCIENCE, V229, P1397, DOI 10.1126/science.4035356; Schmitt FC, 2006, NEUROBIOL DIS, V23, P689, DOI 10.1016/j.nbd.2006.05.008; SHEN KF, 1988, BRAIN RES, V475, P305, DOI 10.1016/0006-8993(88)90619-1; Sleven H, 2006, NEUROCHEM INT, V48, P75, DOI 10.1016/j.neuint.2005.10.002; STARR MS, 1993, PHARMACOL BIOCHEM BE, V45, P321, DOI 10.1016/0091-3057(93)90246-P; Szabo C, 1996, BRAIN RES BULL, V41, P131, DOI 10.1016/0361-9230(96)00159-1; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; THOMPSON SM, 1985, J NEUROSCI, V5, P817; Tikuisis P, 2000, J APPL PHYSIOL, V89, P1403, DOI 10.1152/jappl.2000.89.4.1403; Tsakiris S, 2000, Z NATURFORSCH C, V55, P271; TURSKI WA, 1983, BEHAV BRAIN RES, V9, P315, DOI 10.1016/0166-4328(83)90136-5; Ullrich S, 2007, BIOCHEM BIOPH RES CO, V352, P662, DOI 10.1016/j.bbrc.2006.11.065; WILLIAMS MB, 1994, EXP NEUROL, V129, P169, DOI 10.1006/exnr.1994.1158; Yang XF, 2005, J PHYSIOL-LONDON, V567, P215, DOI 10.1113/jphysiol.2005.088948; Yang XF, 2001, ANN NEUROL, V49, P721, DOI 10.1002/ana.1021; YOUNG RSK, 1991, PEDIATR RES, V29, P191, DOI 10.1203/00006450-199102000-00018; Yun HY, 1997, MOL PSYCHIATR, V2, P300, DOI 10.1038/sj.mp.4000272; Zimmer C, 2003, CLIN J PAIN, V19, P233, DOI 10.1097/00002508-200307000-00006	92	3	3	0	7	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	MAY	2013	38	5					906	915		10.1007/s11064-013-0995-2			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	116SO	WOS:000316903200002	23389664				2022-02-06	
J	Ownsworth, T; Stewart, E; Fleming, J; Griffin, J; Collier, AM; Schmidt, J				Ownsworth, Tamara; Stewart, Ea; Fleming, Jennifer; Griffin, Janelle; Collier, Ann Maree; Schmidt, Julia			Development and Preliminary Psychometric Evaluation of the Self-Perceptions in Rehabilitation Questionnaire (SPIRQ) for Brain Injury Rehabilitation	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article							AWARENESS DEFICITS; ADULTS; ADJUSTMENT	OBJECTIVE. The Self-Perceptions in Rehabilitation Questionnaire (SPIRQ) is a brief measure developed to monitor client self-perceptions, motivation, and emotional reactions throughout rehabilitation. We describe the SPIRQ's development and preliminary psychometric evaluation. METHOD. One hundred five adults with traumatic brain injury attending two brain injury rehabilitation units completed the SPIRQ during occupational therapy sessions. A subset (n = 33) completed the SPIRQ twice over a 5- to 7-day interval to examine test retest reliability. RESULTS. Exploratory factor analysis yielded three factors: Changes in Self and Life Plans, Self in Rehabilitation, and Emotional Reactions. Their internal consistency was sound (as =.72-33). Test retest reliability was generally acceptable (rs = .67-.81), and scores did not significantly change between testing occasions (p > .05). CONCLUSION. We found preliminary support for the SPIRO scales' reliability and construct validity. Future empirical evaluation and potential clinical applications of the SPIRQ in occupational therapy are discussed.	[Ownsworth, Tamara; Stewart, Ea] Griffith Univ, Sch Appl Psychol, Mt Gravatt, Qld 4122, Australia; [Ownsworth, Tamara; Stewart, Ea] Griffith Univ, Griffith Inst Hlth, Mt Gravatt, Qld 4122, Australia; [Fleming, Jennifer; Schmidt, Julia] Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld 4072, Australia; [Fleming, Jennifer; Griffin, Janelle; Collier, Ann Maree] Princess Alexandra Hosp, Occupat Therapy Dept, Woolloongabba, Qld 4102, Australia; [Fleming, Jennifer] Metro South Hlth Serv Dist, Ctr Functioning & Hlth Res, Buranda, Qld, Australia; [Schmidt, Julia] Royal Rehabil Ctr, Sydney, NSW, Australia		Ownsworth, T (corresponding author), Griffith Univ, Sch Appl Psychol, Mt Gravatt, Qld 4122, Australia.	j.fleming@ug.edu.au	Ownsworth, Tamara/ABB-6961-2021	Ownsworth, Tamara/0000-0003-1835-7094; Schmidt, Julia/0000-0003-2004-4871			Abreu BC, 2001, ARCH PHYS MED REHAB, V82, P49, DOI 10.1053/apmr.2001.9167; Dirette D, 2002, BRAIN INJURY, V16, P861, DOI 10.1080/02699050210131902; Doig E, 2009, AM J OCCUP THER, V63, P559, DOI 10.5014/ajot.63.5.559; Domholdt E, 2005, REHABILITATION RES P; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fleming J., 2006, BRAIN IMPAIR, V7, P83, DOI [https://doi.org/10.1375/brim.7.2.83, DOI 10.1375/BRIM.7.2.83, 10.1375/brim.7.2.83]; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleming JM, 1996, BRAIN INJURY, V10, P1; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; GUADAGNOLI E, 1988, PSYCHOL BULL, V103, P265, DOI 10.1037/0033-2909.103.2.265; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Hatcher L, 1994, STEP BY STEP APPROAC, P325; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; Mallery P., 2003, SPSS WINDOWS STEP ST, V4th; Nunnally J., 1994, PSYCHOMETRIC THEORY; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth T. L., 2009, 6 SAT S NEUR REH TAL; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Ownsworth T, 2011, J INT NEUROPSYCH SOC, V17, P112, DOI 10.1017/S1355617710001311; Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076; Pallant J.F., 2007, SPSS SURVIVAL MANUAL; Pollock N, 1998, CANADIAN OCCUPATIONA; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Tate RL, 2010, COMPENDIUM TESTS SCA; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Turner B, 2009, AM J OCCUP THER, V63, P609, DOI 10.5014/ajot.63.5.609	31	3	3	0	7	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490			AM J OCCUP THER	Am. J. Occup. Ther.	MAY-JUN	2013	67	3					336	344		10.5014/ajot.2013.007625			9	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	139LP	WOS:000318584500011	23597692	Green Published			2022-02-06	
J	Robbins, L; Conidi, F				Robbins, Lawrence; Conidi, Frank			Stop Football ... Save Brains: A Point Counterpoint Discussion	HEADACHE			English	Article						concussion; chronic traumatic encephalopathy; football; head trauma; headache; helmets; subconcussive event	HIGH-SCHOOL; CONCUSSION; IMPACT; EPIDEMIOLOGY; SPORTS; INJURY	In a recent Opinion Editorial posted on the Listserv of the Southern Headache Society (http://www.SouthernHeadache.org), Dr. Lawrence Robbins of the Robbins Headache Clinic, Northbrook, Illinois, explored how headaches resulting from trauma are sometimes difficult to treat and often remain refractory. Most neurologists likely encounter young athletes who have a moderate-to-severe post-concussion syndrome. The following discussion, therefore, is relevant to the practice of headache medicine. In this Point Counterpoint, Dr. Robbins has repurposed his OpEd once more for Headache, followed by a response from Dr. Frank Conidi of the Florida Center for Headache and Sports Neurology, and Team Neurologist for the Florida Panthers of the National Hockey League. The discussion concludes with a retort from Dr. Robbins.	[Robbins, Lawrence] Robbins Headache Clin, Northbrook, IL 60062 USA; [Conidi, Frank] Florida Ctr Headache & Sports Neurol, Port St Lucie, FL USA; [Conidi, Frank] Florida State Univ, Coll Med, Port St Lucie, FL USA		Robbins, L (corresponding author), Robbins Headache Clin, 1535 Lake Cook Rd,Suite 506, Northbrook, IL 60062 USA.						Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Cantu R., 2012, CONCUSSIONS OUR KIDS; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Eckner JT, 2011, J NEUROTRAUM, V28, P2079, DOI 10.1089/neu.2011.1910; Fatsis S., 2012, DEADSPIN        1115; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Millspaugh J, 1937, US NAVAL MED B, V35; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Pellman Elliot J, 2006, Neurosurg Focus, V21, pE12; Robbins L., 2012, REALCLEARSPORTS 1206; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Solomon GS, 2011, CLIN SPORT MED, V30, P165, DOI 10.1016/j.csm.2010.09.002; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B	30	3	3	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	MAY	2013	53	5					817	823		10.1111/head.12104			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	134VN	WOS:000318243800009	23574194				2022-02-06	
J	Schaafsma, FG; Middleton, J; De Wolf, A; Tate, R; Cameron, ID				Schaafsma, Frederieke G.; Middleton, James; De Wolf, Annelies; Tate, Robyn; Cameron, Ian D.			THE ASSOCIATION OF COMPENSATION AND LONG-TERM HEALTH STATUS FOR PEOPLE WITH SEVERE TRAUMATIC INJURIES	JOURNAL OF REHABILITATION MEDICINE			English	Article						compensation; severe traumatic brain injury; traumatic spinal cord injury; health status; long-term recovery; SPRS; DRS; SF-36; FIMTM	MEASURING PSYCHOSOCIAL RECOVERY; BRAIN-INJURY; PSYCHOMETRIC PROPERTIES; MONEY MATTERS; FOLLOW-UP; SCALE; COMMUNITY; COHORT; CLAIMS; PAIN	Objective: It was hypothesized that, for people with severe traumatic injuries, no association between long-term health status and receiving financial compensation would be detected. Design: Two prospective cohort studies. Subjects: A group of people with severe traumatic brain injury (n=132) and a group of people with traumatic spinal cord injury (n=58). Methods: Health status and functioning were measured at baseline and at 5 years follow-up for both injury groups. Results per group were compared between those who received compensation and those who were non-compensable. Results: In the brain injury cohort those receiving financial compensation showed a significantly worse Disability Rating Scale score after 5 years compared to the non-receiving group (p=0.01). Financial compensation was a modest predictor for being disabled (scores >= 4) after 5 years (Exp (B)=2.47, 95% confidence interval 1.03 to 5.93). In the spinal cord injury cohort those receiving financial compensation scored significantly lower with the Short-Form 36 General Health Survey/Physical Component Summarise scores after 5 years than those who did not (p=0.04). Again, receiving financial compensation had a modest predictive value for the Short-Form 36/Physical Component Summarise scores after 5 years (B=-4.72, SE=2.16, 95% confidence interval -9.05 to -0.38). Conclusion: Financial compensation may have a small negative association with recovery, even for people with severe traumatic injury.	[Schaafsma, Frederieke G.; Middleton, James; De Wolf, Annelies; Tate, Robyn; Cameron, Ian D.] Univ Sydney, Sydney Med Sch, Rehabil Studies Unit, Sydney, NSW 2006, Australia		Cameron, ID (corresponding author), Univ Sydney, Rehabil Studies Unit, Ryde 1680, Australia.	ian.cameron@sydney.edu.au		Middleton, James/0000-0002-2777-8619			American Spinal Injury Association, 2006, STAND NEUR CLASS SPI; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bryant B, 1997, MED SCI LAW, V37, P326, DOI 10.1177/002580249703700408; Cassidy JD, 2000, NEW ENGL J MED, V342, P1179, DOI 10.1056/NEJM200004203421606; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Gabbe BJ, 2007, MED J AUSTRALIA, V187, P14, DOI 10.5694/j.1326-5377.2007.tb01108.x; Glenny Christine, 2009, BMC Geriatr, V9, P52, DOI 10.1186/1471-2318-9-52; Harris I, 2005, JAMA-J AM MED ASSOC, V293, P1644, DOI 10.1001/jama.293.13.1644; Harris IA, 2008, J TRAUMA, V64, P969, DOI 10.1097/01.ta.0000245972.83948.1a; Harris IA, 2009, MED J AUSTRALIA, V190, P619, DOI 10.5694/j.1326-5377.2009.tb02589.x; Krug, 2002, INJURY LEADING CAUSE; Kuipers P, 2004, BRAIN INJURY, V18, P161, DOI 10.1080/0269905031000149524; Littleton S, 2010, INJURY, V41, P904, DOI DOI 10.1016/J.INJURY.2010.02.011; MacKenzie EJ, 2005, J BONE JOINT SURG AM, V87A, P1801, DOI 10.2106/JBJS.E.00032; Middleton J, 2010, EVALUATION SPINAL CO; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROHLING ML, 1995, HEALTH PSYCHOL, V14, P537, DOI 10.1037/0278-6133.14.6.537; Stevenson CE, 1996, SF 36 INTERIM NORMS; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate R.L., 2006, BRAIN IMPAIR, V7, P1, DOI DOI 10.1375/brim.7.1.1; Tate RL, 2004, ARCH PHYS MED REHAB, V85, P538, DOI 10.1016/j.apmr.2003.08.078; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P239, DOI 10.1016/j.acn.2005.12.004	22	3	3	0	6	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977			J REHABIL MED	J. Rehabil. Med.	MAY	2013	45	5					446	451		10.2340/16501977-1135			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	163OB	WOS:000320345700005	23494289	gold, Green Submitted			2022-02-06	
J	Togher, L				Togher, Leanne			Improving Communication for People with Brain Injury in the 21st Century: The Value of Collaboration	BRAIN IMPAIRMENT			English	Article						traumatic brain injury; communication partner training; collaboration; aphasia; rehabilitation; research translation	CONTROLLED-TRIAL; PARTNERS; DISCOURSE; IMPACT	This paper describes the value of collaboration from two perspectives. The first perspective highlights the benefit of teaching communication partners collaborative communication strategies to facilitate the interactions of people with traumatic brain injury (TBI). Collaborative strategies encompass the provision of collaborative intent, emotional and cognitive support, positive questioning styles and collaborative turn taking. Translating research outcomes into accessible resources is described with reference to the TBI Express website which has video demonstrations of conversation strategies for communication partners of people with TBI. The broader meaning of collaboration is also discussed, with particular focus on the advantages collaboration can provide in advancing rehabilitation outcomes for people with acquired brain injury, their families and social networks. Collaboration is described in terms of encompassing all relevant contributors to the development of research advances, including people with acquired brain injury, their families and social networks, stakeholders, clinicians, peak bodies, students and researchers. Two examples of large-scale research collaborations occurring within Australia are described, including the NHMRC Clinical Centre of Research Excellence in Aphasia Rehabilitation and the NHMRC Moving Ahead Centre for Research Excellence in Brain Recovery, also known as Moving Ahead.	[Togher, Leanne] Univ Sydney, Fac Hlth Sci, Lidcombe, NSW 2141, Australia		Togher, L (corresponding author), Univ Sydney, Fac Hlth Sci, Discipline Speech Pathol, POB 170, Lidcombe, NSW 2141, Australia.	leanne.togher@sydney.edu.au	Togher, Leanne/AAC-7083-2019	Togher, Leanne/0000-0002-4518-6748			Adamovich B. B., 1992, SCALES COGNITIVE ABI; Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Bogart E, 2012, BRAIN INJURY, V26, P221, DOI 10.3109/02699052.2011.648711; Eggins S., 1997, ANAL CASUAL CONVERSA; Guo YE, 2008, BRAIN INJURY, V22, P83, DOI 10.1080/02699050701824150; Hagen C, 1984, LANGUAGE DISORDERS A, P245; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Jorgensen M, 2009, BRAIN INJURY, V23, P727, DOI 10.1080/02699050903133954; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Kertesz A., 2006, W APHASIA BATTERY RE; McDonald S, 2012, BRAIN IMPAIR, V13, P256, DOI 10.1017/BrImp.2012.21; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 2000, APHASIOLOGY, V14, P365, DOI 10.1080/026870300401414; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Togher L, 2011, TBI EXPRESS SOCIAL C; Togher L., J REHABILITATION MED; Togher L, 2012, DISABIL REHABIL, V34, P1562, DOI 10.3109/09638288.2012.656788; Togher L, 2010, APHASIOLOGY, V24, P914, DOI 10.1080/02687030903422478; Togher L, 2009, BRAIN IMPAIR, V10, P188, DOI 10.1375/brim.10.2.188; Tu LV, 2011, BRAIN INJURY, V25, P560, DOI 10.3109/02699052.2011.571655; Ylvisaker M., 1993, STAFF DEV CLIN INTER, P57; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker M., 1985, HEAD INJURY REHABILI, P311; Ylvisaker M, 1998, TRAUMATIC BRAIN INJU, P303; Ylvisaker M., 2001, LANGUAGE INTERVENTIO, P745; Ylvisaker M. E., 1998, TRAUMATIC BRAIN INJU; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P239, DOI 10.1055/s-2008-1064200; Ylvisaker Mark, 1993, Seminars in Speech and Language, V14, P74, DOI 10.1055/s-2008-1064160; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P308, DOI 10.1055/s-2008-1064205	31	3	3	0	12	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646			BRAIN IMPAIR	Brain Impair.	MAY	2013	14	1			SI		130	138		10.1017/BrImp.2013.3			9	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	189EY	WOS:000322251300011					2022-02-06	
J	Wang, JK; Zhao, XD				Wang, Jikun; Zhao, Xudong			Family Functioning Assessed by Self-Reported and Observer-Reported Ratings of Depressed Patients and Their Partners	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article						Family functioning; Family Assessment Device; McMaster Clinical Rating Scale; major depressive disorder; self-reported and observer-reported ratings	TRAUMATIC BRAIN-INJURY; ASSESSMENT DEVICE; MAJOR DEPRESSION; MOOD DISORDERS; MCMASTER MODEL; ADOLESCENTS; SCALE; PREDICTORS; INVENTORY; VALIDITY	This study explored subjectively perceived and objectively rated family dysfunction using the self-report Family Assessment Device (FAD) and observer-rated McMaster Clinical Rating Scale (MCRS), respectively. Perceived differences in family functioning ratings between 86 depressed patients and their partners and the degree of agreement between the subjective and objective rating scales were analyzed. There were significant correlations for perceived family functioning between the patients and their partners. There were moderate to significant correlations between patients' perceptions on five of the seven dimensions of the FAD (excluding problem solving and roles) and those dimensions of the MCRS. Findings showed moderate to significant correlations between six dimensions of the FAD and MCRS, excluding problem solving. Results on the FAD and MCRS were significantly correlated and considered equivalent. This suggests that these two instruments can be used individually or in combination to provide a comprehensive understanding of family functioning of couples with a depressed partner.	[Wang, Jikun; Zhao, Xudong] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Psychosomat Med, Shanghai 200092, Peoples R China; [Wang, Jikun] Shanghai Normal Univ, Inst Educ, Shanghai, Peoples R China		Wang, JK (corresponding author), Shanghai East Hosp, Jimo Rd 150, Shanghai 200120, Peoples R China.	liwangjk@gmail.com			Ministry of Science and Technology of the People's Republic of ChinaMinistry of Science and Technology, China [2009BAI77B05]	This study was supported by a grant from the Ministry of Science and Technology of the People's Republic of China (2009BAI77B05).	Alderfer MA, 2008, J PEDIATR PSYCHOL, V33, P1046, DOI 10.1093/jpepsy/jsm083; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Barney MC, 2005, BRAIN INJURY, V19, P801, DOI 10.1080/02699050400024961; Beck AT, 1997, BEHAV RES THER, V35, P785, DOI 10.1016/S0005-7967(97)00025-9; Drumm M, 2000, J FAM THER, V22, P225, DOI 10.1111/1467-6427.00148; Hayden LC, 1998, J FAM PSYCHOL, V12, P7, DOI 10.1037/0893-3200.12.1.7; Heru AM, 2004, J AFFECT DISORDERS, V83, P221, DOI 10.1016/j.jad.2004.04.013; Kabacoff R.I., 1990, J FAM PSYCHOL, V3, P431, DOI [10.1037/h0080547, DOI 10.1037/H0080547]; KEITNER GI, 1995, AM J PSYCHIAT, V152, P1002; Keitner GI, 2003, J CLIN PSYCHOL, V59, P873, DOI 10.1002/jclp.10179; Keitner GI, 1997, J AFFECT DISORDERS, V44, P57, DOI 10.1016/S0165-0327(97)00032-3; Keitner GI., 2010, CLIN MANUAL COUPLES; Koyama A, 2004, PSYCHIAT CLIN NEUROS, V58, P495, DOI 10.1111/j.1440-1819.2004.01291.x; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; Max JE, 1998, BRAIN INJURY, V12, P41; Miller IW, 2000, J ABNORM PSYCHOL, V109, P539, DOI 10.1037/0021-843X.109.3.539; MILLER IW, 1994, FAM PROCESS, V33, P53, DOI 10.1111/j.1545-5300.1994.00053.x; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Ogburn KM, 2010, PSYCHOPATHOLOGY, V43, P312, DOI 10.1159/000319400; Ryan C.E., 2005, EVALUATING TREATING; Sheets ES, 2010, J FAM PSYCHOL, V24, P371, DOI 10.1037/a0020352; Shek DTL, 2002, RES SOCIAL WORK PRAC, V12, P502, DOI 10.1177/1049731502012004003; STEVENSONHINDE J, 1995, FAM PROCESS, V34, P337, DOI 10.1111/j.1545-5300.1995.00337.x; Svanborg P, 2001, J AFFECT DISORDERS, V64, P203, DOI 10.1016/S0165-0327(00)00242-1; Tamplin A, 1998, J AFFECT DISORDERS, V48, P1, DOI 10.1016/S0165-0327(97)00105-5; Tamplin A, 2001, EUR CHILD ADOLES PSY, V10, P170, DOI 10.1007/s007870170023; Wang JK, 2012, INT J SOC PSYCHIAT; Weinstock LM, 2006, J CONSULT CLIN PSYCH, V74, P1192, DOI 10.1037/0022-006X.74.6.1192	28	3	5	0	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-3018			J NERV MENT DIS	J. Nerv. Ment. Dis.	MAY	2013	201	5					384	388		10.1097/NMD.0b013e31828e115a			5	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	139AF	WOS:000318552900005	23595098				2022-02-06	
J	Castano-Monsalve, B; Bernabeu-Guitart, M; Lopez, R; Bulbena-Vilarrasa, A; Quemada, JI				Castano-Monsalve, Beatriz; Bernabeu-Guitart, Montserrat; Lopez, Raquel; Bulbena-Vilarrasa, Antoni; Ignacio Quemada, Jose			Alcohol and drug use disorders in patients with traumatic brain injury: neurobehavioral consequences and caregiver burden	REVISTA DE NEUROLOGIA			Spanish	Article						Alcohol; Behavioral disorders; Caregiver burden; Drugs; Neuropsychiatric Inventory; Traumatic brain injury	SUBSTANCE-ABUSE; NEUROPSYCHIATRIC INVENTORY; INTOXICATION; ADAPTATION; DISABILITY; MISUSE; SCALE	Alcohol and drug use disorders in patients with traumatic brain injury: neurobehavioral consequences and caregiver burden Aims. To describe the prevalence of alcohol and drugs use in patients with traumatic brain injury (TBI), and to assess their relationship with neuropsychiatric disorders, functioning and caregiver burden. Patients and methods. 156 patients with a history of moderate and severe TBI were evaluated. The use of alcohol and drugs was determined. The Neuropsychiatric Inventory (NPI) and the Zarit questionnaire were applied to caregivers. The patients functioning were assessed with the Disability Rating Scale (DRS) and Glasgow Outcome Scale Extended (GOSE). Results. 36 patients (23%) were regular users of alcohol and other drugs before the TBI. Neuropsychiatric disorders were more frequent and severe in this group, especially irritability and agitation-aggressiveness. Their caregivers perceived a higher burden. After TBI, 16 patients (44.4%) relapsed in alcohol-drugs consumption. Having a higher age and living with a partner were associated with higher rates of abstinence. Conclusion. The history of alcohol and drugs abuse is common in patients with TBI and it is a risk factor for development of behavioral disorders. More active interventions are needed aimed to detect these cases and work for prevention of relapse after trauma.	[Castano-Monsalve, Beatriz; Bernabeu-Guitart, Montserrat; Lopez, Raquel] Inst Univ Neurorehabil Guttmann UAB, Unidad Dano Cerebral, E-08916 Badalona, Barcelona, Spain; [Castano-Monsalve, Beatriz; Bernabeu-Guitart, Montserrat; Lopez, Raquel] Inst Univ Neurorehabil Guttmann UAB, Dept Invest, E-08916 Badalona, Barcelona, Spain; [Bulbena-Vilarrasa, Antoni] INAD, Inst Neuropsiquiatria & Adicc, Barcelona, Spain; [Ignacio Quemada, Jose] Hosp Aita Menni, Serv Dano Cerebral, Bilbao, Vizcaya, Spain		Castano-Monsalve, B (corresponding author), Inst Univ Neurorehabil Guttmann UAB, Unidad Dano Cerebral, Cami Can Ruti S-N, E-08916 Badalona, Barcelona, Spain.	bcastano@guttmann.com					American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andelic Nada, 2010, J Trauma Manag Outcomes, V4, P6, DOI 10.1186/1752-2897-4-6; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; De Guise E, 2009, BRAIN INJURY, V23, P853, DOI 10.1080/02699050903283221; Hagen C, 1972, RANCHO LOS AMIGOS LE; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Jong CN, 1999, BRAIN INJURY, V13, P1017; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; KAPLAN C P, 1992, Brain Injury, V6, P337, DOI 10.3109/02699059209034948; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Marmarou A., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI [10.1097/00001199-199009000-00006, DOI 10.1097/00001199-199009000-00006]; Martin M, 1996, REV GERONTOL, V6, P46; Ministerio de Sanidad, 2004, INF PLAN NAC DROG; Moreno P, 2012, ALCOHOL FACTORES PSI; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; Vilalta-Franch J, 1999, REV NEUROLOGIA, V29, P15, DOI 10.33588/rn.2901.99226; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	34	3	4	0	12	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	APR 1	2013	56	7					363	369		10.33588/rn.5607.2012412			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	129YZ	WOS:000317881200003	23520005				2022-02-06	
J	Gupta, V; Kaur, M; Kundu, ZS; Kaplia, A; Singh, D				Gupta, Vinay; Kaur, Maneet; Kundu, Zile Singh; Kaplia, Aseem; Singh, Deepinderjit			Traumatic anterior hip dislocation in a 12-year-old child	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Hip; Dislocations; Child		Hip dislocation in children can occur congenitally in isolation or in conjunction with other congenital abnormalities. Traumatic hip dislocations in children are relatively uncommon and anterior dislocation of hip joint is even rarer. We report such a case following unusual mode of injury in a 12-year-old child. The patient underwent successful emergent closed reduction of left hip. The clinical course and follow-up assessment of the patient was otherwise uneventful. At 2 years' follow-up there was no evidence of osteoarthritis, coxa magna, heterotrophic calcification, in congruency of the joints or avascular necrosis of the head of femur.	[Gupta, Vinay; Kaplia, Aseem] Fortis Healthcare, Dept Orthopaed, Mohali, India; [Kaur, Maneet] Dayanand Med Coll & Hosp, Dept Emergency Med, Ludhiana, Punjab, India; [Kundu, Zile Singh] Pandit Bhagwat Dayal Sharma Post Grad Inst Med Sc, Dept Orthopaed, Rohtak, Haryana, India; [Singh, Deepinderjit] Maharishi Markandeshwar Med Coll & Hosp, Dept Orthopaed, Kumarhatti Solan, Himachal Prades, India		Gupta, V (corresponding author), Fortis Healthcare, Dept Orthopaed, Mohali, India.	drvinaygupta15@yahoo.co.in					Badina A, 2011, CLIN DYSMORPHOL, V20, P114, DOI 10.1097/MCD.0b013e328343f958; BARQUET A, 1982, ACTA ORTHOP SCAND, V53, P809, DOI 10.3109/17453678208992298; Blaiser Rd, 2006, ROCKWOOD GREENS FRAC, P861; Canale ST, 2008, CAMPBELLS OPERATIVE, P1628; Chang JD, 2012, J ORTHOP SCI, V17, P87, DOI 10.1007/s00776-011-0077-8; DELEE JC, 1996, FRACTURES ADULTS, V2, P1756; FUNK FJ, 1962, J BONE JOINT SURG AM, V44, P1135, DOI 10.2106/00004623-196244060-00008; Hamilton PR, 1988, J PEDIATR ORTHOPED, V18, P691; Herrera-Soto JA, 2009, J AM ACAD ORTHOP SUR, V17, P15, DOI 10.5435/00124635-200901000-00003; Hiertonn T, 1968, J Bone Joint Surg Br, V50, P542; HOUGAARD K, 1986, ARCH ORTHOP TRAUM SU, V106, P32, DOI 10.1007/BF00435649; Imagama T, 2012, ORTHOPEDICS, V35, pE426, DOI 10.3928/01477447-20120222-33; Knight DMA, 2011, J PEDIATR ORTHOPED, V31, P638, DOI 10.1097/BPO.0b013e3182285fa5; Kutty S, 2001, PEDIATR EMERG CARE, V17, P32, DOI 10.1097/00006565-200102000-00009; OFFIERSKI CM, 1981, J BONE JOINT SURG BR, V63, P194, DOI 10.1302/0301-620X.63B2.7217141; Sanders S, 2008, BULL HOSP JT DIS, V66, P320; Sinnema M, 2011, AM J MED GENET A, V155A, P2112, DOI 10.1002/ajmg.a.34171; Zrig M, 2009, ACTA ORTHOP BELG, V75, P328	18	3	3	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	APR	2013	16	2					122	125		10.3760/cma.j.issn.1008-1275.2013.02.012			4	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VF1GZ	WOS:000442010800012	23540904				2022-02-06	
J	Gyawali, GP; Pokharel, B; Pokharel, RK				Gyawali, Gopal Prasad; Pokharel, Bishnu; Pokharel, Rohit Kumar			Irreducible Anterior Dislocation of the Elbow without associated Fracture	JOURNAL OF NEPAL MEDICAL ASSOCIATION			English	Article						anterior dislocation; elbow; open reduction	OLECRANON FRACTURE; RADIAL HEAD; CHILDREN; JOINT	Anterior dislocation of the elbow joint is a rare entity and is usually associated with injuries to surrounding bony and soft tissues. Simple dislocation of the joint is managed conservatively. An eight years old girl had traumatic anterior dislocation of the elbow joint with intact distal neurovascular status. X-rays showed no associated bony injury. Close reductions failed. Per operative findings showed no intra-articular fracture and the radial head was button holed into the anterior joint capsule. Reduction was achieved openly and maintained in a posterior slab for four weeks. Active and assisted mobilization started after removal of the slab. At ten month follow-up there was almost full range of movement of the joint.	[Gyawali, Gopal Prasad; Pokharel, Bishnu; Pokharel, Rohit Kumar] Inst Med, Dept Orthopaed & Trauma Surg, Kathmandu, Nepal		Pokharel, RK (corresponding author), Inst Med, Dept Orthopaed & Trauma Surg, Kathmandu, Nepal.	pokharel.rohit@gmail.com					Aversano F, 2011, J ORTHOP TRAUMA, V25, pE38, DOI 10.1097/BOT.0b013e3181dc245d; Butler MA, 2012, J HAND SURG-AM, V37A, P999, DOI 10.1016/j.jhsa.2012.02.037; Chbani B, 2012, CHIR MAIN, V31, P371, DOI 10.1016/j.main.2012.04.009; COLE RJ, 1994, J HAND SURG-AM, V19A, P614; Fadili M, 2001, Tunis Med, V79, P251; Fernandez Gutierrez C, 1996, REV ESP CIR OSTEOART, V31, P206; Guitton TG, 2009, J BONE JOINT SURG AM, V91A, P1487, DOI 10.2106/JBJS.H.00855; JACKSON JA, 1940, AM J SURG, V47, P479; Linscheid RL, 1965, J BONE JOINT SURG AM, V47, P1355; OURY JH, 1972, J TRAUM, V12, P170, DOI 10.1097/00005373-197202000-00011; OVEJERO AMH, 1988, REV CHIR ORTHOP, V74, P257; Queipo-de-Llano Temboury A, 2007, TECH HAND EXTREM SUR, V11, P18; Rasool MN, 2004, J BONE JOINT SURG BR, V86B, P1050, DOI 10.1302/0301-620X.86B7.14505; RIEL KA, 1993, UNFALLCHIRURG, V96, P529; Ring D, 1997, J ORTHOP TRAUMA, V11, P545, DOI 10.1097/00005131-199711000-00001; Saouti R, 2003, Acta Orthop Belg, V69, P197; Simonies Panayiotis P, 2006, J SHOULDER ELB SURG, V15, P249; Sulko J, 2000, Chir Narzadow Ruchu Ortop Pol, V65, P13; Takami H, 1997, CLIN ORTHOP RELAT R, P168; Takase K, 2011, J PEDIATR ORTHOP B, V20, P345, DOI 10.1097/BPB.0b013e32834534cb; Tees FJ, 1923, ANN SURG, V77, P612; Torchia ME, 1998, J SHOULDER ELB SURG, V7, P539, DOI 10.1016/S1058-2746(98)90209-9; Venkatram N, 2006, EMERG MED J, V23, DOI 10.1136/emj.2005.033878; Wilkerson R D, 1993, Iowa Orthop J, V13, P223; Winslow R., 1913, SURG GYNECOL OBSTET, V16, P570	25	3	4	0	0	NEPAL MEDICAL ASSOC	KATHMANDU	NMA BUILDING, SIDDIHI SADAN, PO BOX 189, EXHIBITION RD, KATHMANDU, 00000, NEPAL	0028-2715	1815-672X		J NEPAL MED ASSOC	J. Nepal Med. Assoc.	APR-JUN	2013	52	6					398	401					4	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; General & Internal Medicine	258TY	WOS:000327482800021	24362669				2022-02-06	
J	Mateen, FJ; Niu, JW; Gao, S; Li, SW; Carone, M; Wijdicks, EFM; Xu, WH				Mateen, Farrah J.; Niu, Jing-Wen; Gao, Shan; Li, Shun-Wei; Carone, Marco; Wijdicks, Eelco F. M.; Xu, Wei-Hai			Causes and Outcomes of Persistent Vegetative State in a Chinese Versus American Referral Hospital	NEUROCRITICAL CARE			English	Article						Coma; Vegetative state; Cardiac arrest; China; Consciousness; Stroke	PREVALENCE; STROKE	To compare the etiologies and clinical outcomes of patients in a persistent vegetative state (PVS) between a Chinese and US referral hospital. A retrospective, observational study at the Peking Union Medical College Hospital, Beijing, China and Johns Hopkins Hospital, Baltimore, USA (2001-2010) was performed. There were 36 cases of PVS diagnosed. In Beijing, there were 19 cases: mean age 57 years, range 3-86, (42 %) female, with 37 % of patients observed to survive more than 1 year (range > 1 month to > 28 years, median > 6 months). Causes of PVS in Beijing were hemorrhagic stroke (n = 4, 21 %), ischemic stroke (n = 2, 11 %), cardiac arrest (n = 5, 26 %, including 4 with attempted cardiopulmonary resuscitation (CPR)), traumatic brain injury (n = 3, 16 %), and one each of mitochondrial encephalomyopathy, acute disseminated encephalomyelitis, Lennox Gastaut Syndrome, and epilepsy with craniopharyngioma (n = 4, 21 %). In Baltimore, there were 17 cases of PVS: mean age 43 years, range 15-83, 59 % female, with 41 % observed to survive more than 1 year (range > 1 month to > 10 years, median > 3 years). Causes of PVS in Baltimore were ischemic stroke (n = 3, 18 %), cardiac arrest (n = 3, 18 %, including one with attempted CPR), traumatic brain injury (n = 3, 18 %), neurodegenerative conditions (n = 2, 12 %), and hypoxic ischemic encephalopathy due to respiratory arrest (n = 3, 18 %), metabolic derangements (n = 2, 12 %), and meningitis (n = 1, 6 %). There may be a long survival period for patients with PVS, including in China where resource constraints exist for acute neurologic care. Stroke appears to be the most common underlying cause of PVS in Chinese patients, followed closely by cardiac arrest with attempted CPR. There appear to be more varied causes of PVS in the US referral hospital with a predominance of stroke, cardiac arrest, and traumatic brain injury.	[Mateen, Farrah J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Mateen, Farrah J.] Johns Hopkins Univ Hosp, Dept Neurol, Baltimore, MD 21287 USA; [Niu, Jing-Wen; Gao, Shan; Li, Shun-Wei; Xu, Wei-Hai] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurol, Beijing 100730, Peoples R China; [Carone, Marco] Univ Calif Berkeley, Div Biostat, Berkeley, CA 94720 USA; [Wijdicks, Eelco F. M.] Mayo Clin, Dept Neurol, Rochester, MN USA		Mateen, FJ (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Room E8527,600 North Wolfe St, Baltimore, MD 21205 USA.	farrah_mateen@hotmail.com; xuwhpumch@yahoo.com.cn	Xu, Wei-Hai/AAD-8932-2020	Mateen, Farrah/0000-0002-4293-8115			American Academy of Neurology, 1995, PRACT PAR ASS MAN PA; Andersen KK, 2009, STROKE, V40, P2068, DOI 10.1161/STROKEAHA.108.540112; Andrews K., 1999, BMJ-BRIT MED J, V306, P1597; Beaumont JG, 2005, NEUROPSYCHOL REHABIL, V15, P184, DOI 10.1080/09602010443000489; Donis J, 2011, BRAIN INJURY, V25, P1101, DOI 10.3109/02699052.2011.577047; HIGASHI K, 1977, J NEUROL NEUROSUR PS, V40, P876, DOI 10.1136/jnnp.40.9.876; HIGASHI K, 1981, J NEUROL NEUROSUR PS, V44, P552, DOI 10.1136/jnnp.44.6.552; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Mateen FJ, 2011, NEUROCRIT CARE, V15, P593, DOI 10.1007/s12028-011-9623-7; Mayor SA, 1999, NEUROLOGY, V52, P1602, DOI 10.1212/WNL.52.8.1602; Reuters, 2009, REUTERS         0217; World Health Organization, DIS HLTH; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Zhang LF, 2003, STROKE, V34, P2091, DOI 10.1161/01.STR.0000087149.42294.8C	14	3	6	0	8	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2013	18	2					266	270		10.1007/s12028-012-9789-7			5	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	105PR	WOS:000316084700017	23099847				2022-02-06	
J	Venara, A; Mauillon, D; Gaudin, A; Rouge-Maillart, C; Jousset, N				Venara, A.; Mauillon, D.; Gaudin, A.; Rouge-Maillart, C.; Jousset, N.			Fatal falls from bicycles: A case report	FORENSIC SCIENCE INTERNATIONAL			English	Article						Protective helmet; Traumatic brain injury; Multiple traumas; Fatal bicycle accident		Though rare occurrences, fatal falls from bicycles are generally linked to the absence of a protective helmet and/or a collision with another vehicle. The case presented here is exceptional due to its circumstances and the consequences of the accident: a fall with no obstacle at a low speed that brought about multiple traumas and the death of a cyclist wearing a protective helmet. Comparing this against a review of cyclist accidentology literature, this case is unique. The increased use of autopsy in terms of forensic accidentology is to be encouraged so as not to misunderstand the possibility of such lesion-based consequences following a simple fall from a bicycle. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Venara, A.; Rouge-Maillart, C.; Jousset, N.] Univ Angers, LUNAM, Angers, France; [Venara, A.; Mauillon, D.; Gaudin, A.; Rouge-Maillart, C.; Jousset, N.] Univ Angers, Angers Univ Hosp, Dept Forens Med, Angers, France; [Rouge-Maillart, C.] LUNAM Univ, GEROM, IRIS IBS Inst Biol Sante, CH Angers, F-49933 Angers, France		Rouge-Maillart, C (corresponding author), Angers Univ Hosp, Dept Forens Med, 4 Rue Larrey, F-49933 Angers 9, France.	Clrouge-maillart@chu-angers.fr					[Anonymous], 2012, OBS NAT INT SEC ROUT; Centre d'Etudes sur les Reseaux les Transports l'Urbanisme et les constructions publiques, 2012, URB CONSTR PUBL ACC; Centre d'Etudes sur les Reseaux les Transports l'Urbanisme et les constructions publiques, 2010, ACC VEL AV VEH GROS; Depreitere B, 2009, J TRAUMA, V66, P1506, DOI 10.1097/TA.0b013e318198a0f8; Heng K. W. J., 2006, SMJ Singapore Medical Journal, V47, P367; Juhra C., 2011, INJURY; MAIMARIS C, 1994, BRIT MED J, V308, P1537, DOI 10.1136/bmj.308.6943.1537; Observatoire National Interministeriel de la Securite Routiere, 2012, SEC ROUT FRANC BIL A; Richter M, 2007, J TRAUMA, V62, P1118, DOI 10.1097/01.ta.0000221060.78894.cb; THOMPSON DC, 1990, AM J PUBLIC HEALTH, V80, P1471, DOI 10.2105/AJPH.80.12.1471; THOMPSON DC, 1990, AM J PUBLIC HEALTH, V80, P1388, DOI 10.2105/AJPH.80.11.1388; Tin ST, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-655	12	3	3	0	9	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	MAR 10	2013	226	1-3					E1	E3		10.1016/j.forsciint.2012.11.013			3	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	115DF	WOS:000316792100001	23312586				2022-02-06	
J	Christensen, EW; Clinton, YC				Christensen, Eric W.; Clinton, Yvette C.			Demographics and Burden on Caregivers of Seriously Wounded, III, and Injured Service Members	JOURNAL OF DISABILITY POLICY STUDIES			English	Article						disability; caregivers; family members; wounded warriors	TRAUMATIC BRAIN-INJURY; SOCIAL SUPPORT; CARE; EMPLOYMENT; WORK; PARTICIPATION; SATISFACTION; DISTRESS; IMPACT; COSTS	The media is replete with stories about the impact on families when they drastically alter their lives to provide care to a service member who is seriously wounded, ill, or injured (WII), though few studies have systematically examined these impacts. Using a 2008 survey of seriously WII service members, the authors found that 27% of caregivers provided an average of more than 40 hr of care per week, 64% of caregivers have provided care for more than a year, and 50% expected they may need to provide care over the long term. The probit and ordered probit results show that significant others (such as a spouse, fiancSe, or girlfriend) bear a greater caregiving burden in both intensity and duration compared to other caregivers. The results also show that duration of caregiving for Reserve Component service members is greater than for Active Component service members.	[Christensen, Eric W.; Clinton, Yvette C.] CNA, Alexandria, VA 22311 USA		Christensen, EW (corresponding author), CNA, 4825 Mark Ctr Dr, Alexandria, VA 22311 USA.	christee@cna.org					Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Ben Arzi N, 2000, BRAIN INJURY, V14, P725; Bobinac A, 2010, J HEALTH ECON, V29, P549, DOI 10.1016/j.jhealeco.2010.05.003; Caldwell, 2008, J DISABIL POLICY STU, V19, P68, DOI [DOI 10.1177/1044207308316093, 10.1177/1044207308316093]; CAPUTO RK, 2002, J FAMILY EC ISSUES, V0023; Choi H., 2010, J FAMILY EC ISSUES, V32, P493; Christensen E., 2009, CNA PUBLICATION; Christensen E., 2007, CNA PUBLICATION; Coe NB, 2009, HEALTH ECON, V18, P991, DOI 10.1002/hec.1512; Department of Veterans Affairs, 2007, AM WARS; DOLE R, 2007, SERVE SUPPORT SIMPLI; Dorfman LT, 1996, FAM RELAT, V45, P46, DOI 10.2307/584769; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Ettner SL, 1996, J HUM RESOUR, V31, P189, DOI 10.2307/146047; ETTNER SL, 1995, DEMOGRAPHY, V32, P63, DOI 10.2307/2061897; Fredriksen KI, 1999, FAM RELAT, V48, P189, DOI 10.2307/585083; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; HOYERT DL, 1992, FAM RELAT, V41, P74, DOI 10.2307/585397; KOLODINSKY J, 2000, J FAMILY EC ISSUES, V0021; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Lai DWL, 2007, J FAM ECON ISS, V28, P411, DOI 10.1007/s10834-007-9073-8; Lee JA, 2001, J BUS PSYCHOL, V16, P277, DOI 10.1023/A:1011165318139; Leigh A, 2010, LABOUR ECON, V17, P140, DOI 10.1016/j.labeco.2009.11.005; Lilly MB, 2007, MILBANK Q, V85, P641, DOI 10.1111/j.1468-0009.2007.00504.x; Lukemeyer A, 2000, J MARRIAGE FAM, V62, P399, DOI 10.1111/j.1741-3737.2000.00399.x; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Matthias R. E., 2008, J DISABIL POLICY STU, V18, P205, DOI [10.1177/1044207307311526, DOI 10.1177/1044207307311526]; McLanahan S.S., 1990, 18 NSFH U WISC CTR D; Mentzakis E, 2009, REV ECON HOUSEHOLD, V7, P283, DOI 10.1007/s11150-008-9047-0; Murray-Swank A, 2007, J REHABIL RES DEV, V44, P801, DOI 10.1682/JRRD.2006.08.0092; MUURINEN JM, 1986, MED CARE, V24, P1007, DOI 10.1097/00005650-198611000-00005; Pagani L, 2008, J FAM ECON ISS, V29, P427, DOI 10.1007/s10834-008-9112-0; Rubin RM, 2009, J FAM ECON ISS, V30, P252, DOI 10.1007/s10834-009-9155-x; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sander AM, 2007, NEUROREHABILITATION, V22, P9; Schwarz R., 2007, FAMILY ADJUSTMENT WO; Stiglitz J.E., 2008, 3 TRILLION DOLLAR WA; STONE RI, 1990, MED CARE, V28, P513, DOI 10.1097/00005650-199006000-00004; Vecchio N, 2009, INT J SOC ECON, V36, P782, DOI 10.1108/03068290910963716; Wakabayashi C, 2005, POPUL RES POLICY REV, V24, P467, DOI 10.1007/s11113-005-3805-y; WILLIAMS AM, 1993, QUAL LIFE RES, V2, P213, DOI 10.1007/BF00435225; Wilson MR, 2007, J FAM ECON ISS, V28, P684, DOI 10.1007/s10834-007-9081-8	43	3	3	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1044-2073	1538-4802		J DISABIL POLICY STU	J. Disabil. Policy Stud.	MAR	2013	23	4					235	244		10.1177/1044207311432314			10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	119AI	WOS:000317068500005					2022-02-06	
J	Kim, H; Colantonio, A				Kim, Hwan; Colantonio, Angela			An examination of discharge against medical advice from brain injury inpatient rehabilitation	BRAIN INJURY			English	Article						Case management; rehabilitation; service delivery	PREDICTORS; IMPACT	Objective: Discharges against medical advice (DAMA) have been considered predictors of adverse outcomes for patients in acute care and psychiatric hospitals. However, little is known about the profile of patients who discharge AMA admitted to rehabilitation hospitals. The aims of this study were to provide a profile of patients who received inpatient rehabilitation services following a traumatic brain injury (TBI) who discharged AMA and to compare this group with the regular discharge group. Research design: Retrospective cohort study. Methods: Hospital discharge data from two national administrative databases were reviewed for the years 2001-2006. Results: The databases yielded 1559 cases of TBI (average length of stay = 51 days). Of these, 31 (2.0%) had recorded DAMA events: one in 50 patients left rehabilitation against medical advice. Compared to regular discharge (n = 1247), DAMA was significantly associated with unemployment, intentional injury, higher motor functions at admission and shorter length of stay. Known factors for DAMA in acute hospitals, such as male sex, young age and substance abuse history, were not significant. Conclusion: Careful screening and assessment of patients who discharge AMA could enable better prevention and management strategies, thus improving health outcomes and enhancing healthcare delivery.	[Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G 1V7, Canada		Colantonio, A (corresponding author), UHN, Toronto Rehabil Inst, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765	Canadian Institutes for Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation; Toronto Rehabilitation InstituteUniversity of Toronto; Ministry of Health and Long Term CareMinistry of Health and Long-Term Care, Ontario	The authors report no conflicts of interest. Financial support was provided by the Canadian Institutes for Health Research Strategic Team Grant in Applied Injury Research # TIR-103946, the Ontario Neurotrauma Foundation, a fellowship through the Toronto Rehabilitation Institute, and a grant to TRI from the Ministry of Health and Long Term Care.	Alfandre DJ, 2009, MAYO CLIN PROC, V84, P255, DOI 10.1016/S0025-6196(11)61143-9; Aujesky D, 2009, ARCH INTERN MED, V169, P287, DOI 10.1001/archinternmed.2008.546; Brook M, 2006, PSYCHIAT SERV, V57, P1192, DOI 10.1176/appi.ps.57.8.1192; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Canada Post, 2012, CAN POST GUID ADDR G; Canadian Institute for Health Information, 2009, NAT REH REP SYST DAT; Canadian Institute for Health Information (CIHI), 2004, INP REH CAN 2002 200; Duno R, 2003, GEN HOSP PSYCHIAT, V25, P46, DOI 10.1016/S0163-8343(02)00253-0; Gerhart KA, 2003, J TRAUMA, V55, P1045, DOI 10.1097/01.TA.0000044353.69681.96; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Heffernan DS, 2011, J TRAUMA, V70, P527, DOI 10.1097/TA.0b013e31820d0ed7; Kaplan GG, 2009, INFLAMM BOWEL DIS, V15, P845, DOI 10.1002/ibd.20835; Kim H, 2010, ARCH PHYS MED REHAB, V91, P8; Kim H, 2011, J TRAUMA, V71, P1219, DOI 10.1097/TA.0b013e3182190fa6; Onukwugha E, 2009, NEUROREHABILITATION, V24, P67, DOI 10.3233/NRE-2009-0455; Onukwugha E, 2010, QUAL SAF HEALTH CARE, V19, P420, DOI 10.1136/qshc.2009.036269; PENNYCOOK AG, 1992, ARCH EMERG MED, V9, P230; Reinke DA, 2009, CLIN PEDIATR, V48, P263, DOI 10.1177/0009922808323109; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603	19	3	3	0	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2013	27	3					325	331		10.3109/02699052.2012.750741			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	096OG	WOS:000315413400010	23438352				2022-02-06	
J	Kropil, F; Schauer, M; Krausch, M; Kropil, P; Topp, SA; Raffel, AM; Eisenberger, CF; Knoefel, WT				Kroepil, F.; Schauer, M.; Krausch, M.; Kroepil, P.; Topp, S. A.; Raffel, A. M.; Eisenberger, C. F.; Knoefel, Wolfram T.			Splenic Artery Switch for Revascularization of the Liver: A Salvage Procedure for Inflammatory Arterial Hemorrhage	WORLD JOURNAL OF SURGERY			English	Article							STENT-GRAFT; MASSIVE HEMORRHAGE; PANCREATIC SURGERY; COVERED STENTS; PANCREATICODUODENECTOMY; MANAGEMENT; DIAGNOSIS; ANEURYSMS; INJURIES	Background Hemorrhage caused by inflammatory vessel erosion represents a life-threatening complication after upper abdominal surgery such as pancreatic head resection. The gold standard therapeutic choice is an endovascular minimally invasive technique such as embolization or stent placement. Hepatic arterial hemorrhage in presence of pancreatitis and peritonitis is a particular challenge is if a standard therapeutic option is not possible. Methods The management of five patients with massive bleeding from the common hepatic artery is described. All patients underwent a splenic artery switch. The splenic artery was dissected close to the splenic hilum and transposed end-to-end to the common hepatic artery after resection of the eroded part. Patients' medical records, radiology reports, and images were reviewed retrospectively. Technical success was defined as immediate cessation of hemorrhage and preserved liver vascularization. Clinical success was defined as hemodynamic stability and adequate long-term liver function. Results Total pancreatectomy and splenectomy were performed in four of the five cases. Hemodynamic stability and good liver perfusion was achieved in these patients. Conclusions Splenic artery switch is an effective, safe procedure for revascularization of the liver in case of hepatic arterial hemorrhage following pancreatic surgery, pancreatitis, and/or peritonitis. The technique is a promising option if a standard procedure-e. g., stent implantation, embolization and surgical repair with alloplastic prosthesis or autologous venous interposition graft-is not possible.	[Kroepil, F.; Schauer, M.; Krausch, M.; Topp, S. A.; Raffel, A. M.; Eisenberger, C. F.; Knoefel, Wolfram T.] Univ Dusseldorf, Univ Hosp Dusseldorf, Fac Med, Dept Gen Visceral & Pediat Surg, D-40225 Dusseldorf, Germany; [Kroepil, P.] Univ Dusseldorf, Fac Med, Dept Radiol, D-40225 Dusseldorf, Germany		Knoefel, WT (corresponding author), Univ Dusseldorf, Univ Hosp Dusseldorf, Fac Med, Dept Gen Visceral & Pediat Surg, Moorenstr 5, D-40225 Dusseldorf, Germany.	Feride.Kroepil@med.uni-duesseldorf.de; knoefel@uni-duesseldorf.de	Kroepil, Feride/M-9755-2013				Baltacioglu F, 2003, CARDIOVASC INTER RAD, V26, P434; Chambers ST, 2005, INTERN MED J, V35, pS72, DOI 10.1111/j.1444-0903.2005.00981.x; de Castro SMM, 2004, BEST PRACT RES CL GA, V18, P847, DOI 10.1016/j.bpg.2004.06.001; Gebauer T, 2004, CHIRURG, V75, P1021, DOI 10.1007/s00104-004-0834-8; Heiss P, 2008, ANN SURG ONCOL, V15, P824, DOI 10.1245/s10434-007-9715-y; HENEGOUWEN MIV, 1995, BRIT J SURG, V82, P1527, DOI 10.1002/bjs.1800821124; Kim W, 2001, J VASC INTERV RADIOL, V12, P965, DOI 10.1016/S1051-0443(07)61577-2; Larson RA, 2002, J VASC SURG, V36, P1260, DOI 10.1067/mva.2002.129645; Makowiec F, 2005, J GASTROINTEST SURG, V9, P1293, DOI 10.1016/j.gassur.2005.08.003; Miura F, 2009, J HEPATO-BILIARY-PAN, V16, P56, DOI 10.1007/s00534-008-0012-3; Otah E, 2002, ARCH SURG-CHICAGO, V137, P55, DOI 10.1001/archsurg.137.1.55; Parikh S, 2010, AM J MED, V123, P111, DOI 10.1016/j.amjmed.2009.05.023; Parkinson TJ, 2007, EUR J VASC ENDOVASC, V33, P684, DOI 10.1016/j.ejvs.2006.12.010; Rumstadt B, 1998, ANN SURG, V227, P236, DOI 10.1097/00000658-199802000-00013; Sanjay P, 2010, PANCREAS, V39, P1211, DOI 10.1097/MPA.0b013e3181e00cad; Sanjay P, 2010, J PANCREAS, V11, P220; Schenker MP, 2001, J VASC INTERV RADIOL, V12, P1263, DOI 10.1016/S1051-0443(07)61549-8; Thomas RM, 2010, J GASTROINTEST SURG, V14, P570, DOI 10.1007/s11605-009-0967-7; Wang MQ, 2010, WORLD J GASTROENTERO, V16, P3716, DOI 10.3748/wjg.v16.i29.3716; Won YD, 2009, EMERG RADIOL, V16, P247, DOI 10.1007/s10140-008-0716-3; Xenos ES, 2003, J VASC SURG, V38, P451, DOI 10.1016/S0741-5214(03)00553-6; Yekebas EF, 2007, ANN SURG, V246, P269, DOI 10.1097/01.sla.0000262953.77735.db; Yoon YS, 2003, HEPATO-GASTROENTEROL, V50, P2208	23	3	3	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313			WORLD J SURG	World J.Surg.	MAR	2013	37	3					591	596		10.1007/s00268-012-1859-7			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	123AA	WOS:000317359100016	23203774				2022-02-06	
J	Sohrevardi, SM; Ahmadinejad, M; Said, K; Sarafzadeh, F; Zadeh, SS; Yousefi, M; Savari, O				Sohrevardi, Seyed Mojtaba; Ahmadinejad, Mehdi; Said, Karamuzian; Sarafzadeh, Farhad; Zadeh, Somayeh Soleimani; Yousefi, Mohammad; Savari, Omid			Evaluation of TGF beta 1, IL-8 and Nitric Oxide in the Serum of Diffuse Axonal Injury Patients and Its Association with Clinical Status and Outcome	TURKISH NEUROSURGERY			English	Article						Diffuse axonal injury; NO; IL-8; TGF beta 1	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; GROWTH-FACTOR; SERIAL MEASUREMENT; BARRIER FUNCTION; ISCHEMIC-STROKE; BLOOD; EXPRESSION; HYPOTHERMIA; RELEASE	AIM: The aim was to evaluate the level of interleukin 8 (IL-8), transforming growth factor beta 1 (TGF beta 1) and Nitric oxide (NO) in diffuse axonal injury (DAI) and its association to the outcome and clinical status. MATERIAL and METHODS: This cross-sectional study was conducted on 20 patients with DAI and 20 patients with multiple traumas without head injury and 20 healthy subjects as controls. Blood levels of IL-8, TGF beta 1 and nitric oxide in the 1st, 2nd, 3rd and 7th days of injury were measured. Glasgow coma scale (GCS) of patients was recorded.The patients' outcome was evaluated by Glasgow Outcome Scale (GOS). RESULTS: The level of TGF beta 1 was increasing during the admission and had the maximum level at the 7th day. In the DAI group, there was significant correlation between GOS score and serum IL-8 at 7th day of admission (r=-0.68, p=0.002). In this group the GCS was found to be significantly correlated with the IL-8 concentration at 7th day of admission (p= 0.026, r=-0.55). CONCLUSION: IL-8 has negative correlation with GCS and GOS.TGF beta 1 could protect the brain from cytotoxics, hypoxia and acidosis so its level comes down in brain injuries as a result of its overuse.	[Sohrevardi, Seyed Mojtaba] Kerman Univ Med Sci, Dept Neurosurg, Neurosci Res Ctr, Kerman, Iran; [Sohrevardi, Seyed Mojtaba] Kerman Univ Med Sci, Dept Neurosurg, Fac Pharm, Kerman, Iran; [Ahmadinejad, Mehdi] Kerman Univ Med Sci, Dept Neurosurg, Physiol Res Ctr, Kerman, Iran; [Ahmadinejad, Mehdi; Sarafzadeh, Farhad; Zadeh, Somayeh Soleimani; Yousefi, Mohammad; Savari, Omid] Kerman Univ Med Sci, Dept Neurosurg, Fac Med, Kerman, Iran; [Said, Karamuzian] Kerman Univ Med Sci, Dept Neurosurg, Kerman, Iran		Sohrevardi, SM (corresponding author), Kerman Univ Med Sci, Dept Neurosurg, Neurosci Res Ctr, Kerman, Iran.	Mehdia50@gmail.com	ahmadinejad, mehdi/AAK-1149-2020; karamouzian, saeid/ABD-1538-2020; sarafzadeh, farhad/AAO-2546-2021; sohrevardi, seyed mojtaba/ABD-6980-2020	sohrevardi, seyed mojtaba/0000-0002-0993-3339; Karamouzian, Saeid/0000-0001-6256-0941			Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Diestel A, 2008, CRYOBIOLOGY, V57, P216, DOI 10.1016/j.cryobiol.2008.08.005; Dziedzic T, 2002, STROKE, V33, P2334, DOI 10.1161/01.STR.0000027211.73567.FA; Fries M, 2009, J CRIT CARE, V24, P453, DOI 10.1016/j.jcrc.2008.10.012; He Li-ming, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P999; Hlatky R, 2003, J CEREBR BLOOD F MET, V23, P582, DOI 10.1097/01.WCB.0000059586.71206.F3; Hlatky R, 2002, ACT NEUR S, V81, P331; Kim JS, 1996, STROKE, V27, P1553, DOI 10.1161/01.STR.27.9.1553; Kostulas N, 1999, STROKE, V30, P2174, DOI 10.1161/01.STR.30.10.2174; LOGAN A, 1992, BRAIN RES, V587, P216, DOI 10.1016/0006-8993(92)91000-5; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Morganti-Kossmann MC, 1999, J NEUROTRAUM, V16, P617, DOI 10.1089/neu.1999.16.617; PERRY VH, 1995, CURR OPIN NEUROBIOL, V5, P636, DOI 10.1016/0959-4388(95)80069-7; Slevin M, 2000, STROKE, V31, P1863, DOI 10.1161/01.STR.31.8.1863; Tarkowski E, 1999, STROKE, V30, P321, DOI 10.1161/01.STR.30.2.321; Tarkowski E, 2000, CEREBROVASC DIS, V10, P200, DOI 10.1159/000016057; Xiong M, 2009, BRAIN RES BULL, V79, P351, DOI 10.1016/j.brainresbull.2009.03.011	19	3	3	0	2	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	MAR	2013	23	2					151	154		10.5137/1019-5149.JTN.5858-12.2			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	123GH	WOS:000317375900004	23546898	Bronze			2022-02-06	
J	Steelman, R				Steelman, Robert			Rapid Physical Assessment of the Injured Child	JOURNAL OF ENDODONTICS			English	Article						Primary survey; secondary survey; trauma; traumatic; brain injury		Traumatic injuries that involve the dentition and maxillofacial region may occur as isolated events in pediatric patients but are often associated with multisystem injuries and traumatic brain injuries. The primary trauma survey serves to identify and treat life-threatening injuries. The secondary trauma survey is a complete examination of the patient after the stabilization of physiological parameters. Frequent neurologic and physical assessments of the injured child are crucial to preventing deterioration. The role of the dental professional is to identify and refer for medical evaluation patients who present with concerning neurologic signs and symptoms after traumatic injuries to the maxillofacial region. (J Endod 2013;39:S9-S12)	[Steelman, Robert] Oregon Hlth & Sci Univ, Portland, OR 97239 USA		Steelman, R (corresponding author), Oregon Hlth & Sci Univ, CDRC P, 707 SW Gaines Rd, Portland, OR 97239 USA.	steelmar@ohsu.edu					*AM COLL SURG, 2004, ADV TRAUM LIF SUPP D; Atabaki SM, 2007, PEDIATR REV, V28, P215, DOI 10.1542/pir.28-6-215; Horeczko T, 2012, CONT PEDS, V40-7; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; Mazzola C, 2002, SEMIN NEUROSURG, V13, P29; Muniz A., 2008, PEDIAT EMERG MED PRA, V5, P1; Pickering A, 2011, ARCH DIS CHILD, V96, P414, DOI 10.1136/adc.2010.202820	7	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0099-2399	1878-3554		J ENDODONT	J. Endod.	MAR	2013	39	3		S			S9	S12		10.1016/j.joen.2012.11.036			4	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	AO6MS	WOS:000341466800004	23439052				2022-02-06	
J	Yaka, C; Bjork, P; Schonberg, T; Erlandsson, A				Yaka, Cane; Bjork, Per; Schonberg, Tommy; Erlandsson, Anna			A Novel In Vitro Injury Model Based on Microcontact Printing Demonstrates Negative Effects of Hydrogen Peroxide on Axonal Regeneration both in Absence and Presence of Glia	JOURNAL OF NEUROTRAUMA			English	Article						axonal injury; axonal regeneration; glia cell response to injury; models of injury; oxidative stress	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; NEURONAL NETWORKS; PROTECTS NEURONS; SIGNAL-TRANSDUCTION; DEFINED GEOMETRY; CELLS; GROWTH; ASTROCYTES; PATTERNS	The molecular processes involved in axonal regeneration after traumatic brain injury (TBI) are still not fully understood. In this study, we have established a novel in vitro injury model of TBI based on microcontact printing (mu CP) that enables close-up investigations of injured neurons. The model is also suitable for quantitative measurements of axonal outgrowth, making it a useful tool in the studies of basic mechanisms behind axonal regeneration. Cortical neurons from mouse embryos are cultured on mu CP cover-slips for 8 days, and the neurons are then injured in a precise manner using a thin plastic tip that does not affect the mu CP pattern of extracellular matrix proteins. By close-up time-lapse experiments and immunostainings, we show that the neurons have a tremendous capacity to regenerate their neurites after injury. The cut induces growth cone formation, and the regenerating axons strictly follow the mu CP pattern. Moreover, by using the injury model, we demonstrate that hydrogen peroxide (H2O2) decreases axonal regeneration after injury without affecting the neurons' ability to form growth cones. Co-culture with glial cells does not rescue the axonal regeneration, indicating that the mechanism by which H2O2 affects axonal regeneration differ from its cytotoxic effect.	[Yaka, Cane; Erlandsson, Anna] Uppsala Univ, Dept Neurosci, S-75185 Uppsala, Sweden; [Bjork, Per; Schonberg, Tommy] Acreo AB, Stockholm, Sweden		Erlandsson, A (corresponding author), Uppsala Univ, Dept Neurosci, S-75185 Uppsala, Sweden.	anna.erlandsson@neuro.uu.se			Tore Nilssons Foundation; Swedish Society of Medicine; Magnus Bergvall foundation; Medical Faculty Foundation for Psychological and Neurological Research, Uppsala University	This study was supported by grants from Tore Nilssons Foundation, the Swedish Society of Medicine, Magnus Bergvall foundation, and the Medical Faculty Foundation for Psychological and Neurological Research, Uppsala University.	Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Behl C, 2000, J NEURAL TRANSM, V107, P393, DOI 10.1007/s007020070082; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Branch DW, 1998, MED BIOL ENG COMPUT, V36, P135, DOI 10.1007/BF02522871; Chown MG, 2007, INT J NANOMED, V2, P333; Chuckowree JA, 2003, J NEUROSCI, V23, P3715; Desagher S, 1996, J NEUROSCI, V16, P2553; Fricke R, 2011, BIOMATERIALS, V32, P2070, DOI 10.1016/j.biomaterials.2010.11.036; Fujita T, 2009, GLIA, V57, P244, DOI 10.1002/glia.20749; Fukui K, 2012, FREE RADICAL RES, V46, P184, DOI 10.3109/10715762.2011.647689; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Haskew-Layton RE, 2010, P NATL ACAD SCI USA, V107, P17385, DOI 10.1073/pnas.1003996107; Jang MJ, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/23/235102; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kehrer JP, 2000, TERATOLOGY, V62, P235, DOI 10.1002/1096-9926(200010)62:4<235::AID-TERA11>3.0.CO;2-3; Kelly TAN, 2010, J NEUROSCI RES, V88, P3024, DOI 10.1002/jnr.22478; Kumaria A, 2008, BRIT J NEUROSURG, V22, P200, DOI 10.1080/02688690701772413; Kunik D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026832; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033090; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029771; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Magnusson AK, 2008, J NEUROSCI RES, V86, P2363, DOI 10.1002/jnr.21688; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Poulain FE, 2010, MOL CELL NEUROSCI, V43, P15, DOI 10.1016/j.mcn.2009.07.012; Ricart KC, 2001, NEUROCHEM RES, V26, P801, DOI 10.1023/A:1011660001941; Roediger B, 2003, NEUROBIOL DIS, V13, P222, DOI 10.1016/S0969-9961(03)00038-X; Schmalenberg KE, 2005, BIOMATERIALS, V26, P1423, DOI 10.1016/j.biomaterials.2004.04.046; Shih AY, 2007, J NEUROCHEM, V101, P109, DOI 10.1111/j.1471-4159.2006.04345.x; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Suter DM, 2011, PROG NEUROBIOL, V94, P91, DOI 10.1016/j.pneurobio.2011.04.002; Taylor AM, 2009, J NEUROSCI, V29, P4697, DOI 10.1523/JNEUROSCI.6130-08.2009; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; Vogt AK, 2003, BIOTECHNOL PROGR, V19, P1562, DOI 10.1021/bp034016f; Vogt AK, 2005, TISSUE ENG, V11, P1757, DOI 10.1089/ten.2005.11.1757; Vogt AK, 2005, BIOMATERIALS, V26, P2549, DOI 10.1016/j.biomaterials.2004.07.031; Wyart C, 2002, J NEUROSCI METH, V117, P123, DOI 10.1016/S0165-0270(02)00077-8; Yeung CK, 2001, NEUROSCI LETT, V301, P147, DOI 10.1016/S0304-3940(01)01628-7; Yin YX, 1998, NATURE, V391, P707, DOI 10.1038/35648	43	3	3	0	13	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAR	2013	30	5					392	402		10.1089/neu.2012.2562			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	103CI	WOS:000315891600009	23057993				2022-02-06	
J	Jung, MA; Kim, HJ; Kang, YJ; Kim, YJ				Jung, Mi Ae; Kim, Hyun Jung; Kang, Youn Joo; Kim, Yon Joon			Development of a Modified Naturalistic Action Test for Korean Patients With Impaired Cognition	ANNALS OF REHABILITATION MEDICINE-ARM			English	Article						Cognition; Executive function; Rehabilitation		Objective To develop and evaluate the psychometric properties of a modified Naturalistic Action Test (m-NAT) for Korean patients with impaired cognition. The NAT was originally designed to assess everyday action impairment associated with higher cortical dysfunction. Methods We developed the m-NAT by adapting the NAT for the Korean cultural background. The m-NAT was modeled as closely as possible on the original version in terms of rules and scoring. Thirty patients receiving neurorehabilitation (twenty-three stroke patients, five traumatic brain injury patients, and two dementia patients) and twenty healthy matched controls were included. Inter-rater reliability was assessed between two raters. Validity was evaluated by comparing the m-NAT score with various measures of attention, executive functions, and daily life. Results Performance on the m-NAT in terms of the total score was significantly different between patients and controls (p<0.01). Patients made significantly more total errors than controls (p<0.01). Omissions error was the most frequent type of error in patient group. Intraclass correlation coefficients for total m-NAT score was 0.95 (95% confidence interval [CI], 0.92 to 0.97; p<0.001); total error was 0.91 (95% CI, 0.89 to 0.92; p<0.001). Total m-NAT score showed moderate to strong correlations with Stroop test interference score & index, Trail Making Test parts A and B, Sustained Attention to Response Task commission error, Functional Independence Measure, Korean instrumental activities of daily living, Korean version of the Cognitive Failures Questionnaire, and Executive Behavior Scale (p<0.05). Conclusion The m-NAT showed very good inter-rater reliability and adequate validity. The m-NAT adjusted to Korean cultural background can be useful in performance-based assessment of naturalistic action for clinical and research purposes.	[Jung, Mi Ae; Kim, Hyun Jung; Kang, Youn Joo; Kim, Yon Joon] Eulji Univ, Dept Rehabil Med, Eulji Gen Hosp, Sch Med, Seoul, South Korea		Kim, HJ (corresponding author), Eulji Gen Hosp, Dept Rehabil Med, 68 Hangeulbiseok Ro, Seoul 139711, South Korea.	khj2603@eulji.ac.kr		Kang, Youn Joo/0000-0002-9938-5435			Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Dawson DR, 2009, ARCH PHYS MED REHAB, V90, pS41, DOI 10.1016/j.apmr.2009.07.012; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Goldberg E, 2005, PSYCHIAT CLIN N AM, V28, P567, DOI 10.1016/j.psc.2005.05.005; Kang S.J., 2002, J KOREAN NEUROL ASS, V20, P8; Kim, 2001, KIMS FRONTAL EXECUTI; Kim HJ, 2011, ANN B BUM SUK ACAD S, V14, P77; Knight C, 2002, NEUROPSYCHOL REHABIL, V12, P231, DOI 10.1080/09602010244000039; MALLOY P, 1993, ARCH CLIN NEUROPSYCH, V8, P185, DOI 10.1016/0887-6177(93)90035-Y; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; Norman D. A., 1986, COGNITIVE NEUROSCIEN, P376; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Schwartz MF, 1998, NEUROPSYCHOLOGY, V12, P13, DOI 10.1037/0894-4105.12.1.13; Schwartz MF, 2002, NEUROPSYCHOL REHABIL, V12, P311, DOI 10.1080/09602010244000084; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shallice T, 2015, FRONTAL LOBE FUNCTIO; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; Uniform Data System for Medical Rehabilitation, 1993, GUID USE UNIF DAT SE	22	3	3	0	1	KOREAN ACAD REHABILITATION MEDICINE	SEOUL	5F, YOUNGHAN BLDG, 742-22 BANPO-DONG, SEOCHO-GU, SEOUL, 137-040, SOUTH KOREA	2234-0645	2234-0653		ANN REHABIL MED-ARM	Ann. Rehabil. Med.-ARM	FEB	2013	37	1					57	65		10.5535/arm.2013.37.1.57			9	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	VC6CV	WOS:000433876900008	23525262	Green Submitted, gold, Green Published			2022-02-06	
J	Kral, JG; Ludvig, N				Kral, John G.; Ludvig, Nandor			Subarachnoid pharmacodialysis for central nervous system disorders	MEDICAL HYPOTHESES			English	Article							CONVECTION-ENHANCED DELIVERY; PLACEBO-CONTROLLED PHASE-3; DRUG-DELIVERY; BRAIN-INJURY; ORAL BG-12; INFUSION; PHARMACOTHERAPY; NEUROGENESIS; STIMULATION; HIPPOCAMPAL	We postulate that alternating use of microcontroller-regulated delivery and drain pumps connected to one or more sealed subarachnoid fluid exchange ports can maintain localized bi-directional molecular fluxes across pia mater covering multiple diseased areas of the cerebral cortex or spinal cord. This system enables local irrigation with drugs and drainage of endogenous neurotoxic molecules normalizing regional neurochemistry and restoring physiological function. Viewing the pia mater as an endogenous dialysis membrane, testing this hypothesis requires demonstrating: (a) benefits of removing neurotoxic molecules from diseased cerebral cortical or spinal areas via subarachnoid dialysis, (b) neuropharmacological effects of subarachnoid drug delivery and (c) evaluating additive effects of combining the two, as a novel, "pharmacodialysis" procedure. Our supporting experimental data show that this procedure can drain proinflammatory cytokines from the neocortex to the subarachnoid cerebrospinal fluid in rats and can prevent focal seizures in monkeys through subarachnoid delivery of muscimol to their neocortex. Subarachnoid pharmacodialysis allows effective site-specific treatment and microcontroller-regulated timing responsive to the evolving course of a disease and can be performed with bedside systems or fully implanted devices. The procedure provides a two-pronged, combined therapy for traumatic brain and spinal cord injuries, cortically localized epilepsy, stroke and tumors as well as psychiatric disorders such as Alzheimer's disease with pathology of the association cortex. Therapeutic subarachnoid pharmacodialysis drainage of endogenous molecules from the neocortical interstitial space offers unprecedented opportunities to gain new insights into the neurochemistry of the human neocortex in real-life conditions over months or even years. (c) 2012 Elsevier Ltd. All rights reserved.	[Kral, John G.; Ludvig, Nandor] Suny Downstate Med Ctr, Dept Surg, Brooklyn, NY 11203 USA		Kral, JG (corresponding author), Suny Downstate Med Ctr, Dept Surg, 450 Clarkson Ave,Box 40, Brooklyn, NY 11203 USA.	jkral@downstate.edu			Epilepsy Research Foundation [140929]	Experimental data for Figs. 2 and 3 were generated with support from Epilepsy Research Foundation grant #140929 to N.L., with contributions from Dr. Hai M. Tang, M.D., Robert C. Switzer III, Ph.D., Shim L. Baptiste, B.S. and Ray Biotech, Inc. (Norcross, GA). For these studies, the control unit of the drug delivery/CSF removal implant was provided by G-Tech Electronic Research & Development, LLC (Croton on Hudson, NY) and the subarachnoid unit by DocXS Biomedical Products, LLC (Ukiah, CA).	Allhenn D, 2012, INT J PHARMACEUT, V436, P299, DOI 10.1016/j.ijpharm.2012.06.025; Bachstetter AD, 2012, J NEUROSCI, V32, P10201, DOI 10.1523/JNEUROSCI.1496-12.2012; Barcia JA, 2009, NEUROTHERAPEUTICS, V6, P337, DOI 10.1016/j.nurt.2009.01.015; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Davis KD, 1997, NAT MED, V3, P671, DOI 10.1038/nm0697-671; Ferrer I, 2012, NEUROBIOL DIS, V46, P508, DOI 10.1016/j.nbd.2011.10.019; Fox RJ, 2012, NEW ENGL J MED, V367, P1087, DOI 10.1056/NEJMoa1206328; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Halkes PHA, 2006, STROKE, V37, P1828, DOI 10.1161/01.STR.0000226993.88307.ff; Harris NG, 2009, J NEUROSCI RES, V87, P2937, DOI 10.1002/jnr.22115; Heiss JD, 2005, J NEUROSURG, V103, P1035, DOI 10.3171/jns.2005.103.6.1035; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jonhagen ME, 1998, DEMENT GERIATR COGN, V9, P246, DOI 10.1159/000017069; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Kobayashi T, 2006, STROKE, V37, P2361, DOI 10.1161/01.STR.0000236025.44089.e1; Kovacs R, 2009, J NEUROSCI, V29, P8565, DOI 10.1523/JNEUROSCI.5698-08.2009; Ksendzovsky A, 2012, J NEUROSURG, V117, P197, DOI 10.3171/2012.4.JNS111528; Kunwar S, 2007, J CLIN ONCOL, V25, P837, DOI 10.1200/JCO.2006.08.1117; Kwong YL, 2009, ANN HEMATOL, V88, P193, DOI 10.1007/s00277-008-0645-y; Larjavaara S, 2007, NEURO-ONCOLOGY, V9, P319, DOI 10.1215/15228517-2007-016; Lin AMY, 2002, NEUROSCI RES, V43, P317, DOI 10.1016/S0168-0102(02)00056-1; Liu L, 2009, J NEUROSCI RES, V87, P3576, DOI 10.1002/jnr.22151; LUDVIG N, 1992, SYNAPSE, V12, P87, DOI 10.1002/syn.890120202; Ludvig N., 2012, DRUG DELIV LETT, V2, P70, DOI DOI 10.2174/2210304x11202010070; Ludvig N., 2010, J EXP STROKE TRANSL, V3, P13; Ludvig N, 2006, EPILEPSIA, V47, P1792, DOI 10.1111/j.1528-1167.2006.00642.x; Ludvig N, 2012, J NEUROSURG, V117, P162, DOI 10.3171/2012.4.JNS111488; Ludvig N, 2012, BRAIN RES, V1441, P1, DOI 10.1016/j.brainres.2011.12.050; Ludvig N, 2012, J NEUROSCI METH, V203, P275, DOI 10.1016/j.jneumeth.2011.10.008; Masi BC, 2012, BIOMATERIALS, V33, P5768, DOI 10.1016/j.biomaterials.2012.04.048; Mueller BK, 2009, BRIT J PHARMACOL, V157, P675, DOI 10.1111/j.1476-5381.2009.00220.x; Nance EA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003594; Noble EE, 2011, AM J PHYSIOL-REG I, V300, pR1053, DOI 10.1152/ajpregu.00776.2010; Pagni CA, 2005, NEUROSURGERY, V57, DOI 10.1227/01.NEU.0000176857.66627.01; Pignataro G, 2007, BRAIN, V130, P151, DOI 10.1093/brain/awl325; Rogawski MA, 2009, NEUROTHERAPEUTICS, V6, P344, DOI 10.1016/j.nurt.2009.01.017; Sanchez-Moreno C, 2004, STROKE, V35, P163, DOI 10.1161/01.STR.0000105391.62306.2E; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shahar T, 2012, J NEURO-ONCOL, V107, P373, DOI 10.1007/s11060-011-0751-x; Sonabend AM, 2011, NEURO-ONCOLOGY, V13, P886, DOI 10.1093/neuonc/nor051; Stein AG, 2000, EPILEPSY RES, V39, P103, DOI 10.1016/S0920-1211(99)00107-2; Stroemer RP, 1997, J CEREBR BLOOD F MET, V17, P597; Tamargo RJ, 2002, EPILEPSY RES, V48, P145, DOI 10.1016/S0920-1211(01)00330-8; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Terry R., 1999, ALZHEIMER DIS, V2nd Edn, P187; Vezzani A, 2008, BRAIN BEHAV IMMUN, V22, P797, DOI 10.1016/j.bbi.2008.03.009; Wang J, 2012, CELL STEM CELL, V11, P23, DOI 10.1016/j.stem.2012.03.016; Willmore LJ, 2009, NEUROCHEM RES, V34, P688, DOI 10.1007/s11064-008-9841-3; Wilz A, 2008, BIOMATERIALS, V29, P3609, DOI 10.1016/j.biomaterials.2008.05.010; Yasuda T, 2012, MOL NEUROBIOL	54	3	3	0	7	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	FEB	2013	80	2					105	111		10.1016/j.mehy.2012.10.005			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	083SO	WOS:000314485700001	23127501				2022-02-06	
J	Wu, XM; Fu, HR; Zou, FH; Jin, W; Xu, T; Gong, PP; Xu, J; Yan, YH; Cui, G; Ke, KF; Gao, YL; Liu, CF; Pan, YJ				Wu, Xinmin; Fu, Hongran; Zou, Feihui; Jin, Wei; Xu, Ting; Gong, Peipei; Xu, Jian; Yan, Yaohua; Cui, Gang; Ke, Kaifu; Gao, Yilu; Liu, Chunfeng; Pan, Yongjin			Increased expression of actin filament-stabilizing protein tropomyosin after rat traumatic brain injury	JOURNAL OF MOLECULAR HISTOLOGY			English	Article						Tropomyosin; Traumatic brain injury; Astrogliosis; Rat	CENTRAL-NERVOUS-SYSTEM; CELL-CYCLE; GLIAL PROLIFERATION; REACTIVE ASTROCYTES; NEURONAL APOPTOSIS; FISSION YEAST; GROWTH-FACTOR; ADULT BRAIN; CORTEX; LOCALIZATION	Tropomyosin (TM), is a coiled-coil dimmer which modulates actin filament properties, has been implicated in the control of actin filament dynamics during cell migration, morphogenesis, and cytokinesis. However, the expressions and possible functions of tropomyosin in central nervous system (CNS) lesion remain unknown. In this study, we found the expression of tropomyosin gradually increased in rat brains subjected to traumatic brain injury (TBI). Double immunofluorescence staining showed tropomyosin was expressed in neurons and reactive astrocytes following TBI but not in quiescent astrocytes in normal brains. Furthermore, we detected that proliferating cell nuclear antigen (PCNA) had the co-localization with GFAP, and tropomyosin. In conclusion, this was the first description of tropomyosin expression in rat traumatic brain. Our date suggested that tropomyosin might be involved in the astrocytes proliferation following TBI.	[Wu, Xinmin; Liu, Chunfeng] Soochow Univ, Affiliated Hosp 2, Dept Neurol, Suzhou, Peoples R China; [Wu, Xinmin; Fu, Hongran; Zou, Feihui; Jin, Wei; Xu, Ting; Gong, Peipei; Yan, Yaohua; Cui, Gang; Ke, Kaifu; Gao, Yilu; Pan, Yongjin] Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong 226001, Jiangsu, Peoples R China; [Xu, Jian] Fourth Peoples Hosp Nantong, Dept Psychiat, Nantong 226001, Jiangsu, Peoples R China		Gao, YL (corresponding author), Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong 226001, Jiangsu, Peoples R China.	YiluGao428@163.com; lwfwxx@126.com; panyj_nt@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81070992]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by the National Natural Science Foundation of China (No. 81070992) and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Arifin Muhammad Zafrullah, 2011, Asian J Neurosurg, V6, P72, DOI 10.4103/1793-5482.92160; BALASUBRAMANIAN MK, 1992, NATURE, V360, P84, DOI 10.1038/360084a0; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; Bohmer RM, 1996, MOL BIOL CELL, V7, P101; Chen J, 2012, J MOL HISTOL; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Copani A, 2001, TRENDS NEUROSCI, V24, P25, DOI 10.1016/S0166-2236(00)01663-5; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Fawcett JW, 1997, CELL TISSUE RES, V290, P371, DOI 10.1007/s004410050943; FERRIER R, 1994, CELL MOTIL CYTOSKEL, V28, P303, DOI 10.1002/cm.970280404; Fujita T, 1998, ACTA NEUROCHIR, V140, P275, DOI 10.1007/s007010050095; GALLOWAY PG, 1990, LAB INVEST, V62, P163; HANNAN AJ, 1995, MOL CELL NEUROSCI, V6, P397, DOI 10.1006/mcne.1995.1030; Hill-Felberg SJ, 1999, J NEUROSCI RES, V57, P271, DOI 10.1002/(SICI)1097-4547(19990715)57:2<271::AID-JNR13>3.0.CO;2-Z; Hughes JAI, 2003, GLIA, V42, P25, DOI 10.1002/glia.10174; Jiang SY, 2012, J MOL HISTOL, V43, P195, DOI 10.1007/s10735-011-9383-x; Kato H, 2003, BRAIN RES BULL, V60, P215, DOI 10.1016/S0361-9230(03)00036-4; Koguchi K, 2002, GLIA, V37, P93, DOI 10.1002/glia.10017; Kurahashi H, 2002, GENES CELLS, V7, P375, DOI 10.1046/j.1365-2443.2002.00526.x; Li WJ, 2003, J NEUROSCI, V23, P6171; Little AR, 2001, NEUROTOXICOLOGY, V22, P607, DOI 10.1016/S0161-813X(01)00032-8; Liu DX, 2001, CELL TISSUE RES, V305, P217, DOI 10.1007/s004410100396; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; LOGAN A, 1992, J NEUROSCI, V12, P3828; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; MORRIS GF, 1989, J BIOL CHEM, V264, P13856; Nieto-Sampedro M, 1999, ADV EXP MED BIOL, V468, P207; Norton WT, 1999, NEUROCHEM RES, V24, P213, DOI 10.1023/A:1022505903312; Percival JM, 2000, CELL MOTIL CYTOSKEL, V47, P189, DOI 10.1002/1097-0169(200011)47:3<189::AID-CM3>3.0.CO;2-C; Perry SV, 2001, J MUSCLE RES CELL M, V22, P5, DOI 10.1023/A:1010303732441; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Schevzov G, 1997, MOL CELL NEUROSCI, V8, P439, DOI 10.1006/mcne.1997.0599; Shi W, 2012, J MOL HISTOL, V43, P37, DOI 10.1007/s10735-011-9366-y; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; STAMM S, 1993, P NATL ACAD SCI USA, V90, P9857, DOI 10.1073/pnas.90.21.9857; Vrhovski B, 2004, NEUROPHARMACOLOGY, V47, P684, DOI 10.1016/j.neuropharm.2004.07.011; WEINBERGER RP, 1993, J CELL BIOL, V120, P205, DOI 10.1083/jcb.120.1.205; Wong K, 2000, CELL MOTIL CYTOSKEL, V45, P121, DOI 10.1002/(SICI)1097-0169(200002)45:2<121::AID-CM4>3.3.CO;2-R; Xu T, 2012, J MOL HISTOL, V43, P335, DOI 10.1007/s10735-012-9408-0; Yan YH, 2012, J MOL HISTOL, V43, P543, DOI 10.1007/s10735-012-9431-1	44	3	3	0	14	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-2379			J MOL HISTOL	J. Mol. Histol.	FEB	2013	44	1					37	45		10.1007/s10735-012-9461-8			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	070GY	WOS:000313495800005	23180152				2022-02-06	
J	Yang, YJ; Jhang, SW; Chen, CM; Chen, YH; Cheng, CY				Yang, Yu-Jen; Jhang, Shang-Wun; Chen, Chien-Min; Chen, Yung-Hsiang; Cheng, Chun-Yuan			Functional preservation of deep brain stimulation electrodes after brain shift induced by traumatic subdural haematoma - case report	BRITISH JOURNAL OF NEUROSURGERY			English	Article						brain shift; deep brain stimulation; traumatic subdural haemorrhage; parkinsonism	IMPLANTATION	A Parkinson's disease patient with deep brain stimulation (DBS) implantation experienced an acute subdural haematoma (SDH) after a fall. The DBS electrodes and brain parenchyma were shifted. Fortunately, the patient recovered after craniectomy and removal of SDH, and the DBS was re-activated with the same parameters. Patients with DBS implants who suffer a traumatic brain injury do not necessarily incur permanent implant failure; there is every chance that the DBS may continue to work as reported here.	[Yang, Yu-Jen; Jhang, Shang-Wun; Chen, Chien-Min; Cheng, Chun-Yuan] Changhua Christian Hosp, Dept Surg, Div Neurosurg, Changhua, Taiwan; [Chen, Yung-Hsiang] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan		Cheng, CY (corresponding author), Changhua Christian Hosp, Dept Surg, Div Neurosurg, 135 Nanhsiao St, Changhua 50006, Taiwan.	83998@cch.org.tw	Chen, Yung-Hsiang/K-6766-2015	Chen, Yung-Hsiang/0000-0002-8756-5113	Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH101-TD-B-111-004]	This study was supported in part by a grant DOH101-TD-B-111-004 from the Taiwan Department of Health Clinical Trial and Research Center of Excellence.	Coley E, 2009, BRIT J NEUROSURG, V23, P179, DOI 10.1080/02688690802673197; Miyagi Y, 2007, J NEUROSURG, V107, P989, DOI 10.3171/JNS-07/11/0989; Nicholson G, 2002, BRIT J ANAESTH, V89, P904, DOI 10.4103/0019-5049.82658	3	3	3	0	4	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0268-8697			BRIT J NEUROSURG	Br. J. Neurosurg.	FEB	2013	27	1					128	129		10.3109/02688697.2012.707703			2	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	072MT	WOS:000313676500030	23121068				2022-02-06	
J	Yeo, SS; Jang, SH				Yeo, Sang Seok; Jang, Sung Ho			Motor recovery via aberrant pyramidal tract in a patient with traumatic brain injury A diffusion tensor tractography study	NEURAL REGENERATION RESEARCH			English	Article						neural regeneration; neuroimaging; diffusion tensor imaging; diffusion tensor tractography; transcranial magnetic stimulation; pyramidal tract; aberrant pyramidal tract; motor paralysis; motor recovery; traumatic brain injury; head trauma; intracerebral hemorrhage; grant-supported paper; photographs-containing paper; neuroregeneration	CORTICOSPINAL TRACT; MEDIAL LEMNISCUS; CORONA RADIATA; AXONAL INJURY; MAGNETIC STIMULATION; FUNCTIONAL MRI; STEM; LOCATION; INFARCT; STROKE	The aberrant pyramidal tract is the collateral pathway of the pyramidal tract through the medial lemniscus in the brainstem. A 21-year-old man presented with right hemiparesis due to a traumatic intracerebral hemorrhage in the left corona radiata. His motor function recovered almost to the normal state at 10 months after onset. Through diffusion tensor tractography, the pyramidal tract in the affected (left) hemisphere showed discontinuation at the pontine level at 13 months after onset. An aberrant pyramidal tract was observed, which originated from the primary motor cortex and the supplementary motor area and descended through the corona radiata, then through the posterior limb of the internal capsule and the medial lemniscus pathway from the midbrain to the pons, finally entered into the pyramidal tract area at the pontomedullary junction. It suggests that the motor functions of the right extremities in this patient had recovered by this aberrant pyramidal tract.	[Yeo, Sang Seok; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2012R1A1A4A01001873]	This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, No. 2012R1A1A4A01001873.	Crosby E, 1962, CORRELATIVE ANATOMY; DAVIDOFF RA, 1990, NEUROLOGY, V40, P332; DEMEURISSE G, 1980, EUR NEUROL, V19, P382, DOI 10.1159/000115178; Han BS, 2007, NEUROREHABILITATION, V22, P151; Han BS, 2010, BRAIN RES, V1326, P75, DOI 10.1016/j.brainres.2010.02.050; Hong JH, 2011, NEURAL REGEN RES, V6, P1027, DOI 10.3969/j.issn.1673-5374.2011.13.012; Hong JH, 2009, NEUROREPORT, V20, P695, DOI 10.1097/WNR.0b013e32832a5c86; Jang SH, 2011, NEUROREHABILITATION, V28, P345, DOI 10.3233/NRE-2011-0662; Jang SH, 2009, J NEUROL NEUROSUR PS, V80, P243, DOI 10.1136/jnnp.2008.146571; Jang SH, 2005, RESTOR NEUROL NEUROS, V23, P51; Jang SH, 2002, AM J PHYS MED REHAB, V81, P844, DOI 10.1097/00002060-200211000-00007; Jang SH, 2011, YONSEI MED J, V52, P553, DOI 10.3349/ymj.2011.52.4.553; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; Jang SH, 2009, NEUROREHABILITATION, V24, P279, DOI 10.3233/NRE-2009-0479; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kim DG, 2009, NEUROREHABILITATION, V25, P117, DOI 10.3233/NRE-2009-0506; Kunimatsu Akira, 2004, Magn Reson Med Sci, V3, P11, DOI 10.2463/mrms.3.11; Lee SK, 2005, RADIOGRAPHICS, V25, P53, DOI 10.1148/rg.251045085; Lindenberg R, 2010, NEUROLOGY, V74, P280, DOI 10.1212/WNL.0b013e3181ccc6d9; NATHAN PW, 1955, BRAIN, V78, P248, DOI 10.1093/brain/78.2.248; NYBERGHANSEN R, 1963, ACTA NEUROL SCAND, V39, P1, DOI 10.1111/j.1600-0404.1963.tb05384.x; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Skoglund TS, 2008, ACTA RADIOL, V49, P98, DOI 10.1080/02841850701561372; Yamamoto T, 1989, No To Shinkei, V41, P777; Yamamoto T., 1995, NEUROL MED TOKYO, V43, P306; Yamashita M, 2001, EUR NEUROL, V45, P75, DOI 10.1159/000052099; Yeo SS, 2011, NEURAL REGEN RES, V6, P1023, DOI 10.3969/j.issn.1673-5374.2011.13.011	28	3	4	0	8	SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES	SHENYANG	PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA	1673-5374			NEURAL REGEN RES	Neural Regen. Res.	JAN 5	2013	8	1					90	94		10.3969/j.issn.1673-5374.2013.01.012			5	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	087VX	WOS:000314793500013	25206377				2022-02-06	
J	Aghazadeh, BS; Khaleghi, M; Pidaparti, R; Najarian, K				Aghazadeh, Babak Seyed; Khaleghi, Morteza; Pidaparti, Ramana; Najarian, Kayvan			Intracranial pressure (ICP) level estimation using textural features of brain CT images	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING-IMAGING AND VISUALIZATION			English	Article						traumatic brain injury; intracranial pressure; anisotropic complex Morlet transform; genetic algorithm; support vector machines		In this study, an optimal feature vector has been extracted from brain computed tomography (CT) images of patients with traumatic brain injury to classify the images into two groups of mild/severe cases. A fully anisotropic Morlet wavelet transform is performed on brain CT images, and the energy of coefficients is extracted as our proposed textural features. Next, genetic algorithms with two fitness functions of (1) K-nearest neighbour and (2) support vector machine classification errors are employed to choose the optimal feature vector. The proposed features and classification algorithm are shown to have reliable performance achieving a good classification accuracy rate of 86.5%.	[Aghazadeh, Babak Seyed] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; [Aghazadeh, Babak Seyed; Khaleghi, Morteza] Worcester Polytech Inst, Mech Engn Dept, Worcester, MA 01609 USA; [Pidaparti, Ramana] Virginia Commonwealth Univ, Mech Engn Dept, Richmond, VA 23284 USA; [Najarian, Kayvan] Virginia Commonwealth Univ, Comp Sci Dept, Richmond, VA 23284 USA		Aghazadeh, BS (corresponding author), Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA.	babak_aghazadeh@meei.harvard.edu					BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; Chen WA, 2010, IEEE INT C BIOINFORM, P510, DOI 10.1109/BIBM.2010.5706619; Chen WN, 2010, LECT NOTES COMPUT SC, V6134, P568, DOI 10.1007/978-3-642-13681-8_66; Cortes C., 1995, MACH LEARN, V297, P273, DOI DOI 10.1007/BF00994018; Cover T.M, 1968, PROC HAWAII INT CONF; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Duda RO., 2000, PATTERN CLASSIFICATI, V2; Heris HK, 2009, COMPUT BIOL MED, V39, P860, DOI 10.1016/j.compbiomed.2009.06.014; Holland J., 1975, ADAPTATION NATURAL A; Ji SY, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-2; KUMAR P, 1995, GEOPHYS RES LETT, V22, P2777, DOI 10.1029/95GL02934; Mahmoud-Ghoneim D, 2003, MAGN RESON IMAGING, V21, P983, DOI 10.1016/S0730-725X(03)00201-7; Najarian K., 2006, BIOMEDICAL SIGNAL IM; Neupauer RM, 2005, COMPUT GEOSCI-UK, V31, P465, DOI 10.1016/j.cageo.2004.10.014; Schmidt B, 1997, STROKE, V28, P2465, DOI 10.1161/01.STR.28.12.2465; Vapnik V. N., 1998, STAT LEARNING THEORY; Watkins L, 2009, MATH GEOSCI, V41, P643, DOI 10.1007/s11004-009-9231-7; Zhang WL, 2007, PROCEEDINGS OF 2007 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-7, P1155	18	3	3	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2168-1163	2168-1171		COMP M BIO BIO E-IV	Comp. Meth. Biomech. Biomed. Eng.		2013	1	3					130	137		10.1080/21681163.2013.773651			8	Engineering, Biomedical	Emerging Sources Citation Index (ESCI)	Engineering	V3Y2X	WOS:000218697000002					2022-02-06	
B	Arciniegas, DB; Silver, JM		Zasler, ND; Katz, DI; Zafonte, RD		Arciniegas, David B.; Silver, Jonathan M.			Pharmacotherapy of Neuropsychiatric Disturbances	BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; MAJOR DEPRESSION; BIPOLAR DISORDER; QUETIAPINE TREATMENT; ANTIPSYCHOTICS; AMANTADINE; METHYLPHENIDATE; SCHIZOPHRENIA; SERTRALINE		[Arciniegas, David B.] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Arciniegas, David B.] TIRR Mem Hermann Hosp, Brain Injury Res Ctr, Houston, TX USA; [Silver, Jonathan M.] NYU, Sch Med, Dept Psychiat, New York, NY USA		Arciniegas, DB (corresponding author), Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA.						Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; Allen MH, 2005, PSYCHIAT PRACT S1, V11, P110; Allen Michael H, 2005, J Psychiatr Pract, V11 Suppl 1, P5, DOI 10.1097/00131746-200511001-00002; Alper K, 2007, BIOL PSYCHIAT, V62, P345, DOI 10.1016/j.biopsych.2006.09.023; American Psychiatric Association, 2006, QUICK REF AM PSYCH A; Andersson S, 1999, BRAIN INJURY, V13, P393, DOI 10.1080/026990599121458; ANGUS WR, 1984, J CLIN PSYCHOPHARM, V4, P203; Arciniegas DB, 2003, INT REV PSYCHIATR, V15, P328, DOI 10.1080/09540260310001606719; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Ballard C, 2009, CURR OPIN PSYCHIATR, V22, P532, DOI 10.1097/YCO.0b013e32833111f9; Beaulieu C, 2008, J HEAD TRAUMA REHAB, V23, P304, DOI 10.1097/01.HTR.0000336843.60961.b7; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Burke JG, 1999, J PSYCHIATR NEUROSCI, V24, P456; Bymaster FP, 2003, PROG NEURO-PSYCHOPH, V27, P1125, DOI 10.1016/j.pnpbp.2003.09.008; Chahine LM, 2006, EPILEPSY BEHAV, V8, P610, DOI 10.1016/j.yebeh.2006.01.017; Chandler M C, 1988, Brain Inj, V2, P309; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Chow Tiffany W, 2005, Curr Psychiatry Rep, V7, P376, DOI 10.1007/s11920-005-0040-5; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; CORRIGAN PW, 1993, HOSP COMMUNITY PSYCH, V44, P125; Crossley NA, 2010, BRIT J PSYCHIAT, V196, P434, DOI 10.1192/bjp.bp.109.066217; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Daniels JP, 2008, J CLIN PSYCHIAT, V69, P497, DOI 10.4088/JCP.v69n0324a; Debette S, 2002, J NEUROL, V249, P1678, DOI 10.1007/s00415-002-0903-1; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; Eames P, 1989, Brain Inj, V3, P319, DOI 10.3109/02699058909029645; Edwards SJ, 2009, CLIN THER, V31, P1345, DOI 10.1016/j.clinthera.2009.07.004; EVANS RW, 1987, J NERV MENT DIS, V175, P106, DOI 10.1097/00005053-198702000-00007; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Fava M, 2006, AM J PSYCHIAT, V163, P1161, DOI 10.1176/appi.ajp.163.7.1161; Foussias G, 2010, CAN J PSYCHIAT, V55, P117, DOI 10.1177/070674371005500302; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gentile S, 2010, PSYCHOPHARMACOLOGY, V212, P119, DOI 10.1007/s00213-010-1939-z; Glenn MB, 1998, J HEAD TRAUMA REHAB, V13, P87, DOI 10.1097/00001199-199810000-00010; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; GUALTIERI CT, 1991, J CLIN PSYCHOPHARM, V11, P280, DOI 10.1097/00004714-199108000-00027; GUALTIERI T, 1989, CLIN NEUROPHARMACOL, V12, P258, DOI 10.1097/00002826-198908000-00003; Guay DRP, 2009, CLIN THER, V31, P1, DOI 10.1016/j.clinthera.2009.01.009; Guay DRR, 2008, AM J GERIATR PHARMAC, V6, P269, DOI 10.1016/j.amjopharm.2008.12.004; Hankin CS, 2011, J PSYCHIATR PRACT, V17, P170, DOI 10.1097/01.pra.0000398410.21374.7d; HOEHNSARIC R, 1990, J CLIN PSYCHOPHARM, V10, P343; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Hornstein A, 1989, J Neuropsychiatry Clin Neurosci, V1, P446; Johnson DE, 2005, EUR J PHARMACOL, V506, P209, DOI 10.1016/j.ejphar.2004.11.015; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; Kane JM, 2002, AM J PSYCHIAT, V159, P1, DOI 10.1176/appi.ajp.159.1.1; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Kim E, 2002, J NEUROPSYCH CLIN N, V14, P202, DOI 10.1176/appi.neuropsych.14.2.202; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kim E, 2006, J NEUROPSYCH CLIN N, V18, P547, DOI 10.1176/appi.neuropsych.18.4.547; Kline AE, 2007, CRIT CARE MED, V35, P919, DOI 10.1097/01.CCM.0000256722.88854.C0; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Kraus MF, 1997, BRAIN INJURY, V11, P455, DOI 10.1080/026990597123430; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Lal S, 1988, Brain Inj, V2, P225, DOI 10.3109/02699058809150946; Lanctot KL, 2010, BRAIN INJURY, V24, P959, DOI 10.3109/02699051003789229; Lane-Brown AT, 2009, NEUROPSYCHOL REHABIL, V19, P481, DOI 10.1080/09602010902949207; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Lichter DC, 2001, FRONTAL-SUBCORTICAL CIRCUITS IN PSYCHIATRIC AND NEUROLOGICAL DISORDERS, P260; Liepert J, 2008, CURR OPIN NEUROL, V21, P639, DOI 10.1097/WCO.0b013e32831897a3; LUCKI I, 1986, PSYCHOPHARMACOLOGY, V88, P426; Marit RS, 2005, J HEAD TRAUMA REHAB, V20, P377, DOI 10.1097/00001199-200507000-00009; MASSAGLI TL, 1991, ARCH PHYS MED REHAB, V72, P219; McAllister TW, 2009, CLIN NEUROPSYCHOL, V23, P1338, DOI 10.1080/13854040903277289; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; MICHALS ML, 1993, J CLIN PSYCHOPHARM, V13, P198; Mittal V, 2011, AM J ALZHEIMERS DIS, V26, P10, DOI 10.1177/1533317510390351; Monji A, 1999, PSYCHOSOMATICS, V40, P448, DOI 10.1016/S0033-3182(99)71215-6; Mysiw WJ, 2006, BRAIN INJURY, V20, P905, DOI 10.1080/02699050600743972; Najdowski AC, 2008, J APPL BEHAV ANAL, V41, P97, DOI 10.1901/jaba.2008.41-97; Narita N, 1996, EUR J PHARMACOL, V307, P117, DOI 10.1016/0014-2999(96)00254-3; NICKELS JL, 1994, BRAIN INJURY, V8, P709, DOI 10.3109/02699059409151025; Novack TA, 2009, J NEUROTRAUM, V26, P1921, DOI 10.1089/neu.2009.0895; Oster TJ, 2007, CNS SPECTRUMS, V12, P764, DOI 10.1017/S1092852900015455; Pabis DJ, 1996, ANN PHARMACOTHER, V30, P278, DOI 10.1177/106002809603000312; Peeters M, 2004, EUR J NEUROSCI, V19, P2212, DOI 10.1111/j.0953-816X.2004.03297.x; POPE HG, 1988, COMPR PSYCHIAT, V29, P34, DOI 10.1016/0010-440X(88)90035-1; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; Rapoport MJ, 2008, J PSYCHOPHARMACOL, V22, P860, DOI 10.1177/0269881107083845; ROSENBERG PB, 1991, J CLIN PSYCHIAT, V52, P263; Roth Robert M, 2007, Curr Treat Options Neurol, V9, P363, DOI 10.1007/s11940-007-0022-5; ROTH T, 1980, ARZNEIMITTEL-FORSCH, V30-1, P891; Rothenhausler HB, 2000, J CLIN PSYCHIAT, V61, P750, DOI 10.4088/JCP.v61n1007; Rummel-Kluge C, 2012, SCHIZOPHRENIA BULL, V38, P167, DOI 10.1093/schbul/sbq042; Rush AJ, 2011, AM J PSYCHIAT, V168, P689, DOI 10.1176/appi.ajp.2011.10111645; SANDEL ME, 1993, BRAIN INJURY, V7, P77, DOI 10.3109/02699059309008159; Saunders KEA, 2009, EPIDEMIOL PSICHIAT S, V18, P172, DOI 10.1017/S1121189X00000427; Schierhout G, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000173; Schmitt JAJ, 2001, J PSYCHOPHARMACOL, V15, P173, DOI 10.1177/026988110101500304; Schreiber S, 1998, INT CLIN PSYCHOPHARM, V13, P273, DOI 10.1097/00004850-199811000-00006; Scott LK, 2009, J NEUROS-PEDIATR, V3, P484, DOI 10.3171/2009.2.PEDS08292; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Sink KM, 2005, JAMA-J AM MED ASSOC, V293, P596, DOI 10.1001/jama.293.5.596; SMITH KR, 1994, ARCH NEUROL-CHICAGO, V51, P653, DOI 10.1001/archneur.1994.00540190029012; SMITH VM, 1995, GASTROINTEST ENDOSC, V41, P182, DOI 10.1016/S0016-5107(05)80620-0; Stanislav SW, 1997, BRAIN INJURY, V11, P335, DOI 10.1080/026990597123494; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; VANLAAR MW, 1992, J CLIN PSYCHOPHARM, V12, P86; VANREEKUM R, 1995, BRAIN INJURY, V9, P49, DOI 10.3109/02699059509004571; Volavka J, 2009, EXPERT OPIN PHARMACO, V10, P1917, DOI 10.1517/14656560903061309; Volavka J, 2009, J CLIN PSYCHIAT, V70, P429, DOI 10.4088/JCP.09ac05081; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Werling LL, 2007, EXP NEUROL, V207, P248, DOI 10.1016/j.expneurol.2007.06.013; Wortzel HS, 2008, CNS DRUGS, V22, P531, DOI 10.2165/00023210-200822070-00001; YASSA R, 1994, J GERIATR PSYCH NEUR, V7, P55, DOI 10.1177/089198879400700110; Zeilig G, 1996, BRAIN INJURY, V10, P591, DOI 10.1080/026990596124160	119	3	3	0	2	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-27-7				2013							1227	1244					18	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BDJ25	WOS:000313536100074					2022-02-06	
J	Boyce, MW; Fekety, DK; Smither, JA				Boyce, Michael W.; Fekety, Drea K.; Smither, Janan A.			Resource Consumption and Simulator Driving Performance Using Adaptive Controls	ASSISTIVE TECHNOLOGY			English	Article						disability; driving; simulation; assistive technology; persons with disabilities; human factors	TRAUMATIC BRAIN-INJURY; REHABILITATION; VALIDITY; DRIVERS	This research seeks to understand the usability of portable assistive driving devices as it relates to driver performance and safety. Through the use of a computer-based simulation, two sets of hand controls were tested in an environment containing driving hazards. Ten participants drove an ambulance through two sessions of high-demand, hazardous scenarios in a computer-based driving simulator. Participants drove one session with each of the two available portable hand control devices. From each of these driving sessions, driving performance metrics were measured in the form of time-to-complete, number of damage-inflicting collisions, percentage of vehicle damage accrued by the end of the drive, and percentage of road course completed. Data were also collected from a posttest survey about which hand control device participants preferred using. Results demonstrated no significant differences between hand control devices with regard to course completion, amount of damage sustained to vehicle, or number of collisions. However, a trend was identified for preference of hand control based on experience, regardless of driving performance. Although the objective results of this study were not significant, the study leads to interesting avenues of future research regarding preference as well as the need for larger populations of individuals with disabilities in simulation studies.	[Boyce, Michael W.; Fekety, Drea K.; Smither, Janan A.] Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA		Boyce, MW (corresponding author), Univ Cent Florida, Dept Psychol, 4000 Cent Florida Blvd,Bldg 99,Suite 306, Orlando, FL 32816 USA.	mboyce@knights.ucf.edu					Anderson S., 2005, 3 INT DRIV S HUM FAC; Bedard M, 2010, AM J OCCUP THER, V64, P336, DOI 10.5014/ajot.64.2.336; Berhane R., 2008, THESIS U S FLORIDA T; Cox DJ, 2010, MIL MED, V175, P411, DOI 10.7205/MILMED-D-09-00081; de Winter JCF, 2009, ERGONOMICS, V52, P137, DOI 10.1080/00140130802277521; Fowler M., 2010, REH ENG ASS TECHN SO; Gray DB, 2006, ARCH PHYS MED REHAB, V87, P189, DOI 10.1016/j.apmr.2005.09.014; Heikkila VM, 2005, DISABIL REHABIL, V27, P1029, DOI 10.1080/09638280500052740; Horberry T, 2010, APPL ERGON, V41, P796, DOI 10.1016/j.apergo.2010.01.006; Ivancic K, 2000, ERGONOMICS, V43, P1966, DOI 10.1080/00140130050201427; Kennedy RS, 1993, INT J AVIAT PSYCHOL, V3, P203, DOI [10.1207/s15327108ijap0303_3, DOI 10.1207/S15327108IJAP0303_3]; Lew HL, 2009, J HEAD TRAUMA REHAB, V24, P51, DOI 10.1097/HTR.0b013e3181956fe3; Lew HL, 2005, BRAIN INJURY, V19, P177, DOI 10.1080/02699050400017171; Marcotte TA, 2008, ARCH PHYS MED REHAB, V89, P1753, DOI 10.1016/j.apmr.2007.12.049; Mathias JL, 2009, INT PSYCHOGERIATR, V21, P637, DOI 10.1017/S1041610209009119; Mobility Conquest, 2011, CONQ WHEELCH MOT; Peters B, 2001, J REHABIL RES DEV, V38, P215; Simone L. K., 2005, 28 ANN REH ENG ASS T; Wilson T, 1983, Int Rehabil Med, V5, P170; Wu S.-Y., 2008, 18 INT C ART REAL TE	20	3	3	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1040-0435	1949-3614		ASSIST TECHNOL	Assist. Technol.		2013	25	3					158	165		10.1080/10400435.2012.737891			8	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	188AE	WOS:000322162700004	24020154				2022-02-06	
J	Eroglu, SE; Onur, O; Ozkaya, S; Denizbasi, A; Demir, H; Ozpolat, C				Eroglu, Serkan Emre; Onur, Ozge; Ozkaya, Sefer; Denizbasi, Arzu; Demir, Hasan; Ozpolat, Cigdem			Analysis of Repeated CT Scan Need in Blunt Head Trauma	EMERGENCY MEDICINE INTERNATIONAL			English	Article							SERIAL COMPUTED-TOMOGRAPHY; BRAIN-INJURY; MANAGEMENT	Background. Computed tomography (CT) is a vital tool in the workup of patients with closed head trauma. The aim of this study was to investigate the necessity of serial CT scans in patients with blunt head trauma. Methods. This is a retrospective study analyzing trauma patients between January and June 2012. Data were analysed by using frequencies, Kolmogorov-Smirnov (K-S), and Chisquare tests. Results. Of the total 351 control Head CTs, it was seen there were no different in 346 (98.6%). In CTs of another 3 patients (0.9%), there were increasing or new, in the other 2 (0.6%) there was a decrease in the pathology present. Of 24 (6.8%) patients who had a hemorrhage in the first CT, there was an increase in the hemorrhage in one of them, a decrease of the pathology in 2 of them. Of 27 (7.7%) patients who had fracture in first CT, 2 had a new intracranial hemorrhage. The relation of the results between the first and second CTs were statistically significant (P < 0.001, chi(2) test). Conclusion. Repeated CT scans after 6 hours in EDs observation rooms are not necessary if first CT is normal in most situations. Special attention may be needed in patients with an underlying chronic disease.	[Eroglu, Serkan Emre; Onur, Ozge; Ozkaya, Sefer; Denizbasi, Arzu; Ozpolat, Cigdem] Marmara Univ, Pendik Res & Training Hosp, Dept Emergency Med, TR-34890 Istanbul, Turkey; [Demir, Hasan] Fatih Sultan Mehmet Res & Training Hosp, Dept Emergency Med, TR-34752 Istanbul, Turkey		Eroglu, SE (corresponding author), Marmara Univ, Pendik Res & Training Hosp, Dept Emergency Med, TR-34890 Istanbul, Turkey.	drseroglu@gmail.com	Altinok, Arzu Denizbasi/AAB-2917-2020	Altinok, Arzu Denizbasi/0000-0002-4589-8251			Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; Dharap SB, 2005, INJURY, V36, P412, DOI 10.1016/j.injury.2004.06.020; Doddamani RS, 2012, INDIAN J NEUROTRAUM, V9, P33, DOI 10.1016/j.ijnt.2012.04.007; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Muakkassa FF, 2012, J AM COLL SURGEONS, V214, P965, DOI 10.1016/j.jamcollsurg.2012.02.004; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039; Turedi S, 2008, J EMERG MED, V34, P253, DOI 10.1016/j.jemermed.2007.05.055; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x	11	3	3	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-2840	2090-2859		EMERG MED INT	Emerg. Med. Int.		2013	2013								916253	10.1155/2013/916253			5	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V34ML	WOS:000215837000030	24367725	Green Submitted, Green Published, gold			2022-02-06	
J	Eskridge, SL; Macera, CA; Galarneau, MR; Holbrook, TL; Woodruff, SI; MacGregor, AJ; Morton, DJ; Shaffer, RA				Eskridge, Susan L.; Macera, Caroline A.; Galarneau, Michael R.; Holbrook, Troy L.; Woodruff, Susan I.; MacGregor, Andrew J.; Morton, Deborah J.; Shaffer, Richard A.			Combat blast injuries: Injury severity and posttraumatic stress disorder interaction on career outcomes in male servicemembers	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						blast injury; career performance outcomes; combat blast; functional outcomes; injury severity; mental health; military discharge; Operation Iraqi Freedom; polytrauma; posttraumatic stress disorder	TRAUMATIC BRAIN-INJURY; OPERATION IRAQI FREEDOM; MILITARY; REGISTRY; SYSTEM; SCORE	The purpose of this study was to describe career performance outcomes after combat blast injury and to examine the relationship between the injury severity and type of military discharge. A retrospective cohort study of 4,255 male service-members injured in a combat blast as a part of Operation Iraqi Freedom was completed. In the total sample, 37.8% experienced a normal discharge and 8.3% had an early discharge. Of the 2,229 members who had a discharge code, 29.8% experienced a disability discharge. Both early attrition and disability discharge proportions were higher in those with posttraumatic stress disorder (PTSD) than in those without PTSD. There was a significant interaction between PTSD and injury severity in the discharge disability outcome. In those without PTSD, there was a dose-response relationship between injury severity and disability discharge. In those with PTSD, injury severity predicted disability discharge. The relationship between injury severity and disability discharge was less striking in service-members with PTSD than without PTSD. The effect of PTSD and injury severity on career performance outcomes after blast injuries should be factored into outcome planning.	[Eskridge, Susan L.; Galarneau, Michael R.; Woodruff, Susan I.; MacGregor, Andrew J.] USN, Hlth Res Ctr, Dept Med Modeling & Simulat, San Diego, CA 92106 USA; [Macera, Caroline A.; Shaffer, Richard A.] USN, Hlth Res Ctr, Dept Def HIV AIDS Prevent Program, San Diego, CA 92106 USA; [Macera, Caroline A.; Shaffer, Richard A.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Holbrook, Troy L.] San Diego State Univ, Sch Social Work, San Diego, CA 92182 USA; [Holbrook, Troy L.] EPI SOAR Consulting Inc, San Diego, CA USA; [Morton, Deborah J.] Univ Calif San Diego, Dept Family & Prevent Med, Div Epidemiol, San Diego, CA 92103 USA		Eskridge, SL (corresponding author), USN, Hlth Res Ctr, 140 Sylvester Rd, San Diego, CA 92106 USA.	susan.eskridge@med.navy.mil		Eskridge, Susan/0000-0002-1817-8355; MacGregor, Andrew/0000-0003-1020-7390	U.S. Navy Bureau of Medicine and Surgery under the Wounded, Ill and Injured/Psychological Health/Traumatic Brain Injury Program [60808]	This material was based on work supported by the U.S. Navy Bureau of Medicine and Surgery under the Wounded, Ill and Injured/Psychological Health/Traumatic Brain Injury Program (Work Unit No. 60808).	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Gennarelli T. A, 2007, ABBREVIATED INJURY S; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Gunderson EKE, 2005, MIL MED, V170, P172; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; LINN S, 1993, INT J EPIDEMIOL, V22, P905, DOI 10.1093/ije/22.5.905; MacGregor AJ, 2009, INJURY, V40, P1004, DOI 10.1016/j.injury.2009.04.006; Mernoff Stephen T, 2010, Med Health R I, V93, P16; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Peleg K, 2004, ANN SURG, V239, P311, DOI 10.1097/01.sla.0000114012.84732.be; Ritenour AE, 2010, ANN SURG, V251, P1140, DOI 10.1097/SLA.0b013e3181e01270; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Zatzick DF, 1997, AM J PSYCHIAT, V154, P1690, DOI 10.1176/ajp.154.12.1690	23	3	3	0	6	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.		2013	50	1					7	15		10.1682/JRRD.2012.01.0004			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	149FE	WOS:000319303600010	23516079	Bronze			2022-02-06	
J	Hansen, G; Grimason, M; Collins, JW; Wainwright, MS				Hansen, Gregory; Grimason, Michele; Collins, James W.; Wainwright, Mark S.			Selective head cooling for the treatment of neurologic complications of acute liver failure in a newborn with disseminated herpes infection	SPRINGERPLUS			English	Article						Acute liver failure; Transcranial doppler; EEG; Neonate; Hypothermia	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; MODERATE HYPOTHERMIA; CARDIOPULMONARY; ENCEPHALOPATHY; THERAPY; CARE	Background: Neurologic complications of pediatric acute liver failure (ALF) are a major determinant of outcome. Management of these complications, including increased intracranial pressure (ICP) is largely supportive. Although hypothermia is an effective treatment for perinatal asphyxia and is used to reduce ICP following traumatic brain injury, it has not been evaluated for neurologic complications of ALF in the newborn. Methods: Case report. Results: We present a case of neonatal herpes simplex virus (HSV)-associated ALF with profound neurologic impairment and increased ICP. The patient was treated with selective head cooling, and monitored with transcranial doppler (TCD) studies of cerebral blood flow velocity, and electroencephalograms (EEG). The duration of head cooling was influenced by absent diastolic flow on TCDs, which subsequently improved during hypothermia. Continuous EEGs captured subclinical seizures, which improved with antiepileptic medications. Her death was attributed to a massive pulmonary hemorrhage and a hypoxemic cardiac arrest secondary to significant coagulopathy. Conclusion: This case demonstrates that selective head cooling may attenuate increased ICP in neonatal encephalopathy, and that TCDs may guide management in the absence of invasive monitoring.	[Hansen, Gregory; Grimason, Michele; Wainwright, Mark S.] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Ruth D & Ken M Davee Pediat Neurocrit Care Progra, Dept Pediat,Feinberg Sch Med, Chicago, IL 60611 USA; [Collins, James W.; Wainwright, Mark S.] Northwestern Univ, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Div Neonatol, Chicago, IL 60611 USA		Wainwright, MS (corresponding author), Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Ruth D & Ken M Davee Pediat Neurocrit Care Progra, Dept Pediat,Feinberg Sch Med, Chicago, IL 60611 USA.	m-wainwright@northwestern.edu		Hansen, Gregory/0000-0002-5355-714X			Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Aggarwal S, 2008, LIVER TRANSPLANT, V14, P1048, DOI 10.1002/lt.21499; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Basu S, 2012, EUR J PEDIATR, V171, P901, DOI 10.1007/s00431-011-1643-y; Ciocca M, 2008, ARCH DIS CHILD, V93, P48, DOI 10.1136/adc.2006.115113; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jalan R, 2004, GASTROENTEROLOGY, V127, P1338, DOI 10.1053/j.gastro.2004.08.005; Jalan R, 1999, LANCET, V354, P1164, DOI 10.1016/S0140-6736(98)12440-6; Lin ZL, 2006, J PERINATOL, V26, P180, DOI 10.1038/sj.jp.7211412; Nolan JP, 2008, RESUSCITATION, V79, P350, DOI 10.1016/j.resuscitation.2008.09.017; O'Brien NF, 2013, PEDIATR CRIT CARE ME, V14, pE126, DOI 10.1097/PCC.0b013e3182712d62; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Raschke RA, 2008, CRIT CARE MED, V36, P2244, DOI 10.1097/CCM.0b013e31818029a3; RiveraPenera T, 1997, J PEDIATR GASTR NUTR, V24, P128, DOI 10.1097/00005176-199702000-00004; Scholefield B, 2013, COCHRANE DB SYST REV, V28, P2; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Sloan MA, 2004, NEUROLOGY, V62, P1468, DOI 10.1212/WNL.62.9.1468; Squires RH, 2006, J PEDIATR-US, V148, P652, DOI 10.1016/j.jpeds.2005.12.051; Stravitz RT, 2009, CRIT CARE MED, V37, pS258, DOI 10.1097/CCM.0b013e3181aa5fb8; Sundaram SS, 2011, J PEDIATR-US, V159, P813, DOI 10.1016/j.jpeds.2011.04.016; Tofteng F, 2002, HEPATOLOGY, V36, P1333, DOI 10.1053/jhep.2002.36944; Melo JRT, 2011, CHILD NERV SYST, V27, P979, DOI 10.1007/s00381-010-1367-8; Verma A, 2006, J PEDIATR GASTR NUTR, V42, P282, DOI 10.1097/01.mpg.0000214156.58659.4c; Wang W, 2010, ARTIF ORGANS, V34, P874, DOI 10.1111/j.1525-1594.2010.01110.x	25	3	3	0	1	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2193-1801			SPRINGERPLUS	SpringerPlus		2013	2								572	10.1186/2193-1801-2-572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V40FS	WOS:000209465100144	24255865	gold, Green Published			2022-02-06	
B	Henrie, M; Elovic, EP		Zasler, ND; Katz, DI; Zafonte, RD		Henrie, Michael; Elovic, Elie P.			Fatigue: Assessment and Treatment	BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; GROWTH-HORMONE REPLACEMENT; EXCESSIVE DAYTIME SLEEPINESS; ANTERIOR-PITUITARY DYSFUNCTION; ACETYL-L-CARNITINE; QUALITY-OF-LIFE; 1ST 2 YEARS; DOUBLE-BLIND; MULTIPLE-SCLEROSIS; MENTAL FATIGUE		[Henrie, Michael] Univ Utah, Dept Phys Med & Rehabil, Salt Lake City, UT 84112 USA; [Elovic, Elie P.] Healths Rehabil Hosp, Sandy, UT USA		Henrie, M (corresponding author), Univ Utah, Dept Phys Med & Rehabil, Salt Lake City, UT 84112 USA.						Aquilani R, 2003, ARCH PHYS MED REHAB, V84, P1258, DOI 10.1016/S0003-9993(03)00148-5; Arciniegas D. B., 2011, TXB TRAUMATIC BRAIN, P553; Arenth PM, 2011, PM&R, V3, pS123, DOI 10.1016/j.pmrj.2011.03.012; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bhagia V, 2010, BRAIN INJURY, V24, P560, DOI 10.3109/02699051003601705; Blomstrand E, 2001, AMINO ACIDS, V20, P25, DOI 10.1007/s007260170063; BLOMSTRAND E, 1991, ACTA PHYSIOL SCAND, V143, P225, DOI 10.1111/j.1748-1716.1991.tb09225.x; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; Brassington JC, 1998, NEUROPSYCHOL REV, V8, P43, DOI 10.1023/A:1025621700003; Breitbart W, 2001, ARCH INTERN MED, V161, P411, DOI 10.1001/archinte.161.3.411; Brody A L, 2001, Semin Clin Neuropsychiatry, V6, P102, DOI 10.1053/scnp.2001.21837; Brown RB, 2005, TXB TRAUMATIC BRAIN, P679; Burke DT, 2003, AM J PHYS MED REHAB, V82, P493, DOI 10.1097/00002060-200307000-00001; BURMAN P, 1995, J CLIN ENDOCR METAB, V80, P3585, DOI 10.1210/jc.80.12.3585; Busek P, 2000, Sb Lek, V101, P233; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; Calvani M, 1999, INT J TISSUE REACT, V21, P1; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Carpenter MB, 1985, TEXT NEUROANATOMY; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; COHEN RA, 1989, ARCH NEUROL-CHICAGO, V46, P676, DOI 10.1001/archneur.1989.00520420096030; Colao A, 1999, J CLIN ENDOCR METAB, V84, P1919, DOI 10.1210/jc.84.6.1919; Cooper MR, 2009, ANN PHARMACOTHER, V43, P721, DOI 10.1345/aph.1L532; COVINGTON EC, 1991, PRIMARY CARE, V18, P341; Deijen JB, 1996, PSYCHONEUROENDOCRINO, V21, P313, DOI 10.1016/0306-4530(95)00050-X; DeLuca J, 2005, ISS CLIN COGN NEUROP, P1; Diamond BJ, 2000, ARCH PHYS MED REHAB, V81, P668, DOI 10.1053/mr.2000.3840; Drevets WC, 2000, PROG BRAIN RES, V126, P413; Dwyer D, 2000, ACTA PHYSIOL SCAND, V170, P211, DOI 10.1046/j.1365-201x.2000.00774.x; EDWARDS OM, 1986, MEDICINE, V65, P281; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Elovic E, 2006, J HEAD TRAUMA REHAB, V21, P426, DOI 10.1097/00001199-200609000-00044; Elovic EP, 2004, J HEAD TRAUMA REHAB, V19, P184, DOI 10.1097/00001199-200403000-00010; Elovic EP, 2003, J HEAD TRAUMA REHAB, V18, P541, DOI 10.1097/00001199-200311000-00008; Elovic EP, 2001, J HEAD TRAUMA REHAB, V16, P603, DOI 10.1097/00001199-200112000-00008; EMONSON DL, 1995, AVIAT SPACE ENVIR MD, V66, P260; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Escamilla RF, 1942, J CLIN ENDOCRINOL, V2, P65, DOI 10.1210/jcem-2-2-65; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Gibney J, 1999, J CLIN ENDOCR METAB, V84, P2596, DOI 10.1210/jc.84.8.2596; Gillis CN, 1997, BIOCHEM PHARMACOL, V54, P1, DOI 10.1016/S0006-2952(97)00193-7; Goldstein, 2000, Curr Treat Options Neurol, V2, P319, DOI 10.1007/s11940-000-0049-3; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; Heilman KM, 2003, CLIN NEUROPSYCHOLOGY; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Hillier SL, 1997, BRAIN INJURY, V11, P661; HOLSBOER F, 1988, ACTA PSYCHIAT SCAND, V77, P72, DOI 10.1111/j.1600-0447.1988.tb08556.x; Iriarte J, 2000, MULT SCLER, V6, P124, DOI 10.1191/135245800678827572; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Johansson JO, 1996, THROMB HAEMOSTASIS, V76, P422; JORGENSEN JOL, 1994, EUR J ENDOCRINOL, V130, P224, DOI 10.1530/eje.0.1300224; Kaiser PR, 2010, NEUROLOGY, V75, P1780, DOI 10.1212/WNL.0b013e3181fd62a2; KALISKY Z, 1985, ARCH PHYS MED REHAB, V66, P25; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; KESHAVAN MS, 1981, BRIT J PSYCHIAT, V138, P157, DOI 10.1192/bjp.138.2.157; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Krupp LB, 1996, CURR OPIN NEUROL, V9, P456, DOI 10.1097/00019052-199612000-00011; Krupp LB, 2000, NEUROLOGY, V55, P934, DOI 10.1212/WNL.55.7.934; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Larsen P, 2003, WILLIAMS TXB ENDOCRI; Leon-Carrion J, 2000, NEUROREHABILITATION, V14, P33; Lequerica A, 39 ANN M INT NEUR SO; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Liotti M, 2000, BIOL PSYCHIAT, V48, P30, DOI 10.1016/S0006-3223(00)00874-X; Logan A C, 2001, Altern Med Rev, V6, P450; MANU P, 1989, J AFFECT DISORDERS, V17, P165, DOI 10.1016/0165-0327(89)90039-6; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; Maurice-Tison S, 1998, BRIT J GEN PRACT, V48, P1245; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; Mitler MM, 2000, SLEEP MED, V1, P231, DOI 10.1016/S1389-9457(00)00031-9; Newman CB, 1998, ENDOCRINOLOGIST, V8, P178, DOI 10.1097/00019616-199805000-00009; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pavlovic D, 2010, EUR J NEUROL, V17, P696, DOI 10.1111/j.1468-1331.2009.02910.x; Pettegrew JW, 2000, MOL PSYCHIATR, V5, P616, DOI 10.1038/sj.mp.4000805; Posner JB., 1980, DIAGNOSIS STUPOR COM, V3; Rammohan KW, 2002, J NEUROL NEUROSUR PS, V72, P179, DOI 10.1136/jnnp.72.2.179; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; Riese H, 1999, NEUROPSYCHOL REHABIL, V9, P189, DOI 10.1080/713755600; RON S, 1980, ELECTROEN CLIN NEURO, V48, P432, DOI 10.1016/0013-4694(80)90135-2; Scholey A, 2010, PSYCHOPHARMACOLOGY, V212, P345, DOI 10.1007/s00213-010-1964-y; Schreiber S, 1998, INT CLIN PSYCHOPHARM, V13, P273, DOI 10.1097/00004850-199811000-00006; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Simpson H, 2002, GROWTH HORM IGF RES, V12, P1, DOI 10.1054/ghir.2001.0263; Tanriverdi F, 2010, PITUITARY, V13, P111, DOI 10.1007/s11102-009-0204-0; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Tylee A, 1999, J CLIN PSYCHIAT, V60, P12; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Wagner GJ, 2000, J CLIN PSYCHIAT, V61, P436, DOI 10.4088/JCP.v61n0608; WALKER GC, 1991, ARCH PHYS MED REHAB, V72, P469; Watson NF, 2007, J CLIN SLEEP MED, V3, P363; WESSELY S, 1989, J NEUROL NEUROSUR PS, V52, P940, DOI 10.1136/jnnp.52.8.940; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Yablon SA, 1998, ARCH PHYS MED REHAB, V79, P594; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	113	3	3	0	2	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-27-7				2013							693	706					14	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BDJ25	WOS:000313536100042					2022-02-06	
J	Hirsch, KG; Josephson, SA				Hirsch, Karen G.; Josephson, S. Andrew			An Update on Neurocritical Care for the Patient With Kidney Disease	ADVANCES IN CHRONIC KIDNEY DISEASE			English	Article						Neurocritical care; Hyponatremia; Seizures; End-stage renal disease	PROTHROMBIN COMPLEX CONCENTRATE; ACUTE ISCHEMIC-STROKE; TECHNOLOGY-ASSESSMENT SUBCOMMITTEE; RENAL REPLACEMENT THERAPY; TRAUMATIC BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; STATUS EPILEPTICUS; NEUROIMMUNOLOGICAL DISORDERS; INTRAVENOUS IMMUNOGLOBULIN; NEUROMUSCULAR DISORDERS	Patients with kidney disease have increased rates of neurologic illness such as intracerebral hemorrhage and ischemic stroke. The acute care of patients with critical neurologic illness and concomitant kidney disease requires unique management considerations including attention to hyponatremia, renal replacement modalities in the setting of high intracranial pressure, reversal of coagulopathy, and seizure management to achieve good neurologic outcomes. (C) 2013 by the National Kidney Foundation, Inc. All rights reserved.	[Hirsch, Karen G.; Josephson, S. Andrew] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA		Josephson, SA (corresponding author), Univ Calif San Francisco, Dept Neurol, Box 0114,505 Parnassus Ave,M-798, San Francisco, CA 94143 USA.	ajosephson@memory.ucsf.edu					Cartmill M, 2000, BRIT J NEUROSURG, V14, P458; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cortese I, 2011, NEUROLOGY, V76, P294, DOI 10.1212/WNL.0b013e318207b1f6; DAVENPORT A, 1993, KIDNEY INT, V43, pS245; Davenport A, 2009, SEMIN DIALYSIS, V22, P165, DOI 10.1111/j.1525-139X.2008.00548.x; Diaz A, 2012, EXPERT REV NEUROTHER, V12, P99, DOI [10.1586/ERN.11.181, 10.1586/ern.11.181]; Diringer MN, 2004, NEUROCRIT CARE, V1, P219, DOI 10.1385/NCC:1:2:219; Diringer MN, 2009, CONTINUUM LIFELONG L, V15, P121; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; FREDRIKSSON K, 1992, STROKE, V23, P972, DOI 10.1161/01.STR.23.7.972; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Gondo F, 1989, NEUROL MED CHIR TOKY, V29, P1125; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; HASAN D, 1989, STROKE, V20, P1156, DOI 10.1161/01.STR.20.9.1156; Hellman RN, 2011, SEMIN NEPHROL, V31, P310, DOI 10.1016/j.semnephrol.2011.05.010; Hirsch KG, 2012, NEUROCRIT CARE; Hughes RAC, 2009, CLIN EXP IMMUNOL, V158, P34, DOI [10.1111/j.1365-2249.2009.04025.X, 10.1111/j.1365-2249.2009.04025.x]; Israni RK, 2006, SEMIN DIALYSIS, V19, P408, DOI 10.1111/j.1525-139X.2006.00195.x; Kaatz S, 2012, AM J HEMATOL, V87, pS141, DOI 10.1002/ajh.23202; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Katz U, 2007, AUTOIMMUN REV, V6, P257, DOI 10.1016/j.autrev.2006.08.011; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; Lehmann HC, 2006, ARCH NEUROL-CHICAGO, V63, P1066, DOI 10.1001/archneur.63.8.1066; Lehmann HC, 2006, ARCH NEUROL-CHICAGO, V63, P930, DOI 10.1001/archneur.63.7.930; Leissinger CA, 2008, AM J HEMATOL, V83, P137, DOI 10.1002/ajh.21046; LO WD, 1987, STROKE, V18, P150, DOI 10.1161/01.STR.18.1.150; Lowenstein DH, 1999, EPILEPSIA, V40, pS3, DOI 10.1111/j.1528-1157.1999.tb00872.x; Mathew RO, 2011, SEMIN DIALYSIS, V24, P192, DOI 10.1111/j.1525-139X.2011.00872.x; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Pabinger I, 2008, J THROMB HAEMOST, V6, P622, DOI 10.1111/j.1538-7836.2008.02904.x; Paczynski RP, 1997, STROKE, V28, P1437, DOI 10.1161/01.STR.28.7.1437; Patwa HS, 2012, NEUROLOGY, V78, P1009, DOI 10.1212/WNL.0b013e31824de293; Riess HB, 2007, THROMB RES, V121, P9, DOI 10.1016/j.thromres.2007.02.009; Robertson GL, 2011, NAT REV ENDOCRINOL, V7, P151, DOI 10.1038/nrendo.2010.229; Rossetti AO, 2011, LANCET NEUROL, V10, P922, DOI 10.1016/S1474-4422(11)70187-9; Scorza FA, 2010, HEMODIAL INT, V14, P364, DOI 10.1111/j.1542-4758.2010.00492.x; Seliger SL, 2003, KIDNEY INT, V64, P603, DOI 10.1046/j.1523-1755.2003.00101.x; Silbergleit R, 2012, NEW ENGL J MED, V366, P591, DOI 10.1056/NEJMoa1107494; Sjoblom L, 2001, STROKE, V32, P2567, DOI 10.1161/hs1101.098523; Smith WS, 2008, STROKE, V39, P1205, DOI 10.1161/STROKEAHA.107.497115; Soliman EZ, 2010, AM HEART J, V159, P1102, DOI 10.1016/j.ahj.2010.03.027; Stacul F, 2011, EUR RADIOL, V21, P2527, DOI 10.1007/s00330-011-2225-0; Stanworth Simon J, 2007, Hematology Am Soc Hematol Educ Program, P179; Thompson HJ, 2012, J NEUROTRAUM, V29, P1864, DOI 10.1089/neu.2011.2284; Wijdicks EFM, 2010, PRACTICE EMERGENCY N; Woo CH, 2009, NEUROCRIT CARE, V11, P228, DOI 10.1007/s12028-009-9238-4; Yee AH, 2010, NEUROSURG CLIN N AM, V21, P339, DOI 10.1016/j.nec.2009.10.011; Zubkov AY, 2009, NEUROLOGY, V72, P200, DOI 10.1212/01.wnl.0000344241.04543.94	51	3	4	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1548-5595	1548-5609		ADV CHRONIC KIDNEY D	Adv. Chronic Kidney Dis.	JAN	2013	20	1					39	44		10.1053/j.ackd.2012.09.003			6	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	068VO	WOS:000313394500007	23265595				2022-02-06	
J	De los Reyes-Aragon, CJ; Diaz, MAR; Herrera, AES; Ruiz, KG				Jose De los Reyes-Aragon, Carlos; Rodriguez Diaz, Melissa Alejandra; Sanchez Herrera, Arturo Enrique; Gutierrez Ruiz, Karol			USEFULNESS OF A PROGRAM OF NEUROPSYCHOLOGICAL REHABILITATION OF MEMORY IN ACQUIRED BRAIN DAMAGE	LIBERABIT-REVISTA DE PSICOLOGIA			Spanish	Article						External memory aids; acquired brain injury; cognitive stimulation; visual imagery; neuropsychological rehabilitation	RANDOMIZED CONTROLLED-TRIAL; CLOSED-HEAD INJURY; ALZHEIMERS-DISEASE; COGNITIVE REHABILITATION; IMAGERY MNEMONICS; TEMPORAL-ORDER; PEOPLE; MICROCOMPUTER; INDIVIDUALS; IMPAIRMENTS	This study evaluated the usefulness of a cognitive and functional rehabilitation of memory program for patients with acquired brain injury. Ten participants with mild-to-moderate cognitive impairment participated in the study; five of them for four months attended a weekly rehabilitation program, while the other five did not receive any neuropsychological intervention. The results showed that the rehabilitation group improved the score in the Wechsler III Memory Scale. Similarly, it was found that the score on the memory scale of failure of the daily life only improved in the group that received rehabilitation. The results suggest that memory rehabilitation program is useful in the treatment of both cognitive and functional sequels resulting from acquired brain damage.	[Jose De los Reyes-Aragon, Carlos; Rodriguez Diaz, Melissa Alejandra; Sanchez Herrera, Arturo Enrique] Univ Norte, Dept Psicol, Barranquilla, Colombia; [Gutierrez Ruiz, Karol] Univ Sinu Elias Bechara Zainum, Secc Cartagena, Cartagena, Colombia		De los Reyes-Aragon, CJ (corresponding author), Univ Norte, Dept Psicol, Barranquilla, Colombia.	cdelosreyes@uninorte.edu.co; melirodriguezdiaz@gmail.com; kaguru2@hotmail.com; arturosanchezherrera@hotmail.com	De los Reyes Aragon, Carlos Jose CDA/E-2585-2015; De los Reyes Aragon, Carlos Jose/P-3516-2019	De los Reyes Aragon, Carlos Jose CDA/0000-0003-4472-0635; De los Reyes Aragon, Carlos Jose/0000-0003-4472-0635			Adams J., 2006, ANN GEN PSYCHIATR, V5, pS288; Akshoomoff NA, 2002, NEUROPSYCHOLOGIA, V40, P539, DOI 10.1016/S0028-3932(01)00129-4; [Anonymous], 1998, NIH Consens Statement, V16, P1; Aragona CJD, 2012, NEUROREHABILITATION, V30, P55, DOI 10.3233/NRE-2011-0727; Arroyo E.M., 2002, ESTIMULACION PSICOCO; Avila R, 2004, BRAZ J MED BIOL RES, V37, P1721, DOI 10.1590/S0100-879X2004001100018; Bennett TL, 2001, ARCH CLIN NEUROPSYCH, V16, P237, DOI 10.1016/S0887-6177(00)00082-2; Berg IJ, 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI DOI 10.1080/09602019108401384; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bottino CMC, 2005, CLIN REHABIL, V19, P861, DOI 10.1191/0269215505cr911oa; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; CERMAK L S, 1975, Cortex, V11, P163; Chen SHA, 1997, BRAIN INJURY, V11, P197; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; COOKE DL, 1995, J CLIN EXP NEUROPSYC, V17, P90, DOI 10.1080/13803399508406585; Davis RN, 2001, ALZ DIS ASSOC DIS, V15, P1, DOI 10.1097/00002093-200101000-00001; De los Reyes-Aragon C. J, 2012, PSICOLOGIA IN PRESS, V29; de Norena D, 2010, REV NEUROLOGIA, V51, P687, DOI 10.33588/rn.5111.2009652; DELIS DC, 1988, J CLIN EXP NEUROPSYC, V10, P421, DOI 10.1080/01688638808408250; DELIS DC, 1986, NEUROPSYCHOLOGIA, V24, P205, DOI 10.1016/0028-3932(86)90053-9; Evans JJ, 2003, J INT NEUROPSYCH SOC, V9, P925, DOI 10.1017/S1355617703960127; Ezrachi O., 1991, J HEAD TRAUMA REHAB, V6, P7; FABIANO RJ, 1995, REHABIL PSYCHOL, V40, P223, DOI 10.1037/0090-5550.40.3.223; Farina E, 2002, ACTA NEUROL SCAND, V105, P365, DOI 10.1034/j.1600-0404.2002.01086.x; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Floyd M, 1997, PSYCHOL AGING, V12, P150, DOI 10.1037/0882-7974.12.1.150; FRASER R, 1988, REHABIL COUNS BULL, V31, P276; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; Gómez Pastor Inmaculada, 2008, Psychological Intervention, V17, P237, DOI 10.4321/s1132-05592008000300002; Gray JM, 1992, NEUROPSYCHOL REHABIL, V2, P97, DOI DOI 10.1080/09602019208401399; Gutierrez K., 2009, PSICOL CARIBE, V24, P147; Hart T, 2004, J HEAD TRAUMA REHAB, V19, P351, DOI 10.1097/00001199-200409000-00001; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; Hewitt J, 2006, NEUROPSYCHOLOGIA, V44, P1468, DOI 10.1016/j.neuropsychologia.2005.11.016; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; JONES MK, 1974, NEUROPSYCHOLOGIA, V12, P21, DOI 10.1016/0028-3932(74)90023-2; Junque C., 1998, TRAUMATISMOS CRANEOC; Kaschel R, 2002, NEUROPSYCHOL REHABIL, V12, P127, DOI 10.1080/09602010143000211; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kerner MJ, 1985, COGNITIVE REHABILITA, V1, P26; Kesslak JP, 1997, BEHAV NEUROL, V10, P137, DOI 10.3233/BEN-1997-10407; Kim HJ, 1999, BRAIN INJURY, V13, P147, DOI 10.1080/026990599121818; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Levin H., 1998, NIH CONS DEV C REH P; Levin HS., 1982, NEUROBEHAVIORAL CONS; Lowther JL, 2004, ARCH CLIN NEUROPSYCH, V19, P105, DOI 10.1016/S0887-6177(02)00222-6; MAHONEY F I, 1965, Md State Med J, V14, P61; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Mejía-Mejía Aurelio, 2007, Rev. salud pública, V9, P26, DOI 10.1590/S0124-00642007000100004; Melton AK, 2005, APHASIOLOGY, V19, P353, DOI 10.1080/02687030444000804; MIDDLETON DK, 1991, PERCEPT MOTOR SKILL, V72, P527, DOI 10.2466/PMS.72.2.527-530; MONTEJO P, 2001, CUADERNOS TRABAJO SO, V14, P255; Montejo P., 2008, 9 C VIRT PSIQ INT; Montejo P., 2002, MANUAL PRACTICO EVAL; Montejo P., 2003, REV ESPANOLA GERIATR, V38, P316, DOI [10.1016/S0211-139X(03)74908-7, DOI 10.1016/S0211-139X(03)74908-7]; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Ostrosky-Solis F., 2001, NEUROPSI EVALUACION; Raskin S., 1992, NEUROREHABILITATION, V2, P38; Rattok J., 1992, NEUROPSYCHOLOGIA, V6, P3954; Richardson JT, 1987, IMAGINAL RELATED MNE, P303; RICHARDSON JTE, 1995, NEUROPSYCHOLOGIA, V33, P1345, DOI 10.1016/0028-3932(95)00068-E; Ries M, 2006, NEUROPSYCHOLOGIA, V44, P2233, DOI 10.1016/j.neuropsychologia.2006.05.021; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Rios-Lago M, 2007, REV NEUROLOGIA, V44, P291, DOI 10.33588/rn.4405.2006208; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; Ryan T V, 1988, Arch Clin Neuropsychol, V3, P165, DOI 10.1016/0887-6177(88)90061-3; SCHMITTEREDGECOMBE M, 1995, J CONSULT CLIN PSYCH, V63, P484; SUNDERLAND A, 1984, J CLIN NEUROPSYCHOL, V6, P127, DOI 10.1080/01688638408401204; Thoene A I, 1995, J Int Neuropsychol Soc, V1, P29; Thomas-Stonell N, 1994, J HEAD TRAUMA REHAB, V9, P25, DOI DOI 10.1097/00001199-199412000-00005; TWUM M, 1994, J CLIN EXP NEUROPSYC, V16, P630, DOI 10.1080/01688639408402674; Vakil E, 1998, NEUROPSY NEUROPSY BE, V11, P212; VAKIL E, 1994, NEUROPSY NEUROPSY BE, V7, P281; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Wechsler D., 1997, ESCALA MEMORIA WECHS; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Wilson BA, 1997, BRAIN INJURY, V11, P259, DOI 10.1080/026990597123566; Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; WILSON BA, 1995, HDB MEMORY DISORDERS, P451; Wood R L, 1987, Int Disabil Stud, V9, P149; ZARIT SH, 1981, GERONTOLOGIST, V21, P158, DOI 10.1093/geront/21.2.158; ZENCIUS A, 1991, Brain Injury, V5, P321, DOI 10.3109/02699059109008102; ZENCIUS A, 1990, Brain Injury, V4, P33, DOI 10.3109/02699059009026146	85	3	3	1	10	UNIV SAN MARTIN PORRES, FAC CIENCIAS COMUNICACION TURISMO & PSICOLOGIA	LIMA	AVE TOMAS MARSANO 242, ANEXOS 2037 SURQUILLO, LIMA, 36, PERU	1729-4827	2223-7666		LIBERABIT-LIMA	Liberabit		2013	19	2					181	194					14	Psychology, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Psychology	V31LF	WOS:000215631000004					2022-02-06	
B	Levine, J; Flanagan, SR		Zasler, ND; Katz, DI; Zafonte, RD		Levine, Jaime; Flanagan, Steven R.			Traumatic Brain Injury in the Elderly	BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION			English	Article; Book Chapter							MILD COGNITIVE IMPAIRMENT; LONG-TERM SURVIVAL; NEUROGENIC HETEROTOPIC OSSIFICATION; HEAD-INJURY; OLDER-ADULTS; INTRACRANIAL HEMORRHAGE; ALZHEIMERS-DISEASE; RISK-FACTORS; PSYCHIATRIC-DISORDERS; PARKINSONS-DISEASE		[Levine, Jaime] NYU, Langone Med Ctr, Dept Phys Med & Rehabil, Rusk Inst Rehabil Med, New York, NY 10003 USA; [Flanagan, Steven R.] NYU, Langone Med Ctr, Dept Rehabil Med, Dept Phys Med & Rehabil,Rusk Inst Rehabil Med, New York, NY USA		Levine, J (corresponding author), NYU, Langone Med Ctr, Dept Phys Med & Rehabil, Rusk Inst Rehabil Med, New York, NY 10003 USA.						ADAMS PF, 1999, VITAL HLTH STAT, V10; Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; [Anonymous], 2008, GULF WAR HLTH, V7, P197; [Anonymous], 2008, GULF WAR HLTH, V7, P333; Baguley I, 2000, BRAIN INJURY, V14, P505; Baldwin RC, 2003, INT J GERIATR PSYCH, V18, P829, DOI 10.1002/gps.940; Born J, 2004, TRENDS COGN SCI, V8, P242, DOI 10.1016/j.tics.2004.04.010; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Busse A, 2006, NEUROLOGY, V67, P2176, DOI 10.1212/01.wnl.0000249117.23318.e1; CAMPBELL AJ, 1990, J CLIN EPIDEMIOL, V43, P1415, DOI 10.1016/0895-4356(90)90110-B; Cantor JB, 2005, J HEAD TRAUMA REHAB, V20, P527, DOI 10.1097/00001199-200511000-00005; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P225; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Ekelman BA, 2001, FUNCTIONAL PERFORMAN, P448; Falsetti P, 2011, CLIN NEUROL NEUROSUR, V113, P22, DOI 10.1016/j.clineuro.2010.08.012; Falsetti P, 2011, J CLIN ULTRASOUND, V39, P12, DOI 10.1002/jcu.20742; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; FRENCH LR, 1985, AM J EPIDEMIOL, V121, P414, DOI 10.1093/oxfordjournals.aje.a114013; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; GARCIA CA, 1984, J AM GERIATR SOC, V32, P339, DOI 10.1111/j.1532-5415.1984.tb02036.x; Gliebus Gediminas, 2007, Am J Alzheimers Dis Other Demen, V22, P57, DOI 10.1177/1533317506295889; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; GOLDSTEIN LB, 1995, NEUROLOGY, V45, P865, DOI 10.1212/WNL.45.5.865; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Harris C, 2003, J AM COLL SURGEONS, V197, P711, DOI 10.1016/S1072-7515(03)00729-4; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Hartikainen S, 2007, J GERONTOL A-BIOL, V62, P1172, DOI 10.1093/gerona/62.10.1172; HEYMAN A, 1984, ANN NEUROL, V15, P335, DOI 10.1002/ana.410150406; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoffman C, 1996, JAMA-J AM MED ASSOC, V276, P1473, DOI 10.1001/jama.276.18.1473; Hoffman JM, 2003, ARCH PHYS MED REHAB, V84, P1165, DOI 10.1016/S0003-9993(03)00232-6; ITO H, 1987, J NEUROSURG, V66, P862, DOI 10.3171/jns.1987.66.6.0862; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Ivascu FA, 2006, J TRAUMA, V61, P318, DOI 10.1097/01.ta.0000223944.25922.91; Jeste DV, 2008, NEUROPSYCHOPHARMACOL, V33, P957, DOI 10.1038/sj.npp.1301492; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Kim J, 2002, J TRAUMA, V53, P38, DOI 10.1097/00005373-200207000-00008; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Leipzig RM, 1999, J AM GERIATR SOC, V47, P30, DOI 10.1111/j.1532-5415.1999.tb01898.x; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; LYNESS JM, 1995, J AM GERIATR SOC, V43, P216, DOI 10.1111/j.1532-5415.1995.tb07325.x; Manly JJ, 2008, ANN NEUROL, V63, P494, DOI 10.1002/ana.21326; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Miranda LB, 2011, J NEUROSURG, V114, P72, DOI 10.3171/2010.8.JNS10298; MOSCICKI EK, 1985, EAR HEARING, V6, P184, DOI 10.1097/00003446-198507000-00003; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; National Center for Statistics and Analysis, 1999, DHHS PUBL; National Institute on Aging, 2009, AG PAG AG YOUR EYES; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2011, NEW ENGL J MED, V364, P2227, DOI 10.1056/NEJMcp0910237; Pieracci FM, 2007, J TRAUMA, V63, P519, DOI 10.1097/TA.0b013e31812e519b; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Plassman BL, 2008, ANN INTERN MED, V148, P427, DOI 10.7326/0003-4819-148-6-200803180-00005; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; RISH BL, 1983, J NEUROSURG, V59, P775, DOI 10.3171/jns.1983.59.5.0775; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; ROZZELLE CJ, 1995, J AM GERIATR SOC, V43, P240, DOI 10.1111/j.1532-5415.1995.tb07329.x; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Salonoja M, 2012, ARCH GERONTOL GERIAT, V54, P160, DOI 10.1016/j.archger.2011.02.015; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Starkstein SE, 2005, INT PSYCHOGERIATR, V17, pS93, DOI 10.1017/S1041610205001973; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Taylor CA, 1999, AM J MED GENET, V88, P742, DOI 10.1002/(SICI)1096-8628(19991215)88:6<742::AID-AJMG29>3.0.CO;2-#; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; *US BUR CENS, STAT ABSTR US; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; Wahl F, 2000, J NEUROTRAUM, V17, P1055, DOI 10.1089/neu.2000.17.1055; WALKER AE, 1971, ARCH NEUROL-CHICAGO, V24, P95, DOI 10.1001/archneur.1971.00480320023001; WALKER AE, 1970, EPILEPSIA, V11, P17, DOI 10.1111/j.1528-1157.1970.tb03861.x; WALKER AE, 1989, ARCH NEUROL-CHICAGO, V46, P23, DOI 10.1001/archneur.1989.00520370025013; Walker MP, 2005, BEHAV BRAIN SCI, V28, P51, DOI 10.1017/S0140525X05000026; WEISS GH, 1982, ARCH NEUROL-CHICAGO, V39, P741, DOI 10.1001/archneur.1982.00510240003001; Woolcott JC, 2009, ARCH INTERN MED, V169, P1952, DOI 10.1001/archinternmed.2009.357; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	112	3	3	0	2	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-27-7				2013							420	433					14	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BDJ25	WOS:000313536100028					2022-02-06	
J	Luchtmann, M; Jachau, K; Adolf, D; Rohl, FW; Baecke, S; Lutzkendorf, R; Muller, C; Bernarding, J				Luchtmann, Michael; Jachau, Katja; Adolf, Daniela; Roehl, Friedrich-Wilhelm; Baecke, Sebastian; Luetzkendorf, Ralf; Mueller, Charles; Bernarding, Johannes			Ethanol modulates the neurovascular coupling	NEUROTOXICOLOGY			English	Article						Ethanol; BOLD; Neurovascular coupling; Hemodynamic response; Balloon model; Hemodynamic modeling	CEREBRAL-BLOOD-FLOW; TRAUMATIC BRAIN-INJURY; BALLOON MODEL; ALCOHOL-INTOXICATION; PHARMACOLOGICAL MRI; HEMORRHAGIC-SHOCK; SIGNAL CHANGES; BOLD CONTRAST; FMRI; ACTIVATION	Despite some evidence of the underlying molecular mechanisms the neuronal basis of ethanol-induced effects on the neurovascular coupling that forms the BOLD (blood oxygenation level dependent) signal is poorly understood. In a recent fMRI (functional magnetic resonance imaging) study monitoring ethanol-induced changes of the BOLD signal a reduction of the amplitude and a prolongation of the BOLD signal were observed. However, the BOLD signal is assumed to consist of a complex superposition of different underlying signals. To gain insight how ethanol influences stimulus efficacy, oxygen extraction, transit time and vessel-related parameters the fMRI time series from the sensori-motor and the visual cortex were analyzed using the balloon model. The results show a region-dependent decrease of the stimulus efficacy to trigger a post-stimulus neurovascular response as well as a prolongation of the transit time through the venous compartment. Oxygen extraction, feedback mechanisms and other vessel-related parameters were not affected. The results may be interpreted as follows: the overall mechanisms of the neurovascular coupling are still acting well at the moderate ethanol level of about 0.8 parts per thousand (in particular the vessel-related parts), but the potency to evoke a neurovascular response is already compromised most obviously in the supplementary motor area responsible for complex synchronizing and planning processes. (C) 2012 Elsevier Inc. All rights reserved.	[Luchtmann, Michael] Univ Magdeburg, Inst Biometry & Med Informat, Dept Neurosurg, D-39120 Magdeburg, Germany; [Jachau, Katja] Univ Magdeburg, Inst Forens Med, D-39120 Magdeburg, Germany; [Adolf, Daniela; Roehl, Friedrich-Wilhelm; Baecke, Sebastian; Luetzkendorf, Ralf; Mueller, Charles; Bernarding, Johannes] Univ Magdeburg, Inst Biometry & Med Informat, D-39120 Magdeburg, Germany		Luchtmann, M (corresponding author), Univ Magdeburg, Inst Biometry & Med Informat, Dept Neurosurg, Leipziger Str 44, D-39120 Magdeburg, Germany.	michael.luchtmann@med.ovgu.de; katja.jachau@med.ovgu.de; daniela.adolf@med.ovgu.de; friedrich-wilhelm.roehl@med.ovgu.de; sebastian.baecke@med.ovgu.de; ralf.luetzkendorf@med.ovgu.de; charles.mueller@med.ovgu.de; johannes.bernarding@med.ovgu.de		Luchtmann, Michael/0000-0002-9947-9095			Aderjan Rolf, 2011, Blutalkohol, V48, P137; ALLAN AM, 1986, LIFE SCI, V39, P2005, DOI 10.1016/0024-3205(86)90324-3; Allan AM, 1987, ALCOHOL ALCOHOL S1, P643; Blaha M, 2003, J CLIN NEUROSCI, V10, P195, DOI 10.1016/S0967-5868(02)00126-1; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Buxton RB, 2012, NEUROIMAGE, V62, P953, DOI 10.1016/j.neuroimage.2012.01.012; Calhoun VD, 2004, NEUROPSYCHOPHARMACOL, V29, P2097, DOI 10.1038/sj.npp.1300543; Calhoun VD, 2004, HUM BRAIN MAPP, V21, P15, DOI 10.1002/hbm.10145; Davies M, 2003, J PSYCHIATR NEUROSCI, V28, P263; Deneux T, 2006, NEUROIMAGE, V32, P1669, DOI 10.1016/j.neuroimage.2006.03.006; Friston KJ, 2000, NEUROIMAGE, V12, P466, DOI 10.1006/nimg.2000.0630; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Gensini G F, 2005, Minerva Med, V96, P121; Geyer S, 1998, J COMP NEUROL, V397, P231, DOI 10.1002/(SICI)1096-9861(19980727)397:2<231::AID-CNE6>3.0.CO;2-1; Giove F, 2003, MAGN RESON IMAGING, V21, P1283, DOI 10.1016/j.mri.2003.08.028; GLAUTIER S, 1992, BRIT J ADDICT, V87, P1489; GORDON EL, 1995, J CEREBR BLOOD F MET, V15, P532, DOI 10.1038/jcbfm.1995.66; GRUBB RL, 1974, STROKE, V5, P630, DOI 10.1161/01.STR.5.5.630; HAMMERSLEY R, 1992, BRIT J ADDICT, V87, P1477; HOFFMAN PL, 1990, FASEB J, V4, P2612, DOI 10.1096/fasebj.4.9.2161371; Hoffman PL, 1984, PHARM BIOCH BEHAV S1, V18, P355; Hoffman PL, 1987, ALCOHOL ALCOHOL S1, P749; Honey G, 2004, TRENDS PHARMACOL SCI, V25, P366, DOI 10.1016/j.tips.2004.05.009; HOWES LG, 1985, BRIT J CLIN PHARMACO, V20, P669, DOI 10.1111/j.1365-2125.1985.tb05126.x; Iadecola C, 1998, NAT NEUROSCI, V1, P263, DOI 10.1038/1074; Ibayashi S, 2000, J Stroke Cerebrovasc Dis, V9, P166, DOI 10.1053/jscd.2000.7219; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; KUSCHINSKY W, 1978, PHYSIOL REV, V58, P656, DOI 10.1152/physrev.1978.58.3.656; Levin JM, 1998, PSYCHIAT RES-NEUROIM, V82, P135, DOI 10.1016/S0925-4927(98)00022-5; Luchtmann M, 2010, EXP BRAIN RES, V204, P1, DOI 10.1007/s00221-010-2277-4; Mandeville JB, 1999, J CEREBR BLOOD F MET, V19, P679, DOI 10.1097/00004647-199906000-00012; MARTIN CS, 1990, J STUD ALCOHOL, V51, P500, DOI 10.15288/jsa.1990.51.500; MATHEW RJ, 1986, STROKE, V17, P1156, DOI 10.1161/01.STR.17.6.1156; Matthews PM, 2006, NAT REV NEUROSCI, V7, P732, DOI 10.1038/nrn1929; Matthews PM, 2009, NEUROMETHODS, V41, P751, DOI 10.1007/978-1-60327-919-2_25; MAYHAN WG, 1995, STROKE, V26, P2097, DOI 10.1161/01.STR.26.11.2097; Mildner T, 2001, MAGN RESON MED, V46, P891, DOI 10.1002/mrm.1274.abs; MRAOVITCH S, 1993, NEUROSCI LETT, V157, P140, DOI 10.1016/0304-3940(93)90722-W; Nicoletti P, 2008, CEPHALALGIA, V28, P9, DOI 10.1111/j.1468-2982.2007.01448.x; Obata T, 2004, NEUROIMAGE, V21, P144, DOI 10.1016/j.neuroimage.2003.08.040; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Rickenbacher E, 2011, ALCOHOL, V45, P725, DOI 10.1016/j.alcohol.2011.04.002; Seidl S, 2000, INT J LEGAL MED, V114, P71, DOI 10.1007/s004140000154; Seifritz E, 2000, PSYCHIAT RES-NEUROIM, V99, P1, DOI 10.1016/S0925-4927(00)00054-8; Sripada CS, 2011, NEUROIMAGE, V55, P371, DOI 10.1016/j.neuroimage.2010.11.062; Stendel R, 2006, ALCOHOL, V38, P139, DOI 10.1016/j.alcohol.2006.06.005; Stephan KE, 2007, NEUROIMAGE, V38, P387, DOI 10.1016/j.neuroimage.2007.07.040; Steward CA, 2005, PSYCHOPHARMACOLOGY, V180, P687, DOI 10.1007/s00213-005-2213-7; Tank D. W., 1992, Current Biology, V2, P525, DOI 10.1016/0960-9822(92)90011-X; Toda N, 2010, ALCOHOL ALCOHOLISM, V45, P347, DOI 10.1093/alcalc/agq028; Uludag K, 2004, NEUROIMAGE, V23, P148, DOI 10.1016/j.neuroimage.2004.05.013; Uludag K, 2009, NEUROIMAGE, V48, P150, DOI 10.1016/j.neuroimage.2009.05.051; VALVERIUS P, 1987, MOL PHARMACOL, V32, P217; Van Horn JD, 2006, NEUROIMAGE, V31, P1209, DOI 10.1016/j.neuroimage.2006.01.020; Villringer A, 1997, ADV EXP MED BIOL, V413, P177; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Yoon HW, 2009, NEUROSCI LETT, V450, P311, DOI 10.1016/j.neulet.2008.12.011; Zink BJ, 1998, J NEUROSURG, V89, P983, DOI 10.3171/jns.1998.89.6.0983; Zink BJ, 1998, ACAD EMERG MED, V5, P9, DOI 10.1111/j.1553-2712.1998.tb02568.x	62	3	3	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0161-813X			NEUROTOXICOLOGY	Neurotoxicology	JAN	2013	34						95	104		10.1016/j.neuro.2012.10.017			10	Neurosciences; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology	085PG	WOS:000314626100011	23159106				2022-02-06	
B	Malec, JF		Zasler, ND; Katz, DI; Zafonte, RD		Malec, James F.			Posthospital Rehabilitation	BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; PORTLAND ADAPTABILITY INVENTORY; COMMUNITY INTEGRATION PROGRAMS; RANDOMIZED CONTROLLED-TRIAL; POST-ACUTE REHABILITATION; OF-THE-LITERATURE; COGNITIVE REHABILITATION; NEUROPSYCHOLOGIC REHABILITATION; OUTCOMES; INTERVENTION		[Malec, James F.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Malec, James F.] Rehabil Hosp Indiana, Indianapolis, IN USA		Malec, JF (corresponding author), Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA.						Altman IM, 2010, ARCH PHYS MED REHAB, V91, P1697, DOI 10.1016/j.apmr.2010.08.001; [Anonymous], 2008, MANUAL MAYO PORTLAND; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; BENYISHAY Y, 1990, REHABILITATION ADULT, P393; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; Braunling-McMorrow D, 2010, BRAIN INJURY, V24, P928, DOI 10.3109/02699052.2010.490518; Cailhol L, 2009, PSYCHIAT RES, V170, P229, DOI 10.1016/j.psychres.2008.09.005; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Covey S, 2003, 7 HABITS HIGHLY EFFE; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; Diller, 2011, HDB HOLISTIC NEUROPS; Eicher V, 2012, ARCH PHYS MED REHAB, V93, P100, DOI 10.1016/j.apmr.2011.06.038; Evans CC, 2008, J HEAD TRAUMA REHAB, V23, P329, DOI 10.1097/01.HTR.0000336845.06704.bc; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Feeney TJ, 2001, J HEAD TRAUMA REHAB, V16, P61, DOI 10.1097/00001199-200102000-00008; Glenn MB, 2005, BRAIN INJURY, V19, P1243, DOI 10.1080/02699050500309460; Glenn MB, 2004, J HEAD TRAUMA REHAB, V19, P482, DOI 10.1097/00001199-200411000-00005; Greenberger D, 1995, MIND MOOD CHANGE YOU; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Heinemann AW, 2004, REHABIL PSYCHOL, V49, P156, DOI 10.1037/0090-5550.49.2.156; Hewitt J, 2005, J ADV NURS, V52, P561, DOI 10.1111/j.1365-2648.2005.03623.x; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; Kean J, 2011, J NEUROTRAUM, V28, P745, DOI 10.1089/neu.2010.1573; Klonoff PS, 2001, BRAIN INJURY, V15, P413, DOI 10.1080/02699050010005968; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Lundqvist A, 2010, BRAIN INJURY, V24, P823, DOI 10.3109/02699051003724986; Malec J, 2005, REHABILITATION TRAUM; Malec JF, 2006, BRAIN INJURY, V20, P227, DOI 10.1080/02699050500488124; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malec JF, 2000, ARCH PHYS MED REHAB, V81, P1007, DOI 10.1053/apmr.2000.6980; Malec JF, 2009, NEW METHODOLOGIES IN; Meyer MJ, 2010, BRAIN INJURY, V24, P722, DOI 10.3109/02699051003692134; Murphy T, 2009, INTERNET BASED EVALU; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Ottenbacher KJ, 2000, AM J PUBLIC HEALTH, V90, P1920, DOI 10.2105/AJPH.90.12.1920; Penna S, 2010, J HEAD TRAUMA REHAB, V25, P52, DOI 10.1097/HTR.0b013e3181c29952; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Sander AM, 2003, ARCH PHYS MED REHAB, V84, P197, DOI 10.1053/apmr.2003.50105; Seale GS, 2002, BRAIN INJURY, V16, P955, DOI 10.1080/02699050210155258; Shadish WR., 2002, EXPT QUASI EXPT DESI; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Trexler L, 1994, CONS C DEV MULT STUD; Trexler LE, 2010, J HEAD TRAUMA REHAB, V25, P440, DOI 10.1097/HTR.0b013e3181d41139; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Vanier M, 2002, ACT NEUR S, V79, P53; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	54	3	3	0	1	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-27-7				2013							1288	1301					14	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BDJ25	WOS:000313536100077					2022-02-06	
B	Martelli, MF; Nicholson, K; Zasler, ND		Zasler, ND; Katz, DI; Zafonte, RD		Martelli, Michael F.; Nicholson, Keith; Zasler, Nathan D.			Psychological Assessment and Management of Post-Traumatic Pain	BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; ILLNESS BEHAVIOR; PRELIMINARY VALIDATION; COPING STRATEGIES; INVENTORY; SCALE; DEPRESSION; INTERVENTIONS; ANTICIPATION; PERFORMANCE		[Martelli, Michael F.] Chapman Senior Care, Senior Serv, NeuroLife Rehab, Richmond, VA USA; [Nicholson, Keith] Toronto Western Hosp, Comprehens Pain Program, Toronto, ON M5T 2S8, Canada; [Zasler, Nathan D.] Concuss Care Ctr Virginia Ltd, Richmond, VA USA; [Zasler, Nathan D.] Tree Life Serv Inc, Richmond, VA USA; [Zasler, Nathan D.] Sheltering Arms Hosp, iWalk Program, Richmond, VA USA; [Zasler, Nathan D.] VCU Dept Phys Med & Rehabil, Richmond, VA USA; [Zasler, Nathan D.] Univ Virginia, Dept Phys Med & Rehabil, Charlottesville, VA USA		Martelli, MF (corresponding author), Chapman Senior Care, Senior Serv, NeuroLife Rehab, Richmond, VA USA.						American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andary MT, 1997, CLIN J PAIN, V13, P244, DOI 10.1097/00002508-199709000-00010; Andrasik F, 2010, CLEVE CLIN J MED S3, V77, pS72; Andrasik F, 2006, WEINERS PAIN MANAGEM, P697; Apkarian AV, 2011, PAIN, V152, pS49, DOI 10.1016/j.pain.2010.11.010; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Asmundson Gordon J. G., 2005, Cognitive Behaviour Therapy, V34, P248, DOI 10.1080/16506070510011557; asser DS, 2012, MED HYPOTHESES, V78, P79; Auerbach SM, 1998, STRESS MANAGEMENT PS; Banks SM, 1996, PSYCHOL BULL, V119, P95, DOI 10.1037/0033-2909.119.1.95; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beck AT, 1993, BECK ANXIETY INVENTO; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Branca B, 2004, J HEAD TRAUMA REHAB, V19, P40, DOI 10.1097/00001199-200401000-00005; BROWN GK, 1987, PAIN, V31, P53, DOI 10.1016/0304-3959(87)90006-6; Brown KS, 2006, WEINERS PAIN MANAGEM, P685; Bruns D, 1996, BATTERY HLTH IMPROVE; Burns JW, 2005, PAIN, V115, P322, DOI 10.1016/j.pain.2005.03.007; Butler R, 1989, PSYCHOL ASSESSMENT, V1, P41; Campbell A, 2006, WEINERS PAIN MANAGEM, P1517; Chiesa A, 2011, J ALTERN COMPLEM MED, V17, P83, DOI 10.1089/acm.2009.0546; Cochrane Collaboration, 2010, COCHR LIB; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Crombez G, 2003, PAIN, V104, P639, DOI 10.1016/S0304-3959(03)00121-0; Dahlstrom W.G., 1975, MMPI HDB RES APPL, V2; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; DeVore JR, 2002, FUNCTIONAL MED DISOR, P21; Evans RW, 2004, NEUROL CLIN, V22, P237, DOI 10.1016/S0733-8619(03)00097-5; Fairbank J C, 1980, Physiotherapy, V66, P271; Ford W., 1983, CSIRONET News, P1; FORDYCE WE, 1988, AM PSYCHOL, V43, P276, DOI 10.1037/0003-066X.43.4.276; Gagliese L., 2001, HDB PAIN ASSESSMENT, P119; Gatchel RJ, 2012, HDB CLIN PSYCHOL COM; Gatchel RJ, 2010, HDB STRESS SCI BIOL; Gatchel RJ, 2006, WEINERS PAIN MANAGEM, P1501; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Giesecke T, 2004, ARTHRITIS RHEUM-US, V50, P613, DOI 10.1002/art.20063; GRACELY RH, 1978, PAIN, V5, P5, DOI 10.1016/0304-3959(78)90020-9; Hadjistavropoulos HD, 2000, BEHAV RES THER, V38, P13, DOI 10.1016/S0005-7967(99)00024-8; Hart Robert P, 2003, Curr Pain Headache Rep, V7, P116, DOI 10.1007/s11916-003-0021-5; Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358; Heaton RK, 1985, PSYCHOSOCIAL PAIN IN; Houben RMA, 2005, J BEHAV MED, V28, P415, DOI 10.1007/s10865-005-9011-x; Jeffery MM, 2011, AHRQ PUBLICATION, V11-EHC064-EF; JENSEN MP, 1991, PAIN, V44, P263, DOI 10.1016/0304-3959(91)90095-F; JENSEN MP, 1994, PAIN, V57, P301, DOI 10.1016/0304-3959(94)90005-1; JENSEN MP, 1995, PAIN, V60, P203, DOI 10.1016/0304-3959(94)00118-X; Jensen MP, 2001, HDB PAIN ASSESSMENT, P15; Joint Commission on Accreditation of Healthcare Organizations, 2001, PAIN MAN STAND; Kaemmer, 1989, MMPI 2 MANUAL ADM SC; Keller L. S., 1991, MMPI 2 MONOGRAPHS; Kerns RD, 2005, PAIN, V116, P302, DOI 10.1016/j.pain.2005.04.022; Kerns RD, 1997, PAIN, V72, P227, DOI 10.1016/S0304-3959(97)00038-9; Kerns RD, 2011, ANNU REV CLIN PSYCHO, V7, P411, DOI 10.1146/annurev-clinpsy-090310-120430; Knott C, 1994, MCN-AM J MATERN-CHIL, V19, P314; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Kulich RJ, 1999, EVALUATION TREATMENT, P301; Kundermann B, 2004, PAIN RES MANAG, V9, P425; Lemstra M, 2002, HEADACHE, V42, P845, DOI 10.1046/j.1526-4610.2002.02202.x; Macedo LG, 2010, PHYS THER, V90, P860, DOI 10.2522/ptj.20090303; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; MAIN CJ, 1995, J PSYCHOSOM RES, V39, P737, DOI 10.1016/0022-3999(95)00040-P; Martelli MF, 2004, J HEAD TRAUMA REHAB, V19, P10, DOI 10.1097/00001199-200401000-00003; Martelli MF, 1998, NEUROREHABILITATION, V11, P51, DOI 10.1016/S1053-8135(98)00009-2; Martelli MF, 1999, J HEAD TRAUMA REHAB, V14, P49, DOI 10.1097/00001199-199902000-00007; Martelli MF, 2002, FUNCTIONAL MED DISOR, P147; Martelli MF, 2007, BRAIN INJURY MED PRI, P723; MARTIN PR, 1993, PSYCHOL MANAGEMENT C; Martinis M, 2005, Current Studies of Biotechnology, Vol IV, P113; McCracken LM, 2006, EUR J PAIN, V10, P23, DOI 10.1016/j.ejpain.2005.01.004; MCCRACKEN LM, 1992, PAIN, V50, P67, DOI 10.1016/0304-3959(92)90113-P; McCracken LM, 2004, PAIN, V107, P159, DOI 10.1016/j.pain.2003.10.012; McCracken LM, 2002, SPINE, V27, P2564, DOI 10.1097/00007632-200211150-00033; McGrath PA., 2001, HDB PAIN ASSESSMENT, V2, P97; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Merskey H, 1994, CLASSIFICATION CHRON; Miller L, 2000, NEUROREHABILITATION, V14, P25; MILLER L, 1993, PSYCHOTHERAPY BRAIN; Millon T, 1977, MCMI 2 MANUAL; MILLON T, 1999, INTERPRETIVE STRATEG; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Morey, 1991, PERSONALITY ASSESSME; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nestoriuc Y, 2008, APPL PSYCHOPHYS BIOF, V33, P125, DOI 10.1007/s10484-008-9060-3; Nicholson K, 2004, J HEAD TRAUMA REHAB, V19, P2, DOI 10.1097/00001199-200401000-00002; Nicholson K, 2006, PSYCHOLOGICAL KNOWLEDGE IN COURT: PTSD, PAIN, AND TBI, P335, DOI 10.1007/0-387-25610-5_18; Nicholson K, 2000, NEUROREHABILITATION, V14, P57; Nicholson K, 2000, NEUROREHABILITATION, V14, P3; Nicholson K, 2002, PAIN MANAGEMENT PRAC, P465; Nicholson K., 2007, CAUSALITY PSYCHOL IN, P374; Nicholson K, 2005, STUD NEUROPSYCH DEV, P133; OKIFUJI A, 1999, HDB PAIN SYNDROMES B, P00077; Othmer S., 2006, WEINERS PAIN MANAGEM, P719; PACKARD RC, 1993, HEADACHE, V33, P359, DOI 10.1111/j.1526-4610.1993.hed3307359.x; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; PILOWSKY I, 1975, J PSYCHOSOM RES, V19, P279, DOI 10.1016/0022-3999(75)90026-4; PILOWSKY I, 1976, PAIN, V2, P61, DOI 10.1016/0304-3959(76)90047-6; Porro CA, 2003, NEUROSCIENTIST, V9, P354, DOI 10.1177/1073858403253660; Porro CA, 2002, J NEUROSCI, V22, P3206, DOI 10.1523/JNEUROSCI.22-08-03206.2002; PRICE DD, 2001, HDB PAIN ASSESMENT, P53; Rainsford AO, 1974, SPINE, V1, P127; Recla JM, 2010, ENJ, V2, P473; Rosenquist RW, 2010, ANESTHESIOLOGY, V112, P810, DOI 10.1097/ALN.0b013e3181c43103; ROSENSTIEL AK, 1983, PAIN, V17, P33, DOI 10.1016/0304-3959(83)90125-2; Rudy TE, 1989, MULTIAXIAL ASSESSMEN; Ruehlman LS, 2005, PAIN, V118, P380, DOI 10.1016/j.pain.2005.09.001; Ruehlman LS, 2005, PAIN, V113, P82, DOI 10.1016/j.pain.2004.09.037; Ruff RL, 2009, J REHABIL RES DEV, V46, P1071, DOI 10.1682/JRRD.2009.05.0062; Scascighini L, 2008, RHEUMATOLOGY, V47, P670, DOI 10.1093/rheumatology/ken021; SCHREIBER S, 1993, PAIN, V54, P107, DOI 10.1016/0304-3959(93)90105-X; Sharp TJ, 2001, CLIN PSYCHOL REV, V21, P857, DOI 10.1016/S0272-7358(00)00071-4; Spielberger C. D., 1999, STATE TRAIT ANGER EX; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Thorn BE, 2007, J PAIN, V8, P938, DOI 10.1016/j.jpain.2007.06.010; Todd D., 1998, COGNIPHOBIA SCALE C, pdomain; Todd D, 1998, FORENSIC EXAMINER, V7, P14; TOLLISON CD, 1992, PAIN PATIENT PROFILE; Turk DC, 2005, REHABIL PSYCHOL, V50, P56, DOI 10.1037/0090-5550.50.1.56; Turk Dennis C, 2004, Spine J, V4, P1, DOI 10.1016/S1529-9430(03)00068-8; TURNER JA, 1984, J CLIN PSYCHOL, V40, P909, DOI 10.1002/1097-4679(198407)40:4<909::AID-JCLP2270400407>3.0.CO;2-J; Tyrer S, 2003, NEUROPSYCHOL REHABIL, V13, P189, DOI 10.1080/09602010244000381; Vendrig AA, 2000, CLIN PSYCHOL REV, V20, P533, DOI 10.1016/S0272-7358(00)00053-2; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Ware J., 2000, SF 36 HLTH SURVEY MA; Whaley L, 1987, NURSING CARE INFANTS; World Health Organization, 2007, INT CLASS FUNCT DIS; Zasler ND, 2011, TXB TRAUMATIC BRAIN, P375; Zasler ND, 2002, PAIN MANAGEMENT PRAC; ZIEGLER DK, 1995, ARCH NEUROL-CHICAGO, V52, P602, DOI 10.1001/archneur.1995.00540300076016	132	3	3	0	1	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-27-7				2013							974	987					14	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BDJ25	WOS:000313536100058					2022-02-06	
J	Marzban, C; Illian, PR; Morison, D; Moore, A; Kliot, M; Czosnyka, M; Mourad, PD				Marzban, Caren; Illian, Paul R.; Morison, David; Moore, Anne; Kliot, Michel; Czosnyka, Marek; Mourad, Pierre D.			A Method for Estimating Zero-Flow Pressure and Intracranial Pressure	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						blood flow; brain; head injury; intracranial pressure; noninvasive	CRITICAL CLOSING PRESSURE; SEVERE HEAD-INJURY; OPTIC-NERVE SONOGRAPHY; NONINVASIVE ASSESSMENT; DOWNSTREAM PRESSURE; CARE; MANAGEMENT; EXPERIENCE; ARTERIAL	Background: It has been hypothesized that the critical closing pressure of cerebral circulation, or zero-flow pressure (ZFP), can estimate intracranial pressure (ICP). One ZFP estimation method used extrapolation of arterial blood pressure as against blood-flow velocity. The aim of this study was to improve ICP predictions. Methods: Two revisions have been considered: (1) the linear model used for extrapolation is extended to a nonlinear equation; and (2) the parameters of the model are estimated by an alternative criterion (not least squares). The method is applied to data on transcranial Doppler measurements of blood-flow velocity, arterial blood pressure, and ICP from 104 patients suffering from closed traumatic brain injury, sampled across the United States and England. Results: The revisions lead to qualitative (eg, precluding negative ICP) and quantitative improvements in ICP prediction. While moving from the original to the revised method, the +/- 2 SD of the error is reduced from 33 to 24 mm Hg, and the root-mean-squared error is reduced from 11 to 8.2 mm Hg. The distribution of root-mean-squared error is tighter as well; for the revised method the 25th and 75th percentiles are 4.1 and 13.7 mm Hg, respectively, as compared with 5.1 and 18.8 mm Hg for the original method. Conclusions: Proposed alterations to a procedure for estimating ZFP lead to more accurate and more precise estimates of ICP, thereby offering improved means of estimating it noninvasively. The quality of the estimates is inadequate for many applications, but further work is proposed, which may lead to clinically useful results.	[Marzban, Caren] Univ Washington, Dept Stat, Appl Phys Lab, Seattle, WA 98195 USA; [Moore, Anne; Kliot, Michel; Mourad, Pierre D.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Mourad, Pierre D.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Dept Neurosurg, Cambridge CB2 2QQ, England		Marzban, C (corresponding author), Univ Washington, Dept Stat, Appl Phys Lab, Seattle, WA 98195 USA.	marzban@stat.washington.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R43NS46824-01A1]; National Space Biomedical Research Institute [SMS00701-2009-513]; PhysioSonics Incorporated; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R42NS046824, R41NS046824] Funding Source: NIH RePORTER	Supported by the National Institutes of Health (Grant R43NS46824-01A1); National Space Biomedical Research Institute (Grant SMS00701-2009-513); and PhysioSonics Incorporated. M. K. and P.D.M. have a significant financial interest in PhysioSonics, one of the sponsors of the research described here.	Aaslid R, 2003, STROKE, V34, P1645, DOI 10.1161/01.STR.0000077927.63758.B6; AASLID R, 1991, STROKE, V22, P1148, DOI 10.1161/01.STR.22.9.1148; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Buhre W, 2003, BRIT J ANAESTH, V90, P291, DOI 10.1093/bja/aeg073; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock RM, 2000, J NEUROTRAUM, V17, P449; BURTON AC, 1951, AM J PHYSIOL, V164, P319, DOI 10.1152/ajplegacy.1951.164.2.319; Czosnyka M, 1999, J NEUROL NEUROSUR PS, V66, P606, DOI 10.1136/jnnp.66.5.606; Czosnyka M, 2007, NEUROSURG FOCUS, V22, P1; Czosnyka M, 2007, NEUROL RES, V29, P672, DOI 10.1179/016164107X240053; Efron B., 1993, INTRO BOOTSTRAP; Freedman, 2005, STAT MODELS THEORY P; Geeraerts T, 2008, INTENS CARE MED, V34, P2062, DOI 10.1007/s00134-008-1149-x; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Hsu HY, 2004, STROKE, V35, pE91, DOI 10.1161/01.STR.0000125303.07282.df; Kalmar AF, 2012, BRIT J ANAESTH, V108, P478, DOI 10.1093/bja/aer448; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Kottenberg-Assenmacher E, 2009, ANESTHESIOLOGY, V110, P370, DOI 10.1097/ALN.0b013e3181942c99; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Michel E, 1997, J CEREBR BLOOD F MET, V17, P1127, DOI 10.1097/00004647-199710000-00015; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Montgomery D.C., 2005, DESIGN ANAL EXPT, Vsixth ed; Moretti R, 2011, ACTA ANAESTH SCAND, V55, P644, DOI 10.1111/j.1399-6576.2011.02432.x; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; R Development Core Team, 2011, R LANG ENV STAT COMP; Ragauskas A, 2005, ACT NEUR S, V95, P357; Sajjadi SA, 2006, ANN NEUROL, V59, P867, DOI 10.1002/ana.20856; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Schmidt B, 2003, STROKE, V34, P84, DOI 10.1161/01.STR.0000047849.01376.AE; Sherman RW, 2002, BRIT J ANAESTH, V89, P687, DOI 10.1093/bja/aef247; Soldatos T, 2009, EMERG MED J, V26, P630, DOI 10.1136/emj.2008.058453; Soldatos T, 2008, CRIT CARE, V12, DOI 10.1186/cc6897; Steiner L A, 2003, Br J Anaesth, V90, P396, DOI 10.1093/bja/aeg532; Thees C, 2002, ANESTHESIOLOGY, V96, P595, DOI 10.1097/00000542-200203000-00014; Weyland A, 2000, J NEUROSURG ANESTH, V12, P210, DOI 10.1097/00008506-200007000-00002	39	3	4	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	2013	25	1					25	32		10.1097/ANA.0b013e318263c295			8	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	057KJ	WOS:000312561800004	22824923	Green Accepted			2022-02-06	
J	Munivenkatappa, A; Shukla, DP; Devi, BI; Kumarsamy, AD; Bhat, DI; Somanna, S				Munivenkatappa, Ashok; Shukla, Dhaval P.; Devi, Bhagavatula Indira; Kumarsamy, Akhil Deepika; Bhat, Dhananjay I.; Somanna, Sampath			Domestic animal-related neuro-trauma: An account, from a tertiary institute	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						Animal-related injuries; animal-inflicted; animal-vehicle collision; neuro-trauma; outcome		Context: Experience of animal-related neurotrauma at an apex institute, National Institute of Mental Health and Neurosciences, Bangalore, India. Aims: The aim of this study is to review epidemiology, clinical findings, and outcome of animal-related traumatic brain injury (TBI) evaluated and treated at our institute. Settings and Design: A retrospective study consisting of demographic data, clinical findings, radiological details, and outcomes. Materials and Methods: The clinical and imaging records of 30 patients treated for animal-related TBI at the emergency services, from January to July 2010. Outcome was assessed by Glasgow outcome scale (GOS). Statistical Analysis Used: SPSS 15.0 version, descriptive statistics. Results: A total of 6190 neurotrauma cases were evaluated and treated during the study period. Among them, 30 (0.48%) were animal-inflicted injuries. Of these cases, animal-vehicle collision and directly animal-inflicted injuries were 15 (50%) each. The mean age of patients were 39.46 (6-71 years). Twenty-nine (96.66%) cases were from rural areas. Twenty-three (76.6%) had mild, 6 (20%) had moderate, and 1 (3.3%) had severe head injury (Glasgow coma scale). Four (13.3%) patients had abnormal pupillary reaction. Associated injuries were found in 25 (83.3%) patients. CT scan was abnormal in 50% (15/30), common finding was contusion in 8 (26.6%) patients, followed by edema in 6 (20%). There were 3 (10%) spine injuries, 1 (3.3%) internal carotid artery (ICA) dissection, and 2 (6.6%) brachial plexuses injuries. Three (10%) required surgery, and 1 (3.3%) patient expired. As per the GOS, good recovery was seen in 8 (80%) patients, moderate disability in 1 (10%), and vegetative state in 1 (10%) patient.	[Munivenkatappa, Ashok; Shukla, Dhaval P.; Devi, Bhagavatula Indira; Kumarsamy, Akhil Deepika; Bhat, Dhananjay I.; Somanna, Sampath] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Hosur Rd, Bangalore 560029, Karnataka, India		Devi, BI (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Hosur Rd, Bangalore 560029, Karnataka, India.	bidevidr@gmail.com	Munivenkatappa, Ashok/ABA-5952-2021				Ameh EA, 2000, PEDIATR SURG INT, V16, P589, DOI 10.1007/s003830000419; Anderson HS, 1994, EFFECTS MOTOR VEHICL; Bahram R, 2004, J ORAL MAXIL SURG, V62, P247, DOI 10.1016/j.joms.2003.04.015; Donham KJ, 2006, AGR MED OCCUPATIONAL, P333; Emet M, 2009, ANN AGR ENV MED, V16, P87; Huijser MP, 2007, SYNTHESIS HIGHWAY PR, P5; Moini Majid, 2011, Acta Med Iran, V49, P163; Moneycontrol.com, ALM 70 IND LIV RUR A; Nogalski A, 2007, ANN AGR ENV MED, V14, P57	9	3	3	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	JAN-MAR	2013	4	1					19	23		10.4103/0976-3147.105604			5	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3W3S	WOS:000218647100007	23546342	Green Published, gold			2022-02-06	
J	Puur, A; Altmets, K; Saava, A; Uuskula, A; Sakkeus, L				Puur, Allan; Altmets, Katre; Saava, Astrid; Uuskuela, Anneli; Sakkeus, Luule			Non-fatal injuries resulting in activity limitations in Estonia-risk factors and association with the incidence of chronic conditions and quality of life: a retrospective study among the population aged 20-79	BMJ OPEN			English	Article						non-fatal injuries; activity limitations; chronic conditions; quality of life; life course epidemiology	TRAUMATIC BRAIN-INJURY; DISABILITY; MODERATE; CRASHES; BURDEN	Objectives Evidence about the health and quality-of-life outcomes of injuries is obtained mainly from follow-up studies of surviving trauma patients; population-based studies are rarer, in particular for countries in Eastern Europe. This study examines the incidence, prevalence and social variation in non-fatal injuries resulting in activity limitations and outcomes of injuries in Estonia. Design A retrospective population-based study. Setting Estonia. Participants 7855 respondents of the face-to-face interviews of the second round of the Estonian Family and Fertility Survey conducted between 2004 and 2005 based on the nationally representative probability sample (n=11192) of the resident population of Estonia aged 20-79. Primary and secondary outcome measures The cumulative incidence and prevalence of injuries leading to activity limitations was estimated. Survival models were applied to analyse variations in the injury risk across sociodemographic groups. The association between injuries and the development of chronic conditions and quality of life was examined using survival and logistic regression models. Results 10% (95% CI 9.4 to 10.7) of the population aged 20-79 had experienced injuries leading to activity limitations; the prevalence of activity limitations due to injuries was 4.4% (95% CI 3.9% to 4.9%). Significant differences in injury risk were associated with gender, education, employment, marital status and nativity. Limiting injury was associated with a doubling of the likelihood of having chronic conditions (adjusted HR 1.97, 95% CI 1.58 to 2.46). Injury exhibited a statistically significant negative association with most quality-of-life measures. Although reduced, these effects persisted after recovery from activity limitations. Conclusions Substantial variation in injury risk across population groups suggests potential for prevention. Men and workers in manual occupations constitute major target groups for injury prevention in Estonia. The association of injury with the development of chronic conditions and reduced quality of life warrants further investigation.	[Puur, Allan; Altmets, Katre; Sakkeus, Luule] Tallinn Univ, Estonian Inst Populat Studies, EE-10120 Tallinn, Estonia; [Altmets, Katre; Saava, Astrid; Uuskuela, Anneli] Univ Tartu, Dept Publ Hlth, EE-50090 Tartu, Estonia		Altmets, K (corresponding author), Tallinn Univ, Estonian Inst Populat Studies, EE-10120 Tallinn, Estonia.	Katre.Altmets@ut.ee	Uuskula, Anneli/H-3303-2015; Sakkeus, Luule/E-9558-2010	Uuskula, Anneli/0000-0002-4036-3856; Sakkeus, Luule/0000-0003-3785-183X	Estonian Ministry of Education and ScienceMinistry of Education and Research, Estonia [SF0130018s11, SF0180060s09]; Estonian Science Foundation [ETF8325]	This work was supported by the Estonian Ministry of Education and Science (research themes SF0130018s11 and SF0180060s09) and the Estonian Science Foundation (grant no. ETF8325).	Altmets K, 2011, EUR J PUBLIC HEALTH, V21, P49, DOI 10.1093/eurpub/ckp239; Ameratunga SN, 2004, INJURY, V35, P1116, DOI 10.1016/j.injury.2003.12.016; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; BULL JP, 1978, INJURY, V9, P184, DOI 10.1016/0020-1383(78)90004-9; de Heer W., 1999, J OFF STAT, V15, P129; Gierveld JD, 2006, RES AGING, V28, P582, DOI 10.1177/0164027506289723; Estonian FFS Working Group, 2004, EST FAM FERT SURV ME; Eurosafe, INJ EUR UN STAT SUMM; GORDON JE, 1949, AM J PUBLIC HEALTH, V39, P504, DOI 10.2105/AJPH.39.4.504; Haagsma JA, 2011, INJURY PREV, V17, P21, DOI 10.1136/ip.2010.026419; Halcomb E, 2005, AUST CRIT CARE, V18, P20; Halcomb Elizabeth, 2005, Aust Crit Care, V18, P17, DOI 10.1016/S1036-7314(05)80020-7; Hannerz H, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-215; Katus K, 2008, RU SERIES C, V26; Kobusingye, 2001, INJURY SURVEILLANCE; Lai T, 2009, SERIES MINISTRY SOCI, P1; Laursen B, 2012, DAN MED J A, V59, P1; Li L, 2001, EUR J PUBLIC HEALTH, V11, P81, DOI 10.1093/eurpub/11.1.81; MacKenzie EJ, 2000, EPIDEMIOL REV, V22, P112, DOI 10.1093/oxfordjournals.epirev.a018006; Moshiro C, 2005, INJURY PREV, V11, P48, DOI 10.1136/ip.2004.005645; Plugge E, 2002, J PUBLIC HEALTH MED, V24, P27, DOI 10.1093/pubmed/24.1.27; Polinder S, 2012, EPIDEMIOL REV, V34, P17, DOI 10.1093/epirev/mxr022; Rutner D, 2006, BRAIN INJURY, V20, P1079, DOI 10.1080/02699050600909904; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sabre L, 2012, SPINAL CORD, V50, P755, DOI 10.1038/sc.2012.54; Sakkeus L, 2012, OPPORTUNITIES CHALLE, P227; SHARE, SURV HLTH AG RET EUR; Shults RA, 2004, J SAFETY RES, V35, P447, DOI 10.1016/j.jsr.2004.06.001; Tiikkaja S, 2009, J EPIDEMIOL COMMUN H, V63, P633, DOI 10.1136/jech.2008.081596; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; United Nations Economic Commission for Europe Population Activities Unit, GEN GEND PROGR; VEIT CT, 1983, J CONSULT CLIN PSYCH, V51, P730, DOI 10.1037/0022-006X.51.5.730; Vikhireva O, 2010, EUR J PUBLIC HEALTH, V20, P695, DOI 10.1093/eurpub/ckp193; WHO, EUR HLTH ALL DAT; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; World Health Organisation, INJ VIOL; World Health Organization, DISABILITY REHABILIT; World Health Organization, 2002, World Report on Violence and Health	39	3	3	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2013	3	7							e002695	10.1136/bmjopen-2013-002695			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	291CO	WOS:000329805500054	23901024	Green Published, gold			2022-02-06	
J	Reznik, JE; Milanese, S; Golledge, J; Biros, E; Gordon, S; Galea, MP				Reznik, Jacqueline; Milanese, Steve; Golledge, Jonathon; Biros, Erik; Gordon, Susan; Galea, Mary			Extracorporeal shock wave therapy as a treatment for heterotopic ossification	PHYSICAL THERAPY REVIEWS			English	Article						Extracorporeal shock-wave therapy; Heterotopic ossification; High energy shock wave therapy; Myositis ossificans	TRAUMATIC BRAIN; BONE; PREVENTION; INJURY; RELIABILITY; TENDINITIS; MANAGEMENT; SAFETY; ELBOW; PAIN	Background: Extracorporeal shock wave therapy (ESWT) is an intervention treatment in musculoskeletal conditions. Heterotopic ossification (HO) is a painful osseous condition of various origins, with the potential to cause significant incapacity. Objectives: To summarize the published data and assess the effectiveness of ESWT as a therapeutic intervention for patients with HO. Methods: A systematic search of the literature using Medline via Ovid, Scopus, CINAHL, and Web of Science databases. Reference lists of all articles found were also hand-searched. Articles were assessed using the Oxford Centre for Evidence Based Medicine (OCEBM) hierarchy of evidence and were critically appraised using the McMaster Critical Review Form for Quantitative Studies. A meta-analysis of data from four independent case studies totaling 52 HO patients treated with ESWT was performed. Outcome was assessed by pain and range of motion (ROM) of hip and knee flexion, since this was the only recorded movement data in the studies. Data were analyzed with a fixed effects model. Results: Only four articles met the inclusion criteria. Hierarchical evidence scores were low, but the articles scored well on the critical appraisal tool. ESWT led to an improvement in knee flexion by approximately 82% [95% confidence interval (CI): 66.58-96.87; P<0.001] and hip flexion of similar to 10% (95% CI: 1.36-20.44; P=0.086). Approximately 25% of relative improvement in ROM can be attributed to alleviation of pain after ESWT (r(2)=0.25; P=0.496). Conclusion: ESWT may be associated with clinically significant improvement of ROM of lower extremities in patients with HO although larger studies are needed to confirm these findings.	[Reznik, Jacqueline; Milanese, Steve; Golledge, Jonathon; Biros, Erik; Gordon, Susan; Galea, Mary] James Cook Univ, Townsville, Qld, Australia; [Milanese, Steve] Univ South Australia, Adelaide, SA, Australia; [Galea, Mary] Univ Melbourne, Melbourne, Vic, Australia		Reznik, JE (corresponding author), James Cook Univ, Discipline Physiotherapy, Townsville, Qld 4811, Australia.	jackie.reznik@jcu.edu.au	Milanese, Steve/F-3898-2013; Galea, Mary/F-4242-2010	Milanese, Steve/0000-0002-6470-3296; Galea, Mary/0000-0003-0045-7978; Gordon, Susan/0000-0002-4760-1212; Reznik, Jacqueline/0000-0002-7324-9531			Albert JD, 2007, J BONE JOINT SURG BR, V89B, P335, DOI 10.1302/0301-620X.89B3.18249; Alvarez RG, 2011, FOOT ANKLE INT, V32, P746, DOI 10.3113/FAI.2011.0746; Amirfeyz R, 2009, INT ORTHOP, V33, P181, DOI 10.1007/s00264-007-0471-1; Aronson JK, 2006, BMJ-BRIT MED J, V333, P1267, DOI 10.1136/bmj.39036.666389.94; Aubut JAL, 2011, NEUROREHABILITATION, V28, P151, DOI 10.3233/NRE-2011-0643; Banovac K, 2004, SPINAL CORD, V42, P707, DOI 10.1038/sj.sc.3101628; Brissot R., 2005, Annales de Readaptation et de Medecine Physique, V48, P581, DOI 10.1016/j.annrmp.2005.04.014; Buchbinder R, 2006, J RHEUMATOL, V33, P1351; BUSCHBACHER R, 1992, AM J PHYS MED REHAB, V71, P86, DOI 10.1097/00002060-199204000-00005; Buselli P, 2010, ULTRASOUND MED BIOL, V36, P397, DOI 10.1016/j.ultrasmedbio.2009.11.007; Cacchio A, 2006, PHYS THER, V86, P672, DOI 10.1093/ptj/86.5.672; Cacchio A, 2009, CLIN CHEM, V55, P195, DOI 10.1373/clinchem.2008.106419; Chaussy C, 2007, J ENDOUROL, V21, P1249, DOI 10.1089/end.2007.9880; Chung B, 2004, AM J SPORT MED, V32, P1660, DOI 10.1177/0363546503262806; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Durovic A, 2009, VOJNOSANIT PREGL, V66, P22; Fijn R, 2003, PHARM WORLD SCI, V25, P138, DOI 10.1023/A:1024830213832; GAJDOSIK RL, 1987, PHYS THER, V67, P1867, DOI 10.1093/ptj/67.12.1867; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Gerdesmeyer L, 2008, AM J SPORT MED, V36, P2100, DOI 10.1177/0363546508324176; Glasziou P, 2007, BMJ-BRIT MED J, V334, P349, DOI 10.1136/bmj.39070.527986.68; Goldman J, 1980, Physiotherapy, V66, P219; Hazan-Molina H, 2011, Refuat Hapeh Vehashinayim (1993), V28, P55; Howick J, 2011, PHILOS EVIDENCE BASE; Johns JS, 1999, J HEAD TRAUMA REHAB, V14, P269, DOI 10.1097/00001199-199906000-00007; Knight LA, 2003, PHYSIOTHERAPY, V89, P471; Kramer JLK, 2012, J NEUROSCI, V32, P12981, DOI 10.1523/JNEUROSCI.3175-12.2012; Mavrogenis AF, 2012, J ORTHOP TRAUMATOL, V13, P69, DOI 10.1007/s10195-012-0193-z; Mavrogenis AF, 2011, ORTHOPEDICS, V34, DOI 10.3928/01477447-20110124-08; McKee MD, 2010, J BONE JOINT SURG AM, V92A, P1316; Melamed E, 2002, AM J PHYS MED REHAB, V81, P670, DOI 10.1097/00002060-200209000-00006; Metzner G, 2010, FOOT ANKLE INT, V31, P790, DOI 10.3113/FAI.2010.0790; Micheli A, 2009, EUR J PEDIATR, V168, P523, DOI 10.1007/s00431-008-0906-8; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; Ogden JA, 2004, J BONE JOINT SURG AM, V86A, P2216, DOI 10.2106/00004623-200410000-00013; Ogden JA, 2001, CLIN ORTHOP RELAT R, P8; Ogden JA, 2001, CLIN ORTHOP RELAT R, P2; Pape HC, 2004, J BONE JOINT SURG BR, V86B, P783, DOI 10.1302/0301-620X.86B6.15356; Reznik JE, 2013, BRAIN INJURY, V27, P242, DOI 10.3109/02699052.2012.729293; Rompe JD, 2006, CLIN ORTHOP RELAT R, P276, DOI 10.1097/01.blo.0000203488.44077.ff; ROTHSTEIN JM, 1983, PHYS THER, V63, P1611, DOI 10.1093/ptj/63.10.1611; SCHAEFFER MA, 1995, ARCH PHYS MED REHAB, V76, P284, DOI 10.1016/S0003-9993(95)80617-2; Speed CA, 2004, J BONE JOINT SURG BR, V86B, P165, DOI 10.1302/0301-620X.86B2.14253; Stoltny Tomasz, 2007, Ortop Traumatol Rehabil, V9, P264; Teasell RW, 2010, SPINAL CORD, V48, P512, DOI 10.1038/sc.2009.175; Torrance David Allen, 2011, J Can Chiropr Assoc, V55, P240; VALCHANOU VD, 1991, INT ORTHOP, V15, P181; van Kampen PJ, 2011, J HEAD TRAUMA REHAB, V26, P384, DOI 10.1097/HTR.0b013e3181f78a59; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Wang Ching-Jen, 2003, Chang Gung Med J, V26, P220; Wang CJ, 2006, AM J SPORT MED, V34, P592, DOI 10.1177/0363546505281811; Wang W, 2005, CHIN J CLIN REHABIL, V9, P187; Wess OJ, 2008, UROL RES, V36, P327, DOI 10.1007/s00240-008-0156-2; Xue DT, 2011, INT ORTHOP, V35, P3, DOI 10.1007/s00264-009-0886-y	54	3	3	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1083-3196	1743-288X		PHYS THER REV	Phys. Ther. Rev.		2013	18	4					300	307		10.1179/1743288X13Y.0000000084			8	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V73HL	WOS:000211700400005		Green Accepted			2022-02-06	
J	Riechers, RG; Shuster, JL; Bryan, KJ; Burant, CJ; Ball, SL				Riechers, Ronald G.; Shuster, Jaime L.; Bryan, Kathryn J.; Burant, Christopher J.; Ball, Sherry L.			Prior housing conditions and sleep loss may affect recovery from brain injury in rats: A pilot study	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						combat; controlled cortical impact; novel housing; premorbid conditions; sensorimotor function; sleep deprivation; social isolation; stress; trauma; traumatic brain injury	CONTROLLED CORTICAL IMPACT; SOCIAL-ISOLATION; DEPRIVATION; NEUROPROTECTION; STRESS; COMBAT; REHABILITATION; CONSEQUENCES; ALLOSTASIS; DISORDERS	The purpose of this study is to understand the effect of combat-associated conditions such as sleep deprivation (SD) on subsequent traumatic brain injury (TBI). Prior to TBI (or sham surgery) induced by controlled cortical impact (CCI), rats were housed singly in chambers that prevented rapid eye movement sleep or allowed unrestricted sleep (no SD). Sensorimotor function was tested pre-SD and retested on postoperative days (PDs) 4, 7, and 14. Two additional control groups were housed socially prior to either CCI or sham surgery. CCI resulted in immediate performance deficits on sensorimotor tasks. The PD on which performance returned to baseline depended on preinjury conditions. Overall, preinjury SD+CCI resulted in an earlier recovery than no SD+CCI, and the no SD+CCI group (housed singly under conditions comparable with the SD group) recovered slower than all other groups. These data are the first to raise the possibility that recovery of sensorimotor function following TBI is affected by preinjury conditions. The data suggest that preinjury SD 24 h in duration may result in faster recovery and that novel or social isolation conditions may impede recovery. Thus, the combat environment may contribute to complexities associated with TBIs common in U.S. servicemembers.	[Riechers, Ronald G.; Shuster, Jaime L.; Bryan, Kathryn J.; Ball, Sherry L.] Louis Stokes Cleveland Dept Vet Affairs Med Ctr V, Cleveland, OH USA; [Riechers, Ronald G.] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; [Shuster, Jaime L.; Ball, Sherry L.] Cleveland State Univ, Dept Psychol, Cleveland, OH 44115 USA; [Burant, Christopher J.] Louis Stokes Cleveland VAMC, Geriatr Res Educ & Clin Ctr, Cleveland, OH 44106 USA; [Burant, Christopher J.] Case Western Reserve Univ, Frances Payne Bolton Sch Nursing, Cleveland, OH 44106 USA; [Ball, Sherry L.] Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Dept Ophthalmol, Cleveland, OH 44106 USA		Ball, SL (corresponding author), Louis Stokes Cleveland VAMC, Res Serv, 151W, Cleveland, OH 44106 USA.	sherry.ball@case.edu		Ball, Sherry/0000-0002-2362-9499	Department of Veterans Affairs Office of Rehabilitation Research and DevelopmentUS Department of Veterans Affairs; Cleveland Veterans Health Administration Medical Research and Education Foundation	This material was based on work supported by the Department of Veterans Affairs Office of Rehabilitation Research and Development and the Cleveland Veterans Health Administration Medical Research and Education Foundation (to Drs. Riechers and Ball).	Auer RN, 2004, METAB BRAIN DIS, V19, P169, DOI 10.1023/B:MEBR.0000043967.78763.5b; Cirelli Chiara, 2011, Handb Clin Neurol, V98, P191, DOI 10.1016/B978-0-444-52006-7.00012-5; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Dalla Libera AL, 2011, BRAIN INJURY, V25, P365, DOI 10.3109/02699052.2011.556107; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430; DIXON CE, 1991, J NEUROSCI METH, V39, P253; EVERSON CA, 1995, BEHAV BRAIN RES, V69, P43, DOI 10.1016/0166-4328(95)00009-I; Filipovic D, 2007, ANN NY ACAD SCI, V1096, P207, DOI 10.1196/annals.1397.087; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kalda A, 2006, J NEUROL SCI, V248, P9, DOI 10.1016/j.jns.2006.05.003; Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002; Kreuzer P, 2011, NEUROSCI LETT, V493, P63, DOI 10.1016/j.neulet.2011.02.044; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Lieberman HR, 2005, BIOL PSYCHIAT, V57, P422, DOI 10.1016/j.biopsych.2004.11.014; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McEwen BS, 2006, METABOLISM, V55, pS20, DOI 10.1016/j.metabol.2006.07.008; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; MENDELSON WB, 1974, PHARMACOL BIOCHEM BE, V2, P553, DOI 10.1016/0091-3057(74)90018-5; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Miller NL, 2011, BEHAV SLEEP MED, V9, P53, DOI 10.1080/15402002.2011.533994; Nishino Seiji, 2011, Handb Clin Neurol, V99, P765, DOI 10.1016/B978-0-444-52007-4.00006-0; PARMEGGIANI PL, 1987, SLEEP, V10, P426; Pedata F, 2001, ANN NY ACAD SCI, V939, P74; Pego JM, 2010, CURR TOP BEHAV NEURO, V2, P97, DOI 10.1007/7854_2009_13; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Robinson SA, 2010, BRAIN RES, V1343, P153, DOI 10.1016/j.brainres.2010.04.031; Stranahan AM, 2006, NAT NEUROSCI, V9, P526, DOI 10.1038/nn1668; van Leeuwen WMA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004589; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Wang CX, 2009, INT J STROKE, V4, P274, DOI 10.1111/j.1747-4949.2009.00317.x; Warden DL, 2000, J HEAD TRAUMA REHAB, V15, P1092, DOI 10.1097/00001199-200010000-00003; Waters RJ, 2005, CURR OPIN CRIT CARE, V11, P105, DOI 10.1097/01.ccx.0000155354.78617.91; Yan J, 2011, BRAIN RES, V1401, P52, DOI 10.1016/j.brainres.2011.05.032; Zhao XR, 2005, STROKE, V36, P129, DOI 10.1161/01.STR.0000149624.87661.18	38	3	3	0	1	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.		2013	50	4					455	462		10.1682/JRRD.2012.04.0061			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	179RS	WOS:000321539600004	23934866	Bronze			2022-02-06	
S	Roujeau, T; Mireau, E; Bourgeois, M		Dulac, O; Lassonde, M; Sarnat, HB		Roujeau, T.; Mireau, E.; Bourgeois, M.			Nonaccidental head injury	PEDIATRIC NEUROLOGY, PT II	Handbook of Clinical Neurology		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; SHAKEN BABY SYNDROME; BATTERED-CHILD SYNDROME; SUBDURAL HEMATOMAS; CARDIOPULMONARY-RESUSCITATION; RETINAL HEMORRHAGE; HOSPITALIZED CHILDREN; MENTAL-RETARDATION; GLUTARIC ACIDURIA; INFANT SYNDROME		[Roujeau, T.] Dept Pediat & Funct Neurosurg, Montpellier, France; [Roujeau, T.; Mireau, E.; Bourgeois, M.] Hop Necker Enfants Malad, Dept Neurosurg, Paris, France		Roujeau, T (corresponding author), Serv Neurochirurg Pediat & Fonctionnelle, 80 Ave Augustin Fliche, F-34295 Montpellier 5, France.	t-roujeau@chu-montpellier.fr					Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; AICARDI J, 1985, DEV MED CHILD NEUROL, V27, P403; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Beheld K, 2005, PEDIATRICS, V115, P192; Biron D, 2005, CHILD ABUSE NEGLECT, V29, P1347, DOI 10.1016/j.chiabu.2005.05.003; Bishop FS, 2007, J NEUROSURG, V106, P222, DOI 10.3171/ped.2007.106.3.222; Bourgeois M, 2008, CHILD NERV SYST, V24, P169, DOI 10.1007/s00381-007-0493-4; CAFFEY J, 1974, PEDIATRICS, V54, P396; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; CARTY H, 1995, BRIT MED J, V310, P344, DOI 10.1136/bmj.310.6976.344; Dashti SR, 1999, PEDIATR NEUROSURG, V31, P302, DOI 10.1159/000028880; Duhaime S, 1992, PEDIATRICS, V90, P179; Emerson MV, 2001, OPHTHALMOLOGY, V108, P36, DOI 10.1016/S0161-6420(00)00474-7; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; FARRELLY C, 1984, J CAN ASSOC RADIOL, V35, P406; GENIESER NB, 1974, RADIOL CLIN N AM, V12, P333; GOETTING MG, 1990, PEDIATRICS, V85, P585; GUTHKELCH AN, 1995, BRIT MED J, V310, P1600, DOI 10.1136/bmj.310.6994.1600b; HOWARD MA, 1993, BRIT J NEUROSURG, V7, P355, DOI 10.3109/02688699309103489; Hughes LA, 2006, J AAPOS, V10, P102, DOI 10.1016/j.jaapos.2005.12.005; KANTER RK, 1986, J PEDIATR-US, V108, P430, DOI 10.1016/S0022-3476(86)80890-3; Keenan HT, 2010, ACAD PEDIATR, V10, P389, DOI 10.1016/j.acap.2010.08.005; Kelly P, 2009, CHILD ABUSE NEGLECT, V33, P393, DOI 10.1016/j.chiabu.2008.09.008; KEMPE CH, 1975, AM J DIS CHILD, V129, P1265, DOI 10.1001/archpedi.1975.02120480003001; KEMPE CH, 1962, JAMA-J AM MED ASSOC, V181, P17, DOI 10.1001/jama.1962.03050270019004; King WJ, 2003, CAN MED ASSOC J, V168, P155; Laskey AL, 2007, CHILD ABUSE NEGLECT, V31, P329, DOI 10.1016/j.chiabu.2006.02.017; Laurent-Vannier A, 2003, NEUROLOGY, V60, P202, DOI 10.1212/01.WNL.0000048201.26494.0B; Laurent-Vannier A, 2000, CHILD NERV SYST, V16, P760, DOI 10.1007/s003810000349; Leventhal JM, 2008, PEDIATRICS, V122, P599, DOI 10.1542/peds.2007-1959; Leventhal JM, 2010, PEDIATRICS, V126, pE104, DOI 10.1542/peds.2009-1076; Mireau E, 2005, SHAKEN BABY SYNDROME; Nassogne MC, 2002, CHILD NERV SYST, V18, P729, DOI 10.1007/s00381-002-0630-z; Newton AW, 2009, CURR OPIN PEDIATR, V21, P252, DOI 10.1097/MOP.0b013e328329263d; Odom A, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.6.e3; PHILLIPS CI, 1987, BRIT J OPHTHALMOL, V71, P578, DOI 10.1136/bjo.71.8.578; Pierre-Kahn V, 2003, OPHTHALMOLOGY, V110, P1718, DOI 10.1016/S0161-6420(03)00581-5; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Renier D, 2000, BEBE SECOUE; Schaal JP, 2008, J GYNECOL OBST BIO R, V37, pS231, DOI 10.1016/S0368-2315(08)74761-6; TARDIEU A, 1860, ANN HYG PUBLIQUE MED, V13, P361, DOI DOI 10.3917/EP.039.0174	43	3	3	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-444-62699-8; 978-0-444-52910-7	HAND CLINIC			2013	112						905	912					8	Clinical Neurology; Pediatrics	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Pediatrics	BA6KI	WOS:000337167400014	23622300				2022-02-06	
J	Seigerman, DA; Choi, D; Donegan, DJ; Yoon, RS; Liporace, FA				Seigerman, Daniel A.; Choi, Daniel; Donegan, Derek J.; Yoon, Richard S.; Liporace, Frank A.			Upper extremity compartment syndrome after minor trauma: an imperative for increased vigilance for a rare, but limb-threatening complication	PATIENT SAFETY IN SURGERY			English	Article						Compartment syndrome; Radial head dislocation; Upper extremity; Compartment pressures		Background: Compartment syndrome of any extremity is a limb-threatening emergency requiring an emergent surgical management. Thus, ruling out compartment syndrome is often high on the list of priorities when treating high-energy injuries and fractures. However, even in the most seemingly benign injuries, this dangerous diagnosis must always remain on the differential and suspicion must remain high. Case presentation: 23-year-old factory worker presents after a low energy entrapment injury to his left forearm. Initial work-up and evaluation noted an isolated radial head dislocation with a normal physical motor and sensory exam. However, maintaining high suspicion for compartment syndrome despite serial normal physical exams, led objective compartment pressure measurement leading to definitive diagnosis. Emergent surgical intervention via compartment fasciotomies was performed, along with closed reduction and ligament repair. At 1 year follow-up, the patient was well-healed, back to work with full range of motion and not activity limitations. Conclusion: Despite a seemingly benign injury pattern, and a relatively low energy mechanism, vigilant concern for compartment syndrome following any kind of entrapment injury should initiate serial examinations and compartment pressure measurements especially in circumstances with continued swelling and inability to perform an accurate clinical assessment due to an obtunded or medicated patient.	[Yoon, Richard S.; Liporace, Frank A.] NYU, Hosp Joint Dis, Dept Orthopaed Surg, Div Orthopaed Trauma, 301 E 17th St,Suite 1402, New York, NY 10003 USA; [Seigerman, Daniel A.; Choi, Daniel; Donegan, Derek J.] UMDNJ, New Jersey Med Sch, Dept Orthopaed Surg, Div Orthopaed Trauma, Newark, NJ 07101 USA		Liporace, FA (corresponding author), NYU, Hosp Joint Dis, Dept Orthopaed Surg, Div Orthopaed Trauma, 301 E 17th St,Suite 1402, New York, NY 10003 USA.	liporace33@gmail.com	Yoon, Richard S./D-2522-2009; CHAMMAS, MICHEL MC/H-9488-2017	Yoon, Richard S./0000-0001-5240-6633; CHAMMAS, MICHEL MC/0000-0001-9251-5236			Baraza N, 2012, J SHOULDER ELB SURG, V21, pE5, DOI 10.1016/j.jse.2011.07.035; BONATUS T, 1995, J ORTHOP TRAUMA, V9, P441, DOI 10.1097/00005131-199505000-00014; Harvey EJ, 2012, J ORTHOP TRAUMA, V26, P699, DOI 10.1097/BOT.0b013e31826df980; HEIDT RS, 1982, CLIN ORTHOP RELAT R, P136; KONG KC, 1993, ARCH ORTHOP TRAUM SU, V112, P304, DOI 10.1007/BF00452972; Mabvuure Nigel Tapiwa, 2012, Open Orthop J, V6, P535, DOI 10.2174/1874325001206010535; Malik A A, 2009, J Perioper Pract, V19, P137; Obert L, 2003, Chir Main, V22, P216, DOI 10.1016/S1297-3203(03)00055-6; Pearson BV, 2007, AM J EMERG MED, V25, P222, DOI 10.1016/j.ajem.2006.06.006; Rethnam Ulfin, 2007, J Med Case Rep, V1, P38, DOI 10.1186/1752-1947-1-38; SALAMA R, 1977, CLIN ORTHOP RELAT R, P156; Takami H, 1997, CLIN ORTHOP RELAT R, P168; Ulmer T, 2002, J ORTHOP TRAUMA, V16, P572, DOI 10.1097/00005131-200209000-00006; Watanabe K, 2005, J SHOULDER ELB SURG, V14, P554, DOI 10.1016/j.jse.2004.08.005; Whitesides, 1996, J Am Acad Orthop Surg, V4, P209	15	3	3	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1754-9493			PATIENT SAF SURG	Patient Saf. Surg.		2013	7								5	10.1186/1754-9493-7-5			5	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	V13PQ	WOS:000214425700005	23390929	Green Published, gold			2022-02-06	
J	Spencer, RJ; McGuire, AP; Tree, HA; Waldron-Perrine, B; Pangilinan, PH; Bieliauskas, LA				Spencer, Robert J.; McGuire, Adam P.; Tree, Heather A.; Waldron-Perrine, Brigid; Pangilinan, Percival H.; Bieliauskas, Linas A.			Report of traumatic brain injury information sources among OIF/OEF Veterans undergoing polytrauma evaluations	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						behavior; information; military; rehabilitation; sequelae; symptoms; TBI; traumatic brain injury; VA; Veterans	MILD HEAD-INJURY; COGNITIVE PERFORMANCE; DIAGNOSIS THREAT; INDIVIDUALS; EXPECTATION; ETIOLOGY	Servicemembers returning from recent conflicts frequently report symptoms associated with traumatic brain injury (TBI) and are subsequently assessed within the Department of Veterans Affairs (VA) medical system. Information on potential cognitive and behavioral correlates of TBI is available from multiple sources. A Veteran's symptom presentation may be significantly influenced by the information he or she has received. Despite knowledge of the relationship between information source and symptom presentation, little work has focused on a characterization of where Veterans receive their information. The present study aims to fill this gap in the literature. We asked 152 Veterans who screened positive for possible TBI within the VA healthcare system about the sources of information they have encountered regarding TBI and its sequelae. "Friends in the military" was the most frequently cited source of information, followed by the Internet, medical professionals, and informational pamphlets. The results of this survey indicate that Veterans are being exposed to information about TBI prior to a formal evaluation and that this information comes from multiple sources of varying reliability. Future research should focus on evaluating and ultimately improving the reliability of this information in order to positively influence the treatment of Veterans.	[Spencer, Robert J.; McGuire, Adam P.; Tree, Heather A.; Waldron-Perrine, Brigid; Bieliauskas, Linas A.] Dept Vet Affairs VA Ann Arbor Healthcare Syst, Dept Mental Hlth Serv, Ann Arbor, MI USA; [Waldron-Perrine, Brigid; Bieliauskas, Linas A.] Univ Michigan Hlth Syst, Dept Psychiat, Ann Arbor, MI USA; [Pangilinan, Percival H.] VA Ann Arbor Healthcare Syst, Dept Phys Med & Rehabil, Ann Arbor, MI USA; [Pangilinan, Percival H.] Univ Michigan Hlth Syst, Dept Phys Med & Rehabil, Ann Arbor, MI USA		Bieliauskas, LA (corresponding author), 2101 Commonwealth Blvd,Ste C, Ann Arbor, MI 48105 USA.	linas@umich.edu		McGuire, Adam/0000-0002-4512-1207			Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; TREE HA, 2011, 39 ANN M INT NEUR SO; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478	11	3	3	0	1	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.		2013	50	1					1	5		10.1682/JRRD.2012.01.0018			5	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	149FE	WOS:000319303600009	23516078	Bronze			2022-02-06	
B	Tenovuo, O; Bullock, MR; Zafonte, RD		Zasler, ND; Katz, DI; Zafonte, RD		Tenovuo, Olli; Bullock, M. Ross; Zafonte, Ross D.			International Systems of Care and Research Agendas	BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; UNITED-STATES; CLINICAL-TRIALS; YOUNG-PEOPLE; RISK-FACTORS; FOLLOW-UP; EPIDEMIOLOGY; OUTCOMES; MILD		[Tenovuo, Olli] Univ Turku, Turku, Finland; [Tenovuo, Olli] Turku Univ Hosp, FIN-20520 Turku, Finland; [Bullock, M. Ross] Univ Miami, Miller Sch Med, Dept Neurosurg, Miami, FL 33136 USA; [Zafonte, Ross D.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Zafonte, Ross D.] Spaulding Rehabil Network, Boston, MA USA; [Zafonte, Ross D.] Massachusetts Gen Hosp, Boston, MA 02114 USA		Tenovuo, O (corresponding author), Univ Turku, Turku, Finland.						Adeleye AO, 2009, NEUROEPIDEMIOLOGY, V32, P136, DOI 10.1159/000182821; ALEXANDER CS, 1992, AM J EPIDEMIOL, V136, P673, DOI 10.1093/oxfordjournals.aje.a116547; Allen S, 2006, ACAD EMERG MED, V13, P427, DOI [10.1197/j.aem.2005.11.003, 10.1111/j.1553-2712.2006.tb00321.x]; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; BAILEY I, 1991, ACTA NEUROCHIR, V110, P97, DOI 10.1007/BF01400674; Baker TD, 2011, J TRAUMA, V70, P991, DOI 10.1097/TA.0b013e31820e27c6; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Berg J, 2005, EUR J NEUROL, V12, P85, DOI 10.1111/j.1468-1331.2005.01200.x; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; BRAAKMAN R, 1994, J NEUROSURG, V80, P797; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cadotte DW, 2011, J NEUROSURG, V114, P1502, DOI 10.3171/2010.12.JNS10808; CARLSSON GS, 1987, J NEUROSURG, V67, P197, DOI 10.3171/jns.1987.67.2.0197; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Caveness W F, 1979, Adv Neurol, V22, P1; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; CONROY C, 1988, NEUROEPIDEMIOLOGY, V7, P13, DOI 10.1159/000110131; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Deb S, 1999, BRAIN INJURY, V13, P369, DOI 10.1080/026990599121557; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Edwards P, 2005, LANCET, V365, P1957; Emanuelson I, 2009, BRAIN INJURY, V23, P612, DOI 10.1080/02699050902973913; Engberg A, 1995, Acta Neurol Scand Suppl, V164, P1; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; Farin A, 2004, ACT NEUR S, V89, P101; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P254, DOI 10.1016/S0303-8467(01)00161-5; Finkelstein E., 2006, INCIDENCE EC BURDEN; GEDYE A, 1989, J AM GERIATR SOC, V37, P970, DOI 10.1111/j.1532-5415.1989.tb07283.x; Groswasser Zeev, 2008, Harefuah, V147, P847; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; HAAS JF, 1987, J NEUROL NEUROSUR PS, V50, P52, DOI 10.1136/jnnp.50.1.52; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hallgren MA, 2010, EUR J PUBLIC HEALTH, V20, P616, DOI 10.1093/eurpub/ckq111; Hashimoto K, 2006, J REHABIL MED, V38, P141, DOI 10.1080/16501970500441690; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kannus P, 2007, INJURY, V38, P81, DOI 10.1016/j.injury.2006.08.027; Kayani NA, 2009, PUBLIC HEALTH REP, V124, P551, DOI 10.1177/003335490912400412; Laalo JP, 2009, J NEUROTRAUM, V26, P2169, DOI 10.1089/neu.2009.1011; Langlois JA., 2004, TRAUMATIC BRAIN INJU; LEVI L, 1990, NEUROEPIDEMIOLOGY, V9, P278, DOI 10.1159/000110784; Lopez AD, 1996, GLOBAL BURDEN DIS CO; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Mar J, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-46; Marchio PS, 2006, NEUROCIRUGIA, V17, P14; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; McBeth PB, 2009, AM J SURG, V197, P560, DOI [10.1016/j.amjsurg.2008.12.016, 10.1016/j.amjsurg.2008.08.010]; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; MCNICHOLL B, 1995, ULSTER MED J, V64, P142; Melo JRT, 2004, ARQ NEURO-PSIQUIAT, V62, P711, DOI 10.1590/S0004-282X2004000400027; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Pakkenberg B, 1997, J COMP NEUROL, V384, P312, DOI 10.1002/(SICI)1096-9861(19970728)384:2<312::AID-CNE10>3.0.CO;2-K; Papadopoulos IN, 2004, BRIT J SURG, V91, P1633, DOI 10.1002/bjs.4752; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Petroni G, 2010, J TRAUMA, V68, P564, DOI 10.1097/TA.0b013e3181ce1eed; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Raja IA, 2001, WORLD J SURG, V25, P1230; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SALGADO MSL, 1988, FORENSIC SCI INT, V36, P91, DOI 10.1016/0379-0738(88)90219-8; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Scott S, 2001, BRIT MED J, V323, P191, DOI 10.1136/bmj.323.7306.191; Shukri A A, 2006, Zh Vopr Neirokhir Im N N Burdenko, P40; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Soderstrom CA, 2001, ACCIDENT ANAL PREV, V33, P771, DOI 10.1016/S0001-4575(00)00091-9; Sommers M S, 1995, AACN Clin Issues, V6, P187; Sosin DM, 1996, BRAIN INJURY, V10, P47; STEIN DG, 1993, J NEURAL TRANSP PLAS, V4, P227, DOI 10.1155/NP.1993.227; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Thompson DC., 1999, COCHRANE DB SYST REV, V308, DOI 10.1002/14651858.CD001855; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TOLONEN J, 1984, ANN CHIR GYNAECOL FE, V73, P14; United Nations, 2010, WORLD POP AG 2009; Vilke GM, 2000, AM J EMERG MED, V18, P159, DOI 10.1016/S0735-6757(00)90009-3; Vukic M, 1999, ACTA NEUROCHIR, V141, P1203, DOI 10.1007/s007010050419; Whedon JM, 2009, J TRAUMA, V67, P822, DOI 10.1097/TA.0b013e31818c1583; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Winqvist S, 2007, NEUROEPIDEMIOLOGY, V29, P136, DOI 10.1159/000110741; Wittenberg MD, 2004, EMERG MED J, V21, P429, DOI 10.1136/emj.2003.006775; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; World Health Organization, 2009, GLOB STAT REP ROAD S; Yang YC, 1987, CHINESE J NEUROSURGE, V3, P23; Zhu GL, 1989, CHIN J NEUROSURG S, V5, P44	116	3	3	0	2	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-27-7				2013							40	52					13	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BDJ25	WOS:000313536100004					2022-02-06	
J	Tsushima, WT; Geling, O; Woo, A				Tsushima, William T.; Geling, Olga; Woo, Angelica			Comparison of Four MMPI-2 Validity Scales in Identifying Invalid Neurocognitive Dysfunction in Traumatic Brain Injury Litigants	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						litigants; MMPI-2; neurocognitive dysfunction; validity	FAKE-BAD-SCALE; HENRY-HEILBRONNER INDEX; WECHSLER-MEMORY-SCALE; BIAS; RBS; DISABILITY; UTILITY; TESTS; METAANALYSIS; SENSITIVITY	Four Minnesota Multiphasic Personality Inventory-2 (MMPI-2) validity scales, the F Scale, Symptom Validity Scale (FBS), Henry-Heilbronner Index (HHI), and Response Bias Scale (RBS), were evaluated in 60 personal injury litigants who sustained a traumatic brain injury (TBI). Based on a modified Slick, Sherman, and Iverson (1999) diagnostic criteria for malingered neurocognitive dysfunction and utilizing test-effort measures embedded in standard neuropsychological testing, a group of 23 patients with probable invalid neurocognitive dysfunction (PI) and a comparable group of 37 patients with noninvalid neurocognitive dysfunction were identified and compared with respect to their MMPI-2 validity scale scores. Logistic regression analyses, receiver-operating characteristic curve and area under the curve analyses, as well as sensitivity, specificity, positive predictive value, and negative predictive value analyses all revealed that RBS performed better than F, FBS, and HHI in classifying PIs. The present results add to a number of recent studies that suggest that RBS is a useful predictor of symptom validity failure and probable neuropsychological malingering among litigating TBI patients. The study also encourages further research employing embedded test-effort measures in classifying invalid neurocognitive dysfunction per the Slick et al. diagnostic criteria.	[Tsushima, William T.] Straub Clin & Hosp, Honolulu, HI 96813 USA; [Geling, Olga] Univ Hawaii, Honolulu, HI 96822 USA; [Woo, Angelica] Creighton Univ, Omaha, NE 68178 USA		Tsushima, WT (corresponding author), Straub Clin & Hosp, 888 South King St, Honolulu, HI 96813 USA.	wtsushima@straub.net			Hawaii Pacific Health Conference Services, Honolulu, HI	This research was supported in part by a summer scholarship awarded to Angelica Woo by the Hawaii Pacific Health Conference Services, Honolulu, HI. The study was approved by the institutional review board of the Hawaii Pacific Health Research Institute. The authors declare no conflict of interest.	Allen L., 1997, CARB 97 MANUAL COMPU; Arbisi PA, 1995, PSYCHOL ASSESSMENT, V7, P424, DOI 10.1037/1040-3590.7.4.424; Archer RP, 2006, J PERS ASSESS, V87, P84, DOI 10.1207/s15327752jpa8701_07; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; Ben-Porath YS, 2010, PSYCHOL INJ LAW, V3, P77, DOI 10.1007/s12207-009-9049-0; Berry DTR, 1995, PSYCHOL ASSESSMENT, V7, P517; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Butcher JN, 2008, PSYCHOL INJ LAW, V1, P191, DOI 10.1007/s12207-007-9002-z; Butcher JN, 2001, MMPI 2 MANUAL ADM SC; Chafetz MD, 2010, CLIN NEUROPSYCHOL, V24, P1045, DOI 10.1080/13854046.2010.481637; Cohen J., 2013, STAT POWER ANAL BEHA; ELWOOD RW, 1993, CLIN PSYCHOL REV, V13, P409, DOI 10.1016/0272-7358(93)90012-B; Etherton Joseph L, 2006, Spine J, V6, P61, DOI 10.1016/j.spinee.2005.05.382; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2010, ARCH CLIN NEUROPSYCH, V25, P274, DOI 10.1093/arclin/acq018; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Green P., 2003, GREENS WORD MEMORY T; GREENE RL, 2008, CLIN ASSESSMENT MALI, P00159; Greiffenstein M.F., 2007, ASSESSMENT FEIGNED C, P210; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Henry GK, 2008, CLIN NEUROPSYCHOL, V22, P919, DOI 10.1080/13854040701625853; Henry GK, 2006, CLIN NEUROPSYCHOL, V20, P786, DOI 10.1080/13854040500287749; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Langeluddecke PM, 2003, ARCH CLIN NEUROPSYCH, V18, P181, DOI 10.1016/S0887-6177(01)00195-0; Larrabee G.J., 2005, FORENSIC NEUROPSYCHO; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LEESHALEY PR, 1992, J CLIN PSYCHOL, V48, P681, DOI 10.1002/1097-4679(199209)48:5<681::AID-JCLP2270480516>3.0.CO;2-Q; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Nelson NW, 2010, CLIN NEUROPSYCHOL, V24, P701, DOI 10.1080/13854040903482863; Nelson NW, 2006, CLIN NEUROPSYCHOL, V20, P39, DOI 10.1080/13854040500459322; O'Bryant SE, 2006, CLIN NEUROPSYCHOL, V20, P533, DOI 10.1080/13854040590967568; Ord JS, 2008, CLIN NEUROPSYCHOL, V22, P689, DOI 10.1080/13854040701425437; Pope K.S., 2006, MMPI MMPI 2 MMPI A C; Rogers R., 2008, CLIN ASSESSMENT MALI, P411; Ross SR, 2006, CLIN NEUROPSYCHOL, V20, P798, DOI 10.1080/13854040500328477; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; Tsushima WT, 2011, CLIN NEUROPSYCHOL, V25, P1403, DOI 10.1080/13854046.2011.613854; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001; Williams CL, 2009, PSYCHOL INJ LAW, V2, P182, DOI 10.1007/s12207-009-9046-3; Wygant DB, 2010, PSYCHOL ASSESSMENT, V22, P745, DOI 10.1037/a0020042	51	3	3	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2013	20	4					263	271		10.1080/09084282.2012.701679			9	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	298ST	WOS:000330345400005	30567044				2022-02-06	
B	Viano, DC		Zasler, ND; Katz, DI; Zafonte, RD		Viano, David C.			Biomechanics of Brain Injury	BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION			English	Article; Book Chapter							PROFESSIONAL FOOTBALL; HEAD-INJURY; INTRACRANIAL PRESSURE; IMPACT PERFORMANCE; SKULL FRACTURE; CONCUSSION; ACCELERATION; PLAYERS; RESPONSES; ELEMENT		[Viano, David C.] ProBiomechanis LLC, Bloomfield, MI USA; [Viano, David C.] Wayne State Univ, Detroit, MI USA		Viano, DC (corresponding author), ProBiomechanis LLC, Bloomfield, MI USA.						ALLEN ME, 1994, SPINE, V19, P1285, DOI 10.1097/00007632-199405310-00017; [Anonymous], HEAD IMP TEL; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Begeman PC, 1980, 24 STAPP CAR CRASH C; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Broglio SP, 2011, NEW ENGL J MED, V365, P279, DOI 10.1056/NEJMc1102689; Chou CC, 1974, SAE T, P398; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Eiband A. M., 1959, 51959E NASA; EWING CL, 1969, 13 STAPP CAR CRASH C; EWING CLT, 1975, 751157 SAE; Funk JR, 2011, ANN BIOMED ENG, V39, P766, DOI 10.1007/s10439-010-0183-3; Gadd C. W, 1966, SAE TECHNICAL PAPER, DOI 10.4271/660793; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA, 1971, 15 STAPP CAR CRASH C; Goldsmith W, 2001, CRIT REV BIOMED ENG, V29, P441, DOI 10.1615/CritRevBiomedEng.v29.i56.10; Goldsmith W, 1984, BIOMECHANICS IMPACT, P149; Goldsmith Werner, 2005, Critical Reviews in Biomedical Engineering, V33, P105, DOI 10.1615/CritRevBiomedEng.v33.i2.20; GURDJIAN ES, 1975, SURG GYNECOL OBSTET, V140, P845; GURDJIAN ES, 1961, SURG GYNECOL OBSTET, V113, P185; Gurdjian ES, 1975, IMPACT HEAD INJURY M; Gurdjian ES, 1955, SURG GYNECOL OBSTET, V101, P688; HODGSON VR, 1972, 16 STAPP CAR CRASH C; Holbourn AHS, 1943, LANCET, V2, P438; Kahane C., 2006, 810739 DOT HS NAT HI; Khalil TB, 1986, MECH HEAD SPINE TRAU, P717; KING AI, 1995, BIOMEDICAL ENG HDB; Linder A, 2008, TRAFFIC INJ PREV, V9, P592, DOI 10.1080/15389580802384669; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; McElhaney J. H., 1979, 790137 SAE, P47; Mertz H J, 1978, Phys Sportsmed, V6, P95, DOI 10.1080/00913847.1978.11948406; Mertz H. J., 1996, 960099 SAE; Mertz Harold J, 2003, Stapp Car Crash J, V47, P155; Mertz HJ, 1985, SAE GOV IND M EXP SA; Mertz HJ, 1994, 941056 SAE INT; National Highway Traffic Safety Administration, 1995, FIN EC ASS FMVSS NO; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Newman JA, 1980, 24 STAPP CAR CRASH C; NEWMAN JA, 1993, ACCIDENTAL INJURY BI, P292; NEWMAN JA, 1975, 19 STAPP CAR CRASH C; Ng TP, 2006, BIOMED SCI INSTRUM, V42, P410; Ommaya A K, 1966, Ann R Coll Surg Engl, V39, P317; Ommaya A.K., 1985, BIOMECHANICS TRAUMA, P245; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; OMMAYA AK, 1995, J NEUROTRAUM, V12, P527, DOI 10.1089/neu.1995.12.527; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Parenteau CS, 2011, 2011011126 SAE; Patrick LM, 1965, 9 STAPP CAR CRASH C; Patrick LM, 1965, 7 STAPP CAR CRASH C; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Prasad AK, 2005, ESV C NHTSA USDOT; Raymond D, 2009, J BIOMECH, V42, P2479, DOI 10.1016/j.jbiomech.2009.07.018; Raymond D, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3194751; Rowson S, 2008, CLIN J SPORT MED, V18, P316, DOI 10.1097/JSM.0b013e31817f016a; SEVERY D M, 1955, Can Serv Med J, V11, P727; SIEGMUND GP, 1997, 973341 SAE; Siegmund GP, 2001, 2001220011 SAE; Smith GR, 1974, 740578 SAE; Snyder RG, 1970, 700398 SAE INT; Society of Automotive Engineers, 1986, J885 SAE; Stapp JP, 1961, GRAVITATIONAL STRESS, P165; Szabo T., 1994, 940532 SAE; Versace J., 1971, REV SEVERITY INDEX; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; VIANO DC, 1989, J BIOMECH, V22, P403, DOI 10.1016/0021-9290(89)90201-7; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; VIANO DC, 1988, J BIOMECH, V21, P387, DOI 10.1016/0021-9290(88)90145-5; VIANO DC, 1999, CRASH PREV INJ CONTR, V1, P35; Wagner R, 1979, 23 STAPP CAR CRASH C; YOGANANDAN N, 1995, J NEUROTRAUM, V12, P659, DOI 10.1089/neu.1995.12.659; Yoganandan N, 2004, CLIN BIOMECH, V19, P225, DOI 10.1016/j.clinbiomech.2003.12.014; ZHANG L., 2001, RECENT ADV BRAIN INJ	78	3	4	0	6	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-27-7				2013							124	136					13	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BDJ25	WOS:000313536100010					2022-02-06	
J	Wong, BLK; Rama, KBS; Kumar, A				Wong, Billy L. K.; Rama, Krishna Boddu Siva; Kumar, Ajeet			Simultaneous dislocation of proximal and distal radio-ulnar joints: a case report	JOURNAL OF ORTHOPAEDIC SURGERY			English	Article						radius fractures; ulna fractures	RADIAL HEAD; TRAUMATIC DISLOCATION; ANTERIOR DISLOCATION; ULNAR JOINT; ADULT; ELBOW	Simultaneous dislocation of the radial head and distal radio-ulnar joint is rare. We report a 71-year-old man with volar dislocation of the radial head and dorsal dislocation of the distal radio-ulnar joint, and discuss the injury mechanism and its management with closed reduction.	[Wong, Billy L. K.; Rama, Krishna Boddu Siva; Kumar, Ajeet] Queen Elizabeth Hosp, South London Healthcare NHS Trust, London SE18 4QH, England		Wong, BLK (corresponding author), Queen Elizabeth Hosp, South London Healthcare NHS Trust, Trauma & Orthopaed Dept, Stadium Rd, London SE18 4QH, England.	billywong@nhs.net					ALEXANDER AH, 1977, CLIN ORTHOP RELAT R, P238; BONATUS T, 1995, J ORTHOP TRAUMA, V9, P441, DOI 10.1097/00005131-199505000-00014; Corbett CH, 1931, BRIT J SURG, V19, P155, DOI 10.1002/bjs.1800197317; EDWARDS GS, 1988, CLIN ORTHOP RELAT R, P61; EVANS EM, 1949, J BONE JOINT SURG BR, V31, P578, DOI 10.1302/0301-620X.31B4.578; HOTCHKISS RN, 1989, J HAND SURG-AM, V14, P256, DOI 10.1016/0363-5023(89)90017-8; Leung YF, 2002, INJURY, V33, P271, DOI 10.1016/S0020-1383(01)00050-X; MORRISSY RT, 1979, CLIN ORTHOP RELAT R, P154; Spicer DDM, 2002, J ORTHOP TRAUMA, V16, P136, DOI 10.1097/00005131-200202000-00013; SPINNER M, 1970, ACTA ORTHOP SCAND, V41, P632, DOI 10.3109/17453677008991554; Tosun B, 2008, ARCH ORTHOP TRAUM SU, V128, P669, DOI 10.1007/s00402-007-0456-y; Verettas D-A J, 2008, Int J Med Sci, V5, P292; Vesely D G, 1967, Clin Orthop Relat Res, V50, P31; VESELY DAVID G., 1967, CLIN ORTHOP RELATED RES, V51, P75; WILEY JJ, 1974, J BONE JOINT SURG BR, VB 56, P501, DOI 10.1302/0301-620X.56B3.501	15	3	3	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2309-4990			J ORTHOP SURG-HONG K	J. Orthop. Surg.		2013	21	1					106	109		10.1177/230949901302100127			4	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	AX0AG	WOS:000346615500027	23630001	gold			2022-02-06	
J	Xiao, B; Wu, FF; Zhang, H; Ma, YB				Xiao, Bo; Wu, Fang-Fang; Zhang, Hong; Ma, Yan-Bin			Safety and efficacy of symptom-driven CT decision rule in fully conscious paediatric patients with symptoms after mild closed head trauma	EMERGENCY MEDICINE JOURNAL			English	Article							COMPUTED-TOMOGRAPHY; INTRACRANIAL INJURY; CANCER RISKS; RADIATION; CHILDREN; PREDICTION	Objects The aim of the authors is to derive a safe, effective and feasible symptom-driven CT rule in fully conscious children >= 3 years with symptoms after head trauma, based on time-framed clinical course, radiological findings, outcome measures and prognosis of patients. Methods Fully conscious but symptomatic children >= 3 years after head injury (1997-2010) with CT performance <= 2 h since injury were included in the study. Additional exclusion criteria were set for patient selection. Evolution of clinical symptoms of patients in 24 h since injury was the focus in current study. Clinical data were extracted from standardised medical records on admission and observation charts. Results Data of 1897 eligible cases were retrospectively reviewed. Traumatic brain injury (TBI) was revealed radiologically in 73 cases (3.8%). Eight cases underwent surgery. Recursive partitioning analysis identified the following factors in the CT rule: any delayed headache commenced between 4 and 10 h since injury; significantly worsening headaches present between 2 and 12 h since injury; vomiting between 6 and 12 h since injury; and headache without significant changes persisted >= 12 h since injury. It has a sensitivity of 100% (95% CI 95.0% to 100.0%) and specificity of 72.1% (95% CI 70.0% to 74.1%) to predict cases with TBI. Conclusions A symptom-driven CT rule has been derived to identify cases at high risk of having TBI in fully conscious, but symptomatic children with mild closed head injury. To be practical, an additional observation rule is added.	[Xiao, Bo; Wu, Fang-Fang; Zhang, Hong; Ma, Yan-Bin] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 3, Dept Neurosurg, Shanghai 201900, Peoples R China		Xiao, B (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 3, Dept Neurosurg, 280 Mohe Rd, Shanghai 201900, Peoples R China.	xiao977@hotmail.com					Atabaki SM, 2008, ARCH PEDIAT ADOL MED, V162, P439, DOI 10.1001/archpedi.162.5.439; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Brody AS, 2002, PEDIATR ANN, V31, P643, DOI 10.3928/0090-4481-20021001-08; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Hall EJ, 2002, PEDIATR RADIOL, V32, P700, DOI 10.1007/S00247-002-0774-8; Hall P, 2004, BMJ-BRIT MED J, V328, P19, DOI 10.1136/bmj.328.7430.19; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Infante-Rivard C, 2000, ENVIRON HEALTH PERSP, V108, P495, DOI 10.2307/3454609; Ingebrigtsen T, 1996, ACTA NEUROL SCAND, V93, P207; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; MANDEL S, 1989, POSTGRAD MED, V85, P213; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Simon B, 2001, J TRAUMA, V51, P231, DOI 10.1097/00005373-200108000-00004; Stein SC, 2006, J TRAUMA, V61, P558, DOI 10.1097/01.ta.0000233766.60315.5e; Sun BC, 2007, ANN EMERG MED, V49, P325, DOI 10.1016/j.annemergmed.2006.08.032; YAMAGUCHI M, 1992, HEADACHE, V32, P427, DOI 10.1111/j.1526-4610.1992.hed3209427.x; Yavasi O, 2011, EUR J EMERG MED, V18, P238, DOI 10.1097/MEJ.0b013e3283449119	21	3	3	2	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	JAN	2013	30	1							e10	10.1136/emermed-2011-200525			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	062CN	WOS:000312896800003	22334639				2022-02-06	
J	Allen, DN; Thaler, NS; Barchard, KA; Vertinski, M; Mayfield, J				Allen, Daniel N.; Thaler, Nicholas S.; Barchard, Kimberly A.; Vertinski, Mary; Mayfield, Joan			Factor Structure of the Comprehensive Trail Making Test in Children and Adolescents With Brain Dysfunction	PSYCHOLOGICAL ASSESSMENT			English	Article						traumatic brain injury (TBI); Comprehensive Trail Making Test; children; confirmatory factor analysis (CFA)	NEUROPSYCHOLOGICAL TEST BATTERY; CONSTRUCT-VALIDITY; CATEGORY TEST; MEMORY; ATTENTION; INJURY; IMPAIRMENT; PROFILES; TASK; FIT	The Comprehensive Trail Making Test (CTMT) is a relatively new version of the Trail Making Test that has a number of appealing features, including a large normative sample that allows raw scores to be converted to standard T scores adjusted for age. Preliminary validity information suggests that CTMT scores are sensitive to brain injury and demonstrate expected correlations with other neuropsychological tests, although the evidence also suggests that the factor structure of the CTMT may differ in children with brain dysfunction in comparison to the standardization sample. The present study addresses this matter by conducting a confirmatory factor analysis (CFA) of the CTMT in 382 children and adolescents. Of the 382, 191 were diagnosed with various forms of brain dysfunction, including 140 who had sustained a traumatic brain injury. The other 191 participants were healthy controls who were individually matched on age and gender to the clinical group with brain dysfunction. Results of the CFA indicated that for the clinical group, a 2-factor model composed of Simple Sequencing and Complex Sequencing/Shifting factors provided the best fit for the data. Although these 2 factors were also Identified in the controls, differences in pattern of loadings were present. Results suggest that the presence of brain dysfunction may alter the factor structure of the CTMT in children and adolescents.	[Allen, Daniel N.; Thaler, Nicholas S.; Barchard, Kimberly A.; Vertinski, Mary] Univ Nevada, Dept Psychol, Las Vegas, NV 89154 USA; [Mayfield, Joan] Our Childrens House Baylor, Dallas, TX USA		Allen, DN (corresponding author), Univ Nevada, Dept Psychol, 4505 Maryland Pkwy,Box 455030, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu		Allen, Daniel/0000-0003-4868-2242			AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Allen DN, 2012, PSYCHOL ASSESSMENT, V24, P556, DOI 10.1037/a0026263; Allen DN, 2010, ARCH CLIN NEUROPSYCH, V25, P618, DOI 10.1093/arclin/acq051; Allen DN, 2009, APPL NEUROPSYCHOL, V16, P262, DOI 10.1080/09084280903297727; Allen DN, 2009, CHILD NEUROPSYCHOL, V15, P543, DOI 10.1080/09297040902748234; Allen DN, 1998, SCHIZOPHR RES, V34, P87, DOI 10.1016/S0920-9964(98)00090-5; Armstrong CM, 2008, ARCH CLIN NEUROPSYCH, V23, P351, DOI 10.1016/j.acn.2007.11.004; Atkinson TM, 2008, J PSYCHOEDUC ASSESS, V26, P42, DOI 10.1177/0734282907301592; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Bauman Johnson WL, 2010, ARCH CLIN NEUROPSYCH, V25, P601, DOI 10.1093/arclin/acq049; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Byrne B. M., 2006, STRUCTURAL EQUATION; Crowe SF, 1998, J CLIN PSYCHOL, V54, P585, DOI 10.1002/(SICI)1097-4679(199808)54:5<585::AID-JCLP4>3.3.CO;2-M; DAMATO RC, 1988, J CLIN PSYCHOL, V44, P934, DOI 10.1002/1097-4679(198811)44:6<934::AID-JCLP2270440614>3.0.CO;2-2; Delis DC, 2003, J INT NEUROPSYCH SOC, V9, P936, DOI 10.1017/S1355617703960139; Demakis GJ, 2004, J CLIN EXP NEUROPSYC, V26, P441, DOI 10.1080/13803390490510149; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Fowler P C, 1987, Arch Clin Neuropsychol, V2, P81, DOI 10.1016/0887-6177(87)90035-7; GASS CS, 1990, PSYCHOL REP, V67, P435, DOI 10.2466/PR0.67.6.435-438; GOLDSTEIN G, 1966, PERCEPT MOTOR SKILL, V22, P347, DOI 10.2466/pms.1966.22.2.347; GOLDSTEIN G, 1972, PERCEPT MOTOR SKILL, V34, P603, DOI 10.2466/pms.1972.34.2.603; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Joreskog K. G., 1993, LISREL 8 USERS REFER; Kamphaus, 2003, REYNOLDS INTELLECTUA; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Krug D, 1995, INT J NEUROSCI, V83, P131, DOI 10.3109/00207459508986332; Langenecker SA, 2007, J CLIN EXP NEUROPSYC, V29, P842, DOI 10.1080/13803390601147611; LUO D, 1994, INTELLIGENCE, V18, P335, DOI 10.1016/0160-2896(94)90033-7; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; MOEHLE KA, 1990, INT J CLIN NEUROPSYC, V12, P107; Mottram L, 2006, DEV NEUROPSYCHOL, V30, P865, DOI 10.1207/s15326942dn3003_6; Pa J, 2010, J INT NEUROPSYCH SOC, V16, P640, DOI 10.1017/S1355617710000408; Park BS, 2009, APPL NEUROPSYCHOL, V16, P1, DOI 10.1080/09084280802636371; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Petrill SA, 1996, BEHAV GENET, V26, P135, DOI 10.1007/BF02359891; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; REITAN RM, 1971, PERCEPT MOTOR SKILL, V33, P575, DOI 10.2466/pms.1971.33.2.575; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; Reitan RM, 2004, ARCH CLIN NEUROPSYCH, V19, P281, DOI 10.1016/S0887-6177(03)00042-8; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; Reynolds CR, 2008, PSYCHOL SCHOOLS, V45, P875, DOI 10.1002/pits.20332; Riccio C., APPL NEUROP IN PRESS; Riccio CA, 2011, ARCH CLIN NEUROPSYCH, V26, P235, DOI 10.1093/arclin/acq105; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; RUSSELL EW, 1982, PERCEPT MOTOR SKILL, V54, P971, DOI 10.2466/pms.1982.54.3.971; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; SCHMID J, 1957, PSYCHOMETRIKA, V22, P53, DOI 10.1007/BF02289209; Smith SR, 2008, CLIN NEUROPSYCHOL, V22, P507, DOI 10.1080/13854040701399269; Steiger J. H., 1980, M PSYCH SOC IOW CIT; SWIERCINSKY DP, 1979, PERCEPT MOTOR SKILL, V48, P231, DOI 10.2466/pms.1979.48.1.231; Thaler N. S., ARCH CLIN N IN PRESS; Thaler NS, 2010, ARCH CLIN NEUROPSYCH, V25, P781, DOI 10.1093/arclin/acq073; Weber P, 2004, PEDIATR NEUROL, V31, P96, DOI 10.1016/j.pediatrneurol.2003.12.010; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wolff HG, 2005, BEHAV RES METHODS, V37, P48, DOI 10.3758/BF03206397; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013	59	3	3	0	14	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	DEC	2012	24	4					964	972		10.1037/a0028521			9	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	055NZ	WOS:000312425000017	22612648				2022-02-06	
J	Juern, JS				Juern, Jeremy S.			Removing the Critically Ill Patient from Mechanical Ventilation	SURGICAL CLINICS OF NORTH AMERICA			English	Article						Respiration, artificial; Ventilator weaning; Tracheostomy; Sedation	POSTEXTUBATION LARYNGEAL EDEMA; RANDOMIZED CONTROLLED-TRIAL; ICU PATIENTS; PNEUMONIA; SEDATION; PROTOCOL; TRACHEOSTOMY; PREVENTION; GUIDELINES; ADULT	Weaning from mechanical ventilation is usually straightforward but is occasionally challenging. Sedation must be used at the appropriate times and with appropriate dosing. A protocol that calls for a daily sedation holiday with a spontaneous breathing trial decreases time on the ventilator. Early tracheostomy is beneficial in traumatic brain injury patients. Noninvasive ventilation is most useful in patients with baseline obstructive sleep apnea and chronic obstructive pulmonary disease.	Med Coll Wisconsin, Dept Surg, Div Trauma & Crit Care, Milwaukee, WI 53226 USA		Juern, JS (corresponding author), Med Coll Wisconsin, Dept Surg, Div Trauma & Crit Care, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.	jjuern@mcw.edu					Amato M, 2009, CRITICAL CARE, P2133; Blackwood B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006904.pub2; Burns KEA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004127.pub2; Deem Steven, 2005, Respir Care, V50, P1617; DHAND R, 1995, AM J RESP CRIT CARE, V151, P1827, DOI 10.1164/ajrccm.151.6.7767526; Diedrich Daniel A, 2011, J Intensive Care Med, V26, P59, DOI 10.1177/0885066610384195; Dries DJ, 2004, J TRAUMA, V56, P943, DOI 10.1097/01.TA.0000124462.61495.45; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Holevar M, 2009, J TRAUMA, V67, P870, DOI 10.1097/TA.0b013e3181b5a960; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; Khemani RG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001000.pub3; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Kriner Eric J, 2005, Respir Care, V50, P1632; Marelich GP, 2000, CHEST, V118, P459, DOI 10.1378/chest.118.2.459; Meade M, 2001, CHEST, V120, p400S, DOI 10.1378/chest.120.6_suppl.400S; NUTMAN J, 1994, CRIT CARE MED, V22, P1591; O'Keeffe T, 2004, J TRAUMA, V57, P855, DOI 10.1097/01.TA.0000083006.48501.B2; Ramirez A, 2009, SURG OBES RELAT DIS, V5, P544, DOI 10.1016/j.soard.2009.05.007; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Rivera L, 1997, ANESTH ANALG, V84, P1250, DOI 10.1097/00000539-199706000-00015; Roberts RJ, 2008, ANN PHARMACOTHER, V42, P686, DOI 10.1345/aph.1K655; Terragni PP, 2010, JAMA-J AM MED ASSOC, V303, P1483, DOI 10.1001/jama.2010.447; Vasquez TL, 2004, OBES SURG, V14, P282, DOI 10.1381/096089204322857717; YANG KL, 1991, NEW ENGL J MED, V324, P1445, DOI 10.1056/NEJM199105233242101	25	3	4	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0039-6109	1558-3171		SURG CLIN N AM	Surg. Clin.-North Am.	DEC	2012	92	6					1475	+		10.1016/j.suc.2012.08.008			10	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	058JI	WOS:000312629500009	23153880				2022-02-06	
J	Kosty, J; Riley, J; Liang, JM; Armstead, WM				Kosty, Jennifer; Riley, John; Liang, Jiaming; Armstead, William M.			Influence of Sex and ERK MAPK on the Pressure Reactivity Index in Newborn Piglets After Fluid Percussion Injury	TRANSLATIONAL STROKE RESEARCH			English	Article						Pressure reactivity index; ERK MAPK; Sex; Autoregulation; Pediatric traumatic brain injury	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; K+ CHANNEL FUNCTION; BLOOD-FLOW; AUTOREGULATION; HYPOTENSION	Greater impairment in autoregulation is seen in male versus female piglets following fluid percussion injury (FPI). This is partially mediated by a greater upregulation of extracellular signal-related kinase mitogen-activated protein kinase (ERK MAPK). We hypothesized that these trends would be reflected by the pressure reactivity index (PRx), a clinical measure of autoregulation. We further hypothesized that PRx values would correlate well with pial artery dilatory responses to hypotension. Male and female piglets were subjected to FPI and treated with a vehicle or ERK MAPK antagonist U 0126 (1 mg/kg IV) 30 min post-injury. FPI led to upregulation of CSF ERK MAPK in untreated piglets of both sexes, however significantly higher PRx values were seen in male versus female piglets. Following administration of U 0126, elevation of ERK MAPK levels was blocked in both sexes and PRx values were significantly improved in the male. A strong correlation was seen between the PRx and pial artery vasomotor activity. These data support previous observations that male piglets demonstrate reversible ERK MAPK-mediated impairment in autoregulation following FPI, which is reflected by the PRx. The strong correlation between the PRx and pial artery vasomotor activity supports the practice of continuously monitoring cerebrovascular autoregulation in patients using this index.	[Kosty, Jennifer; Riley, John; Armstead, William M.] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Liang, Jiaming] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu		Riley, John/0000-0002-7932-8935	National Institute of Health-National Institute of Neurological Disorders and Stroke T-32 Predoctoral Training grant;  [RO1HD57355]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD057355] Funding Source: NIH RePORTER	This work was funded by a National Institute of Health-National Institute of Neurological Disorders and Stroke T-32 Predoctoral Training grant (JK) and RO1HD57355 (WMA).	Armstead WM, 2011, J NEUROTRAUM, V28, P105, DOI 10.1089/neu.2010.1581; Armstead WM, 2010, CRIT CARE MED, V38, P1868, DOI 10.1097/CCM.0b013e3181e8ac1a; Armstead WM, 2010, J NEUROTRAUM, V27, P391, DOI 10.1089/neu.2009.1094; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 1997, STROKE, V28, P2273, DOI 10.1161/01.STR.28.11.2273; Armstead WM, 2009, J CEREB BLOOD FLOW M, V29, P543; Atabaki SM, 2007, PEDIATR REV, V28, P215, DOI 10.1542/pir.28-6-215; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Chesnut RM, 1997, J TRAUMA, V42, pS4, DOI 10.1097/00005373-199705001-00002; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002; Donders J, 2003, J HEAD TRAUMA REHAB, V18, P106, DOI 10.1097/00001199-200303000-00002; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Duhaime AC, 1999, EXP TOXICOL PATHOL, V51, P172, DOI 10.1016/S0940-2993(99)80091-8; Faul M, 2010, TRAUMATIC BRAIN INJU; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P643, DOI 10.3109/02688699308995093; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Kasemsri T, 1997, AM J PHYSIOL-HEART C, V273, pH2639; Kasemsri T, 1997, STROKE, V28, P190, DOI 10.1161/01.STR.28.1.190; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; PAMPIGLIONE G, 1971, P ROY SOC MED, V64, P429, DOI 10.1177/003591577106400441; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Vavilala MS, 2006, DEV NEUROSCI-BASEL, V28, P348, DOI 10.1159/000094161; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	33	3	3	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1868-4483	1868-601X		TRANSL STROKE RES	Transl. Stroke Res.	DEC	2012	3	4					460	465		10.1007/s12975-012-0196-3			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	041MX	WOS:000311407000007	23525515	Green Accepted			2022-02-06	
J	Li, HW; Chang, HF; Yu, YM; Dai, GX; Yin, ZY				Li Hong-wei; Chang Hong-fa; Yu Yong-min; Dai Guo-xin; Yin Zhi-yong			Forensic medical study on morphology and formative mechanism of blunt head injury	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Brain; Head injuries, closed; Craniocerebral trauma; Forensic medicine		Objective: To study the patterns and morphologic characteristics of blunt head injury and analyse its formative mechanism in attempt to provide references for medicolegal expertise. Methods: The statistical analysis was done in terms of gender, age, as well as the nature, pattern, location, and feature of the injuries. Results: Among the 202 cases of head injury-induced death, 124 were male and 78 female with the age ranging from 1-81 years. Death caused by homicide was dominant (106, 52.5%), followed by suicide (49, 24.3%) and accident (44, 21.8%). The majority of suicide-induced death were by falling from height, and traffic crash was responsible for majority of unexpected death cases. The morphology and pathogenesis of the injuries varied according to differences on the mode, magnitude, and orientation of the outside force giving rise to blunt injury as well as the character of vulnerants. Conclusion: Studies on the morphology and its formative rationale of blunt head injury will offer easy access to medicolegal expertise on the mode and character of the injury.	[Li Hong-wei; Chang Hong-fa; Yu Yong-min; Dai Guo-xin] Evidence Identificat Ctr Chongqing, Publ Secur Bur, Chongqing 400021, Peoples R China; [Yin Zhi-yong] Third Militeray Med Univ, Inst Surg Res, Daping Hosp, Chongqing 400042, Peoples R China		Yin, ZY (corresponding author), Third Militeray Med Univ, Inst Surg Res, Daping Hosp, Chongqing 400042, Peoples R China.	zyyin@cta.cq.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31170908, 31271006, 81072504, 30800243]; Natural Science Foundation of Chongqing of ChinaNatural Science Foundation of Chongqing [CSTC2009AB0208]; Key Projects Foundation of the Ministry of Public Security [2009 ZDYJCQSJ007]	The paper was supported by the National Natural Science Foundation of China (31170908, 31271006, 81072504 and 30800243), the Natural Science Foundation of Chongqing of China (CSTC2009AB0208) and the Key Projects Foundation of the Ministry of Public Security (2009 ZDYJCQSJ007).	Bouderka MA, 2004, J TRAUMA, V57, P251, DOI 10.1097/01.TA.0000087646.68382.9A; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; McNair ND, 1999, NURS CLIN N AM, V34, P637; Neuwelt E, 2008, LANCET NEUROL, V7, P84, DOI 10.1016/S1474-4422(07)70326-5; Pintar F A, 2001, Biomed Sci Instrum, V37, P429; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295	8	3	3	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	DEC	2012	15	6					342	345		10.3760/cma.j.issn.1008-1275.2012.06.005			4	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VF1GM	WOS:000442002300005	23186923				2022-02-06	
J	Luna-Lario, P; Seijas-Gomez, R; Tirapu-Ustarroz, J; Hernaez-Goni, P; Mata-Pastor, I				Luna-Lario, Pilar; Seijas-Gomez, Raquel; Tirapu-Ustarroz, Javier; Hernaez-Goni, Pilar; Mata-Pastor, Ignacio			Factorial structure of the dysexecutive questionnaire in a sample of the Spanish population with acquired brain injury and memory deficit complaints	REVISTA DE NEUROLOGIA			Spanish	Article						Acquired brain injury; DEX; Dysexecutive questionnaire; Executive deficits; Memory loss	ECOLOGICAL VALIDITY; EXECUTIVE FUNCTIONS; SUBSTANCE-ABUSERS; FRONTAL SYMPTOMS; TEMPORAL-LOBE; DEX; LESIONS; NEUROPSYCHOLOGY; BEHAVIOR; VERSION	Introduction and aims. The dysexecutive questionnaire (DEX) has been used to study executive deficits in both clinical samples (both psychiatric and neurological) and non-clinical samples, although agreement on its factorial structure is lacking. The aim of this research is to study that structure in the self-administered version in a sample of the Spanish population with acquired brain injury and memory loss complaints, and to compare that solution with those obtained in other studies. Patients and methods. The questionnaire was administered to 119 subjects with acquired brain injury with different aetiologies (traumatic, vascular, tumours, multiple sclerosis, toxic-metabolic and others). Results. The Cronbach's alpha coefficient was 0.88. All the items showed adequate discriminatory power, except item 15. No relation was found between the total score on the DEX and the age, gender and time elapsed since the injury. A negative correlation between total score and level of schooling was confirmed. The total score does not follow a normal distribution. The five-factor solution accounts for a higher percentage of the total variance than those of two, three and four factors (63.76%). Conclusions. The Spanish version of the DEX is an instrument that is valid for evaluating general dysexecutive symptoms in subjects with acquired brain injury. The five-factor factorial structure (planning, cognitive control, inhibition, social awareness and impulse control) offers a greater wealth of information because it measures more aspects of the dysexecutive pathology and therefore appears to be more useful in the clinical setting. It is advisable to use the questionnaire in an early stage of evaluation or screening and to use it as a complement to the proxy-reported version.	[Tirapu-Ustarroz, Javier] Complejo Hosp Navarra, Fdn Argibide, Clin Ubarmin, Serv Neuropsicol, E-31486 Elcano, Navarra, Spain; [Luna-Lario, Pilar; Tirapu-Ustarroz, Javier; Hernaez-Goni, Pilar] Complejo Hosp Navarra, Serv Navarro Salud, Elcano, Navarra, Spain; [Seijas-Gomez, Raquel] Hosp Univ Son Espases, Palma De Mallorca, Baleares, Spain		Tirapu-Ustarroz, J (corresponding author), Complejo Hosp Navarra, Fdn Argibide, Clin Ubarmin, Serv Neuropsicol, Elcano S-N, E-31486 Elcano, Navarra, Spain.	jtirapuu@cfnavarra.es					Amieva H, 2003, BRAIN COGNITION, V53, P129, DOI 10.1016/S0278-2626(03)00094-0; Benedet M., 1998, TEST APRENDIZAJE VER; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P376, DOI 10.1017/S1355617705050423; Bisiachi PS, 1996, PROSPECTIVE MEMORY T, P199; Bodenburg S, 2008, J NERV MENT DIS, V196, P75, DOI 10.1097/NMD.0b013e31815faa2b; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Chan RCK, 2001, BRIT J PSYCHOL, V92, P551, DOI 10.1348/000712601162338; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chaytor N, 2007, BRAIN INJURY, V21, P615, DOI 10.1080/02699050701426949; Dobbins IG, 2002, NEURON, V35, P989, DOI 10.1016/S0896-6273(02)00858-9; Dobbs AR, 1996, PROSPECTIVE MEMORY T, P199; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Fuster J., 1989, PREFRONTAL CORTEX AN; Garcia-Molina A, 2007, AN PSICOL-SPAIN, V23, P289; Gerstorf D, 2008, AGING NEUROPSYCHOL C, V15, P424, DOI 10.1080/13825580701640374; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Jurado MA, 1997, NEUROPSYCHOLOGIA, V35, P635, DOI 10.1016/S0028-3932(96)00112-1; Jurica PJ, 1999, MEM COGNITION, V27, P648, DOI 10.3758/BF03211558; Kopelman MD, 1997, NEUROPSYCHOLOGIA, V35, P1533, DOI 10.1016/S0028-3932(97)00076-6; Larson MJ, 2006, J CLIN EXP NEUROPSYC, V28, P968, DOI 10.1080/13803390600646860; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Llanero-Luque M, 2008, REV NEUROLOGIA, V47, P457, DOI 10.33588/rn.4709.2008257; McDaniel MA, 1999, NEUROPSYCHOLOGY, V13, P103, DOI 10.1037/0894-4105.13.1.103; Mooney B, 2006, APPL NEUROPSYCHOL, V13, P12, DOI 10.1207/s15324826an1301_2; Nolde SF, 1998, NEUROREPORT, V9, P3509, DOI 10.1097/00001756-199810260-00032; NORMAN DA, 1980, TECHNICAL REPORT, P99; Perez EJP, 2009, ADICCIONES, V21, P155, DOI 10.20882/adicciones.243; Pedrero-Perez EJ, 2009, REV NEUROLOGIA, V48, P624, DOI 10.33588/rn.4812.2008654; Pedrero-Perez EJ, 2011, REV NEUROLOGIA, V52, P394, DOI 10.33588/rn.5207.2010731; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Petrides M, 1994, HDB NEUROPSYCHOLOGY, V9, P59; Petrides M., 1998, PREFRONTAL CORTEX EX, P103; Postle BR, 2001, COGN AFFECT BEHAV NE, V1, P10, DOI 10.3758/CABN.1.1.10; Rugg MD, 1999, NEUROIMAGE, V10, P520, DOI 10.1006/nimg.1999.0488; de Leon JMS, 2010, ADICCIONES, V22, P233, DOI 10.20882/adicciones.184; de Leon JMRS, 2010, REV NEUROLOGIA, V51, P650, DOI 10.33588/rn.5111.2010270; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; SUNDERLAND A, 1984, J CLIN NEUROPSYCHOL, V6, P127, DOI 10.1080/01688638408401204; Tirapu-Ustarroz J, 2007, REV NEUROLOGIA, V44, P479, DOI 10.33588/rn.4408.2006295; Tirapu-Ustarroz J, 2005, REV NEUROLOGIA, V41, P475, DOI 10.33588/rn.4108.2005240; Tirapu-Ustarroz J, 2012, NEUROPSICOLOGIA CORT, P87, DOI 10.1016/B978-84-458-2066-7.00007-0.; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Vilkki J, 1998, NEUROPSYCHOLOGY, V12, P268, DOI 10.1037/0894-4105.12.2.268; Wechsler D., 2004, ESCALA MEMORIA WECHS; Wilson B, 1989, RIVERMEAD BEHAV MEMO; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014	50	3	3	1	9	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	DEC 1	2012	55	11					641	650		10.33588/rn.5511.2012549			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	069AJ	WOS:000313407000001	23172090				2022-02-06	
J	Martelli, M; Barban, F; Zoccolotti, P; Silveri, MC				Martelli, Marialuisa; Barban, Francesco; Zoccolotti, Pierluigi; Silveri, Maria Caterina			Slowing of Information Processing in Alzheimer Disease: Motor as Well as Cognitive Factors	COGNITIVE AND BEHAVIORAL NEUROLOGY			English	Article						reaction times; information processing; Sternberg paradigm; noncognitive components; Alzheimer disease	TRAUMATIC BRAIN-INJURY; ATTENTIONAL PROCESSES; VISUAL-SEARCH; DEMENTIA; TIME; SPEED; PERFORMANCE; MEMORY; INDIVIDUALS; DIAGNOSIS	Objective: To use Sternberg's Additive Factor Method to determine whether patients with mild Alzheimer disease (AD) are slow in information processing and/or response execution. Methods: We gave an odd-even categorization task to 16 patients with probable mild AD and 17 age-matched healthy controls. We recorded reaction and movement times to stimuli varying for noise, target set size, stimulus-response compatibility, and fore-period interval, to probe the cognitive and motor stages of information processing. Results: Both groups performed the task accurately, indicating good preservation of odd-even categorization in mild AD. The AD group's reaction times were similar to the controls' across conditions, and not selectively affected in any of the cognitive stages of the Additive Factor Method. However, the AD group's movement times were slower than the controls' across conditions. Conclusions: AD patients' performance on a task requiring categorization ability was slowed more by motor than cognitive components of information processing. When evaluating the performance of patients with AD in reaction-time paradigms, we should not attribute group differences solely to differences in cognitive processing. Execution components should also be considered.	[Martelli, Marialuisa; Zoccolotti, Pierluigi] Fdn Santa Lucia, Ist Ricovero & Cura Carattere Sci, Neuropsychol Unit, Rome, Italy; [Martelli, Marialuisa; Zoccolotti, Pierluigi] Univ Roma La Sapienza, Dept Psychol, I-00185 Rome, Italy; [Barban, Francesco; Silveri, Maria Caterina] Catholic Univ, Ctr Med Aging, Memory Clin, Rome, Italy		Martelli, M (corresponding author), Univ Roma La Sapienza, Dept Psychol, Via Marsi 78, I-00185 Rome, Italy.	marialuisa.martelli@uniroma1.it	Martelli, Marialuisa/J-5757-2012; Zoccolotti, Pierluigi/H-4437-2019	Martelli, Marialuisa/0000-0001-7806-9540; Zoccolotti, Pierluigi/0000-0002-6351-2455	Italian Department of Health; Italian Department of Education, University and Research (Ministero dell'Istruzione, dell'Universita e della Ricerca); European CommissionEuropean CommissionEuropean Commission Joint Research Centre [MRTN-CT-2004-512141]	Supported by a grant from the Italian Department of Health to the Istituto Di Ricovero e Cura a Carattere Scientifico Fondazione Santa Lucia and a PRIN (Ricerche di Rilevante Interesse Nazionale) 2005 grant from the Italian Department of Education, University and Research (Ministero dell'Istruzione, dell'Universita e della Ricerca) to M.C.S.; P.Z. is a member of the Marie Curie Research and Training Network: Language and Brain (RTN-lab), funded by the European Commission (MRTN-CT-2004-512141) as part of its Sixth Framework Programme.	Baddeley AD, 2001, BRAIN, V124, P1492, DOI 10.1093/brain/124.8.1492; BOAZ TL, 1993, PSYCHOL AGING, V8, P294, DOI 10.1037/0882-7974.8.2.294; Bonin-Guillaume S, 2000, CAH PSYCHOL COGN, V19, P245; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cohen J., 2013, STAT POWER ANAL BEHA; COLES MGH, 1985, J EXP PSYCHOL HUMAN, V11, P529, DOI 10.1037/0096-1523.11.5.529; Cronin-Golomb A, 2007, CORTEX, V43, P952, DOI 10.1016/S0010-9452(08)70693-2; DEARY IJ, 1991, BRAIN, V114, P2543, DOI 10.1093/brain/114.6.2543; Di Russo F, 2005, J NEUROTRAUM, V22, P297; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Ferraro FR, 1999, AGING NEUROPSYCHOL C, V6, P260, DOI 10.1076/1382-5585(199912)06:04;1-B;FT260; FILOTEO JV, 1992, J CLIN EXP NEUROPSYC, V14, P871, DOI 10.1080/01688639208402541; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foster JK, 1999, NEUROPSYCHOLOGY, V13, P223, DOI 10.1037/0894-4105.13.2.223; Gail A, 2006, J NEUROSCI, V26, P9376, DOI 10.1523/JNEUROSCI.1570-06.2006; Graham N. V. S, 1989, VISUAL PATTERN ANAL; HASBROUCQ T, 1995, J MOTOR BEHAV, V27, P251, DOI 10.1080/00222895.1995.9941715; Incoccia C, 2004, CORTEX, V40, P111, DOI 10.1016/S0010-9452(08)70924-9; Jentzsch I, 2007, J EXP PSYCHOL HUMAN, V33, P610, DOI 10.1037/0096-1523.33.3.610; Kerr B, 1998, AGING-CLIN EXP RES, V10, P401, DOI 10.1007/BF03339887; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Leuthold H, 2002, BIOL PSYCHOL, V60, P173, DOI 10.1016/S0301-0511(02)00032-7; Leuthold H, 1996, J EXP PSYCHOL GEN, V125, P307, DOI 10.1037/0096-3445.125.3.307; Lien MC, 2002, PSYCHON B REV, V9, P212, DOI 10.3758/BF03196277; MCCLELLAND JL, 1979, PSYCHOL REV, V86, P287, DOI 10.1037/0033-295X.86.4.287; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mendez MF, 1997, BRAIN COGNITION, V34, P301, DOI 10.1006/brcg.1997.0923; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Myerson J, 2003, PSYCHON B REV, V10, P262, DOI 10.3758/BF03196491; NEBES RD, 1992, J CLIN EXP NEUROPSYC, V14, P317, DOI 10.1080/01688639208402831; PARASURAMAN R, 1992, BRAIN, V115, P711, DOI 10.1093/brain/115.3.711; PATE DS, 1994, COGN NEUROPSYCHOL, V11, P321, DOI 10.1080/02643299408251978; Pelli DG, 2006, VISION RES, V46, P4646, DOI 10.1016/j.visres.2006.04.023; PELLI DG, 1988, CLIN VISION SCI, V2, P187; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; Pignatti R, 2005, J CLIN EXP NEUROPSYC, V27, P436, DOI 10.1080/13803390490520427; Ratcliff R, 2004, PSYCHON B REV, V11, P755, DOI 10.3758/BF03196631; Ratcliff R, 2000, PSYCHON B REV, V7, P1, DOI 10.3758/BF03210723; Resulaj A, 2009, NATURE, V461, P263, DOI 10.1038/nature08275; Robertson I., 1994, TEST EVERYDAY ATTENT; Rosler A, 2005, CORTEX, V41, P512, DOI 10.1016/S0010-9452(08)70191-6; Salthouse TA, 2000, DEBATES PSYCHOL, P19; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; SIMON JR, 1978, J GERONTOL, V33, P553, DOI 10.1093/geronj/33.4.553; Spivey MJ, 2007, CONTINUITY MIND; Sternberg S, 2001, ACTA PSYCHOL, V106, P147, DOI 10.1016/S0001-6918(00)00045-7; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Tales A, 2004, NEUROPSYCHOLOGIA, V42, P335, DOI 10.1016/j.neuropsychologia.2003.08.002; Tales A, 2002, NEUROPSYCHOLOGIA, V40, P1849, DOI 10.1016/S0028-3932(02)00073-8; Tippett WJ, 2006, BRAIN RES, V1102, P92, DOI 10.1016/j.brainres.2006.04.049; Townsend JT, 2004, PERCEPT PSYCHOPHYS, V66, P953, DOI 10.3758/BF03194987	53	3	3	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1543-3633	1543-3641		COGN BEHAV NEUROL	Cogn. Behav. Neurol.	DEC	2012	25	4					175	185		10.1097/WNN.0b013e318274fc44			11	Behavioral Sciences; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	062TB	WOS:000312944200004	23277138				2022-02-06	
J	Nadig, AS; King, AT				Nadig, Adarsh S.; King, Andrew T.			Traumatic extradural haematoma revealed after contralateral decompressive craniectomy	BRITISH JOURNAL OF NEUROSURGERY			English	Article						traumatic extradural haematoma; contralateral extradural haematoma; decompressive craniectomy; head trauma; temporal bone fracture		Traumatic extradural haematoma following a severe head injury is well documented in neurosurgical literature. We report a case of traumatic extradural haematoma which initially was concealed by the high intracranial pressure (ICP) and revealed after the contralateral decompressive craniectomy. A 21-year-old roofer sustained severe head injury from a fall. The CT brain showed right sided fronto-temporal contusions with small acute subdural haematoma and left orbital roof fracture extending into the temporal bone. ICP was above 45 mmHg even after maximal medical therapy. Decompressive craniectomy was performed on the right side along with contusionectomy. Within an hour, ICP spiked and the CT brain showed left side extradural haematoma. The second surgery demonstrated a bleeding middle meningeal artery associated with the left temporal bone fracture. The clinical sequence of events, radiological and operative findings revealed this to be a traumatic extradural haematoma sustained at the initial trauma. This was revealed after the tamponade effect was released from the initial decompressive craniectomy on the contralateral side.	[Nadig, Adarsh S.; King, Andrew T.] Greater Manchester Neurosci Ctr, Dept Neurosurg, Salford M6 8HD, Lancs, England		Nadig, AS (corresponding author), Greater Manchester Neurosci Ctr, Dept Neurosurg, 2nd Floor,Stott Lane, Salford M6 8HD, Lancs, England.	anomaly77@doctors.org.uk; andrew.king@srft.nhs.uk	King, Andrew/AAR-1656-2020	King, Andrew/0000-0002-6546-7248			Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Sahuquillo J, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Su TM, 2008, J TRAUMA, V65, P1298, DOI 10.1097/TA.0b013e31815885d9	3	3	3	0	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0268-8697			BRIT J NEUROSURG	Br. J. Neurosurg.	DEC	2012	26	6					877	879		10.3109/02688697.2012.697217			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	043KY	WOS:000311543700018	22762248				2022-02-06	
J	Potter, M; Wang, A				Potter, Michael; Wang, Angela			Simultaneous Dislocation of the Radiocapitellar and Distal Radioulnar Joints Without Fracture: Case Report	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Article						Dislocation; distal radioulnar; radiocapitellar		Simultaneous dislocation of the distal radioulnar joint and the radial head without fracture is an uncommon injury. Prior reports have described closed treatment of this injury. We report a case of paired dislocation without fracture that required open reduction of both articulations in the acute setting. Potential mechanisms responsible for this pattern and recommendations for management of similar patients are described. Copyright (C) 2012 by the American Society for Surgery of the Hand. All rights reserved.	[Potter, Michael; Wang, Angela] Univ Utah, Dept Orthopaed Surg, Salt Lake City, UT 84108 USA		Wang, A (corresponding author), Univ Utah, Dept Orthopaed Surg, 590 Wakara Way, Salt Lake City, UT 84108 USA.	angela.wang@hsc.utah.edu					ESSEXLOPRESTI P, 1951, J BONE JOINT SURG BR, V33, P244, DOI 10.1302/0301-620X.33B2.244; Leung YF, 2002, INJURY, V33, P271, DOI 10.1016/S0020-1383(01)00050-X; Malik AK, 2005, INJURY, V36, P324, DOI 10.1016/j.injury.2004.02.018; Mulford Jonathan S, 2010, J Trauma, V68, pE23, DOI 10.1097/TA.0b013e3181568db2; PAPAGEORGIOU C, 1995, ACTA ORTHOP SCAND, V66, P180, DOI 10.3109/17453679508995519; Pfaeffle HJ, 2000, J HAND SURG-AM, V25A, P683, DOI 10.1053/jhsu.2000.9416; Spicer DDM, 2002, J ORTHOP TRAUMA, V16, P136, DOI 10.1097/00005131-200202000-00013; Tosun B, 2008, ARCH ORTHOP TRAUM SU, V128, P669, DOI 10.1007/s00402-007-0456-y; Verettas D-A J, 2008, Int J Med Sci, V5, P292	9	3	3	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0363-5023	1531-6564		J HAND SURG-AM	J. Hand Surg.-Am. Vol.	DEC	2012	37A	12					2502	2505		10.1016/j.jhsa.2012.08.004			4	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	V34LX	WOS:000209089000009	23044481				2022-02-06	
J	Sample, PL; Greene, D; Johns, NR				Sample, Pat L.; Greene, David; Johns, Nikole R.			Life-Bombing-Injury-Life: A qualitative follow-up study of Oklahoma City bombing survivors with TBI	BRAIN INJURY			English	Article						Support; work; services; employment; traumatic brain injury; post-traumatic stress disorder; PTSD	PERCEPTIONS; AFGHANISTAN; IRAQ	Primary objective: To learn about and come to an understanding of the recovery process and outcomes experienced by the survivors of the 1995 Oklahoma City bombing, who sustained a traumatic brain injury (TBI) along with other injuries in the blast. Research design: A phenomenological study was conducted using in-person interviews, document and video-tape review, internet communication and researcher journals as the primary data set. Methods and procedures: A total of 20 of the 46 bombing survivors with TBI (44%) agreed to be a part of the study. The data collection process focused on stories about service needs, services accessed and long-term outcomes of the participants. Main outcome and results: The researchers' data analysis yielded four themes (Trauma-Healing-Support; What TBI?; How I went back to work and life; Now I really need assistance!) that represented the content and meanings of the interviews and supplemental data. Conclusions: A common thread running through the interviews of survivors with TBI was their portrayal of life-long medical, emotional, vocational and residential needs since the bombing. What they experienced in the months-extending into years-after the bombing was beyond their own anticipation and that of their families and healthcare professionals.	[Sample, Pat L.; Greene, David; Johns, Nikole R.] Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA		Greene, D (corresponding author), Colorado State Univ, Dept Occupat Therapy, 213 Occupat Therapy Bldg, Ft Collins, CO 80523 USA.	david.greene@colostate.edu			Oklahoma State Department of Health; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U17/CCU624802]	This study was funded in part by the Oklahoma State Department of Health, with grant funds from the Centers for Disease Control and Prevention (Grant # U17/CCU624802). The opinions expressed in this article do not necessarily represent the opinions of either of the granting agencies.	[Anonymous], 2005, OKLAHOMA TODAY MAGAZ; Anteau C M, 1997, Crit Care Nurs Clin North Am, V9, P231; Benight CC, 2000, J APPL SOC PSYCHOL, V30, P1331, DOI 10.1111/j.1559-1816.2000.tb02523.x; Cavanaugh L, 2001, TAPESTRY VIDEO KFOR; Clark Anne E., 2006, MUSEUM WALKING TOUR; Darragh AR, 2001, AM J OCCUP THER, V55, P191, DOI 10.5014/ajot.55.2.191; Folkman S., 1984, STRESS; Glenshaw MT, 2009, J TRAUMA, V66, P508, DOI 10.1097/TA.0b013e31815d9b72; Hersley J, 2004, SIMPLE TRUTHS REAL S; Hogan DE, 1999, ANN EMERG MED, V34, P160, DOI 10.1016/S0196-0644(99)70224-6; Injury Prevention Services-Oklahoma State Department of Health, 1996, INV PHYS INJ DIR ASS; Kight M., 1995, FOREVER CHANGED REME; Linenthal, 2003, UNFINISHED BOMBING O; Mallonee S, 1996, JAMA-J AM MED ASSOC, V276, P382, DOI 10.1001/jama.276.5.382; Maningas P A, 1997, Prehosp Disaster Med, V12, P80; Moustakas C.E., 1994, PHENOMENOLOGICAL RES; North C S, 2001, Mil Med, V166, P51; North Carol S, 2004, Ann Clin Psychiatry, V16, P209, DOI 10.1080/10401230490522034; North CS, 1999, JAMA-J AM MED ASSOC, V282, P755, DOI 10.1001/jama.282.8.755; North CS, 2002, J TRAUMA STRESS, V15, P171, DOI 10.1023/A:1015286909111; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Pfefferbaum B, 1999, J AM ACAD CHILD PSY, V38, P1372, DOI 10.1097/00004583-199911000-00011; Pfefferbaum B, 2001, Mil Med, V166, P49; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Teague DD, 2004, CLIN ORTHOP RELAT R, V422, P77; Walilko T, 2009, J TRAUMA, V67, P131; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	29	3	3	1	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2012	26	13-14					1670	1683		10.3109/02699052.2012.700090			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	041RU	WOS:000311419700013	22823537				2022-02-06	
J	Thalayasingam, M; Veerakumarasivam, A; Kulanthayan, S; Khairuddin, F; Cheah, IGS				Thalayasingam, M.; Veerakumarasivam, A.; Kulanthayan, S.; Khairuddin, F.; Cheah, I. G. S.			Clinical clues for head injuries amongst Malaysian infants: Accidental or non-accidental?	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Accidental and non accidental head injury; Infants; Child abuse; Subdural haemorrhage	SHAKEN BABY SYNDROME; TRAUMATIC BRAIN-INJURY; YOUNG-CHILDREN; SUBDURAL HEMORRHAGE; CEREBRAL TRAUMA; ABUSE; FRACTURES; OUTCOMES	Identifying the differences between infants with non-accidental head injuries (NAHI) and accidental head injuries (AHI) may help alert clinicians to recognize markers of abuse. A retrospective review of infants < 1 year of age admitted to a tertiary referral centre in Malaysia over a two year period with a diagnosis of head injury or abnormal computed tomography head scans was conducted to identify the clinical features pointing towards a diagnosis of NAHI by comparing the socio-demographics, presenting complaints, clinical features and the extent of hospital investigations carried out. NAHI infants were more likely to be symptomatic, under a non-related caregiver's supervision, and presented with inconsistent or no known mechanism of injury. Subdural haemorrhages were more common in NAHI infants. The history, mechanism of injury, presenting signs and symptoms as well as the nature of the injuries sustained are all valuable clues as to whether a head injury sustained during infancy is likely to be accidental or not. (C) 2012 Elsevier Ltd. All rights reserved.	[Thalayasingam, M.] Univ Putra Malaysia, Dept Pediat, Fac Med & Hlth Sci, Serdang 43400, Selangor Darul, Malaysia; [Veerakumarasivam, A.] Perdana Univ, Grad Sch Med, Serdang 43400, Selangor Darul, Malaysia; [Kulanthayan, S.] Univ Putra Malaysia, Dept Community Hlth, Fac Med & Hlth Sci, Serdang 43400, Selangor Darul, Malaysia; [Veerakumarasivam, A.; Khairuddin, F.] Univ Putra Malaysia, Med Genet Lab, Fac Med & Hlth Sci, Serdang 43400, Selangor Darul, Malaysia; [Cheah, I. G. S.] Hosp Kuala Lumpur, Dept Pediat, Inst Pediat, Kuala Lumpur 50586, Malaysia		Thalayasingam, M (corresponding author), Univ Putra Malaysia, Dept Pediat, Fac Med & Hlth Sci, Serdang 43400, Selangor Darul, Malaysia.	drmeerat@yahoo.com	Veerakumarasivam, Abhi/AAX-3876-2020; Cheah, Irene/ABE-7730-2020	Veerakumarasivam, Abhi/0000-0002-2676-1815; 			Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; Cadzow SP, 2000, J PAEDIATR CHILD H, V36, P322, DOI 10.1046/j.1440-1754.2000.00515.x; CHEAH IGS, 1994, ANN TROP PAEDIATR, V14, P325, DOI 10.1080/02724936.1994.11747737; Department of Statistics Malaysia, 2010, MONTHL STAT B MAL JA; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; GALLAGHER SS, 1984, AM J PUBLIC HEALTH, V74, P1340, DOI 10.2105/AJPH.74.12.1340; Gerber P, 2007, CHILD NERV SYST, V23, P499, DOI 10.1007/s00381-006-0267-4; Green MA, 1996, BRIT J OPHTHALMOL, V80, P282, DOI 10.1136/bjo.80.4.282; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; Hobbs C, 2005, ARCH DIS CHILD, V90, P952, DOI 10.1136/adc.2003.037739; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Kairys SW, 2001, PEDIATRICS, V108, P206; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kelly P, 2008, J PAEDIATR CHILD H, V44, P99, DOI 10.1111/j.1440-1754.2007.01234.x; Kemp AM, 2002, ARCH DIS CHILD, V86, P98, DOI 10.1136/adc.86.2.98; King WJ, 2003, CAN MED ASSOC J, V168, P155; KRUGMAN RD, 1993, PEDIATRICS, V92, P872; Lee A. C. W., 1999, Hong Kong Medical Journal, V5, P337; Levin A, 2000, ADV PEDIATR, V18, P151; Linnan M, 2007, INNOCENTI WORKING PA; Marret MJ, 2000, MALAYSIAN J PEDIAT C, V12, P42; Mei-Zahav M, 2002, ARCH DIS CHILD, V86, P334, DOI 10.1136/adc.86.5.334; MESERVY CJ, 1987, AM J ROENTGENOL, V149, P173, DOI 10.2214/ajr.149.1.173; Morad Y, 2002, AM J OPHTHALMOL, V134, P354, DOI 10.1016/S0002-9394(02)01628-8; Nakagawa TA, 2004, CONT PEDIAT, V21, P37; Organization W.H, 2008, GLOBAL BURDEN DIS 20; Sane SM, 2000, PEDIATRICS, V105, P1345; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; US Department of Health and Human Services, 2001, CHILD MALTREATMENT; WALLER AE, 1989, AM J PUBLIC HEALTH, V79, P310, DOI 10.2105/AJPH.79.3.310	34	3	3	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	DEC	2012	43	12					2083	2087		10.1016/j.injury.2012.02.010			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	028XM	WOS:000310458600020	22424957				2022-02-06	
J	Chung, U; Seo, JS; Kim, YH; Son, GH; Hwang, JJ				Chung, Ukhee; Seo, Joong-Seok; Kim, Yu-Hoon; Son, Gi Hoon; Hwang, Juck-Joon			Quantitative analyses of postmortem heat shock protein mRNA profiles in the occipital lobes of human cerebral cortices: Implications in cause of death	MOLECULES AND CELLS			English	Article						cause of death; heat shock protein (HSP); molecular pathology; mRNA; postmortem brain tissue	ENDOTHELIAL GROWTH-FACTOR; GENE-EXPRESSION ANALYSIS; MOUSE-BRAIN; MICROARRAY; QUALITY; STRESS; FAMILY; HEAT-SHOCK-PROTEIN-70; DEGRADATION; TRANSCRIPTS	Quantitative RNA analyses of autopsy materials to diagnose the cause and mechanism of death are challenging tasks in the field of forensic molecular pathology. Alterations in mRNA profiles can be induced by cellular stress responses during supravital reactions as well as by lethal insults at the time of death. Here, we demonstrate that several gene transcripts encoding heat shock proteins (HSPs), a gene family primarily responsible f or cellular stress responses, can be differentially expressed in the occipital region of postmortem human cerebral cortices with regard to the cause of death. HSPA2 mRNA levels were higher in subjects who died due to mechanical asphyxiation (ASP), compared with those who died by traumatic injury (TI). By contrast, HSPA7 and A13 gene transcripts were much higher in the TI group than in the ASP and sudden cardiac death (SCD) groups. More importantly, relative abundances between such HSP mRNA species exhibit a stronger correlation to, and thus provide more discriminative information on, the death process than does routine normalization to a housekeeping gene. Therefore, the present study proposes alterations in HSP mRNA composition in the occipital lobe as potential forensic biological markers, which may implicate the cause and process of death.	[Chung, Ukhee; Son, Gi Hoon; Hwang, Juck-Joon] Korea Univ, Coll Med, Dept Legal Med, Seoul 136705, South Korea; [Seo, Joong-Seok; Kim, Yu-Hoon] Natl Forens Serv, Div Forens Med, Seoul 158707, South Korea		Hwang, JJ (corresponding author), Korea Univ, Coll Med, Dept Legal Med, Seoul 136705, South Korea.	songh@korea.ac.kr; jjhwang@korea.ac.kr		Son, Gi Hoon/0000-0001-9758-5903	Korean government through National Forensic Service; Ministry of Public Administration and Security [1315000312, NFS-NG-2011-01]; Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2009-0088886, 2011-0019232]; Glami Co., Ltd., Seoul, Korea; 21stC Frontier R&D Program in Neuroscience	This work was supported by the Korean government through the National Forensic Service, Ministry of Public Administration and Security (Grant #: 1315000312, NFS-NG-2011-01) and the Ministry of Education, Science and Technology (Grant #: 2009-0088886 and 2011-0019232), and by a grant to Dr. J.-J. Hwang from the Glami Co., Ltd., Seoul, Korea. Microarray experiments were carried out by the help of Neurogene Bank Service in the Korea University College of Medicine supported by the 21stC Frontier R&D Program in Neuroscience. BioScience Writers edited the manuscript prior to submission.	AOKI M, 1993, BRAIN RES, V601, P185, DOI 10.1016/0006-8993(93)91709-2; Bjarnadottir SG, 2010, J AGR FOOD CHEM, V58, P7408, DOI 10.1021/jf100697h; BRUN A, 1976, ARCH PSYCHIAT NERVEN, V223, P15, DOI 10.1007/BF00367450; Calabrese V, 2006, ANTIOXID REDOX SIGN, V8, P444, DOI 10.1089/ars.2006.8.444; Catts VS, 2005, MOL BRAIN RES, V138, P164, DOI 10.1016/j.molbrainres.2005.04.017; Chang Z, 2012, MOL CELLS, V33, P465, DOI 10.1007/s10059-012-2246-9; Choe HK, 2011, STRESS, V14, P194, DOI 10.3109/10253890.2010.529972; Courts C, 2011, J FORENSIC SCI, V56, P1464, DOI 10.1111/j.1556-4029.2011.01894.x; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Dabir DV, 2004, AM J PATHOL, V164, P155, DOI 10.1016/S0002-9440(10)63106-9; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI [10.1016/j.febslet.2007.05.039, 10.1016/j.febsiet.2007.05.039]; Diller KR, 2006, ANNU REV BIOMED ENG, V8, P403, DOI 10.1146/annurev.bioeng.7.060804.100449; Durrenberger PF, 2010, J NEUROPATH EXP NEUR, V69, P70, DOI 10.1097/NEN.0b013e3181c7e32f; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Fujimoto M, 2010, FEBS J, V277, P4112, DOI 10.1111/j.1742-4658.2010.07827.x; Gotohda Takako, 2000, Journal of Medical Investigation, V47, P76; Haas C, 2009, FORENSIC SCI INT-GEN, V3, P80, DOI 10.1016/j.fsigen.2008.11.003; Hecker JG, 2011, CELL STRESS CHAPERON, V16, P119, DOI 10.1007/s12192-010-0224-8; Heinrich M, 2007, INT J LEGAL MED, V121, P136, DOI 10.1007/s00414-006-0131-9; Heinrich M, 2007, FORENSIC SCI INT-GEN, V1, P163, DOI 10.1016/j.fsigen.2007.01.002; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ikematsu K, 2008, FORENSIC SCI INT, V179, P152, DOI 10.1016/j.forsciint.2008.05.007; Ikematsu Kazuya, 2006, Legal Medicine, V8, P128, DOI 10.1016/j.legalmed.2005.08.012; Jardine D, 2011, PHYSIOL GENOMICS, V43, P974, DOI 10.1152/physiolgenomics.00062.2011; Juusola J, 2003, FORENSIC SCI INT, V135, P85, DOI 10.1016/S0379-0738(03)00197-X; Lee J, 2005, FASEB J, V19, P1356, DOI 10.1096/fj.04-3552fje; LEONARD S, 1993, BIOL PSYCHIAT, V33, P456, DOI 10.1016/0006-3223(93)90174-C; LEUNG TKC, 1992, GENOMICS, V12, P74, DOI 10.1016/0888-7543(92)90409-L; Maeda H, 2011, LEGAL MED-TOKYO, V13, P55, DOI 10.1016/j.legalmed.2010.12.005; Maeda H, 2010, FORENSIC SCI INT, V203, P83, DOI 10.1016/j.forsciint.2010.07.024; Mash DC, 2009, FORENSIC SCI INT, V190, pE13, DOI 10.1016/j.forsciint.2009.05.012; Miyazato T, 2012, INT J LEGAL MED, V126, P581, DOI 10.1007/s00414-012-0698-2; Muranyi M, 2005, MOL BRAIN RES, V139, P80, DOI 10.1016/j.molbrainres.2005.05.023; OTTERSON GA, 1994, EMBO J, V13, P1216, DOI 10.1002/j.1460-2075.1994.tb06371.x; Popova T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-91; Preece P, 2003, MOL BRAIN RES, V118, P60, DOI 10.1016/S0169-328X(03)00337-1; Price JL, 2012, TRENDS COGN SCI, V16, P61, DOI 10.1016/j.tics.2011.12.011; Romi F, 2011, EUR NEUROL, V66, P65, DOI 10.1159/000329373; Sanoudou D, 2004, PHYSIOL GENOMICS, V16, P222, DOI 10.1152/physiolgenomics.00137.2003; SHARP FR, 1993, STROKE, V24, pI72; Stetler RA, 2010, PROG NEUROBIOL, V92, P184, DOI 10.1016/j.pneurobio.2010.05.002; Takahashi Hiroyuki, 2009, Legal Medicine, V11, P181, DOI 10.1016/j.legalmed.2009.03.008; Talaat AM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf103; Tomita H, 2004, BIOL PSYCHIAT, V55, P346, DOI 10.1016/j.biopsych.2003.10.013; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vennemann M, 2010, FORENSIC SCI INT, V203, P71, DOI 10.1016/j.forsciint.2010.07.006; Vennemann M, 2010, FORENSIC SCI INT, V203, P76, DOI 10.1016/j.forsciint.2010.07.007; Ishikawa Takaki, 2006, Legal Medicine, V8, P28, DOI 10.1016/j.legalmed.2006.05.004; Zhao D, 2008, FORENSIC SCI INT, V177, P176, DOI 10.1016/j.forsciint.2007.12.004; Zhao Dong, 2009, Leg Med (Tokyo), V11 Suppl 1, pS290, DOI 10.1016/j.legalmed.2009.01.094; Zubakov D, 2008, INT J LEGAL MED, V122, P135, DOI 10.1007/s00414-007-0182-6; Zubakov D, 2010, INT J LEGAL MED, V124, P217, DOI 10.1007/s00414-009-0402-3	52	3	3	0	6	KOREAN SOC MOLECULAR & CELLULAR  BIOLOGY	SEOUL	635-4, YUCKSAM-DONG, GANGNAM-GU, SEOUL 135-703, SOUTH KOREA	1016-8478	0219-1032		MOL CELLS	Mol. Cells	NOV	2012	34	5					473	480		10.1007/s10059-012-0214-z			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	043AZ	WOS:000311516400008	23135635	Green Published			2022-02-06	
J	Gepp, RD; Nadal, LG				Gepp, Ricardo de Amoreira; Nadal, Luiz Guilherme			Spinal cord trauma in children under 10 years of age: clinical characteristics and prevention	CHILDS NERVOUS SYSTEM			English	Article						Spinal cord; Trauma; Children; Incidence	LONG-TERM SURVIVAL; INJURY	This study analyzed the clinical characteristics of spinal cord injury (SCI) in children 10 years of age and younger, forms of prevention, and ways to improve treatment. Ninety-three children were reviewed between 1996 and 2009. The variables studied were type, age, cause, neurological level, association between SCI and traumatic brain injury (TBI), arthrodesis surgery, time elapsed between trauma and diagnosis, and causes of death. The statistical evaluations were done using the chi-square and ANOVA scales, in the SPSS program version 11.0. The most common cause was automobile crash accidents. Getting run over by a car was second (29.1 %), followed by firearm injuries (11.8 %). The thoracic spine was the most commonly impacted area. Evaluation showed that 83.9 % had complete neurological injury. Associated TBI was present in 35.5 % of the cases. Only 21.5 % of the patients required arthrodesis of the spine. In 31.2 % of the cases, myelopathy was not diagnosed at the time of the accident. There was no statistical correlation between TBI and a delayed diagnosis of SCI (p = 0.231). Five children (5.4 %) died. The study showed that the cause of the trauma is associated to the child's age and that prevention is important. Trauma from automobile crash accidents was the main cause, and, in older children, firearm injuries are an important risk. Spinal cord injury was not always diagnosed in children at the time of accident. Educating family members and training emergency teams to adequately treat children with multiple traumas are measures that can help reduce the incidence of SCIs and neurological damage.	[Gepp, Ricardo de Amoreira] SARAH Network Rehabil Hosp, Dept Neurosurg, Brasilia, DF, Brazil; [Nadal, Luiz Guilherme] SARAH Network Rehabil Hosp, Dept Stat, Brasilia, DF, Brazil		Gepp, RD (corresponding author), SARAH Network Rehabil Hosp, Dept Neurosurg, Brasilia, DF, Brazil.	ricardogepp@zipmail.com.br					ANDERSON JM, 1980, MAYO CLIN PROC, V55, P499; Brown RL, 2001, J PEDIATR SURG, V36, P1107, DOI 10.1053/jpsu.2001.25665; Carreon LY, 2004, J SPINAL DISORD TECH, V17, P477, DOI 10.1097/01.bsd.0000132290.50455.99; Cirak B, 2004, J PEDIATR SURG, V39, P607, DOI 10.1016/j.jpedsurg.2003.12.011; Neumann CR, 2009, J TRAUMA, V67, P67, DOI 10.1097/TA.0b013e3181aa63f3; Shavelle RM, 2007, J SPINAL CORD MED, V30, pS48, DOI 10.1080/10790268.2007.11753969; Shavelle RM, 2006, J SPINAL CORD MED, V29, P511, DOI 10.1080/10790268.2006.11753901; Vitale MG, 2006, J PEDIATR ORTHOPED, V26, P745, DOI 10.1097/01.bpo.0000235400.49536.83; Wang MY, 2004, SPINE, V29, P1493, DOI 10.1097/01.BRS.0000129026.03194.0F	9	3	3	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	NOV	2012	28	11					1919	1924		10.1007/s00381-012-1846-1			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	021FY	WOS:000309871900014	22798024				2022-02-06	
J	Kasirye, Y; Epperla, N; Manne, JR; Bapani, S; Garcia-Montilla, RJ				Kasirye, Yusuf; Epperla, Narendranath; Manne, Janaki; Bapani, Sowjanya; Garcia-Montilla, Romel			Brain Abscesses Complicating Acute Pneumococcal Meningitis During Etanercept Therapy	CLINICAL MEDICINE & RESEARCH			English	Article						Brain abscess; Etanercept; Immunosuppression; Pneumococcal meningitis		Brain abscess formation as a sequelae of community-acquired pneumococcal meningitis is extremely rare, accounting for less than 1% of all meningitis complications. Although metastatic seeding from a distal peripheral septic focus has been observed, this phenomenon most commonly occurs in the context of ear, nose and throat infections, post-cranial neurosurgical procedures, traumatic open cranial injury, or immunosuppression. We present the case of a man, 61 years old, on etanercept therapy for ankylosing spondylitis who developed multiple brain abscesses as a complication of pneumococcal meningitis. We believe that the predisposition to this extremely rare complication of a particularly aggressive pneumococcal meningitis was most likely due to the underlying immunosuppression resulting from etanercept therapy. As far as we know, this case is the first report linking multiple brain abscess formation in a patient with community-acquired pneumococcal meningitis with etanercept therapy.	[Kasirye, Yusuf] Marshfield Clin Pk Falls Ctr, Dept Internal Med, 50 Sherry Ave, Park Falls, WI 54552 USA; [Epperla, Narendranath; Manne, Janaki; Bapani, Sowjanya; Garcia-Montilla, Romel] Marshfield Clin Fdn Med Res & Educ, Dept Internal Med, Marshfield, WI USA		Kasirye, Y (corresponding author), Marshfield Clin Pk Falls Ctr, Dept Internal Med, 50 Sherry Ave, Park Falls, WI 54552 USA.	kasirye.yusuf@marshfieldclinic.org	Epperla, Narendranath/Y-3943-2019	Epperla, Narendranath/0000-0002-8216-3457			Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; Bresnihan B, 2003, RHEUM DIS CLIN N AM, V29, P185, DOI 10.1016/S0889-857X(02)00101-1; Bruns AHW, 2008, EUR RESPIR J, V32, P726, DOI 10.1183/09031936.00003608; Calin A, 2004, ANN RHEUM DIS, V63, P1594, DOI 10.1136/ard.2004.020875; Carpenter J, 2007, EUR J CLIN MICROBIOL, V26, P1, DOI 10.1007/s10096-006-0236-6; DEBEER FC, 1984, ARCH DIS CHILD, V59, P653, DOI 10.1136/adc.59.7.653; Ellerin T, 2003, ARTHRITIS RHEUM-US, V48, P3013, DOI 10.1002/art.11301; Furst DE, 2010, SEMIN ARTHRITIS RHEU, V39, P327, DOI 10.1016/j.semarthrit.2008.10.002; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; HANSSON LO, 1993, SCAND J INFECT DIS, V25, P625, DOI 10.3109/00365549309008552; Hasbun R, 2001, NEW ENGL J MED, V345, P1727, DOI 10.1056/NEJMoa010399; Hatherill M, 1999, ARCH DIS CHILD, V81, P417, DOI 10.1136/adc.81.5.417; Hughes DC, 2010, POSTGRAD MED J, V86, P478, DOI 10.1136/pgmj.2010.097022; Jereb M, 2001, INFECTION, V29, P209, DOI 10.1007/s15010-001-1165-z; Jorens PG, 2005, NEURORADIOLOGY, V47, P758, DOI 10.1007/s00234-005-1423-3; Kastenbauer S, 2003, BRAIN, V126, P1015, DOI 10.1093/brain/awg113; Katchanov J, 2009, NEURORADIOLOGY, V51, P723, DOI 10.1007/s00234-009-0565-0; Keshet R, 2009, AM J MED SCI, V337, P248, DOI 10.1097/MAJ.0b013e31818af6de; Killingley B, 2005, J Infect, V51, pE49, DOI 10.1016/j.jinf.2004.08.015; Kompoti M, 2008, EUR J INTERN MED, V19, P261, DOI 10.1016/j.ejim.2007.06.016; PELTOLA HO, 1982, LANCET, V1, P980; Simon L, 2004, CLIN INFECT DIS, V39, P206, DOI 10.1086/421997; Tak PP, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/1478-6354-13-S1-S5, 10.1186/ar3096]; TILLETT WILLIAM S., 1930, JOUR EXP MED, V52, P561, DOI 10.1084/jem.52.4.561; Tobinick E, 2009, CNS DRUGS, V23, P713, DOI 10.2165/11310810-000000000-00000; Tobinick EL, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-27; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; Weisfelt M, 2006, LANCET NEUROL, V5, P332, DOI 10.1016/S1474-4422(06)70409-4; Weisfelt M, 2006, LANCET NEUROL, V5, P123, DOI 10.1016/S1474-4422(05)70288-X	30	3	3	0	0	MARSHFIELD CLINIC	MARSHFIELD	1000 N OAK AVE, MAILSTOP ML7, MARSHFIELD, WI 54449 USA	1539-4182	1554-6179		CLIN MED RES	Clin. Med. Res.	NOV 1	2012	10	4					230	235		10.3121/cmr.2012.1049			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V55LV	WOS:000210495000004	22634540	Bronze, Green Published			2022-02-06	
J	Misic-Pavkov, G; Novovic, Z; Bozic, K; Kolundzija, K; Kovacevic, SI; Drakic, D; Lukic, T; Jelkic, M				Misic-Pavkov, G.; Novovic, Z.; Bozic, K.; Kolundzija, K.; Kovacevic, S. I.; Drakic, D.; Lukic, T.; Jelkic, M.			Forensic aspect of late subjective complaints after traumatic brain injury	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Brain injury; Posttraumatic complaints; Forensic aspect; Post traumatic headache	MINOR HEAD-INJURY; DEPRESSION; COMPENSATION; EPIDEMIOLOGY; PREDICTION; SEQUELAE; NEUROSIS; EUROPE; SCALE; SLEEP	BACKGROUND: The subjective complaints in patients with TBI (Traumatic Brain Injury) may persist for years. The most frequent complaints are headache, dizziness, drowsiness, mood disturbances, and memory and concentration disturbances. It is assumed that these complaints are caused by injury itself on one hand and psychological, emotional and motivation factors on the other. AIM: Evaluation of late posttraumatic complaints in patients with TBI more than a year after the trauma, and establishing their correlations to the severity of TBI and involvement in the lawsuits for financial compensation (litigation). MATERIALS AND METHODS: Ninety patients with the diagnosis of TBI were divided, according to the severity of the injury, in two groups: mild and with moderate-to-severe. The second classification criterion was litigation. A subjective complaints scale has been designed for the purpose of this research taking into consideration both anamnesis and hetero-anamnesis data. RESULTS: Cognitive disturbance, aggressiveness and sleep disturbance are more frequently reported by the subgroup of moderate-to-severe TBI patients, and they have not been related to the litigation. Posttraumatic headache (PTH) turned out to be a distinctive complaint regarding both classification criteria. Vegetative disturbances are significantly related to litigation, but not to the degree of injury. CONCLUSIONS: Predictive complaints reflecting the severity of TBI are memory deficit, concentration problems, and aggressiveness and sleep disturbance. Vegetative disturbances are predictive in relation to compensation claims. PTH is important from the forensic point of view for the patients with moderate to severe TBI.	[Misic-Pavkov, G.; Kolundzija, K.; Kovacevic, S. I.] Clin Ctr Vojvodina, Psychiat Clin, Novi Sad, Serbia; [Novovic, Z.] Univ Novi Sad, Fac Philosophy, Dept Psychol, Novi Sad 21000, Serbia; [Bozic, K.] Clin Ctr Vojvodina, Neurol Clin, Novi Sad, Serbia; [Drakic, D.; Lukic, T.] Fac Law, Novi Sad, Serbia; [Jelkic, M.] Mil Med Ctr Novi Sad, Novi Sad, Serbia		Misic-Pavkov, G (corresponding author), Clin Ctr Vojvodina, Psychiat Clin, Hajduk Veljkova 1-7, Novi Sad, Serbia.	gmisicpavkov@gmail.com					ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bordini EJ, 2002, NEUROREHABILITATION, V17, P93; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Cartlidge NEF, 1981, HEAD INJURY, P95; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; de Kruijk JR, 2001, BRAIN INJURY, V15, P117, DOI 10.1080/026990501458353; Demakis GJ, 2010, APPL NEUROPSYCHOL, V17, P183, DOI 10.1080/09084282.2010.499752; Drake AI, 2006, BRAIN INJURY, V20, P469, DOI 10.1080/02699050600676370; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; FROWEIN RA, 1990, ADV NEUROTRAUMATOLOG, V3, P90; HINKELDEY N S, 1990, Brain Injury, V4, P115, DOI 10.3109/02699059009026157; JACOBSON R, 1994, FOCUS DEPRESSION, V2, P1; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; KENNEDY F, 1946, COMPENSATION MED, V1, P19; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; LANCE JC, 2000, CURR TREAT OPTION NE, V4, P89; Larrabee GJ, 2000, CLIN GUIDE NEUROPSYC, P301; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; MENDELSON G, 1995, J PSYCHOSOM RES, V39, P695, DOI 10.1016/0022-3999(94)00154-W; MERSKEY H, 1972, BRAIN, V95, P521, DOI 10.1093/brain/95.3.521; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; MURERIWA J, 1990, CENT AFR J MED, V36, P315; PACKARD RC, 1992, HEADACHE, V32, P496, DOI 10.1111/j.1526-4610.1992.hed3210496.x; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; THOMPSON GN, 1965, AM J PSYCHIAT, V121, P1043, DOI 10.1176/ajp.121.11.1043; Thomsen I V, 1987, Brain Inj, V1, P131, DOI 10.3109/02699058709034452; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18	40	3	3	0	5	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	NOV	2012	16	13					1806	1813					8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	076DI	WOS:000313936300006	23208964				2022-02-06	
J	Onal, MB; Civelek, E; Kircelli, A; Yakupoglu, H; Albayrak, T				Onal, Mehmet Bulent; Civelek, Erdinc; Kircelli, Atilla; Yakupoglu, Hakan; Albayrak, Tuna			Re-formation of acute parietal epidural hematoma following rapid spontaneous resolution in a multitraumatic child: a case report	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Epidural; hematoma; trauma	EXTRADURAL HEMATOMA	Acute epidural hematomas resulting from traumatic brain injury remain among the most common causes of mortality and disability. In the literature, there are cases about the resolution and recurrence of spinal epidural hematomas. This case is characterized by the rapid disappearance and re-formation of an acute cranial epidural hematoma (EDH) associated with no overlying skull fracture. Various authors have reported resolution of EDHs managed conservatively, but rapid resolution and recurrence of cranial EDH was not reported before.	[Onal, Mehmet Bulent] Siirt State Hosp, Dept Neurosurg, Siirt, Turkey; [Albayrak, Tuna] Siirt State Hosp, Dept Anesthesiol & Reanimat, Siirt, Turkey; [Civelek, Erdinc] Baskent Univ Istanbul Hastanesi, Beyin & Sinir Cerrahisi Anabilim Dali, Istanbul, Turkey; [Kircelli, Atilla] Goztepe Safak Hosp, Dept Neurosurg, Istanbul, Turkey; [Yakupoglu, Hakan] Medicana Ankara Hosp, Dept Neurosurg, Ankara, Turkey		Civelek, E (corresponding author), Baskent Univ Istanbul Hastanesi, Beyin & Sinir Cerrahisi Anabilim Dali, Istanbul, Turkey.	civsurgeon@yahoo.com	Civelek, Erdinc/ABI-6105-2020	Civelek, Erdinc/0000-0002-3988-4064; Kircelli, Atilla/0000-0003-2109-1274			AOKI N, 1988, J NEUROSURG, V68, P149, DOI 10.3171/jns.1988.68.1.0149; Balmer B, 2006, CHILD NERV SYST, V22, P363, DOI 10.1007/s00381-005-1254-x; CHEN TY, 1993, NEUROSURGERY, V32, P176, DOI 10.1227/00006123-199302000-00004; Cheung PSY, 2007, INJURY, V38, P76, DOI 10.1016/j.injury.2006.08.059; Deniz FE, 2010, ULUS TRAVMA ACIL CER, V16, P280; Park HK, 2009, BRIT J NEUROSURG, V23, P617, DOI 10.3109/02688690902999302; SERVADEI F, 1989, J TRAUMA, V29, P880, DOI 10.1097/00005373-198906000-00030; Taussky P, 2008, SWISS MED WKLY, V138, P281, DOI 2008/19/smw-12056; Tong WS, 2011, NEURORADIOLOGY, V53, P305, DOI 10.1007/s00234-010-0659-8; WEAVER D, 1981, J NEUROSURG, V54, P248, DOI 10.3171/jns.1981.54.2.0248	10	3	3	0	2	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	NOV	2012	18	6					524	526		10.5505/tjtes.2012.91129			3	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	091TO	WOS:000315072900012	23588913	Bronze			2022-02-06	
J	Silva, SCFE; Settervall, CHC; de Sousa, RMC				Fuerbringer e Silva, Silvia Cristina; Constanti Settervall, Cristina Helena; Cardoso de Sousa, Regina Marcia			Post-traumatic amnesia and post-trauma quality of life	REVISTA DA ESCOLA DE ENFERMAGEM DA USP			English	Article						Craniocerebral trauma; Amnesia; Amnesia, transient global; Quality of life	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; GALVESTON ORIENTATION	The present study aims to compare quality of life of victims with long and short term post-traumatic amnesia and to analyze the relation between quality of life and length of amnesia, including or not the comatose period. This prospective cohort study, gathered data during the hospital stay and 3 and 6 months post-trauma. Blunt traumatic brain injury patients, over 14 years old, with no prior diagnosis of dementia or brain injury, admitted to a trauma center 12 hours post-trauma were included. The results were unfavorable among patients with long term amnesia. Correlation between length of post-traumatic amnesia and quality of life domains were more expressive when excluded comatose period, indicating that it must not be computed in the length of post-traumatic amnesia.	[Fuerbringer e Silva, Silvia Cristina] Sao Camilo Univ Ctr, Sao Paulo, Brazil; [Constanti Settervall, Cristina Helena] Univ Sao Paulo, Grad Program Adult Hlth, Sch Nursing, Sao Paulo, Brazil; [Cardoso de Sousa, Regina Marcia] Univ Sao Paulo, Med Surg Nursing Dept, Sch Nursing, Sao Paulo, Brazil		de Sousa, RMC (corresponding author), Av Dr Eneas dr Carvalho Aguiar,419 Cerqueira Cesa, BR-05403000 Sao Paulo, Brazil.	vian@usp.br	Sousa, Regina M/H-1108-2012	Sousa, Regina M/0000-0002-2575-7937	State of Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [06/58200-1]	This study was funded by the State of Sao Paulo Research Foundation (FAPESP). Processo 06/58200-1.	Ahmed S, 2000, BRAIN INJURY, V14, P765; Alves ALA, 2009, REV SAUDE PUBL, V43, P154, DOI 10.1590/S0034-89102009000100020; Avesani R, 2005, BRAIN INJURY, V19, P933, DOI 10.1080/02699050400002371; Ciconelli R.M., 1999, REV BRAS REUMATOL, V39, P143, DOI DOI 10.1590/S0482-50042010000300005; De Guise E, 2005, BRAIN INJURY, V19, P263, DOI 10.1080/02699050400004971; DePalma J A, 2001, Crit Care Nurs Q, V23, P42; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; Silva SCFE, 2009, REV ESC ENFERM USP, V43, P1027; Genta Pedro Rodrigues, 2005, J. bras. pneumol., V31, P48, DOI 10.1590/S1806-37132005000100009; Guilfoyle MR, 2010, J NEUROTRAUM, V27, P2173, DOI 10.1089/neu.2010.1353; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Ladera-Fernandez V, 2001, REV NEUROLOGIA, V32, P467, DOI 10.33588/rn.3205.2000170; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Martinez JAB, 2004, CHEST, V125, P425, DOI 10.1378/chest.125.2.425; McMillan TM, 2004, BRAIN INJURY, V18, P935, DOI 10.1080/02699050410001675915; Serna Edilene Curvelo Hora, 2006, Rev. Latino-Am. Enfermagem, V14, P183; Silva Cleuza Braga da, 2009, Fisioter. Pesqui., V16, P311; Silva Silvia Cristina Fürbringer e, 2007, Acta paul. enferm., V20, P24, DOI 10.1590/S0103-21002007000100005; WILSON JTL, 1994, J NEUROL NEUROSUR PS, V57, P198, DOI 10.1136/jnnp.57.2.198	21	3	4	1	8	UNIV SAO PAOLO	CERQUERA CESAR	AV  DR ENEAS DE CARVALHO AGUIAR, 419, CERQUERA CESAR, SP 05403-000, BRAZIL	0080-6234	1980-220X		REV ESC ENFERM USP	Rev. Esc. Enferm. USP	OCT	2012	46				SI		30	37		10.1590/S0080-62342012000700005			8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	160SM	WOS:000320139700005	23250255	Green Published, gold			2022-02-06	
J	Gerds, TA; Lauridsen, E; Ahrensburg, SS; Andreasen, JO				Gerds, Thomas Alexander; Lauridsen, Eva; Ahrensburg, Soren Steno; Andreasen, Jens Ove			The dental trauma internet calculator	DENTAL TRAUMATOLOGY			English	Article						classification; dental trauma; diagnosis; permanent tooth; prevalence; prognosis	AVULSED PERMANENT INCISORS; REPLANTATION; INTRUSION; TEETH	Background/Aim Prediction tools are increasingly used to inform patients about the future dental health outcome. Advanced statistical methods are required to arrive at unbiased predictions based on follow-up studies. Materials and methods The Internet risk calculator at the Dental Trauma Guide provides prognoses for teeth with traumatic injuries based on the Copenhagen trauma database: http://www.dentaltraumaguide.org The database includes 2191 traumatized permanent teeth from 1282 patients that were treated at the dental trauma unit at the University Hospital in Copenhagen (Denmark) in the period between 1972 and 1991. Subgroup analyses and estimates of event probabilities were based on the KaplanMeier and the AalenJohansen method. Results The Internet risk calculator shows individualized prognoses for the short- and long-term healing outcome of traumatized teeth with the following injuries: concussion, subluxation, extrusion, lateral luxation, intrusion, avulsion, crown fractures without luxation, root fractures and alveolar fractures. The prognoses for pulp necrosis, pulp canal obliteration, infection-related root resorption, ankylosis, surface resorption, marginal bone loss, and tooth loss were based on the tooth's root development stage and other risk factors at the time of the injury. Conclusions This article explains the database, the functionality and the statistical approach of the Internet risk calculator.	[Gerds, Thomas Alexander] Univ Copenhagen, Dept Biostat, DK-1014 Copenhagen K, Denmark; [Lauridsen, Eva] Univ Copenhagen, Sch Dent, Dept Pediat Dent & Clin Genet, DK-1014 Copenhagen K, Denmark; [Ahrensburg, Soren Steno; Andreasen, Jens Ove] Copenhagen Univ Hosp, Ctr Rare Oral Dis, Dept Oral & Maxillofacial Surg, Copenhagen, Denmark		Gerds, TA (corresponding author), Univ Copenhagen, Dept Biostat, Oster Farimagsgade 5 B, DK-1014 Copenhagen K, Denmark.	tagteam@sund.ku.dk		Gerds, Thomas Alexander/0000-0002-5955-816X			Andersen P.K., 1993, SPRINGER SERIES STAT; ANDREASEN F M, 1985, Endodontics and Dental Traumatology, V1, P207; ANDREASEN FM, 1988, ENDOD DENT TRAUMATOL, V4, P202; ANDREASEN FM, 1989, ENDOD DENT TRAUMATOL, V5, P11; Andreasen FM, 1985, DENT TRAUMATOL, V1, P160; Andreasen JO, 2006, DENT TRAUMATOL, V22, P90, DOI 10.1111/j.1600-9657.2006.00422.x; Andreasen JO, 2006, DENT TRAUMATOL, V22, P99, DOI 10.1111/j.1600-9657.2006.00423.x; ANDREASEN JO, 1995, ENDOD DENT TRAUMATOL, V11, P76; ANDREASEN JO, 1995, ENDOD DENT TRAUMATOL, V11, P69; ANDREASEN JO, 1995, ENDOD DENT TRAUMATOL, V11, P51; ANDREASEN JO, 1995, ENDOD DENT TRAUMATOL, V11, P59; Chuang SK, 2001, J DENT RES, V80, P2016, DOI 10.1177/00220345010800111301; Gerds TA, 2009, FAILURE TIME ANAL, P259; Hermann NV, 2012, DENT TRAUMATOL, V28, P386, DOI 10.1111/j.1600-9657.2012.01165.x; Hermann NV, 2012, DENT TRAUMATOL, V28, P394, DOI 10.1111/edt.12000; Lauridsen E, 2012, DENT TRAUMATOL, V28, P371, DOI 10.1111/j.1600-9657.2011.01101.x; Lauridsen E, 2012, DENT TRAUMATOL, V28, P364, DOI 10.1111/j.1600-9657.2011.01102.x; Lauridsen E, 2012, DENT TRAUMATOL, V28, P379, DOI 10.1111/j.1600-9657.2011.01100.x; Williams R L, 1995, Lifetime Data Anal, V1, P171, DOI 10.1007/BF00985768; YING Z, 1994, J MULTIVARIATE ANAL, V50, P17, DOI 10.1006/jmva.1994.1031	20	3	3	1	15	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469			DENT TRAUMATOL	Dent. Traumatol.	OCT	2012	28	5					351	357		10.1111/j.1600-9657.2012.01161.x			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	009ZC	WOS:000309063100004	22805605				2022-02-06	
J	Glass, NE; Kaltenbach, LA; Fleming, SB; Arbogast, PG; Cotton, BA				Glass, Nina E.; Kaltenbach, Lisa A.; Fleming, Sloan B.; Arbogast, Patrick G.; Cotton, Bryan A.			The impact of beta-blocker therapy on anemia after traumatic brain injury	TRANSFUSION			English	Article							ERYTHROID COLONY FORMATION; HEAD-INJURY; IMPROVED OUTCOMES; HYPERCATECHOLAMINE STATE; ADRENERGIC AGONISTS; IMPROVED SURVIVAL; CELL TRANSFUSION; ERYTHROPOIESIS; EXPOSURE; HYPOXIA	BACKGROUND: An increase in endogenous catecholamine levels after traumatic brain injury (TBI) is well described. Animal studies suggest that postinjury anemia is exacerbated by a persistent hyperadrenergic state. This study aims to determine if beta-blocker (BB) exposure affects anemia after TBI. STUDY DESIGN AND METHODS: We reviewed a Level I trauma registry for patients with TBI, examining markers of anemia between patients who received BB with those who did not. RESULTS: A total of 174 patients were exposed to BB (BB+) and 245 were not exposed (BB-). The mean age in the BB+ group was 50 years (vs. 36 years in BB-group, p < 0.001). The mean injury severity score was 33.6 for the BB+ group (vs. 30.8 for BB-group, p = 0.01). While BB+ patients were more likely to receive a transfusion (60.9% vs. 35.1%, p < 0.001), BB+ patients reached their nadir hemoglobin (Hb) at a later day of hospitalization and their rate of decrease in Hb was significantly slower (both p < 0.001). Choosing Hb cutoffs for anemia of both 7 and 10 g/dL, Kaplan-Meier demonstrated a significant delay in time to anemia. CONCLUSION: This study suggests beta-blockade delays anemia after TBI. Elaboration of this effect may demonstrate an additional benefit of beta-blockade after head injury.	NYU, Dept Surg, Sch Med, New York, NY 10016 USA; Vanderbilt Univ, Med Ctr, Dept Biostat & Pharmacol, Nashville, TN USA; Univ Texas Hlth Sci Ctr, Dept Surg, Houston, TX USA; Univ Texas Hlth Sci Ctr, Ctr Translat Injury Res, Houston, TX USA		Cotton, BA (corresponding author), UTHSC CeTIR, 6410 Fannin,1100 UPB, Houston, TX 77030 USA.	bryan.a.cotton@uth.tmc.edu		Glass, Nina/0000-0002-6821-4289			Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; BELEGU M, 1983, AM J PHYSIOL, V245, pC322, DOI 10.1152/ajpcell.1983.245.5.C322; Berglund B, 2002, SCAND J MED SCI SPOR, V12, P31, DOI 10.1034/j.1600-0838.2002.120106.x; BROWN JE, 1977, J CLIN INVEST, V60, P70, DOI 10.1172/JCI108771; Brugnara C, 2000, CRIT REV CL LAB SCI, V37, P93, DOI 10.1080/10408360091174196; Carson JL, 1996, LANCET, V348, P1055, DOI 10.1016/S0140-6736(96)04330-9; Chiu W, 2007, J TRAUMA, V63, P510; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Enderson BL, 2007, J TRAUMA, V62, P33; FINK GD, 1977, J PHARMACOL EXP THER, V202, P199; Fonseca RB, 2005, J TRAUMA, V59, P884, DOI 10.1097/01.ta.0000187653.64300.f5; George ME, 2008, NEUROCRIT CARE, V8, P337, DOI 10.1007/s12028-008-9066-y; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; JELKMANN W, 1979, J PHARMACOL EXP THER, V211, P99; Khan W, 2006, HEART, V92, P1856, DOI 10.1136/hrt.2005.083998; Madjdpour C, 2006, MINERVA ANESTESIOL, V72, P283; Malhotra A, 2005, J TRAUMA, V59, P889; MCLEOD AA, 1982, BRIT HEART J, V47, P221; Neil-Dwyer G, 1990, Acta Neurochir Suppl (Wien), V47, P102; Pendem S, 2006, NEUROCRIT CARE, V4, P63, DOI 10.1385/NCC:4:1:063; Pryor JP, 2007, J TRAUMA, V62, P61; Riordan WP, 2007, J TRAUMA, V63, P503, DOI 10.1097/TA.0b013e3181271c34; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Vialet R, 2008, ACTA ANAESTH SCAND, V52, P601, DOI 10.1111/j.1399-6576.2008.01620.x; ZIVNY J, 1983, J PHARMACOL EXP THER, V226, P222; Zyuz'kov GN, 2005, B EXP BIOL MED+, V140, P13, DOI 10.1007/s10517-005-0399-7	28	3	4	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0041-1132			TRANSFUSION	Transfusion	OCT	2012	52	10					2155	2160		10.1111/j.1537-2995.2012.03609.x			6	Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology	030CM	WOS:000310545600014	22420303				2022-02-06	
J	Graf, M; Lorenz, B				Graef, M.; Lorenz, B.			How to deal with diplopia	REVUE NEUROLOGIQUE			English	Article						Binocular diplopia; Diagnostics; Monocular diplopia; Strabismus	HEAD-TILT TEST; NERVE; ABSENCE; DISORDERS	Diplopia is a frequent neuro-ophthalmologic symptom with diverse etiologies. This article describes elementary diagnostic tests and frequent causes of diplopia. Monocular diplopia persists when the other eye is closed and usually disappears when the patient looks through a pinhole. It is usually caused by errors in the optical media of the eye and has to be differentiated from spectacle-induced side effect and non-organic disorders. A sign of non-organic etiology is absence of change in image position when the head is tilted. Binocular diplopia disappears regardless of which eye is closed. Binocular diplopia occurs when the images of both eyes cannot be fused. The most frequent direct cause of diplopia is acquired strabismus. Knowledge of several specific types of strabismus enables efficient patient management. Congenital and decompensating strabismus like accommodative esotropia, pathophoria, strabismus surso- and deorsoadductorius, retraction syndrome, Brown's syndrome and esotropia in high myopia only need ophthalmologic treatment. Orbital injury, orbital tumor, ocular myositis, Graves orbitopathy and vascular disease usually require multidisciplinary management. Neurogenic paresis, superior oblique myokymia, ocular neuromyotonia, myasthenia, chronic progressive external ophthalmoplegia (CPEO), internuclear ophthalmoplegia (INO) and skew deviation require specific neurologic examination. Treatment of diplopia includes treatment of the fundamental disorder, monocular occlusion, prisms and strabismus surgery. (C) 2012 Elsevier Masson SAS. All rights reserved.	[Graef, M.; Lorenz, B.] Univ Klinikum Giessen & Marburg, D-35392 Giessen, Germany; [Graef, M.; Lorenz, B.] Univ Giessen, Dept Ophthalmol, D-35392 Giessen, Germany		Graf, M (corresponding author), Univ Klinikum Giessen & Marburg, Giessen Campus,Friedrichstr 18, D-35392 Giessen, Germany.	michael.h.graef@augen.med.uni-giessen.de					Bartalena L, 2008, EUR J ENDOCRINOL, V158, P273, DOI 10.1530/EJE-07-0666; Brandt T, 1998, NEURO-OPHTHALMOLOGY, V19, P83, DOI 10.1076/noph.19.2.83.3944; Crone RA, 1973, DIPLOPIA; Deschauer M, 2008, ESSENT OPHTHALMOL, P267, DOI 10.1007/978-3-540-33679-2_15; Dieterich M, 2008, ESSENT OPHTHALMOL, P283, DOI 10.1007/978-3-540-33679-2_16; Eckstein A, 2010, ESSENT OPHTHALMOL, P207, DOI 10.1007/978-3-540-85851-5_16; Engle EC, 2007, ARCH NEUROL-CHICAGO, V64, P633, DOI 10.1001/archneur.64.5.633; Engle EC, 2007, ARCH OPHTHALMOL-CHIC, V125, P189, DOI 10.1001/archopht.125.2.189; Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002; Graf M, 2005, KLIN MONATSBL AUGENH, V222, P142, DOI 10.1055/s-2005-857929; Herzau V, 1996, KLIN MONATSBL AUGENH, V208, P33, DOI 10.1055/s-2008-1035165; Kaeser PF, 2012, ACTA OPHTHALMOL, V90, pE310, DOI 10.1111/j.1755-3768.2011.02354.x; Kaufmann HJ, 2012, STRABISMUS; Krzizok TH, 1997, ARCH OPHTHALMOL-CHIC, V115, P1019, DOI 10.1001/archopht.1997.01100160189008; LANG J., 1968, P219; Lorenz B, 2012, STRABISMUS, P158; Neugebauer A, 2010, ESSENT OPHTHALMOL, P77, DOI 10.1007/978-3-540-85851-5_7; Parsa CF, 1998, AM J OPHTHALMOL, V125, P399, DOI 10.1016/S0002-9394(99)80158-5; ROBINSON DA, 1985, VISION RES, V25, P1983, DOI 10.1016/0042-6989(85)90023-9; Rosen ES, 1998, NEUROOPHTHALMOLOGY; Rosenbaum AL, 1999, CLIN STRABISMUS MANA; Spielmann A., 1997, STRABISMES ANAL CLIN; Strupp M, 2011, J NEUROL, V258, P1207, DOI [10.1007/s00415-011-6135-5, 10.1007/s00415-011-5999-8, 10.1007/s00415-010-5874-z]; Thomke F, 2008, AUGENBEWEGUNGSSTORUN; Uchiyama E, 2010, AM J OPHTHALMOL, V149, P508, DOI 10.1016/j.ajo.2009.09.022; Von Noorden GK, 2002, THEORY MANAGEMENT ST; WULLE KG, 1987, KLIN MONATSBL AUGENH, V190, P167, DOI 10.1055/s-2008-1050348; Yang HK, 2012, OPHTHALMOLOGY, V119, P170, DOI 10.1016/j.ophtha.2011.06.038; Zee D.S., 1999, NEUROLOGY EYE MOVEME, V3rd	29	3	3	1	15	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0035-3787	2213-0004		REV NEUROL-FRANCE	Rev. Neurol.	OCT	2012	168	10					720	728		10.1016/j.neurol.2012.08.001			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	050MM	WOS:000312057400009	22986079				2022-02-06	
J	Knuepffer, C; Murdoch, BE; Lloyd, D; Lewis, FM; Hinchliffe, FJ				Knuepffer, C.; Murdoch, B. E.; Lloyd, D.; Lewis, F. M.; Hinchliffe, F. J.			Reduced N400 semantic priming effects in adult survivors of paediatric and adolescent traumatic brain injury	BRAIN AND LANGUAGE			English	Article						Paediatric; Traumatic brain injury; Diffuse axonal injury; Event-related potential; Semantic priming; N400; Long-term outcomes; Language	EVENT-RELATED POTENTIALS; CLOSED-HEAD-INJURY; RECEPTIVE VOCABULARY; LANGUAGE-ACQUISITION; MEMORY STRUCTURE; CHILDREN; CHILDHOOD; COMPREHENSION; DEFICITS; CONNECTIVITY	The immediate and long-term neural correlates of linguistic processing deficits reported following paediatric and adolescent traumatic brain injury (TBI) are poorly understood. Therefore, the current research investigated event-related potentials (ERPs) elicited during a semantic picture-word priming experiment in two groups of highly functioning individuals matched for various demographic variables and behavioural language performance. Participants in the TBI group had a recorded history of paediatric or adolescent TBI involving injury mechanisms associated with diffuse white matter pathology, while participants in the control group never sustained any insult to the brain. A comparison of N400 Mean Amplitudes elicited during three experimental conditions with varying semantic relatedness between the prime and target stimuli (congruent, semantically related, unrelated) revealed a significantly smaller N400 response in the unrelated condition in the TBI group, indicating residual linguistic processing deviations when processing demands required the quick detection of a between-category (unrelated) violation of semantic expectancy. (C) 2012 Elsevier Inc. All rights reserved.	[Knuepffer, C.; Murdoch, B. E.; Lloyd, D.; Lewis, F. M.] Univ Queensland, Ctr Neurogen Commun Disorders Res, Brisbane, Qld, Australia; [Lloyd, D.] Univ Queensland, Ctr Sensorimotor Neurosci, Brisbane, Qld, Australia; [Hinchliffe, F. J.] Mater Hlth Serv, Mater Med Res Inst, Brisbane, Qld, Australia		Knuepffer, C (corresponding author), Univ Queensland, Ctr Neurogen Commun Disorders Res, Brisbane, Qld, Australia.	c.knuepffer@uq.edu.au	LEWIS, Fiona/F-9076-2010; Murdoch, Bruce E/C-1397-2012	LEWIS, Fiona/0000-0002-2181-1983; 	Motor Accident Insurance Commission of Queensland	The authors would like to acknowledge the support of Peta Scott and Tang Oudomvilay in recording and post-processing the auditory ERP stimuli. Further acknowledgements are made to the helpful input of Associate Professor David Copland and Dr. Asad Khan in discussing the ERP paradigm and statistical analyses, respectively. We would also like to thank three anonymous reviewers for their helpful comments on an earlier version of this manuscript. This project was supported by a grant from the Motor Accident Insurance Commission of Queensland.	Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Anderson V. A., 2010, PEDIATRICS, V129, P254; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baggio G, 2011, LANG COGNITIVE PROC, V26, P1338, DOI 10.1080/01690965.2010.542671; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Brauer J, 2008, NEUROIMAGE, V41, P1484, DOI 10.1016/j.neuroimage.2008.03.027; Brauer J, 2011, CEREB CORTEX, V21, P459, DOI 10.1093/cercor/bhq108; Byrne JM, 1995, CHILD NEUROPSYCHOL, V1, P211, DOI 10.1080/09297049508400226; BYRNE JM, 1995, J CLIN EXP NEUROPSYC, V17, P9, DOI 10.1080/13803399508406576; Byrne JM, 1999, DEV MED CHILD NEUROL, V41, P740, DOI 10.1017/S0012162299001504; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Catroppa C, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P765, DOI 10.1007/978-0-387-76978-3_25; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; Connolly JF, 2000, INT J PSYCHOPHYSIOL, V37, P31, DOI 10.1016/S0167-8760(00)00093-3; Connolly JF, 2000, INT J PSYCHOPHYSIOL, V38, P55, DOI 10.1016/S0167-8760(00)00130-6; CONNOLLY JF, 1995, J CLIN EXP NEUROPSYC, V17, P548, DOI 10.1080/01688639508405145; Connolly JF, 1999, ARCH PHYS MED REHAB, V80, P1309, DOI 10.1016/S0003-9993(99)90035-7; D'Arcy RCN, 1999, NEUROPSYCHOLOGIA, V37, P1477, DOI 10.1016/S0028-3932(99)00057-3; D'Arcy RCN, 2003, CLIN NEUROPHYSIOL, V114, P662, DOI 10.1016/S1388-2457(03)00007-5; de Zubicaray GI, 2011, NEUROIMAGE, V54, P1488, DOI 10.1016/j.neuroimage.2010.08.058; DeBoer T., 2005, METHODOLOGICAL HDB R, P263; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Desroches AS, 2009, J COGNITIVE NEUROSCI, V21, P1893, DOI 10.1162/jocn.2008.21142; Docking K, 2000, BRAIN INJURY, V14, P89, DOI 10.1080/026990500120952; Duffau H, 2005, BRAIN, V128, P797, DOI 10.1093/brain/awh423; Duncan C. C., 2011, INT J PSYCHOPHYSIOLO; Duncan CC, 2005, INT J PSYCHOPHYSIOL, V58, P133, DOI 10.1016/j.ijpsycho.2005.05.011; Duncan CC, 2003, PSYCHOPHYSIOLOGY, V40, P45, DOI 10.1111/1469-8986.00006; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Dunn L.M., 1997, PEABODY PICTURE VOCA, V3rd Edition; Dunn LM., 1981, PEABODY PICTURE VOCA; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Federmeier KD, 2007, PSYCHOPHYSIOLOGY, V44, P491, DOI 10.1111/j.1469-8986.2007.00531.x; Federmeier KD, 1999, J MEM LANG, V41, P469, DOI 10.1006/jmla.1999.2660; Friederici AD, 2005, TRENDS COGN SCI, V9, P481, DOI 10.1016/j.tics.2005.08.008; Friederici AD, 2006, NEURON, V52, P941, DOI 10.1016/j.neuron.2006.12.002; Friederici Angela D, 2004, Curr Neurol Neurosci Rep, V4, P466, DOI 10.1007/s11910-004-0070-0; Friederici AD, 2009, TRENDS COGN SCI, V13, P175, DOI 10.1016/j.tics.2009.01.001; Friedrich M, 2005, NEUROREPORT, V16, P653, DOI 10.1097/00001756-200504250-00028; Friedrich M, 2004, J COGNITIVE NEUROSCI, V16, P1465, DOI 10.1162/0898929042304705; Friedrich M, 2010, BRAIN LANG, V114, P66, DOI 10.1016/j.bandl.2009.07.004; Gaetz M, 2002, CLIN NEUROPHYSIOL, V113, P1665, DOI 10.1016/S1388-2457(02)00270-5; Gaetz M, 2001, J HEAD TRAUMA REHAB, V16, P386, DOI 10.1097/00001199-200108000-00008; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Hagoort P., 2000, NEUROCOGNITION LANGU; Hahne A, 2004, J COGNITIVE NEUROSCI, V16, P1302, DOI 10.1162/0898929041920504; Hanten G, 2004, ANN NEUROL, V56, P847, DOI 10.1002/ana.20298; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; Hanten G, 2009, TOP LANG DISORD, V29, P236, DOI 10.1097/TLD.0b013e3181b531f0; Hart J, 2007, J INT NEUROPSYCH SOC, V13, P865, DOI 10.1017/S135561770707110X; Henderson LM, 2011, BRAIN LANG, V117, P88, DOI 10.1016/j.bandl.2010.12.003; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Jones R, 2003, PARENTAL OCCUPATION; Jonsson CA, 2004, BRAIN INJURY, V18, P921, DOI 10.1080/02699050410001671900; Jordan F M, 1988, Brain Inj, V2, P179, DOI 10.3109/02699058809150943; Jordan FM, 1996, BRAIN INJURY, V10, P729, DOI 10.1080/026990596123990; Kahan TA, 1999, PSYCHON B REV, V6, P105, DOI 10.3758/BF03210816; Kaplan E., 2001, BOSTON NAMING TEST; Karunanayaka PR, 2007, NEUROREHABILITATION, V22, P355; Kawohl W., 2009, NEUROREHABILITATION, V24, P282; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; KORIAT A, 1981, MEM COGNITION, V9, P587, DOI 10.3758/BF03202353; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; Levin HS, 2012, PEDIATRICS, V129, pE494, DOI 10.1542/peds.2011-3403; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Lew HL, 2007, J CLIN NEUROPHYSIOL, V24, P398, DOI 10.1097/WNP.0b013e318150694b; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Luck S.J., 2005, INTRO EVENT RELATED, V1st ed.; Marchand Y, 2002, CLIN NEUROPHYSIOL, V113, P1715, DOI 10.1016/S1388-2457(02)00224-9; McNamara T.P., 2005, SEMANTIC PRIMING PER; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; MEYER DE, 1976, SCIENCE, V192, P27, DOI 10.1126/science.1257753; MILLS DL, 1993, J COGNITIVE NEUROSCI, V5, P317, DOI 10.1162/jocn.1993.5.3.317; Mills DL, 2004, J COGNITIVE NEUROSCI, V16, P1452, DOI 10.1162/0898929042304697; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Molfese DL, 2008, DEV NEUROPSYCHOL, V33, P682, DOI 10.1080/87565640802418647; Molfese DL, 1999, DEV NEUROPSYCHOL, V16, P373, DOI 10.1207/S15326942DN1603_19; Morse S, 1999, Pediatr Rehabil, V3, P139; MUNTE TF, 1994, ARCH NEUROL-CHICAGO, V51, P482, DOI 10.1001/archneur.1994.00540170058017; Neely J.H., 1991, BASIC PROCESSES READ, P264; Nelson DL, 2004, BEHAV RES METH INS C, V36, P402, DOI 10.3758/BF03195588; NEVILLE HJ, 1980, BRAIN LANG, V11, P300, DOI 10.1016/0093-934X(80)90130-3; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Picton TW, 2007, DEV NEUROPSYCHOL, V31, P249, DOI 10.1080/87565640701228732; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Popescu M, 2009, NEUROREPORT, V20, P1104, DOI 10.1097/WNR.0b013e32832e9c97; Rugg M. D., 1996, ELECTROPHYSIOLOGY MI; Rugg M. D., 1994, COGNITIVE ELECTROPHY; RUGG MD, 1985, PSYCHOPHYSIOLOGY, V22, P642, DOI 10.1111/j.1469-8986.1985.tb01661.x; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; Steinhauer K, 2008, HANDBOOK OF THE NEUROSCIENCE OF LANGUAGE, P91, DOI 10.1016/B978-0-08-045352-1.00009-4; Stiles J., 2012, DEV PSYCHOBIOLOGY; Strangman GE, 2009, NEUROREHAB NEURAL RE, V23, P226, DOI 10.1177/1545968308324225; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1961, LANCET, V2, P443; Sullivan JR, 2010, APPL NEUROPSYCHOL, V17, P93, DOI 10.1080/09084281003708852; Szekely A, 2005, CORTEX, V41, P7, DOI 10.1016/S0010-9452(08)70174-6; Szekely A, 2004, J MEM LANG, V51, P247, DOI 10.1016/j.jml.2004.03.002; Torkildsen JV, 2006, J NEUROLINGUIST, V19, P431, DOI 10.1016/j.jneuroling.2006.01.002; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; Van Overschelde JP, 2004, J MEM LANG, V50, P289, DOI 10.1016/j.jml.2003.10.003; Van Petten C, 2006, BRAIN LANG, V97, P279, DOI 10.1016/j.bandl.2005.11.003; Weber-Fox C, 2003, BRAIN LANG, V85, P231, DOI 10.1016/S0093-934X(02)00587-4; Whitney-Sesma H., 2005, ASSESSMENT COGNITIVE; Wiig E. H., 1989, TEST LANGUAGE COMPET; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007; [No title captured]	118	3	3	0	17	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X	1090-2155		BRAIN LANG	Brain Lang.	OCT	2012	123	1					52	63		10.1016/j.bandl.2012.06.009			12	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	003NT	WOS:000308619300006	22819620				2022-02-06	
J	Rasul, FT; Pereira, EAC; Waldmann, C; Bojanic, S				Rasul, Fahid Tariq; Pereira, Erlick A. C.; Waldmann, Carl; Bojanic, Stana			Effective management of severe traumatic brain injury in a district hospital	BRITISH JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury (TBI); intracranial pressure (ICP); intensive care unit (ICU); NICE; Glasgow Outcome Score (GOS)	SEVERE HEAD-INJURIES; INTRACRANIAL-PRESSURE; DECOMPRESSIVE CRANIECTOMY; NEUROCRITICAL CARE; MORTALITY; SYSTEM; TRENDS	The authors investigated how effectively adults with severe traumatic brain injury (TBI) can be managed in a district general hospital intensive care unit offering intracranial pressure monitoring (ICPM) receiving advice from a neurosurgical unit. A single-centre case series with retrospective review of prospectively collected information was undertaken of 44 consecutive patients presenting over seven years from January 2003 to January 2010 with severe traumatic brain injury to a single district general hospital intensive care unit serving a population of 500,000 adults. A prospectively entered clinical database was used to obtain information including patient demographics, Glasgow Coma Score (GCS) on admission, ICPM insertion, ICPM-related complications, inpatient mortality and neurosurgical advice. Case notes were used to ratify information and obtain neurorehabilitation clinic functional outcome scores. Forty-four patients were identified (40 male, age range 16-77 years). Mortality in intensive care was 30%. Twenty-eight patients received frontal twist drill ICPM following neurosurgical advice. ICPM had 2 (7%) device malfunctions but no other complications. Twelve additional patients were transferred to tertiary centres. Patients (23 of 31) who survived ICU stay (74%) were referred to neurorehabilitation. Mean clinic follow-up was 14 months. All patients had a Glasgow Outcome Score (GOS) of 3 or 4 at initial clinic assessment. Twenty-two improved to GOS to 4 or 5 at clinic discharge. One patient died prior to clinic discharge. Carefully selected patients with severe TBI can be managed safely and effectively in a district general hospital offering ICPM insertion if transfer to a neurosurgical centre is not possible. Neurosurgical advice regarding patient selection and on-going management is fundamental to provid a good service. Protocol driven therapies provide a useful systematic approach to doctors who do not deal with severe TBI on a routine basis.	[Rasul, Fahid Tariq] Royal Berkshire Hosp, Intens Care Unit, Dept Intens Care Med, Reading, Berks, England; [Pereira, Erlick A. C.; Bojanic, Stana] John Radcliff Hosp, Dept Neurol Surg, Oxford OX3 9DU, England		Rasul, FT (corresponding author), Royal Berkshire Hosp, Intens Care Unit, Dept Intens Care Med, Reading, Berks, England.	fahidrasul@doctors.org.uk	Pereira, Erlick/AAB-5335-2020	Pereira, Erlick/0000-0003-0452-4023			Addy A, 1996, CLIN INTENS CARE, V7, P87; Ashkan K, 2001, BRIT J NEUROSURG, V15, P342; Barratt H, 2010, EMERG MED J, V27, P173, DOI 10.1136/emj.2009.075382; Clayton TJ, 2004, BRIT J ANAESTH, V93, P761, DOI 10.1093/bja/aeh249; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; DiRusso SM, 2005, J TRAUMA, V59, P84, DOI 10.1097/01.TA.0000171462.28379.F3; Ehtisham A, 2009, NEUROCRIT CARE, V10, P241, DOI 10.1007/s12028-008-9097-4; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Fuller G, 2011, BRIT J NEUROSURG, V25, P414, DOI 10.3109/02688697.2011.570882; Fuller G, 2011, J NEUROSURG ANESTH, V23, P198, DOI 10.1097/ANA.0b013e3182161816; Gabbe BJ, 2011, ANN SURG, V253, P138, DOI 10.1097/SLA.0b013e3181f6685b; Hannan EL, 2005, J AM COLL SURGEONS, V200, P584, DOI 10.1016/j.jamcollsurg.2004.12.016; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Hutchinson PJ, 2011, BRIT J NEUROSURG, V25, P441, DOI 10.3109/02688697.2011.583366; Hutchinson PJ, 2006, BMJ-BRIT MED J, V332, P118, DOI 10.1136/bmj.332.7533.118-a; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Maartens NF, 2002, BRIT J NEUROSURG, V16, P290, DOI 10.1080/02688690220148897; Mendelow AD, 2008, LANCET, V372, P685, DOI 10.1016/S0140-6736(08)61280-5; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Petsas A, 2010, J NEUROSURG ANESTH, V22, P354, DOI 10.1097/ANA.0b013e3181f0da95; POON WS, 1991, INJURY, V22, P323, DOI 10.1016/0020-1383(91)90016-8; Resnick DK, 1997, J TRAUMA, V42, P1108, DOI 10.1097/00005373-199706000-00021; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Stevenson MD, 2001, INJURY, V32, P267, DOI 10.1016/S0020-1383(00)00191-1; Teig M, 2010, J NEUROSURG ANESTH, V22, P357, DOI 10.1097/ANA.0b013e3181f0dada	28	3	3	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	OCT	2012	26	5					736	742		10.3109/02688697.2012.690909			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	002JE	WOS:000308527100019	22612267				2022-02-06	
J	Rubial-Alvarez, S; Veiga-Suarez, M				Rubial-Alvarez, Sandra; Veiga-Suarez, Maria			Clinical profile in subjects with acquired brain injury in chronic phase in a social and health care center	REVISTA DE NEUROLOGIA			Spanish	Article						Acquired brain injury; Chronic phase; Neuropsychology; Personality disorder; Rehabilitation; Social and health care	COGNITIVE REHABILITATION	Introduction. There are few resources for acquired brain injury (ABI) in post-hospitalary phase in our country. At this level of carefulness, Personal Autonomy Promotion Center in Bergondo contemplates like a social and health care resource in order to facilitate community integration in subjects with ABI. Aims. To describe clinical profile in the subjects admitted in our unit, and to assess intervention possibilities with clinico-functional recovery goals in the chronic phases in ABI. Patients and methods. Sample of 105 subjects admitted in our center until December 2010. 86 men and 19 women, with a mean age of 32.16 years old and a most frequent evolution time of less than 5 years (64.76%). Variables collected were: sex, age, etiology, evolution time, personality changes diagnosis, admission FIM, previous participation in rehabilitation programmes and have recovery goals. Results. The main etiology was traumatic brain injury (62.5%). The 54.28% of the subjects was taking physical rehabilitation at the moment of admission, while the 49.52% had participated in neuropsychological interventions. Physical recovery goals were identified in the 42.85% of the subjects and the 78.09% had goals in neuropsychology field. Conclusion. The clinical profile observed was young man with sequelae caused by a traumatic brain injury suffered in last five years, who has received poor neuropsychological care and that still takes physiotherapy treatment.	[Rubial-Alvarez, Sandra; Veiga-Suarez, Maria] Minist Sanidad, Serv Sociales & Igualdad, Ctr Promoc Auton Personal Bergondo, Unidad Dano Cerebral Adquirido, Bergondo, A Coruna, Spain		Rubial-Alvarez, S (corresponding author), Ctr Promoc Auton Personal Bergondo, Camino Praia Regueiro S-N, E-15165 Fiobre Bergondo, A Coruna, Spain.	srubiala@imserso.es					Asociacion Americana de Psiquiatria, 2002, MAN DIAGN EST TRAST; Castellanos-Pinedo F, 2012, REV NEUROLOGIA, V54, P357, DOI 10.33588/rn.5406.2011714; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Defensor del Pueblo, 2006, DANO CEREBRAL SOBREV; Geurtsen GJ, 2010, J REHABIL MED, V42, P97, DOI 10.2340/16501977-0508; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Herrero T, 2006, MANUAL SERMEF REHABI, P611; Lopez-Hernandez B, 2003, 2 INT C NEUR INT; Munoz-Cespedes JM, 2001, REV NEUROLOGIA, V32, P351, DOI 10.33588/rn.3204.2000456; Munoz-Cespedes JM, 1999, PSICOLOGIA REHABILIT, P153; Parish L, 2007, NEUROPSYCHOL REHABIL, V17, P230, DOI 10.1080/09602010600750675; Pelegrin-Valero C, 2001, REV NEUROLOGIA, V32, P681, DOI 10.33588/rn.3207.2000180; Rao AK, 2004, STROKE REHABILITATIO, P92; Sanchez I, 2006, MANUAL SERMEF REHABI, P557; Sohlberg MM, 2001, COGNITIVE REHABILITA, P337; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Yates PJ, 2003, NEUROPSYCHOL REHABIL, V13, P291, DOI 10.1080/09602010244000408; [No title captured]	21	3	3	0	4	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010			REV NEUROLOGIA	Rev. Neurologia	OCT 1	2012	55	7					392	398		10.33588/rn.5507.2012227			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	038OQ	WOS:000311184400002	23011857				2022-02-06	
J	Tomaszewski, W				Tomaszewski, Wieslaw			THE IMPACT OF THERAPIST TRAINING IN INTERPERSONAL COMMUNICATION ON REHABILITATION OUTCOME FOR TRAUMATIC BRAIN INJURY PATIENTS	ACTA NEUROPSYCHOLOGICA			English	Article						emotional disturbances; social discomfort; communication disorders		Background: The aim of the study was to evaluate the effectiveness of rehabilitation of traumatic brain injury (TBI) patients when conducted by therapists who had participated in a training program on effective patient communication, as compared to rehabilitation administered by therapists without this training. Material/Methods: The study included 40 TBI patients under treatment in a phased rehabilitation program. The experimental group (E) included 20 patients trained by therapists who participated in the training course on effective patient communication, while the control group (K) included 20 patients trained by rehabilitation therapists who did not participate in this program. The research methods included analysis of documentation, structured clinical interview, and the Rehabilitation Effectiveness Rating Scale. Results: The differences between the results obtained at baseline and follow-up from group E were highly significant for both mental and physical comfort and the assessment of the ability to communicate. The contingency coefficient indicates a significant relationship between the program and the improvement of mental and physical comfort (C-sk = 0.644), and the ability to communicate (C-sk = 0.47). These same differences were not significant in group K. Conclusions: There was a significant association between the therapists' participation in training for effective patient communication and the psycho-physical comfort of patients, as well as their ability to communicate in social situations. The rehabilitation of patients after traumatic brain injury is thus more effective when conducted by therapists trained in effective patient communication.	[Tomaszewski, Wieslaw] Coll Physiotherapy, T KoSciuszki 4, PL-50038 Wroclaw, Poland		Tomaszewski, W (corresponding author), Coll Physiotherapy, T KoSciuszki 4, PL-50038 Wroclaw, Poland.	w.tomaszewski@wp.pl					Agrawal Amit, 2012, Int J Crit Illn Inj Sci, V2, P167, DOI 10.4103/2229-5151.100915; Baranowski P, 2000, Ortop Traumatol Rehabil, V2, P17; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Gainotti G., 2003, HDB CLIN NEUROPSYCHO, P368; Kaczmarek B.L.J., 2003, CLASSIC CASES NEUROP, V2, P131; Kadzielawa D, 2003, NEUROPSYCHOLOGICZNE, P17; KOLB B, 2003, FUNDAMENTALS HUMAN N; Lefebvre Helene, 2007, J Trauma Nurs, V14, P100; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Moskala M., 2000, POURAZOWE KRWIAKI SR; Moskala M, 2007, MICROSC MICROANAL, V13, P211, DOI 10.1017/S1431927607070286; Pachalska M., 1998, SKALE OCENY EFEKTYWN; Pachalska M., 2013, NEUROPSYCHOLOGIA KLI; Pachalska M., 2007, Neuropsychologia kliniczna: urazy mozgu; Pachalska M., 2003, ACTA NEUROPSYCHOLOGI, V1, P194; Pachalska M., 2001, ORTOPEDIA TRAUMATOLO, V3, P109; Pachalska M, 2010, MED SCI MONITOR, V16, pCS157; Prigatano G.P., 2003, HDB CLIN NEUROPSYCHO, P387; Rehman Tausif, 2008, Cases J, V1, P203, DOI 10.1186/1757-1626-1-203; Talar J., 2003, NEUROREHABILITACJA P; Tepas JJ, 2013, J TRAUMA ACUTE CARE, V74, P143, DOI 10.1097/TA.0b013e3182788b5a; World Health Organization ( WHO), 2004, WORLD HLTH REP 2004	23	3	3	0	0	MEDSPORTPRESS PUBLISHING HOUSE	WARSAW	UL MARYMONCKA 34 SKR 23, WARSAW, 01813, POLAND	1730-7503	2084-4298		ACTA NEUROPSYCHOL	Acta Neuropsychol.	OCT-DEC	2012	10	4					509	518		10.5604/17307503.1030212			10	Psychology	Emerging Sources Citation Index (ESCI)	Psychology	V1K8D	WOS:000216994600005					2022-02-06	
J	Lin, X; Li, M; Shang, AJ; Hu, YZ; Yang, X; Ye, L; Bian, SY; Wang, ZF; Zhou, DB				Lin, Xin; Li, Min; Shang, Aijia; Hu, Yazhuo; Yang, Xiao; Ye, Ling; Bian, Suyan; Wang, Zhongfeng; Zhou, Dingbiao			Neuroglobin expression in rats after traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						neuroglobin; traumatic brain injury; neuron; apoptosis; cerebral cortex; Bax; Bcl-2; neural regeneration	DAMAGE; EDEMA; PATHOPHYSIOLOGY; MECHANISMS; APOPTOSIS; ISCHEMIA; PROTECTS; NEURONS; MODEL	In this study, we used a rat model of severe closed traumatic brain injury to explore the relationship between neuroglobin, brain injury and neuronal apoptosis. Real-time PCR showed that neuroglobin mRNA expression rapidly increased in the rat cerebral cortex, and peaked at 30 minutes and 48 hours following traumatic brain injury. Immunohistochemical staining demonstrated that neuroglobin expression increased and remained high 2 hours to 5 days following injury. The rate of increase in the apoptosis-related Bax/Bcl-2 ratio greatly decreased between 30 minutes and 1 hour as well as between 48 and 72 hours post injury. Expression of neuroglobin and the anti-apoptotic factor Bcl-2 greatly increased, while that of the proapoptotic factor decreased, in the cerebral cortex post severe closed traumatic brain injury. It suggests that neuroglobin might protect neurons from apoptosis after traumatic injury by regulating Bax/Bcl-2 pathway.	[Shang, Aijia; Zhou, Dingbiao] Gen Hosp Chinese PLA, Dept Neurosurg, Div Surg, Beijing 100853, Peoples R China; [Lin, Xin] Gen Hosp Chinese PLA, Dept Surg, Div Nanlou, Beijing 100853, Peoples R China; [Li, Min] Huangsi Aesthet Surg Hosp, Dept Traumat Aesthet Surg, Beijing 100120, Peoples R China; [Hu, Yazhuo; Ye, Ling] Gen Hosp Chinese PLA, Inst Geriatr, Beijing 100853, Peoples R China; [Yang, Xiao] Acad Mil Med Sci, Inst Microbiol & Epidemiol, Beijing 100071, Peoples R China; [Bian, Suyan] Gen Hosp Chinese PLA, Dept Cardiol, Div Nanlou, Beijing 100853, Peoples R China; [Wang, Zhongfeng] Fudan Univ, Inst Brain Sci, Shanghai 200032, Peoples R China; [Wang, Zhongfeng] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China		Zhou, DB (corresponding author), Gen Hosp Chinese PLA, Dept Neurosurg, Div Surg, Beijing 100853, Peoples R China.				National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30400465, 30571903]; Medical Neurobiology of State Key Laboratory of Fudan University [09-08]	This work was supported by General Program of National Natural Science Foundation of China, No. 30400465, 30571903; Open Project from Medical Neurobiology of State Key Laboratory (09-08) of Fudan University.	Barzo P, 1997, ACT NEUR S, V70, P119; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2004, NEWS PHYSIOL SCI, V19, P110, DOI 10.1152/nips.01513.2003; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Formigli L, 2000, J CELL PHYSIOL, V182, P41, DOI 10.1002/(SICI)1097-4652(200001)182:1<41::AID-JCP5>3.0.CO;2-7; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; Liu JX, 2009, J NEUROSCI RES, V87, P164, DOI 10.1002/jnr.21826; Maier CM, 2002, NEUROSCIENTIST, V8, P323, DOI 10.1177/107385840200800408; Marmarou A, 2003, ACT NEUR S, V86, P7; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; *MIN SCI TECHN PEO, GUID SUGG CAR US LAB; Pavlov EV, 2001, J CELL BIOL, V155, P725, DOI 10.1083/jcb.200107057; Shang AJ, 2006, BRAIN RES, V1078, P219, DOI 10.1016/j.brainres.2006.01.064; Soustiel JF, 2010, NEUROTHERAPEUTICS, V7, P13, DOI 10.1016/j.nurt.2009.11.001; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Wakasugi K, 2003, J BIOL CHEM, V278, P36505, DOI 10.1074/jbc.M305519200; Zhang CG, 2002, BIOCHEM BIOPH RES CO, V290, P1411, DOI 10.1006/bbrc.2002.6360	21	3	4	2	18	SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES	SHENYANG	PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA	1673-5374			NEURAL REGEN RES	Neural Regen. Res.	SEP 5	2012	7	25					1960	1966		10.3969/j.issn.1673-5374.2012.25.006			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	018BT	WOS:000309635700006	25624825				2022-02-06	
J	Ahmadian, A; Baaj, AA; Garcia, M; Carey, C; Rodriguez, L; Storrs, B; Tuite, GF				Ahmadian, Amir; Baaj, Ali A.; Garcia, Michael; Carey, Carolyn; Rodriguez, Luis; Storrs, Bruce; Tuite, Gerald F.			Decompressive craniectomy with massive intractable intraoperative cerebral edema: utilization of silicone sheet for temporary scalp closure Case report	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						decompressive craniectomy; cranioplasty; cerebral edema; scalp closure; silicone; trauma	TRAUMATIC BRAIN-INJURY; CHILDREN; PALSY	The authors present a case of extreme brain herniation encountered during decompressive craniectomy in a 21-month-old boy who suffered a trauma event that necessitated temporary scalp closure in which a sterile silicone sheet was placed. Although the clinical situation is usually expected to lead to brain death or severe disability, the patient's 3-year follow-up examination revealed a highly functional child with a good quality of life. The authors discuss the feasibility and advantages of temporary scalp expansion as a treatment option when extreme brain herniation is encountered during craniotomy. (http://thejns.org/doi/abs/10.3171/2012.6.PEDS11567)	[Carey, Carolyn; Rodriguez, Luis; Storrs, Bruce; Tuite, Gerald F.] Univ S Florida, All Childrens Hosp, Inst Neurosci, St Petersburg, FL 33701 USA; [Garcia, Michael] Univ S Florida, All Childrens Hosp, Dept Anesthesia, St Petersburg, FL 33701 USA; [Ahmadian, Amir; Baaj, Ali A.; Carey, Carolyn; Rodriguez, Luis; Storrs, Bruce; Tuite, Gerald F.] Univ S Florida, Dept Neurosurg, Tampa, FL USA		Tuite, GF (corresponding author), Univ S Florida, All Childrens Hosp, Inst Neurosci, 601 5th St S,Suite 511, St Petersburg, FL 33701 USA.	geraldtuite@gmail.com					Aghakhani N, 2009, J NEUROS-PEDIATR, V3, P66, DOI 10.3171/2008.10.PEDS08116; Appelboom G, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11177; Bourke-Taylor H, 2003, DEV MED CHILD NEUROL, V45, P92, DOI 10.1017/S0012162203000185; Burger R, 2008, ACTA NEUROCHIR SUPPL, V102, P93, DOI 10.1007/978-3-211-85578-2_19; Cushing H, 1905, SURG GYNECOL OBSTET, V1, P297; Frye RE, 2012, DEV MED CHILD NEUROL, V54, P298, DOI 10.1111/j.1469-8749.2011.04157.x; Guresir E, 2011, NEUROSURGERY, V68, P1527, DOI 10.1227/NEU.0b013e31820edd82; Jacob AT, 2011, PEDIATR NEUROSURG, V47, P81, DOI 10.1159/000329624; Johnston MV, 2009, DEV DISABIL RES REV, V15, P94, DOI 10.1002/ddrr.64; Ma JP, 2011, CRIT CARE, V15, DOI 10.1186/cc10358; Quinn TM, 2011, ACTA NEUROL SCAND, V123, P239, DOI 10.1111/j.1600-0404.2010.01397.x; Timmons SD, 2011, NEW ENGL J MED, V365, P373, DOI 10.1056/NEJMc1106421; Wang HH, 2006, PHYS THER, V86, P1351, DOI 10.2522/ptj.20050259; Zimmerman IL, 2005, MENT RETARD DEV D R, V11, P238, DOI 10.1002/mrdd.20078	14	3	3	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	SEP	2012	10	3					195	199		10.3171/2012.6.PEDS11567			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	990KD	WOS:000307628500008	22793163				2022-02-06	
J	Balck, F; Dinkel, A				Balck, Friedrich; Dinkel, Andreas			Partners of Patients with Acute Brain Injury: Anxiety and Depression in the Acute and Sub-Acute Phase	PSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE			German	Article						couples; traumatic brain injury; subarachnoid haemorrhage; anxiety; depression	SEVERE HEAD-INJURY; QUALITY-OF-LIFE; NEUROLOGICAL REHABILITATION; PSYCHOLOGICAL DISTRESS; GENDER-DIFFERENCES; FAMILY CAREGIVERS; STROKE; RELATIVES; INDIVIDUALS; TRANSITION	There are only few studies that deal with psychological distress in short-term carers of patients with acute brain injuries. We investigated the prevalence of anxiety and depression in partners (N = 70) of patients with traumatic brain injury (TBI) or subarachnoid haemorrhage (SAB). Furthermore, we analysed the influence of injury-related, personal, and contextual factors on psychological distress. Partners were interviewed, on average, 40,3 days (SD = 15,7, Range 12-85) after the patient's brain injury. They filled out the Beck Anxiety Inventory (BAI) and the Beck Depression Inventory (BDI). Moderate to severe anxiety was prevalent in 30,0% of the partners, and 14,3% experienced significant depression. Partners of patients low in functional capacity exhibited a higher level of depression. Women were more distressed than men. Additional burden due to psychosocial background stress, acute care of the patient, and daily visits were associated with higher psychological distress.	[Dinkel, Andreas] Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Psychosomat Med & Psychotherapie, D-81675 Munich, Germany; [Balck, Friedrich] Tech Univ Dresden, Abt Med Psychol & Med Soziol, Univ Klinikum Carl Gustav Carus, Dresden, Germany		Dinkel, A (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Psychosomat Med & Psychotherapie, Langerstr 3, D-81675 Munich, Germany.	a.dinkel@tum.de	Dinkel, Andreas/AAP-4681-2021				Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Cope DN, 1994, J HEAD TRAUMA REHAB, V9, P67; Dinkel A, 2003, PRAX KLIN VERHALTENS, V16, P116; Dombovy ML, 1998, BRAIN INJURY, V12, P443, DOI 10.1080/026990598122412; Forsberg-Warleby G, 2001, STROKE, V32, P1646, DOI 10.1161/01.STR.32.7.1646; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; Grant JS, 2000, BRAIN INJURY, V14, P1089; Greenwood N, 2010, J CLIN NURS, V19, P2032, DOI 10.1111/j.1365-2702.2009.03163.x; Hammerling E, 2008, Z NEUROPSYCHOL, V19, P223, DOI 10.1024/1016-264X.19.4.223; Han B, 1999, STROKE, V30, P1478, DOI 10.1161/01.STR.30.7.1478; Hautzinger M., 1995, BECK DEPRESSIONS INV; Hellawell DJ, 2001, DISABIL REHABIL, V23, P300, DOI 10.1080/769979114; Himaj J, 2011, REHABILITATION, V50, P94, DOI 10.1055/s-0030-1263189; Hoffmann B, 2006, AKTUEL NEUROL, V33, P287, DOI 10.1055/s-2005-915348; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Katzlberger F, 2000, PSYCHOTHER PSYCH MED, V50, P209, DOI 10.1055/s-2000-13248; King RB, 2001, RES NURS HEALTH, V24, P307, DOI 10.1002/nur.1032; Kitze K, 2002, Rehabilitation (Stuttg), V41, P401; Kotila M, 1998, STROKE, V29, P368, DOI 10.1161/01.STR.29.2.368; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Lehto US, 2008, SUPPORT CARE CANCER, V16, P1231, DOI 10.1007/s00520-008-0410-8; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; Low CA, 2006, ANN BEHAV MED, V32, P235, DOI 10.1207/s15324796abm3203_10; MAHONEY F I, 1965, Md State Med J, V14, P61; Margraf, 2007, BECK ANGST INVENTAR; Morrison V, 2005, J PSYCHOSOM RES, V59, P209, DOI 10.1016/j.jpsychores.2005.02.019; Norup A, 2011, NEUROPSYCHOL REHABIL, V21, P306, DOI 10.1080/09602011.2011.558766; Norup A, 2010, BRAIN INJURY, V24, P81, DOI 10.3109/02699050903508200; Novack TA, 1991, J HEAD TRAUMA REHAB, V6, P69; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Pinquart M, 2006, J GERONTOL B-PSYCHOL, V61, pP33, DOI 10.1093/geronb/61.1.P33; Riggio S, 2011, NEUROL CLIN, V29, P35, DOI 10.1016/j.ncl.2010.10.008; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; Roding J, 2009, DISABIL REHABIL, V31, P1092, DOI 10.1080/09638280802510965; SCHULZ R, 1988, PSYCHOL AGING, V3, P131, DOI 10.1037/0882-7974.3.2.131; Stier-Jarmer M, 2002, PHYS MED REHAB KUROR, V12, P260, DOI 10.1055/s-2002-35154; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538; TEASDALE G, 1974, LANCET, V2, P81; Teasdale TW, 2005, BRAIN INJURY, V19, P1041, DOI 10.1080/02699050500110397; Turner B, 2011, NEUROPSYCHOL REHABIL, V21, P64, DOI 10.1080/09602011.2010.527747; Turner BJ, 2008, DISABIL REHABIL, V30, P1153, DOI 10.1080/09638280701532854; Visser-Meily A, 2009, STROKE, V40, P1399, DOI 10.1161/STROKEAHA.108.516682; Wilz G, 2007, PSYCHOTHER PSYCHOSOM, V57, pe1; Wilz G, 2008, CEREBROVASC DIS, V25, P311, DOI 10.1159/000118375; Yee JL, 2000, GERONTOLOGIST, V40, P147, DOI 10.1093/geront/40.2.147	45	3	3	0	18	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0937-2032	1439-1058		PSYCHOTHER PSYCH MED	Psychother. Psychosom. Med. Psychol.	SEP	2012	62	9-10					352	358		10.1055/s-0032-1312679			7	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	018HM	WOS:000309650900004	22700107				2022-02-06	
J	Darby, DG; Master, CL; Grady, MF				Darby, David G.; Master, Christina L.; Grady, Matthew F.			Computerized Neurocognitive Testing in the Medical Evaluation of Sports Concussion	PEDIATRIC ANNALS			English	Article							TEST-RETEST RELIABILITY; COGNITIVE ASSESSMENT; TEST-PERFORMANCE; MANAGEMENT; CHILDREN; BATTERY; ADOLESCENTS; RECOVERY; SCORES; IMPACT	David G. Darby, MBBS, PhD, FRACP, is a Behavioral Neurologist at The Florey Neuroscience Institutes and Mental Health, University of Melbourne, Parkville VIC, Australia. Christina L. Master, MD, is the Associate Program Director, Primary Care Sports Medicine Fellowship, The Children's Hospital of Philadelphia; and Associate Professor of Clinical Pediatrics, Departments of Surgery and Pediatrics, Division of Pediatric Orthopedics and Sports Medicine, Perelman School of Medicine at the University of Pennsylvania. Matthew F. Grady, MD, is the Director, Primary Care Sports Medicine Fellowship, The Children's Hospital of Philadelphia; and Assistant Professor of Clinical Pediatrics, Departments of Surgery and Pediatrics, Division of Pediatric Orthopedics and Sports Medicine, Perelman School of Medicine at the University of Pennsylvania. Address correspondence to: David G. Darby, MBBS, PhD, FRACP, The Florey Institute of Neuroscience and Mental Health, Level 3, Alan Gilbert Building, 161 Barry Street, University of Melbourne, Parkville VIC 3010, Australia; email: ddarby@unimelb.edu.au. Disclosure: Dr. Darby is a founder, shareholder, and now consultant to CogState Ltd, which commercializes the Axon Sports computerized testing products. Drs. Master and Grady have no relevant financial relationships to disclose. doi: 10.3928/00904481-20120827-11	[Darby, David G.] Univ Melbourne, Florey Neurosci Inst & Mental Hlth, Parkville, Vic 3010, Australia; [Master, Christina L.; Grady, Matthew F.] Childrens Hosp Philadelphia, Philadelphia, PA USA; [Master, Christina L.; Grady, Matthew F.] Univ Penn, Perelman Sch Med, Div Pediat Orthoped & Sports Med, Dept Surg, Philadelphia, PA 19104 USA; [Master, Christina L.; Grady, Matthew F.] Univ Penn, Perelman Sch Med, Div Pediat Orthoped & Sports Med, Dept Pediat, Philadelphia, PA 19104 USA		Darby, DG (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Level 3,Alan Gilbert Bldg,161 Barry St, Parkville, Vic 3010, Australia.	ddarby@unimelb.edu.au		Master, Christina/0000-0002-6717-4270			Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Bartels C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-118; Betts J, 2006, CHILD NEUROPSYCHOL, V12, P205, DOI 10.1080/09297040500488522; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Brown CN, 2007, J ATHL TRAINING, V42, P515; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2004, BRIT J SPORT MED, V38, P273, DOI 10.1136/bjsm.2003.000293; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collie A, 2004, 2 INT C CONC SPORT N; Collie A, 2007, CONTEMP CLIN TRIALS, V28, P391, DOI 10.1016/j.cct.2006.10.010; Darby D, 2002, NEUROLOGY, V59, P1042, DOI 10.1212/WNL.59.7.1042; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Eckner JT, 2011, J ATHL TRAINING, V46, P409; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Fredrickson J, 2010, NEUROEPIDEMIOLOGY, V34, P65, DOI 10.1159/000264823; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kirkwood MW, 2009, ACTA PAEDIATR, V98, P1409, DOI 10.1111/j.1651-2227.2009.01448.x; Lewis MS, 2011, NEUROUROL URODYNAM, V30, P183, DOI 10.1002/nau.20963; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Maruff P, 2001, BRIT J SPORT MED, V35, P374; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory Paul, 2009, Scand J Med Sci Sports, V19, P452, DOI 10.1111/j.1600-0838.2009.00978.x; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Moriarity J, 2004, NEUROLOGY, V62, P1497, DOI 10.1212/WNL.62.9.1497; Moriarity JM, 2012, BRIT J SPORT MED, DOI [10.1136/bjsports-2011-090893, DOI 10.1136/BJSP0RTS-2011-090893]; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Randolph C, 2005, J ATHL TRAINING, V40, P139; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	39	3	3	0	26	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0090-4481	1938-2359		PEDIATR ANN	Pediatr. Annu.	SEP	2012	41	9					371	376		10.3928/00904481-20120827-11			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	082NM	WOS:000314398700011	22953983				2022-02-06	
J	Kim, Y; Kwon, SB; Park, HJ; Kim, MJ; Hong, SS; Kang, SY; Jung, S; Hwang, SH				Kim, Yerim; Kwon, Seok-Beom; Park, Hyun-Ju; Kim, Min-Ji; Hong, Seong-Sook; Kang, Suk Yun; Jung, San; Hwang, Sung-Hee			Predictors of functional outcome of patients in neurological intensive care unit	NEUROLOGY ASIA			English	Article							ACUTE ISCHEMIC-STROKE; NEUROCRITICAL CARE; SURVIVAL; IMPACT; TERM	Background: Little is known regarding the functional outcome and quality of life of neuro-ICU survivors. In Korea, the neuro-ICU concept was introduced relatively late and data about long term outcome and predictors concerning functional outcome is scarce. The main objective of this study was to analyze functional outcome and mortality, and to determine prognostic predictors for the outcome in patients admitted to Korean neuro-ICUs. Methods: Consecutive adult (>= 15-years-of-age) patients admitted to a neuro-ICU due to various causes including ischemic or hemorrhagic stroke, and other neurological or neurosurgical problems such as traumatic brain injury, seizure, or drug intoxication during an 18-month period from July 2008 through December 2009 were included. Demographic and clinical variables were compared between groups stratified based on 6-month modified Rankin scale score. Results: Of 555 patients, there were significant differences in age (P=0.013), sex (P=0.02), hospital stay (P<0.01), neuro-ICU stay (P<0.01), admission diagnosis (P=0.001), intubation (P<0.01), mechanical ventilation (P<0.01), tracheostomy (P<0.01), comorbid conditions such as atrial fibrillation (P<0.01), cardiac complication (P<0.01) and pulmonary complication (P<0.01), a high Therapeutic Intervention Scoring System (TISS-28) score (P<0.01), and a high Acute Physiology and chronic health evaluation (APACHE) II score (P<0.01) between favorable and unfavorable outcome groups. The overall mortality rate was 15.0% (n=83). In multivariable logistic regression analysis, age, sex, high TISS-28, high APACHE II score, intubation, and cardiac complication were independent predictors of unfavorable outcome. Conclusion: The identified predictors for functional outcomes in Korean neuro-ICU patients will be an important aid in diagnosing and treating neuro-ICU patients.	[Kim, Yerim; Kwon, Seok-Beom; Park, Hyun-Ju; Kim, Min-Ji; Kang, Suk Yun; Jung, San; Hwang, Sung-Hee] Hallym Univ, Coll Med, Dept Neurol, Seoul 150950, South Korea; [Hong, Seong-Sook] Soonchunhyang Univ, Coll Med, Dept Radiol, Seoul, South Korea		Kwon, SB (corresponding author), Hallym Univ, Coll Med, Dept Neurol, 948-1,DaeRim1 Dong, Seoul 150950, South Korea.	neukwon@hallym.ac.kr					Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Bershad EM, 2008, NEUROCRIT CARE, V9, P287, DOI 10.1007/s12028-008-9051-5; Bion JF, 1999, BRIT MED BULL, V55, P2, DOI 10.1258/0007142991902268; Broessner G, 2007, CRIT CARE MED, V35, P2025, DOI 10.1097/01.ccm.0000281449.07719.2b; Bushnell CD, 1999, NEUROLOGY, V52, P1374, DOI 10.1212/WNL.52.7.1374; Demoule A, 2005, J GERONTOL A-BIOL, V60, P129, DOI 10.1093/gerona/60.1.129; 구미지, 2002, [Korean Journal of Adult Nursing, 성인간호학회지], V14, P93; Kiphuth IC, 2010, CRIT CARE, V14, DOI 10.1186/cc9192; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kurtz P, 2011, NEUROCRIT CARE, V15, P477, DOI 10.1007/s12028-011-9539-2; Lan MY, 2006, J FORMOS MED ASSOC, V105, P653, DOI 10.1016/S0929-6646(09)60164-9; Markandaya M, 2011, NEUROCRIT CARE; Mateen FJ, 2011, NEUROCRIT CARE, V15, P593, DOI 10.1007/s12028-011-9623-7; Nfor TK, 2006, ANAESTHESIA, V61, P731, DOI 10.1111/j.1365-2044.2006.04707.x; Rabinstein AA, 2004, CEREBROVASC DIS, V18, P325, DOI 10.1159/000080771; Resche-Rigon M, 2006, CRIT CARE, V10, DOI 10.1186/cc3921; Rincon F, 2010, NEUROCRIT CARE, V13, P75, DOI 10.1007/s12028-010-9347-0; Sadaka F, 2011, NEUROCRIT CARE; Santoli F, 2001, INTENS CARE MED, V27, P1141, DOI 10.1007/s001340100998; Saposnik G, 2009, CEREBROVASC DIS, V27, P537, DOI 10.1159/000214216; Somme D, 2003, INTENS CARE MED, V29, P2137, DOI 10.1007/s00134-003-1929-2; Venker J, 2005, ANAESTHESIA, V60, P541, DOI 10.1111/j.1365-2044.2005.04180.x; Yilmaz GR, 2007, JPN J INFECT DIS, V60, P87; 신증수, 2004, Korean Journal of Anesthesiology, V47, P385	24	3	3	0	1	ASEAN NEUROLOGICAL ASSOC	KUALA LUMPUR	UNIV MALAYA MEDICAL CENTRE, NEUROLOGY LABORATORY, KUALA LUMPUR, 59100, MALAYSIA	1823-6138			NEUROL ASIA	Neurol. Asia	SEP	2012	17	3					219	225					7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013AS	WOS:000309278500008					2022-02-06	
J	Lanzino, DJ; Rabinstein, A; Kinlaw, D; Hepburn, SB; Ness, BM; Olson, KJ; Sobie, SM; Hollman, JH				Lanzino, Desiree J.; Rabinstein, Alejandro; Kinlaw, Denise; Hepburn, Stephanie B.; Ness, Brandon M.; Olson, Karen J.; Sobie, Sarah M.; Hollman, John H.			Coordination Tests in Persons With Acute Central Nervous System Pathology: Assessment of Interrater Reliability and Known-Group Validity	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						coordination; neurologic examination; psychomotor performance	ATAXIA RATING-SCALE; TO-NOSE TEST; EXTREMITY MOTOR COORDINATION; TRAUMATIC BRAIN-INJURY; ESSENTIAL TREMOR; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; MOVEMENT; ICARS; SYMPTOMS	Background and Purpose: Coordination testing is a standard part of the neurologic examination, yet the psychometric properties of many tests used by practitioners are unknown. This study investigated the interrater reliability and known-group validity of limb coordination tests in participants with acute central nervous system (CNS) pathology. Methods: Twenty-five participants with CNS pathology completed 20 different limb coordination tests administered at bedside by a physical therapist. Examinations were videotaped and independently rated by a neurologist, a physical therapist, and a student physical therapist using a 5-point ordinal scale. Nine tests were also timed. Results were analyzed for interrater reliability and the degree to which they differed between groups categorized as having or not having coordination deficits. Results: Participants were individuals who had been diagnosed with either a CNS vascular lesion or intracranial tumor. Timed test scores had higher levels of agreement (mean intraclass correlation coefficient [ICC], 0.69-0.97) than ordinal scores (mean kappa(free) 0.56-0.91). Scores from 5 of the 9 timed measures and 8 of the 20 ordinal measures differed between groups. Discussion and Conclusions: Eleven tests were scored reliably between raters (kappa > 0.60 or ICC > 0.75) and were performed differently between groups with and without coordination deficits (P <= 0.05). These tests are recommended for use when examining patients with acute neurologic pathology from a vascular lesion or tumor. They are simple to perform and require only a stopwatch to complete. Future studies should explore the sensitivity and specificity of these tests in disease states and their correlation with functional measures.	[Lanzino, Desiree J.] Mayo Clin, Coll Med, Mayo Sch Hlth Sci, Rochester, MN 55905 USA		Lanzino, DJ (corresponding author), Mayo Clin, Coll Med, Mayo Sch Hlth Sci, Siebens 11-06,200 1st St SW, Rochester, MN 55905 USA.	Lanzino.desiree@mayo.edu	Hollman, John H./AAG-9301-2019	Hollman, John/0000-0003-4690-223X			Andrews A Williams, 2008, J Neurol Phys Ther, V32, P122, DOI 10.1097/NPT.0b013e3181847a2f; Arceneaux JM, 1997, INT J NEUROSCI, V89, P281, DOI 10.3109/00207459708988480; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; BAIN PG, 1993, J NEUROL NEUROSUR PS, V56, P868, DOI 10.1136/jnnp.56.8.868; Ballard C, 1997, ACTA NEUROL SCAND, V96, P366; Blumenfeld H., 2002, NEUROANATOMY CLIN CA; BRENNAN RL, 1981, EDUC PSYCHOL MEAS, V41, P687, DOI 10.1177/001316448104100307; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Burk K, 2009, MOVEMENT DISORD, V24, P1779, DOI 10.1002/mds.22660; Butcher Scott J, 2004, J Cardiopulm Rehabil, V24, P274, DOI 10.1097/00008483-200407000-00013; Desrosiers J, 2006, DISABIL REHABIL, V28, P221, DOI 10.1080/09638280500158372; Desrosiers J, 2005, ARCH PHYS MED REHAB, V86, P993, DOI 10.1016/j.apmr.2004.11.007; DESROSIERS J, 1995, AGE AGEING, V24, P108, DOI 10.1093/ageing/24.2.108; Dewey HM, 1999, CEREBROVASC DIS, V9, P323, DOI 10.1159/000016006; Erasmus LP, 2001, J NEUROSCI METH, V108, P25, DOI 10.1016/S0165-0270(01)00373-9; Ferrarin M, 2005, MED BIOL ENG COMPUT, V43, P349, DOI 10.1007/BF02345812; Feys PG, 2003, ARCH PHYS MED REHAB, V84, P79, DOI 10.1053/apmr.2003.50068; Friesner I, 1922, ARCH NEURO PSYCHIATR, V7, P584, DOI 10.1001/archneurpsyc.1922.02190110035004; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Haaxma CA, 2010, MOVEMENT DISORD, V25, P1150, DOI 10.1002/mds.23100; Holmes G, 1917, BRAIN, V40, P461, DOI 10.1093/brain/40.4.461; Hurvitz EA, 2003, ARCH PHYS MED REHAB, V84, P444, DOI 10.1053/apmr.2003.50001; Kimber TE, 2003, J NEUROL NEUROSUR PS, V74, P258, DOI 10.1136/jnnp.74.2.258; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Largo RH, 2001, DEV MED CHILD NEUROL, V43, P436, DOI 10.1017/S0012162201000810; LOUIS ED, 1995, ARCH NEUROL-CHICAGO, V52, P1201, DOI 10.1001/archneur.1995.00540360079019; Louis ED, 2001, MOVEMENT DISORD, V16, P89, DOI 10.1002/1531-8257(200101)16:1<89::AID-MDS1001>3.0.CO;2-L; Louis ED, 1999, MOVEMENT DISORD, V14, P462, DOI 10.1002/1531-8257(199905)14:3<462::AID-MDS1012>3.0.CO;2-V; Miller TM, 2005, NEUROLOGY, V65, P1165, DOI 10.1212/01.wnl.0000180608.76190.10; Orient J. M., 2005, SAPIRAS ART SCI BEDS; OTT BR, 1995, J GERIATR PSYCH NEUR, V8, P71; PARDO B, 1993, MOVEMENT DISORD, V8, P278, DOI 10.1002/mds.870080305; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; RUFF RM, 1993, PERCEPT MOTOR SKILL, V76, P1219, DOI 10.2466/pms.1993.76.3c.1219; Schmahmann JD, 2009, MOVEMENT DISORD, V24, P1820, DOI 10.1002/mds.22681; Schmitz TJ, 2007, PHYS REHABILITATION, P193; Schoch B, 2007, MOVEMENT DISORD, V22, P2162, DOI 10.1002/mds.21543; Seidel HM, 2006, MOSBYS GUIDE PHYS EX, V6th; Stacy MA, 2007, MOVEMENT DISORD, V22, P833, DOI 10.1002/mds.21412; Storey E, 2004, MOVEMENT DISORD, V19, P190, DOI 10.1002/mds.10657; Swaine BR, 2005, ARCH PHYS MED REHAB, V86, P1665, DOI 10.1016/j.apmr.2004.11.021; SWAINE BR, 1993, PHYS THER, V73, P71, DOI 10.1093/ptj/73.2.71; Teitelbaum JS, 2002, CAN J NEUROL SCI, V29, P337, DOI 10.1017/S0317167100002201; Tison F, 2002, MOVEMENT DISORD, V17, P1248, DOI 10.1002/mds.10290; Trouillas P, 1997, J NEUROL SCI, V145, P205, DOI 10.1016/S0022-510X(96)00231-6; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd	46	3	3	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	SEP	2012	36	3					122	130		10.1097/NPT.0b013e3182641d36			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	999AY	WOS:000308282700003	22850331				2022-02-06	
J	Pampin, F; Bou, G; Galeiras, R; Freire, D; Bouza, MT; Zuniga, MD				Pampin, Francisco; Bou, German; Galeiras, Rita; Freire, David; Teresa Bouza, Maria; del Carmen Zuniga, Maria			Aeromonas and meningitis: An unusual presentation	NEUROCIRUGIA			Spanish	Article						Aeromonas; Meningitis; Traumatic brain injury	PYOGENIC MENINGITIS	The natural habitat of the genus Aeromonas is an aquatic environment. We describe the case of a patient suffering severe traumatic brain injury and meningitis by A. hydrophyla. (C) 2011 Sociedad Espanola de Neurocirugia. Published by Elsevier Espana, S.L. All rights reserved.	[Pampin, Francisco; Galeiras, Rita; Freire, David; Teresa Bouza, Maria] Complejo Hosp Univ A Coruna, Serv Med Intens, La Coruna, Spain; [Bou, German; del Carmen Zuniga, Maria] Complejo Hosp Univ A Coruna, Microbiol Serv, La Coruna, Spain		Pampin, F (corresponding author), Complejo Hosp Univ A Coruna, Serv Med Intens, La Coruna, Spain.	franpampinhuerta@gmail.com	; Bou, German/H-6683-2015	Galeiras, Rita/0000-0002-8551-3731; Bou, German/0000-0001-8837-0062			Campo C, 2001, ENFERM INFEC MICR CL, V19, P161, DOI 10.1016/S0213-005X(01)72596-7; ELLISON RT, 1984, ARCH INTERN MED, V144, P2078, DOI 10.1001/archinte.144.10.2078; Fratzia JD, 1993, EMERGEN MED, V5, P245; JACOB L, 1988, BRIT J HOSP MED, V39, P449; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Jorgensen JH, 2006, METHODS ANTIMICROBIA, P12; Ouderkirk JP, 2004, CLIN INFECT DIS, V38, pE36, DOI 10.1086/381438; PARRAS F, 1993, CLIN INFECT DIS, V17, P1058, DOI 10.1093/clinids/17.6.1058; QADRI SMH, 1976, J CLIN MICROBIOL, V3, P102; Sarasqueta R, 1998, Enferm Infecc Microbiol Clin, V16, P491; Seetha K S, 2004, Indian J Med Microbiol, V22, P191; Walsh TR, 1997, J ANTIMICROB CHEMOTH, V40, P171, DOI 10.1093/jac/40.2.171	12	3	3	0	3	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	1130-1473			NEUROCIRUGIA	Neurocirugia	SEP-OCT	2012	23	5					200	202		10.1016/j.neucir.2011.09.001			3	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	029ER	WOS:000310478100005	22841528				2022-02-06	
J	Rezaei, S; Asgari, K; Yousefzadeh, S; Moosavi, HA; Kazemnejad, E				Rezaei, Sajjad; Asgari, Karim; Yousefzadeh, Shahrokh; Moosavi, Heshmat-Allah; Kazemnejad, Ehsan			Effects of Neurosurgical Treatment and Severity of Head Injury on Cognitive Functioning, General Health and Incidence of Mental Disorders in Patients With Traumatic Brain Injury	ARCHIVES OF TRAUMA RESEARCH			English	Article						Brain Injury; Neurosurgery; Cognitive Aspect; Mental Health		Background: Neurosurgical treatment and the severity of head injury (HI) can have remarkable effect on patients' neuropsychiatric outcomes. Objectives: This research aimed to study the effect of these factors on cognitive functioning, general health and incidence of mental disorders in patients with a traumatic brain injury (TBI). Patients and Methods: In this descriptive, longitudinal study, 206 TBI patients entered the study by consecutive sampling; they were then compared according to neurosurgery status and severity of their HI. Both groups underwent neurosurgical and psychological examinations. The mini mental state examination (MMSE) and general health questionnaire-28 items (GHQ-28) were administered to the study participants. At follow-up, four months later, the groups underwent a structured clinical interview by a psychiatrist based on the diagnostic and statistical manual of mental disorders, fourth edition (DSM-IV) diagnostic criteria regarding the presence of mental disorders. Results: Analysis of covariance (ANCOVA) and multivariate analysis of covariance (MANCOVA) were performed and adjusted for the effect of confounding variables (age, gender, Glasgow outcome scale (GOS), and level of education). The severity of HI had the most significant effect for the following variables; cognitive functioning and physical symptoms (P<0.05). The effect of the neurosurgical treatment factor was not significant; however, the interaction effect of the two variables on social dysfunction, and total score of the GHQ-28 questionnaire appeared to be significant (P<0.05). Fisher's exact test indicated that after a four month follow-up period, no significant differences were seen between the two groups (with or without neurosurgery) in the incidence of mental disorders, while Test showed that having a more severe HI is significantly correlated with the incidence of mental disorders (P<0.01). Conclusions: The implications of this study should be discussed with an emphasis on negative, effective factors on the cognitive - behavioral and neuropsychiatric outcomes of a TBI. Published by Kowssar, 2012. cc3.0.	[Rezaei, Sajjad] Univ Isfahan, Guilan Rd Trauma Res Ctr, Dept Psychol, Esfahan, IR, Iran; [Asgari, Karim] Univ Isfahan, Dept Psychol, Esfahan, IR, Iran; [Yousefzadeh, Shahrokh; Kazemnejad, Ehsan] Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Rasht, IR, Iran; [Moosavi, Heshmat-Allah] Guilan Univ Med Sci, Dept Psychiat, Rasht, IR, Iran		Rezaei, S (corresponding author), Univ Isfahan, Guilan Rd Trauma Res Ctr, Esfahan, IR, Iran.	Rezaei_psy@hotmail.com	Rezaei, Sajjad/J-5086-2017	Rezaei, Sajjad/0000-0001-7292-9669	Guilan Road Trauma Research Center	This study was supported by Guilan Road Trauma Research Center.	Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Breed ST, 2004, ARCH PHYS MED REHAB, V85, pS61, DOI 10.1016/j.apmr.2003.08.115; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Finset A, 1999, PSYCHOSOM MED, V61, P576, DOI 10.1097/00006842-199907000-00024; Hanten G, 2011, NEUROPSYCHOLOGIA, V49, P486, DOI 10.1016/j.neuropsychologia.2010.12.007; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Heltemes K. J., 2011, INJURY; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; MARION DW, 1999, TRAUMATIC BRAIN INJU; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Nazari R, 2010, J BABOL U MED SCI, V12, P58; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rezaei S., 2012, Iranian Journal of Psychiatry and Clinical Psychology, V18, P13; Rezaei S, 2010, J GUILAN U MED SCI, V20, P56; Rezaei S, 2011, DANESHVAR, V18, P9; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Smith D. H., 2006, BCMJ, V48, P510; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Youmans JR, 2004, YOUMANS NEUROLOGICAL; [张金响 Zhang Jinxiang], 2006, [中国法医学杂志, Chinese Journal of Forensic Medicine], V21, P24	31	3	5	0	0	KASHAN UNIV MEDICAL SCIENCES	KASHAN	PO BOX 87159-88141, KASHAN, REPUBLIC ISLAMIC 00000, IRAN	2251-953X	2251-9599		ARCH TRAUMA RES	Arch. Trauma Res.	FAL	2012	1	3					93	100		10.5812/atr.6546			8	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	V23ZR	WOS:000215127800003	24396755	Green Submitted, Green Published			2022-02-06	
J	Rubenstein, R				Rubenstein, Richard			Traumatic Brain Injury: Risk Factors and Biomarkers of Alzheimer's Disease and Chronic Traumatic Encephalopathy	CURRENT GERIATRICS REPORTS			English	Article						Traumatic brain injury; Alzheimer's disease; Chronic traumatic encephalopathy; Risk factors; Amyloid beta; Tau; Biomarkers; Neurodegenerative disease		A complex interaction between genetic and environmental risk factors has often been a suspected trigger for the development of neurodegenerative disease. Yet of all the possible environmental risk factors, trauma to the central nervous system is one of the most consistent candidates for initiating the molecular cascades that result in several neurodegenerative diseases including Alzheimer's disease (AD). In almost all of the studies investigating traumatic brain injury and AD risk, AD was diagnosed based on clinical criteria for probable or possible AD, without neuropathological verification. Recent evidence also suggests that mild traumatic brain injury, including repetitive concussions and subconcussive trauma, can provoke another distinctive neurodegeneration termed chronic traumatic encephalopathy. Because most reports were based on clinical diagnostic criteria that may lack the specificity to rule out other causes of dementia, it is possible that the increased incidence of dementia following head injuries is due to CTE, alone or in conjunction with other neurodegenerative conditions such as AD. The search for, and validation of, biomarkers for specific neurodegenerative diseases provide disease diagnosis and indicators of risk and disease progression, and offer a means to monitor therapeutic efficacy.	[Rubenstein, Richard] Suny Downstate Med Ctr, Dept Neurol, 450 Clarkson Ave, Brooklyn, NY 11203 USA; [Rubenstein, Richard] Suny Downstate Med Ctr, Dept Physiol, Brooklyn, NY 11203 USA; [Rubenstein, Richard] Suny Downstate Med Ctr, Dept Pharmacol, Brooklyn, NY 11203 USA		Rubenstein, R (corresponding author), Suny Downstate Med Ctr, Dept Neurol, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	richard.rubenstein@downstate.edu			Department of DefenseUnited States Department of Defense	Dr. Richard Rubenstein has received grants from the Department of Defense.	Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; BANCHER C, 1993, NEUROSCI LETT, V162, P179, DOI 10.1016/0304-3940(93)90590-H; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Blennow K, 2003, BRAIN RES BULL, V61, P235, DOI 10.1016/S0361-9230(03)00086-8; Brunden KR, 2008, J ALZHEIMERS DIS, V14, P393; Buerger K, 2002, ARCH NEUROL-CHICAGO, V59, P1267, DOI 10.1001/archneur.59.8.1267; De Meyer G, 2010, ARCH NEUROL-CHICAGO, V67, P949, DOI 10.1001/archneurol.2010.179; Ellison D., 2004, NEUROPATHOLOGY REFER, V2nd ed.; Engelborghs S, 2006, NEUROCHEM INT, V48, P286, DOI 10.1016/j.neuint.2005.11.002; Fjell AM, 2010, CEREB CORTEX, V20, P2069, DOI 10.1093/cercor/bhp279; Fjell AM, 2010, J NEUROSCI, V30, P2088, DOI 10.1523/JNEUROSCI.3785-09.2010; Fjell AM, 2010, NEUROIMAGE, V49, P1820, DOI 10.1016/j.neuroimage.2009.09.029; Fodero-Tavoletti MT, 2011, BRAIN, V134, P1089, DOI 10.1093/brain/awr038; Glodzik L, 2011, NEUROBIOL AGING, V32, P2131, DOI 10.1016/j.neurobiolaging.2009.12.026; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Guillozet AL, 2003, ARCH NEUROL-CHICAGO, V60, P729, DOI 10.1001/archneur.60.5.729; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hampel H, 2004, DEMENT GERIATR COGN, V17, P350, DOI 10.1159/000077170; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jellinger KA, 1998, J NEURAL TRANSM-SUPP, P77; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Josephs KA, 2008, ANN NEUROL, V63, P204, DOI 10.1002/ana.21223; KAYED R, 2003, SCIENCE, V301, P1847; Lewczuk P, 2004, NEUROBIOL AGING, V25, P273, DOI 10.1016/S0197-4580(03)00086-1; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Maslow K, 2008, ALZHEIMERS DEMENT, V4, P110, DOI 10.1016/j.jalz.2008.02.005; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mulder C, 2010, CLIN CHEM, V56, P248, DOI 10.1373/clinchem.2009.130518; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; O'Bryant SE, 2010, ARCH NEUROL-CHICAGO, V67, P1077, DOI 10.1001/archneurol.2010.215; Oddo S, 2006, J BIOL CHEM, V281, P39413, DOI 10.1074/jbc.M608485200; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rosso SM, 2003, ARCH NEUROL-CHICAGO, V60, P1209, DOI 10.1001/archneur.60.9.1209; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Seabrook GR, 2007, MOL INTERV, V7, P261, DOI 10.1124/mi.7.5.8; Tanzi RE, 1996, NEUROBIOL DIS, V3, P159, DOI 10.1006/nbdi.1996.0016; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018	44	3	3	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	2196-7865			CURR GERIATR REP	Curr. Geriatr. Rep.	SEP	2012	1	3					143	148		10.1007/s13670-012-0020-7			6	Geriatrics & Gerontology	Emerging Sources Citation Index (ESCI)	Geriatrics & Gerontology	V3S8Y	WOS:000218556700003		Bronze			2022-02-06	
J	Horswell, BB; Jaskolka, MS				Horswell, Bruce B.; Jaskolka, Michael S.			Pediatric Head Injuries	ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA			English	Article						Head injuries; Children; Scalp injury; Growing skull fracture	GROWING SKULL FRACTURES; MANAGEMENT	Head injuries in children are common, comprising more than half of all injuries sustained. The mortality and morbidity associated with traumatic head injury in children is staggering, and the cumulative effect of such on the pediatric and general populations is propagated through related health care measures and subsequent socioeconomic burden. The majority of deaths due to trauma in children are caused by brain injury. This article reviews the evaluation and management of scalp injuries in the pediatric patient. The second portion addresses skull fractures, the specter of child abuse, management of acute fracture, and the phenomenon of growing skull fractures.	[Horswell, Bruce B.; Jaskolka, Michael S.] Charleston Area Med Ctr, Charleston, WV 25302 USA		Horswell, BB (corresponding author), Charleston Area Med Ctr, 830 Penn Ave,Suite 302, Charleston, WV 25302 USA.	bruce.horswell@camc.org					Anonymous, 2011, Morbidity and Mortality Weekly Report, V60, P13; [Anonymous], 2010, NTDB ANN PED REP; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; Chan J, 2004, INT J PEDIATR OTORHI, V68, P877, DOI 10.1016/j.ijporl.2004.01.021; Cox CS, 2006, PEDIAT TRAUMA PATHOP, P73; Da Dalt L, 2006, EUR J PEDIATR, V165, P142, DOI 10.1007/s00431-005-0019-6; Dickson L, 2010, PLAST RECONSTR SURG, V125, p151E, DOI 10.1097/PRS.0b013e3181d45b69; Djientcheu VD, 2006, CHILD NERV SYST, V22, P721, DOI 10.1007/s00381-005-0010-6; Dyke CG, 1938, DIAGNOSTIC ROENTGENO, P1; Earnest Lisa M, 2005, Facial Plast Surg Clin North Am, V13, P345, DOI 10.1016/j.fsc.2004.12.003; Gibney J., 1984, ASPRS ANN SCI M LAS; GOLDSTEIN F, 1967, J NEUROSURG, V27, P541, DOI 10.3171/jns.1967.27.6.0541; Hoffman JF., 2007, LOCAL FLAPS FACIAL R, P637; Hoffmann JF, 2001, OTOLARYNG CLIN N AM, V34, P571, DOI 10.1016/S0030-6665(05)70006-2; Hospenthal DR, 2011, J TRAUMA, V71, pS290, DOI 10.1097/TA.0b013e318227add8; Howship J., 1816, PRACTICAL OBSERVATIO; Husson B, 1996, PEDIATR RADIOL, V26, P744, DOI 10.1007/BF01383396; Hutchinson J, 2008, MANUAL PEDIAT TRAUMA, P61; Iida N, 2000, AESTHET PLAST SURG, V24, P137, DOI 10.1007/s002660010022; Jaskolka Michael S, 2010, Atlas Oral Maxillofac Surg Clin North Am, V18, P139, DOI 10.1016/j.cxom.2010.08.001; KEENER EB, 1959, J NEUROSURG, V16, P424, DOI 10.3171/jns.1959.16.4.0424; Keith AH, 2005, INT J PEDIATR OTORHI, V69, P21; Lee Samson, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P249, DOI 10.1097/01.moo.0000233595.61305.d8; LENDE RA, 1961, J NEUROSURG, V18, P479, DOI 10.3171/jns.1961.18.4.0479; Mason AC, 2000, ANN PLAS SURG, V45, P531; Matthaiou DK, 2009, INFECT DIS CLIN N AM, V23, P405, DOI 10.1016/j.idc.2009.01.012; MUHONEN MG, 1995, SURG NEUROL, V43, P367, DOI 10.1016/0090-3019(95)80066-P; NAIMURRAHMAN, 1994, BRIT J NEUROSURG, V8, P667, DOI 10.3109/02688699409101180; Pezzotta S, 1985, J Neurosurg Sci, V29, P129; RAMAMURTHI B, 1970, J NEUROSURG, V32, P427, DOI 10.3171/jns.1970.32.4.0427; ROSENTHAL SA, 1970, J NEUROSURG, V32, P431, DOI 10.3171/jns.1970.32.4.0431; Ruiz Ramon L, 2010, Atlas Oral Maxillofac Surg Clin North Am, V18, P69, DOI 10.1016/j.cxom.2010.08.005; Sanford RA, 2010, J NEUROSURG-PEDIATR, V5, P213, DOI 10.3171/2009.9.PEDS09180; Schmelzeisen R, 1999, J CRANIO MAXILL SURG, V27, P153, DOI 10.1016/S1010-5182(99)80043-2; Seline PC, 2005, DERMATOL CLIN, V23, P13, DOI 10.1016/j.det.2004.09.011; Singhal A, 2008, CHILD NERV SYST, V24, P605, DOI 10.1007/s00381-007-0552-x; Smith JL, 2006, PEDIAT TRAUMA PATHOP, P211; Swanson RW, 2007, LOCAL FLAPS FACIAL R, P667; TAVERAS JM, 1953, J NEUROSURG, V10, P233, DOI 10.3171/jns.1953.10.3.0233; THOMPSON JB, 1973, J NEUROSURG, V39, P493, DOI 10.3171/jns.1973.39.4.0493; van Rappard J H, 1988, Facial Plast Surg, V5, P280, DOI 10.1055/s-2008-1064764; VANRAPPARD JHA, 1988, PLAST RECONSTR SURG, V82, P833, DOI 10.1097/00006534-198811000-00016; Vignes JR, 2007, J PEDIATR-US, V151, P316, DOI 10.1016/j.jpeds.2007.04.041; Wymann NME, 2008, J ORAL MAXIL SURG, V66, P58, DOI 10.1016/j.joms.2007.04.023; Yu Michael, 2010, W V Med J, V106, P12	45	3	3	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3699	1558-1365		ORAL MAXIL SURG CLIN	Oral Maxillofac. Surg. Clin. N. Am.	AUG	2012	24	3					337	+		10.1016/j.coms.2012.05.003			15	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	000IQ	WOS:000308380300003	22857716				2022-02-06	
J	Kang, SH; Kim, MJ; Shin, IY; Park, DW; Sohn, JW; Yoon, YK				Kang, Seong Hee; Kim, Min Ja; Shin, Il Young; Park, Dae Won; Sohn, Jang Wook; Yoon, Young Kyung			Bromocriptine for Control of Hyperthermia in a Patient with Mixed Autonomic Hyperactivity after Neurosurgery: A Case Report	JOURNAL OF KOREAN MEDICAL SCIENCE			English	Article						Central Fever; Bromocriptine; Suprasellar Tumor; Neurosurgery; Autonomic Dysfunction	TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE-UNIT; PAROXYSMAL SYMPATHETIC HYPERACTIVITY; DIENCEPHALIC EPILEPSY; DYSFUNCTION; SEIZURES; FEVER	Mixed autonomic hyperactivity disorder (MAHD) among patients with acquired brain injury can be rare. A delayed diagnosis of MAHD might exacerbate the clinical outcome and increase healthcare expenses with unnecessary testing. However, MAHD is still an under-recognized and evolving disease entity. A 25-yr-old woman was admitted the clinic due to craniopharyngioma. After an extensive tumor resection, she complained of sustained fever, papillary contraction, hiccup, lacrimation, and sighing. An extensive evaluation of the sustained fever was conducted. Finally, the cause for MAHD was suspected, and the patient was successfully treated with bromocriptine for a month.	[Kang, Seong Hee; Kim, Min Ja; Park, Dae Won; Sohn, Jang Wook; Yoon, Young Kyung] Korea Univ, Coll Med, Div Infect Dis, Dept Internal Med, Seoul 136705, South Korea; [Shin, Il Young] Hallym Univ, Coll Med, Dept Neurosurg, Anyang, South Korea		Yoon, YK (corresponding author), Korea Univ, Coll Med, Anam Hosp, Div Infect Dis,Dept Internal Med, 73 Inchon Ro, Seoul 136705, South Korea.	young7912@korea.ac.kr	Kyung, Yoon Young/AAS-3428-2020	Yoon, Young Kyung/0000-0001-8435-935X; KIM, MIN JA/0000-0002-2125-7521; Park, Dae Won/0000-0002-7653-686X	City of Seoul [10920]; National Research Foundation of Korea (NRF)National Research Foundation of Korea; Korean government (MEST)Ministry of Education, Science and Technology, Republic of KoreaKorean Government [K20902001448-10E0100-03010]	This study was financially supported by the City of Seoul Grant #10920 and a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (no. K20902001448-10E0100-03010).	Baguley IJ, 2008, SEMIN NEUROL, V28, P716, DOI 10.1055/s-0028-1105971; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; BENARROCH EE, 1993, MAYO CLIN PROC, V68, P988, DOI 10.1016/S0025-6196(12)62272-1; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; Commichau C, 2003, NEUROLOGY, V60, P837, DOI 10.1212/01.WNL.0000047344.28843.EB; FOX RH, 1973, BRIT MED J, V2, P693, DOI 10.1136/bmj.2.5868.693; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; GIROUD M, 1988, CHILD NERV SYST, V4, P252, DOI 10.1007/BF00270925; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Penfield W, 1929, ARCH NEURO PSYCHIATR, V22, P358, DOI 10.1001/archneurpsyc.1929.02220020174010; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; Rabinstein AA, 2007, J NEUROL NEUROSUR PS, V78, P1278, DOI 10.1136/jnnp.2006.112730; Rossitch E Jr, 1988, Br J Neurosurg, V2, P471, DOI 10.3109/02688698809029601; Russo RN, 2000, J PAEDIATR CHILD H, V36, P283, DOI 10.1046/j.1440-1754.2000.00485.x; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; von Wild KRH, 2008, ACT NEUR S, V101, P55	19	3	4	0	2	KOREAN ACAD MEDICAL SCIENCES	SEOUL	302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA	1011-8934			J KOREAN MED SCI	J. Korean Med. Sci.	AUG	2012	27	8					965	968		10.3346/jkms.2012.27.8.965			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	984UP	WOS:000307218200021	22876068	gold, Green Published, Green Submitted			2022-02-06	
J	Marcus, HE; Spohr, FA; Bottiger, BW; Grau, S; Padosch, SA				Marcus, H. E.; Spoehr, F. A.; Boettiger, B. W.; Grau, S.; Padosch, S. A.			Nutritional therapy in traumatic brain injury. Update 2012	ANAESTHESIST			German	Article						Intensive care; Enteral nutrition; Parenteral nutrition; Treatment outcome; Mortality	MECHANICALLY VENTILATED PATIENTS; EARLY ENTERAL NUTRITION; INSULIN THERAPY; ILL PATIENTS; HYPERGLYCEMIA; SUPPLEMENTATION; HOMEOSTASIS; INTOLERANCE; PNEUMONIA; MAGNESIUM	Severe traumatic brain injury ranks among the most common causes of death in young adults in western countries. Severe traumatic brain injury is typically followed by a pronounced pathophysiological cascade that accounts for many deaths. The aim of intensive care medicine after traumatic brain injury is to minimize and to control the consequences of this potentially fatal cascade. The avoidance of hypoxemia, arterial hypotension, intracranial hypertension, hyperthermia, hyperglycemia, hypoglycemia and thromboembolic complications is essential in preventing this cascade. The effect of nutrition has been rather underestimated as a means of improving the outcome after traumatic brain injury. Nutrition should be started within the first 24 h after trauma. Enteral, wherever applicable, should be the route of administration of nutrition. Enteral administration of the whole calculated calorie requirement on day 1 after trauma, if possible, lowers the infection and overall complication rates. The present review gives an update of a practical approach to nutrition in traumatic brain injury.	[Marcus, H. E.; Spoehr, F. A.; Boettiger, B. W.; Padosch, S. A.] Uniklin Koln, Klin Anasthesiol & Operat Intens Med, D-50937 Cologne, Germany; [Grau, S.] Uniklin Koln, Klin Allgemeine Neurochirurg, D-50937 Cologne, Germany		Padosch, SA (corresponding author), Uniklin Koln, Klin Anasthesiol & Operat Intens Med, Kerpener Str 62, D-50937 Cologne, Germany.	stephan.padosch@uk-koeln.de	Grau, Stefan/AAW-8930-2021	Grau, Stefan/0000-0002-9742-527X			Andrews B T, 1994, Neurosurg Clin N Am, V5, P707; Assadi F, 2012, J NEPHROL, V25, P473, DOI 10.5301/jn.5000060; Bock W, 2006, SCHADEL HIRN VERLETZ; Bratton SL, 2007, J NEUROTRAUM, V24, P77; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Charrueau C, 2009, J NEUROTRAUM, V26, P1911, DOI 10.1089/neu.2008.0737; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLIFTON GL, 1986, J NEUROSURG, V64, P895, DOI 10.3171/jns.1986.64.6.0895; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Cole C.D., 2004, NEUROSURG FOCUS, V16, P1; Cook AM, 2008, NUTR CLIN PRACT, V23, P608, DOI 10.1177/0884533608326060; Dickerson RN, 2009, JPEN-PARENTER ENTER, V33, P646, DOI 10.1177/0148607109335307; Drakulovic MB, 1999, LANCET, V354, P1851, DOI 10.1016/S0140-6736(98)12251-1; Feng D, 2007, J INT MED RES, V35, P644, DOI 10.1177/147323000703500509; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Fresenius M, 2008, REPETITORIUM INTENSI; Garg R, 2006, STROKE, V37, P267, DOI 10.1161/01.STR.0000195175.29487.30; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; HARIRI RJ, 1993, J NEUROSURG, V79, P421, DOI 10.3171/jns.1993.79.3.0421; Hatton J, 1998, PRACTICE NEUROSURGER, pS381; Kattelmann KK, 2006, J AM DIET ASSOC, V106, P1226, DOI 10.1016/j.jada.2006.05.320; KIRBY DF, 1991, JPEN-PARENTER ENTER, V15, P298, DOI 10.1177/0148607191015003298; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; Lepelletier D, 2010, J NEUROSURG ANESTH, V22, P32, DOI 10.1097/ANA.0b013e3181bdf52f; Liao KH, 2009, SURG NEUROL, V72, P66, DOI 10.1016/j.surneu.2009.07.004; Lindsey KA, 2010, NUTRITION, V26, P784, DOI 10.1016/j.nut.2009.08.013; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Marik PE, 2001, CRIT CARE MED, V29, P2264, DOI 10.1097/00003246-200112000-00005; Marik PE, 2003, INTENS CARE MED, V29, P867, DOI 10.1007/s00134-003-1744-9; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Myburgh J, 2007, NEW ENGL J MED, V357, P874; NORTON JA, 1988, J NEUROSURG, V68, P62, DOI 10.3171/jns.1988.68.1.0062; Perel P, 2006, COCHRANE DB SYST REV, V18; Pfab F, 2011, ANESTH ANALG, V112, P150, DOI 10.1213/ANE.0b013e3181fdfac8; Rhoney Denise H, 2006, Nutr Clin Pract, V21, P462, DOI 10.1177/0115426506021005462; Rhoney DH, 2002, NEUROL RES, V24, P613, DOI 10.1179/016164102101200456; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Sampalis JS, 1999, J TRAUMA, V46, P565, DOI 10.1097/00005373-199904000-00004; Schroder S, 2007, ANAESTHESIST, V56, P1217, DOI 10.1007/s00101-007-1260-3; Sen AP, 2010, NEUROTHERAPEUTICS, V7, P91, DOI 10.1016/j.nurt.2009.10.014; Singer P, 2009, CLIN NUTR, V28, P387, DOI 10.1016/j.clnu.2009.04.024; Taylor SJ, 1999, CRIT CARE MED, V27, P2525, DOI 10.1097/00003246-199911000-00033; Unterberg A, 2003, AKTUEL NEUROL, V30, P59, DOI 10.1055/s-2003-37567; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Young B, 1996, J NEUROTRAUM, V13, P25, DOI 10.1089/neu.1996.13.25; YOUNG B, 1992, J NEUROTRAUM, V9, pS375	51	3	6	0	12	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	AUG	2012	61	8					696	702		10.1007/s00101-012-2061-x			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	996RG	WOS:000308110500007	22847557				2022-02-06	
J	Al-Qattan, MM				Al-Qattan, Mohammad M.			A Closed Phalangeal Neck Fracture With 180-Degree Rotation of the Phalangeal Head and Concurrent Displaced Salter-Harris II Fracture	ANNALS OF PLASTIC SURGERY			English	Article						phalangeal neck; fracture; Salter-Harris	PROXIMAL PHALANX; CHILDREN; MALUNION; HAND	Closed type III phalangeal neck fractures with 180-degree rotation is a rare iatrogenic injury that occurs following failed attempts at closed reduction. Prior to closed reduction, the phalangeal head is in 90-degree rotation. Longitudinal traction during closed reduction then converts the deformity into 180-degree rotation. We present the first documented non-iatrogenic case of phalangeal neck fracture with 180-degree rotation that was also associated with a displaced Salter-Harris II fracture at the same joint. The blood supply of the phalangeal head in that scenario is discussed along with precautions that should be taken during open reduction and internal fixation to avoid avascular necrosis of the phalangeal head.	King Saud Univ, Dept Surg, Riyadh 11415, Saudi Arabia		Al-Qattan, MM (corresponding author), King Saud Univ, Dept Surg, POB 18097, Riyadh 11415, Saudi Arabia.	moqattan@hotmail.com			College of Medicine Research Center, King Saud University, Riyadh, Saudi Arabia	Conflicts of interest and sources of funding: Supported by the College of Medicine Research Center, King Saud University, Riyadh, Saudi Arabia.	Al-Qattan MM, 2006, J HAND SURG-BRIT EUR, V31B, P484, DOI 10.1016/j.jhsb.2006.06.005; Al-Qattan MM, 2010, INJURY, V41, P1084, DOI 10.1016/j.injury.2010.06.017; Al-Qattan MM, 2010, J HAND SURG-AM, V35A, P1269, DOI 10.1016/j.jhsa.2010.03.038; Al-Qattan MM, 2009, J HAND SURG-EUR VOL, V34E, P104, DOI 10.1177/1753193408091430; Al-Qattan MM, 2001, J HAND SURG-BRIT EUR, V26, P112, DOI 10.1054/jhsb.2000.0506; Al-Qattan MM, 2004, INJURY, V35, P1207, DOI 10.1016/j.injury.2003.09.042; Al-Qattan MM, 2004, INJURY, V35, P1185, DOI 10.1016/j.injury.2003.09.043; Al-Qattan MM, 1999, J HAND SURG-BRIT EUR, V24B, P693, DOI 10.1054/jhsb.1999.0260; Al-Qattan MM, 2000, HAND CLIN, V16, P535; BARTON NJ, 1979, HAND, V11, P134, DOI 10.1016/S0072-968X(79)80025-X; BARTON NJ, 1984, J BONE JOINT SURG BR, V66, P159, DOI 10.1302/0301-620X.66B2.6707048; Cornwall R, 2004, J HAND SURG-AM, V29A, P458, DOI 10.1016/j.jhsa.2004.01.008; DIXON GL, 1972, CLIN ORTHOP RELAT R, P151; Hennrikus WL, 2003, J BONE JOINT SURG BR, V85B, P273, DOI 10.1302/0301-620X.85B2.13167; LEONARD MH, 1970, CLIN ORTHOP RELAT R, P160; MINTZER CM, 1994, J HAND SURG-BRIT EUR, V19B, P594, DOI 10.1016/0266-7681(94)90122-8; NEWINGTON DP, 1995, J HAND SURG-BRIT EUR, V20B, P353, DOI 10.1016/S0266-7681(05)80093-2; SIMMONS BP, 1987, J HAND SURG-AM, V12A, P1079, DOI 10.1016/S0363-5023(87)80117-X; Waters PM, 2004, J HAND SURG-AM, V29A, P707, DOI 10.1016/j.jhsa.2004.03.007	19	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-7043			ANN PLAS SURG	Ann. Plast. Surg.	JUL	2012	69	1					35	37		10.1097/SAP.0b013e31821ee47b			3	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	961RJ	WOS:000305485200009	21629049				2022-02-06	
J	Furlan, JC; Hawryluk, GW; Austin, J; Fehlings, MG				Furlan, Julio C.; Hawryluk, Gregory W.; Austin, James; Fehlings, Michael G.			Spinal haemorrhage during anticoagulant regimen for thromboprophylaxis: a unique form of central nervous system haemorrhage	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							SPONTANEOUS INTRACEREBRAL HEMORRHAGE; CORD-INJURY; INTRACRANIAL HEMORRHAGE; INFLAMMATORY RESPONSE; MANAGEMENT; DISCONTINUATION; GUIDELINES; LESIONS; CARE	Introduction The management of anticoagulation (AC) therapy in patients with central nervous system (CNS) haemorrhage remains challenging. This study examines the potential factors associated with spinal haematoma among patients who develop CNS haemorrhage while on AC therapy. Methods Based on a systematic review using MEDLINE and EMBASE, two reviewers screened publications and extracted data on all CNS-haemorrhage cases. First, all cases were grouped into brain, posterior fossa and spinal haemorrhage. Second, the spinal-haemorrhage group was subdivided into those patients experiencing complete neurological recovery, incomplete recovery, no recovery and death. Finally, axonal survival and inflammatory response after spinal cord injury (SCI) due to trauma and spinal haemorrhage were examined using postmortem spinal cord tissue. Results Data were extracted from 72 publications including 553 patients. There were significant differences among the CNS groups regarding patient characteristics and management, while their outcomes were comparable. Outcomes among the spinal-haemorrhage subgroups were not associated with patient characteristics and management. Postmortem examination of spinal cord showed that axonal survival and inflammatory response in a spinal-haemorrhage case were similar to a case of traumatic SCI. Conclusions The results of this study suggest that the management of patients with spinal haemorrhage considerably differ from individuals with an intracranial haemorrhage during AC. However, survival and neurological recovery appear to be comparable among the CNS groups. The studied factors failed to discriminate the patient subgroups according to survival and neurological recovery. Finally, the neuropathology result reinforces the possibility that the mechanism of SCI may not be relevant for axonal survival and inflammatory response within the spinal cord.	[Furlan, Julio C.; Hawryluk, Gregory W.; Austin, James; Fehlings, Michael G.] Univ Hlth Network, Toronto Western Res Inst, Div Genet & Dev, Toronto, ON, Canada; [Furlan, Julio C.] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada; [Furlan, Julio C.] Univ Toronto, Lyndhurst Ctr, Toronto Rehabil Inst, Toronto, ON, Canada; [Hawryluk, Gregory W.; Austin, James; Fehlings, Michael G.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Hawryluk, Gregory W.; Fehlings, Michael G.] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Fehlings, Michael G.] Univ Hlth Network, Toronto Western Hosp, Div Neurosurg, Toronto, ON, Canada		Furlan, JC (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Div Genet & Dev, 399 Bathurst St,McL 12-407, Toronto, ON, Canada.	jcfurlan@gmail.com	Furlan, Julio/Q-8290-2018	Furlan, Julio/0000-0002-2038-0018; Fehlings, Michael/0000-0002-5722-6364	Christopher & Dana Reeve Foundation; AO Spine North America	This research project was funded by Christopher & Dana Reeve Foundation (JCF, MGF) and AO Spine North America (GH, MGF).	Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; Citterio A, 2004, ARCH PHYS MED REHAB, V85, P1483, DOI 10.1016/j.apmr.2003.09.028; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Furlan JC, 2006, SPINE, V31, P2674, DOI 10.1097/01.brs.0000244569.91204.01; Furlan JC, 2011, J NEUROTRAUM, V28, P1371, DOI 10.1089/neu.2009.1147; Furlan JC, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E13; Gris D, 2008, EXP NEUROL, V211, P259, DOI 10.1016/j.expneurol.2008.01.033; Gupta A, 2008, SPINAL CORD, V46, P482, DOI 10.1038/sj.sc.3102168; HART RG, 1995, STROKE, V26, P1471, DOI 10.1161/01.STR.26.8.1471; Hawryluk GWJ, 2010, J THROMB HAEMOST, V8, P1500, DOI 10.1111/j.1538-7836.2010.03882.x; Jacobs WB, 2003, NEUROSURGERY, V53, P943, DOI 10.1227/01.NEU.0000083592.74383.B1; Kakulas BA, 1999, SPINAL CORD, V37, P79, DOI 10.1038/sj.sc.3100807; KASE CS, 1985, NEUROLOGY, V35, P943, DOI 10.1212/WNL.35.7.943; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; New PW, 2008, SPINAL CORD, V46, P406, DOI 10.1038/sj.sc.3102152; Phan TG, 2000, ARCH NEUROL-CHICAGO, V57, P1710, DOI 10.1001/archneur.57.12.1710; Scivoletto G, 2011, SPINAL CORD, V49, P391, DOI 10.1038/sc.2010.85; Steiner T, 2006, CEREBROVASC DIS, V22, P294, DOI 10.1159/000094831; Wijdicks EFM, 1998, NEUROSURGERY, V42, P769, DOI 10.1097/00006123-199804000-00053	19	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JUL	2012	83	7					746	752		10.1136/jnnp-2011-301366			7	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	953XQ	WOS:000304907500016	22566595				2022-02-06	
J	Krysl, P; Bondi, MW; Ward, SR; Frank, LR				Krysl, Petr; Bondi, Mark W.; Ward, Samuel R.; Frank, Lawrence R.			On Sources of Error in Finite Element Simulations of Blast Effects in the Human Brain	JOURNAL OF COMPUTATIONAL AND NONLINEAR DYNAMICS			English	Article						finite element simulation; traumatic brain injury; TBI; blast injury; helmet; MRI	DIFFUSE AXONAL INJURY; CORPUS-CALLOSUM; MODERATE; MILD	Recent military conflicts in Iraq and Afghanistan have resulted in an increase in the number of blast related traumatic brain injuries (blast-TBI). It is assumed that the primary mechanism for blast-TBI is the interaction between the blast pressure wave and the central nervous system, but the details of this mechanism are poorly understood. The conditions of such blast injuries are highly variable, and the presence or absence of protective devices such as vehicles or helmets is presumed to have a strong influence on pressure waves. Because of the complexity of this problem and the difficulty of in situ measurement of these effects in actual combat scenarios, one approach is to develop efficient numerical simulations that have the fidelity to reliably model the interaction of the brain and the pressure and shear waves. Here we examine the distribution of pressures and principal strains (stretches) in a brain impinged upon by a blast wave incident from orthogonal directions as simulated by a finite element coupled fluid-solid dynamic interaction framework. We assess the various sources of errors in finite element simulations of wave propagating through tissue, the modeling error, the discretization error, and the error of input parameters (data uncertainty). We conclude that the least important source of error is the assumption of linear kinematics and linear constitutive equation. The discretization error is significant, and controlling it will remain a challenge. The most significant source of error is found to be the input parameter uncertainty (experimental variability) and lack of knowledge of the detailed mechanics of deformation of the brain tissues under conditions of blast loading. [DOI: 10.1115/1.4006143]	[Krysl, Petr] Univ Calif San Diego, Dept Struct Engn, Jacobs Sch Engn, La Jolla, CA 92093 USA; [Bondi, Mark W.] Univ Calif San Diego, Dept Psychiat, VA San Diego Healthcare Syst, La Jolla, CA 92093 USA; [Ward, Samuel R.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Ward, Samuel R.] Univ Calif San Diego, Dept Orthopaed Surg, La Jolla, CA 92093 USA; [Ward, Samuel R.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Frank, Lawrence R.] Univ Calif San Diego, UCSD Ctr Funct MRI, VA San Diego Healthcare Syst, La Jolla, CA 92093 USA		Krysl, P (corresponding author), Univ Calif San Diego, Dept Struct Engn, Jacobs Sch Engn, La Jolla, CA 92093 USA.	pkrysl@ucsd.edu		Ward, Samuel R./0000-0002-4470-155X			Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bloom JS, 2005, NEUROPSYCHOL REV, V15, P59, DOI 10.1007/s11065-005-6252-y; Bradshaw DRS, 2001, J BIOMECH, V34, P85, DOI 10.1016/S0021-9290(00)00135-4; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Cranford TW, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/1/016001; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Evans AC., 1997, NEUROIMAGE, V5, pS425, DOI DOI 10.1016/S1053-8119(97)80018-3; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Grujicic M, 2011, J MATER ENG PERFORM, V20, P877, DOI 10.1007/s11665-010-9724-z; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Krysl P, 2008, INT J NUMER METH ENG, V74, P754, DOI 10.1002/nme.2192; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Kwan R. K.-S., 1996, LECT NOTES COMPUTER; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Mast T. D., 2000, Acoustics Research Letters Online, V1, P37, DOI 10.1121/1.1336896; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nishimoto T, 1998, J BIOMECH ENG-T ASME, V120, P140, DOI 10.1115/1.2834294; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Saraf H, 2007, J BIOMECH, V40, P1960, DOI 10.1016/j.jbiomech.2006.09.021; Shattuck DW, 2001, IEEE T MED IMAGING, V20, P1167, DOI 10.1109/42.963819; Stenfelt S, 2000, J ACOUST SOC AM, V107, P422, DOI 10.1121/1.428314; Subramaniam KV, 2009, INT J IMPACT ENG, V36, P965, DOI 10.1016/j.ijimpeng.2009.01.001; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; TAYLOR RL, 1976, INT J NUMER METH ENG, V10, P1211, DOI 10.1002/nme.1620100602; Teland J., 2010, P MEET AC, V9; Wahl M., 2005, REV NEUROSCI, V19, P451; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412	36	3	3	0	10	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	1555-1423	1555-1415		J COMPUT NONLIN DYN	J. Comput. Nonlinear Dyn.	JUL	2012	7	3							031008	10.1115/1.4006143			9	Engineering, Mechanical; Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mechanics	958VU	WOS:000305269800008					2022-02-06	
J	Lazaridis, C; DeSantis, SM; Vandergrift, AW; Krishna, V				Lazaridis, Christos; DeSantis, Stacia M.; Vandergrift, Alex W.; Krishna, Vibhor			Cerebral blood flow velocity changes and the value of the pulsatility index post decompressive craniectomy	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Cerebral blood flow; Decompressive craniectomy; Flow velocity; Pulsatility index	TRAUMATIC BRAIN-INJURY; HEMODYNAMIC-CHANGES	Decompressive craniectomy (DC) is used to relieve intractable intracranial hypertension and/or to prevent or reverse cerebral herniation. Significant controversy exists on selection of candidates, timing of the procedure and neurologic outcomes. Furthermore, the cerebral hemodynamic consequences post-DC have been researched only recently. We report on two consecutive patients who underwent DC in our institution and reviewed the literature on cerebral blood flow changes post-craniectomy. One patient had unilateral DC and the second had a suboccipital decompression (SOC). Cerebral blood flow velocities (FV) and pulsatility indices (PI) were recorded via transcranial Doppler (TCD). To Our knowledge, this is the first report on FV/PI monitoring after SOC. TCD is a readily available, non-invasive test. The PI may provide useful information regarding timing and effectiveness of DC. (C) 2011 Elsevier Ltd. All rights reserved.	[Lazaridis, Christos] Med Univ S Carolina, Neurosci Intens Care Unit, Charleston, SC 29425 USA; [Vandergrift, Alex W.; Krishna, Vibhor] Med Univ S Carolina, Dept Neurosurg, Charleston, SC 29425 USA; [DeSantis, Stacia M.] Med Univ S Carolina, Dept Biostat, Charleston, SC 29425 USA		Lazaridis, C (corresponding author), Med Univ S Carolina, Neurosci Intens Care Unit, 96 Jonathan Lucas St,Suite 307 CSB, Charleston, SC 29425 USA.	lazaridi@musc.edu	Krishna, Vibhor/AAG-3809-2019				Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Czosnyka M, 1996, J NEUROSURG, V84, P79, DOI 10.3171/jns.1996.84.1.0079; Daboussi A, 2009, J NEUROSURG ANESTH, V21, P339, DOI 10.1097/ANA.0b013e3181b1dbba; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4	6	3	4	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	JUL	2012	19	7					1052	1054		10.1016/j.jocn.2011.08.039			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040LJ	WOS:000311323800032	22555129				2022-02-06	
J	Pappadis, MR; Sander, AM; Leung, P; Struchen, MA				Pappadis, Monique R.; Sander, Angelle M.; Leung, Patrick; Struchen, Margaret A.			THE IMPACT OF PERCEIVED ENVIRONMENTAL BARRIERS ON COMMUNITY INTEGRATION IN PERSONS WITH TRAUMATIC BRAIN INJURY	ACTA NEUROPSYCHOLOGICA			English	Article						participation; environment; outcomes assessment (health care); rehabilitation		Background Earlier models of disability emphasized the impact of only injury-related factors impeding community integration. However, recent models incorporate the significance of physical and social environment on community integration. This study aimed to identify perceived environmental barriers that impact community integration among an ethnically diverse sample of persons with traumatic brain injury (TBI). Material/Methods: A total of 167 patients with medically documented TBI, consecutively admitted to the Neurosurgery Service at a Level I trauma center, participated in this study. Participants completed assessments in their homes at least 6 months post injury. Environmental barriers were assessed using the Craig Hospital Inventory of Environmental Factors - Short Form (CHIEFSF). Community integration was evaluated using the Community Integration Measure (CIM) and the Craig Handicap Assessment and Reporting Technique - Short Form (CHART-SF). Results: After accounting for injury severity, race and pre-injury productivity, MANCOVA results indicated that service/assistance barriers was significantly associated with decreased community integration. Trends were found for physical/structural and attitudinal/support barriers. Multiple regression analyses revealed that physical/structural barriers were associated with decreased independent participation, belonging, and occupation/productivity outcomes. Service/assistance barriers were associated with both decreased independent participation and mobility. Attitudinal/support barriers were associated with increased community mobility. Conclusions: Certain environmental barriers perceived by persons with TBI may negatively impact their reintegration to the community post injury. Identifying such barriers may help develop programs or policies to reduce barriers, while facilitating improved access to health care and other services after injury.	[Pappadis, Monique R.; Sander, Angelle M.; Struchen, Margaret A.] TIRR Mem Hermann Hosp, Brain Injury Res Ctr, 2323 S Shepherd Dr,Suite 907, Houston, TX 77019 USA; [Pappadis, Monique R.; Leung, Patrick] Univ Houston, Grad Coll Social Work, Houston, TX 77004 USA; [Sander, Angelle M.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Cty Hosp Dist, Ctr Trauma Rehabil Res, Houston, TX USA		Pappadis, MR (corresponding author), TIRR Mem Hermann Hosp, Brain Injury Res Ctr, 2323 S Shepherd Dr,Suite 907, Houston, TX 77019 USA.	Monique.Pappadis@memorialhermann.org		Pappadis, Monique R./0000-0003-4742-4380	National Institute on Disability and Rehabilitation Research, U.S. Department of EducationUS Department of Education [H133B031117, H133B090023, H133A070043]	This work was supported by grants from the National Institute on Disability and Rehabilitation Research, U.S. Department of Education to TIRR Memorial Hermann (grant nos. H133B031117, H133B090023 and H133A070043). Special thanks to the patients and staff of Harris County Hospital District's Ben Taub General Hospital and Quentin Mease Community Hospital, particularly to Dr. Shankar Gopinath, Dr. Claudia Robertson, and Dr. Faye Chiou-Tan.	Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Corrigan JA, 2008, ARCH PHYS MED REHAB, V89, P912, DOI 10.1016/j.apmr.2007.12.027; Craig Hospital Research Department, 2001, CRAIG HOSP INV ENV F; Cusick CP, 2001, ARCH PHYS MED REHAB, V82, P1018, DOI 10.1053/apmr.2001.25098; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; Mellick D., 1993, J REHABILITATION OUT, V3, P12; Nightingale N.J., 2007, BRAIN IMPAIR, V8, P101; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pachalska M, 2012, MED SCI MONITOR, V18, pCR432; Pledger C, 2003, AM PSYCHOL, V58, P279, DOI 10.1037/0003-066X.58.4.279; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Reistetter Timothy A, 2005, Occup Ther Int, V12, P196; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Sander AM, 2011, J HEAD TRAUMA REHAB, V26, P158, DOI 10.1097/HTR.0b013e3181e7537e; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Sander AM, 2009, NEUROREHABILITATION, V24, P15, DOI 10.3233/NRE-2009-0450; Seibert PS, 2002, BRAIN INJURY, V16, P837, DOI 10.1080/02699050210131939; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; TEASDALE G, 1974, LANCET, V2, P81; US Department of Education Office of Special Education and Rehabilitative Services National Institute on Disability and Rehabilitation Research, 2000, LONG RANG PLAN 1999; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; World Health Organization, 2007, INT CLASS FUNCT DIS	33	3	3	0	1	MEDSPORTPRESS PUBLISHING HOUSE	WARSAW	UL MARYMONCKA 34 SKR 23, WARSAW, 01813, POLAND	1730-7503	2084-4298		ACTA NEUROPSYCHOL	Acta Neuropsychol.	JUL-SEP	2012	10	3					385	397		10.5604/17307503.1023681			13	Psychology	Emerging Sources Citation Index (ESCI)	Psychology	V1K7W	WOS:000216993900003		Bronze			2022-02-06	
J	Stein, SC				Stein, Sherman C.			Comparative effectiveness in neurosurgery: what it means, how it is measured, and why it matters	NEUROSURGICAL FOCUS			English	Article						comparative effectiveness; cost-effectiveness; quality of life; utility; decision analysis	TRAUMATIC BRAIN-INJURY; EXAMPLE; TRIALS; HEALTH; LIFE	Comparative effectiveness research has recently been the subject of intense discussion. With congressional support, there has been increasing funding and publication of studies using comparative effectiveness and related methodology. The neurosurgical field has been relatively slow to accept and embrace this approach. The author outlines the procedures and rationale of comparative effectiveness, illustrates how it applies to neurosurgical topics, and explains its importance. (http://thejns.org/doi/abs/10.3171/2012.2.FOCUS1232)	[Stein, Sherman C.] Univ Penn, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA		Stein, SC (corresponding author), Hosp Univ Penn, Dept Neurosurg, 310 Spruce St, Philadelphia, PA 19106 USA.	Sherman.stein@uphs.upenn.edu					Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Aoki N, 1998, MED DECIS MAKING, V18, P357, DOI 10.1177/0272989X9801800401; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Claxton G, 2011, EC MED CARE; Congressional Budget Office, 2007, RES COMP EFF MED TRE; Dreyer NA, 2010, HEALTH AFFAIR, V29, P1818, DOI 10.1377/hlthaff.2010.0666; Economopoulos KP, 2011, STROKE, V42, P687, DOI 10.1161/STROKEAHA.110.606079; Einarson TR, 1997, CLIN THER, V19, P559, DOI 10.1016/S0149-2918(97)80140-3; FIELDS WS, 1970, J AMER MED ASSOC, V211, P1993, DOI 10.1001/jama.211.12.1993; Garber AM, 2010, HEALTH AFFAIR, V29, P1805, DOI 10.1377/hlthaff.2010.0647; Gartlehner G., 2006, CRITERIA DISTINGUISH; Gold M., 1996, COST EFFECTIVENESS H; Hay JW, 2009, CANCER, V115, P489; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Marko NF, 2012, NEUROSURGERY, V70, P425, DOI 10.1227/NEU.0b013e3182320a9e; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Neugebauer E, 2002, RESTOR NEUROL NEUROS, V20, P161; Neumann PJ, 2009, HEALTH AFFAIR, V28, P1366, DOI 10.1377/hlthaff.28.5.1366; Olsen JA, 2001, HEALTH ECON, V10, P39, DOI 10.1002/1099-1050(200101)10:1<39::AID-HEC563>3.0.CO;2-E; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Sox HC, 2007, MED DECISION MAKING; US Department of Health and Human Services, 2009, AM REC REINV ACT 200; Wu AW, 2010, HEALTH AFFAIR, V29, P1863, DOI 10.1377/hlthaff.2010.0660	24	3	3	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	JUL	2012	33	1							E1	10.3171/2012.2.FOCUS1232			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	968PX	WOS:000305997400002	22746226				2022-02-06	
J	Wang, F; Hoang, D; Medvecky, M; Amankulor, N; Teng, E; Narayan, D				Wang, Frederick; Hoang, Don; Medvecky, Michael; Amankulor, Nduka; Teng, Edward; Narayan, Deepak			A Novel Cranioplasty Technique Incorporating Cancellous Femoral Bone and Recombinant Bone Morphogenic Protein 2	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Calvarial reconstruction; cranioplasty; autologous bone graft; bone morphogenic protein osteointegrative; craniofacial surgery	INFECTION FOLLOWING CRANIOTOMY; LARGE CRANIAL DEFECTS; CALVARIAL DEFECTS; STROMAL CELLS; RECONSTRUCTION; GRAFT; SURGERY; TISSUE; SKULL; DESIGN	Large calvarial defects in the setting of chronic infection and limited autologous donor sites present challenging problems for the reconstructive surgeon. We report on a novel osteogenic implant as a potential calvarial reconstruction solution. Two patients with an extensive history of severe traumatic brain injury and multiple cranial operations desired delayed calvarial reconstruction subsequent to removal of infected acrylic and titanium implants. These patients underwent harvesting of cancellous femoral bone and bone marrow, which was placed between 2 layers of recombinant bone morphogenic protein 2 impregnated in acellular collagen sponges and an outer layer of sturdily pliable Vicryl mesh to create a moldable osteogenic implant construct. The construct was molded into the shape of the defect and secured with sutures to the skull surrounding the defect. The osteogenic implant showed evidence of bone formation and maintained coverage over the original calvarial defect at 26 months postoperatively as well as subjective satisfaction by both patients and the senior surgeon. This technically straightforward technique with acceptable functional and aesthetic outcomes may be useful to reconstructing selected calvarial defects.	[Narayan, Deepak] Yale Univ, Sch Med, Dept Plast & Reconstruct Surg, Sect Plast & Reconstruct Surg, New Haven, CT 06520 USA; [Wang, Frederick] Univ Calif San Francisco, Sect Plast & Reconstruct Surg, San Francisco, CA 94143 USA; [Medvecky, Michael] Yale Univ, Dept Orthoped Surg, New Haven, CT 06520 USA; [Amankulor, Nduka] Yale Univ, Dept Neurol Surg, New Haven, CT 06520 USA		Narayan, D (corresponding author), Yale Univ, Sch Med, Dept Plast & Reconstruct Surg, Sect Plast & Reconstruct Surg, POB 208062, New Haven, CT 06520 USA.	deepak.narayan@yale.edu	Wang, Frederick/AAT-7555-2021	Wang, Frederick/0000-0003-2026-5172			Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282; Benglis D, 2008, NEUROSURGERY, V62, P423, DOI 10.1227/01.neu.0000326030.24220.d8; Cabraja M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS091; Carsten M, 2006, CALVARIAL RECONSTRUC; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Chen TM, 2008, J TRAUMA, V65, P1321, DOI 10.1097/TA.0b013e3181574edf; Chim H, 2005, PLAST RECONSTR SURG, V116, P1726, DOI 10.1097/01.prs.0000182386.78775.cd; Clune JE, 2011, J CRANIOFAC SURG, V22, P319, DOI 10.1097/SCS.0b013e3181f7e0e2; Cowan CM, 2005, TISSUE ENG, V11, P645, DOI 10.1089/ten.2005.11.645; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; Dashti SR, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/6/E10; Dickinson BP, 2008, PLAST RECONSTR SURG, V121, P209, DOI 10.1097/01.prs.0000293870.64781.12; Elsalanty ME, 2008, J ORAL MAXIL SURG, V66, P277, DOI 10.1016/j.joms.2007.06.626; Fallucco MA, 2009, J CRANIOFAC SURG, V20, P1759, DOI 10.1097/SCS.0b013e3181b5d08e; FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Greene AK, 2008, PLAST RECONSTR SURG, V122, P563, DOI 10.1097/PRS.0b013e31817d61c1; He DM, 2010, J NEUROSURG, V112, P319, DOI 10.3171/2009.1.JNS08976; Idali B, 2004, MED MALADIES INFECT, V34, P221, DOI 10.1016/j.medmal.2003.12.011; Inoue Akira, 1995, Neurologia Medico-Chirurgica, V35, P804; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; KRAUSE JO, 1995, J ORTHOP TRAUMA, V9, P145, DOI 10.1097/00005131-199504000-00010; LEE C, 1995, J CRANIO MAXILL SURG, V23, P133, DOI 10.1016/S1010-5182(05)80001-0; Mankani MH, 2006, AM J PATHOL, V168, P542, DOI 10.2353/ajpath.2006.050407; Marino JT, 2010, ORTHOP CLIN N AM, V41, P15, DOI 10.1016/j.ocl.2009.08.003; Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003; Neovius E, 2010, J PLAST RECONSTR AES, V63, P1615, DOI 10.1016/j.bjps.2009.06.003; Poukens J, 2008, INT J MED ROBOT COMP, V4, P46, DOI 10.1002/rcs.171; Rogers GF, 2011, PLAST RECONSTR SURG, V127, P1631, DOI 10.1097/PRS.0b013e31821084f0; Schorl M, 2009, CENT EUR NEUROSURG, V70, P68, DOI 10.1055/s-0028-1093355; Smith DM, 2008, J CRANIOFAC SURG, V19, P1315, DOI 10.1097/SCS.0b013e3181843369; Smith DM, 2008, J CRANIOFAC SURG, V19, P1244, DOI 10.1097/SCS.0b013e3181843312; Szpalski C, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10201; Tadros M, 2008, FACIAL PLAST SURG, V24, P135, DOI 10.1055/s-2008-1037455	34	3	3	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JUL	2012	23	4					1083	1086		10.1097/SCS.0b013e31824e69b9			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	978AJ	WOS:000306710200073	22777455				2022-02-06	
J	Chabok, SY; Kapourchali, SR; Saberi, A; Mohtasham-Amiri, Z				Chabok, Shahrokh Yousefzade; Kapourchali, Sara Ramezani; Saberi, Alia; Mohtasham-Amiri, Zahra			Operative and nonoperative linguistic outcomes in brain injury patients	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Aphasia; Pragmatic disorder; Cognitive deficit; Traumatic brain injury	DECOMPRESSIVE CRANIECTOMY; EXTRALINGUISTIC COMMUNICATION; SURGICAL DECOMPRESSION; EXECUTIVE DYSFUNCTION; PROGNOSTIC-FACTORS; APHASIA TYPE; MANAGEMENT; TERM; HYPERTENSION; LANGUAGE	Objective and background: Linguistic function is one of vulnerable aspects of traumatic brain injury (TBI) which may have destructive effects on patients' communicative activities and daily life, years following trauma. This paper attempts to answer the controversy whether surgery affects increase and decrease of linguistic impairment or not. Materials and methods: Two hundred forty-one TBI patients aged 18-65 with abnormal CT findings and at least 20 minute post-trauma amnesia (PTA), who were conscious at discharge, participated in this study. Based on operative intervention, the samples were divided into two groups: operative and nonoperative. Cognitive and aphasic deficits were inspected formally and pragmatic disorder was informally appraised at discharge. Results: The groups had no significant differences in aphasia incidence and language pragmatic impairment, though they were significantly distinctive in aphasia subcategories and cognitive deficit after trauma. Fluent aphasia was more common in both groups alike. In aphasia subcategories, however, transcortical sensory aphasia (TSA) in operative and anomia in nonoperative group were the most prevalent. Several variables appeared strikingly related to higher aphasia in operative groups as follows: moderate to severe injury, 18-35 and over 50 years of age, more than 1 week PTA, intracranial surgery of multiple lesions in left or bilateral hemisphere fronto-temporal cortex plus post-trauma cognitive and pragmatic impairments, and diffuse axonal injuries. Discussion: Almost certainly, meaningful drop of cognitive function post surgery roots back in significant loss of initial consciousness level. Related factors to postoperative aphasia suggest taking policies through surgery intervention. Discerning the indispensable contributions of neurosurgeons, neurolinguists, and neuroscientists, results inspire more clinical future studies. (C) 2012 Elsevier B.V. All rights reserved.	[Chabok, Shahrokh Yousefzade; Kapourchali, Sara Ramezani; Saberi, Alia; Mohtasham-Amiri, Zahra] Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Rasht, Guilan Province, Iran		Kapourchali, SR (corresponding author), Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Rasht, Guilan Province, Iran.	s.ramezanislp@gmail.com	Ramezani, Sara/E-6926-2012; Saberi, Alia/X-4857-2018; Mohtasham-Amiri, Zahra/C-4469-2012	Ramezani, Sara/0000-0001-6096-7975; Mohtasham-Amiri, Zahra/0000-0002-4896-6248; Yousefzadeh-Chabok, Shahrokh/0000-0002-8825-3015			Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Baldo JV, 2010, BRAIN LANG, V113, P59, DOI 10.1016/j.bandl.2010.01.004; Baldo JV, 2005, BRAIN LANG, V92, P240, DOI 10.1016/j.bandl.2004.06.103; Bara BG, 2001, BRAIN LANG, V77, P72, DOI 10.1006/brln.2000.2430; Bhatnagar SC, 2002, BRAIN LANG, V83, P353, DOI 10.1016/S0093-934X(02)00039-1; BROWN JW, 1983, J NERV MENT DIS, V171, P431, DOI 10.1097/00005053-198307000-00007; Caroli M, 2001, SURG NEUROL, V56, P82, DOI 10.1016/S0090-3019(01)00540-7; Chapey R., 2008, LANGUAGE INTERVENTIO; Code C., 1987, APHASIOLOGY, V1, P339, DOI DOI 10.1080/02687038708248854; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; Cooper P R, 1976, Surg Neurol, V5, P25; Coplin WM, 2001, NEUROL RES, V23, P277, DOI 10.1179/016164101101198433; COPPENS P, 1991, APHASIOLOGY, V5, P279, DOI 10.1080/02687039108248529; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; De Marco I, 2007, J PRAGMATICS, V39, P134, DOI 10.1016/j.pragma.2006.08.009; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GAAB MR, 1990, ACT NEUR S, V51, P326; Garagnani M, 2008, EUR J NEUROSCI, V27, P492, DOI 10.1111/j.1460-9568.2008.06015.x; GERL A, 1980, Zentralblatt fuer Neurochirurgie, V41, P125; GLOSSER G, 1993, NARRATIVE DISCOURSE IN NEUROLOGICALLY IMPAIRED AND NORMAL AGING ADULTS, P191; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Helm-Estabrooks N, 2002, J COMMUN DISORD, V35, P171, DOI 10.1016/S0021-9924(02)00063-1; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Jonsson CA, 2009, BRAIN INJURY, V23, P1008, DOI 10.3109/02699050903379354; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Kuo JR, 2011, J FORMOS MED ASSOC, V110, P258, DOI 10.1016/S0929-6646(11)60038-7; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Lotfy M, 2010, EGYPT J NEUROL PSYCH, V47, P255; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Meier U, 2005, ACT NEUR S, V95, P55; Meier U, 2000, ACTA NEUROCHIR SUPPL, V76, P475; Messing-Junger AM, 2003, ZBL NEUROCHIR, V64, P171; MICELI G, 1981, ACTA NEUROL SCAND, V64, P370; Nilipour R, 1993, PERSIAN APHASIA TEST; Otawara Y, 2009, SURG NEUROL, V72, P592, DOI 10.1016/j.surneu.2009.06.016; Bartolome MVP, 2009, NEUROLOGIA, V24, P379; Potagas C, 2011, NEUROPSYCHOLOGIA, V49, P2874, DOI 10.1016/j.neuropsychologia.2011.06.013; Rengachary SS, 2005, PRINCIPLE NEUROSURGE; Soukiasian HJ, 2002, AM SURGEON, V68, P1066; Soukup VM, 1998, BRAIN DEV-JPN, V20, P589, DOI 10.1016/S0387-7604(98)00049-7; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Tremont G, 2000, CLIN NEUROPSYCHOL, V14, P295, DOI 10.1076/1385-4046(200008)14:3;1-P;FT295; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Vukovic M, 2008, J COMMUN DISORD, V41, P531, DOI 10.1016/j.jcomdis.2008.04.001; Whelan BM, 2006, BRAIN LANG, V99, P183, DOI 10.1016/j.bandl.2006.06.100; Winter CD, 2005, J CLIN NEUROSCI, V12, P619, DOI 10.1016/j.jocn.2005.02.002; Wong GKC, 2010, J NEUROL SCI, V299, P5, DOI 10.1016/j.jns.2010.08.059; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951	53	3	4	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	JUN 15	2012	317	1-2					130	136		10.1016/j.jns.2012.02.009			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	942VF	WOS:000304077400023	22418055				2022-02-06	
J	Ali, A; Konakondla, S; Zwagerman, NT; Peng, CY; Schafer, S; Ding, JY; Dornbos, D; Sikharam, C; Geng, XK; Guthikonda, M; Kreipke, CW; Rafols, JA; Ding, YC				Ali, Ahmer; Konakondla, Sanjay; Zwagerman, Nathan T.; Peng, Changya; Schafer, Steven; Ding, Jamie Y.; Dornbos, David, III; Sikharam, Chaitanya; Geng, Xiaokun; Guthikonda, Murali; Kreipke, Christian W.; Rafols, Jose A.; Ding, Yuchuan			Glycerol accumulation in edema formation following diffuse traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						Diffuse brain injury; Hypoxia; Hypoxia inducible factor (HIF)-1alpha; Aquaporin-9	MEMBRANE PHOSPHOLIPID DEGRADATION; CEREBRAL-ARTERY OCCLUSION; INTERSTITIAL GLYCEROL; RAT-BRAIN; WATER HOMEOSTASIS; TISSUE GLYCEROL; MODEL; EXPRESSION; ISCHEMIA; AQUAPORIN-4	Traumatic brain injury (TBI) induces brain edema via water and glycerol transport channels, called aquaporins (AQPs). The passage of glycerol across brain cellular compartments has been shown during edema. Using a modified impact/head acceleration rodent model of diffuse TBI, we assessed the role of hypoxia inducible factor (HIF)-1alpha in regulating AQP9 expression and glycerol accumulation during the edema formation. Adult (400-425 g) male Sprague-Dawley rats received a closed head injury with a weight drop (450 g, 2-m height) and were allowed to survive up to 48 hours. Some rat groups were administered 2-methoxyestradiol (2ME2, a HIF-1alpha inhibitor) 30 minutes after injury and were euthanized at 4 and 24 hours after injury. Brain edema was measured directly by water content, and glycerol concentration was determined by the Cayman Glycerol Assay. HIF-1alpha and AQP9 protein levels were assessed by Western immunoblotting. This study demonstrated a significant (P<0.05) increase in brain water content at 4-48 hours following impact. Cerebral glycerol was significantly (P<0.05) up-regulated at as early as 1 hour and remained at high levels for up to 48 hours. Similarly, significant (P<0.05) increases in HIF-1alpha and AQP9 protein levels were found at 1 hour and up to 48 hours after injury. Compared to untreated but injured rats, inhibition of HIF-1alpha by 2ME2 significantly (P<0.05) reduced the TBI-induced AQP9 up-regulation. This reduction was temporally associated with significant (P<0.05) decreases in both edema and glycerol accumulation. The data suggested an associated induction of HIF-1alpha, AQP9, and extracellular glycerol accumulation in edema formation following diffuse TBI. The implication of HIF-1alpha and AQP9 underlying TBI-induced edema formation offers possibilities for novel TBI therapies.	[Ding, Yuchuan] Wayne State Univ, Sch Med, Dept Neurosurg, Detroit, MI 48201 USA; [Ding, Jamie Y.] Princeton Univ, Butler Coll, Princeton, NJ 08544 USA; [Zwagerman, Nathan T.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsuburgh, PA USA		Ding, YC (corresponding author), Wayne State Univ, Sch Med, Dept Neurosurg, 550 E Canfield, Detroit, MI 48201 USA.	yding@med.wayne.edu	Dornbos, David/AAF-5091-2019				ABE K, 1987, J NEUROCHEM, V48, P503, DOI 10.1111/j.1471-4159.1987.tb04121.x; Agre P, 2004, NEUROSCIENCE, V129, P849, DOI 10.1016/j.neuroscience.2004.10.001; Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Badaut J, 2004, NEUROSCIENCE, V129, P971, DOI 10.1016/j.neuroscience.2004.06.035; Badaut J, 2001, J CEREBR BLOOD F MET, V21, P477, DOI 10.1097/00004647-200105000-00001; Badaut J, 2007, METAB BRAIN DIS, V22, P251, DOI 10.1007/s11011-007-9057-2; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Chen WQ, 2008, NEUROBIOL DIS, V31, P433, DOI 10.1016/j.nbd.2008.05.020; Clausen T, 2005, J NEUROSURG, V103, P233, DOI 10.3171/jns.2005.103.2.0233; DHILLON HS, 1994, J NEUROTRAUM, V11, P405, DOI 10.1089/neu.1994.11.405; Ding JY, 2009, BRAIN RES, V1268, P125, DOI 10.1016/j.brainres.2009.02.060; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Frykholm P, 2001, J NEUROL NEUROSUR PS, V71, P455, DOI 10.1136/jnnp.71.4.455; Griesdale DEG, 2004, SURG NEUROL, V61, P418, DOI 10.1016/j.surneu.2003.10.047; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Helton R, 2005, J NEUROSCI, V25, P4099, DOI 10.1523/JNEUROSCI.4555-04.2005; Higashida T, 2011, CURR NEUROVASC RES, V8, P44, DOI 10.2174/156720211794520251; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Kaur C, 2006, GLIA, V54, P826, DOI 10.1002/glia.20420; Kimelberg HK, 2004, NEUROSCIENCE, V129, P851, DOI 10.1016/j.neuroscience.2004.07.033; Kleffner I, 2008, STROKE, V39, P1333, DOI 10.1161/STROKEAHA.107.500785; Konig K, 2001, J NEUROSURG, V94, P621, DOI 10.3171/jns.2001.94.4.0621; Marklund N, 1997, NEUROREPORT, V8, P1457, DOI 10.1097/00001756-199704140-00026; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Nielsen S, 1997, J NEUROSCI, V17, P171; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Papadopoulos MC, 2002, MT SINAI J MED, V69, P242; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; PASCHEN W, 1986, METAB BRAIN DIS, V1, P37, DOI 10.1007/BF00998475; Peerdeman SM, 2003, INTENS CARE MED, V29, P1825, DOI 10.1007/s00134-003-1850-8; Rafols JA, 2007, NEUROL RES, V29, P348, DOI 10.1179/016164107X204657; Ribeiro MD, 2006, J NEUROSCI RES, V83, P1231, DOI 10.1002/jnr.20819; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Stahl N, 2003, ACTA NEUROL SCAND, V108, P211, DOI 10.1034/j.1600-0404.2003.00095.x; Stahl N, 2001, INTENS CARE MED, V27, P1215, DOI 10.1007/s001340101004; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Veenith Tonny, 2009, World J Emerg Surg, V4, P7, DOI 10.1186/1749-7922-4-7; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang HL, 2009, J HUAZHONG U SCI-MED, V29, P150, DOI 10.1007/s11596-009-0203-4; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Zador Z, 2007, PROG BRAIN RES, V161, P185, DOI 10.1016/S0079-6123(06)61012-1	45	3	3	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUN	2012	34	5					462	468		10.1179/1743132812Y.0000000014			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	974UF	WOS:000306462200007	22450152				2022-02-06	
J	Coskun, R; Gundogan, K; Tanriverdi, F; Guven, M; Sungur, M				Coskun, Ramazan; Gundogan, Kursat; Tanriverdi, Fatih; Guven, Muhammet; Sungur, Murat			Effects of endosulfan intoxication on pituitary functions	CLINICAL TOXICOLOGY			English	Article						Endosulfan; Intoxication; Pituitary functions	TRAUMATIC BRAIN-INJURY; ORGANOCHLORINE PESTICIDE; OXIDATIVE STRESS; STIMULATION TEST; CELLS; HYPOPITUITARISM; TOXICITY; RATS	Context. We investigated the effects of endosulfan intoxication on pituitary functions in three patients. Methods. This is an observational case series including three patients with endosulfan intoxication. Patients were evaluated 3 months after the acute event. Results. Based on the baseline hormonal values and dynamic endocrine tests, one patient had hypothalamo-pituitary-adrenal axis impairment and was diagnosed as ACTH deficiency (peak cortisol level was found 13.12 mu g/dl after low dose ACTH stimulation test), and another one had GH-IGF-I axis impairment and was diagnosed as GH deficiency (peak GH level was found 1.06 mu g/L after glucagon stimulation test). Conclusions. Endosulfan intoxication might cause pituitary hormone deficiencies after the acute phase. Therefore, patients with endosulfan toxicity should be followed for possible pituitary gland dysfunction.	[Coskun, Ramazan; Gundogan, Kursat; Guven, Muhammet; Sungur, Murat] Erciyes Univ, Fac Med, Internal Med Intens Care Unit, TR-38039 Kayseri, Turkey		Coskun, R (corresponding author), Erciyes Univ, Fac Med, Internal Med Intens Care Unit, TR-38039 Kayseri, Turkey.	ramcos@erciyes.edu.tr	Sungur, Murat/AAU-5564-2020; Guven, Muhammet/AAA-9689-2021	Guven, Muhammet/0000-0001-9874-7185			[Anonymous], 2008, J CLIN ENDOCRINOL ME, V83, P379; Bajpayee M, 2006, ENVIRON MOL MUTAGEN, V47, P682, DOI 10.1002/em.20255; Caride A, 2010, TOXICOL LETT, V197, P106, DOI 10.1016/j.toxlet.2010.05.006; Cooper Mark Stuart, 2007, J Intensive Care Med, V22, P348, DOI 10.1177/0885066607307832; DICKSTEIN G, 1991, J CLIN ENDOCR METAB, V72, P773, DOI 10.1210/jcem-72-4-773; Dorval J, 2005, ENVIRON TOXICOL CHEM, V24, P1273, DOI 10.1897/03-523.1; Durukan P, 2009, EUR J EMERG MED, V16, P53, DOI 10.1097/MEJ.0b013e3283088e2b; Eyer F, 2004, J TOXICOL-CLIN TOXIC, V42, P927, DOI 10.1081/CLT-200035456; Hayes W.J., 1991, HDB PESTICIDE TOXICO; Kalender S, 2004, TOXICOLOGY, V202, P227, DOI 10.1016/j.tox.2004.05.010; Kalender Y, 2004, TOXICOLOGY, V200, P205, DOI 10.1016/j.tox.2004.03.017; Kucuker H, 2009, BASIC CLIN PHARMACOL, V104, P49, DOI 10.1111/j.1742-7843.2008.00216.x; Kunitomi M, 2002, INT J OBESITY, V26, P361, DOI 10.1038/sj.ijo.0801899; Leblond VS, 2001, GEN COMP ENDOCR, V121, P48, DOI 10.1006/gcen.2000.7556; Orak M, 2010, AKAD ACIL TIP DERGIS, V9, P158; Orme SM, 1998, CLIN ENDOCRINOL, V49, P773, DOI 10.1046/j.1365-2265.1998.00610.x; Roberts DM, 2004, J CLIN NEUROSCI, V11, P760, DOI 10.1016/j.jocn.2003.09.021; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; SINGH SK, 1990, INDIAN J EXP BIOL, V28, P953; Smith A. G., 1991, HDB PESTICIDE TOXICO, P731; Tanriverdi Fatih, 2006, Expert Rev Pharmacoecon Outcomes Res, V6, P131, DOI 10.1586/14737167.6.2.131; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2010, J NEUROTRAUM, V27, P301, DOI 10.1089/neu.2009.1102; Wade MG, 2002, TOXICOL SCI, V67, P207, DOI 10.1093/toxsci/67.2.207; Wozniak AL, 2005, ENVIRON HEALTH PERSP, V113, P431, DOI 10.1289/ehp.7505	25	3	4	0	5	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	1556-3650			CLIN TOXICOL	Clin. Toxicol.	JUN	2012	50	5					441	443		10.3109/15563650.2012.676647			3	Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Toxicology	942RR	WOS:000304065200012	22468982				2022-02-06	
J	Huang, HC; Fu, CY; Hsieh, CH; Wang, YC; Wu, SC; Chen, RJ; Huang, JC				Huang, H. -C.; Fu, C. -Y.; Hsieh, C. -H.; Wang, Y. -C.; Wu, S. -C.; Chen, R. -J.; Huang, J. -C.			Lodox/Statscan facilitates the early detection of commonly overlooked extracranial injuries in patients with traumatic brain injury	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Lodox; Statscan; Traumatic brain injury; Extremities injuries	X-RAY; MULTIPLE INJURIES; COMPUTERIZED TOMOGRAPHY; DELAYED DIAGNOSIS; CERVICAL-SPINE; LODOX STATSCAN; HEAD TRAUMA; FRACTURES; RADIOLOGY; CHILDREN	Traumatic brain injury (TBI) is a common diagnosis in the emergency department. Brain computed tomography (CT) has become a standard diagnostic tool with which to examine TBI patients. Conventional X-rays are ineffective for the evaluation of torso or extremity injuries. In the current study, we attempted to establish a diagnostic modality to evaluate systemically initially unconscious patients in the emergency department with a rapid screening technique characterized by sufficient information, low cost and low radiation exposure. From January 2008 to December 2009, patients with diminished level of consciousness received the Lodox/Statscan for evaluation of extracranial injuries were enrolled in this study. The accuracy of this diagnostic modality in detecting torso or extremity injuries in initially unconscious patients was analyzed by comparing the initial diagnosis (by the Lodox/Statscan) with the final diagnosis (confirmed by torso CT scan or after two weeks of follow-up). There were 1,210 patients with TBI whose extracranial injuries were evaluated by the Lodox/Statscan. After excluding intra-abdominal injuries, the overall sensitivity rates of the Lodox/Statscan in diagnosing torso injuries and extremity injuries were 89.7% and 90.2%, respectively. No long bone fracture was missed by the Lodox/Statscan. The sensitivity and specificity of the Lodox/Statscan in diagnosing long bone fractures were both 100%. Most patients with torso injuries that were missed by the Lodox/Statscan could be managed conservatively without further treatment or complications. All of the missed extremity injuries were distal bone fractures. The Lodox/Statscan can provide benefits for surveying extracranial injuries in patients with diminished level of consciousness. The Lodox/Statscan also emits a notably low dose of radiation and appears to be a relatively inexpensive adjunct to screen torso or extremity injuries in TBI patients.	[Huang, H. -C.; Fu, C. -Y.; Hsieh, C. -H.; Wang, Y. -C.; Wu, S. -C.; Chen, R. -J.; Huang, J. -C.] China Med Univ Hosp, Trauma & Emergency Ctr, Taichung 404, Taiwan; [Huang, H. -C.; Fu, C. -Y.; Wang, Y. -C.; Chen, R. -J.] Taipei Med Univ, Wan Fang Hosp, Trauma & Emergency Surg Dept, Taipei 116, Taiwan		Wu, SC (corresponding author), China Med Univ Hosp, Trauma & Emergency Ctr, 2 Yuh Der Rd, Taichung 404, Taiwan.	adam0936287309@yahoo.com.tw; drfu5564@yahoo.com.tw; hsiehchihsun@yahoo.com.tw; traumawang@yahoo.com.tw; rw114@www.cmuh.org.tw; rayjchen@tmu.edu.tw; gary.kmt@msa.hinet.net					Aaland MO, 1996, SURGERY, V120, P774, DOI 10.1016/S0039-6060(96)80030-4; American College of Surgeons Committee on Trauma, 2008, ADV TRAUM LIF SUPP ADV TRAUM LIF SUPP; Andresen R, 1999, INVEST RADIOL, V34, P46, DOI 10.1097/00004424-199901000-00007; Ball CG, 2007, SCAND J SURG, V96, P67, DOI 10.1177/145749690709600113; Beningfield SJ, 1999, S AFR MED J, V89, P1182; Berlin L, 2001, AM J ROENTGENOL, V176, P317, DOI 10.2214/ajr.176.2.1760317; Berne JD, 1999, J TRAUMA, V47, P896, DOI 10.1097/00005373-199911000-00014; Boffard KD, 2006, J TRAUMA, V60, P1175, DOI 10.1097/01.ta.0000220393.26629.6c; Chen RJ, 2010, J TRAUMA, V69, P826, DOI 10.1097/TA.0b013e3181bb86ce; Compagnone G, 2005, RADIAT PROT DOSIM, V114, P164, DOI 10.1093/rpd/nch508; Deyle S, 2010, INJURY, V41, P818, DOI 10.1016/j.injury.2010.03.021; Exadaktylos AK, 2008, INJURY, V39, P525, DOI 10.1016/j.injury.2007.10.019; FRENCH BN, 1977, SURG NEUROL, V7, P171; Fu CY, 2008, AM J EMERG MED, V26, p965e5; GARLAND DE, 1981, CLIN ORTHOP RELAT R, P162; HEINRICH SD, 1994, J BONE JOINT SURG AM, V76A, P561, DOI 10.2106/00004623-199404000-00011; Huda W, 2008, MED PHYS, V35, P5713, DOI 10.1118/1.3013604; Irving BJ, 2008, RADIAT PROT DOSIM, V130, P482, DOI 10.1093/rpd/ncn073; JUHL M, 1990, INJURY, V21, P110, DOI 10.1016/0020-1383(90)90067-5; Knobel GJ, 2006, SAMJ S AFR MED J, V96, P593; KOO AH, 1977, RADIOLOGY, V123, P345, DOI 10.1148/123.2.345; Kusano Nozomu, 2002, Tech Hand Up Extrem Surg, V6, P119, DOI 10.1097/00130911-200209000-00004; LAASONEN EM, 1991, J TRAUMA, V31, P257, DOI 10.1097/00005373-199131020-00019; Langlois JA., 2004, TRAUMATIC BRAIN INJU; MERINODEVILLASANTE J, 1976, AM J ROENTGENOL, V126, P765, DOI 10.2214/ajr.126.4.765; Mulligan ME, 2006, EMERG RADIOL, V13, P129, DOI 10.1007/s10140-006-0525-5; MURPHY DG, 1995, ANN EMERG MED, V26, P434, DOI 10.1016/S0196-0644(95)70110-9; Obaid AK, 2006, AM SURGEON, V72, P951; Olson SA, 2005, CLIN ORTHOP RELAT R, P30, DOI 10.1097/01.blo.01000159893.41205.85; Platzer P, 2006, EUR SPINE J, V15, P1801, DOI 10.1007/s00586-006-0084-1; SOBUS KML, 1993, ARCH PHYS MED REHAB, V74, P902; Tabuenca J, 2000, CLIN ORTHOP RELAT R, P78; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wei CJ, 2006, ACTA RADIOL, V47, P710, DOI 10.1080/02841850600806340; WOODRING JH, 1992, J TRAUMA, V33, P698, DOI 10.1097/00005373-199211000-00019	35	3	3	0	7	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933			EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	JUN	2012	38	3					319	326		10.1007/s00068-012-0176-z			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	953GP	WOS:000304855300015	26815965				2022-02-06	
J	Srivastava, C; Singh, SK; Ojha, BK; Chandra, A				Srivastava, Chhitij; Singh, Sunil K.; Ojha, B. K.; Chandra, Anil			Intracranial penetrating glass injury: A case report	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						Intracranial; Penetrating; Glass injury; Head injury; Parietal bone		A case of penetrating head injury caused by glass is reported. Rarely does this material cause such an injury. Most of the intracranial foreign bodies occur around the orbit, frontal sinus, nasal and temporal area. Intracranial penetration of glass to the parietal region is rare due to the hardness and thickness of overlying parietal bone. Other reports of this unusual type of head injury are reviewed. Management and possible complications of this type of injury are discussed. Copyright (C) 2012, Neurotrauma Society of India. All rights reserved.	[Srivastava, Chhitij; Singh, Sunil K.; Ojha, B. K.; Chandra, Anil] Earlier KGMC, CSM Med Univ, Dept Neurosurg, Lucknow, Uttar Pradesh, India		Srivastava, C (corresponding author), Earlier KGMC, CSM Med Univ, Dept Neurosurg, Lucknow, Uttar Pradesh, India.	drcsrivastava@gmail.com					Allen TJ, 1998, FORENSIC SCI INT, V93, P209, DOI 10.1016/S0379-0738(98)00045-0; Bokhari AA, 1997, J HAND SURG-BRIT EUR, V22B, P202, DOI 10.1016/S0266-7681(97)80063-0; DELACEY G, 1985, BRIT J RADIOL, V58, P27, DOI 10.1259/0007-1285-58-685-27; DICKINSON G, 1989, CAN MED ASSOC J, V140, P265; Edgar K., 1983, PAEDIATRICS, V72, P223; KIECK CF, 1984, J NEUROSURG, V60, P42, DOI 10.3171/jns.1984.60.1.0042; Rothschild MA, 2001, FORENSIC SCI INT, V121, P161, DOI 10.1016/S0379-0738(01)00392-9; Sharma A, 2006, J TRAUMA, V60, P891, DOI 10.1097/01.ta.0000214597.97664.0f; Shih TY, 2002, PEDIATR NEUROSURG, V37, P35, DOI 10.1159/000065100	9	3	3	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	JUN	2012	9	1					64	66		10.1016/j.ijnt.2012.04.003			3	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M3E	WOS:000218385700014					2022-02-06	
J	Wendel, C; Schweinsberg, ESZ				Wendel, Claudia; Schweinsberg, Ellen Schenk zu			ICE-Based Clinical Documentation and Evaluation in the Field of Neurological Rehabilitation	ZEITSCHRIFT FUR NEUROPSYCHOLOGIE			German	Article						ICF; neuropsychology; rehabilitation; participation; outcome	QUALITY-OF-LIFE; PERSONAL CONTEXTUAL FACTORS; TRAUMATIC BRAIN-INJURY; INTERNATIONAL CLASSIFICATION; STROKE REHABILITATION; OUTCOME MEASURES; HEALTH ICF; CORE SETS; DISABILITY; PARTICIPATION	In the years to come, the ICF (International Classification of Functioning, Disability and Health) will be implemented in the daily routines of neurological rehabilitation for the documentation of health status, for controlling interventions as well as for their evaluation. In this paper, essential terms and concepts concerning the ICF will be clarified. International studies will be examined in relation to their implication for clinical daily clinical routines. ICF allows a differential description of the situation of an individual with a health condition, which can be mainly affected by personal and environmental factors. By using the ICF and focusing on participation, professional acting in the context of neurological rehabilitation can be sustainably amended. Clearly focusing on the enhancement of functioning equates to a new understanding of rehabilitation, which does not follow a deficit-orientated logic of treating health problems anymore.	[Wendel, Claudia; Schweinsberg, Ellen Schenk zu] Hsch Magdeburg Stendal, DE-39576 Stendal, Germany		Wendel, C (corresponding author), Hsch Magdeburg Stendal, Osterburgerstr 25, DE-39576 Stendal, Germany.	claudia.wendel@hs-magdeburg.de					[Anonymous], 2001, 9 BUCH SOZIALGESETZB; Arthanat S, 2004, DISABIL REHABIL, V26, P235, DOI 10.1080/09638280310001644889; Battaglia M, 2004, DEV MED CHILD NEUROL, V46, P98; Bernabeu M, 2009, NEUROREHAB NEURAL RE, V23, P464, DOI 10.1177/1545968308328725; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Cibis W, 2009, GESUNDHEITSWESEN, V71, P429, DOI 10.1055/s-0029-1224140; Cieza A, 2008, GESUNDHEITSWESEN, V70, P569, DOI 10.1055/s-2008-1080933; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cieza A, 2005, QUAL LIFE RES, V14, P1225, DOI 10.1007/s11136-004-4773-0; Cieza A, 2002, J REHABIL MED, V34, P205, DOI 10.1080/165019702760279189; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P445, DOI 10.1097/00001199-200411000-00003; Ewert T, 2008, GESUNDHEITSWESEN, V70, P600, DOI 10.1055/s-2008-1067459; Farin E, 2008, REHABILITATION, V47, P67, DOI 10.1055/s-2008-1042445; Farin E, 2011, Gesundheitswesen, V73, pe1, DOI 10.1055/s-0030-1247536; Fischer S, 2009, Z NEUROPSYCHOL, V20, P285, DOI 10.1024/1016-264X.20.4.285; Franke A, 2011, NEUROREHA, V3, P107; Fries W, 2008, REHABILITATION, V47, P265, DOI 10.1055/s-2008-1081473; FRIES W, 2007, TEILHABEN NEUE KONZE; Frommelt P., 2010, NEUROREHABLITATION, P633; Geyh S, 2007, QUAL LIFE RES, V16, P833, DOI 10.1007/s11136-007-9174-8; Geyh S., 2007, THESIS LUDWIG MAXIMI; Geyh Szilvia, 2011, Am J Phys Med Rehabil, V90, pS79, DOI 10.1097/PHM.0b013e318230fb68; Heel S, 2008, Z NEUROPSYCHOL, V19, P253, DOI 10.1024/1016-264X.19.4.253; Heuschmann PU, 2005, FORTSCHR NEUROL PSYC, V73, P74, DOI 10.1055/s-2004-830172; Kirschneck M, 2011, PHYS MED REHAB KUROR, V21, P11, DOI 10.1055/s-0030-1265159; Lange J., 2010, TAG 11 NACHW WISS FA, P281; Lezak, 2008, MANUAL MAYO PORTLAND; Mau W, 2007, QUERSCHNITT REHABILI, P16; Mead N, 2000, SOC SCI MED, V51, P1087, DOI 10.1016/S0277-9536(00)00098-8; Muller M, 2011, J REHABIL MED, V43, P92, DOI 10.2340/16501977-0622; Noonan VK, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-93; Nordenfelt L, 2006, DISABIL REHABIL, V28, P1461, DOI 10.1080/09638280600925886; Perenboom RJM, 2003, DISABIL REHABIL, V25, P577, DOI 10.1080/0963828031000137081; Pfaff H, 2003, GESUNDHEITSVERSORGUN, P13; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Poppl D., 2010, EVALUATION TEILHABE; Post MWM, 2008, J REHABIL MED, V40, P620, DOI 10.2340/16501977-0223; Reed GM, 2005, REHABIL PSYCHOL, V50, P122, DOI 10.1037/0090-5550.50.2.122; Rentsch HP., 2006, ICF REHABILITATION P, V2; Salter K, 2005, DISABIL REHABIL, V27, P315, DOI 10.1080/09638280400008545; Salter K, 2005, DISABIL REHABIL, V27, P507, DOI 10.1080/0963828040008552; Salter KL, 2007, INT J REHABIL RES, V30, P339, DOI 10.1097/MRR.0b013e3282f144b7; Sandstrom M, 2007, CLIN REHABIL, V21, P833, DOI 10.1177/0269215507077278; Schuntermann M., 2008, GEH ICF FACHT 2008 P; Stier-Jarmer M, 2005, DISABIL REHABIL, V27, P389, DOI 10.1080/09638280400014022; Stucki G, 2005, DISABIL REHABIL, V27, P349, DOI 10.1080/09638280400013941; Stucki G, 2002, DISABIL REHABIL, V24, P932, DOI 10.1080/09638280210148594; Stucki G, 2007, J REHABIL MED, V39, P279, DOI 10.2340/16501977-0041; Viol M, 2007, GESUNDHEITSWESEN, V69, P34, DOI 10.1055/s-2007-970147; Viol M, 2006, GESUNDHEITSWESEN, V68, P747, DOI 10.1055/s-2006-927328; Wedel-Parlow F.-K., 2010, NEUROREHABILITATION, P499; Wendel C., NEUROREHABIL 2 UNPUB, V2; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; Whiteneck GG, 2001, AM J PHYS MED REHAB, V80, P305, DOI 10.1097/00002060-200104000-00017; WHO, 2005, INT KLASS FUNKT BEH; Worrall L, 2011, APHASIOLOGY, V25, P309, DOI 10.1080/02687038.2010.508530; Wynia K, 2009, DISABIL REHABIL, V31, P1008, DOI 10.1080/09638280802509488	57	3	3	0	8	VERLAG HANS HUBER	BERN 9	LANGGASS-STRASSE 76, CH-3000 BERN 9, SWITZERLAND	1016-264X	1664-2902		Z NEUROPSYCHOL	Z. Neuropsychol.	JUN	2012	23	2					65	79		10.1024/1016-264X/a000067			15	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	964DY	WOS:000305675100001					2022-02-06	
J	Yang, SN; Park, SW; Jung, HY; Rah, UW; Kim, YH; Chun, MH; Paik, NJ; Yoo, SD; Pyun, SB; Kim, MW; Lee, SG; Park, BK; Shin, H; Shin, YI; Lee, H; Han, TR				Yang, Seung Nam; Park, Si-Woon; Jung, Han Young; Rah, Ueon Woo; Kim, Yun-Hee; Chun, Min Ho; Paik, Nam-Jong; Yoo, Seung Don; Pyun, Sung-Bom; Kim, Min Wook; Lee, Sam-Gyu; Park, Byung Kyu; Shin, Heesuk; Shin, Yong Il; Lee, Heeyeon; Han, Tai Ryoon			Korean Brain Rehabilitation Registry for Rehabilitation of Persons with Brain Disorders: Annual Report in 2009	JOURNAL OF KOREAN MEDICAL SCIENCE			English	Article						Registries; Rehabilitation; Korea; Brain	LENGTH-OF-STAY; INPATIENT REHABILITATION; STROKE REHABILITATION; SENSITIVITY	This first annual report provides a description of patients discharged from rehabilitation facilities in Korea based on secondary data analysis of Korean Brain Rehabilitation Registry V1.0 subscribed in 2009. The analysis included 1,697 records of patients with brain disorders including stroke, traumatic brain injury, brain tumor and other disorders from 24 rehabilitation facilities across Korea. The data comprised 1,380 cases of stroke, 104 cases of brain injury, 55 cases of brain tumor, and 58 cases of other brain diseases. The functional status of each patient was measured using the Korean version of the Modified Barthel Index (KMBI). The average change in the KMBI score was 15.9 for all patients in the inpatient rehabilitation facility. The average length of stay for inpatient rehabilitation was 36.9 days. The transfer rates to other hospitals were high, being 62.4% when all patients were considered. Patients with brain disorders of Korea in 2009 and measurable functional improvement was observed in patients. However, relatively high percentages of patients were not discharged to the community after inpatient rehabilitation. Based on the results of this study, consecutive reports of the status of rehabilitation need to be conducted in order to provide useful information to many practitioners.	[Paik, Nam-Jong; Han, Tai Ryoon] Seoul Natl Univ, Coll Med, Dept Rehabil Med, Seoul 110799, South Korea; [Yang, Seung Nam; Park, Si-Woon] Natl Rehabil Ctr, Dept Rehabil Med, Seoul, South Korea; [Yang, Seung Nam; Pyun, Sung-Bom; Park, Byung Kyu] Korea Univ, Coll Med, Dept Rehabil Med, Seoul 136705, South Korea; [Park, Si-Woon] Myongji Choonhey Rehabil Hosp, Dept Rehabil Med, Seoul, South Korea; [Jung, Han Young] Inha Univ, Sch Med, Dept Rehabil Med, Inchon, South Korea; [Rah, Ueon Woo] Ajou Univ, Coll Med, Dept Rehabil Med, Suwon 441749, South Korea; [Kim, Yun-Hee] Sungkyunkwan Univ, Sch Med, Dept Rehabil Med, Seoul, South Korea; [Chun, Min Ho] Univ Ulsan, Coll Med, Dept Rehabil Med, Seoul, South Korea; [Yoo, Seung Don] Kyung Hee Univ, Coll Med, Dept Rehabil Med, Seoul, South Korea; [Kim, Min Wook] Catholic Univ, Korea Med Sch, Dept Rehabil Med, Seoul, South Korea; [Lee, Sam-Gyu] Chonnam Natl Univ, Sch Med, Dept Rehabil Med, Kwangju, South Korea; [Shin, Heesuk] Gyeongsang Natl Univ, Sch Med, Dept Rehabil Med, Jinju, South Korea; [Shin, Yong Il] Pusan Natl Univ, Sch Med, Dept Rehabil Med, Pusan 609735, South Korea; [Shin, Yong Il] Wonkwang Univ, Coll Med, Dept Rehabil Med, Iksan, South Korea; [Lee, Heeyeon] Natl Rehabil Ctr Res Inst, Dept Rehabil Stand & Policy, Seoul, South Korea		Han, TR (corresponding author), Seoul Natl Univ, Coll Med, Dept Rehabil Med, 103 Daehak Ro, Seoul 110799, South Korea.	tairyoon@snu.ac.kr	Paik, Nam-Jong/D-5798-2012; Han, Tai Ryoon/J-5712-2012; Yoo, Seung Don/AAI-8609-2020; Kim, Yun Hee/F-4600-2014	Paik, Nam-Jong/0000-0002-5193-8678; Yoo, Seung Don/0000-0003-4513-2560; 			Bhandari VK, 2005, ARCH PHYS MED REHAB, V86, P2081, DOI 10.1016/j.apmr.2005.05.008; GRANGER CV, 1992, AM J PHYS MED REHAB, V71, P108, DOI 10.1097/00002060-199204000-00009; Jung HY, 2007, ANN REHABIL MED-ARM, V31, P283; Jung HY, 2010, BRAIN NEUROREHABIL, V3, P34; Katrak PH, 2011, PM&R, V3, P716, DOI 10.1016/j.pmrj.2011.04.011; Meyer M, 2012, DISABIL REHABIL, V34, P1077, DOI 10.3109/09638288.2011.631681; Murakami M, 2002, AM J PHYS MED REHAB, V81, P279, DOI 10.1097/00002060-200204000-00006; Ottenbacher KJ, 2004, JAMA-J AM MED ASSOC, V292, P1687, DOI 10.1001/jama.292.14.1687; Quinn TJ, 2011, STROKE, V42, P1146, DOI 10.1161/STROKEAHA.110.598540; Shah S, 2000, CLIN REHABIL, V14, P551, DOI 10.1191/0269215500cr360oa; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6	11	3	3	0	2	KOREAN ACAD MEDICAL SCIENCES	SEOUL	302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA	1011-8934	1598-6357		J KOREAN MED SCI	J. Korean Med. Sci.	JUN	2012	27	6					691	696		10.3346/jkms.2012.27.6.691			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	959MR	WOS:000305317000017	22690103	Green Submitted, Green Published, gold			2022-02-06	
J	Kim, SH; Kim, SW				Kim, Sung Hoon; Kim, Seok Won			Sixth and Twelfth Cranial Nerve Palsies Following Basal Skull Fracture Involving Clivus and Occipital Condyle	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Basal skull fracture; Cranial nerve palsy	HEAD-INJURY	Oblique basal skull fractures resulting from lateral crushing injuries involving both clivus and occipital condyle are rare due to their deep locations. Furthermore, these fractures may present clinically with multiple cranial nerve injuries because neural exit routes are restricted in this intricate region. The authors present an interesting case of basal skull fractures involving the clivus and occipital condyle and presenting with sixth and contralateral twelfth cranial nerve deficits. Clinico-anatomic correlations and the courses of cranial nerve deficits are reiterated. To the authors' knowledge, no other report has been previously issued on concomitant sixth and contralateral twelfth cranial nerve palsies following closed head injury.	[Kim, Seok Won] Chosun Univ, Sch Med, Dept Neurosurg, Kwangju 501717, South Korea; [Kim, Sung Hoon] Younsei Univ, Wonju Coll Med, Dept Rehabil, Wonju, South Korea		Kim, SW (corresponding author), Chosun Univ, Sch Med, Dept Neurosurg, 588 Seoseok Dong, Kwangju 501717, South Korea.	chosunns@hanmail.net		kim, sunghoon/0000-0002-1570-3230			ANDERSON PA, 1988, SPINE, V13, P731, DOI 10.1097/00007632-198807000-00004; Dagi TF, 1995, OPERATIVE NEUROSURGI, P117; Dhaliwal A, 2006, J NEURO-OPHTHALMOL, V26, P4, DOI 10.1097/01.wno.0000204661.48806.1d; JENNETT B, 1980, J NEUROL NEUROSUR PS, V43, P289, DOI 10.1136/jnnp.43.4.289; Kerman M, 2002, NEUROSURG QUART, V12, P23, DOI 10.1097/00013414-200203000-00003; Khan N, 2000, SURG NEUROL, V54, P171, DOI 10.1016/S0090-3019(00)00284-6; Lee YS, 1994, J KOREAN NEUROSURG S, V23, P1038; Menku A, 2004, NEUROSURG REV, V27, P194, DOI 10.1007/s10143-004-0320-2; Ommaya AK, 1996, NEUROSURGERY, V2, P2773	9	3	5	0	1	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711			J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	MAY	2012	51	5					305	307		10.3340/jkns.2012.51.5.305			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	972BZ	WOS:000306252800012	22792430	Green Published, gold, Green Submitted			2022-02-06	
J	Pai, AB; Zadov, Y; Hickman, A				Pai, Ajit B.; Zadov, Yevgeny; Hickman, Allison			Patient Safety in Rehabilitation Medicine: Traumatic Brain Injury	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Patient safety; Rehabilitation; Traumatic brain injury; Military; Medical error; Communication; Medication reconciliation	SUBSTANCE-ABUSE; RISK-FACTORS; EMERGENCY-DEPARTMENTS; HOSPITALIZED-PATIENTS; NURSING-HOMES; FOLLOW-UP; CARE; MANAGEMENT; IDENTIFICATION; DISCREPANCIES	This article describes patient safety after traumatic brain injury (TBI). Patient safety in rehabilitation after TBI is important. Thorough assessment on initial evaluation, vigilance for medical and procedural errors, appropriate communication between medical professionals, and evaluation of systems-based practices increases patient safety. It is the responsibility of the rehabilitation treatment team to ensure that appropriate measures are taken to reduce risk of adverse events. This article is intended to promote discussion of patient safety after TBI within rehabilitation teams and to help improve outcomes throughout the spectrum of recovery.	[Pai, Ajit B.; Zadov, Yevgeny] Hunter Holmes McGuire VA Med Ctr, Richmond, VA 23249 USA; [Pai, Ajit B.; Hickman, Allison] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA		Pai, AB (corresponding author), Hunter Holmes McGuire VA Med Ctr, 1201 Broad Rock Blvd, Richmond, VA 23249 USA.	ajit.pai@va.gov					Aiken L H, 2001, J Health Adm Educ, VSpec No, P117; Alvarez DJ, 2002, AM FAM PHYSICIAN, V65, P653; Alvarez L, 2008, NY TIMES, pA1; American Nurses Association, 2001, HLTH SAF SURV, V32; [Anonymous], 2011, CAS STAT; [Anonymous], 2011, VIRTUAL LIFETIME ELE; Ashman TA, 2004, BRAIN INJURY, V18, P191, DOI 10.1080/0269905031000149506; Axell AIRG, 2002, ACTA ANAESTH SCAND, V46, P726, DOI 10.1034/j.1399-6576.2002.460616.x; B Jones, 2003, C MILD TRAUM BRAIN I; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bond CA, 2007, PHARMACOTHERAPY, V27, P481, DOI 10.1592/phco.27.4.481; Borrill C, 2000, BRIT J HLTH CARE MAN, V6, P364, DOI DOI 10.12968/BJHC.2000.6.8.19300; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Carlson KF, 2012, J HEAD TRAUMA REHAB, V27, P14, DOI 10.1097/HTR.0b013e318236bd86; Carstens D, 2009, J ENG TECHNOL MANAGE, V26, P15, DOI 10.1016/j.jengtecman.2009.03.006; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Chang EF, 2007, NEUROSURGERY, V61, P222, DOI [10.1227/01.NEU.0000197101.68538.E6, 10.1227/01.neu.0000279217.45881.69]; Chen JWY, 2009, J REHABIL RES DEV, V46, P685, DOI 10.1682/JRRD.2008.09.0130; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; Cifu D.X., 2009, CRIT REV PHYS REHABI, V21, P197, DOI DOI 10.1615/CRITREVPHYSREHABI1MED.V2113-4.10; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Cortes Tara A, 2004, J Gerontol Nurs, V30, P10; D'Amour Danielle, 2005, J Interprof Care, V19 Suppl 1, P116, DOI 10.1080/13561820500082529; Defense and Veterans Brain Injury Center, 2011, DOD WORLDW NUMB TRAU; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Douketis JD, 2008, CHEST, V133, p299S, DOI 10.1378/chest.08-0675; Espinosa-Aguilar A, 2008, J TRAUMA, V64, P1327, DOI 10.1097/TA.0b013e3181469ebe; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fischer H, 2010, US MILITARY CASUALTY; Flanagan E, 2011, INFECT DIS CLIN N AM, V25, P271, DOI 10.1016/j.idc.2010.11.008; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Gleason KM, 2004, AM J HEALTH-SYST PH, V61, P1689, DOI 10.1093/ajhp/61.16.1689; GURWITZ JH, 1994, J AM GERIATR SOC, V42, P33, DOI 10.1111/j.1532-5415.1994.tb06070.x; Halfon P, 2001, J CLIN EPIDEMIOL, V54, P1258, DOI 10.1016/S0895-4356(01)00406-1; Harrison JF, 1999, J ACCID EMERG MED, V16, P339; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoogendoorn WE, 1999, SCAND J WORK ENV HEA, V25, P387, DOI 10.5271/sjweh.451; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kahn DM, 1998, CHEST, V114, P535, DOI 10.1378/chest.114.2.535; Kelly NA, 2012, J AM MED DIR ASSOC, pe9; Kelly NA, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2011.02.007; Kindig DA, 2004, HLTH LITERACY PRESCR; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; KOEHOORN M, 2002, CREATING HIGH QUALIT; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; Kuehn BM, 2010, JAMA-J AM MED ASSOC, V304, P1427, DOI 10.1001/jama.2010.1327; Langley Gayle, 2011, Intensive Crit Care Nurs, V27, P67, DOI 10.1016/j.iccn.2010.12.001; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Lesar TS, 1997, ARCH INTERN MED, V157, P1569, DOI 10.1001/archinte.157.14.1569; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Lv LQ, 2011, J TRAUMA, V71, P538, DOI 10.1097/TA.0b013e31820ebee1; Madden C, 1998, ACAD EMERG MED, V5, P1123, DOI 10.1111/j.1553-2712.1998.tb02677.x; Maklebust J, 1994, Adv Wound Care, V7, P27; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; Morse JM, 2002, AM J INFECT CONTROL, V30, P376, DOI 10.1067/mic.2002.125808; Mylotte JM, 2000, CLIN INFECT DIS, V30, P425, DOI 10.1086/313708; Naumann M, 2004, CURR MED RES OPIN, V20, P981, DOI 10.1185/030079904125003962; O'Connor Patricia, 2006, Healthc Q, V9 Spec No, P43; Rangel-Castillo L, 2006, CRIT CARE CLIN, V22, P713, DOI 10.1016/j.ccc.2006.06.003; Rockhill CM, 2012, J NEUROTRAUMA; Ronald Lisa A, 2002, AAOHN J, V50, P120; Rozich John D, 2004, Jt Comm J Qual Saf, V30, P5; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Sanders AB, 1997, ACAD EMERG MED, V4, P854, DOI 10.1111/j.1553-2712.1997.tb03807.x; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Sgadari A, 1997, AGE AGEING, V26, P49, DOI 10.1093/ageing/26.suppl_2.49; Snow V, 2009, J GEN INTERN MED, V24, P971, DOI 10.1007/s11606-009-0969-x; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Terrell KM, 2006, J AM MED DIR ASSOC, V7, P499, DOI 10.1016/j.jamda.2006.03.004; Terrell KM, 2009, ACAD EMERG MED, V16, P441, DOI 10.1111/j.1553-2712.2009.00382.x; Terrell KM, 2005, ACAD EMERG MED, V12, P114, DOI 10.1197/j.aem.2004.10.013; The Joint Commission, 2004, ROOT CAUS SENT EV 19; TINETTI ME, 1991, JAMA-J AM MED ASSOC, V265, P468, DOI 10.1001/jama.265.4.468; Tjia J, 2009, J GEN INTERN MED, V24, P630, DOI 10.1007/s11606-009-0948-2; United States Army, 2010, HLTH PROM RISK RED S; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Vanderploeg R, 2008, TRAUMATIC BRAIN INJU, P7; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Velji Karima, 2008, Healthc Q, V11, P72; Verhoef J, 2001, CAN MED ASSOC J, V165, P31; Wagner LM, 2011, J HEALTHC QUAL; West SL, 2011, NEUROREHABILITATION, V29, P1, DOI 10.3233/NRE-2011-0671; Yassi Annalee, 2002, Hosp Q, V5, P70	92	3	3	0	15	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2012	23	2					349	+		10.1016/j.pmr.2012.02.009			23	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	949KO	WOS:000304575300011	22537698				2022-02-06	
J	Qiu, BH; Xu, SX; Fang, LX; Chotai, S; Li, WG; Qi, ST				Qiu, Binghui; Xu, Shuxiang; Fang, Luxiong; Chotai, Silky; Li, Weiguang; Qi, Songtao			Surgical Strategies for Neurological Function Preservation in Severe Brain Contusion	TURKISH NEUROSURGERY			English	Article						Traumatic brain injury; Brain contusion; Decompressive craniectomy; Neurological function preservation	POSTTRAUMATIC MASS LESIONS; DECOMPRESSIVE CRANIECTOMY; MULTICENTER SURVEY; INJURY; MANAGEMENT; GUIDELINES; PROGNOSIS; EDEMA	AIM: Traditional surgical strategies for severe brain contusion are constantly associated with variable degree of postoperative neurological dysfunction, which is in part attributed to the location and severity of contusion. The purpose of this study was to compare and evaluate these current surgical strategies, with an emphasis on neurological function preservation. MATERIAL and METHODS: A retrospective review of surgical strategies employed for 142 cases of severe brain contusion was performed. The surgical strategies were stratified into four types, Type I, Simple DC, without resection of contusion; II, Resection of contusion, combined with DC; Ill, Safe cerebral lobe resection and DC, without resection of contusion; IV, Simple resection of contusion, without decompression. The patients were accordingly separated into four groups. RESULTS: The favorable prognosis rate in Group I, II and III was higher than Group IV on 6-month follow-up Glasgow Outcome Score (GOS). No significant difference of mortality rate was observed among Group I, II and III (p>0.05), but the favorable prognosis rate of Group II was lower than Group I and III (p<0.05). CONCLUSION: Simple DC and safe cerebral lobe resection combined with DC might achieve better therapeutic effect, and could be recommended as the preferred surgical strategies for severe brain contusion.	[Qiu, Binghui; Xu, Shuxiang; Fang, Luxiong; Chotai, Silky; Li, Weiguang; Qi, Songtao] So Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China		Qiu, BH (corresponding author), So Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China.	qiubui@gdvnet.com					Aarabi B, 2009, NEUROSURGERY, V64, P927, DOI 10.1227/01.NEU.0000341907.30831.D2; Ahmadi SA, 2010, BRAIN INJURY, V24, P1539, DOI 10.3109/02699052.2010.523049; Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; BRAIN TRAUM FD, 1996, J NEUROTRAUM, V13, P641; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Bullock MR, 2006, NEUROSURGERY, V58, P25; Chibbaro S, 2007, SURG NEUROL, V68, P632, DOI 10.1016/j.surneu.2006.12.046; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Compagnone C, 2007, NEUROSURGERY, V61, P232, DOI [10.1227/01.neu.0000279218.53504.fe, 10.1227/01.NEU.0000186239.10915.09]; Eberle BM, 2010, INJURY, V41, P894, DOI 10.1016/j.injury.2010.02.023; Flanagan Steven R, 2008, Neuropsychiatr Dis Treat, V4, P877; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Huang APH, 2008, J NEUROTRAUM, V25, P1347, DOI 10.1089/neu.2008.0625; Jiang JY, 2008, CHIN J TRAUMATOL, V11, P222, DOI 10.1016/S1008-1275(08)60046-2; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Katayama Y, 2003, ACTA NEUROCHIR SUPPL, V86, P323; Kawamata T, 2006, ACTA NEUROCHIR SUPPL, V96, P3; Kawamata Tatsuro, 2007, Neurosurg Focus, V22, pE5, DOI 10.3171/foc.2007.22.5.6; LANGFITT TW, 1966, J NEUROSURG, V24, P47, DOI 10.3171/jns.1966.24.1.0047; Marion DW, 2006, NEUROSURGERY, V58, P655; Marmarou A, 2006, ACTA NEUROCHIR SUPPL, V96, P24; Naredi S, 1998, INTENS CARE MED, V24, P446, DOI 10.1007/s001340050594; Nilsson P, 2005, ACTA NEUROCHIR SUPPL, V95, P51; Rossi S, 2008, MINERVA ANESTESIOL, V74, P579; Rubiano AM, 2009, ULUS TRAVMA ACIL CER, V15, P28; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P64, DOI 10.1007/s00508-006-0765-0; Wang MC, 2007, J TRAUMA, V62, P1250, DOI 10.1097/01.ta.0000215581.50234.56; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; Yatsushige H, 2010, ACTA NEUROCHIR SUPPL, V106, P265, DOI 10.1007/978-3-211-98811-4_50	31	3	3	0	1	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	MAY	2012	22	3					329	335		10.5137/1019-5149.JTN.5333-11.0			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	957ZW	WOS:000305206600011	22665001	Bronze			2022-02-06	
J	Silva, DD; Brito, JNPD; Ibiapina, JO; Lima, MFMB; Medeiros, ARGD; Queiroz, BHCE; Paiva, ALC; Guedes, VOD				Silva, Danilo dos Santos; Pearce de Oliveira Brito, Jose Nazareno; Ibiapina, Jerusia Oliveira; Miranda Batista Lima, Marcel Fernando; Goncalves de Vasconcelos Medeiros, Andrea Ribeiro; Carvalho e Queiroz, Barbara Hamedy; Campos Paiva, Aline Lariessy; de Melo Guedes, Vanessa Olimpio			Closed head injury in rats. Histopathological aspects in an experimental weight drop model	ACTA CIRURGICA BRASILEIRA			English	Article						Models, Animal; Brain Injuries; Pathology; Rats	CONTROLLED CORTICAL IMPACT; TRAUMATIC BRAIN-INJURY	PURPOSE: To study histopathological findings due to a model of closed head injury by weight loss in rats. METHODS: A platform was used to induce closed cranial lesion controlled by weight loss with a known and predefined energy. 25 male Wistar rats (Rattus novergicus albinus) were divided in five equal groups which received different cranial impact energy levels: G1, G2, G3 and G4 with 0.234J, 0.5J, 0.762J and 1J respectively and G5 (Sham). Under the effect of analgesia, the brain of each group was collected and prepared for histopathological analysis by conventional optic microscopy. RESULTS: It was observed greater number of injured neurons in animals of group 4, however neuronal death also could be noticed in animals of group 5. Intraparenchymal hemorrhages were more frequent in animals of group 4 and the cytotoxic brain swelling and vascular congestion were more intense in this group. CONCLUSION: The histopathological analysis of these findings allowed to observe typical cranial trauma alterations and these keep close relation with impact energy.	Piaui State Univ UESPI, Fac Med, Dept Expt Surg, Teresina, PI, Brazil; Sao Marcos Hosp, Dept Pathol, Piaui Assoc Canc Care, Teresina, PI, Brazil		Brito, JNPD (corresponding author), Rua Desembargador Cesar Rego Monteiro 1220, BR-64049580 Teresina, PI, Brazil.	nazapearce@uol.com.br			National Council for Scientific and Technological Development (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)	National Council for Scientific and Technological Development (CNPq)	Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dvilevicius AE, 2008, ARQ BRAS NEUROCIR, V27, P42; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Park HK, 1999, CRIT REV NEUROSURG, V9, P44, DOI 10.1007/s003290050108; Silva DD, 2011, ACTA CIR BRAS, V26, P94, DOI 10.1590/S0102-86502011000200004	11	3	3	0	1	ACTA CIRURGICA BRASILEIRA	SAO PAULO	ALAMEDA RIO CLARO, 179-41, SAO PAULO, SP 01332-010, BRAZIL	0102-8650			ACTA CIR BRAS	Acta Cir. Bras.	APR	2012	27	4					290	294					5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	931EP	WOS:000303198700002	22534802				2022-02-06	
J	Link, JN; Kropf, M; Hirsch, MA; Hammond, FM; Karlawish, J; Schur, L; Kruse, D; Davis, CS				Link, Jessica N.; Kropf, Martha; Hirsch, Mark Alexander; Hammond, Flora M.; Karlawish, Jason; Schur, Lisa; Kruse, Douglas; Davis, Christine S.			Assessing Voting Competence and Political Knowledge: Comparing Individuals with Traumatic Brain Injuries and "Average'' College Students	ELECTION LAW JOURNAL			English	Article							DISABILITY; CAPACITY; MODERATE; OUTCOMES; ADULTS; VOTE	The majority of U.S. states have constitutional language, statutes, or court decisions that if applied as worded, could bar individuals with traumatic brain injury (TBI) from voting. Here, we investigate the difference between the voting competence and political knowledge of individuals with TBI and that of "average'' college students using measures of voting capacity and election-specific political knowledge. We recruited 14 individuals with TBI who are participating in a larger study on the relationship between disability and political participation at Carolinas Medical Center. We compared their responses to healthy controls (HC) (students at a large public university in North Carolina; n = 22) on voting competency and political knowledge using the Competency Assessment Tool for Voting (designed by Appelbaum, Bonnie, and Karlawish), as well as measures of 2008 election information and questions drawn from the United States Citizen and Immigration Services citizenship exam. To the best of our knowledge, this is the first study to compare election-specific knowledge of persons with TBI and HCs. We find that those with TBI scored similarly to the healthy controls on competence to vote and election-specific knowledge. We conclude suffrage laws should not be based on overly broad, general assumptions regarding the cognitive capacity of citizens, but on whether or not they express a desire to vote.	[Link, Jessica N.; Kropf, Martha] Univ North Carolina Charlotte, Dept Polit Sci & Publ Adm, 9201 Univ City Blvd,440 Fretwell Hall, Charlotte, NC 28223 USA; [Hirsch, Mark Alexander] Carolinas Rehabil Charlotte, Charlotte, NC USA; [Hammond, Flora M.] Carolinas Rehabil, Traumat Brain Injury Model Syst Project, Charlotte, NC USA; [Karlawish, Jason] Univ Penn, Div Geriatr, Ralston Penn Ctr, Med, Philadelphia, PA 19104 USA; [Schur, Lisa; Kruse, Douglas] Rutgers Univ New Brunswick, Sch Management & Labor Relat, New Brunswick, NJ USA; [Davis, Christine S.] Univ North Carolina Charlotte, Dept Commun Studies, Charlotte, NC 28223 USA		Kropf, M (corresponding author), Univ North Carolina Charlotte, Dept Polit Sci & Publ Adm, 9201 Univ City Blvd,440 Fretwell Hall, Charlotte, NC 28223 USA.	mekropf@uncc.edu	Kruse, Douglas/S-6103-2019; Schur, Lisa/AAH-1855-2020; Hirsch, Mark A./D-2798-2016; Davis, Christine/K-4850-2019	Kruse, Douglas/0000-0002-7121-7616; Schur, Lisa/0000-0002-3752-0777; Hirsch, Mark A./0000-0002-8997-7971; 	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD055202-01, HD055202-02S1]; Carolinas HealthCare Foundation, Charlotte, North Carolina	This study was partially supported by National Institutes of Health, grants HD055202-01 and HD055202-02S1, and by a grant from Carolinas HealthCare Foundation, Charlotte, North Carolina.	Appelbaum PS, 2000, PSYCHIATR SERV, V51, P849, DOI 10.1176/appi.ps.51.7.849; Appelbaum PS, 2005, AM J PSYCHIAT, V162, P2094, DOI 10.1176/appi.ajp.162.11.2094; Arnoldy B., 2006, CHRISTIAN SCI MONITO; Baldwin ML, 2006, ELGAR ORIG REF, P119; Berinsky AJ, 2011, POLIT BEHAV, V33, P357, DOI 10.1007/s11109-010-9134-9; Berry, 1993, UNDERSTANDING REGRES, DOI 10.4135/9781412986427; BIAA (Brain Injury Association of America), 2011, BIAA AD NEW TBI DEF; Carpini MX, 1993, AM J POLIT SCI, P1179, DOI DOI 10.2307/2111549; Carpini MXD., 1997, WHAT AM KNOW POLITIC; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Corrigan JD, 2008, JAMA-J AM MED ASSOC, V300, P720, DOI 10.1001/jama.300.6.720; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Davis C., 2010, BRAIN INJURY, V24, P208; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Elovic E, 1999, TOP SPINAL CORD INJ, V5, P1, DOI DOI 10.1310/V75J-RE76-20GH-X7BY; Etzioni A, 2007, POLIT QUART, V78, P353, DOI 10.1111/j.1467-923X.2007.00864.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Galston WA, 2004, PS-POLIT SCI POLIT, V37, P263, DOI 10.1017/S1049096504004202; GENTILINI M, 1989, MILD HEAD INJURY, P163; GREEN BB, 1980, POLITY, V13, P184, DOI 10.2307/3234580; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Hirsch Mark A., 2010, 2010 MIDW POL SCI AS; Hoofien D, 2004, J CLIN EXP NEUROPSYC, V26, P278, DOI 10.1076/jcen.26.2.278.28084; Hurme S. B., 2007, MCGEORGE LAW REV, V38, P931; Johnson Bill, 2008, ROCKY MOUNTAIN NEWS; Karlan Pamela, 2007, MCGEORGE LAW REV, V38, P917; Karlawish JHT, 2008, J AGING SOC POLICY, V20, P65, DOI 10.1300/J031v20n01_04; Karlawish JHT, 2002, NEUROLOGY, V58, P1100, DOI 10.1212/WNL.58.7.1100; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Lowenheim O, 2009, SECUR DIALOGUE, V40, P145, DOI 10.1177/0967010609103074; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mondak JJ, 2004, J POLIT, V66, P492, DOI 10.1111/j.1468-2508.2004.00161.x; Mondak JJ, 2001, POLIT BEHAV, V23, P199, DOI 10.1023/A:1015015227594; Raad R, 2009, PSYCHIAT SERV, V60, P624, DOI 10.1176/appi.ps.60.5.624; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Schriner K, 1997, PUBLIUS J FEDERALISM, V27, P75, DOI 10.1093/oxfordjournals.pubjof.a029929; Schriner K., 2005, DESERVING ENTITLED S; Schur L, 2002, POLIT RES QUART, V55, P167, DOI 10.1177/106591290205500107; SCHUR L, 1998, J DISABIL POLICY STU, V9, P3, DOI DOI 10.1177/104420739800900202; Schur LA, 2000, SOC SCI QUART, V81, P571; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wolfinger R. E., 1980, WHO VOTES; Yuker H, 1988, ATTITUDES PERSONS DI; [No title captured]	53	3	3	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1533-1296	1557-8062		ELECT LAW J	Elect. Law J.	MAR	2012	11	1					52	69		10.1089/elj.2011.0121			18	Law; Political Science	Emerging Sources Citation Index (ESCI)	Government & Law	V1Y9P	WOS:000217362400005					2022-02-06	
J	Matthes, G; Bernhard, M; Kanz, KG; Waydhas, C; Fischbacher, M; Fischer, M; Bottiger, BW				Matthes, G.; Bernhard, M.; Kanz, K. G.; Waydhas, C.; Fischbacher, M.; Fischer, M.; Boettiger, B. W.			Emergency anesthesia, airway management and ventilation in major trauma. Background and key messages of the interdisciplinary S3 guidelines for major trauma patients	UNFALLCHIRURG			German	Article						Multiple trauma; Airway management; Endotracheal intubation; Capnography; Emergency anesthesia	RAPID-SEQUENCE INTUBATION; ADVANCED LIFE-SUPPORT; HOSPITAL ENDOTRACHEAL INTUBATION; CRITICALLY-ILL PATIENTS; IN-LINE STABILIZATION; TIDAL CARBON-DIOXIDE; ACUTE LUNG INJURY; TRACHEAL INTUBATION; BRAIN-INJURY; PREHOSPITAL AIRWAY	Patients with multiple trauma presenting with apnea or a gasping breathing pattern (respiratory rate < 6/min) require prehospital endotracheal intubation (ETI) and ventilation. Additional indications are hypoxia (SpO2 < 90% despite oxygen insufflation and after exclusion of tension pneumothorax), severe traumatic brain injury [Glasgow Coma Scale (GCS) < 9], trauma-associated hemodynamic instability [systolic blood pressure (SBP) < 90 mmHg] and severe chest trauma with respiratory insufficiency (respiratory rate > 29/min). The induction of anesthesia after preoxygenation is conducted as rapid sequence induction (analgesic, hypnotic drug, neuromuscular blocking agent). With the availability of ketamine as a viable alternative, the use of etomidate is not encouraged due to its side effects on adrenal function. An electrocardiogram (ECG), blood pressure measurement and pulse oximetry are needed to monitor the emergency anesthesia and the secured airway. Capnography is absolutely mandatory to confirm correct placement of the endotracheal tube and to monitor tube dislocations as well as ventilation in the prehospital and hospital setting. Because airway management is often complicated in trauma patients, alternative devices need to be available preclinical and a fiber-optic endoscope should be available within the hospital. Use of these alternative measures for airway management and ventilation should be considered at the latest after a maximum of three unsuccessful endotracheal intubation attempts. Emergency medical service (EMS) physicians should to be trained in emergency anesthesia, ETI and alternative methods of airway management on a regular basis. Within hospitals ETI, emergency anesthesia and ventilation are to be conducted by trained and experienced anesthesiologists. When a difficult airway or induction of anesthesia is expected, endotracheal intubation should be supervised or conducted by an anesthesiologist. Normoventilation should be the goal of mechanical ventilation. After arrival in the resuscitation room the ventilation will be controlled and guided with the help of arterial blood gas analyses. After temporary removal of a cervical collar, the cervical spine needs to be immobilized by means of manual in-line stabilization when securing the airway.	[Boettiger, B. W.] Univ Klinikum Koln AoR, Klin Anasthesiol & Operat Intens Med, D-50937 Cologne, Germany; [Matthes, G.] Univ Greifswald, D-17487 Greifswald, Germany; [Matthes, G.] Unfallkrankenhaus Berlin, Klin Unfallchirurg & Orthopadie, Berlin, Germany; [Bernhard, M.] Univ Klinikum Leipzig, Zent Notaufnahme Notaufnahmestn, Leipzig, Germany; [Kanz, K. G.] Klinikum Univ Munchen Innenstadt, Chirurg Klin & Poliklin, Munich, Germany; [Waydhas, C.; Fischbacher, M.] Univ Klinikum Essen, Unfallchirurg Klin, Essen, Germany; [Fischer, M.] Kliniken Landkreises Goppingen gGmbH, Klin Eichert, Klin Anasthesiol Operat Intens Med Notfallmed & S, Goppingen, Germany		Bottiger, BW (corresponding author), Univ Klinikum Koln AoR, Klin Anasthesiol & Operat Intens Med, Kerpener Str 62, D-50937 Cologne, Germany.	bernd.boettiger@uk-koeln.de					Adnet F, 1998, ANN EMERG MED, V32, P454, DOI 10.1016/S0196-0644(98)70175-1; Albrecht E, 2006, EUR J TRAUMA, V32, P516, DOI DOI 10.1007/S00068-006-6001-Z; AMATO MBP, 1995, AM J RESP CRIT CARE, V152, P1835, DOI 10.1164/ajrccm.152.6.8520744; American College of Surgeons Committee on Trauma, 2008, ATLS STUD COURS MAN; [Anonymous], 2004, DIN TASCH, pS385; [Anonymous], 2004, 17891999 EN, P244; Arbabi S, 2004, J TRAUMA, V56, P1029, DOI 10.1097/01.TA.0000123036.20919.4B; Aufmkolk M, 2003, UNFALLCHIRURG, V106, P746, DOI 10.1007/s00113-003-0640-7; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Becke K, 2007, ANASTH INTENSIVMED, V9, P624; Berlac P, 2008, ACTA ANAESTH SCAND, V52, P897, DOI 10.1111/j.1399-6576.2008.01673.x; Berlot G, 2009, EUR J EMERG MED, V16, P312, DOI 10.1097/MEJ.0b013e32832d3aa1; Bernhard M, 2011, EUR J ANAESTH, V28, P75, DOI 10.1097/EJA.0b013e328342325a; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Bonhomme V, 2009, CURR OPIN ANESTHESIO, V22, P579, DOI 10.1097/ACO.0b013e32832e7adb; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P87; Braun U, 2004, ANASTH INTENSIVMED, V45, P302; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Caplan RA, 2003, ANESTHESIOLOGY, V98, P1269; Caulfield EV, 2009, J TRAUMA, V66, P1577, DOI 10.1097/TA.0b013e3181a3931d; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 1997, J TRAUMA, V42, pS4, DOI 10.1097/00005373-199705001-00002; Cobas MA, 2009, ANESTH ANALG, V109, P489, DOI 10.1213/ane.0b013e3181aa3063; Cogbill TH, 2008, J TRAUMA, V65, P994, DOI 10.1097/TA.0b013e318184ce12; Combes X, 2006, ACAD EMERG MED, V13, P828, DOI 10.1197/j.aem.2006.02.016; Cotton BA, 2008, ARCH SURG-CHICAGO, V143, P62, DOI 10.1001/archsurg.143.1.62; Cudnik MT, 2007, PREHOSP EMERG CARE, V11, P224, DOI 10.1080/10903120701205208; Davis DP, 2010, J TRAUMA, V69, P294, DOI 10.1097/TA.0b013e3181dc6c7f; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Deakin CD, 2010, RESUSCITATION, V81, P1305, DOI 10.1016/j.resuscitation.2010.08.017; Deakin CD, 2010, RESUSCITATION, V81, P539, DOI 10.1016/j.resuscitation.2010.02.001; Deutsche Gesellschaft fur Anasthesiologie und Intensivmedizin und Berufsverbande Deutscher Anasthesisten, 2007, ANASTH INTENSIVMED, V39, P470; Dewar D, 2009, INJURY, V40, P912, DOI 10.1016/j.injury.2009.05.024; DIN-Taschenbuch 257Rettungsdienst, 2004, 75079200208 DIN, pS177; DiRusso SM, 2005, J TRAUMA, V59, P84, DOI 10.1097/01.TA.0000171462.28379.F3; Dunham CM, 2003, J TRAUMA, V55, P162, DOI 10.1097/01.ta.0000083335.93868.2c; Dupanovic M, 2010, CURR OPIN ANESTHESIO, V23, P276, DOI 10.1097/ACO.0b013e3283360b4f; Eckstein M, 2000, J TRAUMA, V48, P643, DOI 10.1097/00005373-200004000-00010; Eich C, 2009, RESUSCITATION, V80, P888, DOI 10.1016/j.resuscitation.2009.05.008; El-Orbany M, 2010, ANESTH ANALG, V110, P1318, DOI 10.1213/ANE.0b013e3181d5ae47; Fakhry SM, 2006, J TRAUMA, V60, P997, DOI 10.1097/01.ta.0000217285.94057.5e; Franschman G, 2009, RESUSCITATION, V80, P1147, DOI 10.1016/j.resuscitation.2009.06.029; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Genzwurker H, 2007, ANAESTHESIST, V56, P665, DOI 10.1007/s00101-007-1194-9; Genzwurker HV, 2008, EUROANAESTHESIA; Gries A, 2008, ANAESTHESIST, V57, P562, DOI 10.1007/s00101-008-1373-3; Grmec S, 2004, EMERG MED J, V21, P518, DOI 10.1136/emj.2002.001974; Hager DN, 2005, AM J RESP CRIT CARE, V172, P1241, DOI 10.1164/rccm.200501-048CP; Heidegger T, 2005, BEST PRACT RES-CLIN, V19, P661, DOI 10.1016/j.bpa.2005.07.001; Helm M, 2006, BRIT J ANAESTH, V96, P67, DOI 10.1093/bja/aei275; Helm M, 2002, BRIT J ANAESTH, V88, P345, DOI 10.1093/bja/88.3.345; Henderson JJ, 2004, ANAESTHESIA, V59, P675, DOI 10.1111/j.1365-2044.2004.03831.x; Hildreth AN, 2008, J TRAUMA, V65, P573, DOI 10.1097/TA.0b013e31818255e8; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; Keel, 2006, EUR J TRAUMA, V32, P387; Keul W, 2004, ANAESTHESIST, V53, P978, DOI 10.1007/s00101-004-0734-9; Klemen P, 2006, ACTA ANAESTH SCAND, V50, P1250, DOI 10.1111/J.1399-6576.2006.01039.X; Konrad C, 1998, ANESTH ANALG, V86, P635; Lackner CK, 2002, NOTFALL RETTUNGSMED, V5, P430; Lavery GG, 2008, CRIT CARE MED, V36, P2163, DOI 10.1097/CCM.0b013e31817d7ae1; Lecky F, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001429.pub2; Lee SW, 2009, J TRAUMA, V67, P526, DOI 10.1097/TA.0b013e3181866432; Liberman M, 2007, CURR OPIN CRIT CARE, V13, P691, DOI 10.1097/MCC.0b013e3282f1e77e; Manoach S, 2007, ANN EMERG MED, V50, P236, DOI 10.1016/j.annemergmed.2007.01.009; Morris C, 2009, ANAESTHESIA, V64, P532, DOI 10.1111/j.1365-2044.2008.05835.x; Mort TC, 2005, CRIT CARE MED, V33, P2672, DOI 10.1097/01.CCM.0000187131.67594.9E; Mort TC, 2004, ANESTH ANALG, V99, P607, DOI 10.1213/01.ANE.0000122825.04923.15; Mort TC, 2005, J CLIN ANESTH, V17, P255, DOI 10.1016/j.jclinane.2005.02.004; Mort TC, 2009, CRIT CARE MED, V37, P68, DOI 10.1097/CCM.0b013e318192845e; Muakkassa FF, 2010, J TRAUMA, V68, P1305, DOI 10.1097/TA.0b013e3181dcd137; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; Mutzbauer TS, 2008, NOTFALL RETTUNGSMED, V11, P310, DOI 10.1007/s10049-008-1038-4; NAEMT, 2009, PRAKL TRAUM PHTLS KO; Newton A, 2008, J TRAUMA, V64, P487, DOI 10.1097/TA.0b013e31802e7476; Paal P, 2010, RESUSCITATION, V81, P148, DOI 10.1016/j.resuscitation.2009.10.023; Pelucio M, 1997, ACAD EMERG MED, V4, P563, DOI 10.1111/j.1553-2712.1997.tb03579.x; Ricard-Hibon A, 2002, EUR J ANAESTH, V19, P361, DOI 10.1017/S0265021502000583; RIVARA FP, 1989, JAMA-J AM MED ASSOC, V261, P566, DOI 10.1001/jama.261.4.566; Ruchholtz S, 2008, DTSCH ARZTEBL INT, V105, P225, DOI 10.3238/arztebl.2008.0225; Ruchholtz S, 2002, J TRAUMA, V52, P879, DOI 10.1097/00005373-200205000-00010; Santoni BG, 2009, ANESTHESIOLOGY, V110, P24, DOI 10.1097/ALN.0b013e318190b556; Schlechtriemen T, 2004, NOTFALL RETTUNGSMED, V7, P231; Schmidt UH, 2008, ANESTHESIOLOGY, V109, P973, DOI 10.1097/ALN.0b013e31818ddb90; Shah CV, 2008, CRIT CARE MED, V36, P2309, DOI 10.1097/CCM.0b013e318180dc74; Silvestri S, 2005, ANN EMERG MED, V45, P497, DOI 10.1016/j.annemergmed.2004.09.014; Sing RF, 1998, AM J EMERG MED, V16, P598, DOI 10.1016/S0735-6757(98)90227-3; Sise MJ, 2009, J TRAUMA, V66, P32, DOI 10.1097/TA.0b013e318191bb0c; Sloane C, 2000, J EMERG MED, V19, P259, DOI 10.1016/S0736-4679(00)00235-3; Stahel PF, 2008, INTENS CARE MED, V34, P402, DOI 10.1007/s00134-007-0889-3; Steinmann D, 2009, ANAESTHESIST, V58, P695, DOI 10.1007/s00101-009-1548-6; Stephens CT, 2009, ANESTH ANALG, V109, P866, DOI 10.1213/ane.0b013e3181ad87b0; Stiell IG, 2008, CAN MED ASSOC J, V178, P1141, DOI 10.1503/cmaj.071154; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Thierbach A, 2004, ANAESTHESIST, V53, P543, DOI 10.1007/s00101-004-0679-z; Timmermann A, 2007, ANAESTHESIST, V56, P328, DOI 10.1007/s00101-007-1153-5; Timmermann A, 2009, ANAESTHESIST, V58, P663, DOI 10.1007/s00101-009-1570-8; Timmermann A, 2010, ANASTH INTENSIVMED, V51, P5; Timmermann A, 2007, ANESTH ANALG, V104, P619, DOI 10.1213/01.ane.0000253523.80050.e9; Timmermann A, 2006, RESUSCITATION, V70, P179, DOI 10.1016/j.resuscitation.2006.01.010; Tracy S, 2006, J TRAUMA, V61, P1162, DOI 10.1097/01.ta.0000243887.90697.06; TRUPKA A, 1995, UNFALLCHIRURG, V98, P111; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; Wang H E, 2001, Prehosp Emerg Care, V5, P134, DOI 10.1080/10903120190939995; Wang HE, 2006, ACAD EMERG MED, V13, P372, DOI 10.1197/j.aem.2005.11.001; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wang HE, 2006, ANN EMERG MED, V47, P532, DOI 10.1016/j.annemergmed.2006.01.016; Wang HE, 2009, RESUSCITATION, V80, P50, DOI 10.1016/j.resuscitation.2008.08.016; Warner KJ, 2008, J TRAUMA, V64, P341, DOI 10.1097/TA.0b013e318160dfb3; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Warner KJ, 2009, J TRAUMA, V67, P45, DOI 10.1097/TA.0b013e3181a92a70; Warner KJ, 2009, J TRAUMA, V66, P26, DOI 10.1097/TA.0b013e3181957a25; Wayne M A, 1999, Prehosp Emerg Care, V3, P107, DOI 10.1080/10903129908958916; Wolfl CG, 2009, UNFALLCHIRURG, V112, P846, DOI 10.1007/s00113-009-1685-z	116	3	3	1	18	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg	MAR	2012	115	3					251	264		10.1007/s00113-011-2138-z			14	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	921LR	WOS:000302479600010	22406918				2022-02-06	
J	Tessitore, E; Schatlo, B; Schaller, C; Schonauer, C				Tessitore, E.; Schatlo, B.; Schaller, C.; Schonauer, C.			Fibrillary Structure is Key for Hemostasis: A Similar Effect of Collagen Fleece and Oxidized Cellulose on Experimental Hemorrhagic Brain Injury	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						traumatic brain injury; local haemostasis; oxidized regenerated cellulose; collagen fleece; fibrillar form	TISSUE REACTION; AGENTS; EFFICACY; NEUROSURGERY; OPERATIONS; GELATIN; MODEL	Background The choice of the ideal hemostatic agent for intraoperative cerebral bleeding is under continuous debate. Our aim was to assess the influence of such materials on bleeding time in hemorrhagic cerebral contusions. We compared oxidized regenerated cellulose in fibrillar form (ORC) to microfibrillar collagen fleece (CF) in an experimental study. Methods N=50 Sprague Dawley rats underwent a bilateral craniectomy. 3 separate standardized superficial cortical impacts were inflicted using a high-speed drill. Immediately after lesion placement, each of the 3 lesions was covered with (a) nothing (control), (b) ORC, or (c) CF. We observed the 3 lesions with a surgical microscope. The bleeding times were recorded for each cerebral lesion and compared using ANOVA test. Results All traumatic lesions produced significant bleeding. The statistical analysis showed a clear reduction in bleeding time for groups treated with either ORC or CF compared to the control group. Lesions covered with ORC and CF showed no significant difference with regard to bleeding time. Conclusions ORC and CF significantly reduce blood loss from hemorrhagic contusions. Our data suggest that they effectively reduce bleeding time. We advocate the use of hemostatic material for limiting bleeding from superficial cortical lesions.	[Tessitore, E.; Schatlo, B.; Schaller, C.] Univ Geneva, Med Ctr, Fac Med, Dept Neurosurg, CH-1211 Geneva, Switzerland; [Schonauer, C.] S Maria delle Grazie, Neurosurg Unit, Naples, Italy		Tessitore, E (corresponding author), Univ Geneva, Med Ctr, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva, Switzerland.	enrico.tessitore@hcuge.ch	SCHATLO, Bawarjan/F-4285-2010; schonauer, claudio/AAG-5695-2019	schonauer, claudio/0000-0002-8644-3640			ACHAUER B M, 1982, Journal of Microsurgery, V3, P242; Alpaslan C, 1997, BRIT J ORAL MAX SURG, V35, P129, DOI 10.1016/S0266-4356(97)90689-6; ARNAD AG, 1986, NEUROSURGERY, V18, P223, DOI 10.1227/00006123-198602000-00022; Cushing H, 1911, ANN SURG, V54, P1, DOI 10.1097/00000658-191107000-00002; Cushing H, 1928, GYNECOL OBSTET, V47, P752; Ereth MH, 2008, NEUROSURGERY, V63, P369, DOI 10.1227/01.NEU.0000327031.98098.DD; FRILEUX P, 1991, ANN CHIR, V45, P261; Gerlach R, 2009, ACTA NEUROCHIR, V151, P873, DOI 10.1007/s00701-009-0409-z; Horsley V, 1892, BMJ-BRIT MED J, V1, P1165; Kruger J, 1992, Zentralbl Neurochir, V53, P33; Levy ML, 1997, NEUROSURGERY, V41, P701, DOI 10.1097/00006123-199709000-00045; LIGHT RU, 1945, ARCH SURG-CHICAGO, V51, P69, DOI 10.1001/archsurg.1945.01230040074001; PERTUISET B, 1982, NEUROCHIRURGIE, V28, P41; PETERSEN JK, 1984, INT J ORAL MAXILLOF, V13, P406; RACCUIA JS, 1992, AM J SURG, V163, P234, DOI 10.1016/0002-9610(92)90108-4; SCHER KS, 1982, SURGERY, V91, P301; Schonauer C, 2004, EUR SPINE J, V13, pS89, DOI 10.1007/s00586-004-0727-z; Tan TC, 2002, NEUROSURGERY, V50, P607, DOI 10.1097/00006123-200203000-00032; UIHLEIN A, 1945, SURG GYNECOL OBSTET, V80, P470; VOORMOLEN JHC, 1987, NEUROSURGERY, V20, P702, DOI 10.1227/00006123-198705000-00005; Wagner WR, 1996, J SURG RES, V66, P100, DOI 10.1006/jsre.1996.0379; YOKOO A, 1982, J NEUROSURG, V57, P323, DOI 10.3171/jns.1982.57.3.0323	22	3	3	2	8	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	MAR	2012	73	2					89	92		10.1055/s-0032-1309064			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	175UM	WOS:000321259100005	22467482				2022-02-06	
J	Saez, LM; Casanova, LJG; Fazio, EA; Alvarez, AG				Martinez Saez, Luis; Guerra Casanova, Luis Jesus; Alcala Fazio, Enrique; Garcia Alvarez, Antonio			Behaviour of high bumper vehicles in pedestrian scenarios with full finite element human models	INTERNATIONAL JOURNAL OF CRASHWORTHINESS			English	Article						Pedestrian safety; pedestrian protection; leg injuries; THUMS; SUV	KNEE-BENDING ANGLE; MECHANISM ANALYSIS; INJURY	The European pedestrian regulations (formerly Directive 2003/102 and currently Regulation 2009/631 and recently modified by Commission Regulation [EU] No. 2011/459) have always approached the protection of lower extremities in pedestrian accidents with tests in the front part of the vehicle using rigid impactors. This approach offers a lot of advantage regarding the repeatability, robustness and reproducibility that these tests need but on the contrary decouple the injury occurrence through the different body areas. It is widely supported to approach pedestrian head protection and lower extremities protection in separate tests; however, there is not such consensus in decoupling pedestrian lower leg injuries from the upper leg injuries, especially in the case of high bumper vehicles. The objective of this paper is to look into the details of this close dependence through a set of simulations with THUMS 50th percentile male pedestrian finite element human model impacted by a wide set of high bumper vehicles. The analysis of both the kinematics and the injury occurrence in these scenarios has shown the strong coupling between the upper and lower leg injuries for this vehicle fleet, requiring therefore assessing both type of injuries at the same time.	[Martinez Saez, Luis; Guerra Casanova, Luis Jesus; Alcala Fazio, Enrique; Garcia Alvarez, Antonio] Tech Univ Madrid UPM INSIA, Univ Inst Automobile Res, Madrid, Spain		Saez, LM (corresponding author), Tech Univ Madrid UPM INSIA, Univ Inst Automobile Res, Madrid, Spain.	luis.martinez@upm.es	SAEZ, LUIS MARTINEZ/J-7201-2012; Garcia Alvarez, Antonio/I-6659-2015; Alcala, Enrique/H-9776-2015	SAEZ, LUIS MARTINEZ/0000-0001-6594-4406; Garcia Alvarez, Antonio/0000-0003-0495-2781; Alcala, Enrique/0000-0001-8690-9968	UE [TIP3-CT-2004-506503]	The work presented in this paper has been performed under the Advanced PROtection Systems Project (APROSYS) funded under the Sixth Framework Programme of the UE, contract number TIP3-CT-2004-506503. The authors would like to give special thanks to Toyota Motor Europe for their valuable contribution for the validation of the LS-DYNA simplified model.	[Anonymous], 2003, OFFICIAL J EUROPEA L, V321; [Anonymous], 2011, OFFICIAL J EUROPEA L, V124; [Anonymous], 2009, OFFICIAL J EUROPEA L, V195; Arnoux PJ, 2008, INT J CRASHWORTHINES, V13, P653, DOI 10.1080/13588260802305089; Ballesteros MF, 2004, ACCIDENT ANAL PREV, V36, P73, DOI 10.1016/S0001-4575(02)00129-X; Bose D, 2007, INT J CRASHWORTHINES, V12, P381, DOI 10.1080/13588260701483185; EEVC Working Group 17, 2002, IMPR TEST METH EV PE; European Enhanced Vehicle-safety Committee: Working Group 10 on Pedestrian Protection, 1994, PROP METH EV PED PRO; Green J., 1998, 37 EEVC WG17; Ishikawa H., 1997, SAE T, V106, P3682; Ishikawa H., 1999, SAE T, V108, P1159; Kress T.A., 1990, 1990 INT IRCOBI C P; Lawrence G., 1998, 16 INT TECHN C ENH S; Maeno T., 2001, 17 INT TECHN C ENH S; Martinez L., 2008, 2008 INT IRCOBI C P; Matsui Y, 2006, INT J CRASHWORTHINES, V11, P97, DOI 10.1533/ijcr.2005.0394; Matsui Y, 2005, ACCIDENT ANAL PREV, V37, P633, DOI 10.1016/j.aap.2005.03.005; Matsui Y, 2003, INT J CRASHWORTHINES, V8, P179, DOI 10.1533/ijcr.2003.0228; Matsui Y., 1998, 16 INT TECHN C ENH S; Matsui Y., 1999, 999 INT IRCOBI C P S; Matsui Yasuhiro, 2004, Traffic Inj Prev, V5, P76, DOI 10.1080/15389580490430272; Nagasaka Kei, 2003, Traffic Inj Prev, V4, P345, DOI 10.1080/714040492; Sakurai M., 1994, 14 INT TECHN C ENH S; Takahashi Y., 2000, 44 STAPP CAR CRASH C; Takeuchi K., 1998, 1998 INT IRCOBI C P; Yasuki T, 2007, INT J CRASHWORTHINES, V12, P645, DOI 10.1080/13588260701619481; Yasuki T., 2005, 19 INT TECHN C ENH S; Yasuki T, 2007, INT J CRASHWORTHINES, V12, P329, DOI 10.1080/13588260701432984	28	3	3	2	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1358-8265	1754-2111		INT J CRASHWORTHINES	Int. J. Crashworthiness	FEB	2012	17	1					1	10		10.1080/13588265.2011.616117			10	Engineering, Manufacturing; Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	896DR	WOS:000300546100001					2022-02-06	
J	Adamson, AM; O'Toole, K; Petersen, C				Adamson, Amanda M.; O'Toole, Kathleen; Petersen, Catherine			Establishing a Pediatric Cognitive Rehabilitation Program: Insurance Issues and Clinical Rationale	CLINICAL NEUROPSYCHOLOGIST			English	Article						Cognitive rehabilitation; Attention; Insurance reimbursement	TRAUMATIC BRAIN-INJURY; REMEDIATION PROGRAM; CHILDREN; CHILDHOOD; CANCER	Technological and medical advances have greatly improved survival rates for many disorders; therefore, more attention is being given to functional outcomes in individuals who have been diagnosed with neurological diseases or disorders. One example of such an endeavor consists of a cognitive rehabilitation program to improve attentional abilities. The current study uses a modification of the original Cognitive Remediation Program to address attentional deficits in children with a variety of neurological disorders. The abbreviated program is designed as a focused, time-limited program that can be easily implemented in inpatient, partial day, or outpatient medical settings using third party payment to fund the program. This article seeks to inform psychologists about how to establish a cognitive rehabilitation program with emphasis placed on providing information about insurance reimbursement and billing procedures. Information is presented regarding billing codes, materials required for reimbursement, the denial/approval process, and percent of the Usual Customary Reasonable charge that was covered. Recommendations to improve the timeliness and efficiency of the reimbursement process, as well as to increase the amount of reimbursement, are highlighted. Directions for future research, including continued documentation of the effectiveness of cognitive rehabilitation programs to establish credibility for procurement of third party payment, are also offered.	[Adamson, Amanda M.] Ctr Pediat Neuropsychol, Palm Beach Gardens, FL USA; [O'Toole, Kathleen] Childrens Healthcare Atlanta, Dept Neuropsychol, Atlanta, GA USA; [Petersen, Catherine] Argosy Univ, Atlanta, GA USA		Adamson, AM (corresponding author), 500 Village Sq Crossing,Suite 103, Palm Beach Gardens, FL 33410 USA.	drmax@neuropsych4kids.com					Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Butler RW, 2008, J CONSULT CLIN PSYCH, V76, P367, DOI 10.1037/0022-006X.76.3.367; Butler RW, 2007, PEDIATRIC NEUROPSYCHOLOGICAL INTERVENTION: A CRITICAL REVIEW OF SCIENCE AND PRACTICE, P444; Butler RW, 2008, DEV DISABIL RES REV, V14, P251, DOI 10.1002/ddrr.33; Butler RW, 2002, J INT NEUROPSYCH SOC, V8, P115, DOI 10.1017/S1355617701020112; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Conners, 2004, CONNERS CONTINUOUS P; EDLUND W, 2004, AAN CLIN PRACTICE GU; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Gioia GA IP, 2000, BEHAV RATING INVENTO; Glang A, 2008, J HEAD TRAUMA REHAB, V23, P243, DOI 10.1097/01.HTR.0000327256.46504.9f; Kerns KA, 1999, DEV NEUROPSYCHOL, V16, P273, DOI 10.1207/S15326942DN1602_9; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Luton LM, 2011, BRAIN INJURY, V25, P409, DOI 10.3109/02699052.2011.558044; Manly T., 1998, TEST EVERYDAY ATTENT; Meichenbaum, 1977, COGNITIVE BEHAV MODI; Preston AS, 2009, J LEARN DISABIL-US, V42, P240, DOI 10.1177/0022219408331042; Reynolds C. R., 2006, BASC 2 BEHAV ASSESSM; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Sohlberg MM., 1999, ATTENTION PROCESS TR; Sparrow EP, 2007, PEDIATRIC NEUROPSYCHOLOGICAL INTERVENTION: A CRITICAL REVIEW OF SCIENCE AND PRACTICE, P30; Thomson JB, 1994, PAY ATTENTION; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; [No title captured]	25	3	3	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2012	26	1					59	73		10.1080/13854046.2011.639313			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	922JN	WOS:000302543300006	22196481				2022-02-06	
J	Barnes, S				Barnes, Scott			'Planning' talk and traumatic brain injury: An exploratory application of conversation analysis	JOURNAL OF INTERACTIONAL RESEARCH IN COMMUNICATION DISORDERS			English	Article						CONVERSATION ANALYSIS; TASK-BASED INTERACTION; TRAUMATIC BRAIN INJURY	COMMUNICATION; DISCOURSE; PEOPLE; ENTITLEMENT; QUESTIONS; APHASIA	Task-based activities of daily living are often a target of assessment and intervention for people with acquired communication disorders, but their interactional organization has not undergone detailed investigation. This study explores a task-based interaction focused on 'planning' involving a man with TBI and his friend. It analyses a half hour recording in which they planned errands that would need to be completed before the man with TBI departed for an overseas holiday. Conversation analytic single episode analysis is used. Discussion focuses on the phases and actions that were used during planning talk. Some speculation about the utility of these practices for planning with a person with TBI is also put forward. Finally, it is suggested that, pending further investigation, a clinical focus on the actions described in the present study might prove useful for structuring and facilitating the participation of people with TBI in routine task-based activities.	[Barnes, Scott] Univ Sydney, Ctr Clin Res Excellence Aphasia Rehabil, Sydney, NSW, Australia		Barnes, S (corresponding author), Univ Sydney, Ctr Clin Res Excellence Aphasia Rehabil, Sydney, NSW, Australia.	scott.barnes@sydney.edu.au		Barnes, Scott/0000-0001-5299-0550			Adamovich B. B., 1992, SCALES COGNITIVE ABI; Asmuss B, 2012, DISCOURSE STUD, V14, P67, DOI 10.1177/1461445611427215; Barnes S. E., 2012, J INTERACTIONAL RES, V3, P179; Barnes S. E., APHASIOLOGY IN PRESS; Beeke Suzanne, 2007, Seminars in Speech and Language, V28, P136, DOI 10.1055/s-2007-970571; Body R, 2005, CLIN LINGUIST PHONET, V19, P379, DOI 10.1080/02699200400027189; Bolden GB, 2008, RES LANG SOC INTERAC, V41, P302, DOI 10.1080/08351810802237909; Bottari C, 2011, BRAIN INJURY, V25, P1306, DOI 10.3109/02699052.2011.624570; Craven A, 2010, DISCOURSE STUD, V12, P419, DOI 10.1177/1461445610370126; Davidson B, 2003, APHASIOLOGY, V17, P243, DOI 10.1080/729255457; Denman A, 2011, DISABIL REHABIL, V33, P243, DOI 10.3109/09638288.2010.511686; Ford Cecilia E., 2002, LANGUAGE TURN SEQUEN, P14; Fox BA, 2010, RES LANG SOC INTERAC, V43, P133, DOI 10.1080/08351811003751680; Gardner R, 2001, LISTENERS TALK RESPO; Goodwin C, 1992, RETHINKING CONTEXT L, P147; Goodwin C., 2003, CONVERSATION BRAIN D; Heritage J, 2005, SOC PSYCHOL QUART, V68, P15, DOI 10.1177/019027250506800103; HERITAGE J, 1994, LANG SOC, V23, P1, DOI 10.1017/S0047404500017656; Heritage J., 1984, GARFINKEL ETHNOMETHO; Heritage J, 2012, RES LANG SOC INTERAC, V45, P30, DOI 10.1080/08351813.2012.646685; HOLLAND AL, 1982, J SPEECH HEAR DISORD, V47, P50, DOI 10.1044/jshd.4701.50; Kaplan E, 1983, BOSTON NAMING TEST; Kertesz A., 2006, W APHASIA BATTERY RE; Lock S, 2001, SUPPORTING PARTNERS; Parr S, 2007, APHASIOLOGY, V21, P98, DOI 10.1080/02687030600798337; Pomerantz A., 1984, STRUCTURES SOCIAL AC, P57, DOI DOI 10.1017/CBO9780511665868.008; Quirk Randolph., 1985, COMPREHENSIVE GRAMMA; Raymond G, 2003, AM SOCIOL REV, V68, P939, DOI 10.2307/1519752; Schegloff E. A., 1973, SEMIOTICA, V8, P289, DOI [10.1515/semi.1973.8.4.289, DOI 10.1515/SEMI.1973.8.4.289]; Schegloff EA, 1996, AM J SOCIOL, V102, P161, DOI 10.1086/230911; SCHEGLOFF EA, 1987, SOC PSYCHOL QUART, V50, P101, DOI 10.2307/2786745; Schegloff EA, 2007, SEQUENCE ORGANIZATION IN INTERACTION: A PRIMER IN CONVERSATION ANALYSIS I, P1, DOI 10.2277/ 0521532795; Snow P, 1997, APHASIOLOGY, V11, P947, DOI 10.1080/02687039708249421; Speer S. A., 2002, DISCOURSE STUD, V4, P511, DOI [10.1177/14614456020040040601, DOI 10.1177/14614456020040040601]; Stivers T, 2005, RES LANG SOC INTERAC, V38, P131, DOI 10.1207/s15327973rlsi3802_1; Stivers T, 2006, LANG SOC, V35, P367, DOI 10.1017/S0047404506060179; Stivers T, 2010, LANG SOC, V39, P1, DOI 10.1017/S0047404509990637; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Waring HZ, 2007, J SOCIOLING, V11, P367, DOI 10.1111/j.1467-9841.2007.00328.x; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005	40	3	3	0	0	EQUINOX PUBLISHING LTD	SHEFFIELD	415, THE WORKSTATION, 15 PATERNOSTER ROW, SHEFFIELD, S1 2BX, ENGLAND	2040-5111	2040-512X		J INTERACT RES COM D	J. Interact. Res. Commun. Disord.		2012	3	2					115	140		10.1558/jircd.v3i2.115			26	Linguistics	Emerging Sources Citation Index (ESCI)	Linguistics	V2W7Q	WOS:000217981300001					2022-02-06	
J	Bolduc-Teasdale, J; Jolicoeur, P; McKerral, M				Bolduc-Teasdale, Julie; Jolicoeur, Pierre; McKerral, Michelle			Multiple ElectrophysiologicalMarkers of Visual-Attentional Processing in a Novel Task Directed toward Clinical Use	JOURNAL OF OPHTHALMOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SHORT-TERM-MEMORY; NEURAL MECHANISMS; LONG-TERM; P3A; DEFICITS; COMPONENT; P300; NEUROPHYSIOLOGY; DISSOCIATION	Individuals who have sustained a mild brain injury (e. g., mild traumatic brain injury or mild cerebrovascular stroke) are at risk to show persistent cognitive symptoms (attention and memory) after the acute postinjury phase. Although studies have shown that those patients perform normally on neuropsychological tests, cognitive symptoms remain present, and there is a need for more precise diagnostic tools. The aim of this study was to develop precise and sensitive markers for the diagnosis of post brain injury deficits in visual and attentional functions which could be easily translated in a clinical setting. Using electrophysiology, we have developed a task that allows the tracking of the processes involved in the deployment of visual spatial attention from early stages of visual treatment (N1, P1, N2, and P2) to higher levels of cognitive processing (no-go N2, P3a, P3b, N2pc, SPCN). This study presents a description of this protocol and its validation in 19 normal participants. Results indicated the statistically significant presence of all ERPs aimed to be elicited by this novel task. This task could allow clinicians to track the recovery of the mechanisms involved in the deployment of visual-attentional processing, contributing to better diagnosis and treatment management for persons who suffer a brain injury.	[Bolduc-Teasdale, Julie; McKerral, Michelle] Ctr Interdisciplinary Res Rehabil, Montreal, PQ H2H 2N8, Canada; [Bolduc-Teasdale, Julie; McKerral, Michelle] Lucie Bruneau Rehabil Ctr, Montreal, PQ H2H 2N8, Canada; [Bolduc-Teasdale, Julie; Jolicoeur, Pierre; McKerral, Michelle] Univ Montreal, Ctr Res Neuropsychol & Cognit, Montreal, PQ H3C 3J7, Canada; [Bolduc-Teasdale, Julie; Jolicoeur, Pierre; McKerral, Michelle] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada		McKerral, M (corresponding author), Ctr Interdisciplinary Res Rehabil, 2275 Laurier Ave E, Montreal, PQ H2H 2N8, Canada.	michelle.mckerral@umontreal.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council (NSERC) of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC); Quebec Rehabilitation Research Network; NSERCNatural Sciences and Engineering Research Council of Canada (NSERC); Canada Fund for Innovation (CFI)Canada Foundation for Innovation; Canada Research Chairs programCanada Research Chairs	This work was supported by the Canadian Institutes of Health Research (scholarship to J. Bolduc-Teasdale), by research funds (awarded to M. Mckerral) from the Natural Sciences and Engineering Research Council (NSERC) of Canada and the Quebec Rehabilitation Research Network, by funding from the NSERC, the Canada Fund for Innovation (CFI), and the Canada Research Chairs program awarded to P. Jolicoeur, and finally by infrastructure support for the Research Centre de for Neuropsychology and Cognition and the Vision Research Network by the Fonds de Recherche en Sante du Quebec (FRSQ).	Brisson B, 2007, NEUROPSYCHOLOGIA, V45, P3038, DOI 10.1016/j.neuropsychologia.2007.05.022; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Carlsson GE, 2004, DISABIL REHABIL, V26, P1373, DOI 10.1080/09638280400000211; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Comerchero MD, 1999, CLIN NEUROPHYSIOL, V110, P24, DOI 10.1016/S0168-5597(98)00033-1; Comerchero MD, 1998, COGNITIVE BRAIN RES, V7, P41, DOI 10.1016/S0926-6410(98)00009-3; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; Eimer M, 1996, ELECTROEN CLIN NEURO, V99, P225, DOI 10.1016/0013-4694(96)95711-9; Elting JW, 2005, CLIN NEUROPHYSIOL, V116, P2606, DOI 10.1016/j.clinph.2005.07.014; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gomez Gonzalez Carlos M., 1994, Brain Topography, V7, P41; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Hagen GF, 2006, INT J PSYCHOPHYSIOL, V59, P8, DOI 10.1016/j.ijpsycho.2005.08.003; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Jolicoeur P, 2008, BRAIN RES, V1215, P160, DOI 10.1016/j.brainres.2008.03.059; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Luck S.J., 2005, INTRO EVENT RELATED, V1st ed.; Luck SJ, 1997, COGNITIVE PSYCHOL, V33, P64, DOI 10.1006/cogp.1997.0660; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P1000, DOI 10.1037/0096-1523.20.5.1000; LUCK SJ, 1990, ELECTROEN CLIN NEURO, V75, P528, DOI 10.1016/0013-4694(90)90139-B; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; Neuhaus AH, 2010, SCHIZOPHR RES, V124, P119, DOI 10.1016/j.schres.2010.08.014; Perterson S. E., 2012, ANNU REV NEUROSCI, V35, P73; Polich, 2003, DETECTION CHANGE EVE, P83, DOI [DOI 10.1007/978-1-4615-0294-4_5, 10.1016/j.neulet.2006.11.066, DOI 10.1016/J.NEULET.2006.11.066]; Polich J, 2003, BRAIN TOPOGR, V15, P141, DOI 10.1023/A:1022637732495; Polich J., 2004, BRAINWAVES MIND RECE, P15; Prime DJ, 2009, J COGNITIVE NEUROSCI, V21, P991, DOI 10.1162/jocn.2009.21105; Robitaille N, 2010, NEUROIMAGE, V53, P1334, DOI 10.1016/j.neuroimage.2010.07.027; Solbakk AK, 2002, CLIN ELECTROENCEPHAL, V33, P102, DOI 10.1177/155005940203300306; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; Szuromi B, 2011, PSYCHOL MED, V41, P1529, DOI 10.1017/S0033291710001996; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Vogel EK, 2000, PSYCHOPHYSIOLOGY, V37, P190, DOI 10.1017/S0048577200981265; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	46	3	3	0	6	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-004X	2090-0058		J OPHTHALMOL	J. Ophthalmol.		2012	2012								618654	10.1155/2012/618654			11	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	046DD	WOS:000311744800001	23227309	gold, Green Submitted, Green Published			2022-02-06	
B	Demorest, RA		Apps, JN; Walter, KD		Demorest, Rebecca A.			The Future of Preventing Concussion in Children and Adolescents	PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES			English	Article; Book Chapter							COLLEGIATE FOOTBALL PLAYERS; PROFESSIONAL FOOTBALL; HEAD IMPACTS; SOCCER PLAYERS; PROTECTIVE HEADGEAR; RISK COMPENSATION; GAME IMPACTS; BRAIN-INJURY; ICE HOCKEY; PERFORMANCE		Childrens Hosp & Res Ctr Oakland, Oakland, CA USA		Demorest, RA (corresponding author), Childrens Hosp & Res Ctr Oakland, Oakland, CA USA.	rebeccademorest@gmail.com					[Anonymous], 2006, Current Sports Medicine Reports, V5, P268, DOI 10.1097/01.CSMR.0000306427.16414.1b; [Anonymous], 2010, 00108M10 NOCSAE DOC; Barbic D, 2005, CLIN J SPORT MED, V15, P294, DOI 10.1097/01.jsm.0000171883.74056.21; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; Biasca N, 2002, BRIT J SPORT MED, V36, P410, DOI 10.1136/bjsm.36.6.410; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Broglio SP, 2004, BRIT J SPORT MED, V38, P561, DOI 10.1136/bjsm.2003.004887; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Delaney JS, 1999, CLIN J SPORT MED, V9, P121; Denny-Brown D, 1941, BRAIN, V64, P7; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Finch CF, 2001, BRIT J SPORT MED, V35, P89, DOI 10.1136/bjsm.35.2.89; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Heck JF, 2004, J ATHL TRAINING, V39, P101; HODGSON VR, 1975, MED SCI SPORT EXER, V7, P225; Hodgson VR, 1980, INTRASCHOLASTIC ATHL, V7; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; Levy ML, 2004, NEUROSURGERY, V55, P649, DOI 10.1227/01.NEU.0000134598.06114.89; Levy ML, 2004, NEUROSURGERY, V55, P656, DOI 10.1227/01.NEU.0000134599.01917.AA; Lewis LM, 2001, ACAD EMERG MED, V8, P604, DOI 10.1111/j.1553-2712.2001.tb00171.x; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; McCaffrey MA, 2007, NEUROSURGERY, V61, P1236, DOI 10.1227/01.neu.0000306102.91506.8b; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McGuine T, 1996, FOOTBALL HELMET FITT, P83; McIntosh A, 2004, BRIT J SPORT MED, V38, P46, DOI 10.1136/bjsm.2002.003103; McIntosh AS, 2009, MED SCI SPORT EXER, V41, P306, DOI 10.1249/MSS.0b013e3181864bee; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; McIntosh AS, 2005, BRIT J SPORT MED, V39, P2, DOI 10.1136/bjsm.2004.016188; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Naunheim R, 2002, J TRAUMA, V53, P691, DOI 10.1097/00005373-200210000-00012; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Pashby T, 2001, CLIN J SPORT MED, V11, P211, DOI 10.1097/00042752-200110000-00001; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P797, DOI 10.1093/neurosurgery/53.3.797; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Singh GD, 2009, DENT TRAUMATOL, V25, P515, DOI 10.1111/j.1600-9657.2009.00808.x; Stuart MJ, 2002, AM J SPORT MED, V30, P39, DOI 10.1177/03635465020300012001; Takeda T, 2005, DENT TRAUMATOL, V21, P134, DOI 10.1111/j.1600-9657.2005.00320.x; Torg JS, 1991, ATHLETIC INJURIES HE, P97; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Wisniewski JF, 2004, DENT TRAUMATOL, V20, P143, DOI 10.1111/j.1600-4469.2004.00259.x; Withnall C, 2005, BRIT J SPORT MED, V39, pI40, DOI 10.1136/bjsm.2005.019174	62	3	3	0	7	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-0-387-89544-4				2012							177	194		10.1007/978-0-387-89545-1_13	10.1007/978-0-387-89545-1		18	Psychology, Clinical; Clinical Neurology; Pediatrics	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Neurosciences & Neurology; Pediatrics	BZV30	WOS:000303027500013					2022-02-06	
J	Dong, XQ; Du, Q; Yu, WH; Zhang, ZY; Zhu, Q; Che, ZH; Wang, H; Chen, J; Yang, SB; Wen, JF				Dong, X. -Q.; Du, Q.; Yu, W. -H.; Zhang, Z. -Y.; Zhu, Q.; Che, Z. -H.; Wang, H.; Chen, J.; Yang, S. -B.; Wen, J. -F.			Plasma resistin, associated with single nucleotide polymorphism-420, is correlated with C-reactive protein in Chinese Han patients with spontaneous basal ganglia hemorrhage	GENETICS AND MOLECULAR RESEARCH			English	Article						Resistin; Polymorphism; C-reactive protein; Intracerebral hemorrhage; Inflammatory reaction	ADIPOKINE GENE-EXPRESSION; TRAUMATIC BRAIN-INJURY; DIABETIC-PATIENTS; SERUM RESISTIN; IN-VITRO; ADIPONECTIN; PROMOTER; STROKE; RISK; CHOLESTEROL	We examined a possible relationship -420C>G SNP of the resistin gene with plasma resistin and C-reactive protein concentrations in intracerebral hemorrhage. Three hundred and forty-four Chinese Han patients with intracerebral hemorrhage and 344 age- and gender-matched healthy controls were included in our study. Plasma resistin and C-reactive concentrations were measured and SNP -420C>G was genotyped. The genotype frequencies in controls and patients were not significantly different (P = 0.672). Plasma resistin and C-reactive protein levels were significantly different between the SNP -420C>G genotypes, even after adjustment for age, gender and body mass index. The common homozygote (C-C) had the lowest resistin and C-reactive protein plasma concentrations; the plasma resistin and C-reactive protein concentrations in the heterozygote (C-G) and the rare allele homozygote (G-G) did not differ significantly. Plasma resistin levels were significantly associated with plasma C-reactive protein level. We conclude that SNP -420C>G of the resistin gene could be involved in the inflammatory component of intracerebral hemorrhage through enhanced production of resistin.	[Dong, X. -Q.; Du, Q.; Yu, W. -H.; Zhang, Z. -Y.; Zhu, Q.; Che, Z. -H.; Wang, H.; Chen, J.] Nanjing Med Univ, Hangzhou Municipal Peoples Hosp 1, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China; [Yang, S. -B.] Shengzhou Peoples Hosp, Dept Neurosurg, Shenzhou, Peoples R China; [Wen, J. -F.] Second Peoples Hosp Cixi City, Dept Neurosurg, Cixi, Peoples R China		Zhu, Q (corresponding author), Nanjing Med Univ, Hangzhou Municipal Peoples Hosp 1, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China.	hzqiangzhu@163.com			Hangzhou Medical Research Fund Scheme A Class Project [2010A009]	Research supported by the Hangzhou Medical Research Fund Scheme A Class Project (Grant #2010A009).	Al-Daghri N, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-10; Bokarewa M, 2005, J IMMUNOL, V174, P5789, DOI 10.4049/jimmunol.174.9.5789; Brown R, 2008, NEUROSCI LETT, V432, P73, DOI 10.1016/j.neulet.2007.12.008; Cho YM, 2004, DIABETOLOGIA, V47, P559, DOI 10.1007/s00125-003-1319-x; Dong XQ, 2010, CRIT CARE, V14, DOI 10.1186/cc9307; Dong XQ, 2010, J CRIT CARE, V25, P243, DOI 10.1016/j.jcrc.2009.09.008; Efstathiou SP, 2007, CLIN CHIM ACTA, V378, P78, DOI 10.1016/j.cca.2006.10.023; Fasshauer M, 2001, BIOCHEM BIOPH RES CO, V288, P1027, DOI 10.1006/bbrc.2001.5874; Hivert MF, 2009, DIABETES, V58, P750, DOI 10.2337/db08-1339; Kaser S, 2003, BIOCHEM BIOPH RES CO, V309, P286, DOI 10.1016/j.bbrc.2003.07.003; Kawanami D, 2004, BIOCHEM BIOPH RES CO, V314, P415, DOI 10.1016/j.bbrc.2003.12.104; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Lin Xing-Jian, 2007, Chinese Medical Sciences Journal, V22, P27; Lu SC, 2002, FEBS LETT, V530, P158, DOI 10.1016/S0014-5793(02)03450-6; Osawa H, 2004, AM J HUM GENET, V75, P678, DOI 10.1086/424761; Osawa H, 2007, DIABETES CARE, V30, P1501, DOI 10.2337/dc06-1936; Pang SS, 2006, CELL MOL IMMUNOL, V3, P29; Piestrzeniewicz K, 2009, CARDIOL J, V16, P36; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; Shetty GK, 2004, DIABETES CARE, V27, P2450, DOI 10.2337/diacare.27.10.2450; Silswal N, 2005, BIOCHEM BIOPH RES CO, V334, P1092, DOI 10.1016/j.bbrc.2005.06.202; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502; Tsukahara T, 2009, DIABETES RES CLIN PR, V84, P179, DOI 10.1016/j.diabres.2008.10.021; Ukkola O, 2008, REGUL PEPTIDES, V149, P56, DOI 10.1016/j.regpep.2007.08.025; Wiesner G, 2006, NEUROREPORT, V17, P1195, DOI 10.1097/01.wnr.0000224776.12647.ba; Wilkinson M, 2007, NEUROENDOCRINOLOGY, V86, P191, DOI 10.1159/000108635; Yoshino T, 2011, INTERNAL MED, V50, P269, DOI 10.2169/internalmedicine.50.4306	28	3	3	0	5	FUNPEC-EDITORA	RIBEIRAO PRETO	RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000, BRAZIL	1676-5680			GENET MOL RES	Genet. Mol. Res.		2012	11	3					1841	1850		10.4238/2012.July.19.4			10	Biochemistry & Molecular Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Genetics & Heredity	006KJ	WOS:000308817800005	22869540	Bronze			2022-02-06	
J	Dutta, G; Demetis, S				Dutta, Gaurav; Demetis, Spiro			Neurogenic Pulmonary Edema Associated with Underlying Lung Disease after a Breakthrough Seizure	CASE REPORTS IN MEDICINE			English	Article							DEATH	Neurogenic pulmonary edema (NPE) can result from various central nervous system disorders such as brain malignancies, traumatic brain injuries, infections, and seizures. Although the pathogenesis is not completely understood, NPE creates an increase in pulmonary interstitial and alveolar fluid. It has been reported with prolonged seizure activity. Treatment for NPE is largely supportive. If unrecognized, it can lead to hypoxia and respiratory arrest. We report a case of NPE in a middle-aged female patient following a breakthrough seizure in whom an immunological cause for respiratory findings was high on the differential list, based on her past medical history and chronicity of symptoms. Rapid symptomatic and radiological improvement following hospitalization led to the correct diagnosis.	[Dutta, Gaurav; Demetis, Spiro] Lutheran Med Ctr, Dept Internal Med, 150 55th St, Brooklyn, NY 11209 USA		Dutta, G (corresponding author), Lutheran Med Ctr, Dept Internal Med, 150 55th St, Brooklyn, NY 11209 USA.	drgauravdutta@gmail.com					COLICE GL, 1985, CLIN CHEST MED, V6, P473; COLICE GL, 1984, AM REV RESPIR DIS, V130, P941; DARNELL JC, 1982, EPILEPSIA, V23, P71, DOI 10.1111/j.1528-1157.1982.tb05054.x; Davison DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11226; Fontes RBV, 2003, J NEUROSURG ANESTH, V15, P144, DOI 10.1097/00008506-200304000-00013; Imai K, 2003, NEUROL SURG TOKYO, V31, P757; LEESTMA JE, 1989, ANN NEUROL, V26, P195, DOI 10.1002/ana.410260203; MARON MB, 1980, J APPL PHYSIOL, V49, P73, DOI 10.1152/jappl.1980.49.1.73; MULROY JJ, 1985, NEUROLOGY, V35, P403, DOI 10.1212/WNL.35.3.403; Ohlmacher AP, 1910, AM J MED SCI, V139, P417; Shanahan W, 1908, N Y MED J, V37, P54; Simon RP, 2010, EPILEPSY BEHAV, V19, P167, DOI 10.1016/j.yebeh.2010.06.025; SIMON RP, 1993, NEUROL CLIN, V11, P309, DOI 10.1016/S0733-8619(18)30155-5; Smith WS, 1997, CHEST, V111, P1326, DOI 10.1378/chest.111.5.1326; TERRENCE CF, 1981, ANN NEUROL, V9, P458, DOI 10.1002/ana.410090508	15	3	3	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-9627	1687-9635		CASE REP MED	Case Rep. Med.		2012	2012								560942	10.1155/2012/560942			3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V25VM	WOS:000215252100191	22919397	Green Published, gold, Green Submitted			2022-02-06	
J	Fung, C; Z'Graggen, WJ; Beck, J; Gralla, J; Jakob, SM; Schucht, P; Raabe, A				Fung, Christian; Z'Graggen, Werner J.; Beck, Juergen; Gralla, Jan; Jakob, Stephan M.; Schucht, Philippe; Raabe, Andreas			Traumatic subarachnoid hemorrhage, basal ganglia hematoma and ischemic stroke caused by a torn lenticulostriate artery	ACTA NEUROCHIRURGICA			English	Article							CEREBRAL VASOSPASM; POSTTRAUMATIC VASOSPASM; HEAD-INJURY; TIME-COURSE	Subarachnoid hemorrhage (SAH), basal ganglia hematoma (BGH) and ischemic stroke are common diseases with diverging therapies. The simultaneous occurrence of these diseases is rare and complicates the therapy. We report the case of a 30-year-old man with a ruptured lenticulostriate artery after traumatic brain injury that caused the combination of SAH, BGH and ischemic stroke and subsequent cerebral vasospasm. This rupture mimicked the pathophysiology and imaging appearance of aneurysmal SAH. The site of rupture was not secured by any treatment; however, hyperdynamic therapy and percutaneous transluminal angioplasty were feasible in this setting to prevent additional delayed neurological deficit.	[Fung, Christian; Z'Graggen, Werner J.; Beck, Juergen; Schucht, Philippe; Raabe, Andreas] Univ Hosp Bern, Dept Neurosurg, CH-3010 Bern, Switzerland; [Fung, Christian; Z'Graggen, Werner J.; Beck, Juergen; Schucht, Philippe; Raabe, Andreas] Univ Bern, Publicat Off, CH-3010 Bern, Switzerland		Raabe, A (corresponding author), Univ Hosp Bern, Dept Neurosurg, CH-3010 Bern, Switzerland.	susan.wieting@insel.ch		Beck, Jurgen/0000-0002-7687-6098			Boto GR, 2001, J NEUROSURG, V94, P224, DOI 10.3171/jns.2001.94.2.0224; Broderick J, 2007, CIRCULATION, V116, pE391, DOI 10.1161/CIRCULATIONAHA.107.183689; Conti A, 2008, ACTA NEUROCHIR, V150, P1197, DOI 10.1007/s00701-008-0141-0; DHARKER SR, 1993, NEUROSURGERY, V33, P863; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; KATZ DI, 1989, NEUROLOGY, V39, P897, DOI 10.1212/WNL.39.7.897; Kieslich M, 2002, J NEUROL NEUROSUR PS, V73, P13, DOI 10.1136/jnnp.73.1.13; Kuroiwa Toshihiko, 1994, Neurologia Medico-Chirurgica, V34, P20, DOI 10.2176/nmc.34.20; Lee DJ, 2008, NEUROSURGERY, V63, P1004, DOI 10.1227/01.NEU.0000327685.90800.F7; MARTIN NA, 1995, J NEUROTRAUM, V12, P897, DOI 10.1089/neu.1995.12.897; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Platz J, 2011, NEUROCRIT CARE, V14, P168, DOI 10.1007/s12028-011-9510-2; Raabe A, 2005, J NEUROSURG, V103, P974, DOI 10.3171/jns.2005.103.6.0974; Shahlaie K, 2009, NEUROCRIT CARE, V10, P61, DOI 10.1007/s12028-008-9138-z; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; WEIR B, 1978, J NEUROSURG, V48, P173, DOI 10.3171/jns.1978.48.2.0173; YAMAKAWA N, 1995, J CLIN NEUROSCI, V2, P55, DOI 10.1016/0967-5868(95)90031-4; Zubkov AY, 1999, J NEUROTRAUM, V16, P763, DOI 10.1089/neu.1999.16.763; Zubkov ZY, 2000, SURG NEUROL, V53, P126	21	3	4	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JAN	2012	154	1					59	62		10.1007/s00701-011-1162-7			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	870BE	WOS:000298643300008	21976234	Green Published, Green Submitted			2022-02-06	
B	Genazzani, AD; Lanzoni, C		Watson, RR		Genazzani, Alessandro D.; Lanzoni, Chiara			DHEA as a Putative Replacement Therapy in the Elderly	DHEA IN HUMAN HEALTH AND AGING			English	Article; Book Chapter							BONE-MINERAL DENSITY; TRAUMATIC BRAIN-INJURY; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ESTROGEN-RECEPTOR-BETA; INTRAVAGINAL DEHYDROEPIANDROSTERONE PRASTERONE; RANDOMIZED CONTROLLED-TRIAL; PERIPHERAL TARGET TISSUES; LATE-POSTMENOPAUSAL WOMEN; PLACEBO-CONTROLLED TRIAL; RAT HIPPOCAMPAL-NEURONS		[Genazzani, Alessandro D.; Lanzoni, Chiara] Univ Modena & Reggio Emilia, Gynecol Endocrinol Ctr, Dept Obstet & Gynecol, Modena, Italy		Genazzani, AD (corresponding author), Univ Modena & Reggio Emilia, Gynecol Endocrinol Ctr, Dept Obstet & Gynecol, Modena, Italy.						Ahmad I, 2005, J NEUROSCI RES, V82, P811, DOI 10.1002/jnr.20685; ARANEO BA, 1993, J INFECT DIS, V167, P830, DOI 10.1093/infdis/167.4.830; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Arlt W, 2001, J CLIN ENDOCR METAB, V86, P4686, DOI 10.1210/jc.86.10.4686; Arlt W, 1998, J CLIN ENDOCR METAB, V83, P1928, DOI 10.1210/jc.83.6.1928; Arlt W, 1999, J CLIN ENDOCR METAB, V84, P2170, DOI 10.1210/jc.84.6.2170; Arnold JT, 2005, AM J PHYSIOL-ENDOC M, V288, pE573, DOI 10.1152/ajpendo.00454.2004; Azcoitia I, 2003, NEUROBIOL AGING, V24, P853, DOI 10.1016/S0197-4580(02)00234-8; Azizi H, 2010, STEM CELLS DEV, V19, P809, DOI 10.1089/scd.2009.0261; Bachmann GA, 2007, MENOPAUSE, V14, P357, DOI 10.1097/gme.0b013e31805170eb; Barad D. H., 2005, FERTIL STERIL, V84; Barad D, 2007, J ASSIST REPROD GEN, V24, P629, DOI 10.1007/s10815-007-9178-x; Barad D, 2006, HUM REPROD, V21, P2845, DOI 10.1093/humrep/del254; Basson R., 2004, ENDOCRINE NEWS, V29, P22; Baulieu EE, 2000, P NATL ACAD SCI USA, V97, P4279, DOI 10.1073/pnas.97.8.4279; Baulieu EE, 1999, ACTA PAEDIATR, V88, P78, DOI 10.1111/j.1651-2227.1999.tb14408.x; BELANGER A, 1994, J CLIN ENDOCR METAB, V79, P1086; BENZ DJ, 1991, ENDOCRINOLOGY, V128, P2723, DOI 10.1210/endo-128-6-2723; Berger L, 2005, J STEROID BIOCHEM, V96, P201, DOI 10.1016/j.jsbmb.2005.02.018; Bergeron R, 1996, J NEUROSCI, V16, P1193; Bernardi F, 2003, GYNECOL ENDOCRINOL, V17, P65, DOI 10.1080/713603176; Blandizzi C, 2007, NEUROCHEM INT, V51, P282, DOI 10.1016/j.neuint.2007.05.013; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; BROOK A, 1991, J ROY SOC MED, V84, P39, DOI 10.1177/014107689108400115; Brown RC, 2003, NEUROBIOL AGING, V24, P57, DOI 10.1016/S0197-4580(02)00048-9; Caranasos G, 1985, Geriatrics, V40, P87; Caranasos G., 1985, GERIATRICS, V40, P90; Cardounel A, 1999, P SOC EXP BIOL MED, V222, P145, DOI 10.1046/j.1525-1373.1999.d01-124.x; Carruba G, 2006, ANN NY ACAD SCI, V1089, P201, DOI 10.1196/annals.1386.027; Carruba G, 2007, J CELL BIOCHEM, V102, P899, DOI 10.1002/jcb.21529; Carson PJ, 2000, ARCH INTERN MED, V160, P2017, DOI 10.1001/archinte.160.13.2017; Casson PR, 2000, HUM REPROD, V15, P2129, DOI 10.1093/humrep/15.10.2129; Casson PR, 1998, FERTIL STERIL, V70, P107, DOI 10.1016/S0015-0282(98)00121-6; CASSON PR, 1993, AM J OBSTET GYNECOL, V169, P1536, DOI 10.1016/0002-9378(93)90431-H; Cefalu CA, 2004, CURR MED RES OPIN, V20, P341, DOI 10.1185/030079903125003062; CHAMI TN, 1995, AM J GASTROENTEROL, V90, P88; Chang DM, 2002, ARTHRITIS RHEUM, V46, P2924, DOI 10.1002/art.10615; Chang WY, 1999, PROSTATE, V40, P115; Charalampopoulos I, 2006, ANN NY ACAD SCI, V1088, P139, DOI 10.1196/annals.1366.003; Charalampopoulos L, 2004, P NATL ACAD SCI USA, V101, P8209, DOI 10.1073/pnas.0306631101; Chen F, 2005, ENDOCRINOLOGY, V146, P4568, DOI 10.1210/en.2005-0368; CHESNUT CH, 1983, METABOLISM, V32, P571, DOI 10.1016/0026-0495(83)90027-6; Ciolino H, 2003, INT J CANCER, V105, P321, DOI 10.1002/ijc.11075; Ciriza I, 2004, J NEUROENDOCRINOL, V16, P58, DOI 10.1111/j.1365-2826.2004.01121.x; COMPAGNONE NA, 1995, ENDOCRINOLOGY, V136, P5212, DOI 10.1210/en.136.11.5212; Compagnone NA, 1998, P NATL ACAD SCI USA, V95, P4678, DOI 10.1073/pnas.95.8.4678; Corey E, 2002, CLIN CANCER RES, V8, P1003; CORPECHOT C, 1981, P NATL ACAD SCI-BIOL, V78, P4704, DOI 10.1073/pnas.78.8.4704; Daynes R. A., 1993, IMMUNOLOGY, V150, pS219; DAYNES RA, 1995, J INVEST DERMATOL, V105, pS14, DOI 10.1111/1523-1747.ep12315187; DAYNES RA, 1990, EUR J IMMUNOL, V20, P793, DOI 10.1002/eji.1830200413; DEFAZIO J, 1984, MATURITAS, V6, P3, DOI 10.1016/0378-5122(84)90060-4; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; Delpedro AD, 1998, J INTERF CYTOK RES, V18, P125, DOI 10.1089/jir.1998.18.125; DEMIRGOREN S, 1991, NEUROSCIENCE, V45, P127, DOI 10.1016/0306-4522(91)90109-2; DEVROEDE G, 1989, DIGEST DIS SCI, V34, P1428, DOI 10.1007/BF01538081; Dhatariya K, 2005, DIABETES, V54, P765, DOI 10.2337/diabetes.54.3.765; Diamond P, 1996, J ENDOCRINOL, V150, pS43; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; DONALD IP, 1985, GERONTOLOGY, V31, P112, DOI 10.1159/000212689; Duan Y, 1997, BONE, V21, P447, DOI 10.1016/S8756-3282(97)00177-4; Eastell R, 2006, J BONE MINER RES, V21, P1215, DOI 10.1359/JBMR.060508; EICH DM, 1993, CIRCULATION, V87, P261, DOI 10.1161/01.CIR.87.1.261; Ellem SJ, 2007, NAT REV CANCER, V7, P621, DOI 10.1038/nrc2174; English MA, 2000, BRIT J CANCER, V83, P550, DOI 10.1054/bjoc.2000.1324; ERSHLER WB, 1993, LYMPHOKINE CYTOK RES, V12, P225; Ervin RB, 2002, J NUTR, V132, P3422, DOI 10.1093/jn/132.11.3422; Fogelman I, 2000, J CLIN ENDOCR METAB, V85, P1895, DOI 10.1210/jc.85.5.1895; Francis PT, 2005, CNS SPECTRUMS, V10, P6, DOI 10.1017/S1092852900014164; GALLAGHER JC, 1991, AM J MED, V90, P171; GELLER J, 1985, SEMIN ONCOL, V12, P28; Genazzam AR, 2010, CLIMACTERIC, V13, P314, DOI 10.3109/13697137.2010.492496; Genazzani A R, 2004, Aging Male, V7, P133; Genazzani AD, 2003, FERTIL STERIL, V80, P1495, DOI 10.1016/j.fertnstert.2003.06.005; Gennari C, 2001, Public Health Nutr, V4, P547; Ghoumari AM, 2003, J NEUROCHEM, V86, P848, DOI 10.1046/j.1471-4159.2003.01881.x; GIAGULLI VA, 1989, J STEROID BIOCHEM, V33, P935, DOI 10.1016/0022-4731(89)90243-4; Gingras S, 1999, ENDOCRINOLOGY, V140, P4573, DOI 10.1210/en.140.10.4573; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; Gleicher N, 2007, FERTIL STERIL, V88, pS232, DOI 10.1016/j.fertnstert.2007.07.792; Gleicher N, 2008, FERTIL STERIL, V89, P780, DOI 10.1016/j.fertnstert.2008.01.072; Goldstat R, 2003, MENOPAUSE, V10, P390, DOI 10.1097/01.GME.0000060256.03945.20; GORDON GB, 1988, J CLIN INVEST, V82, P712, DOI 10.1172/JCI113652; Green JE, 2001, CANCER RES, V61, P7449; GREENBLATT RB, 1950, J CLIN ENDOCRINOL, V10, P1547, DOI 10.1210/jcem-10-12-1547; Griffin LD, 2004, NAT MED, V10, P704, DOI 10.1038/nm1073; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartel C, 1998, J ENDOCRINOL, V157, P433, DOI 10.1677/joe.0.1570433; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; HEYMEN S, 1993, DIS COLON RECTUM, V36, P593, DOI 10.1007/BF02049867; Hosking D, 1998, NEW ENGL J MED, V338, P485, DOI 10.1056/NEJM199802193380801; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; ISAACS JT, 1984, CANCER RES, V44, P5785; Jakob F, 1997, J STEROID BIOCHEM, V61, P167; Jankowski CM, 2006, J CLIN ENDOCR METAB, V91, P2986, DOI 10.1210/jc.2005-2484; Jellinger KA, 2004, J NEUROL NEUROSUR PS, V75, P511; Judd HL, 1996, JAMA-J AM MED ASSOC, V275, P370, DOI 10.1001/jama.1996.03530290040035; Kalmijn S, 1998, J CLIN ENDOCR METAB, V83, P3487, DOI 10.1210/jc.83.10.3487; Karishma KK, 2002, EUR J NEUROSCI, V16, P445, DOI 10.1046/j.1460-9568.2002.02099.x; Kendall A, 2006, ANN ONCOL, V17, P584, DOI 10.1093/annonc/mdj127; Kim SB, 2003, J CLIN ENDOCR METAB, V88, P5199, DOI 10.1210/jc.2003-030646; Kimonides VG, 1999, NEUROSCIENCE, V89, P429, DOI 10.1016/S0306-4522(98)00347-9; KLEIN H, 1988, J STEROID BIOCHEM, V30, P119, DOI 10.1016/0022-4731(88)90084-2; Krazeisen A, 1999, FEBS LETT, V460, P373, DOI 10.1016/S0014-5793(99)01366-6; KRISHNARAJ R, 1987, CLIN IMMUNOL IMMUNOP, V45, P268, DOI 10.1016/0090-1229(87)90042-0; Kurata K, 2004, J PHARMACOL EXP THER, V311, P237, DOI 10.1124/jpet.104.067629; LABRIE F, 1993, EUR UROL, V24, P94; Labrie F, 2005, J ENDOCRINOL, V187, P169, DOI 10.1677/joe.1.06264; Labrie F, 1997, J CLIN ENDOCR METAB, V82, P2396, DOI 10.1210/jc.82.8.2396; Labrie F, 1998, STEROIDS, V63, P322, DOI 10.1016/S0039-128X(98)00007-5; Labrie F, 2001, FRONT NEUROENDOCRIN, V22, P185, DOI 10.1006/frne.2001.0216; LABRIE F, 1991, MOL CELL ENDOCRINOL, V78, pC113, DOI 10.1016/0303-7207(91)90116-A; Labrie F, 1997, J CLIN ENDOCR METAB, V82, P3498, DOI 10.1210/jc.82.10.3498; Labrie F, 1997, STEROIDS, V62, P148, DOI 10.1016/S0039-128X(96)00174-2; Labrie F., 2010, MENOPAUSE MANAG, V19, P14; Labrie F, 2008, J STEROID BIOCHEM, V111, P178, DOI 10.1016/j.jsbmb.2008.06.003; Labrie F, 2007, NAT CLIN PRACT ENDOC, V3, P584, DOI 10.1038/ncpendmet0559; Labrie F, 2006, J STEROID BIOCHEM, V99, P182, DOI 10.1016/j.jsbmb.2006.02.004; Labrie F, 2009, MENOPAUSE, V16, P923, DOI 10.1097/gme.0b013e31819e85c6; Labrie F, 2009, MENOPAUSE, V16, P907, DOI 10.1097/gme.0b013e31819e8e2d; Labrie F, 2009, MENOPAUSE, V16, P897, DOI 10.1097/gme.0b013e31819e8930; Labrie F, 2009, MENOPAUSE, V16, P30, DOI 10.1097/gme.0b013e31817b6132; Lasco A, 2001, EUR J ENDOCRINOL, V145, P457, DOI 10.1530/eje.0.1450457; Laughlin GA, 2000, J CLIN ENDOCR METAB, V85, P3561, DOI 10.1210/jc.85.10.3561; Liao GH, 2009, BRAIN RES, V1270, P140, DOI 10.1016/j.brainres.2009.03.027; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Lipton Stuart A., 2005, Current Alzheimer Research, V2, P155, DOI 10.2174/1567205053585846; Liu DM, 2002, J BIOL CHEM, V277, P21379, DOI 10.1074/jbc.M200491200; Lockhart EM, 2002, NEUROSCI LETT, V328, P33, DOI 10.1016/S0304-3940(02)00448-2; LORIA RM, 1988, J MED VIROL, V26, P301, DOI 10.1002/jmv.1890260310; Lubet RA, 1998, CANCER RES, V58, P921; MAJEWSKA MD, 1990, BRAIN RES, V526, P143, DOI 10.1016/0006-8993(90)90261-9; MARTEL C, 1992, J STEROID BIOCHEM, V41, P597, DOI 10.1016/0960-0760(92)90390-5; MARTEL C, 1994, MOL CELL ENDOCRINOL, V104, P103, DOI 10.1016/0303-7207(94)90056-6; Martin C, 2004, J CLIN ENDOCR METAB, V89, P2928, DOI 10.1210/jc.2003-031847; Martin LJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1831; Marx CE, 2000, BRAIN RES, V871, P104, DOI 10.1016/S0006-8993(00)02452-5; Marx CE, 2006, BIOL PSYCHIAT, V60, P1287, DOI 10.1016/j.biopsych.2006.06.017; McLachlan JA, 1996, J IMMUNOL, V156, P328; McPherson SJ, 2007, ENDOCRINOLOGY, V148, P566, DOI 10.1210/en.2006-0906; MEIKLE AW, 1992, J STEROID BIOCHEM, V42, P293, DOI 10.1016/0960-0760(92)90132-3; Meiring PJ, 1998, S AFR MED J, V88, P888; MELCHIOR CL, 1992, PHARMACOL BIOCHEM BE, V43, P223, DOI 10.1016/0091-3057(92)90661-X; Mellon SH, 2008, BRAIN RES REV, V57, P410, DOI 10.1016/j.brainresrev.2007.05.012; MIGEON CJ, 1957, J CLIN ENDOCR METAB, V17, P1051, DOI 10.1210/jcem-17-9-1051; Miller KK, 2002, J CLIN ENDOCR METAB, V87, P2770, DOI 10.1210/jc.87.6.2770; MOGHISSI E, 1984, J CLIN ENDOCR METAB, V59, P417, DOI 10.1210/jcem-59-3-417; MORALES AJ, 1994, J CLIN ENDOCR METAB, V78, P1360, DOI 10.1210/jc.78.6.1360; Morales AJ, 1998, CLIN ENDOCRINOL, V49, P421, DOI 10.1046/j.1365-2265.1998.00507.x; Morales C, 2008, AM J MED GENET A, V146A, P66, DOI 10.1002/ajmg.a.32058; Muller M, 2006, J CLIN ENDOCR METAB, V91, P3988, DOI 10.1210/jc.2005-2433; MURASKO DM, 1986, AM J MED, V81, P612, DOI 10.1016/0002-9343(86)90546-2; Naylor JC, 2008, J CLIN ENDOCR METAB, V93, P3173, DOI 10.1210/jc.2007-1229; NEED AG, 1987, CLIN ORTHOP RELAT R, P273; NOTTESTAD SY, 1987, J BONE MINER RES, V2, P221; OKABE T, 1995, J CLIN ENDOCR METAB, V80, P2993, DOI 10.1210/jc.80.10.2993; ORENTREICH N, 1984, J CLIN ENDOCR METAB, V59, P551, DOI 10.1210/jcem-59-3-551; ORENTREICH N, 1992, J CLIN ENDOCR METAB, V75, P1002, DOI 10.1210/jc.75.4.1002; Pal L, 2003, ENDOCRIN METAB CLIN, V32, P669, DOI 10.1016/S0889-8529(03)00046-X; Palmert MR, 2001, J CLIN ENDOCR METAB, V86, P4536, DOI 10.1210/jc.86.9.4536; Panjari M, 2010, MATURITAS, V66, P172, DOI 10.1016/j.maturitas.2009.12.017; Parker CR, 1997, J CLIN ENDOCR METAB, V82, P3898, DOI 10.1210/jc.82.11.3898; Perkins SN, 1997, CARCINOGENESIS, V18, P989, DOI 10.1093/carcin/18.5.989; PIKE MC, 1983, NATURE, V303, P767, DOI 10.1038/303767a0; Pluchino N, 2005, GYNECOL ENDOCRINOL, V20, P144, DOI 10.1080/09513590400021169; Pluchino N, 2008, MATURITAS, V59, P293, DOI 10.1016/j.maturitas.2008.02.004; Prestwood KM, 2003, JAMA-J AM MED ASSOC, V290, P1042, DOI 10.1001/jama.290.8.1042; PYE JK, 1985, LANCET, V2, P373; Rao KVN, 1999, CANCER RES, V59, P3084; Regelson W., 1990, BIOL ROLE DEHYDROEPI, P101; Regelson W., 1988, ANN N Y ACAD SCI, V521, P260; REITER EO, 1977, J PEDIATR-US, V90, P766, DOI 10.1016/S0022-3476(77)81244-4; Rioux JE, 2000, MENOPAUSE, V7, P156, DOI 10.1097/00042192-200007030-00005; Risbridger GP, 2007, J MOL ENDOCRINOL, V39, P183, DOI 10.1677/JME-07-0053; SANSONI P, 1993, BLOOD, V82, P2767; SAVVAS M, 1988, BRIT MED J, V297, P331, DOI 10.1136/bmj.297.6644.331; Schmidt M, 2000, J ENDOCRINOL, V164, P161, DOI 10.1677/joe.0.1640161; Schwartz AG, 2004, AGEING RES REV, V3, P171, DOI 10.1016/j.arr.2003.05.001; SCHWARTZ AG, 1995, J CELL BIOCHEM, P210; SEEMAN E, 1982, J CLIN INVEST, V69, P1302, DOI 10.1172/JCI110570; SHERWIN BB, 1987, PSYCHOSOM MED, V49, P397, DOI 10.1097/00006842-198707000-00009; SHERWIN BB, 1988, J AFFECT DISORDERS, V14, P177, DOI 10.1016/0165-0327(88)90061-4; SHERWIN BB, 1984, AM J OBSTET GYNECOL, V148, P552, DOI 10.1016/0002-9378(84)90746-4; SHERWIN BB, 1985, AM J OBSTET GYNECOL, V151, P153, DOI 10.1016/0002-9378(85)90001-8; Shifren JL, 2000, NEW ENGL J MED, V343, P682, DOI 10.1056/NEJM200009073431002; Signoretti S, 2001, AM J PATHOL, V159, P13, DOI 10.1016/S0002-9440(10)61666-5; Simoncini T, 2003, ENDOCRINOLOGY, V144, P3449, DOI 10.1210/en.2003-0044; SIZONENKO PC, 1975, J CLIN ENDOCR METAB, V41, P894, DOI 10.1210/jcem-41-5-894; SKLAR CA, 1980, J CLIN ENDOCR METAB, V51, P548, DOI 10.1210/jcem-51-3-548; Solerte SB, 1999, J CLIN ENDOCR METAB, V84, P3260, DOI 10.1210/jc.84.9.3260; SONNENBERG A, 1994, AM J GASTROENTEROL, V89, P62; Steckelbroeck S, 2004, J BIOL CHEM, V279, P10784, DOI 10.1074/jbc.M313308200; Stomati M, 2000, GYNECOL ENDOCRINOL, V14, P342, DOI 10.3109/09513590009167703; Straub RH, 1998, J CLIN ENDOCR METAB, V83, P2012, DOI 10.1210/jc.83.6.2012; Suzuki M, 2004, P NATL ACAD SCI USA, V101, P3202, DOI 10.1073/pnas.0307325101; Tamagno E, 2003, NEUROBIOL DIS, V14, P291, DOI 10.1016/S0969-9961(03)00131-1; Tracz MJ, 2006, J CLIN ENDOCR METAB, V91, P2011, DOI 10.1210/jc.2006-0036; Valimaki MJ, 2007, CLIN THER, V29, P1937, DOI 10.1016/j.clinthera.2007.09.017; van Vollenhoven RF, 1999, LUPUS, V8, P181, DOI 10.1191/096120399678847588; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; VANVOLLENHOVEN RF, 1994, ARTHRITIS RHEUM, V37, P1305, DOI 10.1002/art.1780370906; vanVollenhoven RF, 1995, ARTHRITIS RHEUM, V38, P1826, DOI 10.1002/art.1780381216; Velde ERT, 2002, HUM REPROD UPDATE, V8, P141, DOI 10.1093/humupd/8.2.141; VERMEULEN A, 1982, J CLIN ENDOCR METAB, V54, P187, DOI 10.1210/jcem-54-1-187; VERMEULEN A, 1976, J STEROID BIOCHEM, V7, P1, DOI 10.1016/0022-4731(76)90156-4; Villareal DT, 2000, CLIN ENDOCRINOL, V53, P561, DOI 10.1046/j.1365-2265.2000.01131.x; Villareal DT, 2003, J AM GERIATR SOC, V51, P985, DOI 10.1046/j.1365-2389.2003.51312.x; Villareal DT, 2001, JAMA-J AM MED ASSOC, V286, P815, DOI 10.1001/jama.286.7.815; VOIGT KD, 1986, J STEROID BIOCHEM, V25, P749, DOI 10.1016/0022-4731(86)90304-3; Wang JM, 2005, J NEUROSCI, V25, P4706, DOI 10.1523/JNEUROSCI.4520-04.2005; Wang L, 2007, J MOL ENDOCRINOL, V38, P467, DOI 10.1677/jme.1.02173; Watts N., 1991, P N AM MENOPAUSE SOC, V101; Weihua Zhang, 2001, Proceedings of the National Academy of Sciences of the United States of America, V98, P6330, DOI 10.1073/pnas.111150898; Weiss EP, 2009, AM J CLIN NUTR, V89, P1459, DOI 10.3945/ajcn.2008.27265; Wenk GL, 2006, BEHAV PHARMACOL, V17, P411, DOI 10.1097/00008877-200609000-00007; Whitehead WE, 2007, AM J GASTROENTEROL, V102, P2230, DOI 10.1111/j.1572-0241.2007.01472.x; Widstrom RL, 2004, SEMIN REPROD MED, V22, P289, DOI 10.1055/s-2004-861546; Williams MRI, 2002, J CLIN ENDOCR METAB, V87, P176, DOI 10.1210/jc.87.1.176; Xilouri M, 2006, EUR J NEUROSCI, V23, P43, DOI 10.1111/j.1460-9568.2005.04548.x; Yen SSC, 1995, ANN NY ACAD SCI, V774, P128, DOI 10.1111/j.1749-6632.1995.tb17377.x; Young DG, 2001, CLIN EXP IMMUNOL, V123, P28, DOI 10.1046/j.1365-2249.2001.01445.x; Young DG, 1999, CLIN EXP IMMUNOL, V117, P476; Young J, 1997, J CLIN ENDOCR METAB, V82, P2578, DOI 10.1210/jc.82.8.2578; Zhang WH, 2002, MOL CELL ENDOCRINOL, V193, P1, DOI 10.1016/s0303-7207(02)00089-8; Zwain IH, 1999, ENDOCRINOLOGY, V140, P880, DOI 10.1210/en.140.2.880; Zwain IH, 1999, ENDOCRINOLOGY, V140, P3843, DOI 10.1210/en.140.8.3843	228	3	3	0	0	CRC PRESS-TAYLOR & FRANCIS GROUP	BOCA RATON	6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA			978-1-4398-3884-6; 978-1-4398-3883-9				2012							9	34					26	Nutrition & Dietetics	Book Citation Index – Science (BKCI-S)	Nutrition & Dietetics	BC5SB	WOS:000353519300003					2022-02-06	
B	Gioia, GA; Vaughan, CG; Sady, MDS		Apps, JN; Walter, KD		Gioia, Gerard A.; Vaughan, Christopher G.; Sady, Maegan D. S.			Developmental Considerations in Pediatric Concussion Evaluation and Management	PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; QUALITY-OF-LIFE; SPORTS-RELATED CONCUSSION; SCHOOL FOOTBALL PLAYERS; POSTURAL STABILITY; AGE SUBGROUPS; CHILDREN; SYMPTOMS; RECOVERY		[Gioia, Gerard A.] George Washington Univ Med, Div Pediat Neuropsychol, SCORE Program, Washington, DC 20037 USA; [Gioia, Gerard A.] George Washington Univ Med, Dept Pediat, Washington, DC USA; [Gioia, Gerard A.] George Washington Univ Med, Dept Psychiat & Behav Sci, Washington, DC USA; [Vaughan, Christopher G.; Sady, Maegan D. S.] Childrens Natl Med Ctr, Div Pediat Neuropsychol, Washington, DC 20010 USA; [Vaughan, Christopher G.] George Washington Univ, Sch Med, Dept Pediat, Washington, DC 20052 USA; [Vaughan, Christopher G.] George Washington Univ, Sch Med, Dept Psychiat & Behav Sci, Washington, DC USA		Gioia, GA (corresponding author), George Washington Univ Med, Div Pediat Neuropsychol, SCORE Program, Washington, DC 20037 USA.	ggioia@childrensnational.org		Sady, Maegan/0000-0002-1438-4477			Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bernstein J.H., 1990, NEUROPSYCHOLOGY, V17; BIERI D, 1990, PAIN, V41, P139, DOI 10.1016/0304-3959(90)90018-9; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Centers for Disease Control and Prevention, 2007, NAT CTR INJ PREV CON; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; De Los Reyes A, 2005, PSYCHOL BULL, V131, P483, DOI 10.1037/0033-2909.131.4.483; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fritz GK, 1996, J PEDIATR PSYCHOL, V21, P153, DOI 10.1093/jpepsy/21.2.153; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia G. A., 2009, BRIT J SPORT MED S1, V43, pi92; Gioia GA, 2011, MANUAL PEDIAT IMMEDI; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Hessen E, 2006, SCAND J PSYCHOL, V47, P245, DOI 10.1111/j.1467-9450.2006.00514.x; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; Lovell M. R., 2002, IMPACT BEST APPROACH; Lovell M, 2008, NEUROL CLIN, V26, P45, DOI 10.1016/j.ncl.2007.12.001; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrory R, 2005, BRIT J SPORT MED S, V39, P58; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; Upton P, 2008, QUAL LIFE RES, V17, P895, DOI 10.1007/s11136-008-9350-5; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-1; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-2; Vincent, 2008, J INT NEUROPSYCH SOC, V1, P204	68	3	3	0	5	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-0-387-89544-4				2012							151	176		10.1007/978-0-387-89545-1_12	10.1007/978-0-387-89545-1		26	Psychology, Clinical; Clinical Neurology; Pediatrics	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Neurosciences & Neurology; Pediatrics	BZV30	WOS:000303027500012					2022-02-06	
J	Hildebrandt, H; Lehmann, P; Kastrup, A				Hildebrandt, H.; Lehmann, P.; Kastrup, A.			Rehabilitation of memory disorders after stroke	NERVENHEILKUNDE			German	Article						Stroke; memory disorder; rehabilitation; neuropsychology; vascular dementia		Memory disorders are frequent after stroke, especially if vascular dementia is subsumed under this label. There are only a few studies on functional or pharmacological treatments of memory disorders after stroke, most of our knowledge on the topic stems from research with patients suffering from traumatic brain injury. In this review we focus more or less exclusively on animal research and human studies on memory disorders after stroke. Animal research shows that enriched environment helps to compensate learning disorders to a high degree, whereas the performance in delayed recall is less significantly improved. These studies also reveal that enriched environment interacts on different molecular biological levels with brain processes (by increasing neurogenesis, availability of brain derived neurotrophic factor, and by decreasing the amount of resulting beta-amyloid plagues). The close relation between early treatment and outcome for recovering from impairments in motor functions seems to be not so important for memory disorders. Research on memory disorders in humans after stroke shows that external memory aids may play an important role for compensation memory disorders in everyday life. In patients with severe memory impairments the use of memory aids depends on the intactness of other cognitive functions like executive functions. Moreover, the combination of intensive training with a few and easy memory strategies seems to be the most effective treatment for patients with mild to moderate memory disorders. Improvement seems to be concentrated on retrieving information more efficiently, but not on consolidating information during delay periods. Selective serotonergic re-uptake inhibitors may help to improve recovery from cognitive impairments and especially of memory disorders, but this has to be replicated in additional studies. Acetylcholinesterase inhibitors improve memory functions in patients with vascular dementia, as long as hippocampal atrophy is low. If hippocampal atrophy is high, acetylcholinesterase inhibitors may be effective in reducing further losses of memory performance, but do not improve performance itself.	[Hildebrandt, H.; Lehmann, P.; Kastrup, A.] Klinikum Bremen Ost, Neurol Klin, D-28325 Bremen, Germany; [Hildebrandt, H.] Carl von Ossietzky Univ Oldenburg, Inst Psychol, D-2900 Oldenburg, Germany		Hildebrandt, H (corresponding author), Klinikum Bremen Ost, Neurol Klin, Zuricher Str 40, D-28325 Bremen, Germany.	helmut.hildebrandt@uni-oldenburg.de						0	3	3	1	14	SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN	STUTTGART	HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY	0722-1541			NERVENHEILKUNDE	Nervenheilkunde		2012	31	6					440	445					6	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	967PN	WOS:000305920400008					2022-02-06	
J	Homolkova, H; Prchlik, M; Tomek, P				Homolkova, Helena; Prchlik, Martin; Tomek, Pavel			The relationship between S100B protein serum levels, injury severity and Glasgow Outcome Scale values in children with CNS injuries	NEUROENDOCRINOLOGY LETTERS			English	Article						craniocerebral injury; protein S100B; GCS (Glasgow Coma Scale); GOS (Glasgow Outcome Scale)	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; AGE; PREDICTION; BIOMARKERS; ADULTS	OBJECTIVES: The S100B protein subgroup is a thermolabile acidic calcium-binding protein, which was first described in association with the central nervous system. Destruction of nerve tissue results in S100B protein release from astrocytes and elevation of its levels in cerebrospinal fluid. If the blood-brain barrier is also damaged, S100B can pass into the systemic circulation and elevated blood levels of S100B can be detected. High S100B serum levels in patients with head injuries are predictive of possible development of secondary brain injury and may be related to the extent of permanent injury to the CNS. MATERIAL AND METHODS: The authors present results obtained from a group of 39 children aged 0 (newborns) to 17 years with an isolated craniocerebral injury. RESULTS: In our group of 39 children (aged 0-17 years) we observed excellent GOS group (GOS - Glasgow Outcome Scale 4 or 5) in 33 patients at the time of transfer from our intensive care unit to the neurological department. There were no deaths and only 6 children were in the poor GOS group (GOS 2 or 3). A second GOS evaluation was performed 6 months later: at this time 36 children were in the excellent GOS group and only 3 children remained in the poor GOS group. CONCLUSIONS: Due to high variability in S100B protein serum levels in children (dependent on age and gender) no correlation between initial S100B levels and GOS was observed for our group of patients. Our results indicate that the rate of decrease of S100B protein levels back to normal values is more meaningful than its absolute value.	[Homolkova, Helena] Thomayers Teaching Hosp, Dept Pediat Neurosurg, Dept Pediat Surg & Traumatol, CZ-14200 Prague 4, Czech Republic; [Prchlik, Martin; Tomek, Pavel] Thomayers Teaching Hosp, Intens Care Unit, Dept Pediat Surg & Traumatol, CZ-14200 Prague 4, Czech Republic		Homolkova, H (corresponding author), Thomayers Teaching Hosp, Dept Pediat Neurosurg, Dept Pediat Surg & Traumatol, Videnska 800, CZ-14200 Prague 4, Czech Republic.	hhomolkova@seznam.cz					Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Brichtova E, 2008, CHILD NERV SYST, V24, P349, DOI 10.1007/s00381-007-0459-6; Castellani C, 2008, CLIN CHEM LAB MED, V46, P1296, DOI 10.1515/CCLM.2008.262; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; Kleindienst A, 2005, J NEUROSURG, V102, P1115, DOI 10.3171/jns.2005.102.6.1115; Lindberg L, 1998, J THORAC CARDIOV SUR, V116, P281, DOI 10.1016/S0022-5223(98)70128-X; Lo TYM, 2009, J NEUROTRAUM, V26, P1479, DOI [10.1089/neu.2008.0753, 10.1089/neu.2008-0753]; Maschmann J, 2000, ACTA PAEDIATR, V89, P553, DOI 10.1080/080352500750027844; Nagdyman N, 2001, PEDIATR RES, V49, P502, DOI 10.1203/00006450-200104000-00011; Nygaard O, 1997, CLIN CHEM, V43, P541; Berger RP, 2006, PEDIATR CRIT CARE ME, V7, P557, DOI 10.1097/01.PCC.0000244426.37793.23; Portela LVC, 2002, CLIN CHEM, V48, P950; Routsi C, 2006, SHOCK, V26, P20, DOI 10.1097/01.shk.0000209546.06801.d7; Shore PM, 2007, J NEUROTRAUM, V24, P75, DOI 10.1089/neu.2006.0062; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Townend WJ, 2002, J NEUROL NEUROSUR PS, V73, P542, DOI 10.1136/jnnp.73.5.542	18	3	4	0	2	MAGHIRA & MAAS PUBLICATIONS	MUNSBACH	MAGHIRA & MAAS S A R L, 6C, RUE GABRIEL LIPPMANN, L-5365 MUNSBACH, LUXEMBOURG	0172-780X	2354-4716		NEUROENDOCRINOL LETT	Neuroendocrinol. Lett.		2012	33	2					207	211					5	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	955RD	WOS:000305037700016	22592203				2022-02-06	
B	Kegel, NE; Lovell, MR		Apps, JN; Walter, KD		Kegel, Nathan E.; Lovell, Mark R.			Methods of Formal Neurocognitive Assessment of Concussion	PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTION; WORKING-MEMORY; YOUNG-CHILDREN; HEAD-INJURY; RECOVERY; ATTENTION; PERFORMANCE; PREDICTORS; OUTCOMES		[Kegel, Nathan E.; Lovell, Mark R.] Univ Pittsburgh, Med Ctr, Sports Med Concuss Program, Pittsburgh, PA 15260 USA		Kegel, NE (corresponding author), Univ Pittsburgh, Med Ctr, Sports Med Concuss Program, Pittsburgh, PA 15260 USA.	kegelne@upmc.edu					Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Anderson VA, 2000, BRAIN INJURY, V14, P679; Anderson V, 2007, BRAIN INJURY, V21, P1399, DOI 10.1080/02699050701785070; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Catroppa C, 2003, NEUROPSYCHOL REHABIL, V13, P517, DOI 10.1080/09602010343000084; (CDC). National Center for Injury Prevention and Control, 2007, HEADS BRAIN INJ YOUR; Centers for Disease Control and Prevention, 2010, WHAT IS TRAUM BRAIN; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Chapman SS, 2005, BEHAV INTERVENT, V20, P37, DOI 10.1002/bin.168; Chevignard MP, 2009, DEV NEUROREHABIL, V12, P76, DOI 10.1080/17518420902777019; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; Collins M, 1999, JAMA-J AM MED ASSOC, V282, P2388; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Gioia GA, 2009, TOP LANG DISORD, V29, P266, DOI 10.1097/TLD.0b013e3181b5322b; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Lovell M. R., 2002, IMPACT BEST APPROACH; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Mandalis A, 2007, DEV NEUROPSYCHOL, V32, P683, DOI 10.1080/87565640701376045; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Park BS, 2009, APPL NEUROPSYCHOL, V16, P1, DOI 10.1080/09084280802636371; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Sonnenberg LK, 2010, BRAIN INJURY, V24, P1003, DOI 10.3109/02699052.2010.489033; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Tsatsanis K. D., 2005, HDB AUTISM PERVASIVE; Van Kampen D., 2006, AM J SPORTS MED, V34, P1; Varni JW, 2004, J RHEUMATOL, V31, P2494; Vincent, 2008, J INT NEUROPSYCH SOC, V1, P204; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	50	3	3	0	4	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-0-387-89544-4				2012							117	131		10.1007/978-0-387-89545-1_10	10.1007/978-0-387-89545-1		15	Psychology, Clinical; Clinical Neurology; Pediatrics	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Neurosciences & Neurology; Pediatrics	BZV30	WOS:000303027500010					2022-02-06	
J	Kochanek, PM; Carney, N; Adelson, PD; Ashwal, S; Bell, MJ; Bratton, S; Carson, S; Chesnut, RM; Ghajar, J; Goldstein, B; Grant, GA; Kissoon, N; Peterson, K; Selden, NR; Tong, KA; Tasker, RC; Vavilala, MS; Wainwright, MS; Warden, CR				Kochanek, Patrick M.; Carney, Nancy; Adelson, P. David; Ashwal, Stephen; Bell, Michael J.; Bratton, Susan; Carson, Susan; Chesnut, Randall M.; Ghajar, Jamshid; Goldstein, Brahm; Grant, Gerald A.; Kissoon, Niranjan; Peterson, Kimberly; Selden, Nathan R.; Tong, Karen A.; Tasker, Robert C.; Vavilala, Monica S.; Wainwright, Mark S.; Warden, Craig R.			Chapter 13. Hyperventilation	PEDIATRIC CRITICAL CARE MEDICINE			English	Article							TRAUMATIC-BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; COMATOSE PATIENTS; CHILDREN; METABOLISM; MANAGEMENT; THERAPY; SCORE		[Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Carney, Nancy; Carson, Susan; Peterson, Kimberly] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Warden, Craig R.] Oregon Hlth & Sci Univ, Doernbecher Childrens Hosp, Portland, OR 97201 USA; [Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Ashwal, Stephen] Loma Linda Univ, Sch Med, Dept Pediat, Div Child Neurol, Loma Linda, CA 92350 USA; [Bratton, Susan] Univ Utah, Sch Med, Salt Lake City, UT 84112 USA; [Chesnut, Randall M.; Vavilala, Monica S.] Univ Washington, Sch Med, Seattle, WA 98195 USA; [Ghajar, Jamshid] Weill Cornell Med Coll, New York, NY USA; [Goldstein, Brahm] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Newark, NJ 07103 USA; [Grant, Gerald A.] Duke Univ, Sch Med, Durham, NC 27706 USA; [Kissoon, Niranjan] Univ British Columbia, British Columbias Childrens Hosp, Vancouver, BC V5Z 1M9, Canada; [Tasker, Robert C.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Tasker, Robert C.] Childrens Hosp Boston, Boston, MA USA; [Wainwright, Mark S.] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA.		Bratton, Susan L./O-2353-2013; Kochanek, Patrick M/D-2371-2015; Tasker, Robert C/R-5837-2019; Kissoon, Niranjan/AAC-6140-2021; Adelson, David/W-2083-2019	Bratton, Susan L./0000-0002-4605-8078; Kochanek, Patrick M/0000-0002-2627-913X; 			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS53; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; BRATTON SL, 2007, J NEUROTRAUMA S1, V24, pS87; Curry R, 2008, PEDIATR CRIT CARE ME, V9, P141, DOI 10.1097/PCC.0B013e318166870e; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Kornecki A, 2002, CHILD NERV SYST, V18, P375, DOI 10.1007/s00381-002-0613-0; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63; SCHNEIDER GH, 1995, ACTA NEUROCHIR, V134, P71, DOI 10.1007/BF01428507; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P153, DOI 10.1136/jnnp.58.2.153; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; STRINGER WA, 1993, AM J NEURORADIOL, V14, P475; von Helden A, 1993, Acta Neurochir Suppl (Wien), V59, P102; Zwienenberg M, 1999, J NEUROTRAUM, V16, P937, DOI 10.1089/neu.1999.16.937	17	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1529-7535			PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JAN	2012	13	1		S			S58	S60		10.1097/PCC.0b013e31823f6765			3	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	982DS	WOS:000307022500013					2022-02-06	
J	Kochanek, PM; Carney, N; Adelson, PD; Ashwal, S; Bell, MJ; Bratton, S; Carson, S; Chesnut, RM; Ghajar, J; Goldstein, B; Grant, GA; Kissoon, N; Peterson, K; Selden, NR; Tong, KA; Tasker, RC; Vavilala, MS; Wainwright, MS; Warden, CR				Kochanek, Patrick M.; Carney, Nancy; Adelson, P. David; Ashwal, Stephen; Bell, Michael J.; Bratton, Susan; Carson, Susan; Chesnut, Randall M.; Ghajar, Jamshid; Goldstein, Brahm; Grant, Gerald A.; Kissoon, Niranjan; Peterson, Kimberly; Selden, Nathan R.; Tong, Karen A.; Tasker, Robert C.; Vavilala, Monica S.; Wainwright, Mark S.; Warden, Craig R.			Chapter 8. Hyperosmolar therapy	PEDIATRIC CRITICAL CARE MEDICINE			English	Article							CEREBRAL-BLOOD-FLOW; INCREASED INTRACRANIAL-PRESSURE; TRAUMATIC BRAIN-INJURY; SALT WASTING SYNDROME; SEVERE HEAD-INJURY; HYPERTONIC SALINE; PERFUSION-PRESSURE; MANNITOL; RESUSCITATION; FLUID		[Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Carney, Nancy; Carson, Susan; Peterson, Kimberly] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Ashwal, Stephen] Loma Linda Univ, Sch Med, Dept Pediat, Div Child Neurol, Loma Linda, CA 92350 USA; [Bratton, Susan] Univ Utah, Sch Med, Salt Lake City, UT 84112 USA; [Chesnut, Randall M.; Vavilala, Monica S.] Univ Washington, Sch Med, Seattle, WA 98195 USA; [Ghajar, Jamshid] Weill Cornell Med Coll, New York, NY USA; [Goldstein, Brahm] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Newark, NJ 07103 USA; [Grant, Gerald A.] Duke Univ, Sch Med, Durham, NC 27706 USA; [Kissoon, Niranjan] Univ British Columbia, British Columbias Childrens Hosp, Vancouver, BC V5Z 1M9, Canada; [Tasker, Robert C.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Tasker, Robert C.] Childrens Hosp Boston, Boston, MA USA; [Wainwright, Mark S.] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA; [Warden, Craig R.] Oregon Hlth & Sci Univ, Doernbecher Childrens Hosp, Portland, OR 97201 USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA.		Adelson, David/W-2083-2019; Kochanek, Patrick M/D-2371-2015; Tasker, Robert C/R-5837-2019; Bratton, Susan L./O-2353-2013; Kissoon, Niranjan/AAC-6140-2021	Kochanek, Patrick M/0000-0002-2627-913X; Bratton, Susan L./0000-0002-4605-8078; 			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS31; Albanese A, 2001, ARCH DIS CHILD, V85, P246, DOI 10.1136/adc.85.3.246; ARJAMAA O, 1992, ACTA PHYSIOL SCAND, V144, P113, DOI 10.1111/j.1748-1716.1992.tb09275.x; Becker DP, 1972, INTRACRANIAL PRESSUR, P309; Berkenbosch JW, 2002, PEDIATR NEUROSURG, V36, P75, DOI 10.1159/000048356; Biestro A, 1997, ACTA NEUROCHIR, V139, P725, DOI 10.1007/BF01420045; Biestro A, 1997, ACTA NEUROCHIR, V139, P732; BINGHAM WF, 1986, SURG NEUROL, V25, P340, DOI 10.1016/0090-3019(86)90207-7; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Carlotti APCP, 2001, J NEUROSURG, V95, P420, DOI 10.3171/jns.2001.95.3.0420; Dean NP, 2007, J NEUROSURG, V107, P387, DOI 10.3171/PED-07/11/387; Dominguez TE, 2004, CRIT CARE MED, V32, P1438, DOI 10.1097/01.CCM.0000124860.91886.C2; Donati-Genet PCM, 2001, J PEDIATR SURG, V36, P1094, DOI 10.1053/jpsu.2001.24770; Eder HG, 2000, CHILD NERV SYST, V16, P21, DOI 10.1007/s003810050005; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; FEIG PU, 1977, NEW ENGL J MED, V297, P1444, DOI 10.1056/NEJM197712292972608; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; JAMES HE, 1980, ACTA NEUROCHIR, V51, P161, DOI 10.1007/BF01406742; Jimenez R, 2006, PEDIATR NEUROL, V35, P261, DOI 10.1016/j.pediatrneurol.2006.05.004; KAIEDA R, 1989, NEUROSURGERY, V24, P671, DOI 10.1227/00006123-198905000-00003; KASOFF SS, 1988, PEDIATR NEUROSCI, V14, P241, DOI 10.1159/000120397; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; KONTOS HA, 1983, ADV EXP MED BIOL, V161, P365; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; LEVIN AB, 1979, NEUROSURGERY, V5, P570, DOI 10.1227/00006123-197911000-00005; MARSHALL LF, 1978, J NEUROSURG, V48, P169, DOI 10.3171/jns.1978.48.2.0169; MCGRAW CP, 1978, SURG NEUROL, V10, P127; MCGRAW CP, 1983, NEUROSURGERY, V13, P269, DOI 10.1227/00006123-198309000-00009; McManus ML, 1998, ANESTHESIOLOGY, V88, P1586, DOI 10.1097/00000542-199806000-00023; MENDELOW AD, 1985, J NEUROSURG, V63, P43, DOI 10.3171/jns.1985.63.1.0043; Miller J D, 1993, Acta Neurochir Suppl (Wien), V57, P152; MILLER JD, 1975, J NEUROSURG, V42, P274, DOI 10.3171/jns.1975.42.3.0274; MOSS GS, 1988, AM J SURG, V155, P425, DOI 10.1016/S0002-9610(88)80106-5; MUIZELAAR JP, 1986, STROKE, V17, P44, DOI 10.1161/01.STR.17.1.44; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; NAKAYAMA SI, 1985, J SURG RES, V38, P180, DOI 10.1016/0022-4804(85)90025-3; Nara I, 1998, ACT NEUR S, V71, P22; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Polderman KH, 2003, CRIT CARE MED, V31, P584, DOI 10.1097/01.CCM.0000050287.68977.84; Procaccio F, 1991, Agressologie, V32, P381; PROUGH DS, 1991, ANESTHESIOLOGY, V75, P319, DOI 10.1097/00000542-199108000-00021; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Rivkees SA, 2008, CURR OPIN PEDIATR, V20, P448, DOI 10.1097/MOP.0b013e328305e403; ROSNER MJ, 1987, NEUROSURGERY, V21, P147, DOI 10.1227/00006123-198708000-00003; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Schierhout G, 2000, COCHRANE DB SYST REV, V1; SCHWARTZ ML, 1984, CAN J NEUROL SCI, V11, P434, DOI 10.1017/S0317167100045960; Segal S, 2001, INTENS CARE MED, V27, P236, DOI 10.1007/s001340000717; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; SMITH HP, 1986, J NEUROSURG, V65, P820, DOI 10.3171/jns.1986.65.6.0820; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P521; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O; Weed LH, 1919, AM J PHYSIOL, V48, P512, DOI 10.1152/ajplegacy.1919.48.4.512; WISE B L, 1961, Surg Forum, V12, P398; WORTHLEY LIG, 1988, J NEUROSURG, V68, P478, DOI 10.3171/jns.1988.68.3.0478; Zornow M H, 1995, New Horiz, V3, P488	64	3	3	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JAN	2012	13	1		S			S36	S41		10.1097/PCC.0b013e31823f6621			6	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	982DS	WOS:000307022500008					2022-02-06	
J	Kouznetsov, E; Brennan, M; Vassilyadi, M				Kouznetsov, Evgueni; Brennan, Maureen; Vassilyadi, Michael			Towards Development of a Survival Prediction Tool for Pediatric Head Injury	PEDIATRIC NEUROSURGERY			English	Article						Pediatrics; Traumatic brain injury; Mathematical model; Prognosis	TRAUMATIC BRAIN-INJURY; MORTALITY	Background: The ability to provide an accurate prognosis for children with traumatic brain injury (TBI) would be useful for the children's families and the caregivers. In this study we examined whether an appropriate mathematical model can predict survival in this patient population. Methods: Data from the Children's Hospital of Eastern Ontario (CHEO) TBI registry was analyzed. First, a series of univariate logistic regressions was performed to ascertain the significance of individual predictors, such as age, maximum Glasgow Coma Scale (GCS) score, maximum head injury Abbreviated Injury Scores (AIS) and the Injury Severity Score (ISS). Second, a multinomial logistic regression was fitted using only individually significant predictors and inmodel predictor significance, and interactions were tested. Only two significant predictors were kept in the final model. This final model was subsequently used to predict survival for each individual patient using the n-1 training set (i.e. Lachenbruch's leave-one-out method). The receiver operating characteristics (ROC) method was used to ascertain specificity-sensitivity trade-offs at different probability cut-offs in order to predict survival. Results: Only the maximum GCS and head injury AIS remained significant, both individually and in the polynomial logistic regression. Empiric ROC curve analyses from leave-one-out survival predictions showed statistical significance (area under the curve = 0.87, Z = 6.8, p < 0.001). Only 12% of cases were misclassified using the 'best' cut-off. Conclusion: An outcome predictive model for pediatric TBI can be devised using an appropriate mathematical model. It may help to estimate expected outcomes in pediatric TBI more objectively. Copyright (c) 2012 S. Karger AG,	[Kouznetsov, Evgueni; Brennan, Maureen; Vassilyadi, Michael] Childrens Hosp Eastern Ontario, Div Neurosurg, Ottawa, ON K1H 8L1, Canada; [Kouznetsov, Evgueni; Vassilyadi, Michael] Ottawa Hosp, Div Neurosurg, Ottawa, ON, Canada		Vassilyadi, M (corresponding author), Childrens Hosp Eastern Ontario, Div Neurosurg, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.	vassilyadi@cheo.on.ca					Doppenberg EMR, 2004, YOUMANS NEUROLOGICAL, P3473; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Lachenbruch P. A., 1975, DISCRIMINANT ANAL; Lo TYM, 2009, J NEUROTRAUM, V26, P1479, DOI [10.1089/neu.2008.0753, 10.1089/neu.2008-0753]; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Ottochian M, 2009, J TRAUMA, V67, P81, DOI 10.1097/TA.0b013e318188b934; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170	9	3	3	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291			PEDIATR NEUROSURG	Pediatr. Neurosurg.		2012	48	1					1	5		10.1159/000340068			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	021LG	WOS:000309885700001	22922420				2022-02-06	
J	Liu, L; Qian, XH; Feng, GD; Wu, MM; Yang, AA; Jiao, XY; You, SW; Ju, G				Liu, Ling; Qian, Xin-Hong; Feng, Guo-Dong; Wu, Ming-Mei; Yang, An-An; Jiao, Xi-Ying; You, Si-Wei; Ju, Gong			Different neuroprotection and therapeutic time windows by two specific diazepam regimens on retinal ganglion cells after optic nerve transection in adult rats	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Diazepam; optic nerve transection; retinal ganglion cells; neuroprotection; GABA receptor; rat	TRANSIENT CEREBRAL-ISCHEMIA; BENZODIAZEPINE BINDING-SITE; HIPPOCAMPAL CA1 NEURONS; TRAUMATIC BRAIN-INJURY; GABA(A) RECEPTORS; POSTISCHEMIC DIAZEPAM; AXONAL REGENERATION; FOREBRAIN ISCHEMIA; GLOBAL-ISCHEMIA; DEATH	Purpose: To compare neuroprotection and therapeutic time windows of two diazepam regimens on retinal ganglion cells (RGCs) after rat optic nerve transection (ONT). Methods: Adult rats received initial intraperitoneal diazepam injections 30 minutes before left ONT, followed by daily diazepam (Regimen-A) or every 8 hours for 3 days (Regimen-B) until they were killed at Day 7 or 14. Initial diazepam in Regimen-A and Regimen-B was delayed to 3, 6, 7, 9, 10, 12 and 6, 7, 8, 9, 10, 12 hours after ONT and these animals survived for 7 days. The effect of daily combinational uses of diazepam and bicuculline was assayed at 7 days. Results: Regimen-A induced higherRGCdensities than those in control and Regimen-B groups at Day 7, but lower density than Regimen-B did at Day 14. When initial diazepam was delayed beyond 6 or 8 hours after ONT with Regimen-A and Regimen-B, the promoting effects of diazepam on RGC densities disappeared. Bicuculline completely inhibited the protection of diazepam. Conclusions: Prolonged neuroprotection on RGCs at Day 14 and extended therapeutic time window for 8 hours can be achieved by Regimen-B, while Regimen-A induces a stronger neuroprotection at Day 7. Diazepam neuroprotection is mediated through GABA(A) receptor.	[Liu, Ling; Feng, Guo-Dong; Wu, Ming-Mei; Yang, An-An; Jiao, Xi-Ying; You, Si-Wei; Ju, Gong] Fourth Mil Med Univ, Inst Neurosci, Xian 710032, Peoples R China; [Qian, Xin-Hong] Fourth Mil Med Univ, Xijing Hosp, Inst Paediat, Xian 710032, Peoples R China		You, SW (corresponding author), Fourth Mil Med Univ, Inst Neurosci, 17 W Changle Rd, Xian 710032, Peoples R China.	yousiwei@fmmu.edu.cn; jugong@fmmu.edu.cn			Chinese National Key Project for Basic Research [2011CB504402]; National Natural Science Foundations of ChinaNational Natural Science Foundation of China (NSFC) [30901649, 30872829, 30973088]; Natural Science Basis Research Plan of Shaanxi Province [2011JQ4008]	This research work was supported by Chinese National Key Project for Basic Research (2011CB504402), National Natural Science Foundations of China (30901649, 30872829 and 30973088) and the Natural Science Basis Research Plan of Shaanxi Province (2011JQ4008).	Aerden LAM, 2004, NEUROSCI LETT, V367, P76, DOI 10.1016/j.neulet.2004.05.083; Anderson M, 2010, ARCH DIS CHILDHOOD-E, V95, P183, DOI 10.1136/adc.2009.176321; Atack JR, 2005, EXPERT OPIN INV DRUG, V14, P601, DOI 10.1517/13543784.14.5.601; Barkana Y, 2004, BRAIN RES BULL, V62, P447, DOI 10.1016/S0361-9230(03)00071-6; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Chen Q, 1999, EXP NEUROL, V160, P215, DOI 10.1006/exnr.1999.7179; Corbett D, 2008, EXP NEUROL, V214, P309, DOI 10.1016/j.expneurol.2008.08.018; Davies LM, 2004, BRAIN RES, V1013, P223, DOI 10.1016/j.brainres.2004.04.015; Dowden J, 1999, BRAIN RES, V829, P1, DOI 10.1016/S0006-8993(99)01229-9; ERDO SL, 1990, EUR J PHARMACOL, V182, P203, DOI 10.1016/0014-2999(90)90515-8; ERDO SL, 1991, BRAIN RES, V542, P254, DOI 10.1016/0006-8993(91)91575-L; Gibson CJ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-38; Hall ED, 1998, BRAIN RES, V798, P325, DOI 10.1016/S0006-8993(98)00478-8; Holt RA, 1997, MOL BRAIN RES, V48, P164, DOI 10.1016/S0169-328X(97)00129-0; JONES TA, 1992, BEHAV BRAIN RES, V51, P1, DOI 10.1016/S0166-4328(05)80306-7; Kuhmonen J, 2002, J PHARM PHARMACOL, V54, P1565, DOI 10.1211/002235702180; Lukasiuk K, 2000, J NEUROCHEM, V74, P2445, DOI 10.1046/j.1471-4159.2000.0742445.x; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.ne.17.030194.003033; Nakazawa T, 2010, JPN J OPHTHALMOL, V54, P156, DOI 10.1007/s10384-009-0785-1; Nikolov R, 2010, TRAKIA J SCI, V8, P102; O'Dell DM, 2000, BRAIN RES, V861, P325, DOI 10.1016/S0006-8993(00)02055-2; Okumichi H, 2008, EXP EYE RES, V86, P727, DOI 10.1016/j.exer.2008.01.019; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Ooba S, 2008, NEUROSCI RES, V62, P195, DOI 10.1016/j.neures.2008.08.005; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Ricci L, 2007, EUR J PHARMACOL, V561, P80, DOI 10.1016/j.ejphar.2006.12.030; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; Sarnowska A, 2009, NEUROCHEM INT, V55, P164, DOI 10.1016/j.neuint.2009.01.024; SCHALLERT T, 1986, BRAIN RES, V379, P104, DOI 10.1016/0006-8993(86)90261-1; Schuettauf F, 2000, INVEST OPHTH VIS SCI, V41, P4313; SCHWARTZ RD, 1994, BRAIN RES, V647, P153, DOI 10.1016/0006-8993(94)91411-7; SCHWARTZ RD, 1995, J NEUROSCI, V15, P529; Schwartz-Bloom RD, 2000, NEUROSCIENCE, V98, P471, DOI 10.1016/S0306-4522(00)00144-5; Schwartz-Bloom RD, 1998, J CEREBR BLOOD F MET, V18, P548, DOI 10.1097/00004647-199805000-00010; SIEGHART W, 1995, PHARMACOL REV, V47, P181; Sigel E, 2011, CURR TOP MED CHEM, V11, P241, DOI 10.2174/156802611794863562; Sucher NJ, 1997, VISION RES, V37, P3483, DOI 10.1016/S0042-6989(97)00047-3; Vorwerk CK, 2004, BRAIN RES BULL, V62, P485, DOI 10.1016/S0361-9230(03)00075-3; Walters RJ, 2000, NAT NEUROSCI, V3, P1274, DOI 10.1038/81800; Watanabe M, 2002, PROG RETIN EYE RES, V21, P529, DOI 10.1016/S1350-9462(02)00037-X; Winkler T, 1997, ACT NEUR S, V70, P216; Wu MM, 2010, CELL TRANSPLANT, V19, P159, DOI 10.3727/096368910X492625; Wu MM, 2003, NEUROSCI LETT, V341, P84, DOI 10.1016/S0304-3940(03)00151-4; Yang XL, 2004, PROG NEUROBIOL, V73, P127, DOI 10.1016/j.pneurobio.2004.04.002; ZARRINDAST MR, 1989, GEN PHARMACOL, V20, P855, DOI 10.1016/0306-3623(89)90343-1	45	3	3	3	11	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028			RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2012	30	4					335	343		10.3233/RNN-2012-110216			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	973OA	WOS:000306368300007	22614954				2022-02-06	
J	Lorentzen, J; Nielsen, D; Holm, K; Baagoe, S; Grey, MJ; Nielsen, JB				Lorentzen, Jakob; Nielsen, Dorthe; Holm, Karl; Baagoe, Susanne; Grey, Michael J.; Nielsen, Jens B.			Neural tension technique is no different from random passive movements in reducing spasticity in patients with traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Spasticity; neural tension; traumatic brain injury	CARPAL-TUNNEL-SYNDROME; TREATMENT PROTOCOLS; MULTIPLE-SCLEROSIS; GLIDING EXERCISES; CEREBRAL-PALSY; STROKE; NERVE; TRIAL; TORQUE	Purpose: Neural tension technique (NTT) is a therapy believed to reduce spasticity and to increase range of motion (ROM). This study compared the ability of NTT and random passive movements (RPMs) to reduce spasticity in the knee flexors in 10 spastic patients with brain injury. Methods: An RCT study with crossover design evaluated muscle tone measured by: 1) hand-held dynamometer; 2) Modified Ashworth Scale (MAS); 3) and ROM by; 4) angles of resistance onset "catch" (R1) compensatory movement (R2); and 5) 'subjectively perceived reduction in muscle tone'. Outcome measures were recorded by three raters before and after a single treatment session. Results: Objective stiffness measured with the hand-held device showed no significant changes for the NTT or RPM (p >= 0.09-0.79). The subjective measures showed significant changes after the NTT for the non-blinded rater (MAS: p < 0.05: R1: p < 0.05; R2: p < 0.05), but for the blinded rater a significant reduction was found only for R1 (p < 0.05) and R2 (p < 0.05). For the non-blinded rater intervention effects were found for R1 (p < 0.01), R2 (p < 0.01) and subjectively perceived tone reduction (p < 0.01). For the blinded rater no intervention effect was found. Conclusions: An objective evaluation of NTT demonstrates that it does not reduce spasticity. However, it does increase ROM with the same effect as RPM.	[Lorentzen, Jakob; Nielsen, Dorthe; Holm, Karl; Baagoe, Susanne] Copenhagen Univ Hosp, Hvidovre Hosp, Dept Neurorehabil TBI Unit, Dept Physiotherapy, Glostrup, Denmark; [Lorentzen, Jakob; Grey, Michael J.; Nielsen, Jens B.] Univ Copenhagen, Dept Exercise & Sport Sci, DK-2200 Copenhagen N, Denmark; [Grey, Michael J.; Nielsen, Jens B.] Univ Copenhagen, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [Grey, Michael J.] Univ Birmingham, Sch Sport & Exercise Sci, Coll Life & Environm Sci, Birmingham, W Midlands, England		Lorentzen, J (corresponding author), Univ Copenhagen, Dept Phys Exercise & Sport Sci, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	jlorentzen@ifi.ku.dk	Nielsen, Jens Bo/C-7632-2015; Grey, Michael J/B-4029-2011	Nielsen, Jens Bo/0000-0001-5568-2916; lorentzen, jakob/0000-0002-7634-0218			Akalin E, 2002, AM J PHYS MED REHAB, V81, P108, DOI 10.1097/00002060-200202000-00006; Baysal O, 2006, INT J CLIN PRACT, V60, P820, DOI 10.1111/j.1742-1241.2006.00867.x; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; BRAR SP, 1991, ARCH PHYS MED REHAB, V72, P186; Butler DS, 2000, SENSITIVE NERVOUS SY; Cadenhead SL, 2002, PHYS THER, V82, P658, DOI 10.1093/ptj/82.7.658; Chung SG, 2005, P ANN INT IEEE EMBS, P3672, DOI 10.1109/IEMBS.2005.1617279; Cleland JA, 2006, MANUAL THER, V11, P279, DOI 10.1016/j.math.2005.07.002; Coppieters MW, 2008, MANUAL THER, V13, P213, DOI 10.1016/j.math.2006.12.008; de Jong LD, 2006, CLIN REHABIL, V20, P656, DOI 10.1191/0269215506cre1007oa; Ellis RF, 2008, J MAN MANIP THER, V16, P8, DOI 10.1179/106698108790818594; Godoi J, 2010, Electromyogr Clin Neurophysiol, V50, P55; Hale L.A., 1995, S AFR J PHYSIOTHER, V51, P3; Harvey LA, 2000, ARCH PHYS MED REHAB, V81, P1340, DOI 10.1053/apmr.2000.9168; Jaberzadeh S, 2005, PHYSIOTHERAPY, V91, P94, DOI 10.1016/j.physio.2004.09.021; Lance J.W., 1980, SPASTICITY DISORDERE, P485; Lorentzen J., 2011, CLIN NEUROPHYSIOL; Lorentzen J, 2010, CLIN NEUROPHYSIOL, V121, P1939, DOI 10.1016/j.clinph.2010.02.167; MATTSSON E, 1990, SCAND J REHABIL MED, V22, P55; Nuyens GE, 2002, ARCH PHYS MED REHAB, V83, P930, DOI 10.1053/apmr.2002.33233; Pinar L, 2005, ADV THER, V22, P467, DOI 10.1007/BF02849867; Prochazka A, 1997, MOVEMENT DISORD, V12, P24, DOI 10.1002/mds.870120106; Selles RW, 2005, ARCH PHYS MED REHAB, V86, P2330, DOI 10.1016/j.apmr.2005.07.305; Shacklock M., 1995, PHYSIOTHERAPY, V81, P9, DOI DOI 10.1016/S0031-9406(05)67024-1; Tal-Akabi A, 2000, MANUAL THER, V5, P214, DOI 10.1054/math.2000.0355; Tuzson AE, 2003, ARCH PHYS MED REHAB, V84, P1363, DOI 10.1016/S0003-9993(03)00199-0; Yeh CY, 2005, ARCH PHYS MED REHAB, V86, P235, DOI 10.1016/j.apmr.2004.03.032; Zhang LQ, 2002, IEEE T NEUR SYS REH, V10, P149, DOI 10.1109/TNSRE.2002.802857	28	3	3	0	11	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.		2012	34	23					1978	1985		10.3109/09638288.2012.665132			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	015WX	WOS:000309478200005	22423894				2022-02-06	
J	Perkins, S				Perkins, Suzanne			An Ecological Perspective on the Comorbidity of Childhood Violence Exposure and Disabilities: Focus on the Ecology of the School	PSYCHOLOGY OF VIOLENCE			English	Article						child maltreatment; disability; language development; ecological framework; school violence	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; INTELLECTUAL DISABILITIES; PHYSICAL ABUSE; MENTAL-HEALTH; SEXUAL-ABUSE; MALTREATMENT; CHILDREN; STUDENTS; CONTEXT	Violence exposure and disabilities frequently co-occur. Rates of disabilities among children with violence exposure range from 3 to 11 times that of nonexposed children. Each can be causal in the development of the other both directly and through less direct pathways. In this article, both direct and indirect influences that can lead to a circular pattern of mutual reinforcement between violence and disabilities are identified. Childhood disability research has historically focused on the individual more than the ecological context. Within the field of childhood violence exposure, the focus is often on perpetrators within the family or community. In this article, the ecological framework is applied to violence and disabilities studies to help integrate the two different research literatures and to examine different levels of influence on the developmental course of both social problems. The experience of school is used as a framework for examining violence and disability transactions at each level of the ecological framework, including the role of bullying and school violence. Finally, areas of intervention within the purview of schooling are identified, particularly those that empower students through mastery-focused school climate and student involvement.	[Perkins, Suzanne] Univ Michigan, Ann Arbor, MI 48109 USA		Perkins, S (corresponding author), Univ Michigan, Dept Psychiat, 2709 Rachel Upjohn Bldg,4250 Plymouth Rd, Ann Arbor, MI 48109 USA.	sperkinz@umich.edu	Perkins, Suzanne/AAE-3406-2019				Achilles GM, 2007, J EMOT BEHAV DISORD, V15, P33, DOI 10.1177/10634266070150010401; Akiba M, 2002, AM EDUC RES J, V39, P829, DOI 10.3102/00028312039004829; Allodi MW, 2007, DISABIL SOC, V22, P639, DOI 10.1080/09687590701560279; Andersen SL, 2008, J NEUROPSYCH CLIN N, V20, P292, DOI 10.1176/appi.neuropsych.20.3.292; Arcus D, 2002, AGGRESSIVE BEHAV, V28, P173, DOI 10.1002/ab.90020; Astor RA, 2009, AM EDUC RES J, V46, P423, DOI 10.3102/0002831208329598; Baker DP, 2001, EDUC EVAL POLICY AN, V23, P1, DOI 10.3102/01623737023001001; Baker JA, 1998, J SCHOOL PSYCHOL, V36, P29, DOI 10.1016/S0022-4405(97)00048-4; Baldry AC, 2003, CHILD ABUSE NEGLECT, V27, P713, DOI 10.1016/S0145-2134(03)00114-5; Beitchman JH, 2001, J AM ACAD CHILD PSY, V40, P75, DOI 10.1097/00004583-200101000-00019; Benbenishty R, 2007, SOC INDIC RES, V84, P333, DOI 10.1007/s11205-007-9116-4; Bickmore K, 2011, EDUC POLICY, V25, P648, DOI 10.1177/0895904810374849; Bon S.C., 2006, J DISABIL POLICY STU, V17, P148, DOI [10.1177/10442073060170030301, DOI 10.1177/10442073060170030301]; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Bronfenbrenner U., 1976, EDUC RESEARCHER, V5, P5, DOI [DOI 10.2307/1174755, 10.3102/0013189X005009005, DOI 10.3102/0013189X005009005]; Brown J, 1998, CHILD ABUSE NEGLECT, V22, P1065, DOI 10.1016/S0145-2134(98)00087-8; Choi J, 2009, BIOL PSYCHIAT, V65, P227, DOI 10.1016/j.biopsych.2008.06.022; Cicchetti D, 2007, DEV PSYCHOPATHOL, V19, P1161, DOI 10.1017/S0954579407000600; Cicchetti D, 2010, CHILD DEV, V81, P252, DOI 10.1111/j.1467-8624.2009.01393.x; Connell CM, 2007, CHILD ABUSE NEGLECT, V31, P573, DOI 10.1016/j.chiabu.2006.12.004; Connor CM, 2010, J SCHOOL PSYCHOL, V48, P433, DOI 10.1016/j.jsp.2010.06.003; Crooks CV, 2007, CHILD MALTREATMENT, V12, P269, DOI 10.1177/1077559507301843; Dahl RE, 2004, ANN NY ACAD SCI, V1021, P1, DOI 10.1196/annals.1308.001; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1271, DOI 10.1016/S0006-3223(99)00045-1; De Bellis MD, 2005, CHILD MALTREATMENT, V10, P150, DOI 10.1177/1077559505275116; Drake B, 1996, CHILD ABUSE NEGLECT, V20, P1003, DOI 10.1016/0145-2134(96)00091-9; Elliott GC, 2005, J INTERPERS VIOLENCE, V20, P1663, DOI 10.1177/0886260505281439; English DJ, 2005, CHILD ABUSE NEGLECT, V29, P441, DOI 10.1016/j.chiabu.2003.09.023; Estell DB, 2009, J CHILD FAM STUD, V18, P136, DOI 10.1007/s10826-008-9214-1; Evans GW, 1997, ENVIRON BEHAV, V29, P638, DOI 10.1177/0013916597295003; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Flannery DJ, 2004, J COMMUNITY PSYCHOL, V32, P559, DOI 10.1002/jcop.20019; Flynt S., 2004, J INSTR PSYCHOL, V31, P330; Fujiura GT, 2000, EXCEPT CHILDREN, V66, P187, DOI 10.1177/001440290006600204; Gellman RA, 2006, PSYCHOL SCHOOLS, V43, P591, DOI 10.1002/pits.20172; Govindshenoy M, 2007, CHILD CARE HLTH DEV, V33, P552, DOI 10.1111/j.1365-2214.2006.00693.x; HART B, 1995, MEANINGFUL DIFFERENC, P268; Hershkowitz I, 2007, AM J ORTHOPSYCHIAT, V77, P629, DOI 10.1037/0002-9432.77.4.629; Horner-Johnson W, 2006, MENT RETARD DEV D R, V12, P57, DOI 10.1002/mrdd.20097; Hyman IA, 1998, J SCHOOL PSYCHOL, V36, P7, DOI 10.1016/S0022-4405(97)87007-0; Jaudes PK, 2008, CHILD ABUSE NEGLECT, V32, P671, DOI 10.1016/j.chiabu.2007.08.007; Jaycox Lisa H, 2009, School Ment Health, V1, P49; Jonson-Reid M, 2004, CHILD MALTREATMENT, V9, P382, DOI 10.1177/1077559504269192; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kendall-Tackett K, 2005, CHILD ABUSE NEGLECT, V29, P147, DOI 10.1016/j.chiabu.2004.09.002; Kim YS, 2006, ARCH GEN PSYCHIAT, V63, P1035, DOI 10.1001/archpsyc.63.9.1035; Kinard E M, 2001, Violence Vict, V16, P323; Kinard EM, 2001, CHILD ABUSE NEGLECT, V25, P33; Knutson JF, 2004, CHILD ABUSE NEGLECT, V28, P925, DOI 10.1016/j.chiabu.2004.04.005; KNUTSON JF, 1993, TOP LANG DISORD, V13, P1, DOI 10.1097/00011363-199308000-00005; McGee R, 2001, DEV PSYCHOPATHOL, V13, P827, DOI 10.1017/S0954579401004059; Miskovic V, 2010, DEV PSYCHOPATHOL, V22, P419, DOI 10.1017/S0954579410000155; MORRISON GM, 1994, EDUC TREAT CHILD, V17, P356; Noble KG, 2005, FUTURE CHILD, V15, P71, DOI 10.1353/foc.2005.0006; Noble KG, 2006, DEVELOPMENTAL SCI, V9, P642; Obradovic J, 2010, CHILD DEV, V81, P270, DOI 10.1111/j.1467-8624.2009.01394.x; Prasad MR, 2005, ARCH DIS CHILD, V90, P82, DOI 10.1136/adc.2003.045583; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Reddy LA, 2009, PSYCHOL SCHOOLS, V46, P132, DOI 10.1002/pits.20359; Reiter S, 2007, INTELLECT DEV DISAB, V45, P174, DOI 10.1352/1934-9556(2007)45[174:BASESW]2.0.CO;2; Risley T. R., 2006, CHILD PSYCHOL MENTAL, V4, P83; Roeser RW, 2000, ELEM SCHOOL J, V100, P443, DOI 10.1086/499650; Rosen D, 2007, J INTERPERS VIOLENCE, V22, P1305, DOI 10.1177/0886260507304551; RYAN R, 1994, COMMUNITY MENT HLT J, V30, P45, DOI 10.1007/BF02188874; Saylor CF, 2009, J DEV PHYS DISABIL, V21, P69, DOI 10.1007/s10882-008-9126-4; Scarborough AA, 2010, CHILD YOUTH SERV REV, V32, P80, DOI 10.1016/j.childyouth.2009.07.015; Sentenac M, 2011, J ADOLESCENT HEALTH, V48, P461, DOI 10.1016/j.jadohealth.2010.07.031; Sidebotham P, 2003, CHILD ABUSE NEGLECT, V27, P337, DOI 10.1016/S0145-2134(03)00010-3; Sidebotham P, 2002, CHILD ABUSE NEGLECT, V26, P1243, DOI 10.1016/S0145-2134(02)00415-5; Simeonsson RJ, 2001, DISABIL REHABIL, V23, P49; Singh-Manoux A, 2006, INT J BEHAV MED, V13, P320, DOI 10.1207/s15327558ijbm1304_7; Skiba RJ, 2006, EXCEPT CHILDREN, V72, P411, DOI 10.1177/001440290607200402; Sobsey D, 1997, CHILD ABUSE NEGLECT, V21, P707, DOI 10.1016/S0145-2134(97)00033-1; Sobsey D., 2002, EXCEPTIONALITY, V10, P29; Solberg ME, 2003, AGGRESSIVE BEHAV, V29, P239, DOI 10.1002/ab.10047; Solomon CR, 1999, CHILD ABUSE NEGLECT, V23, P339, DOI 10.1016/S0145-2134(99)00006-X; Spencer N, 2005, PEDIATRICS, V116, P609, DOI 10.1542/peds.2004-1882; Springer KW, 2007, CHILD ABUSE NEGLECT, V31, P517, DOI 10.1016/j.chiabu.2007.01.003; Stalker K, 2012, CHILD ABUSE REV, V21, P24, DOI 10.1002/car.1154; Sullivan PM, 2010, PRACTICAL GUIDE TO THE EVALUATION OF CHILD PHYSICAL ABUSE AND NEGLECT, P335, DOI 10.1007/978-1-4419-0702-8_10; Sullivan PM, 2009, CLIN CHILD FAM PSYCH, V12, P196, DOI 10.1007/s10567-009-0056-1; Sullivan PM, 2000, CHILD ABUSE NEGLECT, V24, P1257, DOI 10.1016/S0145-2134(00)00190-3; Sullivan PM, 1998, SEX DISABIL, V16, P295, DOI 10.1023/A:1023019912548; Veltman M. W., 2001, TRAUMA VIOLENCE ABUS, V2, P215, DOI DOI 10.1177/1524838001002003002; Weikart, 2008, J SCH VIOLENCE, V7, P3, DOI DOI 10.1080/15388220801973813; Welsh WN, 2000, J RES CRIME DELINQ, V37, P243, DOI 10.1177/0022427800037003001; WESTLING M, 2002, LEARNING ENVIRON RES, V5, P253, DOI DOI 10.1023/A:1021972206111; Wigham S, 2011, J MENT HEALTH RES IN, V4, P19, DOI 10.1080/19315864.2010.534576; Wilcox Pamela, 2006, J Prim Prev, V27, P293, DOI 10.1007/s10935-006-0034-z; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	101	3	3	0	11	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	2152-0828	2152-081X		PSYCHOL VIOLENCE	Psychol. Violence	JAN	2012	2	1					75	89		10.1037/a0026137			15	Psychology, Clinical; Criminology & Penology; Family Studies	Social Science Citation Index (SSCI)	Psychology; Criminology & Penology; Family Studies	087EW	WOS:000314745100007	34621555	Green Accepted			2022-02-06	
J	Pomerleau, G; Hurteau, AM; Parent, L; Doucet, K; Corbin-Berrigan, LA; Gagnon, I				Pomerleau, Genevieve; Hurteau, Anne-Marie; Parent, Line; Doucet, Katrine; Corbin-Berrigan, Laurie-Ann; Gagnon, Isabelle			Developmental trajectories of infants and toddlers with good initial presentation following moderate or severe traumatic brain injury: A pilot clinical assessment project	JOURNAL OF PEDIATRIC REHABILITATION MEDICINE			English	Article						Traumatic brain injury; children; language development; motor development		Objective: The purpose of this study was to review the feasibility and usefulness of instituting a clinical protocol of scheduled assessments for children after a moderate or severe traumatic brain injury (TBI) sustained before the age of 2 years and showing no immediate deficits at hospital discharge, as well as to explore the early developmental trajectories of these children. Design: Exploratory analytical cohort study. Setting: Pediatric Trauma Center Out-patient services. Participants: 31 children were followed within the clinical protocol of scheduled assessments. Outcome measures: The protocol included an immediate post-injury clinical assessment of infants who sustained a TBI and follow-up assessments at the ages of 9 months, 18 months (if injured prior to that age), 30 months, and 42 months. Domains assessed at each scheduled visit included hearing, speech and language, motor performance, personal social abilities, and adaptive behaviors. Results: Clinicians reported few difficulties with scheduling or administering the assessments, maintaining a 67% participation rate at the end of the follow-up period, thus demonstrating the feasibility of the protocol in this population. Scores on the majority of formal tests showed high variability and 15-20% of children presented with clinically significant motor and/or language delays. By 42 months of age, difficulties with adaptive behavior and personal social abilities were identified in our sample of children when compared to published norms. Qualitative clinical findings from professionals identified between 25-50% of children with potential attentional difficulties throughout the follow-up period. Conclusion: Findings from this study demonstrate the feasibility of implementing a clinical protocol of assessment for infants and toddlers who sustain a TBI before the age of 2 years and present with no impairments at the time of discharge from hospital. Developmental problems in this population appear to be easier to identify later in the toddler years as opposed to immediately following the TBI, emphasizing the importance of providing screening for developmental issues in this population prior to school entry.	[Pomerleau, Genevieve; Hurteau, Anne-Marie; Parent, Line; Doucet, Katrine; Corbin-Berrigan, Laurie-Ann; Gagnon, Isabelle] McGill Univ, Hlth Ctr, Montreal Childrens Hosp, Montreal, PQ, Canada; [Pomerleau, Genevieve; Gagnon, Isabelle] McGill Univ, Fac Med, Montreal, PQ, Canada; [Hurteau, Anne-Marie] Univ Montreal, Fac Med, Montreal, PQ, Canada		Gagnon, I (corresponding author), Trauma Programs, C-833, Montreal, PQ H3H 1P3, Canada.	Isabelle.gagnon8@mcgill.ca		Gagnon, Isabelle/0000-0003-2043-1644	Trauma Programs; Research Institute of The Montreal Children's Hospital, McGill University Health Center; Fonds de recherche du Quebec-SanteFonds de la Recherche en Sante du Quebec	The authors wish to thank the Trauma Programs and the Research Institute of The Montreal Children's Hospital, McGill University Health Center for their support to this study. IG is supported by a career award from the Fonds de recherche du Quebec-Sante.	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2007, BRAIN INJURY, V21, P1399, DOI 10.1080/02699050701785070; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bonnier C, 2007, J CHILD NEUROL, V22, P519, DOI 10.1177/0883073807302604; Brownell R., 2000, EXPRESSIVE ONE WORD; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2008, J CHILD NEUROL, V23, P486, DOI 10.1177/0883073807309773; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; Cook LG, 2008, NEUROREHABILITATION, V23, P467; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Edwards S., 1997, REYNELL DEV LANGUAGE; Elbaum B, 2010, J EARLY INTERVENTION, V32, P255, DOI 10.1177/1053815110384723; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Folio M.R., 2000, PEABODY DEV MOTOR SC, V2nd; Froehlich TE, 2007, ARCH PEDIAT ADOL MED, V161, P857, DOI 10.1001/archpedi.161.9.857; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Hagtvet K. A., 1990, SCANDINAVIAN J ED RE, V34, P77; Hanten G, 2004, ANN NEUROL, V56, P847, DOI 10.1002/ana.20298; Hymel KP, 2007, PEDIATRICS, V119, P922, DOI 10.1542/peds.2006-3111; Jantz P. B., 2007, TRAUMATIC BRAIN INJU, V22; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Makaroff KL, 2003, DEV MED CHILD NEUROL, V45, P497, DOI 10.1017/S0012162203000926; Martin C, 2008, CURR OPIN PEDIATR, V20, P294, DOI 10.1097/MOP.0b013e3282ff0dfa; Millichap JG, 2008, PEDIATRICS, V121, pE358, DOI 10.1542/peds.2007-1332; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Newborg J., 1984, BATTELLE DEV INVENTO; Ornstein TJ, 2009, J CHILD PSYCHOL PSYC, V50, P506, DOI 10.1111/j.1469-7610.2008.01997.x; Prigatano GP, 2008, BRAIN INJURY, V22, P491, DOI 10.1080/02699050802084902; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; SAIGAL S, 1991, J PEDIATR-US, V118, P751, DOI 10.1016/S0022-3476(05)80043-5; Snodgrass C, 2006, BRAIN INJURY, V20, P825, DOI 10.1080/02699050600832585; Tavano A, 2009, BRAIN INJURY, V23, P167, DOI 10.1080/02699050802657012; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Tomblin JB, 1997, J SPEECH LANG HEAR R, V40, P1245, DOI 10.1044/jslhr.4006.1245; Tonks J, 2009, DEV MED CHILD NEUROL, V51, P8, DOI 10.1111/j.1469-8749.2008.03219.x; van Hartingsveldt Margo J, 2005, Occup Ther Int, V12, P1, DOI 10.1002/oti.11; Van Heugten CM, 2006, BRAIN INJURY, V20, P895, DOI 10.1080/02699050600832015; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007; [No title captured]	49	3	3	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1874-5393	1875-8894		J PEDIATR REHAB MED	J. Pediatr. Rehab. Med.		2012	5	2					89	97		10.3233/PRM-2012-0200			9	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	VG7KH	WOS:000448277600003	22699099				2022-02-06	
J	Roll, WG; Saroka, KS; Mulligan, BP; Hunter, MD; Dotta, BT; Gang, N; Scott, MA; St-Pierre, LS; Persinger, MA				Roll, William G.; Saroka, Kevin S.; Mulligan, Bryce P.; Hunter, Mathew D.; Dotta, Blake T.; Gang, Noa; Scott, Mandy A.; St-Pierre, Linda S.; Persinger, Michael A.			Case report: A prototypical experience of 'poltergeist' activity, conspicuous quantitative electroencephalographic patterns, and sLORETA profiles - suggestions for intervention	NEUROCASE			English	Article						Quantitative electroencephalography; sLORETA; Poltergeist-like phenomena; Geomagnetic sensitivity; Right temporal lobe; Closed head injury	INCREASED GEOMAGNETIC-ACTIVITY; SENSED PRESENCE; BRAIN; EEG; HALLUCINATIONS; TOMOGRAPHY; BEHAVIOR; TIME	People who report objects moving in their presence, unusual sounds, glows around other people, and multiple sensed presences but do not meet the criteria for psychiatric disorders have been shown to exhibit electrical anomalies over the right temporal lobes. This article reports the striking quantitative electroencephalography, sLORETA results, and experimental elicitation of similar subjective experiences in a middle-aged woman who has been distressed by these classic phenomena that began after a head injury. She exhibited a chronic electrical anomaly over the right temporoinsular region. The rotation of a small pinwheel near her while she 'concentrated' upon it was associated with increased coherence between the left and right temporal lobes and concurrent activation of the left prefrontal region. The occurrence of the unusual phenomena and marked 'sadness' was associated with increased geomagnetic activity; she reported a similar mood when these variations were simulated experimentally. Our quantitative measurements suggest people displaying these experiences and possible anomalous energies can be viewed clinically and potentially treated.	[Saroka, Kevin S.; Mulligan, Bryce P.; Hunter, Mathew D.; Dotta, Blake T.; Gang, Noa; Scott, Mandy A.; St-Pierre, Linda S.; Persinger, Michael A.] Laurentian Univ, Behav Neurosci Program, Clin Neuropsychol Lab, Sudbury, ON P3E 2C6, Canada; [Saroka, Kevin S.; Mulligan, Bryce P.; Hunter, Mathew D.; Dotta, Blake T.; Gang, Noa; Scott, Mandy A.; St-Pierre, Linda S.; Persinger, Michael A.] Laurentian Univ, Grad Psychol Program, Clin Neuropsychol Lab, Sudbury, ON P3E 2C6, Canada; [Roll, William G.] Univ W Georgia, Dept Psychol, Carrollton, GA USA; [Persinger, Michael A.] Laurentian Univ, Biomol Sci Program, Sudbury, ON P3E 2C6, Canada		Persinger, MA (corresponding author), Laurentian Univ, Behav Neurosci Program, Clin Neuropsychol Lab, Sudbury, ON P3E 2C6, Canada.	mpersinger@laurentian.ca					Babayev ES, 2007, ADV SPACE RES, V40, P1941, DOI 10.1016/j.asr.2007.02.099; BANCAUD J, 1994, BRAIN, V117, P71, DOI 10.1093/brain/117.1.71; BEAR DM, 1979, CORTEX, V15, P357, DOI 10.1016/S0010-9452(79)80064-7; BEAR DM, 1977, ARCH NEUROL-CHICAGO, V34, P454, DOI 10.1001/archneur.1977.00500200014003; Booth JN, 2005, INT J NEUROSCI, V115, P1053, DOI 10.1080/00207450590901521; Booth JN, 2009, J NEUROPSYCH CLIN N, V21, P279, DOI 10.1176/appi.neuropsych.21.3.279; Burr HS, 1972, BLUEPRINT IMMORTALIT; Craig AD, 2009, BRAIN, V132, DOI 10.1093/brain/awp038; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dotta B. T., 2011, INCREASED PHOT UNPUB; Dotta BT, 2011, BRAIN RES, V1388, P77, DOI 10.1016/j.brainres.2011.03.001; GEARHART L, 1986, PERCEPT MOTOR SKILL, V62, P463, DOI 10.2466/pms.1986.62.2.463; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Koenig T, 2002, NEUROIMAGE, V16, P41, DOI 10.1006/nimg.2002.1070; Lehmann D, 2010, NEUROIMAGE, V49, P1073, DOI 10.1016/j.neuroimage.2009.07.054; Michon AL, 1997, NEUROSCI LETT, V224, P53, DOI 10.1016/S0304-3940(97)13446-2; Mulert C, 2004, NEUROIMAGE, V22, P83, DOI 10.1016/j.neuroimage.2003.10.051; Mulligan B. P., 2011, EXPT SIMULATIO UNPUB; Mulligan BP, 2010, ADV SPACE RES, V45, P940, DOI 10.1016/j.asr.2009.12.008; Owen A. R. G., 1964, CAN WE EXPLAIN POLTE; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Persinger M.A., 2010, J CONSCIOUSNESS EXPL, V1, P808; Persinger M. A., 1995, NEUROSCI LETT, V84, P527; Persinger M. A., 2011, INT J GEOSCIENCES, V2, P363; Persinger M. A., 2005, INT J BIOMETEOROL, V115, P713; PERSINGER MA, 1988, NEUROSCI LETT, V88, P271, DOI 10.1016/0304-3940(88)90222-4; PERSINGER MA, 1993, PERCEPT MOTOR SKILL, V76, P915, DOI 10.2466/pms.1993.76.3.915; PERSINGER MA, 1993, J CLIN PSYCHOL, V49, P33, DOI 10.1002/1097-4679(199301)49:1<33::AID-JCLP2270490106>3.0.CO;2-H; PERSINGER MA, 1993, PSYCHOL REP, V72, P1059, DOI 10.2466/pr0.1993.72.3c.1059; RAJARAM M, 1981, NEUROSCI LETT, V24, P187, DOI 10.1016/0304-3940(81)90246-9; RAVITZ LJ, 1959, AM J CLIN HYPN, V1, P135, DOI 10.1080/00029157.1959.10401782; Roll W. G., 1986, HDB PARAPSYCHOLOGY, P120; Roll W. G., 2001, HAUNTINGS POLTERGEIS, P123; Roll W. G., 1973, RES PARAPSYCHOLOGY, P100; Roll W. G., 2003, J SCI EXPLORATION, V17, P75; Roll W. G., 2004, UNLEASHED POLTERGEIS; ROLL WG, 1973, J AM SOC PSYCHICAL R, V67, P267; Saroka KS, 2011, OPEN BEHAV SCI J, V5, P24; Sommer IEC, 2008, BRAIN, V131, P3169, DOI 10.1093/brain/awn251; Szechtman H, 1998, P NATL ACAD SCI USA, V95, P1956, DOI 10.1073/pnas.95.4.1956; Wagner M, 2004, BRAIN TOPOGR, V16, P277; Winterer G, 2001, BRAIN TOPOGR, V13, P299, DOI 10.1023/A:1011184814194	42	3	3	0	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase		2012	18	6					527	536		10.1080/13554794.2011.633532			10	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	040LC	WOS:000311323100010	22229671				2022-02-06	
J	Russo, RN; Rice, J; Chern, PM; Raftos, J				Russo, Remo Nunzio; Rice, James; Chern, Phei Ming; Raftos, Jeremy			Minimal and mild paediatric brain injury: A 3-year cohort of consecutive presentations	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Brain injury; closed head injury; trauma; child	HEAD-INJURY; CHILDREN; CLASSIFICATION; SCALE	Objective: To determine the number of children with minimal and mild traumatic brain injury (TBI) and their demographic factors, causes, associated signs/symptoms and management. Methods: A cross-sectional analysis of consecutive presentations to a tertiary paediatric centre. Results: There were 2043 presentations of minimal and mild TBI over 3 years (minimal TBI = 79.7% [n = 1628]; mild TBI = 20.3% [n = 415]). Mean age was 5.12 years (SD = 5.14) with children <= 3 years comprising 53.2% (n = 1086). There was a bimodal distribution in mild TBI with peaks at 0-2 and 13-15 years. The male-to-female ratio was 1.6:1. Only 34.6% of GCS scores were documented. Falls caused most injury. Overall, 6.3% (n = 129) required hospital admission and 29.1% (n = 594) were reviewed clinically. Conclusion: Minimal and mild TBI is common, representing a significant burden on individuals, families and healthcare providers. High rates of follow-up impact on the healthcare system and warrant further investigation.	[Russo, Remo Nunzio] Womens & Childrens Hlth Network, Dept Paediat Rehabil, Adelaide, SA 5006, Australia; [Russo, Remo Nunzio; Rice, James] Flinders Univ S Australia, Sch Med, Fac Hlth Sci, Adelaide, SA, Australia; [Chern, Phei Ming] Hosp Tengku Ampuan Rahimah, Dept Rehabil Med, Klang, Selangor, Malaysia		Russo, RN (corresponding author), Womens & Childrens Hlth Network, Dept Paediat Rehabil, Womens & Childrens Hosp Campus,72 King William Rd, Adelaide, SA 5006, Australia.	ray.russo@health.sa.gov.au					Australian Bureau of Statistics, 2005, MORT MORB CHILDR ACC; Australian Institute of Health and Welfare, 2004, CHILDR DIS AUSTR; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Brener I, 2004, J HEAD TRAUMA REHAB, V19, P405, DOI 10.1097/00001199-200409000-00005; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Fabbri A, 2010, INJURY, V41, P913, DOI 10.1016/j.injury.2010.03.002; Falk AC, 2005, CHILD NERV SYST, V21, P430, DOI 10.1007/s00381-005-1142-4; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Homer CJ, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e78; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; O'Flaherty SJ, 2000, ARCH PHYS MED REHAB, V81, P723, DOI 10.1016/S0003-9993(00)90100-X; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Seeley Helen M, 2007, Health Informatics J, V13, P135, DOI 10.1177/1460458207076469; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; TEASDALE G, 1974, LANCET, V2, P81	19	3	3	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.		2012	15	1					13	18		10.3109/17518423.2011.625558			6	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Rehabilitation	878YZ	WOS:000299295400002	21999660				2022-02-06	
J	Silva, MA; Donnell, AJ; Kim, MS; Vanderploeg, RD				Silva, Marc A.; Donnell, Alison J.; Kim, Michelle S.; Vanderploeg, Rodney D.			Abnormal Neurological Exam Findings in Individuals with Mild Traumatic Brain Injury (mTBI) Versus Psychiatric and Healthy Controls	CLINICAL NEUROPSYCHOLOGIST			English	Article						Brain injuries; Head injuries; Closed head injuries; Mental disorders; Neurologic manifestations; Postconcussion syndrome	DIAGNOSTIC INTERVIEW SCHEDULE; POSTTRAUMATIC-STRESS-DISORDER; POSTCONCUSSIVE SYMPTOMS; CONTINGENCY-TABLES; SEQUELAE; RATES	In those with a history of mild traumatic brain injury (mTBI), cognitive and emotional disturbances are often misattributed to that preexisting injury. However, causal determinations of current symptoms cannot be conclusively determined because symptoms are often nonspecific to etiology and offer virtually no differential diagnostic value in postacute or chronic phases. This population-based study examined whether the presence of abnormalities during neurological examination would distinguish between mTBI (in the chronic phase), healthy controls, and selected psychiatric conditions. Retrospective analysis of data from 4462 community-dwelling Army veterans was conducted. Diagnostically unique groups were compared on examination of cranial nerve function and other neurological signs. Results demonstrated that individuals with mTBI were no more likely than those with a major depressive disorder, generalized anxiety disorder, posttraumatic stress disorder, or somatoform disorder to show any abnormality. Thus, like self-reported cognitive and emotional symptoms, the presence of cranial nerve or other neurological abnormalities offers no differential diagnostic value. Clinical implications and study limitations are presented.	[Silva, Marc A.; Donnell, Alison J.; Kim, Michelle S.; Vanderploeg, Rodney D.] James A Haley Vet Hosp, Div Mental Hlth & Behav Sci, Tampa, FL 33612 USA; [Donnell, Alison J.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Donnell, Alison J.; Vanderploeg, Rodney D.] Def & Vet Brain Injury Ctr, Tampa, FL USA; [Vanderploeg, Rodney D.] James A Haley Vet Hosp, HSR&D RR&D Ctr Excellence Maximizing Rehabil Outc, Tampa, FL 33612 USA; [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychiat & Neurosci, Tampa, FL USA		Vanderploeg, RD (corresponding author), James A Haley Vet Hosp, Div Mental Hlth & Behav Sci, 13000 Bruce B Downs Blvd,Psychol Serv 116B, Tampa, FL 33612 USA.	rodney.vanderploeg@va.gov	Silva, Marc A./J-1874-2019	Silva, Marc A./0000-0002-3879-6054	Department of Veterans Affairs, Veteran Health Administration (VHA); Defense and Veterans Brain Injury Center (DVBIC)US Department of Veterans Affairs; James A. Haley Veterans' HospitalUS Department of Veterans Affairs	The research reported here was supported by the Department of Veterans Affairs, Veteran Health Administration (VHA), and the Defense and Veterans Brain Injury Center (DVBIC). Further support was provided by the James A. Haley Veterans' Hospital. The views expressed herein are of the authors and do not necessarily reflect the views of the official policies of the Department of Veterans Affairs or the U.S. Government.	American Psychiatric Association, 1980, DIAGN STAT MAN MENT; Baker AJ, 2011, J TRAUMA, V71, pS472, DOI 10.1097/TA.0b013e318232e7da; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; BERKSON J, 1978, J STAT PLAN INFER, V2, P27, DOI 10.1016/0378-3758(78)90019-8; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; CAMILLI G, 1978, PSYCHOL BULL, V85, P163, DOI 10.1037/0033-2909.85.1.163; Centers for Disease Control Vietnam Experience Study, 1989, HLTH STAT VIETN VE C; Centers for Disease Control Vietnam Experience Study, 1989, HLTH STAT VIETN VE B; Cohen J., 2013, STAT POWER ANAL BEHA; Dejong R, 1979, NEUROLOGICAL EXAMINA; DESTEFANO F, 1988, JAMA-J AM MED ASSOC, V259, P2701; DESTEFANO F, 1988, JAMA-J AM MED ASSOC, V259, P2708; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; FEUERMAN T, 1988, NEUROSURGERY, V22, P449, DOI 10.1227/00006123-198803000-00001; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gillig P.M., 2010, PSYCHIATRY, V7, P25; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Green S.B., 2008, USING SPSS WINDOWS M, V5th ed.; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; HELZER JE, 1988, SOC PSYCH PSYCH EPID, V23, P6, DOI 10.1007/BF01788437; HELZER JE, 1985, ARCH GEN PSYCHIAT, V42, P657; HESSELBROCK V, 1982, ARCH GEN PSYCHIAT, V39, P674; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kern RC, 2000, LARYNGOSCOPE, V110, P2106, DOI 10.1097/00005537-200012000-00025; Larrabee G.J., 2011, FORENSIC NEUROPSYCHO; Leitch EF, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2004.016477; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; Mayo Clinic and Mayo Foundation, 1981, CLIN EX NEUR; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Muthu P, 2001, EMERG MED J, V18, P310, DOI 10.1136/emj.18.4.310; REGIER DA, 1984, ARCH GEN PSYCHIAT, V41, P934; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; Robins LN, 1985, DIAGNOSTIC INTERVIEW; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sheskin D, 2004, HDB PARAMETRIC NONPA; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; UPTON GJG, 1982, J ROY STAT SOC A STA, V145, P86, DOI 10.2307/2981423; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; WITTCHEN HU, 1989, ARCH GEN PSYCHIAT, V46, P437; WITTCHEN HU, 1985, ARCH GEN PSYCHIAT, V42, P677; Wittenbrook JM, 1941, J NERV MENT DIS, V94, P170, DOI 10.1097/00005053-194194020-00004; Yates F., 1934, J R STAT SOC, V1, P217, DOI DOI 10.2307/2983604	51	3	3	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2012	26	7					1102	1116		10.1080/13854046.2012.723753			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	027DE	WOS:000310331200004	23020281				2022-02-06	
J	Standefer, KD; Pierce, WA; Sucato, DJ; Kim, HKW				Standefer, Karen Divita; Pierce, William A.; Sucato, Daniel J.; Kim, Harry K. W.			Detecting a Disruption of Blood Flow to the Femoral Head After Ischemic Injury Using 4 Different Techniques: A Preliminary Study	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						femoral head; laser doppler; ischemia; avascular necrosis; osteonecrosis	LASER-DOPPLER FLOWMETRY; AVASCULAR NECROSIS; CONGENITAL DISLOCATION; CLINICAL-EXPERIENCE; PRESSURE; HIP; PIGLET; OSTEONECROSIS; EPIPHYSIS; PERFUSION	Background: Disruption of blood flow to the femoral head can have a detrimental effect on the clinical outcome after a closed or open reduction for the treatment of developmental dysplasia of the hip and after a treatment of slipped capital femoral epiphysis. Availability of a clinically reliable and easy-to-use technique to monitor the blood flow before, during, and after a therapeutic intervention may allow early detection and more effective management of this complication. An experimental investigation was performed to evaluate 4 different sensors/techniques for their ability to detect an acute disruption of blood flow to the immature femoral head. Methods: Under general anesthesia, the femoral heads of 10 immature pigs were exposed and total head ischemia was induced by ligating the femoral neck and transecting the ligamentum teres. Blood flow was assessed before and after the induction of ischemia using 1 of 4 techniques. The following sensors/techniques were evaluated: fiber optic pressure (FOP), piezoelectric pressure, partial pressure of oxygen, and laser Doppler flowmetry (LDF). The time taken to observe a 50% reduction of the preischemia level was determined and the sensor outputs were monitored until each reached a steady level. Results: All techniques demonstrated a reduction in their respective measurements after a disruption of blood flow to the femoral head. However, the response time differed, even between the 2 pressure sensors (FOP and piezoelectric pressure at 3 and 15 min, respectively). The fastest response time for a 50% reduction was observed with the LDF (2 min) and the FOP (3 min) sensors. The partial pressure of oxygen was the slowest to change, taking over 30 minutes. Technique-dependent advantages and disadvantages were seen. The FOP sensor was fragile and susceptible to the positioning of the sensor tip. The LDF sensor was susceptible to motion artifact. Conclusions: The LDF and the FOP sensors demonstrated a rapid decline in their respective measurements after the induction of ischemia. Clinical Relevance: These techniques may prove to be useful in the assessment of an acute disruption of the femoral head blood flow.	[Standefer, Karen Divita; Pierce, William A.; Sucato, Daniel J.; Kim, Harry K. W.] UT SW Med Ctr, Texas Scottish Rite Hosp Children, Ctr Excellence Hip Disorders, Dept Orthopaed Surg, Dallas, TX USA		Kim, HKW (corresponding author), Texas Scottish Rite Hosp Children, Res Dept, 2222 Welborn St, Dallas, TX 75219 USA.	harry.kim@tsrh.org	Kim, Harry/AAF-7176-2020; Kim, Harry/AAE-1892-2020	Kim, Harry/0000-0002-0330-4777			Amarasekera HW, 2008, J BONE JOINT SURG BR, V90B, P442, DOI 10.1302/0301-620X.90B4.20050; BELCARO G, 1989, ANGIOLOGY, V40, P953, DOI 10.1177/000331978904001103; Bucholz RW., 1978, HIP P 6 OP SCI M HIP, P43; Fernandes HM, 1998, ACT NEUR S, V71, P44; KALAMCHI A, 1980, J BONE JOINT SURG AM, V62, P876, DOI 10.2106/00004623-198062060-00002; KIAER T, 1990, J BONE JOINT SURG BR, V72, P1023, DOI 10.1302/0301-620X.72B6.2246284; KIAER T, 1988, CLIN ORTHOP RELAT R, P149; Kim HKW, 2001, J BONE JOINT SURG AM, V83A, P688, DOI 10.2106/00004623-200105000-00007; Kim HKW, 2002, J BONE JOINT SURG AM, V84A, P1329, DOI 10.2106/00004623-200208000-00007; Koskinen LOD, 2005, NEUROSURGERY, V56, P693, DOI 10.1227/01.NEU.0000156609.95596.24; Maitinez-Manas RM, 2000, J NEUROL NEUROSUR PS, V69, P82, DOI 10.1136/jnnp.69.1.82; Menezes NM, 2007, RADIOLOGY, V242, P129, DOI 10.1148/radiol.2421050680; Notzli HP, 2002, J BONE JOINT SURG BR, V84B, P300, DOI 10.1302/0301-620X.84B2.12146; PINET E, 2009, J SENSORS; PURINS K, ACTA NEUROCHIR WIEN, V152, P681; Rowe SM, 2006, ACTA ORTHOP, V77, P33, DOI 10.1080/17453670610045678; SALTER RB, 1969, CAN J SURG, V12, P44; Shapiro F, 2009, J BONE JOINT SURG AM, V91A, P2903, DOI 10.2106/JBJS.H.01464; Stewart C, 2008, NEUROSURGERY, V63, P1159, DOI 10.1227/01.NEU.0000333265.19131.7C; SWIONTKOWSKI MF, 1987, CLIN ORTHOP RELAT R, P181; SWIONTKOWSKI MF, 1986, J ORTHOP RES, V4, P362, DOI 10.1002/jor.1100040313; SWIONTKOWSKI MF, 1993, ACTA ORTHOP SCAND, V64, P196, DOI 10.3109/17453679308994570; VEGTER J, 1991, ACTA ORTHOP SCAND, V62, P337, DOI 10.3109/17453679108994465; WINSOR T, 1987, ANGIOLOGY, V38, P727, DOI 10.1177/000331978703801001	24	3	3	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	JAN-FEB	2012	32	1					75	80		10.1097/BPO.0b013e31823b1a90			6	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	866IW	WOS:000298375000015	22173392				2022-02-06	
J	Thaler, NS; Mayfield, J; Reynolds, CR; Hadland, C; Allen, DN				Thaler, Nicholas S.; Mayfield, Joan; Reynolds, Cecil R.; Hadland, Cora; Allen, Daniel N.			Teacher-Reported Behavioral Disturbances in Children With Traumatic Brain Injury: An Examination of the BASC-2	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						assessment/diagnosis; child/clinical/pediatric; school; tests; trauma		Pediatric traumatic brain injury (TBI) is associated with behavioral disturbances that can interfere with adjustment in the classroom. As such, standardized assessments of behavioral disturbances following TBI are useful in treatment planning and rehabilitation, although few studies have examined the sensitivity of standardized behavior assessments to behavioral abnormalities in this population. The present study compared the Behavior Assessment System for Children-Second Edition Teacher Rating Scale (BASC-2 TRS) profiles of 25 children who sustained TBI to those of 25 matched controls and to the BASC-2 standardization sample. Results indicated that teachers endorsed externalizing and school-related problems more severely and frequently than internalizing problems, with the greatest elevations on the Hyperactivity, Attention Problems, and Learning Problems subscales. In addition, BASC-2 scores appeared unrelated to IQ but were influenced by achievement functioning. Findings are consistent with previous studies of behavioral abnormalities in children with TBI and provide support for the usefulness of the BASC-2 TRS in evaluating behavioral disturbances in children that result from TBI.	[Thaler, Nicholas S.; Hadland, Cora; Allen, Daniel N.] Univ Nevada, Dept Psychol, Las Vegas, NV 89154 USA; [Mayfield, Joan] Our Childrens House Baylor, Dallas, TX USA; [Reynolds, Cecil R.] Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77843 USA; [Reynolds, Cecil R.] Texas A&M Univ, Dept Neurosci, College Stn, TX USA		Allen, DN (corresponding author), Univ Nevada, Dept Psychol, Neuropsychol Res Program, 4505 Maryland Pkwy, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu		Allen, Daniel/0000-0003-4868-2242			Achenbach T., 1991, INTEGRATIVE GUIDE 19; Allen DN, 2010, ARCH CLIN NEUROPSYCH, V25, P618, DOI 10.1093/arclin/acq051; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Arroyos-Jurado E, 2000, J SCHOOL PSYCHOL, V38, P571, DOI 10.1016/S0022-4405(00)00053-4; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barker-Collo S., 2007, BRAIN IMPAIR, V8, DOI [DOI 10.1375/BRIM.8.1.22, https://doi.org/10.1375/brim.8.1.22]; Bender HA, 2008, EPILEPSY BEHAV, V13, P237, DOI 10.1016/j.yebeh.2008.03.007; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; Dooley JJ, 2008, BRAIN INJURY, V22, P836, DOI 10.1080/02699050802425444; Gioia G.A., 2000, BRIEF BEHAV RATING I; Gross D, 2004, RES NURS HEALTH, V27, P413, DOI 10.1002/nur.20040; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Johnson M.B., 1989, WOODCOCK JOHNSON PSY; Kamphaus, 2003, REYNOLDS INTELLECTUA; Kim S, 2006, J SCHOOL PSYCHOL, V44, P287, DOI 10.1016/j.jsp.2006.05.003; Lee S. W., 1994, BEHAV DISORDERS, V19, P87; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; LOEBER R, 1990, J CLIN CHILD PSYCHOL, V19, P136, DOI 10.1207/s15374424jccp1902_5; Mahone EM, 2002, CHILD NEUROPSYCHOL, V8, P258, DOI 10.1076/chin.8.4.258.13510; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; McAuley C, 2000, BRIT J SOC WORK, V30, P91, DOI 10.1093/bjsw/30.1.91; McCandless Stephen, 2007, J Atten Disord, V10, P381, DOI 10.1177/1087054706292115; MCCONAUGHY SH, 1992, J AM ACAD CHILD PSY, V31, P932, DOI 10.1097/00004583-199209000-00023; McGlamery ME, 2007, EMOT BEHAV DIFFIC, V12, P29, DOI 10.1080/13632750601135899; Pineda DA, 2007, EUR CHILD ADOLES PSY, V16, P337, DOI 10.1007/s00787-007-0605-4; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Randazzo KV, 2003, J AM ACAD CHILD PSY, V42, P1343, DOI 10.1097/01.chi.0000085753.71002.da; Reynolds C.R., 2004, BEHAV ASSESSMENT SYS, V2; Reynolds CR., 1992, BEHAV ASSESSMENT SYS; Sullivan JR, 2006, ARCH CLIN NEUROPSYCH, V21, P495, DOI 10.1016/j.acn.2006.05.008; Titus JB, 2008, PSYCHOL SCHOOLS, V45, P893, DOI 10.1002/pits.20333; Toplak ME, 2009, CHILD NEUROPSYCHOL, V15, P53, DOI 10.1080/09297040802070929; Vanderploeg RD, 1998, PSYCHOL ASSESSMENT, V10, P277, DOI 10.1037/1040-3590.10.3.277; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Wetherington CE, 2010, J PEDIATR PSYCHOL, V35, P662, DOI 10.1093/jpepsy/jsp081; Yeates KO., 2006, EXCEPTIONALITY, V14, P141, DOI DOI 10.1207/S15327035EX1403_; Yuspeh RL, 1998, APPL NEUROPSYCHOL, V5, P149, DOI 10.1207/s15324826an0503_6	39	3	3	0	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2012	1	1					30	37		10.1080/21622965.2012.665776			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	V31KD	WOS:000208881600005	23428275				2022-02-06	
J	Belina, S; Kovacic, S				Belina, Stanko; Kovacic, Sanja			CT Follow-Up and Clinical Outcome in Severe Traumatic Injury Patients	COLLEGIUM ANTROPOLOGICUM			English	Article						traumatic brain injury; computer tomography; clinical outcome	POSTTRAUMATIC VEGETATIVE STATE; CLOSED-HEAD INJURY; BRAIN-INJURY; PROGNOSIS; RECOVERY; COMA; DAMAGE	Determining a patient's prognosis after severe traumatic brain injury remains difficult and complex. The purpose of the present study was following up patients with severe traumatic brain injury by correlating their clinical outcome and sequential computer tomography (CT) findings. We investigated 51 patients who survived the first year following an accident. All patients underwent successive CT examinations within a maximum period of 2 years. The patients' outcomes depended on the underlying brain damage and are presented by the Glasgow Outcome Scale. Based on the investigated data we concluded that the worst outcomes were experienced by patients with initial massive cerebral edema, extensive subdural hematoma and intraventricular hemorrhage, followed by stroke as subacute CT finding and cerebral atrophy as chronic finding visible at follow-up CT scans. The majority of lesions identified by CT scan were found in the frontal lobes, basal ganglia, and temporal lobes. We suggest that CT examination still represents a simple and useful tool in attempting to predict the clinical outcome in patients with severe traumatic brain injury.	[Kovacic, Sanja] Zabok Gen Hosp, Dept Neurol, Zabok 49210, Croatia; [Belina, Stanko] Hosp Med Rehabil, Dept Radiol, Krapinske Toplice, Croatia		Kovacic, S (corresponding author), Zabok Gen Hosp, Dept Neurol, Bracak 8, Zabok 49210, Croatia.	sanja.drca@kr.t-com.hr	Bozic, Sanja/AAM-5715-2021	Bozic, Sanja/0000-0002-7623-241X			Armstead WM, 2010, CRIT CARE MED, V38, P1868, DOI 10.1097/CCM.0b013e3181e8ac1a; BATES D, 1991, J NEUROL NEUROSUR PS, V54, P569, DOI 10.1136/jnnp.54.7.569; BRAAKMAN R, 1988, ACTA NEUROCHIR, V95, P49, DOI 10.1007/BF01793082; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; DENNIS AM, 2007, INTENS CARE MED, V21, P1011; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Hlatky R., 2003, NEUROSURG FOCUS, V14, P1; Husson EC, 2010, J REHABIL MED, V42, P425, DOI 10.2340/16501977-0566; JENNETT B, 1975, LANCET, V1, P480; Jeon IC, 2008, J KOREAN NEUROSURG S, V44, P295, DOI 10.3340/jkns.2008.44.5.295; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1993, HEAD INJURY; Lee Bruce, 2005, NeuroRx, V2, P372; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; LEVY DE, 1981, ANN INTERN MED, V94, P293, DOI 10.7326/0003-4819-94-3-293; MAKI Y, 1980, CHILD BRAIN, V7, P113; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; SAZBON L, 1991, J NEUROL NEUROSUR PS, V54, P149, DOI 10.1136/jnnp.54.2.149; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966	31	3	4	0	1	COLLEGIUM ANTROPOLOGICUM	ZAGREB	INST ANTHROPOLOGICAL RESEARCH, GAJEVA 32, PO BOX 290, HR-10000 ZAGREB, CROATIA	0350-6134			COLLEGIUM ANTROPOL	Coll. Anthropol.	DEC	2011	35	4					1197	1202					6	Anthropology	Social Science Citation Index (SSCI)	Anthropology	879AW	WOS:000299303100034	22397259				2022-02-06	
J	Bhattacharya, P; Pandey, AK; Paul, S				Bhattacharya, Pallab; Pandey, Anand Kr.; Paul, Sudip			Minocycline and magnesium in combination may be a good therapeutic intervention for cerebral ischemia	MEDICAL HYPOTHESES			English	Article							TRAUMATIC BRAIN-INJURY; PROTECTS PC12 CELLS; 5-LIPOXYGENASE ACTIVATION; NITRIC-OXIDE; STROKE; RATS; NEUROPROTECTION; NEUROTOXICITY; SUPEROXIDE; REGIONS	A neuroprotective strategy through a combination therapy is always being superior to any other singular therapeutic interventions, as these acts through a multifauceted approach within the brain during cerebral ischemia. Therefore, the development of a potential new combination of drug is necessitated which can bring about desirable improved neuroprotection targeting different pathways against ischemic stroke. Numerous past studies have enumerated the neuroprotective roles of minocycline and magnesium administered in single against cerebral ischemia in animal model hence we hypothesized that by using magnesium with minocycline in combination would provide additive neuroprotection than either of the agents used alone. In this article, we discuss our hypothesis regarding the possibility of minocycline and magnesium as a potent combination which may have a positive therapeutic role in treatment of cerebral ischemia through its anti-inflammatory, anti-apoptotic and anti-oxidative characteristics with magnesium contributing as a regulator of increased calcium influx. (C) 2011 Elsevier Ltd. All rights reserved.	[Bhattacharya, Pallab; Pandey, Anand Kr.; Paul, Sudip] Banaras Hindu Univ, Inst Technol, Sch Biomed Engn, Varanasi 221005, UP, India		Bhattacharya, P (corresponding author), Banaras Hindu Univ, Inst Technol, Sch Biomed Engn, Varanasi 221005, UP, India.	pallab.bhu@gmail.com	Paul, Sudip/AAE-8890-2020	PAUL, SUDIP/0000-0001-9856-539X			ALTURA BM, 1981, FED PROC, V40, P2672; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Bednar MM, 1999, STROKE, V30, P887, DOI 10.1161/01.STR.30.4.887; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUCHILL BR, 1978, CELL BIOL, V76, P439; Burgos-Ramos E, 2008, NEUROSCIENCE, V154, P1458, DOI 10.1016/j.neuroscience.2008.04.036; Choi D, 2000, NEUROBIOL DIS, V7, P552, DOI 10.1006/nbdi.2000.0354; Chu XP, 2002, J NEUROPHYSIOL, V87, P2555, DOI 10.1152/jn.00741.2001; Dhandapani SS, 2008, INDIAN J NEUROTRAUM, V5, P27, DOI 10.1016/S0973-0508(08)80025-1; Dyken ML, 1998, SEMIN NEUROL, V18, P441, DOI 10.1055/s-2008-1040897; Ghabriel MN, 2006, ACTA NEUROCHIR SUPPL, V96, P402; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; Grotta J, 2002, STROKE, V33, P306, DOI 10.1161/str.33.1.306; Guevara I, 1998, CLIN CHIM ACTA, V274, P177, DOI 10.1016/S0009-8981(98)00060-6; HALLAK M, 1992, AM J OBSTET GYNECOL, V167, P1605, DOI 10.1016/0002-9378(92)91749-Z; Hans Chetan Parkash, 2002, Indian Journal of Experimental Biology, V40, P1275; He Y, 2001, BRAIN RES, V909, P187, DOI 10.1016/S0006-8993(01)02681-6; Kelso ML, 2011, NEUROSCI LETT, V488, P60, DOI 10.1016/j.neulet.2010.11.003; Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487; Kriz J, 2003, ANN NEUROL, V53, P429, DOI 10.1002/ana.10500; Lin SZ, 2001, NEUROSCI LETT, V315, P61, DOI 10.1016/S0304-3940(01)02324-2; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Napieralski JA, 1999, MOL BRAIN RES, V71, P78, DOI 10.1016/S0169-328X(99)00155-2; Ozben T, 2005, NITRIC OXIDE-BIOL CH, V13, P210, DOI 10.1016/j.niox.2005.07.005; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004764; Song Y, 2004, NEUROREPORT, V15, P2181, DOI 10.1097/00001756-200410050-00007; Song Y, 2006, BRAIN RES, V1085, P57, DOI 10.1016/j.brainres.2006.02.042; Steiner T, 1998, CEREBROVASC DIS, V8, P198, DOI 10.1159/000015851; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; van den Heuvel Corinna, 2004, Clin Calcium, V14, P9; Verma R, 2010, EUR J PHARMACOL, V638, P65, DOI 10.1016/j.ejphar.2010.04.021; Wang CX, 2003, BRAIN RES, V963, P327, DOI 10.1016/S0006-8993(02)04045-3; Wang JZ, 2004, J BIOL CHEM, V279, P19948, DOI 10.1074/jbc.M313629200; Zhou Y, 2006, LIFE SCI, V79, P1645, DOI 10.1016/j.lfs.2006.05.022	36	3	4	0	8	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877			MED HYPOTHESES	Med. Hypotheses	DEC	2011	77	6					1129	1131		10.1016/j.mehy.2011.09.019			3	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	853BG	WOS:000297400600049	21985758				2022-02-06	
J	Koh, JO				Koh, J. O.			Effect of snowboard-related concussion safety education for recognizing possible concussions	JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS			English	Article						Wounds and injuries; Accidents; Snow sports	SEX-DIFFERENCES; HEAD-INJURIES; SKIERS; SPORT	Aim. The aim of this study was to examine the understanding of snowboard-related concussion and to measure the recognition of possible concussion occurrence after an intervention of snowboard-related concussion safety education in snowboarding. Methods. Incidence cohort design. Setting: 2008-2009 season Gangwon-do Ski resorts, South Korea. A total of 208 university students (female-72; male-136; age-18 to 32) who registered for a snowboarding class and received credit participated in this project. Snowboard-related concussion safety education class was administered for 30 minutes before the snowboard class began. The knowledge of snowboard-related concussion before and after the safety education was evaluated. Concussion data were collected via a self-report case form at the last day of snowboarding class. The incidence of possible concussion and factors associated with concussions were analyzed by chi(2) test. Results. The mean score of snowboard-related concussion knowledge improved from fifteen points to eighteen points out of 20 total points possible. Overall the incidence of concussion was 10 per 100 snowboarder-exposures. chi(2) tests showed concussion rates to be significantly different in female snowboarders (P=0.00) and in helmet users (P=0.02). Conclusion. The incidence of possible concussion is high among snowboarding class participants. Emphasis should be given for instituting pre-participation balance training, especially for females to reduce falling in snowboarding. To verify the effects of pre-participation balance training and falling results in a concussion, more research is needed in the future.	Daegu Haany Univ, Dept Oriental Sports Med, Ho 5220, South Korea		Koh, JO (corresponding author), Daegu Haany Univ, Dept Oriental Sports Med, 290 Yugok Dong Kyungsan Si Kyungbuk, Ho 5220, South Korea.	kohjaeok@hotmail.com		Koh, Jae Ok/0000-0002-3639-0739	Daegu Haany University KyxLin Foundation	This research was supported by a grant from Daegu Haany University KyxLin Foundation in 2009.	Anderson MK, 2005, FDN ATHLETIC TRAININ; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Covassin T, 2003, J ATHL TRAINING, V38, P238; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Fukuda O, 2001, AM J SPORT MED, V29, P437, DOI 10.1177/03635465010290040901; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Hagel B, 2005, MED SPORT SCI, V48, P74, DOI 10.1159/000084284; Hayes JR, 2008, J PEDIATR SURG, V43, P928, DOI 10.1016/j.jpedsurg.2007.12.041; Hentschel S, 2001, CAN J NEUROL SCI, V28, P42; Ko HS, 2008, THESIS SOGANG U SEOU; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Koh JO, 2008, J KOR PHYS ED ASS GI, V22, P99; Koh JO, 2006, J KOR PHYS ED ASS GI, V20, P17; Korea Ski-resort Business Association [Personal contact], INJ REP 2003 2009; Kweon SH, 2007, J KOR SPORTS MED, V25, P78; Malliou P, 2004, PERCEPT MOTOR SKILL, V99, P149, DOI 10.2466/PMS.99.5.149-154; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; O'Neill DF, 1999, AM J SPORT MED, V27, P94; Prwall JA, 1995, INJURY, V26, P539; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578	22	3	3	0	6	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0022-4707			J SPORT MED PHYS FIT	J. Sports Med. Phys. Fit.	DEC	2011	51	4					625	632					8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	888WV	WOS:000300036200012	22212265				2022-02-06	
J	Li, S; Huang, MM; Wang, XH; Wang, XX; Chen, F; Lei, H; Jiang, FG				Li, Shuang; Huang, Mingming; Wang, Xinghua; Wang, Xuxia; Chen, Fei; Lei, Hao; Jiang, Fagang			Retinal Metabolic Changes in an Experimental Model of Optic Nerve Transection by Ex Vivo H-1 Magnetic Resonance Spectroscopy	NEUROCHEMICAL RESEARCH			English	Article						Optic nerve transection; Glutamate; GABA; Magnetic resonance spectroscopy; Metabolism	TRAUMATIC BRAIN-INJURY; RESOLUTION H-1-NMR SPECTROSCOPY; PROTON MR SPECTROSCOPY; GANGLION-CELLS; RAT RETINA; IN-VIVO; GLUTAMATE RECEPTORS; N-ACETYLASPARTATE; VERTEBRATE RETINA; NEURONAL DEATH	This study aims to investigate the retinal metabolic processes in a rat axotomy model. Retinal metabolic changes in optic nerve transection (ONT) rat model were analyzed by H-1 magnetic resonance spectroscopy (H-1-MRS). Retinal ganglion cells (RGCs) densities were assessed from retinal whole mounts. The retina was stained immunohistochemically with glial fibrillary acidic protein (GFAP). The results showed that the retina in ONT rats had significantly decreased concentrations of gamma-aminobutyric acid (GABA), N-acetylaspartate (NAA), taurine (Tau), creatine (Cr) and increased concentrations of alanine (Ala) compared with control. Examination of glutamate (Glu), glutamine (Gln) and Glx (Glu + Gln) concentrations disclosed no significant differences. The mean density of RGCs reduced from 2,249 +/- A 87 cells/mm(2) in control group to 320 +/- A 56 cells/mm(2) in ONT group. GFAP immunoreactivity was markedly higher in ONT group than that in control group. The retinal metabolism after ONT was associated with neurotransmitter recycling/production perturbation, as well as other metabolic disequilibrium.	[Li, Shuang; Wang, Xinghua; Chen, Fei; Jiang, Fagang] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Ophthalmol, Wuhan 430022, Peoples R China; [Huang, Mingming; Wang, Xinghua; Lei, Hao] Chinese Acad Sci, Wuhan Inst Phys & Math, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan 430071, Peoples R China		Jiang, FG (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Ophthalmol, Wuhan 430022, Peoples R China.	ashuangli@126.com; mingminghuang@126.com; xinghua-wang@hotmail.com; wangxuxia@wipm.ac.cn; chenfei72@126.comm; leihao@wipm.ac.cn; fgjiang@hotmail.com	, 雷皓/H-8147-2019; Lei, Hao/A-7004-2008	, 雷皓/0000-0003-3412-1241; Lei, Hao/0000-0003-3412-1241	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30700922]	This work was supported by grant 30700922 from National Natural Science Foundation of China.	Ashwal S, 2004, J NEUROTRAUM, V21, P1539, DOI 10.1089/0897715042441756; BELL JD, 1991, BIOCHIM BIOPHYS ACTA, V1096, P101, DOI 10.1016/0925-4439(91)90046-C; Chan KC, 2009, EXP EYE RES, V88, P61, DOI 10.1016/j.exer.2008.10.002; Chen K, 2009, BRAIN RES, V1279, P131, DOI 10.1016/j.brainres.2009.04.054; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; EITAN S, 1994, SCIENCE, V264, P1764, DOI 10.1126/science.7911602; Farooque M, 1996, J NEUROTRAUM, V13, P537, DOI 10.1089/neu.1996.13.537; Gao HC, 2007, NEUROCHEM INT, V50, P386, DOI 10.1016/j.neuint.2006.09.012; GRIBBESTAD IS, 1994, GRAEF ARCH CLIN EXP, V232, P494, DOI 10.1007/BF00195360; Grosskreutz CL, 2005, EXP EYE RES, V80, P681, DOI 10.1016/j.exer.2004.11.017; Hashimoto M, 2004, JPN J OPHTHALMOL, V48, P353, DOI 10.1007/s10384-004-0086-7; Hunter JV, 2005, AM J NEURORADIOL, V26, P482; Kermer P, 2001, BRAIN RES PROTOC, V7, P255, DOI 10.1016/S1385-299X(01)00076-9; Kielczewski JL, 2005, INVEST OPHTH VIS SCI, V46; Lam DMK, 1997, INVEST OPHTH VIS SCI, V38, P553; Li CX, 2008, NEUROCHEM RES, V33, P2342, DOI 10.1007/s11064-008-9739-0; Lieven CJ, 2006, INVEST OPHTH VIS SCI, V47, P1477, DOI 10.1167/iovs.05-0921; Makoroff KL, 2005, PEDIATR RADIOL, V35, P668, DOI 10.1007/s00247-005-1441-7; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Munemasa Y, 2008, INVEST OPHTH VIS SCI, V49, P3535, DOI 10.1167/iovs.08-1716; Ngumah QC, 2006, EXP EYE RES, V83, P390, DOI 10.1016/j.exer.2006.01.015; Nguyen SM, 2003, ANTIOXID REDOX SIGN, V5, P629, DOI 10.1089/152308603770310293; Panagis L, 2005, EUR J NEUROSCI, V21, P2305, DOI 10.1111/j.1460-9568.2005.04046.x; Pears MR, 2005, J BIOL CHEM, V280, P42508, DOI 10.1074/jbc.M507380200; Poitry S, 2000, J NEUROSCI, V20, P1809; Pow DV, 2002, GLIA, V37, P153, DOI 10.1002/glia.10026; Ramonet D, 2004, HIPPOCAMPUS, V14, P586, DOI 10.1002/hipo.10188; RANGO M, 1995, MAGNET RESON MED, V33, P595, DOI 10.1002/mrm.1910330503; Saransaari P, 2010, AMINO ACIDS, V38, P739, DOI 10.1007/s00726-009-0278-z; Somorjai RL, 1996, JMRI-J MAGN RESON IM, V6, P437, DOI 10.1002/jmri.1880060305; Thoreson WB, 1999, PROG RETIN EYE RES, V18, P765, DOI 10.1016/S1350-9462(98)00031-7; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; Vorwerk CK, 1996, INVEST OPHTH VIS SCI, V37, P1618; Weishaupt JH, 2001, RESTOR NEUROL NEUROS, V19, P19; Wellard RM, 2004, BRAIN, V127, P1302, DOI 10.1093/brain/awh157; Wharton BA, 2004, ARCH DIS CHILD-FETAL, V89, pF497, DOI 10.1136/adc.2003.048389; Xue LP, 2006, NEUROSCIENCE, V143, P117, DOI 10.1016/j.neuroscience.2006.07.044; Yang XL, 2004, PROG NEUROBIOL, V73, P127, DOI 10.1016/j.pneurobio.2004.04.002	38	3	4	1	3	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190			NEUROCHEM RES	Neurochem. Res.	DEC	2011	36	12					2427	2433		10.1007/s11064-011-0570-7			7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	841MN	WOS:000296516500028	21842271				2022-02-06	
J	Panayiotou, A; Crowe, S; Jackson, M				Panayiotou, Anita; Crowe, Simon; Jackson, Martin			An Analogue Study of the Psychological and Psychosocial Processes Associated With Post-concussion Symptoms	AUSTRALIAN PSYCHOLOGIST			English	Article						analogue; expectation; "good-old days" phenomenon; hypochondriasis; mild traumatic brain injury (mTBI); post-concussion syndrome	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; GOOD-OLD-DAYS; POSTCONCUSSION SYNDROME; EXPECTATION; COMPLAINTS; RECOVERY; MODERATE; STRESS; SPORTS	This study used an analogue design to investigate post-concussion syndrome and the psychological and psychosocial processes associated with post-concussion symptom (PCSx) reporting. The study examined the role of expectation in reporting of PCSx, the nature of associated psychological and psychosocial difficulties, and the good-old-days phenomenon. Forty-five healthy participants were randomly assigned to one of two groups: (1) a control group or (2) an expectation group who were asked to perform as if they had experienced a mild traumatic brain injury. Fourteen psychiatric patients comprised the clinical group. Self-report questionnaires assessing PCSx and psychological and psychosocial variables were administered. It was hypothesised that PCSx would be non-specific, that the expectation group would report greater dysfunction than controls, and that the good-old-days phenomenon would cause the expectation and clinical groups to underestimate pre-morbid PCSx. All participants reported some degree of dysfunction, and the expectation and clinical groups underestimated past PCSx. The expectation group reported more PCSx and psychological and psychosocial dysfunction than controls, resembling the clinical group. The results demonstrate that expectation can cause otherwise healthy individuals to resemble a clinical group in terms of their level of endorsement of psychological and psychosocial dysfunction.	[Panayiotou, Anita; Crowe, Simon; Jackson, Martin] La Trobe Univ, Sch Psychol Sci, Bundoora, Vic 3086, Australia		Crowe, S (corresponding author), La Trobe Univ, Sch Psychol Sci, Bundoora, Vic 3086, Australia.	s.crowe@latrobe.edu.au		Crowe, Simon/0000-0002-4407-8542			American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; BERGNER M, 1976, INT J HEALTH SERV, V6, P393, DOI 10.2190/RHE0-GGH4-410W-LA17; Bigler E, 1990, TRAUMATIC BRAIN INJU, P13; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BOHNEN N, 1993, NEUROPSY NEUROPSY BE, V6, P193; BOHNEN NI, 1995, BRAIN INJURY, V9, P27, DOI 10.3109/02699059509004568; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Gaetz M, 2000, BRAIN INJURY, V14, P815; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goodyear B., 1998, FORENSIC EXAMINER, V7, P32; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Greiffenstein M. F., 2000, BRAIN INJ SOURCE, V4, P26; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Iverson G.L., 2007, BRAIN INJURY MED PRI, P333; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrea M., 2008, MILD TRAUMATIC BRAIN; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Pallant J.F., 2007, SPSS SURVIVAL MANUAL; Panayiotou A, 2010, J CLIN EXP NEUROPSYC, V32, P463, DOI 10.1080/13803390903164371; PETERSON C, 1982, COGNITIVE THER RES, V6, P287, DOI 10.1007/BF01173577; Pilowsky I, 1994, MANUAL ILLNESS BEHAV; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Raskin SA, 1997, BRAIN INJURY, V11, P587, DOI 10.1080/026990597123287; Rosenberg M., 1965, SOC ADOLESCENT SELF; ROSENTHAL M, 1993, ANN EMERG MED, V22, P1048, DOI 10.1016/S0196-0644(05)82749-0; ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0092976; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; World Health Organization, 2004, ICD 10 INT STAT CLAS	55	3	3	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0005-0067	1742-9544		AUST PSYCHOL	Aust. Psychol.	DEC	2011	46	4					210	218		10.1111/j.1742-9544.2010.00018.x			9	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	855OM	WOS:000297574100003					2022-02-06	
J	Schupp, W				Schupp, W.			DGRW-Update: Neurology - From Empirical Strategies Towards Evidence Based Interventions	REHABILITATION			German	Article						neurorehabilitation; evidence based interventions; guidelines; return to work; long term care		Stroke, Multiple Sclerosis (MS), traumatic brain injuries (TBI) and neuropathies are the most important diseases in neurological rehabilitation financed by the German Pension Insurance. The primary goal is vocational (re)integration. Driven by multiple findings of neuroscience research the traditional holistic approach with mainly empirically derived strategies was developed further and improved by new evidence-based interventions. This process had been, and continues to be, necessary to meet the health-economic pressures for ever shorter and more efficient rehab measures. Evidence-based interventions refer to symptom-oriented measures, to team-management concepts, as well as to education and psychosocial interventions. Drug therapy and/or neurophysiological measures can be added to increase neuroregeneration and neuroplasticity. Evidence-based aftercare concepts support sustainability and steadiness of rehab results. Mirror therapy, robot-assisted training, mental training, task-specific training, and above all constraint-induced movement therapy (CIMT) can restore motor arm and hand functions. Treadmill training and robot-assisted training improve stance and gait. Botulinum toxine injections in combination with physical and redressing methods are superior in managing spasticity. Guideline-oriented management of associated pain syndromes (myofascial, neuropathic, complex-regional=dystrophic) improve primary outcome and quality of life. Drug therapy with so-called co-analgetics and physical therapy play an important role in pain management. Swallowing disorders lead to higher mortality and morbidity in the acute phase; stepwise diagnostics (screening, endoscopy, radiology) and specific swallowing therapy can reduce these risks and frequently can restore normal eating und drinking. In our modern industrial societies communicative and cognitive disturbances are more impairing than the above mentioned disorders. Speech and language therapy (SLT) is dominant in communicative disorders; the therapists use communicative and/or linguistics-oriented strategies. SLT must begin early after disease onset and with high frequency to elicit good results. PG assisted (self-)training, possibly telemedically applied, can increase training frequency and time and, hence, improve outcome in aphasia. High-frequency and task-specific training, often PC-assisted, were found to be relevant for improving cognitive functions in all dimensions. Several strategies seem to be efficient in neglect. Visual field deficits can be treated restitutively and compensatingly by PC-assisted training. Attention, memory and executive dysfunctions each require multimodal specific treatment strategies, performed in single and group therapy and in PC-assisted training. Also, education of patients to cope with their impairments and disabilities is another important part. Combined medically and vocationally oriented rehabilitation settings are necessary for raising the rate of return-to-work, especially in patients with motor hand impairments or cognitive disorders. Education of patients and relatives to cope with the chronic neurological diseases and disablements highly improve the sustainability of rehab results and can, in the long run, also reduce mortality and admission to nursing homes. Appropriate physical activity and sports are relevant in the phase of aftercare, by stabilizing both motor coordination and cognitive factors; in MS patients fatigue can be diminished effectively. The main mental comorbidities are anxiety and depression. Pharmacological and psychological treatments have been found to be equally important in this context. Frequently, these mental disorders appear in the phase of aftercare and long-term course only, then worsening outcome sustainability. Efficient concepts to deal with this aspect are still missing. The ambulatory health care system can not cope with it until now. The multitude of evidence-based interventions have over the last 20 years after the Rehab Commission of the Federation of the German Pension Insurance Institutes contributed decisively to even improving primary outcomes and quality of life of neurological patients in spite of shortened length of stay and other restrictions. Neurorehabilitative research, especially the clinically oriented part, had a major influence on the process of professionalization of all members in the neurorehabilitative team. This fact enables new and more efficient organizational structures and working processes within the team; the discussion on this topic has however only just started.	[Schupp, W.] Fachklin Herzogenaurach, Abt Neurol & Neuropsychol, D-91074 Herzogenaurach, Germany		Schupp, W (corresponding author), Fachklin Herzogenaurach, Chefarzt Abt Neurol & Neuropsychol, Reuth 1, D-91074 Herzogenaurach, Germany.	neurologie@fachklinik-herzogenaurach.de						0	3	3	2	70	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0034-3536			REHABILITATION	Rehabilitation	DEC	2011	50	6					354	362		10.1055/s-0031-1285916			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	881AO	WOS:000299451900002	22134865				2022-02-06	
J	Balik, V; Lehto, H; Hoza, D; Phornsuwannapha, S; Toninelli, S; Romani, R; Sulla, I; Hernesniemi, J				Balik, V.; Lehto, H.; Hoza, D.; Phornsuwannapha, S.; Toninelli, S.; Romani, R.; Sulla, I.; Hernesniemi, J.			Post-Traumatic Frontal and Parieto-Occipital Extradural Haematomas: a Retrospective Analysis of 41 Patients and Review of the Literature	CENTRAL EUROPEAN NEUROSURGERY			English	Article						epidural; frontal; parietal; occipital; extradural haematoma; epidural haematoma	CHRONIC EPIDURAL HEMATOMA; CONSERVATIVE MANAGEMENT; SUBPERIOSTEAL HEMATOMA; EXOPHTHALMOS; EXPERIENCE; PROGNOSIS; SURGERY; INJURY; BRAIN; SINUS	Background: The purpose of this study was to analyse the differences between patients with frontal (FEDH) or parieto-occipital (POEDH) epidural haematomas and evaluate possible statistically significant prognostic factors. Material and methods: In this retrospective study of a group of 41 patients with a FEDH (17) or POEDH (24 individuals), the authors analysed the influence of gender, age, type of injury, clinical presentation, Glasgow coma scale (GCS) score on admission, radiological findings, and time interval from trauma to surgery on outcomes. A good recovery and moderate disability were considered a "good" or "favourable outcome", whereas severe disability, a vegetative state or death was a "poor outcome". Results: In the POEDH subgroup, a higher GCS score on admission and a younger age were statistically significant prognostic factors for a better outcome (p = 0.006, rs = 0.702). In the subgroup of patients with FEDHs, the results were not significant. However, patients with FEDHs more frequently had "good outcomes" than members of the POEDH subgroup (88.2 vs. 70.9%). Children (<= 18 years old) constituted a smaller portion of the POEDH subgroup (12.5%) than those in the FEDH subgroup (41.2%). The evaluation of time intervals between the accident and surgery (<= 24 h vs. >24 h) showed no significant influence on outcomes in any of the studied subgroups. However, patients undergoing surgery within 24 h of their injury had a less favourable GCS score on admission than those operated on more than 24 h after their injury. Subacute and chronic clinical courses predominated in patients with a FEDH (10/17 FEDH vs. 11/22 POEDH). Different accompanying intradural lesions occurred in 12 patients of the POEDH subgroup, but only in 2 of the FEDH subgroup (50 vs. 11.8%). However, the presence of such lesions did not significantly deteriorate surgical outcomes in either of the subgroups.	[Sulla, I.] Pavol Jozef Safarik Univ Kosice, Fac Med, AD Ctr, Dept Neurosurg, Kosice 04011, Slovakia; [Balik, V.] Univ Hosp Olomouc, Dept Neurosurg, Olomouc, Czech Republic; [Lehto, H.; Toninelli, S.; Romani, R.; Hernesniemi, J.] Helsinki Univ Hosp, Dept Neurosurg, Helsinki, Finland; [Hoza, D.] Charles Univ Prague, Prague, Czech Republic; [Hoza, D.] Univ Hosp Motol, Dept Neurosurg, Prague, Czech Republic; [Phornsuwannapha, S.] Police Gen Hosp, Dept Surg, Div Neurosurg, Bangkok, Thailand		Sulla, I (corresponding author), Pavol Jozef Safarik Univ Kosice, Fac Med, AD Ctr, Dept Neurosurg, Trieda SNP 1, Kosice 04011, Slovakia.	sullaigorz@gmail.com					ASKENASY HM, 1962, NEUROCHIRURGIA, V4, P206; Bahloul K, 2009, CLIN NEUROL NEUROSUR, V111, P893, DOI 10.1016/j.clineuro.2009.08.005; Balik V, 2007, BRATISL MED J, V108, P409; Balik V, 2010, CENT EUR NEUROSURG, V71, P167, DOI 10.1055/s-0030-1249046; Balmer B, 2006, CHILD NERV SYST, V22, P363, DOI 10.1007/s00381-005-1254-x; Bejjani GK, 1996, PEDIATR NEUROSURG, V25, P302, DOI 10.1159/000121144; Bezircioglu H, 1996, J TRAUMA, V41, P696, DOI 10.1097/00005373-199610000-00016; BOLLINGER B, 1987, NEURORADIOLOGY, V29, P315, DOI 10.1007/BF00451781; BORZONE M, 1988, ACTA NEUROCHIR, V93, P55, DOI 10.1007/BF01409903; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; Bullock M Ross, 2006, Neurosurgery, V58, pS7; BULLOCK R, 1982, SURG NEUROL, V18, P300, DOI 10.1016/0090-3019(82)90353-6; CLARE FB, 1961, JAMA-J AM MED ASSOC, V177, P887, DOI 10.1001/jama.1961.03040390001001; CLAVEL M, 1982, ACTA NEUROCHIR, V66, P71, DOI 10.1007/BF01809305; Cohen JE, 1996, J TRAUMA, V41, P120, DOI 10.1097/00005373-199607000-00019; COOK RJ, 1988, ACTA NEUROCHIR, V95, P90, DOI 10.1007/BF01790766; CORDOBES F, 1981, J NEUROSURG, V54, P179, DOI 10.3171/jns.1981.54.2.0179; CORRADDU M, 1984, CLIN NEUROL NEUROSUR, V86, P115, DOI 10.1016/0303-8467(84)90076-3; CUCCINIELLO B, 1993, ACTA NEUROCHIR, V120, P47, DOI 10.1007/BF02001469; da Costa LB, 2003, ARQ NEURO-PSIQUIAT, V61, P1039, DOI 10.1590/S0004-282X2003000600030; DEVRIES J, 1981, NEURORADIOLOGY, V22, P167, DOI 10.1007/BF00346762; FAGER CA, 1958, SURG CLIN N AM, V38, P877; FANKHAUSER H, 1982, ACTA NEUROCHIR, V60, P29, DOI 10.1007/BF01401747; Fiume D, 1985, Riv Neurol, V55, P350; GALLAGHE.JP, 1968, J NEUROSURG, V29, P1, DOI 10.3171/jns.1968.29.1.0001; GARZAMERCADO R, 1978, SURG NEUROL, V9, P103; Gdovinova Z, 2009, TXB GEN NEUROLOGY, P152; GLOWACKI J, 1989, Neurosurgical Review, V12, P190, DOI 10.1007/BF01790646; Gorgulu A, 2000, NEUROSURG REV, V23, P30, DOI 10.1007/s101430050028; GREVSTEN S, 1982, ACTA CHIR SCAND, V148, P97; Gruskiewicz J, 1976, Surg Neurol, V5, P122; GRUSZKIE.J, 1972, J NEUROSURG, V37, P613, DOI 10.3171/jns.1972.37.5.0613; GRUSZKIEWICZ J, 1973, NEUROCHIRURGIA, V16, P54; GUTHKELCH AN, 1949, J NEUROSURG, V6, P180, DOI 10.3171/jns.1949.6.2.0180; Hamlat A, 2005, ACTA NEUROCHIR, V147, P1055, DOI 10.1007/s00701-005-0601-8; Heinzelmann M, 1996, INJURY, V27, P345, DOI 10.1016/0020-1383(95)00223-5; HIRSH LF, 1980, NEUROSURGERY, V6, P508, DOI 10.1227/00006123-198005000-00002; HOOPER R, 1959, BRIT J SURG, V47, P71, DOI 10.1002/bjs.18004720114; HUNT J, 1995, AUST NZ J SURG, V65, P83, DOI 10.1111/j.1445-2197.1995.tb07266.x; IWAKUMA T, 1974, J NEUROSURG, V41, P104, DOI 10.3171/jns.1974.41.1.0104; IWAKUMA T, 1973, J NEUROSURG, V38, P488, DOI 10.3171/jns.1973.38.4.0488; JACKSON IJ, 1950, J NEUROSURG, V7, P444, DOI 10.3171/jns.1950.7.5.0444; JAMIESON KG, 1968, J NEUROSURG, V29, P13, DOI 10.3171/jns.1968.29.1.0013; JAMJOOM A, 1992, Acta Neurochirurgica, V115, P86, DOI 10.1007/BF01406363; Jamjoom AB, 1997, NEUROSURG REV, V20, P227, DOI 10.1007/BF01105892; Jawahar G, 1985, J Indian Med Assoc, V83, P416; JENNETT B, 1975, LANCET, V1, P480; JONES NR, 1993, BRIT J NEUROSURG, V7, P465, DOI 10.3109/02688699308995068; KARS Z, 1985, NEUROCHIRURGIA, V28, P145; Kett-White R, 1999, BRIT J NEUROSURG, V13, P77, DOI 10.1080/02688699944258; KISSEL P, 1989, Journal of Emergency Medicine, V7, P365, DOI 10.1016/0736-4679(89)90307-7; Kotil Kadir, 2006, Ulus Travma Acil Cerrahi Derg, V12, P164; KUDAY C, 1994, ACTA NEUROCHIR, V131, P203, DOI 10.1007/BF01808613; KVARNES TL, 1978, ACTA NEUROCHIR, V41, P223, DOI 10.1007/BF01809151; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; LOBATO RD, 1988, J NEUROSURG, V68, P48, DOI 10.3171/jns.1988.68.1.0048; Maggi G, 1998, J Neurosurg Sci, V42, P95; MAZZA C, 1982, ACTA NEUROCHIR, V65, P67, DOI 10.1007/BF01405443; MCKISSOCK W, 1960, LANCET, V2, P167; MOHANTY A, 1995, PEDIATR NEUROSURG, V23, P57, DOI 10.1159/000120936; Munoz-Sanchez MA, 2009, BRAIN INJURY, V23, P39, DOI 10.1080/02699050802590346; NAGANE M, 1994, SURG NEUROL, V42, P65, DOI 10.1016/0090-3019(94)90252-6; Naja A, 2002, NEUROCHIRURGIE, V48, P101; NEDD K, 1993, BRAIN INJURY, V7, P469, DOI 10.3109/02699059309008174; OKAMOTO H, 1983, SURG NEUROL, V20, P461, DOI 10.1016/0090-3019(83)90028-9; ONEILL OR, 1994, SURG NEUROL, V42, P308, DOI 10.1016/0090-3019(94)90398-0; Owler BK, 2005, CHILD NERV SYST, V21, P262, DOI 10.1007/s00381-004-1014-3; PATERNITI S, 1994, ACTA NEUROCHIR, V131, P207, DOI 10.1007/BF01808614; Pereira CU, 2004, J BRAS NEUROCIRURG, V15, P18; PILLAY R, 1995, S AFR MED J, V85, P672; POZZATI E, 1987, J TRAUMA, V27, P579, DOI 10.1097/00005373-198705000-00024; POZZATI E, 1980, J TRAUMA, V20, P795, DOI 10.1097/00005373-198009000-00015; Pringle J Hogarth, 1938, Edinb Med J, V45, P741; RAPPAPORT ZH, 1982, NEUROSURGERY, V10, P487; Reale F, 1984, J Neurosurg Sci, V28, P9; RICE JO, 1976, J ORAL SURG, V34, P639; RIVAS JJ, 1988, NEUROSURGERY, V23, P44, DOI 10.1227/00006123-198807000-00010; ROBERTSON JH, 1982, SURG NEUROL, V17, P468, DOI 10.1016/S0090-3019(82)80021-9; ROMANO A, 1983, SURG NEUROL, V19, P77; Saiful M N, 2007, Med J Malaysia, V62, P156; SEELIG JM, 1984, NEUROSURGERY, V15, P617, DOI 10.1227/00006123-198411000-00001; SERVADEI F, 1989, ACTA NEUROCHIR, V96, P39, DOI 10.1007/BF01403493; Sinha AK, 2009, CENT EUR NEUROSURG, V70, P52, DOI 10.1055/s-2008-0042; SPARACIO RR, 1972, J TRAUM, V12, P435, DOI 10.1097/00005373-197205000-00016; STEPHANOV S, 1992, SURG NEUROL, V37, P329, DOI 10.1016/0090-3019(92)90162-G; STEWART CR, 1993, BRIT J OPHTHALMOL, V77, P179, DOI 10.1136/bjo.77.3.179; Sulla I., 2003, Folia Veterinaria, V47, P95; Sullivan TP, 1999, AM J NEURORADIOL, V20, P107; TATAGIBA M, 1989, SURG NEUROL, V32, P453, DOI 10.1016/0090-3019(89)90011-6; Uzan M, 1998, J Neurosurg Sci, V42, P89; WATANABE T, 1995, ACTA NEUROCHIR, V132, P150, DOI 10.1007/BF01404865; WATTS C, 1976, SOUTHERN MED J, V69, P1539, DOI 10.1097/00007611-197612000-00006; Wood RL, 1981, APPL CONDITIONING TH, P81; ZUCCARELLO M, 1983, ACTA NEUROCHIR, V67, P57, DOI 10.1007/BF01401668	94	3	3	0	3	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	1868-4904	1868-4912		CENT EUR NEUROSURG	Cent. Eur. Neurosurg.	NOV	2011	72	4					169	175		10.1055/s-0031-1286261			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	846HN	WOS:000296887900001	22012694				2022-02-06	
J	Conway, TL; Hammer, PS; Galarneau, MR; Larson, GE; Edwards, NK; Schmied, EA; Ly, HL; Schmitz, KJ; Webb-Murphy, JA; Boucher, WC; Johnson, DC; Ghaed, SG				Conway, Terry L.; Hammer, Paul S.; Galarneau, Michael R.; Larson, Gerald E.; Edwards, Nathan K.; Schmied, Emily A.; Ly, Hoa L.; Schmitz, Kimberly J.; Webb-Murphy, Jennifer A.; Boucher, Wayne C.; Johnson, Douglas C.; Ghaed, Shiva G.			Theater Mental Health Encounter Data (TMHED): Overview of Study Design and Methods	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; US MILITARY COHORT; PSYCHIATRIC-DISORDERS; WAR VETERANS; IRAQ; DEPLOYMENT; CARE; AFGHANISTAN; SYMPTOMS	Research has documented higher risks for mental health problems among service members deployed to war zones, yet a research limitation has been that assessment has generally occurred often years after combat exposure. The Operational Stress Control and Readiness program integrated mental health practitioners with 1st Marine Division units serving in Iraq. This team documented mental health visits between January 2006 and January 2007 and developed the Theater Mental Health Encounter Database (TMHED). This report describes the TMHED study design, measures, and cases. Of I,336 patients (3,180 patient visits), 10% were women, 75% were high school educated, 55% were mid-paygrade enlisted, and 63% were on their first combat deployment. Compared with the overall deployed population, patient percentages included higher percentages of Marines and Navy personnel but lower percentages of Army and Air Force personnel, more junior enlisted but fewer officers, and fewer college graduates. TMHED provides an unprecedented opportunity to study early psychiatric intervention in a combat zone and prospectively examines postdeployment health and career outcomes.	[Conway, Terry L.; Galarneau, Michael R.; Larson, Gerald E.; Edwards, Nathan K.; Schmied, Emily A.; Ly, Hoa L.; Johnson, Douglas C.] USN, Hlth Res Ctr, San Diego, CA 92106 USA; [Hammer, Paul S.; Schmitz, Kimberly J.; Webb-Murphy, Jennifer A.; Ghaed, Shiva G.] USN, San Diego Med Ctr, NCCOSC, San Diego, CA 92134 USA; [Boucher, Wayne C.] OSCAR Program, Div Surgeon Off, Marine Div 1, Camp Pendleton, CA 92055 USA		Conway, TL (corresponding author), USN, Hlth Res Ctr, 140 Sylvester Rd, San Diego, CA 92106 USA.				U.S. Department of Defense, Bureau of Medicine under NHRC Work UnitUnited States Department of Defense [60812, 60819]	The authors thank James Zouris for providing the population parameters for U.S. service personnel deployed in the Iraqi combat theater during the study's time frame. This work was supported in part by the U.S. Department of Defense, Bureau of Medicine, under NHRC Work Unit Numbers 60812 and 60819.	Dedert EA, 2009, J PSYCHIATR RES, V43, P830, DOI 10.1016/j.jpsychires.2009.01.004; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hoge CW, 2002, AM J PSYCHIAT, V159, P1576, DOI 10.1176/appi.ajp.159.9.1576; JORDAN BK, 1991, ARCH GEN PSYCHIAT, V48, P207, DOI 10.1001/archpsyc.1991.01810270019002; Kang HK, 2005, NEW ENGL J MED, V352, P1289, DOI 10.1056/NEJMp058024; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; LeardMann CA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1273; MacGregor AJ, 2009, MIL MED, V174, P224, DOI 10.7205/MILMED-D-03-9107; Prigerson HG, 2002, AM J PUBLIC HEALTH, V92, P59, DOI 10.2105/AJPH.92.1.59; Rosenheck RA, 2007, HEALTH AFFAIR, V26, P1720, DOI 10.1377/hlthaff.26.6.1720; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Taubman S. B., 2009, Medical Surveillance Montly Report, V16, P2; Warner CH, 2007, MIL MED, V172, P907, DOI 10.7205/MILMED.172.9.907; Warner CH, 2011, AM J PSYCHIAT, V168, P378, DOI 10.1176/appi.ajp.2010.10091303	20	3	3	0	3	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075			MIL MED	Milit. Med.	NOV	2011	176	11					1243	1252		10.7205/MILMED-D-11-00122			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	845NR	WOS:000296830300007	22165651				2022-02-06	
J	de Ribaupierre, S				de Ribaupierre, Sandrine			Trauma and Impaired Consciousness	NEUROLOGIC CLINICS			English	Article						Traumatic brain injury; Concussion; Diffuse axonal injury; Vegetative state; Consciousness; Coma	CEREBRAL-BLOOD-FLOW; DIFFUSE AXONAL INJURY; SEVERE BRAIN-INJURY; CEREBROVASCULAR PRESSURE REACTIVITY; MAGNETIC-RESONANCE SPECTROSCOPY; WHITE-MATTER INJURY; SEVERE HEAD-INJURY; SPREADING DEPRESSION; INTRACRANIAL-PRESSURE; EXTRACELLULAR POTASSIUM	This article discusses brain trauma and impaired consciousness. It reviews the various states of impaired consciousness related to trauma, with an historical and current literature viewpoint. The causes and pathophysiology of impaired consciousness in concussion, diffuse axonal injury, and focal brain lesions are discussed and management options evaluated.	Univ Western Ontario, Div Neurosurg, Dept Clin Neurol Sci, Victoria Hosp, London, ON N6A 5W9, Canada		de Ribaupierre, S (corresponding author), Univ Western Ontario, Div Neurosurg, Dept Clin Neurol Sci, Victoria Hosp, 800 Commissioners Rd E, London, ON N6A 5W9, Canada.	Sandrine.deRibaupierre@lhsc.on.ca	de Ribaupierre, Sandrine/B-7707-2015; de Ribaupierre, Sandrine/H-1844-2013	de Ribaupierre, Sandrine/0000-0001-7096-2289; 			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adelson PD, 1998, ACT NEUR S, V71, P250; Agrawal D, 2005, J NEUROSURG, V102, P167, DOI 10.3171/jns.2005.102.2.0167; Amantini A, 2005, CLIN NEUROPHYSIOL, V116, P229, DOI 10.1016/j.clinph.2004.07.008; Ariza M, 2004, ARCH NEUROL-CHICAGO, V61, P541, DOI 10.1001/archneur.61.4.541; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Babikian T, 2010, J NEUROTRAUM, V27, P473, DOI 10.1089/neu.2009.1058; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; Bayir H, 2003, CRIT CARE MED, V31, pS112, DOI 10.1097/01.CCM.0000042464.46603.0E; Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; BIROS MH, 1987, AM J EMERG MED, V5, P271, DOI 10.1016/0735-6757(87)90349-4; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; BUGE A, 1975, REV NEUROL, V131, P121; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Carpentier A, 2006, J NEUROTRAUM, V23, P674, DOI 10.1089/neu.2006.23.674; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; Carter BG, 2005, INTENS CARE MED, V31, P840, DOI 10.1007/s00134-005-2634-0; Cazalis F, 2006, BRAIN INJURY, V20, P1019, DOI 10.1080/02699050600664384; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chesnut R M, 1991, Neurosurg Clin N Am, V2, P267; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Crespi F, 2007, CURR VASC PHARMACOL, V5, P305, DOI 10.2174/157016107782023398; CROMPTON MR, 1966, LANCET, V2, P938; Cruse D, 2010, CURR OPIN NEUROL, V23, P656, DOI 10.1097/WCO.0b013e32833fd4e7; Davis GA, 2009, BRIT J SPORT MED, V43, pI36, DOI 10.1136/bjsm.2009.058123; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dow RS, 1944, AM J PSYCHIAT, V101, P174, DOI 10.1176/ajp.101.2.174; DRUMMOND JC, 1987, NEUROSURGERY, V20, P830, DOI 10.1227/00006123-198706000-00002; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10210; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fabregas N, 2004, ANESTHESIOLOGY, V101, P43, DOI 10.1097/00000542-200407000-00009; FICK DS, 1995, POSTGRAD MED, V97, P53, DOI 10.1080/00325481.1995.11945958; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Garcia-Larrea L., 1993, Neurophysiologie Clinique, V23, P141; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gasparovic C, 2001, J NEUROTRAUM, V18, P241, DOI 10.1089/08977150151070856; Gebke Kevin B, 2002, Curr Sports Med Rep, V1, P23; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Giza CC, 2001, J ATHL TRAINING, V36, P228; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Gupta RK, 2005, EPILEPSIA, V46, P1465, DOI 10.1111/j.1528-1167.2005.01205.x; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hayes R L, 1986, Cent Nerv Syst Trauma, V3, P163; Hebb MO, 2007, J NEUROTRAUM, V24, P579, DOI 10.1089/neu.2006.0146; Hlatky R, 2005, NEUROSURGERY, V57, P917, DOI 10.1227/01.NEU.0000180025.43747.fc; Horiguchi T, 2005, BRAIN RES, V1062, P127, DOI 10.1016/j.brainres.2005.09.010; Horiguchi T, 2005, BRAIN RES, V1039, P84, DOI 10.1016/j.brainres.2005.01.047; HUBSCHMANN OR, 1983, J NEUROSURG, V59, P289, DOI 10.3171/jns.1983.59.2.0289; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; JELLINGER K, 1970, J NEUROL SCI, V10, P51, DOI 10.1016/0022-510X(70)90091-2; JENNETT B, 1972, LANCET, V1, P734; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; JONES BE, 1977, BRAIN RES, V124, P473, DOI 10.1016/0006-8993(77)90948-9; JONES BE, 1977, BRAIN RES, V127, P23, DOI 10.1016/0006-8993(77)90378-X; Kampfl A, 1997, ACT NEUR S, V70, P112; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KATAYAMA Y, 1990, ACT NEUR S, V51, P271; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; KAWAHARA N, 1995, NEUROL RES, V17, P9, DOI 10.1080/01616412.1995.11740281; Kawai N, 2010, J NEUROTRAUM, V27, P2131, DOI 10.1089/neu.2010.1464; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; Kelly JP, 2001, J ATHL TRAINING, V36, P249; KOBAYASHI S, 1995, J CEREBR BLOOD F MET, V15, P721, DOI 10.1038/jcbfm.1995.92; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Leclerc S, 2001, SPORTS MED, V31, P629, DOI 10.2165/00007256-200131080-00007; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LEVITT P, 1978, BRAIN RES, V139, P219, DOI 10.1016/0006-8993(78)90925-3; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCQUILLEN JB, 1988, AM J FOREN MED PATH, V9, P12, DOI 10.1097/00000433-198803000-00004; MOORE RY, 1978, J COMP NEUROL, V180, P417, DOI 10.1002/cne.901800302; Nakabayashi M, 2007, J NEUROSURG, V106, P370, DOI 10.3171/jns.2007.106.3.370; NEDERGAARD M, 1988, BRAIN RES, V449, P395, DOI 10.1016/0006-8993(88)91062-1; NILSSON B, 1977, J NEUROSURG, V47, P252, DOI 10.3171/jns.1977.47.2.0252; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Owen AM, 2007, CURR OPIN NEUROL, V20, P632, DOI 10.1097/WCO.0b013e3282f15669; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Plum F, 1970, Trans Am Neurol Assoc, V95, P27; Plum F., 1982, DIAGNOSIS STUPOR COM, V3rd; Putukian M, 2009, BRIT J SPORT MED, V43, pI28, DOI 10.1136/bjsm.2009.058230; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Reddy CC, 2009, CURR SPORT MED REP, V8, P10, DOI 10.1249/JSR.0b013e31819539ca; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rohlwink UK, 2010, CHILD NERV SYST, V26, P453, DOI 10.1007/s00381-009-1033-1; ROSENTHAL M, 1979, BRAIN RES, V162, P113, DOI 10.1016/0006-8993(79)90760-1; Rosomoff HL, 1996, CRIT CARE MED, V24, pS48; Rothstein TL, 2000, J CLIN NEUROPHYSIOL, V17, P486, DOI 10.1097/00004691-200009000-00007; Rutigliano D, 2006, J PEDIATR SURG, V41, P83, DOI 10.1016/j.jpedsurg.2005.10.010; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; SAPER CB, 1978, J COMP NEUROL, V182, P575, DOI 10.1002/cne.901820402; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schmidt O.I., 2004, EUR J TRAUMA, V30, P135, DOI DOI 10.1007/S00068-004-1394-9; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Sherman AL, 2000, NEUROLOGY, V54, P889, DOI 10.1212/WNL.54.4.889; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Son BC, 2000, ACT NEUR S, V76, P13; Spinos P, 2010, J TRAUMA, V69, P789, DOI 10.1097/TA.0b013e3181edea67; Sroufe NS, 2010, PEDIATRICS, V125, pE1331, DOI 10.1542/peds.2008-2364; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; SUTTON LN, 1995, PEDIATR NEUROSURG, V22, P81, DOI 10.1159/000120881; TAKAHASHI H, 1981, J NEUROSURG, V55, P708, DOI 10.3171/jns.1981.55.5.0708; TEASDALE G, 1974, LANCET, V2, P81; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; van Rossem K, 1999, ADV EXP MED BIOL, V471, P209; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vink R, 1990, Magnes Res, V3, P163; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; Vink R, 1990, J NEUROTRAUM, V7, P21, DOI 10.1089/neu.1990.7.21; Wahl M, 1993, Acta Neurochir Suppl (Wien), V57, P64; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; YINGLING CD, 1975, ELECTROEN CLIN NEURO, V39, P635, DOI 10.1016/0013-4694(75)90076-0; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; Zarza-Lucianez A, 2007, REV NEUROLOGIA, V44, P465, DOI 10.33588/rn.4408.2006306; Zhang J, 2010, J NEUROTRAUM, V27, P35, DOI 10.1089/neu.2009.1049; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	159	3	3	1	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	NOV	2011	29	4					883	+		10.1016/j.ncl.2011.07.012			21	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	853BN	WOS:000297401300011	22032665				2022-02-06	
J	Elbrond-Bek, H; Wellejus, A; Kelly, NM; Weidner, MS; Jorgensen, SH				Elbrond-Bek, H.; Wellejus, A.; Kelly, N. M.; Weidner, M. S.; Jorgensen, S. H.			2-(Cyclohexylamino)-1-(4-cyclopentylpiperazin-1-yl)-2-methylpropan-1-one, a novel compound with neuroprotective and neurotrophic effects in vitro	NEUROCHEMISTRY INTERNATIONAL			English	Article						Neuroprotection; Neurotrophic effects; Sigma-1; Excitotoxicity; Oxidative stress; Neurite outgrowth	SIGMA(1) RECEPTOR AGONIST; INTRACELLULAR CALCIUM; NEURODEGENERATION; EXCITOTOXICITY; NEUROTOXICITY; ACTIVATION; MECHANISMS; TOXICITY; ISCHEMIA; NEURONS	Focusing on development of novel drug candidates for the treatment of neurodegenerative diseases, we developed and synthesized a new compound, 2-(cyclohexylamino)-1-(4-cyclopentylpiperazin-1-yl)-2methylpropan-1-one (amido-piperizine 1). The compound demonstrated robust neuroprotective properties after both glutamate excitotoxicity and peroxide induced oxidative stress in primary cortical cultures. Furthermore, amido-piperizine 1 was found to significantly induce neurite outgrowth in vitro which could suggest central reparative and regenerative potential of the compound. With these potential beneficial effects in CNS, the ability of the amido-piperizine 1 to penetrate the blood-brain barrier was tested using MDR1-MDCK cells. Amido-piperizine 1 was found not to be a P-gp substrate and to have a high blood-brain barrier penetration potential, indicating excellent availability to the CNS. Moreover, amido-piperizine 1 had a fast metabolic clearance rate in vitro, suggesting that parenteral in vivo administration seems preferable. As an attempt to elucidate a possible mechanism of action, we found that amido-piperizine 1 bound in nano-molar range to the sigma-1 receptor, which could explain the observed neuroprotective and neurotrophic properties, and with a 100-fold lower affinity to the sigma-2 receptor. These results propose that amido-piperizine 1 may hold promise as a drug candidate for the treatment of stroke/traumatic brain injury or other neurodegenerative diseases. (C) 2011 Elsevier B.V. All rights reserved.	[Elbrond-Bek, H.; Wellejus, A.; Kelly, N. M.; Weidner, M. S.; Jorgensen, S. H.] Nensius Res AS, DK-2100 Copenhagen, Denmark		Wellejus, A (corresponding author), Nensius Res AS, Symb Sci Pk,Fruebjergvej 3, DK-2100 Copenhagen, Denmark.	anja.wellejus@gmail.com					Ajmo CT, 2006, CURR NEUROVASC RES, V3, P89, DOI 10.2174/156720206776875849; Arias-Carrion O, 2009, J NEURAL TRANSM-SUPP, P279, DOI 10.1007/978-3-211-92660-4_23; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Chang A, 2008, BRAIN, V131, P2366, DOI 10.1093/brain/awn157; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; DECOSTER MA, 1995, BRAIN RES, V671, P45, DOI 10.1016/0006-8993(94)01294-R; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Fariello RG, 2007, NEUROTHERAPEUTICS, V4, P110, DOI 10.1016/j.nurt.2006.11.011; GIROS B, 1993, TRENDS PHARMACOL SCI, V14, P43, DOI 10.1016/0165-6147(93)90029-J; Gonsette RE, 2008, J NEUROL SCI, V274, P48, DOI 10.1016/j.jns.2008.06.029; GU H, 1994, J BIOL CHEM, V269, P7124; Guzman-Lenis MS, 2009, NEUROSCIENCE, V162, P31, DOI 10.1016/j.neuroscience.2009.03.067; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Jennings JS, 2008, MINI-REV MED CHEM, V8, P689, DOI 10.2174/138955708784567377; Johannessen M, 2009, AM J PHYSIOL-CELL PH, V296, pC1049, DOI 10.1152/ajpcell.00431.2008; Katnik C, 2006, J PHARMACOL EXP THER, V319, P1355, DOI 10.1124/jpet.106.107557; Kaur C, 2008, CURR MED CHEM, V15, P3068, DOI 10.2174/092986708786848640; Kelly N.M., SYNTHESIS 2 CY UNPUB; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kim HC, 2003, LIFE SCI, V72, P769, DOI 10.1016/S0024-3205(02)02309-3; Kim HC, 2001, LIFE SCI, V69, P915, DOI 10.1016/S0024-3205(01)01181-X; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lazarov O, 2010, EXP NEUROL, V223, P267, DOI 10.1016/j.expneurol.2009.08.009; Li LA, 2010, NEUROPHARMACOLOGY, V59, P323, DOI 10.1016/j.neuropharm.2010.02.009; Li Z, 2009, J CEREBR BLOOD F MET, V29, P287, DOI 10.1038/jcbfm.2008.118; LYSKO PG, 1992, STROKE, V23, P414, DOI 10.1161/01.STR.23.3.414; Marrazzo A, 2005, NEUROREPORT, V16, P1223, DOI 10.1097/00001756-200508010-00018; Maurice T, 1998, NEUROSCIENCE, V83, P413, DOI 10.1016/S0306-4522(97)00405-3; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; Meunier J, 2006, BRIT J PHARMACOL, V149, P998, DOI 10.1038/sj.bjp.0706927; Nicholls DG, 2004, CURR MOL MED, V4, P149, DOI 10.2174/1566524043479239; Nishimura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002558; Paquette MA, 2009, PSYCHOPHARMACOLOGY, V204, P743, DOI 10.1007/s00213-009-1505-8; Radio NM, 2008, NEUROTOXICOLOGY, V29, P361, DOI 10.1016/j.neuro.2008.02.011; Senda T, 1998, EUR J PHARMACOL, V342, P105, DOI 10.1016/S0014-2999(97)01450-7; Shen YC, 2008, J NEUROCHEM, V104, P558, DOI 10.1111/j.1471-4159.2007.05058.x; Sisodiya SM, 2002, BRAIN, V125, P22, DOI 10.1093/brain/awf002; Summerfield SG, 2007, J PHARMACOL EXP THER, V322, P205, DOI 10.1124/jpet.107.121525; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; TAKAHASHI H, 1995, STROKE, V26, P1676, DOI 10.1161/01.STR.26.9.1676; Takebayashi M, 2002, J PHARMACOL EXP THER, V303, P1227, DOI 10.1124/jpet.102.041970; Tan F, 2010, NEUROPHARMACOLOGY, V59, P416, DOI 10.1016/j.neuropharm.2010.05.014; Tchedre KT, 2008, INVEST OPHTH VIS SCI, V49, P2577, DOI 10.1167/iovs.07-1101; Toyohara Jun, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P190; URBAN P, 1991, FEBS LETT, V286, P142, DOI 10.1016/0014-5793(91)80960-B; Vagnerova K, 2006, ANESTH ANALG, V103, P430, DOI 10.1213/01.ane.0000226133.85114.91; Villard V, 2009, NEUROPSYCHOPHARMACOL, V34, P1552, DOI 10.1038/npp.2008.212; Vucic S, 2009, CURR MOL MED, V9, P255, DOI 10.2174/156652409787847173; Wang Q, 2005, INT J PHARMACEUT, V288, P349, DOI 10.1016/j.ijpharm.2004.10.007; Werling LL, 2007, NEUROLOGIST, V13, P272, DOI 10.1097/NRL.0b013e3180f60bd8; Yang SF, 2007, ANESTH ANALG, V104, P1179, DOI 10.1213/01.ane.0000260267.71185.73; YOUDIM MBH, 1991, BIOCHEM PHARMACOL, V41, P155, DOI 10.1016/0006-2952(91)90471-G; Zhang HL, 2002, J NEUROPHYSIOL, V87, P2867, DOI 10.1152/jn.2002.87.6.2867	54	3	3	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	NOV	2011	59	6					821	829		10.1016/j.neuint.2011.08.003			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	853BH	WOS:000297400700009	21854820				2022-02-06	
J	Nagarsheth, KH; Gandhi, SS; Heidel, RE; Kurek, SJ; Angel, C				Nagarsheth, Khanjan H.; Gandhi, Sagar S.; Heidel, Robert E.; Kurek, Stanley J.; Angel, Carlos			A Mathematical Model to Predict Length of Stay in Pediatric ATV Accident Victims	JOURNAL OF SURGICAL RESEARCH			English	Article						pediatric; ATV; trauma; mathematical model; hospital length of stay	TERRAIN-VEHICLE INJURIES	Background. Children under age 12 y represent 15% of all-terrain vehicle (ATV)-related deaths, and those under 16 y old represent > 36% of deaths nationwide. In recent years, this has accounted for an increasing proportion of pediatric trauma victims and longer hospitalizations secondary to worsened injuries. We believe it is possible to create a simple mathematical model that can be used to predict hospital length of stay. Methods. A retrospective review of the trauma registry was performed for all pediatric patients who were involved in ATV accidents from January 2000 to December 2009. Four hundred twenty pediatric patients were identified. A model to predict for total LOS in pediatric patients involved in ATV accidents was constructed. SPSS ver. 17 (SPSS Inc., Chicago, IL) was utilized to conduct all statistical analyses. Statistical significance of regression coefficients was assumed at a P < 0.05 level. Results. We performed a hierarchical multiple regression analysis to build a model that would predict for total length of stay (LOS). A logarithmic transformation was employed on LOS as a dependent variable due to skewness. In Step 1, ISS accounted for a 25% increase in shared variance in LOS (P < 0.001). In Step 2, Glasgow Coma Score (GCS) accounted for 4.3% more variance in LOS (P < 0.001). Finally, in Step 3, the presence of a closed head injury further increased (3.6%) the amount of shared variance in the model (P < 0.001). The final model accounts for 32.9% of the shared variance in total LOS. When using the logarithmic transformation, the final model is: Total LOS = 1.00 + 0.05 injury severity score (ISS) - 0.06 (GCS) + 0.35 closed head injury (CHI). Conclusion. Based on our data and statistical analysis, we found it was possible to create a mathematical model that could predict hospital LOS in pediatric ATV accident victims. (C) 2011 Elsevier Inc. All rights reserved.	[Nagarsheth, Khanjan H.; Gandhi, Sagar S.; Heidel, Robert E.; Kurek, Stanley J.; Angel, Carlos] Univ Tennessee, Med Ctr, Knoxville, TN 37920 USA		Nagarsheth, KH (corresponding author), Univ Tennessee, Med Ctr, 4850 Briar Rock Lane, Knoxville, TN 37920 USA.	Khanjan.Nagarsheth@gmail.com		Heidel, Robert/0000-0002-1518-8072			Aiken L. S., 2013, APPL MULTIPLE REGRES, DOI 10.4324/9780203774441; Campbell BT, 2010, J PEDIATR SURG, V45, P925, DOI 10.1016/j.jpedsurg.2010.02.021; Carr AM, 2004, NEUROSURGERY, V54, P861, DOI 10.1227/01.NEU.0000114922.46342.38; *CONS FED AM ATV, SAF CRIS AM CHILDR R; Consumer Product Safety Commission, 1998, ALL TERR VEH EXP INJ; DUKE EM, 108181 SEN US DEP HL; GARDNER S, 2010, 2008 ANN REPORT ATV, P1; Kelleher CM, 2005, J PEDIATR SURG, V40, P929, DOI 10.1016/j.jpedsurg.2005.03.007; Killingsworth JB, 2005, PEDIATRICS, V115, pE316, DOI 10.1542/peds.2004-1585; Kute B, 2007, J PEDIATR ORTHOPED, V27, P851, DOI 10.1097/bpo.0b013e31815a60c4; Rodgers GB, 1999, ACCIDENT ANAL PREV, V31, P409, DOI 10.1016/S0001-4575(98)00080-3; SMILTH LM, 2005, J TRAUMA, V58, P783; 2009, NEISS DATA HIGHLIGHT	13	3	3	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804			J SURG RES	J. Surg. Res.	NOV	2011	171	1					28	30		10.1016/j.jss.2011.03.063			3	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	839LS	WOS:000296368000024	21514601				2022-02-06	
J	Nass, RD; Elger, CE; Fink, GR; Burghaus, L				Nass, R. D.; Elger, C. E.; Fink, G. R.; Burghaus, L.			Concussive Convulsions: Seizure or no Seizure?	FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE			German	Article						epilepsy; traumatic brain injury; concussive convulsions; impact seizures	POSTTRAUMATIC EPILEPSY; CEREBRAL CONCUSSION; SPORT; UNCONSCIOUSNESS; TRAUMA	Convulsions following traumatic brain injury (TBI) represent a diagnostic and therapeutic challenge. They can be differentiated into late (> 7 days after TBI), early (1 - 7 days after TBI), immediate (within the first 24 h after TBI), and impact seizures (within seconds after TBI). Some authors suggest that most impact seizures are non-epileptic in origin and hence coined the term "concussive convulsions" for benign impact seizures. Early and late post-traumatic seizures frequently indicate structural brain damage and transition to chronic, post-traumatic epilepsy. The data for impact seizures or concussive convulsions is less clear: only a small percentage of impact seizures is associated with structural brain damage and the development of post-traumatic epilepsy, rather the majority of cases are benign and associated with an excellent prognosis. Here, we present a case report as a starting point for pathophysiological and clinical considerations regarding convulsions that start within seconds after TBI.	[Fink, G. R.; Burghaus, L.] Univ Klinikum Koln, Klin & Poliklin Neurol, D-50924 Cologne, Germany; [Nass, R. D.; Elger, C. E.] Univ Klin Bonn, Klin Epileptol, Bonn, Germany		Burghaus, L (corresponding author), Univ Klinikum Koln, Klin & Poliklin Neurol, Kerpener Str 62, D-50924 Cologne, Germany.	lothar.burghaus@uk-koeln.de	Fink, Gereon R./E-1616-2012	Fink, Gereon R./0000-0002-8230-1856; Nass, Robert Daniel/0000-0003-4446-8898			Anderson-Barnes VCW, 2010, TRAUMATIC BRAIN INJU, V16, P17; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Barry E, 1998, EPILEPSIA, V39, P427, DOI 10.1111/j.1528-1157.1998.tb01395.x; Barry Elizabeth, 1997, Epilepsia, V38, P49; Beer R, 2008, LEITLINIEN DIAGNOSTI; Chadwick D, 1997, BRIT MED J, V314, P1283; Clear D, 2000, EPILEPSIA, V41, P243, DOI 10.1111/j.1528-1157.2000.tb00147.x; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; D'Ambrosio R, 2010, EPILEPSY CURR, V10, P61, DOI 10.1111/j.1535-7511.2010.01358.x; Denny-Brown D, 1940, J PHYSIOL-LONDON, V99, P153, DOI 10.1113/jphysiol.1940.sp003887; Dias MS, 1999, PEDIATR NEUROSURG, V30, P232, DOI 10.1159/000028803; Dudek FE, 2010, EPILEPSY CURR, V10, P91, DOI 10.1111/j.1535-7511.2010.01368.x; Emanuelson I, 2009, BRAIN INJURY, V23, P612, DOI 10.1080/02699050902973913; Evans RW, 2011, POST TRAUMATIC SEIZU; Firsching R, 2001, WORLD J SURG, V25, P1221; FOLTZ EL, 1953, J NEUROSURG, V10, P342, DOI 10.3171/jns.1953.10.4.0342; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Hallen O, 1969, Nervenarzt, V40, P460; HAYES RL, 1984, SCIENCE, V223, P301, DOI 10.1126/science.6701514; Holmes JF, 2004, ANN EMERG MED, V43, P706, DOI 10.1016/j.annemergmed.2003.11.008; Jennet B, 1975, CHARACTER EARLY EPIL, P179; KRAYENBUHL H, 1970, EPILEPSIA, V11, P59, DOI 10.1111/j.1528-1157.1970.tb03867.x; Lewrenz H, 1996, SCHRIFTENREIHE BUNDE; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; McCrory P, 2001, BRIT J SPORT MED, V35, P146, DOI 10.1136/bjsm.35.3.146; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; McCrory PR, 1997, BRIT MED J, V314, P171, DOI 10.1136/bmj.314.7075.171; McCrory PR, 1998, SPORTS MED, V25, P131, DOI 10.2165/00007256-199825020-00005; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Parko KL, 2010, TRAUMATIC BRAIN INJU, V16, P110; Perron AD, 2001, ACAD EMERG MED, V8, P296, DOI 10.1111/j.1553-2712.2001.tb01312.x; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Sander JWAS, 1997, BRIT MED J, V314, P158, DOI 10.1136/bmj.314.7075.158; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; Westbrook LE, 1998, EPILEPSIA, V39, P978, DOI 10.1111/j.1528-1157.1998.tb01447.x; Wolf P, 2001, EPILEPSIA, V42, P573	40	3	3	0	8	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0720-4299	1439-3522		FORTSCHR NEUROL PSYC	Forschritte Neurol. Psychiatr.	NOV	2011	79	11					655	659		10.1055/s-0031-1281688			5	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	854SF	WOS:000297513800005	22002819				2022-02-06	
J	Zheng, XG; Chopp, M; Lu, Y; Jiang, J; Zhao, DP; Ding, C; Yang, HY; Zhang, L; Jiang, F				Zheng, Xuguang; Chopp, Michael; Lu, Yong; Jiang, James; Zhao, Danping; Ding, Christopher; Yang, Hongyan; Zhang, Li; Jiang, Feng			Atorvastatin reduces functional deficits caused by photodynamic therapy in rats	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						glioma; photodynamic therapy; functional deficits; atorvastatin	TRAUMATIC BRAIN-INJURY; NUDE-MOUSE; CEREBRAL-ISCHEMIA; ANGIOGENESIS; GLIOMA; STROKE; SYNAPTOGENESIS; GLIOBLASTOMA; EXPRESSION; REDUCTION	Clinical studies have indicated that photodynamic therapy (PDT) significantly prolonged the median survival of patients with gliomas. Experimental studies demonstrate that increasing optical energy and photosensitizer dose leads to increased volume of tumor necrosis. However, increasing the light dose delivered to the tumor may increase the risks of inducing permanent neurological deficits. In the current study, we sought to test the behavioral deficits induced in normal rats by brain PDT and the neurorestorative effects of atorvastatin on PDT-induced behavioral deficits. Considering its potential as a combination treatment of brain tumors, we investigated both in vitro and in vivo whether atorvastatin treatment promotes brain tumor growth. Non-tumored Fischer rats received PDT (n=18). Nine of the PDT-treated animals were treated with atorvastatin. Control animals underwent the same surgical procedure, but did not receive Photofrin and laser light. PDT-treated animals had significant behavioral deficits on Days 2, 5, 7, 9 and 14 after PDT, compared with surgery controls. PDT-treated animals receiving atorvastatin displayed significantly ameliorated behavioral deficits on Days 7, 9 and 14 after PDT, compared to PDT-treated rats. In vitro tumor cell viability and growth were evaluated. Atorvastatin did not affect the growth of glioma cells. Fischer rats with intracranial 7-day-old 9L glioma tumor cell implantation were randomly subjected to no treatment, PDT alone, atorvastatin alone, or combined treatment with atorvastatin and PDT (6 rats/group). Our data indicate that atorvastatin did not promote tumor growth in either PDT treated and non-treated rats. However, atorvastatin significantly reduced the cell damage caused by PDT. To further test the mechanisms underlying the atorvastatin-mediated reduction of functional deficits, we investigated the effects of atorvastatin on angiogenesis and synaptogenesis. Our data demonstrate that atorvastatin significantly induced angiogenesis and synaptogenesis in the PDT-damaged brain tissue. Our data indicate that PDT induces functional deficits. Atorvastatin treatment promotes functional restoration after PDT, but does not promote glioma growth in vitro and in vivo. Atorvastatin reduces astrocyte and endothelial cell damage caused by PDT and induces angiogenesis and synaptogenesis after PDT. Thus consideration and further testing of the combination of atorvastatin and PDT for the treatment of glioma is warranted.	[Zheng, Xuguang; Chopp, Michael; Lu, Yong; Jiang, James; Zhao, Danping; Ding, Christopher; Yang, Hongyan; Zhang, Li; Jiang, Feng] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA		Jiang, F (corresponding author), Henry Ford Hosp, Dept Neurol, 2799 W Grand Blvd, Detroit, MI 48202 USA.	fengj@neuro.hfh.edu	Lu, Yong/B-9859-2015				BURGER PC, 1989, CANCER-AM CANCER SOC, V63, P2014, DOI 10.1002/1097-0142(19890515)63:10<2014::AID-CNCR2820631025>3.0.CO;2-L; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Chopp M, 1996, RADIAT RES, V146, P461, DOI 10.2307/3579308; Chopp M, 1996, PHOTOCHEM PHOTOBIOL, V64, P707, DOI 10.1111/j.1751-1097.1996.tb03128.x; DELZOPPO GJ, 1994, CEREBROVAS BRAIN MET, V6, P47; EVANS S, 1990, J NATL CANCER I, V82, P34, DOI 10.1093/jnci/82.1.34; Gollnick SO, 2003, BRIT J CANCER, V88, P1772, DOI 10.1038/sj.bjc.6600864; Gollnick SO, 1997, CANCER RES, V57, P3904; Hanlon JG, 2001, J PHOTOCH PHOTOBIO B, V64, P55, DOI 10.1016/S1011-1344(01)00189-0; Jiang F, 2005, NEUROSURGERY, V57, P320, DOI 10.1227/01.NEU.0000166665.43838.0D; Jiang F, 2008, PHOTOCHEM PHOTOBIOL, V84, P128, DOI 10.1111/j.1751-1097.2007.00208.x; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Krishnamurthy S, 2000, LASER SURG MED, V27, P224, DOI 10.1002/1096-9101(2000)27:3<224::AID-LSM4>3.3.CO;2-R; Lu DY, 2004, J NEUROSURG, V101, P822, DOI 10.3171/jns.2004.101.5.0822; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; NICHOLAS MK, 1997, CANC NERVOUS SYSTEM, P464; NSEYO UO, 1990, UROLOGY, V36, P167, DOI 10.1016/0090-4295(90)80220-H; SCHALLERT T, 1990, CAN J PSYCHOL, V44, P276, DOI 10.1037/h0084244; Seyfried D, 2004, J NEUROSURG, V101, P104, DOI 10.3171/jns.2004.101.1.0104; Stylli SS, 2006, J CLIN NEUROSCI, V13, P709, DOI 10.1016/j.jocn.2005.11.012; Stylli SS, 2006, J CLIN NEUROSCI, V13, P615, DOI 10.1016/j.jocn.2005.11.014; Zhang XP, 2009, J NEUROSCI METH, V181, P178, DOI 10.1016/j.jneumeth.2009.05.004; Zhang ZG, 1999, J NEUROSCI, V19, P10898, DOI 10.1523/JNEUROSCI.19-24-10898.1999; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002	27	3	3	0	9	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439			INT J ONCOL	Int. J. Oncol.	NOV	2011	39	5					1133	1141		10.3892/ijo.2011.1163			9	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	826YN	WOS:000295391600009	21850369	Bronze			2022-02-06	
J	Balaratnasingam, C; Cringle, SJ; Fatehee, N; Morgan, WH; Yu, DY				Balaratnasingam, Chandrakumar; Cringle, Stephen J.; Fatehee, Naeem; Morgan, William H.; Yu, Dao-Yi			Comparison of fluctuating and sustained neural pressure perturbations on axonal transport processes in the optic nerve	BRAIN RESEARCH			English	Article						Axonal transport; Intracranial pressure; Optic nerve; High-pressure; Fluctuating-pressure	ELEVATED INTRAOCULAR-PRESSURE; CEREBROSPINAL-FLUID PRESSURE; TRAUMATIC BRAIN-INJURY; AXOPLASMIC-TRANSPORT; HEAD; MECHANISMS; ISOTHIOCYANATE; ASTROCYTES; EXPRESSION; DAMAGE	Pressure changes within the central nervous system (CNS) have the capacity to provoke neurodegeneration by perturbing axonal homeostatic processes. The pathogenic role of axonal transport dysfunction in diseases characterised by sustained pressure elevation have been clearly delineated, however the patho-physiogical mechanisms underlying neurological disorders typified by measurable fluctuations in CNS pressure remains unclarified. This study utilises the rabbit optic nerve, a myelinated, mammalian neuronal tract to compare the effects of sustained pressure elevation and fluctuating pressure change on axonal transport processes. In 5 rabbits, neural pressure was sustained at 10 mm Hg and 40 mm Hg in the right and left optic nerves, respectively, for 6 hours. In another 5 rabbits, neural pressure was modulated between 7.5 mm Hg and 57.5 mm Hg at 30 minute intervals in the right optic nerve, and sustained at 40 mm Hg in the left optic nerve for 6 hours. Rhodamine-beta-isothiocyanate, an axonal transport tracer, was used to quantify axonal transport differences between normal-, high- and fluctuating-pressure nerves. Axonal transport rates in high-pressure nerves were significantly lower than normal-pressure nerves. The effects of fluctuating-pressure and sustained high-pressure on axonal transport processes were not significantly different. The findings of this study suggest that the magnitude of pressure elevation and the profile of pressure change over time is important in modulating axonal function. It also implicates the importance of axonal transport dysfunction in the process of neurodegeneration. These results may have relevance for understanding patho-physiological mechanisms involved in pseudotumor cerebri, syringomyelia, hydrocephalus and glaucoma diseases characterised by fluctuating pressure changes. (C) 2011 Elsevier B.V. All rights reserved.	[Balaratnasingam, Chandrakumar; Cringle, Stephen J.; Fatehee, Naeem; Morgan, William H.; Yu, Dao-Yi] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Perth, WA, Australia; [Balaratnasingam, Chandrakumar; Cringle, Stephen J.; Fatehee, Naeem; Yu, Dao-Yi] Univ Western Australia, ARC Ctr Excellence Vis Sci, Perth, WA, Australia		Yu, DY (corresponding author), Univ Western Australia, Ctr Ophthalmol & Visual Sci, Nedlands, WA 6009, Australia.	dyyu@cyllene.uwa.edu.au		Yu, Dao-Yi/0000-0002-9490-534X; Cringle, Stephen/0000-0002-5427-554X			ANDERSON DR, 1974, INVEST OPHTH VISUAL, V13, P771; Balaratnasingam C, 2011, NEUROSCIENCE, V177, P269, DOI 10.1016/j.neuroscience.2010.12.053; Balaratnasingam C, 2008, INVEST OPHTH VIS SCI, V49, P986, DOI 10.1167/iovs.07-1090; Balaratnasingam C, 2007, INVEST OPHTH VIS SCI, V48, P3632, DOI 10.1167/iovs.06-1002; Balaratnasingam C, 2010, INVEST OPHTH VIS SCI, V51, P3019, DOI 10.1167/iovs.09-4692; Balaratnasingam C, 2009, J NEUROSCI RES, V87, P2973, DOI 10.1002/jnr.22120; Balaratnasingam C, 2009, BRAIN RES, V1263, P155, DOI 10.1016/j.brainres.2009.01.031; Balaratnasingam C, 2008, BRAIN RES, V1244, P142, DOI 10.1016/j.brainres.2008.09.044; Balaratnasingam C, 2009, INVEST OPHTH VIS SCI, V50, P2824, DOI 10.1167/iovs.08-3206; BLUM JJ, 1988, MATH BIOSCI, V90, P233, DOI 10.1016/0025-5564(88)90068-5; Brown A, 2003, J CELL BIOL, V160, P817, DOI 10.1083/jcb.200212017; BYNKE HG, 1961, ACTA NEUROL SCAND, V37, P34, DOI 10.1111/j.1600-0404.1961.tb06051.x; Chan PH, 2004, NEUROCHEM RES, V29, P1943, DOI 10.1007/s11064-004-6869-x; CHOU SM, 1970, NEUROLOGY, V20, P607, DOI 10.1212/WNL.20.6.607; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; DiLeonardi AM, 2009, BRAIN RES, V1263, P174, DOI 10.1016/j.brainres.2009.01.021; ECKER A, 1955, ARCH NEURO PSYCHIATR, V74, P641, DOI 10.1001/archneurpsyc.1955.02330180059006; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; Fatehee N, 2011, INVEST OPHTH VIS SCI, V52, P6192, DOI 10.1167/iovs.10-7137; Frolkis VV, 1997, EXP GERONTOL, V32, P441, DOI 10.1016/S0531-5565(96)00168-4; Huh JW, 2003, J NEUROTRAUM, V20, P975, DOI 10.1089/089771503770195821; LIU W, 1994, J NEUROCHEM, V63, P1625; LORENZO A V, 1970, Brain Behavior and Evolution, V93, P679, DOI 10.1093/brain/93.4.679; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Martin BA, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000089; May CA, 2008, OPEN OPHTHALMOL J, V2, P94, DOI 10.2174/1874364100802010094; MICELI D, 1993, BRAIN RES, V601, P289, DOI 10.1016/0006-8993(93)91723-6; MINCKLER DS, 1976, AM J OPHTHALMOL, V82, P741, DOI 10.1016/0002-9394(76)90012-X; MORGAN WH, 1995, INVEST OPHTH VIS SCI, V36, P1163; Morgan WH, 2002, INVEST OPHTH VIS SCI, V43, P3236; NADELHAFT I, 1976, BIOPHYS J, V16, P1125, DOI 10.1016/S0006-3495(76)85762-1; Perlson E, 2010, TRENDS NEUROSCI, V33, P335, DOI 10.1016/j.tins.2010.03.006; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; RADIUS RL, 1980, INVEST OPHTH VIS SCI, V19, P158; RADIUS RL, 1981, ARCH OPHTHALMOL-CHIC, V99, P1253, DOI 10.1001/archopht.1981.03930020127016; Reynolds AJ, 2000, BRAIN RES REV, V33, P169, DOI 10.1016/S0165-0173(00)00028-X; RUBINOW SI, 1980, BIOPHYS J, V30, P137, DOI 10.1016/S0006-3495(80)85082-X; SHIRAKASHI M, 1990, ACTA OPHTHALMOL, V68, P37; SOSSI N, 1983, ARCH OPHTHALMOL-CHIC, V101, P94, DOI 10.1001/archopht.1983.01040010096017; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; THANOS S, 1987, BRAIN RES, V406, P317, DOI 10.1016/0006-8993(87)90799-2; TSO MOM, 1977, ARCH OPHTHALMOL-CHIC, V95, P1458, DOI 10.1001/archopht.1977.04450080168023; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Xin XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020142	46	3	3	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 12	2011	1417						67	76		10.1016/j.brainres.2011.08.022			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	838RK	WOS:000296309700008	21911211				2022-02-06	
J	Sosa, I; Linic, IS; Petaros, A; Desnica, A; Bosnar, A				Sosa, Ivan; Linic, Ines Strenja; Petaros, Anja; Desnica, Andrej; Bosnar, Alan			The potential value of early screening for neurological deficits in participants in certain sports	MEDICAL HYPOTHESES			English	Article							TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; HEAD-INJURY; CEREBRAL LOCALIZATION; DEMENTIA-PUGILISTICA; PARKINSONS-DISEASE; CEREBELLUM; BOXERS; MOTOR; CONCUSSION	Physicians occasionally encounter the punch-drunk syndrome among boxers after longlasting careers characterized by blows to the head. The list of sports leading to punch-drunk syndrome is rapidly increasing, making it a notable public health problem. A lack of specific findings leads to defects in reporting the condition, and consequently to delay in treatment. Although the rigorous enforcement of sport rules and constant improvements of sporting equipment have decreased the occurrence of the syndrome, early detection of punch-drunk syndrome is crucial and would have comprehensive benefits. Two groups of signs and symptoms can be identified: dementia and Parkinsonism. A prompt diagnosis with a correct classification of the suspected cases is crucial. Therefore, we offer an overview of the symptomatology as well as proposing the introduction of a screening method among risk groups based on generic and minute neurological examination and dementia testing. (C) 2011 Elsevier Ltd. All rights reserved.	[Sosa, Ivan; Petaros, Anja; Bosnar, Alan] Rijeka Univ, Fac Med, Dept Forens Med & Criminalist, Rijeka 51000, Croatia; [Linic, Ines Strenja] Rijeka Univ Hosp, Neurol Clin, Rijeka, Croatia; [Desnica, Andrej] Zagreb Univ Hosp, Neurosurg Clin, Zagreb, Croatia		Sosa, I (corresponding author), Rijeka Univ, Fac Med, Dept Forens Med & Criminalist, Brace Branchetta 20, Rijeka 51000, Croatia.	isosa@medri.hr	Sosa, Ivan/I-6327-2013; Sosa, Ivan/F-3562-2011	Sosa, Ivan/0000-0002-6869-3734; Strenja, Ines/0000-0002-2910-2217; Petaros, Anja/0000-0001-7003-6488			Ackermann H, 2007, CEREBELLUM, V6, P202, DOI 10.1080/14734220701266742; Adams CW, 1998, J NEUROL NEUROSUR PS, V52, P600; Areza-Fegyveres R, 2007, ARQ NEURO-PSIQUIAT, V65, P830, DOI 10.1590/S0004-282X2007000500019; Asthagiri AR, 2003, CLIN SPORT MED, V22, P559, DOI 10.1016/S0278-5919(02)00111-4; Baird LC, 2010, NEUROSURGERY, V67, P1444, DOI 10.1227/NEU.0b013e3181e5e2cd; Brown J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2030; BROWN RG, 1984, LANCET, V2, P1262, DOI 10.1016/S0140-6736(84)92807-1; Carlock KS, 1997, CLIN IMAG, V21, P411; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; Defebvre L, 2006, NEUROPHYSIOL CLIN, V36, P319, DOI 10.1016/j.neucli.2006.11.003; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Dessi F, 1998, Rev Prat, V48, P1873; DREW RH, 1986, J CLIN PSYCHOL, V42, P520, DOI 10.1002/1097-4679(198605)42:3<520::AID-JCLP2270420319>3.0.CO;2-6; Duyckaerts C, 1999, Rev Neurol (Paris), V155 Suppl 4, pS17; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Elble RJ, 1996, J CLIN NEUROPHYSIOL, V13, P133, DOI 10.1097/00004691-199603000-00004; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Evans B, 2009, INT J INJ CONTROL SA, V16, P9, DOI 10.1080/17457300902732045; Findley LJ, 1996, J CLIN NEUROPHYSIOL, V13, P122, DOI 10.1097/00004691-199603000-00003; Forstl H, 2010, DTSCH ARZTEBL INT, V107, P835, DOI 10.3238/arztebl.2010.0835; Galvin JE, 2010, BRAIN, V133, P3290, DOI 10.1093/brain/awq204; Gambrell Robert C, 2007, Curr Sports Med Rep, V6, P317; GUTERMAN A, 1987, SPORTS MED, V4, P194, DOI 10.2165/00007256-198704030-00004; Hanninen Tuomo, 2010, Duodecim, V126, P2013; Henderson VW, 2007, CLIMACTERIC, V10, P92, DOI 10.1080/13697130701534097; Kalaria RN, 2003, INT PSYCHOGERIATR, V15, P47, DOI 10.1017/S1041610203008950; Karenberg A, 2009, J HIST NEUROSCI, V18, P248, DOI 10.1080/09647040802026027; KASTE M, 1982, LANCET, V2, P1186; Kim KW, 2005, DEMENT GERIATR COGN, V19, P324, DOI 10.1159/000084558; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; MARTINELLI P, 1986, J NEURAL TRANSM, P141; McCrory P, 2004, BRIT J SPORT MED, V38, DOI 10.1136/bjsm.2003.006338; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Moriarity J, 2004, NEUROLOGY, V62, P1497, DOI 10.1212/WNL.62.9.1497; Moslener MD, 2010, CURR SPORT MED REP, V9, P134, DOI 10.1249/JSR.0b013e3181dfccd9; Nowak LA, 2009, CLIN NEUROPATHOL, V28, P275, DOI 10.2379/NPX0800; PAYNE EE, 1968, NEUROCHIRURGIA, V11, P173; Petrosini L, 1998, PROG NEUROBIOL, V56, P191, DOI 10.1016/S0301-0082(98)00036-7; Raivio MM, 2008, J MED ETHICS, V34, P882, DOI 10.1136/jme.2008.025015; Rao G, 2003, JAMA-J AM MED ASSOC, V289, P347, DOI 10.1001/jama.289.3.347; Ravdin LD, 2003, CLIN J SPORT MED, V13, P21, DOI 10.1097/00042752-200301000-00005; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Rodriguez RG, 2009, REGULATION BOXING HI, P23; Rose FC, 2009, J HIST NEUROSCI, V18, P239, DOI 10.1080/09647040802025052; Ruocco AC, 2007, J NEUROPSYCH CLIN N, V19, P27, DOI 10.1176/appi.neuropsych.19.1.27; Salawu F K, 2010, Niger J Med, V19, P126; Salim A, 2002, SOUTHERN MED J, V95, P929; Salman MS, 2002, J CHILD NEUROL, V17, P1, DOI 10.1177/088307380201700101; Savica R, 2010, ARCH NEUROL-CHICAGO, V67, P798, DOI 10.1001/archneurol.2010.135; Schneider SA, 2010, CURR NEUROL NEUROSCI, V10, P431, DOI 10.1007/s11910-010-0136-0; Sharpe JA, 2008, BRAIN COGNITION, V68, P241, DOI 10.1016/j.bandc.2008.08.015; Solomon B, 2007, EXPERT OPIN INV DRUG, V16, P819, DOI 10.1517/13543784.16.6.819; Srinivasan S, 2010, NEUROL INDIA, V58, P702, DOI 10.4103/0028-3886.72167; STEWART WF, 1994, AM J EPIDEMIOL, V139, P573, DOI 10.1093/oxfordjournals.aje.a117047; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; Strong MJ, 2003, ANN NEUROL, V54, pS20, DOI 10.1002/ana.10574; Villemure R, 2011, BRAIN INJURY, V25, P53, DOI 10.3109/02699052.2010.531881; Walker HK, 1990, CLIN METHODS HIST PH, P360; Widnell K, 2005, MOVEMENT DISORD, V20, pS17, DOI 10.1002/mds.20459; Zazryn TR, 2008, NEUROL CLIN, V26, P257, DOI 10.1016/j.ncl.2007.11.004; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	63	3	3	0	7	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	OCT	2011	77	4					633	637		10.1016/j.mehy.2011.07.002			5	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	827PL	WOS:000295440300037	21803503				2022-02-06	
J	Wiskirchen, DE; Kuti, JL; Nicolau, DP				Wiskirchen, Dora E.; Kuti, Joseph L.; Nicolau, David P.			Acute Physiology and Chronic Health Evaluation II Score Is a Better Predictor of Mortality than IBMP-10 in Patients with Ventilator-Associated Pneumonia	SURGICAL INFECTIONS			English	Article							APACHE-II; CLASSIFICATION-SYSTEM; SEVERITY	Background: The (Immunodeficiency, Blood pressure [< 90 mm Hg], Multilobular intiltrates [chest x-ray], Platelets [< 100 x 10(9)/L], hospitalization [< 10 days] before the onset of ventilator-associated pneumonia [VAP]) IBMP-10 is a new scoring system proposed as an easy-to-use alternative to the Acute Physiology and Chronic Health Evaluation II (APACHE II) score for predicting mortality in patients with ventilator-associated pneumonia (VAP). The objective of this study was to determine the validity of the IBMP-10 score compared with APACHE II in predicting mortality for an independent population consisting predominantly of surgical and neurotrauma patients. Methods: The IBMP-10 and APACHE II scores on the day of VAP diagnosis were calculated, and areas under the receiver-operating characteristic curves (AUROCs) were compared to determine the tests' abilities to predict 14- and 28-day mortality. Results: A total of 168 patients meeting the radiologic and clinical criteria for VAP for a single hospitalization between 2004 and 2007 were included; 80% of these were from the surgical or neurotrauma intensive care unit. Overall mortality rates were 15% and 23% at 14 and 28 days, respectively. The AUROC for the IMBP-10 score for predicting 14-day mortality was 0.609 (p = 0.084) compared with 0.648 (p = 0.017) for the APACHE II score. Both IBMP-10 and APACHE II AUROCs for predicting 14-day mortality were lower than observed in the original score validation (0.808 and 0.743, respectively). The AUROCs for predicting 28-day mortality were 0.602 (p = 0.056) and 0.705 (p < 0.001) for IBMP10 and APACHE II, respectively. Conclusions: The IBMP-10 score was less reliable than the APACHE II score in predicting 14-day mortality in this independent population of VAP patients. This finding highlights the need for additional validation of new disease severity scoring systems in a study population independent of the population used to derive score criteria, as well as in more specific populations of critically ill patients.	[Wiskirchen, Dora E.; Kuti, Joseph L.; Nicolau, David P.] Hartford Hosp, Ctr Antiinfect Res & Dev, Hartford, CT 06102 USA; [Nicolau, David P.] Hartford Hosp, Div Infect Dis, Dept Med, Hartford, CT 06102 USA		Nicolau, DP (corresponding author), Hartford Hosp, Ctr Antiinfect Res & Dev, 80 Seymour St, Hartford, CT 06102 USA.	dnicola@harthosp.org			Center for Anti-Infective Research and Development, Hartford Hospital	We thank Ilene Staff, Ph.D., for her assistance with statistical analyses. This study was undertaken with funds from the Center for Anti-Infective Research and Development, Hartford Hospital.	*AM THOR SOC BOARD, 2005, AM J RESP CRIT CARE, P288; Gursel G, 2006, RESPIRATION, V73, P503, DOI 10.1159/000088708; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lisboa T, 2008, CHEST, V134, P1208, DOI 10.1378/chest.08-1106; Mirsaeidi M, 2009, CLIN INFECT DIS, V49, P72, DOI 10.1086/599349; Napolitano LM, 2010, CLIN INFECT DIS, V51, pS67, DOI 10.1086/653052; Nicasio AM, 2010, J CRIT CARE, V25, P69, DOI 10.1016/j.jcrc.2009.02.014; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Wiskirchen D. E., 2011, Clinical Pulmonary Medicine, V18, P181, DOI 10.1097/CPM.0b013e318222b594	10	3	5	0	0	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1096-2964			SURG INFECT	Surg. Infect.	OCT	2011	12	5					385	390		10.1089/sur.2010.096			6	Infectious Diseases; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Surgery	846MB	WOS:000296905900010	22004437				2022-02-06	
J	Fridley, J; Mackey, J; Hampton, C; Duckworth, E; Bershad, E				Fridley, J.; Mackey, J.; Hampton, C.; Duckworth, E.; Bershad, E.			Internal carotid artery dissection and stroke associated with wakeboarding	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Carotid artery dissection; Trauma; Wakeboarding; Water sports; Stroke	INJURIES	Wakeboarding is a popular water sport but has significant potential for trauma due to the high velocities, rotational maneuvers, acceleratory forces, water obstacles, and general lack of protective equipment used. Head or neck trauma is a concern, which may be even more common with wakeboarding than other water sports, but the true trauma incidence is unknown and probably underreported. While traumatic brain injury has been reported to occur during wakeboarding we present an unusual mechanism of central nervous system injury in which a young adult male developed a carotid artery dissection and stroke shortly following a wakeboarding accident. (C) 2011 Elsevier Ltd. All rights reserved.	[Fridley, J.; Duckworth, E.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Mackey, J.; Hampton, C.; Bershad, E.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA		Fridley, J (corresponding author), Baylor Coll Med, Dept Neurosurg, 1709 Dryden,Suite 750, Houston, TX 77030 USA.	fridley@bcm.edu					Carson WG, 2004, AM J SPORT MED, V32, P164, DOI 10.1177/0363546503258910; Chia JKK, 2000, PEDIATR NEUROSURG, V32, P291, DOI 10.1159/000028957; Debette S, 2009, LANCET NEUROL, V8, P668, DOI 10.1016/S1474-4422(09)70084-5; Engelter ST, 2007, STROKE, V38, P2605, DOI 10.1161/STROKEAHA.107.489666; Gonzales-Portillo F, 2002, NEUROL RES, V24, P395, DOI 10.1179/016164102101200087; Hostetler SG, 2005, AM J SPORT MED, V33, P1065, DOI 10.1177/0363546504271748; Lucas C, 1998, STROKE, V29, P2646, DOI 10.1161/01.STR.29.12.2646; Touze E, 2003, NEUROLOGY, V61, P1347, DOI 10.1212/01.WNL.0000094325.95097.86	8	3	3	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	SEP	2011	18	9					1258	1260		10.1016/j.jocn.2011.02.013			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812VC	WOS:000294320000028	21742504				2022-02-06	
J	Gregorio, GW; Visser-Meily, JMA; Tan, FES; Post, MWM; van Heugten, CM				Gregorio, Gisela Wolters; Visser-Meily, Johanna M. A.; Tan, Frans E. S.; Post, Marcel W. M.; van Heugten, Carolina M.			Changes in the coping styles of spouses and the influence of these changes on their psychosocial functioning the first year after a patient's stroke	JOURNAL OF PSYCHOSOMATIC RESEARCH			English	Article						Burden; Caregivers; Coping; Depression; Quality of life; Stroke	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; SOCIAL SUPPORT; GROUP INTERVENTION; FAMILY CAREGIVERS; CHRONIC PHASE; STRATEGIES; BURDEN; REHABILITATION; DEPRESSION	Objective: The objective of this study was to examine the changes in Spouses' coping styles that occur in the first year after a patient's stroke and the influence of these changes on the spouses' psychosocial functioning. Methods: A total of 211 spouses of patients with stroke were assessed at three different time points using self-reported questionnaires (at the time of the patient's admission to inpatient rehabilitation, 2 months after discharge and 1 year poststroke). We used linear mixed-model and multiple linear regression analyses to analyse the data. Results: Spouses' use of an active coping style decreased significantly in the first year poststroke. There were no significant overall changes in the use of a passive coping style. The use of a passive coping style at admission and increases in passive coping style in the first year poststroke predicted worse psychosocial functioning 1 year poststroke. The models explained between 32% and 50% of the variance in quality of life, depressive symptoms and strain. Conclusion: The present study indicates that spouses' passive coping style is maladaptive poststroke when used in the acute as well as in the chronic phase. Use of an active coping style decreases in the first year poststroke, but these decreases do not predict psychosocial outcomes. (C) 2011 Elsevier Inc. All rights reserved.	[Gregorio, Gisela Wolters; van Heugten, Carolina M.] Maastricht Univ, Sch Mental Hlth & Neurosci, Fac Hlth Med & Life Sci, NL-6200 MD Maastricht, Netherlands; [Visser-Meily, Johanna M. A.; Post, Marcel W. M.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Visser-Meily, Johanna M. A.; Post, Marcel W. M.] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, Utrecht, Netherlands; [Tan, Frans E. S.] Maastricht Univ, Fac Hlth Med & Life Sci Methodol & Stat, NL-6200 MD Maastricht, Netherlands; [van Heugten, Carolina M.] Maastricht Univ, Fac Psychol, Dept Neuropsychol & Psychopharmacol, NL-6200 MD Maastricht, Netherlands		van Heugten, CM (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci, Fac Hlth Med & Life Sci, Locat DRT 12,POB 616, NL-6200 MD Maastricht, Netherlands.	c.vanheugten@maastrichtuniversity.nl	Post, Marcel/AAS-2502-2021				Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Banningh LWAJW, 2008, CLIN REHABIL, V22, P731, DOI 10.1177/0269215508090774; Belsley DA., 1980, REGRESSION DIAGNOSTI, DOI 10.1002/0471725153; Blais MC, 2007, BRAIN INJURY, V21, P357, DOI 10.1080/02699050701311075; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Carnes S.L., 2005, FAM SYST HEALTH, V23, P186, DOI DOI 10.1037/1091-7527.23.2.186; Chadda RK, 2007, SOC PSYCH PSYCH EPID, V42, P923, DOI 10.1007/s00127-007-0242-8; Chronister J, 2006, REHABIL PSYCHOL, V51, P190, DOI 10.1037/0090-5550.51.3.190; Claar RL, 2005, J PSYCHOSOM RES, V59, P1, DOI 10.1016/j.jpsychores.2005.03.007; COLLIN C, 1990, J NEUROL NEUROSUR PS, V53, P576, DOI 10.1136/jnnp.53.7.576; Cooper C, 2008, INT J GERIATR PSYCH, V23, P929, DOI 10.1002/gps.2007; Dawson DR, 2006, BRAIN COGNITION, V60, P214; de Haan R, 1993, Ned Tijdschr Geneeskd, V137, P917; Engler P, 2006, PSYCHOSOM MED, V68, P985, DOI 10.1097/01.psy.0000245901.82935.cb; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Farmer JE, 2003, J HEAD TRAUMA REHAB, V18, P116, DOI 10.1097/00001199-200303000-00003; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P571, DOI 10.1037/0022-3514.50.3.571; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fugl-Meye KS., 1991, CLIN REHABIL, V5, P25, DOI [10.1177/026921559100500105, DOI 10.1177/026921559100500105]; GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897; Grant JS, 2001, INT J REHABIL RES, V24, P181, DOI 10.1097/00004356-200109000-00003; Gregorio GW, 2011, J REHABIL MED, V43, P190, DOI 10.2340/16501977-0633; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Hepp U, 2005, PSYCHOTHER PSYCHOSOM, V74, P379, DOI 10.1159/000087786; KRAMER BJ, 1993, FAM RELAT, V42, P383, DOI 10.2307/585338; Lannoo E, 2004, BRAIN INJURY, V18, P203, DOI 10.1080/02699050310001596905; LAZARUS RS, 1993, PSYCHOSOM MED, V55, P234, DOI 10.1097/00006842-199305000-00002; Minnes P, 2000, BRAIN INJURY, V14, P737; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; Myaskovsky Larissa, 2003, Prog Transplant, V13, P183; Osborne J.W., 2008, BEST PRACTICES QUANT, P451; Ownsworth T, 2004, NEUROPSYCHOL REHABIL, V14, P535, DOI 10.1080/09602010343000538; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Qiu YR, 2008, J CLIN NURS, V17, P1563, DOI 10.1111/j.1365-2702.2007.02156.x; Riedijk SR, 2006, DEMENT GERIATR COGN, V22, P405, DOI 10.1159/000095750; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; Schepers VP, 2005, ARCH PHYS MED REHAB, V86, P1472, DOI 10.1016/j.apmr.2004.11.039; Schretlen DJ, 2000, REHABIL PSYCHOL, V45, P260, DOI 10.1037/0090-5550.45.3.260; Schreurs PJG., 1993, UTRECHTSE COPING LIJ; Secker DL, 2005, J NEUROL NEUROSUR PS, V76, P491, DOI 10.1136/jnnp.2004.042291; Tellegen B., 1988, UTRECHTSE COPING LIJ; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; Visser-Meily A, 2005, CEREBROVASC DIS, V20, P443, DOI 10.1159/000088983; Visser-Meily A, 2008, PATIENT EDUC COUNS, V73, P153, DOI 10.1016/j.pec.2008.03.011; Visser-Meily A, 2009, STROKE, V40, P1399, DOI 10.1161/STROKEAHA.108.516682; Webb C, 1998, SCHIZOPHR RES, V34, P169; Wilz G, 2007, BEHAV RES THER, V45, P2508, DOI 10.1016/j.brat.2007.04.010; Wolters G, 2010, NEUROPSYCHOL REHABIL, V20, P587, DOI 10.1080/09602011003683836	50	3	3	0	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3999	1879-1360		J PSYCHOSOM RES	J. Psychosomat. Res.	SEP	2011	71	3					188	193		10.1016/j.jpsychores.2011.01.013			6	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	812TK	WOS:000294315600012	21843755				2022-02-06	
J	Hilbert, P; Kern, BC; Langer, S; Jakubetz, J; Stuttmann, R				Hilbert, P.; Kern, B. -C.; Langer, S.; Jakubetz, J.; Stuttmann, R.			Methohexital for treatment of intracranial hypertension	ANAESTHESIST			German	Article						Barbiturate; Coma; Brain injuries; Intracranial hypertension; Intracranial pressure	BARBITURATE COMA THERAPY; TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; ICP REDUCTION; PRESSURE	Background. Barbiturate coma therapy is a useful method to control increased intracranial pressure (ICP) in patients with severe brain damage if standard measures have failed to lower ICP. Pentobarbital (not available in Germany) and thiopental (in Germany only approved for induction of anesthesia) have frequently been used in patients with intracranial hypertension and the effects and side-effects are well-described. However, little is known about the effect of methohexital (the only barbiturate in Germany approved for maintaining anesthesia) in lowering increased ICP. Therefore, the effect of methohexital on ICP was studied in patients where standard measures had failed to control intracranial hypertension. Method. A retrospective observational study was carried out with the inclusion criteria of patient age a parts per thousand yen18 years and methohexital therapy for 12 h or more with ICP monitoring in place. Methohexital was administered following a standardized algorithm to patients for whom standard measures, such as deep anesthesia, normoventilation, cerebral perfusion pressure (CPP) > 65 mmHg, osmotherapy, neurosurgical evacuation of mass lesions, had failed to lower ICP. Methohexital was used if the ICP had risen above 20-25 mmHg for more the 20-30 min and otherwise manageable causes for the ICP increase had been ruled out. Methohexital was given continuously in addition to standard analgesia and sedation in doses of 2-4-6 mg/kg body weight (BW), depending on the ICP lowering effect. The records of the patient data management system from the years 2008/2009 were used to compare the ICP and CPP before and during methohexital administration. For statistical analyses Student's t-test was applied for measured values and the chi(2)-test was applied for percentage values whereby p < 0.05 was defined as being statistically significant. Results. During the study period 36 patients required methohexital therapy and 30 fulfilled the inclusion criteria. In 26 out of 30 patients the data were complete and these 26 patients were included in the data analyses. Of the patients 6 (23%) died due to elevated intracranial hypertension and 20 patients (77%) survived. In all patients methohexital lowered the ICP from 25.2 mmHg (standard deviation, SD +/- 4.3 mmHg) to 19.8 mmHg (SD +/- 12.5 mmHg) within the first 24 h, this result closely failed to reach a level of significance. In the 20 survivors methohexital lowered the ICP from 25.88 mmHg (SD +/- 4.8 mmHg) to 14.25 mmHg (SD +/- 6.9 mmHg) within the first 24 h, which is statistically highly significant. In non-survivors the ICP had risen from 24 mmHg (SD +/- 2.6 mmHg) to 32 mmHg (SD +/- 16.3 mmHg) within the first 24 h despite all efforts. Due to the CPP driven volume and vasopressor therapy no significant changes in the CPP during methohexital administration were observed. No significant changes in brain temperature (as possible cause for the decrease of the ICP) were observed. Non-survivors received significantly more methohexital due to increased ICP and required significantly more vasopressor therapy to maintain a sufficient CPP. Conclusions. Methohexital showed a clear trend for decreasing ICP in patients with intracranial hypertension refractory to standard therapeutic measures. In survivors the effect was highly significant. Patients not responding to methohexital therapy seemed to have an unfavorable outcome.	[Hilbert, P.; Langer, S.; Jakubetz, J.; Stuttmann, R.] BG Kliniken Bergmannstrost Halle Saale, Klin Anasthesiol Intens & Notfallmed, D-06112 Halle, Germany; [Kern, B. -C.] BG Kliniken Bergmannstrost Halle Saale, Klin Neurochirurg, D-06112 Halle, Germany		Hilbert, P (corresponding author), BG Kliniken Bergmannstrost Halle Saale, Klin Anasthesiol Intens & Notfallmed, Merseburgerstr 165, D-06112 Halle, Germany.	Peter.Hilbert@Bergmannstrost.com		Hilbert-Carius, Peter/0000-0002-4704-2377			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; An HS, 2010, J KOREAN NEUROSURG S, V47, P252, DOI 10.3340/jkns.2010.47.4.252; BOHN D, 1989, CRIT CARE MED, V17, pS118; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CUNITZ G, 1978, ANAESTHESIST, V27, P64; *DTSCH GES NEUR, 2007, SCHAD HIRN TRAUM ERW; *DTSCH GES NEUR, 2008, LEITL DGN 2008 HIRND; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Horsley JS, 1937, LANCET, V1, P141; Huettemann Egbert, 2006, J Anesth, V20, P86, DOI 10.1007/s00540-005-0377-2; Huettemann E, 2006, ANN CARD ANAESTH, V9, P126; Humar M, 2004, J PHARMACOL EXP THER, V311, P1232, DOI 10.1124/jpet.104.071332; Huschak G, 2008, J NEUROSURG ANESTH, V20, P105, DOI 10.1097/ANA.0b013e31815f528c; Kim YI, 2008, J KOREAN NEUROSURG S, V44, P141, DOI 10.3340/jkns.2008.44.3.141; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Perez-Barcena J, 2005, NEUROCIRUGIA, V16, P5; Perez-Barcena J, 2008, CRIT CARE, V12, DOI 10.1186/cc6999; ROBERTS I, 2009, COCHRANE DB SYST REV, V1999; Schickendantz J, 1999, CRIT CARE MED, V27, P1570, DOI 10.1097/00003246-199908000-00028; SHAPIRO HM, 1973, BRIT J ANAESTH, V45, P1057, DOI 10.1093/bja/45.10.1057; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; WOODCOCK J, 1982, STROKE, V13, P785, DOI 10.1161/01.STR.13.6.785	23	3	4	0	10	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	SEP	2011	60	9					819	826		10.1007/s00101-011-1881-4			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	822YG	WOS:000295085900004	21509574				2022-02-06	
J	Kean, J; Abell, M; Malec, JF; Trzepacz, PT				Kean, Jacob; Abell, Malene; Malec, James F.; Trzepacz, Paula T.			Rasch Analysis of the Orientation Log and Reconsideration of the Latent Construct During Inpatient Rehabilitation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						delirium; posttraumatic amnesia; posttraumatic confusion; Rasch analysis	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; POSTTRAUMATIC AMNESIA; GALVESTON ORIENTATION; ACUTE CONFUSION; SERIAL MEASUREMENT; COGNITIVE TEST; VALIDATION; RECOVERY; SCALE	Primary Objectives: To investigate the measurement properties of the Orientation Log (O-Log) and a hybrid scale using Rasch analysis techniques and to explore the relations between the items of the 2 scales and the latent linear construct modeled in the Rasch analysis. Design: Calibration of data collected weekly during inpatient rehabilitation. Participants: Ninety patients admitted for rehabilitation after traumatic brain injury. Results: Measure reliability/construct validity of the O-Log was too low to justify restructuring of disordered rating scales, but the broader set of items in the hybrid scale demonstrated good measure reliability/construct validity prior to and following rating scale restructuring. Both O-Log and hybrid measures demonstrated statistical fit with the linear latent construct, suggesting that orientation and memory are only a subset of symptoms in a broader syndrome. Conclusions: Posttraumatic amnesia is by definition a proxy measure of a broader syndrome during early recovery and not a measure of the syndrome itself. The results suggest that the O-Log cannot reliably measure progress during early recovery. Furthermore, the analysis suggests that the construct of posttraumatic amnesia is too narrow and should be revisited to improve monitoring of recovery and prognostic estimation after brain injury.	[Kean, Jacob; Malec, James F.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Kean, Jacob; Malec, James F.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Abell, Malene] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Trzepacz, Paula T.] Eli Lilly & Co, Indianapolis, IN 46285 USA		Kean, J (corresponding author), Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA.	jakean@indiana.edu	Trzepacz, Paula/AAQ-3330-2021	Kean, Jacob/0000-0002-8577-0586			Alderson AL, 2003, ARCH PHYS MED REHAB, V84, P668, DOI 10.1016/S0003-9993(03)04842-6; ANDRICH D, 2005, APPL RASCH MEASUREME, P308; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Bode RK, 2000, J HEAD TRAUMA REHAB, V15, P637, DOI 10.1097/00001199-200002000-00004; Bond T. G., 2007, APPL RASCH MODEL FUN, V2; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; DANIEL WF, 1987, CORTEX, V23, P169, DOI 10.1016/S0010-9452(87)80030-8; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; Hart RP, 1996, PSYCHOSOMATICS, V37, P533, DOI 10.1016/S0033-3182(96)71517-7; Israelian MK, 2000, REHABIL PSYCHOL, V45, P284, DOI 10.1037/0090-5550.45.3.284; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Katz D, 1992, J HEAD TRAUMA REHAB, V72, P1, DOI [10.1097/00001199-200501000-00008, DOI 10.1097/00001199-200501000-00008]; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; KEAN J, BRAIN INJ IN PRESS; Lee D, 2004, REHABIL PSYCHOL, V49, P167, DOI 10.1037/0090-5550.49.2.167; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Linacre J, 1994, RASCH MEAS T, V7, P328; Linacre J M, 1999, J Outcome Meas, V3, P103; LINACRE JM, 2009, WINSTEPS 3 6; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Sherer M, 2008, ARCH PHYS MED REHAB, V89, P42, DOI 10.1016/j.apmr.2007.08.128; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; STENNER AJ, 2008, RASCH MEASUREMENT T, V22, P1152; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Symonds C P, 1937, Proc R Soc Med, V30, P1081; Symonds CP, 1928, BRIT MED J, V1928, P829, DOI 10.1136/bmj.2.3540.829; Tate R.L., 2000, BRAIN IMPAIR, V1, P116, DOI [10.1375/brim.1.2.116, DOI 10.1375/BRIM.1.2.116]; Traumatic Brain Injury Model Systems, TRAUM BRAIN INJ MOD; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; TRZEPACZ PT, 2004, TXB TRAUMATIC BRAIN, P175; WILSON JTL, 1994, J NEUROL NEUROSUR PS, V57, P198, DOI 10.1136/jnnp.57.2.198	39	3	3	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2011	26	5					364	374		10.1097/HTR.0b013e3181ea4e2c			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	814VO	WOS:000294485500005	20808240				2022-02-06	
J	Miller, JJ; Wendt, JT; Potter, N				Miller, John J.; Wendt, John T.; Potter, Nick			Implications for concussion assessments and return-to-play standards in intercollegiate football: How are the risks managed?	JOURNAL OF APPLIED SPORT MANAGEMENT			English	Article						Concussion; Guidelines		The lack of understanding regarding the symptoms and effects of concussions by athletes and coaches can generate pressure on both the team physicians to diagnose concussions as well as the sport administrators who need to be aware what concussion protocols are being followed. The significance of appropriate diagnosis of a concussion and the return-to-play protocols may be complicated by the number of guidelines available as well as the reliance on the athlete to self-report the symptoms of a concussion. While the grading guidelines have advanced the use of uniform terminology and increased awareness of concussion signs and symptoms, the lack of scientific method in creating the concussion management guidelines called their effectiveness into question. A total of 65 head football athletic trainers were surveyed to determine how medical personnel at selected universities managed the risk of concussions in intercollegiate football. The results indicated that nearly 70% of the respondents indicated that between five to eight football players on their respective teams incurred a concussion during the season. However, no dominant guidelines for assessing a concussion were revealed as none of the guidelines were employed by more than 29% of the population. Finally, 50% did not believe that the same guidelines should be used for an initial concussion assessments or subsequent concussions. Because no two people can be diagnosed in exactly the same way, guidelines may inhibit proper treatment. However, should an error in judgment occur, litigation against the physician, the athletic administrator, and the university may result.	[Miller, John J.] Troy Univ, Coll Hlth & Human Serv, Troy, AL 36082 USA; [Wendt, John T.] Univ St Thomas, Minneapolis, MN USA; [Potter, Nick] Kansas City Chiefs, Kansas City, MO USA		Miller, JJ (corresponding author), Troy Univ, Coll Hlth & Human Serv, Troy, AL 36082 USA.	johnm@troy.edu					[Anonymous], 2010, BOWL CHAMPIONSHIP SE; [Anonymous], 2009, ASS PRESS; [Anonymous], 2010, THE NCAA NEWS; AYRES JD, 1994, J LEGAL MED, V15, P421, DOI 10.1080/01947649409510953; Bean A. G., 1995, MARK RES, V7, P20; Bey T, 2009, WEST J EMERG MED, V10, P6; Cantu R. C., 1995, PHYS SPORT MED, P2327; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Colorado Medical Society School and Sports Medicine Committee, 1990, COLO MED, V87, P4; Copeland J, 2010, NEW DATA SUGGEST SHI; Davis LL., 1992, APPL NURS RES, V5, P194, DOI DOI 10.1016/S0897-1897(05)80008-4; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Harmon KG, 1999, AM FAM PHYSICIAN, V60, P887; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; Kent A, 2002, J SPORT MANAGE, V16, P230, DOI 10.1123/jsm.16.3.230; Litwin M., 1995, MEASURE SURVEY RELIA; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; LYNN MR, 1986, NURS RES, V35, P382; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Mosely R., 2010, DUCKS TAKE NO CHANCE; Mosely R, 2010, BARNER LOOKS GOOD SC; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Nunnally J.C., 1959, TESTS MEASUREMENTS A; Oliaro S, 2001, J ATHL TRAINING, V36, P257; Polit DF, 2006, RES NURS HEALTH, V29, P489, DOI 10.1002/nur.20147; Rosoff A J, 1995, Health Matrix Clevel, V5, P369; ROTHSTEIN AL, 1985, RES DESIGN STAT PHYS; Rutherford A, 2005, J CLIN EXP NEUROPSYC, V27, P299, DOI 10.1080/13803390490515504; Schwarz A, 2009, NY TIMES, pA1; Sheehan KB, 1999, J ADVERTISING RES, V39, P45; University of Pittsburgh Medical Center, 2008, SPORTS CONC FACT SHE; WOOLF SH, 1995, AM FAM PHYSICIAN, V51, P1455	45	3	3	0	0	SAGAMORE PUBL LLC	URBANA	1807 N FEDERAL DR, URBANA, IL 61801 USA	2327-0179	2327-0187		J APPL SPORT MANAG	J. Appl. Sport Manag.	SEP	2011	3	1			SI		91	+					16	Hospitality, Leisure, Sport & Tourism	Emerging Sources Citation Index (ESCI)	Social Sciences - Other Topics	VE2NR	WOS:000438888300010					2022-02-06	
J	Tonks, J; Williams, WH; Mounce, L; Harris, D; Frampton, I; Yates, P; Slater, A				Tonks, James; Williams, W. Huw; Mounce, Luke; Harris, Duncan; Frampton, Ian; Yates, Phil; Slater, Alan			'Trails B or not Trails B?' Is attention-switching a useful outcome measure?	BRAIN INJURY			English	Article						Children; adolescents; paediatrics; attention-switching; executive functions; outcome	DIFFICULTIES QUESTIONNAIRE; EXECUTIVE FUNCTION; DEFICIT/HYPERACTIVITY DISORDER; ADOLESCENCE; STRENGTHS; CHILDHOOD; VALIDITY; CHILDREN; VERSION	Primary objective: Difficulties with attention contribute to behavioural and cognitive problems during childhood and may reflect subtle deficits in executive functioning (EF). Attention problems in early childhood have also been found to predict higher levels of anxiety and depression symptoms at 10 years old. It has also been reported that attention problems during childhood may be differentially related to later-emerging distinct EF difficulties. Many of these findings, however, rely on teacher-ratings of attention difficulties. Methods and procedures: This study administered neuropsychological tests of attention-switching and EF to 67 healthy children aged 9-15 years of age. It additionally measured socio-emotional behavioural functioning. Main outcomes and results: A critical phase of improvement was found at 10 years of age. Correlations were found between attention-switching skills and EF. Attention-switching skills were also correlated with socio-emotional functioning. Conclusions: Attention-switching skills have some interdependence with EF, but in paediatric assessment such skills are easier to routinely assess than many of the currently available tests of EF. It is suggested that attention-switching ability may prove to be a useful predictor of EF performance in understanding long-term outcome after a neurological event such as traumatic brain injury.	[Tonks, James] Univ Exeter, Sch Psychol, Washington Singer Labs, Exeter EX4 4QG, Devon, England; [Tonks, James] NHS Devon, Exeter, Devon, England; [Yates, Phil] Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England		Tonks, J (corresponding author), Univ Exeter, Sch Psychol, Washington Singer Labs, Perry Rd, Exeter EX4 4QG, Devon, England.	j.tonks@exeter.ac.uk	Mounce, Luke/AAX-1911-2020	Mounce, Luke/0000-0002-6089-0661; williams, huw/0000-0003-0670-2620; FRAMPTON, Ian/0000-0003-0018-472X; Tonks, James/0000-0003-3930-9294	University of Exeter	This research was carried out with PhD scholarship funding provided by the University of Exeter. The authors report no conflicts of interest.	Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Benson D.F., 1986, FRONTAL LOBES; Biederman J, 2004, J CONSULT CLIN PSYCH, V72, P757, DOI 10.1037/0022-006X.72.5.757; Cannon R, 2009, INT J NEUROSCI, V119, P404, DOI 10.1080/00207450802480325; Delis D.C., 2001, D KEFS DELIS KAPLAN; Elderkin-Thompson V, 2008, NEUROPSYCHOLOGY, V22, P626, DOI 10.1037/0894-4105.22.5.626; Engel-Yeger B., 2009, NEUROPSYCHOL REHABIL, V21, P1; Eslinger PJ, 2000, DEV NEUROPSYCHOL, V18, P297, DOI 10.1207/S1532694203Eslinger; Friedman NP, 2007, PSYCHOL SCI, V18, P893, DOI 10.1111/j.1467-9280.2007.01997.x; Goodman R, 1999, J CHILD PSYCHOL PSYC, V40, P791, DOI 10.1111/1469-7610.00494; Goodman R, 2000, EUR CHILD ADOLES PSY, V9, P129, DOI 10.1007/s007870050008; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; KOLB B, 2003, FUNDAMENTALS HUMAN N; KUNTSI J, 2006, BMC PSYCHIATRY, V5, P1; Leech SL, 2006, J AM ACAD CHILD PSY, V45, P223, DOI 10.1097/01.chi.0000184930.18552.4d; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; PENNINGTON BF, 2002, DEV PSYCHOPATHOLOGY; Romano E., 2002, PREVALENCE HYPERACTI; RUTTER M, 1967, J CHILD PSYCHOL PSYC, V8, P1, DOI 10.1111/j.1469-7610.1967.tb02175.x; Turkstra LS, 2000, APHASIOLOGY, V14, P349, DOI 10.1080/026870300401405; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006	23	3	3	0	12	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	2011	25	10					958	964		10.3109/02699052.2011.589792			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	801TZ	WOS:000293464800005	21745176				2022-02-06	
J	Ede, A; Buddhadev, H; Irwin, K; Driver, S				Ede, Alison; Buddhadev, Harsh; Irwin, Kelley; Driver, Simon			Circuit Training Recommendations for Individuals With a Traumatic Brain Injury	STRENGTH AND CONDITIONING JOURNAL			English	Article								CIRCUIT TRAINING CAN BE A SAFE AND BENEFICIAL PROGRAM FOR ADULTS WITH A TRAUMATIC BRAIN INJURY. TO PRODUCE DESIRED BENEFITS, CIRCUIT PROGRAMS SHOULD BE PERFORMED 3 TIMES PER WEEK AND INCORPORATE FLEXIBILITY, AEROBIC, AND STRENGTH TRAINING COMPONENTS.	[Ede, Alison; Buddhadev, Harsh; Irwin, Kelley; Driver, Simon] Univ N Texas, Dept Kinesiol Hlth Promot & Recreat, Denton, TX 76203 USA		Ede, A (corresponding author), Univ N Texas, Dept Kinesiol Hlth Promot & Recreat, Denton, TX 76203 USA.						Bhambhani Y, 2003, ARCH PHYS MED REHAB, V84, P1629, DOI 10.1053/S0003-9993(03)00343-5; Blake H, 2009, CLIN REHABIL, V23, P589, DOI 10.1177/0269215508101736; Borg G, 1998, BORGS PERCEIVED EXER, P39; DANIELS L, 2007, DANIELS WORTHINGHAMS, P1; Dawes H, 2006, DISABIL REHABIL, V28, P1243, DOI 10.1080/09638280600554595; Driver S, 2004, BRAIN INJURY, V18, P847, DOI 10.1080/02699050410001671856; Driver S, 2005, STRATEGIES, V18, P11; DRIVER S, 2009, J COGN REHABIL, V33, P4; Driver S, 2009, BRAIN INJURY, V23, P203, DOI 10.1080/02699050802695574; DURSTINE JL, 2009, ACSMS EXERCISE MANAG, P287; Esquenazi A, 2004, J HEAD TRAUMA REHAB, V19, P109, DOI 10.1097/00001199-200403000-00004; HUNTER M, 1990, PHYS THER, V70, P363, DOI 10.1093/ptj/70.6.363; Lee MJ, 2008, J AM GERIATR SOC, V56, P976, DOI 10.1111/j.1532-5415.2008.01707.x; Maud PJ, 2006, PHYSL ASSESSMENT HUM, P1; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; US Department of Health and Human Services, 2008 PHYS ACT GUID A	16	3	3	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1524-1602	1533-4295		STRENGTH COND J	Strength Cond. J.	AUG	2011	33	4					48	51		10.1519/SSC.0b013e318211f99d			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	825YF	WOS:000295317400009					2022-02-06	
J	Irwin, K; Ede, A; Buddhadev, H; Driver, S				Irwin, Kelley; Ede, Alison; Buddhadev, Harsh; Driver, Simon			Physical Activity and Traumatic Brain Injury	STRENGTH AND CONDITIONING JOURNAL			English	Article							CAPACITY	COMPLETING THE RECOMMENDED AMOUNTS OF PHYSICAL ACTIVITY IN THE FORM OF STRENGTH AND CONDITIONING EXERCISES EACH WEEK MAY PREVENT REGRESSION OF PERFORMANCE, DECREASE THE RISKS OF SECONDARY HEALTH CONDITIONS, AND IMPROVE THE FUNCTIONAL CAPACITY OF AN INDIVIDUAL WITH A TRAUMATIC BRAIN INJURY HELPING REGAIN INDEPENDENCE AFTER INJURY.	[Irwin, Kelley; Ede, Alison; Buddhadev, Harsh; Driver, Simon] Univ N Texas, Dept Kinesiol Hlth Promot & Recreat, Denton, TX 76203 USA		Irwin, K (corresponding author), Univ N Texas, Dept Kinesiol Hlth Promot & Recreat, Denton, TX 76203 USA.						Bhambhani Y, 2005, ARCH PHYS MED REHAB, V86, P268, DOI 10.1016/j.apmr.2004.04.022; Driver S, 2004, BRAIN INJURY, V18, P847, DOI 10.1080/02699050410001671856; DURSTINE JL, 2009, ACSMS EXERCISE MANAG, P287; Ede A, 2011, STRENGTH COND J, V33, P48, DOI 10.1519/SSC.0b013e318211f99d; FINKELSTEIN E, 2006, INCIDENCE EC BURDEN, P98; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Langlois JA, 2006, TRAUMATIC BRAIN INJU; McHenry MA, 2001, BRAIN INJURY, V15, P741, DOI 10.1080/02699050010013932; National Institute of Neurological Disorders and Stroke, 2009, TRAUM BRAIN INJ HOP; The U. S. Department of Health and Human Services, 2009, 2008 PHYS ACT GUID A; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vitale AE, 1996, BRAIN INJURY, V10, P367, DOI 10.1080/026990596124377; Zoerink D. A., 1991, Therapeutic Recreation Journal, V25, P19; [No title captured]	15	3	3	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1524-1602			STRENGTH COND J	Strength Cond. J.	AUG	2011	33	4					43	47		10.1519/SSC.0b013e318210e899			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	825YF	WOS:000295317400007					2022-02-06	
J	Alvarez, JML; Lemaur, MEV; Quevedo, OP; Canal, JML; de Laguna, AJB; Llapurt, EC; de Casas, AMS; Jorge, RG				Lopez Alvarez, J. M.; Valeron Lemaur, M. E.; Perez Quevedo, O.; Liminana Canal, J. M.; Jimenez Bravo de Laguna, A.; Consuegra Llapurt, E.; Moron Saen de Casas, A.; Gonzalez Jorge, R.			Severe pediatric head injuries (II): factors associated to morbidity-mortality	MEDICINA INTENSIVA			Spanish	Article						Severe head injury pediatric patients; Risk factors; Morbidity; Mortality	TRAUMATIC BRAIN-INJURY; PROGNOSTIC-FACTORS; YOUNG-CHILDREN; INTENSIVE-CARE; RISK-FACTORS; EPIDEMIOLOGY; PERSPECTIVE; PREDICTORS; EXPERIENCE; CHILDHOOD	Objective: To describe the factors associated to morbidity-mortality in pediatric patients with severe head injury (SHI). Material and method: A review was made of the patients admitted to the Pediatric Intensive Care Unit (PICU) with SHI between July 1983 and December 2009. Results: Of the 389 patients with head injuries, 174 (45%) presented SHI. The mean age of these subjects was 67 (9) months, with a Glasgow Coma Score (GCS) of 5.5 (1.8) and a PRISM score of 10.6 (6.7). Thirty-nine percent of the patients showed diffuse encephalic injury (DEI) in the computed tomography (CT) study. Seventy-nine percent of the patients subjected to intracranial pressure monitoring (ICP) presented intracranial hypertension. These patients had a greater incidence of serious sequelae (66.7 vs. 23.1%; p = 0.01). Sequelae of clinical relevance were recorded in 59 patients (34%), and proved serious in 64% of the cases. The mortality rate among the patients with SHI was 24.7%, and mortality was significantly associated with a lower GCS score, hyperglycemia, intracranial hypertension and the presence of mydriasis or shock. The mortality rate associated to severe DEI was significantly higher than in the case of mild-moderate DEI (87.5 vs. 7.2%; p < 0.001). The independent mortality risk factors in the pediatric patients with SHI were found to be the presence of mydriasis (OR: 31.27), intracranial hypertension (OR: 13.23) and hyperglycemia (OR: 3.10). Conclusions: a) SHI in pediatric patients was associated with high morbidity-mortality; b) intracranial hypertension was associated to the development of serious sequelae; c) independent mortality risk factors were the existence of mydriasis, intracranial hypertension and hyperglycemia. (C) 2010 Elsevier Espana, S.L. and SEMICYUC. All rights reserved.	[Lopez Alvarez, J. M.; Valeron Lemaur, M. E.; Perez Quevedo, O.; Jimenez Bravo de Laguna, A.; Consuegra Llapurt, E.; Moron Saen de Casas, A.; Gonzalez Jorge, R.] Complejo Hosp Univ Insular Materno Infantil Canar, Unidad Med Intens Pediat, Las Palmas Gran Canaria, Las Palmas, Spain; [Liminana Canal, J. M.] Univ Las Palmas Gran Canaria, Fac Med, Dept Bioestadist, Las Palmas Gran Canaria, Spain		Alvarez, JML (corresponding author), Complejo Hosp Univ Insular Materno Infantil Canar, Unidad Med Intens Pediat, Las Palmas Gran Canaria, Las Palmas, Spain.	jmloal@hotmail.com					Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Alted López Emilio, 2009, Med. Intensiva, V33, P16; Bahloul M, 2009, INJURY, V40, P535, DOI 10.1016/j.injury.2008.04.018; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; CRUZ J, 1993, CRIT CARE MED, V21, P1225, DOI 10.1097/00003246-199308000-00025; Diamond IR, 2009, J PEDIATR SURG, V44, P981, DOI 10.1016/j.jpedsurg.2009.01.039; ESPARZA J, 1985, CHILD NERV SYST, V1, P109, DOI 10.1007/BF00706691; FAIST F, 1983, J TRAUMA, V23, P775; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; FERNANDEZ A, 2001, MED INTENSIVA, V25, P8; Foulkes MA, 1991, J NEUROSURG S, V75, P8, DOI 10.3171/sup.1991.75.1s.00s8; HENAO FJ, 1991, J TRAUMA, V31, P74, DOI 10.1097/00005373-199101000-00014; Jackson S, 2000, ACTA NEUROCHIR SUPPL, V76, P453; JENNETT B, 1975, LANCET, V1, P480; Johnson DL, 1998, PEDIATR NEUROSURG, V28, P167, DOI 10.1159/000028643; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kieslich M, 2001, DISABIL REHABIL, V23, P665; Kochanek PM, 2009, PEDIATR CRIT CARE ME, V10, P517, DOI 10.1097/PCC.0b013e3181ab88cd; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; LANG DA, 1994, J NEUROSURG, V80, P675, DOI 10.3171/jns.1994.80.4.0675; LEVI L, 1991, BRIT J NEUROSURG, V5, P617, DOI 10.3109/02688699109002885; LOPEZ JM, 2003, MED INTENSIVA, V27, P155; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Mansfield RT, 1997, CRIT CARE CLIN, V13, P611, DOI 10.1016/S0749-0704(05)70331-6; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Odebode TO, 2004, PEDIATR SURG INT, V20, P348, DOI 10.1007/s00383-004-1196-5; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Pillai S, 2001, PEDIATR NEUROSURG, V34, P98, DOI 10.1159/000056002; POLLACK MM, 1988, CRIT CARE MED, V16, P1110, DOI 10.1097/00003246-198811000-00006; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Reviejo K, 2002, MED INTENSIVA, V26, P241; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Salim A, 2008, AM SURGEON, V74, P1088; TEADALE G, 1974, LANCET, V2, P81; TEPAS JJ, 1990, J PEDIATR SURG, V25, P92, DOI 10.1016/S0022-3468(05)80170-8; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; WARD JD, 1994, PEDIATR NEUROSURG, V20, P183, DOI 10.1159/000120784; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011	43	3	3	0	2	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	0210-5691			MED INTENSIVA	Med. Intensiv.	AUG-SEP	2011	35	6					337	343		10.1016/j.medin.2011.02.006			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	796NI	WOS:000293057600004	21496960	Green Published			2022-02-06	
J	Mauritz, W; Wilbacher, I; Leitgeb, J; Majdan, M; Janciak, I; Brazinova, A; Rusnak, M				Mauritz, W.; Wilbacher, I.; Leitgeb, J.; Majdan, M.; Janciak, I.; Brazinova, A.; Rusnak, M.			One-year outcome and course of recovery after severe traumatic brain injury	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Brain injury; Traumatic; Three-month outcome; Twelve-month outcome; Glasgow Outcome Scale; Glasgow Coma Scale	EPIDEMIOLOGY; EFFICACY	Goal To describe the outcome of patients with severe traumatic brain injury (TBI) 3, 6 and 12 months after trauma. Methods Between January 2001 and December 2005, 13 European centres enrolled 1,172 patients with severe TBI defined as Glasgow Coma Scale (GCS) score < 9. Demographic data, trauma severity, results of computed tomography (CT) scans, data on status, treatment and outcome were recorded. The five-level Glasgow Outcome Scale (GOS) score was used to classify patients as having a "favourable" (GOS scores 5 and 4) or an "unfavourable outcome" (GOS scores 3, 2 and 1). Results and conclusions Of the 1,172 patients, 37% died in the intensive care unit (ICU) and 8.5% died after ICU discharge. At 12 months after trauma, almost half of the outcomes (46.6%) were classified as "favourable" (33% "good recovery", 13.6% "moderate disability") and 7.9% were classified as "unfavourable" (6.1% "severe disability", 1.8% "vegetative status"). As in previous studies, long-term outcomes were influenced by age, severity of trauma, first GCS score, pupillary status and CT findings (e.g. subdural haematoma and closed basal cistern on the first CT scan). Patients with "good recovery" had a high likelihood to remain in that category (91%). Patients with "moderate disability" had a 50% chance to improve to "good recovery". Patients with "severe disability" had a 40% chance to improve and had a 4% chance of death. Patients with "vegetative status" were more likely to die (42%) than to improve (31%). Changes were more likely to occur during the first than during the second half-year after trauma.	[Mauritz, W.; Wilbacher, I.; Leitgeb, J.; Majdan, M.; Janciak, I.; Brazinova, A.; Rusnak, M.] INRO, A-1080 Vienna, Austria; [Mauritz, W.] Trauma Hosp Lorenz Boehler, Vienna, Austria; [Leitgeb, J.] Med Univ Vienna, Dept Trauma Surg, Vienna, Austria; [Majdan, M.; Brazinova, A.; Rusnak, M.] Trnava Univ, Fac Hlth & Social Serv, Dept Publ Hlth, Trnava, Slovakia		Mauritz, W (corresponding author), INRO, Moelkergasse 4-3, A-1080 Vienna, Austria.	walter.mauritz@igeh.org	Majdan, Marek/K-5017-2012; Brazinova, Alexandra/C-4265-2016; Rusnak, Martin/K-9349-2016	Majdan, Marek/0000-0001-8037-742X; Brazinova, Alexandra/0000-0003-0625-256X; Rusnak, Martin/0000-0003-3321-1042	European UnionEuropean Commission [ICA2-CT-2002-100]; Austrian Worker's Compensation Board (AUVA) [FK 33/ 2003]; Austrian National Bank [8987]	We are very grateful to the collaborators from the participating centres: M. Bartosova MD (Michalovce, Slovakia), F. Botha MD (Linz, Austria), F. Chmeliczek MD (Salzburg, Austria), G. Clarici MD (Graz, Austria), J. de Riggo MD (St. Martin, Slovakia), K. Dizdarevic MD (Sarajevo, Bosnia-Herzegovina), D. Girotto MD (Rijeka, Croatia), H.-D. Gulle MD (Klagenfurt, Austria), M. Kaniansky MD (Banska Bystrica, Slovakia), W. Moser MD (Klagenfurt, Austria), Prof. M. Soljakova MD (Skopje, Former Yugoslav Republic of Macedonia), B. Splavski MD (Osijek, Croatia), Prof. Z. Todorova MD (Skopje, Former Yugoslav Republic of Macedonia), Ernst Trampitsch MD (Klagenfurt, Austria), Prof. M. Vukic MD (Zagreb, Croatia). The data used for this study were collected for a project funded by a European Union grant (Project "ResearchTreat- TBI''; 6th Framework Program: INCO-DEV: International Cooperation with Developing Countries 1998-2002; contract number: ICA2-CT-2002-100) and for another project funded by the Austrian Worker's Compensation Board (AUVA; contract number FK 33/ 2003) and by the "Jubila " umsfonds'' of the Austrian National Bank (project number 8987). The International Neurotrauma Research Organization (INRO) was supported by an annual grant from Mrs. Ala Auersperg-Isham and Mr. Ralph Isham, and by donations from various sources.	BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Firsching R, 2001, WORLD J SURG, V25, P1221; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Lippert-Gruener M, 2007, BRAIN INJURY, V21, P1001, DOI 10.1080/02699050701468933; Lu J, 2005, ACT NEUR S, V95, P281; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805; Mauritz W, 2003, CLIN RES REGUL AFF, V20, P81, DOI 10.1081/CRP-120018744; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Stiver SI, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E5; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y	22	3	3	1	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	AUG	2011	37	4					387	395		10.1007/s00068-010-0053-6			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	804FB	WOS:000293638600008	26815275				2022-02-06	
J	Arnold, PM; Christiano, LD; Klemp, JA; Anderson, KK				Arnold, Paul M.; Christiano, Lana D.; Klemp, Joshua A.; Anderson, Karen K.			Nontraumatic Spontaneous Acute Subdural Hematoma in Identical Teenage Twins 1 Year Apart	PEDIATRIC EMERGENCY CARE			English	Article						spontaneous acute subdural hematoma; ASDH; adolescent twins; full neurological recovery; increased intracranial pressure	RAPID RESOLUTION; ARTERIAL ORIGIN; MORTALITY; COAGULOPATHY; MORBIDITY; RUPTURE	Objectives: Acute subdural hematoma (ASDH) is a life-threatening injury with a high mortality rate. Most ASDH cases are a result of trauma; nontraumatic causes are relatively rare with an incidence rate of 3% to 5%. We report an unusual series of 2 patients, identical twins, who had nontraumatic subdural hematomas 1 year apart, one at age 15 and the other at age 16. Methods (Case Presentations): Identical twin brothers presented 1 year and 10 days apart to an academic medical center after incurring confusion, decreased mental functioning, and a subsequent comatose state. The injuries occurred while the patients were playing football, but there was no evidence of traumatic blow to the head in either brother. Results: Both patients had computed tomographic scans and both underwent emergency surgery for hematoma evacuation. Both patients recovered full neurological function and remained healthy 12 years after surgery. Conclusions: Acute spontaneous subdural hematoma is an emergent medical condition that may result in rapid neurological decline and must be addressed in a timely fashion. After evacuation of the hematoma, intracranial pressure decreases and cerebral perfusion pressure increases, which may allow normal perfusion of the brain. Consequently, prompt recognition and evacuation of an ASDH can drastically improve prognosis. Rarely, subdural hematoma can occur without head injury and should be in the differential diagnosis of athletes who rapidly become comatose.	[Arnold, Paul M.; Klemp, Joshua A.; Anderson, Karen K.] Univ Kansas, Med Ctr, Dept Neurosurg, Kansas City, KS 66160 USA; [Christiano, Lana D.] Univ Med & Dent New Jersey, Dept Neurol Surg, Newark, NJ 07103 USA		Arnold, PM (corresponding author), Univ Kansas, Med Ctr, Dept Neurosurg, 3901 Rainbow Blvd,MS 3021, Kansas City, KS 66160 USA.	parnold@kumc.edu					Akioka Naoki, 2007, J Stroke Cerebrovasc Dis, V16, P109, DOI 10.1016/j.jstrokecerebrovasdis.2006.11.007; AVIS SP, 1993, AM J FOREN MED PATH, V14, P130, DOI 10.1097/00000433-199306000-00005; Bershad EM, 2008, J NEUROSURG, V109, P664, DOI 10.3171/JNS/2008/109/10/0664; Depreitere B, 2003, ACTA NEUROCHIR, V145, P541, DOI 10.1007/s00701-003-0020-7; HESSELBROCK R, 1984, SURG NEUROL, V21, P363, DOI 10.1016/0090-3019(84)90115-0; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Kim KH, 2009, J KOREAN NEUROSURG S, V45, P143, DOI 10.3340/jkns.2009.45.3.143; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; Koc RK, 1997, SURG NEUROL, V47, P9, DOI 10.1016/S0090-3019(96)00150-4; Koerbel A, 2005, BRIT J RADIOL, V78, P646, DOI 10.1259/bjr/60601877; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; Matsuyama T, 1997, SURG NEUROL, V48, P193, DOI 10.1016/S0090-3019(96)00484-3; Matsuyama T, 1997, SURG NEUROL, V47, P423, DOI 10.1016/S0090-3019(96)00398-9; Missori P, 2000, ACTA NEUROCHIR, V142, P697, DOI 10.1007/s007010070115; Naama O, 2009, J NEUROSURG SCI, V53, P157; OBRIEN PK, 1974, J NEUROSURG, V41, P435, DOI 10.3171/jns.1974.41.4.0435; ONO M, 1984, J NEUROSURG, V60, P365, DOI 10.3171/jns.1984.60.2.0365; PIOTROWSKI WP, 1995, UNFALLCHIRURG, V98, P432; Saleh T, 2010, SOUTH MED J, V103, P714, DOI 10.1097/SMJ.0b013e3181d7e378; Verweij BH, 2001, J NEUROSURG, V95, P569, DOI 10.3171/jns.2001.95.4.0569; Wen L, 2009, IRISH J MED SCI, V178, P367, DOI 10.1007/s11845-008-0168-5; Westermaier T, 2007, NEUROSURGERY, V61, P482, DOI 10.1227/01.NEU.0000290893.85072.F9; WILBERGER JE, 1990, J TRAUMA, V30, P733, DOI 10.1097/00005373-199006000-00014; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212	24	3	3	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JUL	2011	27	7					649	651		10.1097/PEC.0b013e3182225637			3	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	788MQ	WOS:000292449500016	21730803				2022-02-06	
J	Chittiboina, P; Banerjee, AD; Nanda, A				Chittiboina, Prashant; Banerjee, Anirban Deep; Nanda, Anil			Do Concomitant Cranium and Axis Injuries Predict Worse Outcome? A Trauma Database Quantitative Analysis	SKULL BASE-AN INTERDISCIPLINARY APPROACH			English	Article						Cervical spine; axis fractures; craniovertebral junction; skull base; trauma database	BRAIN-INJURY; CT; MANAGEMENT; FRACTURE; SCAN	We performed a trauma database analysis to identify the effect of concomitant cranial injuries on outcome in patients with fractures of the axis. We identified patients with axis fractures over a 14-year period. A binary outcome measure was used. Univariate and multiple logistic regression analysis were performed. There were 259 cases with axis fractures. Closed head injury was noted in 57% and skull base trauma in 14%. Death occurred in 17 cases (6%). Seventy-two percent had good outcome. Presence of abnormal computed tomography head findings, skull base fractures, and visceral injury was significantly associated with poor outcome. Skull base injury in association with fractures of the axis is a significant independent predictor of worse outcomes, irrespective of the severity of the head injury. We propose that presence of concomitant cranial and upper vertebral injuries require careful evaluation in view of the associated poor prognosis.	[Chittiboina, Prashant; Banerjee, Anirban Deep; Nanda, Anil] LSUHSC, Dept Neurosurg, Shreveport, LA 71130 USA		Nanda, A (corresponding author), LSUHSC, Dept Neurosurg, POB 33932, Shreveport, LA 71130 USA.	ananda@lsuhsc.edu	Chittiboina, Prashant/AAE-3799-2020; Chittiboina, Prashant/T-7177-2017	Chittiboina, Prashant/0000-0001-9349-4756; Chittiboina, Prashant/0000-0001-9349-4756			Bloom AI, 1997, CLIN RADIOL, V52, P198, DOI 10.1016/S0009-9260(97)80273-5; Cunningham J, 2011, J EMERG MED, V40, P262, DOI 10.1016/j.jemermed.2008.08.017; Daffner RH, 1996, AM J ROENTGENOL, V167, P365, DOI 10.2214/ajr.167.2.8686605; Dashti R, 2007, EUR SPINE J, V16, pS261, DOI 10.1007/s00586-006-0270-1; Feiz-Erfan I, 2007, J NEUROSURG, V107, P364, DOI 10.3171/JNS-07/08/0364; FRYE G, 1994, ANN EMERG MED, V23, P797, DOI 10.1016/S0196-0644(94)70316-7; Greene KA, 1997, SPINE, V22, P1843, DOI 10.1097/00007632-199708150-00009; Hadley MN, 2002, NEUROSURGERY, V50, pS125; Hargrove J, 2005, CRIT CARE, V9, P376, DOI 10.1186/cc3518; Harris JH, 2001, RADIOLOGY, V218, P337, DOI 10.1148/radiology.218.2.r01fe53337; Hunink MGM, 2005, RADIOLOGY, V235, P375, DOI 10.1148/radiol.2352040727; Johnson F, 2008, OTOLARYNG CLIN N AM, V41, P597, DOI 10.1016/j.otc.2008.01.006; KIRSHENBAUM K J, 1990, Journal of Emergency Medicine, V8, P183, DOI 10.1016/0736-4679(90)90230-S; KOHLENBERGER C, 1994, JAMA-J AM MED ASSOC, V271, P1200; KOONSMAN M, 1992, AM J SURG, V164, P487, DOI 10.1016/S0002-9610(05)81186-9; Krakenes J, 2001, NEURORADIOLOGY, V43, P1089, DOI 10.1007/s002340100648; LINK TM, 1995, RADIOLOGY, V196, P741, DOI 10.1148/radiology.196.3.7644638; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Rodriguez RM, 1997, CRIT CARE MED, V25, P1801, DOI 10.1097/00003246-199711000-00016; Saboori M, 2007, CLIN NEUROL NEUROSUR, V109, P399, DOI 10.1016/j.clineuro.2007.01.013; Sharma B R, 2005, J Clin Forensic Med, V12, P21, DOI 10.1016/j.jcfm.2004.08.002; Sun PP, 2000, J NEUROSURG, V93, P28, DOI 10.3171/spi.2000.93.1.0028	23	3	3	0	1	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	1531-5010	1532-0065		SKULL BASE-INTERD AP	Skull Base-Interdiscip. Appr.	JUL	2011	21	4					249	254		10.1055/s-0031-1280679			6	Clinical Neurology; Otorhinolaryngology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Otorhinolaryngology; Surgery	794DV	WOS:000292876600006	22470268	Green Published			2022-02-06	
J	Dennis, JP; Ghahramanlou-Holloway, M; Cox, DW; Brown, GK				Dennis, John P.; Ghahramanlou-Holloway, Marjan; Cox, Daniel W.; Brown, Gregory K.			A Guide for the Assessment and Treatment of Suicidal Patients With Traumatic Brain Injuries	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						suicide; suicide attempt; suicidal ideation; suicidal intent; suicide prevention; self-directed violence classification system (SDVCS); risk assessment; traumatic brain injury (TBI)	POSTTRAUMATIC-STRESS-DISORDER; TOWER-OF-BABEL; RISK-FACTORS; MENTAL-DISORDERS; AFRICAN-AMERICAN; SELF-HARM; PSYCHIATRIC-DISORDERS; MAJOR DEPRESSION; REVISED NOMENCLATURE; CLINICAL PREDICTORS	People with traumatic brain injuries (TBIs) are at elevated risk for suicide. Postinjury cognitive limitations, personality factors, and psychological problems may independently or in conjunction with preinjury correlates contribute to suicidal thoughts and behaviors. Rehabilitation practitioners can best serve the needs of this high-risk population by increasing their knowledge and competence in evidence-informed approaches to suicide prevention. This article provides a review of suicide nomenclature, epidemiology, risk and protective factors, as well as evidence-informed assessment, management, and treatment practices for suicidal patients. The science of clinical practice in the area of rehabilitation and suicide prevention is in its infancy. Practitioners who provide treatment for suicidal patients with TBI are encouraged to adapt and individualize existing evidence-informed suicide assessment and prevention practices for implementation within their settings. Each patient with a TBI who endorses suicidal thoughts and/or behaviors presents a complex array of clinical challenges associated with the nature of his or her brain injury, preinjury, and postinjury functioning. Clinical as well as research recommendations are provided in the context of an understanding of such challenges and an overriding objective of minimizing suicide risk during the recovery process and maximizing treatment gains.	[Dennis, John P.; Ghahramanlou-Holloway, Marjan; Cox, Daniel W.] Uniformed Serv Univ Hlth Sci, Dept Med & Clin Psychol, Bethesda, MD 20814 USA; [Brown, Gregory K.] Univ Penn, Dept Psychiat, Psychopathol Res Unit, Philadelphia, PA 19104 USA		Dennis, JP (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Med & Clin Psychol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	john.dennis.ctr@usuhs.mil			Department of Health and Human Services, PHSUnited States Department of Health & Human ServicesUnited States Public Health Service [5-T32-MH019931]; Department of DefenseUnited States Department of Defense [W81XWH-08-2-0172]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019931] Funding Source: NIH RePORTER	Funding for this manuscript was received from the Department of Health and Human Services, PHS grant number 5-T32-MH019931 and the Department of Defense Congressionally Directed Medical Research Program, grant number W81XWH-08-2-0172.	Agerbo E, 2002, BMJ-BRIT MED J, V325, P74, DOI 10.1136/bmj.325.7355.74; Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; *AM ASS SUIC, SUIC FACT SHEETS STA; American Psychiatric Association, 2003, PRACT GUID ASS TREAT; Anderson PL, 2002, SUICIDE LIFE-THREAT, V32, P131, DOI 10.1521/suli.32.2.131.24405; [Anonymous], 2010, MEM RE STAND SUIC NO; ASNIS GM, 1994, HOSP COMMUNITY PSYCH, V45, P127; Beautrais AL, 2003, AUST NZ J PSYCHIAT, V37, P595, DOI 10.1046/j.1440-1614.2003.01236.x; Beautrais AL, 1996, AM J PSYCHIAT, V153, P1009; Beck A.T., 1988, MANUAL BECK HOPELESS; Beck AT, 1999, SUICIDE LIFE-THREAT, V29, P1; BECK AT, 1985, AM J PSYCHIAT, V142, P559; Bertolote JM, 2003, BRIT J PSYCHIAT, V183, P382, DOI 10.1192/bjp.183.5.382; Blum RW, 2003, AM J PUBLIC HEALTH, V93, P456, DOI 10.2105/AJPH.93.3.456; BONGAR B, 2002, SUICIDAL PATIENT CLI; Borges G, 2010, J CLIN PSYCHIAT, V71, P1617, DOI 10.4088/JCP.08m04967blu; Borowsky IW, 2001, PEDIATRICS, V107, P485, DOI 10.1542/peds.107.3.485; BRENNER L, J CLIN PSYC IN PRESS; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Brown G.K., 2000, REV SUICIDE ASSESSME; Brown GK, 2005, JAMA-J AM MED ASSOC, V294, P563, DOI 10.1001/jama.294.5.563; Brown GK, 2001, INT J GERIATR PSYCH, V16, P593, DOI 10.1002/gps.468; Busch KA, 2003, J CLIN PSYCHIAT, V64, P14, DOI 10.4088/JCP.v64n0105; *C SSRS, COL U MED CTR CTR SU; Carr JR, 2004, SUICIDE LIFE-THREAT, V34, P233, DOI 10.1521/suli.34.3.233.42785; Carter G, 2005, BRIT J PSYCHIAT, V186, P253, DOI 10.1192/bjp.186.3.253; CASSIDY JW, 1989, J HEAD TRAUMA REHAB, V4, P67; [Centers for Disease Control and Prevention National Center for Injury Prevention and Control], 2010, WEB BAS INJ STAT QUE; Cha CB, 2009, J AM ACAD CHILD PSY, V48, P422, DOI 10.1097/CHI.0b013e3181984f44; Cheng ATA, 2000, BRIT J PSYCHIAT, V177, P360, DOI 10.1192/bjp.177.4.360; Cole TB, 2005, JAMA-J AM MED ASSOC, V294, P623, DOI 10.1001/jama.294.5.623; DAVIDSON JRT, 1991, PSYCHOL MED, V21, P713, DOI 10.1017/S0033291700022352; Eisenberg ME, 2006, J ADOLESCENT HEALTH, V39, P662, DOI 10.1016/j.jadohealth.2006.04.024; Ellis T.E., 1996, CHOOSING LIVE DEFEAT; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621; Freeman TW, 2000, J NERV MENT DIS, V188, P460, DOI 10.1097/00005053-200007000-00011; Garroutte EM, 2003, SOC SCI MED, V56, P1571, DOI 10.1016/S0277-9536(02)00157-0; Gilman SE, 2001, AM J PUBLIC HEALTH, V91, P933, DOI 10.2105/AJPH.91.6.933; GOLDSTEIN RB, 1991, ARCH GEN PSYCHIAT, V48, P418; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; GUNNELL DJ, 1995, BRIT MED J, V311, P226, DOI 10.1136/bmj.311.6999.226; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Harriss L, 2005, J AFFECT DISORDERS, V86, P225, DOI 10.1016/j.jad.2005.02.009; Harriss L, 2005, BRIT J PSYCHIAT, V186, P60, DOI 10.1192/bjp.186.1.60; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Horsfield SA, 2002, INT J PSYCHIAT MED, V32, P337, DOI 10.2190/KQ48-XT0L-2H14-5UMV; Huang DB, 2005, BRAIN INJURY, V19, P903, DOI 10.1080/02699050400004773; *I MED, 2002, RED SUIC NAT IMP; *INT ASS SUIC PREV, INT ASS SUIC PREV IA; Jobes D., 2006, MANAGING SUICIDAL RI; Joiner TE, 2002, J SOC CLIN PSYCHOL, V21, P531, DOI 10.1521/jscp.21.5.531.22624; Joiner TE, 2007, BEHAV RES THER, V45, P539, DOI 10.1016/j.brat.2006.04.007; Karlin, 2008, SAFETY PLAN TREATMEN; KELLERMANN AL, 1986, NEW ENGL J MED, V314, P1557, DOI 10.1056/NEJM198606123142406; Kleespies P. M., 2009, BEHAV EMERGENCIES EV; KRUG E, 2010, WORLD REPORT VIOLENC; Krupinski M, 1998, EUR ARCH PSY CLIN N, V248, P141, DOI 10.1007/s004060050031; Kuipers P, 2000, J HEAD TRAUMA REHAB, V15, P1275, DOI 10.1097/00001199-200012000-00007; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Levenson JL., 2005, PRIM PSYCHIAT, V12, P16; Linehan MM, 2006, ARCH GEN PSYCHIAT, V63, P757, DOI 10.1001/archpsyc.63.7.757; LINEHAN MM, 1991, ARCH GEN PSYCHIAT, V48, P1060; Linehan MM., 1993, SKILLS TRAINING MANU, V1st edn; Linehan MM., 1993, COGNITIVE BEHAV TREA; Lizardi D, 2008, J PSYCHIATR RES, V42, P815, DOI 10.1016/j.jpsychires.2007.09.007; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; Marion MS, 2003, SUICIDE LIFE-THREAT, V33, P33, DOI 10.1521/suli.33.1.33.22780; Marshall RD, 2001, AM J PSYCHIAT, V158, P1467, DOI 10.1176/appi.ajp.158.9.1467; McCauley SR, 2006, BRAIN INJURY, V20, P519, DOI 10.1080/02699050600676651; McMillan D, 2007, PSYCHOL MED, V37, P769, DOI 10.1017/S0033291706009664; Meadows LA, 2005, AM J COMMUN PSYCHOL, V36, P109, DOI 10.1007/s10464-005-6236-3; Moscicki EK, 2001, CLIN NEUROSCI RES, V1, P310, DOI 10.1016/S1566-2772(01)00032-9; Munjas, 2009, STRATEGIES SUICIDE P; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; NORDSTROM P, 1995, ACTA PSYCHIAT SCAND, V92, P345, DOI 10.1111/j.1600-0447.1995.tb09595.x; O'Donnell L, 2004, AM J COMMUN PSYCHOL, V33, P37, DOI 10.1023/B:AJCP.0000014317.20704.0b; Oquendo MA, 2004, AM J PSYCHIAT, V161, P1433, DOI 10.1176/appi.ajp.161.8.1433; Oquendo MA, 2003, AM J PSYCHIAT, V160, P580, DOI 10.1176/appi.ajp.160.3.580; Oquendo MA, 2007, AM J PSYCHIAT, V164, P134, DOI 10.1176/appi.ajp.164.1.134; Owens D, 2002, BRIT J PSYCHIAT, V181, P193, DOI 10.1192/bjp.181.3.193; Pellmar T.C., 2002, REDUCING SUICIDE NAT; Posner K., 2006, COLUMBIA SUICIDE SEV; PRIESTER MJ, 1993, J PSYCHOPATHOL BEHAV, V15, P239, DOI 10.1007/BF01371381; Qin P, 2005, ARCH GEN PSYCHIAT, V62, P427, DOI 10.1001/archpsyc.62.4.427; Qin P, 2003, ARCH GEN PSYCHIAT, V60, P797, DOI 10.1001/archpsyc.60.8.797; Resnick MD, 1997, JAMA-J AM MED ASSOC, V278, P823, DOI 10.1001/jama.278.10.823; Rowland SM, 2005, BRAIN INJURY, V19, P77, DOI 10.1080/02699050410001719988; Rudd MD, 2006, SUICIDE LIFE-THREAT, V36, P255, DOI 10.1521/suli.2006.36.3.255; RUDD MD, 1994, AM J ORTHOPSYCHIAT, V64, P136, DOI 10.1037/h0079492; Rudd MD., 2001, TREAT MAN PRACTITION; Shea S., 2002, PRACTICAL ART SUICID; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Silverman MM, 2007, SUICIDE LIFE-THREAT, V37, P248, DOI 10.1521/suli.2007.37.3.248; Silverman MM, 2007, SUICIDE LIFE-THREAT, V37, P264, DOI 10.1521/suli.2007.37.3.264; Simon RI, 2007, SUICIDE LIFE-THREAT, V37, P518, DOI 10.1521/suli.2007.37.5.518; Simpson G, 2003, J HEAD TRAUMA REHAB, V18, P445, DOI 10.1097/00001199-200309000-00006; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Simpson G, 2007, CRISIS, V28, P35, DOI 10.1027/0227-5910.28.1.35; Slaby AE, 1998, RISK MANAGEMENT WITH SUICIDAL PATIENTS, P34; Speckens AEM, 2005, SUICIDE LIFE-THREAT, V35, P365, DOI 10.1521/suli.2005.35.4.365; STANLEY B, COG BEHAV P IN PRESS; Steer R., 2006, FOCUS, V4, P291, DOI DOI 10.1176/foc.4.2.291; Suokas J, 2001, ACTA PSYCHIAT SCAND, V104, P117, DOI 10.1034/j.1600-0447.2001.00243.x; Suominen K, 1996, ACTA PSYCHIAT SCAND, V94, P234, DOI 10.1111/j.1600-0447.1996.tb09855.x; Tarrier N, 2008, BEHAV MODIF, V32, P77, DOI 10.1177/0145445507304728; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Till C, 2009, BRAIN INJURY, V23, P655, DOI 10.1080/02699050902970794; *US DEP VET AFF, 2011, VISN 19 MIRECC ED SE; Verona E, 2001, J ABNORM PSYCHOL, V110, P462, DOI 10.1037//0021-843X.110.3.462; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; Wenzel A., 2009, COGNITIVE THERAPY SU; WHO (World Health Organization), SUIC PREV SUPRE; Yen S, 2003, J ABNORM PSYCHOL, V112, P375, DOI 10.1037/0021-843X.112.3.375	118	3	3	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2011	26	4					244	256		10.1097/HTR.0b013e3182225528			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	789FZ	WOS:000292501700002	21734508				2022-02-06	
J	Puentes, K; Ribeiro, C; Jardim, P; Santos, A; Magalhaes, T				Puentes, Katerina; Ribeiro, Cristina; Jardim, Patricia; Santos, Agostinho; Magalhaes, Teresa			Non-fatal gunshot wounds in the context of intimate partner violence. The importance of a multidisciplinary approach: A case report	JOURNAL OF FORENSIC AND LEGAL MEDICINE			English	Article						Intimate partner violence; Sexual assault; Gunshot wounds; Multidisciplinary approach; 3D-MSCT; Three-dimensional reconstitution	DOMESTIC VIOLENCE	According to Portuguese law, if a case of intimate partner violence is noticed or suspected by a professional working in public services, reporting it to 1 he police, medico-legal services or directly to the public prosecutor is mandatory. However, in most cases, reporting does not take place, despite its vital importance in triggering the multidisciplinary intervention that will ensure the correct and timely diagnosis and protection of the victim. In the present case, the victim, a 37 year-old woman, was sexually and physically abused by her husband in their home, and was physically abused again at the victim's mother's house. The victim mentioned that her husband struck her in the head with a hammer and shot a handgun while in her mother's house. However, she denied having a gunshot wound. The couple's daughter was also slapped in the face by her father. The police took the victim to the emergency room of a central hospital to receive medical attention, while the medical examiner on duty was called to the same emergency room to perform a medico-legal evaluation in the context of the intimate partner violence reported to the police. Medico-legal assessment revealed scalp injuries that had not been detected during the first inspection by the emergency room attending physicians who had performed a neurological examination, which revealed no neurological dysfunction. A cranial computed tomography with three-dimensional reconstitution and virtual dissection, requested by the medical examiner, revealed two projectiles trapped in between the inner and the outer table of the cranium, with linear fractures only in the inner table and no brain injuries. Gynecological examination with the collection of biological evidence, also performed by the medical examiner, made it possible to identify a male DNA profile matching her husband's. The victim was subjected to neurosurgery and a follow-up, and was released one month after the traumatic event. A forensic psychological evaluation, performed one month after the traumatic event, revealed the presence of reactive symptoms to the occurrence. This multidisciplinary intervention and the use of modern diagnosis imaging techniques allowed for a timely diagnosis and treatment, adequate protection of the victim and her family, as well as the identification of the aggressor, who was arrested. (C) 2011 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.	[Puentes, Katerina; Ribeiro, Cristina; Jardim, Patricia; Santos, Agostinho; Magalhaes, Teresa] Natl Inst Legal Med, N Branch, P-4050167 Oporto, Portugal; [Puentes, Katerina; Ribeiro, Cristina; Jardim, Patricia; Santos, Agostinho; Magalhaes, Teresa] Fdn Sci & Technol FCT, Forens Sci Ctr, P-3000213 Coimbra, Portugal; [Ribeiro, Cristina; Jardim, Patricia; Santos, Agostinho; Magalhaes, Teresa] Univ Porto, Fac Med, Oporto, Portugal; [Magalhaes, Teresa] Univ Porto, Biomed Sci Inst Abel Salazar, Oporto, Portugal		Puentes, K (corresponding author), Natl Inst Legal Med, N Branch, P-4050167 Oporto, Portugal.	alkimed@yahoo.es	Magalhaes, Teresa/J-7897-2013	Magalhaes, Teresa/0000-0002-8098-8076; Santos, Agostinho/0000-0002-1396-4234			*ACPO, 2004, GUID INV DOM VIOL, P12; BROOKMAN F, 2003, REDUCING HOMICIDE RE; DELAHUNTA EA, 1995, AM J EMERG MED, V13, P74, DOI 10.1016/0735-6757(95)90247-3; Hoyle C, 2008, CHILD YOUTH SERV REV, V30, P323, DOI 10.1016/j.childyouth.2007.10.009; Jeffery AJ, 2008, CLIN RADIOL, V63, P1160, DOI 10.1016/j.crad.2008.03.003; Kahana T, 1999, BRIT J RADIOL, V72, P129, DOI 10.1259/bjr.72.854.10365061; KOSS MP, 1991, ARCH INTERN MED, V151, P342, DOI 10.1001/archinte.151.2.342; Puentes K, 2009, J FORENSIC LEG MED, V16, P407, DOI 10.1016/j.jflm.2009.04.003; Walsh Amy, 2009, Minn Med, V92, P37; World Health Organization, 2003, GUID MED LEG CAR VIC, P75	10	3	3	0	15	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1752-928X			J FORENSIC LEG MED	J. Forensic Leg. Med.	JUL	2011	18	5					221	224		10.1016/j.jflm.2011.04.003			4	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	792AH	WOS:000292712400007	21663871				2022-02-06	
J	Sung, JJ; Mapstone, TB; El-Amm, CA				Sung, Josephine J.; Mapstone, Timothy B.; El-Amm, Christian A.			Spontaneous Resolution of Diabetes Insipidus After Cranioplasty and Cranial Defect Repair	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Cranioplasty; bone morphogentic protein 2; diabetes insipidus; neurologic improvement; sunken skin syndrome; paradoxical herniation; frozen bone flap; bone preservation	TRAUMATIC BRAIN-INJURY; SINKING SKIN FLAP; DECOMPRESSIVE CRANIECTOMY; BLOOD-FLOW; DYSFUNCTION; MANAGEMENT	We describe the resolution of persistent diabetes insipidus after cranioplasty with autogenous bone and bone morphogentic protein 2-infused collagen matrix in a patient who had large bilateral craniectomies for trauma. A potential pathogenic mechanism is presented.	[El-Amm, Christian A.] Univ Oklahoma, Hlth Sci Ctr, Dept Surg, Sect Plast & Reconstruct Surg, Oklahoma City, OK 73104 USA; [Mapstone, Timothy B.] Univ Oklahoma, Hlth Sci Ctr, Dept Neurosurg, Oklahoma City, OK 73104 USA; [Sung, Josephine J.] Univ Oklahoma, Sch Med, Oklahoma City, OK 73104 USA		El-Amm, CA (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Surg, Sect Plast & Reconstruct Surg, 920 SL Young Blvd,WP-2220, Oklahoma City, OK 73104 USA.	Christian-ElAmm@ouhsc.edu					Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; BLEVINS LS, 1992, CRIT CARE MED, V20, P69, DOI 10.1097/00003246-199201000-00019; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4; GRANTHAM EG, 1948, J NEUROSURG, V5, P19, DOI 10.3171/jns.1948.5.1.0019; GUIDO LJ, 1976, J NEUROSURG, V45, P348, DOI 10.3171/jns.1976.45.3.0348; Isago T, 2004, ANN PLAS SURG, V53, P288, DOI 10.1097/01.sap.0000106433.89983.72; Kuo JR, 2004, J CLIN NEUROSCI, V11, P486, DOI 10.1016/j.jocn.2003.06.005; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Nemergut EC, 2005, J NEUROSURG, V103, P448, DOI 10.3171/jns.2005.103.3.0448; PORTER RJ, 1948, J NEUROL NEUROSUR PS, V11, P258, DOI 10.1136/jnnp.11.4.258; Rahme R, 2010, NEUROSURGERY, V67, pE214, DOI 10.1227/01.NEU.0000370015.94386.1F; Sakamoto S, 2006, CLIN NEUROL NEUROSUR, V108, P583, DOI 10.1016/j.clineuro.2005.03.012; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; SEGAL DH, 1994, NEUROSURGERY, V34, P729, DOI 10.1227/00006123-199404000-00024; TABADDOR K, 1976, J NEUROSURG, V44, P506, DOI 10.3171/jns.1976.44.4.0506; Tsagarakis S, 2005, Pituitary, V8, P251, DOI 10.1007/s11102-006-6049-x; WALKER AE, 1963, ARCH NEUROL-CHICAGO, V9, P105, DOI 10.1001/archneur.1963.00460080015001; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053	21	3	3	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JUL	2011	22	4					1536	1537		10.1097/SCS.0b013e31821da32f			2	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	796OT	WOS:000293062100094	21778861				2022-02-06	
J	Ersoz, M; Kaya, K; Akkus, S; Ozel, S				Ersoz, Murat; Kaya, Kurtulus; Akkus, Selami; Ozel, Sumru			Urodynamic Findings in Patients with Traumatic Brain Injury	TURKIYE FIZIKSEL TIP VE REHABILITASYON DERGISI-TURKISH JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION			Turkish	Article						Traumatic brain injury; urodynamics; overactive detrusor; bladder filling sensation	DETRUSOR INSTABILITY; DOUBLE-BLIND; URINARY-INCONTINENCE; OXYBUTYNIN; PROPANTHELINE; PLACEBO; TRIAL; CHLORIDE; WOMEN	Objective: The aim of this study was to investigate the urodynamic findings and characteristics of lower urinary tract dysfunction in patients with traumatic brain injury (TBI). Materials and Methods: Thirty patients (25 male, 5 female) with TBI, who had neurogenic lower urinary tract dysfunction, were investigated retrospectively. Urodynamic examinations were performed, maximum cystometric capacity, residual urine, presence of storage dysfunction (bladder capacity<300 ml) and emptying dysfunction (residual urine >50 ml), and presence of bladder filling sensation, type of detrusor activity and bladder emptying method were determined Results: The mean age of the subjects was 31.9 +/- 16.3 years. The mean maximum cystometric capacity was 228 +/- 155 ml. Postvoiding residual urine was present in 15 patients and the mean residual urine was 128 143 ml. Bladder filling sensation was normal in 16 (55.2%), diminished in 11(37.9%) and was absent in 2(6.9%). Frequencies of storage and emptying dysfunctions were 20 (66.7%) and 8 (26.7%), respectively and 4 patients (13.3%) had both storage and emptying dysfunctions. Three patients (10%) had normoactive, 23 (76.7%) had overactive and 4 (13.3%) had underactive detrusor. Twenty-five patients (83%) were emptying their bladder spontaneously, 4 (13.3%) by intermittent catheterization and 1(3.3%) by indwelling catheter. Nine (36%) of the 25 patients who were emptying their bladder spontaneously were using urinary condom, 2 (8%) were using diapers. In the evaluation of nine patients who were given anticholinergic/antispasmodic therapy and had control urodynamic investigation pre- and post-treatment, the median values of cystometric capacities were 99 (min: 48-max: 420) and 158 (min: 52-max: 448) ml, respectively. Increase in cystometric capacity was observed in eight of nine patients. Conclusion: Bladder storage dysfunction is frequent in patients with TBI which is mainly due to detrusor overactivity. Bladder filling sensation was present at least to some degree in the great majority of them and again, a great majority of the patients were able to void spontaneously. Turk J Phys Med Rehab 2011;57:80-4.	[Kaya, Kurtulus] Tatvan Devlet Hastanesi, Fizik Tedavi & Rehabil Klinigi, Bitlis, Turkey; [Ersoz, Murat; Akkus, Selami] Ankara Fizik Tedavi Rehabil Egitim & Arastirma Ha, Fizik Tedavi & Rehabil Klinigi 6, Ankara, Turkey; [Ozel, Sumru] Ankara Fizik Tedavi Rehabil Egitim & Arastirma Ha, Fizik Tedavi & Rehabil Klinigi 3, Ankara, Turkey		Kaya, K (corresponding author), Tatvan Devlet Hastanesi, Fizik Tedavi & Rehabil Klinigi, Bitlis, Turkey.	kurtulusky@yahoo.com					Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Alloussi S, 1998, J CLIN RES, V1, P439; Cardozo L, 2000, BJU INT, V85, P659, DOI 10.1046/j.1464-410x.2000.00575.x; Chua K, 2003, BRAIN INJURY, V17, P469, DOI 10.1080/02699050210154268; ERSOZ M, 2006, DEMET SAGLIK DERGISI, V4, P20; GAJEWSKI JB, 1986, J UROLOGY, V135, P966, DOI 10.1016/S0022-5347(17)45940-4; HOLMES DM, 1989, BRIT J OBSTET GYNAEC, V96, P607, DOI 10.1111/j.1471-0528.1989.tb03263.x; KAYA K, 2008, FTR BIL, V2, P92; Krimchansky BZ, 1999, BRAIN INJURY, V13, P899; MADERSBACHER H, 1995, EUR UROL, V28, P240; Moiyadi AV, 2007, NEUROREHABILITATION, V22, P93; MOORE KH, 1990, BRIT J UROL, V66, P479, DOI 10.1111/j.1464-410X.1990.tb14992.x; Oostra K, 1996, BRAIN INJURY, V10, P459, DOI 10.1080/026990596124313; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; TAPP AJS, 1990, BRIT J OBSTET GYNAEC, V97, P521, DOI 10.1111/j.1471-0528.1990.tb02523.x; THUROFF JW, 1991, J UROLOGY, V145, P813, DOI 10.1016/S0022-5347(17)38459-8; YOUNGSON HA, 1994, BRAIN INJURY, V8, P23, DOI 10.3109/02699059409150956	17	3	3	0	4	GALENOS YAYINCILIK	FINDIKZADE	MOLLA GURANI CAD 22-2, FINDIKZADE, ISTANBUL 34093, TURKEY	1302-0234			TURK FIZ TIP REHAB D	Turk. Fiz. Tip Rehabil. Derg.	JUN	2011	57	2					80	84		10.4274/tftr.57.16			5	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	837GG	WOS:000296178500005					2022-02-06	
J	Gardner, CJ; Javadpour, M; Morgan, C; Daousi, C; Macfarlane, IA; Cuthbertson, DJ				Gardner, C. J.; Javadpour, M.; Morgan, C.; Daousi, C.; Macfarlane, I. A.; Cuthbertson, D. J.			Hypopituitarism - a late consequence of aneurysmal subarachnoid haemorrhage?	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Subarachnoid haemorrhage; hypopituitarism; growth hormone deficiency; aneurysm	TRAUMATIC BRAIN-INJURY; PITUITARY DYSFUNCTION	Over the last decade subarachnoid haemorrhage (SAH) has increasingly been recognised as a cause of hypopituitarism. We report on the case of a patient with evidence of growth hormone deficiency manifesting after a period of time, with a favourable response to growth hormone replacement. This is followed by a review of the current literature.	[Gardner, C. J.; Morgan, C.; Daousi, C.; Macfarlane, I. A.; Cuthbertson, D. J.] Aintree Univ Hosp NHS Fdn Trust, Univ Dept Diabet & Endocrinol, Liverpool, Merseyside, England; [Javadpour, M.] Walton Ctr Neurol & Neurosurg NHS Fdn Trust, Dept Neurosurg, Liverpool, Merseyside, England		Cuthbertson, DJ (corresponding author), Aintree Univ Hosp NHS Fdn Trust, Acad Endocrine Unit, 3rd Floor Clin Sci Ctr,Longmoor Lane, Liverpool L9 7AL, Merseyside, England.	daniel.cuthbertson@liverpool.ac.uk	Javadpour, Mohsen/AAX-4657-2020	Javadpour, Mohsen/0000-0001-9836-1741; Cuthbertson, Daniel/0000-0002-6128-0822	PfizerPfizer	CG and DC are in receipt of an investigator initiated research grant from Pfizer. Study design, data collection and data analysis were performed independantly of Pfizer.	Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x	4	3	4	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0268-8697			BRIT J NEUROSURG	Br. J. Neurosurg.	JUN	2011	25	3					337	338		10.3109/02688697.2010.546900			2	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	769QR	WOS:000291033800009	21355768				2022-02-06	
J	Matschke, J; Puschel, K; Glatzel, M				Matschke, J.; Pueschel, K.; Glatzel, M.			Traumatic brain injury and sport	RECHTSMEDIZIN			German	Article						Sports; Traumatic brain injury; Chronic traumatic encephalopathy; Dementia; Amyotrophic lateral sclerosis	AMYOTROPHIC-LATERAL-SCLEROSIS; HEAD-INJURY; DEMENTIA-PUGILISTICA; FATAL INJURIES; CONCUSSION; SEQUELAE; RISK	In virtually any sports discipline the participants are at risk to suffer traumatic brain injury. Injury may occur with accidental falls or with non-intentional collisions with other athletes. Boxing and other combat sports, however, are unique with intentional and voluntary infliction of traumatic injury on the combatant. Recently, the medical focus has shifted from accidental acute often fatal forms of traumatic brain injury to potentially hazardous chronic repetitive mild head injury, such as concussion and the possible relationship to neurodegenerative processes. In this review the main issues of acute and chronic neurotrauma related to sports activities are discussed. Because of the extreme popularity of sports worldwide the implications of head injuries are enormous.	[Matschke, J.; Glatzel, M.] Univ Klinikum Hamburg Eppendorf, Inst Neuropathol, D-20246 Hamburg, Germany; [Pueschel, K.] Univ Klinikum Hamburg Eppendorf, Inst Rechtsmed, D-20246 Hamburg, Germany		Matschke, J (corresponding author), Univ Klinikum Hamburg Eppendorf, Inst Neuropathol, Martinistr 52, D-20246 Hamburg, Germany.	matschke@uke.de	Glatzel, Markus/G-3356-2011; Matschke, Jakob/F-6641-2013; Glatzel, Markus/V-8844-2019	Glatzel, Markus/0000-0002-7720-8817; Matschke, Jakob/0000-0001-6080-0198; Glatzel, Markus/0000-0002-7720-8817			Armon C, 2007, J NEUROL SCI, V262, P45, DOI 10.1016/j.jns.2007.06.021; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Bey T, 2009, WEST J EMERG MED, V10, P6; Bianco M, 2007, INT J SPORTS MED, V28, P697, DOI 10.1055/s-2007-964863; Biasca N, 2006, UNFALLCHIRURG, V109, P101, DOI 10.1007/s00113-005-1046-5; Biasca N, 2007, PROG BRAIN RES, V161, P263, DOI 10.1016/S0079-6123(06)61019-4; Byard RW, 2009, FORENSIC SCI MED PAT, V5, P36, DOI 10.1007/s12024-008-9063-7; Cajigal S., 2007, NEUROLOGY TODAY, V7, P1; CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; COLMANT HJ, 1980, Z RECHTSMED, V84, P263, DOI 10.1007/BF02098751; Eaton Lynn, 2002, BMJ, V325, P1133; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Esiri M., 2006, Oppenheimer's Diagnostic Neuropathology: A Practical Manual, VThird ed; Forstl H, 2010, DTSCH ARZTEBL INT, V107, P835, DOI 10.3238/arztebl.2010.0835; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; GONZALES TA, 1951, JAMA-J AM MED ASSOC, V146, P1506, DOI 10.1001/jama.1951.03670160048012; GUTERMAN A, 1987, SPORTS MED, V4, P194, DOI 10.2165/00007256-198704030-00004; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; JORDAN BD, 1987, ARCH NEUROL-CHICAGO, V44, P453, DOI 10.1001/archneur.1987.00520160083020; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; LINDSAY KW, 1980, BRIT MED J, V281, P789, DOI 10.1136/bmj.281.6243.789; LUNDBERG GD, 1983, JAMA-J AM MED ASSOC, V249, P250, DOI 10.1001/jama.1983.03330260068037; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Nowak LA, 2009, CLIN NEUROPATHOL, V28, P275, DOI 10.2379/NPX0800; Raschka C, 2008, RECHTSMEDIZIN, V18, P167, DOI 10.1007/s00194-008-0525-8; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; Ryan AJ, 1998, CLIN SPORT MED, V17, P155, DOI 10.1016/S0278-5919(05)70070-3; Schmidt P, 2008, RECHTSMEDIZIN, V18, P161, DOI 10.1007/s00194-008-0521-z; SCHNEIDER R, 1961, JAMA-J AM MED ASSOC, V177, P362, DOI 10.1001/jama.1961.03040320006002; TYSVAER AT, 1989, ACTA NEUROL SCAND, V80, P151, DOI 10.1111/j.1600-0404.1989.tb03858.x; UNTERHARNSCHEIDT F, 1970, TEX REP BIOL MED, V28, P421; Weber JT, 2007, PROG BRAIN RES, V161, P253, DOI 10.1016/S0079-6123(06)61018-2; Williams DJ, 1996, PATHOLOGY, V28, P102, DOI 10.1080/00313029600169653; YARNELL PR, 1973, NEUROLOGY, V23, P196, DOI 10.1212/WNL.23.2.196; Zazryn T, 2006, BRIT J SPORT MED, V40, P670, DOI 10.1136/bjsm.2006.025924; Zazryn TR, 2008, NEUROL CLIN, V26, P257, DOI 10.1016/j.ncl.2007.11.004; MEYERS KONVERSATIONS	43	3	3	3	17	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9819	1434-5196		RECHTSMEDIZIN	Rechtsmedizin	JUN	2011	21	3					191	196		10.1007/s00194-011-0752-2			6	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	769RP	WOS:000291036300004					2022-02-06	
J	Stulik, J; Nesnidal, P; Sebesta, P; Vyskocil, T; Kryl, J				Stulik, J.; Nesnidal, P.; Sebesta, P.; Vyskocil, T.; Kryl, J.			Kyphotic Deformities of the Cervical Spine	ACTA CHIRURGIAE ORTHOPAEDICAE ET TRAUMATOLOGIAE CECHOSLOVACA			Czech	Article						cervical spine; kyphosis; osteotomy; deformity correction	SPONDYLOTIC MYELOPATHY; PLATE STABILIZATION; SCREW FIXATION; RIGID PLATES; ANTERIOR; FUSION; INSTABILITY; KYPHOSIS; LAMINECTOMY; CORPECTOMY	PURPOSE OF THE STUDY The development of a cervical kyphotic deformity can be associated with a degenerative disease, trauma, tumour, developmental anomaly and also a surgical procedure. Post-operative kyphosis can develop after both the anterior and posterior surgical approaches. The deformity can also result from systemic diseases, such as ankylosing spondylitis or rheumatoid arthritis. The aim of the study was to make the clinical and radiographic evaluation of a group of patients with kyphotic deformity treated at our department. MATERIAL Between May 2005 and April 2010, a total of 102 patients underwent correction of cervical kyphosis at our department. (Center for Spinal Surgery). Of them, 90 patients with complete medical records and post-operative periods longer than 6 months were included in this study. There were 36 men and 54 women ranging in age from 13 to 90 years and with an average of 56.7 years. In six patients cervical kyphosis was caused by an inveterate injury, in 71 by degenerative disease, in six it developed in association with rheumatoid arthritis, and in seven patients it was due to previous surgery. Patients with acute trauma, tumour, infectious disease or congenital anomaly were not included. METHODS All patients were examined before surgery by radiography in antero-posterior and lateral projection, including flexion-extension bending films, and by CT scanning of ultrathin cross-sections with sagittal, frontal and recently also 3D reconstructions. Magnetic resonance imaging in three planes was also performed. On the basis of the results and clinical examination, the operative strategy was planned. Surgery was carried out from the anterior or the posterior approach, or the combined approach was used. Three-stage surgery was performed in one patient. The surgical outcome was assessed using the Nurick score and Neck Disability Index (NDI), the Visual Analogue Scale (VAS) was used to evaluate pain intensity or paraesthesia. Statistical analysis was done using the Chi-square test and paired t-test. RESULTS The average NDI value was 25.5 before surgery and 14.3 and 14.9 at one and two years after surgery, respectively. Compared with the pre-operative state, improvement or no changes were recorded in 89.7 % of the patients; transient deterioration occurred in 10.3 %. Improvements found were as follows: by one degree in 46.2 % of the patients, by two degrees in 18 %, by three degrees in 5.1 % and by five degrees in 2.6 % of the patients. The condition remained unchanged in 18 % of the patients. The average outcome was an improvement by one degree. The average pre-operative Nurick score was 0.7; an average post-operative value of 0.6 was recorded at both one and two years of follow-up. The average VAS value for neck and radicular pain was 5.7 pre-operatively, and 2.5 and 2.7 at one and two post-operative years, respectively. Out of 90 patients, complete bone union was achieved at 6 months after surgery in 88 patients (97.8 %). The average pre-operative value for the cervical curvature index (Ishihara) was -13.7; the average pre-operative cervical kyphosis was -14.4 degrees, ranging from -2.2 to -44.0 degrees. After surgery, the average Ishihara index was +15.3 and the average lordosis was + 13.5 degrees, with a range of -16.0 to + 37.4 degrees. DISCUSSION A single/isolated anterior approach can be used for fixed deformities without ankylosing spondylitis. It allows for decompression of the anterior pathology and for correction of cervical kyphosis with use of instrumentation and structural graft. A combined ventral-dorsal approach is appropriate in fixed deformities or deformities involving the cervico-thoracic junction. The main principle of correction is to lengthen the cervical spinal column in the front and to shorten it at the back by anterior decompression with or without instrumentation and by subsequent posterior stabilisation. An isolated/single dorsal correction can be used in the case of successful correction by traction or specific head positioning on the table without anterior nerve compression. In severe fixed deformities such as Bekhterev's disease, the chin can be so close to the chest as to interfere with eating and breathing. The deformity most often develops at the cervico-thoracic junction and requires treatment by osteotomy. CONCLUSIONS The results of the study showed a marked improvement in the patients' quality of life after kyphosis correction, improved neurological status and an improved posture seen on radiograms of the cervical spine. The study also revealed a higher number of potential complications associated, in particular, with corrective osteotomy. The best results were achieved with the combined surgical approach; however, the choice of a surgical method was independent of the patient's clinical status.	[Stulik, J.; Nesnidal, P.; Sebesta, P.; Vyskocil, T.; Kryl, J.] Spondylochirurg Oddeleni FN Motol, Chirurg Klin 3, Prague 15006 5, Czech Republic; [Stulik, J.; Sebesta, P.; Vyskocil, T.; Kryl, J.] 1 LF UK FN Motol, Chirurg Klin 3, Prague, Czech Republic; [Stulik, J.] 2 LF UK FN Motol, Ortoped Klin Deti Dospelych, Prague, Czech Republic		Stulik, J (corresponding author), Spondylochirurg Oddeleni FN Motol, Chirurg Klin 3, V Uvalu 84, Prague 15006 5, Czech Republic.		Kryl, Jan/I-7305-2017; Stulik, Jan/I-6650-2017; Nesnidal, Petr/I-6683-2017; Vyskocil, Tomas/I-6963-2017	Kryl, Jan/0000-0003-3560-8967; Stulik, Jan/0000-0002-8980-849X; Nesnidal, Petr/0000-0003-1630-8168; Vyskocil, Tomas/0000-0003-4346-2822			Abumi K, 1999, SPINE, V24, P2389, DOI 10.1097/00007632-199911150-00017; Albert TJ, 1998, SPINE, V23, P2738, DOI 10.1097/00007632-199812150-00014; Benzel EC, 2001, BIOMECHANICS SPINE S; Brindza P, 2009, ACTA CHIR ORTHOP TR, V76, P382; BUTLER JC, 1992, ORTHOP CLIN N AM, V23, P505; CALLAHAN RA, 1977, J BONE JOINT SURG AM, V59, P991, DOI 10.2106/00004623-197759080-00001; Caspar W, 1999, SURG NEUROL, V52, P345, DOI 10.1016/S0090-3019(99)00100-7; CATTELL HS, 1967, J BONE JOINT SURG AM, VA 49, P713, DOI 10.2106/00004623-196749040-00013; Duff SE, 2000, J NEUROSURG, V93, P283, DOI 10.3171/spi.2000.93.2.0283; Geisler FH, 1998, SPINE, V23, P911, DOI 10.1097/00007632-199804150-00013; GORE DR, 1986, SPINE, V11, P521, DOI 10.1097/00007632-198607000-00003; Heller JG, 2001, SPINE, V26, P1330, DOI 10.1097/00007632-200106150-00013; HERMAN JM, 1994, J NEUROSURG, V80, P963, DOI 10.3171/jns.1994.80.6.0963; Ishihara A, 1968, Nihon Seikeigeka Gakkai Zasshi, V42, P1033; JOHNSTON FG, 1995, J NEUROSURG, V82, P234, DOI 10.3171/jns.1995.82.2.0234; Kaptain GJ, 2000, J NEUROSURG, V93, P199, DOI 10.3171/spi.2000.93.2.0199; Katsuura A, 1996, J SPINAL DISORD, V9, P470; KOTANI Y, 1994, SPINE, V19, P2529, DOI 10.1097/00007632-199411001-00007; McAfee PC, 1995, J BONE JOINT SURG AM, V77A, P1791, DOI 10.2106/00004623-199512000-00001; McMaster MJ, 1997, J BONE JOINT SURG BR, V79B, P197, DOI 10.1302/0301-620X.79B2.7095; Mummaneni PV, 2008, J NEUROSURG-SPINE, V9, P515, DOI 10.3171/SPI.2008.10.08226; Pitzen TR, 2009, SPINE, V34, P641, DOI 10.1097/BRS.0b013e318198ce10; SAVINI R, 1987, SPINE, V12, P178, DOI 10.1097/00007632-198703000-00015; Spivak Jeffrey M., 1997, P1027; Steinmetz MP, 2007, NEUROSURGERY, V60, P90, DOI 10.1227/01.NEU.0000215553.49728.B0; Steinmetz MP, 2002, J NEUROSURG, V97, P330, DOI 10.3171/spi.2002.97.3.0330; Stewart Todd J, 2005, Neurosurgery, V56, P191; Stulik J, 2009, ACTA CHIR ORTHOP TR, V76, P479; Stulik J, 2007, EUR SPINE J, V16, P1689, DOI 10.1007/s00586-007-0451-6; Suchomel P, 2009, ACTA CHIR ORTHOP TR, V76, P137; Uchida K, 2009, J NEUROSURG-SPINE, V11, P521, DOI 10.3171/2009.2.SPINE08385; URIST MR, 1958, J BONE JOINT SURG AM, V40, P833, DOI 10.2106/00004623-195840040-00007; Vaccaro AR, 2001, SPINE, V26, pS111, DOI 10.1097/00007632-200112151-00019; Wang B, 2006, SPINE, V31, P1327, DOI 10.1097/01.brs.0000218508.86258.d4; ZDEBLICK TA, 1989, J BONE JOINT SURG AM, V71A, P170, DOI 10.2106/00004623-198971020-00002	35	3	3	2	8	GALEN SRO	PRAGUE 5	NA BELIDLE 34, PRAGUE 5, 150 00, CZECH REPUBLIC	0001-5415			ACTA CHIR ORTHOP TR	Acta Chir. Orthop. Traumatol. Cechoslov.	JUN	2011	78	3					215	224					10	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	789RD	WOS:000292533100005	21729637				2022-02-06	
J	Wani, AA; Ramzan, AU; Malik, NK; Kumar, A; Dhar, A; Nizami, FA; Chibber, SS; Wani, M				Wani, Abrar A.; Ramzan, Altaf U.; Malik, Nayil K.; Kumar, Ashish; Dhar, Anil; Nizami, Furqan A.; Chibber, Sarabjit S.; Wani, M. A.			Brain abscess complicating hemorrhagic contusion in a case of closed head injury: Case report	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						brain abscess; hemorrhagic contusion		Brain contusions commonly are identified in patients with traumatic brain injury (TBI) and represent regions of primary neuronal and vascular injury. These edematous lesions contain punctate parenchymal hemorrhages, which are termed micro-hemorrhages. These hemorrhages rarely get infected by hematogenous spread of microorganisms causing a brain abscess. Delayed brain abscess formation in the contusion is a very rare entity. We report a one year old patient who had traumatic right parietal hemorrhagic contusion with no external wound. She was managed conservatively. Two weeks after injury he deteriorated in neurological status and was found to have developed brain abscess. Patient underwent immediate craniotomy with drainage of abscess and excision of abscess wall; she was discharged home after one week. Infective complication can occur rarely even after closed head injury and should be kept as a differential diagnosis in a patient with delayed deterioration.	[Wani, Abrar A.; Ramzan, Altaf U.; Malik, Nayil K.; Kumar, Ashish; Dhar, Anil; Nizami, Furqan A.; Chibber, Sarabjit S.; Wani, M. A.] Sherikashmir Inst Med Sci, Dept Neurosurg, Srinagar, Jammu & Kashmir, India		Wani, AA (corresponding author), Sherikashmir Inst Med Sci, Dept Neurosurg, Srinagar, Jammu & Kashmir, India.	abrarwani@rediffmail.com					BELLER AJ, 1973, J NEUROL NEUROSUR PS, V36, P757, DOI 10.1136/jnnp.36.5.757; Britt R, 1985, NEUROSURGERY, P1928; Dashti SR, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/6/E12; GARFIELD J, 1969, BRIT MED J, V2, P7, DOI 10.1136/bmj.2.5648.7; KASAMO S, 1992, Neurological Surgery, V20, P433; Lee MZ, 2006, YOUMANS NEUROLOGICAL, V5, P5041; MAMPALAM TJ, 1988, NEUROSURGERY, V23, P451, DOI 10.1227/00006123-198810000-00008; Moorthy RK, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/6/E3; MORGAN H, 1973, J NEUROSURG, V38, P698, DOI 10.3171/jns.1973.38.6.0698; SAMSON DS, 1973, AM J MED, V54, P201, DOI 10.1016/0002-9343(73)90224-6; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Thomas SG, 2009, NEUROL INDIA, V57, P73, DOI 10.4103/0028-3886.48812; WOOD JH, 1979, J NEUROL NEUROSUR PS, V42, P63, DOI 10.1136/jnnp.42.1.63; WOOD JH, 1978, J NEUROSURG, V48, P264, DOI 10.3171/jns.1978.48.2.0264; YANG SY, 1993, SURG NEUROL, V39, P290, DOI 10.1016/0090-3019(93)90008-O; ZIMMERMAN RA, 1977, COMPUT AXIAL TOMOGR, V1, P271	16	3	3	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	JUN	2011	8	1					49	50		10.1016/S0973-0508(11)80026-2			2	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M2E	WOS:000218383100011					2022-02-06	
J	Dasarathi, M; Grace, J; Kelly, T; Forsyth, R				Dasarathi, M.; Grace, J.; Kelly, T.; Forsyth, R.			Utilization of mental health services by survivors of severe paediatric traumatic brain injury: a population-based study	CHILD CARE HEALTH AND DEVELOPMENT			English	Article						ADHD; mental health; offending behaviour; traumatic brain injury	CHILDREN; ADOLESCENTS; PREDICTORS; DISORDER; CARE	A study of general and specialist mental health and psychology service provider records confirms very high rates of utilization by a population of survivors of severe paediatric traumatic brain injury.	[Forsyth, R.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Dasarathi, M.; Kelly, T.; Forsyth, R.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Child Neurol, Newcastle Upon Tyne, Tyne & Wear, England; [Grace, J.] Northumberland Tyne & Wear NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England		Forsyth, R (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	r.j.forsyth@newcastle.ac.uk	Forsyth, Rob J/I-9226-2012; Forsyth, Rob/H-9193-2019	Forsyth, Rob J/0000-0002-5657-4180; Forsyth, Rob/0000-0002-5657-4180			*BRIT SOC REH MED, 1998, REH TRAUM BRAIN INJ; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Demellweek Colin, 2002, Pediatr Rehabil, V5, P81, DOI 10.1080/136384902320807194; Department of Communities and Local Government, 2007, IND MULT DEPR; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; Forsyth R, 2010, CHILD CARE HLTH DEV, V36, P1, DOI 10.1111/j.1365-2214.2009.01044.x; Forsyth RJ, 2010, ARCH DIS CHILD, V95, P554, DOI 10.1136/adc.2009.161083; Forsyth RJ, 2010, ARCH DIS CHILD, V95, P266, DOI 10.1136/adc.2008.147926; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	24	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1862	1365-2214		CHILD CARE HLTH DEV	Child Care Health Dev.	MAY	2011	37	3					418	421		10.1111/j.1365-2214.2010.01199.x			4	Psychology, Developmental; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Pediatrics	745GA	WOS:000289152700016	21276036				2022-02-06	
J	Gravlee, JR; Barrett, JJ				Gravlee, Jocelyn R.; Barrett, John J.			Transient Global Amnesia in a Collegiate Baseball Player with Type I Diabetes Mellitus: A Case Report	JOURNAL OF ATHLETIC TRAINING			English	Article						memory loss; neurologic conditions; athletes	MIGRAINE	Objective: To present the case of a collegiate pitcher with type I diabetes mellitus who developed transient global amnesia and to characterize the acute onset of symptoms and clinical diagnosis of this rarely reported neurologic condition in the student athlete population. Background: A 21-year-old collegiate pitcher with type I diabetes mellitus was found by his roommate to have acute-onset memory loss. The athletic trainer identified normal blood glucose levels and normal vital signs but profound amnesia. The patient was evaluated by his team physician and referred to the local emergency department for acute-onset memory disturbance. Differential Diagnosis: Hypoglycemia, ketoacidosis, adverse drug reaction, infectious disease, transient epileptic amnesia, transient ischemic attack, acute confusional state, complex partial seizure, psychogenic amnesia, migraine, intracerebral hemorrhage, traumatic brain injury, tumor, and transient global amnesia. Treatment: Diagnostic studies included computed tomography of the head, urine and serum toxicology, urinalysis, blood glucose level, electrolytes, blood urea nitrogen level, creatinine level, complete blood count, and electroencephalography. The patient was admitted overnight to the neurology service. The next morning, electroencephalography was repeated, and magnetic resonance imaging of the head with contrast was performed. The patient was discharged with the diagnosis of transient global amnesia. Uniqueness: Transient global amnesia is considered a benign condition characterized by an acute episode of memory disturbance involving the inability to form new memories and recall recent events. It is rare in young people, with only 3 case reports involving young athletes published in the literature. Conclusions: Transient global amnesia is a rarely diagnosed neurologic disturbance that may present acutely in student athletes, although most reported cases affect older adults. Unfamiliarity with the symptoms may cause anxiety for the athlete and bystanders. Transient global amnesia does not result in long-term neurologic deficit, and neurologic function will return to baseline.	[Gravlee, Jocelyn R.] Univ Florida, Coll Med, Dept Community Hlth & Family Med, Gainesville, FL 32611 USA; [Barrett, John J.] Univ Florida, Athlet Assoc Inc, Sports Hlth Dept, Gainesville, FL 32611 USA		Gravlee, JR (corresponding author), Univ Florida, Coll Med, Dept Community Hlth & Family Med, POB 117500, Gainesville, FL 32611 USA.	jgravlee@ufl.edu					AMIT R, 1986, HEADACHE, V26, P17, DOI 10.1111/j.1526-4610.1986.hed2601017.x; Bender MB, 1956, J HILLSIDE HOSP, V5, P212; CHALMERS J, 1991, DIABETES CARE, V14, P922, DOI 10.2337/diacare.14.10.922; DINSMORE WW, 1983, J NEUROL NEUROSUR PS, V46, P876, DOI 10.1136/jnnp.46.9.876; Fisher CM, 1958, T AM NEUROL ASSOC, V83, P5; Guyotat MM, 1956, J MED LYON, V37, P697; HODGES JR, 1990, J NEUROL NEUROSUR PS, V53, P834, DOI 10.1136/jnnp.53.10.834; Holemans X, 2001, DIABETIC MED, V18, P761, DOI 10.1046/j.1464-5491.2001.00481.x; JENSEN TS, 1980, DEV MED CHILD NEUROL, V22, P654; Owen D, 2007, POSTGRAD MED J, V83, P236, DOI 10.1136/pgmj.2006.052472; Quinette P, 2006, BRAIN, V129, P1640, DOI 10.1093/brain/awl105; Shekhar R, 2008, INT J CLIN PRACT, V62, P939, DOI 10.1111/j.1742-1241.2007.01564.x; Tosi L, 1997, CLIN NEUROL NEUROSUR, V99, P63, DOI 10.1016/S0303-8467(96)00595-1	13	3	3	0	4	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050			J ATHL TRAINING	J. Athl. Train.	MAY-JUN	2011	46	3					319	321					3	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	770YC	WOS:000291123400015	21669103				2022-02-06	
J	Hayward, E; Hunt, K				Hayward, Elizabeth; Hunt, Katharine			Clinical neuroprotection and secondary neuronal injury mechanisms	ANAESTHESIA AND INTENSIVE CARE MEDICINE			English	Article						cerebral protection; secondary brain injury; stroke; subarachnoid haemorrhage; traumatic brain injury		Anaesthetists and intensive care physicians commonly encounter cerebral injury in their clinical practice. Insults may arise from cardiac arrest and traumatic brain injury, can follow cardiothoracic, vascular or major orthopaedic surgery, and are also seen in medical conditions including subarachnoid haemorrhage, central nervous system infection, epilepsy and stroke. In all cases, neuronal injury may lead to severe disability or death; however, aggressive early treatment may result in improvements to patient morbidity and mortality. Neuroprotection involves an intervention, initiated before the onset of ischaemia that can modify the cascade of events which lead to permanent cell damage when left unchecked. Neuroresuscitation refers to treatment aimed at restoring blood flow and oxygenation to cells that have already become exposed to an ischaemic insult.	[Hayward, Elizabeth] North Cent Thames Rotat, London, England; [Hunt, Katharine] Natl Hosp Neurol & Neurosurg, London, England		Hayward, E (corresponding author), North Cent Thames Rotat, London, England.						Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Brain Trauma Foundation, 2007, GUID MAN SEV TRAUM B; National Institute for Health and Clinical Excellence, 2007, HEAD INJ ASS INV EAR; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5	4	3	3	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1472-0299	1878-7584		ANAEST INTENS CARE M	Anaesth. Intensiv. Care Med.	MAY	2011	12	5					198	200		10.1016/j.mpaic.2011.02.004			3	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	V09DH	WOS:000214123200005					2022-02-06	
J	Park, YS; Kim, JP; Chang, WS; Chang, JW				Park, Young Seok; Kim, Joo Pyung; Chang, Won Seok; Chang, Jin Woo			Management of a DBS System in Patients With Traumatic Brain Injury: Case Report	NEUROMODULATION			English	Article						Deep brain stimulation; essential tremor; Image fusion; Tourette's syndrome	SUBTHALAMIC NUCLEUS STIMULATION; PARKINSONS-DISEASE; MOVEMENT-DISORDERS; ESSENTIAL TREMOR; THALAMUS; BALANCE	Introduction: The use of deep brain stimulation (DBS) is growing. While these patients may suffer from traumatic brain injuries, treatment guidelines for these patients have not yet been reported. This case report demonstrates a strategy for traumatic brain injury after DBS implantation. Clinical presentation: A 46-year-old man underwent bilateral DBS in the posterior subthalamic area for essential tremor, which improved both distal and proximal tremor. Two years later, he underwent emergent hematoma evacuation due to a motor vehicle associated injury. A 23-year-old male patient presented with severe Tourette's syndrome characterized by a vocal and self lip biting motor tic. There was a good effect of chronic bilateral thalamic DBS at CM-Pf. Five months later, he had acute subdural hematoma after a motorcycle accident. Instead of removing stimulation electrodes immediately after traumatic brain injury, the patient was reassessed after recovery. Merged preoperative magnetic resonance images and brain computed tomography images, and clinical reassessments were used to plan future treatment. Conclusion: We recommend removing only the hematoma, leaving the electrodes in position, and then reassessing the electrode position using merged images. The clinical correlation with electrode migration also should be checked. If the patient can tolerate stimulation with a minor displacement, the electrodes should be left in position and the stimulation parameter needs to be adjusted. If not, the stimulation electrodes should be deactivated or repositioned appropriately, depending on the patient's conditions.	[Park, Young Seok] CHA Univ, Dept Neurosurg, Bundang CHA Hosp, Songnam, South Korea; [Park, Young Seok; Kim, Joo Pyung; Chang, Won Seok; Chang, Jin Woo] Yonsei Univ, Dept Neurosurg, Coll Med, Severance Hosp, Seoul 120752, South Korea		Chang, JW (corresponding author), Yonsei Univ, Dept Neurosurg, Coll Med, 134 Shinchon Dong, Seoul 120752, South Korea.	jchang@yuhs.ac		Chang, Won Seok/0000-0003-3145-4016; Chang, Jin Woo/0000-0002-2717-0101			Aziz TZ, 2001, STEREOT FUNCT NEUROS, V77, P87, DOI 10.1159/000064602; BENABID AL, 1987, APPL NEUROPHYSIOL, V50, P344; Binder DK, 2005, NEUROSURGERY, V56, P722, DOI 10.1227/01.NEU.0000156473.57196.7E; Deuschl G, 2002, ADV NEUROL, V89, P115; Earhart GM, 2009, MOVEMENT DISORD, V24, P386, DOI 10.1002/mds.22356; Egidi M, 2002, NEUROL SCI, V23, pS71, DOI 10.1007/s100720200075; Fraix V, 2006, J NEUROL NEUROSUR PS, V77, P443, DOI 10.1136/jnnp.2005.077677; Freund HJ, 2005, BRAIN, V128, P2222, DOI 10.1093/brain/awh634; Goodman RR, 2006, J NEUROL NEUROSUR PS, V77, P12, DOI 10.1136/jnnp.2005.069161; Johnson MD, 2008, NEUROTHERAPEUTICS, V5, P294, DOI 10.1016/j.nurt.2008.01.010; Koga T, 2009, ACTA NEUROCHIR, V151, P465, DOI 10.1007/s00701-009-0279-4; Koller WC, 2000, NEUROLOGY, V55, pS29; McClelland Shearwood 3rd, 2005, Neurosurg Focus, V19, pE12; Ondo WG, 2006, MOVEMENT DISORD, V21, P2243, DOI 10.1002/mds.21165; Pahwa R, 2006, J NEUROSURG, V104, P506, DOI 10.3171/jns.2006.104.4.506; Plaha P, 2004, J NEUROSURG, V101, P48, DOI 10.3171/jns.2004.101.1.0048; Pollak P, 2002, MOVEMENT DISORD, V17, pS75, DOI 10.1002/mds.10146; Servello D, 2009, NEUROPSYCH DIS TREAT, V5, P183; Shin M, 2007, NEUROPHYSIOL CLIN, V37, P457, DOI 10.1016/j.neucli.2007.09.005; SIEGFRIED J, 1994, STEREOT FUNCT NEUROS, V62, P71, DOI 10.1159/000098599	20	3	3	0	1	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1094-7159			NEUROMODULATION	Neuromodulation	MAY-JUN	2011	14	3					214	218		10.1111/j.1525-1403.2011.00348.x			5	Medicine, Research & Experimental; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Neurosciences & Neurology	772GP	WOS:000291222600005	21992242				2022-02-06	
J	Smith, A				Smith, Amber		OPA Auto Task Force	Ontario Psychological Association Guidelines for Assessment and Treatment in Auto Insurance Claims	PSYCHOLOGICAL INJURY & LAW			English	Article						Treatment guidelines; Ontario; MVA survivors		The Ontario Psychological Association Guidelines for Assessment and Treatment in Auto Insurance Claims was published on the Ontario Psychological Association website in July, 2010 (Smith, A., and OPA Auto Task Force, 2010, Ontario Psychological Association Guidelines for Assessment and Treatment in Auto Insurance Claims. Ontario Psychological Association, Toronto, Ontario. Retrieved from http://www.psych.on.ca/files/members/OPA_Auto_Practice_Guidelines_July292010_July_30_2010.pdf). Excerpts are reproduced in the journal because of the comprehensive nature of the document. To our knowledge, this is the first time that state or provincial guidelines have included all the major psychological diagnoses in rehabilitation work with motor vehicle accident survivors (chronic pain, post-traumatic stress disorder, traumatic brain injury, depression). Space limitations preclude publishing of the full document, but it should be consulted. The present excerpt focuses on the nature of the psychological injuries and the best practices in treating them, along with cautions for assessment, comorbidities and polytrauma, litigation distress and barriers and complications in recovery.				Amber@kaplanpsychologists.com					Acquired Brain Injury Rehabilitation, 2010, INF SHEET; AERA, 1999, STAND ED PSYCH TEST; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Antonuccio DO, 1997, BEHAV THER, V28, P187, DOI 10.1016/S0005-7894(97)80043-3; Barnsley L., 2004, PAIN RES MANAG, V8, P33; Beck JG, 2007, PROF PSYCHOL-RES PR, V38, P629, DOI 10.1037/0735-7028.38.6.629; Benight CC, 2008, J CONSULT CLIN PSYCH, V76, P677, DOI 10.1037/0022-006X.76.4.677; BEUTLER LE, 2000, PRESCRIPTIVE PSYCHOT; Blanchard E. B., 2004, CRASH ASSESSMENT TRE; Blanchard E. B., 1997, CRASH ASSESSMENT TRE; Blanchard EB, 1996, BEHAV RES THER, V34, P775, DOI 10.1016/0005-7967(96)00038-1; BLANCHARD EB, 1995, J NERV MENT DIS, V183, P495, DOI 10.1097/00005053-199508000-00001; Blanchard EB, 1998, J ANXIETY DISORD, V12, P21, DOI 10.1016/S0887-6185(97)00047-9; Blanchard EB, 2003, BEHAV THER, V34, P351, DOI 10.1016/S0005-7894(03)80005-9; Blanchard EB, 1997, J TRAUMA STRESS, V10, P215, DOI 10.1002/jts.2490100205; Blumenthal JA, 2002, AM J CARDIOL, V89, P164, DOI 10.1016/S0002-9149(01)02194-4; Brammer R, 2002, PSYCHOL ASSESSMENT, V14, P110, DOI 10.1037/1040-3590.14.1.110; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Breslau N, 2000, BIOL PSYCHIAT, V48, P902, DOI 10.1016/S0006-3223(00)00933-1; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Bryant R. A., 2008, MOTOR VEHICLE COLLIS; Bryant RA, 2003, BIOL PSYCHIAT, V53, P789, DOI 10.1016/S0006-3223(02)01895-4; Bryant RA, 1999, AM J PSYCHIAT, V156, P1780; Bryant RA, 1998, J CONSULT CLIN PSYCH, V66, P862, DOI 10.1037/0022-006X.66.5.862; Bryant RA, 2005, J CONSULT CLIN PSYCH, V73, P334, DOI 10.1037/0022-006X.73.2.334; Bryant RA, 1998, PSYCHOL ASSESSMENT, V10, P215, DOI 10.1037/1040-3590.10.3.215; Bryant RA, 2003, BEHAV RES THER, V41, P489, DOI 10.1016/S0005-7967(02)00179-1; Bryant RA, 2003, J NERV MENT DIS, V191, P191, DOI 10.1097/00005053-200303000-00009; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 2002, AUST NZ J PSYCHIAT, V36, P205, DOI 10.1046/j.1440-1614.2002.01009.x; Bryant RA, 2008, J CONSULT CLIN PSYCH, V76, P695, DOI 10.1037/a0012616; BURSTEIN A, 1984, PSYCHOSOMATICS, V25, P681, DOI 10.1016/S0033-3182(84)72977-X; Canadian Chiropractic Association, 2010, PRACT GUID MAN WHIPL; Canadian Institute for Health Information, 2001, NAT HLTH EXP TRENDS; Canadian Psychiatric Association, 2001, CLIN PRACT GUID TREA; Canadian Psychiatric Association, 2006, CLIN PRACT GUID MAN; Canadian Psychiatric Association, 2005, CLIN PRACT GUID TREA; Canadian Psychological Association, 2001, PUTT HUM BEHA HEART; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Carty J, 2006, J AFFECT DISORDERS, V90, P257, DOI 10.1016/j.jad.2005.11.011; Caudill M, 2002, MANAGING PAIN IT MAN; Cepoiu M, 2008, J GEN INTERN MED, V23, P25, DOI 10.1007/s11606-007-0428-5; Chan AOM, 2003, J CLIN PSYCHIAT, V64, P175, DOI 10.4088/JCP.v64n0210; Chapman SL, 2000, CLIN J PAIN, V16, P169, DOI 10.1097/00002508-200006000-00011; Chiles JA, 1999, CLIN PSYCHOL-SCI PR, V6, P204, DOI 10.1093/clipsy/6.2.204; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Chou R, 2009, SPINE, V34, P1078, DOI 10.1097/BRS.0b013e3181a103b1; Cohen JA, 2007, J AM ACAD CHILD PSY, V46, P811, DOI 10.1097/chi.0b013e3180547105; Courtois CA, 2004, PSYCHOTHERAPY, V41, P412, DOI 10.1037/0033-3204.41.4.412; Creamer M, 2004, BEHAV RES THER, V42, P315, DOI 10.1016/S0005-7967(03)00141-4; Deykin EY, 2001, PSYCHOSOM MED, V63, P835, DOI 10.1097/00006842-200109000-00018; Dobson KS, 2008, J CONSULT CLIN PSYCH, V76, P468, DOI 10.1037/0022-006X.76.3.468; Druss BG, 2000, AM J PSYCHIAT, V157, P1274, DOI 10.1176/appi.ajp.157.8.1274; Duckworth M. P, 2008, MOTOR VEHICLE COLLIS; Ehlers A, 2003, ARCH GEN PSYCHIAT, V60, P1024, DOI 10.1001/archpsyc.60.10.1024; Ehlers A, 1998, J ABNORM PSYCHOL, V107, P508, DOI 10.1037/0021-843X.107.3.508; Family Caregiver Alliance, 2010, FACT SHEET PUBL TRAU; Fecteau G., 1999, BEHAV COGN PSYCHOTHE, V27, P201; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; FLOR H, 1992, PAIN, V49, P221, DOI 10.1016/0304-3959(92)90145-2; Foa EB, 1997, ANNU REV PSYCHOL, V48, P449, DOI 10.1146/annurev.psych.48.1.449; FOA EB, 1991, J CONSULT CLIN PSYCH, V59, P715, DOI 10.1037/0022-006X.59.5.715; Freebury R., 1998, STANDARDS GUIDELINES; Gardea M A, 2000, Curr Rev Pain, V4, P18; Geisser ME, 1996, PAIN, V66, P207, DOI 10.1016/0304-3959(96)03038-2; Gillies L. A., 2002, CLIN HDB PSYCHOL DIS; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Golden GA, 1997, CAN FAM PHYSICIAN, V43, P1098; Goossens MEJB, 1997, J OCCUP REHABIL, V7, P15, DOI 10.1007/BF02765873; Gould RA, 1995, CLIN PSYCHOL REV, V15, P819, DOI 10.1016/0272-7358(95)00048-8; GREEN MM, 1993, MED J AUSTRALIA, V159, P529, DOI 10.5694/j.1326-5377.1993.tb138006.x; Greenberger D., 1995, MIND OVER MOOD; Grunfeld T., 2003, 37 ANN CONV ASS ADV; Hart Robert P, 2003, Curr Pain Headache Rep, V7, P116, DOI 10.1007/s11916-003-0021-5; Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358; Harvey AG, 1999, J CONSULT CLIN PSYCH, V67, P985, DOI 10.1037/0022-006X.67.6.985; Harvey AG, 1998, J CONSULT CLIN PSYCH, V66, P507, DOI 10.1037/0022-006X.66.3.507; Harvey AG, 1998, J NERV MENT DIS, V186, P333, DOI 10.1097/00005053-199806000-00002; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Harvey AG, 1999, J TRAUMA STRESS, V12, P519, DOI 10.1023/A:1024723205259; Health Canada, 2009, ENV SCAN WORKPL HLTH; Hickling E. J., 2008, MOTOR VEHICLE COLLIS; Hickling E. J., 2006, OVERCOMING TRAUMA YO; HICKLING EJ, 1992, J ANXIETY DISORD, V6, P285, DOI 10.1016/0887-6185(92)90040-E; Holbrook TL, 1998, J TRAUMA, V45, P315, DOI 10.1097/00005373-199808000-00018; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Hollon SD, 2005, ARCH GEN PSYCHIAT, V62, P417, DOI 10.1001/archpsyc.62.4.417; Hunsley J, 2003, CAN PSYCHOL, V44, P61, DOI 10.1037/h0085818; Iezzi T., 2008, MOTOR VEHICLE COLLIS; International Testing Commission, 2000, INT GUID TEST US; Iverson G. L., 2008, MOTOR VEHICLE COLLIS; JACOBS DF, 1988, PSYCHOTHER, V25, P377, DOI 10.1037/h0085359; JACOBS DF, 1987, J CLIN PSYCHOL, V43, P729, DOI 10.1002/1097-4679(198711)43:6<729::AID-JCLP2270430615>3.0.CO;2-Z; Jenewein J, 2009, J PSYCHOSOM RES, V66, P119, DOI 10.1016/j.jpsychores.2008.07.011; Johansson C, 1998, BEHAV RES THER, V36, P915, DOI 10.1016/S0005-7967(98)00079-5; Jurisic B, 2009, CRISIS, V30, P34, DOI 10.1027/0227-5910.30.1.34; Karjalainen K, 2003, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD002193; Karjalainen KA, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002194, DOI 10.1002/14651858.CD002194]; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Lechnyr R, 1993, EAP DIGEST, V22; Lechnyr R., 1992, J OREGON PSYCHOL ASS, V38, P8; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Libon DJ, 2010, J INT NEUROPSYCH SOC, V16, P566, DOI 10.1017/S1355617710000214; Lowenstein L., 2001, POLICE J, V74, P9; Maercker A., 2006, BMC PSYCHIATRY, V6, P495; Maes M, 2000, EUR ARCH PSY CLIN N, V250, P156, DOI 10.1007/s004060070034; Marks I, 1998, ARCH GEN PSYCHIAT, V55, P317, DOI 10.1001/archpsyc.55.4.317; Mayou R, 1997, PSYCHOSOM MED, V59, P578, DOI 10.1097/00006842-199711000-00004; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; Mayou R, 2001, BRIT J PSYCHIAT, V179, P528, DOI 10.1192/bjp.179.6.528; Mayou R, 2001, AM J PSYCHIAT, V158, P1231, DOI 10.1176/appi.ajp.158.8.1231; Mayou RA, 2002, BEHAV RES THER, V40, P665, DOI 10.1016/S0005-7967(01)00069-9; McNally Richard J, 2003, Psychol Sci Public Interest, V4, P45, DOI 10.1111/1529-1006.01421; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; Nicholson K, 2000, NEUROREHABILITATION, V14, P95; NORRIS FH, 1992, J CONSULT CLIN PSYCH, V60, P409, DOI 10.1037/0022-006X.60.3.409; O'Donnell ML, 2008, J CONSULT CLIN PSYCH, V76, P923, DOI 10.1037/a0012918; Ontario Neurotrauma Foundation, 2010, ABI DAT PIL PROJ; Ontario Psychological Association, 1990, ONT PSYCH ASS OPA GU; Ontario Psychological Association, 2001, PSYCH ASS TREATM GUI; Ontario Psychological Association Auto Task Force, 2005, OPA GUID ASS TREATM; Ontario Psychological Association Auto Task Force, 2005, COMP DOC OPA GUID AS; Organisation for Economic Co-operation and Development, 2009, OECH HLTH DAT 2009 S; Parikh SV, 2009, J AFFECT DISORDERS, V117, pS15, DOI 10.1016/j.jad.2009.06.042; Patten SB, 2009, J AFFECT DISORDERS, V117, pS5, DOI 10.1016/j.jad.2009.06.044; Pepping M., 2003, CLIN NEUROPSYCHOLOGY; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Quebec, 2001, REG ASS MED EQ VIABL; RESICK PA, 1988, BEHAV THER, V19, P385, DOI 10.1016/S0005-7894(88)80011-X; RESICK PA, 2001, CLIN HDB PSYCHOL DIS; Romanow RJ, 2003, CAN PSYCHOL, V44, P283, DOI 10.1037/h0086954; ROTHBAUM BO, 1992, J TRAUMA STRESS, V5, P455, DOI 10.1007/BF00977239; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; SACCO WP, 1995, HDB DEPRESSION; Schillaci J, 2009, PROF PSYCHOL-RES PR, V40, P39, DOI 10.1037/a0013910; Schmitz N, 2007, PSYCHOSOM MED, V69, P332, DOI 10.1097/PSY.0b013e31804259e0; Schnurr PP, 2000, J NERV MENT DIS, V188, P496, DOI 10.1097/00005053-200008000-00004; Seabury S. A., 2004, WORKING PAPER DATA A; Shalev AY, 2002, BIOL PSYCHIAT, V51, P532, DOI 10.1016/S0006-3223(02)01335-5; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Sharp TJ, 2001, CLIN PSYCHOL REV, V21, P857, DOI 10.1016/S0272-7358(00)00071-4; Simon EP, 2000, MIL MED, V165, P954, DOI 10.1093/milmed/165.12.954; Simpson JSA, 2001, CANCER PRACT, V9, P19, DOI 10.1046/j.1523-5394.2001.91005.x; Slater MA, 1997, PAIN, V71, P257, DOI 10.1016/S0304-3959(97)03374-5; Soo C, 2007, COCHRANE DB SYST REV, V3; Stephens T, 2001, Chronic Dis Can, V22, P18; Sterling M, 2003, PAIN, V104, P509, DOI 10.1016/S0304-3959(03)00078-2; Taylor S, 2001, J CONSULT CLIN PSYCH, V69, P541, DOI 10.1037//0022-006X.69.3.541; Taylor S., 1999, INT HDB ROAD TRAFFIC; The AGREE Collaboration, 2001, APPR GUID RES EV AGR; TURNER JA, 1993, PAIN, V52, P169, DOI 10.1016/0304-3959(93)90128-C; van der Kolk BA, 2005, J TRAUMA STRESS, V18, P389, DOI 10.1002/jts.20047; Walker EA, 2003, ARCH GEN PSYCHIAT, V60, P369, DOI 10.1001/archpsyc.60.4.369; Wallis BJ, 1997, PAIN, V73, P15, DOI 10.1016/S0304-3959(97)00060-2; WHO, 2004, WORLD REPORT ROAD TR; [No title captured]	158	3	3	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	MAY	2011	4	2	2		SI		89	126		10.1007/s12207-011-9103-6			38	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	VB4ED	WOS:000415464400001					2022-02-06	
J	Ha, SN; Callahan, JD; Cohen-Gadol, AA				Ha Son Nguyen; Callahan, James D.; Cohen-Gadol, Aaron A.			Life-saving decompressive craniectomy for diffuse cerebral edema during an episode of new-onset diabetic ketoacidosis	CHILDS NERVOUS SYSTEM			English	Article						Cerebral edema; Diabetic ketoacidosis; Craniectomy	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; REFRACTORY INTRACRANIAL HYPERTENSION; SURGICAL DECOMPRESSION; RISK-FACTORS; SUBARACHNOID HEMORRHAGE; HERPETIC ENCEPHALITIS; BIFRONTAL CRANIECTOMY; ARGININE-VASOPRESSIN; AGGRESSIVE TREATMENT	Diabetic ketoacidosis (DKA), a well-known complication of diabetes mellitus, is associated with severe diffuse cerebral edema leading to brain herniation and death. Survival from an episode of symptomatic cerebral edema has been associated with debilitating neurological sequelae, including motor deficits, visual impairment, memory loss, seizures, and persistent vegetative states. A review of the literature reveals scant information regarding the potential surgical options for these cases. The authors present their case in which they used a craniectomy to treat this life-threatening condition. After reportedly suffering nausea and vomiting, a 12-year-old male presented to the emergency room with lethargy and was diagnosed with acute DKA. After appropriate treatment, the patient became comatose. A CT scan revealed diffuse cerebral edema. To decrease intracranial pressure and prevent further progression of brain herniation, a bifrontal decompressive craniectomy with duraplasty was performed. The patient's neurological function gradually improved, and he returned to school and his regular activities with only minimal cognitive deficits. Given the high mortality and morbidity associated with DKA-related edema, we believe decompressive craniectomy should be considered for malignant cerebral edema and herniation syndrome.	[Ha Son Nguyen; Callahan, James D.; Cohen-Gadol, Aaron A.] Goodman Campbell Brain & Spine, Clarian Neurosci, Indianapolis, IN USA; [Ha Son Nguyen; Callahan, James D.; Cohen-Gadol, Aaron A.] Indiana Univ, Dept Neurol Surg, Indianapolis, IN 46204 USA		Cohen-Gadol, AA (corresponding author), Goodman Campbell Brain & Spine, Clarian Neurosci, 1801 N Senate Blvd 610, Indianapolis, IN USA.	acohenmd@gmail.com		Cohen-Gadol, Aaron/0000-0002-4946-1524; Nguyen, Ha/0000-0002-3515-278X			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Adamo MA, 2008, J NEUROSURG, V108, P174, DOI 10.3171/JNS/2008/108/01/0174; Adamo MA, 2009, J NEUROSURG-PEDIATR, V3, P334, DOI 10.3171/2008.12.PEDS08310; Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; BW TA, 2001, CHILD NERV SYST, V3, P154; Cagavi F, 2005, ANGIOLOGY, V56, P107, DOI 10.1177/000331970505600116; Chibbaro S, 2007, SURG NEUROL, V68, P632, DOI 10.1016/j.surneu.2006.12.046; De Luca GP, 2000, ACTA NEUROCHIR SUPPL, V76, P401; Di Rienzo A, 2008, ACTA NEUROCHIR, V150, P1057, DOI 10.1007/s00701-008-0019-1; Dillon ES, 1936, AM J MED SCI, V192, P360, DOI 10.1097/00000441-193609000-00007; Doerfler A, 2001, STROKE, V32, P813, DOI 10.1161/01.STR.32.3.813; DUCK SC, 1988, J PEDIATR-US, V113, P10, DOI 10.1016/S0022-3476(88)80521-3; Dunger DB, 2004, PEDIATRICS, V113, P133; Edge JA, 2000, DIABETES-METAB RES, V16, P316, DOI 10.1002/1520-7560(2000)9999:9999<::AID-DMRR143>3.0.CO;2-R; Edge JA, 2001, ARCH DIS CHILD, V85, P16, DOI 10.1136/adc.85.1.16; Eskandar EN, 1997, NEUROSURGERY, V40, P836, DOI 10.1097/00006123-199704000-00035; Figaji AA, 2006, SAMJ S AFR MED J, V96, P969; Figaji AA, 2008, ACTA NEUROCHIR SUPPL, V102, P77, DOI 10.1007/978-3-211-85578-2_15; FISHER CM, 1994, SURG NEUROL, V41, P65, DOI 10.1016/0090-3019(94)90210-0; Glaser N, 2001, NEW ENGL J MED, V344, P264, DOI 10.1056/NEJM200101253440404; Glaser N, 2009, PEDIATR DIABETES, V10, P534, DOI 10.1111/j.1399-5448.2009.00511.x; Glaser NS, 2004, J PEDIATR-US, V145, P164, DOI 10.1016/j.jpeds.2004.03.045; Guresir E, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0954; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hieu PD, 1996, CHILD NERV SYST, V12, P270; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Jabbar A, 2004, DIABETIC MED, V21, P920, DOI 10.1111/j.1464-5491.2004.01249.x; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Keller E, 2005, ACTA NEUROCHIR SUPPL, V94, P177; Kilincer C, 2005, CLIN NEUROL NEUROSUR, V107, P412, DOI 10.1016/j.clineuro.2004.09.018; Kilincer C, 2005, ACTA NEUROCHIR, V147, P587, DOI 10.1007/s00701-005-0493-7; Kilincer C, 2010, ACTA NEUROCHIR, V152, P557, DOI 10.1007/s00701-009-0476-1; Koh MS, 2000, SURG NEUROL, V53, P225, DOI 10.1016/S0090-3019(00)00163-4; KONDZIOLKA D, 1988, NEUROSURGERY, V23, P143, DOI 10.1227/00006123-198808000-00002; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Koul PB, 2009, CLIN PEDIATR, V48, P135, DOI 10.1177/0009922808323907; Lam TI, 2009, AM J PHYSIOL-CELL PH, V297, pC278, DOI 10.1152/ajpcell.00093.2009; Lam TL, 2005, DIABETES, V54, P510, DOI 10.2337/diabetes.54.2.510; Lanterna LA, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0910; Lawrence SE, 2005, J PEDIATR-US, V146, P688, DOI 10.1016/j.jpeds.2004.12.041; Lemcke J, 2010, ACTA NEUROCHIR SUPPL, V106, P231, DOI 10.1007/978-3-211-98811-4_43; Levin DL, 2008, PEDIATR CRIT CARE ME, V9, P320, DOI 10.1097/PCC.0b013e31816c7082; Lindegaard Karl-Fredrik, 2008, Tidsskr Nor Laegeforen, V128, P303; Madikians A, 2009, CURR TREAT OPTION NE, V11, P393, DOI 10.1007/s11940-009-0044-2; Mahoney CP, 1999, PEDIATR NEUROL, V21, P721, DOI 10.1016/S0887-8994(99)00079-X; Manley GT, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS.JUNE09.INTRO; Marcin James P, 2005, Pediatr Crit Care Med, V6, P489, DOI 10.1097/01.PCC.0000164636.58381.8F; Marcin JP, 2002, J PEDIATR-US, V141, P793, DOI 10.1067/mpd.2002.128888; Marinkovic I, 2009, NEUROSURGERY, V65, P780, DOI 10.1227/01.NEU.0000351775.30702.A9; Masuhr F, 2008, Front Neurol Neurosci, V23, P132; MC DM, 1955, AM J PHYSIOL, V180, P545; Meier U, 2005, ACT NEUR S, V95, P55; Meier U, 2008, ACTA NEUROCHIR SUPPL, V102, P29, DOI 10.1007/978-3-211-85578-2_6; Meier U, 2000, ACTA NEUROCHIR SUPPL, V76, P475; Mellado P, 2003, REV MED CHILE, V131, P1434; Muir AB, 2004, DIABETES CARE, V27, P1541, DOI 10.2337/diacare.27.7.1541; Nobre MC, 2007, ARQ NEURO-PSIQUIAT, V65, P107, DOI 10.1590/S0004-282X2007000100022; O'Donnell ME, 2005, AM J PHYSIOL-CELL PH, V289, pC283, DOI 10.1152/ajpcell.00001.2005; Pasantes-Morales H, 2010, NEUROSCIENCE, V168, P871, DOI 10.1016/j.neuroscience.2009.11.074; Pedersen SF, 2006, AM J PHYSIOL-REG I, V291, pR1, DOI 10.1152/ajpregu.00782.2005; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Rabelino GAG, 2008, PEDIATR NEUROL, V39, P201, DOI 10.1016/j.pediatrneurol.2008.06.006; Raffelsieper B, 2002, ANASTH INTENSIV NOTF, V37, P157, DOI 10.1055/s-2002-21800; Reddy AK, 2002, NEUROL INDIA S, V50, pS66; ROSENBLOOM AL, 1990, DIABETES CARE, V13, P22, DOI 10.2337/diacare.13.1.22; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sapru A, 2005, J PEDIATR ENDOCR MET, V18, P865; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; SCHWAB S, 1995, NERVENARZT, V66, P430; Schwab S, 1997, NEUROLOGY, V48, P412, DOI 10.1212/WNL.48.2.412; Scozzafava J, 2007, NEUROCRIT CARE, V6, P49, DOI 10.1385/NCC:6:1:49; SHEFFER Z, 1991, J CARDIOVASC PHARM, V18, P878, DOI 10.1097/00005344-199112000-00014; Sherry Nicole A, 2008, Paediatr Drugs, V10, P209; Shrier DA, 1999, AM J NEURORADIOL, V20, P1885; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; STRANGE K, 1992, J AM SOC NEPHROL, V3, P12; STRANGE K, 1992, AM J PHYSIOL, V263, pC412, DOI 10.1152/ajpcell.1992.263.2.C412; Taferner E, 2001, INTENS CARE MED, V27, P1426, DOI 10.1007/s001340101027; Tasker Robert C, 2005, Pediatr Crit Care Med, V6, P405, DOI 10.1097/01.PCC.0000164343.20418.37; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; VENES JL, 1975, J NEUROSURG, V42, P429, DOI 10.3171/jns.1975.42.4.0429; Weber J, 2004, ZBL NEUROCHIR, V65, P135, DOI 10.1055/s-2004-816239; WOOD E G, 1990, Pediatric Emergency Care, V6, P285, DOI 10.1097/00006565-199012000-00009; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yao Y, 2007, ACTA NEUROCHIR, V149, P1219, DOI 10.1007/s00701-007-1415-7; Yatsushige H, 2010, ACTA NEUROCHIR SUPPL, V106, P265, DOI 10.1007/978-3-211-98811-4_50; Yildizdas D, 2006, INDIAN PEDIATR, V43, P771	91	3	3	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	APR	2011	27	4					657	664		10.1007/s00381-010-1285-9			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	733II	WOS:000288256000018					2022-02-06	
J	Lubillo, S; Blanco, J; Lopez, P; Dominguez, J; Ruiz, C; Molina, I; Morera, J				Lubillo, S.; Blanco, J.; Lopez, P.; Dominguez, J.; Ruiz, C.; Molina, I.; Morera, J.			Does decompressive craniectomy improve other parameters besides ICP? Effects of the decompressive craniectomy on tissular pressure?	MEDICINA INTENSIVA			Spanish	Article						Decompressive; Craniectomy; Intracraneal hypertension; Brain tissue oxygen pressure	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; HIGH INTRACRANIAL-PRESSURE; THERAPEUTIC HYPOTHERMIA; CEREBRAL OXYGENATION; HYPERTENSION; MANAGEMENT; EDEMA; HEMICRANIECTOMY; PROTOCOL	Second level therapeutic maneuvres for controlling intracranial hypertension (ICH) proposed by the European Brain Injury Consortium and the American Association of Neurological Surgeons include barbiturates, moderate hypothermia and more recently the decompressive craniectomy (DC),In most patients, ICP can be maintained below 25 mmHg after a DC. However, the exact effect of DC on brain oxygenation (PtiO2) still unclear. From our point of view the ptIo2 monitoring with the probe located in the healthy area of the most severely damaged cerebral hemisphere is not only a important tool for timing craniectomy in the future but also for evaluating the therapeutic effectivity of DC. (C) 2010 Elsevier Espana, S.L. and SEMICYUC. All rights reserved.	[Lubillo, S.; Lopez, P.; Ruiz, C.; Molina, I.] Hosp Univ Nuestra Senora de Candelaria, Unidad Med Intens, San Cristobal la Laguna, Spain; [Blanco, J.] Hosp Univ Dr Negrin, Unidad Med Intens, Gran Canaria, Spain; [Dominguez, J.] Hosp Univ Nuestra Senora Candelaria, Serv Neurocirugia, San Cristobal la Laguna, Spain; [Morera, J.] Hosp Univ Dr Negrin, Serv Neurocirugia, Gran Canaria, Spain		Lubillo, S (corresponding author), Hosp Univ Nuestra Senora de Candelaria, Unidad Med Intens, San Cristobal la Laguna, Spain.	lubimon@gmail.com	Concepcion, Ruiz/L-2808-2014	Concepcion, Ruiz/0000-0003-4332-6812			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Boret H, 2006, ACTA ANAESTH SCAND, V50, P252, DOI 10.1111/j.1399-6576.2005.00862.x; Bratton S L, 2007, J NEUROTRAUMA S1, V24, pS71, DOI DOI 10.1089/NEU.2007.9985; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Cooper P R, 1976, Surg Neurol, V5, P25; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; De Luca GP, 2000, ACTA NEUROCHIR SUPPL, V76, P401; GAAB MR, 1990, ACT NEUR S, V51, P326; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Jaeger M, 2005, ACT NEUR S, V95, P117; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; Lubillo S, 2009, MED INTENSIVA, V33, P74, DOI 10.1016/S0210-5691(09)70685-0; LUBILLO S, 2004, MED INTENSIVA S1, V28, P1; LUBILLO S, 1983, MED INTENSIVA, V7, P33; LUBILLO S, 2006, PACIENTE NEUROCRITIC, P57; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MARMAROU A, 1991, J NEUROSURG, V75, pS21, DOI 10.3171/sup.1991.75.1s.0s21; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Meier U, 2006, ACTA NEUROCHIR SUPPL, V96, P373; Miller J D, 1993, Acta Neurochir Suppl (Wien), V57, P152; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; RANSOHOFF J, 1971, J NEUROSURG, V34, P70, DOI 10.3171/jns.1971.34.1.0070; Reithmeier T, 2005, ACTA NEUROCHIR, V147, P947, DOI 10.1007/s00701-005-0543-1; ROBERTS I, 2000, COCHRANE DB SYST REV, V2; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sahuquillo J, 2002, NEUROCIRUGIA, V13, P78; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; YAMAKAMI I, 1993, NEUROL MED CHIR TOKI, V33, P13; Yoshida K, 1996, J NEUROL NEUROSUR PS, V61, P166, DOI 10.1136/jnnp.61.2.166	37	3	3	1	3	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	0210-5691	1578-6749		MED INTENSIVA	Med. Intensiv.	APR	2011	35	3					166	169		10.1016/j.medin.2010.09.011			4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751JD	WOS:000289612400005	21208690				2022-02-06	
J	Baranovic, S; Lubina, IZ; Nikolic, T; Maldini, B				Baranovic, Senka; Lubina, Ivan Zvonimir; Nikolic, Tatjana; Maldini, Branka			Successful Use of Recombinant Factor VIIa in Traumatic Liver Injury - A Case Report	COLLEGIUM ANTROPOLOGICUM			English	Article						recombinant FVIIa; polytrauma; liver; coagulopathy; hemorrhage; hemostasis	ACTIVATED FACTOR-VII; HEMORRHAGE; COAGULOPATHY; TRANSFUSION; EXPERIENCE; MANAGEMENT; SURGERY; PATIENT; RFVIIA	The paper describe the use of rFVIIa in the management of massive bleeding in a patient with polytrauma involving liver injury. An 18-year-old girl with severe polytrauma sustained during a bus car collision. She had multiple musculoskeletal injuries, severe concussion of the liver with amputation of the left liver lobe, disruption of the left hepatic vein from the inferior vena cava, and impaired hemostasis. Acute bleeding (> 5 L) was not improved by conservative methods and a single dose of rFVIIa 90 mu g/kg was administered. Infusion of rFVIIa resulted in an immediate clinical effect with rapid improvements in blood laboratory measurements and coagulation parameters. rFVIIa should be considered as an adjunctive treatment for the control of hemorrhage in severely injured patients with uncontrolled bleeding and impaired hemostasis.	[Baranovic, Senka] Univ Zagreb, Univ Hosp Traumatol, Dept Anesthesiol, Zagreb 10000, Croatia; [Baranovic, Senka] Univ Zagreb, Univ Hosp Traumatol, Intens Care Unit, Zagreb 10000, Croatia; [Lubina, Ivan Zvonimir] Univ Zagreb, Univ Hosp Traumatol, Dept Radiol, Zagreb 10000, Croatia; [Nikolic, Tatjana] Univ Zagreb, Univ Hosp Traumatol, Dept Phys Med & Rehabil, Zagreb 10000, Croatia; [Maldini, Branka] Univ Zagreb, Sveti Duh Univ Hosp, Dept Anesthesiol, Zagreb 10000, Croatia; [Maldini, Branka] Univ Zagreb, Sveti Duh Univ Hosp, Intens Care Unit, Zagreb 10000, Croatia		Baranovic, S (corresponding author), Univ Zagreb, Univ Hosp Traumatol, Dept Anesthesiol, Draskoviceva 19, Zagreb 10000, Croatia.	senka.baranovic1@zg.t-com.hr					Aggarwal A, 2001, BLOOD, V98, p66B; Armand R, 2003, TRANSFUS MED REV, V17, P223, DOI 10.1016/S0887-7963(03)00022-1; BECTON D, 2001, BLOOD, V98, P11; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Chiu J, 2002, CURR OPIN HEMATOL, V9, P544, DOI 10.1097/00062752-200211000-00014; Colombo Fabio, 2005, Chir Ital, V57, P695; Duane TM, 2004, J TRAUMA, V57, P494, DOI 10.1097/01.TA.0000141026.20937.81; Dutton RP, 2004, J TRAUMA, V57, P709, DOI 10.1097/01.TA.0000140646.66852.AB; Dutton RP, 2003, J CLIN ANESTH, V15, P184, DOI 10.1016/S0952-8180(03)00034-5; Erhardtsen E, 2002, INTENS CARE MED, V28, pS248, DOI 10.1007/s00134-002-1472-6; Gabriel DA, 2004, J THROMB HAEMOST, V2, P1816, DOI 10.1111/j.1538-7836.2004.01015.x; Gao Jinmou, 2002, Chin J Traumatol, V5, P346; Gao JM, 2003, WORLD J SURG, V27, P703, DOI 10.1007/s00268-003-6573-z; Girgin Sadullah, 2006, Ulus Travma Acil Cerrahi Derg, V12, P35; Gowers CJD, 2005, ANAESTH INTENS CARE, V33, P196, DOI 10.1177/0310057X0503300207; Grounds M, 2003, BLOOD REV, V17, pS11, DOI 10.1016/S0268-960X(03)90002-6; Gur S, 2003, HEPATO-GASTROENTEROL, V50, P2109; Hardy JF, 2002, CAN J ANAESTH, V49, pS4; Hoyt DB, 2004, SEMIN HEMATOL, V41, P40, DOI 10.1053/j.seminhematol.2003.11.009; Kamphusien PW, 2002, AM J MED, V112, P332, DOI 10.1016/S0002-9343(01)01116-0; Kenet G, 1999, LANCET, V354, P1879, DOI 10.1016/S0140-6736(99)05155-7; Kulkarni R, 2004, J TRAUMA, V56, P1348, DOI 10.1097/01.TA.0000033142.35804.01; Martinowitz U, 2002, CAN J ANAESTH, V49, pS15; Martinowitz U, 2001, J TRAUMA, V51, P431, DOI 10.1097/00005373-200109000-00002; O'Neill PA, 2002, J TRAUMA, V52, P400, DOI 10.1097/00005373-200202000-00034; Pepe PE, 2003, BRIT MED J, V327, P1119, DOI 10.1136/bmj.327.7424.1119; Siegel LJ, 2004, ANESTHESIOLOGY, V100, P441, DOI 10.1097/00000542-200402000-00037; Silva MA, 2004, SEMIN HEMATOL, V41, P132, DOI 10.1053/j.seminhematol.2003.11.022; Spahn DR, 2005, BRIT J ANAESTH, V95, P130, DOI 10.1093/bja/aei169; Stein Deborah M, 2004, Curr Opin Crit Care, V10, P520, DOI 10.1097/01.ccx.0000144770.96342.65	30	3	3	0	1	COLLEGIUM ANTROPOLOGICUM	ZAGREB	INST ANTHROPOLOGICAL RESEARCH, GAJEVA 32, PO BOX 290, HR-10000 ZAGREB, CROATIA	0350-6134			COLLEGIUM ANTROPOL	Coll. Anthropol.	MAR	2011	35	1					193	196					4	Anthropology	Social Science Citation Index (SSCI)	Anthropology	755HX	WOS:000289920800034	21661370				2022-02-06	
J	Kreipke, CW; Reynolds, CA; Schafer, PC; Schafer, S; Pirooz, R; Rafols, JA				Kreipke, Christian W.; Reynolds, Christian A.; Schafer, Patrick C.; Schafer, Steven; Pirooz, Ryan; Rafols, Jose A.			Endothelin receptors A and B are expressed in distinct cellular compartments of rat hippocampus following global ischemia: an immunocytochemical study	NEUROLOGICAL RESEARCH			English	Article						Ischemia; Glia; Neurovascular unit	MATRIX METALLOPROTEINASES; BRAIN; MODEL; INVOLVEMENT; ANTAGONIST; ASTROCYTES; OCCLUSION; CALCIUM; NEURONS; INJURY	Objectives: The syntheses of endothelin receptors A and B were previously shown to be upregulated in rat dorsal hippocampus after traumatic brain injury. Here we characterize endothelin receptor A and endothelin receptor B cellular distribution in hippocampus after permanent global brain ischemia and their possible association to nerve cell injury. Methods: Twenty-minute global ischemia was induced using the Pulsinelli's four-vessel occlusion in conjunction with systemic hypovolemia in male rats. Endothelin receptor A and endothelin receptor B immunoreactivities from sham-operated and ischemic rats were assessed qualitatively in dentate gyrus, Cornu Ammonis, and hilus regions of the hippocampus. Quantitative immunoreactivity measurements were also obtained by optical densitometry. Results: In sham-operated control hippocampus, endothelin receptor A immunoreactivity was absent in nerve cell bodies but strongly expressed in the mossy fiber pathway (axons of dentate gyrus granule cells). After ischemia endothelin receptor A immunoreactivity in the same regions was reduced by 40-50% from control. In contrast, endothelin receptor B immunoreactivity in control hippocampus was widely distributed in pyramidal neurons, granule cells and glial cells, this immunoreactivity increasing by approximately 25-30% after ischemia. Discussion: Endothelin receptor A's marked decrease in mossy fibers after ischemia may contribute to glutamate release from mossy fiber terminals, thus enhancing excitotoxic effects on their Cornu Ammonis synaptic targets. Additionally, endothelin receptor B increased expression in neurons and glia could be related to a more generalized activation of survival mechanisms involving elements of the neurovascular unit.	[Kreipke, Christian W.; Reynolds, Christian A.; Schafer, Patrick C.; Schafer, Steven; Pirooz, Ryan; Rafols, Jose A.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA		Rafols, JA (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 E Canfield Ave, Detroit, MI 48201 USA.	jrafols@med.wayne.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS39860, NS064976]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS064976, R01NS039860] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health Grants NS39860 (JAR) and NS064976 (CWK). A partial report of these findings was presented at the ET-10 Conference in Bergamo, Italy.	ABE K, 1995, STROKE, V26, P1478, DOI 10.1161/01.STR.26.8.1478; Adibhatla RM, 2006, FREE RADICAL BIO MED, V40, P376, DOI 10.1016/j.freeradbiomed.2005.08.044; Armstead WM, 1996, J NEUROSURG, V85, P901, DOI 10.3171/jns.1996.85.5.0901; Bazan NG, 2005, MOL NEUROBIOL, V32, P89, DOI 10.1385/MN:32:1:089; Caragine LP, 1998, BRAIN RES, V793, P255, DOI 10.1016/S0006-8993(98)00182-6; Chan PH, 2004, NEUROCHEM RES, V29, P1943, DOI 10.1007/s11064-004-6869-x; Danielyan L, 2005, EUR J CELL BIOL, V84, P907, DOI 10.1016/j.ejcb.2005.07.001; DeGracia DJ, 2004, J NEUROSCI RES, V77, P771, DOI 10.1002/jnr.20225; DeGracia DJ, 2007, J CEREBR BLOOD F MET, V27, P875, DOI 10.1038/sj.jcbfm.9600388; FEUERSTEIN G, 1994, PEPTIDES, V15, P467, DOI 10.1016/0196-9781(94)90207-0; FUXE K, 1992, EXP BRAIN RES, V88, P131, DOI 10.1007/BF02259134; Gasche Y, 2006, FRONT BIOSCI-LANDMRK, V11, P1289, DOI 10.2741/1883; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; HORI S, 1992, ENDOCRINOLOGY, V130, P1885, DOI 10.1210/en.130.4.1885; Hoyte L, 2004, CURR MOL MED, V4, P131, DOI 10.2174/1566524043479248; Kallakuri S, 2007, NEUROL RES, V29, P362, DOI 10.1179/016164107X204675; Koyama Y, 1999, GLIA, V26, P268, DOI 10.1002/(SICI)1098-1136(199905)26:3<268::AID-GLIA8>3.0.CO;2-G; Kreipke CW, 2006, MICROVASC RES, V71, P197, DOI 10.1016/j.mvr.2006.02.002; LAMPL Y, 1997, STROKE, V29, P1257; Lee KS, 1997, ANN NY ACAD SCI, V825, P95, DOI 10.1111/j.1749-6632.1997.tb48419.x; Matsuo Y, 2001, STROKE, V32, P2143, DOI 10.1161/hs0901.94259; MCKENZIE AL, 1995, J NEUROTRAUM, V12, P257, DOI 10.1089/neu.1995.12.257; MCNAMARA JO, 1994, J NEUROSCI, V14, P3413; Mori K, 2001, BEHAV BRAIN RES, V120, P159, DOI 10.1016/S0166-4328(00)00371-5; PETITO CK, 1987, NEUROLOGY, V37, P1281, DOI 10.1212/WNL.37.8.1281; Petrov T, 2002, NEUROSCIENCE, V115, P275, DOI 10.1016/S0306-4522(02)00345-7; PULSINELLI WA, 1983, J NEUROCHEM, V40, P1500, DOI 10.1111/j.1471-4159.1983.tb13599.x; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Rogers SD, 2003, GLIA, V41, P180, DOI 10.1002/glia.10173; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Samdani AF, 1997, STROKE, V28, P1283, DOI 10.1161/01.STR.28.6.1283; SLOVITER RS, 1994, ANN NEUROL, V35, P640, DOI 10.1002/ana.410350604; Starkov AA, 2004, CELL CALCIUM, V36, P257, DOI 10.1016/j.ceca.2004.02.012; TSUBOKAWA H, 1995, NEUROSCI LETT, V191, P95, DOI 10.1016/0304-3940(95)11569-4; Wieloch T, 1996, ADV NEUROL, V71, P371; Williams PA, 2004, EPILEPSIA, V45, P1210, DOI 10.1111/j.0013-9580.2004.60403.x; Zheng Z, 2004, NEUROL RES, V26, P884, DOI 10.1179/016164104X2357	38	3	3	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAR	2011	33	2					162	168		10.1179/016164111X12881719352291			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	723OM	WOS:000287516600007	21801590				2022-02-06	
J	Reynolds, CA; Kallakuri, S; Bagchi, M; Schafer, S; Kreipke, CW; Rafols, JA				Reynolds, Christian A.; Kallakuri, Srinivasu; Bagchi, Mihir; Schafer, Steven; Kreipke, Christian W.; Rafols, Jose A.			Endothelin receptor A antagonism reduces the extent of diffuse axonal injury in a rodent model of traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						Diffuse axonal injury; Endothelin-1; Endothelin receptor A antagonism	AMYLOID PRECURSOR PROTEIN; HEAD-INJURY; BETA-APP; HYPOPERFUSION; SYSTEM; BQ-123; DAMAGE	Objectives: While endothelin-1 and its receptors have traditionally been associated with mediating vasoreactivity, we have recently shown that the vast majority of endothelin receptor A expression following traumatic brain injury is localized within the neuron. While it has been suggested that endothelin receptor A plays a role in influencing neuronal integrity, the significance of neuronally expressed endothelin receptor A remains unclear. One report suggests that endothelin-1 signaling mediates diffuse axonal injury. Therefore, this work sought to determine whether treatment with BQ-123, a selective endothelin receptor A antagonist, diminishes the extent of diffuse axonal injury following trauma. Methods: A total of 12 male Sprague-Dawley rats (350-400 g) were used in this study. Two groups (n=6 per group) were generated as follows: sham operation and traumatic brain injury+1.0 mg/kg BQ-123 delivered intravenously 30 minutes prior to the injury. Trauma was induced using a weight acceleration impact device. Animals were terminated 24 or 48 hours after trauma, and a series of six coronal sections through the entire anterior-posterior extent of the corpus callosum were selected from each brain for quantification of diffuse axonal injury by beta-amyloid precursor protein immunostaining. Results: Our data indicated that animals treated with BQ-123 30 minutes prior to trauma showed a significant reduction in diffuse axonal injury in corpus callosum at both 24 and 48 hours post-injury. Conclusion: The results show that endothelin receptor A antagonism reduced the extent of diffuse axonal injury, demonstrating a potential influence of the endothelin system on the intra-axonal cascade of molecular events underlying diffuse axonal injury.	[Reynolds, Christian A.; Kallakuri, Srinivasu; Bagchi, Mihir; Schafer, Steven; Kreipke, Christian W.; Rafols, Jose A.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Kreipke, Christian W.; Rafols, Jose A.] John D Dingell Vet Affairs Med Ctr, Detroit, MI USA		Rafols, JA (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Room 9312 Scott Hall,540 E Canfield, Detroit, MI 48201 USA.	jrafols@med.wayne.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS NS064976]; VA Rehabilitation Research & Development Merit Award [RX000224]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS064976] Funding Source: NIH RePORTER	This work was supported by grants from National Institutes of Health (no. NINDS NS064976) and a VA Rehabilitation Research & Development Merit Award (no. RX000224) to Christian Kreipke.	Armstead WM, 1996, J NEUROSURG, V85, P901, DOI 10.3171/jns.1996.85.5.0901; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Danielyan L, 2005, EUR J CELL BIOL, V84, P907, DOI 10.1016/j.ejcb.2005.07.001; DiLeonardi AM, 2009, BRAIN RES, V1263, P174, DOI 10.1016/j.brainres.2009.01.021; Faul M, 2010, TRAUMATIC BRAIN INJU; FEUERSTEIN G, 1994, PEPTIDES, V15, P467, DOI 10.1016/0196-9781(94)90207-0; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Hughes PM, 2003, J NEUROPATH EXP NEUR, V62, P1276, DOI 10.1093/jnen/62.12.1276; Kallakuri S, 2010, NEUROSCIENCE, V168, P820, DOI 10.1016/j.neuroscience.2010.01.018; Kreipke CW, 2010, NEUROL RES, V32, P209, DOI 10.1179/174313209X414515; LEWEN A, 1995, NEUROREPORT, V6, P357, DOI 10.1097/00001756-199501000-00032; National Research Council, 1996, GUID CAR US LAB AN; Palombi O, 2006, NEUROINFORMATICS, V4, P299, DOI 10.1385/NI:4:4:299; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rafols JA, 2007, NEUROL RES, V29, P348, DOI 10.1179/016164107X204657; Sato M, 1998, BRAIN RES, V809, P39, DOI 10.1016/S0006-8993(98)00817-8; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Souza-Rodrigues RD, 2008, BRAIN RES, V1200, P78, DOI 10.1016/j.brainres.2007.11.025; Steiner J, 2004, NITRIC OXIDE-BIOL CH, V10, P162, DOI 10.1016/j.niox.2004.03.005; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Uesugi M, 1998, BRAIN RES, V786, P235, DOI 10.1016/S0006-8993(97)01431-5	23	3	4	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAR	2011	33	2					192	196		10.1179/016164111X12881719352453			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	723OM	WOS:000287516600011	21801594				2022-02-06	
J	Vilar-Lopez, R; Perez-Garcia, M; Sanchez-Barrera, MB; Rodriguez-Fernandez, A; Gomez-Rio, M				Vilar-Lopez, R.; Perez-Garcia, M.; Sanchez-Barrera, M. B.; Rodriguez-Fernandez, A.; Gomez-Rio, M.			Symptom Validity Testing and Its Underlying Psychophysiological Response Pattern: A Preliminary Study	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Malingering; Victoria Symptom Validity Test; Poor effort; Psychophysiology; Autonomous response	TRAUMATIC BRAIN-INJURY; MEMORY IMPAIRMENT; TEST-PERFORMANCE; CLINICAL NEUROPSYCHOLOGY; SIMULATED MALINGERERS; COGNITIVE DEFICIT; SKIN-CONDUCTANCE; FORCED-CHOICE; REACTION-TIME; VALIDATION	Very little is known about the autonomic psychophysiological responses while individuals are executing a Symptom Validity Test. Therefore, the aim of this study is to analyze the peripheral psychophysiological correlates (electrodermal conductance and heart rate) during the performance of the Victoria Symptom Validity Test (VSVT). The sample of this study was composed of 30 participants who underwent the VSVT under two conditions: Exaggeration of cognitive deficits (ECD) and normal effort. Our results showed differences on skin conductance between correct answers and errors limited to the decision-making phase of the ECD condition. Those differences found in the maximum conductance value when participants decide to simulate their deficits could be related to emotional activation. No differences were found on the variable heart rate between the two conditions of the study. Implications of these results are discussed.	[Vilar-Lopez, R.] Univ Granada, Dept Personalidad Evaluac & Tratamiento Psicol, Fac Psicol, E-18071 Granada, Spain; [Vilar-Lopez, R.; Perez-Garcia, M.] Univ Granada, Inst Neurosci F Oloriz, E-18071 Granada, Spain; [Rodriguez-Fernandez, A.; Gomez-Rio, M.] Hosp Univ Virgen de las Nieves, Serv Med Nucl, Granada, Spain		Vilar-Lopez, R (corresponding author), Univ Granada, Dept Personalidad Evaluac & Tratamiento Psicol, Fac Psicol, Campus Cartuja S-N, E-18071 Granada, Spain.	rvilar@ugr.es	Garcia, Miguel Perez/F-9630-2010; Rodriguez-Fernandez, Antonio/AAB-3469-2019; Vilar-Lopez, Raquel/I-7847-2016	Garcia, Miguel Perez/0000-0003-4775-7556; Vilar-Lopez, Raquel/0000-0001-9639-0143	 [FIS 03/1142]	This study has been supported with funds from the grant "Concordancia entre los aspectos clinicos, neuropsicologicos y de neuroimagen funcional en pacientes con sindrome post-conmocional (FIS 03/1142)," whose principal researcher is MG-R.	Amrhein C, 2004, INT J PSYCHOPHYSIOL, V54, P231, DOI 10.1016/j.ijpsycho.2004.05.009; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bender SD, 2004, ARCH CLIN NEUROPSYCH, V19, P49, DOI 10.1016/S0887-6177(02)00165-8; Bernat E, 2006, PSYCHOPHYSIOLOGY, V43, P93, DOI 10.1111/j.1469-8986.2006.00380.x; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; Bigler ED, 2006, ARCH CLIN NEUROPSYCH, V21, P503, DOI 10.1016/j.acn.2006.03.008; Brennan AM, 2006, APPL NEUROPSYCHOL, V13, P1, DOI 10.1207/s15324826an1301_1; Browndyke JN, 2008, BRAIN INJURY, V22, P481, DOI 10.1080/02699050802084894; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Demakis GJ, 2004, APPL NEUROPSYCHOL, V11, P222; Doss R.C., 1999, J FORENSIC NEUROPSYC, V1, P5, DOI [https://doi.org/10.1300/J151v01n04_02, DOI 10.1300/J151V01N04_02, 10.1300/J151v01n04_02]; Ellwanger J, 1999, J CLIN EXP NEUROPSYC, V21, P866, DOI 10.1076/jcen.21.6.866.850; Erdal K, 2004, ARCH CLIN NEUROPSYCH, V19, P73; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Gouvier WD, 2003, NEURO S B C, P405; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Grubin D, 2005, J FORENSIC PSYCHI PS, V16, P357, DOI 10.1080/14789940412331337353; Haines ME, 2001, CLIN NEUROPSYCHOL, V15, P171, DOI 10.1076/clin.15.2.171.1891; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Holmquist LA, 2002, ARCH CLIN NEUROPSYCH, V17, P143, DOI 10.1016/S0887-6177(00)00106-2; Iacono WG, 2000, HDB PSYCHOPHYSIOLOGY, P772; Inman TH, 1998, PSYCHOL ASSESSMENT, V10, P128, DOI 10.1037/1040-3590.10.2.128; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lee TMC, 2005, NEUROIMAGE, V28, P305, DOI 10.1016/j.neuroimage.2005.06.051; Loring DW, 2007, CLIN NEUROPSYCHOL, V21, P522, DOI 10.1080/13854040600611384; Macciocchi SN, 2006, ARCH CLIN NEUROPSYCH, V21, P395, DOI 10.1016/j.acn.2006.06.003; Meijer EH, 2007, PSYCHOPHYSIOLOGY, V44, P814, DOI 10.1111/j.1469-8986.2007.00543.x; MITTENBERG W, 2002, J FORENSIC NEUROPSYC, V3, P227, DOI DOI 10.1300/J151V03N01_03; Rogers R., 1997, CLIN ASSESSMENT MALI, P398; Rosenfeld JP, 1999, INT J PSYCHOPHYSIOL, V33, P3, DOI 10.1016/S0167-8760(99)00021-5; SLICK D, 1994, J CLIN EXP NEUROPSYC, V16, P472, DOI 10.1080/01688639408402657; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Slick DJ, 2003, CLIN NEUROPSYCHOL, V17, P390, DOI 10.1076/clin.17.3.390.18090; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Strauss E, 2002, ARCH CLIN NEUROPSYCH, V17, P423, DOI 10.1016/S0887-6177(01)00126-3; Strauss E, 1999, CLIN NEUROPSYCHOL, V13, P420, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT420; Sweet JJ, 2002, CLIN NEUROPSYCHOL, V16, P109, DOI 10.1076/clin.16.2.109.13237; Swihart AA, 2008, J CLIN EXP NEUROPSYC, V30, P120, DOI 10.1080/13803390701249044; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tardif HP, 2000, INT J PSYCHOPHYSIOL, V36, P1, DOI 10.1016/S0167-8760(00)00083-0; Tardif HP, 2002, INT J PSYCHOPHYSIOL, V46, P147, DOI 10.1016/S0167-8760(02)00090-9; van Hooff JC, 2009, INT J PSYCHOPHYSIOL, V73, P246, DOI 10.1016/j.ijpsycho.2009.04.002; Willison J, 2006, ARCH CLIN NEUROPSYCH, V21, P41, DOI 10.1016/j.acn.2005.07.005	45	3	4	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2011	26	2					133	143		10.1093/arclin/acq099			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	726RX	WOS:000287744900006	21169274	Bronze			2022-02-06	
J	Grigorian, AS; Gilerovich, EG; Pavlichenko, NN; Kruglyakov, PV; Sokolova, IB; Polyntsev, DG				Grigorian, A. S.; Gilerovich, E. G.; Pavlichenko, N. N.; Kruglyakov, P. V.; Sokolova, I. B.; Polyntsev, D. G.			Effect of Transplantation of Mesenchymal Stem Cells on Neuronal Survival and Formation of a Glial Scar in the Brain of Rats with Severe Traumatic Brain Injury	BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE			English	Article						cell therapy; mesenchymal stem cells; traumatic brain injury; glyosis	MARROW; DIFFERENTIATE	We studied the effect of various methods of transplantation of mesenchymal stem cells on neuronal survival in rat brain 1 and 6 weeks after severe traumatic brain injury. It was found that intracerebral and systemic transplantation of mesenchymal stem cells improves neuronal survival in the piriform cortex of the contralateral hemisphere without affecting neuronal survival in the marginal zone of the traumatic cavity and amygdaloid nuclei. Intracerebral transplantation of mesenchymal stem cells increases the content of the astroglial component of the scar in the borderline zone of the traumatic cavity.	[Grigorian, A. S.; Pavlichenko, N. N.; Kruglyakov, P. V.; Sokolova, I. B.; Polyntsev, D. G.] Trans Tekhnol Co, St Petersburg, Russia; [Gilerovich, E. G.] Russian Acad Med Sci, Inst Expt Med, N Western Branch, St Petersburg, Russia		Grigorian, AS (corresponding author), Trans Tekhnol Co, St Petersburg, Russia.	cell_therapy@mail.ru	Gilerovich, Elena/C-2183-2012	Gilerovich, Elena/0000-0002-8074-2041; Pavlichenko, Natalia/0000-0002-4455-6743			FRIEDENSTEIN AJ, 1995, CALCIFIED TISSUE INT, V56, pS17, DOI 10.1007/BF03354643; Haas S, 2005, CURR OPIN NEUROL, V18, P59, DOI 10.1097/00019052-200502000-00012; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Korochkin L I, 2005, Morfologiia, V127, P7; KORZHEVSKII DE, 2005, MORFOLOGIYA, V128, P77; Levy YS, 2004, J MOL NEUROSCI, V24, P353, DOI 10.1385/JMN:24:3:353; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Muraglia A, 2000, J CELL SCI, V113, P1161; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Podgornyi OV, 2004, B EXP BIOL MED+, V137, P348, DOI 10.1023/B:BEBM.0000035126.42951.44; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Shapira Y, 1997, J NEUROSURG ANESTH, V9, P118, DOI 10.1097/00008506-199704000-00003; VIKTOROV IV, 2002, VESTN ROS AKAD MED+, V24, P30; Woodbury D, 2002, J NEUROSCI RES, V69, P908, DOI 10.1002/jnr.10365	15	3	6	0	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0007-4888	1573-8221		B EXP BIOL MED+	Bull. Exp. Biol. Med.	FEB	2011	150	4					551	555		10.1007/s10517-011-1187-1			5	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	737JK	WOS:000288564900038	22268062				2022-02-06	
B	Alexander, DN	Zollman, FS			Alexander, David N.	Zollman, FS		Imaging in Moderate to Severe Traumatic Brain Injury	MANUAL OF TRAUMATIC BRAIN INJURY MANAGEMENT			English	Article; Book Chapter									Univ Calif Los Angeles, Dept Neurol, Neurol Rehabil & Res Unit, Los Angeles, CA 90024 USA		Alexander, DN (corresponding author), Univ Calif Los Angeles, Dept Neurol, Neurol Rehabil & Res Unit, Los Angeles, CA 90024 USA.						EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Siskas N, 2003, NEURORADIOLOGY, V45, P283, DOI 10.1007/s00234-002-0887-7; WILBERGER JE, 1990, NEUROSURGERY, V27, P208, DOI 10.1227/00006123-199008000-00006	6	3	3	0	0	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-01-7				2011							157	165					9	Neurosciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BUN80	WOS:000289864500024					2022-02-06	
J	Brauer, J; Hay, CC; Francisco, G				Brauer, Jennifer; Hay, Catherine Cooper; Francisco, Gerard			A Retrospective Investigation of Occupational Therapy Services Received Following a Traumatic Brain Injury	OCCUPATIONAL THERAPY IN HEALTH CARE			English	Article						continuum of care; occupational therapy; quality of life; traumatic brain injury		The purpose of this qualitative study is to gain insight on the continuum of occupational therapy services provided for individuals with traumatic brain injury (TBI) and to gather inputs from such individuals' caregivers regarding their perspectives on the lived experience of TBI in relationship to received occupational therapy services. Participants answered semi-structured interview questions to describe each stage of occupational therapy along the continuum of care. The themes that emerged were related to the roles that caregivers assumed at each stage of recovery and their perspectives on services provided by occupational therapists. Occupational therapy was viewed as an important part of rehabilitation along the continuum of care, but there were challenges with receiving consistent and appropriate care, especially with the transition to home care. Opportunities for improving the flow of transition and general provision of care were discussed.	[Brauer, Jennifer; Hay, Catherine Cooper; Francisco, Gerard] TIRR Mem Hermann, 1333 Moursund, Houston, TX 77054 USA		Brauer, J (corresponding author), TIRR Mem Hermann, 1333 Moursund, Houston, TX 77054 USA.	Jennifer.Brauer@memorialhermann.org		Hay, Catherine/0000-0003-0416-2712			Chronister J, 2010, NEUROREHABILITATION, V27, P49, DOI 10.3233/NRE-2010-0580; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Glover A, 2003, DISABIL REHABIL, V25, P750, DOI 10.1080/0963828021000058503; Goodman D., 2002, CARE MANAGEMENT, V6, P31; Kielhofner G., 2006, RES OCCUPATIONAL THE; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Man DWK, 2004, BRAIN INJURY, V18, P577, DOI 10.1080/02699050310001646143; de la Plata CM, 2007, J HEAD TRAUMA REHAB, V22, P113, DOI 10.1097/01.HTR.0000265099.29436.56; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; O'Sullivan A., 2007, AOTAS SOC STATEMENT; Phillips VL, 2004, J HEAD TRAUMA REHAB, V19, P217, DOI 10.1097/00001199-200405000-00003; Pickett Hauber R., 2002, J NEUROSCIENCE NURSI, V34, P20; Taylor RR, 2009, AM J OCCUP THER, V63, P198, DOI 10.5014/ajot.63.2.198; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Tyerman A, 2001, NEUROREHABILITATION, V16, P59; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062	16	3	3	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0738-0577	1541-3098		OCCUP THER HEALTH CA	Occup. Ther. Health Care		2011	25	2-3					119	130		10.3109/07380577.2011.570420			12	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	VA1WK	WOS:000409699000003	23899029				2022-02-06	
B	Catroppa, C; Anderson, VA		Schoenberg, MR; Scott, JG		Catroppa, Cathy; Anderson, Vicki A.			Pediatric Traumatic Brain Injury (TBI): Overview	LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH			English	Article; Book Chapter							CLOSED-HEAD-INJURY; FOLLOW-UP; EXECUTIVE FUNCTION; YOUNG-CHILDREN; INTELLECTUAL DISABILITY; ATTENTIONAL SKILLS; SHORT-TERM; RECOVERY; MILD; CHILDHOOD	The aim of this chapter is to provide an overview of the: (1) prevalence of pediatric TBI; (2) the symptoms associated with pediatric TBI; (3) outcomes and predictors of pediatric TB!; and (4) rehabilitation in this area.	[Catroppa, Cathy; Anderson, Vicki A.] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Dept Psychol,Australian Ctr Child Neuropsychol St, Melbourne, Vic 3052, Australia; [Catroppa, Cathy] Univ Melbourne, Melbourne, Vic 3052, Australia		Catroppa, C (corresponding author), Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Dept Psychol,Australian Ctr Child Neuropsychol St, Melbourne, Vic 3052, Australia.	cathy.catroppa@mcri.edu.au; Vicki.anderson@rch.org.au	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436			ALVES W, 1992, STATE ARTS REV, V6, P21; Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; ANDERSON V, 2006, OUTCOME FOLLOWING TB; ANDERSON V, 2005, UNDERSTANDING PREDIC; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Anderson V, 2007, BRAIN INJURY, V21, P1399, DOI 10.1080/02699050701785070; ASANOW RF, 1991, J PEDIATR PSYCHOL, V16, P543; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; Begali V., 1987, HEAD INJURY CHILDREN; Begali V., 1992, HEAD INJURY CHILDREN; BRESLAU N, 1990, ARCH GEN PSYCHIAT, V47, P15; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Catroppa C, 2003, NEUROPSYCHOL REHABIL, V13, P517, DOI 10.1080/09602010343000084; Catroppa C, 1999, CHILD NEUROPSYCHOL, V5, P251, DOI 10.1076/0929-7049(199912)05:04;1-R;FT251; CATROPPA C, 2010, NEW FRONTIERS PEDIAT; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Catroppa C, 2007, CHILD NEUROPSYCHOL, V13, P240, DOI 10.1080/09297040600837362; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHORAZY AJL, 1985, HEAD INJURY REHABILI; CICERONE K, 1990, NEUROPSYCHOLOGY EVER, P271; CLANG A, 1997, STUDENTS ACQUIRED BR; COSTER WJ, 1994, AM J OCCUP THER, V48, P211, DOI 10.5014/ajot.48.3.211; Cronin AF, 2001, AM J OCCUP THER, V55, P377, DOI 10.5014/ajot.55.4.377; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; DAVIS MJ, 1995, J DENT CHILD, V62, P93; Dennis M, 1996, DEV NEUROPSYCHOL, V12, P77, DOI 10.1080/87565649609540641; Dennis M., 1989, CLIN NEUROPSYCHOLOGY; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; DiScala C, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199704000-00002; DISCALA C, 1993, NATL PEDIAT TRAUMA R; ELSON LM, 1994, SEMIN NEUROL, V14, P8, DOI 10.1055/s-2008-1041053; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; FENNELL EB, 1992, ADV CHILD NEUROPSYCH, V1; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Gavidia-Payne S, 2002, J INTELLECT DEV DIS, V27, P31, DOI 10.1080/13668250120119626; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Goldstein B, 1994, Pediatr Rev, V15, P213, DOI 10.1542/pir.15-6-213; GOLDSTEIN FC, 1987, J LEARN DISABIL, V20, P518, DOI 10.1177/002221948702000903; Goldstein FC, 1992, COGNITIVE DISORDERS; Gronwall D, 1997, J Int Neuropsychol Soc, V3, P592; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; HIGH WM, 1990, J CLIN EXP NEUROPSYC, V12, P703, DOI 10.1080/01688639008401013; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hudson AM, 2003, J INTELL DISABIL RES, V47, P238, DOI 10.1046/j.1365-2788.2003.00486.x; HYND GW, 1988, INTERCRANIAL INJURIE; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; KLONOFF R, 1996, CLIN NEUROPSYCHOL, V12, P31; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; MILLER JD, 1991, NEUROPSYCHOLOGY, V5, P235; Miller L, 1996, J COGNITIVE REHABILI, V15, P8; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; PAPERO PH, 1993, NEUROPSYCHOL REHABIL, V3, P321, DOI 10.1080/09602019308401445; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; PONSFORD J, 1997, J INT NEUROPSYCH SOC, V3, P225; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; ROBERTS MA, 1995, BRAIN INJURY, V9, P427, DOI 10.3109/02699059509008202; RUTTER M, 1983, DEV NEUROPSYCHIATRY; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Sanders M R, 1999, Clin Child Fam Psychol Rev, V2, P71, DOI 10.1023/A:1021843613840; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Stablum F, 1996, CORTEX, V32, P261, DOI 10.1016/S0010-9452(96)80050-5; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; TEASDALE G, 1974, LANCET, V2, P81; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; WOODS D, 2007, NEW FRONTIERS PEDIAT; YEATES K, 1999, PEDIAT NEUROPSYCHOLO, P192; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	88	3	3	0	1	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-0-387-70703-7				2011							765	786		10.1007/978-0-387-76978-3_25	10.1007/978-0-387-76978-3		22	Clinical Neurology; Neurosciences; Psychology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Psychology	BTF43	WOS:000286799800025					2022-02-06	
S	Corrigan, F; Ziebell, JM; Vink, R		Lane, EL; Dunnett, SB		Corrigan, Frances; Ziebell, Jenna M.; Vink, Robert			Models of Rodent Cortical Traumatic Brain Injury	ANIMAL MODELS OF MOVEMENT DISORDERS, VOL II	Neuromethods		English	Article; Book Chapter						Neurotrauma; Injury models; Rats; Closed head injury; Anaesthesia; Gender	LATERAL FLUID-PERCUSSION; DIFFUSE AXONAL INJURY; WATER MAZE PERFORMANCE; ACUTE NEURONAL DEGENERATION; IMPACT-ACCELERATION MODEL; NECROSIS-FACTOR-ALPHA; BEHAVIORAL DEFICITS; COGNITIVE DEFICITS; RAT-BRAIN; POSTTRAUMATIC NEURODEGENERATION	The absence of a pharmacological therapy that is effective in the treatment of traumatic brain injury (TB!) highlights the need for further research into the secondary mechanisms that are initiated by the traumatic event, and which determine eventual neurological outcome. Various animal models of TBI exist, with each attempting to replicate different aspects of human brain injury. If an effective pharmacological therapy is to be developed and accepted by the neurotrauma community, it is critical that there is consistency across various laboratories in how these models are applied. The present review critically analyses the benefits and pitfalls of the common rodent models of TBI that are widely used today.	[Corrigan, Frances; Ziebell, Jenna M.; Vink, Robert] Univ Adelaide, Neurosci Res Ctr, Sch Med Sci, Adelaide, SA, Australia		Corrigan, F (corresponding author), Univ Adelaide, Neurosci Res Ctr, Sch Med Sci, Adelaide, SA, Australia.		Vink, Robert/S-5616-2019; Ziebell, Jenna/Y-4496-2019; Vink, Robert/J-7351-2012	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Ziebell, Jenna/0000-0003-2497-4347; Corrigan, Frances/0000-0001-6150-8893			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Beaumont A, 1999, NEUROL RES, V21, P742, DOI 10.1080/01616412.1999.11741008; Berman RF, 2000, J NEUROSURG, V93, P821, DOI 10.3171/jns.2000.93.5.0821; Blumbergs PC, 1997, HEAD INJURY PATHOPHY, P39; Bramlett HM, 1999, J NEUROTRAUM, V16, P1035, DOI 10.1089/neu.1999.16.1035; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Cook NL, 2009, J NEUROSCI RES, V87, P34, DOI 10.1002/jnr.21846; DeKosky ST, 1996, ANN NEUROL, V39, P123, DOI 10.1002/ana.410390118; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Dhillon HS, 1999, J NEUROTRAUM, V16, P455, DOI 10.1089/neu.1999.16.455; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Dutcher SA, 1998, J NEUROTRAUM, V15, P421, DOI 10.1089/neu.1998.15.421; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Fox GB, 1999, J NEUROTRAUM, V16, P377, DOI 10.1089/neu.1999.16.377; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Giza CC, 2002, J NEUROTRAUM, V19, P387, DOI 10.1089/08977150252932352; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Hanell A, 2010, J NEUROTRAUM, V27, P1297, DOI 10.1089/neu.2009.1255; Harford-Wright E, 2010, NEUROSCI LETT, V481, P26, DOI 10.1016/j.neulet.2010.06.044; Hayes R L, 1987, Brain Inj, V1, P1, DOI 10.3109/02699058709034437; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Hoane MR, 1998, BRAIN RES BULL, V45, P45, DOI 10.1016/S0361-9230(97)00288-8; Jacobs G, 2000, 445 TRL LTD; Jia F, 2010, J NEUROTRAUM, V27, P1059, DOI 10.1089/neu.2009.1067; Kallakuri S, 2003, EXP BRAIN RES, V148, P419, DOI 10.1007/s00221-002-1307-2; Kita T, 2000, INT J LEGAL MED, V113, P221, DOI 10.1007/s004149900095; Kita T, 1997, INT J LEGAL MED, V110, P305, DOI 10.1007/s004140050093; LAURER HL, 2002, ENCY HUMAN BRAIN; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Lifshitz Jonathan, 2009, P369, DOI 10.1007/978-1-60327-185-1_32; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Mao HJ, 2010, BIOMECH MODEL MECHAN, V9, P763, DOI 10.1007/s10237-010-0212-z; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou Christina R., 2009, P393, DOI 10.1007/978-1-60327-185-1_34; Matsushita Y, 2001, CRIT CARE MED, V29, P2060, DOI 10.1097/00003246-200111000-00004; Maughan PH, 2000, J NEUROTRAUM, V17, P1141, DOI 10.1089/neu.2000.17.1141; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Napieralski JA, 1998, EXP NEUROL, V154, P80, DOI 10.1006/exnr.1998.6893; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; PAPPIUS HM, 1983, NEUROCHEM RES, V8, P63, DOI 10.1007/BF00965654; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Piper IR, 1996, J NEUROSCI METH, V69, P171, DOI 10.1016/S0165-0270(96)00046-5; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; Rafols JA, 2007, NEUROL RES, V29, P348, DOI 10.1179/016164107X204657; Reid WM, 2010, J NEUROTRAUM, V27, P1243, DOI 10.1089/neu.2010.1270; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Royle SJ, 1999, BRAIN RES, V816, P337, DOI 10.1016/S0006-8993(98)01122-6; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schmidt RH, 2000, J NEUROTRAUM, V17, P1129, DOI 10.1089/neu.2000.17.1129; Schmidt RH, 1999, J NEUROTRAUM, V16, P1139, DOI 10.1089/neu.1999.16.1139; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Sunyer B, 2008, AMINO ACIDS, V34, P485, DOI 10.1007/s00726-007-0511-6; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tan AA, 2009, J NEUROTRAUM, V26, P539, DOI 10.1089/neu.2008.0611; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tran LD, 2006, J NEUROTRAUM, V23, P1330, DOI 10.1089/neu.2006.23.1330; Vink R, 2001, J NEUROTRAUM, V18, P839, DOI 10.1089/089771501316919201; Witgen BM, 2006, J NEUROTRAUM, V23, P1320, DOI 10.1089/neu.2006.23.1320; Yamaki T, 1998, BRAIN RES PROTOC, V3, P100, DOI 10.1016/S1385-299X(98)00030-0; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	107	3	3	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	0893-2336		978-1-61779-300-4	NEUROMETHODS	Neuromethods		2011	62						193	209		10.1007/978-1-61779-301-1_11	10.1007/978-1-61779-301-1		17	Cell Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Cell Biology; Neurosciences & Neurology	BYN46	WOS:000299440600011					2022-02-06	
B	Drescher, KD; Burgoyne, M; Casas, E; Lovato, L; Curran, E; Pivar, I; Foy, DW		Freeman, SM; Moore, BA; Freeman, A		Drescher, Kent D.; Burgoyne, Marissa; Casas, Elizabeth; Lovato, Lauren; Curran, Erika; Pivar, Ilona; Foy, David W.			Issues of Grief, Loss, Honor, and Remembrance: Spirituality and Work With Military Personnel and Their Families	LIVING AND SURVIVING IN HARMS WAY: A PSYCHOLOGICAL TREATMENT HANDBOOK FOR PRE- AND POST-DEPLOYMENT OF MILITARY PERSONNEL			English	Article; Book Chapter							QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; CHILDHOOD SEXUAL-ABUSE; MENTAL-HEALTH PROBLEMS; POSTTRAUMATIC GROWTH; MEDICAL REHABILITATION; AFRICAN-AMERICAN; CHRONIC ILLNESS; NATIONAL SURVEY; TERMINALLY ILL		[Drescher, Kent D.] Natl Ctr PTSD, Disseminat & Training Div, Menlo Pk, CA USA; [Casas, Elizabeth] Pepperdine Univ, Clin Psychol Program, Los Angeles, CA USA; [Casas, Elizabeth] Los Angeles Ambulatory Care Ctr, Mental Hlth Serv, Los Angeles, CA USA; [Lovato, Lauren] VA Long Beach Healthcare Syst, Long Beach, CA USA; [Pivar, Ilona] New Mexico VA Hlth Care Syst, Albuquerque, NM USA; [Pivar, Ilona] New Mexico VA Hlth Care Syst, Santa Fe, NM USA; [Foy, David W.] Pepperdine Univ, Grad Sch Educ & Psychol, Malibu, CA 90263 USA; [Foy, David W.] Honolulu Div, Honolulu, HI USA		Drescher, KD (corresponding author), Natl Ctr PTSD, Disseminat & Training Div, Menlo Pk, CA USA.						Abeles R, 1999, MULTIDIMENSIONAL MEA; Ahlstrom G, 2007, J CLIN NURS, V16, P76, DOI 10.1111/j.1365-2702.2006.01580.x; Ai AL, 2005, J INTERPERS VIOLENCE, V20, P523, DOI 10.1177/0886260504272896; Alferi S M, 1999, J Health Psychol, V4, P343, DOI 10.1177/135910539900400304; Anderson MJ, 2005, DEATH STUD, V29, P811, DOI 10.1080/07481180500236602; *APA, 2004, RES FACT STRAT; BAHR HM, 1980, J SOC PSYCHOL, V110, P219, DOI 10.1080/00224545.1980.9924249; Brady MJ, 1999, PSYCHO-ONCOLOGY, V8, P417, DOI 10.1002/(SICI)1099-1611(199909/10)8:5<417::AID-PON398>3.3.CO;2-W; Brillhart Barbara, 2005, Rehabil Nurs, V30, P31; Brymer M., 2006, PSYCHOL 1 AID FIELD, V2nd ed.; Carlock D., 2007, ISSUES SCI TECHNOLOG; Chally PS, 2004, ARCH PHYS MED REHAB, V85, pS60, DOI 10.1016/j.apmr.2004.03.013; Chang BH, 2003, INT J PSYCHIAT MED, V33, P223, DOI 10.2190/NM3D-EWYR-4B59-DFM8; Chang BH, 2001, INT J PSYCHIAT MED, V31, P77, DOI 10.2190/0NQA-YAJ9-W0AM-YB3P; Cordova MJ, 2001, HEALTH PSYCHOL, V20, P176, DOI 10.1037//0278-6133.20.3.176; Cotton SP, 1999, PSYCHO-ONCOL, V8, P429, DOI 10.1002/(SICI)1099-1611(199909/10)8:5<429::AID-PON420>3.0.CO;2-P; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; *DEF MANP DAT CTR, 2008, GLOB WAR TERR CAS ST; DEGRAFF AH, 2006, THESIS U NO COLORADO; Doxey C., 1997, INT J PSYCHOL RELIG, V7, P179, DOI [10.1207/s15327582ijpr0703_6, DOI 10.1207/S15327582IJPR0703_6]; Drescher K. D., 2004, GROUP J, V28, P71; DRESCHER KD, 2007, EXAMINATION MO UNPUB; Drescher KD., 1995, NATL CTR PTSD CLIN Q, V5, P4; ELLIOTT DM, 1994, J INTERPERS VIOLENCE, V9, P95, DOI 10.1177/088626094009001006; Fallot RD, 2005, J BEHAV HEALTH SER R, V32, P215, DOI 10.1007/BF02287268; Fehring R J, 1997, Oncol Nurs Forum, V24, P663; Ferrell B R, 1995, Oncol Nurs Forum, V22, P915; FINKELHOR D, 1990, CHILD ABUSE NEGLECT, V14, P19, DOI 10.1016/0145-2134(90)90077-7; Fitchett G, 1999, REHABIL PSYCHOL, V44, P333, DOI 10.1037//0090-5550.44.4.333; Flannelly L T, 2001, Issues Ment Health Nurs, V22, P253, DOI 10.1080/01612840152053093; Fontana A, 2004, J NERV MENT DIS, V192, P579, DOI 10.1097/01.nmd.0000138224.17375.55; Ford JD, 1999, J CONSULT CLIN PSYCH, V67, P3, DOI 10.1037/0022-006X.67.1.3; FORD MR, 1994, THESIS CALIFORNIA ST; Gall TL, 2006, CHILD ABUSE NEGLECT, V30, P829, DOI 10.1016/j.chiabu.2006.01.003; Gillard M., 1999, AUSTRALASIAN J DISAS, V3; Gitlin LN, 2007, J AM GERIATR SOC, V55, P1023, DOI 10.1111/j.1532-5415.2007.01224.x; Grace, 1988, J TRAUMA STRESS, V1, P399, DOI DOI 10.1002/JTS.2490010403; GROSMAN D, 1995, KILLING PSYCHOL COST; HALL TA, 1995, J PSYCHOL THEOL, V23, P129, DOI 10.1177/009164719502300205; HALLETT JD, 1994, AM J OCCUP THER, V48, P241, DOI 10.5014/ajot.48.3.241; Hewson D, 1997, SOC SCI MED, V44, P1129, DOI 10.1016/S0277-9536(96)00244-4; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; JACKSON KI, 2006, IMPACT CHURCH ATTEND; Jones JM, 2007, J BLACK PSYCHOL, V33, P125, DOI 10.1177/0095798407299511; Kaczorowski J M, 1989, Hosp J, V5, P105; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; KANE D, 1993, J PSYCHOL THEOL, V21, P228, DOI 10.1177/009164719302100306; Kennedy KE, 1998, J SCI STUD RELIG, V37, P322; Kim J, 2000, REHABIL PSYCHOL, V45, P365, DOI 10.1037/0090-5550.45.4.365; KIM JJ, 2002, THESIS NW U CHICAGO; Krejci Mark J, 2004, J Child Sex Abus, V13, P85, DOI 10.1300/J070v13n02_05; Kurtz M E, 1995, Health Care Women Int, V16, P253; Kutner Jean S, 2003, Palliat Support Care, V1, P231; Larson D. B., 1997, SCI RES SPIRITUALITY; LARSON DB, 1986, AM J PSYCHIAT, V143, P329; MacNair RM, 2005, PERPETRATION INDUCED; MAGYARRUSSELL GM, 2005, THESIS BOWLING GREEN; Martz E, 2004, DEATH STUD, V28, P1, DOI 10.1080/07481180490249201; Matheis EN, 2006, REHABIL PSYCHOL, V51, P265, DOI 10.1037/0090-5550.51.3.265; MATON KI, 1989, J SCI STUD RELIG, V28, P310, DOI 10.2307/1386742; McColl MA, 2000, DISABIL REHABIL, V22, P555, DOI 10.1080/096382800416805; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; MCINTOSH DN, 1993, J PERS SOC PSYCHOL, V65, P812, DOI 10.1037/0022-3514.65.4.812; McNulty K, 2004, REHABIL PSYCHOL, V49, P91, DOI 10.1037/0090-5550.49.2.91; Mickley J, 1993, Oncol Nurs Forum, V20, P1171; Mickley J R, 1992, Image J Nurs Sch, V24, P267; MILLER WR, 1997, INTEGRATING SPIRITUA, P179; Moschella VD, 1997, J RELIG HEALTH, V36, P17, DOI 10.1023/A:1027432730591; *MULT FORC IR SURG, 2006, MENT HLTH ADV TEAM M; Murphy SA, 2003, DEATH STUD, V27, P381, DOI 10.1080/07481180302879; Murphy SA, 2002, FAM COMMUNITY HEALTH, V25, P71, DOI 10.1097/00003727-200204000-00010; Nairn RC, 2003, PSYCHO-ONCOL, V12, P428, DOI 10.1002/pon.654; NISSIM NE, 2003, THESIS FAIRLEIGH DIC; Pargament K., 1997, PSYCHOL RELIG COPING; PARGAMENT KI, 1990, AM J COMMUN PSYCHOL, V18, P793, DOI 10.1007/BF00938065; Patel SS, 2002, AM J KIDNEY DIS, V40, P1013, DOI 10.1053/ajkd.2002.36336; Pivar IL, 2004, J ANXIETY DISORD, V18, P745, DOI 10.1016/j.janxdis.2003.09.005; Potter M L, 2000, J Holist Nurs, V18, P311, DOI 10.1177/089801010001800403; POVOLNY MA, 1993, J APPL REHAB COUNSEL, V24, P31; Powell T, 2007, BRAIN INJURY, V21, P31, DOI 10.1080/02699050601106245; Pritt AF, 1998, J SCI STUD RELIG, V37, P273, DOI 10.2307/1387527; Reed P G, 1991, Appl Nurs Res, V4, P122; REED PG, 1987, RES NURS HEALTH, V10, P335, DOI 10.1002/nur.4770100507; REED PG, 1986, RES NURS HEALTH, V9, P35, DOI 10.1002/nur.4770090107; Riley BB, 1998, ARCH PHYS MED REHAB, V79, P258, DOI 10.1016/S0003-9993(98)90004-1; ROSSITER CL, 1992, THESIS U CINCINNATI; RYNEARSON EK, 1995, BRIT J PSYCHIAT, V166, P507, DOI 10.1192/bjp.166.4.507; Salo JA, 2005, ANXIETY STRESS COPIN, V18, P361, DOI 10.1080/10615800500289524; Schnoll RA, 2000, CANCER PRACT, V8, P298, DOI 10.1046/j.1523-5394.2000.86006.x; Schultz R. C., 1985, J APPL REHABILITATIO, V16, P45; Schuster MA, 2001, NEW ENGL J MED, V345, P1507, DOI 10.1056/NEJM200111153452024; Smith BW, 2000, J COMMUNITY PSYCHOL, V28, P169, DOI 10.1002/(SICI)1520-6629(200003)28:2<169::AID-JCOP5>3.0.CO;2-I; *SPIN CORD INJ QUA, 2000, VA HLTH CAR ATL FY 2; Sulmasy Daniel P, 2002, Gerontologist, V42 Spec No 3, P24; Tate DG, 2002, AM J PHYS MED REHAB, V81, P400, DOI 10.1097/00002060-200206000-00002; Thompson MP, 1997, J SCI STUD RELIG, V36, P44, DOI 10.2307/1387881; *VA OFF RES DEV, 2007, QUAL ENH RES IN SPIN; Wan G J, 1999, J Outcome Meas, V3, P200; WEAVER A. J., 1998, J PSYCHOL CHRISTIANI, V17, P220; Weaver KE, 2004, AIDS BEHAV, V8, P175, DOI 10.1023/B:AIBE.0000030248.52063.11; Witvliet CVO, 2004, J TRAUMA STRESS, V17, P269, DOI 10.1023/B:JOTS.0000029270.47848.e5; Woods TE, 1999, J PSYCHOSOM RES, V46, P165, DOI 10.1016/S0022-3999(98)00078-6; Wortmann JH, 2008, DEATH STUD, V32, P703, DOI 10.1080/07481180802289507; YATES JW, 1981, MED PEDIATR ONCOL, V9, P121, DOI 10.1002/mpo.2950090204	105	3	3	0	4	ROUTLEDGE	ABINGDON	2 PARK SQ, MILTON PARK, ABINGDON OX14 4RN, OXFORD, ENGLAND			978-0-203-89390-6				2011							437	465					29	Psychology, Clinical; Psychiatry	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Psychology; Psychiatry	BUU04	WOS:000290304900023					2022-02-06	
B	Gazit, Z; Pelled, G; Sheyn, D; Kimelman, N; Gazit, D		Atala, A; Lanza, R; Thomson, JA; Nerem, R		Gazit, Zulma; Pelled, Gadi; Sheyn, Dima; Kimelman, Nadav; Gazit, Dan			Mesenchymal Stem Cells	PRINCIPLES OF REGENERATIVE MEDICINE, 2ND EDITION			English	Article; Book Chapter							MARROW STROMAL CELLS; HUMAN BONE-MARROW; TRAUMATIC BRAIN-INJURY; MEDIATED GENE-THERAPY; AUTOLOGOUS CHONDROCYTE TRANSPLANTATION; BETA-TRICALCIUM PHOSPHATE; POSTERIOR SPINAL-FUSION; INSULIN-PRODUCING CELLS; RAT PANCREATIC EXTRACT; UMBILICAL-CORD BLOOD		[Gazit, Zulma; Pelled, Gadi; Sheyn, Dima; Kimelman, Nadav; Gazit, Dan] Hebrew Univ Jerusalem, Hadassah Fac Dent Med, Skeletal Biotechnol Lab, Jerusalem, Israel; [Gazit, Zulma; Pelled, Gadi; Gazit, Dan] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA; [Gazit, Zulma; Pelled, Gadi; Gazit, Dan] Cedars Sinai Med Ctr, CS RMI, Los Angeles, CA 90048 USA		Gazit, Z (corresponding author), Hebrew Univ Jerusalem, Hadassah Fac Dent Med, Skeletal Biotechnol Lab, Jerusalem, Israel.		Sheyn, Dmitriy/AAZ-7350-2020; Campioni, Diana/O-4552-2015	Sheyn, Dmitriy/0000-0002-3333-1485; Campioni, Diana/0000-0003-1650-8354; Gazit, Dan/0000-0002-0554-0028; Pelled, Gadi/0000-0003-3857-5531			Abedin M, 2004, CIRC RES, V95, P671, DOI 10.1161/01.RES.0000143421.27684.12; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Akiyama Y, 2002, J NEUROSCI, V22, P6623; Altman GH, 2001, FASEB J, V15, P270, DOI 10.1096/fj.01-0656fje; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Arinzeh TL, 2003, J BONE JOINT SURG AM, V85A, P1927, DOI 10.2106/00004623-200310000-00010; Aslan H, 2006, STEM CELLS, V24, P1728, DOI 10.1634/stemcells.2005-0546; Aslan H, 2006, TISSUE ENG, V12, P877, DOI 10.1089/ten.2006.12.877; Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Bartsch G, 2005, STEM CELLS DEV, V14, P337, DOI 10.1089/scd.2005.14.337; Bayes-Genis A, 2005, TRANSPL P, V37, P4077, DOI 10.1016/j.transproceed.2005.09.103; Bertram H, 2005, BIOCHEM BIOPH RES CO, V331, P1185, DOI 10.1016/j.bbrc.2005.04.034; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Black IB, 2001, BLOOD CELL MOL DIS, V27, P632, DOI 10.1006/bcmd.2001.0423; Bonafe Francesca, 2003, Ital Heart J Suppl, V4, P299; Boquest AC, 2005, MOL BIOL CELL, V16, P1131, DOI 10.1091/mbc.E04-10-0949; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202; Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007; Burt Richard K., 2002, Autoimmunity Reviews, V1, P133, DOI 10.1016/S1568-9972(02)00033-2; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Caplan AI, 1997, CLIN ORTHOP RELAT R, P254; Chacko SM, 2009, AM J PHYSIOL-HEART C, V296, pH1263, DOI 10.1152/ajpheart.01311.2008; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chandra V, 2009, STEM CELLS, V27, P1941, DOI 10.1002/stem.117; Chang C, 2008, CYTOTHERAPY, V10, P796, DOI 10.1080/14653240802461924; Chang CH, 2009, PANCREAS, V38, P275, DOI 10.1097/MPA.0b013e318191521c; Chao YX, 2009, J NEUROIMMUNOL, V216, P39, DOI 10.1016/j.jneuroim.2009.09.003; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chen LB, 2004, WORLD J GASTROENTERO, V10, P3016; Chen Y, 2002, BIOCHEM BIOPH RES CO, V298, P121, DOI 10.1016/S0006-291X(02)02394-X; Choi KS, 2005, BIOCHEM BIOPH RES CO, V330, P1299, DOI 10.1016/j.bbrc.2005.03.111; Chong AKS, 2007, J BONE JOINT SURG AM, V89A, P74, DOI 10.2106/JBJS.E.01396; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Cinotti G, 2004, J BONE JOINT SURG BR, V86B, P135, DOI 10.1302/0301-620X.86B1.14308; Conrad C, 2002, EXP HEMATOL, V30, P887, DOI 10.1016/S0301-472X(02)00865-2; Cortes F, 1999, BLOOD, V93, P826, DOI 10.1182/blood.V93.3.826.403k28_826_837; Cova L, 2010, BRAIN RES, V1311, P12, DOI 10.1016/j.brainres.2009.11.041; Crevensten G, 2004, ANN BIOMED ENG, V32, P430, DOI 10.1023/B:ABME.0000017545.84833.7c; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Cristino S, 2005, J BIOMED MATER RES A, V73A, P275, DOI 10.1002/jbm.a.30261; Dabeva MD, 2003, SEMIN LIVER DIS, V23, P349; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Devine MJ, 2002, J ORTHOP RES, V20, P1232, DOI 10.1016/S0736-0266(02)00051-7; Dharmasaroja P, 2009, J CLIN NEUROSCI, V16, P12, DOI 10.1016/j.jocn.2008.05.006; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Ding YC, 2009, DIABETES, V58, P1797, DOI 10.2337/db09-0317; Dinser R, 2009, J TISSUE ENG REGEN M, V3, P124, DOI 10.1002/term.148; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dong QY, 2008, CLIN INVEST MED, V31, pE328; Dressler MR, 2005, J ORTHOP RES, V23, P287, DOI 10.1016/j.orthres.2004.06.017; Dumont RJ, 2002, NEUROSURGERY, V51, P1239, DOI 10.1097/00006123-200211000-00020; Elliott DM, 2008, SPINE, V33, P588, DOI 10.1097/BRS.0b013e318166e0a2; Ezquer FE, 2008, BIOL BLOOD MARROW TR, V14, P631, DOI 10.1016/j.bbmt.2008.01.006; Fazel S, 2005, J THORAC CARDIOV SUR, V130, P1310, DOI 10.1016/j.jtcvs.2005.07.012; Fernandez M, 1997, BONE MARROW TRANSPL, V20, P265, DOI 10.1038/sj.bmt.1700890; Figliuzzi M, 2009, TRANSPL P, V41, P1797, DOI 10.1016/j.transproceed.2008.11.015; Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803; FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x; FRIEDENSTEIN AJ, 1982, EXP HEMATOL, V10, P217; Fukuda K, 2005, CIRC J, V69, P1431, DOI 10.1253/circj.69.1431; Fukuda K, 2003, BONE MARROW TRANSPL, V32, pS25, DOI 10.1038/sj.bmt.1703940; Fukuda K, 2001, ARTIF ORGANS, V25, P187, DOI 10.1046/j.1525-1594.2001.025003187.x; Fukuda Keiichi, 2003, Hum Cell, V16, P83, DOI 10.1111/j.1749-0774.2003.tb00138.x; Fukuda Keiichi, 2002, Congenital Anomalies, V42, P1, DOI 10.1111/j.1741-4520.2002.tb00847.x; Gan JC, 2003, CLIN ORTHOP RELAT R, P305, DOI 10.1097/01.blo.0000063796.98363.9a; Gan YK, 2008, BIOMATERIALS, V29, P3973, DOI 10.1016/j.biomaterials.2008.06.026; Gazit D, 1999, J GENE MED, V1, P121, DOI 10.1002/(SICI)1521-2254(199903/04)1:2<121::AID-JGM26>3.0.CO;2-J; Gille J, 2002, ANN ANAT, V184, P325, DOI 10.1016/S0940-9602(02)80047-4; Glavaski-Joksimovic A, 2009, CELL TRANSPLANT, V18, P801, DOI 10.3727/096368909X470801; Goncalves MAFV, 2006, HUM MOL GENET, V15, P213, DOI 10.1093/hmg/ddi438; Gotherstrom C, 2004, AM J OBSTET GYNECOL, V190, P239, DOI 10.1016/j.ajog.2003.07.022; Greco SJ, 2007, J IMMUNOL, V179, P3342, DOI 10.4049/jimmunol.179.5.3342; Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369; GRONTHOS S, 1995, BLOOD, V85, P929, DOI 10.1182/blood.V85.4.929.bloodjournal854929; Gu WD, 2010, NEUROPATHOLOGY, V30, P205, DOI 10.1111/j.1440-1789.2009.01063.x; Gulotta LV, 2009, AM J SPORT MED, V37, P2126, DOI 10.1177/0363546509339582; Gysin R, 2002, GENE THER, V9, P991, DOI 10.1038/sj.gt.3301772; Harris MT, 2004, J ORTHOP RES, V22, P998, DOI 10.1016/j.orthres.2004.02.012; Hiyama A, 2008, J ORTHOP RES, V26, P589, DOI 10.1002/jor.20584; Hoffmann A, 2006, J CLIN INVEST, V116, P940, DOI 10.1172/JCI22689; Hoffmann A, 2002, J CELL SCI, V115, P769; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867; Hutson EL, 2005, TISSUE ENG, V11, P1407, DOI 10.1089/ten.2005.11.1407; Im GI, 2001, J BONE JOINT SURG BR, V83B, P289, DOI 10.1302/0301-620X.83B2.10495; Imanishi Y, 2009, J ARTIF ORGANS, V12, P187, DOI 10.1007/s10047-009-0465-4; Itescu S, 2003, J MOL MED, V81, P288, DOI 10.1007/s00109-003-0432-0; Jain M, 2005, CORONARY ARTERY DIS, V16, P93, DOI 10.1097/00019501-200503000-00003; Javazon EH, 2004, EXP HEMATOL, V32, P414, DOI 10.1016/j.exphem.2004.02.004; Joggerst SJ, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001124; Johnson MR, 2009, ACTA BIOMATER, V5, P23, DOI 10.1016/j.actbio.2008.09.001; Johnson T. V., 2009, INVEST OPHTH VIS SCI, V51, P2051; Jones E, 2008, RHEUMATOLOGY, V47, P126, DOI 10.1093/rheumatology/kem206; Juncosa-Melvin N, 2006, TISSUE ENG, V12, P681, DOI 10.1089/ten.2006.12.681; Kang XQ, 2005, WORLD J GASTROENTERO, V11, P3479, DOI 10.3748/wjg.v11.i22.3479; Kastrinaki MC, 2008, TISSUE ENG PART C-ME, V14, P333, DOI 10.1089/ten.tec.2008.0173; Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021; Kawamura K, 2005, EXP HEMATOL, V33, P865, DOI 10.1016/j.exphem.2005.05.010; Kawate K, 2006, ARTIF ORGANS, V30, P960, DOI 10.1111/j.1525-1594.2006.00333.x; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050; Kim SY, 2004, DEV DYNAM, V230, P1, DOI 10.1002/dvdy.20012; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; Kon E, 2000, J BIOMED MATER RES, V49, P328; Krause K, 2009, HEART, V95, P1145, DOI 10.1136/hrt.2008.155077; Kubo H, 2009, GENES CELLS, V14, P407, DOI 10.1111/j.1365-2443.2009.01281.x; Kumar S., 2010, MOL THER IN PRESS; Kumar S, 2007, FASEB J, V21, P3917, DOI 10.1096/fj.07-8275com; Lange C, 2005, WORLD J GASTROENTERO, V11, P4497, DOI 10.3748/wjg.v11.i29.4497; Lardon J, 2002, HISTOCHEM CELL BIOL, V117, P535, DOI 10.1007/s00418-002-0412-4; Le Maitre CL, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2611; Lee CCI, 2010, EXP HEMATOL, V38, P46, DOI 10.1016/j.exphem.2009.11.001; Lee JW, 2009, EXPERT OPIN BIOL TH, V9, P1259, DOI 10.1517/14712590903213651; Lee JA, 2010, PEDIATR RES, V67, P42, DOI 10.1203/PDR.0b013e3181bf594b; Lee PH, 2008, CLIN PHARMACOL THER, V83, P723, DOI 10.1038/sj.clpt.6100386; Li TF, 2009, EPILEPSY RES, V84, P238, DOI 10.1016/j.eplepsyres.2009.01.002; Li WJ, 2009, J TISSUE ENG REGEN M, V3, P1, DOI 10.1002/term.127; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Lin P, 2009, TRANSPL P, V41, P1891, DOI 10.1016/j.transproceed.2009.02.078; Liu YC, 2002, TISSUE ENG, V8, P709, DOI 10.1089/107632702760240616; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Madec AM, 2009, DIABETOLOGIA, V52, P1391, DOI 10.1007/s00125-009-1374-z; Madonna R, 2009, ARTERIOSCL THROM VAS, V29, P1723, DOI 10.1161/ATVBAHA.109.187179; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Majumdar MK, 2003, J BIOMED SCI, V10, P228, DOI 10.1159/000068710; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Marshall CJ, 1999, DEV DYNAM, V215, P139, DOI 10.1002/(SICI)1097-0177(199906)215:2<139::AID-DVDY6>3.0.CO;2-#; Martens TP, 2009, CELL TRANSPLANT, V18, P297, DOI 10.3727/096368909788534915; Mastrogiacomo M, 2005, Orthod Craniofac Res, V8, P277, DOI 10.1111/j.1601-6343.2005.00350.x; Minguell JJ, 2006, EXP BIOL MED, V231, P39; Mizuno Hiroshi, 2003, Journal of Nippon Medical School, V70, P300; Mohamadnejad M, 2007, ARCH IRAN MED, V10, P459; Moriscot C, 2005, STEM CELLS, V23, P594, DOI 10.1634/stemcells.2004-0123; Moutsatsos IK, 2001, MOL THER, V3, P449, DOI 10.1006/mthe.2001.0291; Na K, 2007, BIOMATERIALS, V28, P2631, DOI 10.1016/j.biomaterials.2007.02.008; Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447; Nesti LJ, 2008, TISSUE ENG PT A, V14, P1527, DOI 10.1089/ten.tea.2008.0215; Niemeyer P, 2007, TISSUE ENG, V13, P111, DOI 10.1089/ten.2006.0114; Noel D, 2007, LEUKEMIA LYMPHOMA, V48, P1283, DOI 10.1080/10428190701361869; Okura H, 2010, TISSUE ENG PART C-ME, V16, P417, DOI [10.1089/ten.tec.2009.0362, 10.1089/ten.TEC.2009.0362]; OKUYAMA R, 1995, EXP CELL RES, V218, P424, DOI 10.1006/excr.1995.1175; Omlor GW, 2010, EUR SPINE J, V19, P601, DOI 10.1007/s00586-009-1255-7; Orlic D, 2003, ANN NY ACAD SCI, V996, P152, DOI 10.1111/j.1749-6632.2003.tb03243.x; Oyagi S, 2006, J HEPATOL, V44, P742, DOI 10.1016/j.jhep.2005.10.026; Palmer GD, 2005, MOL THER, V12, P219, DOI 10.1016/j.ymthe.2005.03.024; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Pelled G, 2007, J BIOMECH, V40, P399, DOI 10.1016/j.jbiomech.2005.12.012; Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153; Phinney Donald G., 2008, V449, P171, DOI 10.1007/978-1-60327-169-1_12; Pimentel-Coelho PM, 2010, STEM CELLS DEV, V19, P299, DOI 10.1089/scd.2009.0403; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pons J, 2009, J GENE MED, V11, P743, DOI 10.1002/jgm.1362; Popp FC, 2009, LIVER TRANSPLANT, V15, P1192, DOI 10.1002/lt.21862; Potapova IA, 2008, AM J PHYSIOL-HEART C, V295, pH2257, DOI 10.1152/ajpheart.00219.2008; Pricola KL, 2009, J CELL BIOCHEM, V108, P577, DOI 10.1002/jcb.22289; Prockop DJ, 2007, CLIN PHARMACOL THER, V82, P241, DOI 10.1038/sj.clpt.6100313; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Pulavendran S, 2010, INT IMMUNOPHARMACOL, V10, P513, DOI 10.1016/j.intimp.2010.01.014; Qi CM, 2009, INT J CARDIOL, V131, P417, DOI 10.1016/j.ijcard.2007.07.164; Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516; Rasmusson I, 2005, EXP CELL RES, V305, P33, DOI 10.1016/j.yexcr.2004.12.013; Reinders MEJ, 2010, NEPHROL DIAL TRANSPL, V25, P17, DOI 10.1093/ndt/gfp552; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Richardson SM, 2008, BIOMATERIALS, V29, P85, DOI 10.1016/j.biomaterials.2007.09.018; Risbud MV, 2007, SPINE, V32, P2537, DOI 10.1097/BRS.0b013e318158dea6; Risbud MV, 2010, AM J PATHOL, V176, P1577, DOI 10.2353/ajpath.2010.090734; Roda B, 2009, STEM CELL REV REP, V5, P420, DOI 10.1007/s12015-009-9088-7; Roda B, 2009, CYTOM PART B-CLIN CY, V76B, P285, DOI 10.1002/cyto.b.20472; Rosen AB, 2007, STEM CELLS, V25, P2128, DOI 10.1634/stemcells.2006-0722; Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1; Sakai D, 2006, BIOMATERIALS, V27, P335, DOI 10.1016/j.biomaterials.2005.06.038; Sakai D, 2005, SPINE, V30, P2379, DOI 10.1097/01.brs.0000184365.28481.e3; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572; Saulnier N, 2009, EUR REV MED PHARMACO, V13, P71; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; Shayesteh YS, 2008, ORAL SURG ORAL MED O, V106, P203, DOI 10.1016/j.tripleo.2007.12.001; Sheyn D, 2008, STEM CELLS, V26, P1056, DOI 10.1634/stemcells.2007-0858; Shibata T, 2008, DIABETES, V57, P3099, DOI 10.2337/db08-0031; Shirley D, 2005, J ORTHOP RES, V23, P1013, DOI 10.1016/j.orthres.2005.01.013; Siepe M, 2005, EUR J CARDIO-THORAC, V28, P318, DOI 10.1016/j.ejcts.2005.03.044; Siniscalco D, 2010, CELL MOL LIFE SCI, V67, P655, DOI 10.1007/s00018-009-0202-4; Smits AM, 2005, J CELL MOL MED, V9, P25, DOI 10.1111/j.1582-4934.2005.tb00334.x; Solari MG, 2009, J AUTOIMMUN, V32, P116, DOI 10.1016/j.jaut.2009.01.003; Song H, 2010, STEM CELLS, V28, P555, DOI 10.1002/stem.302; Sonoyama W, 2005, CURR TOP DEV BIOL, V67, P305, DOI 10.1016/S0070-2153(05)67010-X; Sordi V, 2010, STEM CELLS, V28, P140, DOI 10.1002/stem.259; Sorrentino A, 2008, EXP HEMATOL, V36, P1035, DOI 10.1016/j.exphem.2008.03.004; Sotiropoulou PA, 2006, STEM CELLS, V24, P74, DOI 10.1634/stemcells.2004-0359; Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100; Steinert AF, 2009, TISSUE ENG PT A, V15, P1127, DOI 10.1089/ten.tea.2007.0252; Steinhardt Y, 2008, TISSUE ENG PT A, V14, P1763, DOI 10.1089/ten.tea.2008.0007; Tai K, 2008, TISSUE ENG PT A, V14, P1709, DOI 10.1089/ten.tea.2007.0241; Tatebe M, 2005, CYTOTHERAPY, V7, P520, DOI 10.1080/14653240500361350; Tfilin M, 2009, MOL PSYCHIAT; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Trivedi P, 2010, STEM CELLS DEV, V19, P1109, DOI 10.1089/scd.2009.0465; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Turgeman G, 2001, J GENE MED, V3, P240; van Velthoven CTJ, 2010, BRAIN BEHAV IMMUN, V24, P387, DOI 10.1016/j.bbi.2009.10.017; Volarevic V, 2010, AUTOIMMUNITY, V43, P255, DOI 10.3109/08916930903305641; WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212; Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504; Wakitani S, 2002, MICROSC RES TECHNIQ, V58, P14, DOI 10.1002/jemt.10111; Walker PA, 2010, STEM CELLS DEV, V19, P867, DOI 10.1089/scd.2009.0188; Wang J, 2009, BRAIN RES, V1262, P7, DOI 10.1016/j.brainres.2009.01.056; Wang QW, 2005, J BIOSCI BIOENG, V100, P418, DOI 10.1263/jbb.100.418; Wang Y, 2009, TRANSPL P, V41, P4352, DOI 10.1016/j.transproceed.2009.08.072; Wei AQ, 2009, TISSUE ENG PT A, V15, P2581, DOI [10.1089/ten.tea.2008.0458, 10.1089/ten.TEA.2008.0458]; Wilkins A, 2009, STEM CELL RES; Wojakowski W, 2005, FOLIA HISTOCHEM CYTO, V43, P229; Wolf D, 2009, SCAND CARDIOVASC J, V43, P39, DOI 10.1080/14017430802100280; Wright VJ, 2002, MOL THER, V6, P169, DOI 10.1006/mthe.2002.0654; Wuertz K, 2009, BIOCHEM BIOPH RES CO, V379, P824, DOI 10.1016/j.bbrc.2008.12.145; Xu RX, 2009, CLIN EXP PHARMACOL P, V36, P176, DOI 10.1111/j.1440-1681.2008.05041.x; Xu YX, 2009, TRANSPL P, V41, P1878, DOI 10.1016/j.transproceed.2009.01.087; Yamaguchi Y, 2005, BRIT J DERMATOL, V152, P616, DOI 10.1111/j.1365-2133.2005.06402.x; Yang F, 2009, MOL THER, V17, P1959, DOI 10.1038/mt.2009.146; Yoon YS, 2005, BIOL CELL, V97, P253, DOI 10.1042/BC20040099; Yoshimura K, 2006, J CELL PHYSIOL, V208, P64, DOI 10.1002/jcp.20636; Yu Y, 2007, MOL THER, V15, P1382, DOI 10.1038/sj.mt.6300202; Yue WM, 2008, STEM CELLS DEV, V17, P785, DOI 10.1089/scd.2007.0243; Zhang W, 2004, STEM CELLS DEV, V13, P263, DOI 10.1089/154732804323099190; Zhang YH, 2009, ANAT REC, V292, P728, DOI 10.1002/ar.20892; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853; Zhou H, 2009, CHINESE MED J-PEKING, V122, P2573, DOI 10.3760/cma.j.issn.0366-6999.2009.21.009; Zhu S., 2009, J SURG RES; Zisa D, 2009, BIOCHEM BIOPH RES CO, V390, P834, DOI 10.1016/j.bbrc.2009.10.058; Zubko R, 2009, AM J THER, V16, P247, DOI 10.1097/MJT.0b013e3181800591; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	239	3	3	0	14	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS			978-0-12-381423-4; 978-0-12-381422-7				2011							285	304		10.1016/B978-0-12-381422-7.10017-3			20	Cell & Tissue Engineering; Developmental Biology	Book Citation Index – Science (BKCI-S)	Cell Biology; Developmental Biology	BCS97	WOS:000311305200017					2022-02-06	
B	Gomez-Medina, O; Elovic, E		Brashear, A; Elovic, E		Gomez-Medina, Omar; Elovic, Elie			Measurement Tools and Treatment Outcomes in Patients With Spasticity	SPASTICITY: DIAGNOSIS AND MANAGEMENT			English	Article; Book Chapter							TOXIN TYPE-A; MODIFIED ASHWORTH SCALE; SPINAL-CORD-INJURY; QUALITY-OF-LIFE; UPPER-LIMB SPASTICITY; FUNCTIONAL AMBULATION PROFILE; SELECTIVE DORSAL RHIZOTOMY; ELBOW FLEXOR SPASTICITY; TRAUMATIC BRAIN-INJURY; MODIFIED TARDIEU SCALE		[Elovic, Elie] Univ Utah, Sch Med, Salt Lake City, UT USA								Al-Khodairy AT, 1998, SPINAL CORD, V36, P854, DOI 10.1038/sj.sc.3100703; Allison SC, 1996, INT J REHABIL RES, V19, P67, DOI 10.1097/00004356-199603000-00007; Allison SC, 2001, INT J REHABIL RES, V24, P15, DOI 10.1097/00004356-200103000-00003; Alon G, 2003, NEUROREHABILITATION, V18, P215; ANGEL RW, 1963, ARCH NEUROL-CHICAGO, V8, P591, DOI 10.1001/archneur.1963.00460060021002; Ansari Noureddin Nakhostin, 2006, Physiotherapy Theory and Practice, V22, P119, DOI 10.1080/09593980600724188; Ansari NN, 2009, NEUROREHABILITATION, V24, P225, DOI 10.3233/NRE-2009-0472; Ansari NN, 2008, BRAIN INJURY, V22, P1007, DOI 10.1080/02699050802530557; Arango-Lasprilla JC, 2009, NEUROREHABILITATION, V24, P5, DOI 10.3233/NRE-2009-0449; ARTIEDA J, 1991, NEUROLOGY, V41, P286, DOI 10.1212/WNL.41.2_Part_1.286; Ashford S, 2006, PHYSIOTHER RES INT, V11, P24, DOI 10.1002/pri.36; ASHWORTH B, 1964, PRACTITIONER, V192, P540; Baer HR, 2001, STROKE, V32, P973, DOI 10.1161/01.STR.32.4.973; Barbeau H, 2007, NEUROREHAB NEURAL RE, V21, P302, DOI 10.1177/1545968306298937; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bernmark E, 2002, APPL ERGON, V33, P541, DOI 10.1016/S0003-6870(02)00072-8; Bischoff C, 1992, Electromyogr Clin Neurophysiol, V32, P449; Blackburn M, 2002, PHYS THER, V82, P25, DOI 10.1093/ptj/82.1.25; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; BOHANNON RW, 1987, PHYS THER, V67, P659, DOI 10.1093/ptj/67.5.659; Bouten CVC, 1997, IEEE T BIO-MED ENG, V44, P136, DOI 10.1109/10.554760; Boviatsis EJ, 2005, CLIN NEUROL NEUROSUR, V107, P289, DOI 10.1016/j.clineuro.2004.09.007; Brashear A, 2002, NEW ENGL J MED, V347, P395, DOI 10.1056/NEJMoa011892; Brashear A, 2002, ARCH PHYS MED REHAB, V83, P1349, DOI 10.1053/apmr.2002.35474; Brown M, 2000, J GERONTOL A-BIOL, V55, pM350, DOI 10.1093/gerona/55.6.M350; CAHAN LD, 1987, APPL NEUROPHYSIOL, V50, P459; Campbell WM, 2002, DEV MED CHILD NEUROL, V44, P660; Cardoso E, 2007, ARQ NEURO-PSIQUIAT, V65, P592, DOI 10.1590/S0004-282X2007000400008; Caty GD, 2008, STROKE, V39, P2803, DOI 10.1161/STROKEAHA.108.516153; Chae J, 2002, NEUROREHAB NEURAL RE, V16, P241, DOI 10.1177/154596802401105180; Chae J, 2003, AM J PHYS MED REHAB, V82, P1, DOI 10.1097/00002060-200301000-00001; Chen HM, 2009, NEUROREHAB NEURAL RE, V23, P435, DOI 10.1177/1545968308331146; Childers MK, 2004, ARCH PHYS MED REHAB, V85, P1063, DOI 10.1016/j.apmr.2003.10.015; Childers MK, 1999, ARCH PHYS MED REHAB, V80, P714, DOI 10.1016/S0003-9993(99)90178-8; Chu ML, 2006, DEV MED CHILD NEUROL, V48, P456, DOI 10.1017/S0012162206000983; Chua KSG, 2000, ARCH PHYS MED REHAB, V81, P1432, DOI 10.1053/apmr.2000.9395; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Cole GF, 2007, ARCH DIS CHILD, V92, P781, DOI 10.1136/adc.2006.111559; DEVISSER BWO, 1989, ELECTROEN CLIN NEURO, V73, P162; Dewald J P, 1996, IEEE Trans Rehabil Eng, V4, P231, DOI 10.1109/86.547923; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; EISEN A, 1979, NEUROLOGY, V29, P1306, DOI 10.1212/WNL.29.9_Part_1.1306; EISEN A, 1987, CAN J NEUROL SCI, V14, P501, DOI 10.1017/S0317167100037999; Elovic E, 2001, STATE ART REV REHABI, V15, P327; Elovic EP, 2008, ARCH PHYS MED REHAB, V89, P799, DOI 10.1016/j.apmr.2008.01.007; Elovic EP, 2004, J HEAD TRAUMA REHAB, V19, P155, DOI 10.1097/00001199-200403000-00007; Esquenazi A, 2008, AM J PHYS MED REHAB, V87, P305, DOI 10.1097/PHM.0b013e318168d36c; Fee JW, 2002, P 2 JOINT EMBS EMBE; FELDMAN AB, 1990, PHYS THER, V70, P602, DOI 10.1093/ptj/70.10.602; Feng C J, 1997, IEEE Trans Rehabil Eng, V5, P253, DOI 10.1109/86.623017; Feng CJ, 1998, ENG MED BIOL SOC, V5, P2317; Feve A, 1997, J NEUROL NEUROSUR PS, V63, P575, DOI 10.1136/jnnp.63.5.575; Finch E, 2002, PHYS REHABILITATION; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; FISHER AG, 1997, ASSESSMENT MOTOR PRO; FISHER MA, 1988, MUSCLE NERVE, V11, P217, DOI 10.1002/mus.880110305; Fleuren JF, 2009, SPINAL CORD, V47, P396, DOI 10.1038/sc.2008.153; Fleuren J F M, 2009, J Electromyogr Kinesiol, V19, pe301, DOI 10.1016/j.jelekin.2008.04.003; Fleuren JF, 2006, ARCH PHYS MED REHAB, V87, P981, DOI 10.1016/j.apmr.2006.03.018; Fosang AL, 2003, DEV MED CHILD NEUROL, V45, P664, DOI 10.1017/S0012162203001245; Fowler EG, 2000, DEV MED CHILD NEUROL, V42, P182; Fowler NK, 1999, CLIN BIOMECH, V14, P646, DOI 10.1016/S0268-0033(99)00016-9; Fowler NK, 1999, J BIOMECH, V32, P721, DOI 10.1016/S0021-9290(99)00054-8; Francisco GE, 2007, BRAIN INJURY, V21, P335, DOI 10.1080/02699050701311018; Friden J, 2003, MUSCLE NERVE, V27, P157, DOI 10.1002/mus.10247; FUGLMEYER AR, 1980, SCAND J REHABIL MED, P85; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gage JR, 2003, J PEDIATR ORTHOPED, V23, P290, DOI 10.1097/00004694-200305000-00003; GHIKA J, 1993, IEEE T BIO-MED ENG, V40, P276, DOI 10.1109/10.216411; GIVEN JD, 1995, J NEUROL NEUROSUR PS, V59, P271, DOI 10.1136/jnnp.59.3.271; GOODKIN DE, 1988, ARCH PHYS MED REHAB, V69, P850; Gracies JM, 2000, ARCH PHYS MED REHAB, V81, P1547, DOI 10.1053/apmr.2000.16346; Gruenthal M, 1997, SPINAL CORD, V35, P686, DOI 10.1038/sj.sc.3100481; HAGBARTH KE, 1968, J NEUROL NEUROSUR PS, V31, P207, DOI 10.1136/jnnp.31.3.207; Haugh AB, 2006, DISABIL REHABIL, V28, P899, DOI 10.1080/09638280500404305; He J, 1998, IEEE Trans Rehabil Eng, V6, P182, DOI 10.1109/86.681184; Held J. P., 1969, REEDUCATION MOTRICE, P31; HELLER A, 1987, J NEUROL NEUROSUR PS, V50, P714, DOI 10.1136/jnnp.50.6.714; HERSHLER C, 1993, EL COMP ENG 1993 CAN, V2, P1299; HUGHES TAT, 2001, ENG MED BIOL SOC 200; Hurvitz EA, 2003, ARCH PHYS MED REHAB, V84, P444, DOI 10.1053/apmr.2003.50001; ILES JF, 1986, J NEUROL NEUROSUR PS, V49, P937, DOI 10.1136/jnnp.49.8.937; KHADEMI A, 1995, ARCH PHYS MED REHAB, V76, P1084; Kim DY, 2005, YONSEI MED J, V46, P546, DOI 10.3349/ymj.2005.46.4.546; Lagalla G, 2000, AM J PHYS MED REHAB, V79, P377, DOI 10.1097/00002060-200007000-00010; Lamoureux EL, 2002, J AM GERIATR SOC, V50, P468, DOI 10.1046/j.1532-5415.2002.50112.x; Lance J W, 1966, Proc Aust Assoc Neurol, V4, P49; LANCE JW, 1980, NEUROLOGY, V30, P1303, DOI 10.1212/WNL.30.12.1303; Lee HM, 2002, J NEUROL NEUROSUR PS, V72, P621, DOI 10.1136/jnnp.72.5.621; Liaw LJ, 2006, CLIN REHABIL, V20, P429, DOI 10.1191/0269215506cr950oa; LITTLE JW, 1985, ARCH PHYS MED REHAB, V66, P19; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; Mackey AH, 2004, DEV MED CHILD NEUROL, V46, P267, DOI 10.1017/S0012162204000428; MAHONEY F I, 1965, Md State Med J, V14, P61; Malhotra S, 2008, CLIN REHABIL, V22, P1105, DOI 10.1177/0269215508095089; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; MATTHEWS WB, 1966, J NEUROL NEUROSUR PS, V29, P201, DOI 10.1136/jnnp.29.3.201; Means KM, 1996, AM J PHYS MED REHAB, V75, P88, DOI 10.1097/00002060-199603000-00003; Medell JL, 2000, J GERONTOL A-BIOL, V55, pM429, DOI 10.1093/gerona/55.8.M429; Michael KM, 2005, ARCH PHYS MED REHAB, V86, P1552, DOI 10.1016/j.apmr.2004.12.026; MILANOV I, 1992, J NEUROL, V239, P287; MILANOV IG, 1992, ACTA NEUROL SCAND, V85, P305; Mizuike C, 2009, GAIT POSTURE, V30, P60, DOI 10.1016/j.gaitpost.2009.02.017; Naghdi Soofia, 2008, Physiotherapy Theory and Practice, V24, P372, DOI 10.1080/09593980802278959; *NAT MS SOC, 2003, MEAS US CLIN STUD MS; Nilsagard Y, 2007, PHYSIOTHER RES INT, V12, P105, DOI 10.1002/pri.358; Noonan VK, 2008, ARCH PHYS MED REHAB, V89, P1074, DOI 10.1016/j.apmr.2007.10.041; Nordmark E, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-54; O'Neill DE, 1998, AM J OTOL, V19, P797; Ohata K, 2008, DEV MED CHILD NEUROL, V50, P152, DOI 10.1111/j.1469-8749.2007.02018.x; Pandyan AD, 2002, CLIN REHABIL, V16, P654, DOI 10.1191/0269215502cr536oa; Pandyan AD, 2001, CLIN BIOMECH, V16, P859, DOI 10.1016/S0268-0033(01)00084-5; Panizza M, 2000, FUNCT NEUROL, V15, P147; Papadonikolakis AS, 2003, ACTA ORTHOP SCAND, V74, P749, DOI 10.1080/00016470310018315; Park KB, 2008, J BONE JOINT SURG AM, V90A, P1712, DOI 10.2106/JBJS.G.00792; Patrick E, 2006, CLIN REHABIL, V20, P173, DOI 10.1191/0269215506cr922oa; Pauri F, 2000, J NEUROL SCI, V181, P89, DOI 10.1016/S0022-510X(00)00439-1; PERNALETE N, 2003, INT J HUM FRIENDLY W, V4; Perry J, 2003, ARCH PHYS MED REHAB, V84, P7, DOI 10.1053/apmr.2003.50057; Perry J, 1999, J HEAD TRAUMA REHAB, V14, P116, DOI 10.1097/00001199-199904000-00003; Pierson SH, 1997, MUSCLE NERVE, pS36; Pierson SH, 2002, SPASTICITY ETIOLOGY, P27; Pisano F, 2000, CLIN NEUROPHYSIOL, V111, P1015, DOI 10.1016/S1388-2457(00)00289-3; POWERS RK, 1989, ANN NEUROL, V25, P32, DOI 10.1002/ana.410250106; Preiss RA, 2003, J BONE JOINT SURG BR, V85B, P943, DOI 10.1302/0301-620X.85B7.13967; Rampazo FM, 2009, REV NEUROLOGIA, V48, P459, DOI 10.33588/rn.4809.2008136; Rash GS, 1999, J BIOMECH, V32, P1337, DOI 10.1016/S0021-9290(99)00140-2; Reinkensmeyer DJ, 2000, J REHABIL RES DEV, V37, P653; Remy-Neris O, 2003, EXP BRAIN RES, V148, P509, DOI 10.1007/s00221-002-1313-4; Richardson D, 1997, CLIN REHABIL, V11, P288, DOI 10.1177/026921559701100404; Richardson D, 2000, J NEUROL NEUROSUR PS, V69, P499, DOI 10.1136/jnnp.69.4.499; Rodgers H, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-59; Roujeau T, 2003, J NEUROL NEUROSUR PS, V74, P913, DOI 10.1136/jnnp.74.7.913; Rousseaux M, 2002, J NEUROL, V249, P76, DOI 10.1007/PL00007851; Rousseaux M, 2009, J NEUROL SCI, V278, P71, DOI 10.1016/j.jns.2008.11.024; Schmit BD, 1999, ANN BIOMED ENG, V27, P815, DOI 10.1114/1.234; Scholtes VAB, 2006, DEV MED CHILD NEUROL, V48, P64; Sehgal N, 1998, Phys Med Rehabil Clin N Am, V9, P949; Sherman SJ, 2000, J NEUROL SCI, V175, P145, DOI 10.1016/S0022-510X(00)00299-9; Shimada H, 2003, AM J PHYS MED REHAB, V82, P511, DOI 10.1097/01.PHM.0000064726.59036.CB; SIETSEMA JM, 1993, AM J OCCUP THER, V47, P19, DOI 10.5014/ajot.47.1.19; Simpson DM, 2009, J NEUROL NEUROSUR PS, V80, P380, DOI 10.1136/jnnp.2008.159657; Skold C, 2002, J REHABIL MED, V34, P25, DOI 10.1080/165019702317242677; Skold C, 2000, ARCH PHYS MED REHAB, V81, P144, DOI 10.1016/S0003-9993(00)90132-1; Sorinola IO, 2009, NEUROREHAB NEURAL RE, V23, P287, DOI 10.1177/1545968308321778; Spaulding SJ, 2003, GAIT POSTURE, V17, P152, DOI 10.1016/S0966-6362(02)00072-3; Stokic DS, 2007, ACTA NEUROCHIR SUPPL, V97, P231; Sullivan JE, 2007, CLIN REHABIL, V21, P142, DOI 10.1177/0269215506071252; Sun J, 1996, ERGONOMICS, V39, P677, DOI 10.1080/00140139608964489; Syczewska M, 2009, J NEUROSCI METH, V178, P340, DOI 10.1016/j.jneumeth.2008.12.031; TARDIEU G, 1954, REV NEUROL, V91, P143; Taricco M., 2000, COCHRANE DB SYST REV, P1131, DOI [10.1002/14651858.CD001131, DOI 10.1002/14651858.CD001131]; Tseng YW, 2002, MOTOR CONTROL, V6, P183, DOI 10.1123/mcj.6.2.183; Turk R, 2008, ARCH PHYS MED REHAB, V89, P1913, DOI 10.1016/j.apmr.2008.01.030; Ubhi T, 2000, ARCH DIS CHILD, V83, P481, DOI 10.1136/adc.83.6.481; Uswatte G, 2005, STROKE, V36, P2493, DOI 10.1161/01.STR.0000185928.90848.2e; Uswatte G, 2006, ARCH PHYS MED REHAB, V87, P1340, DOI 10.1016/j.apmr.2006.06.006; van der Kolk JH, 2001, EQUINE VET J, V33, P110, DOI 10.2746/042516401776767368; Van der Lee JH, 2001, ARCH PHYS MED REHAB, V82, P14, DOI 10.1053/apmr.2001.18668; van der Linden ML, 2003, J PEDIATR ORTHOPED, V23, P308, DOI 10.1097/00004694-200305000-00007; VANBOGART J, 2001, ENG MED BIOL SOC 200, V2, P1190; Vles GF, 2008, EUR J PAEDIATR NEURO, V12, P231, DOI 10.1016/j.ejpn.2007.08.002; Voerman GE, 2009, J NEUROL NEUROSUR PS, V80, P175, DOI 10.1136/jnnp.2008.147090; Vogel Lawrence C, 2002, J Spinal Cord Med, V25, P297; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; Wang RY, 1998, AM J PHYS MED REHAB, V77, P282, DOI 10.1097/00002060-199807000-00003; Wang XG, 1999, BIOL CYBERN, V80, P449, DOI 10.1007/s004220050538; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; WARTENBERG R, 1951, NEUROLOGY, V1, P18, DOI 10.1212/WNL.1.1.18; Welmer AK, 2006, CEREBROVASC DIS, V21, P247, DOI 10.1159/000091222; Westgren N, 1998, ARCH PHYS MED REHAB, V79, P1433, DOI 10.1016/S0003-9993(98)90240-4; WEWERS ME, 1990, RES NURS HEALTH, V13, P227, DOI 10.1002/nur.4770130405; White H, 2007, GAIT POSTURE, V26, P97, DOI 10.1016/j.gaitpost.2006.07.012; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; WINTERS TF, 1987, J BONE JOINT SURG AM, V69A, P437; Wright M, 2003, J INTELL DISABIL RES, V47, P85, DOI 10.1046/j.1365-2788.2003.00444.x; Yang TF, 2003, AM J PHYS MED REHAB, V82, P284, DOI 10.1097/01.PHM.0000056989.67763.07; YEH CY, 2000, P 22 ANN C IEEE ENG, V3, P1856; Yelnik A, 2008, NEUROPHYSIOL CLIN, V38, P439, DOI 10.1016/j.neucli.2008.09.008; YOUNG RR, 1987, CLIN ORTHOP RELAT R, V219, P50; Zhang LQ, 2000, ARCH PHYS MED REHAB, V81, P901, DOI 10.1053/apmr.2000.5582; ZHANG LQ, 2002, P 2 JOINT EMBS MBES; Zhao JG, 2009, J NEUROL SCI, V276, P143, DOI 10.1016/j.jns.2008.09.018	185	3	3	0	5	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-933864-51-8				2011							51	70					20	Clinical Neurology; Rehabilitation	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Rehabilitation	BQT45	WOS:000281793400005					2022-02-06	
J	Karaoglan, A; Akdemir, O; Cinar, N; Cal, MA; Kelten, B; Uzun, H; Colak, A				Karaoglan, Alper; Akdemir, Osman; Cinar, Nilgun; Cal, Mehmet Alpay; Kelten, Bilal; Uzun, Hafize; Colak, Ahmet			Correlation between leptin and pro-inflammatory cytokines in cortical contusion injury model	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Interleukin-1 beta; interleukin-6; leptin; tumor necrosis factor-alpha; traumatic brain injury	IMMUNE-RESPONSE; SERUM LEPTIN; BRAIN-INJURY; IMMUNODEFICIENCY; TUBERCULOSIS; EXPRESSION	BACKGROUND The present study aimed to investigate time-dependent changes in leptin concentrations in brain tissue following experimental traumatic brain injury and to examine the relationship with cytokines. METHODS After circular craniectomy, 33 male Wistar-albino rats were positioned on a stereotaxic frame and subjected to cortical contusion injury and then divided into 3 groups based on the depth of deformation as: 0 mm (sham controls, n=3), 1.5 mm (moderate injury, n=15) and 2.7 mm (severe injury, n=15). Animals were sacrificed on the 1st, 3rd and 5th days post-injury. RESULTS One day after moderate injury, interleukin-1 beta (IL-1 beta), IL-6, tumor necrosis factor-alpha (TNF-alpha), and leptin levels were found to be markedly increased in the brain tissue. On the 3rd and 5th days, the levels returned to the sham-control levels. Following severe injury, IL-1 beta, IL-6 and TNF-alpha levels increased in correlation after the 1st day and reached the sham-control levels on the same days. However, leptin tissue levels decreased on the 1st and 3rd days and normalized to the sham-control levels on the 5th day. CONCLUSION Our results showed that the release of leptin is decreased in the early stage of severe injury. Thus, leptin replacement may play an important role in therapy in cases with severe traumatic brain injury.	[Karaoglan, Alper; Cal, Mehmet Alpay; Kelten, Bilal; Colak, Ahmet] Maltepe Univ, Fac Med, Dept Neurosurg, Istanbul, Turkey; [Cinar, Nilgun] Maltepe Univ, Fac Med, Dept Neurol, Istanbul, Turkey; [Akdemir, Osman] Taksim Training & Res Hosp, Dept Neurosurg, Istanbul, Turkey; [Uzun, Hafize] Istanbul Univ, Cerrahpasa Fac Med, Dept Biochem, Istanbul, Turkey		Karaoglan, A (corresponding author), Feyzullah Cad 39, TR-34843 Istanbul, Turkey.	drkaraoglan@yahoo.com	Uzun, Hafize/D-4811-2019; Cal, Mehmet/ABD-5665-2020	Uzun, Hafize/0000-0002-1347-8498; 			Ahima RS, 2006, PROG BRAIN RES, V153, P155, DOI 10.1016/S0079-6123(06)53009-2; Cakir B, 1999, HORM RES, V52, P279, DOI 10.1159/000023495; Faggioni R, 2001, FASEB J, V15, P2565, DOI 10.1096/fj.01-0431rev; Grunfeld C, 1996, J CLIN ENDOCR METAB, V81, P4342, DOI 10.1210/jc.81.12.4342; Kain ZN, 1999, J CLIN ENDOCR METAB, V84, P2438, DOI 10.1210/jc.84.7.2438; KIM JH, 2010, CLIN NUTR; Kino Y, 2003, BURNS, V29, P449, DOI 10.1016/S0305-4179(03)00062-7; Lin J, 2004, PEPTIDES, V25, P2187, DOI 10.1016/j.peptides.2004.08.006; Matarese G, 2000, EUR CYTOKINE NETW, V11, P7; Meisel SR, 2001, CARDIOLOGY, V95, P206, DOI 10.1159/000047373; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Moses AGW, 2001, BRIT J SURG, V88, P588, DOI 10.1046/j.1365-2168.2001.01743.x; Patel L, 2002, J PEDIATR ENDOCR MET, V15, P963; Rigaux P, 2005, JOINT BONE SPINE, V72, P146, DOI 10.1016/j.jbspin.2004.05.012; Schulze PC, 2003, EUR J HEART FAIL, V5, P33, DOI 10.1016/S1388-9842(02)00177-0; SHI Y, 2006, REGUL PEPTIDES, V15, P27; Signore AP, 2008, J NEUROCHEM, V106, P1977, DOI 10.1111/j.1471-4159.2008.05457.x; Spear ML, 2001, BIOL NEONATE, V80, P35, DOI 10.1159/000047117; Stover John F, 2003, Med Sci Monit, V9, pBR382; Tang BL, 2008, BIOCHEM BIOPH RES CO, V368, P181, DOI 10.1016/j.bbrc.2008.01.063; van Crevel R, 2002, J CLIN ENDOCR METAB, V87, P758, DOI 10.1210/jc.87.2.758; Wei HH, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-19; Zhang F, 2008, J NEUROCHEM, V107, P578, DOI 10.1111/j.1471-4159.2008.05645.x	23	3	4	0	0	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.		2011	17	4					298	302		10.5505/tjtes.2011.69077			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	813EU	WOS:000294350400003	21935825	Bronze			2022-02-06	
J	Keightley, M; Green, S; Reed, N; Agnihotri, S; Wilkinson, A; Lobaugh, N				Keightley, Michelle; Green, Stephanie; Reed, Nick; Agnihotri, Sabrina; Wilkinson, Amy; Lobaugh, Nancy			An Investigation of the Effects of Sports-related Concussion in Youth Using Functional Magnetic Resonance Imaging and the Head Impact Telemetry System	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Medicine; Issue 47; Mild traumatic brain injury; concussion; fMRI; youth; Head Impact Telemetry System	FOOTBALL; CHILDREN	One of the most commonly reported injuries in children who participate in sports is concussion or mild traumatic brain injury (mTBI)(1). Children and youth involved in organized sports such as competitive hockey are nearly six times more likely to suffer a severe concussion compared to children involved in other leisure physical activities(2). While the most common cognitive sequelae of mTBI appear similar for children and adults, the recovery profile and breadth of consequences in children remains largely unknown(2), as does the influence of pre-injury characteristics (e.g. gender) and injury details (e.g. magnitude and direction of impact) on long-term outcomes. Competitive sports, such as hockey, allow the rare opportunity to utilize a pre-post design to obtain pre-injury data before concussion occurs on youth characteristics and functioning and to relate this to outcome following injury. Our primary goals are to refine pediatric concussion diagnosis and management based on research evidence that is specific to children and youth. To do this we use new, multi-modal and integrative approaches that will: 1. Evaluate the immediate effects of head trauma in youth 2. Monitor the resolution of post-concussion symptoms (PCS) and cognitive performance during recovery 3. Utilize new methods to verify brain injury and recovery To achieve our goals, we have implemented the Head Impact Telemetry (HIT) System. (Simbex; Lebanon, NH, USA). This system equips commercially available Easton S9 hockey helmets (Easton-Bell Sports; Van Nuys, CA, USA) with single-axis accelerometers designed to measure real-time head accelerations during contact sport participation (3 - 5). By using telemetric technology, the magnitude of acceleration and location of all head impacts during sport participation can be objectively detected and recorded. We also use functional magnetic resonance imaging (fMRI) to localize and assess changes in neural activity specifically in the medial temporal and frontal lobes during the performance of cognitive tasks, since those are the cerebral regions most sensitive to concussive head injury (6). Finally, we are acquiring structural imaging data sensitive to damage in brain white matter.	[Keightley, Michelle; Green, Stephanie; Reed, Nick; Agnihotri, Sabrina] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5S 1A1, Canada; [Keightley, Michelle] Univ Toronto, Toronto, ON M5S 1A1, Canada; [Keightley, Michelle; Wilkinson, Amy] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Keightley, Michelle] Bloorview Kids Rehab, Toronto, ON, Canada; [Keightley, Michelle] Toronto Rehab, Toronto, ON, Canada; [Lobaugh, Nancy] Sunnybrook Hlth Sci Ctr, Stony Brook, NY USA; [Lobaugh, Nancy] Univ Toronto, Fac Med, Toronto, ON M5S 1A1, Canada		Keightley, M (corresponding author), Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5S 1A1, Canada.	michelle.keightley@utoronto.ca			Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Ontario Neurotrauma Foundation (ONF)	We would like to thank the Canadian Institutes of Health Research (CIHR) and the Ontario Neurotrauma Foundation (ONF) who have provided funding for this research.	[Anonymous], 2010, MULT AUD STEAD STAT; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Frackowiack R.S.J., 2003, HUMAN BRAIN FUNCTION; Gibson E., 2009, J MAGN IN PRESS  OCT; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McIntosh AR, 1996, NEUROIMAGE, V3, P143, DOI 10.1006/nimg.1996.0016; MCINTOSH AR, 1994, J NEUROPHYSIOL, V72, P1717, DOI 10.1152/jn.1994.72.4.1717; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024	14	3	3	1	19	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	JAN	2011		47							e2226	10.3791/2226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V36LF	WOS:000209212800008	21248710	Green Published			2022-02-06	
J	Kopczak, A; von Rosen, F; Krewer, C; Schneider, HJ; Stalla, GK; Schneider, M				Kopczak, A.; von Rosen, F.; Krewer, C.; Schneider, H. J.; Stalla, G. K.; Schneider, M.			Differences in the insulin tolerance test in patients with brain damage depending on posture	EUROPEAN JOURNAL OF ENDOCRINOLOGY			English	Article							GROWTH HORMONE RESPONSE; FATTY ACID CORTISOL; PITUITARY DYSFUNCTION; INJURY; HYPOGLYCEMIA; HYPOPITUITARISM; PREVALENCE; MULTICENTER; VALUES	Objective: The insulin tolerance test (ITT) is the gold standard for the diagnosis of GH deficiency (GHD) and hypocortisolism. As hypopituitarism is a common disorder after traumatic brain injury (TBI) and subarachnoid hemorrhage (SAH), the test is increasingly used in patients with pre-existing brain damage. Design: A cross-sectional, observational study. Methods: Fifty-six patients (41 TBI and 15 SAH) were tested with the ITT (0.15 IE/kg body weight, mean glucose 33 mg/dl). In 38 patients, the test was performed in a supine position; the other 18 patients were in a sitting position during the ITT. Results: Hypocortisolism and GHD were more often diagnosed in a supine than in a sitting position (hypocortisolism: 55.3% supine versus 0% sitting, P < 0.0001; GHD: 42.1% supine versus 11.1% sitting, P = 0.03). Patients in a sitting position suffered more often from symptoms such as tachycardia (61.1% sitting versus 15.8% supine, P = 0.001), trembling (22.2 vs 7.9%, NS), and sweating (66.7 vs 28.9%, P = 0.007). There were no significant differences between the groups in drowsiness (72.2% sitting versus 65.8% supine, NS), dizziness (44.4 vs 44.7%, NS), and fatigue (33.3 vs 15.8%, NS). Because of somnolence, the hypoglycemic state could only be stopped with i.v. administration of glucose in 25 supine patients (66%). In contrast, none of the 18 patients (0%) tested in a sitting position got somnolent or was in need of i.v. application of glucose (P < 0.001). Conclusions: In patients with brain injury, posture might affect rates of diagnosing GHD and hypocortisolism and sympathetic symptoms in the ITT. These findings are exploratory and need replication in a standardized setting.	[Kopczak, A.; Krewer, C.; Schneider, M.] Schon Klin Bad Aibling, D-83043 Bad Aibling, Germany; [von Rosen, F.] Schon Klin Bad Staffelstein, D-96231 Bad Staffelstein, Germany; [Schneider, H. J.] Univ Munich, Univ Hosp Innenstadt, D-80336 Munich, Germany; [Stalla, G. K.] Max Planck Inst Psychiat, Clin Endocrinol Grp, D-80804 Munich, Germany		Schneider, M (corresponding author), Schon Klin Bad Aibling, Kolbermoorer Str 72, D-83043 Bad Aibling, Germany.	mschneider@schoen-kliniken.de	Krewer, Carmen/H-2845-2019	Krewer, Carmen/0000-0002-4153-0791; Kopczak, Anna/0000-0002-5037-2342	Pfizer GmbH, Germany [NRA 6280051]	This work was part of the project 'Patients after traumatic brain injury or subarachnoid hemorrhage - screening for hypopituitarism' (project number NRA 6280051), which was supported by an unrestricted grant from Pfizer GmbH, Germany.	Berg C, 2010, EXP CLIN ENDOCR DIAB, V118, P139, DOI 10.1055/s-0029-1225611; BORG WP, 1994, J CLIN INVEST, V93, P1677, DOI 10.1172/JCI117150; Borm K, 2005, EUR J ENDOCRINOL, V153, P521, DOI 10.1530/eje.1.01992; Brabant G, 2003, HORM RES, V60, P53, DOI 10.1159/000071871; Greenwald BND, 2009, MT SINAI J MED, V76, P182, DOI 10.1002/msj.20103; GREENWOO.FC, 1966, J CLIN INVEST, V45, P429, DOI 10.1172/JCI105357; HOFFMAN DM, 1994, LANCET, V344, P482, DOI 10.1016/S0140-6736(94)91821-X; Horne RSC, 2002, EARLY HUM DEV, V69, P25, DOI 10.1016/S0378-3782(02)00025-7; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; LANDON J, 1966, J CLIN INVEST, V45, P437, DOI 10.1172/JCI105358; Luther MS, 2008, CLIN REHABIL, V22, P1034, DOI 10.1177/0269215508092821; Nye EJ, 2001, J NEUROENDOCRINOL, V13, P524, DOI 10.1046/j.1365-2826.2001.00664.x; Routh VH, 2002, PHYSIOL BEHAV, V76, P403, DOI 10.1016/S0031-9384(02)00761-8; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Skinner RD, 2004, PROG BRAIN RES, V143, P291, DOI 10.1016/S0079-6123(03)43028-8; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Yeste D, 2007, HORM RES, V67, P42, DOI 10.1159/000096055	20	3	3	0	2	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	0804-4643	1479-683X		EUR J ENDOCRINOL	Eur. J. Endocrinol.	JAN	2011	164	1					31	36		10.1530/EJE-10-0821			6	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	698ZF	WOS:000285633000005	20980438	Bronze			2022-02-06	
B	Kovarsky, D; Walsh, I		Candlin, CN; Sarangi, S		Kovarsky, Dana; Walsh, Irene			Uncomfortable moments in speech-language therapy discourse	HANDBOOK OF COMMUNICATION IN ORGANISATIONS AND PROFESSIONS	Handbooks of Applied Linguistics-Communication Competence Language and Communication Problems Practical Solutions		English	Article; Book Chapter								We examined uncomfortable moments that surfaced as speech-language pathologists (SLPs) were engaged in therapy. Their clients were adults with aphasia and traumatic brain injury. The uncomfortable moments involved instances when positive rapport was threatened by challenges to the professional face of the SLPs. Such moments did not occur frequently and were of interest because of the premium placed on avoiding them. Analysis revealed that when therapy participants competed over the interpretation of communicative actions and events, the construal and evaluation of meaning was dominated by a clinical logic rooted in traditional, impairment-based therapy. Here, an underlying conduit metaphor of communication (Reddy 1979) and oracular reasoning (Mehan 1990) contributed to the construction of uncomfortable moments. Implications are discussed in terms of alternative models of intervention that are evolving.	[Walsh, Irene] Univ Dublin Trinity Coll, Speech & Language Pathol, Dublin 2, Ireland		Kovarsky, D (corresponding author), Univ Rhode Isl, Dept Commun Disorders, Kingston, RI 02881 USA.			Walsh, Irene/0000-0003-4009-2627			Ainsworth-Vaughn N., 1998, CLAIMING POWER DOCTO; Bobkoff K., 1986, CHILD LANG TEACH THE, V2, P50, DOI [10.1177/026565908600200105, DOI 10.1177/026565908600200105]; Cazden CourtneyB., 1988, CLASSR DISCOURSE; Duchan J, 2001, TOP LANG DISORD, V22, P37, DOI 10.1097/00011363-200111000-00005; Duchan J., 2005, DIAGNOSIS CULTURAL P; Elman R. J., 2005, APHASIA RELATED NEUR, P39; Erickson F., 1982, COUNSELOR GATEKEEPER; Ferrara K., 1994, THERAPEUTIC WAYS WOR; Goffman Erving, 1981, FORMS TALK; Gumperz J., 1982, DISCOURSE STRATEGIES; Hand Linda, 2003, THESIS DEP LING MACQ; Hanks W., 1996, LANGUAGE COMMUNICATI; KOVARSKY D, 1992, TOP LANG DISORD, V12, P76, DOI 10.1097/00011363-199205000-00009; Kovarsky D, 1997, LANG SPEECH HEAR SER, V28, P219, DOI 10.1044/0161-1461.2803.219; Kovarsky D, 1999, CONSTRUCTING (IN) COMPETENCE, P291; Kovarsky Dana, 2007, Commun Med, V4, P53, DOI 10.1515/CAM.2007.029; Kovarsky Dana, 1989, THESIS U TEXAS AUSTI; LABOV W., 1977, THERAPEUTIC DISCOURS; Levinson, 1987, POLITENESS SOME UNIV; Marshall R., 1993, AM J SPEECH-LANG PAT, V2, P31, DOI DOI 10.1044/1058-0360.0202.31; Maynard DW, 1999, CONSTRUCTING (IN) COMPETENCE, P171; McTear M., 1991, MISCOMMUNICATION PRO, P195; MEHAN H, 1990, CONFLICT TALK SOCIOL, P160; MEITUS IJ, 1983, DIAGNOSIS SPEECH LAN; Ortony A., 1979, METAPHOR THOUGHT, P284, DOI DOI 10.1017/CBO9781139173865.012; Panagos John M., 1996, P41; PRUTTING CA, 1978, J SPEECH HEAR DISORD, V43, P123, DOI 10.1044/jshd.4302.123; Ripich D., 1984, J CHILDHOOD COMMUNIC, V7, P17; Simmons-Mackie N, 1999, CONSTRUCTING (IN) COMPETENCE, P313; Simmons-Mackie N, 2007, TOP LANG DISORD, V27, P5, DOI 10.1097/00011363-200701000-00003; Simmons-Mackie Nina, 2001, LANGUAGE INTERVENTIO, P246; Sinclair John McHardy, 1975, ANAL DISCOURSE ENGLI; Spencer-Oatey Helen, 2005, J POLITENESS RES-LAN, V1, P95, DOI DOI 10.1515/JPLR.2005.1.1.95; van Kleeck Anne, 1986, NSSLHA J, V14, P25; Walsh IP, 2007, TOP LANG DISORD, V27, P24, DOI 10.1097/00011363-200701000-00004	35	3	3	0	2	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY			978-3-11-021422-2; 978-3-11-018831-8	HANDB APPL LINGUIST			2011	3						193	214			10.1515/9783110214222		22	Linguistics; Language & Linguistics	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Linguistics	BC4JQ	WOS:000352563900009					2022-02-06	
B	McGuire, JR		Brashear, A; Elovic, E		McGuire, John R.			Epidemiology of Spasticity in the Adult and Child	SPASTICITY: DIAGNOSIS AND MANAGEMENT			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; CEREBRAL-PALSY; UNITED-STATES; MULTIPLE-SCLEROSIS; PREVALENCE; STROKE; SCALE; PATHOPHYSIOLOGY; ASSOCIATION		Med Coll Wisconsin, Dept Phys Med & Rehabil, Milwaukee, WI 53226 USA		McGuire, JR (corresponding author), Med Coll Wisconsin, Dept Phys Med & Rehabil, Milwaukee, WI 53226 USA.						Anson CA, 1996, INT J REHABIL RES, V19, P55, DOI 10.1097/00004356-199603000-00006; Appelros P, 2002, CEREBROVASC DIS, V14, P161, DOI 10.1159/000065680; ASHWORTH B, 1964, PRACTITIONER, V192, P540; Barnes MP, 2003, NEUROREHAB NEURAL RE, V17, P66, DOI 10.1177/0888439002250449; Bejot Y, 2007, J NEUROL SCI, V262, P85, DOI 10.1016/j.jns.2007.06.025; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Brown AW, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2007.12.001; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Burke D, 1988, Adv Neurol, V47, P401; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; CARR JH, 1985, PHYS THER, V65, P175, DOI 10.1093/ptj/65.2.175; Denny-Brown D., 1966, CEREBRAL CONTROL MOV, P170; Elovic E, 2001, STATE ART REV REHABI, V15, P327; Elovic EP, 2004, J HEAD TRAUMA REHAB, V19, P155, DOI 10.1097/00001199-200403000-00007; Francisco GE, 2002, ARCH PHYS MED REHAB, V83, pA21; Frankel H L, 1969, Paraplegia, V7, P179; Goodin DS, 1998, MULT SCLER J, V4, P444, DOI 10.1177/135245859800400508; Gracies JM, 2005, MUSCLE NERVE, V31, P552, DOI 10.1002/mus.20285; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Himpens E, 2008, DEV MED CHILD NEUROL, V50, P334, DOI 10.1111/j.1469-8749.2008.02047.x; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Hutchinson R, 2008, UPPER MOTOR NEURONE SYNDROME AND SPASTICITY: CLINICAL MANAGEMENT AND NEUROPHYSIOLOGY, 2ND EDITION, P214, DOI 10.1017/CBO9780511544866.013; Johnson RL, 1998, SPINAL CORD, V36, P45, DOI 10.1038/sj.sc.3100494; KATZ RT, 1989, ARCH PHYS MED REHAB, V70, P144; KEITH RA, 1997, ADV CLIN ASSESS, V1, P6; Krigger KW, 2006, AM FAM PHYSICIAN, V73, P91; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lance J., 1980, DISORDERED MOTOR CON, P487; Little JF, 1993, REHABILITATION MED P, P666; LITTLE JW, 1989, AM J PHYS MED REHAB, V68, P32, DOI 10.1097/00002060-198902000-00009; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lundstrom E, 2008, EUR J NEUROL, V15, P533, DOI 10.1111/j.1468-1331.2008.02114.x; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; MAHONEY F I, 1965, Md State Med J, V14, P61; Malhotra S, 2008, CLIN REHABIL, V22, P1105, DOI 10.1177/0269215508095089; Mayer Nathaniel H, 2003, Phys Med Rehabil Clin N Am, V14, P855, DOI 10.1016/S1047-9651(03)00093-7; MAYER NH, 1997, MUSCLE NERVE       S, V6, P1; MAYNARD FM, 1990, ARCH PHYS MED REHAB, V71, P566; McGuire J, 1996, MED MANAGEMENT LONG, P277; MUTCH L, 1992, DEV MED CHILD NEUROL, V34, P547; Neyer JR, 2007, JAMA-J AM MED ASSOC, V298, P279; Noreau L, 2000, AM J PHYS MED REHAB, V79, P526, DOI 10.1097/00002060-200011000-00009; ODwyer NJ, 1996, BRAIN, V119, P1737, DOI 10.1093/brain/119.5.1737; Paneth N, 2006, CLIN PERINATOL, V33, P251, DOI 10.1016/j.clp.2006.03.011; RANKIN J, 1957, Scott Med J, V2, P200; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rizzo MA, 2004, MULT SCLER, V10, P589, DOI 10.1191/1352458504ms1085oa; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Semlyen JK, 1996, J NEUROL REHABIL, V10, P251; Sheean G, 2008, UPPER MOTOR NEURONE SYNDROME AND SPASTICITY: CLINICAL MANAGEMENT AND NEUROPHYSIOLOGY, 2ND EDITION, P9, DOI 10.1017/CBO9780511544866.003; Skold C, 1999, ARCH PHYS MED REHAB, V80, P1548, DOI 10.1016/S0003-9993(99)90329-5; Sommerfeld DK, 2004, STROKE, V35, P134, DOI 10.1161/01.STR.0000105386.05173.5E; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; *US DEP HHS, 2006, INT CLASS SIS 9 REV; WADE DT, 1987, J NEUROL NEUROSUR PS, V50, P177, DOI 10.1136/jnnp.50.2.177; Walter JS, 2002, J REHABIL RES DEV, V39, P53; Watkins, 1999, PHYSIOTHERAPY, V85, P405, DOI 10.1016/S0031-9406(05)65498-3; Watkins CL, 2002, CLIN REHABIL, V16, P515, DOI 10.1191/0269215502cr512oa; Wedekind C, 2005, BRAIN INJURY, V19, P681, DOI 10.1080/02699050400025182; Welmer AK, 2006, CEREBROVASC DIS, V21, P247, DOI 10.1159/000091222; Wichers MJ, 2005, DISABIL REHABIL, V27, P583, DOI 10.1080/09638280400018445; Yeargin-Allsopp M, 2008, PEDIATRICS, V121, P547, DOI 10.1542/peds.2007-1270	62	3	3	0	2	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-933864-51-8				2011							5	15					11	Clinical Neurology; Rehabilitation	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Rehabilitation	BQT45	WOS:000281793400002					2022-02-06	
B	Moore, BA; Hopewell, CA; Grossman, D		Freeman, SM; Moore, BA; Freeman, A		Moore, Bret A.; Hopewell, C. Alan; Grossman, Dave			After the Battle: Violence and the Warrior	LIVING AND SURVIVING IN HARMS WAY: A PSYCHOLOGICAL TREATMENT HANDBOOK FOR PRE- AND POST-DEPLOYMENT OF MILITARY PERSONNEL			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; PREDICTION; VIETNAM		[Moore, Bret A.] Indian Hlth Serv, Ft Peck, MT USA; [Moore, Bret A.] USA, Combat Stress Control Unit 85, Ft Hood, TX USA; [Hopewell, C. Alan] Moncrief Army Hosp, Ft Jackson, SC USA; [Hopewell, C. Alan] Landstuhl Army Reg Med Ctr, Landstuhl, Germany; [Hopewell, C. Alan] Brooke Army Med Ctr, Ft Sam Houston, TX 78234 USA		Moore, BA (corresponding author), Indian Hlth Serv, Ft Peck, MT USA.						Bonta J, 1998, PSYCHOL BULL, V123, P123, DOI 10.1037/0033-2909.123.2.123; CASTRO C, 2006, BATTLEMIND; Csikszentmihalyi M., 1990, FLOW PSYCHOL OPTIMAL; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; DONAVONWESTBY MD, 1999, GENETIC SOCIAL GEN P, V125, P75; *DVBIC, 2006, DEF VET BRAIN INJ CT; Eaves D., 1999, SPOUSAL ASSAULT RISK; EPPERSON DL, 1995, ANN C ASS TREATM SEX; Grossman D., 2007, COMBAT PSYCHOL PHYSL; Grossman D., 1995, KILLING PSYCHOL COST; Hall H. V., 2002, VIOLENCE PREDICTION; Hanson RK, 1998, J CONSULT CLIN PSYCH, V66, P348, DOI 10.1037/0022-006X.66.2.348; Hare RD, 1991, MANUAL HARE PSYCHOPA; Harris GT, 1997, PSYCHIAT SERV, V48, P1168; HODIERNE R, 2007, NAVY TIMES      0325; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HOPEWELL CA, 2007, MILITARY PERSONNEL C; JAMES W, 2003, HABIT; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Monahan J, 1996, CRIM JUSTICE BEHAV, V23, P107, DOI 10.1177/0093854896023001008; Monahan J., 1994, VIOLENCE MENTAL DISO; *NCPTSD, 2004, IR WAR CLIN GUID; PARADIS CM, 1994, HOSP COMMUNITY PSYCH, V45, P714; Schopp RF, 1996, AM PSYCHOL, V51, P939; SCHOPP RF, 1995, BEHAV SCI LAW, V13, P159, DOI 10.1002/bsl.2370130203; Schultz D. P., 1987, HIST MODERN PSYCHOL; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taft C., 2004, IRAQ WAR CLIN GUIDE, P70; Taft CT, 2007, J FAM PSYCHOL, V21, P270, DOI 10.1037/0893-3200.21.2.270; Taft CT, 2005, J CONSULT CLIN PSYCH, V73, P151, DOI 10.1037/0022-006X.73.1.151; TONKONOGY JM, 1992, J NEUROPSYCH CLIN N, V4, P45; Whitley, 1998, STOLEN VALOR VIETNAM; *WIK, 2008, CRIM WASH DC; WOLFGANG J, 1985, NCJ96017; Zoroya G., 2005, US TODAY        0303, P1; ZOROYA G, 2007, US TODAY        1122, P3; 2007, STARS STRIPES   1222, P2; 2004, NEW YORK POST   1219, P28	38	3	3	0	2	ROUTLEDGE	ABINGDON	2 PARK SQ, MILTON PARK, ABINGDON OX14 4RN, OXFORD, ENGLAND			978-0-203-89390-6				2011							307	327					21	Psychology, Clinical; Psychiatry	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Psychology; Psychiatry	BUU04	WOS:000290304900017					2022-02-06	
J	O'Donnell, L; Begg, L; Lipson, L; Elvander, E				O'Donnell, Lolita; Begg, Lisa; Lipson, Linda; Elvander, Erika			Trauma Spectrum Disorders: Emerging Perspectives on the Impact on Military and Veteran Families	JOURNAL OF LOSS & TRAUMA			English	Article								This article summarizes the findings from the Second Annual Trauma Spectrum Disorders Conference, which was held in December 2009 and was sponsored by the Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury in conjunction with the Department of Veterans Affairs and the National Institutes of Health. The conference covered recent research on the impact of trauma spectrum disorders on military and veteran families and caregivers during deployment, homecoming, and reintegration. Attendees highlighted the need for research studies that examine the needs of warriors with trauma spectrum disorders on a deeper level. Current interventions for trauma spectrum disorders were discussed, as well as recommendations for advancing the quality of care for warriors and their families in the future.	[O'Donnell, Lolita; Begg, Lisa; Lipson, Linda; Elvander, Erika] Def Ctr Excellence Psychol Hlth & Traumat Brain I, Arlington, VA USA		O'Donnell, L (corresponding author), 2345 Crystal Dr,Suite 120, Arlington, VA 22202 USA.	Lolita.Odonnell@tma.osd.mil					*DEF CTR EXC, 2009, P 2 ANN TRAUM SPECTR; FLAKE E, 2009, VOICES CHILDREN ADOL; RAND, 2008, INV WOUNDS WAR PSYCH, VMG-720-CCF	3	3	3	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1532-5024			J LOSS TRAUMA	J. Loss Trauma		2011	16	3					284	290		10.1080/15325024.2010.519269			7	Psychology, Social	Social Science Citation Index (SSCI)	Psychology	766LQ	WOS:000290784200006					2022-02-06	
B	Schultz, IZ; Winter, A; Wald, J		Schultz, IZ; Rogers, ES		Schultz, Izabela Z.; Winter, Alanna; Wald, Jaye			Evidentiary Support for Best Practices in Job Accommodation in Mental Health: Employer-Level Interventions	WORK ACCOMMODATION AND RETENTION IN MENTAL HEALTH			English	Article; Book Chapter							TRAUMATIC BRAIN INJURY; PSYCHIATRIC DISABILITIES; WORKPLACE; ILLNESS; PEOPLE; WORK; STIGMA; REHABILITATION; PERFORMANCE; EXPERIENCES		[Wald, Jaye] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2A1, Canada; [Schultz, Izabela Z.] Univ British Columbia, Scarfe Lib 297, Dept Educ & Counselling Psychol & Special Educ, Vancouver, BC V6T 1Z4, Canada		Wald, J (corresponding author), Univ British Columbia, Dept Psychiat, 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada.	ischultz@telus.net; alanna.winter@worksafebc.com; jwald@interchange.ubc.ca; ischultz@telus.net					AKABAS SH, 2004, MENTAL HLTH DISORDER; Angermeyer MC, 2004, INT J SOC PSYCHIATR, V50, P153, DOI 10.1177/0020764004043115; Atkins R., 2002, BR J THER REHABIL, V9, P92; BALDWIN M, 2010, HDB JOB ACCOMMODATIO; Banks B, 2001, PSYCHIATR REHABIL J, V24, P389, DOI 10.1037/h0095066; BELL H, 2003, J VOCAT REHABIL, V18, P43; Berndt ER, 1998, J HEALTH ECON, V17, P511, DOI 10.1016/S0167-6296(97)00043-X; Beyer S., 1999, J VOCATIONAL REHABIL, V12, P137; Bond GR, 2001, PSYCHIATR SERV, V52, P313, DOI 10.1176/appi.ps.52.3.313; Bond GR, 1997, PSYCHIATR SERV, V48, P335; CENTER C, 2010, HDB WORK ACCOMMODATI; COLES A, 1996, J APPL REHABIL COUNS, V27, P40; Corrigan PW, 2007, REHABIL PSYCHOL, V52, P451, DOI 10.1037/0090-5550.52.4.451; Crowther RE, 2001, BMJ-BRIT MED J, V322, P204, DOI 10.1136/bmj.322.7280.204; Curl RM, 1996, J HEAD TRAUMA REHAB, V11, P75, DOI 10.1097/00001199-199602000-00009; Dewa Carolyn S, 2004, Healthc Pap, V5, P12; Dewa CS, 2000, SOC SCI MED, V51, P41, DOI 10.1016/S0277-9536(99)00431-1; DEWA CS, 2010, HDB WORK ACCOMMODATI; Fabian E. S., 1993, PSYCHOSOC REHABIL, V17, P164, DOI DOI 10.1037/H0095591; Franche RL, 2005, HANDBOOK OF COMPLEX OCCUPATIONAL DISABILITY CLAIMS: EARLY RISK IDENTIFICATIONS, INTERVENTION, AND PREVENTION, P93, DOI 10.1007/0-387-28919-4_5; Gates LB, 1998, PSYCHIATR REHABIL J, V21, P264, DOI 10.1037/h0095303; GATES LB, 2010, HDB WORK ACCOMMODATI; Gerber PJ, 2003, LEARNING DISABILITIE, V18, P132; GNAM WH, 2005, HDB COMPLEX OCCUPATI; Goldner Elliot, 2004, Healthc Pap, V5, P76; Granger B, 1997, J VOCAT REHABIL, V9, P235, DOI DOI 10.1016/S1052; GREENWOOD R, 1987, J REHABIL, V53, P37; HAFFEY WJ, 1991, J HEAD TRAUMA REHAB, V6, P24; HARNOIS G, 2000, MENTAL HLTH WORK IMP, P1; Haslam C, 2005, J AFFECT DISORDERS, V88, P209, DOI 10.1016/j.jad.2005.07.009; Hirsh A, 1996, J VOCAT REHABIL, V7, P217; Holzberg Emily, 2001, Work, V16, P245; JACOBS HE, 1992, HOSP COMMUNITY PSYCH, V43, P365; JACOBS HE, 1984, REHABIL COUNS BULL, V24, P87; *JAN, 2010, ACC SEAR MENT HLTH I; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; MacDonald-Wilson KL, 2002, COMMUNITY MENT HLT J, V38, P35, DOI 10.1023/A:1013955830779; MACDONALDWILSON K, 1994, REASONABLE WORKPLACE; MACDONALDWILSON KL, 2010, HDB WORK ACCOMMODATI; Mancuso L., 1993, CASE STUDIES REASONA; Massaro J., 2003, J VOCAT REHABIL, V18, P15; MCFARLIN DB, 1991, EMPLOYEE RESPONSIBIL, V0004, P00107; McHugh S., 2002, J VOCATIONAL REHABIL, V17, P155; MEANS CD, 1997, J APPL REHABIL COUNS, V28, P13; Mpofu E, 1999, J REHABIL, V65, P33; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P495; *NOD, 2004, LANDM DIS SURV FINDS; Rogan P, 2003, J VOCATIONAL REHABIL, V19, P5; ROGERS ES, 2010, HDB WORK ACCOMMODATI; Schultz I. Z., 2010, HDB JOB ACCOMMODATIO; Standing Senate Committee on Social Affairs Science and Technology, 2004, MENT HLTH MENT DIS A, P1; Stengler-Wenzke K, 2004, FORTSCHR NEUROL PSYC, V72, P7; Storey K, 1996, REHABIL COUNS BULL, V40, P62; WARREN CG, 2000, TRAUMATIC BRAIN INJU, P129; WEED RO, 1993, NARPPS J, V8, P126; WEHMAN P, 1993, AM J PHYS MED REHAB, V72, P355; World Health Organization, 2001, WORLD HLTH REP 2001; [No title captured]	58	3	3	0	3	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-1-4419-0427-0				2011							409	423		10.1007/978-1-4419-0428-7_22	10.1007/978-1-4419-0428-7		15	Public, Environmental & Occupational Health; Psychology; Psychology, Multidisciplinary	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Public, Environmental & Occupational Health; Psychology	BSO47	WOS:000285117700022					2022-02-06	
J	Smrcka, M				Smrcka, Martin			Monitoring of Patients with Severe Head Injury	CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE			Czech	Article						severe head injury; multimodal monitoring	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; NEAR-INFRARED SPECTROSCOPY; INTRA-CRANICAL PRESSURE; TISSUE OXYGEN; INTRACRANIAL-PRESSURE; REGIONAL OXYGENATION; CLINICAL-EXPERIENCE; BLOOD-FLOW; METABOLISM	Head injury is defined as severe in patients with a post-resuscitation Glasgow coma scale (GCS) figure of <= 8. Such patients are relatively deeply unconscious and cannot follow instructions. Therefore we need continuously to monitor those parameters that provide us with important information regarding patient condition and brain function. in recent years, the possibility of monitoring certain cerebral and intracranial function parameters has been added to the routine intensive care watch repertoire of pulse oxymetry, blood pressure, body temperature, laboratory monitoring, central venous pressure, fluid balance, end-tidal CO2, etc. Monitoring of neurological status, particularly the level of consciousness (GCS) and the pupils is obvious. In terms of invasive intracranial monitoring it is currently practically mandatory that intracranial pressure (ICP) be monitored, either by means of external ventricular drainage or by intraparenchymal probe. As well as this, we monitor cerebral perfusion pressure (CPP). Monitoring of brain tissue oxymetry (PtiO(2)) is becoming a standard modality, while microdialysis is also frequent in some departments. CT monitoring is very important to the clinician, particularly in the initial phases after the injury, mainly as an indication for decision-making in certain operative procedures. Individual approaches to multimodal monitoring have to be evaluated in relationship to one another and the patient. Special types of software help us to evaluate the indices of vascular reactivity and this knowledge is currently used to establish the optimal CPP for the individual patient. Monitoring of cerebral physiology should not be purposeless, but should serve for early diagnostics of pathological conditions and at the same time may indicate a correctly performed therapeutical intervention.	[Smrcka, Martin] LF MU, Neurochirurg Klin, Brno 62500, Czech Republic; [Smrcka, Martin] FN Brno, Brno 62500, Czech Republic		Smrcka, M (corresponding author), LF MU, Neurochirurg Klin, Jihlavska 20, Brno 62500, Czech Republic.	msmrcka@fnbrno.cz	Smrcka, Martin/AAM-8872-2021	Smrcka, Martin/0000-0002-9191-8700			American Association of Neurological Surgeons, 1996, J NEUROTRAUM, V13, P639; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; *BRAIN TRAUM FDN, 2007, J NEUROTRAUMA S1, V24, pS45; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Buchner K, 2000, ZBL NEUROCHIR, V61, P69, DOI 10.1055/s-2000-8262; CONTANT CF, 1993, J NEUROTRAUMA S1, V10, pS102; CRUZ J, 1993, J NEUROSURG, V79, P228, DOI 10.3171/jns.1993.79.2.0228; CRUZ J, 1993, CRIT CARE MED, V21, P1225, DOI 10.1097/00003246-199308000-00025; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Filaun M, 2008, CESK SLOV NEUROL N, V71, P657; Filippi R, 2000, NEUROSURG REV, V23, P94; Fox JL, 2010, CAN J EMERG MED, V12, P355; Gal R, 2007, CESK SLOV NEUROL N, V70, P562; Gautschi OP, 2009, ANASTH INTENSIV NOTF, V44, P268, DOI 10.1055/s-0029-1222434; Gibbs EL, 1942, J BIOL CHEM, V144, P325; HATIBOGLU MT, 1992, J ANAT, V180, P191; Hejcl A, 2009, CESK SLOV NEUROL N, V72, P511; Hejcl A, 2007, Cas Lek Cesk, V146, P307; Hlatky Roman, 2002, Curr Opin Anaesthesiol, V15, P489, DOI 10.1097/00001503-200210000-00003; Hoelper BM, 2005, ACTA NEUROCHIR, V147, P767, DOI 10.1007/s00701-005-0512-8; Jaeger M, 2005, ACT NEUR S, V95, P117; Jaeger M, 2005, ACTA NEUROCHIR, V147, P51, DOI 10.1007/s00701-004-0408-z; Jimenez R, 2006, PEDIATR NEUROL, V35, P261, DOI 10.1016/j.pediatrneurol.2006.05.004; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; KIRKPATRICK PJ, 1995, J NEUROSURG, V83, P963, DOI 10.3171/jns.1995.83.6.0963; Langfitt T W, 1969, Clin Neurosurg, V16, P436; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; MILLER JD, 1973, ARCH NEUROL-CHICAGO, V28, P265, DOI 10.1001/archneur.1973.00490220073011; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; PARAMORE CG, 1994, ACTA NEUROCHIR, V127, P79, DOI 10.1007/BF01808552; PIEK J, 1990, INTENS CARE MED, V16, P184, DOI 10.1007/BF01724800; Poca MA, 2005, NEUROCIRUGIA, V16, P301; Powner David J, 2005, J Intensive Care Med, V20, P28, DOI 10.1177/0885066604271750; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; Rosenthal G, 2011, J NEUROSURG, V114, P62, DOI 10.3171/2010.6.JNS091360; Schneider GH, 2002, ACT NEUR S, V81, P77; Sinclair HL, 2010, CRIT CARE, V14, DOI 10.1186/cc8220; Smielewski P, 2008, ACTA NEUROCHIR SUPPL, V102, P145, DOI 10.1007/978-3-211-85578-2_30; Stahl N, 2001, INTENS CARE MED, V27, P1215, DOI 10.1007/s001340101004; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; STOCCHETTI N, 1994, NEUROSURGERY, V34, P38; TEASDALE G, 1974, LANCET, V2, P81; UNGERSTEDT U, 1974, B SCHWEIZ AKAD MED, V30, P44; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Wahlstrom MR, 2009, ACTA ANAESTH SCAND, V53, P18, DOI 10.1111/j.1399-6576.2008.01798.x; WELCH K, 1980, J NEUROSURG, V52, P693, DOI 10.3171/jns.1980.52.5.0693; White H, 2008, ANESTH ANALG, V107, P979, DOI 10.1213/ane.0b013e31817e7b1a; Wintermark M, 2008, J NEURORADIOLOGY, V35, P253, DOI 10.1016/j.neurad.2008.03.005; YABLON JS, 1993, J CLIN MONITOR, V9, P171, DOI 10.1007/BF01617024; Zweifel C, 2010, J NEUROTRAUM, V27, P1951, DOI 10.1089/neu.2010.1388; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	60	3	3	0	5	CZECH MEDICAL SOC	PRAGUE 2	SOKOLSKA 31, PRAGUE 2 120 26, CZECH REPUBLIC	1210-7859	1802-4041		CESK SLOV NEUROL N	Cesk. Slov. Neurol. Neurochir.		2011	74	1					9	20					12	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	727HB	WOS:000287787700001					2022-02-06	
B	Stanford, LD; Dorflinger, JM		Reynold, CR; FletcherJanzen, E		Stanford, Lisa D.; Dorflinger, Jill M.			Pediatric Brain Injury: Mechanisms and Amelioration	HANDBOOK OF CLINICAL CHILD NEUROPSYCHOLOGY, THIRD EDITION			English	Article; Book Chapter							CLOSED HEAD-INJURY; YOUNG-CHILDREN; UNITED-STATES; COMA; MANAGEMENT; OUTCOMES; TRAUMA; PATHOPHYSIOLOGY; EPIDEMIOLOGY; SEQUELAE		[Stanford, Lisa D.] Univ Illinois, Med Ctr, Dept Psychiat & Neurol, Chicago, IL 60612 USA; [Dorflinger, Jill M.] Alexian Bros Behav Hlth Syst, Hoffman Estates, IL 60169 USA		Stanford, LD (corresponding author), Univ Illinois, Med Ctr, Dept Psychiat & Neurol, Chicago, IL 60612 USA.	LStanford@psych.uic.edu					Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V., 1997, J INT NEUROPSYCH SOC, V3, P553; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Arbogast KB, 2005, PEDIATRICS, V116, P180, DOI 10.1542/peds.2004-2671; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; Atabaki SM, 2007, PEDIATR REV, V28, P215, DOI 10.1542/pir.28-6-215; BALL JD, 1994, ADV MED PSYCHOTHERAP, V7, P39; BARIN JJ, 1985, HEAD INJURY REHABILI, P361; Bates E, 1995, HDB CHILD LANGUAGE, P96; Bauer R, 2004, EXP TOXICOL PATHOL, V56, P65, DOI 10.1016/j.etp.2004.04.002; Beers SR, 2007, J NEUROTRAUM, V24, P97, DOI 10.1089/neu.2006.0055; BENGALI V, 1992, HEAD INJURY CHILDREN; Benz B, 1999, RESTOR NEUROL NEUROS, V14, P135; BIJUR PE, 1990, PEDIATRICS, V86, P337; BIJUR PE, 1995, TRAUMATIC HEAD INJUR, P147; BLACHER J, 1984, SEVERELY HANDICAPPED; BLOOM D, 2000, J INT NEUROPSYCH SOC, V6, P226; Blosser JL, 1991, J HEAD TRAUMA REHAB, V6, P73; BOLL TJ, 1983, J CLIN CHILD PSYCHOL, V12, P74, DOI 10.1080/15374418309533114; BOLL TJ, 1982, HEAD INJURY, P363; BOND MR, 1983, REHABILITATION HEAD, P97; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; BRUCE DA, 1979, CHILD BRAIN, V5, P174; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Coffey C. E., 1998, TXB PEDIAT NEUROPSYC, P1093; Cohen SB, 1985, HEAD INJURY REHABILI, P383; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dennis M, 1994, HDB PERCEPTION COGNI, P219; DEPOMPEI R, 1989, TOP LANG DISORD, V9, P78, DOI 10.1097/00011363-198903000-00008; DIVACK JA, 1985, HEAD INJURY REHABILI, P347; DROTAR D, 1975, PEDIATRICS, V56, P710; Durston S, 2001, J AM ACAD CHILD PSY, V40, P1012, DOI 10.1097/00004583-200109000-00009; EISELE J, 1995, HDB CHILD LANGUAGE, P664; Eisele JA, 2006, J HEAD TRAUMA REHAB, V21, P537, DOI 10.1097/00001199-200611000-00008; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; EWINGCOBBS L, 1985, HEAD INJURY REHABILI, P3; FARMER JE, 1995, SCHOOL PSYCHOL REV, V24, P230; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; GOLDEN CJ, 1983, CLIN NEUROPSYCHOLOGY; GOODGLASS H, 1979, HDB BEHAV NEUROPSYCH, V2, P1; Gray H., 1918, ANATOMY HUMAN BODY; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Gronwall D, 1997, J Int Neuropsychol Soc, V3, P592; HAHN YS, 1988, CHILD NERV SYST, V4, P34; HAUSER WA, 1983, PEDIATRIC HEAD TRAUM, P271; HEBB D. O., 1942, PROC AMER PHIL SOC, V85, P275; Hebb MO, 2007, CAN J SURG, V50, P187; Hymel KP, 2007, PEDIATRICS, V119, P922, DOI 10.1542/peds.2006-3111; JAFFE D, 1991, NEW ENGL J MED, V324, P1477; JAMES HE, 1986, PEDIATR ANN, V15, P16, DOI 10.3928/0090-4481-19860101-05; JENNETT B, 1972, DEV MED CHILD NEUROL, V14, P137; JENNETT B, 1972, SCI F NEUROLOGY, P441; Jennett B, 1981, MANAGEMENT HEAD INJU; Johns Manville Corporation, 1975, FED REG; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kennard MA, 1940, ARCH NEURO PSYCHIATR, V44, P377, DOI 10.1001/archneurpsyc.1940.02280080137008; Kennard MA, 1942, ARCH NEURO PSYCHIATR, V48, P227, DOI 10.1001/archneurpsyc.1942.02290080073002; KLONOFF H, 1971, AM J PUBLIC HEALTH N, V61, P2405, DOI 10.2105/AJPH.61.12.2405; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Kreutzer J, 1988, J HEAD TRAUMA REHAB, V3, P51, DOI DOI 10.1097/00001199-198812000-00008; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEHR E, 1990, PSYCHOL MANAGEMENT T, P99; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; Levin HS., 1982, NEUROBEHAVIORAL CONS; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; Lezak M, 1994, NEUROPSYCHOLOGICAL A; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; McKinlay WW, 1988, J HEAD TRAUMA REHAB, p[3, 64]; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Rosen CD, 1986, HEAD TRAUMA ED REINT; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; RYAN TV, 1996, PAEDIAT NEUROPSYCHOL, P117; SCHNEIDER GE, 1979, NEUROPSYCHOLOGIA, V17, P557, DOI 10.1016/0028-3932(79)90033-2; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; SEMRUDCLIKEMAN M, 1991, HDB PSYCHOSOCIAL CHA, P279; SHAFFER D, 1995, TRAUMATIC HEAD INJUR, P55; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; Tasker RC, 2006, DEV NEUROSCI-BASEL, V28, P302, DOI 10.1159/000094156; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2004, DEV NEUROPSYCHOL, V25, P199, DOI 10.1207/s15326942dn2501&2_11; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; WAALAND PK, 1991, J HEAD TRAUMA REHAB, V3, P51; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; Yeates KO, 1997, J CLIN EXP NEUROPSYC, V19, P825, DOI 10.1080/01688639708403763; Zwienenberg M, 1999, J NEUROTRAUM, V16, P937, DOI 10.1089/neu.1999.16.937; [No title captured]; [No title captured]; 1990, FED REG; [No title captured]	106	3	3	0	1	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-1-4419-8145-5				2011							169	186		10.1007/978-0-387-78867-8_7			18	Psychology, Clinical; Clinical Neurology; Psychology	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Neurosciences & Neurology	BSK48	WOS:000284746000007					2022-02-06	
B	Stover, JF; Stocker, R		Oestern, HJ; Trentz, O; Uranues, S		Stover, John F.; Stocker, Reto			Intensive Care Treatment Options of Elevated Intracranial Pressure Following Severe Traumatic Brain Injury	HEAD, THORACIC, ABDOMINAL, AND VASCULAR INJURIES-TRAUMA SURGERY I	European Manual of Medicine		English	Article; Book Chapter							SEVERE HEAD-INJURY; CEREBRAL-BLOOD-FLOW; ANEURYSMAL SUBARACHNOID HEMORRHAGE; ABDOMINAL COMPARTMENT SYNDROME; CORTICAL SPREADING DEPRESSION; LATE POSTTRAUMATIC SEIZURES; RANDOMIZED CLINICAL-TRIAL; CRITICALLY-ILL PATIENTS; GLASGOW COMA SCALE; CEREBROSPINAL-FLUID		[Stover, John F.; Stocker, Reto] Univ Zurich Hosp, CH-8091 Zurich, Switzerland		Stover, JF (corresponding author), Univ Zurich Hosp, Ramistr 100, CH-8091 Zurich, Switzerland.	john.stover@usz.ch; reto.stocker@usz.ch					Abadal-Centellas JM, 2007, J TRAUMA, V62, P282, DOI 10.1097/01.ta.0000199422.01949.78; An G, 2008, CRIT CARE MED, V36, P1304, DOI 10.1097/CCM.0b013e31816929f4; [Anonymous], 2000, COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD000033; Bartnik BL, 2007, J NEUROTRAUM, V24, P181, DOI 10.1089/neu.2006.0038; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Bayir H, 2008, CRIT CARE, V12, DOI 10.1186/cc6779; Beer R, 2008, J NEUROL, V255, P1617, DOI 10.1007/s00415-008-0059-8; Beghi E, 2003, EPILEPSIA, V44, P21, DOI 10.1046/j.1528-1157.44.s10.1.x; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Bhatia A, 2007, INTENS CARE MED, V33, P1263, DOI 10.1007/s00134-007-0678-z; Bhatia A, 2007, INTENS CARE MED, V33, P1322, DOI 10.1007/s00134-007-0660-9; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Boyer A, 2006, INT J CLIN PHARM TH, V44, P309; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; Chan MTV, 2005, ACT NEUR S, V95, P63; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Chiaretti A, 2008, EUR J PAEDIATR NEURO, V12, P195, DOI 10.1016/j.ejpn.2007.07.016; Citerio G, 2001, CRIT CARE MED, V29, P1466, DOI 10.1097/00003246-200107000-00027; Citerio Giuseppe, 2003, Curr Opin Crit Care, V9, P120, DOI 10.1097/00075198-200304000-00007; Clay AS, 2007, CHEST, V132, P1368, DOI 10.1378/chest.06-2940; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Coles JP, 2007, BRIT J ANAESTH, V99, P49, DOI 10.1093/bja/aem141; Compagnone C, 2007, NEUROSURGERY, V61, P232, DOI [10.1227/01.neu.0000279218.53504.fe, 10.1227/01.NEU.0000186239.10915.09]; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cormio M, 1999, J NEUROTRAUM, V16, P927, DOI 10.1089/neu.1999.16.927; Cremer OL, 2007, PROG BRAIN RES, V162, P153, DOI 10.1016/S0079-6123(06)62009-8; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; Davis DP, 2005, J EMERG MED, V29, P391, DOI 10.1016/j.jemermed.2005.04.012; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; Diaz-Arrastia R, 2006, J HEAD TRAUMA REHAB, V21, P361, DOI 10.1097/00001199-200607000-00007; Dickenmann M, 2008, AM J KIDNEY DIS, V51, P491, DOI 10.1053/j.ajkd.2007.10.044; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dusick JR, 2012, PITUITARY, V15, P2, DOI 10.1007/s11102-008-0130-6; Edwards P, 2005, LANCET, V365, P1957; Ekelund A, 2002, ACTA NEUROCHIR, V144, P703, DOI 10.1007/s00701-002-0959-9; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Feihl F, 2009, INTENS CARE MED, V35, P45, DOI 10.1007/s00134-008-1297-z; Feihl F, 2009, INTENS CARE MED, V35, P198, DOI 10.1007/s00134-008-1298-y; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gaab M R, 1994, Zentralbl Neurochir, V55, P135; GAEHTGENS P, 1987, J CEREBR BLOOD F MET, V7, P259, DOI 10.1038/jcbfm.1987.61; Gale SC, 2007, AM SURGEON, V73, P454; Ge YL, 2007, ACTA ANAESTH SCAND, V51, P1331, DOI 10.1111/j.1399-6576.2007.01448.x; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Goodman JC, 1996, J NEUROTRAUM, V13, P549, DOI 10.1089/neu.1996.13.549; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Hare GMT, 2007, J APPL PHYSIOL, V103, P1021, DOI 10.1152/japplphysiol.01315.2006; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hata JS, 2008, NEUROCRIT CARE, V9, P37, DOI 10.1007/s12028-007-9015-1; Hattori N, 2004, J NUCL MED, V45, P775; Hebb MO, 2007, J NEUROTRAUM, V24, P579, DOI 10.1089/neu.2006.0146; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hedenstierna G, 2000, J CLIN MONITOR COMP, V16, P329, DOI 10.1023/A:1011491231934; Hildreth AN, 2008, J TRAUMA, V65, P573, DOI 10.1097/TA.0b013e31818255e8; Hoedemaekers CW, 2007, CRIT CARE, V11, DOI 10.1186/cc6104; Holbein M, 2009, CRIT CARE, V13, DOI 10.1186/cc7711; Hopwood SE, 2005, J CEREBR BLOOD F MET, V25, P391, DOI 10.1038/sj.jcbfm.9600050; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hutchinson P, 2009, ACTA NEUROCHIR, V151, P51, DOI 10.1007/s00701-008-0169-1; Hutchinson PJ, 2005, PHYSIOL MEAS, V26, P423, DOI 10.1088/0967-3334/26/4/008; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Jaeger M, 2005, ACTA NEUROCHIR, V147, P51, DOI 10.1007/s00701-004-0408-z; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Joseph DK, 2004, J TRAUMA, V57, P687, DOI 10.1097/01.TA.0000140645.84897.F2; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kemp CD, 2008, AM SURGEON, V74, P866; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Kiening KL, 2003, BRIT J NEUROSURG, V17, P311, DOI 10.1080/02688690310001601199; Kirchhoff C, 2008, EUR J MED RES, V13, P464; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kroppenstedt SN, 1999, J NEUROSURG, V90, P520, DOI 10.3171/jns.1999.90.3.0520; Lai Y, 2008, J NEUROCHEM, V104, P1700, DOI 10.1111/j.1471-4159.2007.05114.x; Lavinio A, 2007, BRIT J ANAESTH, V99, P237, DOI 10.1093/bja/aem118; Leal-Noval SR, 2006, INTENS CARE MED, V32, P1733, DOI 10.1007/s00134-006-0376-2; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; Lescot T, 2008, CURR OPIN CRIT CARE, V14, P129, DOI 10.1097/MCC.0b013e3282f63c51; Lewis Charmaine A, 2004, Curr Opin Crit Care, V10, P13, DOI 10.1097/00075198-200402000-00003; Lichter-Konecki U, 2008, J INHERIT METAB DIS, V31, P492, DOI 10.1007/s10545-008-0834-9; Llompart-Pou JA, 2007, J ENDOCRINOL INVEST, V30, P393, DOI 10.1007/BF03346316; LONGSTRETH WT, 1984, ANN NEUROL, V15, P59, DOI 10.1002/ana.410150111; Lozier AP, 2008, NEUROSURGERY, V62, P688, DOI [10.1227/01.neu.0000316273.35833.7c, 10.1227/01.NEU.0000017465.78245.6C]; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Maier B, 2007, SHOCK, V27, P610, DOI 10.1097/shk.0b013e31802f9eaf; Malbrain MLNG, 2005, CURR OPIN CRIT CARE, V11, P156, DOI 10.1097/01.ccx.0000155355.86241.1b; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Marik PE, 2008, CRIT CARE MED, V36, P3080, DOI 10.1097/CCM.0b013e31818c3801; Marin-Caballos A, 2005, CRIT CARE, V9, pR670, DOI 10.1186/cc3822; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; Mazzini L, 2003, EPILEPSIA, V44, P569, DOI 10.1046/j.1528-1157.2003.34902.x; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Meier R, 2008, CRIT CARE, V12, DOI 10.1186/cc6974; Meixensberger J, 2004, NEUROL RES, V26, P414, DOI 10.1179/016164104225014094; Meixensberger J, 2001, NEUROL RES, V23, P801, DOI 10.1179/016164101101199379; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Metz C, 1998, J CEREBR BLOOD F MET, V18, P332, DOI 10.1097/00004647-199803000-00012; Minambres E, 2003, CRIT CARE MED, V31, P933, DOI 10.1097/01.CCM.0000055370.66389.59; Mirzayan MJ, 2008, NEUROL RES, V30, P457, DOI 10.1179/174313208X276907; Moller K, 2002, J CEREBR BLOOD F MET, V22, P118, DOI 10.1097/00004647-200201000-00014; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Nelson DW, 2004, CRIT CARE MED, V32, P2428, DOI 10.1097/01.CCM.0000147688.08813.9C; Neumann JO, 2008, INTENS CARE MED, V34, P1676, DOI 10.1007/s00134-008-1123-7; Nilsson P, 2005, ACTA NEUROCHIR SUPPL, V95, P51; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Ottens AK, 2008, J NEUROCHEM, V104, P1404, DOI 10.1111/j.1471-4159.2007.05086.x; Otterspoor LC, 2008, CURR OPIN ANESTHESIO, V21, P544, DOI 10.1097/ACO.0b013e32830f44fb; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Pendem S, 2006, NEUROCRIT CARE, V4, P63, DOI 10.1385/NCC:4:1:063; Perez Augusto, 2003, Pediatr Crit Care Med, V4, P33; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Pleines UE, 1998, J NEUROTRAUM, V15, P399, DOI 10.1089/neu.1998.15.399; Poca MA, 2007, J NEUROSURG, V106, P530, DOI 10.3171/jns.2007.106.4.530; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Powner DJ, 2008, CURR OPIN CRIT CARE, V14, P163, DOI 10.1097/MCC.0b013e3282f57528; Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/NCC:5:1:61; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Roche RAP, 2004, NEUROSCI LETT, V362, P1, DOI 10.1016/j.neulet.2003.11.064; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; Sakowitz OW, 2007, J TRAUMA, V62, P292, DOI 10.1097/01.ta.0000203560.03937.2d; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; Sarrafzadeh A S, 2000, Neurosurg Focus, V9, pe2; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Scalea TM, 2007, J TRAUMA, V62, P647, DOI 10.1097/TA.0b013e31802ee542; Schmittner MD, 2007, J NEUROSURG ANESTH, V19, P257, DOI 10.1097/ANA.0b013e31811f3feb; Seifman MA, 2008, J CEREBR BLOOD F MET, V28, P684, DOI 10.1038/sj.jcbfm.9600603; Skoglund TS, 2005, ACTA ANAESTH SCAND, V49, P337, DOI 10.1111/j.1399-6576.2005.00624.x; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Sperry JL, 2007, J TRAUMA, V63, P487, DOI 10.1097/TA.0b013e31812e51fc; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; Stocchetti N, 2005, J NEUROL NEUROSUR PS, V76, P1135, DOI 10.1136/jnnp.2004.041269; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Stover JF, 1999, PSYCHOPHARMACOLOGY, V141, P66, DOI 10.1007/s002130050807; Stover JF, 1998, EUR NEUROL, V39, P223, DOI 10.1159/000007938; Stover JF, 1999, CRIT CARE MED, V27, P1351, DOI 10.1097/00003246-199907000-00028; Strong AJ, 2000, STROKE, V31, P214, DOI 10.1161/01.STR.31.1.214; Strong AJ, 2007, CURR OPIN CRIT CARE, V13, P126, DOI 10.1097/MCC.0b013e32807faffb; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Takamiya M, 2007, J NEUROTRAUM, V24, P1833, DOI 10.1089/neu.2007.0336; Thomale UW, 2007, NEUROL RES, V29, P594, DOI 10.1179/016164107X166272; Thorat JD, 2008, J CLIN NEUROSCI, V15, P143, DOI 10.1016/j.jocn.2006.08.014; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Tisdall MM, 2006, BRIT J ANAESTH, V97, P18, DOI 10.1093/bja/ael109; Tisdall MM, 2008, J NEUROSURG, V109, P424, DOI 10.3171/JNS/2008/109/9/0424; Tokutomi T, 2007, NEUROSURGERY, V61, P256, DOI [10.1227/01.NEU.00000038737.13185.C4, 10.1227/01.neu.0000279221.38257.1a]; Tyagi R, 2007, NEUROSURG REV, V30, P277, DOI 10.1007/s10143-007-0091-7; Vajkoczy P, 2003, J NEUROSURG, V98, P1227, DOI 10.3171/jns.2003.98.6.1227; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vanhorebeek I, 2007, CRIT CARE MED, V35, pS496, DOI 10.1097/01.CCM.0000278051.48643.91; Velmahos GC, 2001, J AM COLL SURGEONS, V192, P147, DOI 10.1016/S1072-7515(00)00790-0; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; Vigue B, 1999, INTENS CARE MED, V25, P445, DOI 10.1007/s001340050878; Vinclair M, 2008, INTENS CARE MED, V34, P714, DOI 10.1007/s00134-007-0970-y; Wahlstrom MR, 2009, ACTA ANAESTH SCAND, V53, P18, DOI 10.1111/j.1399-6576.2008.01798.x; Wakai A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub4; White H, 2008, EUR J ANAESTH, V25, P104, DOI 10.1017/S0265021507003420; White H, 2008, ANESTH ANALG, V107, P979, DOI 10.1213/ane.0b013e31817e7b1a; White H, 2006, INTENS CARE MED, V32, P981, DOI 10.1007/s00134-006-0173-y; Willmore LJ, 2009, NEUROCHEM RES, V34, P688, DOI 10.1007/s11064-008-9841-3; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613; Zapantis Antonia, 2005, Crit Care Nurs Clin North Am, V17, P211, DOI 10.1016/j.ccell.2005.04.011; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	213	3	3	0	0	SPRINGER-VERLAG BERLIN	BERLIN	HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY			978-3-540-88121-6	EUR MAN MED			2011							93	152		10.1007/978-3-540-88122-3_2	10.1007/978-3-540-88122-3		60	Surgery	Book Citation Index – Science (BKCI-S)	Surgery	BUN06	WOS:000289808700002					2022-02-06	
S	van Dommelen, JAW; Hrapko, M; Peters, GWM		Bilston, LE		van Dommelen, J. A. W.; Hrapko, M.; Peters, G. W. M.			Constitutive Modelling of Brain Tissue for Prediction of Traumatic Brain Injury	NEURAL TISSUE BIOMECHANICS	Studies in Mechanobiology Tissue Engineering and Biomaterials		English	Article; Book Chapter							MECHANICAL-BEHAVIOR; SHEAR; DEFORMATION	To develop protective measures for crash situations, an accurate assessment of injury risk is required. By using a Finite Element model of the head, the mechanical behaviour of the brain can be predicted for any acceleration and improved injury criteria can be developed and implemented into safety standards. Many head models are based on a detailed geometrical description of the anatomical components. However, for reliable predictions of injury, also an accurate constitutive model for brain tissue is required that is applicable for large deformations and complex loading conditions that occur during an impact to the head. This chapter deals with constitutive modelling of brain tissue. Different approaches towards modelling of the mechanical response of biological tissues are discussed. A short overview of the large strain behaviour of brain tissue and constitutive models that have been developed for this material is given. A non-linear viscoelastic model for brain tissue is then discussed in more detail. The model is based on a multi-mode Maxwell model and consists of a non-linear elastic mode in combination with a number of viscoelastic modes. For this model, also a numerical implementation scheme is given. The influences of constitutive non-linearities of brain tissue in numerical head model simulations are shown by comparing the performance of the model of Hrapko et al. with a simplified version, based on neo-Hookean elastic behaviour, and a third non-linear constitutive model from literature.	[van Dommelen, J. A. W.; Hrapko, M.; Peters, G. W. M.] Eindhoven Univ Technol, Mat Technol Inst, NL-5600 MB Eindhoven, Netherlands		van Dommelen, JAW (corresponding author), Eindhoven Univ Technol, Mat Technol Inst, POB 513, NL-5600 MB Eindhoven, Netherlands.	J.A.W.v.Dommelen@tue.nl; Matej.Hrapko@gmail.com; G.W.M.Peters@tue.nl					ARBOGAST KB, 1995, P 39 STAPP CAR CRASH, P153; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; BANDAK FA, 1994, P 38 STAPP CAR CRASH, P148; Bilston LE, 2001, BIORHEOLOGY, V38, P335; Brands Dave W A, 2002, Stapp Car Crash J, V46, P103; Brands DWA, 2004, J BIOMECH, V37, P127, DOI 10.1016/S0021-9290(03)00243-4; BRANDS DWA, 2002, IMPLEMENTATION SLIDI; BRANDS DWA, 2000, P 44 STAPP CAR CRASH, P249; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; DARVISH KK, 1999, 24 ANN M; DARVISH KK, 1998, P ASME INT MECH ENG, V39; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Fung Y.C., 1981, BIOMECHANICS MECH PR; GURDJIAN ES, 1962, JAMA-J AM MED ASSOC, V182, P509, DOI 10.1001/jama.1962.03050440001001; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Hrapko M, 2009, INT J CRASHWORTHINES, V14, P245, DOI 10.1080/13588260802440290; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Hrapko M, 2008, BIORHEOLOGY, V45, P663, DOI 10.3233/BIR-2008-0512; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Macosko CW, 1994, RHEOLOGY PRINCIPLES; Meaney DF, 2003, BIOMECH MODEL MECHAN, V1, P279, DOI 10.1007/s10237-002-0020-1; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Miller K, 1999, J BIOMECH, V32, P531, DOI 10.1016/S0021-9290(99)00010-X; Miller K, 2000, Med Sci Monit, V6, P158; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2001, J BIOMECH, V34, P651, DOI 10.1016/S0021-9290(00)00236-0; MOERMAN K, 2006, TNODV22005IN017, V2005; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Nicolle S, 2005, BIORHEOLOGY, V42, P209; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; Peters GWM, 1997, BIORHEOLOGY, V34, P127, DOI 10.1016/S0006-355X(97)00009-7; Peters GWM, 1997, J NON-NEWTON FLUID, V68, P205, DOI 10.1016/S0377-0257(96)01511-X; Prange M T, 2000, Stapp Car Crash J, V44, P205; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; PRANGE MT, 1998, S P CTR DIS CONTR WA; RUAN JS, 1994, P 38 STAPP CAR CRASH, P111; Shen F, 2006, J BIOMECH ENG-T ASME, V128, P797, DOI 10.1115/1.2264393; TAKHOUNTS EG, 1999, P 27 INT WORKSH, P141; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Versace J, 1971, SAE TECHNICAL PAPER, DOI [10.4271/710881, DOI 10.4271/710881]; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Wismans, 1997, P 41 STAPP CAR CRASH, V41, P315, DOI DOI 10.4271/973338	48	3	3	0	3	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES	1868-2006		978-3-642-13889-8	STUD MECHANOBIOL TIS	Stud. Mechanobiol. Tissue Eng. Biomater.		2011	3						41	67		10.1007/8415_2010_16	10.1007/978-3-642-13890-4		27	Biotechnology & Applied Microbiology; Engineering, Biomedical; Neurosciences	Book Citation Index – Science (BKCI-S)	Biotechnology & Applied Microbiology; Engineering; Neurosciences & Neurology	BWN19	WOS:000294272200004					2022-02-06	
B	Vidal-Taboada, JM; Mahy, N; Rodriguez, MJ		Chang, RCC		Vidal-Taboada, Jose M.; Mahy, Nicole; Rodriguez, Manuel J.			Microglia, Calcification and Neurodegenerative Diseases	NEURODEGENERATIVE DISEASES - PROCESSES, PREVENTION, PROTECTION AND MONITORING			English	Article; Book Chapter							AMYOTROPHIC-LATERAL-SCLEROSIS; TRAUMATIC BRAIN-INJURY; BASAL FOREBRAIN LESION; MOLECULAR-MECHANISMS; ALZHEIMERS-DISEASE; CELL-DEATH; IN-VIVO; EXCITOTOXIC NEURODEGENERATION; DEPENDENT NEURODEGENERATION; NEUROLOGICAL DISORDERS		[Vidal-Taboada, Jose M.] Univ Barcelona, Unitat Bioquim & Biol Mol, Fac Med, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona, Spain		Vidal-Taboada, JM (corresponding author), Univ Barcelona, Unitat Bioquim & Biol Mol, Fac Med, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain.		Rodriguez, Manuel J/L-2212-2014	Rodriguez, Manuel J/0000-0002-4476-004X			Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Andre-Frei V, 2000, CALCIFIED TISSUE INT, V66, P204, DOI 10.1007/s002230010041; Andres N, 2000, NEUROSCIENCE, V101, P807, DOI 10.1016/S0306-4522(00)00459-0; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Barat R, 2011, WATER RES, V45, P3744, DOI 10.1016/j.watres.2011.04.028; Beck A, 2004, CELL CALCIUM, V35, P47, DOI 10.1016/S0143-4160(03)00171-4; Beers DR, 2011, BRAIN, V134, P1293, DOI 10.1093/brain/awr074; Bernal F, 2000, EXP NEUROL, V161, P686, DOI 10.1006/exnr.1999.7293; Bernal F, 2000, HIPPOCAMPUS, V10, P296, DOI 10.1002/1098-1063(2000)10:3<296::AID-HIPO10>3.0.CO;2-C; Bernal F, 2009, J NEUROSCI RES, V87, P1240, DOI 10.1002/jnr.21930; Bernardino L, 2008, STEM CELLS, V26, P2361, DOI 10.1634/stemcells.2007-0914; Bianchi R, 2010, NEUROBIOL AGING, V31, P665, DOI 10.1016/j.neurobiolaging.2008.05.017; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; BOATELL LL, 1992, NEUROSCI LETT, V136, P203, DOI 10.1016/0304-3940(92)90049-D; BOATELL ML, 1995, J NEUROCHEM, V64, P285; BROUILLET E, 1993, J NEUROCHEM, V60, P356, DOI 10.1111/j.1471-4159.1993.tb05859.x; Buzsaki G., 2006, RHYRHMS OF THE BRAIN; Chan SL, 2006, J BIOL CHEM, V281, P37391, DOI 10.1074/jbc.M605552200; Chan WY, 2007, BRAIN RES REV, V53, P344, DOI 10.1016/j.brainresrev.2006.11.002; Chen Q, 1998, MOL PHARMACOL, V53, P564, DOI 10.1124/mol.53.3.564; Chen Q, 1999, EXP NEUROL, V160, P215, DOI 10.1006/exnr.1999.7179; Chi LY, 2006, STEM CELLS, V24, P34, DOI 10.1634/stemcells.2005-0076; COLEMAN P, 1990, NEUROBIOL AGING, V11, P1, DOI 10.1016/0197-4580(90)90055-5; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Edwards MM, 2006, J NEURAL TRANSM, V113, P1709, DOI 10.1007/s00702-006-0479-5; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Fontaine V, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-07-j0001.2002; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Halliday GM, 2011, MOVEMENT DISORD, V26, P6, DOI 10.1002/mds.23455; Hashimoto N, 2003, ACTA NEUROPATHOL, V106, P150, DOI 10.1007/s00401-003-0715-0; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Herrera AJ, 2000, NEUROBIOL DIS, V7, P429, DOI 10.1006/nbdi.2000.0289; Hertz L, 2008, NEUROPHARMACOLOGY, V55, P289, DOI 10.1016/j.neuropharm.2008.05.023; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; KATAYAMA Y, 1995, BRAIN PATHOL, V5, P427, DOI 10.1111/j.1750-3639.1995.tb00621.x; KESSLAK JP, 1995, NEUROSCI LETT, V188, P117, DOI 10.1016/0304-3940(95)11415-S; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim KM, 1995, SCANNING MICROSCOPY, V9, P1137; KODAKA T, 1994, J ELECTRON MICROSC, V43, P307; LeJeune H, 1996, NEUROSCIENCE, V74, P349; Li CY, 2011, CURR ALZHEIMER RES, V8, P67; Lievens JC, 2000, GLIA, V29, P222, DOI 10.1002/(SICI)1098-1136(20000201)29:3<222::AID-GLIA4>3.0.CO;2-0; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Mahy N, 1996, NEUROSCI LETT, V213, P169; Mahy N, 1999, ACTA NEUROPATHOL, V98, P217, DOI 10.1007/s004010051072; Mates JM, 2002, INT J BIOCHEM CELL B, V34, P439, DOI 10.1016/S1357-2725(01)00143-1; Mattson MP, 2006, ANTIOXID REDOX SIGN, V8, P1997, DOI 10.1089/ars.2006.8.1997; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Mullany P, 1996, EUR J PHARMACOL, V309, P311, DOI 10.1016/0014-2999(96)00464-5; Nicolle MM, 1996, NEUROSCIENCE, V74, P741, DOI 10.1016/0306-4522(96)00147-9; Obrenovitch TP, 2000, INT J DEV NEUROSCI, V18, P281, DOI 10.1016/S0736-5748(99)00096-9; Olney JW, 1997, ARCH NEUROL-CHICAGO, V54, P1234, DOI 10.1001/archneur.1997.00550220042012; Ovanesov MV, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-50; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Petegnief V, 2004, NEUROCHEM INT, V44, P287, DOI 10.1016/S0197-0186(03)00136-0; Petegnief V, 1999, NEUROSCIENCE, V94, P105, DOI 10.1016/S0306-4522(99)00299-7; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; Ramonet D, 2006, J NEUROSCI RES, V83, P147, DOI 10.1002/jnr.20711; Ramonet D, 2004, HIPPOCAMPUS, V14, P586, DOI 10.1002/hipo.10188; Ramonet D, 2002, J PHYSIOLOGY-PARIS, V96, P307, DOI 10.1016/S0928-4257(02)00020-7; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Reali C, 2005, J NEUROSCI RES, V81, P677, DOI 10.1002/jnr.20584; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Robledo P, 1999, HIPPOCAMPUS, V9, P527, DOI 10.1002/(SICI)1098-1063(1999)9:5<527::AID-HIPO6>3.3.CO;2-L; Rodriguez Manuel J, 2009, Curr Drug Abuse Rev, V2, P99; Rodriguez MJ, 2009, J NEUROTRAUM, V26, P1823, DOI 10.1089/neu.2008.0553; Rodriguez MJ, 2005, J NEUROCHEM, V95, P651, DOI 10.1111/j.1471-4159.2005.03394.x; Rodriguez MJ, 2004, J NEUROSCI RES, V77, P344, DOI 10.1002/jnr.20177; Rodriguez MJ, 2000, INT J DEV NEUROSCI, V18, P299, DOI 10.1016/S0736-5748(99)00098-2; Rodriguez MJ, 2001, NEUROBIOL DIS, V8, P59, DOI 10.1006/nbdi.2000.0332; Sáfadi Marco A. P., 2003, Braz J Infect Dis, V7, P325, DOI 10.1590/S1413-86702003000500007; Sapolsky RM, 2001, J NEUROCHEM, V76, P1601, DOI 10.1046/j.1471-4159.2001.00203.x; SAURA J, 1995, EUR J NEUROSCI, V7, P1569, DOI 10.1111/j.1460-9568.1995.tb01152.x; Saura J, 1997, NEUROBIOL AGING, V18, P497, DOI 10.1016/S0197-4580(97)00113-9; SAURA J, 1994, J NEURAL TRANSM-SUPP, P89; Schinder AF, 1996, J NEUROSCI, V16, P6125; Schwartz M, 2006, TRENDS NEUROSCI, V29, P68, DOI 10.1016/j.tins.2005.12.005; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Surendrababu N. R. S., 2006, Indian Journal of Pediatrics, V73, P527, DOI 10.1007/BF02759900; Suzumura A, 2006, ANN NY ACAD SCI, V1088, P219, DOI 10.1196/annals.1366.012; Tanuma N, 2006, ACTA NEUROPATHOL, V112, P195, DOI 10.1007/s00401-006-0083-7; Tramontina F, 2006, CELL MOL NEUROBIOL, V26, P81, DOI 10.1007/s10571-006-9099-8; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; Verkhratsky A., 2007, V45, P465; Verkhratsky A, 2005, PHYSIOL REV, V85, P201, DOI 10.1152/physrev.00004.2004; VILLA A, 1994, EUR J NEUROSCI, V6, P1491, DOI 10.1111/j.1460-9568.1994.tb01010.x; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009	98	3	3	0	3	INTECH EUROPE	RIJEKA	JANEZA TRDINE9, RIJEKA, 51000, CROATIA			978-953-307-485-6				2011							301	322			10.5772/1252		22	Clinical Neurology; Neurosciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BG1KI	WOS:000386854400014					2022-02-06	
J	Warsh, J; Janssen, I; Pickett, W				Warsh, Joel; Janssen, Ian; Pickett, William			Do overweight and obese youth take longer to recover from injury?	INTERNATIONAL JOURNAL OF INJURY CONTROL AND SAFETY PROMOTION			English	Article						epidemiology; obesity; pediatrics; wounds; injuries	TRAUMATIC BRAIN-INJURY; PHYSICAL-ACTIVITY; BODY-MASS; FAT DISTRIBUTION; HEALTH BEHAVIOR; RISK-FACTORS; CHILDREN; IMPACT; ADOLESCENTS; VALIDITY	The objective of the study was to examine the effects of overweight and obesity on times to recovery among Canadian youth who have suffered one or more types of injury. The data source was the 2002 Canadian Health Behaviour in School-Aged Children (HBSC) survey. The study population included 7266 youth in grades 6 through 10 sampled from all Canadian provinces and territories. Of these, 2831 students reported an injury event and were included in the analysis. Kaplan-Meier curves and hazard ratios (HR) were used to profile survival functions and estimate relative hazards for non-recovery from injury events among normal weight, overweight and obese youth. Youth who were obese and suffered a combined injury (broken bone and strain/sprain) took longer to recover (HR: 1.81, 95% CI 0.99-3.32) compared to normal weight youth. HR for injury recovery in obese youth were not significantly elevated for broken bones (1.15, 95% CI 0.61-2.19) and sprain/strains (1.17, 95% CI 0.73-1.85) in isolation. Obesity was associated with times for injury recovery among injured youth. If these findings are confirmed in other settings, clinicians providing an injury recovery prognosis may need to take into account BMI status and allow for extra recovery time for patients in this age range.	[Pickett, William] Queens Univ, Dept Community Hlth, Kingston, ON, Canada; Queens Univ, Dept Epidemiol, Kingston, ON, Canada; Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada		Pickett, W (corresponding author), Queens Univ, Dept Community Hlth, Kingston, ON, Canada.	will.pickett@queensu.ca	Janssen, Ian/B-7700-2009	Janssen, Ian/0000-0003-2159-3012	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP 394-791] Funding Source: Medline		Booth ML, 2001, BRIT J SPORT MED, V35, P263, DOI 10.1136/bjsm.35.4.263; Boyce W., 2009, KEY FINDINGS HLTH BE; Brener ND, 2003, J ADOLESCENT HEALTH, V32, P281, DOI 10.1016/S1054-139X(02)00708-5; Brown CVR, 2006, J PEDIATR SURG, V41, P88, DOI 10.1016/j.jpedsurg.2005.10.012; Caprio S, 1996, AM J CLIN NUTR, V64, P12, DOI 10.1093/ajcn/64.1.12; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Chau N, 2007, EUR J EPIDEMIOL, V22, P327, DOI 10.1007/s10654-007-9118-1; CHRISTOFFEL KK, 1992, PEDIATRICS, V89, P1027; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Currie C, 2008, SOC SCI MED, V66, P1429, DOI 10.1016/j.socscimed.2007.11.024; Dietz WH, 1998, PEDIATRICS, V101, P518; Goodman E, 2000, PEDIATRICS, V106, P52, DOI 10.1542/peds.106.1.52; Goulding Ailsa, 2007, Med Sport Sci, V51, P102, DOI 10.1159/000103007; Himes JH, 2005, ANN EPIDEMIOL, V15, P272, DOI 10.1016/j.annepidem.2004.08.010; Janssen I, 2004, PEDIATRICS, V113, P1187, DOI 10.1542/peds.113.5.1187; Janssen I, 2005, OBES REV, V6, P123, DOI 10.1111/j.1467-789X.2005.00176.x; Janssen I, 2004, J ADOLESCENT HEALTH, V35, P360, DOI [10.1016/j.jadohealth.2003.11.095, 10.1016/S1054-139X(04)00058-8]; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kohen D E, 2000, Inj Prev, V6, P223, DOI 10.1136/ip.6.3.223; Krebs NF, 2007, PEDIATRICS, V120, pS193, DOI 10.1542/peds.2007-2329D; Leet AI, 2005, J BONE JOINT SURG AM, V87A, P2609, DOI 10.2106/JBJS.D.02019; Makk S., 2007, HLTH WOMAN, V17, P222; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Prochaska JJ, 2001, ARCH PEDIAT ADOL MED, V155, P554, DOI 10.1001/archpedi.155.5.554; RIDDOCH CJ, 1995, SPORTS MED, V19, P86, DOI 10.2165/00007256-199519020-00002; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Rothman KJ, 2005, AM J PUBLIC HEALTH, V95, pS144, DOI 10.2105/AJPH.2004.059204; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sipski ML, 2004, ARCH PHYS MED REHAB, V85, P1826, DOI 10.1016/j.apmr.2004.04.031; Statistics Canada, 2009, OV CAN CHILDR AD; Timm NL, 2005, ARCH PEDIAT ADOL MED, V159, P33, DOI 10.1001/archpedi.159.1.33; Tsuritani I, 2002, MATURITAS, V42, P23, DOI 10.1016/S0378-5122(02)00025-7; VOORS AW, 1977, AM J EPIDEMIOL, V106, P101, DOI 10.1093/oxfordjournals.aje.a112439; Warner JT, 1997, ANN HUM BIOL, V24, P209, DOI 10.1080/03014469700004942; Wearing SC, 2006, OBES REV, V7, P209, DOI 10.1111/j.1467-789X.2006.00216.x; World Health Organization, 2001, FIND 2006 HBSC SURV; Xiang H, 2005, AM J PREV MED, V29, P41, DOI 10.1016/j.amepre.2005.03.013	37	3	3	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1745-7300	1745-7319		INT J INJ CONTROL SA	Int. J. Inj. Control Saf. Promot.		2011	18	2					143	149	PII 935202797	10.1080/17457300.2010.540329			7	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	772WR	WOS:000291269300008	21424972				2022-02-06	
J	Jang, SH				Jang, Sung Ho			Delayed neurological deterioration following head trauma	NEURAL REGENERATION RESEARCH			English	Article						brain injury; ataxia; axonal injury; head trauma	DIFFUSE AXONAL INJURY; MENTAL-STATE-EXAMINATION; BRAIN-INJURY; HUMANS	We report a patient who presented with neurological deterioration 26 days after a motor vehicle accident. A 25-year-old man crashed a car onto farmland from a height of approximately 3 meters. Neurological deterioration including ataxia and visual disturbance became apparent 26 days after the accident. Brain magnetic resonance imaging did not reveal any abnormality, but brain single photon emission computed tomography showed mild hypoperfusion in the left frontotemporal lobe. An ophthalmic examination revealed no specific abnormality, but visual-evoked potentials revealed prolonged latencies in both eyes. We propose that this neurological deterioration might have resulted from traumatic axonal injury. As such, future studies should examine preventive strategies against delayed deterioration in patients with head trauma.	Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			Korean GovernmentKorean Government [KRF-2008-314-E00173]	This work was supported by National Research Foundation of Korea Grant funded by the Korean Government, No. KRF-2008-314-E00173.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Aoki N, 1996, NEUROL RES, V18, P145; Blumbergs PC, 1998, J CLIN NEUROSCI, V5, P123, DOI 10.1016/S0967-5868(98)90026-1; Corbo J, 2004, ANN EMERG MED, V44, P57, DOI 10.1016/j.annemergmed.2003.11.010; DELISA JA, 1993, REHABILITATION MED P, P825; DICK JPR, 1984, J NEUROL NEUROSUR PS, V47, P496, DOI 10.1136/jnnp.47.5.496; FLEISHMAN FA, 1962, J APPL PSYCHOL, V46, P96; FLEMING JFR, 1968, CAN J SURG, V11, P166; Gieron MA, 1998, PEDIATR NEUROL, V19, P382, DOI 10.1016/S0887-8994(98)00072-1; Han C, 2008, ARCH GERONTOL GERIAT, V47, P302, DOI 10.1016/j.archger.2007.08.012; Hong JH, 2009, BRAIN RES BULL, V80, P30, DOI 10.1016/j.brainresbull.2009.05.021; Jackson CFE, 1970, STROKE, V1, P278, DOI 10.1161/01.STR.1.4.278; KJAER M, 1980, ACTA NEUROL SCAND, V62, P1; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Nishio M, 1998, NEUROL SURG TOKYO, V26, P425; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; RAM Z, 1989, J NEUROSURG, V71, P608, DOI 10.3171/jns.1989.71.4.0608; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15; TANNEBAUM RD, 1995, ACAD EMERG MED, V2, P523, DOI 10.1111/j.1553-2712.1995.tb03253.x; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Urasaki E, 2001, NEUROL MED-CHIR, V41, P306, DOI 10.2176/nmc.41.306	25	3	3	0	2	SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES	SHENYANG	PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA	1673-5374			NEURAL REGEN RES	Neural Regen. Res.	DEC	2010	5	23					1829	1831		10.3969/j.issn.1673-5374.2010.23.011			3	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	718FQ	WOS:000287106900011					2022-02-06	
J	Kelly, JC; O'Callaghan, A; Mc Mullin, L; Clinton, O; Binchy, J				Kelly, J. C.; O'Callaghan, A.; Mc Mullin, L.; Clinton, O.; Binchy, J.			Management of traumatic head injuries in a rural Irish hospital: implications of the NICE guidelines	IRISH JOURNAL OF MEDICAL SCIENCE			English	Article						Head; Injury; Trauma; Hospital; NICE; Guidelines; CT; Scan; Skull; Radiology	GUIDANCE; CHILDREN; IMPACT; RULE	The NICE guidelines were published in 2003 in an effort to standardise the management of traumatic head injuries, and advise a CT brain in certain situations. To evaluate the influence of the NICE guidelines on the management of head injuries in a county hospital. Complete clinical data were obtained for all patients with traumatic head injuries attending the ED of a county hospital from 2001 to 2005. Symptoms, examination details and outcome data were made available. The influence of the NICE guidelines on their management was then evaluated. Application of the NICE guidelines to these patients would have resulted in a 56% increase in the rate of CT brains being performed. No patient who did not have a CT brain had an adverse outcome. It is possible with limited resources and normal neurological observations that patients over the age of 65 can be managed safely.	[Kelly, J. C.; O'Callaghan, A.; Mc Mullin, L.; Clinton, O.; Binchy, J.] Roscommon Cty Hosp, Dept Surg & Emergency Med, Roscommon, Ireland; [Kelly, J. C.; O'Callaghan, A.; Mc Mullin, L.; Clinton, O.; Binchy, J.] Natl Univ Ireland, Acad Dept Surg, Galway, Ireland		Kelly, JC (corresponding author), Roscommon Cty Hosp, Dept Surg & Emergency Med, Roscommon, Ireland.	johncokelly@gmail.com					Boyle A, 2004, EMERG MED J, V21, P426, DOI 10.1136/emj.2002.002063; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Goodacre S, 2008, EMERG MED J, V25, P556, DOI 10.1136/emj.2007.055723; Kannus P, 1999, JAMA-J AM MED ASSOC, V281, P1895, DOI 10.1001/jama.281.20.1895; Kannus P, 2007, INJURY, V38, P81, DOI 10.1016/j.injury.2006.08.027; Roche SJ, 2008, INJURY, V39, P436, DOI 10.1016/j.injury.2007.12.012; Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85; Shravat BP, 2006, EMERG MED J, V23, P109, DOI 10.1136/emj.2004.022327; Stein SC, 2008, PEDIATR NEUROSURG, V44, P448, DOI 10.1159/000172967; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Sultan HY, 2004, EMERG MED J, V21, P420, DOI 10.1136/emj.2003.011353; Swann IJ, 2001, EMERG MED J, V18, P352, DOI 10.1136/emj.18.5.352; Yates D, 2007, BMJ-BRIT MED J, V335, P719, DOI 10.1136/bmj.39331.702951.47	13	3	3	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0021-1265			IRISH J MED SCI	Irish J. Med. Sci.	DEC	2010	179	4					557	560		10.1007/s11845-010-0499-x			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666MN	WOS:000283119600015	20512534				2022-02-06	
J	Shin, TH; Gong, CB; Kim, MS; Kim, JS; Bai, DS; Kim, OL				Shin, Tae-Hee; Gong, Chang-Bong; Kim, Min-Su; Kim, Jin-Sung; Bai, Dai-Seg; Kim, Oh-Lyong			Development of a Cognitive Level Explanation Model in Brain Injury: Comparisons between Disability and Non-Disability Evaluation Groups	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Disability evaluation; Brain injury; Malingering	CLOSED-HEAD-INJURY; ADULT INTELLIGENCE SCALE; WAIS-R; MILD	Objective : We investigated whether Disability Evaluation (DE) situations influence patients' neuropsychological test performances and psychopathological characteristics and which variable play a role to establish an explanation model using statistical analysis. Methods : Patients were 536 (56.6%) brain-injured persons who met inclusion and exclusion criteria, classified into the DE group (DE; n = 300, 56.0%) and the non-DE group (NDE; n = 236, 44.0%) according to the neuropsychological testing's purpose. Next, we classified DE subjects into DE cluster 1 (DEC1; 91, 17.0%), DE cluster 2 (DEC2; 125; 23.3%), and DE cluster 3 (DEC3; 84, 15.7%) via two-step cluster analysis, to specify DE characteristics. All patients completed the K-WAIS, K-MAS, K-BNT, SCL-90-R, and MMPI. Results: In comparisons between DE and NDE, the DE group showed lower intelligence quotients and more severe psychopathologic symptoms, as evaluated by the SCL-90-R and MMPI, than the NDE group did. When comparing the intelligence among the DE groups and NDE group, DEC1 group performed worst on intelligence and memory and had most severe psychopathologic symptoms than the NDE group did. The DEC2 group showed modest performance increase over the DEC1 and DEC3, similar to the NDE group. Paradoxically, the DEC3 group performed better than the NDE group did on all variables. Conclusion : The DE group showed minimal "faking bad" patterns. When we divided the DE group into three groups, the DEC1 group showed typical malingering patterns, the DEC2 group showed passive malingering patterns, and the DEC3 group suggested denial of symptoms and resistance to treatment.	[Shin, Tae-Hee; Kim, Min-Su; Kim, Oh-Lyong] Yeungnam Univ, Coll Med, Dept Neurosurg, Taegu 705717, South Korea; [Gong, Chang-Bong] Dong Eui Med Ctr, Dept Neurosurg, Pusan, South Korea		Kim, OL (corresponding author), Yeungnam Univ, Coll Med, Dept Neurosurg, 317-1 Daemyeong Dong, Taegu 705717, South Korea.	olkim@med.yu.ac.kr			Yeungnam University	This research was supported by the Yeungnam University research grants in 2008.	ARCIA E, 1993, BRAIN INJURY, V7, P481, DOI 10.3109/02699059309008175; BERNARD LC, 1993, ARCH CLIN NEUROPSYCH, V8, P539, DOI 10.1016/0887-6177(93)90054-5; BOARD J, 1980, J CLIN NEUROPSYCHOL, V2, P209; Boone K. B., 2007, ASSESSMENT FEIGNED C; BRYANT RA, 1999, COGNITIVE NEUROPSYCH, V4, P227, DOI DOI 10.1080/135468099395945; DELIS DC, 1991, HDB NEUROPSYCHOLOGY, P3; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; Gouvier W. D., 1988, ARCH CLIN NEUROPSYCH, V3, P331; GRONWALL D, 1989, ASSESSMENT BEHAV CON, V7, P72; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Johnson JL, 1998, PERCEPT MOTOR SKILL, V87, P152, DOI 10.2466/pms.1998.87.1.152; Johnstone L, 2003, BRIT J CLIN PSYCHOL, V42, P303, DOI 10.1348/01446650360703401; Junghwa Lee, 2003, Journal of KISS: Computing Practices, V9, P213; KELLY R, 1975, Forensic Science, V6, P17, DOI 10.1016/0300-9432(75)90219-8; Kim GI, 1984, SYMPTOM CHECKLIST 90; Kim H. H., 1997, KOREAN VERSION BOSTO; KIM HG, 2001, KOREAN J CLIN PSYCHO, V29, P155; Kim JS, 2009, J KOREAN NEUROSURG S, V46, P459, DOI 10.3340/jkns.2009.46.5.459; Kim YH, 1989, KOREAN VERSION MINNE; KOO BH, 2006, J KOREAN SOC BIOL TH, V12, P182; Larrabee GJ, 2005, FORENSIC NEUROPSYCHO, P3; Larrabee GJ, 2000, CLIN GUIDE NEUROPSYC, P301; LEE HS, 2001, KOREAN VERSION MEMOR; LEE KS, 1994, J KOREAN NEUROSURG S, V23, P276; LEE SW, 1999, J KOREAN NEUROSURG S, V28, P1288; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Lezak MD, 2004, NEUROPSYCHOLOGICAL A, P157; Lu P. H., 2007, ASSESSMENT FEIGNED C; MENDELOW AD, 1983, BRIT MED J, V287, P1173, DOI 10.1136/bmj.287.6400.1173; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; NEWCOMBE F, 1987, NEUROBEHAVIORAL RECO, P129; Oakley D A, 1999, Cogn Neuropsychiatry, V4, P243, DOI 10.1080/135468099395954; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PARK KC, 2000, J KOREAN NEUROSURG S, V29, P196; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P67; Sierra M, 1999, COGN NEUROPSYCHIATRY, V4, P267, DOI [10.1080/135468099395963, DOI 10.1080/135468099395963]; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; Vogenthaler D R, 1989, Brain Inj, V3, P355, DOI 10.3109/02699058909004560; Wechsler, 1997, WECHSLER ADULT INTEL; WIGGINS EC, 1988, LAW HUMAN BEHAV, V12, P57, DOI 10.1007/BF01064274; WILLIAMS JM, 1991, MEMORY ASSESSMENT SC; WILSON B, 1991, Brain Injury, V5, P189, DOI 10.3109/02699059109008089; Yeom T. H., 1992, KOREAN VERSION WECHS; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593	45	3	4	0	5	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	DEC	2010	48	6					506	517		10.3340/jkns.2010.48.6.506			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	727TY	WOS:000287826700007	21430977	gold, Green Published			2022-02-06	
J	Young, G				Young, Gerald			Trends in Psychological/ Psychiatric Injury and Law: Continuing Education, Practice Comments, Recommendations	PSYCHOLOGICAL INJURY & LAW			English	Article						Psychological injury; Literature review; Practice recommendations; Court	POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE-BEHAVIORAL THERAPY; FAKE BAD SCALE; SYMPTOM VALIDITY SCALE; TRAUMATIC BRAIN-INJURY; CANMAT CLINICAL GUIDELINES; MAJOR DEPRESSIVE DISORDER; CHRONIC PAIN; RESPONSE BIAS; INTERPERSONAL PSYCHOTHERAPY	This literature review of the major topics in the field of psychological/psychiatric injury and law is aimed at developing commentary for practice in the area. The field is a fast-developing one, with over ten major topics that it needs to integrate. In particular, the present review focuses current work on: law (evidence, tort); forensic psychology; assessment and testing; psychological injuries (posttraumatic stress disorder, chronic pain, traumatic brain injury, other); the APA DSM-5 draft (Diagnostic and statistical manual of mental disorders; American Psychiatric Association 2010); malingering; causality; multicultural considerations; disability; the American Medical Association (AMA) Guides to the evaluation of permanent impairment (Rondinelli et al. 2008); models; and treatment. At the end of each section of the article, practice comments introduce critical issues in applying the research to psychological work in the area. Whether undertaking tort evaluations, disability, and treatment plan assessments or treating individuals with psychological injuries, the professional needs state-of-the-art information in all the areas listed in order to remain scientifically informed, comprehensive, and impartial. The article concludes with recommendations for an integrated field in psychological/psychiatric injury and law, study in the field, research in its major areas, best practice policies, for example in assessment and treatment, and model building.	[Young, Gerald] York Univ, Glendon Coll, Dept Psychol, 2275 Bayview Ave, Toronto, ON M4N 3M6, Canada		Young, G (corresponding author), York Univ, Glendon Coll, Dept Psychol, 2275 Bayview Ave, Toronto, ON M4N 3M6, Canada.	gyoung@glendon.yorku.ca					Allen LA, 2010, PSYCHIAT CLIN N AM, V33, P579, DOI 10.1016/j.psc.2010.04.014; American Law Institute, 2007, REST LAW 3 TORTS LIA; American Psychiatric Association, 2010, PROP DRAFT REV DSM D; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; American Psychological Association, 2017, ETH PRINC PSYCH COD; Anagnostis C, 2004, SPINE, V29, P2290, DOI 10.1097/01.brs.0000142221.88111.0f; [Anonymous], 2008, OCC MED PRACT GUID; Association, 2008, GUIDES EVALUATION PE; Beck JG, 2007, PROF PSYCHOL-RES PR, V38, P629, DOI 10.1037/0735-7028.38.6.629; Ben-Porath YS, 2010, PSYCHOL INJ LAW, V3, P77, DOI 10.1007/s12207-009-9049-0; Ben-Porath YS, 2009, PSYCHOL INJ LAW, V2, P62, DOI 10.1007/s12207-009-9037-4; Berry DTR, 2010, PSYCHOL INJ LAW, V3, P295, DOI 10.1007/s12207-010-9087-7; Beutler L. E., 2010, INTEGRATING SCI PRAC, V1, P10; Bos JM, 2010, ESSENTIALS OF GENOMIC AND PERSONALIZED MEDICINE, P336; Briere J., 2001, DETAILED ASSESSMENT; Brodsky S. L., 2004, COPING CROSS EXAMINA; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Brown TA, 2009, BEHAV RES THER, V47, P487, DOI 10.1016/j.brat.2009.02.016; Bruns D., 2011, AAPM TXB PAIN MED; Bruns D., 2003, BATTERY HLTH IMPROVE; Bruns D, 2010, PSYCHOL INJ LAW, V3, P169, DOI 10.1007/s12207-010-9079-7; Bruns D, 2011, BEHAVIORAL HEALTH DISABILITY: INNOVATIONS IN PREVENTION AND MANAGEMENT, P73, DOI 10.1007/978-0-387-09814-2_4; Bryant RA, 2008, J CONSULT CLIN PSYCH, V76, P695, DOI 10.1037/a0012616; Bryant RA, 2010, PSYCHOL INJ LAW, V3, P111, DOI 10.1007/s12207-010-9071-2; Burchett DL, 2010, ASSESSMENT, V17, P497, DOI 10.1177/1073191110378972; Butcher J.N., 2001, MINNESOTA MULTIPHASI; Butcher J.N., 1989, MANUAL RESTANDARDIZE; Butcher JN, 2010, ANNU REV CLIN PSYCHO, V6, P1, DOI 10.1146/annurev.clinpsy.121208.131420; Butcher JN, 2008, PSYCHOL INJ LAW, V1, P191, DOI 10.1007/s12207-007-9002-z; Carleton RN, 2009, J ANXIETY DISORD, V23, P791, DOI 10.1016/j.janxdis.2009.03.003; Castillo LG, 2009, REHABIL PSYCHOL, V54, P351, DOI 10.1037/a0017801; Castonguay LG., 2006, PRINCIPLES THERAPEUT; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Chou R, 2009, SPINE, V34, P1078, DOI 10.1097/BRS.0b013e3181a103b1; Committee on the Revision of the Specialty Guidelines for Forensic Psychology, 2010, SPEC GUID FOR PSYCH; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; DeRoon-Cassini TA, 2010, REHABIL PSYCHOL, V55, P1, DOI 10.1037/a0018601; Disorbio J. M., 2002, BRIEF BATTERY HLTH I; Dobson KS, 2008, J CONSULT CLIN PSYCH, V76, P468, DOI 10.1037/0022-006X.76.3.468; Dohrenwend BP, 2010, PSYCHOL INJ LAW, V3, P89, DOI 10.1007/s12207-010-9072-1; Drapeau M., 2010, INTEGRATING SCI PRAC, V1, P3; Driessen E, 2010, PSYCHIAT CLIN N AM, V33, P537, DOI 10.1016/j.psc.2010.04.005; Duckworth M. P., 2008, MOTOR VEHICLE COLLIS, P311; Duckworth MP, 2010, PSYCHOL INJ LAW, V3, P241, DOI 10.1007/s12207-010-9086-8; Duckworth MP, 2005, CLIN J PAIN, V21, P251, DOI 10.1097/00002508-200505000-00008; Engdahl B, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/066005; Faust D, 2010, ANNU REV CLIN PSYCHO, V6, P49, DOI 10.1146/annurev.clinpsy.3.022806.091523; Finch M, 2008, PSYCHOL INJ LAW, V1, P20, DOI 10.1007/s12207-007-9001-0; First M. B., 2010, PSYCHOL INJURY LAW, V3; Fournier J. C., 2010, INTEGRATING SCI PRAC, V1, P22; Fournier J. C., 2010, INTEGRATING SCI PRAC, V1, P24; Frances A, 2010, PSYCHIAT TIMES; Frances A, 2010, J AM ACAD PSYCHIATRY, V38, P11; Franche RL, 2009, PSYCHOL INJ LAW, V2, P225, DOI 10.1007/s12207-009-9053-4; Frank E, 2007, AM J PSYCHIAT, V164, P761, DOI 10.1176/appi.ajp.164.5.761; Frasure-Smith N, 2005, CURR DIR PSYCHOL SCI, V14, P39, DOI 10.1111/j.0963-7214.2005.00331.x; Frueh B. C., 2010, PSYCHOL INJ IN PRESS, V3; Gass CS, 2010, PSYCHOL INJ LAW, V3, P81, DOI 10.1007/s12207-009-9063-2; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Gervais RO, 2009, CLIN NEUROPSYCHOL, V23, P549, DOI 10.1080/13854040902823265; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2009, CLIN NEUROPSYCHOL, V23, P996, DOI 10.1080/13854040902748249; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Ginzburg K, 2010, J AFFECT DISORDERS, V123, P249, DOI 10.1016/j.jad.2009.08.006; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Gold LH, 2008, J AM ACAD PSYCHIATRY, V36, pS3; Goldfreid M. R., 2010, INTEGRATING SCI PRAC, V1, P14; Goldhill S, 2009, SOPHOCLES AND THE GREEK TRAGIC TRADITION, P1, DOI 10.1007/978-1-84800-921-9_4; Gordeev S A, 2008, Neurosci Behav Physiol, V38, P707, DOI 10.1007/s11055-008-9036-z; Green P., 2005, GREENS WORLD MEMORY; Greiffenstein M.F., 2007, ASSESSMENT FEIGNED C, P210; Gupta S, 2010, PSYCHOL TRAUMA-US, V2, P83, DOI 10.1037/a0018959; Haack S., 2008, SETON HALL LAW REV, V38, P1053; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heilbrun K., 2009, FDN FORENSIC MENTAL; Heilbrun K., 2001, PRINCIPLES FORENSIC; Henry GK, 2006, CLIN NEUROPSYCHOL, V20, P786, DOI 10.1080/13854040500287749; Hoffman BM, 2007, HEALTH PSYCHOL, V26, P1, DOI 10.1037/0278-6133.26.1.1; Hofmann SG, 2010, PSYCHIAT CLIN N AM, V33, P701, DOI 10.1016/j.psc.2010.04.006; Hopwood CJ, 2010, REHABIL PSYCHOL, V55, P307, DOI 10.1037/a0020516; Howard KJ, 2010, PSYCHOL INJ LAW, V3, P203, DOI 10.1007/s12207-010-9082-z; Hunter LR, 2010, PSYCHOL BULL, V136, P211, DOI 10.1037/a0018133; Ji GC, 2010, J NEUROSCI, V30, P5451, DOI 10.1523/JNEUROSCI.0225-10.2010; Johnstone B., 2010, HDB REHABILITATION P, P179; Kane A. W, 2011, EVALUATION PERSONAL; Kane A. W., 2010, ESSENTIALS FORENSIC, P85; Keefe FJ, 2004, J PAIN, V5, P195, DOI 10.1016/j.jpain.2004.02.576; Kendall-Tackett K., 2010, PSYCHONEUROIMMUNOLOG, P113; King DW, 1998, PSYCHOL ASSESSMENT, V10, P90, DOI 10.1037/1040-3590.10.2.90; KOCH WJ, 2006, PSYCHOL INJURIES FOR; Kubany ES, 2010, PSYCHOL TRAUMA-US, V2, P77, DOI 10.1037/a0019185; Kusnetz S., 1979, DHEW PUBL, V79; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Laugharne J, 2010, CURR OPIN PSYCHIATR, V23, P25, DOI 10.1097/YCO.0b013e3283345dc5; Lazar S. G., 2010, INTEGRATING SCI PRAC, V1, P26; Leclair N., 2009, ASSESSING IMPAIRMENT, P59; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Liedl A, 2010, PSYCHOL MED, V40, P1215, DOI 10.1017/S0033291709991310; Liedl Alexandra, 2008, Torture, V18, P69; Livesley W. J., 2010, PSYCHOL INJ IN PRESS, V3; Long ME, 2009, PSYCHOL INJ LAW, V2, P167, DOI 10.1007/s12207-009-9043-6; Main CJ, 2008, PAIN MANAGEMENT PRAC, V2nd; Margoshes B. G., 2000, OCCUPATIONAL MUSCULO, P47; Markowitz J., 2010, PRACTICE GUIDELINE T; Martelli MF, 2007, BRAIN INJURY MED PRI, P723; Martelli MF, 2008, NEUROREHABILITATION, V23, P115; Mason S, 2006, BRIT J CLIN PSYCHOL, V45, P217, DOI 10.1348/014466505X50158; Mayou RA, 2002, BEHAV RES THER, V40, P665, DOI 10.1016/S0005-7967(01)00069-9; McClintock SM, 2010, CNS SPECTRUMS, V15, P304, DOI 10.1017/S109285290002753X; McCracken LM, 2006, EUR J PAIN, V10, P23, DOI 10.1016/j.ejpain.2005.01.004; McCrea M., 2008, MILD TRAUMATIC BRAIN; McFarlane AC, 2010, PSYCHOL INJ LAW, V3, P100, DOI 10.1007/s12207-010-9074-z; McGrath RE, 2010, PSYCHOL BULL, V136, P450, DOI 10.1037/a0019216; McNally RJ, 2003, ANNU REV PSYCHOL, V54, P229, DOI 10.1146/annurev.psych.54.101601.145112; MELTON GB, 2007, PSYCHOL EVALUATIONS; Melzack R, 2006, PSYCHOLOGICAL KNOWLEDGE IN COURT: PTSD, PAIN, AND TBI, P129, DOI 10.1007/0-387-25610-5_7; Melzack Ronald, 2005, Pain Pract, V5, P85, DOI 10.1111/j.1533-2500.2005.05203.x; Millon T., 2006, MILLON CLIN MULTIAXI, VThird; Millon T., 1997, MILLON CLIN MULTIAXI, V2nd ed.; Morey, 1991, PERSONALITY ASSESSME; Morey L.C., 2007, PERSONALITY ASSESSME; Naifeh JA, 2010, PSYCHOL ASSESSMENT, V22, P666, DOI 10.1037/a0019783; Nelson NW, 2010, CLIN NEUROPSYCHOL, V24, P701, DOI 10.1080/13854040903482863; Nicholson K., 2007, CAUSALITY PSYCHOL IN, P373; Norman SB, 2008, PSYCHOL MED, V38, P533, DOI 10.1017/S0033291707001389; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; Olatunji BO, 2010, PSYCHIAT CLIN N AM, V33, P557, DOI 10.1016/j.psc.2010.04.002; Otis JD, 2010, PSYCHOL SERV, V7, P126, DOI 10.1037/a0020512; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Palyo SA, 2005, PAIN, V117, P121, DOI 10.1016/j.pain.2005.05.028; Parikh SV, 2009, J AFFECT DISORDERS, V117, pS15, DOI 10.1016/j.jad.2009.06.042; Patten SB, 2009, J AFFECT DISORDERS, V117, pS5, DOI 10.1016/j.jad.2009.06.044; Peterson DB, 2009, PSYCHOL INJ LAW, V2, P205, DOI 10.1007/s12207-009-9056-1; Pledger C, 2003, AM PSYCHOL, V58, P279, DOI 10.1037/0003-066X.58.4.279; Pole N, 2008, CLIN PSYCHOL-SCI PR, V15, P35, DOI 10.1111/j.1468-2850.2008.00109.x; Poleshuck EL, 2010, PROF PSYCHOL-RES PR, V41, P312, DOI 10.1037/a0019924; Pope K. S., 2011, ETHICS PSYCHOTHERAPY; Powers MB, 2010, CLIN PSYCHOL REV, V30, P635, DOI 10.1016/j.cpr.2010.04.007; Poyner G, 2010, PSYCHOL INJ LAW, V3, P130, DOI 10.1007/s12207-010-9076-x; Reed Group, 2009, MED DIS ADV; Reitan R. M., 1985, HALSTED REITAN NEURO; Richards PM, 2010, PSYCHOL INJ LAW, V3, P3, DOI 10.1007/s12207-010-9065-0; Robinson JS, 2010, PSYCHOL TRAUMA-US, V2, P71, DOI 10.1037/a0018954; Robinson M. E., 2010, HDB REHABILITATION P, P119; Rogers R., 1992, STRUCTURED INTERVIEW; Rogers R., 2010, STRUCTURED INTERVIEW; Rogers R, 2008, CLIN ASSESSMENT MALI; Rubenzer S., 2010, OPEN ACCESS J FORENS, V2, P273; Rubenzer S, 2009, PSYCHOL INJ LAW, V2, P114, DOI 10.1007/s12207-009-9045-4; Ruff RM, 2009, PSYCHOL INJ LAW, V2, P34, DOI 10.1007/s12207-009-9029-4; SARASON IG, 1978, J CONSULT CLIN PSYCH, V46, P932, DOI 10.1037/0022-006X.46.5.932; Sareen J, 2007, PSYCHOSOM MED, V69, P242, DOI 10.1097/PSY.0b013e31803146d8; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P63, DOI 10.1007/s12207-010-9066-z; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P25, DOI 10.1007/s12207-010-9068-x; Schatman ME, 2010, PSYCHOL INJ LAW, V3, P182, DOI 10.1007/s12207-010-9083-y; Schatman ME, 2010, PSYCHOL INJ LAW, V3, P165, DOI 10.1007/s12207-010-9085-9; Schultz I. Z., 2010, PSYCHOL INJ IN PRESS, V3; Schultz I. Z., 2005, HDB COMPLEX OCCUPATI; Schultz IZ, 2009, PSYCHOL INJ LAW, V2, P199, DOI 10.1007/s12207-009-9061-4; Sellbom M., 2008, CLIN ASSESSMENT MALI, V3rd ed., P182; Sharp TJ, 2001, CLIN PSYCHOL REV, V21, P857, DOI 10.1016/S0272-7358(00)00071-4; Simms LJ, 2002, J ABNORM PSYCHOL, V111, P637, DOI 10.1037//0021-843X.111.4.637; SIMON RI, 2004, TXB FORENSIC PSYCHIA; Sinclair DC, 2010, J OCCUP ENVIRON MED, V52, P456, DOI 10.1097/JOM.0b013e3181d284d7; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smith A., 2010, ONTARIO PSYCHOL ASS; Smith TW, 2007, PSYCHOSOM MED, V69, P441, DOI 10.1097/PSY.0b013e3180600a65; Stamm B.H., 1996, MEASUREMENT STRESS T, P386; Sullivan MJL, 2009, PSYCHOL INJ LAW, V2, P238, DOI 10.1007/s12207-009-9055-2; Tate DG, 2003, AM PSYCHOL, V58, P289, DOI 10.1037/0003-066X.58.4.289; Teasell RW, 2010, PAIN RES MANAG, V15, P285, DOI 10.1155/2010/979070; Thomas ML, 2010, PSYCHOL ASSESSMENT, V22, P492, DOI 10.1037/a0019229; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; Tollison C. D., 1995, P3 PAIN PATIENT PROF; Tombaugh T.N., 1996, TEST MEMORY MALINGER; United States Government Printing Office, 2009, FED RUL EV; Vittengl JR, 2007, J CONSULT CLIN PSYCH, V75, P475, DOI 10.1037/0022-006X.75.3.475; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Wachtel PL, 2010, PSYCHOANAL PSYCHOL, V27, P251, DOI 10.1037/a0020532; Wald J, 2009, PSYCHOL INJ LAW, V2, P254, DOI 10.1007/s12207-009-9059-y; Weathers FW, 1996, MEASUREMENT STRESS T, P250; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Williams CL, 2009, PSYCHOL INJ LAW, V2, P182, DOI 10.1007/s12207-009-9046-3; Work Loss Data Institute, 2008, OFF DIS GUID; World Health Organization, 2007, INT CLASS FUNCT DIS; Worzer WE, 2009, PSYCHOL INJ LAW, V2, P215, DOI 10.1007/s12207-009-9060-5; Wygant DB, 2010, PSYCHOL ASSESSMENT, V22, P745, DOI 10.1037/a0020042; Young G., 2007, CAUSALITY PSYCHOL IN, P87; Young G, 2010, PSYCHOL INJ IN PRESS, V3; Young G., 2007, CAUSALITY PSYCHOL IN; Young G., 2006, PSYCHOL KNOWLEDGE CO; Young G., 2007, CAUSALITY PSYCHOL IN, P49; Young G, 2008, PSYCHOL INJ LAW, V1, P287, DOI 10.1007/s12207-008-9023-2; Young G, 2008, PSYCHOL INJ LAW, V1, P150, DOI 10.1007/s12207-008-9019-y; Young G, 2008, PSYCHOL INJ LAW, V1, P224, DOI 10.1007/s12207-008-9021-4; Young G, 2008, PSYCHOL INJ LAW, V1, P161, DOI 10.1007/s12207-008-9017-0; Young G, 2010, INT J LAW PSYCHIAT, V33, P73, DOI 10.1016/j.ijlp.2009.12.009; Zinbarg RE, 2010, PSYCHIAT CLIN N AM, V33, P711, DOI 10.1016/j.psc.2010.04.003	199	3	3	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	DEC	2010	3	4					323	355		10.1007/s12207-010-9092-x			33	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	VB3ZG	WOS:000415451700009					2022-02-06	
J	Arrangoiz, R; Opreanu, RC; Mosher, BD; Morrison, CA; Stevens, P; Kepros, JP				Arrangoiz, Rodrigo; Opreanu, Razvan C.; Mosher, Benjamin D.; Morrison, Chet A.; Stevens, Penny; Kepros, John P.			Reduction of Radiation Dose in Pediatric Brain CT Is Not Associated with Missed Injuries or Delayed Diagnosis	AMERICAN SURGEON			English	Article							COMPUTED-TOMOGRAPHY; TRAUMA PATIENTS; CANCER; SCAN; TIME	Increased accuracy of CTs in the identification of traumatic injuries compared with physical examination or conventional radiography is well documented. Our goal was to identify the most effective strategy for decreasing radiation exposure while retaining the benefits of computerized imaging. Based on a literature review and our trauma registry, the mortality risk of untreated injuries was compared with that of patients who received treatment of injuries diagnosed by CT. Because automated exposure control of tube current is not routinely used with brain CT, this region was identified as the initial focus for a dose-saving algorithm. CT settings were adjusted for children studies and the new settings were implemented into four protocols based on age. Images were compared and reviewed by radiologists for the ability to identify traumatic injuries. Effective dose (ED) was estimated using Monte Carlo simulations. The lifetime incidence and mortality for thyroid cancer and leukemia were assessed. In-hospital mortality of unidentified injury in trauma patients is 8.0%. Forty dose-saving CTs were performed and no injuries were missed. The ED decreased by 5.2-, 4.5-, 2.62-, and 2.5-fold in each group. Decreasing the ED is achievable, theoretically decreases the cancer risk and does not increase the missed injury rate.	[Arrangoiz, Rodrigo; Opreanu, Razvan C.; Morrison, Chet A.; Kepros, John P.] Michigan State Univ, Coll Human Med, Dept Surg, Lansing, MI USA; [Mosher, Benjamin D.; Morrison, Chet A.; Stevens, Penny; Kepros, John P.] Sparrow Hlth Syst, E Lansing, MI USA		Arrangoiz, R (corresponding author), Michigan State Univ, Dept Surg, 1215 E Michigan Ave, Lansing, MI 48909 USA.	rodrigo.arrangois@ht.msu.edu	Arrangoiz, Rodrigo/K-4262-2019	Arrangoiz, Rodrigo/0000-0003-2838-5056			Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Brenner DJ, 2004, RADIOLOGY, V232, P735, DOI 10.1148/radiol.2323031095; Clarke JR, 2002, J TRAUMA, V52, P420, DOI 10.1097/00005373-200203000-00002; Hayward R, 2003, BRIT MED J, V326, P1273, DOI 10.1136/bmj.326.7401.1273; HUBERWAGNER S, 2009, LANCET          0324; Huda W, 1997, AM J ROENTGENOL, V169, P1487, DOI 10.2214/ajr.169.6.9393150; KALENDER WA, 1990, RADIOLOGY, V176, P181, DOI 10.1148/radiology.176.1.2353088; Kalra MK, 2004, J KOREAN MED SCI, V19, P159, DOI 10.3346/jkms.2004.19.2.159; Livingston DH, 1998, J TRAUMA, V44, P273, DOI 10.1097/00005373-199802000-00005; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; RABIN RC, 2007, NY TIMES, P381; RIZZO AG, 1995, J TRAUMA, V38, P338, DOI 10.1097/00005373-199503000-00005; Salim A, 2006, ARCH SURG-CHICAGO, V141, P468, DOI 10.1001/archsurg.141.5.468; Self ML, 2003, AM J SURG, V186, P609, DOI 10.1016/j.amjsurg.2003.08.003; *UNSCEAR, 1993, 1993 REP SOURC EFF I; VADIM F, 2009, LUNG, V187, P143; Wurmb TE, 2009, J TRAUMA, V66, P658, DOI 10.1097/TA.0b013e31817de3f4	18	3	3	2	3	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA	0003-1348			AM SURGEON	Am. Surg.	NOV	2010	76	11					1255	1259					5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	676GU	WOS:000283899800015	21140695				2022-02-06	
J	Brywczynski, J; McKinney, J; Pepe, PE; Eckstein, M; Myers, JB; Fowler, RL; Slovis, CM				Brywczynski, Jeremy; McKinney, Jared; Pepe, Paul E.; Eckstein, Marc; Myers, J. Brent; Fowler, Raymond L.; Slovis, Corey M.		Writing Grp US Metropolitan	Emergency Medical Services Transport Decisions in Posttraumatic Circulatory Arrest: Are National Practices Congruent?	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Prehospital; Emergency medical services; Blunt and penetrating; Trauma arrest; Transport decisions	TRAUMATIC CARDIAC-ARREST; CARDIOPULMONARY-RESUSCITATION; BRAIN-INJURY; PATIENT; THORACOTOMY; TERMINATION; MANAGEMENT; PULSELESS; TRIAGE	Objective: To catalog the 9-1-1 emergency medical services (EMS) transport practices for posttraumatic circulatory arrest patients (PTCAPs) in the majority of the nation's largest municipalities and to compare those practices to guidelines recommended by the National Association of EMS Physicians (NAEMSP) and American College of Surgeons Committee on Trauma (ACSCOT). Methods: A survey was conducted in 33 of the nation's largest cities primarily to determine whether or not individual EMS systems transport PTCAPs to hospitals and, if so, whether or not the initial electrocardiographic (ECG) rhythm or mechanism of injury affected those transport decisions. Results: All 33 cities (100%) responded. Seven (21%) indicated that EMS would transport an "asystolic blunt trauma patient" emergently or "leave the transport decision to paramedic judgment" despite NAEMSP-ACSCOT guidelines to terminate resuscitation in such cases. Likewise, 15 (46%) of the 33 EMS agencies would transport "asystolic penetrating trauma patients" emergently. Similarly, 27 (82%) would transport penetrating injury patients and 20 (61%) would transport blunt trauma patients with persistent ECG activity but no palpable pulses. However, only five systems had policies that included a minimum ECG heart rate criterion for transport, and all agencies that monitor ECG (n = 32) would transport PTCAPs found with ventricular fibrillation. Conclusions: Many of the nation's highest volume EMS systems transport certain PTCAPs emergently, contrary to NAEMSP-ACSCOT guidelines to terminate resuscitative efforts in such cases. Reasons for these discrepancies should be evaluated to help better delineate applicable consensus guidelines for large urban EMS agencies.	[Brywczynski, Jeremy; McKinney, Jared; Slovis, Corey M.] Vanderbilt Univ, Med Ctr, Dept Emergency Med, Nashville, TN USA; [Pepe, Paul E.; Fowler, Raymond L.] Univ Texas SW Med Ctr Dallas, Dallas, TX USA; [Pepe, Paul E.; Fowler, Raymond L.] Parkland Hlth & Hosp Syst, Dallas, TX USA; [Eckstein, Marc] Univ So Calif, Keck Sch Med, Med Ctr, Dept Emergency Med, Los Angeles, CA 90033 USA; [Myers, J. Brent] Wake Cty, Dept Emergency Med Serv, Raleigh, NC USA; Wake Emergency Phys PA, Raleigh, NC USA		Brywczynski, J (corresponding author), Vanderbilt Univ Sch Med, Dept Emergency Med, 1313 21st Ave S,703 Oxford House, Nashville, TN 37232 USA.	jeremy.brywczynski@vanderbilt.edu					Alanezi Khaled, 2004, CJEM, V6, P263; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; BARISHANSKY RM, 2006, EMERG MED SERVICES, V35, P1; Battistella FD, 1999, ARCH SURG-CHICAGO, V134, P742, DOI 10.1001/archsurg.134.7.742; Biggers W A Jr, 1996, Prehosp Disaster Med, V11, P195; COPASS MK, 1984, AM J SURG, V148, P20, DOI 10.1016/0002-9610(84)90284-8; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; DURHAM LA, 1992, J TRAUMA, V32, P775, DOI 10.1097/00005373-199206000-00019; Eckstein M, 1998, Prehosp Emerg Care, V2, P132, DOI 10.1080/10903129808958857; ECKSTEIN M, 2008, EMERGENCY MED SERVIC; FULTON RL, 1995, J AM COLL SURGEONS, V181, pA209; Hall WL, 2004, RESUSCITATION, V60, P175, DOI 10.1016/j.resuscitation.2003.09.013; Hopson Laura R, 2003, Prehosp Emerg Care, V7, P141, DOI 10.1080/10903120390937274; Kahn C A, 2001, Prehosp Emerg Care, V5, P261, DOI 10.1080/10903120190939751; Klein KR, 2008, DISASTER MED PUBLIC, V2, pS40, DOI 10.1097/DMP.0b013e3181734eb6; Lapinsky SE, 1996, NEW ENGL J MED, V335, P674, DOI 10.1056/NEJM199608293350916; Lockey D, 2006, ANN EMERG MED, V48, P240, DOI 10.1016/j.annemergmed.2006.03.015; Manning JE, 2000, SHOCK, V13, P152, DOI 10.1097/00024382-200013020-00010; O'Brien E, 2008, PREHOSP EMERG CARE, V12, P57, DOI 10.1080/10903120701707989; Pepe P E, 2001, Prehosp Emerg Care, V5, P79, DOI 10.1080/10903120190940399; Pepe PE, 2008, CURR OPIN ANESTHESIO, V21, P216, DOI 10.1097/ACO.0b013e3282f60a46; Pepe PE, 2009, CRIT CARE MED, V37, pS91, DOI 10.1097/CCM.0b013e318192154d; ROPPOLO LP, 2004, INTENSIVE CARE EMERG, P139; ROSEMURGY AS, 1993, J TRAUMA, V35, P468, DOI 10.1097/00005373-199309000-00022; SHIMAZU S, 1983, J TRAUMA, V23, P213, DOI 10.1097/00005373-198303000-00006; Sirbaugh PE, 1999, ANN EMERG MED, V33, P174, DOI 10.1016/S0196-0644(99)70391-4; Stratton SJ, 1998, J TRAUMA, V45, P96, DOI 10.1097/00005373-199807000-00021; WALL MJ, 1994, J TRAUMA, V36, P131, DOI 10.1097/00005373-199401000-00025; Warner KJ, 2008, PREHOSP EMERG CARE, V12, P162, DOI 10.1080/10903120801907299; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; US METROPOLITAN MUNI	31	3	3	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2010	69	5					1154	1159		10.1097/TA.0b013e3181eda9aa			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	678VK	WOS:000284110100037	21068619				2022-02-06	
J	McAllister, TW				McAllister, Thomas W.			Psychiatric Disorders and Traumatic Brain Injury: What Is The Connection?	PSYCHIATRIC ANNALS			English	Article							AMYLOID PRECURSOR PROTEIN; HEAD-INJURY; COGNITIVE REHABILITATION; ALZHEIMERS-DISEASE; AXIS-I; MILD; MEMORY; BETA; TBI; RECOMMENDATIONS		Dartmouth Med Sch, Dept Psychiat, Lebanon, NH USA		McAllister, TW (corresponding author), Dartmouth Med Sch, Dept Psychiat, 1 Med Ctr Dr, Lebanon, NH USA.	thomas.w.mcallister@dartmouth.edu					Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; BOURDON KH, 1992, PUBLIC HEALTH REP, V107, P663; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Chau David T, 2004, Curr Psychiatry Rep, V6, P391, DOI 10.1007/s11920-004-0026-8; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cripe LI, 1987, COGNITIVE REHABILITA, V5, P18; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Feldman G, 2007, PSYCHIAT CLIN N AM, V30, P39, DOI 10.1016/j.psc.2006.12.001; FREEDMAN PE, 1987, J NEUROL NEUROSUR PS, V50, P398, DOI 10.1136/jnnp.50.4.398; Galea S, 2008, EPIDEMIOLOGY, V19, P47, DOI 10.1097/EDE.0b013e31815c1dbf; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; Hart T, 2006, ARCH PHYS MED REHAB, V87, P647, DOI 10.1016/j.apmr.2006.01.016; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; Lovell Mark R., 1994, P133; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; McAllister T W, 2000, Semin Clin Neuropsychiatry, V5, P275, DOI 10.1053/scnp.2000.9557; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; MCMILLAN TM, 1987, J NEUROL NEUROSUR PS, V50, P393, DOI 10.1136/jnnp.50.4.393; MEGA M, 2001, FRONTAL LOBES NEUROP; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; O'Jile JR, 2006, ARCH CLIN NEUROPSYCH, V21, P293, DOI 10.1016/j.acn.2006.03.003; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Park E, 2006, J NEUROPATH EXP NEUR, V65, P226, DOI 10.1097/01.jnen.0000202888.29705.93; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P581, DOI 10.1080/13803390500434474; Ruff R. M., 1989, MILD HEAD INJURY, P176; Starkstein SE, 2005, INT PSYCHOGERIATR, V17, pS93, DOI 10.1017/S1041610205001973; Tanielian T., 2008, INVISIBLE WOUNDS WAR; TEASDALE G, 1974, LANCET, V2, P81; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Uryu K, 2004, NEUROBIOL AGING, V25, pS303, DOI 10.1016/S0197-4580(04)80996-5; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wei WH, 2005, ARCH PHYS MED REHAB, V86, P905, DOI 10.1016/j.apmr.2004.09.026; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; Yudofsky S.C., 2005, TXB TRAUMATIC BRAIN, P27	72	3	3	0	5	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0048-5713	1938-2456		PSYCHIAT ANN	Psychiatr. Ann.	NOV	2010	40	11					533	539		10.3928/00485713-20101018-04			7	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	736IX	WOS:000288488200004					2022-02-06	
J	Nowakowski, AM; Muller-Gerbl, M; Valderrabano, V				Nowakowski, Andre M.; Mueller-Gerbl, Magdalena; Valderrabano, Victor			Surgical Approach for a New Knee Prosthesis Concept (TSTP) Retaining Both Cruciate Ligaments	CLINICAL ANATOMY			English	Article						total knee arthroplasty; surgical technique; transversal support tibial plateau	COMPLETE CADAVERS; GAIT ANALYSIS; ARTHROPLASTY; PRESERVATION; KINEMATICS; NERVE	The transversal support tibial plateau (TSTP) concept was developed to retain both cruciate ligaments during total knee arthroplasty. TSTP design consists of two individual joint surfaces, reinforced beneath the joint line by two joint surface supports and buttressed by a single transversal support (TS). This configuration is devised to provide good bony anchoring especially for the TS, and to ensure long-term alignment of the individual joint surfaces. TS insertion requires a small extra incision. This study assessed techniques to implant the TS into the tibia. Using a specially designed aiming device, TS insertion from each side was evaluated in 13 human cadaveric knees (10 formalin-fixed, two Thiel embalmed, one fresh) at defined intervals of 15, 25, and 35 mm beneath the joint line. Particular attention was paid to potentially endangered structures, e.g., the medial collateral ligament (MCL), pes anserinus, and common peroneal nerve, as well as impediments to insertion, e.g., the fibula. TS implantation was successfully performed using both medial and lateral approaches. From medial, the TS was inserted safely at the 15 mm interval with the knee in maximum flexion and external rotation. With increasing intervals, however, the MCL and pes anserinus became progressively more susceptible to injury. In contrast, with the lateral approach, the operative field was quite close to the fibular head for the 25 mm interval. However, with the knee in extension, no other important structures were at risk. Clin. Anat. 23:985-991, 2010. (C) 2010 Wiley-Liss, Inc.	[Nowakowski, Andre M.; Valderrabano, Victor] Univ Basel, Dept Orthoped, CH-4031 Basel, Switzerland; [Nowakowski, Andre M.; Mueller-Gerbl, Magdalena] Univ Basel, Inst Anat, CH-4031 Basel, Switzerland		Nowakowski, AM (corresponding author), Univ Basel, Dept Orthoped, Spitalstr 21, CH-4031 Basel, Switzerland.	andrej.nowakowski@unibas.ch			SGOT	Contract grant sponsor: SGOT grant.	Banks SA, 2005, KNEE SURG SPORT TR A, V13, P551, DOI 10.1007/s00167-004-0565-x; Bolanos AA, 1998, J ARTHROPLASTY, V13, P906, DOI 10.1016/S0883-5403(98)90198-X; Dennis DA, 1996, CLIN ORTHOP RELAT R, P107; Fick R, 1904, HDB ANATOMIE MECHANI, P342; Fuchs S, 2002, INT J REHABIL RES, V25, P65, DOI 10.1097/00004356-200203000-00010; Hamelynck KJ, 2002, LCS MOBILE BEARING K; Hertel R, 2001, ORTHOPADE, V30, P363, DOI 10.1007/s001320170085; Ishii Y, 1998, J Orthop Sci, V3, P310, DOI 10.1007/s007760050058; Kachar SM, 2008, J ARTHROPLASTY, V23, P927, DOI 10.1016/j.arth.2007.07.019; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; LEWANDOWSKI A, 1997, ARTHROPLASTY, V12, P777; NOWAKOWSKI AM, 2002, DYNAMISCHE IN VITRO; Nowakowski AM, 2006, ORTHOPADISCHE PRAXIS, V42, P419; Robertsson O, 2000, ACTA ORTHOP SCAND, V71, P376, DOI 10.1080/000164700317393376; Rubel IF, 2004, J BONE JOINT SURG AM, V86A, P1625, DOI 10.2106/00004623-200408000-00004; Stiehl JB, 2000, J ARTHROPLASTY, V15, P545, DOI 10.1054/arth.2000.4638; Stiehl JB, 1999, J ARTHROPLASTY, V14, P293, DOI 10.1016/S0883-5403(99)90054-2; THIEL W, 1992, ANN ANAT, V174, P185, DOI 10.1016/S0940-9602(11)80346-8; Thiel W, 2002, ANN ANAT, V184, P267, DOI 10.1016/S0940-9602(02)80121-2	19	3	4	0	6	WILEY-LISS	HOBOKEN	DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA	0897-3806			CLIN ANAT	Clin. Anat.	NOV	2010	23	8					985	991		10.1002/ca.21031			7	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	684BV	WOS:000284522900027	20949497				2022-02-06	
J	Uslu, M; Kilincoglu, V; Toker, S; Kalender, AM; Dogan, A; Sebik, A				Uslu, Mustafa; Kilincoglu, Volkan; Toker, Serdar; Kalender, Ali Murat; Dogan, All; Sebik, Ahmet			Comparison of anti-edema effects of iloprost and diclofenac sodium on traumatic rat paw edema	ACTA ORTHOPAEDICA ET TRAUMATOLOGICA TURCICA			English	Article						Anti-edema effect; diclofenac sodium; iloprost; rat paw volume; traumatic soft tissue edema	PROSTACYCLIN ANALOG ILOPROST; NECROSIS-FACTOR PRODUCTION; CRITICAL LIMB ISCHEMIA; DIFFUSE BRAIN-INJURY; BONE-MARROW EDEMA; ACUTE LUNG INJURY; BLOOD-FLOW; TNF-ALPHA; INHIBITION; MODEL	Objectives: The aim of this study was to compare the anti-edema effects of a stable prostacyclin analogue, iloprost, with parenteral and local forms of a non-steroidal anti-inflammatory drug, diclofenac sodium, on traumatic soft tissue edema. Methods: Thirty-two adult male rats were randomly divided into 4 equal groups. Traumatic edema in one paw of each rat was produced by established protocol. Different drugs were then administered to each group: intraperitoneal (i.p.) saline (group 1, control group), topical diclofenac gel (group 2), i.p. diclofenac sodium (group 3), and i.p. iloprost (group 4). The volume of the paws was measured at baseline (before trauma) and at 1 hour, 2 hours, 4 hours, 8 hours, 24 hours, 48 hours, and 72 hours after trauma. The anti-edema effects of these 3 drugs (diclofenac gel, diclofenac sodium i.p., iloprost i.p.) were compared to each other and to the control group. Results: The greatest increase in paw edema in the first, second and fourth hours was seen in the control and iloprost groups. At the 4-hour measurement, edema levels were all equal except control group. Following 4- and 8-hour measurements, edema began to decrease in all groups. After 8 and 24 hours, the fastest decrease in edema was in iloprost group, with complete resolution of edema by 72 hours. The next fastest decrease in paw volume was seen with i.p. diclofenac sodium, followed by diclofenac gel. Conclusion: Iloprost has experimentally higher anti-edema effect than diclofenac sodium for the conservative treatment of the traumatic soft tissue edema.	[Uslu, Mustafa] GATA, Dept Orthoped & Traumatol, Ankara, Turkey; [Kilincoglu, Volkan; Toker, Serdar] Dumlupinar Univ, Dept Orthoped & Traumatol, Fac Med, TR-43270 Kutahya, Turkey; [Kalender, Ali Murat] Kahramanmaras Sutcu Imam Univ, Dept Orthoped & Traumatol, Fac Med, Kahramanmaras, Turkey; [Dogan, All; Sebik, Ahmet] Yuzuncu Yil Univ, Dept Orthoped & Traumatol, Fac Med, Van, Turkey		Toker, S (corresponding author), Dumlupinar Univ, Tip Fak, Ortoped & Travmatol Anabilim Dali, Tavsanli Yolu,10 Km, TR-43270 Kutahya, Turkey.	tokerserdar@hotmail.com	Toker, Serdar/L-7990-2013; ., alidogan67/AAD-1666-2019				Aigner N, 2002, J BONE JOINT SURG BR, V84B, P1050, DOI 10.1302/0301-620X.84B7.13175; [Anonymous], 2000, Eur J Vasc Endovasc Surg, V20, P358; Baltalarli A, 2006, ANN VASC SURG, V20, P49, DOI 10.1007/s10016-005-9284-0; BARLOW Y, 1992, BRIT MED BULL, V48, P698, DOI 10.1093/oxfordjournals.bmb.a072572; Bertani S, 1999, Br Homeopath J, V88, P101, DOI 10.1054/homp.1999.0310; Bettoni L, 2002, CLIN RHEUMATOL, V21, P244, DOI 10.1007/PL00011223; Bhaskar K, 2004, Boll Chim Farm, V143, P208; BROCK FE, 1990, SCHWEIZ MED WSCHR, V120, P1477; Brunner M, 2005, BRIT J CLIN PHARMACO, V60, P573, DOI 10.1111/j.1365-2125.2005.02484.x; Choi M. J., 2005, International Journal of Cosmetic Science, V27, P211, DOI 10.1111/j.1467-2494.2005.00264.x; Czeslick EG, 2003, EUR J CLIN INVEST, V33, P1013, DOI 10.1046/j.1365-2362.2003.01241.x; Davies SL, 2005, J NEUROSCI METH, V148, P161, DOI 10.1016/j.jneumeth.2005.04.020; Dembinski R, 2005, EUR RESPIR J, V25, P81, DOI 10.1183/09031936.04.10085504; Di Renzo M, 2005, PROSTAG LEUKOTR ESS, V73, P405, DOI 10.1016/j.plefa.2005.05.025; Dionne R, 2002, ENDOD TOPICS, V3, P32, DOI DOI 10.1034/J.1601-1546.2002.30104.X; Disch AC, 2005, J BONE JOINT SURG BR, V87B, P560, DOI 10.1302/0301-620X.87B4.15658; Duthois S, 2003, DIABETES METAB, V29, P36, DOI 10.1016/S1262-3636(07)70005-8; EKERDT R, 1992, ARCH DERMATOL RES, V284, pS18, DOI 10.1007/BF00638235; Eldor R, 2004, DIABETIC MED, V21, P1161, DOI 10.1111/j.1464-5491.2004.01358.x; Escribano E, 2003, EUR J PHARM SCI, V19, P203, DOI 10.1016/S0928-0987(03)00103-9; FIESSINGER JN, 1990, LANCET, V335, P555, DOI 10.1016/0140-6736(90)90346-7; Gao IK, 2002, RHEUMATOL INT, V22, P45, DOI 10.1007/s00296-002-0187-x; Gradl G, 2005, SHOCK, V24, P219, DOI 10.1097/01.shk.0000174022.33182.4b; Gryglewski R J, 2001, Med Sci Monit, V7, P1; Hotta N, 1996, DIABETES, V45, P361, DOI 10.2337/diabetes.45.3.361; Jorres A, 1997, CYTOKINE, V9, P119, DOI 10.1006/cyto.1996.0145; Jung S, 1997, J AUTOIMMUN, V10, P519, DOI 10.1006/jaut.1997.0159; Kirchheiner J, 2003, BRIT J CLIN PHARMACO, V55, P51, DOI 10.1046/j.1365-2125.2003.01712.x; Koksel O, 2005, PULM PHARMACOL THER, V18, P235, DOI 10.1016/j.pupt.2004.12.005; Konstandinidou M, 1998, J INORG BIOCHEM, V70, P63, DOI 10.1016/S0162-0134(98)00015-4; Lehmann C, 2001, CRIT CARE MED, V29, P1412, DOI 10.1097/00003246-200107000-00019; Li MH, 2005, ACTA PHARMACOL SIN, V26, P865, DOI 10.1111/j.1745-7254.2005.00151.x; Mahgoub AA, 2002, PHARMACOL RES, V45, P1, DOI 10.1006/phrs.2001.0856; MARRIEB EN, 2006, HUMAN ANATOMY PHYSL; Marsolais D, 2003, LAB INVEST, V83, P991, DOI 10.1097/01.LAB.0000078688.07696.AC; Mazzone A, 1999, EUR J CLIN INVEST, V29, P1; MULLER B, 1987, PROSTA LEUKOTR MED, V29, P187, DOI 10.1016/0262-1746(87)90008-4; Nasrallah R, 2004, PROSTAG LEUKOTR ESS, V70, P455, DOI 10.1016/j.plefa.2003.09.004; Noble Kim A, 2005, J Perianesth Nurs, V20, P56; Olschewski H, 1996, ANN INTERN MED, V124, P820, DOI 10.7326/0003-4819-124-9-199605010-00006; Petje G, 2004, EXPERT OPIN PHARMACO, V5, P1455, DOI 10.1517/14656566.5.7.1455; Piper IR, 1998, BRIT J ANAESTH, V80, P639, DOI 10.1093/bja/80.5.639; Pusey CD, 2002, BRIT MED J, V324, P609, DOI 10.1136/bmj.324.7337.609; Rautoma P, 2000, CAN J ANAESTH, V47, P220, DOI 10.1007/BF03018916; Rivers J K, 2004, Skin Therapy Lett, V9, P1; ROD RS, 2004, ESSENTIALS ANATOMY P; Rowlands TE, 1999, EUR J VASC ENDOVASC, V18, P439, DOI 10.1053/ejvs.1999.0929; Sacco S, 1998, J NEUROCHEM, V71, P2063; Selvam C, 2005, BIOORG MED CHEM LETT, V15, P1793, DOI 10.1016/j.bmcl.2005.02.039; Siobal Mark, 2004, Respir Care, V49, P640; Stratton R, 2002, FASEB J, V16, P1949, DOI 10.1096/fj.02-0204fje; Swartbol P, 1997, J BIOMED MATER RES, V36, P400, DOI 10.1002/(SICI)1097-4636(19970905)36:3<400::AID-JBM15>3.0.CO;2-H; Szczesny G, 2000, Chir Narzadow Ruchu Ortop Pol, V65, P315; Szczesny G, 2001, J TRAUMA, V51, P508, DOI 10.1097/00005373-200109000-00014; Takahashi M, 2001, J HEALTH SCI, V47, P464, DOI 10.1248/jhs.47.464; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Veroux P, 2004, CURR THER RES CLIN E, V65, P255, DOI 10.1016/S0011-393X(04)80067-5; Zulian F, 2004, RHEUMATOLOGY, V43, P229, DOI 10.1093/rheumatology.keg480; Zulian F, 1998, BRIT J RHEUMATOL, V37, P228	59	3	3	0	2	TURKISH ASSOC ORTHOPAEDICS TRAUMATOLOGY	ISTANBUL	SEHREMINI MAH KOYUNCU SK CIGDEM APT NO 4 D 5 FATIH, ISTANBUL, 00000, TURKEY	1017-995X			ACTA ORTHOP TRAUMATO	Acta Orthop. Traumatol. Turc.	NOV-DEC	2010	44	6					484	491		10.3944/AOTT.2010.2229			8	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	729IR	WOS:000287942600012	21358256	gold, Green Submitted			2022-02-06	
J	Aries, MJH; De Jong, BM; Uyttenboogaart, M; Regtien, JG; van der Naalt, J				Aries, M. J. H.; De Jong, B. M.; Uyttenboogaart, M.; Regtien, J. G.; van der Naalt, J.			Traumatic cervical artery dissection in head injury: The value of follow-up brain imaging	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Head injury; Cervical artery; Dissection; Stroke; Deterioration; Imaging	BLUNT CEREBROVASCULAR INJURIES; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIAGNOSIS	Introduction: Traumatic cervical artery dissection (TCAD) is a relative infrequent complication of traumatic brain injury (TBI). Since TCAD is associated with morbidity in a considerable percentage of patients, it is important to obtain clues for recognising TCAD in this category of patients. Methods: Retrospective case-cohort study in severe TBI patients. Results: Five patients with traumatic cervical artery dissection after severe TBI, leading to ischemic strokes, are described. Secondary deterioration to coma was present in four out of five patients during admission. The diagnosis of TCAD was delayed in most cases because the secondary deterioration was often attributed to multisystem problems related to trauma patients, i.e. shock or hypoxia or medication effects. Local clinical symptoms and signs suggestive of TCAD are difficult to detect in this patient group. In all patients, the CT-scan on admission demonstrated no abnormalities. A follow-up scan at day 2 revealed that in all patients abnormalities in the vascular territories had evolved. Conclusion: With this case-cohort study we underline the importance of considering TCAD in severe TBI patients and emphasise the role for standard follow-up brain imaging. Also possible treatment consequences are discussed. (C) 2010 Elsevier B.V. All rights reserved.	[Aries, M. J. H.; De Jong, B. M.; Uyttenboogaart, M.; Regtien, J. G.; van der Naalt, J.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol & Crit Care, NL-9700 RB Groningen, Netherlands		Aries, MJH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol & Crit Care, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	m.j.h.aries@neuro.umcg.nl		van der Naalt, Joukje/0000-0001-9873-2418			[Anonymous], 2007, J NEUROTRAUMA S1, V24; Berne JD, 2001, J AM COLL SURGEONS, V192, P314, DOI 10.1016/S1072-7515(01)00772-4; Berne JD, 2006, J TRAUMA, V60, P1204, DOI 10.1097/01.ta.0000220435.55791.ce; Biffl WL, 2006, J TRAUMA, V60, P745, DOI 10.1097/01.ta.0000204034.94034.c4; Biffl WL, 2002, J TRAUMA, V53, P850, DOI 10.1097/00005373-200211000-00008; Biffl WL, 1999, AM J SURG, V178, P517, DOI 10.1016/S0002-9610(99)00245-7; Carrillo EH, 1999, J TRAUMA, V46, P1120, DOI 10.1097/00005373-199906000-00030; Cothren CC, 2004, ARCH SURG-CHICAGO, V139, P540, DOI 10.1001/archsurg.139.5.540; Eachempati SR, 1998, J TRAUMA, V45, P997, DOI 10.1097/00005373-199812000-00004; Flis CM, 2007, EUR RADIOL, V17, P820, DOI 10.1007/s00330-006-0346-7; Hoit DA, 2008, J SPINAL DISORD TECH, V21, P259, DOI 10.1097/BSD.0b013e318141fce8; Hughes KM, 2000, AM SURGEON, V66, P1023; Kraus RR, 1999, AM J SURG, V178, P190, DOI 10.1016/S0002-9610(99)00157-9; Lobato RD, 2005, NEUROCIRUGIA, V16, P217; Mayberry JC, 2004, ARCH SURG-CHICAGO, V139, P609, DOI 10.1001/archsurg.139.6.609; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; Provenzale JM, 2009, AM J ROENTGENOL, V193, P1167, DOI 10.2214/AJR.08.1688; Shapiro ML, 2005, ARCH SURG-CHICAGO, V140, P211, DOI 10.1001/archsurg.140.2.211; Singh RR, 2004, EUR J VASC ENDOVASC, V27, P577, DOI 10.1016/j.ejvs.2004.01.005	19	3	3	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467			CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	OCT	2010	112	8					691	694		10.1016/j.clineuro.2010.05.015			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	651ZG	WOS:000281967300010	20580486				2022-02-06	
J	Bodack, MI				Bodack, Marie I.			Pediatric acquired brain injury	OPTOMETRY-JOURNAL OF THE AMERICAN OPTOMETRIC ASSOCIATION			English	Article						Acquired brain injury; Traumatic brain injury; Cerebral vascular accident; Pediatric; Eye; Vision; Strabismus; Visual field defect	HEAD-INJURIES; NERVE PALSIES; EPIDEMIOLOGY; DISORDERS; CHILDREN; NEGLECT; STROKE	BACKGROUND: Although pediatric patients are sometimes included in studies about visual problems in patients with acquired brain injury (ABI), few studies deal solely with children. Unlike studies dealing with adult patients, in which mechanisms of brain injury are divided into cerebral vascular accident (CVA) and traumatic brain injury (TBI), studies on pediatric patients deal almost exclusively with traumatic brain injury, specifically caused by accidents. CASE REPORT: Here we report on the vision problems of 4 pediatric patients, ages 3 to 18 years, who were examined in the ophthalmology/optometry clinic at a children's hospital. All patients had an internally caused brain injury and after the initial insult manifested problems in at least one of the following areas: acuity, binocularity, motility (tracking or saccades), accommodation, visual fields, and visual perceptual skills. CONCLUSION: Pediatric patients can suffer from a variety of oculo-visual problems after the onset of head injury. These patients may or may not be symptomatic and can benefit from optometric intervention. Optometry 2010;81:516-527	Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA		Bodack, MI (corresponding author), Cincinnati Childrens Hosp, Med Ctr, MLC 4008,3333 Burnet Ave, Cincinnati, OH 45229 USA.	marie.bodack@cchmc.org					Agran PF, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.3.e45; Allegri RF, 2000, REV NEUROLOGIA, V30, P491, DOI 10.33588/rn.3005.99645; Atabaki SM, 2007, PEDIATR REV, V28, P215, DOI 10.1542/pir.28-6-215; Barlow Karen, 2004, Pediatr Rehabil, V7, P195, DOI 10.1080/13638490410001715331; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; CHAPMAN SB, 2007, BRAIN INJ PROF, V3, P10; Ciuffreda K, 2001, VISUAL VESTIBULAR CO, P1; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Cohen A., 2003, J OPTOM VIS DEV, V34, P111; COHEN JM, 1992, J AM OPTOM ASSOC, V63, P60; Dhaliwal A, 2006, J NEURO-OPHTHALMOL, V26, P4, DOI 10.1097/01.wno.0000204661.48806.1d; DIMANCESCU MD, 2007, ACQUIRED BRAIN INJUR, P4; Driver J, 2001, COGNITION, V79, P39, DOI 10.1016/S0010-0277(00)00124-4; Fullerton HJ, 2003, NEUROLOGY, V61, P189, DOI 10.1212/01.WNL.0000078894.79866.95; Garzia RP, 1996, VISION READING; GIANUTSOS R, 2002, UNDERSTANDING MANAGI, P247; Groffman S, 2006, OPTOMETRIC MANAGEMEN, V2nd, P241; Han M H Esther, 2008, Optometry, V79, P252, DOI 10.1016/j.optm.2008.01.001; Hellerstein L F, 1995, J Am Optom Assoc, V66, P634; Hessen E, 2006, SCAND J PSYCHOL, V47, P245, DOI 10.1111/j.1467-9450.2006.00514.x; Horneman G, 2005, INT J REHABIL RES, V28, P245, DOI 10.1097/00004356-200509000-00007; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kedar S, 2006, J AAPOS, V10, P249, DOI 10.1016/j.jaapos.2006.01.181; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; KODSI SR, 1992, AM J OPHTHALMOL, V114, P568, DOI 10.1016/S0002-9394(14)74484-8; KRAUS JF, 1989, PSYCHIAT MED, V7, P11; Langlois JA, 2006, TRAUMATIC BRAIN INJU; LEE AG, 1999, J AM OPTOM ASSOC, V10, P624; LESLIE S, 2009, OPTOMETRY VISION DEV, V40, P25; Lynch JK, 2002, PEDIATRICS, V109, P116, DOI 10.1542/peds.109.1.116; PADULA WV, 1988, NEUROOPTOMETRIC REHA, P78; PADULA WV, 1992, J OPTOM VIS DEV, V23, P4; Poggi G, 2000, BRAIN INJURY, V14, P833, DOI 10.1080/026990500421930; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; Rode G, 2001, NEUROPSYCHOLOGIA, V39, P1250, DOI 10.1016/S0028-3932(01)00064-1; SABATES NR, 1991, J CLIN NEURO-OPHTHAL, V11, P273; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; STEIN JF, 1989, Q J EXP PHYSIOL CMS, V74, P583, DOI 10.1113/expphysiol.1989.sp003314; Suchoff I B, 1999, J Am Optom Assoc, V70, P301; SUCHOFF IB, 2000, LIGHTHOUSE HDB VISIO, P549; Suchoff Irwin B, 2004, Optometry, V75, P305, DOI 10.1016/S1529-1839(04)70067-6; SUTER PS, 1995, TRAUMATIC BRAIN INJU, P187; TEASDALE G, 1974, LANCET, V2, P81; Weiss NJ, 1995, CLIN USES PRISM SPEC, P279; MICROMEDEX HLTH CARE	47	3	3	0	4	AMER OPTOMETRIC ASSN INC	ST LOUIS	243 N LINDBERGH BLVD, ST LOUIS, MO 63141 USA	1529-1839	1558-1527		OPTOMETRY	Optometry	OCT	2010	81	10					516	527		10.1016/j.optm.2010.06.004			12	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	777MV	WOS:000291626700006	20716493				2022-02-06	
J	Kim, YJ				Kim, Young-Ju			Night admission to the emergency department: a factor delaying time to surgery in patients with head injury	JOURNAL OF CLINICAL NURSING			English	Article						admission; head injury; night; nurses; nursing; surgery	TRAUMATIC BRAIN-INJURY; CARE	Aim. To investigate factors influencing time from patient's arrival at the emergency department to surgery in patients with head injury. Background. A better understanding of factors influencing variation in time from patient's arrival at the emergency department to surgery for patients with head trauma could reduce mortality and morbidity associated with injury. Design. A cross-sectional study of secondary data. Methods. The sample represented 493 patients with head injury requiring surgery from the 17 level I and II trauma centres. Data were extracted from the National Trauma Data Bank version 4.0. Two-level hierarchical models were used to analyse data at the patient level while incorporating a unique random effect for each trauma centre. Factors entered in the models included patient characteristics and trauma centre characteristics. Results. Patients with a Glasgow coma scale score of 3-8 in the first ED assessment had earlier time to surgery compared with those with a Glasgow coma scale of 13-15 (beta = -0 center dot 31, 95% CI = -0 center dot 43-0 center dot 18). Patients who arrived at the hospital during the nighttime (6pm-8am) had a significantly delayed time to surgery than those who arrived during the daytime (8am-6pm) (beta = -0 center dot 15, 95% CI = -0 center dot 26 to -0 center dot 04). Conclusions. The more severely the injured patients were the faster surgery was performed. The time, when patients arrived to the emergency department was found to be a significant factor influencing time to surgery. Patients who arrived at emergency department at night had longer time to surgery than those who arrived during daytime, despite they were more severely head injured than those who arrived during the day. Relevance to clinical practice. When surgical intervention in head-injured patients is anticipated, especially during the night shift, time from patient's arrival at emergency department to surgery should be consistently assessed to identify opportunities for improvement in the structure and process of trauma care.	[Kim, Young-Ju] Sungshin Womens Univ, Coll Nursing, Seoul, South Korea		Kim, YJ (corresponding author), 249-1 Dongseon Dong, Seoul 136742, South Korea.	yjkim727@sungshin.ac.kr			Sungshin Women's University	This work was supported by the Sungshin Women's University Research Grant.	*AM COLL SURG COMM, 2004, NAT TRAUM DAT BANK; Anderson EH, 2003, NURS RES, V52, P1, DOI 10.1097/00006199-200301000-00001; Blank-Reid C, 2000, Crit Care Nurs Clin North Am, V12, P477; Bryk, 1992, HIERARCHICAL LINEAR; CHESNUT R, 1999, TRAUMATIC BRAIN INJU, P81; Chesnut RM, 2004, CRIT CARE CLIN, V20, P25, DOI 10.1016/S0749-0704(03)00090-3; Cohen J., 2013, STAT POWER ANAL BEHA; *COMM TRAUM AM COL, 1998, RES OPT CAR INJ PAT; *CTR MED MED SERV, 2003, ICD 9 CM EXP HOSP, V1; DUCKER TB, 1990, EARLY CARE INJURED P, P25; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; Fischer J, 2001, Crit Care Nurs Q, V23, P52; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; Kaplan LJ, 1997, INJURY, V28, P449, DOI 10.1016/S0020-1383(97)00088-0; Kim YJ, 2007, J TRAUMA, V63, P676, DOI 10.1097/01.ta.0000236056.38623.5b; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; MAULE K, 1994, CHEM ENG-LONDON, P3; MCNICHOLL BP, 1992, BRIT J SURG, V79, P171, DOI 10.1002/bjs.1800790226; Meagher R J, 2000, Clin Neurosurg, V46, P127; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Richardson JTE., 2000, CLIN NEUROPSYCHOLOGI; Ross Cynthia, 2006, J Trauma Nurs, V13, P193; Sinclair Tracey D, 2006, J Trauma Nurs, V13, P175; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Soukiasian HJ, 2002, AM SURGEON, V68, P1066; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; TRUNKEY DD, 1990, TRAUMA PUBLIC HLTH P, P3; [No title captured]	29	3	3	0	2	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0962-1067			J CLIN NURS	J. Clin. Nurs.	OCT	2010	19	19-20					2763	2770		10.1111/j.1365-2702.2009.03024.x			8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	651AJ	WOS:000281896700009	20384672				2022-02-06	
J	Tellez-Zenteno, JF; Nguyen, R; Hernandez-Ronquillo, L				Francisco Tellez-Zenteno, Jose; Nguyen, Rita; Hernandez-Ronquillo, Lizbeth			Injuries, accidents and mortality in epilepsy: A review of its prevalence risk factors and prevention	REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION			Spanish	Article						Epilepsy; Injuries; Accidents; Mortality; SUDEP	SUDDEN UNEXPECTED DEATH; ANTIEPILEPTIC DRUGS; SEIZURE DISORDERS; UNEXPLAINED DEATH; FRACTURE RISK; BURNS; SHOULDER; PEOPLE; RESPONSIBILITY; DISLOCATION	Currently, there is intense clinical research into various aspects of the medical risks relating to epilepsy, including total and cause-specific mortality, accidents and injuries in patients with epilepsy and mortality related with seizures. Submersion injuries, motor vehicle accidents, burns, and head injuries are among the most feared epilepsy-related injuries. Published risk factors for injuries include the number of antiepileptic drugs, history of generalized seizures, and seizure frequency. In general, studies focusing on populations with more severe forms of epilepsy tend to report substantially higher risks of injuries than those involving less selected populations. On the other hand, studies based in non selected populations of people with epilepsy have not shown an increase frequency of injuries in people with epilepsy compared with the general population. Some studies have shown that patients with epilepsy are more frequently admitted to the hospital following an injury. Possible explanations include are more cautious attitude of clinicians toward injuries occurring in the setting of seizures; hospitalization required because of seizures and not to the injuries themselves; and hospitalization driven by other issues, such as comorbidities, which are highly prevalent in patients with epilepsy. This article reviews information about specific type of injuries such as fractures, burns, concussions, dislocations, etc. Finally this article review in a comprehensive way information of mortality in patients with epilepsy. Aspects of mortality discussed in this review are: epidemiology, causes of mortality, sudden death in epilepsy and prevention measures	[Francisco Tellez-Zenteno, Jose; Nguyen, Rita; Hernandez-Ronquillo, Lizbeth] Univ Saskatchewan, Dept Med, Div Neurol, Saskatoon, SK S7N 0W0, Canada		Tellez-Zenteno, JF (corresponding author), Royal Univ Hosp, Dept Med, Div Neurol, 103 Hosp Dr,Box 26,Room 1622, Saskatoon, SK S7N OW8, Canada.	jft084@mail.usask.ca	Tellez-Zenteno, Jose F./AAM-3096-2020; Ronquillo, Lizbeth Hernandez/J-4826-2015	Ronquillo, Lizbeth Hernandez/0000-0001-7057-9343			Aboukasm AG, 1997, ARCH FAM MED, V6, P185, DOI 10.1001/archfami.6.2.185; Aldenkamp T, 2004, EPILEPSIA, V45, P54, DOI 10.1111/j.0013-9580.2004.33403.x; ANNEGERS JF, 1989, EPILEPSIA, V30, P348, DOI 10.1111/j.1528-1157.1989.tb05308.x; Appleton RE, 2003, ARCH DIS CHILD, V88, P1091, DOI 10.1136/adc.88.12.1091; Beghi E, 2005, EPILEPSIA, V46, P40, DOI 10.1111/j.1528-1167.2005.00407.x; Beghi E, 2005, BMJ-BRIT MED J, V331, P60, DOI 10.1136/bmj.331.7508.60; Beghi E, 2005, LANCET NEUROL, V4, P71, DOI 10.1016/S1474-4422(05)00971-3; Beghi E, 2002, EPILEPSIA, V43, P1076, DOI 10.1046/j.1528-1157.2002.18701.x; Berg AT, 2004, ARCH PEDIAT ADOL MED, V158, P1147, DOI 10.1001/archpedi.158.12.1147; Bird JM, 1997, EPILEPSIA, V38, pS52, DOI 10.1111/j.1528-1167.1997.tb06295.x; Buck D, 1997, EPILEPSIA, V38, P439, DOI 10.1111/j.1528-1157.1997.tb01733.x; Buhler M, 2002, J SHOULDER ELB SURG, V11, P339, DOI 10.1067/mse.2002.124524; BULL JP, 1964, BRIT MED J, V2, P1421, DOI 10.1136/bmj.2.5422.1421; Carpio A, 2005, EPILEPSIA, V46, P28, DOI 10.1111/j.1528-1167.2005.00404.x; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P818; Christensen J, 2007, LANCET NEUROL, V6, P693, DOI 10.1016/S1474-4422(07)70175-8; COCKERELL OC, 1995, LANCET, V346, P1228, DOI 10.1016/S0140-6736(95)92933-9; Currie CJ, 1998, EPILEPSIA, V39, P537, DOI 10.1111/j.1528-1157.1998.tb01417.x; Dulac O, 1997, EPILEPSIA, V38, P1054; Faught E, 2008, NEUROLOGY, V71, P1572, DOI 10.1212/01.wnl.0000319693.10338.b9; Forsgren L, 2005, EPILEPSIA, V46, P18, DOI 10.1111/j.1528-1167.2005.00403.x; Gosens T, 2000, SEIZURE-EUR J EPILEP, V9, P446, DOI 10.1053/seiz.2000.0418; HAMPTON KK, 1988, BRIT MED J, V296, P1659, DOI 10.1136/bmj.296.6637.1659; Jones MW, 1998, CAN J NEUROL SCI, V25, pS24, DOI 10.1017/S0317167100034934; Josty IC, 2000, EPILEPSIA, V41, P453, DOI 10.1111/j.1528-1157.2000.tb00188.x; Krauss GL, 2001, NEUROLOGY, V57, P1780, DOI 10.1212/WNL.57.10.1780; Krauss GL, 1999, NEUROLOGY, V52, P1324, DOI 10.1212/WNL.52.7.1324; KRISTIANSEN B, 1984, INJURY, V16, P108, DOI 10.1016/S0020-1383(84)80009-1; Lawn ND, 2004, NEUROLOGY, V63, P1565, DOI 10.1212/01.WNL.0000142991.14507.B5; Lhatoo SD, 2005, EPILEPSIA, V46, P36, DOI 10.1111/j.1528-1167.2005.00406.x; Lings S, 2001, NEUROLOGY, V57, P435, DOI 10.1212/WNL.57.3.435; Logroscino G, 2005, EPILEPSIA, V46, P46, DOI 10.1111/j.1528-1167.2005.00409.x; Logroscino G, 2005, EPILEPSIA, V46, P3, DOI 10.1111/j.1528-1167.2005.00399.x; MAISELS DO, 1964, LANCET, V1, P1298; MASLAND RL, 1978, ANN NEUROL, V4, P485, DOI 10.1002/ana.410040602; McLachlan RS, 2007, EPILEPSIA, V48, P1500, DOI 10.1111/j.1528-1167.2007.01051.x; Monte CPJA, 2007, SEIZURE-EUR J EPILEP, V16, P1, DOI 10.1016/j.seizure.2006.10.002; Nei M, 2007, CURR NEUROL NEUROSCI, V7, P335, DOI 10.1007/s11910-007-0051-1; Nikolas H, 2007, EPILEPSY BEHAV, V10, P363, DOI 10.1016/j.yebeh.2007.01.005; Persson HBI, 2002, EPILEPSIA, V43, P768, DOI 10.1046/j.1528-1157.2002.15801.x; Pompili M, 2006, EPILEPSY BEHAV, V9, P641, DOI 10.1016/j.yebeh.2006.06.019; RICHARDS EH, 1968, EPILEPSIA, V9, P127, DOI 10.1111/j.1528-1157.1968.tb05134.x; Rimmer RB, 2007, J BURN CARE RES, V28, P318, DOI 10.1097/BCR.0B013E318031A161; Severson CA, 2003, NAT NEUROSCI, V6, P1139, DOI 10.1038/nn1130; SHAW JL, 1971, J BONE JOINT SURG AM, VA 53, P1437, DOI 10.2106/00004623-197153070-00023; SHETH RD, 1995, J PEDIATR-US, V127, P256, DOI 10.1016/S0022-3476(95)70304-7; Sheth SG, 2004, NEUROLOGY, V63, P1002, DOI 10.1212/01.WNL.0000138590.00074.9A; SILBERGELD D L, 1991, Journal of the Royal College of Surgeons of Edinburgh, V36, P139; So EL, 2008, EPILEPSIA, V49, P93, DOI 10.1111/j.1528-1167.2008.01932.x; So EL, 2009, EPILEPSIA, V50, P917, DOI 10.1111/j.1528-1167.2008.01906.x; Souverein PC, 2005, EPILEPSIA, V46, P304, DOI 10.1111/j.0013-9580.2005.23804.x; Spencer S, 2008, LANCET NEUROL, V7, P525, DOI 10.1016/S1474-4422(08)70109-1; SPITZ MC, 1994, EPILEPSIA, V35, P764, DOI 10.1111/j.1528-1157.1994.tb02508.x; Spitz MC, 1998, EPILEPSIA, V39, P904, DOI 10.1111/j.1528-1157.1998.tb01189.x; Stephen LJ, 1999, SEIZURE-EUR J EPILEP, V8, P339, DOI 10.1053/seiz.1999.0301; Tellez-Zenteno JF, 2006, NEUROLOGY, V66, P1490, DOI 10.1212/01.wnl.0000209300.49308.8f; Tellez-Zenteno JF, 2005, EPILEPSY RES, V65, P101, DOI 10.1016/j.eplepsyres.2005.05.004; Tellez-Zenteno JF, 2008, EPILEPSIA, V49, P954, DOI 10.1111/j.1528-1167.2007.01499.x; TEMPEST MN, 1956, BMJ-BRIT MED J, V1, P1387, DOI 10.1136/bmj.1.4980.1387; Tomson T, 2005, EPILEPSIA, V46, P54, DOI 10.1111/j.1528-1167.2005.00411.x; Tomson T, 2004, EPILEPSY RES, V60, P1, DOI 10.1016/j.eplepsyres.2004.05.004; Tomson T, 2000, J NEUROL, V247, P15, DOI 10.1007/s004150050004; Tomson T, 2008, LANCET NEUROL, V7, P1021, DOI 10.1016/S1474-4422(08)70202-3; van den Broek M, 2004, EPILEPSIA, V45, P667, DOI 10.1111/j.0013-9580.2004.33903.x; Vestergaard P, 2005, ACTA NEUROL SCAND, V112, P277, DOI 10.1111/j.1600-0404.2005.00474.x; Vestergaard P, 1999, ACTA NEUROL SCAND, V99, P269, DOI 10.1111/j.1600-0404.1999.tb00675.x; WALLER JA, 1965, NEW ENGL J MED, V273, P1413, DOI 10.1056/NEJM196512232732605; Zwimpfer TJ, 1997, J NEUROSURG, V86, P433, DOI 10.3171/jns.1997.86.3.0433	68	3	4	0	8	INST NACIONAL NUTRICION	MEXICO	VASCO DE QUIROZA 15, COLONIA SECCION XVI, TLALPAN, MEXICO 14000 D F, MEXICO	0034-8376	2564-8896		REV INVEST CLIN	Rev. Investig. Clin.	SEP-OCT	2010	62	5					466	479					14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	733BG	WOS:000288234800012	21416735				2022-02-06	
J	Su, IC; Wang, KC; Huang, SH; Li, CH; Kuo, LT; Lee, JE; Tseng, HM; Tu, YK				Su, I-Chang; Wang, Kuo-Chuan; Huang, Shih-Hao; Li, Chien-Hsun; Kuo, Lu-Ting; Lee, Jin-Er; Tseng, Ham-Min; Tu, Yong-Kwang			Differential CT features of acute lentiform subdural hematoma and epidural hematoma	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Computed tomography; Epidural hematoma; Subdural hematoma; Differential diagnosis; Traumatic brain injury; Postoperative complications		Objectives: Acute subdural hematoma (SDH) normally appears as a panhemispheric collection of blood with a crescent configuration. However, a number of SDH show lentiform appearances, mimicking acute epidural hematoma (EDH). In this study, we reported our experiences with this special disease entity. Radiological features that aided in the accurate localization of the hematoma were also addressed. Patients and methods: From among 51 acute SDH cases who were surgically treated between July 2007 and April 2008, five cases whose SDH had a localized convex appearance were enrolled. Surgical records and CT images were retrospectively reviewed. Important CT features that could differentiate lentiform SDH from EDH were especially analyzed. Results: Subdural adhesions were major causes of localized SDH in four out of five patients, all of whom had previous neurosurgical interventions or radiotherapy. Though those hematomas appeared as biconvex on CT scans, four differential features could be identified in favor of SDH. These included a crescentic tail, an obtuse angle at the margin of the hematoma, a dural line above the hematoma and a direct connection to the underlying intracerebral hematomas. Conclusions: Biconvex localized SDH might be misinterpreted as acute EDH if the diagnosis is based on the shape of the hematoma alone. This study emphasized that a detailed evaluation of surgical histories and CT features are mandatory in differentiating lentiform SDH and EDH. (C) 2010 Elsevier B.V. All rights reserved.	[Su, I-Chang; Wang, Kuo-Chuan; Huang, Shih-Hao; Li, Chien-Hsun; Kuo, Lu-Ting; Tseng, Ham-Min; Tu, Yong-Kwang] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan; [Lee, Jin-Er] Buddhist Tzu Chi Gen Hosp, Dept Neurol, Taipei, Taiwan		Tu, YK (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, 7 Chung San S Rd, Taipei 100, Taiwan.	yktu@ntu.edu.tw	Kuo, Lu-Ting/AAU-3205-2021	Kuo, Lu-Ting/0000-0002-1405-8700; Tu, Yong-kwang/0000-0003-2113-1176; LI, CHIEN-HSUN/0000-0001-7671-9618; WANG, KUOCHUAN/0000-0002-4083-4689			BRAUN J, 1987, AM J NEURORADIOL, V8, P171; D'Amato L, 2007, J Neurosurg Sci, V51, P107; DOHERTY DL, 1988, ARCH PHYS MED REHAB, V69, P542; FORBES GS, 1978, RADIOLOGY, V126, P143, DOI 10.1148/126.1.143; Hurvitz S A, 1989, Brain Inj, V3, P63, DOI 10.3109/02699058909008075; Kapsalaki EZ, 2007, CLIN NEUROL NEUROSUR, V109, P287, DOI 10.1016/j.clineuro.2006.11.005; PALMER JD, 1994, NEUROSURGERY, V35, P1061, DOI 10.1227/00006123-199412000-00007; Palmer JD, 1994, NEUROSURGERY, V35, P1064; Provenzale J, 2007, EMERG RADIOL, V14, P1, DOI 10.1007/s10140-007-0587-z; REED D, 1986, AM J NEURORADIOL, V7, P417; SMIRNIOTOPOULOS JG, 1987, AM J NEURORADIOL, V8, P1146; Watanabe K, 1999, ANN NUCL MED, V13, P33, DOI 10.1007/BF03165425; Westermaier T, 2007, NEUROSURGERY, V61, P482, DOI 10.1227/01.NEU.0000290893.85072.F9	13	3	3	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467			CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	SEP	2010	112	7					552	556		10.1016/j.clineuro.2010.03.001			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	636YF	WOS:000280779900002	20483531				2022-02-06	
J	Tandon, SS; Hoskins, I; Azhar, S				Tandon, Saira S.; Hoskins, Iffath; Azhar, Salman			Intrathecal baclofen pump - a viable therapeutic option in pregnancy	OBSTETRIC MEDICINE			English	Article						high-risk pregnancy; maternal-fetal medicine		Baclofen, a gamma-aminobutyric acid analogue, is used as a muscle relaxant and antispasmodic to relieve symptoms in patients with intractable spasticity arising from cerebral or spinal aetiology such as in traumatic brain injury or multiple sclerosis. As it is often used in women of reproductive age, it is imperative to know the safety and associated maternal and fetal risks. The Food and Drug Administration has assigned the drug to Pregnancy Category C because of the lack of controlled data in humans. Animal studies have revealed an increased incidence of omphalocele if used in doses several times the recommended human dose. Baclofen should only be given during pregnancy when the benefits outweigh the risks. Baclofen is considered compatible with breast feeding by the American Academy of Pediatrics.	[Tandon, Saira S.; Hoskins, Iffath] Lutheran Med Ctr, Dept Obstet & Gynaecol, Brooklyn, NY 11220 USA; [Azhar, Salman] Lutheran Med Ctr, Stroke & Rehabil, Brooklyn, NY USA		Tandon, SS (corresponding author), Lutheran Med Ctr, Dept Obstet & Gynaecol, Brooklyn, NY 11220 USA.	dr_saira_ahmad@hotmail.com					Dalton CM, 2008, MULT SCLER J, V14, P571, DOI 10.1177/1352458507085552; DELHAAS EM, 1992, PARAPLEGIA, V30, P527, DOI 10.1038/sc.1992.110; Moran LR, 2004, PEDIATRICS, V114, P267; Munoz FC, 2000, ANN PHARMACOTHER, V34, P956; Ratnayaka BDM, 2001, BRIT MED J, V323, P85, DOI 10.1136/bmj.323.7304.85; Roberts AG, 2003, NEUROLOGY, V61, P1156, DOI 10.1212/01.WNL.0000086806.65430.40; Sepulveda W, 1998, J ULTRAS MED, V17, P171	7	3	3	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1753-495X	1753-4968		OBSTET MED	Obstet. Med.	SEP	2010	3	3					119	120		10.1258/om.2010.100016			2	Obstetrics & Gynecology	Emerging Sources Citation Index (ESCI)	Obstetrics & Gynecology	V5F2K	WOS:000219553700009	27576877	Green Published			2022-02-06	
J	Colak, T; Duman, C; Bamac, B; Aydin, A; Ozbek, A; Yildiz, K; Bicer, U				Colak, Tuncay; Duman, Can; Bamac, Belgin; Aydin, Adem; Ozbek, Aydin; Yildiz, Kursat; Bicer, Umit			Ischemia Modified Albumin Levels Following Mild Closed Head Trauma in the Rat	TURKIYE KLINIKLERI TIP BILIMLERI DERGISI			English	Article						Rats; craniocerebral trauma	BRAIN-INJURY; MYOCARDIAL-ISCHEMIA; CEREBRAL-ISCHEMIA; BINDING; PATHOPHYSIOLOGY; VULNERABILITY; MANAGEMENT; MARKER; MODEL	Objective: Mild traumatic brain injury (MTBI) is one of the most frequent neurological damage types in which complex physiological and biochemical events occur in traumatized area. Regional ischemia can occur in the acute phase after trauma. Recently, both clinical and experimental studies have shown that ischemia modified albumin (IMA) is one of the most promising blood markers of ischemia. In this study, whether serum IMA values can be used in rats as a marker for intracranial ischemia caused by trauma is investigated. Material and Methods: Wistar-albino adult rats were utilized in this study. Rats were exposed to MTBI by using a trauma device. Frontal and parietal brain tissues were taken for histopathological investigation. Serum IMA values of traumatised and control rats were measured with the ACB (albumin cobalt binding) test. Results: While the absolute IMA values were 0.576 +/- 0.048 for trauma group, it was identified as 0.568 +/- 0.055 for control group. There was no statistically significant difference between trauma and control groups in the mean value of the IMA. In our histopathological analysis, necrosis associated with hypoxia in the outer layers of brain cortex as a result of the trauma applied to rats, and neuron damage in the inner layers of the cortex were observed. In addition, red neurons were detected in the brain cortex as a result of early stage neuron damage associated with ischemia. Conclusion: We found that there is no significant increase in IMA levels in rats with trauma suggesting that this biomarker would not be useful in detecting early ischemic changes in MTBI.	[Colak, Tuncay; Bamac, Belgin; Ozbek, Aydin] Kocaeli Univ, Fac Med, Dept Anat, Kocaeli, Turkey; [Duman, Can] Kocaeli Univ, Fac Med, Dept Biochem, Kocaeli, Turkey; [Aydin, Adem] Kocaeli Univ, Fac Med, Dept Orthoped & Traumatol, Kocaeli, Turkey; [Yildiz, Kursat] Kocaeli Univ, Fac Med, Dept Pathol, Kocaeli, Turkey; [Bicer, Umit] Kocaeli Univ, Fac Med, Dept Forens Med, Kocaeli, Turkey		Colak, T (corresponding author), Kocaeli Univ, Fac Med, Dept Anat, Kocaeli, Turkey.	tuncayc@kocaeli.edu.tr	Ozbek, Aydin/J-4519-2018; Bamac, Belgin/F-7373-2018; Ozbek, Aydin/AAV-6294-2020; Colak, Tuncay/F-5749-2018; Yildiz, Demir Kursat/F-9919-2018	Ozbek, Aydin/0000-0001-5864-8166; Colak, Tuncay/0000-0002-9483-3243; 			Akdemir G, 2008, TURKIYE KLIN J NEURO, V1, P6; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bar-Or D, 2000, J EMERG MED, V19, P311, DOI 10.1016/S0736-4679(00)00255-9; Bar-Or D, 2001, AM HEART J, V141, P985, DOI 10.1067/mhj.2001.114800; Bekman ZM, 2007, TURKIYE KLIN J INT M, V3, P35; Collinson PO, 2008, J CLIN PATHOL, V61, P1025, DOI 10.1136/jcp.2007.053363; DE KJ, 2001, BRAIN INJURY, V15, P99; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Gunduz A, 2008, AM J EMERG MED, V26, P874, DOI 10.1016/j.ajem.2007.11.023; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Murshid WR, 1998, ACTA NEUROCHIR, V140, P56, DOI 10.1007/s007010050058; Nabika S, 2007, PEDIATR NEUROSURG, V43, P312, DOI 10.1159/000103313; Roy D, 2004, CLIN CHEM, V50, P1656, DOI 10.1373/clinchem.2004.031690; SADLER PJ, 1994, EUR J BIOCHEM, V220, P193, DOI 10.1111/j.1432-1033.1994.tb18614.x; Senes M, 2007, ANN CLIN BIOCHEM, V44, P43, DOI 10.1258/000456307779596057; Son BC, 2000, ACT NEUR S, V76, P13; TALWALKAR S, 2008, INN CLIN LAB SCI, V88, P132; Talwalkar SS, 2008, ANN CLIN LAB SCI, V38, P132; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; Voller B, 2001, BRAIN INJURY, V15, P107, DOI 10.1080/026990501458344; YAGMUR Y, 2000, T KLIN J MED SCI, V20, P123; ZINI I, 1992, NEUROSCI LETT, V138, P279, DOI 10.1016/0304-3940(92)90933-X	28	3	3	0	6	ORTADOGU AD PRES & PUBL CO	ANKARA	TURKOCAGI CAD NO 30, BALGAT, ANKARA, 06520, TURKEY	1300-0292			TURK KLIN TIP BILIM	Turk. Klin. Tip Bilim. Derg.	AUG	2010	30	4					1171	1176		10.5336/medsci.2009-11356			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	667IO	WOS:000283186700007					2022-02-06	
J	Hasegawa, Y; Tanaka, T; Kato, N; Kaku, S; Arai, T; Abe, T				Hasegawa, Yuzuru; Tanaka, Toshihide; Kato, Naoki; Kaku, Shougo; Arai, Takao; Abe, Toshiaki			Arachnoidplasty for Traumatic Subdural Hygroma Associated With Arachnoid Cyst in the Middle Fossa	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						arachnoid cyst; middle fossa; arachnoidplasty; subdural hygroma; head injury	SURGICAL-TREATMENT; HEAD-INJURY; DISAPPEARANCE; FENESTRATION; CHILDREN	A 5-year old boy presented with an arachnoid cyst in the middle cranial fossa with mild midline shift manifesting as headache and loss of activity. Computed tomography (CT) showed subdural hygroma. Burr-hole drainage was carried out and symptoms were improved postoperatively. However, recollection of subdural hygroma was found on follow-up CT 3 weeks after subdural drainage. He underwent craniotomy, and tearing of the outer wall of the arachnoid cyst was observed. The ruptured cyst wall was tightly closed by arachnoidplasty to prevent cerebrospinal fluid leakage. Arachnoidplasty was effective for traumatic subdural hygroma with arachnoid cyst for reconstruction.	[Hasegawa, Yuzuru; Tanaka, Toshihide; Kato, Naoki; Arai, Takao] Jikei Univ, Sch Med, Kashiwa City Hosp, Dept Neurosurg, Chiba 2778567, Japan; [Kaku, Shougo] Natl Hosp Org, Yokohama Med Ctr, Dept Neurosurg, Kanagawa, Japan; [Abe, Toshiaki] Jikei Univ, Sch Med, Dept Neurosurg, Tokyo, Japan		Tanaka, T (corresponding author), Jikei Univ, Sch Med, Kashiwa City Hosp, Dept Neurosurg, 163-1 Kashiwa Shita, Chiba 2778567, Japan.	ttanaka@jikei.ac.jp	Kato, Naoki/F-3104-2019; Tanaka, Toshihide/AAE-9219-2019	Kato, Naoki/0000-0001-5041-6985; Tanaka, Toshihide/0000-0002-6474-6317			Albuquerque FC, 1997, NEUROSURGERY, V41, P951, DOI 10.1097/00006123-199710000-00036; CIRICILLO SF, 1991, J NEUROSURG, V74, P230, DOI 10.3171/jns.1991.74.2.0230; Fewel ME, 1996, PEDIATR NEUROSURG, V25, P165, DOI 10.1159/000121119; GALASSI E, 1980, SURG NEUROL, V14, P211; Levy ML, 2003, NEUROSURGERY, V53, P1138, DOI 10.1227/01.NEU.0000089060.65702.03; MORI T, 1995, NEUROSURGERY, V36, P938, DOI 10.1227/00006123-199505000-00008; Parsch CS, 1997, NEUROSURGERY, V40, P483, DOI 10.1097/00006123-199703000-00010; PUNZO A, 1992, NEUROCHIRURGIA, V35, P35; RAFFEL C, 1988, NEUROSURGERY, V23, P338, DOI 10.1227/00006123-198809000-00009; Shigemori M, 1996, SURG NEUROL, V45, P189, DOI 10.1016/S0090-3019(96)80015-2; Tamburrini G, 2003, CHILD NERV SYST, V19, P159, DOI 10.1007/s00381-003-0724-2; VARMA TRK, 1981, J NEUROL NEUROSUR PS, V44, P29, DOI 10.1136/jnnp.44.1.29; YAMANOUCHI Y, 1986, CHILD NERV SYST, V2, P40, DOI 10.1007/BF00274033	13	3	3	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	AUG	2010	50	8					698	701		10.2176/nmc.50.698			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	639VZ	WOS:000281005400025	20805659	Bronze			2022-02-06	
J	Noble, KA				Noble, Kim A.			Traumatic Brain Injury and Increased Intracranial Pressure	JOURNAL OF PERIANESTHESIA NURSING			English	Article								Traumatic brain injury (TBI) affects approximately 1.4 million individuals and has a mortality rate greater than 30% in the first 72 hours after injury The patient with TBI can present a significant challenge for the perianesthesia nurse in the acute care setting. Increased intracranial pressure is a common consequence of TBI and the rapid assessment and management can affect the long term outcome of the patient with TBI. New monitoring modalities have been developed to monitor cerebral blood flow and nutritional supply to neurologic tissues. A case scenario will be used to identify priorities for the perianesthesia nurse caring for this challenging patient. (C) 2010 by American Society of PeriAnesthesia Nurses	Widener Univ, Dept Nursing, Chester, PA 19013 USA		Noble, KA (corresponding author), Widener Univ, Dept Nursing, 1 Univ Pl, Chester, PA 19013 USA.	kimnoble@verizon.net					Barazangi N, 2008, NEUROL INDIA, V56, P405; Cowley NJ, 2008, TRAUMA, V10, P35, DOI 10.1177/1460408608089322; Drain CB, 2009, PERIANESTHESIA NURSI; Grathwohl KW, 2008, ANESTHESIOLOGY, V109, P44, DOI 10.1097/ALN.0b013e31817c02e3; Hebb MO, 2007, CAN J SURG, V50, P187; Maerz LL, 2009, INT ANESTHESIOL CLIN, V47, P25, DOI 10.1097/AIA.0b013e3181950030; Porth C. M., 2009, PATHOPHYSIOLOGY CONC	7	3	3	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1089-9472			J PERIANESTH NURS	J. PeriAnesthesia Nurs.	AUG	2010	25	4					242	247		10.1016/j.jopan.2010.05.008			6	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	767XU	WOS:000290893000007	20656261				2022-02-06	
J	Prikryl, P; Selucky, J; Grenar, J; Skacel, P				Prikryl, P.; Selucky, J.; Grenar, J.; Skacel, P.			Latarjet Procedure for the Treatment of Inveterated Shoulder Dislocations	ACTA CHIRURGIAE ORTHOPAEDICAE ET TRAUMATOLOGIAE CECHOSLOVACA			Czech	Article						irreducible shoulder dislocation; Latarjet procedure	ANTERIOR INSTABILITY; BRISTOW PROCEDURE	PURPOSE OF THE STUDY Transfer of the tip of the coracoid process to the anterior margin of the glenoid is a procedure indicated in shoulder instability due to bone lesion. However, it is also used in inveterated shoulder dislocations refractory to conservative treatment that require open reduction of the joint. The bone block thus created allows for more effective and safer rehabilitation than does a temporary rigid Ki-wire fixation of the humeral head. The aim of this retrospective study was to evaluate the group of patients treated for irreducible inveterated shoulder dislocations by the Latarjet procedure. MATERIAL Between 2005 and 2009, 16 patients with inveterated anterior shoulder dislocations were operated on. The group comprised 11 men and five women with an average age of 58 years. In all patients the duration of shoulder dislocation was longer than 3 days and reduction that would keep the humeral head in the glenoid socket was not possible even under general anaesthesia. The reasons for the late treatment included a delayed visit to the doctor's because the injury was not considered serious, the dislocation being missed in the presence of other more serious conditions, and even an overlooking by the attending physician. The longest time between the dislocation and its treatment was 23 days. Alcohol abuse was evident in some of the patients. METHODS In the patients with irreducible inveterated shoulder dislocations who were referred to us, closed reduction was attempted in the first place. When this failed or when spontaneous dislocation subsequently occurred, open revision surgery was carried out. After coagula and synovia were removed from the glenoid socket, the head still had a tendency to dislocate spontaneously. Subsequently, the Latarjet procedure;was performed this involved osteotomy of the coracoid process, retaining the attachment of the short head of the biceps brachii, and its transposition, through a split in the subscapularis tendon, to the anterior lower margin of the glenoid. The process was fixed with two traction screws to create a firm bone barrier preventing dislocation. RESULTS The functional outcome was assessed at 6 months after surgery,;using the Constant score its average value was 60 points (35 to 85). From the evaluation of individual cases it appeared that the longer the time of shoulder dislocation, the worse the functional outcome of treatment. In comparison with the patients treated by open reduction with a temporary rigid Ki-wire fixation, the Latarjet procedure was clearly beneficial. DISCUSSION Before the Latarjet procedure has been adopted, inveterated dislocations were treated by open reduction and a temporary fixation of the head in the socket by means of Ki-wires for three weeks. The functional outcomes following inveterated dislocation and rigid fixation were pitiable. Although the shoulder was articulated, its motion was restricted and painful. The procedure described here allows the patient to start early rehabilitation while maintaining shoulder stability. CONCLUSIONS Inveterated irreducible shoulder dislocation is a rare diagnosis which is usually associated with the patient's personality disorder or is missed in patients with a disorder of consciousness. The treatment is difficult, but with the use of the procedure described here it is possible, with some limitation, to restore the shoulder function and its range of motion.	[Prikryl, P.; Selucky, J.; Grenar, J.; Skacel, P.] Nemocnice Prerov, Ortoped Traumatol Oddeleni, Prerov 75000, Slovakia		Prikryl, P (corresponding author), Nemocnice Prerov, Ortoped Oddeleni, Dvorakova 75, Prerov 75000, Slovakia.	pavlik.prikryl@seznam.cz					Allain J, 1998, J BONE JOINT SURG AM, V80A, P841, DOI 10.2106/00004623-199806000-00008; Arrigoni P, 2008, ARTHROSCOPY, V24, P514, DOI 10.1016/j.arthro.2007.11.021; BARTONICEK J, 2004, ZAKLADY KLIN ANATOMI; Boileau P, 2007, ARTHROSCOPY, V23, P593, DOI 10.1016/j.arthro.2007.03.096; Burkhart SS, 2007, ARTHROSCOPY, V23, P1033, DOI 10.1016/j.arthro.2007.08.009; Chow J.C., 2001, ADV ARTHROSCOPY; Cole BJ, 2000, J BONE JOINT SURG AM, V82A, P1108, DOI 10.2106/00004623-200008000-00007; Collin P, 2007, REV CHIR ORTHOP, V93, P126, DOI 10.1016/S0035-1040(07)90215-9; Huguet D, 1996, Acta Orthop Belg, V62, P200; Jahoda D, 2008, ACTA CHIR ORTHOP TR, V75, P422; Lafosse L, 2007, ARTHROSCOPY, V23, DOI 10.1016/j.arthro.2007.06.008; Maquieira Gerardo J, 2007, J Shoulder Elbow Surg, V16, pe13, DOI 10.1016/j.jse.2006.04.001; Matthes G, 2007, J Orthop Surg (Hong Kong), V15, P4; Maynou C, 2005, J BONE JOINT SURG BR, V87B, P1096, DOI 10.1302/0301-620X.87B8.14605; Musil D, 2009, ACTA CHIR ORTHOP TR, V76, P98; Pap G, 1997, ZBL CHIR, V122, P321; PRIKRYL P, 2007, ARTROSKOPIE RAMENE; ROCKWOOD C, 2004, SHOULDER; ROWE CR, 1981, J BONE JOINT SURG AM, V63, P863, DOI 10.2106/00004623-198163060-00001; Sadovsky P, 2006, Acta Chir Orthop Traumatol Cech, V73, P23; Schroder DI, 2006, AM J SPORT MED, V34, P778, DOI 10.1177/0363546505282618; SNYDER SJ, 1995, SHOULDER ARTHROSCOPY; [No title captured]	23	3	3	0	4	GALEN SRO	PRAGUE 5	NA BELIDLE 34, PRAGUE 5, 150 00, CZECH REPUBLIC	0001-5415			ACTA CHIR ORTHOP TR	Acta Chir. Orthop. Traumatol. Cechoslov.	AUG	2010	77	4					327	331					5	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	646JE	WOS:000281535100010	21059331				2022-02-06	
J	Inamasu, J; Nakatsukasa, M; Suzuki, M; Miyatake, S				Inamasu, Joji; Nakatsukasa, Masashi; Suzuki, Masaru; Miyatake, Satoru			Therapeutic Hypothermia for Out-of-Hospital Cardiac Arrest: An Update for Neurosurgeons	WORLD NEUROSURGERY			English	Article						Out-of-hospital cardiac arrest; Prehospital cooling; Randomized controlled trial; Therapeutic hypothermia; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; SURFACE COOLING DEVICE; MILD HYPOTHERMIA; COMATOSE SURVIVORS; CLINICAL-TRIAL; SUBARACHNOID HEMORRHAGE; CEREBRAL RESUSCITATION; INDUCTION; EFFICACY; COLD	BACKGROUND: Neurosurgeons have been familiar with the idea that hypothermia is protective against various types of brain injuries, including traumatic brain injury (TBI). Recent randomized controlled trials, however, have failed to demonstrate the efficacy of therapeutic hypothermia (TH) in patients with TBI. On the other hand, TH becomes popular in the treatment of out-of-hospital cardiac arrest (OHCA) survivors, after randomized controlled trials have shown that survival rate and functional outcome is improved with the use of TH in selected patients. We believe that knowledge on the recent progress in TH for OHCA is useful for neurosurgeons, because feedback of information obtained in the treatment of OHCA may revitalize the interest in TH for neurosurgical disorders, particularly TBI. METHODS: A review of the literature was conducted with the use of PubMed. RESULTS: Various cooling techniques and devices have been developed and trialed in the treatment of OHCA survivors, including prehospital cooling with bolus ice-cold saline, endovascular cooling catheters, and new generation surface cooling devices, some of which have already been known to neurosurgeons. The efficacy of these new methods and devices has been demonstrated in many preliminary studies, and phase III trials are also expected. CONCLUSIONS: Neurosurgeons and critical care medicine physicians pursue the same goal of rescuing the brain from the secondary injury despite the difference in etiology (focal trauma vs. global ischemia), with the presumption that earlier and faster implementation of TH will result in better outcome. Thoughtful application of knowledge and techniques obtained in OHCA to TBI under a rigorously controlled situation will make a small, but significant difference in the outcome of TBI victims.	[Inamasu, Joji; Nakatsukasa, Masashi] Saiseikai Utsunomiya Hosp, Dept Neurosurg, Utsunomiya, Tochigi, Japan; [Suzuki, Masaru; Miyatake, Satoru] Keio Univ, Sch Med, Dept Emergency & Crit Care Med, Tokyo, Japan		Inamasu, J (corresponding author), Saiseikai Utsunomiya Hosp, Dept Neurosurg, Utsunomiya, Tochigi, Japan.	ginamasu@aol.com	Inamasu, Joji/R-7314-2019				Abate MG, 2008, MINERVA ANESTESIOL, V74, P425; Abou-Chebl A, 2004, NEUROCRIT CARE, V1, P131, DOI 10.1385/NCC:1:2:131; Al-Senani FM, 2004, RESUSCITATION, V62, P143, DOI 10.1016/j.resuscitation.2004.02.016; Arnaoutoglou H, 2006, MINERVA ANESTESIOL, V72, P763; Arrich J, 2007, CRIT CARE MED, V35, P1041, DOI 10.1097/01.CCM.0000259383.48324.35; Atkins DL, 2006, PEDIATRICS, V117, pE989; Berger C, 2007, EXP NEUROL, V204, P131, DOI 10.1016/j.expneurol.2006.10.002; Bergman R, 2008, RESUSCITATION, V76, P142, DOI 10.1016/j.resuscitation.2007.06.011; Bernard S, 2004, CRIT CARE MED, V32, P897, DOI 10.1097/01.CCM.0000115263.08805.EF; Bernard S, 2003, RESUSCITATION, V56, P9, DOI 10.1016/S0300-9572(02)00276-9; Bernard SA, 1997, ANN EMERG MED, V30, P146, DOI 10.1016/S0196-0644(97)70133-1; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bottiger Bernd W, 2007, Crit Care, V11, P162, DOI 10.1186/cc6100; Bouch DC, 2008, BRIT J ANAESTH, V100, P591, DOI 10.1093/bja/aen075; Brooks SC, 2008, RESUSCITATION, V77, P286, DOI 10.1016/j.resuscitation.2008.01.017; Bruel C, 2008, CRIT CARE, V12, DOI 10.1186/cc6809; Callaway CW, 2002, RESUSCITATION, V52, P159, DOI 10.1016/S0300-9572(01)00462-2; Cariou A, 2008, RESUSCITATION, V76, P397, DOI 10.1016/j.resuscitation.2007.10.003; Cheung Ka Wai, 2006, CJEM, V8, P329; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Clifton Guy L, 2004, Curr Opin Crit Care, V10, P116, DOI 10.1097/00075198-200404000-00007; Deem S, 2007, RESP CARE, V52, P443; Doufas AG, 2003, STROKE, V34, P1218, DOI 10.1161/01.STR.0000068787.76670.A4; FAY T, 1959, J NEUROSURG, V16, P239, DOI 10.3171/jns.1959.16.3.0239; Flint AC, 2007, NEUROCRIT CARE, V7, P109, DOI 10.1007/s12028-007-0068-y; Gasser S, 2003, J NEUROSURG ANESTH, V15, P240, DOI 10.1097/00008506-200307000-00012; Gunn AJ, 2008, J PEDIATR-US, V152, P55, DOI 10.1016/j.jpeds.2007.06.003; Hachimi-Idrissi S, 2001, RESUSCITATION, V51, P275, DOI 10.1016/S0300-9572(01)00412-9; Hampton T, 2007, JAMA-J AM MED ASSOC, V298, P1994, DOI 10.1001/jama.298.17.1994; Haugk M, 2007, RESUSCITATION, V75, P76, DOI 10.1016/j.resuscitation.2007.03.001; Hay AW, 2008, ANAESTHESIA, V63, P15, DOI 10.1111/j.1365-2044.2007.05262.x; Hinz J, 2007, J NEUROSURG ANESTH, V19, P130, DOI 10.1097/ANA.0b013e318032a208; Hoedemaekers CW, 2007, CRIT CARE, V11, DOI 10.1186/cc6104; Holzer M, 2008, EUR J ANAESTH, V25, P31, DOI 10.1017/S0265021507003274; Holzer M, 2005, CRIT CARE MED, V33, P414, DOI 10.1097/01.CCM.0000153410.87750.53; Holzer M, 2002, NEW ENGL J MED, V346, P549; Holzer M, 2006, STROKE, V37, P1792, DOI 10.1161/01.STR.0000227265.52763.16; Hovdenes J, 2007, ACTA ANAESTH SCAND, V51, P137, DOI 10.1111/j.1399-6576.2006.01209.x; Hutchison JS, 2008, PEDIATR CLIN N AM, V55, P529, DOI 10.1016/j.pcl.2008.02.011; Inamasu J, 2002, ANN EMERG MED, V40, P220, DOI 10.1067/mem.2002.123697; Inamasu J, 2001, RESUSCITATION, V51, P207, DOI 10.1016/S0300-9572(01)00429-4; Inamasu J, 2006, J CLIN NEUROSCI, V13, P733, DOI 10.1016/j.jocn.2005.03.018; Ishikawa K, 2000, J TRAUMA, V49, P912, DOI 10.1097/00005373-200011000-00020; Janata A, 2008, CRIT CARE MED, V36, P895, DOI 10.1097/CCM.0B013E318165FB33; Kamarainen A, 2008, RESUSCITATION, V76, P360, DOI 10.1016/j.resuscitation.2007.08.015; Keller E, 2003, INTENS CARE MED, V29, P939, DOI 10.1007/s00134-003-1685-3; Kim F, 2007, CIRCULATION, V115, P3064, DOI 10.1161/CIRCULATIONAHA.106.655480; Kliegel A, 2005, RESUSCITATION, V64, P347, DOI 10.1016/j.resuscitation.2004.09.002; Kliegel A, 2007, RESUSCITATION, V73, P46, DOI 10.1016/j.resuscitation.2006.08.023; Kochanek PM, 2008, NEW ENGL J MED, V359, P1179; Ly HQ, 2005, AM HEART J, V150, DOI 10.1016/j.ahj.200502.049; Mayer SA, 2005, CRIT CARE MED, V33, P2844, DOI 10.1097/01.CCM.0000191124.55576.66; Mayer SA, 2004, CRIT CARE MED, V32, P2508, DOI 10.1097/01.CCM.0000147441.39670.37; Nagao K, 2000, J AM COLL CARDIOL, V36, P776, DOI 10.1016/S0735-1097(00)00779-8; Nakamura T, 1999, J NEUROSURG, V91, P114, DOI 10.3171/jns.1999.91.1.0114; Narayan RK, 2001, NEW ENGL J MED, V344, P602, DOI 10.1056/NEJM200102223440810; Nolan JP, 2005, RESUSCITATION, V67, pS39, DOI 10.1016/j.resuscitation.2005.10.009; Oddo M, 2006, CRIT CARE MED, V34, P1865, DOI 10.1097/01.CCM.0000221922.08878.49; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Pichon N, 2007, CRIT CARE, V11, DOI 10.1186/cc5956; Polderman KH, 2006, CRIT CARE, V10, DOI 10.1186/cc5023; Polderman KH, 2005, CRIT CARE MED, V33, P2744, DOI 10.1097/01.CCM.0000190427.88735.19; Polderman KH, 2004, INTENS CARE MED, V30, P1860, DOI 10.1007/s00134-004-2383-5; RIDENOUR TR, 1992, STROKE, V23, P733, DOI 10.1161/01.STR.23.5.733; SAFAR P, 1978, CRIT CARE MED, V6, P215, DOI 10.1097/00003246-197807000-00003; Safar P, 2003, ANN EMERG MED, V41, P887, DOI 10.1067/mem.2003.215; Schefold JC, 2009, INT J CARDIOL, V132, P387, DOI 10.1016/j.ijcard.2007.12.008; Shiozaki T, 2003, J NEUROSURG, V99, P47, DOI 10.3171/jns.2003.99.1.0047; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Simosa HF, 2007, AM SURGEON, V73, P461; Skulec R, 2008, ACTA ANAESTH SCAND, V52, P188, DOI 10.1111/j.1399-6576.2007.01510.x; Soar J, 2007, BRIT MED J, V335, P459, DOI 10.1136/bmj.39315.519201.BE; Steinberg GK, 2004, NEUROSURGERY, V55, P307, DOI 10.1227/01.NEU.0000129683.99430.8C; Storm C, 2008, CLIN RES CARDIOL, V97, P768, DOI 10.1007/s00392-008-0678-1; Suffoletto BP, 2008, PREHOSP EMERG CARE, V12, P52, DOI 10.1080/10903120701707880; Tiainen M, 2007, STROKE, V38, P2303, DOI 10.1161/STROKEAHA.107.483867; Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975; Uray T, 2008, RESUSCITATION, V77, P331, DOI 10.1016/j.resuscitation.2008.01.005; van Zanten ARH, 2005, CRIT CARE MED, V33, P1449, DOI 10.1097/01.CCM.0000166710.64724.34; Vanden Hoek Terry L, 2004, Crit Care Med, V32, pS425, DOI 10.1097/01.CCM.0000134259.59793.B8; Varon J, 2008, CHEST, V133, P1267, DOI 10.1378/chest.07-2190; Vayrynen T, 2008, RESUSCITATION, V76, P207, DOI 10.1016/j.resuscitation.2007.07.023; Wang H, 2006, ACTA NEUROCHIR, V148, P565, DOI 10.1007/s00701-006-0747-z; Wolff B, 2009, INT J CARDIOL, V133, P223, DOI 10.1016/j.ijcard.2007.12.039; Wu XR, 2005, J TRAUMA, V59, P291, DOI 10.1097/01.ta.0000179445.76729.2c; Zanelli S, 2008, J PERINATOL, V28, P171, DOI 10.1038/sj.jp.7211896; Zhao DH, 2008, RESUSCITATION, V77, P242, DOI 10.1016/j.resuscitation.2007.10.015	89	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUL	2010	74	1					120	128		10.1016/j.wneu.2010.02.065			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	792VG	WOS:000292777900029	21300001				2022-02-06	
J	Jaffee, M; Martin, EM				Jaffee, Michael; Martin, Elisabeth Moy			Defense and Veterans Brain Injury Center: Program Overview and Research Initiatives	MILITARY MEDICINE			English	Article							HEAD-INJURY; REHABILITATION; TRIAL	For more than 16 years, the Defense and Veterans Brain Injury Center (at one time known as the Defense and Veterans Head Injury Program) has served to develop and disseminate clinical guidelines and undertake innovative clinical research initiatives and educational programs to serve active duty personnel, their dependents, and veterans with traumatic brain injury (TBI). Through educational initiatives and collaboration with civilian institutions, the center is ensuring that critical discoveries surrounding TBI prevention, screening, and treatment are made available to preserve and improve the health of those within and outside the military health system.	[Jaffee, Michael; Martin, Elisabeth Moy] Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC 20012 USA		Jaffee, M (corresponding author), Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, POB 59181, Washington, DC 20012 USA.						Cope DN, 2005, J HEAD TRAUMA REHAB, V20, P128, DOI 10.1097/00001199-200503000-00002; Dutton RP., 2005, CLIN INTENSIVE CARE, V16, P97, DOI DOI 10.3109/09563070500116911; HALL K, 2007, STANDARDIZING WAR TR; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; KENNEDY K, 2008, TESTING BREAKTHROUGH; MOORE D, 2009, RETURNING SERVICE ME; *NAT CTR INJ PREV, 2008, CTR DIS CONTR PREV; ROBERT M, 2008, SPEECH DELIVERED SEC, V29; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Salazar AM, 2000, J HEAD TRAUMA REHAB, V15, P1081, DOI 10.1097/00001199-200010000-00002; TANIELIAN T, 2008, IMISIBLE WOUNDS WAR; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Walilko T, 2009, J TRAUMA, V67, P1311, DOI 10.1097/TA.0b013e31819adc36	13	3	3	0	2	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075			MIL MED	Milit. Med.	JUL	2010	175	7		S			37	41		10.7205/MILMED-D-10-00170			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	624EP	WOS:000279799400008	23634477	Bronze			2022-02-06	
J	Johnson, LSM				Johnson, L. Syd M.			Implications of Recent Neuroscientific Findings in Patients with Disorders of Consciousness	NEUROETHICS			English	Article						Misdiagnosis; Disorders of consciousness; Vegetative state; Minimally conscious state; Classical conditioning; Neuroscience	PERSISTENT VEGETATIVE STATE; TRAUMATIC BRAIN-INJURY; LIFE DECISION-MAKING; OWN NAME; PERSONAL PERSPECTIVES; COGNITIVE RECOVERY; CEREBRAL RESPONSE; ZOLPIDEM; AROUSAL; STIMULATION	A pressing issue in neuroscience is the high rate of misdiagnosis of disorders of consciousness. As new research on patients with disorders of consciousness has revealed surprising and previously unknown cognitive capacities, the need to develop better and more reliable methods of diagnosing these disorders becomes more urgent. So too the need to expand our ethical and social frameworks for thinking about these patients, to accommodate new concerns that will accompany new revelations. A recent study on trace conditioning and learning in vegetative and minimally conscious patients shows promise as a potential diagnostic and prognostic tool, both for differentiating between states of diminished consciousness, and for predicting patient outcomes, but it also generates fresh concerns about quality of life in patients previously thought to be completely unaware. Optimism about progress in diagnosing and treating disorders of consciousness must be tempered by the understanding that not all progress will necessarily be good for all patients. The prognosis for most patients remains bleak, and we must remain vigilant to acute questions and concerns about welfare and quality of life.	[Johnson, L. Syd M.] Dalhousie Univ, Novel Tech Eth, Halifax, NS, Canada		Johnson, LSM (corresponding author), Dalhousie Univ, Novel Tech Eth, Halifax, NS, Canada.	syd.johnson@dal.ca		Johnson, L. Syd/0000-0002-9486-4613	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP 77670]; NNF [80045]	Research funded by Canadian Institutes of Health Research, MOP 77670, Therapeutic Hopes and ethical concerns: Clinical research in the neurosciences, and by NNF 80045, States of Mind: Emerging Issues in Neuroethics.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ANDREWS K, 1993, BRIT MED J, V306, P1597, DOI 10.1136/bmj.306.6892.1597; [Anonymous], 2009, BBC NEWS; Beaumont JG, 2005, NEUROPSYCHOL REHABIL, V15, P184, DOI 10.1080/09602010443000489; Bekinschtein TA, 2009, NAT NEUROSCI, V12, P1343, DOI 10.1038/nn.2391; Bernat JL, 2007, NEUROLOGY, V68, P885, DOI 10.1212/01.wnl.0000258973.95355.68; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; Boly M, 2008, LANCET NEUROL, V7, P1013, DOI 10.1016/S1474-4422(08)70219-9; Childs NL, 1996, NEW ENGL J MED, V334, P24, DOI 10.1056/NEJM199601043340105; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Clauss R, 2006, NEUROREHABILITATION, V21, P23; Clauss RP, 2000, S AFR MED J, V90, P68; Cohen SI, 2008, AM J PHYS MED REHAB, V87, P229, DOI 10.1097/PHM.0b013e318161971b; Connolly K, 2009, GUARDIAN; DEMERTZI A, 2009, ENCY CONSCIOUSNESS, P147; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; DYER C, 2009, GUARDIAN        1120; Eisenberg JB, 2008, NEUROETHICS-NETH, V1, P75, DOI 10.1007/s12152-007-9000-6; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Fernandez-Espejo D, 2008, BRAIN INJURY, V22, P882, DOI 10.1080/02699050802403573; Fins JJ, 2005, HASTINGS CENT REP, V35, P22, DOI 10.2307/3527759; Fins JJ, 2006, HASTINGS CENT REP, V36, P8, DOI 10.1353/hcr.2006.0094; Fins JJ, 2008, AM J BIOETHICS, V8, pW5, DOI 10.1080/15265160801891227; Fins Joseph J, 2006, Palliat Support Care, V4, P169; Giacino JT, 2006, ARCH PHYS MED REHAB, V87, pS67, DOI 10.1016/j.apmr.2006.07.272; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GRENVIK A, 1980, International Anesthesiology Clinics, V18, P1; Harmon Katherine, 2009, SCI AM; Hughes S, 2005, BRAIN INJURY, V19, P1197, DOI 10.1080/02699050500309296; Jennett B, 2005, PROG BRAIN RES, V150, P537, DOI 10.1016/S0079-6123(05)50037-2; Kahane G, 2009, J MED PHILOS, V34, P6, DOI 10.1093/jmp/jhn038; Kobylarz E, 2004, ARCH NEUROL-CHICAGO, V61, P1357, DOI 10.1001/archneur.61.9.1357; Lancioni GE, 2009, BRAIN INJURY, V23, P154, DOI 10.1080/02699050802672771; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 2007, CURR OPIN NEUROL, V20, P609, DOI 10.1097/WCO.0b013e3282f1d6dd; Laureys S, 2007, SCI AM, V296, P84, DOI 10.1038/scientificamerican0507-84; Lo B, 2002, NEW ENGL J MED, V346, P1489, DOI 10.1056/NEJM200205093461912; MACHADO C, 2008, SOC P CLIN NEUROPHYS, V119, pE101; Macniven JA, 2003, BRAIN INJURY, V17, P525, DOI 10.1080/0269905031000086254; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; *MSNBC COM, 2009, STUD PAT VEG STAT CA; Noe Alva, 2009, OUT OUR HEADS WHY YO; Owen AM, 2008, NAT REV NEUROSCI, V9, P235, DOI 10.1038/nrn2330; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; PALLISTER D, 2006, GUARDIAN        1207; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Qiu J, 2007, LANCET NEUROL, V6, P946, DOI 10.1016/S1474-4422(07)70255-7; Racine E, 2008, NEUROLOGY, V71, P1027, DOI 10.1212/01.wnl.0000320507.64683.ee; Rousseau MC, 2008, BRAIN INJURY, V22, P123, DOI 10.1080/02699050801895415; Schiff N, 1999, J COGNITIVE NEUROSCI, V11, P650, DOI 10.1162/089892999563715; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Schiff ND, 2009, ARCH NEUROL-CHICAGO, V66, P697, DOI 10.1001/archneurol.2009.79; Schnakers C, 2007, CURR OPIN NEUROL, V20, P620, DOI 10.1097/WCO.0b013e3282f169d9; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Singh R, 2008, BRAIN INJURY, V22, P103, DOI 10.1080/02699050701829704; Staffen W, 2006, J NEUROL NEUROSUR PS, V77, P1383, DOI 10.1136/jnnp.2006.095166; Takehara K, 2003, J NEUROSCI, V23, P9897; Thompson RF, 1997, INT REV NEUROBIOL, V41, P151, DOI 10.1016/S0074-7742(08)60351-7; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Wijdicks EFM, 2006, MAYO CLIN PROC, V81, P1155, DOI 10.4065/81.9.1155; Wilson BA, 2001, BRAIN INJURY, V15, P1083, DOI 10.1080/02699050110082197; Wilson FC, 2002, NEUROREHABILITATION, V17, P231; Woodruff-Pak DS, 2008, TRENDS NEUROSCI, V31, P105, DOI 10.1016/j.tins.2007.11.006	66	3	3	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1874-5490	1874-5504		NEUROETHICS-NETH	Neuroethics	JUL	2010	3	2					185	196		10.1007/s12152-010-9073-5			12	Ethics; Medical Ethics; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Medical Ethics; Biomedical Social Sciences	688SB	WOS:000284871600009					2022-02-06	
J	Laurent, S; Thibaud, JL; Hordeaux, J; Reyes-Gomez, E; Delisle, F; Blot, S; Colle, MA				Laurent, S.; Thibaud, J. L.; Hordeaux, J.; Reyes-Gomez, E.; Delisle, F.; Blot, S.; Colle, M. A.			Chronic Traumatic Brain Injury in a Dog	JOURNAL OF COMPARATIVE PATHOLOGY			English	Article						brain injury; chronic; cortical atrophy; dog; trauma	CENTRAL-NERVOUS-SYSTEM; HEAD-INJURY; PREVENTION; ATROPHY	Chronic traumatic brain injury is rare in man and has not been previously documented in clogs This report describes a 2-year-old female American Staffordshire bull terrier that was referred with forelimb and hindlimb ataxia, decreased vigilance and disorientation following repeated aggression and physical abuse by its owner. A diffuse cortical lesion was suspected Cerebrospinal fluid analysis revealed neutrophilic pleocytosis and computed tomography showed marked widening of the cerebral ado with mild bilateral ventriculomegaly. The dog vas humanely destroyed in view of the poor prognosis Necropsy examination revealed narrowing of the cerebral cortical gyri and consequent widening of the sulei without distortion or displacement of the neural parenchyma These features were consistent with bilateral diffuse cortical atrophy Microscopically, there were chronic subarachnoid haemorrhages and the cortical subpial layer displayed spongiosis, capillary hyperplasia, astrocytosis, microgliosis and frequent neuronal necrosis occurring in a characteristic laminar pattern This histopathological pattern of damage was significantly different from that previously described in people suffering from repeated traumatic brain injuries over a long period of time (C) 2009 Elsevier Ltd. All rights reserved	[Laurent, S.; Hordeaux, J.; Colle, M. A.] Ecole Natl Vet Nantes, INRA, Unite Anat Pathol, UMR 703, F-44307 Nantes, Loire Atlantiqu, France; [Thibaud, J. L.; Blot, S.] Ecole Natl Vet Alfort, Lab Neurobiol, Unite Neurol, Maisons Alfort, France; [Reyes-Gomez, E.] Ecole Natl Vet Alfort, Unite Embryol Histol Anat Pathol, Maisons Alfort, France; [Delisle, F.] Ecole Natl Vet Alfort, Ctr Cancerol Vet, Maisons Alfort, France		Colle, MA (corresponding author), Ecole Natl Vet Nantes, INRA, Unite Anat Pathol, UMR 703, BP 40706, F-44307 Nantes, Loire Atlantiqu, France.		Blot, Stephane/K-7573-2019; Blot, Stephane/F-7420-2011	Reyes-Gomez, Edouard/0000-0003-0017-6930; Blot, Stephane/0000-0002-8982-0317			COLTER S, 1988, VET CLIN N AM-SMALL, V18, P545, DOI 10.1016/S0195-5616(88)50054-2; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Graham DY, 2002, HELICOBACTER, V7, P1, DOI 10.1046/j.1523-5378.2002.00048.x; Grossman RI, 2003, NEURORADIOLOGY REQUI, P243; GUTERMAN A, 1987, SPORTS MED, V4, P194, DOI 10.2165/00007256-198704030-00004; Heath D L, 1999, J Neurosci Nurs, V31, P97; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEVIN HS, 1992, NEUROSURGERY, V31, P1117, DOI 10.1227/00006123-199212000-00021; MACDONALD RL, 1991, STROKE, V22, P971, DOI 10.1161/01.STR.22.8.971; Maxie MG, 2007, JUBB KENNEDY PALMERS, V1, P283; McIntosh TK, 1996, EUR J ANAESTH, V13, P291, DOI 10.1046/j.1365-2346.1996.00981.x; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; STILLER JW, 1985, PSYCHIAT CLIN N AM, V8, P339; TIPOLD A, 1994, J SMALL ANIM PRACT, V35, P311, DOI 10.1111/j.1748-5827.1994.tb03293.x; TIPOLD A, 1995, J VET INTERN MED, V9, P304, DOI 10.1111/j.1939-1676.1995.tb01089.x; TOMITA H, 1997, NEUROLOGIA MED CHIRU, V37, P818; ZACHARY JF, 2007, PATHOLOGIC BASIS VET, P833	20	3	3	0	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9975	1532-3129		J COMP PATHOL	J. Comp. Pathol.	JUL	2010	143	1					75	80		10.1016/j.jcpa.2009.12.008			6	Pathology; Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Pathology; Veterinary Sciences	620PF	WOS:000279511100013	20106486				2022-02-06	
J	McNeill, MM				McNeill, Margaret M.			7000 Miles and 7 Days From the Battlefield	AACN ADVANCED CRITICAL CARE			English	Article						brain injury; critical care; military; rehabilitation; trauma; war	INTENSIVE-CARE-UNIT; TRAUMATIC BRAIN-INJURY; MULTIDISCIPLINARY ROUNDS; POSTTRAUMATIC-STRESS; CONTROLLED-TRIAL; CHRONIC PAIN; POLYTRAUMA; REHABILITATION; HYPOTHERMIA; STRATEGIES	Critically injured combat casualties are rapidly evacuated from the battlefield, and within hours of their injuries they begin a 7000-mile journey home, often arriving in the United States within 7 days. National Naval Medical Center in Bethesda, Maryland, is a major facility for wounded warrior care in the Military Health System. Throughout the facility, the staff from a variety of disciplines and all military services provides care for military personnel with injuries and illnesses, with the goal of optimizing recovery and quality of life. The foundational evidence for select aspects of this care is discussed. Innovations in training and care delivery include the Air Force Nurse Corps' Critical Care Fellowship, the new inpatient Traumatic Brain Injury Unit, and the National Intrepid Center for Excellence for Traumatic Brain Injury and Psychological Health. The future of the Medical Center includes a new name, expanded staff, and newly constructed space by Department of Defense Base Realignment and Closure activities.	[McNeill, Margaret M.] Malcolm Grow Med Ctr, Med Grp 779, 1050 W Perimeter Rd, Andrews Afb, MD 20762 USA		McNeill, MM (corresponding author), Malcolm Grow Med Ctr, Med Grp 779, 1050 W Perimeter Rd, Andrews Afb, MD 20762 USA.	mcneillm@aol.com					Aiken LJ, 2010, DIMENS CRIT CARE NUR, V29, P13, DOI 10.1097/DCC.0b013e3181be4a1a; American Academy of Physical Medicine & Rehabilitation, WHAT IS PHYS; [Anonymous], 2008, FED REGISTER, V73, P27805; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Billington EO, 2009, CRIT CARE, V13, DOI 10.1186/cc8227; Buckenmaier CC, 2009, PAIN MED, V10, P1487, DOI 10.1111/j.1526-4637.2009.00731.x; Carson SS, 1996, JAMA-J AM MED ASSOC, V276, P322, DOI 10.1001/jama.276.4.322; Chestnut R M, 1998, Evid Rep Technol Assess (Summ), P1; Davidson JE, 2007, CRIT CARE MED, V35, P605, DOI 10.1097/01.CCM.0000254067.14607.EB; Department of Veterans Affairs, VA POL SYST CAR; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Dutton RP, 2003, J TRAUMA, V55, P913, DOI 10.1097/01.TA.0000093395.34097.56; Fang R, 2008, CRIT CARE MED, V36, pS383, DOI 10.1097/CCM.0b013e31817e3213; Fountas KN, 2006, NEUROCRIT CARE, V5, P55, DOI 10.1385/NCC:5:1:55; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Institute for Healthcare Improvement, 2010, IMPR MAP GETT START; Johnson V, 2009, AM SURGEON, V75, P1171; Kim MM, 2010, ARCH INTERN MED, V170, P369, DOI 10.1001/archinternmed.2009.521; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Lee MD, 2007, CRIT CARE MED, V35, P497, DOI 10.1097/01.CCM.0000254338.87182.AC; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Malchow RJ, 2008, CRIT CARE MED, V36, pS346, DOI 10.1097/CCM.0b013e31817e2fc9; Murphy DJ, 2009, CRIT CARE, V13, DOI 10.1186/cc7113; National Naval Medical Center, 2009, 7 E INP TRAUM BRAIN; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Perkins FM, 2000, ANESTHESIOLOGY, V93, P1123, DOI 10.1097/00000542-200010000-00038; Robinson Adam M., USN SURGEON GEN NAVY; Rupich K, 2009, J NEUROSCI NURS, V41, P159, DOI 10.1097/JNN.0b013e3181a23ec1; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Sims JM, 2006, DIMENS CRIT CARE NUR, V25, P175, DOI 10.1097/00003465-200607000-00011; Toth JC, 2009, BKAT 8 BASIC KNOWLED; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Wilson T., COMFORT EXPANDS CARE; Zatzick DF, 2007, PSYCHOL MED, V37, P1469, DOI 10.1017/S0033291707000943	36	3	3	0	0	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1559-7768	1559-7776		AACN ADV CRIT CARE	AACN Adv. Crit. Care	JUL-SEP	2010	21	3					307	315		10.1097/NCI.0b013e3181e59f8e			9	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	VF8QR	WOS:000443774200009	20683232				2022-02-06	
J	Stiller-Ostrowski, JL				Stiller-Ostrowski, Jennifer L.			Fourth Cranial Nerve Palsy in a Collegiate Lacrosse Player: A Case Report	JOURNAL OF ATHLETIC TRAINING			English	Article						trochlear nerve; neurologic injuries; visual disturbances	TROCHLEAR NERVE; IV; VI	Objective: To present the case of a National Collegiate Athletic Association Division I men's lacrosse athlete with fourth cranial nerve injury as the result of a minor traumatic blow. Background: The athlete was struck on the right side of his head during a lacrosse game. On-field evaluation revealed no cervical spine involvement or loss of consciousness. He complained of headache and dizziness, with delayed reports of visual disturbance. Sideline visual acuity and cranial nerve screenings appeared within normal limits. Consultation with the team physician indicated that immediate referral to the emergency department was unnecessary. Differential Diagnosis: Concussion, third cranial nerve palsy, fourth cranial nerve palsy. Treatment: The certified athletic trainer safely removed the athlete from the playing field and monitored him on the sideline. After being seen by the team physician, the patient was referred to a neurologist, ophthalmologist, and finally a neuro-ophthalmologist before a definitive diagnosis was made. The palsy did not necessitate surgical intervention, resolving with conservative treatment. The athlete was able to return to full athletic ability at his preinjury level by 8 months postinjury. Uniqueness: Superior oblique palsy as the result of fourth cranial nerve injury is the most frequent isolated cranial nerve palsy; however, these palsies are often underdiagnosed by health professionals. Such palsies are uncommon within the athletic realm, making timely diagnosis even less likely. Conclusions: Cranial nerve palsy may present very subtly in patients. Therefore, on-field health care providers should be aware of the descriptions and types of compensations that signal nerve injury.	Lasell Coll, Newton, MA 02466 USA		Stiller-Ostrowski, JL (corresponding author), Lasell Coll, 1844 Commonwealth Ave,Wass 8, Newton, MA 02466 USA.	jostrowski@lasell.edu					Blumenfeld H., 2002, NEUROANATOMY CLIN CA; Brazis PW, 2009, SEMIN NEUROL, V29, P14, DOI 10.1055/s-0028-1124019; BRAZIS PW, 1993, MAYO CLIN PROC, V68, P501, DOI 10.1016/S0025-6196(12)60201-8; Brodal A., 1981, NEUROLOGICAL ANATOMY; Carpenter MB, 1991, CORE TEXT NEUROANATO; Dalley AF., 1999, CLIN ORIENTED ANATOM; Garnham L, 1997, AUST NZ J OPHTHALMOL, V25, P31, DOI 10.1111/j.1442-9071.1997.tb01272.x; Kawarai T, 2009, EUR NEUROL, V62, P256, DOI 10.1159/000232932; KEANE JR, 1993, NEUROLOGY, V43, P2439, DOI 10.1212/WNL.43.12.2439; Martin JH., 2003, NEUROANATOMY TEXT AT; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; MITCHELL PR, 1982, OPHTHALMOLOGY, V89, P484; Patten J, 1996, NEUROLOGICAL DIFFERE, V2nd; RUSH JA, 1981, ARCH OPHTHALMOL-CHIC, V99, P76, DOI 10.1001/archopht.1981.03930010078006; Wilson-Pauwels L., 1998, CRANIAL NERVES ANATO	15	3	3	1	2	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050			J ATHL TRAINING	J. Athl. Train.	JUL-AUG	2010	45	4					407	410		10.4085/1062-6050-45.4.407			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	627FY	WOS:000280026100015	20617917	Green Published			2022-02-06	
J	Cadosch, D; Al-Mushaiqri, MS; Gautschi, OP; Chan, E; Jung, FJ; Skirving, AP; Filgueira, L				Cadosch, Dieter; Al-Mushaiqri, Mohamed S.; Gautschi, Oliver P.; Chan, Erwin; Jung, Florian J.; Skirving, Allan P.; Filgueira, Luis			Immune response deviation and enhanced expression of chemokine receptor CCR4 in TBI patients due to unknown serum factors	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Chemokines; Cytokines; Monocytes; T-lymphocytes; CCR4	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; HEAD-INJURY; T-CELLS; INFLAMMATION; RESPONSIVENESS; ACTIVATION; SCALE	Background: Severe brain trauma leads to an activation of the immune system. To this date, neither the exact perturbation of the specific immune reaction induced by the traumatic brain injury (TBI), nor the interactions leading to the infiltration of peripheral immune cells into the brain are fully understood. Patients and methods: Serum was collected from 17 patients with TBI and a long bone fracture, 24 patients with an isolated long bone fracture and from healthy individuals. The effect of the serum on normal human monocytes and T-lymphocytes was tested in vitro by assessing proliferation and expression of surface markers, chemokine receptors and cytokines. Results: Serum collected from patients with a TBI and a long bone fracture increased the expression of the chemokine receptor CCR4 in monocytes when compared to patients with an isolated long bone fracture. Extending this comparison to T-lymphocytes, the serum from TBI patients induced lower proliferation rates and decreased expression of the pro-inflammatory cytokine TNF-alpha, while simultaneously increasing the secretion of immune-modulatory cytokines (IL-4, IL-10 and TGF-beta) (p < 0.05). Conclusion: Patients with a TBI release currently unknown soluble factors into the circulating blood that up regulate expression of chemokine receptor CCR4 in peripheral blood monocytes whilst concurrently inducing expression of immunosuppressive cytokines by activated T-lymphocytes. (C) 2009 Elsevier Ltd. All rights reserved.	[Cadosch, Dieter; Al-Mushaiqri, Mohamed S.; Gautschi, Oliver P.; Chan, Erwin; Filgueira, Luis] Univ Western Australia, Sch Anat & Human Biol, Crawley, WA 6009, Australia; [Cadosch, Dieter; Gautschi, Oliver P.; Skirving, Allan P.] Royal Perth Hosp, Dept Orthopaed & Trauma Surg, Perth, WA, Australia; [Cadosch, Dieter; Jung, Florian J.] State Hosp Winterthur, Dept Surg, Winterthur, Switzerland; [Cadosch, Dieter] Univ Zurich, Dept Trauma Surg, Zurich, Switzerland		Cadosch, D (corresponding author), Univ Western Australia, Sch Anat & Human Biol, 35 Stirling Highway, Crawley, WA 6009, Australia.	dcadosch@gmx.net	Filgueira, Luis/B-6492-2008; Flow, CMCA/C-4191-2013	Filgueira, Luis/0000-0002-2266-6650			Andrew DP, 2001, J IMMUNOL, V166, P103, DOI 10.4049/jimmunol.166.1.103; Benveniste EN, 1998, CYTOKINE GROWTH F R, V9, P259, DOI 10.1016/S1359-6101(98)00015-X; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; COLLICOTT P E, 1980, Journal of the American Medical Association, V243, P1156, DOI 10.1001/jama.243.11.1156; Csuka E, 2000, NEUROREPORT, V11, P2587, DOI 10.1097/00001756-200008030-00047; Galimberti D, 2008, MULT SCLER, V14, P547, DOI 10.1177/1352458507084268; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Kremlev SG, 2005, J NEUROIMMUNOL, V162, P71, DOI 10.1016/j.jneuroim.2005.01.010; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Liao F, 1999, J IMMUNOL, V162, P186; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; MARSHALL LF, 1992, J NEUROTRAUMA, V9, P287; MOORE FA, 1995, SURG CLIN N AM, V75, P257, DOI 10.1016/S0039-6109(16)46587-4; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Nakajima Kazuyuki, 2004, Curr Drug Targets Cardiovasc Haematol Disord, V4, P65, DOI 10.2174/1568006043481284; Radstake TRDJ, 2005, ANN RHEUM DIS, V64, P359, DOI 10.1136/ard.2003.017566; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Ransohoff RM, 1998, TRENDS NEUROSCI, V21, P154, DOI 10.1016/S0166-2236(97)01198-3; TEASDALE G, 1974, LANCET, V2, P81; Yoshie O, 1997, J LEUKOCYTE BIOL, V62, P634, DOI 10.1002/jlb.62.5.634	26	3	3	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JUN	2010	41	6					E4	E9		10.1016/j.injury.2009.09.001			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	596QL	WOS:000277700000025	19781699				2022-02-06	
J	Cifu, DX				Cifu, David X.			Geriatric Rehabilitation Services in the Veterans Health Administration	GENERATIONS-JOURNAL OF THE AMERICAN SOCIETY ON AGING			English	Article							TRAUMATIC BRAIN-INJURY; HIP FRACTURE; OLDER-ADULTS; STROKE REHABILITATION; RHEUMATOID-ARTHRITIS; PHYSICAL-ACTIVITY; EXERCISE; OUTCOMES; HOME; DISEASE							Cifu, David/0000-0003-1600-9387			Agre JC, 1997, ARCH PHYS MED REHAB, V78, P681, DOI 10.1016/S0003-9993(97)90073-3; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; Buchner DM, 1997, WESTERN J MED, V167, P258; Carne W, 2005, NEUROREHABILITATION, V20, P161; CARNE W, 2006, J REHABILITATION RES, V42, P779; Carr DB, 2006, AM FAM PHYSICIAN, V73, P1029; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; CIFU DX, 1993, ARCH PHYS MED REHAB, V74, P44; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, pS35, DOI 10.1016/S0003-9993(99)90101-6; Cook AM, 2008, ASSIST TECHNOL, P545; Corrado OJ, 2001, AGE AGEING, V30, P11, DOI 10.1093/ageing/30.suppl_3.11; Crotty M, 2003, ARCH PHYS MED REHAB, V84, P1237, DOI 10.1016/S0003-9993(03)00141-2; de Goede CJT, 2001, ARCH PHYS MED REHAB, V82, P509, DOI 10.1053/apmr.2001.22352; Dubinsky RM, 2000, NEUROLOGY, V54, P2205, DOI 10.1212/WNL.54.12.2205; Durch JS, 2006, NOISE MILITARY SERVI; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Ferrell B, 2002, J AM GERIATR SOC, V50, pS205, DOI 10.1046/j.1532-5415.50.6s.1.x; FISHER NM, 1991, ARCH PHYS MED REHAB, V72, P365; Flick CL, 1999, ARCH PHYS MED REHAB, V80, pS21, DOI 10.1016/S0003-9993(99)90098-9; Fox CM, 2002, AM J SPEECH-LANG PAT, V11, P111, DOI 10.1044/1058-0360(2002/012); Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Glassman SJ, 2001, ARCH PHYS MED REHAB, V82, pS47, DOI 10.1053/apmr.2001.22439; Harkins SW, 1996, CLIN GERIATR MED, V12, P435; Katz P, 2001, J AM GERIATR SOC, V49, P808; KNOWELDEN J, 1991, J PUBLIC HEALTH MED, V13, P182, DOI 10.1093/oxfordjournals.pubmed.a042616; Kramer AM, 1997, JAMA-J AM MED ASSOC, V277, P396, DOI 10.1001/jama.277.5.396; LANGHORNE P, 1993, LANCET, V342, P395, DOI 10.1016/0140-6736(93)92813-9; Leveille SG, 1999, AM J EPIDEMIOL, V149, P654; Leveille SG, 2002, J AM GERIATR SOC, V50, P671, DOI 10.1046/j.1532-5415.2002.50161.x; Levy R, 2001, J AM GERIATR SOC, V49, P1400; MACHOVER SAUL, 1966, ARCH PHYS MED REHABIL, V47, P737; Mangione KK, 1999, J GERONTOL A-BIOL, V54, pM184, DOI 10.1093/gerona/54.4.M184; Metsios GS, 2008, RHEUMATOLOGY, V47, P239, DOI 10.1093/rheumatology/kem260; MINOR MA, 1989, ARTHRITIS RHEUM, V32, P1396, DOI 10.1002/anr.1780321108; Morgan K, 1998, AGE AGEING, V27, P35, DOI 10.1093/ageing/27.suppl_3.35; Munin MC, 1998, JAMA-J AM MED ASSOC, V279, P847, DOI 10.1001/jama.279.11.847; Murray PK, 2003, ARCH PHYS MED REHAB, V84, P1129, DOI 10.1016/S0003-9993(03)00149-7; OH TH, 1995, ARCH PHYS MED REHAB, V76, pS41, DOI 10.1016/S0003-9993(95)80598-2; OTTENBACHER KJ, 1993, ARCH NEUROL-CHICAGO, V50, P37, DOI 10.1001/archneur.1993.00540010033014; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; ReinaRosenbaum R, 1997, ARCH PHYS MED REHAB, V78, P240, DOI 10.1016/S0003-9993(97)90027-7; Roig RL, 2004, ARCH PHYS MED REHAB, V85, pS12, DOI 10.1016/j.apmr.2004.03.007; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; Shephard RJ, 1999, CIRCULATION, V99, P963, DOI 10.1161/01.CIR.99.7.963; Singh MAF, 2002, J GERONTOL A-BIOL, V57, pM262, DOI 10.1093/gerona/57.5.M262; Stewart DG, 1998, NEUROREHABILITATION, V10, P13, DOI 10.3233/NRE-1998-10103; STEWART DG, 1994, J BACK MUSCULOSKELET, V4, P135, DOI 10.3233/BMR-1994-4211; Stewart DG, 2001, ARCH PHYS MED REHAB, V82, P347, DOI 10.1053/apmr.2001.20838; Tinetti ME, 1999, ARCH PHYS MED REHAB, V80, P916, DOI 10.1016/S0003-9993(99)90083-7; *US BUR CENS, 2000, 65 YEARS OLD POP 200; Weinrich M, 2004, NEUROREHAB NEURAL RE, V18, P12, DOI 10.1177/0888439003262041; Worsowicz GM, 1998, ARCH PHYS MED REHAB, V79, pS60, DOI 10.1016/S0003-9993(98)90125-3	53	3	3	0	4	AMER SOC AGING	SAN FRANCISCO	833 MARKET ST, STE 511, SAN FRANCISCO, CA 94103-1824 USA	0738-7806			GENERATIONS	Generations-J. Am. Soc. Aging	SUM	2010	34	2					64	73					10	Gerontology	Social Science Citation Index (SSCI)	Geriatrics & Gerontology	685VJ	WOS:000284655900010					2022-02-06	
J	Jones, DG				Jones, D. Gareth			Peering into People's Brains: Neuroscience's Intrusion into Our Inner Sanctum	PERSPECTIVES ON SCIENCE AND CHRISTIAN FAITH			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CEREBRAL-BLOOD-FLOW; PROPRANOLOL; NEUROETHICS; BEHAVIOR; DRUGS	"Peering into the brain" has a number of connotations: from directly examining aspects of the functioning of an individual's brain and hence what that individual may be thinking, to investigating the power of neuroscience to provide insights into characteristic features of our humanity. This article picks up on these different connotations and surveys several areas in neuroscience that raise issues of relevance for the Christian community. This is the domain of neuroethics, with particular reference to the prospects opened up by brain imaging and, in particular, functional magnetic resonance imaging (fMRI). Use of this and allied imaging procedures opens up the possibilities of locating brain regions involved in religious experiences, from glossolalia to meditation, suggesting that there are neural correlates of activities central to Christian communities. This raises the issue of causation that is discussed by reference to the brain regions involved in "disgust," altruistic acts, and religious visions. Cognitive enhancement, sometimes referred to as cosmetic neurology, is discussed within the broader canvas of the use of neurocognitive enhancers for nonmedical reasons, and the theological issues raised by this and by the use of drugs to block the formation of traumatic memories. Neural vulnerability raises the specter of those with brain injuries that lead to aberrant behavior, sometimes at odds with these individuals' moral and spiritual values; an appreciation of the pathological element in these situations is stressed. While neuroethics is not as novel as often suggested, it brings home the importance of ongoing dialogue between science and theology in understanding the prospects and limitations of the technologies, their potential contribution to human well-being, and the ever-present threat posed by unwarranted mechanistic and deterministic thinking. A framework provided by a holistic view of humans within their environment and by the importance of relationships within the human community provides an essential element in Christian thinking.	[Jones, D. Gareth] Univ Otago, Ctr Bioeth, Dunedin, New Zealand; [Jones, D. Gareth] Univ Otago, Anat & Struct Biol, Dunedin, New Zealand		Jones, DG (corresponding author), Univ Otago, Ctr Bioeth, Dunedin, New Zealand.						[Anonymous], PROMISE PREDICAMENT; Azari N. P., GOD SCI MEET, P33; Baskin JH, 2007, AM J LAW MED, V33, P239, DOI 10.1177/009885880703300205; Booth JN, 2005, INT J NEUROSCI, V115, P1053, DOI 10.1080/00207450590901521; Brunet A, 2008, J PSYCHIATR RES, V42, P503, DOI 10.1016/j.jpsychires.2007.05.006; BRUNNER HG, 1993, AM J HUM GENET, V52, P1032; Cakic V, 2009, J MED ETHICS, V35, P611, DOI 10.1136/jme.2009.030882; Caspi A, 2002, SCIENCE, V297, P851, DOI 10.1126/science.1072290; CHATTERJEE, 2003, PSYCHOPHARMACOLOGY, V165, P260; Chatterjee A, 2006, J MED ETHICS, V32, P110, DOI 10.1136/jme.2005.013599; Chatterjee A, 2007, CAMB Q HEALTHC ETHIC, V16, P129, DOI 10.1017/S0963180107070156; Dodd ML, 2005, ARCH NEUROL-CHICAGO, V62, P1377, DOI 10.1001/archneur.62.9.noc50009; Farah MJ, 2005, TRENDS COGN SCI, V9, P34, DOI 10.1016/j.tics.2004.12.001; Feresin E., 2009, NATURE NEWS; Fins JJ, 2008, AM J BIOETHICS, V8, P37, DOI 10.1080/15265160701841975; Fischbach RL, 2008, AM J BIOETHICS, V8, P47, DOI 10.1080/15265160701828568; Glannon W, 2006, J MED ETHICS, V32, P74, DOI 10.1136/jme.2005.012575; Glannon W, 2006, BIOETHICS, V20, P37, DOI 10.1111/j.1467-8519.2006.00474.x; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Illes J, 2006, TRENDS NEUROSCI, V29, P511, DOI 10.1016/j.tins.2006.07.002; Jones D, 2007, NATURE, V447, P768, DOI 10.1038/447768a; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; Khoshbin LS, 2007, AM J LAW MED, V33, P171, DOI 10.1177/009885880703300202; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Maher B, 2008, NATURE, V452, P674, DOI 10.1038/452674a; McNamara P, 2002, ZYGON, V37, P143, DOI 10.1111/1467-9744.00418; Mehta MA, 2000, J NEUROSCI, V20; Mobbs D, 2007, PLOS BIOL, V5, P693, DOI 10.1371/journal.pbio.0050103; Moll J, 2005, COGN BEHAV NEUROL, V18, P68, DOI 10.1097/01.wnn.0000152236.46475.a7; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Murphy Nancey, 2006, BODIES SOULS SPIRITE, P103; Newberg A, 2001, PSYCHIAT RES-NEUROIM, V106, P113, DOI 10.1016/S0925-4927(01)00074-9; Newberg AB, 2006, PSYCHIAT RES-NEUROIM, V148, P67, DOI 10.1016/j.pscychresns.2006.07.001; Persinger MA, 2002, J NERV MENT DIS, V190, P533, DOI 10.1097/00005053-200208000-00006; Peters T., 2005, DIALOG-J THEOLOGY, V44, P381, DOI [10.1111/j.0012-2033.2005.00282.x, DOI 10.1111/J.0012-2033.2005.00282.X]; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; Ratcliffe M, 2006, GOD SCI MEET BRAIN E, V2, P81; SAFIRE W, 2002, NEUROETHICS MAPPING; Sahakian B, 2007, NATURE, V450, P1157, DOI 10.1038/4501157a; Sandel M.J., 2007, CASE PERFECTION ETHI; Savulescu J, 2008, NEUROETHICS-NETH, V1, P31, DOI 10.1007/s12152-007-9002-4; Tancredi LR, 2007, AM J LAW MED, V33, P271, DOI 10.1177/009885880703300206; Todd RM, 2009, NAT NEUROSCI, V12, P1217, DOI 10.1038/nn1009-1217; Vaiva G, 2003, BIOL PSYCHIAT, V54, P947, DOI 10.1016/S0006-3223(03)00412-8; Whitaker Maja I, 2009, SPEAKING DEAD HUMAN; Yesavage JA, 2002, NEUROLOGY, V59, P123, DOI 10.1212/WNL.59.1.123	47	3	3	0	0	AMER SCIENTIFIC AFFILIATION	IPSWICH	PO BOX 668, IPSWICH, MA 01938 USA	0892-2675			PERSPECT SCI CHRIST	Perspect. Sci. Christ. Faith	JUN	2010	62	2					122	132					11	Religion	Emerging Sources Citation Index (ESCI)	Religion	V8X5E	WOS:000422056900006					2022-02-06	
J	Nordness, AS; Beukelman, DR; Ullman, C				Nordness, Amy S.; Beukelman, David R.; Ullman, Cara			Impact of Alphabet Supplementation on Speech and Pause Durations of Dysarthric Speakers with Traumatic Brain Injury: A Research Note	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article						Traumatic brain injury; dysarthria; alphabet supplementation	INTELLIGIBILITY; STRATEGIES	Alphabet supplementation (AS) provides individuals with severe dysarthria a means to use their natural speech to communicate more effectively. The purpose of this study was to document the speech and pause temporal characteristics of alphabet supplemented speech compared to habitual speech for individuals with traumatic brain injury. Pause time during AS was significantly greater than pause time during habitual speech. Although speech time also increased during AS, it did not differ significantly from habitual speech. Alphabet supplementation also led to an increase in intelligibility and a decrease in speaking rate. These results are consistent with past research on different populations.	[Nordness, Amy S.; Beukelman, David R.; Ullman, Cara] Univ Nebraska, Univ Nebraska Med Ctr, Munroe Meyer Inst, Lincoln, NE USA		Nordness, AS (corresponding author), Univ Nebraska Med Ctr, Speech Language Pathol Munroe Meyer Inst Genet &, 600 S 42nd St, Omaha, NE 68198 USA.	asnordness@unmc.edu			Barkley Trust; Madonna Rehabilitation Hospital; Quality Living, Inc; National Institute on Disability and Rehabilitation Research (NIDRR), U.S. Department of EducationUS Department of Education [H113 980026]	The authors thank the participants in this study as well as support from the Barkley Trust, Madonna Rehabilitation Hospital, and Quality Living, Inc. This publication was produced in part under Grant #H113#980026 from the National Institute on Disability and Rehabilitation Research (NIDRR), U.S. Department of Education. The opinions expressed in this publication are those of the grantee and do not necessarily reflect those of NIDRR or the Department of Education.	Beukelman DR, 2002, J MED SPEECH-LANG PA, V10, P237; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246, DOI 10.1044/jshr.1202.246; Duffy, 2005, MOTOR SPEECH DISORDE; Green JR, 2004, J MED SPEECH-LANG PA, V12, P149; Hanson EK, 2004, J MED SPEECH-LANG PA, V12, pIX; Hustad KC, 2008, J SPEECH LANG HEAR R, V51, P1438, DOI 10.1044/1092-4388(2008/07-0185); Hustad KC, 2005, J SPEECH LANG HEAR R, V48, P996, DOI 10.1044/1092-4388(2005/068); Hustad KC, 2005, AUGMENT ALTERN COMM, V21, P256, DOI 10.1080/07434610500194854; Hustad KC, 2003, J SPEECH LANG HEAR R, V46, P462, DOI 10.1044/1092-4388(2003/038); Kent RD, 1999, J COMMUN DISORD, V32, P141, DOI 10.1016/S0021-9924(99)00004-0; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469	11	3	3	0	4	DELMAR CENGAGE LEARNING	FLORENCE	PO BOX 6904, FLORENCE, KY 41022-6904 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	JUN	2010	18	2					35	U2					11	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	606HV	WOS:000278414500005					2022-02-06	
J	Bowman, SM; Aitken, ME; Sharp, GB				Bowman, Stephen M.; Aitken, Mary E.; Sharp, Gregory B.			Disparities in hospital outcomes for injured people with epilepsy/seizures	EPILEPSIA			English	Article						Injury; Epilepsy; Seizures; Disparities; Hospitalizations; Outcomes	INDEPENDENT PREDICTOR; BLOOD-TRANSFUSION; EUROPEAN COHORT; EPILEPSY; MORTALITY; ACCIDENTS; SUICIDE; SEIZURES; TRAUMA; GREAT	P>Purpose: Controlling for injury and patient characteristics, one would expect comparable in-hospital outcomes for injured patients with and without epilepsy. The historical stigma associated with epilepsy is well-documented, yet potential disparities in injury care for people with epilepsy/seizures have not been examined. We compared in-hospital outcomes of injured patients with epilepsy/seizures with patients without epilepsy/seizures and tested the hypothesis that injured people with epilepsy have worse outcomes. Methods: Existing data were analyzed from the Nationwide Inpatient Sample-the largest, longitudinal, all-payer inpatient care database in the United States. Injured patients of all ages were included. Multivariable logistic regression was used to control for patient and hospital characteristics. Main outcome measure: in-hospital mortality. Results: When controlling for patient and injury characteristics, our results show that people with epilepsy/seizures were more likely to die in-hospital than people without epilepsy [odds ratio (OR) 1.17, p < 0.001]. People with epilepsy were significantly more likely to have a traumatic brain injury diagnosis than similar individuals without epilepsy (unintentional injuries OR 2.81, p < 0.001; interpersonal violence OR 6.0, p < 0.001). By mechanism of injury, significantly increased risk of death was observed for injuries from falls (OR 1.21, p < 0.001), other transport injuries (OR 2.04, p = 0.01), struck by/against (OR 1.85, p = 0.02), and suffocation (OR 10.93, p = 0.009). People with epilepsy/seizures receiving firearm injuries were less likely to die in-hospital (OR 0.25, p < 0.001). Discussion: Disparities in hospital outcomes for people with epilepsy deserve further attention. Identifying the underlying causes of these disparities will allow for the development of targeted prevention interventions.	[Bowman, Stephen M.; Aitken, Mary E.; Sharp, Gregory B.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA		Bowman, SM (corresponding author), Arkansas Childrens Hosp, Dept Pediat, CARE Peds Slot 512-26,1 Childrens Way, Little Rock, AR 72202 USA.	bowmanstephenm@uams.edu	Bowman, Stephen/AAF-2154-2019; Aitken, Mary/ABG-6119-2021	Aitken, Mary/0000-0002-8318-9755	Epilepsy Foundation	This project was supported by the Epilepsy Foundation through the generous support of the Patricia L. Nangle Fund.We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.	American College of Surgeons Committee on Trauma, 2006, RESOURCES OPTIMAL CA, P55; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beghi E, 2002, EPILEPSIA, V43, P1076, DOI 10.1046/j.1528-1157.2002.18701.x; Bell GS, 2008, NEUROLOGY, V71, P578, DOI 10.1212/01.wnl.0000323813.36193.4d; Bell GS, 2009, EPILEPSIA, V50, P1933, DOI 10.1111/j.1528-1167.2009.02106.x; Caspermeyer JJ, 2006, MAYO CLIN PROC, V81, P300, DOI 10.4065/81.3.300; Charles A, 2007, AM SURGEON, V73, P1; Fernandes PT, 2007, SEIZURE-EUR J EPILEP, V16, P320, DOI 10.1016/j.seizure.2007.01.008; Ficker DM, 2000, EPILEPSIA, V41, pS7, DOI 10.1111/j.1528-1157.2000.tb01519.x; *J HOPK U TRIAN IN, 1997, ICDMAP90 J HOPK U TR; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Mainio A, 2007, EPILEPSY BEHAV, V11, P389, DOI 10.1016/j.yebeh.2007.05.012; MORRIS JA, 1990, JAMA-J AM MED ASSOC, V263, P1942, DOI 10.1001/jama.263.14.1942; Pompili M, 2006, EPILEPSY BEHAV, V9, P641, DOI 10.1016/j.yebeh.2006.06.019; Robinson WP, 2005, J TRAUMA, V58, P437, DOI 10.1097/01.TA.0000153935.18997.14; Segal JB, 2001, TRANSFUSION, V41, P530, DOI 10.1046/j.1537-2995.2001.41040530.x; Sirven JI, 2002, MAYO CLIN PROC, V77, P977; Sirven JI, 2007, MAYO CLIN PROC, V82, P1535, DOI 10.4065/82.12.1535; Tomson T, 2004, EPILEPSY RES, V60, P1, DOI 10.1016/j.eplepsyres.2004.05.004; Van Brakel Wim H, 2006, Psychol Health Med, V11, P307, DOI 10.1080/13548500600595160; van den Broek M, 2004, EPILEPSIA, V45, P667, DOI 10.1111/j.0013-9580.2004.33903.x; Wirrell EC, 2006, EPILEPSIA, V47, P79, DOI 10.1111/j.1528-1167.2006.00666.x; [No title captured]	23	3	3	0	0	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0013-9580			EPILEPSIA	Epilepsia	MAY	2010	51	5					862	867		10.1111/j.1528-1167.2009.02492.x			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587OA	WOS:000277000900019	20067501				2022-02-06	
J	Halstead, ME				Halstead, Mark E.			Contact Sports for Young Athletes: Keys to Safety	PEDIATRIC ANNALS			English	Article							HIGH-SCHOOL; SOCCER HEADGEAR; CONCUSSION; INJURIES; FOOTBALL; LACROSSE; PLAYERS; COLLARS; FACE		[Halstead, Mark E.] Washington Univ, Sch Med, Dept Orthoped, St Louis, MO USA; [Halstead, Mark E.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA		Halstead, ME (corresponding author), Washington Univ, Sch Med, 14532 S Outer Forty Dr, Chesterfield, MO 63017 USA.	halsteadm@wustl.edu					Barbic D, 2005, CLIN J SPORT MED, V15, P294, DOI 10.1097/01.jsm.0000171883.74056.21; Boden BP, 1999, KNEE SURG SPORT TR A, V7, P262, DOI 10.1007/s001670050160; Broglio SP, 2003, J ATHL TRAINING, V38, P220; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gorden JA, 2003, J ATHL TRAINING, V38, P209; *I MED, 2002, IOM WORKSH NEUR CONS; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; McCarroll JR., 1984, PHYS SPORTS MED, V12, P113, DOI [10.1080/00913847.1984.11701775, DOI 10.1080/00913847.1984.11701775]; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1197/aemj.10.1.85; Rowson S, 2008, CLIN J SPORT MED, V18, P316, DOI 10.1097/JSM.0b013e31817f016a; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2; Webster DA, 1999, MED SCI SPORT EXER, V31, P938, DOI 10.1097/00005768-199907000-00004; Yard EE, 2008, AM J SPORT MED, V36, P1930, DOI 10.1177/0363546508318047	17	3	3	0	0	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0090-4481			PEDIATR ANN	Pediatr. Annu.	MAY	2010	39	5					275	278		10.3928/00904481-20100422-07			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	595GT	WOS:000277599400008	20506980				2022-02-06	
J	Janigro, D				Janigro, Damir			NOT AGAIN! THE ROLE OF BLOOD-BRAIN BARRIER FAILURE IN EPILEPTOGENESIS: A MOLECULAR UPDATE	EPILEPSY CURRENTS			English	Article							PERMEABILITY; PILOCARPINE; DISRUPTION; EPILEPSY	Transcriptome Profiling Reveals TGF-beta Signaling Involvement in Epileptogenesis. Cacheaux LP, Ivens S, David Y, Lakhter AJ, Bar-Klein G, Shapira M, Heinemann U, Friedman A, Kaufer D. J Neurosci 2009; 29(28): 8927-8935. Brain injury may result in the development of epilepsy, one of the most common neurological disorders. We previously demonstrated that albumin is critical in the generation of epilepsy after blood-brain barrier (BBB) compromise. Here, we identify TGF-beta pathway activation as the underlying mechanism. We demonstrate that direct activation of the TGF-beta pathway by TGF-beta 1 results in epileptiform activity similar to that after exposure to albumin. Coimmunoprecipitation revealed binding of albumin to TGF-beta receptor II, and Smad2 phosphorylation confirmed downstream activation of this pathway. Transcriptome profiling demonstrated similar expression patterns after BBB breakdown, albumin, and TGF-beta 1 exposure, including modulation of genes associated with the TGF-beta pathway, early astrocytic activation, inflammation, and reduced inhibitory transmission. Importantly, TGF-beta pathway blockers suppressed most albumin-induced transcriptional changes and prevented the generation of epileptiform activity. Our present data identifies the TGF-beta pathway as a novel putative epileptogenic signaling cascade and therapeutic target for the prevention of injury-induced epilepsy. Astrocytic Dysfunction in Epileptogenesis: Consequence of Altered Potassium and Glutamate Homeostasis? David Y, Cacheaux LP, Ivens S, Lapilover E, Heinemann U, Kaufer D, Friedman A. J Neurosci 2009; 29(34): 10588-10599. Focal epilepsy often develops following traumatic, ischemic, or infectious brain injury. While the electrical activity of the epileptic brain is well characterized, the mechanisms underlying epileptogenesis are poorly understood. We have recently shown that in the rat neocortex, long-lasting breakdown of the blood-brain barrier (BBB) or direct exposure of the neocortex to serum-derived albumin leads to rapid upregulation of the astrocytic marker glial fibrillary acidic protein, followed by delayed (within 4-7 day) development of an epileptic focus. We investigated the role of astrocytes in epileptogenesis in the BBB-breakdown and albumin models of epileptogenesis. We found similar, robust changes in astrocytic gene expression in the neocortex within hours following treatment with deoxycholic acid (BBB breakdown) or albumin. These changes predict reduced clearance capacity for both extracellular glutamate and potassium. Electrophysiological recordings in vitro confirmed the reduced clearance of activity-dependent accumulation of both potassium and glutamate 24 hour following exposure to albumin. We used a NEURON model to simulate the consequences of reduced astrocytic uptake of potassium and glutamate on EPSPs. The model predicted that the accumulation of glutamate is associated with frequency-dependent (> 100 Hz) decreased facilitation of EPSPs, while potassium accumulation leads to frequency-dependent (10-50 Hz) and NMDA-dependent synaptic facilitation. In vitro electrophysiological recordings during epileptogenesis confirmed frequency-dependent synaptic facilitation leading to seizure-like activity. Our data indicate a transcription-mediated astrocytic transformation early during epileptogenesis. We suggest that the resulting reduction in the clearance of extracellular potassium underlies frequency-dependent neuronal hyperexcitability and network synchronization.									Cornford EM, 1999, ADV DRUG DELIVER REV, V36, P145, DOI 10.1016/S0169-409X(98)00082-9; Fabene PF, 2008, NAT MED, V14, P1377, DOI 10.1038/nm.1878; Janigro D, 1997, J NEUROSCI, V17, P2813; Marchi N, 2007, EPILEPSIA, V48, P1934, DOI 10.1111/j.1528-1167.2007.01185.x; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Marchi N, 2009, NEUROBIOL DIS, V33, P171, DOI 10.1016/j.nbd.2008.10.002; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Uva L, 2008, NEUROSCIENCE, V151, P303, DOI 10.1016/j.neuroscience.2007.10.037; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	10	3	3	0	3	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1535-7597			EPILEPSY CURR	Epilepsy Curr.	MAY-JUN	2010	10	3					67	69		10.1111/j.1535-7511.2010.01359.x			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	652PU	WOS:000282022100006	20502594	Green Published			2022-02-06	
J	Jung, CS; Zweckberger, K; Schick, U; Unterberg, AW				Jung, Carla S.; Zweckberger, Klaus; Schick, Uta; Unterberg, Andreas W.			Attitude and Opinion of Neurosurgeons Concerning Protective Bicycle-Helmet Use	JOURNAL OF NEUROTRAUMA			English	Article						bicycle; helmet; traumatic brain injury	PREVENTING HEAD-INJURIES; SAFETY HELMETS; UNITED-STATES; ADULTS	Wearing protective helmets decreases the risk of incurring traumatic brain injury (TBI) in bicycle accidents. In 2007, the German Neurosurgical Society advocated compulsory use of bicycle helmets. Although neurosurgeons are the specialists who primarily treat patients with TBI in Europe, the distribution of helmet users among neurosurgeons (NS), as well as factors that influence the decision to wear helmets and whether professional knowledge or experience in TBI influences the use or attitude concerning bicycle helmets, remains unclear. A total of 55 neurosurgical departments in Germany, Austria, and Switzerland were contacted and asked to answer anonymous questionnaires concerning helmet use and TBI experience. To compare the neurosurgical attitude with that of a "non-neurosurgical, non-TBI-educated'' control group, people of the general public (PUB) were interviewed. A total of 465 NS and 546 PUB returned questionnaires, with 49.7% of the NS and 44.5% of PUB indicated that they wear helmets while bicycling. Trauma experience did effect the personal decision of whether to wear bicycle helmets. Support of compulsory use was influenced by TBI experience. Furthermore, the incidence of helmet use in children was correlated to actual helmet use and disposition of their parents to make helmet use compulsory. NS and PUB behaved in similar ways. Only half wear protective helmets, while the others show cognitive dissonant behavior. With respect to compulsory helmet use, NS are also split in half. Experience with TBI and trauma education has effects. However, education alone does not suffice in promoting the use of bicycle helmets.	[Jung, Carla S.; Zweckberger, Klaus; Schick, Uta; Unterberg, Andreas W.] Univ Heidelberg, Dept Neurosurg, D-69120 Heidelberg, Germany		Jung, CS (corresponding author), Univ Heidelberg, Dept Neurosurg, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	carla.jung@med.uni-heidelberg.de					Abu-Zidan FM, 2007, EMERG MED AUSTRALAS, V19, P366, DOI 10.1111/j.1742-6723.2007.00967.x; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Barkow K M, 1991, Wis Med J, V90, P279; Bolen JR, 1998, ARCH FAM MED, V7, P72, DOI 10.1001/archfami.7.1.72; DANNENBERG AL, 1993, PUBLIC HEALTH REP, V108, P212; Ehrlich PF, 2001, J PEDIATR SURG, V36, P763, DOI 10.1053/jpsu.2001.22955; Evans B, 2009, INT J INJ CONTROL SA, V16, P9, DOI 10.1080/17457300902732045; Finnoff JT, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e4; Macpherson A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005401.pub3; RICKELS E, 2006, 1257 ZUCKSCHW GMBH; Rosenkranz KA, 2003, INJURY, V34, P825, DOI 10.1016/S0020-1383(02)00389-3; SILVERBERG D, 1992, EUR J EPIDEMIOL, V8, P826, DOI 10.1007/BF00145327; Sosin DM, 1996, PEDIATRICS, V98, P868; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; Tsai WC, 2004, J CLIN NEUROSCI, V11, P126, DOI 10.1016/S0967-5868(03)00156-5	16	3	3	0	11	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAY	2010	27	5					871	875		10.1089/neu.2009.1130			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	599LX	WOS:000277915400009	20143959				2022-02-06	
J	Mauer, UM; Schulz, C; Rothe, R; Kunz, U				Mauer, Uwe Max; Schulz, Chris; Rothe, Ronny; Kunz, Ulrich			German military neurosurgery at home and abroad	NEUROSURGICAL FOCUS			English	Article						military neurosurgery; history of military neurosurgery; Afghanistan; International Security Assistance Force		For many years, the experience of neurosurgeons from the German Armed Forces was limited to the peacetime care of patients in Germany. In 1995, German military neurosurgeons were deployed abroad for the first time. Since the beginning of the International Security Assistance Force mission, there has been a rapidly increasing number of opportunities for military neurosurgeons to broaden their experience during deployments abroad. Since the first deployment of a neurosurgeon to the German field hospital in Mazar-e-Sharif, Afghanistan, a total of 140 neurosurgical procedures have been performed there. Sixty-four surgeries were performed for cranial or spinal neurotrauma management. During the entire period, only 10 International Security Assistance Force members required acute or urgent neurosurgical interventions. The majority of neurosurgical procedures were performed in Afghan patients who received acute and elective treatment whenever the necessary infrastructure was available in the field hospital. Fifteen patients from the Afghan National Army and Police and 115 local patients underwent neurosurgery. Sixty-two procedures were carried out under acute or urgent conditions, and 78 operations were elective. (DOI: 10.3171/2010.2.FOCUS1010)	[Mauer, Uwe Max; Schulz, Chris; Kunz, Ulrich] German Armed Forces Hosp, Dept Neurosurg, D-89070 Ulm, Germany; [Rothe, Ronny] German Armed Forces Cent Hosp, Dept Neurosurg, Koblenz, Germany		Mauer, UM (corresponding author), German Armed Forces Hosp, Dept Neurosurg, Oberer Eselsberg 40, D-89070 Ulm, Germany.	UweMaxMauer@bundeswehr.org						0	3	4	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	MAY	2010	28	5							E14	10.3171/2010.2.FOCUS1010			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	589ZU	WOS:000277193600014	20568930				2022-02-06	
J	Reno, J				Reno, Joseph			Military aeromedical evacuation, with special emphasis on craniospinal trauma	NEUROSURGICAL FOCUS			English	Article						military aeromedical evacuation; casualty; trauma; traumatic brain injury		This brief intends to educate civilian neurosurgeons on the structure and function of the US military aeromedical evacuation (AE) system, with special focus on the role of the military neurosurgeon. It highlights the thought process required to participate as a surgical provider in the AE system. It further clarifies the expanded role the AE system plays in nonbattle evacuation. (DOI: 10.3171/2010.2.FOCUS1023)	95th Aeromed & Dent Squadron, Edwards AFB, Edwards AFB, CA 93524 USA		Reno, J (corresponding author), 95th Aeromed & Dent Squadron, Edwards AFB, 55 N Wolfe Ave, Edwards AFB, CA 93524 USA.	joseph.reno@edwards.af.mil					BROOKS AFB, 2008, FLIGHT SURG CHECKLIS, P1; SCOTT AFB, 2007, 41307 HQ USAFSGN AIR	2	3	5	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	MAY	2010	28	5							E12	10.3171/2010.2.FOCUS1023			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	589ZU	WOS:000277193600012	20568928				2022-02-06	
J	Cameron, MH; Klein, EL				Cameron, Michelle H.; Klein, Eve L.			Screening for Medical Disease-Nervous System Disorders	JOURNAL OF HAND THERAPY			English	Article							EATON MYASTHENIC SYNDROME; MULTIPLE-SCLEROSIS; HERPES-ZOSTER; ISCHEMIC-STROKE; MINI-COG; DIAGNOSIS; REHABILITATION; NEUROPATHIES; STIMULATION; DEMENTIA	Narrative Review. In general, nervous system disorders present with changes in sensation, strength, and cognitive function that must be recognized early for the timely referral often needed for optimal outcome This article summarizes screening for nervous system disorders in patients who present to the hand therapist and the typical findings associated with common neurologic disorders Recommendations for referral by the hand therapist of patients with a screening examination consistent with a nervous system disorder are also presented Central nervous system (CNS) disorders discussed in this article include stroke, traumatic brain and spinal cord injury, CNS tumors, Parkinson disease, dementia, epilepsy, and multiple sclerosis This is followed by a discussion of the peripheral nervous system (PNS) disorders of acquired and hereditary polyneuropathies, Guillam-Barre syndrome and myasthenia gravis Lastly, there is a brief discussion of amyotrophic lateral sclerosis, a disorder affecting both the CNS and PNS	[Cameron, Michelle H.; Klein, Eve L.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA		Cameron, MH (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd,CR120, Portland, OR 97239 USA.						*AM AC NEUR, AAN GUID SUMM DET DI; Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; BARRETT KM, 2008, CONTINUUM LIFE LONG, V14, P13; Berciano J, 2003, CURR OPIN NEUROL, V16, P613, DOI 10.1097/00019052-200310000-00008; Bertorini T, 2004, NEUROLOGIST, V10, P327, DOI 10.1097/01.nrl.0000145596.38640.27; *BMJ EV CTR, PARK DIS; Borson S, 2003, J AM GERIATR SOC, V51, P1451, DOI 10.1046/j.1532-5415.2003.51465.x; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; CARMICHAEL JK, 1991, AM FAM PHYSICIAN, V44, P203; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; *CDC, TRAUM BRAIN INJ US E; *CDC, CDC INJ CTR; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; del Zoppo GJ, 2009, STROKE, V40, P2945, DOI 10.1161/STROKEAHA.109.192535; DRACHMAN DB, 1994, NEW ENGL J MED, V330, P1797, DOI 10.1056/NEJM199406233302507; DRISLANE F, 2006, BLUEPRINTS NEUROLOGY; EVANS RW, 2003, SAUNDERS MANUAL NEUR; Firth H.V., 2005, OXFORD DESK REFERENC; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forst T, 2004, DIABETES NUTR METAB, V17, P163; Garssen MPJ, 2004, NEUROLOGY, V63, P2393, DOI 10.1212/01.WNL.0000148589.87107.9C; Greenberg H, 1999, BRAIN TUMORS; Gregory Mary Ann, 2005, Rehabil Nurs, V30, P207; HART RG, 1990, STROKE, V21, P1111, DOI 10.1161/01.STR.21.8.1111; HELLER JL, CONVULSIONS; HUFF JS, NEOPLASMS SPINAL COR; Kappos L, 2007, LANCET, V370, P389, DOI 10.1016/S0140-6736(07)61194-5; Kesselring J, 2005, LANCET NEUROL, V4, P643, DOI 10.1016/S1474-4422(05)70193-9; Khan F, 2008, J NEUROL NEUROSUR PS, V79, P1230, DOI 10.1136/jnnp.2007.133777; Khan Fary, 2004, Aust Fam Physician, V33, P1013; Kumar D, 1997, DIABETES CARE, V20, P1702, DOI 10.2337/diacare.20.11.1702; Lee JS, 2008, FOOD SCI BIOTECHNOL, V17, P203; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; Miller RG, 2002, AM J PHYS MED REHAB, V81, pS99, DOI 10.1097/00002060-200211001-00011; *NAI I NEUR DIS, NAT I NEUR DIS STROK; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; National Institute of Neurological Disorders and Stroke, NAT I NEUR DIS STROK; Newswanger DL, 2004, AM FAM PHYSICIAN, V69, P2405; Peripheral Neuropathy, PERIPHERAL NEUROPATH; Rasmussen T, 1975, Adv Neurol, V8, P227; Reichstein L, 2005, DIABETOLOGIA, V48, P824, DOI 10.1007/s00125-005-1728-0; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Sanders DB, 2003, ANN NY ACAD SCI, V998, P500, DOI 10.1196/annals.1254.065; Stankus SJ, 2000, AM FAM PHYSICIAN, V61, P2437; STIEN J, 2004, STROKE FAMILY NEW GU; Storr LK, 2006, MULT SCLER, V12, P235, DOI 10.1191/135248506ms1250oa; STROMMEN GL, 1988, PHARMACOTHERAPY, V8, P52; Surawicz TS, 1998, J NEURO-ONCOL, V40, P151, DOI 10.1023/A:1006091608586; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; THORSTEINSSON G, 1977, ARCH PHYS MED REHAB, V58, P8; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tranchant C, 2009, REV NEUROL-FRANCE, V165, P149, DOI 10.1016/j.neurol.2009.01.005; Warner LE, 1999, ANNU REV MED, V50, P263, DOI 10.1146/annurev.med.50.1.263; WEYTINGH MD, 1995, J NEUROL, V242, P466, DOI 10.1007/BF00873551; Wirtz PW, 2002, CLIN NEUROL NEUROSUR, V104, P359, DOI 10.1016/S0303-8467(02)00054-9; Wokke J, 1996, LANCET, V348, P795, DOI 10.1016/S0140-6736(96)03181-9; WOLF PA, 2004, STROKE PATHOPHYSIOLO, P13; FACTS FIGURES GLANCE	60	3	3	0	6	HANLEY & BELFUS-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0894-1130	1545-004X		J HAND THER	J. Hand Ther.	APR-JUN	2010	23	2					158	171		10.1016/j.jht.2009.11.003			14	Orthopedics; Rehabilitation; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Rehabilitation; Surgery	596JI	WOS:000277680700005	20153950				2022-02-06	
J	Gu, JW; Yang, WT; Cheng, JM; Yang, T; Qu, Y; Kuang, YQ; Huang, HD; Yang, LB; He, WQ; Min, L				Gu, Jianwen; Yang, Wentao; Cheng, Jingmin; Yang, Tao; Qu, Yan; Kuang, Yongqin; Huang, Haidong; Yang, Libin; He, Weiqi; Min, Lu			Temporal and spatial characteristics and treatment strategies of traumatic brain injury in Wenchuan earthquake	EMERGENCY MEDICINE JOURNAL			English	Article							ACUTE-RENAL-FAILURE; MARMARA EARTHQUAKE; CRUSH SYNDROME	Objective To analyse the temporal and spatial characteristics of traumatic brain injury and the distribution of combined injuries in the Wenchuan earthquake, and describe the treatment opportunities and preferences for therapy. Methods The diagnosis and treatment of 92 patients with traumatic brain injury who survived the massive earthquake (magnitude 8) in Wenchuan, Sichuan Province, on 12 May 2008 were systematically analysed. Results The patients all came from the plains northwest of Chengdu city. Seventy-six patients were admitted during the early stage (within 12 h) after the earthquake. Ten patients underwent surgery and three patients died. Conclusion Patients with traumatic brain injury during the early period accounted for a large proportion of the patients wounded in the Wenchuan earthquake, and their conditions changed quickly. The patients all came from the plain area which has convenient transportation. After admission, providing first-aid early had a significant effect on increasing the success of treatment for these patients.	[Gu, Jianwen; Yang, Wentao; Cheng, Jingmin; Yang, Tao; Qu, Yan; Kuang, Yongqin; Huang, Haidong; Yang, Libin; He, Weiqi; Min, Lu] Gen Hosp Peoples Liberat Army Chengdu Mil Reg, Dept Neurosurg, Chengdu 610083, Sichuan, Peoples R China		Gu, JW (corresponding author), Gen Hosp Peoples Liberat Army Chengdu Mil Reg, Dept Neurosurg, Chengdu 610083, Sichuan, Peoples R China.	gujianwen2000@yahoo.com.cn					ATEF MR, 1994, Q J MED, V87, P35; Barbera Joseph A., 1996, Emergency Medicine Clinics of North America, V14, P399, DOI 10.1016/S0733-8627(05)70258-3; Demirkiran O, 2003, EMERG MED J, V20, P247, DOI 10.1136/emj.20.3.247; Pocan S, 2002, MIL MED, V167, P516, DOI 10.1093/milmed/167.6.516; Sever MS, 2002, CRIT CARE MED, V30, P2443, DOI 10.1097/00003246-200211000-00007; [温世浩 Wen Shihao], 2007, [灾害学, Journal of Catastrophology], V22, P138	6	3	5	1	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205			EMERG MED J	Emerg. Med. J.	MAR	2010	27	3					216	219		10.1136/emj.2008.065342			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	571VA	WOS:000275782800022	20304892				2022-02-06	
J	Gugger, OS; Kapfhammer, JP				Gugger, Olivia S.; Kapfhammer, Josef P.			Reduced Size of the Dendritic Tree Does Not Protect Purkinje Cells From Excitotoxic Death	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						cerebellum; Purkinje cells; glutamate, excitotoxic death; dendritic tree; neuronal development; AMPA	ORGANOTYPIC SLICE CULTURES; CEREBELLAR GRANULE CELLS; TRAUMATIC BRAIN-INJURY; VESICULAR GLUTAMATE TRANSPORTERS; EXCITATORY AMINO-ACIDS; RAT CEREBELLAR; AMPA NEUROTOXICITY; IN-VITRO; NEURONS; DEGENERATION	Purkinje cell loss by excitotoxic damage is a typical finding in many cerebellar diseases. One important aspect of this high sensitivity of Purkinje cells to excitotoxic death might be the enormous size of their dendritic tree, with a high load of excitatory glutamate receptors. We have studied whether reduction in the size of the dendritic tree might confer resistance against excitotoxic death to Purkinje cells. We have grown Purkinje cells in organotypic cerebellar slice cultures under chronic activation of metabotropic glutamate receptors or of protein kinase C. Both treatments strongly reduced dendritic tree size. After this treatment, cells were exposed to the glutamate receptor agonist AMPA, which has a strong excitotoxic effect on Purkinje cells. We found that Purkinje cells with small dendritic trees were as sensitive to AMPA exposure as untreated control cells with large dendritic trees. Immunostaining against vesicular glutamate transporter 1 revealed that the small dendritic trees were densely covered by glutamatergic terminals. Our results indicate that the expansion of the dendritic tree and the total number of AMPA receptors per neuron do not play a major role in determining the susceptibility of Purkinje cells to excitotoxic death. (C) 2009 Wiley-Liss, Inc.	[Gugger, Olivia S.; Kapfhammer, Josef P.] Univ Basel, Dept Biomed, Inst Anat, CH-4056 Basel, Switzerland		Kapfhammer, JP (corresponding author), Univ Basel, Dept Biomed, Inst Anat, Pestalozzistr 20, CH-4056 Basel, Switzerland.				University of Basel; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [31003A-116624]	Contract grant sponsor University of Basel, Contract grant sponsor Swiss National Science Foundation. Contract grant number 31003A-116624	Adcock KH, 2004, NEUROSCIENCE, V127, P137, DOI 10.1016/j.neuroscience.2004.04.032; Ai JL, 2002, NEUROSCI LETT, V332, P155, DOI 10.1016/S0304-3940(02)00945-X; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Barenberg P, 2001, NEUROSCI RES, V40, P245, DOI 10.1016/S0168-0102(01)00234-6; Bastianelli E, 2003, CEREBELLUM, V2, P242, DOI 10.1080/14734220310022289; Bergmann M, 1996, J NEUROSCI RES, V43, P78, DOI 10.1002/jnr.490430110; Cebers G, 1998, BRAIN RES, V779, P194, DOI 10.1016/S0006-8993(97)01123-2; Douyard J, 2007, J COMP NEUROL, V502, P141, DOI 10.1002/cne.21294; Dupont JL, 2006, CEREBELLUM, V5, P243, DOI 10.1080/14734220600905317; Dusart I, 1997, J NEUROSCI, V17, P3710; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; GARTHWAITE G, 1984, NEUROSCI LETT, V48, P361, DOI 10.1016/0304-3940(84)90065-X; GARTHWAITE G, 1991, EUR J NEUROSCI, V3, P715, DOI 10.1111/j.1460-9568.1991.tb01668.x; GARTHWAITE G, 1991, EUR J NEUROSCI, V3, P729, DOI 10.1111/j.1460-9568.1991.tb01669.x; Garthwaite J, 1990, Adv Exp Med Biol, V268, P505; HACK NJ, 1995, DEV BRAIN RES, V87, P55, DOI 10.1016/0165-3806(95)00054-H; Hioki H, 2003, NEUROSCIENCE, V117, P1, DOI 10.1016/S0306-4522(02)00943-0; Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030; KAPTHAMMER JP, 2005, BIOVALLEY MONOGRAPHS, V1, P74; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Mansouri B, 2007, EUR J PHARMACOL, V557, P106, DOI 10.1016/j.ejphar.2006.11.032; Mautes AEM, 1996, NEUROSCI LETT, V214, P95, DOI 10.1016/0304-3940(96)12916-5; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; Metzger F, 2000, EUR J NEUROSCI, V12, P1993, DOI 10.1046/j.1460-9568.2000.00086.x; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Park E, 2006, J NEUROPATH EXP NEUR, V65, P226, DOI 10.1097/01.jnen.0000202888.29705.93; RESINK A, 1994, BRAIN RES, V655, P222, DOI 10.1016/0006-8993(94)91617-9; Schrenk K, 2002, NEUROSCIENCE, V110, P675, DOI 10.1016/S0306-4522(01)00559-0; Shuttleworth CWR, 2001, J NEUROSCI, V21, P4225, DOI 10.1523/JNEUROSCI.21-12-04225.2001; Sirzen-Zelenskaya A, 2006, EUR J NEUROSCI, V24, P2978, DOI 10.1111/j.1460-9568.2006.05196.x; Slemmer JE, 2007, EUR J NEUROSCI, V26, P649, DOI 10.1111/j.1460-9568.2007.05708.x; Strahlendorf J, 2003, BRAIN RES, V994, P146, DOI 10.1016/j.brainres.2003.09.048; Strahlendorf J, 1999, NEUROSCI RES COMMUN, V25, P149, DOI 10.1002/(SICI)1520-6769(199911/12)25:3<149::AID-NRC4>3.0.CO;2-S; Strahlendorf JC, 1998, NEUROCHEM RES, V23, P1355, DOI 10.1023/A:1020742404945; Takamori S, 2006, NEUROSCI RES, V55, P343, DOI 10.1016/j.neures.2006.04.016; Weyer A, 2003, J NEUROSCI RES, V73, P400, DOI 10.1002/jnr.10655; Yamashita A, 2006, NEUROSCI RES, V55, P264, DOI 10.1016/j.neures.2006.03.007	37	3	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	MAR	2010	88	4					774	783		10.1002/jnr.22247			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	550YY	WOS:000274172400008	19798747				2022-02-06	
J	Mangels, JA; Manzi, A; Summerfield, C				Mangels, Jennifer A.; Manzi, Alberto; Summerfield, Christopher			The First Does the Work, But the Third Time's the Charm: The Effects of Massed Repetition on Episodic Encoding of Multimodal Face-Name Associations	JOURNAL OF COGNITIVE NEUROSCIENCE			English	Article							EVENT-RELATED POTENTIALS; TRAUMATIC BRAIN-INJURY; LONG-TERM-MEMORY; ELECTROPHYSIOLOGICAL EVIDENCE; HIPPOCAMPAL-FORMATION; RECOGNITION MEMORY; PROPER-NAMES; RECOLLECTION; RETRIEVAL; FAMILIARITY	In social interactions, it is often necessary to rapidly encode the association between visually presented faces and auditorily presented names. The present study used event-related potentials to examine the neural correlates of associative encoding for multimodal face-name pairs. We assessed study-phase processes leading to high-confidence recognition of correct pairs (and consistent rejection of recombined foils) as compared to lower-confidence recognition of correct pairs (with inconsistent rejection of recombined foils) and recognition failures (misses). Both high-and low-confidence retrieval of face-name pairs were associated with study-phase activity suggestive of item-specific processing of the face (posterior inferior temporal negativity) and name (fronto-central negativity). However, only those pairs later retrieved with high confidence recruited a sustained centro-parietal positivity that an ancillary localizer task suggested may index an association-unique process. Additionally, we examined how these processes were influenced by massed repetition, a mnemonic strategy commonly employed in everyday situations to improve face-name memory. Differences in subsequent memory effects across repetitions suggested that associative encoding was strongest at the initial presentation, and thus, that the initial presentation has the greatest impact on memory formation. Yet, exploratory analyses suggested that the third presentation may have benefited later memory by providing an opportunity for extended processing of the name. Thus, although encoding of the initial presentation was critical for establishing a strong association, the extent to which processing was sustained across subsequent immediate (massed) presentations may provide additional encoding support that serves to differentiate face-name pairs from similar (recombined) pairs by providing additional encoding opportunities for the less dominant stimulus dimension (i.e., name).	[Mangels, Jennifer A.] CUNY Bernard M Baruch Coll, New York, NY 10010 USA; [Summerfield, Christopher] Univ Oxford, Oxford, England		Mangels, JA (corresponding author), CUNY Bernard M Baruch Coll, 55 Lexington Ave, New York, NY 10010 USA.	jenimangels@gmail.com			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21MH066129]; Second University of Naples; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH066129] Funding Source: NIH RePORTER	This research was supported by an NIH grant R21MH066129 to J.A. Mangels. Alberto Manzi was supported by funding from the Second University of Naples. We thank Sam Gershman, who provided assistance with development and execution of the study, as well as Matt Greene who provided assistance with programming and recording of all the name stimuli.	Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; CHALLIS BH, 1993, J EXP PSYCHOL LEARN, V19, P115, DOI 10.1037/0278-7393.19.1.115; Chua EF, 2007, HIPPOCAMPUS, V17, P1071, DOI 10.1002/hipo.20340; Curran T, 2004, NEUROPSYCHOLOGIA, V42, P1088, DOI 10.1016/j.neuropsychologia.2003.12.011; Curran T, 2000, MEM COGNITION, V28, P923, DOI 10.3758/BF03209340; Donaldson DI, 1999, COGNITIVE BRAIN RES, V8, P1, DOI 10.1016/S0926-6410(98)00051-2; Donaldson DI, 1998, NEUROPSYCHOLOGIA, V36, P377, DOI 10.1016/S0028-3932(97)00143-7; Duarte A, 2004, COGNITIVE BRAIN RES, V18, P255, DOI 10.1016/j.cogbrainres.2003.10.010; FABIANI M, 1986, PSYCHOPHYSIOLOGY, V23, P298, DOI 10.1111/j.1469-8986.1986.tb00636.x; Guillaume C, 2009, BRAIN RES, V1248, P149, DOI 10.1016/j.brainres.2008.10.069; Guo CY, 2006, BRAIN RES, V1118, P142, DOI 10.1016/j.brainres.2006.08.034; Guo CY, 2005, COGNITIVE BRAIN RES, V22, P153, DOI 10.1016/j.cogbrainres.2004.08.009; Heisz JJ, 2006, VISION RES, V46, P4604, DOI 10.1016/j.visres.2006.09.026; Hux K, 2000, BRAIN INJURY, V14, P907; Itier RJ, 2004, NEUROIMAGE, V21, P1518, DOI 10.1016/j.neuroimage.2003.12.016; James LE, 2004, PSYCHOL AGING, V19, P515, DOI 10.1037/0882-7974.19.3.515; Khader P, 2007, COGN AFFECT BEHAV NE, V7, P212, DOI 10.3758/CABN.7.3.212; Kirwan CB, 2004, HIPPOCAMPUS, V14, P919, DOI 10.1002/hipo.20014; Manasse NJ, 2005, BRAIN INJURY, V19, P633, DOI 10.1080/02699050400013667; Mangels JA, 2001, COGNITIVE BRAIN RES, V11, P77, DOI 10.1016/S0926-6410(00)00066-5; Mantyla T, 2002, ACTA PSYCHOL, V109, P95, DOI 10.1016/S0001-6918(01)00054-3; Martin-Loeches M, 2005, INT J PSYCHOPHYSIOL, V55, P113, DOI 10.1016/j.ijpsycho.2004.06.007; Martinez A., 1998, 24 COMP VIS CTR; Mnatsakanian EV, 2007, BRAIN TOPOGR, V20, P21, DOI 10.1007/s10548-007-0027-0; Mnatsakanian EV, 2004, CLIN NEUROPHYSIOL, V115, P880, DOI 10.1016/j.clinph.2003.11.027; Muller HM, 1996, NEUROREPORT, V8, P221; Naveh-Benjamin M, 2004, PSYCHOL AGING, V19, P541, DOI 10.1037/0882-7974.19.3.541; Neuschatz J, 2005, AM J PSYCHOL, V118, P79; Otten LJ, 2002, NAT NEUROSCI, V5, P1339, DOI 10.1038/nn967; Palermo R, 2007, NEUROPSYCHOLOGIA, V45, P75, DOI 10.1016/j.neuropsychologia.2006.04.025; PALLER KA, 1987, ELECTROEN CLIN NEURO, V67, P360, DOI 10.1016/0013-4694(87)90124-6; Parkin AJ, 1995, CONSCIOUS COGN, V4, P387, DOI 10.1006/ccog.1995.1046; Rand-Giovannetti E, 2006, NEUROBIOL AGING, V27, P173, DOI 10.1016/j.neurobiolaging.2004.12.013; Ranganath C, 2005, TRENDS COGN SCI, V9, P374, DOI 10.1016/j.tics.2005.06.009; Rossion B, 1999, CLIN NEUROPHYSIOL, V110, P449, DOI 10.1016/S1388-2457(98)00037-6; Saxe R, 2006, NEUROIMAGE, V30, P1088, DOI 10.1016/j.neuroimage.2005.12.062; Scanlan LC, 1997, Q J EXP PSYCHOL-A, V50, P183; Schweinberger SR, 2002, NEUROPSYCHOLOGIA, V40, P2057, DOI 10.1016/S0028-3932(02)00050-7; Small SA, 2001, NAT NEUROSCI, V4, P442, DOI 10.1038/86115; Sperling R, 2003, NEUROIMAGE, V20, P1400, DOI 10.1016/S1053-8119(03)00391-4; Sperling RA, 2001, HUM BRAIN MAPP, V14, P129, DOI 10.1002/hbm.1047; Summerfield C, 2006, PLOS BIOL, V4, P855, DOI 10.1371/journal.pbio.0040128; Summerfield C, 2006, J COGNITIVE NEUROSCI, V18, P1120, DOI 10.1162/jocn.2006.18.7.1120; Tsivilis D, 2001, NEURON, V31, P497, DOI 10.1016/S0896-6273(01)00376-2; Uncapher MR, 2006, NEURON, V52, P547, DOI 10.1016/j.neuron.2006.08.011; Van Petten C, 2000, PSYCHOPHYSIOLOGY, V37, P551, DOI 10.1017/S0048577200990541; VanPetten C, 1996, PSYCHOPHYSIOLOGY, V33, P491; Woodruff CC, 2006, BRAIN RES, V1100, P125, DOI 10.1016/j.brainres.2006.05.019	48	3	3	0	3	M I T PRESS	CAMBRIDGE	238 MAIN STREET, STE 500, CAMBRIDGE, MA 02142-1046 USA	0898-929X			J COGNITIVE NEUROSCI	J. Cogn. Neurosci.	MAR	2010	22	3					457	473		10.1162/jocn.2009.21201			17	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	565QO	WOS:000275309500005	19301990				2022-02-06	
J	Marzban, M; Bakhtiary, M; Mehdizadeh, M; Joghataei, MT; Khoei, S; Mahabadi, VP; Hashemian, SJ; Tondar, M; Laribi, B; Ebrahimi, A; Abhari, B				Marzban, Mohsen; Bakhtiary, Mehrdad; Mehdizadeh, Mehdi; Joghataei, Mohamad Taghi; Khoei, Samideh; Mahabadi, Vahid Pirhajati; Hashemian, Seyed Jafar; Tondar, Mandi; Laribi, Bahareh; Ebrahimi, Asghar; Abhari, Babak			Intravenous Injection of Human Umbilical Cord Matrix Stem Cell (Wharton Jelly Stem Cell) Provides Functional Recovery in a Rat Model of Traumatic Brain Injury	YAKHTEH			English	Article						Stem Cell; Injection; Brain Injury	BONE-MARROW; CEREBRAL-ISCHEMIA; STROMAL CELLS; TRANSPLANTATION; NEUROGENESIS; GROWTH; NEOVASCULARIZATION; PROLIFERATION; ENHANCEMENT; RECRUITMENT	Objective: This study was designed to examine the effects of human umbilical cord matrix stem cell (hUCMSC) administration in rats for 6 weeks after traumatic brain injury (TBI). Materials and Methods: Adult male Wistar rats (n = 30) were injured with controlled cortical impact device and divided into three groups. The treatment group (n = 10) was injected with 2 x 10(6) hUCMSC intravenously, the vehicle group (n = 10) received phosphate buffered saline (PBS) whereas the control group (n = 10) receive nothing. All injections were performed one day after injury into the tail veins of the rats. All cells were labelled with Brdu before injection. Evaluation of the neurological function of the rats was performed before and after injury using Neurological Severity Scores (NSS). The rats were sacrificed 6 weeks after TBI and brain sections were stained using Brdu immunohistochemistry. Results: Statistically significant improvement in functional outcome was observed in the treatment group compared with the control group (p < 0.01). This benefit was visible 1 week after TBI and persisted for six weeks (end of trial). Histological analysis showed that hUCMSC were present in the lesion boundary zone at 6 weeks in all cell injected animals. Conclusion: Rats injected with hUCMSC after TBI survive for at least six weeks and show functional improvemnt.	[Marzban, Mohsen; Bakhtiary, Mehrdad; Mehdizadeh, Mehdi; Joghataei, Mohamad Taghi; Mahabadi, Vahid Pirhajati; Hashemian, Seyed Jafar; Tondar, Mandi; Abhari, Babak] Iran Univ Med Sci, Dept Anat, Tehran, Iran; [Bakhtiary, Mehrdad; Mehdizadeh, Mehdi; Joghataei, Mohamad Taghi] Iran Univ Med Sci, Cellular & Mol Res Ctr, Tehran, Iran; [Khoei, Samideh] Iran Univ Med Sci, Dept Med Phys, Tehran, Iran; [Laribi, Bahareh] Iran Univ Med Sci, Dept Immunol, Tehran, Iran; [Ebrahimi, Asghar] Milano Bicocca Univ, Dept Biosci & Biotechnol, Milan, Italy		Marzban, M (corresponding author), Iran Univ Med Sci, Dept Anat, POB 14155-6183, Tehran, Iran.	mohsen136051@yahoo.com	Marzban, Mohsen/B-1746-2019; Khoei, Samideh/T-2591-2019	Marzban, Mohsen/0000-0001-5558-2392; 	Research Authority of Iran University of Medical Sciences	This study was supported financially by the Research Authority of Iran University of Medical Sciences. The authors wish to acknowledge Dr. Mohammad Taghi Joghataei, Head of Department of Anatomy for his help, and Masoomeh Bakhshayesh, technician of cellular and molecular research center for her cooperation and help. There is no conflict of interest in this article.	Ay I, 2001, MOL BRAIN RES, V87, P71, DOI 10.1016/S0169-328X(00)00285-0; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; CHEN ST, 1986, STROKE, V17, P738, DOI 10.1161/01.STR.17.4.738; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Ding DC, 2007, NEUROBIOL DIS, V27, P339, DOI 10.1016/j.nbd.2007.06.010; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dutton Richard P, 2003, Curr Opin Crit Care, V9, P503, DOI 10.1097/00075198-200312000-00007; Gunnarsson T, 2003, CURR OPIN NEUROL, V16, P717, DOI 10.1097/00019052-200312000-00012; HEFTI F, 1986, J NEUROSCI, V6, P2155; Heil M, 2002, AM J PHYSIOL-HEART C, V283, pH2411, DOI 10.1152/ajpheart.01098.2001; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Jiang W, 2001, STROKE, V32, P1201, DOI 10.1161/01.STR.32.5.1201; Jomura S, 2007, STEM CELLS, V25, P98, DOI 10.1634/stemcells.2006-0055; Kobayashi K, 1998, EARLY HUM DEV, V51, P223, DOI 10.1016/S0378-3782(97)00123-0; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999; Li Y, 1998, J NEUROL SCI, V156, P119, DOI 10.1016/S0022-510X(98)00036-7; Medicetty S, 2004, EXP NEUROL, V190, P32, DOI 10.1016/j.expneurol.2004.06.023; Mitchell KE, 2003, STEM CELLS, V21, P50, DOI 10.1634/stemcells.21-1-50; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Rosomoff HL, 1996, CRIT CARE MED, V24, pS48; Schaper W, 1996, CIRC RES, V79, P911, DOI 10.1161/01.RES.79.5.911; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Stumm RK, 2002, J NEUROSCI, V22, P5865; Weiss ML, 2003, EXP NEUROL, V182, P288, DOI 10.1016/S0014-4886(03)00128-6; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998	29	3	3	0	0	ROYAN INST	TEHRAN	PO BOX 19395-4644, TEHRAN, 00000, IRAN	1561-4921	1753-8086		YAKHTEH	Yakhteh	SPR	2010	12	1					87	+					13	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	607PR	WOS:000278518800012					2022-02-06	
J	Tschan, CA; Hermann, EJ; Wagner, W; Krauss, JK; Oertel, JMK				Tschan, Christoph A.; Hermann, Elvis J.; Wagner, Wolfgang; Krauss, Joachim K.; Oertel, Joachim M. K.			Waterjet dissection in pediatric cranioplasty Technical note	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						Erbejet 2; waterjet dissection; hydrojet dissection; cranioplasty; surgical technique; hemostasis	TRAUMATIC BRAIN-INJURY; ENDOSCOPIC MUCOSAL RESECTION; ADHESION PREVENTIVE MATERIAL; DECOMPRESSIVE CRANIECTOMY; HYDROSURGERY SYSTEM; IN-VIVO; CHILDREN; DEBRIDEMENT; JET; NEUROSURGERY	Object. Waterjet dissection has been shown to separate tissues of different resistance, with preservation of blood vessels. In cranioplasty, separation of subcutaneous tissue and dura mater is often difficult to achieve because the various tissue layers strongly adhere to each other after decompressive craniotomy. In the present study, the potential advantages and drawbacks of the waterjet technique in cranioplasty after craniectomy and duraplasty are addressed. Methods. The waterjet effect on fresh human cadaveric dura mater specimens as well as on several dural repair patches was tested in vitro under standardized conditions, with waterjet pressures up to 80 bar. Subsequently, 8 pediatric patients (5 boys, 3 girls; mean age 9.9 years, range 1.2-16.7 years) who had been subjected to decompressive craniectomy (7 with duraplasty including bovine pericardium as a dural substitute, I without duraplasty in congenital craniosynostosis) underwent waterjet cranioplasty. The waterjet was used to separate the galea and the dura mater. The technique was applied tangentially between the dura and the galea, with different pressure levels LIP to 50 bar. Results. In vitro, fresh cadaveric human dura mater as well as 2 different dural repair substitutes showed a very high resistance to waterjet dissection up to 80 bar. The human dura and the various substitutes were dissected only after long-lasting exposure to the waterjet. Human dura was perforated at pressures of 60 bar and higher. Bovine pericardium dural substitute Was perforated at pressures of 55 bar and higher. Artificial nonabsorbable polyesterurethane dural substitute was dissected at pressures of 60 bar and higher. In the clinical setting, the waterjet was able to separate galea and dura with minimal bleeding. No blood transfusion was required. Dissection of scarred tissue was possible by a waterjet of 40 bar pressure. Tissue layers were stretched and separated by the waterjet dissection, and a very reliable hemostasis resulted. This resulted in an effective reduction of bleeding, with < 60 ml blood loss in 7 of the 8 cases. Neither a dural tear nor a perforation of any duraplasty occurred during operative preparation. There were no operative or postoperative complications. Conclusions. The experimental and clinical data show that waterjet separation of dura mater, dural substitute, and galea can be performed with a high level of safety to avoid dural tears. The waterjet dissection stretches tissue layers, which results in a reliable hemostasis effect. This potentially results in an effective reduction of surgical blood loss, which should be the focus of further Studies. (DOI: 10.3171/2009.10.PEDS09308)	[Tschan, Christoph A.; Wagner, Wolfgang; Oertel, Joachim M. K.] Johannes Gutenberg Univ Mainz, Univ Med, Neurochirurg Klin & Poliklin, D-55131 Mainz, Germany; [Hermann, Elvis J.; Krauss, Joachim K.] Hannover Med Sch, Neurochirurg Klin & Poliklin, D-30623 Hannover, Germany		Oertel, JMK (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med, Neurochirurg Klin & Poliklin, Langenbeckstr 1, D-55131 Mainz, Germany.	oertelj@freenet.de	Oertel, Joachim/AAO-5012-2021		Friedhelm Frees Stiftung, Wiesbaden, Germany	The authors state that they have no financial interest in the technology presented in the manuscript. This study was supported by a grant from the Friedhelm Frees Stiftung, Wiesbaden, Germany.	Adamo MA, 2009, J NEUROSURG-PEDIATR, V3, P334, DOI 10.3171/2008.12.PEDS08310; Bell MJ, 2008, INDIAN J PEDIATR, V75, P1159, DOI 10.1007/S12098-008-0240-1; Caputo WJ, 2008, INT WOUND J, V5, P288, DOI 10.1111/j.1742-481X.2007.00490.x; Chao MT, 2009, PLAST RECONSTR SURG, V123, P976, DOI 10.1097/PRS.0b013e31819ba46f; Cubison TCS, 2006, BURNS, V32, P714, DOI 10.1016/j.burns.2006.01.023; de Oliveira RS, 2007, CHILD NERV SYST, V23, P1097, DOI 10.1007/s00381-007-0413-7; Gilardino MS, 2009, PLAST RECONSTR SURG, V123, P983, DOI 10.1097/PRS.0b013e318199f6ad; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Granick M, 2006, WOUND REPAIR REGEN, V14, pS1, DOI 10.1111/j.1524-475X.2005.00096.x; Granick MS, 2007, OSTOMY WOUND MANAG, V53, P64; Granick MS, 2006, WOUND REPAIR REGEN, V14, P394, DOI 10.1111/j.1743-6109.2006.00136.x; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Greene AK, 2008, PLAST RECONSTR SURG, V122, P563, DOI 10.1097/PRS.0b013e31817d61c1; GRUBER R, 1988, Z KINDERCHIR, V43, P375; Gurunluoglu Raffi, 2007, World J Emerg Surg, V2, P10, DOI 10.1186/1749-7922-2-10; GURUSAMY KS, 2009, COCHRANE DB SYST REV, V21, P6880; Josan VA, 2005, CHILD NERV SYST, V21, P200, DOI 10.1007/s00381-004-1068-2; Kaehler GFBA, 2007, EUR SURG RES, V39, P93, DOI 10.1159/000099597; Kahler Georg F B A, 2007, Surg Technol Int, V16, P107; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Kimble RM, 2008, BURNS, V34, P297, DOI 10.1016/j.burns.2007.08.018; Klein MB, 2005, J BURN CARE REHABIL, V26, P483, DOI 10.1097/01.bcr.0000185398.13095.c5; Lee CH, 2007, CLIN NEUROL NEUROSUR, V109, P667, DOI 10.1016/j.clineuro.2007.05.015; Lingenfelder T, 2009, SURG ENDOSC, V23, P1531, DOI 10.1007/s00464-009-0433-3; Messing-Junger AM, 2003, ZBL NEUROCHIR, V64, P171; Narayan D, 2002, NEUROSURG CLIN N AM, V13, P505, DOI 10.1016/S1042-3680(02)00022-0; Oertel J, 2004, MINIM INVAS NEUROSUR, V47, P154, DOI 10.1055/s-2004-818512; Oertel J, 2004, ACTA NEUROCHIR, V146, P713, DOI 10.1007/s00701-004-0265-9; Oertel J, 2004, J NEUROSURG, V100, P498, DOI 10.3171/jns.2004.100.3.0498; Oertel J, 2003, NEUROSURG REV, V26, P168, DOI 10.1007/s10143-002-0244-7; Oertel J, 2003, EUR J SURG ONCOL, V29, P407, DOI 10.1053/ejso.2002.1428; Oertel J, 2003, NEUROSURGERY, V52, P153, DOI 10.1097/00006123-200301000-00020; Oertel Joachim, 2005, Neurosurgery, V56, P142, DOI 10.1227/01.NEU.0000144316.87764.13; Oertel J, 2006, J NEUROSURG, V105, P928, DOI 10.3171/jns.2006.105.6.928; Orliaguet GA, 2008, PEDIATR ANESTH, V18, P455, DOI 10.1111/j.1460-9592.2008.02507.x; Piek J, 1998, J NEUROSURG, V89, P861, DOI 10.3171/jns.1998.89.5.0861; Piek J, 2002, J NEUROSURG, V96, P690, DOI 10.3171/jns.2002.96.4.0690; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Rennekampff HO, 2006, BURNS, V32, P64, DOI 10.1016/j.burns.2005.07.010; Sold MG, 2008, SURG ENDOSC, V22, P443, DOI 10.1007/s00464-007-9449-8; Tschan CA, 2009, ACTA NEUROCHIR, V151, P1473, DOI 10.1007/s00701-009-0333-2; Tschan C, 2009, J NEUROSURG, V110, P656, DOI 10.3171/2008.5.17561; Vakis A, 2006, CLIN NEUROL NEUROSUR, V108, P798, DOI 10.1016/j.clineuro.2005.11.026	43	3	3	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	MAR	2010	5	3					243	249		10.3171/2009.10.PEDS09308			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	562WJ	WOS:000275085800004	20192640				2022-02-06	
J	Varjacic, M; Bakran, Z; Tusek, S; Bujisic, G				Varjacic, Martina; Bakran, Zarko; Tusek, Srecko; Bujisic, Gordana			Assessment of Long-Term Activity Limitations and Participation Restrictions of Persons with Traumatic Brain Injury Using the Disability Rating Scale	COLLEGIUM ANTROPOLOGICUM			English	Article						Disability rating scale; assessment; rehabilitation; traumatic brain injury		The rehabilitation of patients with traumatic brain injury (TBI), or intracranial injury, is the most complex segment of rehabilitation. The majority of patients with TBI are young, and the consequences are temporary or permanent limitation of activities and participation. Rehabilitation is primarily carried out in special hospitals for medical rehabilitation, and occasionally continues with rehabilitation on an outpatient basis or in the patient's home. The question of when treatment and rehabilitation is complete is often posed. An investigation of 40 patients with TBI was conducted at the completion of hospital rehabilitation and again three to five years after the completion of hospital treatment to assess the disability rating scale (DRS). The average age of patients was 33 years at the time of occurrence of the TBI, and the great majority were male (90%). The follow-up survey was conducted at the patient's home, and only in a few cases in the Osijek University Hospital or the Krapinske Toplice Special Hospital for Medical Rehabilitation. The DRS is an assessment of the level of activity and participation through four components: arousability, awareness, responsivity; cognitive ability for self-care activities; dependence on others; psychosocial adaptability and total DRS. Statistical testing was conducted at a significance level of 95%, and data analysis was carried out on the licensed programme STATISTICA 6.1 (StatSoft inc. 1983-2003, license no. AGA304B211928E61). The Wilcoxon test was used to determine statistical differences. After three to five years, there were no cases of statistically significant worsening or improvement of arousability, awareness and responsivity (0.067890, p>0.05) or cognitive ability for self-care activities (0.108810, p>0.05). However, there was a statistically significant improvement in dependence on others (0.000012, p<0.05) and psychosocial adaptation (0.011719, p<0.05). The TBI patients in the study had statistically significant improvement of their activities and progression three to five years after the completion of hospital rehabilitation monitored using the DRS (0.000004, p<0.05). These results refer only to those patients who continued to live in a family environment. It is necessary to conduct further study to determine an improvement or worsening of activities and participation of patients with TBI who continued living outside a family (senior rest home, social care institute, private home for seniors amid the disabled). The present study established that there is improvement in patients with TBI living in a family environment even three to five years after the completion of inpatient medical rehabilitation, particularly in the segments of dependence on others in activities of everyday life, education and employment.	[Varjacic, Martina; Bakran, Zarko] Special Hosp Med Rehabil Krapinske Toplice, Dept Neurol Rehabil, Krapinske Toplice 49217, Croatia; [Tusek, Srecko] Special Hosp Med Rehabil Krapinske Toplice, Dept Internal Med, Krapinske Toplice 49217, Croatia; [Bujisic, Gordana] Coll Lavoslav Ruzicka, Vukovar, Croatia		Bakran, Z (corresponding author), Special Hosp Med Rehabil Krapinske Toplice, Dept Neurol Rehabil, Gajeva 2, Krapinske Toplice 49217, Croatia.	mirjana.bakran@zg.t-com.hr					BAKRAN Z, 2000, FIZIKALNA MED REHAB; DUBROJA I, 1998, THESIS U ZAGREB ZAGR; KATZ DI, 2007, BRAIN INJURY MED; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; STINEMAN MG, 2005, PHYS MED REHABILITAT; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; WINKLER AP, 1990, NEUROLOGICAL REHABIL; Wright J, 2000, J HEAD TRAUMA REHAB, V15, P734, DOI 10.1097/00001199-200002000-00011	9	3	3	0	5	COLLEGIUM ANTROPOLOGICUM	ZAGREB	INST ANTHROPOLOGICAL RESEARCH, GAJEVA 32, PO BOX 290, HR-10000 ZAGREB, CROATIA	0350-6134			COLLEGIUM ANTROPOL	Coll. Anthropol.	MAR	2010	34			1			157	164					8	Anthropology	Social Science Citation Index (SSCI)	Anthropology	577OB	WOS:000276232100027	20402313				2022-02-06	
J	Robinson, LR; Micklesen, PJ				Robinson, Lawrence R.; Micklesen, Paula J.			Does Stimulus Rate Matter When Performing Somatosensory Evoked Potentials for Coma Patients?	NEUROCRITICAL CARE			English	Article						Somatosensory evoked potentials; Coma; Prognosis; Stimulation rate	EARLY PREDICTION	Introduction It is unclear whether the rate of stimulation for somatosensory evoked potentials (SEPs) can influence the presence or absence of cortical responses to median nerve stimulation in comatose patients. If so, this could affect how SEPs are performed and interpreted for prognostication in coma. Our objective was to determine how frequently our comatose patients had absent median nerve SEP responses at 3 Hz stimulation, but present responses at 1 Hz stimulation, and to report outcomes of these patients. Methods We reviewed SEP recordings in 639 comatose patients over a 9-year period. All had stimulation at 3 Hz and 1 Hz. This is a retrospective review. Results There were seven patients who had absent median nerve SEP responses at 3 Hz stimulation bilaterally, but had present responses at 1 Hz on one or both sides. Six of the seven died. One 16-year-old patient with traumatic brain injury awoke, but had moderate disability. Conclusions Stimulation rate is an important determinant of presence or absence of cortical responses in about 1% of comatose patients. It is unclear whether such patients have a different outcome that those with absent responses at both rates of stimulation.	[Robinson, Lawrence R.; Micklesen, Paula J.] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA; [Robinson, Lawrence R.; Micklesen, Paula J.] Univ Washington, Sch Med, Harborview Med Ctr Electrodiagnost Lab, Seattle, WA 98195 USA		Robinson, LR (corresponding author), Univ Washington, Sch Med, Dept Rehabil Med, POB 356380, Seattle, WA 98195 USA.	lorenzo@u.washington.edu	Robinson, Lawrence/D-8455-2013	Robinson, Lawrence/0000-0002-9590-8745			Araki A, 1999, BRAIN DEV-JPN, V21, P118, DOI 10.1016/S0387-7604(98)00092-8; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; Deuschl G., 1999, RECOMMENDATIONS PRAC; FUJII M, 1994, ELECTROEN CLIN NEURO, V92, P518, DOI 10.1016/0168-5597(94)90136-8; MADL C, 1993, LANCET, V341, P855, DOI 10.1016/0140-6736(93)93061-5; Robinson LR, 1997, AM J PHYS MED REHAB, V76, P191, DOI 10.1097/00002060-199705000-00005; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; Sherman AL, 2000, NEUROLOGY, V54, P889, DOI 10.1212/WNL.54.4.889; Urasaki E, 2002, CLIN NEUROPHYSIOL, V113, P1794, DOI 10.1016/S1388-2457(02)00291-2; Zandbergen EGJ, 1998, LANCET, V352, P1808, DOI 10.1016/S0140-6736(98)04076-8	10	3	3	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	FEB	2010	12	1					69	73		10.1007/s12028-009-9191-2			5	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	571HL	WOS:000275742800012	19225910				2022-02-06	
J	Aiken, LJ; Bibeau, PD; Cilento, BJ; Boutin, R				Aiken, Loretta J.; Bibeau, Patrice D.; Cilento, Barbara J.; Boutin, Robin			A Personal Reflection A Case Study in Family-Centered Care at the National Naval Medical Center in Bethesda, Maryland	DIMENSIONS OF CRITICAL CARE NURSING			English	Article						Family-centered care; Traumatic brain injury; Traumatic injury		This article describes the family-centered care that the National Naval Medical Center provided to the family members of a war-wounded soldier. It also includes the compelling written thoughts of a mother's bedside vigil during the 32 days her son spent in a sedated and ventilated state in the intensive care unit.	[Aiken, Loretta J.] Natl Naval Med Ctr, Bethesda, MD 20889 USA; [Bibeau, Patrice D.] Bur Med & Surg, Navy Med Lean Sigma Continuous Proc Improvement P, Washington, DC USA; [Cilento, Barbara J.] Natl Naval Med Ctr, Intens Care Unit, Bethesda, MD 20889 USA		Aiken, LJ (corresponding author), Natl Naval Med Ctr, Dept Cardiac Surg, 8901 Wisconsin Ave, Bethesda, MD 20889 USA.	vmiracle@aol.com					Gay R, 2008, CASUALTY CARE LIFE C; Hickey J, 2003, CLIN PRACTICE NEUROL	2	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0730-4625	1538-8646		DIMENS CRIT CARE NUR	Dimens. Crit. Care Nurs.	JAN-FEB	2010	29	1					13	19		10.1097/DCC.0b013e3181be4a1a			7	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	V2K5P	WOS:000217664000004	20010189				2022-02-06	
B	Anderson, V; Jacobs, R; Harvey, AS		Anderson, V; Jacobs, R; Anderson, PJ		Anderson, Vicki; Jacobs, Rani; Harvey, A. Simon			Executive functions after frontal lobe insult in childhood	EXECUTIVE FUNCTIONS AND THE FRONTAL LOBES: A LIFESPAN PERSPECTIVE	Studies on Neuropsychology Neurology and Cognition		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; PREFRONTAL CORTEX; HEAD-INJURY; CORTICAL REORGANIZATION; DIVERSE REGIONS; WORKING-MEMORY; CHILDREN; LESIONS; ATTENTION; AGE		[Anderson, Vicki] Univ Melbourne, Sch Behav Sci, Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia; [Jacobs, Rani] Univ Melbourne, Sch Psychol, Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia; [Harvey, A. Simon] Univ Melbourne, Royal Childrens Hosp, Childrens Neurosci Ctr, Melbourne, Vic, Australia		Anderson, V (corresponding author), Univ Melbourne, Sch Behav Sci, Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia.						ACKERLY S, 1948, ASS RES NERVOUS MENT, V27, P479; Alexander MP, 2000, SEMIN NEUROL, V20, P427, DOI 10.1055/s-2000-13175; Alivisatos B, 1997, NEUROPSYCHOLOGIA, V35, P111, DOI 10.1016/S0028-3932(96)00083-8; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson P, 2001, CLIN NEUROPSYCHOL, V15, P81, DOI 10.1076/clin.15.1.81.1905; Anderson P, 1996, CLIN NEUROPSYCHOL, V10, P54, DOI 10.1080/13854049608406663; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson V, 2005, J INT NEUROPSYCH SOC, V11, P817, DOI 10.1017/S1355617705051052; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P319, DOI 10.1080/713755568; Anderson V, 1997, J Int Neuropsychol Soc, V3, P147; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; ANDERSON V, 1988, P 13 ANN BRAIN IMP C, P223; Anderson V, 2002, PRINCIPLES FRONTAL L, P504; ANDERSON V, 2001, DEV NEUROPSYCHOLOGY; Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; ARAM DM, 1994, NEUROPSYCHOLOGIA, V32, P85, DOI 10.1016/0028-3932(94)90071-X; Barbas H, 1992, Adv Neurol, V57, P91; BARKLEY RA, 1996, ATTENTION MEMORY EXE, P00307; Barnes MA, 2001, BRAIN LANG, V76, P253, DOI 10.1006/brln.2000.2385; BARR M, 1993, HUMAN NERVOUS SYSTEM, P173; BASSER LS, 1962, BRAIN, V85, P427, DOI 10.1093/brain/85.3.427; Bates E, 1999, DEV COGN NEUROSCI, P533; Beauregard M, 1995, NEUROREPORT, V6, P2521, DOI 10.1097/00001756-199512150-00018; Benson D.F., 1986, FRONTAL LOBES; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; Bertolino A, 1997, CEREB CORTEX, V7, P740, DOI 10.1093/cercor/7.8.740; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; CHI J, 1991, ARCH NEUROL-CHICAGO, V34, P346; Chiron C, 1997, BRAIN, V120, P1057, DOI 10.1093/brain/120.6.1057; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Couper E., 2002, BRAIN IMPAIR, V3, P105, DOI [DOI 10.1375/BRIM.3.2.105, 10.1375/brim.3.2.105]; Dagher A, 1999, BRAIN, V122, P1973, DOI 10.1093/brain/122.10.1973; DAMASIO AR, 1994, SCI AM, V271, P144, DOI 10.1038/scientificamerican1094-144; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dennis M, 2001, J HEAD TRAUMA REHAB, V16, P456, DOI 10.1097/00001199-200110000-00005; Dennis M, 1989, CLIN NEUROPSYCHOLOGY, P89; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Diamond A, 1996, DEV PSYCHOBIOL, V29, P315, DOI 10.1002/(SICI)1098-2302(199605)29:4<315::AID-DEV2>3.0.CO;2-T; Diamond A., 2002, PRINCIPLES FRONTAL L, P466, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0029; DIAMOND A, 1985, NEUR ABSTR 2, V11, P832; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; DIDUS E, 2000, PEDIAT REHABILITATIO, V3, P177; Edelman G.M., 1987, NEURAL DARWINISM THE; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; ESLINGER PJ, 1991, NEUROLOGY, V41, P450, DOI 10.1212/WNL.41.3.450; Eslinger PJ, 1999, DEV NEUROPSYCHOL, V15, P157, DOI 10.1080/87565649909540744; Eslinger PJ, 2000, DEV NEUROPSYCHOL, V18, P297, DOI 10.1207/S1532694203Eslinger; ESLINGER PJ, 1997, DEV PREFRONTAL CORTE, P295; Espy KA, 1997, DEV NEUROPSYCHOL, V13, P495, DOI 10.1080/87565649709540690; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; Fuster J M, 1993, Curr Opin Neurobiol, V3, P160, DOI 10.1016/0959-4388(93)90204-C; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; Garth J, 1997, Pediatr Rehabil, V1, P99; Gibbs J.C., 1992, MORAL MATURITY MEASU; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giedd JN, 1996, CEREB CORTEX, V6, P551, DOI 10.1093/cercor/6.4.551; Gioia GA IP, 2000, BEHAV RATING INVENTO; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; GOLDBERG E, 1994, J NEUROPSYCH CLIN N, V6, P371; Golden C. J., 1981, NEUROPSYCHOLOGICAL A, P277; GOLDMANRAKIC PS, 1987, CHILD DEV, V58, P601, DOI 10.2307/1130201; Hale S, 1997, DEV PSYCHOL, V33, P364, DOI 10.1037/0012-1649.33.2.364; Harlow J.M., 1993, PUBLICATIONS MASSACH, V4, P274, DOI [DOI 10.1177/0957154X9300401407, https://doi.org/10.1177/0957154X9300401407]; HUDSPETH WJ, 1990, J EDUC PSYCHOL, V82, P881, DOI 10.1037/0022-0663.82.4.881; HUTTENLOCHER PR, 1997, DEV PREFRONTAL CORTE, P69; Jacobs R, 2002, CHILD NEUROPSYCHOL, V8, P93, DOI 10.1076/chin.8.2.93.8726; Jacobs R., 2001, CLIN NEUROPSYCHOL, V2, P101; Jacobs R, 2007, CORTEX, V43, P792, DOI 10.1016/S0010-9452(08)70507-0; JERNIGAN TL, 1990, DEV MED CHILD NEUROL, V32, P379; Johnson MH, 2000, CHILD DEV, V71, P75, DOI 10.1111/1467-8624.00120; KAIL R, 1986, CHILD DEV, V57, P969, DOI 10.1111/j.1467-8624.1986.tb00259.x; Kelly T., 2000, CLIN NEUROPSYCHOL, V1, P38; Kennard MA, 1936, AM J PHYSIOL, V115, P138, DOI 10.1152/ajplegacy.1936.115.1.138; Kennard MA, 1938, J NEUROPHYSIOL, V1, P477, DOI 10.1152/jn.1938.1.6.477; Kennard MA, 1942, ARCH NEURO PSYCHIATR, V48, P227, DOI 10.1001/archneurpsyc.1942.02290080073002; KENNEDY C, 1982, ANN NEUROL, V12, P333, DOI 10.1002/ana.410120404; Kirk U, 1985, HEMISPHERIC FUNCTION, P193; Klingberg T, 1997, CEREB CORTEX, V7, P465, DOI 10.1093/cercor/7.5.465; Klingberg T, 1999, NEUROREPORT, V10, P2817, DOI 10.1097/00001756-199909090-00022; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Knight RT, 1997, J COGNITIVE NEUROSCI, V9, P75, DOI 10.1162/jocn.1997.9.1.75; Kohlberg L., 1984, PSYCHOL MORAL DEV; Kolb B, 2004, BRAIN COGNITION, V55, P104, DOI 10.1016/s0278-2626(03)00278-1; Kolb B, 2000, DEV NEUROPSYCHOL, V18, P423, DOI 10.1207/S1532694208Kolb; KOLB B, 1993, BEHAV NEUROSCI, V107, P799, DOI 10.1037/0735-7044.107.5.799; Kolb B., 2002, PRINCIPLES FRONTAL L, P541; Korkman M., 1998, MANUAL NEPSY; Krikorian R, 1998, CLIN NEUROPSYCHOL, V12, P305, DOI 10.1076/clin.12.3.305.1984; Leung HC, 2000, CEREB CORTEX, V10, P552, DOI 10.1093/cercor/10.6.552; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LIDOW MS, 1991, P NATL ACAD SCI USA, V88, P10218, DOI 10.1073/pnas.88.22.10218; Luria A.R., 1973, WORKING BRAIN; MARLOWE WB, 1992, BRAIN COGNITION, V20, P205, DOI 10.1016/0278-2626(92)90070-3; MATEER CA, 1990, J CLIN EXP NEUROPSYC, V12, P95; MATTHEWS L, 2001, CLIN NEUROPSYCHOL, V2, P85; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; PAPERO PH, 1993, NEUROPSYCHOL REHABIL, V3, P321, DOI 10.1080/09602019308401445; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Passingham RE, 2000, EXP BRAIN RES, V133, P103, DOI 10.1007/s002210000405; Pentland L, 1998, NEUROPSYCHOL REHABIL, V8, P301, DOI 10.1080/713755572; Petrides M, 1999, EUR J NEUROSCI, V11, P1011, DOI 10.1046/j.1460-9568.1999.00518.x; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V34, P227; PRIGATANO GP, 1993, NEUROPSYCHOL REHABIL, V3, P411, DOI 10.1080/09602019308401449; Raedler TJ, 1998, CURR OPIN NEUROBIOL, V8, P157, DOI 10.1016/S0959-4388(98)80019-6; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Rey A., 1964, EXAMEN CLIN PSYCHOL; Scheibel Arnold, 1990, NEUROBIOLOGY HIGHER, P239; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; SIMONDS RJ, 1989, BRAIN LANG, V37, P42, DOI 10.1016/0093-934X(89)90100-4; Smidts DP, 2004, DEV NEUROPSYCHOL, V26, P385, DOI 10.1207/s15326942dn2601_2; Sowell ER, 2003, LANCET, V362, P1699, DOI 10.1016/S0140-6736(03)14842-8; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; STAUDT M, 1993, PEDIATR RADIOL, V23, P169, DOI 10.1007/BF02013824; Stuss D., 2002, PR FRONTAL LOBE FUNC, P392, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0025; Stuss D.T., 1994, NEUROPSYCHOLOGY, V8, P355, DOI [https://doi.org/10.1037/0894-4105.8.3.355, DOI 10.1037/0894-4105.8.3.355]; Stuss DT, 1998, J INT NEUROPSYCH SOC, V4, P265, DOI 10.1017/S1355617798002653; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; STUSS DT, 1992, BRAIN COGNITION, V20, P8, DOI 10.1016/0278-2626(92)90059-U; Stuss DT, 1999, NEUROPSYCHOLOGIA, V37, P1005, DOI 10.1016/S0028-3932(98)00158-4; Tamm L, 2002, J AM ACAD CHILD PSY, V41, P1231, DOI 10.1097/00004583-200210000-00013; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; THATCHER RW, 1992, BRAIN COGNITION, V20, P24, DOI 10.1016/0278-2626(92)90060-Y; THATCHER RW, 1991, DEV NEUROPSYCHOL, V7, P397, DOI 10.1080/87565649109540500; Todd JA, 1996, NEUROPSYCHOL REHABIL, V6, P81, DOI 10.1080/713755500; Tranel D, 2000, DEV NEUROPSYCHOL, V18, P273, DOI 10.1207/S1532694201Tranel; Tranel D., 2002, PRINCIPLES FRONTAL L, P338, DOI DOI 10.1093/ACPROF:OSO/9780195134971.001.0001; UEMURA E, 1978, J NEUROPATH EXP NEUR, V37, P487, DOI 10.1097/00005072-197809000-00004; VARGHAKHADEM F, 1985, BRAIN, V108, P677, DOI 10.1093/brain/108.3.677; WABER DP, 1985, J CLIN EXP NEUROPSYC, V7, P264, DOI 10.1080/01688638508401259; Walsh K. W., 1978, NEUROPSYCHOLOGY CLIN; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; Wood AG, 2004, NEUROLOGY, V63, P1035, DOI 10.1212/01.WNL.0000140707.61952.CA; Yakovlev PI, 1967, REGIONAL DEV BRAIN E, P3; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; [No title captured]; [No title captured], DOI DOI 10.1080/13854048708520056	156	3	3	0	4	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND			978-1-13687-354-6	STUD NEUROPSYCHOL NE			2010							269	298					30	Psychology, Biological; Psychology, Developmental; Psychology; Psychology, Experimental	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology	BVE09	WOS:000291249500014					2022-02-06	
J	Andersson, EE; Lund, J; Mansson, J				Andersson, Elisabeth Elgmark; Lund, Josefinne; Mansson, Josefinne			Traumatic brain injury in children between 7-12 years of age	DEVELOPMENTAL NEUROREHABILITATION			English	Article						epidemiology; injury occurrence; playgrounds; prevention; recreation centres	UNITED-STATES; PREDICTORS; SCALE	Objective: The purpose of this study was to describe the amount of traumatic brain injuries among children in the western part of Sweden. Methods: Based on a randomized controlled study, a retrospective analysis was conducted of data for children of 257 children 7-12 years of age. The journals were collected from 1997-2000. Results: The results showed that the most common causes were play and sports and that the accidents occurred in the school environment in the afternoon, whilst the least amount of accidents took place in the home. Nearly half of all the children were admitted to the hospital. Most accidents occurred in March and the least number of accidents occurred during the summer months. Conclusion: Prevention strategies are needed, especially for play and sport activities in recreation centres and playgrounds. These places are a high risk in causing a TBI for children after a day at school.	[Andersson, Elisabeth Elgmark] Jonkoping Univ, Sch Hlth Sci, Dept Rehabil Med, S-55111 Jonkoping, Sweden; [Lund, Josefinne] Rehabil Unit, Jonkoping, Sweden; [Mansson, Josefinne] Rehabil Unit, Eksjo, Sweden; [Mansson, Josefinne] Hoglands Hosp, Eksjo, Sweden		Andersson, EE (corresponding author), Jonkoping Univ, Sch Hlth Sci, Dept Rehabil Med, Box 1026, S-55111 Jonkoping, Sweden.	elisabeth.elgmark@hhj.hj.se		Elgmark Andersson, Elisabeth/0000-0002-2049-4170	Health and Medical Care Executive Board of the Vastra Gotaland Region, Sweden	The study was supported by the Health and Medical Care Executive Board of the Vastra Gotaland Region, Sweden. We thank the secretary at AUW consulting, Falkenberg, Sweden and we are grateful for the support of Torbjorn Falkmer, OT, PhD, Professor at School of Health Sciences, Department of Rehabilitation, Jonkoping University, Sweden.	Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; Catroppa C, 2009, DEV NEUROREHABIL, V12, P53, DOI 10.1080/17518420802634476; FALK AC, 2007, STOCKHOLM EXPERIENCE, V10, P49; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kozlowski KF, 2007, NEUROREHABILITATION, V22, P191; LEININGER REK, 2009, AM J SPORTS MED, V35, P288; Mello MJ, 2009, ACAD EMERG MED, V16, P243, DOI 10.1111/j.1553-2712.2009.00357.x; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Purper-Ouakil D, 2007, EUR CHILD ADOLES PSY, V16, P505, DOI 10.1007/s00787-007-0627-y; RICHARDS D, 2007, HUMAN BRAIN ITS DISO; *SBU, 2006, SYST LITT; *SBU, 2000, STAT BER MED UTV HJA; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Singh S, 2008, PEDIATRICS, V121, pE954, DOI 10.1542/peds.2007-0767; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; *WHO, 1996, ICD 10 STAT CLASS DI; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	21	3	3	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.		2010	13	5					346	350		10.3109/17518423.2010.503671			5	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Rehabilitation	686MB	WOS:000284699300006	20828331				2022-02-06	
B	Ashley, MJ; Leal, R; Mehta, Z; Ashley, JG; Ashley, MJ		Ashley, MJ		Ashley, Mark J.; Leal, Rose; Mehta, Zenobia; Ashley, Jessica G.; Ashley, Matthew J.			Cognitive Disorders: Diagnosis and Treatment in Traumatic Brain Injury	TRAUMATIC BRAIN INJURY: REHABILITATION, TREATMENT, AND CASE MANAGEMENT, 3RD EDITION			English	Article; Book Chapter							FUNCTIONAL NEUROANATOMY; PERCEPTUAL SALIENCE; SEMANTIC MEMORY; WORKING-MEMORY; NEURAL BASIS; ATTENTION; REHABILITATION; CATEGORIZATION; INTRAPARIETAL; ACTIVATION		[Ashley, Mark J.; Leal, Rose; Mehta, Zenobia; Ashley, Jessica G.] Ctr Neuro Skills, Bakersfield, CA 93313 USA; [Ashley, Matthew J.] Univ Calif Irvine, Irvine, CA USA		Ashley, MJ (corresponding author), Ctr Neuro Skills, Bakersfield, CA 93313 USA.						Adamovich B. B., 1992, SCALES COGNITIVE ABI; Amaral DG, 2000, PRINCIPLES NEURAL SC, P337; American Speech-Language-Hearing Association, 1990, GUID SPEECH LANG PAT, V32, P85; Anderson, 1980, COGNITIVE PSYCHOL IT; [Anonymous], 2008, Technol Eval Cent Assess Program Exec Summ, V23, P1; Baddeley A. D., 1970, Q J EXPT PSYCHOL, V61, P13; Bares M, 2001, CLIN NEUROPHYSIOL, V112, P2022, DOI 10.1016/S1388-2457(01)00671-X; Bartolomeo P, 2008, CORTEX, V44, P107, DOI 10.1016/j.cortex.2006.07.001; Barton J. S., 2008, NEUROLOGY, V58, P71; BECKER DP, 1988, WESTERN J MED, V148, P670; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; BLACK J E, 1987, Society for Neuroscience Abstracts, V13, P1596; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Bontke C. F., 1993, J HEAD TRAUMA REHAB, V8, P34; Bowerman M., 1976, NORMAL DEFICIENT CHI; Bowleska A., 1981, Z PSYCHOL Z ANGEW PS, V189, P67; Bruner J.S., 1956, STUDY THINKING; BRUNER JS, 1964, AM PSYCHOL, V19, P1, DOI 10.1037/h0044160; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; BURGER RA, 1980, J PSYCHOLINGUIST RES, V9, P355, DOI 10.1007/BF01067448; Cappla SF, 2008, CURR OPIN NEUROL, V21, P669, DOI 10.1097/WCO.0b013e328316e6e0; CARAMAZZA A, 1982, BRAIN LANG, V15, P161, DOI 10.1016/0093-934X(82)90054-2; CARON AJ, 1969, DEV PSYCHOL, V1, P333, DOI 10.1037/h0027698; CAVALLI M, 1981, CORTEX, V17, P545, DOI 10.1016/S0010-9452(81)80061-5; CHANNON S, 1989, NEUROPSYCHOLOGIA, V27, P777, DOI 10.1016/0028-3932(89)90002-X; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Clark H. H., 1977, PSYCHOL LANGUAGE; Coelho CA, 1996, J SPEECH HEAR RES, V39, pS5, DOI 10.1044/jshr.3905.s5; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Constantinidou F, 2005, J HEAD TRAUMA REHAB, V20, P143, DOI 10.1097/00001199-200503000-00003; Constantinidou F, 2008, J HEAD TRAUMA REHAB, V23, P312, DOI 10.1097/01.HTR.0000336844.99079.2c; CORBETTA M, 1991, J NEUROSCI, V11, P2383; CORBETTA M, 1993, J NEUROSCI, V13, P1202; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; CRAIK FIM, 1969, BRIT J PSYCHOL, V60, P315, DOI 10.1111/j.2044-8295.1969.tb01202.x; CRANNELL CW, 1957, J PSYCHOL, V44, P319, DOI 10.1080/00223980.1957.9713089; Crutcher K. A., 1991, LEARNING MEMORY BIOL; Curtis CE, 2006, NEUROSCIENCE, V139, P173, DOI 10.1016/j.neuroscience.2005.04.070; Damasio H, 2001, NEUROIMAGE, V13, P1053, DOI 10.1006/nimg.2001.0775; DARWIN CJ, 1972, COGNITIVE PSYCHOL, V3, P255, DOI 10.1016/0010-0285(72)90007-2; Daube J. R., 1978, MED NEUROSCIENCES AP; Davies D. R., 1984, SELECTIVE SUSTAINED; Desgranges B, 1998, NEUROIMAGE, V8, P198, DOI 10.1006/nimg.1998.0359; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; DUNCAN J, 1980, PSYCHOL REV, V87, P272, DOI 10.1037/0033-295X.87.3.272; EIDELBERG E, 1971, BRAIN, V94, P91, DOI 10.1093/brain/94.1.91; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; GAINOTTI G, 1981, BRAIN LANG, V13, P201, DOI 10.1016/0093-934X(81)90090-0; Galan RF, 2006, NEURAL COMPUT, V18, P10, DOI 10.1162/089976606774841558; GLUCKSBERG S, 1966, J EXP PSYCHOL, V71, P659, DOI 10.1037/h0023118; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P560, DOI 10.1152/jn.1972.35.4.560; Goldstein K., 1948, LANGUAGE LANGUAGE DI; GOODGLASS H, 1979, HDB BEHAV NEUROBIOLO, V2; GROBER E, 1980, BRAIN LANG, V10, P318, DOI 10.1016/0093-934X(80)90059-0; GROSSMAN M, 1978, BRAIN LANG, V6, P112, DOI 10.1016/0093-934X(78)90049-4; Grossman M, 1996, BRAIN LANG, V55, P96; GROSSMAN M, 1987, BRAIN COGNITION, V6, P55, DOI 10.1016/0278-2626(87)90046-7; Grossman M., 1980, M INT NEUR SOC SAN F; GUMMOW L, 1983, CLIN PSYCHOL REV, V3, P255, DOI 10.1016/0272-7358(83)90015-6; Habib R, 2003, TRENDS COGN SCI, V7, P241, DOI 10.1016/S1364-6613(03)00110-4; Harley J. P., 1992, NEUROREHABILITATION, V2, P62; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Heaton PDRK., 1993, WISCONSIN CARD SORTI; HEILMAN KM, 1972, NEUROLOGY, V22, P660, DOI 10.1212/WNL.22.6.660; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; Hillyard Steven A., 1995, P665; HIRST W, 1988, BRAIN COGNITION, V8, P379, DOI 10.1016/0278-2626(88)90060-7; HOUGH MS, 1993, APHASIOLOGY, V7, P335, DOI 10.1080/02687039308249515; Kaas AL, 2007, CEREB CORTEX, V17, P1637, DOI 10.1093/cercor/bhl074; KAGAN J, 1965, CHILD DEV, V36, P609; Kagan J., 1966, PERCEPTUAL DEV CHILD, P487; KAHNEMAN D, 1970, ACTA PSYCHOL, V33, P118, DOI 10.1016/0001-6918(70)90127-7; Kahneman D., 1973, ATTENTION EFFORT; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; KOLB B, 2003, FUNDAMENTALS HUMAN N; KOSSLYN SM, 1988, SCIENCE, V240, P1621, DOI 10.1126/science.3289115; Kosslyn SM, 1995, HUM BRAIN MAPP, V3, P107, DOI 10.1002/hbm.460030207; LHERMITTE F, 1971, REV NEUROL-FRANCE, V125, P81; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Little DM, 2005, COGNITIVE BRAIN RES, V25, P33, DOI 10.1016/j.cogbrainres.2005.04.015; Little DM, 2004, COGNITIVE BRAIN RES, V22, P84, DOI 10.1016/j.cogbrainres.2004.07.011; MANDLER G, 1969, J VERB LEARN VERB BE, V8, P410, DOI 10.1016/S0022-5371(69)80134-9; Mandler G., 1967, PSYCHOL LEARN MOTIV, V1, P327; Martin A. C, 2000, NEW COGNITIVE NEUROS, P1023; Mather N., 2001, WOODCOCK JOHNSON 3 T; MESULAM MM, 1978, J PSYCHIATR RES, V14, P249, DOI 10.1016/0022-3956(78)90027-4; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MORAY N, 1965, J ACOUST SOC AM, V38, P196, DOI 10.1121/1.1909631; Muma J. R., 1979, MUMA ASSESSMENT PROG; MUMA JR, 1978, LANGUAGE HDB CONCEPT; Murdock B. B., 1972, PSYCHOL LEARN MOTIV, V5, P67; Naatanen R., 1979, ORIENTING REFLEX HUM, P61; NAUTA WJH, 1986, LIMBIC SYSTEM FUNCTI, P00043; Navakkode S, 2007, NEUROPHARMACOLOGY, V52, P1547, DOI 10.1016/j.neuropharm.2007.02.010; Neisser U., 1967, COGNITIVE PSYCHOL; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; NORMAN DA, 1986, COGNITIVE NEUROSCIEN, P376; ODOM RD, 1973, CHILD DEV, V44, P425; ODOM RD, 1970, J EXP CHILD PSYCHOL, V9, P156, DOI 10.1016/0022-0965(70)90080-9; OLSON DR, 1970, PSYCHOL REV, V77, P257, DOI 10.1037/h0029436; PETERSEN SE, 1987, NEUROPSYCHOLOGIA, V25, P97, DOI 10.1016/0028-3932(87)90046-7; Piaget J., 1962, PLAY DREAMS IMITATIO; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Posner M.I., 1975, HDB PSYCHOBIOLOGY, P441, DOI [DOI 10.1016/B978-0-12-278656-3.50019-3, 10.3758/BF03333099, DOI 10.3758/BF03333099]; Posner M.I., 1975, ATTENTION PERFORMANC, V41, P509; POSNER MI, 1994, P NATL ACAD SCI USA, V91, P7398, DOI 10.1073/pnas.91.16.7398; Posner Michael I., 1995, P615; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ranganath C, 2006, NEUROSCIENCE, V139, P277, DOI 10.1016/j.neuroscience.2005.06.092; Reed K. M., 1998, J CARE MANAGEMENT, V4, P18; Reed K. M., 1998, J CARE MANAGEMENT, V4, P21; RIPS LJ, 1973, J VERB LEARN VERB BE, V12, P1, DOI 10.1016/S0022-5371(73)80056-8; RIPS LJ, 1975, J VERB LEARN VERB BE, V14, P665, DOI 10.1016/S0022-5371(75)80055-7; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; ROSCH E, 1976, J EXP PSYCHOL HUMAN, V2, P491, DOI 10.1037/0096-1523.2.4.491; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; ROSCH E, 1975, COGNITIVE PSYCHOL, V7, P573, DOI 10.1016/0010-0285(75)90024-9; ROSCH E, 1975, CROSS CULTURAL PERSP, P177; ROSCH E, 1976, THINKING READINGS CO, P212; Rosch Eleanor, 1973, COGNITIVE DEV ACQUIS, P111; Ross D. G., 1986, ROSS INFORM PROCESSI; SALTZ E, 1967, J EXP PSYCHOL, V73, P1, DOI 10.1037/h0024184; Saykin AJ, 1999, BRAIN, V122, P1963, DOI 10.1093/brain/122.10.1963; SCHEIBEL MADGE E., 1967, BRAIN RES, V6, P60, DOI 10.1016/0006-8993(67)90183-7; SCHWARTZ ML, 1984, J COMP NEUROL, V226, P403, DOI 10.1002/cne.902260309; SHIFFRIN RM, 1969, PSYCHOL REV, V76, P179, DOI 10.1037/h0027277; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; SHOBEN EJ, 1976, J VERB LEARN VERB BE, V15, P365, DOI 10.1016/S0022-5371(76)90032-3; SIREVAAG A M, 1988, Society for Neuroscience Abstracts, V14, P1135; Smith CD, 2001, J NEUROIMAGING, V11, P165, DOI 10.1111/j.1552-6569.2001.tb00028.x; Smith E. E., 1974, PSYCHOL LEARNING MOT; SMITH EE, 1974, PSYCHOL REV, V81, P214, DOI 10.1037/h0036351; Smith EE, 2000, NEW COGNITIVE NEUROS, P1013; Sohlberg M. M., 1989, ATTENTION PROCESS TR; Sokovlov E. N., 1963, PERCEPTION CONDITION; Spurling G. A., 1960, PSYCHOL MONOGR, V74, P498; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; THOMAS CL, 1993, TABERS CYCLOPEDIC ME; THOMPSON RF, 1970, ATTENTION CONTEMPORA, P367; TREISMAN AM, 1964, AM J PSYCHOL, V77, P206, DOI 10.2307/1420127; TREXLER LE, 1988, BRAIN COGNITION, V8, P291, DOI 10.1016/0278-2626(88)90056-5; TULVING E, 1985, AM PSYCHOL, V40, P385, DOI 10.1037/0003-066x.40.4.385; Tulving E., 1983, ELEMENTS EPISODIC ME; Tyler Stephen A., 1969, COGNITIVE ANTHR; Vaidya CJ, 2008, DEV DISABIL RES REV, V14, P261, DOI 10.1002/ddrr.40; van Zomerer A. H., 1994, CLIN NEUROPSYCHOLOGY; Voss J. F., 1972, ORG MEMORY, P174; Vygotsky L.V., 1986, THOUGHT LANGUAGE; Watson R. T., 1973, NEUROLOGY, V23, P367; WATSON RT, 1973, NEUROLOGY, V23, P1003, DOI 10.1212/WNL.23.9.1003; WAYLAND S, 1985, BRAIN COGNITION, V4, P338, DOI 10.1016/0278-2626(85)90026-0; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	157	3	3	0	0	CRC PRESS-TAYLOR & FRANCIS GROUP	BOCA RATON	6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA			978-1-4398-4982-8; 978-1-4200-7194-8				2010							583	619		10.1201/9781439849828-c19	10.1201/9781439849828		37	Clinical Neurology; Rehabilitation	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Rehabilitation	BF7QW	WOS:000384329900020					2022-02-06	
J	Astrand, R; Unden, J; Hesselgard, K; Reinstrup, P; Romner, B				Astrand, Ramona; Unden, Johan; Hesselgard, Karin; Reinstrup, Peter; Romner, Bertil			Clinical Factors Associated with Intracranial Complications after Pediatric Traumatic Head Injury: An Observational Study of Children Submitted to a Neurosurgical Referral Unit	PEDIATRIC NEUROSURGERY			English	Article						Traumatic brain injury, children; Head injury, pediatric, complications; Intracranial hemorrhage; Neurosurgery; Management routines; Helmet	BRAIN-INJURY; COMPUTED-TOMOGRAPHY; DECISION RULE; MANAGEMENT; EPIDEMIOLOGY; PREDICTION; CANCER; RISKS; MILD	Background: Clinically validated guidelines for the management of head injury in children do not exist, and the treatment is often based upon adult management routines. In order to examine the safety of this procedure, an analysis of clinical factors associated with complications after pediatric head injury was attempted. Method: We performed a descriptive retrospective study, including patients who received any S06 diagnosis during treatment in the Neurointensive Care Unit at Lund University Hospital between 2002 and 2007. One hundred children were included during the 6 years. Results: During 6 years, 100 children with head injury needed neurointensive care or neurosurgery for their injury in southern Sweden. Traffic accidents (50%) were the main cause of head trauma, followed by falls (36%). Thirty-two percent of all children were injured in bicycle and motorcycle accidents. Both loss of consciousness and amnesia were absent in 23% of the children with intracranial injury. Seven children with intracranial injury, 6 of them requiring neurosurgery, were classed as having minimal head injury according to the Head Injury Severity Scale (HISS). Interesting differences in intracranial injuries between helmet users and nonusers were observed. Conclusion: Children with minimal head injuries (according to HISS) may develop intracranial complications and may even require neurosurgical intervention. Hence, the HISS classification, as well as other risk classifications based upon unconsciousness and amnesia, are unreliable in children. Copyright (C) 2010 S. Karger AG, Basel	[Romner, Bertil] Rigshosp, Dept Neurosurg, Ctr Neurosci, DK-2100 Copenhagen, Denmark; [Astrand, Ramona] Univ Lund Hosp, Dept Neurosurg, S-22185 Lund, Sweden; [Astrand, Ramona] Lund Univ, Lund, Sweden; [Hesselgard, Karin] Univ Lund Hosp, Acad Med E Consulting, S-22185 Lund, Sweden; [Reinstrup, Peter] Univ Lund Hosp, Dept Anaesthesiol, S-22185 Lund, Sweden; [Unden, Johan] Halmstad Cty Hosp, Dept Anaesthesiol & Intens Care, Halmstad, Sweden		Romner, B (corresponding author), Rigshosp, Dept Neurosurg, Ctr Neurosci, Sect NK 2092,Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	bertil.romner@rh.regionh.dk					Astrand R, 2006, ACTA NEUROL SCAND, V113, P262, DOI 10.1111/j.1600-0404.2005.00573.x; Atabaki SM, 2008, ARCH PEDIAT ADOL MED, V162, P439, DOI 10.1001/archpedi.162.5.439; Batchelor J, 2002, EMERG MED J, V19, P515, DOI 10.1136/emj.19.6.515; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Bergman DA, 1999, PEDIATRICS, V104, P1407; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Castellani C, 2009, ACTA PAEDIATR, V98, P1607, DOI 10.1111/j.1651-2227.2009.01423.x; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Eid H. O., 2007, SMJ Singapore Medical Journal, V48, P884; Eid H. O., 2007, SMJ Singapore Medical Journal, V48, P693; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Falk AC, 2005, CHILD NERV SYST, V21, P430, DOI 10.1007/s00381-005-1142-4; Fitzharris M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-11; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Hall EJ, 2008, BRIT J RADIOL, V81, P362, DOI 10.1259/bjr/01948454; Holsti M, 2005, PEDIATR EMERG CARE, V21, P639, DOI 10.1097/01.pec.0000181426.25342.a9; Ingebrigtsen T, 1998, NEUROEPIDEMIOLOGY, V17, P139, DOI 10.1159/000026165; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; JOHANSSON E, 1991, SCAND J REHABIL MED, V23, P179; Kim K A, 2000, Neurosurg Focus, V8, pe3; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; McLeod TCV, 2005, J ATHL TRAINING, V40, P123; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Norlund A, 2006, BMJ-BRIT MED J, V333, P469, DOI 10.1136/bmj.38918.659120.4F; Palchak MJ, 2004, PEDIATRICS, V113, pE507, DOI 10.1542/peds.113.6.e507; Servadei F, 2003, INJURY PREV, V9, P257, DOI 10.1136/ip.9.3.257; Shafi S, 1998, J PEDIATR SURG, V33, P317, DOI 10.1016/S0022-3468(98)90454-7; Simon B, 2001, J TRAUMA, V51, P231, DOI 10.1097/00005373-200108000-00004; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stranjalis G, 2008, J TRAUMA, V65, P789, DOI 10.1097/TA.0b013e3181469e26; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099	34	3	3	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2010	46	2					101	109		10.1159/000319006			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	635UX	WOS:000280683500003	20664236				2022-02-06	
J	Castello, MB; Cabello, JT; Goixart, LS; Foradada, JT; Siurana, MJP; Galito, EA				Badia Castello, Mariona; Trujillano Cabello, Javier; Servia Goixart, Luis; Tarragona Foradada, Jordi; Panades Siurana, M. Jose; Amoros Galito, Esther			Occult donor metastatic adenocarcinoma. Contribution of the forensic autopsy. A case report	ANNALS OF TRANSPLANTATION			English	Article						organ donation; tumor transmission; forensic autopsy	LIVER RETRANSPLANTATION; TRANSPLANT RECIPIENT; MALIGNANCY; TRANSMISSION; SARCOMA; KIDNEY; UPDATE	Background: The transmission of malignancies from the organ donor to the recipients is an uncommon complication, but it can be fatal. Older donors may increase the risk of tumor transmission. A forensic autopsy will help identify diseases that. might be transmitted to the recipient. Case Report: Donor was a 75-year-old man with traumatic brain injury caused by an accidental fall, which led to brain death. lie had no previous cancer history. The forensic autopsy conducted on the following day revealed a suspicious spot in the lung, on which a biopsy was done. Histological examination confirmed the presence of a metastatic adenocarcinoma in the lung 7 clays after both kidneys had been transplanted. After notifying the transplant team, both recipients underwent: an early transplant nephrectomy. 15 months later, no signs of malignancy have been detected in the recipients and so they have received a new transplant. Conclusions: Conducting a forensic autopsy on donors deceased as a result of a fatality offers an additional opportunity to detect previously undiagnosed malignancies. Any suspicious lesion found that could compromise transplant: viability should be notified to the transplant: team notwithstanding the pathologist's legal requirements. This case shows the need for an exhaustive donor evaluation, including, in selected cases, the performance of an autopsy.	[Badia Castello, Mariona; Trujillano Cabello, Javier; Servia Goixart, Luis] Hosp Arnau Vilanova, Intens Care Unit, Lleida 25198, Spain; [Tarragona Foradada, Jordi; Panades Siurana, M. Jose] Dept Pathol & Mol Genet, Lleida, Spain; [Amoros Galito, Esther] Univ Lleida, Legal Med Inst Catalonia, IRBLLEIDA, Lleida, Spain		Castello, MB (corresponding author), Hosp Arnau Vilanova, Intens Care Unit, Avda Rovira Roure 80, Lleida 25198, Spain.	marionabadia@wanadoo.es	Trujillano, Javier/A-4325-2010; Goixart, Lluis Servia/C-6561-2011; Castello, Maria Badia/C-7234-2011; Trujillano, Javier/AAZ-8142-2021	Trujillano, Javier/0000-0001-8071-7711; Goixart, Lluis Servia/0000-0001-9513-1465; Trujillano, Javier/0000-0001-8071-7711; Tarragona, Jordi/0000-0002-1459-4087			Buell Joseph F, 2004, Ann Transplant, V9, P53; Burton EC, 1998, JAMA-J AM MED ASSOC, V280, P1245, DOI 10.1001/jama.280.14.1245; Castiglione AG, 2004, TRANSPL P, V36, P421, DOI 10.1016/j.transproceed.2004.02.056; Collignon FP, 2004, AM J TRANSPLANT, V4, P15, DOI 10.1046/j.1600-6143.2003.00289.x; CONLON PJ, 1995, J AM SOC NEPHROL, V6, P54; Detry O, 2005, LIVER TRANSPLANT, V11, P696, DOI 10.1002/lt.20457; FERNANDEZZINKE E, 2000, REV ESP TRANSP, V9, P214; Frutos MA, 2002, REV ESP TRANSPLANTES, V11, P33; Gandhi Manish J., 2007, Cell and Tissue Banking, V8, P267, DOI 10.1007/s10561-007-9036-1; Garrido G, 2008, TRANSPLANTATION, V85, pS61, DOI 10.1097/TP.0b013e31816c2f55; Gerstenkorn C, 2003, CLIN TRANSPLANT, V17, P473, DOI 10.1034/j.1399-0012.2003.00072.x; HARVEY L, 1981, J CLIN PATHOL, V34, P116, DOI 10.1136/jcp.34.2.116; IVANOVSKI N, 1991, TRANSPL P, V23, P2626; Kauffman HM, 2007, TRANSPLANTATION, V84, P272, DOI 10.1097/01.tp.0000267919.93425.fb; Krapp JD, 2005, TRANSPLANT INT, V18, P1109, DOI 10.1111/j.1432-2277.2005.00178.x; Lipshutz GS, 2003, LIVER TRANSPLANT, V9, P1102, DOI 10.1053/jlts.2003.50174; Molina DK, 2007, AM J FOREN MED PATH, V28, P1, DOI 10.1097/01.paf.0000257388.83605.0a; *ONT, 2006, COM TRASPL CONS INT; Ortiz JA, 2005, AM J TRANSPLANT, V5, P1559, DOI 10.1111/j.1600-6143.2005.00824.x; Venettoni Sante, 2004, Ann Transplant, V9, P15	20	3	3	0	3	INDEX COPERNICUS INT	WARSAW	AL JEROZOLIMSKIE 146 C STR, WARSAW, 02-305, POLAND	1425-9524			ANN TRANSPL	Ann. Transpl.	JAN-MAR	2010	15	1					67	71					5	Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Surgery; Transplantation	585JQ	WOS:000276821900011	20305322				2022-02-06	
J	Benge, JF; Caroselli, JS; Reed, K; Zgaljardic, DJ				Benge, Jared F.; Caroselli, Jerome S.; Reed, Karen; Zgaljardic, Dennis J.			Changes in supervision needs following participation in a residential post-acute brain injury rehabilitation programme	BRAIN INJURY			English	Article						Supervision; post-acute rehabilitation; residential; outcomes	CLINICAL-SIGNIFICANCE; CARE; INDIVIDUALS; BURDEN; 1-YEAR; SCALE	Objective: Supervision needs typically increase following moderate-to-severe traumatic brain injury (TBI). Research assessing the impact of TBI residential rehabilitation programmes on supervision needs is limited. Research design: Prospective cross-sectional study. Methods and procedures: Ninety-four participants with moderate-to-severe TBI admitted to a post-acute brain injury rehabilitation programme (PABIR) were administered the supervision rating scale (SRS) at admission and at 1 month post-discharge. To account for spontaneous neurological recovery, patients were separated into those who were less than 1 year (L1Y, n=55) or greater than 1 year (G1Y, n=39) post-injury. Experimental intervention: None. Main outcomes and results: A mixed factorial design yielded a significant interaction (F(1, 92) = 18.2; p < 0.0001) with post-hoc results revealing that the L1Y group improved more dramatically in terms of supervision needs than the G1Y group. Using reliable change methodologies, 52.7% of the L1Y demonstrated decreasing scores on the SRS vs 20.5% of the G1Y group. Conclusions: Decreases in supervision needs following PABIR can be found, even after accounting for the impact of spontaneous neurological recovery both at the group and individual level.	[Benge, Jared F.] Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [Benge, Jared F.] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Caroselli, Jerome S.] TIRR Mem Hermann Hosp, Houston, TX USA; [Reed, Karen; Zgaljardic, Dennis J.] Transit Learning Ctr, Galveston, TX USA; [Zgaljardic, Dennis J.] Univ Texas Med Branch, Galveston, TX USA		Benge, JF (corresponding author), Michael E DeBakey VA Med Ctr, 2002 Holcombe Blvd, Houston, TX 77030 USA.	jared.benge@va.gov		Benge, Jared/0000-0001-6201-3278			Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hart T, 2003, ARCH PHYS MED REHAB, V84, P221, DOI 10.1053/apmr.2003.50023; Hermann BP, 1996, EPILEPSIA, V37, P942, DOI 10.1111/j.1528-1157.1996.tb00531.x; High WM, 2006, ARCH PHYS MED REHAB, V87, P334, DOI 10.1016/j.apmr.2005.11.028; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199502000-00004; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JACOBSON NS, 1984, BEHAV THER, V15, P336, DOI 10.1016/S0005-7894(84)80002-7; Jennett B, 1981, MANAGEMENT HEAD INJU; JOHNSTON M V, 1991, Brain Injury, V5, P141, DOI 10.3109/02699059109008085; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Mills VM, 2006, BRAIN INJURY, V20, P1183, DOI 10.1080/02699050600983172; Sawrie S M, 1996, J Int Neuropsychol Soc, V2, P556; Seale GS, 2002, BRAIN INJURY, V16, P955, DOI 10.1080/02699050210155258; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540	22	3	3	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	6					844	850		10.3109/02699051003724960			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	620MT	WOS:000279504700006	20377342				2022-02-06	
J	Davies, SC; Jones, KM; Rafoth, MA				Davies, Susan C.; Jones, Kevin M.; Rafoth, Mary A.			Effects of a Self-Monitoring Intervention on Children With Traumatic Brain Injury	JOURNAL OF APPLIED SCHOOL PSYCHOLOGY			English	Article						self-monitoring; traumatic brain injury; behavior rating	EXECUTIVE FUNCTION; CLASSROOM-BEHAVIOR; ON-TASK; STUDENTS; MANAGEMENT; ADOLESCENTS; ATTENTION; ACCURACY; BOYS; TBI	The purpose of this study was to examine the effects of a self-monitoring intervention on teachers' direct behavior ratings of 3 students with traumatic brain injury. The authors used a multiple-baseline-across-participants design to evaluate the effect of the strategy on each child's classwork and classroom behavior. The self-monitoring strategy included 3 components: self-ratings, matching self-ratings and teacher ratings, and teacher feedback. Results indicated that the strategy improved performance for all three children, as well as self-monitoring accuracy. The authors discuss the implications for future research, including the need for a component analysis of self-monitoring treatments.	[Davies, Susan C.] Univ Dayton, Dayton, OH 45469 USA; [Jones, Kevin M.] Louisiana State Univ, Shreveport, LA 71105 USA; [Rafoth, Mary A.] Indiana Univ Penn, Indiana, PA USA		Davies, SC (corresponding author), Univ Dayton, Dept Counselor Educ & Human Serv, 300 Coll Pk, Dayton, OH 45469 USA.	sdavies1@notes.udayton.edu		Davies, Susan/0000-0003-4027-2310	Indiana University of Pennsylvania, School of Graduate Studies and Research; Miami University, School of Education and Allied Professions	This work was supported in part by a Graduate Student Research Grant from Indiana University of Pennsylvania, School of Graduate Studies and Research and a Small Research Grant from Miami University, School of Education and Allied Professions.	Barkley R, 1989, TREATMENT CHILDHOOD, P39; Barry LM, 2003, J POSIT BEHAV INTERV, V5, P238, DOI 10.1177/10983007030050040701; BERG RA, 1986, CHILD NEUROPSYCHOL, V2, P113; Cancio EJ, 2004, J EMOT BEHAV DISORD, V12, P9, DOI 10.1177/10634266040120010201; Chafouleas SM, 2006, J POSIT BEHAV INTERV, V8, P174, DOI 10.1177/10983007060080030601; Chafouleas SM, 2005, PSYCHOL SCHOOLS, V42, P669, DOI 10.1002/pits.20102; Cheney D, 2008, J SPEC EDUC, V42, P108, DOI 10.1177/0022466907313349; Dykeman B, 2003, J INSTRUCTIONAL PSYC, P225; EWINGCOBBS L, 1998, TRAUMATIC BRAIN INJU, P11; Freeman KA, 2004, BEHAV MODIF, V28, P402, DOI 10.1177/0145445503258982; Glang A, 2004, NEUROREHABILITATION, V19, P219; Gurdin LS, 2005, BEHAV INTERVENT, V20, P3, DOI 10.1002/bin.172; HALLAHAN DP, 1983, J LEARN DISABIL, V16, P616, DOI 10.1177/002221948301601011; Hayes S. C., 1992, METHODOLOGICAL ISSUE, P491; HINSHAW SP, 1984, J CONSULT CLIN PSYCH, V52, P739, DOI 10.1037/0022-006X.52.5.739; Hoff KE, 1998, SCHOOL PSYCHOL REV, V27, P290; Hughes C., 2004, ADV LEARNING BEHAV D, P1; Individuals With Disabilities Education Act Data, 2006, DAT TABL OSEP STAT B; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Luria A.R., 1966, HIGHER CORTICAL FUNC; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Ornstein TJ, 2009, J CHILD PSYCHOL PSYC, V50, P506, DOI 10.1111/j.1469-7610.2008.01997.x; PETERSON L, 2006, ED TREATMENT CHILDRE, V0029, P00001; RHODE G, 1983, J APPL BEHAV ANAL, V16, P171, DOI 10.1901/jaba.1983.16-171; Riley-Tillman TC, 2008, J POSIT BEHAV INTERV, V10, P136, DOI 10.1177/1098300707312542; Selznick L, 2000, BEHAV INTERVENT, V15, P243, DOI 10.1002/1099-078X(200007/09)15:3<243::AID-BIN59>3.3.CO;2-T; SEMRUDCLIKEMAN M, 2001, TRAUMATIC BRAIN INJU; Shapiro E. S., 1994, BEHAV CHANGE CLASSRO; Shapiro ES, 1998, J LEARN DISABIL, V31, P545, DOI 10.1177/002221949803100604; SMITH DJ, 1992, SCHOOL PSYCHOL REV, V21, P59; Steege MW, 2001, SCHOOL PSYCHOL REV, V30, P252; Tamm Leanne, 2007, J Atten Disord, V10, P372, DOI 10.1177/1087054706289946; Teeter P.A., 1997, CHILD NEUROPSYCHOLOG; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; Yeates KO., 2006, EXCEPTIONALITY, V14, P141, DOI DOI 10.1207/S15327035EX1403_; Ylvisaker M, 2000, TOP LANG DISORD, V20, P29, DOI 10.1097/00011363-200020020-00005; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU, P125	41	3	3	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1537-7903	1537-7911		J APPL SCH PSYCHOL	J. Appl. Sch. Psychol.		2010	26	4					308	326		10.1080/15377903.2010.518587			19	Psychology, Educational	Emerging Sources Citation Index (ESCI)	Psychology	V81AT	WOS:000212223800003					2022-02-06	
J	Martinez, MD; Rocha, J; Clavel-Arcas, C; Mack, KA				de Lourdes Martinez T, Maria; Rocha C, Julio; Clavel-Arcas, Carme; Mack, Karin A.			Nonfatal unintentional injuries in children aged < 15 years in Nicaragua	INTERNATIONAL JOURNAL OF INJURY CONTROL AND SAFETY PROMOTION			English	Article						unintentional injuries; children; falls; burns; poisonings; injury surveillance	TRAUMATIC BRAIN-INJURY; CHILDHOOD INJURIES; UNITED-STATES; EMERGENCY; MORBIDITY; SURVEILLANCE; POISONINGS; INFANTS; PATTERN; BURNS	The objective of this study was to describe the nonfatal unintentional injuries among children aged 515 years treated in four emergency departments (EDs) in Nicaragua. The 2004 Injury Surveillance System included all cases of injuries that attended the four hospital EDs (n = 37,577). We analysed the records of 13,426 children aged 515 years who sustained nonfatal unintentional injuries. The leading causes of injuries were falls (50.5%), blunt force trauma (13.2%) and transport-related incidents (11.5%). Transport-related injuries primarily involved cyclists (42.3%) and motor-vehicle passengers (32.5%). Ten per cent of the injured children were hospitalised. This is the first study to present the epidemiology of nonfatal unintentional injuries among children treated in EDs in Nicaragua. Unintentional injuries are an important cause of morbidity, but the burden remains largely unaddressed. The implementation of the already well-established transportation-related prevention strategies should be a priority. Prevention of falls (falls being the leading cause of injury among children) demands further study.	[Clavel-Arcas, Carme; Mack, Karin A.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA; [de Lourdes Martinez T, Maria] UNAN Leon, Fac Ciencias Med, Leon, Nicaragua; [Rocha C, Julio] HEODRA, Leon, Nicaragua; [Clavel-Arcas, Carme] Ctr Dis Control & Prevent, Pan Amer Hlth Org, Atlanta, GA USA		Mack, KA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA.	kmack@cdc.gov	MACK, KARIN/P-9227-2019; Mack, Karin A/A-3263-2012; Solebo, Colette N/B-6615-2008	Mack, Karin A/0000-0001-9274-3001; Solebo, Colette N/0000-0001-9764-2541			Al Hazmi AM, 1998, ANN SAUDI MED, V18, P457, DOI 10.5144/0256-4947.1998.457; Andiran N, 2004, TURKISH J PEDIATR, V46, P147; Ashman TA, 2006, MT SINAI J MED, V73, P999; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; BANCO L, 1994, PEDIATR EMERG CARE, V10, P98, DOI 10.1097/00006565-199404000-00010; Bener A, 1998, EUR J EPIDEMIOL, V14, P175, DOI 10.1023/A:1007444109260; Deen JL, 1999, B WORLD HEALTH ORGAN, V77, P518; Espitia-Hardeman Victoria, 2007, Int J Inj Contr Saf Promot, V14, P69; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Kivisto JE, 2008, ACTA PAEDIATR, V97, P790, DOI 10.1111/j.1651-2227.2008.00771.x; Kobusingye, 2001, INJURY SURVEILLANCE; Krug, 2002, INJURY LEADING CAUSE; Langley John D., 1992, Morbidity and Mortality Weekly Report, V41, P181; Lee S T, 1982, Ann Acad Med Singap, V11, P358; Mack KA, 2008, PEDIATRICS, V121, P930, DOI 10.1542/peds.2007-1731; *MIN SAL, 2004, PLAN NAC SAL 2004 20; *MIN SAL, MIN SAL SIST NAC EST; Mintegi S, 2006, PEDIATR EMERG CARE, V22, P334, DOI 10.1097/01.pec.0000215651.50008.1b; Morrison A, 1999, ARCH DIS CHILD, V80, P533, DOI 10.1136/adc.80.6.533; Morrongiello BA, 1998, J APPL DEV PSYCHOL, V19, P625, DOI 10.1016/S0193-3973(99)80059-8; ONUBA O, 1988, TROP DOCT, V18, P106, DOI 10.1177/004947558801800306; *PAHO, 2007, NIC HLTH AM 2007, V2; Peden M, 2008, WORLD REPORT CHILD I; PEDEN M, 2002, INJURY CHARTBOOK GRA; Petridou E, 2005, EUR J PUBLIC HEALTH, V15, P9, DOI 10.1093/eurpub/cki103; Poulos R, 2007, INJURY PREV, V13, P322, DOI 10.1136/ip.2007.015693; Quayle K S, 2000, Inj Prev, V6, P255, DOI 10.1136/ip.6.4.255; Razzak JA, 2004, PUBLIC HEALTH, V118, P114, DOI 10.1016/S0033-3506(03)00147-1; Runyan CW, 2005, AM J PREV MED, V28, P80, DOI 10.1016/j.amepre.2004.09.017; Shrestha S R, 2006, JNMA J Nepal Med Assoc, V45, P300; Sklaver BA, 2008, REV PANAM SALUD PUBL, V24, P379; Snodgrass A. M., 2006, SMJ Singapore Medical Journal, V47, P376; Spinks A, 2008, J BURN CARE RES, V29, P482, DOI 10.1097/BCR.0b013e3181776ed9; Stokes Mark, 2005, Int J Inj Contr Saf Promot, V12, P1, DOI 10.1080/17457300512331342180; Sukhai A., 2002, THESIS KAROLINSKA I; TERCERO F, 1999, INT J CONSUMER PRODU, V6, P33; WHO, COUNTR PROF	37	3	3	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1745-7300	1745-7319		INT J INJ CONTROL SA	Int. J. Inj. Control Saf. Promot.		2010	17	1					3	11		10.1080/17457300903525117			9	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	618ZF	WOS:000279394900002	20182936				2022-02-06	
J	Doncevic, S; Boerman, HL				Doncevic, Selina; Boerman, Heidi L.			Continuum of care: Military health care providers and the traumatic brain injured service members	NEUROREHABILITATION			English	Article							POSTTRAUMATIC-STRESS-DISORDER; IRAQ; METAANALYSIS; AFGHANISTAN; DEPLOYMENT; PERSONNEL; ADULTS; RISK; WAR	This article will address and describe the military continuum of care and its implications for the health care providers intimately involved in the treatment of service members who sustain traumatic brain injuries (TBI). Clinical Practice Guidelines have been created and distributed for treatment of TBI sustained by service members in both the deployed setting and in the continental United States (CONUS). The military has established specific levels of care each with specific purpose in the treatment continuum that extends from the battlefield to the most advanced military treatment facility (MTF). The health care providers who care for this particular patient population can also face unique opportunities, challenges and rewards.	[Doncevic, Selina; Boerman, Heidi L.] Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC 20012 USA		Doncevic, S (corresponding author), Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, POB 59181, Washington, DC 20012 USA.	selina.doncevic@us.army.mil					Aiken Loretta J, 2008, Crit Care Nurs Clin North Am, V20, P31, DOI 10.1016/j.ccell.2007.10.002; BARNSTEINER JH, 1990, AM J MATERNAL CHILD, V15, P223; Beekley AC, 2007, SURG CLIN N AM, V87, P157, DOI 10.1016/j.suc.2006.09.008; *BORD I, 2004, EM WAR SURG; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Covey CDC, 2009, J BONE JOINT SURG AM, V91A, P998, DOI 10.2106/JBJS.G.01287; Dominguez-Gomez E, 2009, J EMERG NURS, V35, P199, DOI 10.1016/j.jen.2008.05.003; Gerhardt RT, 2008, PREHOSP EMERG CARE, V12, P359, DOI 10.1080/10903120802101058; Gerhardt RT, 2009, ANN EMERG MED, V53, P169, DOI 10.1016/j.annemergmed.2008.04.013; Grieger TA, 2007, MIL MED, V172, P451, DOI 10.7205/MILMED.172.5.451; HAVIN L, 2009, COMMUNICATION   0814; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; Jones M, 2008, EUR J PUBLIC HEALTH, V18, P422, DOI 10.1093/eurpub/ckn031; Kenny Deborah J, 2008, Crit Care Nurs Clin North Am, V20, P41, DOI 10.1016/j.ccell.2007.10.013; KRAUSE C, ALABAMA NURSE, V32, P18; Maguen S, 2008, MIL MED, V173, P1; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Stewart Della W, 2009, Medsurg Nurs, V18, P91; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	20	3	3	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2010	26	3					285	290		10.3233/NRE-2010-0564			6	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	603OQ	WOS:000278218300012	20448318				2022-02-06	
J	Habalova, J; Kanta, M; Ehler, E; Nahlovsky, J; Bartos, M				Habalova, J.; Kanta, M.; Ehler, E.; Nahlovsky, J.; Bartos, M.			The Use of Regional Cerebral Oximetry as a Non-invasive Method to Monitor Neurointensive Care Patients	CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE			Czech	Article						traumatic brain injury; near-infrared spectroscopy; regional cerebral oximetry; intracranial pressure; vasospasms; cerebral ischemia	NEAR-INFRARED SPECTROSCOPY; OXYGEN-SATURATION; BRAIN; PERFUSION; ISCHEMIA; HEMORRHAGE; INJURY; ACUPUNCTURE; SURGERY; ARTERY	This study summarises the theoretical and practical aspects of non-invasive continuous measurement of regional cerebral oxygenation using near-infrared spectroscopy (NIRS) in neurosurgical patients. The authors describe their own practical experience of monitoring patients with brain damage and also present illustrative case studies (a patient with severe cerebral contusions, a patient with subarachnoid haemorrhage and vasospasms arising out of aneurysm rupture, and a patient with spontaneous hypertonic intracerebral bleeding). A common aim in the treatment of neuro-intensive patients is to maintain adequate cerebral oxygenation. Regional cerebral oximetry appears to be a promising non-invasive method continuously to monitor the extent of cerebral damage in a neuro-intensive care environment. The technique may prove to be a viable tool for fast and accurate diagnostics as well as reflecting the effect of treatment not only in neuro-intensive care but in other clinical applications.	[Habalova, J.; Kanta, M.; Nahlovsky, J.; Bartos, M.] LF UK, Neurochirurg Klin, Hradec Kralove 50005, Czech Republic; [Habalova, J.; Kanta, M.; Nahlovsky, J.; Bartos, M.] FN Hradec Kralove, Hradec Kralove 50005, Czech Republic; [Ehler, E.] Pardubicka Krajska Nemocnice, Neurol Klin, Pardubice, Czech Republic		Habalova, J (corresponding author), LF UK, Neurochirurg Klin, Sokolska 581, Hradec Kralove 50005, Czech Republic.	j.habalova@seznam.cz		Ehler, Edvard/0000-0002-0595-7712; Kanta, Martin/0000-0001-6745-8428; Ehler, Edvard/0000-0001-6212-6301			Al-Rawi PG, 2001, STROKE, V32, P2492, DOI 10.1161/hs1101.098356; Al-Rawi PG, 2006, STROKE, V37, P2720, DOI 10.1161/01.STR.0000244807.99073.ae; Alessandri B, 1999, ACT NEUR S, V75, P21; Bhambhani Y, 2006, J REHABIL RES DEV, V43, P845, DOI 10.1682/JRRD.2005.09.0151; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; de Vries JW, 2000, PEDIATR CARDIOL, V21, P461, DOI 10.1007/s002460010110; Edmonds HL, 1996, J CARDIOTHOR VASC AN, V10, P15, DOI 10.1016/S1053-0770(96)80174-1; Fearn SJ, 2001, J THORAC CARDIOV SUR, V121, P1150, DOI 10.1067/mtc.2001.114099; Fearn SJ, 2000, J VASC SURG, V31, P989, DOI 10.1067/mva.2000.104598; GERMON TJ, 1994, BRIT J ANAESTH, V73, P503, DOI 10.1093/bja/73.4.503; GERMON TJ, 1995, J NEUROL NEUROSUR PS, V58, P477, DOI 10.1136/jnnp.58.4.477; HABALOVA J, 2006, ROCENKA INTENZIVNI M, P128; HABALOVA J, 2005, NEUROL PRO PRAXI SA, P13; HABALOVA J, 2006, NEUROCHIRURGIE, P25; Hejcl A, 2009, CESK SLOV NEUROL N, V72, P383; HERNANDEZAVILA G, 1995, AM J NEURORADIOL, V16, P1618; Irani F, 2007, CLIN NEUROPSYCHOL, V21, P9, DOI 10.1080/13854040600910018; Kaminogo M, 1999, STROKE, V30, P407, DOI 10.1161/01.STR.30.2.407; KAMINOGO M, 1995, STROKE, V26, P2358, DOI 10.1161/01.STR.26.12.2358; Kampfl A, 1997, ACT NEUR S, V70, P112; Kazui S, 1996, STROKE, V27, P1783, DOI 10.1161/01.STR.27.10.1783; Krakow K, 2000, EUR NEUROL, V43, P39, DOI 10.1159/000008127; Kussman BD, 2007, J THORAC CARDIOV SUR, V133, P648, DOI 10.1016/j.jtcvs.2006.09.034; Litscher G, 1997, BIOMED TECH, V42, P74, DOI 10.1515/bmte.1997.42.4.74; Litscher G, 1998, NEUROL RES, V20, pS28; Martens P, 1998, STROKE, V29, P2363, DOI 10.1161/01.STR.29.11.2363; MCCORMICK PW, 1992, J NEUROSURG, V76, P315, DOI 10.3171/jns.1992.76.2.0315; McLeod AD, 2003, ANESTH ANALG, V97, P851, DOI 10.1213/01.ANE.0000072541.57132.BA; Moritz S, 2007, ANESTHESIOLOGY, V107, P563, DOI 10.1097/01.anes.0000281894.69422.ff; Ogasawara K, 2003, NEUROSURGERY, V53, P309, DOI 10.1227/01.NEU.0000073547.86747.F3; Ogasawara K, 2006, SURG NEUROL, V65, P577, DOI 10.1016/j.surneu.2005.07.011; Ohmae E, 2006, NEUROIMAGE, V29, P697, DOI 10.1016/j.neuroimage.2005.08.008; Otevrel F, 2007, CESK SLOV NEUROL N, V70, P168; Paolin A, 2002, NEUROSURGERY, V51, P949, DOI 10.1227/01.NEU.0000027881.33381.3F; Rasmussen P, 2007, J CEREBR BLOOD F MET, V27, P1082, DOI 10.1038/sj.jcbfm.9600416; Razumovsky Alexander Y, 2006, Curr Cardiol Rep, V8, P17, DOI 10.1007/s11886-006-0005-2; Roberts JS, 2006, CRIT CARE MED, V34, P2217, DOI 10.1097/01.CCM.0000227182.51591.21; Schwarz G, 2004, NEUROL RES, V26, P698, DOI 10.1179/016164104225015912; Schwarz G, 1996, J NEUROSURG ANESTH, V8, P189, DOI 10.1097/00008506-199607000-00001; Smrcka M, 2009, CESK SLOV NEUROL N, V72, P245; Ungerstedt U, 2004, CURR PHARM DESIGN, V10, P2145, DOI 10.2174/1381612043384105; Vespa Paul, 2003, Neurosurg Focus, V15, pE4; Vets Ph, 2004, Acta Anaesthesiol Belg, V55, P215; VILLRINGER A, 1993, NEUROSCI LETT, V154, P101, DOI 10.1016/0304-3940(93)90181-J; Yu QJ, 2001, CHINESE MED J-PEKING, V114, P257; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003	46	3	3	1	2	CZECH MEDICAL SOC	PRAGUE 2	SOKOLSKA 31, PRAGUE 2 120 26, CZECH REPUBLIC	1210-7859	1802-4041		CESK SLOV NEUROL N	Cesk. Slov. Neurol. Neurochir.		2010	73	3					285	293					9	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	629UA	WOS:000280224000014					2022-02-06	
B	Lau, A; Tymianski, M		McQueen, CA		Lau, A.; Tymianski, M.			Excitotoxicity	COMPREHENSIVE TOXICOLOGY, VOL 13: NERVOUS SYSTEM AND BEHAVIORAL TOXICOLOGY, 2ND EDITION			English	Article; Book Chapter							FOCAL CEREBRAL-ISCHEMIA; METHYL-D-ASPARTATE; NITRIC-OXIDE SYNTHASE; APOPTOSIS-INDUCING FACTOR; TRAUMATIC BRAIN-INJURY; AMYOTROPHIC-LATERAL-SCLEROSIS; METABOTROPIC GLUTAMATE RECEPTORS; TERT-BUTYL-NITRONE; CULTURED CORTICAL-NEURONS; 3-NITROPROPIONIC ACID NEUROTOXICITY		[Lau, A.; Tymianski, M.] Toronto Western Res Inst, Toronto, ON, Canada		Lau, A (corresponding author), Toronto Western Res Inst, Toronto, ON, Canada.						Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; ABELE AE, 1990, NEUROSCI LETT, V115, P195, DOI 10.1016/0304-3940(90)90454-H; ALBERS GW, 1995, STROKE, V26, P254, DOI 10.1161/01.STR.26.2.254; ALBIN RL, 1992, NEUROLOGY, V42, P733, DOI 10.1212/WNL.42.4.733; ALBIN RL, 1990, ENGL J MED, V322, P1293; Alexi T, 1998, EXP NEUROL, V153, P74, DOI 10.1006/exnr.1998.6842; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Bath PM, 2001, COCHRANE DB SYST REV; BEAL MF, 1991, J NEUROSCI, V11, P1649; BEAL MF, 1993, J NEUROCHEM, V61, P1147, DOI 10.1111/j.1471-4159.1993.tb03633.x; BEAL MF, 1992, ANN NEUROL, V31, P119, DOI 10.1002/ana.410310202; BEAL MF, 1994, ANN NEUROL, V36, P882, DOI 10.1002/ana.410360613; BEAL MF, 1995, J NEUROCHEM, V65, P919; BEAL MF, 1992, FASEB J, V6, P3338, DOI 10.1096/fasebj.6.15.1464368; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; Beal MF, 1998, BBA-BIOENERGETICS, V1366, P211, DOI 10.1124/jpet.112.192138; BEAL MF, 1989, SYNAPSE, V3, P38, DOI 10.1002/syn.890030106; BEAL MF, 1993, J NEUROSCI, V13, P4181; BEAL MF, 1991, J NEUROCHEM, V57, P1068, DOI 10.1111/j.1471-4159.1991.tb08258.x; BEHRENS MI, 1995, NEUROREPORT, V6, P545, DOI 10.1097/00001756-199502000-00034; BENVENISTE H, 1989, J CEREBR BLOOD F MET, V9, P629, DOI 10.1038/jcbfm.1989.90; Besancon E, 2008, TRENDS PHARMACOL SCI, V29, P268, DOI 10.1016/j.tips.2008.02.003; Bizat N, 2003, J BIOL CHEM, V278, P43245, DOI 10.1074/jbc.M305057200; BOIREAU A, 1994, NEUROREPORT, V5, P2657, DOI 10.1097/00001756-199412000-00063; BONDY SC, 1993, BRAIN RES, V610, P229, DOI 10.1016/0006-8993(93)91405-H; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; BRIDGES RJ, 1991, EUR J PHARMACOL, V192, P199, DOI 10.1016/0014-2999(91)90093-6; BRORSON JR, 1995, STROKE, V26, P1259, DOI 10.1161/01.STR.26.7.1259; BROUILLET E, 1994, NEUROSCI LETT, V177, P58, DOI 10.1016/0304-3940(94)90044-2; BROUILLET E, 1995, P NATL ACAD SCI USA, V92, P7105, DOI 10.1073/pnas.92.15.7105; BROWNE SE, 1994, BRAIN RES, V641, P10, DOI 10.1016/0006-8993(94)91809-0; BRUNO V, 1995, NEUROPHARMACOLOGY, V34, P1089, DOI 10.1016/0028-3908(95)00077-J; BRUNO V, 1995, EUR J NEUROSCI, V7, P1906, DOI 10.1111/j.1460-9568.1995.tb00712.x; BUCHAN AM, 1994, NEUROSCIENCE, V61, P1, DOI 10.1016/0306-4522(94)90054-X; BUCHAN AM, 1991, NEUROREPORT, V2, P473, DOI 10.1097/00001756-199108000-00016; BUISSON A, 1992, BRIT J PHARMACOL, V106, P766, DOI 10.1111/j.1476-5381.1992.tb14410.x; BULLOCK R, 1990, STROKE, V21, P32; Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; CAO XH, 1994, BRAIN RES, V644, P267, DOI 10.1016/0006-8993(94)91689-6; CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633; CARREAU A, 1994, EUR J PHARMACOL, V256, P241, DOI 10.1016/0014-2999(94)90549-5; Chan P, 1997, J PHARMACOL EXP THER, V280, P439; Chan PH, 1998, J NEUROSCI, V18, P8292, DOI 10.1523/jneurosci.18-20-08292.1998; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; CHERAMY A, 1992, NEUROSCI LETT, V147, P209, DOI 10.1016/0304-3940(92)90597-Z; Chinopoulos C, 2004, J NEUROCHEM, V91, P471, DOI 10.1111/j.1471-4159.2004.02732.x; CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; CHOI DW, 1988, J NEUROSCI, V8, P185; CHOW HS, 1994, BRAIN RES, V639, P102, DOI 10.1016/0006-8993(94)91769-8; Christensen T., 1989, J CEREB BLOOD FLOW M, V9, P629; CLOUGHHELFMAN C, 1991, FREE RADICAL RES COM, V15, P177, DOI 10.3109/10715769109049138; COPANI A, 1991, NEUROREPORT, V2, P763, DOI 10.1097/00001756-199112000-00008; COYLE JT, 1976, NATURE, V263, P244, DOI 10.1038/263244a0; Czyz A, 2002, J NEUROCHEM, V81, P379, DOI 10.1046/j.1471-4159.2002.00851.x; DAWSON VL, 1993, J NEUROSCI, V13, P2651; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Dawson VL, 1996, J NEUROSCI, V16, P2479; de Pina-Benabou MH, 2005, STROKE, V36, P2232, DOI 10.1161/01.STR.0000182239.75969.d8; DIFAZIO MC, 1992, NEUROLOGY, V42, P402, DOI 10.1212/WNL.42.2.402; Du YS, 1997, P NATL ACAD SCI USA, V94, P11657, DOI 10.1073/pnas.94.21.11657; DUGAN LL, 1995, J NEUROSCI, V15, P6377; DURE LS, 1991, ANN NEUROL, V30, P785, DOI 10.1002/ana.410300607; DYKENS JA, 1987, J NEUROCHEM, V49, P1222, DOI 10.1111/j.1471-4159.1987.tb10014.x; DYKENS JA, 1994, J NEUROCHEM, V63, P584; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; EIMERL S, 1994, J NEUROCHEM, V62, P1223; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Escott KJ, 1998, J CEREBR BLOOD F MET, V18, P281, DOI 10.1097/00004647-199803000-00006; Faddis BT, 1997, J NEUROSCI, V17, P951; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Farahani R, 2005, GLIA, V50, P351, DOI 10.1002/glia.20213; FAVIT A, 1992, J CEREBR BLOOD F MET, V12, P638, DOI 10.1038/jcbfm.1992.88; FERRANTE RJ, 1993, EXP NEUROL, V119, P46, DOI 10.1006/exnr.1993.1006; Fink SL, 1996, EXP NEUROL, V138, P298, DOI 10.1006/exnr.1996.0068; Frantseva MV, 2002, J CEREBR BLOOD F MET, V22, P453, DOI 10.1097/00004647-200204000-00009; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; GASPARY HL, 1994, EUR J PHARMACOL, V262, P197, DOI 10.1016/0014-2999(94)90733-1; GILL R, 1995, J CEREBR BLOOD F MET, V15, P197, DOI 10.1038/jcbfm.1995.25; GILL R, 1991, BRIT J PHARMACOL, V103, P2030, DOI 10.1111/j.1476-5381.1991.tb12371.x; GOLDING EM, 1995, MOL CHEM NEUROPATHOL, V24, P137, DOI 10.1007/BF02962139; GOTTI B, 1988, J PHARMACOL EXP THER, V247, P1211; Graham SH, 1996, J PHARMACOL EXP THER, V276, P1; GRAHAM SH, 1993, J CEREBR BLOOD F MET, V13, P88, DOI 10.1038/jcbfm.1993.11; Grant ER, 1997, J BIOL CHEM, V272, P647; GREENAMYRE JT, 1987, J NEUROCHEM, V48, P543, DOI 10.1111/j.1471-4159.1987.tb04127.x; GREENAMYRE JT, 1985, SCIENCE, V227, P1496, DOI 10.1126/science.2858129; GREENAMYRE JT, 1994, ANN NEUROL, V35, P655, DOI 10.1002/ana.410350605; GREENAMYRE JT, 1994, NEUROSCI LETT, V171, P17, DOI 10.1016/0304-3940(94)90593-2; GREENE JG, 1995, J NEUROCHEM, V64, P2332; GREENE JG, 1993, J NEUROCHEM, V61, P1151, DOI 10.1111/j.1471-4159.1993.tb03634.x; GROTTA J, 1995, STROKE, V26, P602, DOI 10.1161/01.STR.26.4.602; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HALL ED, 1990, STROKE, V21, P83; HAMADA J, 1995, J CEREBR BLOOD F MET, V15, P779, DOI 10.1038/jcbfm.1995.98; HAMADA Y, 1994, PEDIATR RES, V35, P10, DOI 10.1203/00006450-199401000-00003; HAMILTON BF, 1987, ACTA NEUROPATHOL, V74, P67, DOI 10.1007/BF00688340; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; HARTLEY DM, 1993, J NEUROSCI, V13, P1993; HENSHAW R, 1994, BRAIN RES, V647, P161, DOI 10.1016/0006-8993(94)91412-5; HEYES MP, 1991, NEUROSCI LETT, V122, P265, DOI 10.1016/0304-3940(91)90874-S; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; Ikonomidou C, 2000, P NATL ACAD SCI USA, V97, P12885, DOI 10.1073/pnas.220412197; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Jenkins BG, 1996, J CEREBR BLOOD F MET, V16, P450, DOI 10.1097/00004647-199605000-00011; Jia YC, 2007, NAT NEUROSCI, V10, P559, DOI 10.1038/nn1870; JONESHUMBLE SA, 1994, LIFE SCI, V54, P245, DOI 10.1016/0024-3205(94)00813-2; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Kaneko S, 2006, J PHARMACOL SCI, V101, P66, DOI 10.1254/jphs.FP0060128; KANO M, 1987, NATURE, V325, P276, DOI 10.1038/325276a0; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Keller JN, 1998, J NEUROSCI, V18, P687; Kiedrowski L, 2004, J NEUROCHEM, V90, P117, DOI 10.1111/j.1471-4159.2004.02462.x; Kingston AE, 1999, ANN NY ACAD SCI, V890, P438, DOI 10.1111/j.1749-6632.1999.tb08022.x; KLOCKGETHER T, 1991, ANN NEUROL, V30, P717, DOI 10.1002/ana.410300513; KOH JY, 1990, BRAIN RES, V533, P315, DOI 10.1016/0006-8993(90)91355-K; Koura SS, 1998, ACT NEUR S, V71, P244; KOWALL NW, 1991, ANN NEUROL, V29, P162, DOI 10.1002/ana.410290208; KUMAR KN, 1991, NATURE, V354, P70, DOI 10.1038/354070a0; Kuroda S, 1999, J CEREBR BLOOD F MET, V19, P778, DOI 10.1097/00004647-199907000-00008; Kuroda S, 1996, NEUROBIOL DIS, V3, P149, DOI 10.1006/nbdi.1996.0015; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; Lagrue E, 2007, PEDIATR RES, V62, P14, DOI 10.1203/PDR.0b013e31806790d7; Laine R, 1998, MOL PHARMACOL, V54, P305, DOI 10.1124/mol.54.2.305; LANGE KW, 1993, N-S ARCH PHARMACOL, V348, P586, DOI 10.1007/BF00167234; Lankiewicz S, 2000, J BIOL CHEM, V275, P17064, DOI 10.1074/jbc.275.22.17064; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; LEES GJ, 1995, NEUROSCI LETT, V188, P113, DOI 10.1016/0304-3940(95)11413-Q; Lees KR, 2006, NEW ENGL J MED, V354, P588, DOI 10.1056/NEJMoa052980; Lewen A., 2009, J NEUROTRAUM, V26, P469; Li JR, 1997, BIOCHEM BIOPH RES CO, V240, P419, DOI 10.1006/bbrc.1997.7672; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; LUCAS DR, 1957, ARCH OPHTHALMOL-CHIC, V58, P193; LUDOLPH AC, 1991, CAN J NEUROL SCI, V18, P492, DOI 10.1017/S0317167100032212; LUDOLPH AC, 1992, ANN NY ACAD SCI, V648, P300, DOI 10.1111/j.1749-6632.1992.tb24562.x; Majewska M D, 1990, Neuroreport, V1, P194, DOI 10.1097/00001756-199011000-00004; MALESSA S, 1991, J NEUROL NEUROSUR PS, V54, P984, DOI 10.1136/jnnp.54.11.984; MALGOURIS C, 1989, J NEUROSCI, V9, P3720; MASSIEU L, 1995, J NEUROCHEM, V64, P2262; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; Matsuda T, 2001, J PHARMACOL EXP THER, V298, P249; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; MCDONALD JW, 1993, BRAIN RES, V624, P239, DOI 10.1016/0006-8993(93)90083-Y; MCGEER EG, 1990, NEUROSCI LETT, V112, P348, DOI 10.1016/0304-3940(90)90229-3; MCGEER EG, 1976, NATURE, V263, P517, DOI 10.1038/263517a0; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; Merino M, 1999, J NEUROCHEM, V73, P750, DOI 10.1046/j.1471-4159.1999.0730750.x; MICHETTI M, 1995, BIOCHEM BIOPH RES CO, V207, P1009, DOI 10.1006/bbrc.1995.1285; Miller RG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub2; Mohr S, 1997, BIOCHEM BIOPH RES CO, V238, P387, DOI 10.1006/bbrc.1997.7304; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; MONYER H, 1990, NEURON, V5, P121, DOI 10.1016/0896-6273(90)90302-V; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MOORE PK, 1993, BRIT J PHARMACOL, V110, P219, DOI 10.1111/j.1476-5381.1993.tb13795.x; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; MOUDY AM, 1995, P NATL ACAD SCI USA, V92, P729, DOI 10.1073/pnas.92.3.729; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; NISHIKAWA T, 1994, STROKE, V25, P877, DOI 10.1161/01.STR.25.4.877; NOVELLI A, 1988, BRAIN RES, V451, P205, DOI 10.1016/0006-8993(88)90765-2; NOWICKI JP, 1991, EUR J PHARMACOL, V204, P339, DOI 10.1016/0014-2999(91)90862-K; Oguro K, 2001, J NEUROSCI, V21, P7534, DOI 10.1523/JNEUROSCI.21-19-07534.2001; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; OZYURT E, 1988, J CEREBR BLOOD F MET, V8, P138, DOI 10.1038/jcbfm.1988.18; Palfi SP, 1996, J NEUROSCI, V16, P3019; PARK CK, 1994, BRAIN RES, V645, P157; PARK CK, 1989, J CEREBR BLOOD F MET, V9, P617, DOI 10.1038/jcbfm.1989.88; PATTEN BM, 1978, ANN NEUROL, V3, P305, DOI 10.1002/ana.410030405; PEARSON RCA, 1985, P NATL ACAD SCI USA, V82, P4531, DOI 10.1073/pnas.82.13.4531; PELLEGRINIGIAMPIETRO DE, 1994, J NEUROCHEM, V62, P1067; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Pignataro G, 2004, NEUROPHARMACOLOGY, V46, P439, DOI 10.1016/j.neuropharm.2003.09.015; Pignataro G, 2007, BRAIN, V130, P151, DOI 10.1093/brain/awl325; Pitsikas N, 2001, PHARMACOL BIOCHEM BE, V68, P443, DOI 10.1016/S0091-3057(00)00469-X; PLAITAKIS A, 1987, ANN NEUROL, V22, P575, DOI 10.1002/ana.410220503; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; PorteraCailliau C, 1997, J COMP NEUROL, V378, P88, DOI 10.1002/(SICI)1096-9861(19970203)378:1<88::AID-CNE5>3.0.CO;2-G; PULSINELLI W, 1993, PROG BRAIN RES, V96, P125; PUTTFARCKEN PS, 1992, NEUROPHARMACOLOGY, V31, P565, DOI 10.1016/0028-3908(92)90189-V; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; RADI R, 1991, J BIOL CHEM, V266, P4244; RANDALL RD, 1992, J NEUROSCI, V12, P1882; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; REYNOLDS IJ, 1995, J NEUROSCI, V15, P3318, DOI 10.1523/jneurosci.15-05-03318.1995; RIEPE M, 1992, BRAIN RES, V586, P61, DOI 10.1016/0006-8993(92)91371-K; ROGERS J, 1985, J NEUROSCI, V5, P2801; ROTHMAN S, 1984, J NEUROSCI, V4, P1884; ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591, DOI 10.1073/pnas.90.14.6591; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106; ROUSSEL S, 1992, HYPERTENSION, V19, P40, DOI 10.1161/01.HYP.19.1.40; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Sattler R, 1998, J NEUROCHEM, V71, P2349; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Schulz JB, 1996, NEUROSCIENCE, V71, P1043, DOI 10.1016/0306-4522(95)00527-7; SCHULZ JB, 1995, J CEREBR BLOOD F MET, V15, P948, DOI 10.1038/jcbfm.1995.120; SCHULZ JB, 1995, J NEUROCHEM, V64, P2239; SCHULZ JB, 1995, J NEUROCHEM, V64, P936, DOI 10.1046/j.1471-4159.1995.64020936.x; Schulz JB, 1995, J NEUROSCI, V15, P8419; SHAW PJ, 1994, BRAIN RES, V655, P195, DOI 10.1016/0006-8993(94)91614-4; SHAW PJ, 1994, BRAIN RES, V655, P186, DOI 10.1016/0006-8993(94)91613-6; SHEARDOWN MJ, 1993, EUR J PHARMACOL, V236, P347, DOI 10.1016/0014-2999(93)90470-3; Shuaib A, 2007, NEW ENGL J MED, V357, P562, DOI 10.1056/NEJMoa070240; SIMON R, 1990, ANN NEUROL, V27, P606, DOI 10.1002/ana.410270604; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Siniscalchi A, 1999, SYNAPSE, V32, P147, DOI 10.1002/(SICI)1098-2396(19990601)32:3<147::AID-SYN1>3.3.CO;2-G; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; SMITH SE, 1993, NEUROREPORT, V4, P1339, DOI 10.1097/00001756-199309150-00013; Snider BJ, 1999, ANN NY ACAD SCI, V893, P243, DOI 10.1111/j.1749-6632.1999.tb07829.x; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; SONSALLA PK, 1992, J NEUROCHEM, V58, P1979, DOI 10.1111/j.1471-4159.1992.tb10081.x; Sonsalla PK, 1998, AMINO ACIDS, V14, P69, DOI 10.1007/BF01345245; Spencer P. S., 1987, J NEUROL SCI, V14, P347; SPENCER PS, 1986, LANCET, V2, P1066, DOI 10.1016/S0140-6736(86)90468-X; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; STEINBERG GK, 1988, STROKE, V19, P1112, DOI 10.1161/01.STR.19.9.1112; SUN AY, 1992, MOL CHEM NEUROPATHOL, V17, P51, DOI 10.1007/BF03159981; Sun HS, 2008, STROKE, V39, P2544, DOI 10.1161/STROKEAHA.107.506048; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; TEITELBAUM JS, 1990, NEW ENGL J MED, V322, P1781, DOI 10.1056/NEJM199006213222505; Tenneti L, 2000, J NEUROCHEM, V74, P134, DOI 10.1046/j.1471-4159.2000.0740134.x; Tenneti L, 1998, J NEUROCHEM, V71, P946; THAYER SA, 1995, CLIN EXP PHARMACOL P, V22, P303, DOI 10.1111/j.1440-1681.1995.tb02004.x; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; TRAYNELIS SF, 1995, SCIENCE, V268, P873, DOI 10.1126/science.7754371; TURSKI L, 1991, NATURE, V349, P414, DOI 10.1038/349414a0; TYMIANSKI M, 1993, NEURON, V11, P221, DOI 10.1016/0896-6273(93)90180-Y; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Volbracht C, 2005, J NEUROCHEM, V93, P1280, DOI 10.1111/j.1471-4159.2005.03122.x; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; WAHL F, 1993, EUR J PHARMACOL, V230, P209, DOI 10.1016/0014-2999(93)90804-Q; WALDVOGEL HJ, 1991, BRAIN RES, V546, P329, DOI 10.1016/0006-8993(91)91497-O; WARNER DS, 1995, J CEREBR BLOOD F MET, V15, P188, DOI 10.1038/jcbfm.1995.24; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; WELLER M, 1993, EUR J PHARM-ENVIRON, V248, P223, DOI 10.1016/0926-6917(93)90048-U; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0; Wu HY, 2005, J BIOL CHEM, V280, P21588, DOI 10.1074/jbc.M501603200; WULLNER U, 1994, J NEUROCHEM, V63, P1772; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; YOUNG AB, 1990, TRENDS PHARMACOL SCI, V11, P126, DOI 10.1016/0165-6147(90)90199-I; YOUNG AB, 1988, SCIENCE, V241, P981, DOI 10.1126/science.2841762; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; YUE TL, 1992, BRAIN RES, V574, P193, DOI 10.1016/0006-8993(92)90816-R; ZEEVALK GD, 1990, J PHARMACOL EXP THER, V253, P1285; ZEEVALK GD, 1991, J PHARMACOL EXP THER, V257, P870; ZHANG FY, 1994, J CEREBR BLOOD F MET, V14, P217, DOI 10.1038/jcbfm.1994.28; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500; Zhang XP, 2002, J NEUROCHEM, V82, P181, DOI 10.1046/j.1471-4159.2002.00975.x; ZHAO Q, 1994, ACTA PHYSIOL SCAND, V152, P349, DOI 10.1111/j.1748-1716.1994.tb09816.x; Zhou P, 2005, J CEREBR BLOOD F MET, V25, P348, DOI 10.1038/sj.jcbfm.9600036; ZUDDAS A, 1992, J NEUROCHEM, V59, P733, DOI 10.1111/j.1471-4159.1992.tb09429.x	267	3	3	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS			978-0-08-046884-6				2010							515	535					21	Neurosciences; Toxicology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Toxicology	BA2JT	WOS:000333465100030					2022-02-06	
J	Lendraitiene, E; Krisciunas, A				Lendraitiene, Egle; Krisciunas, Aleksandras			Physical therapy for persons with traumatic brain injury	MEDICINA-LITHUANIA			Lithuanian	Article						traumatic brain injury; rehabilitation; physical therapy	FUNCTIONAL INDEPENDENCE MEASURE; CONTROLLED-TRIAL; HEAD-INJURIES; WALKING SPEED; REHABILITATION; SCALE; RELIABILITY; MODERATE; OUTCOMES; NEUROREHABILITATION	Traumatic brain injury is a major public health problem and may result in significant impairment of an individual's physical, cognitive, and psychosocial functioning. Therefore, special attention must be paid to physical therapy that plays an important role in early rehabilitation. Physical therapists have the opportunity to apply various scales and tests for assessment of the functional status of patients with traumatic brain injury and effectiveness of physical therapy: Functional Independence Measure, Disability Rating Scale, Barthel Index, Glasgow Coma Scale, Glasgow Outcome Scale, Rancho Los Amigos Scale, Mini-Mental State Examination, etc. This review presents the analysis of morbidity and mortality after traumatic brain injury, possibilities to assess patients' functional status, characteristics of physical therapy, and factors influencing the efficiency of physical therapy. Complications such as contractures, spasticity, sleep disturbances, impaired balance, as well as the attention and behavior disorders, lack of motivation, depression make difficulties in application of physical therapy and rehabilitation for the persons with traumatic brain injury.	[Lendraitiene, Egle; Krisciunas, Aleksandras] Lithuanian Univ Hlth Sci, Dept Rehabil, Med Acad, LT-50028 Kaunas, Lithuania		Lendraitiene, E (corresponding author), Lithuanian Univ Hlth Sci, Dept Rehabil, Med Acad, LT-50028 Kaunas, Lithuania.	egle_77@yahoo.com		White, Maghan/0000-0002-7278-1892			Adekoya N, 2004, PUBLIC HEALTH REP, V119, P486, DOI 10.1016/j.phr.2004.07.006; Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; Bhambhani Y, 2005, ARCH PHYS MED REHAB, V86, P268, DOI 10.1016/j.apmr.2004.04.022; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Brown TH, 2005, J HEAD TRAUMA REHAB, V20, P402, DOI 10.1097/00001199-200509000-00002; Canning CG, 2003, CLIN REHABIL, V17, P355, DOI 10.1191/0269215503cr620oa; Cho YW, 2005, NEUROREHABILITATION, V20, P71; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Choy NL, 2002, AUST J PHYSIOTHER, V48, P35, DOI 10.1016/S0004-9514(14)60280-4; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; *CTR NEUR, OV TRAUM BRAIN INJ; Dallmeijer AJ, 2005, J REHABIL MED, V37, P346, DOI 10.1080/16501970510038284; Diller L, 2005, ARCH PHYS MED REHAB, V86, P1075, DOI 10.1016/j.apmr.2004.11.009; Elhan AH, 2005, J REHABIL MED, V37, P306, DOI 10.1080/16501970510037573; Formisano R, 2005, ACT NEUR S, V93, P201; Franckeviciute Egle, 2005, Medicina (Kaunas), V41, P1; GAIZAUSKIENE A, 2006, VAIKU MIRTINGUMAS SE, P26; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P142, DOI 10.1097/00001199-200603000-00007; Hart T, 2006, ARCH PHYS MED REHAB, V87, P647, DOI 10.1016/j.apmr.2006.01.016; Horn TS, 2005, ARCH PHYS MED REHAB, V86, P1127, DOI 10.1016/j.apmr.2004.11.013; Houlden H, 2006, CLIN REHABIL, V20, P153, DOI 10.1191/0269215506cr917oa; Hudak AM, 2005, J NEUROTRAUM, V22, P1319, DOI 10.1089/neu.2005.22.1319; Iacono Laura A, 2005, J Trauma Nurs, V12, P77; Jang SH, 2004, YONSEI MED J, V45, P743, DOI 10.3349/ymj.2004.45.4.743; JARZEMSKAS E, 2003, KLIN NEUROLOGIJA, P706; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; Jiang Ji-Yao, 2004, Chin J Traumatol, V7, P341; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; KRISCIUNAS A, 2003, TRAUMATOLOGINIU LIGO, P51; Lannoo E, 2004, BRAIN INJURY, V18, P203, DOI 10.1080/02699050310001596905; Liesiene Ruta, 2006, Medicina (Kaunas), V42, P355; Lu J, 2005, ACT NEUR S, V95, P281; Malec JF, 2004, REHABIL PSYCHOL, V49, P55, DOI 10.1037/0090-5550.49.1.55; Marin RS, 2005, J HEAD TRAUMA REHAB, V20, pCP1; Mehrholz J, 2005, CLIN REHABIL, V19, P63, DOI 10.1191/0269215505cr824oa; Moseley AM, 2004, J HEAD TRAUMA REHAB, V19, P341, DOI 10.1097/00001199-200407000-00008; Motin M, 2005, BRAIN INJURY, V19, P693, DOI 10.1080/02699050400013600; *NAT CTR PHYS ACT, DIS COND; Newstead Ann H, 2005, J Neurol Phys Ther, V29, P18; Ng YS, 2005, NEUROREHABILITATION, V20, P97; Orient-Lopez F, 2004, REV NEUROLOGIA, V39, P901, DOI 10.33588/rn.3910.2004302; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Perennou D., 2005, Annales de Readaptation et de Medecine Physique, V48, P317, DOI 10.1016/j.annrmp.2005.04.009; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Rincon-Ferrari MD, 2004, J TRAUMA, V57, P1234, DOI 10.1097/01.TA.0000119200.70853.23; Schmitter-Edgecombe M, 2006, J HEAD TRAUMA REHAB, V21, P131, DOI 10.1097/00001199-200603000-00006; Shukri A A, 2006, Zh Vopr Neirokhir Im N N Burdenko, P40; Singer BJ, 2004, DISABIL REHABIL, V26, P335, DOI 10.1080/0963828032000174070; Smrcka M, 2005, Bratisl Lek Listy, V106, P144; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Tieves Kelly S, 2005, WMJ, V104, P22; Trentz OA, 2005, CRIT CARE MED, V33, P399, DOI 10.1097/01.CCM.0000152221.87477.21; Turani N, 2004, SCAND J CARING SCI, V18, P103, DOI 10.1111/j.1471-6712.2004.00262.x; Turner-Stokes L, 2004, CLIN MED, V4, P61, DOI 10.7861/clinmedicine.4-1-61; van den Broek MD, 2005, J HEAD TRAUMA REHAB, V20, P464, DOI 10.1097/00001199-200509000-00007; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; von Wild KRH, 2005, ACTA NEUROCHIR SUPPL, V93, P15; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Wilson DJ, 2006, AM J PHYS MED REHAB, V85, P68, DOI 10.1097/01.phm.0000193507.28759.37; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901; Zygun DA, 2005, CAN J NEUROL SCI, V32, P87, DOI 10.1017/S0317167100016930	63	3	4	1	9	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1010-660X	1648-9144		MEDICINA-LITHUANIA	Med. Lith.		2010	46	10					712	719		10.3390/medicina46100101			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	737RP	WOS:000288586200010	21393991	gold			2022-02-06	
B	McDonald, S		Anderson, V; Jacobs, R; Anderson, PJ		McDonald, Skye			Social information processing difficulties in adults and implications for treatment	EXECUTIVE FUNCTIONS AND THE FRONTAL LOBES: A LIFESPAN PERSPECTIVE	Studies on Neuropsychology Neurology and Cognition		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; CLOSED HEAD-INJURY; EMOTIONAL FACIAL EXPRESSIONS; FRONTOTEMPORAL DEMENTIA; ASPERGER-SYNDROME; DECISION-MAKING; NEURAL SYSTEMS; HUMAN AMYGDALA; PERCEPTION DEFICITS; EXECUTIVE FUNCTIONS		Univ New S Wales, Sch Psychol, Sydney, NSW, Australia		McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.		McDonald, Skye/G-4118-2014	McDonald, Skye/0000-0003-0723-6094			Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs R, 2004, J COGNITIVE NEUROSCI, V16, P453, DOI 10.1162/089892904322926782; Adolphs R, 2003, BRAIN COGNITION, V52, P61, DOI 10.1016/S0278-2626(03)00009-5; Adolphs R, 1996, J NEUROSCI, V16, P7678; Adolphs R, 1999, PSYCHOL SCI, V10, P167, DOI 10.1111/1467-9280.00126; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Adolphs R, 2002, EMOTION, V2, P23, DOI 10.1037/1528-3542.2.1.23; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; ALEXANDER MP, 1984, NEUROLOGY, V34, P752, DOI 10.1212/WNL.34.6.752; ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; Angrilli A, 1999, NEUROREPORT, V10, P1741, DOI 10.1097/00001756-199906030-00021; AVIS J, 1991, CHILD DEV, V62, P460, DOI 10.2307/1131123; Bara BG, 1997, BRAIN LANG, V59, P7, DOI 10.1006/brln.1997.1812; BARBER R, 1995, J NEUROL NEUROSUR PS, V59, P61, DOI 10.1136/jnnp.59.1.61; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; Baron-Cohen S, 1999, NEUROCASE, V5, P475, DOI 10.1093/neucas/5.6.475; BARONCOHEN S, 1994, BRIT J PSYCHIAT, V165, P640, DOI 10.1192/bjp.165.5.640; BaronCohen S, 1997, VIS COGN, V4, P311, DOI 10.1080/713756761; BARONCOHEN S, 1989, BRIT J DEV PSYCHOL, V7, P113, DOI 10.1111/j.2044-835X.1989.tb00793.x; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; BASSILI JN, 1978, J EXP PSYCHOL HUMAN, V4, P373, DOI 10.1037/0096-1523.4.3.373; Bauminger N, 2002, J AUTISM DEV DISORD, V32, P283, DOI 10.1023/A:1016378718278; Beatty WW, 2003, MULT SCLER, V9, P148, DOI 10.1191/1352458503ms897oa; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Berthoz S, 2002, BRAIN, V125, P1696, DOI 10.1093/brain/awf190; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; Body R., 1999, BRAIN DAM B; BORNHOFEN C, J HEAD TRAU IN PRESS; BORNHOFEN C, NEUROPSYCHO IN PRESS; BOROD JC, 1986, NEUROPSYCHOLOGIA, V24, P169; Borod JC, 1993, NEUROPSYCHOLOGY, V7, P445, DOI DOI 10.1037/0894-4105.7.4.445; BOWLER DM, 1992, J CHILD PSYCHOL PSYC, V33, P877, DOI 10.1111/j.1469-7610.1992.tb01962.x; Breen Nora, 2002, Cogn Neuropsychiatry, V7, P113, DOI 10.1080/13546800143000203; Broks P, 1998, NEUROPSYCHOLOGIA, V36, P59, DOI 10.1016/S0028-3932(97)00105-X; Brown P., 1978, QUESTIONS POLITENESS; Buchanan TW, 2004, BEHAV NEUROSCI, V118, P429, DOI 10.1037/0735-7044.118.2.429; Calder AJ, 2002, NEUROPSYCHOLOGIA, V40, P1129, DOI 10.1016/S0028-3932(02)00008-8; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Channon S, 2000, NEUROPSYCHOLOGIA, V38, P1006, DOI 10.1016/S0028-3932(99)00154-2; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; CHARMAN T, 1995, COGNITIVE DEV, V10, P287, DOI 10.1016/0885-2014(95)90013-6; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; CICONE M, 1980, CORTEX, V16, P145, DOI 10.1016/S0010-9452(80)80029-3; CLARK HH, 1980, COGNITION, V8, P111, DOI 10.1016/0010-0277(80)90009-8; Cornelissen K, 2003, J COGNITIVE NEUROSCI, V15, P444, DOI 10.1162/089892903321593153; Critchley H, 2000, HUM BRAIN MAPP, V9, P93, DOI 10.1002/(SICI)1097-0193(200002)9:2<93::AID-HBM4>3.0.CO;2-Z; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; CROSSON B, 1987, CLIN NEUROPSYCHOL, V1, P335, DOI DOI 10.1080/13854048708520069; Damasio A., 1983, NEUROPSYCHOLOGY HUMA; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; DAVIS HL, 1995, AUST J PSYCHOL, V47, P25, DOI 10.1080/00049539508258765; DELAHUNTY A, 1993, PSYCHOL MED, V23, P221, DOI 10.1017/S0033291700039015; DELAHUNTY A, 1994, TREATM ISS LONG TERM; DELMOLINO LM, 2000, DISS ABSTR INT B, V61, P2752; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dennis M, 2000, APHASIOLOGY, V14, P391, DOI 10.1080/026870300401423; Docking K, 2000, BRAIN INJURY, V14, P89, DOI 10.1080/026990500120952; Docking K, 1999, BRAIN INJURY, V13, P953; DONAHOE CP, 1990, PSYCHIATRY, V53, P329; Dujardin K, 2004, NEUROPSYCHOLOGIA, V42, P239, DOI 10.1016/S0028-3932(03)00154-4; Ekman P., 1976, PICTURES FACIAL AFFE; ESTEVES F, 1994, COGNITION EMOTION, V8, P393, DOI 10.1080/02699939408408949; Ferstl EC, 2002, NEUROIMAGE, V17, P1599, DOI 10.1006/nimg.2002.1247; Fine C, 2001, BRAIN, V124, P287, DOI 10.1093/brain/124.2.287; FLANAGAN S, 1995, BRAIN INJURY, V9, P321, DOI 10.3109/02699059509005773; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Frommann N, 2003, PSYCHIAT RES, V117, P281, DOI 10.1016/S0165-1781(03)00039-8; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; GOEL V, 1995, NEUROREPORT, V6, P1741, DOI 10.1097/00001756-199509000-00009; Gordon ACL, 1998, J EXP CHILD PSYCHOL, V68, P70, DOI 10.1006/jecp.1997.2423; Gorno-Tempini ML, 2001, NEUROIMAGE, V14, P465, DOI 10.1006/nimg.2001.0811; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; GUSTAFSON L, 1993, DEMENTIA, V4, P143, DOI 10.1159/000107313; Hadwin J, 1996, DEV PSYCHOPATHOL, V8, P345, DOI 10.1017/S0954579400007136; Happe F, 2001, NEUROPSYCHOLOGIA, V39, P83, DOI 10.1016/S0028-3932(00)00093-2; HAPPE FGE, 1993, COGNITION, V48, P101, DOI 10.1016/0010-0277(93)90026-R; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Harmer CJ, 2001, NAT NEUROSCI, V4, P17, DOI 10.1038/82854; Heberlein AS, 2004, J COGNITIVE NEUROSCI, V16, P1143, DOI 10.1162/0898929041920423; HOLLAND AL, 1974, J SPEECH HEAR RES, V17, P589, DOI 10.1044/jshr.1704.589; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Hughes C, 1998, BRIT J DEV PSYCHOL, V16, P233, DOI 10.1111/j.2044-835X.1998.tb00921.x; Hughes C, 1999, PSYCHOL SCI, V10, P429, DOI 10.1111/1467-9280.00181; HUMPHREYS GW, 1993, NEUROPSYCHOLOGIA, V31, P173, DOI 10.1016/0028-3932(93)90045-2; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Kampe KKW, 2001, NATURE, V413, P589, DOI 10.1038/35098149; Kan Y, 2002, CORTEX, V38, P623, DOI 10.1016/S0010-9452(08)70026-1; Karafin MS, 2004, J COGNITIVE NEUROSCI, V16, P1796, DOI 10.1162/0898929042947856; KARMILOFFSMITH A, 1995, J COGNITIVE NEUROSCI, V7, P196, DOI 10.1162/jocn.1995.7.2.196; Kawashima R, 1999, BRAIN, V122, P779, DOI 10.1093/brain/122.4.779; Keane J, 2002, NEUROPSYCHOLOGIA, V40, P655, DOI 10.1016/S0028-3932(01)00156-7; Keenan T, 1998, NEW ZEAL J PSYCHOL, V27, P36; Keightley ML, 2003, NEUROPSYCHOLOGIA, V41, P585, DOI 10.1016/S0028-3932(02)00199-9; Kendall E, 1997, J HEAD TRAUMA REHAB, V12, P68, DOI 10.1097/00001199-199706000-00007; Lavenu I, 1999, ALZ DIS ASSOC DIS, V13, P96, DOI 10.1097/00002093-199904000-00007; LEDOUX JE, 1984, J NEUROSCI, V4, P683; LEEKAM SR, 1991, COGNITION, V40, P203, DOI 10.1016/0010-0277(91)90025-Y; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Lough S, 2001, NEUROCASE, V7, P123, DOI 10.1076/neur.7.2.123.16266; Lough S, 2002, J PSYCHOSOM RES, V53, P639, DOI 10.1016/S0022-3999(02)00433-6; Luria AR., 1976, BASIC PROBLEMS NEURO; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Martin I, 2004, J AUTISM DEV DISORD, V34, P311, DOI 10.1023/B:JADD.0000029553.52889.15; Martin I, 2005, APHASIOLOGY, V19, P712, DOI 10.1080/02687030500172203; MCALPINE C, 1992, BEHAV MODIF, V16, P559, DOI 10.1177/01454455920164007; MCDONALD S, 1993, COGNITIVE NEUROPSYCH, V10, P297, DOI 10.1080/02643299308253466; McDonald S, 1998, BRAIN LANG, V61, P88, DOI 10.1006/brln.1997.1846; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; McDonald S., 2005, BRAIN IMPAIR, V6, P58, DOI [DOI 10.1375/BRIM.6.1.56.65481, 10.1375/brim.6.1.56.65481]; McDonald S., 2002, AWARENESS SOCIAL INF; MCFALL RM, 1982, BEHAV ASSESS, V4, P1; McHugo GJ, 1996, MOTIV EMOTION, V20, P85, DOI 10.1007/BF02253867; McKenzie K., 2000, BRIT J LEARN DISABIL, V28, P143; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milne E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-12-j0001.2001; MILNE J, 1987, BEHAV PSYCHOTHER, V15, P144, DOI 10.1017/S014134730001123X; MILTON SB, 1984, CLIN APHASIOLOGY C P, P114; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; MURRAY LL, 1995, APHASIOLOGY, V9, P397, DOI 10.1080/02687039508248212; NEARY D, 1990, J AM GERIATR SOC, V38, P71, DOI 10.1111/j.1532-5415.1990.tb01601.x; Nudo RJ, 1996, J NEUROPHYSIOL, V75, P2144, DOI 10.1152/jn.1996.75.5.2144; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; OHMAN A, 1994, J ABNORM PSYCHOL, V103, P231, DOI 10.1037/0021-843X.103.2.231; OHMAN A, 2000, SER AFFECTIVE SCI, P296; OZONOFF S, 1995, J AUTISM DEV DISORD, V25, P415, DOI 10.1007/BF02179376; Ozonoff S, 1996, BRAIN LANG, V52, P411, DOI 10.1006/brln.1996.0022; Park NW, 2001, NEUROPSYCHOLOGIA, V39, P7, DOI 10.1016/S0028-3932(00)00101-9; Pearce S, 1998, BRAIN COGNITION, V38, P150, DOI 10.1006/brcg.1998.1018; Penn DL, 2000, SCHIZOPHR RES, V46, P217, DOI 10.1016/S0920-9964(00)00005-0; PERNER J, 1985, J EXP CHILD PSYCHOL, V39, P437, DOI 10.1016/0022-0965(85)90051-7; Phelps EA, 2003, NEUROPSYCHOLOGIA, V41, P203, DOI 10.1016/S0028-3932(02)00150-1; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Pizzamiglio L, 1998, ARCH NEUROL-CHICAGO, V55, P561, DOI 10.1001/archneur.55.4.561; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; PRIGATANO GP, 1982, PERCEPT MOTOR SKILL, V54, P859, DOI 10.2466/pms.1982.54.3.859; Pulvermuller F, 2001, STROKE, V32, P1621, DOI 10.1161/01.STR.32.7.1621; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Roncone R, 2004, NEUROPSYCHOL REHABIL, V14, P421, DOI 10.1080/09602010343000291; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; SANTORO J, 1994, BRAIN INJURY, V8, P265, DOI 10.3109/02699059409150978; Sarfati Y, 2000, PSYCHOPATHOLOGY, V33, P246, DOI 10.1159/000029153; Snowden JS, 2003, NEUROPSYCHOLOGIA, V41, P688, DOI 10.1016/S0028-3932(02)00221-X; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; SPIERS MV, 1994, BRAIN INJURY, V8, P463, DOI 10.3109/02699059409150998; Sprengelmeyer R, 1996, BRAIN, V119, P1647, DOI 10.1093/brain/119.5.1647; STEWART CA, 1995, RES DEV DISABIL, V16, P365, DOI 10.1016/0891-4222(95)00024-H; Stone VE, 2003, NEUROPSYCHOLOGIA, V41, P209, DOI 10.1016/S0028-3932(02)00151-3; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stone VE, 2002, P NATL ACAD SCI USA, V99, P11531, DOI 10.1073/pnas.122352699; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; STUSS DT, 1978, NEUROLOGY, V28, P1166, DOI 10.1212/WNL.28.11.1166; Surian L, 1996, Cogn Neuropsychiatry, V1, P55, DOI 10.1080/135468096396703; TagerFlusberg H, 1997, DEV NEUROPSYCHOL, V13, P487, DOI 10.1080/87565649709540689; Taub E, 1998, REHABIL PSYCHOL, V43, P152, DOI 10.1037/0090-5550.43.2.152; THENEUROBIOLOGY.AR, 2001, NEUROBIOLOGY, V11, P231; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Tranel D, 2002, CORTEX, V38, P589, DOI 10.1016/S0010-9452(08)70024-8; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; van der Gaag M, 2002, SCHIZOPHRENIA BULL, V28, P167, DOI 10.1093/oxfordjournals.schbul.a006919; VONCRAMON DY, 1992, NEUROPSYCHOL REHABIL, V2, P207; Watson RI, 1978, GREAT PSYCHOL; Weinstein A, 1996, BRAIN COGNITION, V32, P223; Wellman HM, 2002, AUTISM, V6, P343, DOI 10.1177/1362361302006004003; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wilson D., 1986, RELEVANCE COMMUNICAT; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Ylvisaker M, 2000, APHASIOLOGY, V14, P407, DOI 10.1080/026870300401432; YOUNG AW, 1995, BRAIN, V118, P15, DOI 10.1093/brain/118.1.15; Zelazo PD, 1996, J CHILD PSYCHOL PSYC, V37, P479, DOI 10.1111/j.1469-7610.1996.tb01429.x; [No title captured]	197	3	3	0	2	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND			978-1-13687-354-6	STUD NEUROPSYCHOL NE			2010							471	499					29	Psychology, Biological; Psychology, Developmental; Psychology; Psychology, Experimental	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology	BVE09	WOS:000291249500022					2022-02-06	
J	Moore, TR; Gilles, E; McComas, JJ; Symons, FJ				Moore, Timothy R.; Gilles, Elizabeth; McComas, Jennifer J.; Symons, Frank J.			Functional analysis and treatment of self-injurious behaviour in a young child with traumatic brain injury	BRAIN INJURY			English	Article						Functional communication; paediatric; vision	OUTCOMES; REINFORCEMENT; SETTINGS; REHABILITATION; MANAGEMENT; SUPPORTS; PEOPLE	Primary objective: There has been no research evaluating the utility of functional analysis (FA) in identifying effective interventions for severe problem behaviour in very young children with traumatic brain injury (TBI). It was hypothesized that FA technology would be applicable for this population and facilitate effective intervention development. Research design: A within-subject A-B-A reversal design was used to evaluate a functional communication training (FCT) intervention. This design allows for a demonstration of experimental control of the intervention over behaviour in single-case research. Methods and procedure: The authors conducted an FA of self-injurious behaviour (SIB) in an 18-month old boy with TBI. Results of the FA suggested that SIB was maintained, at least in part, by contingent maternal attention. An FCT intervention was used to teach a request for attention using an alternative communication device. Main outcomes and results: The FCT intervention reduced SIB to near zero and resulted in consistent use of an alternative communication device, functionally replacing SIB with desirable behaviour. The child's mother was coached to conduct all treatment sessions and reported satisfaction with the process. Conclusion: Analysis of behavioural function may play an important role in developing effective interventions for very young TBI patients with behaviour problems.	[McComas, Jennifer J.; Symons, Frank J.] Univ Minnesota, Dept Educ Psychol, Minneapolis, MN 55455 USA; [Gilles, Elizabeth] Childrens Hosp, Dept Neurol, St Paul, MN USA; [Moore, Timothy R.] Univ Minnesota, Inst Community Integrat, Minneapolis, MN 55455 USA		Moore, TR (corresponding author), 102 Patee Hall,150 Pillsbury Dr SE, Minneapolis, MN 55455 USA.	moore618@umn.edu			Observational Methods Lab in the Department of Educational Psychology at the University of Minnesota; Eunice Kennedy Shriver NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [44763, 47201]	The authors report no conflicts of interest. This research was supported, in part, by the Observational Methods Lab in the Department of Educational Psychology at the University of Minnesota and Eunice Kennedy Shriver NICHD Grant No's: 44763, 47201 to the University of Minnesota.	Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Braithwaite KL, 2000, BEHAV INTERVENT, V15, P21, DOI 10.1002/(SICI)1099-078X(200001/03)15:1<21::AID-BIN45>3.3.CO;2-R; CARR EG, 1985, J APPL BEHAV ANAL, V18, P111, DOI 10.1901/jaba.1985.18-111; Derby KM, 1997, J APPL BEHAV ANAL, V30, P507, DOI 10.1901/jaba.1997.30-507; Ducharme JM, 1999, BRAIN INJURY, V13, P645, DOI 10.1080/026990599121232; DUHAIME A, 2000, NEW ENGL J MED, V338, P1822; Durand VM, 1999, J APPL BEHAV ANAL, V32, P247, DOI 10.1901/jaba.1999.32-247; Gardner RM, 2003, J HEAD TRAUMA REHAB, V18, P52, DOI 10.1097/00001199-200301000-00007; Hanley GP, 2003, J APPL BEHAV ANAL, V36, P147, DOI 10.1901/jaba.2003.36-147; Harding J, 2005, AM J MENT RETARD, V110, P205, DOI 10.1352/0895-8017(2005)110<205:EORBSA>2.0.CO;2; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; IWATA BA, 1994, J APPL BEHAV ANAL, V27, P197, DOI 10.1901/jaba.1994.27-197; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; LALLI JS, 1995, J APPL BEHAV ANAL, V28, P261, DOI 10.1901/jaba.1995.28-261; Lang R, 2008, J APPL BEHAV ANAL, V41, P441, DOI 10.1901/jaba.2008.41-441; MacLean WE, 2002, INFANT YOUNG CHILD, V14, P31, DOI 10.1097/00001163-200204000-00005; Mirenda P., 1997, AUGMENTATIVE ALTERNA, V13, P207, DOI [10.1080/07434619712331278048, DOI 10.1080/07434619712331278048]; ONeill R. E., 1997, FUNCTIONAL ASSESSMEN, V2nd; Pace GM, 2005, BRAIN INJURY, V19, P365, DOI 10.1080/02699050400013691; Persel CS, 1997, BRAIN INJURY, V11, P751; Rothwell NA, 1999, BRAIN INJURY, V13, P521; Shirley MJ, 1997, J APPL BEHAV ANAL, V30, P93, DOI 10.1901/jaba.1997.30-93; Tiger JH, 2008, BEHAV ANAL PRACT, V1, P16; Treadwell K, 1996, J HEAD TRAUMA REHAB, V11, P62, DOI 10.1097/00001199-199602000-00008; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Yody BB, 2000, J HEAD TRAUMA REHAB, V15, P1041, DOI 10.1097/00001199-200008000-00006	27	3	3	0	6	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	12					1511	1518		10.3109/02699052.2010.523043			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	667NR	WOS:000283200800014	20961176				2022-02-06	
J	Murphy, BP				Murphy, Brendan P.			Beyond the first episode: Candidate factors for a risk prediction model of schizophrenia	INTERNATIONAL REVIEW OF PSYCHIATRY			English	Article							NEUROLOGICAL SOFT-SIGNS; MINOR PHYSICAL ANOMALIES; SUBSTANCE USE DISORDERS; TRAUMATIC BRAIN-INJURY; EPIDEMIOLOGIC 1ST-EPISODE PSYCHOSIS; ADVANCING PATERNAL AGE; CLINICAL HIGH-RISK; DAILY TOBACCO USE; 2-YEAR FOLLOW-UP; QUALITY-OF-LIFE	Many early psychosis services are financially compromised and cannot offer a full tenure of care to all patients. To maintain viability of services it is important that those with schizophrenia are identified early to maximize long-term outcomes, as are those with better prognoses who can be discharged early. The duration of untreated psychosis remains the mainstay in determining those who will benefit from extended care, yet its ability to inform on prognosis is modest in both the short and medium term. There are a number of known or putative genetic and environmental risk factors that have the potential to improve prognostication, though a multivariate risk prediction model combining them with clinical characteristics has yet to be developed. Candidate risk factors for such a model are presented, with an emphasis on environmental risk factors. More work is needed to corroborate many putative factors and to determine which of the established factors are salient and which are merely proxy measures. Future research should help clarify how gene-environment and environment-environment interactions occur and whether risk factors are dose-dependent, or if they act additively or synergistically, or are redundant in the presence (or absence) of other factors.	[Murphy, Brendan P.] So Hlth, Recovery & Prevent Psychosis Serv, Melbourne, Vic, Australia; [Murphy, Brendan P.] Monash Univ, Sch Psychol Med, Melbourne, Vic 3004, Australia		Murphy, BP (corresponding author), Recovery & Prevent Psychosis Serv, Community Serv Bldg,145 Cleeland St, Dandenong, Vic 3175, Australia.	Brendan.Murphy@med.monash.edu.au					Addington J, 2004, PSYCHOL MED, V34, P277, DOI 10.1017/S0033291703001156; Addington J, 2003, SCHIZOPHR RES, V62, P23, DOI 10.1016/S0920-9964(02)00408-5; Aleman A, 2003, ARCH GEN PSYCHIAT, V60, P565, DOI 10.1001/archpsyc.60.6.565; Amminger GP, 2007, BIOL PSYCHIAT, V61, P1215, DOI 10.1016/j.biopsych.2006.09.034; AMMINGER GP, 2008, SCHIZOPHR RES, V102, pS252; Amore M, 2003, BIOL NEONATE, V83, P97, DOI 10.1159/000067960; Arendt M, 2005, BRIT J PSYCHIAT, V187, P510, DOI 10.1192/bjp.187.6.510; Arseneault L, 2004, BRIT J PSYCHIAT, V184, P110, DOI 10.1192/bjp.184.2.110; Ascher-Svanum H, 2006, J CLIN PSYCHIAT, V67, P453, DOI 10.4088/JCP.v67n0317; Ashdown H, 2006, MOL PSYCHIATR, V11, P47, DOI 10.1038/sj.mp.4001748; Atladottir HO, 2009, PEDIATRICS, V124, P687, DOI 10.1542/peds.2008-2445; Bachmann S, 2005, AM J PSYCHIAT, V162, P2337, DOI 10.1176/appi.ajp.162.12.2337; Bailer J, 1996, ACTA PSYCHIAT SCAND, V93, P368, DOI 10.1111/j.1600-0447.1996.tb10662.x; Barnes TRE, 2006, BRIT J PSYCHIAT, V188, P237, DOI 10.1192/bjp.bp.104.007237; Barnett JH, 2007, BRIT J PSYCHIAT, V190, P515, DOI 10.1192/bjp.bp.106.024448; Bayer TA, 1999, J PSYCHIATR RES, V33, P543, DOI 10.1016/S0022-3956(99)00039-4; Bennouna M, 2007, ENCEPHALE, V33, P616; Berger GE, 2007, J CLIN PSYCHIAT, V68, P1867, DOI 10.4088/JCP.v68n1206; Berman SM, 2009, MOL PSYCHIATR, V14, P123, DOI 10.1038/mp.2008.90; Bertelsen M, 2009, SCHIZOPHR RES, V107, P173, DOI 10.1016/j.schres.2008.09.018; Birchwood M, 1997, BRIT J PSYCHIAT, V170, P2, DOI 10.1192/bjp.170.1.2; Birchwood M, 1998, BRIT J PSYCHIAT, V172, P53, DOI 10.1192/S0007125000297663; Bo Mortensen P, 2007, BIOL PSYCHIAT, V61, P688, DOI 10.1016/j.biopsych.2006.05.024; Boden R, 2009, SCHIZOPHR RES, V107, P232, DOI 10.1016/j.schres.2008.10.004; Boks MPM, 2007, PSYCHIAT RES, V149, P273, DOI 10.1016/j.psychres.2006.04.008; Boks MPM, 2000, SCHIZOPHR RES, V43, P109, DOI 10.1016/S0920-9964(99)00145-0; Bombin I, 2005, SCHIZOPHRENIA BULL, V31, P962, DOI 10.1093/schbul/sbi028; Bouras N, 2004, J INTELL DISABIL RES, V48, P548, DOI 10.1111/j.1365-2788.2004.00623.x; Bow-Thomas CC, 1999, PSYCHIAT RES, V86, P131, DOI 10.1016/S0165-1781(99)00023-2; Boydell J, 2001, BMJ-BRIT MED J, V323, P1336, DOI 10.1136/bmj.323.7325.1336; Breier A, 2000, PSYCHIATR SERV, V51, P1249, DOI 10.1176/appi.ps.51.10.1249; Breier AF, 1999, AM J PSYCHIAT, V156, P294; Breunis MN, 2003, BIOL PSYCHIAT, V53, P157, DOI 10.1016/S0006-3223(02)01452-X; Brown AS, 2007, ARCH GEN PSYCHIAT, V64, P31, DOI 10.1001/archpsyc.64.1.31; Brown AS, 2009, AM J PSYCHIAT, V166, P683, DOI 10.1176/appi.ajp.2008.08010089; Brown AS, 2000, AM J PSYCHIAT, V157, P438, DOI 10.1176/appi.ajp.157.3.438; Brown AS, 2005, AM J PSYCHIAT, V162, P767, DOI 10.1176/appi.ajp.162.4.767; Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774; Buhler B, 2002, SCHIZOPHR RES, V54, P243, DOI 10.1016/S0920-9964(01)00249-3; Buka SL, 2001, ARCH GEN PSYCHIAT, V58, P1032, DOI 10.1001/archpsyc.58.11.1032; Butzlaff RL, 1998, ARCH GEN PSYCHIAT, V55, P547, DOI 10.1001/archpsyc.55.6.547; BYRNE A, 1991, CAN J PSYCHIAT, V36, P735, DOI 10.1177/070674379103601008; Byrne M, 2004, SOC PSYCH PSYCH EPID, V39, P87, DOI 10.1007/s00127-004-0715-y; Byrne M, 2003, ARCH GEN PSYCHIAT, V60, P673, DOI 10.1001/archpsyc.60.7.673; BYRNE M, 2002, BRIT J PSYCHIAT, V43, P19; Byrne M, 2007, SCHIZOPHR RES, V97, P51, DOI 10.1016/j.schres.2007.07.018; Cahn W, 2006, BRIT J PSYCHIAT, V189, P381, DOI 10.1192/bjp.bp.105.015701; Cahn W, 2009, EUR NEUROPSYCHOPHARM, V19, P147, DOI 10.1016/j.euroneuro.2008.10.006; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; CANNONSPOOR HE, 1982, SCHIZOPHRENIA BULL, V8, P470, DOI 10.1093/schbul/8.3.470; Cantor-Graae E, 2005, AM J PSYCHIAT, V162, P12, DOI 10.1176/appi.ajp.162.1.12; Cantwell R, 1999, BRIT J PSYCHIAT, V174, P150, DOI 10.1192/bjp.174.2.150; Cardno AG, 1999, ARCH GEN PSYCHIAT, V56, P162, DOI 10.1001/archpsyc.56.2.162; CARPENTER WT, 1991, J NERV MENT DIS, V179, P517, DOI 10.1097/00005053-199109000-00001; Carroll LS, 2009, GENOME MED, V1, DOI 10.1186/gm102; CHAKRAVARTI A, 1999, NAT GENET, V21, pS56; CHAN RC, 2009, NEUROSCIENCE BIOBEHA; CHAN RC, 2009, SCHIZOPHRENIA B; Chen CK, 2003, PSYCHOL MED, V33, P1407, DOI 10.1017/S0033291703008353; Compton MT, 2007, EARLY INTERV PSYCHIA, V1, P236, DOI 10.1111/j.1751-7893.2007.00036.x; Compton MT, 2007, SCHIZOPHR RES, V94, P64, DOI 10.1016/j.schres.2007.04.002; Compton MT, 2009, AM J PSYCHIAT, V166, P1251, DOI 10.1176/appi.ajp.2009.09030311; Compton MT, 2009, SCHIZOPHRENIA BULL, V35, P425, DOI 10.1093/schbul/sbn151; CONUS P, 2009, SCHIZOPHRENIA B; Cooper C, 2008, BRIT J PSYCHIAT, V192, P185, DOI 10.1192/bjp.bp.107.042291; Corcoran CM, 2008, SCHIZOPHR RES, V106, P286, DOI 10.1016/j.schres.2008.08.008; Craddock N, 2005, J MED GENET, V42, P193, DOI 10.1136/jmg.2005.030718; Craig TK, 2004, BMJ-BRIT MED J, V329, P1067, DOI 10.1136/bmj.38246.594873.7C; Crow T, 2007, BRIT J PSYCHIAT, V191, P180, DOI 10.1192/bjp.191.2.180; Crumlish N, 2009, BRIT J PSYCHIAT, V194, P18, DOI 10.1192/bjp.bp.107.048942; Cullberg J, 2006, ACTA PSYCHIAT SCAND, V114, P274, DOI 10.1111/j.1600-0447.2006.00788.x; Dalman C, 2008, AM J PSYCHIAT, V165, P59, DOI 10.1176/appi.ajp.2007.07050740; Davies G, 2003, SCHIZOPHRENIA BULL, V29, P587, DOI 10.1093/oxfordjournals.schbul.a007030; Dazzan P, 2002, BRIT J PSYCHIAT, V181, pS50, DOI 10.1192/bjp.181.43.s50; Dazzan P, 2008, BRIT J PSYCHIAT, V193, P197, DOI 10.1192/bjp.bp.107.045450; de Haan L, 2003, SCHIZOPHRENIA BULL, V29, P341, DOI 10.1093/oxfordjournals.schbul.a007009; De Silva MJ, 2005, J EPIDEMIOL COMMUN H, V59, P619, DOI 10.1136/jech.2004.029678; Degenhardt L, 2006, CAN J PSYCHIAT, V51, P556, DOI 10.1177/070674370605100903; DELISI LE, 1991, PSYCHIAT RES, V38, P39, DOI 10.1016/0165-1781(91)90051-P; DELISI LE, 1992, SCHIZOPHRENIA BULL, V18, P209, DOI 10.1093/schbul/18.2.209; DeLisi LE, 2008, SCHIZOPHRENIA BULL, V34, P312, DOI 10.1093/schbul/sbm164; Dickerson FB, 1999, PSYCHIATR SERV, V50, P515, DOI 10.1176/ps.50.4.515; Dickerson FB, 2003, ARCH GEN PSYCHIAT, V60, P466, DOI 10.1001/archpsyc.60.5.466; DOHRENWEND BP, 1992, SCIENCE, V255, P946, DOI 10.1126/science.1546291; DONE DJ, 1991, BRIT MED J, V302, P1576, DOI 10.1136/bmj.302.6792.1576; Dossetor David R, 2007, Clin Child Psychol Psychiatry, V12, P537, DOI 10.1177/1359104507078476; Drake RJ, 2007, J CLIN PSYCHIAT, V68, P81, DOI 10.4088/JCP.v68n0111; Drukker M, 2005, SOC SCI MED, V61, P185, DOI 10.1016/j.socscimed.2004.11.041; Drukker M, 2003, SOC SCI MED, V57, P825, DOI 10.1016/S0277-9536(02)00453-7; Eaton WW, 2006, AM J PSYCHIAT, V163, P521, DOI 10.1176/appi.ajp.163.3.521; Eaton WW, 2004, BRIT MED J, V328, P438, DOI 10.1136/bmj.328.7437.438; EATON WW, 1992, SCHIZOPHR RES, V6, P181, DOI 10.1016/0920-9964(92)90001-L; Edwards J, 1999, SCHIZOPHR RES, V40, P147, DOI 10.1016/S0920-9964(99)00043-2; EHLERS S, 1993, J CHILD PSYCHOL PSYC, V34, P1327, DOI 10.1111/j.1469-7610.1993.tb02094.x; Emsley R, 2008, CURR OPIN PSYCHIATR, V21, P173, DOI 10.1097/YCO.0b013e3282f33f76; Emsley R, 2006, J CLIN PSYCHIAT, V67, P1707, DOI 10.4088/JCP.v67n1106; Etain B, 2008, BIPOLAR DISORD, V10, P867, DOI 10.1111/j.1399-5618.2008.00635.x; FINNEY GOH, 1989, LANCET, V2, P1214; FISHER HL, 2009, SCHIZOPHRENIA B; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Flyckt L, 2006, J CLIN PSYCHIAT, V67, P916, DOI 10.4088/JCP.v67n0608; Frans EM, 2008, ARCH GEN PSYCHIAT, V65, P1034, DOI 10.1001/archpsyc.65.9.1034; GANGULI R, 1987, ANN NY ACAD SCI, V496, P676, DOI 10.1111/j.1749-6632.1987.tb35829.x; Gattaz WF, 2004, EUR ARCH PSY CLIN N, V254, P23, DOI 10.1007/s00406-004-0431-3; GEDDES J, 1994, BRIT J PSYCHIAT, V165, P664, DOI 10.1192/bjp.165.5.664; Gilvarry CM, 1996, SCHIZOPHR RES, V19, P33, DOI 10.1016/0920-9964(95)00045-3; Goff DC, 2005, J CLIN PSYCHIAT, V66, P183, DOI 10.4088/JCP.v66n0205; GOFF DC, 2003, PSYCHOL MED, V33, P723; GOLDBERG EM, 1963, BRIT J PSYCHIAT, V109, P785, DOI 10.1192/bjp.109.463.785; Goswami U, 2006, BRIT J PSYCHIAT, V188, P366, DOI 10.1192/bjp.188.4.366; Gourion D, 2004, PSYCHIAT RES, V125, P21, DOI 10.1016/j.psychres.2003.06.001; Gourion D, 2003, SCHIZOPHR RES, V63, P181, DOI 10.1016/S0920-9964(02)00333-X; Green AI, 2004, SCHIZOPHR RES, V66, P125, DOI 10.1016/j.schres.2003.08.001; HAFNER H, 1993, BRIT J PSYCHIAT, V162, P80, DOI 10.1192/bjp.162.1.80; Hafner H, 1999, EUR ARCH PSY CLIN N, V249, P14; Hambrecht M, 2000, AUST NZ J PSYCHIAT, V34, P468, DOI 10.1080/j.1440-1614.2000.00736.x; HARE E, 2009, AM J MED GENETICS B; Harris D, 2000, AM J ADDICTION, V9, P28; Harris MG, 2005, SCHIZOPHR RES, V79, P85, DOI 10.1016/j.schres.2005.05.024; Harrison G, 1996, PSYCHOL MED, V26, P697, DOI 10.1017/S0033291700037715; Heikkila J, 2002, PSYCHIAT RES, V111, P155, DOI 10.1016/S0165-1781(02)00134-8; Henquet C, 2005, BMJ-BRIT MED J, V330, P11, DOI 10.1136/bmj.38267.664086.63; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hickie IB, 2009, MED J AUSTRALIA, V190, pS5; HICKIE IB, 2009, MED J AUSTRALIA, V190, P17; Hickling FW, 1999, BRIT J PSYCHIAT, V175, P283, DOI 10.1192/bjp.175.3.283; Hofvander B, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-35; Horrobin DF, 1998, SCHIZOPHR RES, V30, P193, DOI 10.1016/S0920-9964(97)00151-5; Insel BJ, 2008, ARCH GEN PSYCHIAT, V65, P1136, DOI 10.1001/archpsyc.65.10.1136; Ismail B, 2000, J PSYCHIAT RES, V34, P45, DOI 10.1016/S0022-3956(99)00034-5; JABLENSKY A, 1992, PSYCHOL MED, P1; Job DE, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-29; JONES P, 1994, LANCET, V344, P1398, DOI 10.1016/S0140-6736(94)90569-X; Jones P., 1997, NEURODEVELOPMENT ADU, P119; JONGBLOET PH, 1988, DIABETES RES CLIN EX, V9, P51; Juvonen H, 2007, ARCH GEN PSYCHIAT, V64, P894, DOI 10.1001/archpsyc.64.8.894; Kane JM, 2001, ARCH GEN PSYCHIAT, V58, P965, DOI 10.1001/archpsyc.58.10.965; KARETKIN C, 2009, J ATTENTION DISORDER; Kelleher I, 2008, BRIT J PSYCHIAT, V193, P378, DOI 10.1192/bjp.bp.108.049536; Kelly BD, 2010, SCHIZOPHR RES, V116, P75, DOI 10.1016/j.schres.2009.10.015; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P527; Khashan AS, 2008, ARCH GEN PSYCHIAT, V65, P146, DOI 10.1001/archgenpsychiatry.2007.20; Kim E, 2008, CURR OPIN PSYCHIATR, V21, P286, DOI 10.1097/YCO.0b013e3282fbcd21; Kirkpatrick B, 2001, ARCH GEN PSYCHIAT, V58, P165, DOI 10.1001/archpsyc.58.2.165; Kirkpatrick B, 2002, AM J PSYCHIAT, V159, P1382, DOI 10.1176/appi.ajp.159.8.1382; Kirkpatrick B, 2002, J NERV MENT DIS, V190, P526, DOI 10.1097/00005053-200208000-00005; Kirkpatrick B, 1998, AM J PSYCHIAT, V155, P1221, DOI 10.1176/ajp.155.9.1221; Kirkpatrick B, 2008, SCHIZOPHR RES, V103, P151, DOI 10.1016/j.schres.2007.12.479; KNIGHT J, 1992, BRIT J PSYCHIAT, V160, P533, DOI 10.1192/bjp.160.4.533; Knight JG, 2007, MOL PSYCHIATR, V12, P424, DOI 10.1038/sj.mp.4001959; Koponen H, 2004, EUR ARCH PSY CLIN N, V254, P9, DOI 10.1007/s00406-004-0485-2; Krabbendam L, 2005, SCHIZOPHRENIA BULL, V31, P795, DOI 10.1093/schbul/sbi060; Kringlen E, 2000, AM J MED GENET, V97, P4, DOI 10.1002/(SICI)1096-8628(200021)97:1<4::AID-AJMG2>3.0.CO;2-J; Kupka RW, 2002, BIOL PSYCHIAT, V51, P305, DOI 10.1016/S0006-3223(01)01217-3; Lambert TJR, 2009, MED J AUSTRALIA, V190, P171, DOI 10.5694/j.1326-5377.2009.tb02339.x; Larsen TK, 2000, SCHIZOPHR RES, V45, P1, DOI 10.1016/S0920-9964(99)00169-3; Larsson K, 2004, DIABETES-METAB RES, V20, P429, DOI 10.1002/dmrr.506; Lawrie SM, 2001, BRIT J PSYCHIAT, V178, P524, DOI 10.1192/bjp.178.6.524; Lawrie SM, 2008, SCHIZOPHRENIA BULL, V34, P330, DOI 10.1093/schbul/sbm158; Leask SJ, 2002, BRIT J PSYCHIAT, V181, P387, DOI 10.1192/bjp.181.5.387; Leask SJ, 2000, BRIT J PSYCHIAT, V177, P218, DOI 10.1192/bjp.177.3.218; Lecrubier Y, 2001, NEUROPSYCHOBIOLOGY, V44, P41, DOI 10.1159/000054913; Leeson VC, 2009, SCHIZOPHR RES, V107, P55, DOI 10.1016/j.schres.2008.08.014; LEFF J, 1992, PSYCHOL MED, V22, P131, DOI 10.1017/S0033291700032797; Lencz T, 2004, SCHIZOPHR RES, V68, P37, DOI 10.1016/S0920-9964(03)00214-7; Lenior ME, 2005, SCHIZOPHRENIA BULL, V31, P781, DOI 10.1093/schbul/sbi010; Lenoir P, 2009, ENCEPHALE, V35, P36, DOI 10.1016/j.encep.2007.12.011; Lester H, 2009, BRIT J PSYCHIAT, V194, P446, DOI 10.1192/bjp.bp.108.053587; Leucht S, 1999, SCHIZOPHR RES, V35, P51, DOI 10.1016/S0920-9964(98)00105-4; Levene JE, 2009, CAN J PSYCHIAT, V54, P446, DOI 10.1177/070674370905400705; Leweke FM, 2004, EUR ARCH PSY CLIN N, V254, P4, DOI 10.1007/s00406-004-0481-6; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; LEWIS G, 1992, LANCET, V340, P137, DOI 10.1016/0140-6736(92)93213-7; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; LIDDLE PF, 1987, BRIT J PSYCHIAT, V151, P145, DOI 10.1192/bjp.151.2.145; LIDDLE PF, 1987, PSYCHOL MED, V17, P49, DOI 10.1017/S0033291700012976; LIDDLE PJ, 1990, BRIT J PSYCHIAT, V151, P145; LIEBERMAN JA, 1994, AM J PSYCHIAT, V151, P1744; LIEBERMAN JA, 2005, SCHIZOPHR RES, V80, P45; Lloyd T, 2008, PSYCHOL MED, V38, P71, DOI 10.1017/S0033291707001158; MACSWEENEY D, 1978, PSYCHOL MED, V8, P151, DOI 10.1017/S0033291700006735; Maki P, 2005, BRIT MED BULL, V73-74, P1, DOI 10.1093/bmb/ldh046; Makikyro T, 1997, SCHIZOPHR RES, V23, P245, DOI 10.1016/S0920-9964(96)00119-3; MALAMA IM, 1988, BRIT J PSYCHIAT, V152, P482, DOI 10.1192/bjp.152.4.482; Malaspina D, 2001, ARCH GEN PSYCHIAT, V58, P361, DOI 10.1001/archpsyc.58.4.361; Malla A, 2008, PSYCHOL MED, V38, P1585, DOI 10.1017/S0033291707002656; Malla A, 2006, PSYCHOL MED, V36, P649, DOI 10.1017/S0033291706007379; Malla AK, 2002, SCHIZOPHR RES, V54, P231, DOI 10.1016/S0920-9964(01)00254-7; Marshall M, 2005, ARCH GEN PSYCHIAT, V62, P975, DOI 10.1001/archpsyc.62.9.975; Mason P, 2008, BRIT J PSYCHIAT, V193, P192, DOI 10.1192/bjp.bp.108.052795; MASON PR, 1995, ACTA PSYCHIAT SCAND, V91, P217, DOI 10.1111/j.1600-0447.1995.tb09771.x; Mathias S, 2008, J CLIN PSYCHIAT, V69, P358, DOI 10.4088/JCP.v69n0304; Mattsson M, 2008, SOC PSYCH PSYCH EPID, V43, P947, DOI 10.1007/s00127-008-0392-3; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; McClellan JM, 2007, BRIT J PSYCHIAT, V190, P194, DOI 10.1192/bjp.bp.106.025585; McCreadie RG, 1997, BRIT J PSYCHIAT, V170, P334, DOI 10.1192/bjp.170.4.334; McGlashan TH, 2008, SCHIZOPHRENIA BULL, V34, P801, DOI 10.1093/schbul/sbn073; McGlashan TH, 2006, SCHIZOPHRENIA BULL, V32, P609, DOI 10.1093/schbul/sbl032; McGlashan TH, 1999, BIOL PSYCHIAT, V46, P899, DOI 10.1016/S0006-3223(99)00084-0; MCGORRY P, 1998, BRIT J PSYCHIAT, V172, pS1; McGorry PD, 2007, MED J AUSTRALIA, V187, pS8, DOI 10.5694/j.1326-5377.2007.tb01327.x; MCGORRY PD, 2007, MED J AUSTRALIA, V187, pS7; McGrath JJ, 1999, SCHIZOPHR RES, V35, P237, DOI 10.1016/S0920-9964(98)00139-X; McGrath J, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-13; McKetin R, 2006, ADDICTION, V101, P1473, DOI 10.1111/j.1360-0443.2006.01496.x; Mechri A, 2010, PSYCHIAT RES, V175, P22, DOI 10.1016/j.psychres.2008.10.013; MEDNICK SA, 1988, ARCH GEN PSYCHIAT, V45, P189, DOI 10.1001/archpsyc.1988.01800260109013; MELTZER HY, 1986, J CLIN PSYCHOPHARM, V6, P329; Menezes NM, 2009, ACTA PSYCHIAT SCAND, V120, P138, DOI 10.1111/j.1600-0447.2009.01346.x; MENEZES PR, 2009, PSYCHOL MED, V23, P1; Messias E, 2004, ARCH GEN PSYCHIAT, V61, P985, DOI 10.1001/archpsyc.61.10.985; Messias E, 2001, J NERV MENT DIS, V189, P608, DOI 10.1097/00005053-200109000-00006; Messias EL, 2007, PSYCHIAT CLIN N AM, V30, P323, DOI 10.1016/j.psc.2007.04.007; Meyer U, 2007, NEUROSCIENTIST, V13, P241, DOI 10.1177/1073858406296401; Mihalopoulos C, 1999, ACTA PSYCHIAT SCAND, V100, P47, DOI 10.1111/j.1600-0447.1999.tb10913.x; Milev P, 2005, AM J PSYCHIAT, V162, P495, DOI 10.1176/appi.ajp.162.3.495; Milev P, 2003, BIOL PSYCHIAT, V54, P608, DOI 10.1016/S0006-3223(03)00293-2; Moore PB, 2001, AM J PSYCHIAT, V158, P1521, DOI 10.1176/appi.ajp.158.9.1521; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Morgan C, 2008, PSYCHOL MED, V38, P1701, DOI 10.1017/S0033291708004534; Morgan C, 2007, PSYCHOL MED, V37, P495, DOI 10.1017/S0033291706009330; Morgan C, 2007, SCHIZOPHRENIA BULL, V33, P3, DOI 10.1093/schbul/sbl053; Morgan VA, 2008, AUST NZ J PSYCHIAT, V42, P74, DOI 10.1080/00048670701732699; Mors O, 1999, SCHIZOPHR RES, V40, P67, DOI 10.1016/S0920-9964(99)00030-4; Mortensen PB, 2003, ARCH GEN PSYCHIAT, V60, P1209, DOI 10.1001/archpsyc.60.12.1209; Mortensen PB, 2003, J AFFECT DISORDERS, V76, P79, DOI 10.1016/S0165-0327(02)00073-3; Mortensen PB, 2008, ARCH GEN PSYCHIAT, V65, P237, DOI 10.1001/archgenpsychiatry.2007.30; Mosholder AD, 2009, PEDIATRICS, V123, P611, DOI 10.1542/peds.2008-0185; Mulvany F, 2001, BMJ-BRIT MED J, V323, P1398, DOI 10.1136/bmj.323.7326.1398; MURPHY BP, 2009, EARLY INTERVENTION P, V3, P94; Murphy BP, 2008, EARLY INTERV PSYCHIA, V2, P27, DOI 10.1111/j.1751-7893.2007.00053.x; Murphy BP, 2006, SCHIZOPHR RES, V88, P5, DOI 10.1016/j.schres.2006.07.002; Murray RM, 1998, J CLIN PSYCHOPHARM, V18, p2S, DOI 10.1097/00004714-199804001-00002; Nettelbladt P, 2009, NORD J PSYCHIAT, V63, P316, DOI 10.1080/08039480902759192; Norman RMG, 2005, SCHIZOPHR RES, V80, P227, DOI 10.1016/j.schres.2005.05.006; Norman RMG, 2001, PSYCHOL MED, V31, P381, DOI 10.1017/S0033291701003488; Nylander L, 2008, CLIN NEUROPSYCHIATR, V5, P43; O'Donovan MC, 2008, NAT GENET, V40, P1392, DOI 10.1038/ng1208-1392; Odegaard O., 1932, ACTA PSYCHIAT NEUR S, V4, P1, DOI DOI 10.1097/00005053-193312000-00060; ODwyer JM, 1997, J INTELL DISABIL RES, V41, P238, DOI 10.1046/j.1365-2788.1997.04444.x; Oken RJ, 1999, SCHIZOPHRENIA BULL, V25, P625, DOI 10.1093/oxfordjournals.schbul.a033407; Padmos RC, 2004, BIOL PSYCHIAT, V56, P476, DOI 10.1016/j.biopsych.2004.07.003; Pantelis C, 2005, SCHIZOPHRENIA BULL, V31, P672, DOI 10.1093/schbul/sbi034; Pedersen CB, 2004, SCHIZOPHR RES, V66, P83, DOI 10.1016/S0920-9964(03)00062-8; Pedersen CB, 2001, ARCH GEN PSYCHIAT, V58, P1039, DOI 10.1001/archpsyc.58.11.1039; Peet M, 2005, DRUGS, V65, P1051, DOI 10.2165/00003495-200565080-00002; Peet M, 2003, PROSTAG LEUKOTR ESS, V69, P477, DOI 10.1016/j.plefa.2003.08.020; Peet M, 1997, SCHIZOPHR RES, V24, P255, DOI 10.1016/S0920-9964(97)82736-3; Penner Justin D, 2007, Expert Rev Neurother, V7, P797, DOI 10.1586/14737175.7.7.797; Perkins DO, 2005, AM J PSYCHIAT, V162, P1785, DOI 10.1176/appi.ajp.162.10.1785; Perkins DO, 2004, BRIT J PSYCHIAT, V185, P18, DOI 10.1192/bjp.185.1.18; Perrin MC, 2007, SCHIZOPHR RES, V90, P251, DOI 10.1016/j.schres.2006.09.024; Petersen L, 2005, BMJ-BRIT MED J, V331, P602, DOI 10.1136/bmj.38565.415000.E01; Petersen L, 2008, CAN J PSYCHIAT, V53, P660, DOI 10.1177/070674370805301005; Prasad KMR, 2005, PSYCHIAT RES-NEUROIM, V140, P147, DOI 10.1016/j.pscychresns.2004.05.009; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rabinowitz J, 2006, SCHIZOPHR RES, V88, P96, DOI 10.1016/j.schres.2006.07.007; Ramirez N, 2010, PSYCHIAT RES, V175, P11, DOI 10.1016/j.psychres.2009.03.013; Read J, 2005, ACTA PSYCHIAT SCAND, V112, P330, DOI 10.1111/j.1600-0447.2005.00634.x; Reichenberg Abraham, 2005, Dialogues Clin Neurosci, V7, P31; Reichenberg A, 2006, SCHIZOPHR RES, V85, P49, DOI 10.1016/j.schres.2006.03.006; Robinson D, 1999, ARCH GEN PSYCHIAT, V56, P241, DOI 10.1001/archpsyc.56.3.241; Roehr B, 2005, BRIT MED J, V331, P476, DOI 10.1136/bmj.331.7515.476; Rosen K, 2005, SCHIZOPHRENIA BULL, V31, P735, DOI 10.1093/schbul/sbi017; Rothermundt M, 2001, BRAIN BEHAV IMMUN, V15, P319, DOI 10.1006/brbi.2001.0648; Roy MA, 2001, SCHIZOPHR RES, V47, P141, DOI 10.1016/S0920-9964(99)00231-5; Ruiz-Veguilla M, 2009, SCHIZOPHR RES, V107, P158, DOI 10.1016/j.schres.2008.08.001; Saha S, 2006, SOC PSYCH PSYCH EPID, V41, P338, DOI 10.1007/s00127-006-0041-7; Saha S, 2006, ACTA PSYCHIAT SCAND, V114, P36, DOI 10.1111/j.1600-0447.2005.00742.x; Sasaki T, 2000, SCHIZOPHR RES, V42, P79, DOI 10.1016/S0920-9964(99)00102-4; Schimmelmann BG, 2008, J PSYCHIATR RES, V42, P982, DOI 10.1016/j.jpsychires.2007.12.001; Schreier A, 2009, ARCH GEN PSYCHIAT, V66, P527, DOI 10.1001/archgenpsychiatry.2009.23; Sewell RA, 2009, INT REV PSYCHIATR, V21, P152, DOI 10.1080/09540260902782802; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Simonsen E, 2007, ACTA PSYCHIAT SCAND, V116, P54, DOI 10.1111/j.1600-0447.2006.00942.x; Singh SP, 2007, BRIT J PSYCHIAT, V191, pS58, DOI 10.1192/bjp.191.50.s58; Sorensen HJ, 2005, ACTA PSYCHIAT SCAND, V112, P26, DOI 10.1111/j.1600-0447.2005.00548.x; Sorensen HJ, 2003, AM J PSYCHIAT, V160, P464, DOI 10.1176/appi.ajp.160.3.464; Sorensen HJ, 2009, SCHIZOPHRENIA BULL, V35, P631, DOI 10.1093/schbul/sbn121; Spauwen J, 2004, ACTA PSYCHIAT SCAND, V110, P356, DOI 10.1111/j.1600-0447.2004.00429.x; St Clair D, 2005, JAMA-J AM MED ASSOC, V294, P557, DOI 10.1001/jama.294.5.557; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Stefanis NC, 2004, SOC PSYCH PSYCH EPID, V39, P364, DOI 10.1007/s00127-004-0771-3; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Susser E, 1996, ARCH GEN PSYCHIAT, V53, P25; Suvisaari J, 2003, AM J PSYCHIAT, V160, P1183, DOI 10.1176/appi.ajp.160.6.1183; Suvisaari J, 1999, AM J PSYCHIAT, V156, P1100; Tamminga CA, 1998, INT CLIN PSYCHOPHARM, V13, pS21, DOI 10.1097/00004850-199803003-00004; Tandon R, 2008, SCHIZOPHR RES, V102, P1, DOI 10.1016/j.schres.2008.04.011; Tandon R, 2008, SCHIZOPHR RES, V100, P4, DOI 10.1016/j.schres.2008.01.022; Tek C, 2001, J NERV MENT DIS, V189, P613, DOI 10.1097/00005053-200109000-00007; Thorup A, 2007, SCHIZOPHR RES, V97, P60, DOI 10.1016/j.schres.2007.06.018; Thorup A, 2007, PSYCHOL MED, V37, P479, DOI 10.1017/S0033291707009944; Thorup A, 2007, J NERV MENT DIS, V195, P396, DOI 10.1097/01.nmd.0000253784.59708.dd; Tienari P, 2004, BRIT J PSYCHIAT, V184, P216, DOI 10.1192/bjp.184.3.216; Tienari P, 2003, AM J PSYCHIAT, V160, P1587, DOI 10.1176/appi.ajp.160.9.1587; Tiffin PA, 2007, EARLY INTERV PSYCHIA, V1, P104, DOI 10.1111/j.1751-7893.2007.00004.x; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P729, DOI 10.1093/schbul/sbl050; Torrey EF, 2009, SCHIZOPHR RES, V114, P1, DOI 10.1016/j.schres.2009.06.017; Torrey EF, 1996, SCHIZOPHR RES, V21, P141; Torrey EF, 1997, SCHIZOPHR RES, V28, P1, DOI 10.1016/S0920-9964(97)00092-3; van Haren NEM, 2003, SCHIZOPHR RES, V64, P41, DOI 10.1016/S0920-9964(03)00018-5; Van Lieshout RJ, 2008, J PSYCHIATR NEUROSCI, V33, P395; van Os J, 2002, AM J EPIDEMIOL, V156, P319, DOI 10.1093/aje/kwf043; Van Os J, 2004, BRIT J PSYCHIAT, V184, P287, DOI 10.1192/bjp.184.4.287; van Winkel R, 2007, ACTA PSYCHIAT SCAND, V116, P119, DOI 10.1111/j.1600-0447.2007.01014.x; van Winkel R, 2006, SCHIZOPHR RES, V88, P47, DOI 10.1016/j.schres.2006.06.033; Veling W, 2008, SOC PSYCH PSYCH EPID, V43, P953, DOI 10.1007/s00127-008-0381-6; Veling W, 2008, AM J PSYCHIAT, V165, P66, DOI 10.1176/appi.ajp.2007.07030423; Veling W, 2007, INT J EPIDEMIOL, V36, P761, DOI 10.1093/ije/dym085; Volkow ND, 2009, SCHIZOPHRENIA BULL, V35, P469, DOI 10.1093/schbul/sbp016; Vonk R, 2007, BIOL PSYCHIAT, V62, P135, DOI 10.1016/j.biopsych.2006.08.041; Waddington JL, 2007, BRIT J PSYCHIAT, V191, pS52, DOI 10.1192/bjp.191.50.s52; Wade D, 2006, BRIT J PSYCHIAT, V189, P229, DOI 10.1192/bjp.bp.105.017236; Wade D, 2006, SCHIZOPHR RES, V81, P145, DOI 10.1016/j.schres.2005.09.010; Wade D, 2005, AUST NZ J PSYCHIAT, V39, P892, DOI 10.1111/j.1440-1614.2005.01699.x; Welham J, 2006, AUST NZ J PSYCHIAT, V40, P935, DOI 10.1111/j.1440-1614.2006.01913.x; Welham J, 2009, SCHIZOPHRENIA BULL, V35, P603, DOI 10.1093/schbul/sbn084; White C, 2009, PSYCHOL MED, V39, P1447, DOI 10.1017/S003329170800514X; Whitty P, 2006, SCHIZOPHR RES, V86, P110, DOI 10.1016/j.schres.2006.04.012; Wiersma D, 1998, SCHIZOPHRENIA BULL, V24, P75, DOI 10.1093/oxfordjournals.schbul.a033315; WIERSMA D, 1983, PSYCHOL MED, V13, P141, DOI 10.1017/S0033291700050145; Wieselgren IM, 1996, ACTA PSYCHIAT SCAND, V93, P9, DOI 10.1111/j.1600-0447.1996.tb10613.x; WILCOX JA, 1987, PSYCHIAT RES, V21, P303, DOI 10.1016/0165-1781(87)90013-8; Wohl M, 2007, EUR PSYCHIAT, V22, P22, DOI 10.1016/j.eurpsy.2006.08.007; Wood SJ, 2009, MED J AUSTRALIA, V190, pS10; Woodberry KA, 2008, AM J PSYCHIAT, V165, P579, DOI 10.1176/appi.ajp.2008.07081242; Wright P, 1996, SCHIZOPHR RES, V20, P261, DOI 10.1016/0920-9964(96)82950-1; Wright P, 1996, AM J PSYCHIAT, V153, P1530; WYATT RJ, 1991, SCHIZOPHRENIA BULL, V17, P325, DOI 10.1093/schbul/17.2.325; Xu MQ, 2009, SCHIZOPHRENIA BULL, V35, P568, DOI 10.1093/schbul/sbn168; Yolken RH, 2008, MOL PSYCHIATR, V13, P470, DOI 10.1038/mp.2008.5; Yuii K, 2007, ANN NY ACAD SCI, V1113, P276, DOI 10.1196/annals.1391.013; Yun Y, 2005, AUST NZ J PSYCHIAT, V39, P460, DOI 10.1080/j.1440-1614.2005.01604.x; Yung AR, 1996, SCHIZOPHRENIA BULL, V22, P353, DOI 10.1093/schbul/22.2.353; Zammit S, 2002, BRIT MED J, V325, P1199, DOI 10.1136/bmj.325.7374.1199; Zammit S, 2004, ARCH GEN PSYCHIAT, V61, P354, DOI 10.1001/archpsyc.61.4.354; Zammit S, 2009, BRIT J PSYCHIAT, V195, P294, DOI 10.1192/bjp.bp.108.062471; Zhang Qingchen, 2003, Curr Psychiatry Rep, V5, P197, DOI 10.1007/s11920-003-0042-0; [No title captured]	342	3	3	0	23	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0954-0261	1369-1627		INT REV PSYCHIATR	Int. Rev. Psych.		2010	22	2					202	223		10.3109/09540261003661833			22	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	610SA	WOS:000278754200011	20504060				2022-02-06	
J	Noggle, CA; Pierson, EE				Noggle, Chad A.; Pierson, Eric E.			The Path Ahead: Future Trends in the Assessment and Treatment of TBI in the Pediatric Population	APPLIED NEUROPSYCHOLOGY			English	Article						assessment; pediatric TBI; TBI; treatment	BRAIN; PLASTICITY	The current article serves as the concluding remarks to this special issue on the assessment and treatment of traumatic brain injury in children and adolescents. The article provides a brief discussion of the changing landscape of clinical and research endeavors within this population and potential directions for the future.	[Noggle, Chad A.] So Illinois Univ, Sch Med, Dept Psychiat, Springfield, IL 62794 USA; [Pierson, Eric E.] Ball State Univ, Dept Educ Psychol, Muncie, IN 47306 USA		Noggle, CA (corresponding author), So Illinois Univ, Sch Med, Dept Psychiat, 901 W Jefferson,POB 19642, Springfield, IL 62794 USA.	cnoggle@siumed.edu					Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Kolb B, 2000, DEV NEUROPSYCHOL, V18, P423, DOI 10.1207/S1532694208Kolb; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; Morgan JE, 2008, TXB CLIN NEUROPSYCHO, P158; Nybo T, 2004, J INT NEUROPSYCH SOC, V10, P719, DOI 10.1017/S1355617704105109; SEMRUDCLIKEMAN M, 2001, TRAUMATIC BRAIN INJU	9	3	5	0	2	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2010	17	2					123	124	PII 922159463	10.1080/09084281003709009			2	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	596CX	WOS:000277662800008	20467953				2022-02-06	
J	Park, S; Park, J; Kim, JM; Kim, JH; Son, J; Chang, D; Choi, SH; Kim, G				Park, S.; Park, J.; Kim, J. M.; Kim, J. H.; Son, J.; Chang, D.; Choi, S. H.; Kim, G.			Penetrating cranial injury due to gunshot in a dog: a case report	VETERINARNI MEDICINA			English	Article						craniectomy; gunshot; traumatic brain injury; dog	BRAIN-INJURY; BULLET; PNEUMOCEPHALUS	A ten-month old, male Black and Tan Coonhound dog was referred with ocular bleeding due to gunshot injury. His mental state was normal. A computed tomography revealed that the bullet was planted in the left cranium. It was presumed that the trajectory of the bullet penetrated from the right medial angle of the eye to the orbit, and changed its track to caudo-dorsal by penetrating the cranium, ending up at the left cranium. The bullet was removed by lateral rostrotentorial craniectomy. No complications were observed during a one-year follow-up except the blindness in the right eye. This is a rare case of gunshot-induced traumatic brain injury featuring a bullet which went through the orbit into the cranium. The damaged frontal lobe seemed to show no neurological signs at the time of first examination in this case. In conclusion, a less aggressive surgical approach is recommended to remove bullets when they are accessible.	[Kim, G.] Chungbuk Natl Univ, Coll Vet Med, Ctr Vet Med, Lab Vet Surg, Cheongju 361763, South Korea		Kim, G (corresponding author), Chungbuk Natl Univ, Coll Vet Med, Ctr Vet Med, Lab Vet Surg, 12 Gaeshin Dong, Cheongju 361763, South Korea.	ghkim@cbu.ac.kr		Kim, Gonhyung/0000-0002-9384-4741; CHOI, Seok Hwa/0000-0002-7003-3655			Agrawal A, 2008, J NEPAL MED ASSOC, V47, P145; Bagley RS, 1996, AM J VET RES, V57, P116; BEBCHUK TN, 1995, VET CLIN N AM-SMALL, V25, P1111, DOI 10.1016/S0195-5616(95)50107-X; Bhatoe HS, 2001, NEUROL INDIA, V49, P29; Bruns JJ, 2009, MT SINAI J MED, V76, P129, DOI 10.1002/msj.20101; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cavanaugh RP, 2008, J SMALL ANIM PRACT, V49, P244, DOI 10.1111/j.1748-5827.2007.00467.x; Coon T, 2006, PEDIATRICS, V117, P227, DOI 10.1542/peds.2005-1098; de Madureira PR, 2009, SAO PAULO MED J, V127, P52, DOI 10.1590/S1516-31802009000100011; Gocer AI, 1996, NEUROSURG REV, V19, P33, DOI 10.1007/BF00346607; Gonul E, 2005, SURG NEUROL, V63, P24, DOI 10.1016/j.surneu.2004.05.043; GONZALEZCRUZ J, 2007, J LOUISIANA STATE ME, V159; Haley AC, 2009, JAVMA-J AM VET MED A, V234, P1295, DOI 10.2460/javma.234.10.1295; Jadhav V, 2008, FRONT BIOSCI, V13, P3793, DOI 10.2741/2968; Kim TW, 2007, J TRAUMA, V62, P1446, DOI 10.1097/01.ta.0000222909.31666.db; Pascual JM, 2009, ACTA NEUROCHIR, V151, P689, DOI 10.1007/s00701-009-0222-8; Platt SR, 2001, J VET INTERN MED, V15, P581, DOI 10.1892/0891-6640(2001)015&lt;0581:TPVOTM&gt;2.3.CO;2; Robaei D, 2004, MED J AUSTRALIA, V181, P329, DOI 10.5694/j.1326-5377.2004.tb06302.x; Shahpurkar VV, 2008, INDIAN J OPHTHALMOL, V56, P345; Shimura T, 1997, NEUROL SURG TOKYO, V25, P607; Sulejczak D, 2008, FOLIA NEUROPATHOL, V46, P213; WILLIAMS AJ, 2007, J NEUROINFLAMM, V30, P4; Zweckberger K, 2008, LARYNGO RHINO OTOL, V87, P121, DOI 10.1055/s-2007-995478	23	3	3	0	5	CZECH ACADEMY AGRICULTURAL SCIENCES	PRAGUE	TESNOV 17, PRAGUE, 117 05, CZECH REPUBLIC	0375-8427	1805-9392		VET MED-CZECH	Vet. Med.		2010	55	5					253	257		10.17221/2995-VETMED			5	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	621LI	WOS:000279579900005		gold			2022-02-06	
B	Schmitt, KU; Niederer, PF; Muser, MH; Walz, F	Schmitt, KU; Niederer, PF; Muser, MH; Walz, F			Schmitt, Kai-Uwe; Niederer, Peter F.; Muser, Markus H.; Walz, Felix	Schmitt, KU; Niederer, PF; Muser, MH; Walz, F		Head Injuries	TRAUMA BIOMECHANICS: ACCIDENTAL INJURY IN TRAFFIC AND SPORTS, THIRD EDITION			English	Article; Book Chapter							COLLEGIATE FOOTBALL PLAYERS; PROFESSIONAL FOOTBALL; BIOMECHANICS; IMPACTS; ACCELERATION; CONCUSSION; HOCKEY		[Schmitt, Kai-Uwe; Niederer, Peter F.] Univ Zurich, Inst Biomed Engn, CH-8092 Zurich, Switzerland; [Schmitt, Kai-Uwe; Niederer, Peter F.] ETH, CH-8092 Zurich, Switzerland; [Muser, Markus H.; Walz, Felix] AGU, CH-8006 Zurich, Switzerland		Schmitt, KU (corresponding author), Univ Zurich, Inst Biomed Engn, ETZ F90,Gloriastr 35, CH-8092 Zurich, Switzerland.						ADVANI S, 1982, HEAD INJURY MECH HUM; *AGU, 2003, WORK GROUP ACC MECH; Allsop D., 1991, P 35 STAPP CAR CRASH, P139; Allsop D, 1988, P 32 STAPP CAR CRASH; ATHA J, 1985, BRIT MED J, V291, P1756, DOI 10.1136/bmj.291.6511.1756; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Beier G., 1980, IRCOBI C BIRM UK, P218; BIASCA N, 2006, SCHWEIZ MED FORUM, V6, P121; Biasca N, 2006, SCHWEIZ MED FORUM, V6, P93; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Gadd C, 1961, NATL RES COUNCIL PUB, P141; Gennarelli T, 1972, P 16 STAPP CAR CRASH, P269; Gennarelli T, 2005, AIS 2005 INJURY SCAL; Goldsmith Werner, 2005, Critical Reviews in Biomedical Engineering, V33, P105, DOI 10.1615/CritRevBiomedEng.v33.i2.20; GOT C, 1978, P 22 STAPP CAR CRASH, P57; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; GURDJIAN ES, 1953, NEUROLOGY, V3, P417, DOI 10.1212/WNL.3.6.417; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; HERTZ, 1993, 37 ANN P AAAM; Hirsch A, 1968, 2876 DEP NAV; Hodgson V. R., 1971, BREAKING STRENGTH HU; Hunter RE, 1999, AM J SPORT MED, V27, P381, DOI 10.1177/03635465990270032101; Huston J, 1975, P INT IRCOBI C BIOM, P153; Junge A, 2006, AM J SPORT MED, V34, P565, DOI 10.1177/0363546505281807; KESSLER JW, 1988, 807432 DOT HS NAT TE; King A. I., 2003, IRCOBI C LISB PORT; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Kleinberger M, 1998, DEV IMPROVED INJURY; KRABBEL G, 1997, THESIS TU BERLIN; Kramer F, 1998, PASSIVE SICHERHEIT K; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; LOWENHIELM P, 1975, J BIOMECH, V8, P351, DOI 10.1016/0021-9290(75)90069-X; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; Melvin J, 2002, ACCIDENTAL INJURY BI; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Nahum A, 1968, P 2 STAPP CAR CRASH; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Newman J, 2000, P 44 STAPP CAR CRASH; Newman J, 2002, ACCIDENTAL INJURY BI; Newman J.A., 1986, P IRCOBI C, P121; Ommaya, 1984, BIOMECHANICS TRAUMA; Ommaya A. K., 1967, P 11 STAPP CAR CRASH, V670906; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Ono I, 1980, P 24 STAPP CAR CRASH; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Prange Michael T, 2004, Stapp Car Crash J, V48, P279; Schneider D., 1972, P 16 STAPP CAR CRASH, P186; Smith DH, 2002, J NEUROTRAUM, V19, P1117, DOI 10.1089/08977150260337921; Smith MS, 2000, J SPORT SCI, V18, P445, DOI 10.1080/02640410050074377; SMITH T, 1988, P IRCOBI C, P271; Sobotta J, 1997, ATLAS ANATOMIE MENSC, V1; Sobotta J, 1997, ATLAS ANATOMIE MENSC, V2; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; TARRIERE C, 1987, RELATIONSHIP EXPT ME; Versace, 1971, P 15 STAPP CAR CRASH, DOI DOI 10.4271/710881; VETTER D, 2000, SEM BIOM DUMM TECHN; Viano D, 2001, CRASHWORTHINESS BIOM; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; Willinger R, 2003, INT J VEHICLE DES, V32, P94, DOI 10.1504/IJVD.2003.003239; Yang K, 2007, P HUM MOD SIM AUT SA; Yen KL, 2000, PEDIATR EMERG CARE, V16, P215, DOI 10.1097/00006565-200006000-00021; Zarzyn T, 2003, BRIT J SPORT MED, V36, P270; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	70	3	3	0	1	SPRINGER-VERLAG BERLIN	BERLIN	HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY			978-3-642-03712-2				2010							63	93		10.1007/978-3-642-03713-9_3	10.1007/978-3-642-03713-9		31	Engineering, Biomedical; Engineering, Mechanical; Sport Sciences	Book Citation Index – Science (BKCI-S)	Engineering; Sport Sciences	BML59	WOS:000272737000003					2022-02-06	
J	Shaqiri, E; Vyshka, G; Sinamati, A; Ymaj, B; Ismaili, Z				Shaqiri, Elmaz; Vyshka, Gentian; Sinamati, Admir; Ymaj, Besim; Ismaili, Zija			Fatal Basilar Thrombosis Possibly Related to Minor Cervical Trauma: A Case Report	CASE REPORTS IN MEDICINE			English	Article							ARTERY THROMBOSIS; OCCLUSION; STROKE	Background. Basilar thrombosis is a potentially fatal event, whose traumatic etiology has been repeatedly stated. Methods. We performed the autopsy and the microscopic examination of the brain stem structures from an individual, whose sudden death raised logical suspicions regarding the causative factor. Results. The brain was swollen and clearly hyperemic; a massive basilar thrombus with complete occlusion of the median segment of the basilar artery was macroscopically seen. The brainstem showed an infarcted zone in the pons, with secondary hemorrhagic changes, mainly in the form of multiple petechial hemorrhages. Pontine arteries showed extensive alterations, mainly in the form of severed endothelium, which suggested a thrombotic-traumatic mechanism as the main etiological factor. Conclusions. Minor injuries, such as slight whiplashes, abrupt neck movements, neck trauma related to the slowing down of the vehicles, and critical neck positioning, can all of them explain a thrombotic event in the basilar artery, leading to a fatal occurrence. Other risk factors may obviously concur, but their importance seems unclear.	[Shaqiri, Elmaz; Sinamati, Admir; Ymaj, Besim; Ismaili, Zija] Univ Hosp Ctr Mother Theresa, Inst Legal Med, Tirana 1005, Albania; [Vyshka, Gentian] Univ Hosp Ctr Mother Theresa, Serv Neurol, Rr Dibres 371, Tirana 1005, Albania		Vyshka, G (corresponding author), Univ Hosp Ctr Mother Theresa, Serv Neurol, Rr Dibres 371, Tirana 1005, Albania.	gvyshka@yahoo.com	Vyshka, Gentian/H-5316-2019	Vyshka, Gentian/0000-0001-5286-1265			Baker WE, 2004, EMERG MED CLIN N AM, V22, P1081, DOI 10.1016/j.emc.2004.05.009; Beaudry M, 2003, CAN J NEUROL SCI, V30, P320, DOI 10.1017/S0317167100003024; Black M, 2002, J CLIN PATHOL, V55, P44, DOI 10.1136/jcp.55.1.44; Davis SM, 2006, STROKE, V37, P2440, DOI 10.1161/01.STR.0000237069.89438.a9; De Decker K, 2003, RESUSCITATION, V59, P147, DOI 10.1016/S0300-9572(03)00157-6; Devuyst G, 2002, ARCH NEUROL-CHICAGO, V59, P567, DOI 10.1001/archneur.59.4.567; Hayem G., 1868, ARCH PHYSL, V1, P270; Heckmann JG, 2006, CEREBROVASC DIS, V21, P140, DOI 10.1159/000090449; Inamasu J, 2006, SURG NEUROL, V65, P238, DOI 10.1016/j.surneu.2005.06.043; Kaye V., VERTEBROBASILAR STRO; KUBIK CS, 1946, BRAIN, V69, P73, DOI 10.1093/brain/69.2.73; LHERMITTE J, 1934, JB PSYCHIATR NEUROL, V51, P91; Lindsberg PJ, 2006, STROKE, V37, P922, DOI 10.1161/01.STR.0000202582.29510.6b; Schonewille WJ, 2005, J NEUROL NEUROSUR PS, V76, P1238, DOI 10.1136/jnnp.2004.049924; SPROGOEJAKOBSEN S, 1990, FORENSIC SCI INT, V45, P239, DOI 10.1016/0379-0738(90)90180-7; Vyshka G., BMJ CASE RE IN PRESS; Weintraub M I, 1995, J Neuroimaging, V5, P16; WEINTRAUB MI, 1993, JAMA-J AM MED ASSOC, V269, P2085, DOI 10.1001/jama.1993.03500160051022	18	3	3	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-9627	1687-9635		CASE REP MED	Case Rep. Med.		2010	2010								401978	10.1155/2010/401978			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V25IJ	WOS:000215218000087	20827380	Green Published, Green Submitted, gold			2022-02-06	
J	Smrcka, M; Neuman, E; Duris, K; Svoboda, T; Duba, M				Smrcka, M.; Neuman, E.; Duris, K.; Svoboda, T.; Duba, M.			Monitoring PtiO(2) and Changes in Oxygen Fraction in the Breathed Mixture after Severe Subarachnoid Haemorrhage	CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE			Czech	Article						brain tissue oxygen; subarachnoid haemorrhage; vasospasm	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; CEREBRAL VASOSPASM; TISSUE PO2; TENSION; MICRODIALYSIS; ANESTHESIA; DELIVERY	Introduction: The aim of this study was to evaluate any possible improvement in outcome for post-severe-SAH patients that might result from monitoring tissue oxygen in the brain (PtiO2, Licox system) and manipulation of the fraction of oxygen in the inhaled mixture of gases (FiO(2)) with respect to PtiO2 value. Material and methods: 45 patients with aneurysm SAH HH 3, 4 and 5 were enrolled in the study (2007-2009). All patients were artificially ventilated. The first group consisted of 22 patients with SAH HH 4 and 5 treated by coiling. The second group consisted of 23 patients with SAH HH 3 and 4 treated by clipping. The groups were randomly divided into experimental and control subgroups. In the experimental subgroups, PtiO2 was monitored. If the PtiO2 value dropped below 15 mmHg and had not improved after 30 minutes, FiO2 was increased from the default values (range 40-55%) to higher levels (range 70-85%). If the PtiO2 level reached 15 mmHg for at least an hour, FiO(2) was brought back to a lower level. Treatment outcome was quantified using the Glasgow Outcome Scale (GOS) and evaluated 3 months after the SAH. Results: The treatment results for patients with and without the use of PtiO2 monitoring did not differ statistically. Conclusion: Therapy with FiO(2) manipulation subsequent to PtiO2 measurements did not improve the outcome in patients suffering from SAH, HH 3, 4 and 5. It appears likely that vasospasm prevents PtiO2 increase in response to FiO(2) elevation.	[Smrcka, M.; Neuman, E.; Duris, K.; Svoboda, T.; Duba, M.] LF MU, Neurochirurg Klin, Brno 62500, Czech Republic; [Smrcka, M.; Neuman, E.; Duris, K.; Svoboda, T.; Duba, M.] FN Brno, Brno 62500, Czech Republic		Smrcka, M (corresponding author), LF MU, Neurochirurg Klin, Jihlavska 20, Brno 62500, Czech Republic.	msmrcka@fnbrno.cz	Smrcka, Martin/AAM-8872-2021	Smrcka, Martin/0000-0002-9191-8700			Chang HS, 2000, J NEUROSURG, V92, P971, DOI 10.3171/jns.2000.92.6.0971; Charbel FT, 2000, SURG NEUROL, V54, P432, DOI 10.1016/S0090-3019(00)00340-2; Charpentier C, 1999, STROKE, V30, P1402, DOI 10.1161/01.STR.30.7.1402; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P191, DOI 10.1097/01.WCB.0000100045.07481.DE; Duris K, 2009, ANEST INTENZIV MED, V20, P102; Filaun M, 2008, CESK SLOV NEUROL N, V71, P657; FISHER CM, 1996, J NEUROSURG, V85, P751; Fujii Y, 1997, J NEUROSURG, V86, P594, DOI 10.3171/jns.1997.86.4.0594; Gal R, 2007, CESK SLOV NEUROL N, V70, P562; Hejcl A, 2007, Cas Lek Cesk, V146, P307; HEROS RC, 1983, ANN NEUROL, V14, P599, DOI 10.1002/ana.410140602; Hirai S, 1996, NEUROSURGERY, V39, P441, DOI 10.1097/00006123-199609000-00002; Hlatky R, 2008, J NEUROSURG, V108, P53, DOI 10.3171/JNS/2008/108/01/0053; Hoelper BM, 2005, ACTA NEUROCHIR, V147, P767, DOI 10.1007/s00701-005-0512-8; Hop JW, 1999, STROKE, V30, P2268, DOI 10.1161/01.STR.30.11.2268; INAGAWA T, 1992, ACTA NEUROCHIR, V115, P79, DOI 10.1007/BF01406362; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; KASSELL NF, 1985, STROKE, V16, P562, DOI 10.1161/01.STR.16.4.562; Kett-White R, 2002, NEUROSURGERY, V50, P1213, DOI 10.1097/00006123-200206000-00008; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Lanzino G, 1996, J NEUROSURG, V85, P410, DOI 10.3171/jns.1996.85.3.0410; Meixensberger J, 2003, NEUROL RES, V25, P445, DOI 10.1179/016164103101201823; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Pachl J, 2005, ACTA NEUROCHIR SUPPL, V95, P141; RABB CH, 1994, ACTA NEUROCHIR, V127, P27, DOI 10.1007/BF01808542; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Scheufler KM, 2002, ANESTH ANALG, V95, P1042, DOI 10.1097/00000539-200210000-00046; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249	31	3	3	1	5	CZECH MEDICAL SOC	PRAGUE 2	SOKOLSKA 31, PRAGUE 2 120 26, CZECH REPUBLIC	1210-7859			CESK SLOV NEUROL N	Cesk. Slov. Neurol. Neurochir.		2010	73	6					694	700					7	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	696MY	WOS:000285446700010					2022-02-06	
J	Speziale, B; Kulbago, S; Menter, A				Speziale, Bette; Kulbago, Sarah; Menter, Amy			Diagnosing and Treating Traumatic Brain Injury Among Veterans of the Afghanistan and Iraq Wars: Implications for Social Work	JOURNAL OF SOCIAL WORK IN DISABILITY & REHABILITATION			English	Article						brain injury; disability; military; Operation Enduring Freedom; Operation Iraqi Freedom; rehabilitation; trauma; veterans		Traumatic brain injury (TBI) is a serious condition affecting many American veterans who have served in Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF). Using a biopsychosocial perspective, the authors delineate and discuss the challenges of diagnosing and treating this neurological disability among soldiers who have returned to the United States from combat theaters in the Middle East. They explain recent changes including the Veterans Affairs Polytrauma System of Care, as well as social work's role on the interdisciplinary team who promote rehabilitation and community reentry for OEF/OIF veterans with TBI.	[Speziale, Bette] Ohio State Univ, Coll Social Work, 325 Stillman Hall,1947 Coll Rd, Columbus, OH 43210 USA; [Kulbago, Sarah] Vet Adm Med Ctr, Dayton, OH USA; [Menter, Amy] Ohio State Univ, Coll Social Work, Columbus, OH 43210 USA		Speziale, B (corresponding author), Ohio State Univ, Coll Social Work, 325 Stillman Hall,1947 Coll Rd, Columbus, OH 43210 USA.	speziale.1@osu.edu					ANISKIEWICZ A, 2007, PSYCHOTHERAPY NEUROP; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Coetzer R, 2007, J HEAD TRAUMA REHAB, V22, P39, DOI 10.1097/00001199-200701000-00005; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Darkins A, 2008, ARCH PHYS MED REHAB, V89, P182, DOI 10.1016/j.apmr.2007.07.027; Engel George L, 2012, Psychodyn Psychiatry, V40, P377, DOI 10.1037/h0089260; Foster M, 2004, SOC SCI MED, V59, P1867, DOI 10.1016/j.socscimed.2004.02.017; Foster M, 2003, SOC SCI MED, V56, P2201, DOI 10.1016/S0277-9536(02)00236-8; Giles GM, 2006, J HEAD TRAUMA REHAB, V21, P168, DOI 10.1097/00001199-200603000-00009; Hill JJ, 2009, AM J PHYS MED REHAB, V88, P605, DOI 10.1097/PHM.0b013e3181ae0f83; Hornstein A., 2005, TXB TRAUMATIC BRAIN, P571; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Kaufman DM, 2007, CLIN NEUROLOGY PSYCH; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; Kronenberger E., 2007, US TODAY, P1; Nakase-Richardson R., 2006, HDB NEUROLOGIC RATIN, P363; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Trudel TM, 2007, J REHABIL RES DEV, V44, P1007, DOI 10.1682/JRRD.2006.12.0167; U.S. Department of Veterans Affairs, 2004, TRAUMATIC BRAIN INJU; U.S. Department of Veterans Affairs, 2010, VA POL SYST CAR; U. S. Department of Veterans Affairs, 2010, FED BEN VET DEP SURV; Underhill AT, 2004, J REHABIL RES DEV, V41, P603, DOI 10.1682/JRRD.2003.06.0094; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163	31	3	3	1	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1536-710X	1536-7118		J SOC WORK DISABIL R	J. Soc. Work Disabil. Rehabil.		2010	9	4					289	302		10.1080/1536710X.2010.523664			14	Social Work	Emerging Sources Citation Index (ESCI)	Social Work	V93VE	WOS:000213088100004	21104517				2022-02-06	
B	Suppiramaniam, V; Abdel-Rahman, EA; Buabeid, MA; Parameshwaran, K		McQueen, CA		Suppiramaniam, V.; Abdel-Rahman, E. A.; Buabeid, M. A.; Parameshwaran, K.			Ion Channels	COMPREHENSIVE TOXICOLOGY, VOL 13: NERVOUS SYSTEM AND BEHAVIORAL TOXICOLOGY, 2ND EDITION			English	Article; Book Chapter							CA2+-ACTIVATED K+ CHANNELS; VOLTAGE-GATED SODIUM; SPIDER PHONEUTRIA-NIGRIVENTER; ACTIVATED POTASSIUM CHANNEL; AMINO-ACID-SEQUENCE; PROTEIN-KINASE-C; TITYUS-SERRULATUS SCORPION; 3D STRUCTURE DETERMINATION; AFFINITY ZINC INHIBITION; TRAUMATIC BRAIN-INJURY		[Suppiramaniam, V.; Abdel-Rahman, E. A.; Buabeid, M. A.; Parameshwaran, K.] Auburn Univ, Auburn, AL 36849 USA		Suppiramaniam, V (corresponding author), Auburn Univ, Auburn, AL 36849 USA.						ABRAMSON SN, 1989, MOL PHARMACOL, V36, P349; Acuna-Castillo C, 2000, J NEUROCHEM, V74, P1529, DOI 10.1046/j.1471-4159.2000.0741529.x; ADACHI S, 1994, J BIOL CHEM, V269, P17677; Adamczyk A, 2006, NEUROREPORT, V17, P1883, DOI 10.1097/WNR.0b013e3280115185; ADAMS ME, 1990, J BIOL CHEM, V265, P861; Ahluwalia J, 2004, NATURE, V427, P853, DOI 10.1038/nature02356; AKAIKE N, 1989, J PHYSIOL-LONDON, V412, P181, DOI 10.1113/jphysiol.1989.sp017610; ALBILLOS A, 1994, J PHYSIOL-LONDON, V477, P197, DOI 10.1113/jphysiol.1994.sp020184; ALBUQUERQUE EX, 1971, J PHARMACOL EXP THER, V176, P511; Amberg GC, 2006, AM J PHYSIOL-CELL PH, V291, pC348, DOI 10.1152/ajpcell.00086.2006; Ameri A, 1998, PROG NEUROBIOL, V56, P211, DOI 10.1016/S0301-0082(98)00037-9; Andres MA, 2009, FEBS LETT, V583, P369, DOI 10.1016/j.febslet.2008.12.024; Antil S, 1999, J BIOL CHEM, V274, P34851, DOI 10.1074/jbc.274.49.34851; Antil-Delbeke S, 2000, J BIOL CHEM, V275, P29594, DOI 10.1074/jbc.M909746199; Antonijevic B, 2007, CLIN MED RES, V5, P71, DOI 10.3121/cmr.2007.701; ARAKAWA O, 1991, BRAIN RES, V551, P58, DOI 10.1016/0006-8993(91)90913-G; ARAUJO DAM, 1993, N-S ARCH PHARMACOL, V347, P205; ARONSTAM RS, 1981, J BIOL CHEM, V256, P2843; Arroyo G, 2003, EUR J PHARMACOL, V475, P11, DOI 10.1016/S0014-2999(03)02084-3; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; AUDESIRK G, 1993, NEUROTOXICOLOGY, V14, P259; AUGUSTE P, 1990, J BIOL CHEM, V265, P4753; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Babot Z, 2007, J NEUROSCI RES, V85, P3687, DOI 10.1002/jnr.21433; BADEN DG, 1989, FASEB J, V3, P1807, DOI 10.1096/fasebj.3.7.2565840; Bardou O, 2009, AM J PHYSIOL-LUNG C, V296, pL145, DOI 10.1152/ajplung.90525.2008; Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Bean BP, 1998, NEURON, V20, P825, DOI 10.1016/S0896-6273(00)80463-8; Beedle AM, 2002, J MEMBRANE BIOL, V187, P225, DOI 10.1007/s00232-001-0166-2; Bentzen BH, 2009, PFLUG ARCH EUR J PHY, V457, P979, DOI 10.1007/s00424-008-0583-5; Benzinger GR, 1998, J BIOL CHEM, V273, P80, DOI 10.1074/jbc.273.1.80; BEVAN S, 1991, J PHYSIOL-LONDON, V433, P145, DOI 10.1113/jphysiol.1991.sp018419; Bezanilla F, 2002, J GEN PHYSIOL, V120, P465, DOI 10.1085/jgp.20028660; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Biel M, 2002, TRENDS CARDIOVAS MED, V12, P206, DOI 10.1016/S1050-1738(02)00162-7; Biel M, 1999, Rev Physiol Biochem Pharmacol, V135, P151, DOI 10.1007/BFb0033672; Blank T, 2004, CNS NEUROL DISORD-DR, V3, P161, DOI 10.2174/1568007043337472; Bohnel H, 2005, VET RES COMMUN, V29, P313, DOI 10.1023/B:VERC.0000048489.45634.32; Boldyreva AA, 2005, B EXP BIOL MED+, V140, P403, DOI 10.1007/s10517-005-0503-z; Borchani L, 1997, TOXICON, V35, P365, DOI 10.1016/S0041-0101(96)00173-0; Bourinet E, 2001, BIOPHYS J, V81, P79, DOI 10.1016/S0006-3495(01)75681-0; Bouton CMLS, 2001, J NEUROCHEM, V76, P1724, DOI 10.1046/j.1471-4159.2001.00168.x; Bradberry Sally M, 2005, Toxicol Rev, V24, P93, DOI 10.2165/00139709-200524020-00003; Bradley J, 2001, SCIENCE, V294, P2095, DOI 10.1126/science.294.5549.2095; Braga MFM, 1999, BRAIN RES, V826, P22, DOI 10.1016/S0006-8993(99)01194-4; Brier TJ, 2003, MOL PHARMACOL, V64, P954, DOI 10.1124/mol.64.4.954; Brosenitsch TA, 2001, J NEUROSCI, V21, P2571, DOI 10.1523/JNEUROSCI.21-08-02571.2001; Brown RL, 2003, J GEN PHYSIOL, V122, P749, DOI 10.1085/jgp.200308823; Bunnelle WH, 2007, J MED CHEM, V50, P3627, DOI 10.1021/jm070018l; Butt AM, 2006, J CELL MOL MED, V10, P33, DOI 10.1111/j.1582-4934.2006.tb00289.x; CANDIA S, 1992, BIOPHYS J, V63, P583, DOI 10.1016/S0006-3495(92)81630-2; Carroll FI, 2004, BIOORG MED CHEM LETT, V14, P1889, DOI 10.1016/j.bmcl.2004.02.007; Cassola AC, 1998, PFLUG ARCH EUR J PHY, V436, P545, DOI 10.1007/s004240050670; Castle NA, 2003, MOL PHARMACOL, V63, P409, DOI 10.1124/mol.63.2.409; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; CHANGEUX JP, 1970, P NATL ACAD SCI USA, V67, P1241, DOI 10.1073/pnas.67.3.1241; Che NY, 2009, PROTEIN EXPRES PURIF, V65, P154, DOI 10.1016/j.pep.2009.02.002; Cheikh A, 2006, TOXICON, V48, P373, DOI 10.1016/j.toxicon.2006.06.016; Chemin J, 2001, EMBO J, V20, P7033, DOI 10.1093/emboj/20.24.7033; Chemin J, 2007, J BIOL CHEM, V282, P32710, DOI 10.1074/jbc.M702746200; Chemin J, 2007, J BIOL CHEM, V282, P2314, DOI 10.1074/jbc.M610033200; Chemin J, 2006, CELL CALCIUM, V40, P121, DOI 10.1016/j.ceca.2006.04.015; Chen CC, 2002, P NATL ACAD SCI USA, V99, P8992, DOI 10.1073/pnas.122245999; Chen JQ, 2000, J MED CHEM, V43, P3478, DOI 10.1021/jm000904v; Chen YC, 2003, ANN NEUROL, V54, P239, DOI 10.1002/ana.10607; CHIAPPINELLI VA, 1983, BRAIN RES, V277, P9, DOI 10.1016/0006-8993(83)90902-2; Chu XP, 2004, J NEUROSCI, V24, P8678, DOI 10.1523/JNEUROSCI.2844-04.2004; Chuang RSI, 1998, NAT NEUROSCI, V1, P668, DOI 10.1038/3669; Clemente GT, 1999, ARCH ORAL BIOL, V44, P103, DOI 10.1016/S0003-9969(98)00109-5; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; COHEN CJ, 1992, MOL PHARMACOL, V42, P947; COHEN CJ, 1988, P NATL ACAD SCI USA, V85, P2412, DOI 10.1073/pnas.85.7.2412; COLQUHOUN D, 1982, BRIT J PHARMACOL, V75, P77, DOI 10.1111/j.1476-5381.1982.tb08759.x; CORDEIRO MD, 1993, TOXICON, V31, P35, DOI 10.1016/0041-0101(93)90354-L; Coscoy S, 1999, J BIOL CHEM, V274, P10129, DOI 10.1074/jbc.274.15.10129; COULTER DA, 1989, NEUROSCI LETT, V98, P74, DOI 10.1016/0304-3940(89)90376-5; CREST M, 1992, J BIOL CHEM, V267, P1640; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Cuppoletti J, 2007, BBA-BIOMEMBRANES, V1768, P1083, DOI 10.1016/j.bbamem.2006.12.015; Dalsgaard T, 2009, INVEST OPHTH VIS SCI, V50, P3819, DOI 10.1167/iovs.08-3168; Daly JW, 2003, P NATL ACAD SCI USA, V100, P11092, DOI 10.1073/pnas.1834430100; Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042; de la Vega RCR, 2004, TOXICON, V43, P865, DOI 10.1016/j.toxicon.2004.03.022; DESHPANDE JK, 1986, ANESTHESIOLOGY, V64, P215, DOI 10.1097/00000542-198602000-00015; DICKENSON AH, 1991, BRIT J PHARMACOL, V104, P1045, DOI 10.1111/j.1476-5381.1991.tb12547.x; DiMascio A, 1972, BUTYROPHENONES PSYCH, P117; Dingledine R, 1999, PHARMACOL REV, V51, P7; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Diochot S., 2009, V46, P99, DOI 10.1007/978-3-540-87895-7_4; Dobrev D, 2003, EUR J PHARMACOL, V461, P105, DOI 10.1016/S0014-2999(03)01319-0; Doering CJ, 2003, J BIOENERG BIOMEMBR, V35, P491, DOI 10.1023/B:JOBB.0000008022.50702.1a; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; Doorty KB, 1997, J BIOL CHEM, V272, P19925, DOI 10.1074/jbc.272.32.19925; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Dzhura IO, 1996, NEUROSCIENCE, V70, P729, DOI 10.1016/S0306-4522(96)83010-7; Ekberg J, 2008, INT J BIOCHEM CELL B, V40, P2363, DOI 10.1016/j.biocel.2007.08.017; Engleman EA, 2008, CNS NEUROL DISORD-DR, V7, P454, DOI 10.2174/187152708786927886; ENYEART JJ, 1990, MOL PHARMACOL, V37, P752; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Escoubas P, 2002, MOL PHARMACOL, V62, P48, DOI 10.1124/mol.62.1.48; EVANS ML, 1991, NEUROSCI LETT, V129, P103, DOI 10.1016/0304-3940(91)90730-H; Eyer Peter, 2003, Toxicological Reviews, V22, P165, DOI 10.2165/00139709-200322030-00004; Faber ES, 2009, CELL BIOCHEM BIOPHYS, V55, P127, DOI 10.1007/s12013-009-9062-7; FELDMAN DH, 1987, FEBS LETT, V214, P295, DOI 10.1016/0014-5793(87)80073-X; FIGUEIREDO SG, 1995, TOXICON, V33, P83, DOI 10.1016/0041-0101(94)00130-Z; FLANNIGAN SA, 1985, CONTACT DERMATITIS, V13, P140; Fonfria E, 2001, NEUROPHARMACOLOGY, V41, P819, DOI 10.1016/S0028-3908(01)00130-7; French RJ, 2004, CURR MED CHEM, V11, P3053, DOI 10.2174/0929867043363866; GALLAGHER RT, 1986, EXPERIENTIA, V42, P823, DOI 10.1007/BF01941539; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; Gandia L, 1998, PFLUG ARCH EUR J PHY, V436, P696, DOI 10.1007/s004240050691; Garcia AG, 2006, PHYSIOL REV, V86, P1093, DOI 10.1152/physrev.00039.2005; Garcia-Valdes J, 2001, FEBS LETT, V505, P369, DOI 10.1016/S0014-5793(01)02791-0; Ghatta S, 2006, PHARMACOL THERAPEUT, V110, P103, DOI 10.1016/j.pharmthera.2005.10.007; Giovannelli L, 1998, J NEURAL TRANSM, V105, P935, DOI 10.1007/s007020050103; GomezLagunas F, 1996, J MEMBRANE BIOL, V152, P49, DOI 10.1007/s002329900084; Gordon D, 2007, TOXICON, V49, P452, DOI 10.1016/j.toxicon.2006.11.016; Graulich A, 2007, J MED CHEM, V50, P5070, DOI 10.1021/jm070412j; GREENBERG DA, 1987, ANN NEUROL, V21, P317, DOI 10.1002/ana.410210402; Grishin A, 2005, AM J PHYSIOL-GASTR L, V289, pG815, DOI 10.1152/ajpgi.00001.2005; Guatimosim C, 1997, BRIT J PHARMACOL, V122, P591, DOI 10.1038/sj.bjp.0701381; Guido W, 2001, DEV BRAIN RES, V132, P97, DOI 10.1016/S0165-3806(01)00283-8; Gurevitz M, 2007, TOXICON, V49, P473, DOI 10.1016/j.toxicon.2006.11.015; HAGIWARA N, 1988, J PHYSIOL-LONDON, V395, P233, DOI 10.1113/jphysiol.1988.sp016916; HAGIWARA S, 1975, J GEN PHYSIOL, V65, P617, DOI 10.1085/jgp.65.5.617; Hansson K, 2004, J BIOL CHEM, V279, P32453, DOI 10.1074/jbc.M313825200; HARRISON NL, 1985, BRIT J PHARMACOL, V84, P381, DOI 10.1111/j.1476-5381.1985.tb12922.x; Haug K, 2003, NAT GENET, V33, P527, DOI 10.1038/ng1121; Heinemann SH, 2007, CELL MOL LIFE SCI, V64, P1329, DOI 10.1007/s00018-007-6565-5; Heron SE, 2007, ANN NEUROL, V62, P560, DOI 10.1002/ana.21169; Hibino H, 2004, J BIOL CHEM, V279, P44065, DOI 10.1074/jbc.M405985200; HILLE B, 1968, J GEN PHYSIOL, V51, P199, DOI 10.1085/jgp.51.2.199; HILLMAN D, 1991, P NATL ACAD SCI USA, V88, P7076, DOI 10.1073/pnas.88.16.7076; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; Honma T, 2006, MAR BIOTECHNOL, V8, P1, DOI 10.1007/s10126-005-5093-2; Horiba M, 2008, LIFE SCI, V82, P554, DOI 10.1016/j.lfs.2007.11.010; Hossain MM, 2008, TOXICOLOGY, V243, P155, DOI 10.1016/j.tox.2007.10.003; Howes JF, 2007, NEUROTHERAPEUTICS, V4, P126, DOI 10.1016/j.nurt.2006.11.001; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.ph.58.030196.001553; HUNT N, 1995, PSYCHOSOMATICS, V36, P541, DOI 10.1016/S0033-3182(95)71609-7; Iftinca M, 2007, NAT NEUROSCI, V10, P854, DOI 10.1038/nn1921; Imlach WL, 2008, J PHARMACOL EXP THER, V327, P657, DOI 10.1124/jpet.108.143933; Imlach WL, 2009, EUR J PHARMACOL, V605, P36, DOI 10.1016/j.ejphar.2008.12.031; Imredy JP, 2000, J MOL BIOL, V296, P1283, DOI 10.1006/jmbi.2000.3522; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; JENKINSON DH, 1960, J PHYSIOL-LONDON, V152, P309, DOI 10.1113/jphysiol.1960.sp006489; Jensen B S, 2002, Expert Opin Ther Targets, V6, P623, DOI 10.1517/14728222.6.6.623; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Joksovic PM, 2007, J NEUROPHYSIOL, V97, P2712, DOI 10.1152/jn.00926.2006; Jones OT, 1997, J NEUROSCI, V17, P6152; Kalapothakis E, 1998, TOXICON, V36, P1843, DOI 10.1016/S0041-0101(98)00105-6; KANEDA M, 1989, BRAIN RES, V497, P187, DOI 10.1016/0006-8993(89)90987-6; Kang HW, 2006, J BIOL CHEM, V281, P4823, DOI 10.1074/jbc.M510197200; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Keller JE, 2006, NEUROSCIENCE, V139, P629, DOI 10.1016/j.neuroscience.2005.12.029; Kern M, 2000, NEUROTOXICOLOGY, V21, P353; Kim HC, 1999, J NEUROPHYSIOL, V81, P1123, DOI 10.1152/jn.1999.81.3.1123; Kim HJ, 2006, J BIOL CHEM, V281, P38573, DOI 10.1074/jbc.M604769200; Kim JA, 2006, J PHARMACOL EXP THER, V318, P230, DOI 10.1124/jpet.106.101402; KISS T, 1994, PHARMACOL REV, V46, P245; Kitchens SA, 2003, J MOL CELL CARDIOL, V35, P515, DOI 10.1016/S0022-2828(03)00075-0; KOCH P, 1990, CARDIOVASC DRUG REV, V8, P238, DOI 10.1111/j.1527-3466.1990.tb00396.x; Konno Y, 2008, INT HEART J, V49, P723, DOI 10.1536/ihj.49.723; KOPPENHOFER E, 1968, PFLUG ARCH EUR J PHY, V303, P133, DOI 10.1007/BF00592631; KOPPENHOFER E, 1968, PFLUG ARCH EUR J PHY, V303, P150, DOI 10.1007/BF00592632; Korukottu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002359; Kourrich S, 2001, BEHAV BRAIN RES, V120, P35, DOI 10.1016/S0166-4328(00)00356-9; Kumari M., 2000, PROG DRUG RES, V54, P152; Kushmerick C, 2001, TOXICON, V39, P991, DOI 10.1016/S0041-0101(00)00238-5; KUSIC R, 1991, HUM EXP TOXICOL, V10, P113, DOI 10.1177/096032719101000204; Lacinova L, 2000, NEUROPHARMACOLOGY, V39, P1254, DOI 10.1016/S0028-3908(99)00202-6; Lacinova L, 2005, GEN PHYSIOL BIOPHYS, V24, P3; Lane GA, 2000, BOOK SOIL P, P341; Lange A, 2006, NATURE, V440, P959, DOI 10.1038/nature04649; Larm JA, 1996, EUR J PHARMACOL, V314, P249, DOI 10.1016/S0014-2999(96)00633-4; Ledoux J, 2008, J GEN PHYSIOL, V131, P125, DOI 10.1085/jgp.200709875; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; Lee LL, 2004, EXP NEUROL, V190, P70, DOI 10.1016/j.expneurol.2004.07.003; Legros C, 1996, FEBS LETT, V390, P81, DOI 10.1016/0014-5793(96)00616-3; Li RA, 2004, TOXICON, V44, P117, DOI 10.1016/j.toxicon.2004.03.028; Liu PS, 2006, TOXICOLOGY, V219, P167, DOI 10.1016/j.tox.2005.11.012; Liu PS, 2006, TOXICOL APPL PHARM, V210, P136, DOI 10.1016/j.taap.2005.09.012; Liu ZG, 1998, J PHARMACOL EXP THER, V284, P526; Llewellyn L. E., 2009, V46, P67, DOI 10.1007/978-3-540-87895-7_3; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; LLINAS RR, 1989, ANN NY ACAD SCI, V560, P103, DOI 10.1111/j.1749-6632.1989.tb24084.x; LOPEZ MG, 1994, PFLUG ARCH EUR J PHY, V427, P348, DOI 10.1007/BF00374544; Lopez-Gonzalez I, 2003, BIOCHEM BIOPH RES CO, V300, P408, DOI 10.1016/S0006-291X(02)02859-0; Lu R, 2006, J PHYSIOL-LONDON, V570, P65, DOI 10.1113/jphysiol.2005.098913; Lujan R, 2009, NAT REV NEUROSCI, V10, P475, DOI 10.1038/nrn2668; Lyons SA, 2002, GLIA, V39, P162, DOI 10.1002/glia.10083; MA JY, 1994, J NEUROSCI, V14, P3835; MA JY, 1993, BRAIN RES, V607, P222; MA JY, 1993, J NEUROSCI, V13, P4872; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.ne.17.030194.003033; Madsen LS, 2005, EUR J IMMUNOL, V35, P1023, DOI 10.1002/eji.200526078; MANALIS RS, 1973, NATURE, V243, P354, DOI 10.1038/243354a0; Martin RL, 2000, J PHARMACOL EXP THER, V295, P302; Mathie A, 2006, PHARMACOL THERAPEUT, V111, P567, DOI 10.1016/j.pharmthera.2005.11.004; Mattei C, 1999, J NEUROSCI RES, V55, P666, DOI 10.1002/(SICI)1097-4547(19990315)55:6<666::AID-JNR2>3.3.CO;2-8; Matthews EA, 2007, EUR J NEUROSCI, V25, P3561, DOI 10.1111/j.1460-9568.2007.05605.x; Matulef K, 2003, ANNU REV CELL DEV BI, V19, P23, DOI 10.1146/annurev.cellbio.19.110701.154854; Mauler F, 2004, EUR J NEUROSCI, V20, P1761, DOI 10.1111/j.1460-9568.2004.03615.x; MCCLESKEY EW, 1987, P NATL ACAD SCI USA, V84, P4327, DOI 10.1073/pnas.84.12.4327; McGahon MK, 2007, CIRC RES, V100, P703, DOI 10.1161/01.RES.0000260182.36481.c9; MEBS D, 1972, H-S Z PHYSIOL CHEM, V353, P243, DOI 10.1515/bchm2.1972.353.1.243; Mellor IR, 2004, TOXICON, V43, P493, DOI 10.1016/j.toxicon.2004.02.003; MEVES H, 1986, ANN NY ACAD SCI, V479, P113, DOI 10.1111/j.1749-6632.1986.tb15565.x; Militante J, 2008, MOL PHARMACOL, V74, P764, DOI 10.1124/mol.108.047134; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MINTZ IM, 1993, NEURON, V10, P889, DOI 10.1016/0896-6273(93)90204-5; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; Mirzoian A, 2002, J PHARMACOL EXP THER, V302, P560, DOI 10.1124/jpet.102.035154; Mori Y, 1996, JPN J PHARMACOL, V72, P83, DOI 10.1254/jjp.72.83; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Mourre C, 1999, J PHARMACOL EXP THER, V291, P943; Nagy J, 2008, CURR NEUROPHARMACOL, V6, P39, DOI 10.2174/157015908783769662; NARAHASHI T, 1971, J GEN PHYSIOL, V58, P54, DOI 10.1085/jgp.58.1.54; NARAHASHI T, 1987, J PHYSIOL-LONDON, V383, P231; NARAHASHI T, 1964, J GEN PHYSIOL, V47, P965, DOI 10.1085/jgp.47.5.965; NARAHASHI T, 1969, SCIENCE, V163, P680, DOI 10.1126/science.163.3868.680; NARAHASHI T, 1960, AM J PHYSIOL, V198, P934, DOI 10.1152/ajplegacy.1960.198.5.934; NARAHASHI T, 1968, J GEN PHYSIOL, V51, P177, DOI 10.1085/jgp.51.2.177; NARAHASHI T, 1967, TOXICOL APPL PHARM, V10, P529, DOI 10.1016/0041-008X(67)90092-0; NARAHASHI T, 1967, SCIENCE, V157, P1438, DOI 10.1126/science.157.3795.1438; NARAHASHI T, 1992, TOXICOL LETT, V64-5, P429, DOI 10.1016/0378-4274(92)90216-7; Nardi A, 2008, CURR MED CHEM, V15, P1126, DOI 10.2174/092986708784221412; NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0; Nelson MT, 2007, J NEUROSCI, V27, P12577, DOI 10.1523/JNEUROSCI.2206-07.2007; Nelson MT, 2007, J NEUROSCI, V27, P8250, DOI 10.1523/JNEUROSCI.1800-07.2007; Nelson MT, 2005, J NEUROSCI, V25, P8766, DOI 10.1523/JNEUROSCI.2527-05.2005; Nicholson GM, 2004, TOXICON, V43, P587, DOI 10.1016/j.toxicon.2004.02.006; Nicholson GM, 2002, CLIN EXP PHARMACOL P, V29, P785, DOI 10.1046/j.1440-1681.2002.03741.x; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Nirthanan S, 2005, BIOCHEM PHARMACOL, V69, P669, DOI 10.1016/j.bcp.2004.10.018; Nolting A, 2007, J BIOL CHEM, V282, P3478, DOI 10.1074/jbc.M607213200; Novello JC, 1999, TOXICON, V37, P651, DOI 10.1016/S0041-0101(98)00206-2; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; O'Neill MJ, 2004, CNS NEUROL DISORD-DR, V3, P181, DOI 10.2174/1568007043337508; OGATA N, 1993, J PHYSIOL-LONDON, V466, P9; OGATA N, 1988, FASEB J, V2, P2895, DOI 10.1096/fasebj.2.13.2458984; Oka M, 2003, PHARMACEUT RES, V20, P897, DOI 10.1023/A:1024078704020; Okazaki R, 2009, INT HEART J, V50, P353, DOI 10.1536/ihj.50.353; OLESEN J, 1988, ANN NY ACAD SCI, V522, P690; OORTGIESEN M, 1993, NEUROTOXICOLOGY, V14, P87; OORTGIESEN M, 1990, TOXICOL APPL PHARM, V103, P165, DOI 10.1016/0041-008X(90)90272-V; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Pan Y, 2005, NEUROSCI LETT, V376, P60, DOI 10.1016/j.neulet.2004.11.024; PANCHENKO VA, 1993, NEUROSCIENCE, V54, P587, DOI 10.1016/0306-4522(93)90230-D; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.physiol.58.1.299; Papp F, 2009, TOXICON, V54, P379, DOI 10.1016/j.toxicon.2009.05.023; Pardo-Lopez L, 2002, J BIOL CHEM, V277, P16403, DOI 10.1074/jbc.M200460200; Park JY, 2006, J PHYSIOL-LONDON, V577, P513, DOI 10.1113/jphysiol.2006.117440; Pedarzani P, 2008, CELL MOL LIFE SCI, V65, P3196, DOI 10.1007/s00018-008-8216-x; Pedarzani P, 2001, J BIOL CHEM, V276, P9762, DOI 10.1074/jbc.M010001200; Pedarzani P, 2005, J BIOL CHEM, V280, P41404, DOI 10.1074/jbc.M509610200; Pedarzani P, 2002, J BIOL CHEM, V277, P46101, DOI 10.1074/JBC.m206465200; Peng SQ, 2002, MOL PHARMACOL, V62, P1418, DOI 10.1124/mol.62.6.1418; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Perucca E, 1997, PHARMACOL RES, V35, P241, DOI 10.1006/phrs.1997.0124; Pimentel C, 2008, PROTEIN SCI, V17, P107, DOI 10.1110/ps.073122908; PINDER RM, 1976, DRUGS, V12, P1, DOI 10.2165/00003495-197612010-00001; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; Pluzhnikov K, 2007, TOXICON, V50, P993, DOI 10.1016/j.toxicon.2007.07.004; Prado MAM, 1996, BIOCHEM J, V314, P145, DOI 10.1042/bj3140145; Pyott SJ, 2007, J BIOL CHEM, V282, P3312, DOI 10.1074/jbc.M608726200; Qian HH, 1998, J NEUROBIOL, V37, P305, DOI 10.1002/(SICI)1097-4695(19981105)37:2<305::AID-NEU9>3.0.CO;2-6; Qiao GF, 2007, BASIC CLIN PHARMACOL, V100, P217, DOI 10.1111/j.1742-7843.2006.00009.x; Quill TA, 2001, P NATL ACAD SCI USA, V98, P12527, DOI 10.1073/pnas.221454998; Ramsden M, 2002, BRAIN RES, V956, P254, DOI 10.1016/S0006-8993(02)03547-3; RANDALL A, 1995, J NEUROSCI, V15, P2995; RANDO TA, 1986, BIOPHYS J, V49, P785, DOI 10.1016/S0006-3495(86)83706-7; RAVDIN PM, 1979, P NATL ACAD SCI USA, V76, P2072, DOI 10.1073/pnas.76.4.2072; Reid CA, 2003, TRENDS NEUROSCI, V26, P683, DOI 10.1016/j.tins.2003.10.003; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; RICH KM, 1990, SCIENCE, V248, P1419, DOI 10.1126/science.2356470; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; Rojas A, 2002, TOXICON, V40, P777, DOI 10.1016/S0041-0101(01)00281-1; ROMANOSILVA MA, 1993, BIOCHEM J, V296, P313, DOI 10.1042/bj2960313; Roosild TP, 2004, TRENDS BIOCHEM SCI, V29, P39, DOI 10.1016/j.tibs.2003.11.008; ROSSI AD, 1993, FASEB J, V7, P1507, DOI 10.1096/fasebj.7.15.8262335; ROY ML, 1992, J NEUROSCI, V12, P2104; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Salemme S, 2007, CELL PHYSIOL BIOCHEM, V20, P55, DOI 10.1159/000104153; SALGADO VL, 1986, ANN NY ACAD SCI, V479, P84, DOI 10.1111/j.1749-6632.1986.tb15563.x; Sanchez-Alonso JL, 2008, NEUROSCI LETT, V439, P275, DOI 10.1016/j.neulet.2008.05.016; Sandhiya S, 2009, INDIAN J MED RES, V129, P223; Sanguinetti MC, 1997, MOL PHARMACOL, V51, P491; Santi CM, 2002, J NEUROSCI, V22, P396, DOI 10.1523/JNEUROSCI.22-02-00396.2002; Saugstad JA, 2004, J BIOL CHEM, V279, P55514, DOI 10.1074/jbc.M411849200; Sausbier M, 2006, J AM SOC NEPHROL, V17, P1275, DOI 10.1681/ASN.2005101111; Schierle GSK, 1999, NEUROSCIENCE, V94, P17, DOI 10.1016/S0306-4522(99)00324-3; SCHILD L, 1991, BIOPHYS J, V59, P523, DOI 10.1016/S0006-3495(91)82269-X; Scuvee-Moreau J, 2004, BRIT J PHARMACOL, V143, P753, DOI 10.1038/sj.bjp.0705979; Seoane A, 2009, J NEUROSCI, V29, P9534, DOI 10.1523/JNEUROSCI.5199-08.2009; Seutin V, 1999, TRENDS PHARMACOL SCI, V20, P268, DOI 10.1016/S0165-6147(99)01334-6; Shakkottai VG, 2001, J BIOL CHEM, V276, P43145, DOI 10.1074/jbc.M106981200; Shields KG, 2005, NEUROSCIENCE, V135, P203, DOI 10.1016/j.neuroscience.2004.08.054; SHRIVASTAV BB, 1976, LIFE SCI, V18, P1077, DOI 10.1016/0024-3205(76)90141-7; Sidach SS, 2002, J NEUROSCI, V22, P2023, DOI 10.1523/JNEUROSCI.22-06-02023.2002; SIMONS TJB, 1987, J NEUROCHEM, V48, P383, DOI 10.1111/j.1471-4159.1987.tb04105.x; Singh Baljinder, 2007, Hum Mutat, V28, P524, DOI 10.1002/humu.9491; Sitges M, 2005, NEUROCHEM INT, V46, P53, DOI 10.1016/j.neuint.2004.07.004; Skov MJ, 2007, INT J TOXICOL, V26, P411, DOI 10.1080/10915810701582970; Soong TW, 2006, TRENDS GENET, V22, P621, DOI 10.1016/j.tig.2006.08.010; SPIERINGS ELH, 1988, ANN NY ACAD SCI, V522, P676; SPIVAK CE, 1982, MOL PHARMACOL, V21, P351; Splawski I, 2006, J BIOL CHEM, V281, P22085, DOI 10.1074/jbc.M603316200; Srairi-Abid N, 2008, FEBS J, V275, P4641, DOI 10.1111/j.1742-4658.2008.06607.x; Srinivasan KN, 2002, J BIOL CHEM, V277, P30040, DOI 10.1074/jbc.M111258200; Stackman RW, 2002, J NEUROSCI, V22, P10163; STAMPE P, 1994, BIOCHEMISTRY-US, V33, P443, DOI 10.1021/bi00168a008; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; STEINMEYER K, 1991, NATURE, V354, P301, DOI 10.1038/354301a0; Strobaek D, 2006, MOL PHARMACOL, V70, P1771, DOI 10.1124/mol.106.027110; Stromgaard K, 2005, TOXICON, V45, P249, DOI 10.1016/j.toxicon.2004.11.013; Sun H, 2008, J GEN PHYSIOL, V132, P101, DOI 10.1085/jgp.200709883; SUN LR, 1995, J NEUROPHYSIOL, V74, P574, DOI 10.1152/jn.1995.74.2.574; Sun XY, 1999, TOXICOL APPL PHARM, V156, P40, DOI 10.1006/taap.1999.8622; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Sziics A, 1997, CELL MOL NEUROBIOL, V17, P273; SZOLCSANYI J, 1990, J PHARMACOL EXP THER, V255, P923; TAKAHASHI K, 1991, J PHARMACOL EXP THER, V256, P169; Talavera K, 2004, J GEN PHYSIOL, V124, P225, DOI 10.1085/jgp.200409050; Tarabova B, 2006, J PHARMACOL EXP THER, V317, P418, DOI 10.1124/jpet.105.095463; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Thiermann H, 1997, HUM EXP TOXICOL, V16, P473, DOI 10.1177/096032719701600809; Thiery E, 2003, J NEURAL TRANSM-SUPP, P105; Thorneloe KS, 2008, AM J PHYSIOL-REG I, V294, pR1737, DOI 10.1152/ajpregu.00840.2006; TOMSIG JL, 1991, BIOCHIM BIOPHYS ACTA, V1069, P197, DOI 10.1016/0005-2736(91)90124-Q; Traboulsie A, 2007, J PHYSIOL-LONDON, V578, P159, DOI 10.1113/jphysiol.2006.114496; TUCKER SB, 1984, INT J DERMATOL, V23, P686, DOI 10.1111/j.1365-4362.1984.tb01236.x; Tudor JE, 1996, NAT STRUCT BIOL, V3, P317, DOI 10.1038/nsb0496-317; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; TYTGAT J, 1991, BRAIN RES, V549, P112, DOI 10.1016/0006-8993(91)90606-V; Tytgat J, 1996, EUR J PHARMACOL, V296, P189, DOI 10.1016/0014-2999(95)00691-5; TYTGAT J, 1988, N-S ARCH PHARMACOL, V337, P690; Tytgat J, 1998, FEBS LETT, V441, P387, DOI 10.1016/S0014-5793(98)01589-0; UCHITEL OD, 1992, P NATL ACAD SCI USA, V89, P3330, DOI 10.1073/pnas.89.8.3330; UJIHARA H, 1995, JPN J PHARMACOL, V67, P267, DOI 10.1254/jjp.67.267; Vais H, 2001, PEST MANAG SCI, V57, P877, DOI 10.1002/ps.392; van der Staay FJ, 1999, NEUROSCI BIOBEHAV R, V23, P1087, DOI 10.1016/S0149-7634(99)00043-3; VARNAI P, 1993, J PHYSIOL-LONDON, V472, P373, DOI 10.1113/jphysiol.1993.sp019952; Villegas E, 2008, TOXICON, V52, P228, DOI 10.1016/j.toxicon.2008.05.019; Voilley N, 2001, J NEUROSCI, V21, P8026, DOI 10.1523/JNEUROSCI.21-20-08026.2001; Wahl P, 2001, MOL PHARMACOL, V59, P9, DOI 10.1124/mol.59.1.9; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Walker CS, 2009, CURR BIOL, V19, P900, DOI 10.1016/j.cub.2009.05.017; Wallace Mark S, 2006, Expert Rev Neurother, V6, P1423, DOI 10.1586/14737175.6.10.1423; Wang SY, 2003, CELL SIGNAL, V15, P151, DOI 10.1016/S0898-6568(02)00085-2; Weinbroum AA, 2005, BRIT MED BULL, V72, P119, DOI 10.1093/bmb/ldh038; Welsby PJ, 2003, J NEUROSCI, V23, P10116, DOI 10.1523/jneurosci.23-31-10116.2003; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Wen L, 2005, BRIT J PHARMACOL, V145, P728, DOI 10.1038/sj.bjp.0706223; Wickenden AD, 2002, PHARMACOL THERAPEUT, V94, P157, DOI 10.1016/S0163-7258(02)00201-2; Woodward JJ, 2004, MOL BRAIN RES, V125, P86, DOI 10.1016/j.molbrainres.2004.03.005; Xiong ZG, 2008, CURR OPIN PHARMACOL, V8, P25, DOI 10.1016/j.coph.2007.09.001; Xiong ZG, 2007, FRONT BIOSCI-LANDMRK, V12, P1376, DOI 10.2741/2154; Xu TL, 2007, CURR MED CHEM, V14, P1753; Yan LZ, 2005, MOL PHARMACOL, V67, P1513, DOI 10.1124/mol.105.011064; Yoshida S, 2005, J PHARMACOL EXP THER, V314, P437, DOI 10.1124/jpet.105.084988; Yousef MI, 2006, TOXICOLOGY, V227, P240, DOI 10.1016/j.tox.2006.08.008; Zarayskiy VV, 2005, TOXICON, V45, P431, DOI 10.1016/j.toxicon.2004.11.015; Zeng XC, 2000, TOXICON, V38, P1009, DOI 10.1016/S0041-0101(99)00212-3; Zhu Q, 2002, BIOCHEMISTRY-US, V41, P11488, DOI 10.1021/bi026136m; ZLOTKIN E, 1993, ARCH INSECT BIOCHEM, V22, P55, DOI 10.1002/arch.940220107	372	3	3	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS			978-0-08-046884-6				2010							129	171					43	Neurosciences; Toxicology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Toxicology	BA2JT	WOS:000333465100009					2022-02-06	
B	Vasterling, JJ; Grande, L; Graefe, AC; Alvarez, JA		Armstrong, CL; Morrow, L		Vasterling, Jennifer J.; Grande, Laura; Graefe, Anna C.; Alvarez, Julie A.			Neuropsychological Assessment of Posttraumatic Stress Disorder (PTSD)	HANDBOOK OF MEDICAL NEUROPSYCHOLOGY: APPLICATIONS OF COGNITIVE NEUROSCIENCE			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; VIETNAM COMBAT VETERANS; SHORT-TERM-MEMORY; POSITRON-EMISSION-TOMOGRAPHY; COGNITIVE-BEHAVIORAL THERAPY; PREDICTS TREATMENT RESPONSE; SMALLER HIPPOCAMPAL VOLUME; ANTERIOR CINGULATE VOLUME; INTIMATE PARTNER VIOLENCE; MEDIAL PREFRONTAL CORTEX		[Vasterling, Jennifer J.; Grande, Laura] VA Boston Healthcare Syst, Psychol Serv, Boston, MA 02130 USA; [Vasterling, Jennifer J.] VA Boston Healthcare Syst, VA Natl Ctr PTSD, Boston, MA 02130 USA; [Vasterling, Jennifer J.; Grande, Laura] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Alvarez, Julie A.] Tulane Univ, Dept Psychol, New Orleans, LA 70118 USA; [Graefe, Anna C.] VA Boston Healthcare Syst, Res Serv, Boston, MA 02130 USA		Vasterling, JJ (corresponding author), VA Boston Healthcare Syst, Psychol Serv, Boston, MA 02130 USA.	jvaster@bu.edu; laura.grande@va.gov; anna.graefe@gmail.com; jalvar@tulane.edu					*AM PSYCH ASS, 2006, PRACT GUID TREATM PA, P1003; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Austin MP, 1999, PSYCHOL MED, V29, P73, DOI 10.1017/S0033291798007788; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Barrett DH, 1996, AM J PSYCHIAT, V153, P1492; Beckham JC, 1998, J TRAUMA STRESS, V11, P811, DOI 10.1023/A:1024409903617; Beckham JC, 1996, J CONSULT CLIN PSYCH, V64, P1068, DOI 10.1037/0022-006X.64.5.1068; Beers SR, 2002, AM J PSYCHIAT, V159, P483, DOI 10.1176/appi.ajp.159.3.483; Ben Arzi N, 2000, BRAIN INJURY, V14, P725; Bigler ED, 2006, PSYCHOLOGICAL KNOWLEDGE IN COURT: PTSD, PAIN, AND TBI, P308, DOI 10.1007/0-387-25610-5_17; Bonne O, 2004, NEUROSCI BIOBEHAV R, V28, P65, DOI 10.1016/j.neubiorev.2003.12.001; Bonne O, 2001, AM J PSYCHIAT, V158, P1248, DOI 10.1176/appi.ajp.158.8.1248; Brady KT, 2000, J CLIN PSYCHIAT, V61, P22; Brandes D, 2002, PSYCHIAT RES, V110, P231, DOI 10.1016/S0165-1781(02)00125-7; Bremner JD, 2006, ANN NY ACAD SCI, V1071, P80, DOI 10.1196/annals.1364.008; BREMNER JD, 1993, AM J PSYCHIAT, V150, P1015; Bremner JD, 1999, POSTTRAUMATIC STRESS DISORDER, P103; Bremner JD, 1995, PSYCHIAT RES, V59, P97; Bremner JD, 1997, ARCH GEN PSYCHIAT, V54, P246; Bremner JD, 2003, AM J PSYCHIAT, V160, P924, DOI 10.1176/appi.ajp.160.5.924; Bremner JD, 1999, AM J PSYCHIAT, V156, P1787; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; Bremner JD, 2003, BIOL PSYCHIAT, V53, P879, DOI 10.1016/S0006-3223(02)01891-7; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; Breslau N, 2004, ARCH GEN PSYCHIAT, V61, P508, DOI 10.1001/archpsyc.61.5.508; Breslau N, 2001, J CLIN PSYCHIAT, V62, P55; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Briere J., 1995, TRAUMA SYMPTOM INVEN; Briere J., 1996, TRAUMA SYMPTOM CHECK; Brown TA, 2001, J ABNORM PSYCHOL, V110, P585, DOI 10.1037//0021-843X.110.4.585; Bryant DM, 1996, EVAL PROGRAM PLANN, V19, P121, DOI 10.1016/0149-7189(96)00003-1; Bryant RA, 2008, PSYCHOL MED, V38, P555, DOI 10.1017/S0033291707002231; Bryant RA, 2008, J PSYCHIATR NEUROSCI, V33, P142; Buckley TC, 2002, COGNITIVE THER RES, V26, P97, DOI 10.1023/A:1013897805918; Buckley TC, 2000, CLIN PSYCHOL REV, V20, P1041, DOI 10.1016/S0272-7358(99)00030-6; Bustamante V, 2001, J TRAUMA STRESS, V14, P791, DOI 10.1023/A:1013050423901; Cahill SP, 1999, J ANXIETY DISORD, V13, P5, DOI 10.1016/S0887-6185(98)00039-5; Carrion VG, 2001, BIOL PSYCHIAT, V50, P943, DOI 10.1016/S0006-3223(01)01218-5; CASSIDAY KL, 1992, COGNITIVE THER RES, V16, P283, DOI 10.1007/BF01183282; Charney Dennis S., 1995, P271; CHARNEY DS, 1993, ARCH GEN PSYCHIAT, V50, P294; Chemtob CM, 1998, J NERV MENT DIS, V186, P701, DOI 10.1097/00005053-199811000-00007; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; CHRISTIANSON SA, 1992, PSYCHOL BULL, V112, P284, DOI 10.1037/0033-2909.112.2.284; Constans JI, 2004, J ABNORM PSYCHOL, V113, P315, DOI 10.1037/0021-843X.113.2.315; CONSTANS JI, 2005, NEUROPSYCHOLOGY PTSD, P00105; Constant EL, 2005, DEPRESS ANXIETY, V21, P78, DOI 10.1002/da.20060; Conway MA, 2005, J MEM LANG, V53, P594, DOI 10.1016/j.jml.2005.08.005; Crowell TA, 2002, CLIN NEUROPSYCHOL, V16, P310, DOI 10.1076/clin.16.3.310.13851; Dalgleish T, 2008, J ABNORM PSYCHOL, V117, P236, DOI 10.1037/0021-843X.117.1.236; Danckwerts A, 2003, NEUROPSYCHOL REV, V13, P221, DOI 10.1023/B:NERV.0000009485.76839.b7; DAVIDSON J, 1989, J NERV MENT DIS, V177, P336, DOI 10.1097/00005053-198906000-00003; Davidson JRT, 1997, PSYCHOL MED, V27, P153, DOI 10.1017/S0033291796004229; Davis LL, 2006, CNS DRUGS, V20, P465, DOI 10.2165/00023210-200620060-00003; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1271, DOI 10.1016/S0006-3223(99)00045-1; De Bellis MD, 2002, BIOL PSYCHIAT, V52, P1066, DOI 10.1016/S0006-3223(02)01459-2; De Bellis MD, 2005, NEUROPSYCHOLOGY PTSD, P153; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; Dekel R, 2006, J FAM PSYCHOL, V20, P709, DOI 10.1037/0893-3200.20.4.709; Department of Veterans Affair, 2004, VA DOD CLIN PRACT GU; Dickie EW, 2008, NEUROPSYCHOLOGIA, V46, P1522, DOI 10.1016/j.neuropsychologia.2008.01.007; Dirkzwager AJE, 2005, J FAM PSYCHOL, V19, P217, DOI 10.1037/0893-3200.19.2.217; Dirkzwager AJE, 2003, PERS INDIV DIFFER, V34, P1545, DOI 10.1016/S0191-8869(02)00198-8; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Driessen M, 2004, BIOL PSYCHIAT, V55, P603, DOI 10.1016/j.biopsych.2003.08.018; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Felmingham K, 2007, PSYCHOL SCI, V18, P127, DOI 10.1111/j.1467-9280.2007.01860.x; Fennema-Notestine C, 2002, BIOL PSYCHIAT, V52, P1089, DOI 10.1016/S0006-3223(02)01413-0; First M., 1997, STRUCTURED CLIN INTE; Flouri E, 2005, J INTERPERS VIOLENCE, V20, P373, DOI 10.1177/0886260504267549; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1002/jts.2490060405; FOA EB, 1991, J ABNORM PSYCHOL, V100, P156, DOI 10.1037/0021-843X.100.2.156; Francati V, 2007, DEPRESS ANXIETY, V24, P202, DOI 10.1002/da.20208; Frederick CJ., 1992, CHILD POSTTRAUMATIC; Freeman TW, 1998, MAGNET RESON MED, V40, P66, DOI 10.1002/mrm.1910400110; Friedman M. J., 2005, NEUROPSYCHOLOGY PTSD, P292; Friedman MJ, 2000, J CLIN PSYCHIAT, V61, P44; Friedman MJ, 2000, EFFECTIVE TREATMENTS FOR PTSD, P84; Friedman MJ, 2007, HDB PTSD SCI PRACTIC, P376; Gaylord KM, 2008, J TRAUMA, V64, pS200, DOI 10.1097/TA.0b013e318160ba42; Geuze E, 2008, NEUROIMAGE, V41, P675, DOI 10.1016/j.neuroimage.2008.03.007; Gil T., 1990, J TRAUMA STRESS, V3, P29, DOI DOI 10.1002/JTS.2490030104; Gilbertson MW, 2007, BIOL PSYCHIAT, V62, P513, DOI 10.1016/j.biopsych.2006.12.023; Gilbertson MW, 2006, J ABNORM PSYCHOL, V115, P484, DOI 10.1037/0021-843X.115.3.484; Gilbertson MW, 2001, J TRAUMA STRESS, V14, P413, DOI 10.1023/A:1011181305501; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Gilboa A, 2004, BIOL PSYCHIAT, V55, P263, DOI 10.1016/j.biopsych.2003.08.004; Gold JI, 2007, MIL PSYCHOL, V19, P71, DOI 10.1080/08995600701323368; Golden AM, 2007, J ABNORM PSYCHOL, V116, P786, DOI 10.1037/0021-843x.116.4.786; Golier J, 1997, INTEGR PHYS BEH SCI, V32, P52, DOI 10.1007/BF02688613; Golier JA, 2002, AM J PSYCHIAT, V159, P1682, DOI 10.1176/appi.ajp.159.10.1682; GREEN BL, 1994, J TRAUMA STRESS, V7, P341, DOI 10.1007/BF02102782; Grossman R, 2002, PSYCHIAT CLIN N AM, V25, P317, DOI 10.1016/S0193-953X(01)00011-9; GURVITS TV, 1993, J NEUROPSYCH CLIN N, V5, P183; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Gurvits TV, 2002, PSYCHIAT RES, V112, P263, DOI 10.1016/S0165-1781(02)00234-2; Gurvits TV, 2000, ARCH GEN PSYCHIAT, V57, P181, DOI 10.1001/archpsyc.57.2.181; Hammaiberg M., 1992, PSYCHOL ASSESSMENT, V4, P67, DOI [10.1037/1040-3590.4.1.67, DOI 10.1037/1040-3590.4.1.67]; Hawkins SS, 2006, J PEDIATR PSYCHOL, V31, P420, DOI 10.1093/jpepsy/jsj039; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Horner MD, 2002, NEUROPSYCHOL REV, V12, P15, DOI 10.1023/A:1015439106231; Institute of Medicine, 2007, TREATM PTSD ASS EV; Isaac CL, 2006, CLIN PSYCHOL REV, V26, P939, DOI 10.1016/j.cpr.2005.12.004; Jelinek L, 2006, J CLIN EXP NEUROPSYC, V28, P940, DOI 10.1080/13803390591004347; Jenkins MA, 1998, AM J PSYCHIAT, V155, P278; Jenkins MA, 2000, CLIN NEUROPSYCHOL, V14, P7, DOI 10.1076/1385-4046(200002)14:1;1-8;FT007; Johnsen GE, 2008, J AFFECT DISORDERS, V111, P74, DOI 10.1016/j.jad.2008.02.007; JORDAN BK, 1992, J CONSULT CLIN PSYCH, V60, P916, DOI 10.1037/0022-006X.60.6.916; Karl A, 2006, BIOL PSYCHOL, V71, P123, DOI 10.1016/j.biopsycho.2005.03.004; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; KASPI SP, 1995, COGNITIVE THER RES, V19, P433, DOI 10.1007/BF02230410; Keane T. M., 2007, HDB PTSD SCI PRACTIC; KEANE TM, 1988, J CONSULT CLIN PSYCH, V56, P85, DOI 10.1037/0022-006X.56.1.85; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; King DW, 1998, PSYCHOL ASSESSMENT, V10, P90, DOI 10.1037/1040-3590.10.2.90; King KA, 2006, APHASIOLOGY, V20, P233, DOI 10.1080/02687030500473155; King LA, 1998, J PERS SOC PSYCHOL, V74, P420, DOI 10.1037/0022-3514.74.2.420; KING N, 1995, PSY PERSP LESB GAY, V2, P1; Kitayama N, 2005, J AFFECT DISORDERS, V88, P79, DOI 10.1016/j.jad.2005.05.014; Koenen KC, 2003, DEV PSYCHOPATHOL, V15, P297, DOI 10.1017/S0954579403000166; Koenen KC, 2001, BRAIN COGNITION, V45, P64, DOI 10.1006/brcg.2000.1256; Kulka RA, 1990, TRAUMA VIETNAM WAR G; Lanius RA, 2001, AM J PSYCHIAT, V158, P1920, DOI 10.1176/appi.ajp.158.11.1920; Lauterbach D, 2007, J TRAUMA STRESS, V20, P161, DOI 10.1002/jts.20194; Leroi I, 2002, AM J EPIDEMIOL, V156, P747, DOI 10.1093/aje/kwf107; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; Liberzon I, 1999, BIOL PSYCHIAT, V45, P817, DOI 10.1016/S0006-3223(98)00246-7; Liberzon I, 2003, STRESS, V6, P151, DOI 10.1080/1025389031000136242; Lindauer RJL, 2008, PSYCHOL MED, V38, P543, DOI 10.1017/S0033291707001432; Lindauer RJL, 2006, BIOL PSYCHIAT, V59, P171, DOI 10.1016/j.biopsych.2005.06.033; MACDONALD HZ, POSTTRAUMAT IN PRESS; Macklin ML, 1998, J CONSULT CLIN PSYCH, V66, P323, DOI 10.1037/0022-006X.66.2.323; Malojcic B, 2008, J NEUROTRAUM, V25, P30, DOI 10.1089/neu.2007.0384; Mathews A, 2002, COGNITION EMOTION, V16, P331, DOI 10.1080/02699930143000518; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; MCFARLANE AC, 1993, BIOL PSYCHIAT, V34, P311, DOI 10.1016/0006-3223(93)90088-U; MCFARLANE AC, 1999, PROG PSYCH, P163; MCNALLY RJ, 1995, BEHAV RES THER, V33, P619, DOI 10.1016/0005-7967(95)00007-K; MCNALLY RJ, 1994, COGNITION EMOTION, V8, P351, DOI 10.1080/02699939408408946; MCNALLY RJ, 1990, J ABNORM PSYCHOL, V99, P398, DOI 10.1037/0021-843X.99.4.398; MCNALLY RJ, 1995, AM J PSYCHIAT, V152, P936; McNally RJ, 1999, J ANXIETY DISORD, V13, P225, DOI 10.1016/S0887-6185(98)00049-8; Meewisse ML, 2005, J TRAUMA STRESS, V18, P299, DOI 10.1002/jts.20037; MELLMAN TA, 1995, AM J PSYCHIAT, V152, P110; Menon PM, 2003, PSYCHIAT RES-NEUROIM, V123, P101, DOI 10.1016/S0925-4927(03)00044-1; Metzger L. J., 2005, NEUROPSYCHOLOGY PTSD, P83; Metzger LJ, 2004, J ABNORM PSYCHOL, V113, P324, DOI 10.1037/0021-843X.113.2.324; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Mobini S, 2007, PSYCHOTHERAPY, V44, P450, DOI 10.1037/0033-3204.44.4.450; Mollica RF, 2002, BRIT J PSYCHIAT, V181, P339, DOI 10.1192/bjp.181.4.339; Monson CM, 2005, J CLIN PSYCHOL, V61, P751, DOI 10.1002/jclp.20096; Monson CM, 2004, J TRAUMA STRESS, V17, P341, DOI 10.1023/B:JOTS.0000038483.69570.5b; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Moradi AR, 1999, J CHILD PSYCHOL PSYC, V40, P357, DOI 10.1111/1469-7610.00453; Nader K., 1996, CLIN ADM PTSD SCALE; Goff BSN, 2006, AM J ORTHOPSYCHIAT, V76, P451, DOI 10.1037/0002-9432.76.4.451; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; Neylan TC, 2004, J TRAUMA STRESS, V17, P41, DOI 10.1023/B:JOTS.0000014675.75686.ee; NORRIS FH, 2004, ASSESSING PSYCHOL TR, P63; Oquendo MA, 2003, AM J PSYCHIAT, V160, P580, DOI 10.1176/appi.ajp.160.3.580; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Parslow RA, 2007, AM J PSYCHIAT, V164, P509, DOI 10.1176/appi.ajp.164.3.509; Pederson CL, 2004, J TRAUMA STRESS, V17, P37, DOI 10.1023/B:JOTS.0000014674.84517.46; Perkins BR, 2002, J CLIN PSYCHOL, V58, P77, DOI 10.1002/jclp.1130; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; RASMUSSON AM, 2003, CNS SPECTR, V8; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; Rauch SL, 2003, NEUROREPORT, V14, P913, DOI 10.1097/01.wnr.0000071767.24455.10; Ravnkilde B, 2003, ACTA PSYCHIAT SCAND, V108, P32, DOI 10.1034/j.1600-0447.2003.00131.x; Resick, 2007, HDB PTSD SCI PRACTIC, P99; Resick PA, 2007, HDB PTSD SCI PRACTIC, P330; Riggs DS, 1998, J TRAUMA STRESS, V11, P87, DOI 10.1023/A:1024409200155; ROBERTS WR, 1982, J ABNORM PSYCHOL, V91, P444, DOI 10.1037/0021-843X.91.6.444; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sachinvala N, 2000, J NERV MENT DIS, V188, P818, DOI 10.1097/00005053-200012000-00005; Safer MA, 1998, APPL COGNITIVE PSYCH, V12, P99, DOI 10.1002/(SICI)1099-0720(199804)12:2<99::AID-ACP509>3.3.CO;2-Z; Saigh PA, 2006, J ABNORM PSYCHOL, V115, P332, DOI 10.1037/0021-843X.115.2.332; Samper RE, 2004, J TRAUMA STRESS, V17, P311, DOI 10.1023/B:JOTS.0000038479.30903.ed; Savic I, 1997, ARCH NEUROL-CHICAGO, V54, P162, DOI 10.1001/archneur.1997.00550140038010; SCHEERINGA M. S., 1994, PTSD SEMISTRUCTURED; Schnurr P. P., 2004, TRAUMA HLTH PHYS HLT; Schnurr PP, 1999, J NERV MENT DIS, V187, P353, DOI 10.1097/00005053-199906000-00004; Schonfeld S, 2007, MEMORY, V15, P339, DOI 10.1080/09658210701256571; Schuff N, 2001, BIOL PSYCHIAT, V50, P952, DOI 10.1016/S0006-3223(01)01245-8; Seedat S, 2004, J AFFECT DISORDERS, V80, P45, DOI 10.1016/S0165-0327(03)00047-8; Selye H., 1956, STRESS LIFE; Shalev AY, 2001, J CLIN PSYCHIAT, V62, P4; Shapiro DA, 1996, CLIN PSYCHOL-SCI PR, V3, P256, DOI 10.1111/j.1468-2850.1996.tb00079.x; Sherman MD, 2005, PROF PSYCHOL-RES PR, V36, P626, DOI 10.1037/0735-7028.36.6.626; Sherman MD, 2006, J MARITAL FAM THER, V32, P479, DOI 10.1111/j.1752-0606.2006.tb01622.x; Shin L.M., 2005, NEUROPSYCHOLOGY PTSD, P59; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Siepmann M, 2003, PSYCHOPHARMACOLOGY, V168, P293, DOI 10.1007/s00213-003-1448-4; SIEVER LJ, 1985, AM J PSYCHIAT, V142, P1017; Silva RR, 2000, AM J PSYCHIAT, V157, P1229, DOI 10.1176/appi.ajp.157.8.1229; Simms LJ, 2002, J ABNORM PSYCHOL, V111, P637, DOI 10.1037//0021-843X.111.4.637; Singareddy Ravi Kumar, 2002, Ann Clin Psychiatry, V14, P183, DOI 10.1023/A:1021190620773; SOLOMON Z, 1992, FAM PROCESS, V31, P289, DOI 10.1111/j.1545-5300.1992.00289.x; SOUTHWICK SM, 2005, NEUROPSYCHOLOGY PTSD; Stein MB, 1997, PSYCHOL MED, V27, P951, DOI 10.1017/S0033291797005242; Stein MB, 2002, BIOL PSYCHIAT, V52, P1079, DOI 10.1016/S0006-3223(02)01414-2; Stein MB, 1999, J TRAUMA STRESS, V12, P527, DOI 10.1023/A:1024775222098; Stover CS, 2005, J TRAUMA STRESS, V18, P707, DOI 10.1002/jts.20079; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sullivan K, 2003, J PSYCHOPATHOL BEHAV, V25, P95, DOI 10.1023/A:1023342915425; Sutherland K, 2007, BEHAV RES THER, V45, P2915, DOI 10.1016/j.brat.2007.08.009; SUTKER PB, 1995, NEUROPSYCHOLOGY, V9, P118, DOI 10.1037/0894-4105.9.1.118; Taft CT, 2008, J CONSULT CLIN PSYCH, V76, P648, DOI 10.1037/a0012576; Taft CT, 2007, J FAM PSYCHOL, V21, P270, DOI 10.1037/0893-3200.21.2.270; Taft CT, 1999, J TRAUMA STRESS, V12, P3, DOI 10.1023/A:1024786030358; Thompson WW, 2008, MIL MED, V173, P576, DOI 10.7205/MILMED.173.6.576; Twamley EW, 2004, PSYCHIAT RES, V126, P265, DOI 10.1016/j.psychres.2004.01.008; UDDO M, 1993, J PSYCHOPATHOL BEHAV, V15, P43, DOI 10.1007/BF00964322; van Achterberg ME, 2001, J CLIN PSYCHIAT, V62, P206, DOI 10.4088/JCP.v62n0312c; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vasterling J.J., 2005, NEUROPSYCHOLOGY PTSD, P178; Vasterling JJ, 2008, J REHABIL RES DEV, V45, P347, DOI 10.1682/JRRD.2007.05.0077; Vasterling JJ, 1997, ASSESSMENT, V4, P51, DOI 10.1177/107319119700400107; Vasterling JJ, 2000, J TRAUMA STRESS, V13, P441, DOI 10.1023/A:1007781107513; Vasterling JJ, 2004, J INT NEUROPSYCH SOC, V10, P709, DOI 10.1017/S1355617704105031; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Vasterling JJ, 2000, ASSESSMENT, V7, P217, DOI 10.1177/107319110000700302; Vasterling JJ, 2000, J TRAUMA STRESS, V13, P241, DOI 10.1023/A:1007754611030; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Veltmeyer Melinda D., 2005, Journal of Integrative Neuroscience, V4, P145, DOI 10.1142/S0219635205000719; Verfaellie M, 2009, NEUROBIOLOGY PTSD, P105; Vermetten E, 2003, BIOL PSYCHIAT, V54, P693, DOI 10.1016/S0006-3223(03)00634-6; Villarreal G, 2002, BIOL PSYCHIAT, V52, P119, DOI 10.1016/S0006-3223(02)01359-8; Wadsworth EJK, 2005, HUM PSYCHOPHARM CLIN, V20, P561, DOI 10.1002/hup.725; Weathers F., 1993, SAN ANT TX ANN CONV; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; WEATHERS FW, 1997, PSYCHOMETRIC THEORY, P98; WESTERINK J, 1999, AUST NZ J PSYCHIAT, V33, P340; Wild J, 2008, BRIT J PSYCHIAT, V193, P254, DOI 10.1192/bjp.bp.107.045922; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Wilson JP, 1996, ASSESSING PSYCHOL TR, P399; Woodward SH, 2006, BIOL PSYCHIAT, V59, P582, DOI 10.1016/j.biopsych.2005.07.033; Yamasue H, 2003, P NATL ACAD SCI USA, V100, P9039, DOI 10.1073/pnas.1530467100; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yasik AE, 2007, BIOL PSYCHIAT, V61, P382, DOI 10.1016/j.biopsych.2006.06.005; YEHUDA R, 1995, AM J PSYCHIAT, V152, P137; Yehuda R, 1999, CAN J PSYCHIAT, V44, P34, DOI 10.1177/070674379904400104; Yehuda R, 2005, PSYCHONEUROENDOCRINO, V30, P678, DOI 10.1016/j.psyneuen.2005.02.007; Yehuda R, 2005, J CLIN EXP NEUROPSYC, V27, P504, DOI 10.1080/138033990520223; Yehuda R, 2002, PSYCHIAT CLIN N AM, V25, P341, DOI 10.1016/S0193-953X(02)00002-3; YEHUDA R, 1995, AM J PSYCHIAT, V152, P1705; Yehuda R, 2001, J PSYCHIAT RES, V35, P261, DOI 10.1016/S0022-3956(01)00032-2; Yehuda R, 2006, BIOL PSYCHIAT, V60, P714, DOI 10.1016/j.biopsych.2006.03.069; Yule W, 2001, J CLIN PSYCHIAT, V62, P23; Zalewski, 1994, Assessment, V1, P133, DOI 10.1177/1073191194001002003	264	3	3	0	5	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-1-4419-1363-0				2010							447	465		10.1007/978-1-4419-1364-7_24	10.1007/978-1-4419-1364-7		19	Medicine, General & Internal; Neurosciences; Psychology	Book Citation Index – Science (BKCI-S)	General & Internal Medicine; Neurosciences & Neurology; Psychology	BQT44	WOS:000281792900024					2022-02-06	
J	Whitaker, AM; Sulzer, J; Walker, E; Mathis, K; Molina, PE				Whitaker, Annie M.; Sulzer, Jesse; Walker, Edith; Mathis, Keisa; Molina, Patricia E.			Sympathetic Modulation of the Host Defense Response to Infectious Challenge during Recovery from Hemorrhage	NEUROIMMUNOMODULATION			English	Article						Cecal ligation/puncture; Hemorrhage; Inflammation; Noradrenergic system; Sympathectomy; Trauma	NECROSIS-FACTOR-ALPHA; HUMAN MONOCYTIC CELLS; TNF-ALPHA; NOREPINEPHRINE; TISSUE; BRAIN; FEVER; LPS; CATECHOLAMINES; STIMULATION	Background: Trauma/hemorrhage (TxHem) is associated with an immediate pro-inflammatory response that, if exaggerated or prolonged, is thought to contribute to the subsequent immunosuppression that characterizes the period after injury. Previously we have demonstrated that chemical sympathectomy (SNSx) accentuates this immediate pro-inflammatory response to TxHem. These findings suggest that the noradrenergic system plays a critical role in limiting the magnitude of the inflammatory response during TxHem and preserving the integrity of the host defense response to a subsequent infectious challenge during the period after TxHem. Objective: To examine the contribution of tissue norepinephrine to the host defense response to an infectious challenge during recovery from TxHem. Methods: Male Sprague-Dawley rats underwent SNSx (6-hydroxy dopa mine, i.p. daily for 3 days) prior to vascular catheter implantation. Conscious, unrestrained rats were subjected to traumatic injury (muscle crush) prior to a fixed-pressure hemorrhage (40 mm Hg for 60 min) and fluid resuscitation followed 24 h later by cecal ligation and puncture (CLP). Results: SNSx impaired the hemodynamic and thermoregulatory response to hemorrhage as indicated by decreased basal blood pressure, impaired blood pressure recovery during fluid resuscitation, and greater hypothermia after CLP. Furthermore, SNSx accentuated the TNF-alpha, IL-1, IL-6, and IL-10 response to TxHem + infection in plasma 6 h after CLP and in peritoneal lavage fluid 24 h after CLP. Conclusion: These results indicate that the integrity of the noradrenergic system is necessary for adequate hemodynamic, thermoregulatory, and inflammatory responses to infection during the period following TxHem. Copyright (C) 2010 S. Karger AG, Basel	[Molina, Patricia E.] LSUHSC, Dept Physiol, New Orleans, LA 70112 USA; Alcohol & Drug Abuse Ctr Excellence, New Orleans, LA USA		Molina, PE (corresponding author), LSUHSC, Dept Physiol, 1901 Perdido St, New Orleans, LA 70112 USA.	pmolin@lsuhsc.edu	Molina, Patricia E./AAK-9814-2021	Molina, Patricia E./0000-0002-3598-384X	Office of Naval ResearchOffice of Naval Research [N00014-97-1-0248]; Department of DefenseUnited States Department of Defense [PR-054196]; Louisiana Board of Regents [110350057A]; NIAAAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [AA7577]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [T32AA007577] Funding Source: NIH RePORTER	The authors would like to thank Curtis Vande Stouwe and Tesslyn Land for their excellent technical assistance. This research was supported by Office of Naval Research Grant N00014-97-1-0248, Department of Defense Grant PR-054196, Louisiana Board of Regents 110350057A, and the NIAAA AA7577.	ABRAHAM E, 1991, CRIT CARE MED, V19, P613, DOI 10.1097/00003246-199105000-00007; BREESE GR, 1970, J PHARMACOL EXP THER, V174, P413; BULLOCH K, 1984, J COMP NEUROL, V228, P57, DOI 10.1002/cne.902280107; DELRUEPEROLLET C, 1995, BRAIN BEHAV IMMUN, V9, P149, DOI 10.1006/brbi.1995.1014; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Farmer P, 2000, AM J PHYSIOL-LUNG C, V279, pL675, DOI 10.1152/ajplung.2000.279.4.L675; GRAHAM C, 1997, J IMMUNOL, V159, P5450; Heijnen CJ, 2002, J NEUROIMMUNOL, V125, P66, DOI 10.1016/S0165-5728(02)00034-6; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; KLIR JJ, 1995, AM J PHYSIOL-REG I, V268, pR480, DOI 10.1152/ajpregu.1995.268.2.R480; Kohm AP, 2001, PHARMACOL REV, V53, P487; Kozak W, 1998, ANN NY ACAD SCI, V856, P33, DOI 10.1111/j.1749-6632.1998.tb08310.x; Leon LR, 1998, AM J PHYSIOL-REG I, V275, pR269, DOI 10.1152/ajpregu.1998.275.1.R269; LeTulzo Y, 1997, J CLIN INVEST, V99, P1516, DOI 10.1172/JCI119314; LONG NC, 1992, AM J PHYSIOL, V263, pR987, DOI 10.1152/ajpregu.1992.263.5.R987; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Molina PE, 2001, NEUROIMMUNOMODULAT, V9, P125, DOI 10.1159/000049016; Molina PE, 1999, LIFE SCI, V66, P399; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; Ollivier V, 1996, J BIOL CHEM, V271, P20828, DOI 10.1074/jbc.271.34.20828; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; Phelan H, 2002, J TRAUMA, V52, P675, DOI 10.1097/00005373-200204000-00010; Remick DG, 2002, SHOCK, V17, P463, DOI 10.1097/00024382-200206000-00004; Rice PA, 2002, BRAIN BEHAV IMMUN, V16, P654, DOI 10.1016/S0889-1591(02)00016-8; SEVERN A, 1992, J IMMUNOL, V148, P3441; SPENGLER RN, 1994, J IMMUNOL, V152, P3024; SPENGLER RN, 1990, J IMMUNOL, V145, P1430; Tanaka S, 1996, J AUTONOM NERV SYST, V60, P121, DOI 10.1016/0165-1838(96)00041-0; vanderPoll T, 1996, J CLIN INVEST, V97, P713, DOI 10.1172/JCI118469; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Ye RD, 2000, AM J PHYSIOL-LUNG C, V279, pL615, DOI 10.1152/ajplung.2000.279.4.L615	33	3	4	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7401	1423-0216		NEUROIMMUNOMODULAT	Neuroimmunomodulation		2010	17	6					349	358		10.1159/000292039			10	Endocrinology & Metabolism; Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Immunology; Neurosciences & Neurology	630SA	WOS:000280292300001	20516716	Green Published, Bronze			2022-02-06	
J	Xu, J; Liu, ZG; Zhu, X; Chen, XB; Tang, H				Xu, Jing; Liu, Zi-Gui; Zhu, Xia; Chen, Xue-Bing; Tang, Hong			Analysis of Pulmonary Infection of Hospitalized Patients Injured in the Wenchuan Earthquake in China	LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION			English	Article						Wenchuan earthquake; Pulmonary infection; Pathogen; Drug sensitivity	INTENSIVE-CARE UNITS; NOSOCOMIAL INFECTIONS; ATTRIBUTABLE COST; RISK-FACTORS; PNEUMONIA; DISASTERS; MORTALITY; VICTIMS; TSUNAMI; IMPACT	Background: On 12 May 2008, a devastating earthquake measuring 8.0 on the Richter scale hit Wenchuan County, Sichuan in China, and resulted in the casualties of thousands of people. Some of the hospitalized earthquake victims can occur pulmonary infection. However, few studies have been conducted on the clinical features of pulmonary infection in hospitalized casualty after Wenchuan Earthquake. Methods: To analyze retrospectively the clinical data of 115 pulmonary infection patients among wounded inpatients in West China Hospital of Sichuan University after the Wenchuan earthquake. Results: In our report, 76 cases (66.1%) of 115 hospitalized earthquake victims with pulmonary infection were patients with age > 60 years; 74 cases (64.3%) of them with long-term hospitalization(> 20 days); 23 cases (20.0%) of them with traumatic brain injury; 71 cases (61.7%) with torso trauma; 58 cases (50.4%) of them were patients with underlying disease; 25 cases(21.7%) of them were the patients treated with mechanical ventilation. A total of 143 nonduplicate clinical isolates from sputum specimen of 115 pulmonary infection patients were analyzed. Gram-negative bacilli were the most commonly isolated pathogens (73.4%). Only 7.7% of total isolates were gram-positive bacteria; 18.9% of total isolates were fungi. There were high rates of multiple drug resistance in most bacteria isolates. The detection rates and resistance rates of Acinetobacter baumannii were higher than others and 81.8% of all Staphylococcus aureus detected from sputum culture were resistant to antibiotics but vancomycin in this group patients. There were 98 cases of recovery, 17 death cases due to lung infection. Conclusions: Most of earthquake inpatients with pulmonary infection were patients with age > 60 years, longer hospital stay or severe trauma. These factors might increase the risk of pulmonary infection in earthquake inpatients. Gram-negative bacilli play the most important role in these pulmonary infection patients. Pandrug-resistant Acinetobacter baumannii and Methicillin resistant S. aureus in this study might increase the risk of nosocomial infection. The prevention and control of pulmonary infection are crucial for earthquake survivors during hospitalization.. [Life Science Journal. 2010; 7(2): 28-34] (ISSN: 1097-8135).	[Xu, Jing; Liu, Zi-Gui; Zhu, Xia; Chen, Xue-Bing; Tang, Hong] Sichuan Univ, W China Hosp, Ctr Infect Dis, Chengdu 610064, Peoples R China; [Xu, Jing; Liu, Zi-Gui; Zhu, Xia; Chen, Xue-Bing; Tang, Hong] Sichuan Univ, State Key Lab Biotherapy, Div Infect Dis, Chengdu 610064, Peoples R China		Tang, H (corresponding author), Sichuan Univ, W China Hosp, Ctr Infect Dis, Chengdu 610064, Peoples R China.	htang6198@hotmail.com			National Key Technologies Research and Development Program of ChinaNational Key Technology R&D Program [2008ZX10002-006, 2008ZX10002-004]; Key Technologies Research of Sichuan Province [2008SZ0039]	This work was supported by the National Key Technologies Research and Development Program of China during the 11th Five-Year Plan Period (No. 2008ZX10002-006 and 2008ZX10002-004) and Key Technologies Research of Sichuan Province (No. 2008SZ0039). The authors would like to thank all staff of Medical Records and Statistics Room in West China Hospital of Sichuan University for extracting data.	Bochicchio GV, 2001, J TRAUMA, V50, P612, DOI 10.1097/00005373-200104000-00004; Bowton DL, 1999, CHEST, V115, p28S, DOI 10.1378/chest.115.suppl_1.28S; CARICATO A, 2009, INTENS CARE MED, V8, P1582; Catania R. A., 1999, Annals Academy of Medicine Singapore, V28, P120; CHEVRET S, 1993, INTENS CARE MED, V19, P256, DOI 10.1007/BF01690545; *CHIN SOC RESP DIS, 2002, MODERN PRACTICAL MED, V14, P158; Clinical and Laboratory Standards Institute, 2007, PERF STAND ANT SUS S; DINKEL RH, 1994, J HOSP INFECT, V28, P297, DOI 10.1016/0195-6701(94)90093-0; Inoue-Sakurai C, 2000, PREV MED, V31, P467, DOI 10.1006/pmed.2000.0744; Joly-Guillou ML, 2005, CLIN MICROBIOL INFEC, V11, P868, DOI 10.1111/j.1469-0691.2005.01227.x; Keven K, 2003, SCAND J INFECT DIS, V35, P110, DOI 10.1080/0036554021000027013; Lai S W, 2000, Eur J Intern Med, V11, P353, DOI 10.1016/S0953-6205(00)00120-5; Magnotti Louis J, 2004, Surg Infect (Larchmt), V5, P237, DOI 10.1089/sur.2004.5.237; Minstry of Health of the People's Republic of China, 2001, NATL MED J CHINA, V81, P314; MULIN B, 1995, EUR J CLIN MICROBIOL, V14, P569, DOI 10.1007/BF01690727; Oncul O, 2002, J HOSP INFECT, V51, P47, DOI 10.1053/jhin.2002.1205; Rosenthal VD, 2005, AM J INFECT CONTROL, V33, P157, DOI 10.1016/j.ajic.2004.08.008; SCERPELLA EG, 1995, INFECT CONT HOSP EP, V16, P92, DOI 10.1086/647063; Simms HH, 1997, ARCH SURG-CHICAGO, V132, P171; Tanaka H, 1999, AM J EMERG MED, V17, P186, DOI 10.1016/S0735-6757(99)90059-1; Uckay I, 2008, J HOSP INFECT, V68, P1, DOI 10.1016/j.jhin.2007.10.018; Warren DK, 2003, CRIT CARE MED, V31, P1312, DOI 10.1097/01.CCM.0000063087.93157.06; Watson JT, 2007, EMERG INFECT DIS, V13, P1, DOI 10.3201/eid1301.060779; WEIHUA W, 2007, CHIN J NOSOCOMIOL, V17, P227; Yorsaengrat Weerawat, 2006, Journal of the Medical Association of Thailand, V89, P518	25	3	3	0	5	MARSLAND PRESS	LANSING	PO BOX 21126, LANSING, MI 48909 USA	1097-8135			LIFE SCI J	Life Sci. J.		2010	7	2					28	34					7	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	670VA	WOS:000283454200006					2022-02-06	
J	Yanai, J; Brick-Turin, Y; Dotan, S; Langford, R; Pinkas, A; Slotkin, TA				Yanai, Joseph; Brick-Turin, Yael; Dotan, Sharon; Langford, Rachel; Pinkas, Adi; Slotkin, Theodore A.			A mechanism-based complementary screening approach for the amelioration and reversal of neurobehavioral teratogenicity	NEUROTOXICOLOGY AND TERATOLOGY			English	Article						Chick; Induction of endogenous cells; Mouse; Neural progenitor transplantation; Neurobehavioral teratogenicity	NEURAL STEM-CELLS; TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; BEHAVIORAL DEFICITS; PRENATAL EXPOSURE; SPATIAL MEMORY; HIPPOCAMPAL NEUROGENESIS; CHLORPYRIFOS EXPOSURE; ADULT NEUROGENESIS; CAUDATE-NUCLEUS	The identification of mechanisms and outcomes for neurobehavioral teratogenesis is critical to our ability to develop therapies to ameliorate or reverse the deleterious effects of exposure to developmental neurotoxicants. We established mechanistically-based complementary models for the study of cholinergic systems in the mouse and the chick. using both environmental neurotoxicants (chlorpyrifos, perfluoroalkyls) and drugs of abuse (heroin, nicotine, PCP). Behavioral evaluations were made using the Morris maze in the mouse, evaluating visuospatial memory related to hippocampal cholinergic systems, and imprinting in the chick, examining behavior dependent on cholinergic innervation of the IMHV. In both models we demonstrated the dependence of neurobehavioral deficits on impairment of cholinergic receptor-induced expression, and translocation of specific PKC isoforms. Understanding this mechanism, we were able to reverse both the synaptic and behavioral deficits with administration of neural progenitors. We discuss the prospects for clinical application of neural progenitor therapy, emphasizing protocols for reducing or eliminating immunologic rejection, as well as minimizing invasiveness of procedures through development of intravenous administration protocols. (C) 2009 Elsevier Inc. All rights reserved.	[Yanai, Joseph; Brick-Turin, Yael; Dotan, Sharon; Langford, Rachel; Pinkas, Adi] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Anat & Cell Biol, Ross Lab Studies Neural Birth Defects, IL-91120 Jerusalem, Israel; [Yanai, Joseph; Slotkin, Theodore A.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA		Yanai, J (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Anat & Cell Biol, Ross Lab Studies Neural Birth Defects, Box 12272, IL-91120 Jerusalem, Israel.	yanai@md.huji.ac.il	Pinkas, Adi/K-9815-2017	Pinkas, Adi/0000-0001-7899-3661; Yanai, Joseph/0000-0003-1685-0176	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [ES13147]; United States-Israel Binational Science FoundationUS-Israel Binational Science Foundation [BSF2005003]; Israeli Anti-Drug Authority; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R21ES014358] Funding Source: NIH RePORTER	This work was supported by the NIH grant ES13147, the United States-Israel Binational Science Foundation BSF2005003 and the Israeli Anti-Drug Authority.	AbuRoumi M, 1996, BRAIN RES BULL, V40, P183, DOI 10.1016/0361-9230(95)02131-0; BARRON S, 1991, PHARMACOL BIOCHEM BE, V39, P423, DOI 10.1016/0091-3057(91)90202-D; BECKER JT, 1980, BRAIN RES, V200, P307, DOI 10.1016/0006-8993(80)90922-1; Beer A, 2005, NEUROPSYCHOPHARMACOL, V30, P156, DOI 10.1038/sj.npp.1300582; Ben-Shaanan TL, 2008, MOL PSYCHIATR, V13, P222, DOI 10.1038/sj.mp.4002084; BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4; BJORKLUND A, 1984, ANNU REV NEUROSCI, V7, P279, DOI 10.1146/annurev.ne.07.030184.001431; Carpentino JE, 2008, J NEUROSCI RES, V86, P512, DOI 10.1002/jnr.21514; COLLIER TJ, 1988, NEWS PHYSIOL SCI, V3, P204; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; DOTAN S, 2008, 2 INT STEM CELL M PO, P52; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Englund U, 2002, P NATL ACAD SCI USA, V99, P17089, DOI 10.1073/pnas.252589099; FERNANDEZ K, 1983, NEUROBEH TOXICOL TER, V5, P351; Ferrari A, 2001, J BIOMED MATER RES, V56, P361, DOI 10.1002/1097-4636(20010905)56:3<361::AID-JBM1104>3.0.CO;2-4; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Hagell P, 2002, NAT NEUROSCI, V5, P627, DOI 10.1038/nn863; Hess DC, 2008, CELL PROLIFERAT, V41, P94, DOI 10.1111/j.1365-2184.2008.00486.x; Izrael M, 2004, J NEUROSCI RES, V78, P499, DOI 10.1002/jnr.20287; Katz S, 2008, J NEUROCHEM, V104, P38, DOI 10.1111/j.1471-4159.2007.05004.x; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Levin ED, 2003, NEUROTOXICOL TERATOL, V25, P51, DOI 10.1016/S0892-0362(02)00322-7; LICHTBLAU L, 1984, NEUROBEH TOXICOL TER, V6, P3; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; MADRAZO I, 1988, NEW ENGL J MED, V318, P51; MADRAZO I, 1987, NEW ENGL J MED, V316, P831, DOI 10.1056/NEJM198704023161402; MCCLEARN G. E., 1970, Contributions to behavior-genetic analysis., P3; MURRELL W, 2008, STEM CELLS; NAVARRO HA, 1988, PEDIATR RES, V24, P465, DOI 10.1203/00006450-198810000-00009; NILSSON OG, 1987, EXP BRAIN RES, V67, P195, DOI 10.1007/BF00269466; NORDBERG A, 1977, ACTA PHYSIOL SCAND, V99, P336, DOI 10.1111/j.1748-1716.1977.tb10386.x; NORDBERG A, 1992, J NEURAL TRANSM-GEN, V88, P199, DOI 10.1007/BF01244733; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; OLTON DS, 1979, NEUROPSYCHOLOGIA, V17, P669, DOI 10.1016/0028-3932(79)90042-3; OLTON DS, 1978, BRAIN RES, V139, P295, DOI 10.1016/0006-8993(78)90930-7; OLTON DS, 1978, EXP NEUROL, V58, P387, DOI 10.1016/0014-4886(78)90096-1; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Palmer TD, 1999, J NEUROSCI, V19, P8487; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Qiao D, 2004, DEV BRAIN RES, V148, P43, DOI 10.1016/j.devbrainres.2003.10.004; RILEY EP, 1989, ANN NY ACAD SCI, V562, P173, DOI 10.1111/j.1749-6632.1989.tb21015.x; ROGELFUCHS Y, 1994, BRAIN RES BULL, V33, P273, DOI 10.1016/0361-9230(94)90194-5; SASTRY BVR, 1991, REPROD FERT DEVELOP, V3, P355, DOI 10.1071/RD9910355; Shahak H, 2003, DEV BRAIN RES, V140, P117, DOI 10.1016/S0165-3806(02)00607-7; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Shim I, 2003, NEUROSURGERY, V53, P416, DOI 10.1227/01.NEU.0000073989.07810.D8; Snyder EY, 2005, J AM GERIATR SOC, V53, pS287, DOI 10.1111/j.1532-5415.2005.53491.x; Sobrian S. K., 1999, Neurotoxicology and Teratology, V21, P327; Song J, 2007, NEUROSCI LETT, V423, P58, DOI 10.1016/j.neulet.2007.05.066; Spear LP, 1996, PHARMACOL BIOCHEM BE, V55, P455, DOI 10.1016/S0091-3057(96)00272-9; Steingart RA, 2000, DEV BRAIN RES, V122, P125, DOI 10.1016/S0165-3806(00)00063-8; Steingart RA, 1998, BRAIN RES BULL, V46, P203, DOI 10.1016/S0361-9230(97)00454-1; Steingart RA, 2000, DEV BRAIN RES, V125, P9, DOI 10.1016/S0165-3806(00)00123-1; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taupin P, 2005, MED SCI MONITOR, V11, pRA247; VALENZUELA MJ, 2008, STEM CELLS DEV; Wachs FP, 2003, LAB INVEST, V83, P949, DOI 10.1097/01.LAB.0000075556.74231.A5; Walton RM, 2008, J NEUROSCI METH, V169, P158, DOI 10.1016/j.jneumeth.2007.12.011; Yan J, 2004, J COMP NEUROL, V480, P101, DOI 10.1002/cne.20344; YANAI J, 1989, DEV BRAIN RES, V48, P255, DOI 10.1016/0165-3806(89)90080-1; YANAI J, 1988, INT J DEV NEUROSCI, V6, P409, DOI 10.1016/0736-5748(88)90046-9; YANAI J, 1993, NEUROPHARMACOLOGY, V32, P113, DOI 10.1016/0028-3908(93)90090-P; Yanai J, 1987, FUNCTIONAL TERATOGEN, P121; Yanai J, 2008, J TOXICOL ENV HEAL A, V71, P131, DOI 10.1080/15287390701613280; Yaniv SP, 2004, BRAIN RES BULL, V63, P339, DOI 10.1016/j.brainresbull.2004.04.006; Zhang HQ, 2004, NEUROREPORT, V15, P1739, DOI 10.1097/01.wnr.0000131676.38437.2d; Zhang PL, 2004, STEM CELLS, V22, P344, DOI 10.1634/stemcells.22-3-344; Zhou MF, 2004, BRAIN RES, V999, P142, DOI 10.1016/j.brainres.2003.10.068	72	3	3	1	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0892-0362	1872-9738		NEUROTOXICOL TERATOL	Neurotoxicol. Teratol.	JAN-FEB	2010	32	1			SI		109	113		10.1016/j.ntt.2009.02.001			5	Neurosciences; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Toxicology	560DF	WOS:000274881500014	19217940	Green Accepted			2022-02-06	
B	Yeates, KO; Anderson, V		Anderson, V; Jacobs, R; Anderson, PJ		Yeates, Keith Owen; Anderson, Vicki			Childhood traumatic brain injury, executive functions, and social outcomes: Toward an integrative model for research and clinical practice	EXECUTIVE FUNCTIONS AND THE FRONTAL LOBES: A LIFESPAN PERSPECTIVE	Studies on Neuropsychology Neurology and Cognition		English	Article; Book Chapter							LONG-TERM OUTCOMES; CLOSED-HEAD-INJURY; INHIBITORY CONTROL; ROMANTIC RELATIONSHIPS; COGNITIVE-DEVELOPMENT; NEURAL SYSTEMS; YOUNG-CHILDREN; FRONTAL LOBES; WHITE-MATTER; MIND		[Yeates, Keith Owen] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Yeates, Keith Owen] Nationwide Childrens Hosp, Dept Psychol, Columbus, OH USA; [Anderson, Vicki] Univ Melbourne, Dept Psychol, Royal Childrens Hosp, Sch Behav Sci, Melbourne, Vic, Australia		Yeates, KO (corresponding author), Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA.		Yeates, Keith/AAJ-4223-2020				Achenbach TM, 1991, MANUAL CHILD BEHAV C; Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Allman JM, 2001, ANN NY ACAD SCI, V935, P107, DOI 10.1111/j.1749-6632.2001.tb03476.x; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2002, PRINCIPLES FRONTAL L, P504; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Asher S.R., 1996, CO THEY KEEP FRIENDS, P366; BARTSCH K, 1989, CHILD DEV, V60, P946, DOI 10.1111/j.1467-8624.1989.tb03526.x; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; BERNDT TJ, 1985, DEV PSYCHOL, V21, P1007, DOI 10.1037/0012-1649.21.6.1007; Berzonsky M.D., 2003, BLACKWELL HDB ADOLES, P330, DOI DOI 10.1002/9780470756607.CH16; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bierman K. L., 2004, PEER REJECTION DEV P; BJORKLUND DF, 1990, DEV REV, V10, P48, DOI 10.1016/0273-2297(90)90004-N; Bohnert AM, 1997, DEV NEUROPSYCHOL, V13, P477, DOI 10.1080/87565649709540688; BROTHERS L, 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Buhrmester D., 1986, FRIENDSHIP SOCIAL IN, P41, DOI DOI 10.1007/978-1-4612-4880-4_3; Cacioppo JT, 2000, PSYCHOL BULL, V126, P829, DOI 10.1037//0033-2909.126.6.829; Cacioppo JT, 2002, PSYCHOSOM MED, V64, P407, DOI 10.1097/00006842-200205000-00005; Carlson SM, 2001, CHILD DEV, V72, P1032, DOI 10.1111/1467-8624.00333; Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Coie J., 1990, PEER REJECTION CHILD, P365; Collins WA, 2003, J RES ADOLESCENCE, V13, P1, DOI 10.1111/1532-7795.1301001; Connolly J, 1999, J YOUTH ADOLESCENCE, V28, P481, DOI 10.1023/A:1021669024820; COOLEY EA, 1997, STUDENTS ACQUIRED BR, P255; Couper E., 2002, BRAIN IMPAIR, V3, P105, DOI [DOI 10.1375/BRIM.3.2.105, 10.1375/brim.3.2.105]; Cowan N., 1997, DEV MEMORY CHILDHOOD, P163; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Csikszentmihalyi M., 1984, BEING ADOLESCENT; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Damasio AR, 2001, ANN NY ACAD SCI, V935, P101; DEMOREST A, 1984, CHILD DEV, V55, P1527, DOI 10.2307/1130022; Dennis M, 1998, BRAIN LANG, V61, P450, DOI 10.1006/brln.1997.1886; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Dennis M, 2006, SER INT NEUROPSYCHOL, P128, DOI 10.1017/CBO9780511545917.007; Diamond A, 1996, DEV PSYCHOBIOL, V29, P315, DOI 10.1002/(SICI)1098-2302(199605)29:4<315::AID-DEV2>3.0.CO;2-T; Diamond A., 2002, PRINCIPLES FRONTAL L, P466, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0029; Didus E, 1999, Pediatr Rehabil, V3, P177; Dodge KA, 2002, PSYCHOL ASSESSMENT, V14, P60, DOI 10.1037//1040-3590.14.1.60; DODGE KA, 1986, MONOGRAPHS SOC RES C, V51, P213; Dowsett SM, 2000, DEV PSYCHOBIOL, V36, P161, DOI 10.1002/(SICI)1098-2302(200003)36:2<161::AID-DEV7>3.0.CO;2-0; Dunn J, 2002, CHILD DEV, V73, P621, DOI 10.1111/1467-8624.00427; ECKERMAN CO, 1990, DEV PSYCHOL, V26, P370, DOI 10.1037/0012-1649.26.3.370; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; ESLINGER PJ, 1997, DEV PREFRONTAL CORTE, P295; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Fox NA, 1995, CHILD DEV, V66, P1770, DOI 10.1111/j.1467-8624.1995.tb00964.x; FOX NA, 1994, DEV PSYCHOPATHOL, V6, P677, DOI 10.1017/S0954579400004739; Fox NA, 2001, CHILD DEV, V72, P1, DOI 10.1111/1467-8624.00262; Frith U, 2001, CURR DIR PSYCHOL SCI, V10, P151, DOI 10.1111/1467-8721.00137; G?nc? A., 1993, EARLY CHILDHOOD RES, V8, P99, DOI DOI 10.1016/S0885-2006(05)80100-0; GERSTADT CL, 1994, COGNITION, V53, P129, DOI 10.1016/0010-0277(94)90068-X; Gest SD, 2001, SOC DEV, V10, P23, DOI 10.1111/1467-9507.00146; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Glang A, 1997, J HEAD TRAUMA REHAB, V12, P32, DOI 10.1097/00001199-199704000-00005; GOEL V, 1995, NEUROREPORT, V6, P1741, DOI 10.1097/00001756-199509000-00009; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goncu A., 2002, BLACKWELL HDB CHILDH, P418; Gordon ACL, 1998, J EXP CHILD PSYCHOL, V68, P70, DOI 10.1006/jecp.1997.2423; Grady CL, 2002, CAN J PSYCHIAT, V47, P327, DOI 10.1177/070674370204700403; Grattan LM, 1989, NEUROPSYCHOLOGY, V3, P175, DOI 10.1037//0894-4105.3.3.175; Guralnick M. J., 1990, J EARLY INTERVENTION, V14, P3, DOI [DOI 10.1177/105381519001400101, 10.1177/105381519001400101]; GURALNICK MJ, 1989, J MENT DEFIC RES, V33, P275; Guralnick MJ, 1999, MENT RETARD DEV D R, V5, P21; Howes C, 1998, SOC DEV, V7, P340, DOI 10.1111/1467-9507.00071; Howes C., 1988, MONOGRAPHS SOC RES C, V53; Hughes C, 1998, BRIT J DEV PSYCHOL, V16, P233, DOI 10.1111/j.2044-835X.1998.tb00921.x; Hughes C, 2002, INFANT CHILD DEV, V11, P201, DOI 10.1002/icd.297; HULME C, 1995, J CHILD PSYCHOL PSYC, V36, P373, DOI 10.1111/j.1469-7610.1995.tb01297.x; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; KAIN W, 2003, SOCIAL BRAIN EVOLUTI, P197; Klingberg T, 1999, NEUROREPORT, V10, P2817, DOI 10.1097/00001756-199909090-00022; Kochanska G, 1996, CHILD DEV, V67, P490, DOI 10.2307/1131828; KRASNOR LR, 1983, CHILD DEV, V54, P1545; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Kuttler AF, 2002, MERRILL PALMER QUART, V48, P105, DOI 10.1353/mpq.2002.0008; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lemerise EA, 2000, CHILD DEV, V71, P107, DOI 10.1111/1467-8624.00124; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; LEVIN HS, 1989, NEUROSURGERY, V24, P223, DOI 10.1227/00006123-198902000-00011; LIVESEY DJ, 1991, AUST J PSYCHOL, V43, P133, DOI 10.1080/00049539108260137; Mah L, 2004, AM J PSYCHIAT, V161, P1247, DOI 10.1176/appi.ajp.161.7.1247; Matsuzawa J, 2001, CEREB CORTEX, V11, P335, DOI 10.1093/cercor/11.4.335; Max JE, 1998, ARCH PHYS MED REHAB, V79, P893, DOI 10.1016/S0003-9993(98)90084-3; MAX JE, 2005, J AM ACAD CHILD ADOL, V44, P432; MCGUIRE TL, 1986, J HEAD TRAUMA REHAB, V1, P1; MELTZOFF AN, 1995, DEV PSYCHOL, V31, P838, DOI 10.1037/0012-1649.31.5.838; Meltzoff AN, 1999, DEVELOPING THEORIES OF INTENTION, P17; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; MIZE J, 1988, DEV PSYCHOL, V24, P782, DOI 10.1037/0012-1649.24.6.782; Moses LJ, 2001, CHILD DEV, V72, P688, DOI 10.1111/1467-8624.00306; Nangle DW, 2003, J CLIN CHILD ADOLESC, V32, P546, DOI 10.1207/S15374424JCCP3204_7; Nassau JH, 1997, J PEDIATR PSYCHOL, V22, P771, DOI 10.1093/jpepsy/22.6.771; NEWCOMB AF, 1995, PSYCHOL BULL, V117, P306, DOI 10.1037/0033-2909.117.2.306; O'Donnell S, 2005, NEUROIMAGE, V24, P948, DOI 10.1016/j.neuroimage.2004.10.014; Ochsner KN, 2001, AM PSYCHOL, V56, P717, DOI 10.1037//0003-066X.56.9.717; OCONNER P, 2002, INJURY RES STAT SERI, V11; Orzhekhovskaya N S, 1981, Neurosci Behav Physiol, V11, P379, DOI 10.1007/BF01184205; PAPERO PH, 1993, NEUROPSYCHOL REHABIL, V3, P321, DOI 10.1080/09602019308401445; Parker J., 2006, DEV PSYCHOPATHOL RIS, V2, P419, DOI DOI 10.1002/9780470939383.CH12; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Pellegrini A.D., 2002, BLACKWELL HDB CHILDH, P438; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Posner MI, 2001, ANN NY ACAD SCI, V935, P208; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; RoseKrasnor L, 1997, SOC DEV, V6, P111, DOI 10.1111/1467-9507.00029; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; RUBIN KH, 1986, MINN SYM CHILD PSYCH, V18, P1; Rubin KH., 2006, HDB CHILD PSYCHOL, P571, DOI DOI 10.1002/9780470147658.CHPSY0310; Rudolph KD, 1997, J APPL DEV PSYCHOL, V18, P107, DOI 10.1016/S0193-3973(97)90017-4; SELMAN RL, 1990, MAKING FRIEND YOUTH; Siegal M, 2002, NAT REV NEUROSCI, V3, P463, DOI 10.1038/nrn844; SODIAN B, 1991, CHILD DEV, V62, P468, DOI 10.1111/j.1467-8624.1991.tb01545.x; Sowell ER, 1999, NEUROIMAGE, V9, P587, DOI 10.1006/nimg.1999.0436; Sowell ER, 1998, DEV NEUROPSYCHOL, V14, P599, DOI 10.1080/87565649809540731; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Stuss DT, 2004, BRAIN COGNITION, V55, P69, DOI 10.1016/s0278-2626(03)00271-9; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Warschausky S, 1997, Pediatr Rehabil, V1, P77; Watson AC, 1999, DEV PSYCHOL, V35, P386, DOI 10.1037/0012-1649.35.2.386; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Winner E., 1988, POINT WORDS CHILDREN; YAKOVLEV P I, 1962, Res Publ Assoc Res Nerv Ment Dis, V39, P3; Yakovlev PI, 1967, REGIONAL DEV BRAIN E, P3; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; YEATES KO, 1991, MERRILL PALMER QUART, V37, P369; YEATES KO, 1990, CLIN PSYCHOL REV, V10, P567, DOI 10.1016/0272-7358(90)90097-T; [No title captured]	146	3	3	0	3	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND			978-1-13687-354-6	STUD NEUROPSYCHOL NE			2010							243	267					25	Psychology, Biological; Psychology, Developmental; Psychology; Psychology, Experimental	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology	BVE09	WOS:000291249500013					2022-02-06	
J	Yi, W; Liu, RZ; Chen, JA; Tao, SZ; Humphrey, O; Bergenheim, AT				Yi, Wei; Liu, Renzhong; Chen, Jian; Tao, Shengzhong; Humphrey, Okechi; Bergenheim, A. Tommy			Trauma Infant Neurologic Score Predicts the Outcome of Traumatic Brain Injury in Infants	PEDIATRIC NEUROSURGERY			English	Article						Traumatic brain injury, infant; Trauma Infant Neurologic Score; Glasgow Outcome Score; Children's Coma Score	INFLICTED HEAD-INJURY; INTRACRANIAL HEMATOMAS; EPIDURAL HEMATOMA; YOUNG-CHILDREN; COMA SCALES; NEUROPATHOLOGY; EPIDEMIOLOGY; EXPERIENCE; DAMAGE	To investigate the clinical features of infancy traumatic brain injury (TBI) and the prognostic value of the Trauma Infant Neurologic Score (TINS), infants <2 years of age with TBI who were admitted from 2000 to 2007 were retrospectively studied. Fifty-six patients with a mean age of 13.3 +/- 6.5 months (range = 2-24) were identified. The clinical diagnoses, in terms of the severest injury, included scalp hematomas (n = 2), skull bone fractures (n = 3), epidural hematomas (n = 21), subdural hematomas (n = 14), cerebral contusion and laceration (n = 4), intracerebral hematomas (n = 7), traumatic subarachnoid hemorrhage (n = 2), diffuse axonal injury (n = 2) and diffuse brain swelling (n = 1). The most common clinical presentations were vomiting (66.1%), paleness (55.4%), irritability (37.3%), pupillary abnormalities (35.7%) and altered consciousness (32.1%). The mechanism of injury included falls (n = 41), vehicle accident (n = 9), abuse (n = 4) and unknown (n = 2). The TINS score ranged from 1 to 10 with a mean of 3.6 (SD = 2.4) in the whole patient cohort. The Children's Coma Scores (CCS) on admission were 13-15 (n = 31), 9-12 (n = 7) and 3-8 (n = 18). Thirty-nine of the infants were operated on and the other 17 infants were treated nonsurgically. Forty-eight patients (86%) were followed up for a period of 1-8 years (mean = 4.4) after discharge. In the followed-up patient cohort, the mean TINS score at admission was 3.8 +/- 2.5. The total clinical outcome, according to the Glasgow Outcome Scale (GOS), was: 37 (77.1%) good recovery, 4 (8.3%) moderately disabled, 1 (2.1%) vegetative and 6 (12.5%) dead. For those who were operated on the outcome was: 25 (78.1%) good recovery, 4 (12.5%) moderately disabled and 3 (9.4%) dead, and for those who were not operated on: 12 (75.0%) good recovery, 1 (6.3%) vegetative and 3 (25.0%) dead. At two years of follow-up, the GOS included 34 (73.9%) good recovery, 3 (6.5%) moderately disabled, 2 (4.3%) severely disabled, 1 (2.2%) vegetative and 6 (13.0%) dead. Statistical tests revealed that the TINS scores were highly associated with the GOS. Higher TINS scores resulted in worse clinical outcome. The CCS scores were also to some degree associated with the GOS score. However, the CCS score on admission was not as discriminating as TINS, predicting only the best and worst outcome in our series. Our study showed that the clinical features of TBI in infants were different from those seen in adults regarding both the distribution of the pathology type and the clinical presenting symptoms. We found that the TINS scoring system is useful for predicting prognosis and outcome in infancy TBI and suggest that it could be routinely used in the infantile population. Copyright (C) 2010 S. Karger AG, Basel	[Yi, Wei; Liu, Renzhong; Humphrey, Okechi] Wuhan Univ, Renmin Hosp, Dept Neurosurg, Wuhan 430060, Peoples R China; [Chen, Jian] Huazhong Univ Sci & Technol, Dept Neurosurg, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Tao, Shengzhong] Zhengzhou Univ, Affiliated Hosp 2, Dept Neurosurg, Zhengzhou, Peoples R China; [Bergenheim, A. Tommy] Umea Univ Hosp, Dept Neurosurg, S-90185 Umea, Sweden		Yi, W (corresponding author), Wuhan Univ, Renmin Hosp, Dept Neurosurg, Wuhan 430060, Peoples R China.	yiwtj@hotmail.com					Beni-Adani L, 1999, J TRAUMA, V46, P306, DOI 10.1097/00005373-199902000-00018; CAFFEY J, 1974, PEDIATRICS, V54, P396; Ciurea AV, 2007, CHILD NERV SYST, V23, P335, DOI 10.1007/s00381-006-0230-4; Couper Z, 2008, BIOMECH MODEL MECHAN, V7, P105, DOI 10.1007/s10237-007-0079-9; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Falk Ann-Charlotte, 2007, Dev Neurorehabil, V10, P49, DOI 10.1080/13638490600864066; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Gjerris F, 1986, Acta Neurochir Suppl (Wien), V36, P155; Herrera EJ, 2000, CHILD NERV SYST, V16, P585, DOI 10.1007/s003810000340; Hymel KP, 2007, PEDIATRICS, V119, P922, DOI 10.1542/peds.2006-3111; Hymel KP, 2004, J PEDIATR-US, V144, P701, DOI 10.1016/j.jpeds.2004.04.005; Igun GO, 2000, E AFR MED J, V77, P9; Kirkham FJ, 2008, DEV MED CHILD NEUROL, V50, P267, DOI 10.1111/j.1469-8749.2008.02042.x; Listman DA, 2003, CURR OPIN PEDIATR, V15, P299, DOI 10.1097/00008480-200306000-00013; Loh JK, 2002, SURG NEUROL, V58, P218, DOI 10.1016/S0090-3019(02)00830-3; Mack KA, 2008, PEDIATRICS, V121, P930, DOI 10.1542/peds.2007-1731; Mandera M, 2000, CHILD NERV SYST, V16, P156, DOI 10.1007/s003810050484; Mandera M, 2002, CHILD NERV SYST, V18, P124, DOI 10.1007/s00381-002-0572-5; Marton E, 2007, CHILD NERV SYST, V23, P873, DOI 10.1007/s00381-007-0314-9; MORRAY JP, 1984, CRIT CARE MED, V12, P1018, DOI 10.1097/00003246-198412000-00002; Munoz-Sanchez M, 2005, CHILD NERV SYST, V21, P128, DOI 10.1007/s00381-004-1036-x; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; REILLY PL, 1988, CHILD NERV SYST, V4, P30; STEWART AL, 1993, BRIT J OBSTET GYNAEC, V100, P711, DOI 10.1111/j.1471-0528.1993.tb14259.x; Tung GA, 2006, PEDIATRICS, V118, P626, DOI 10.1542/peds.2006-0130; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; [谢坚 Xie Jian], 2004, [中华小儿外科杂志, Chinese Journal of Pediatric Surgery], V25, P242; YAGER JY, 1990, AM J DIS CHILD, V144, P1088, DOI 10.1001/archpedi.1990.02150340032019	31	3	4	0	8	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2010	46	4					259	266		10.1159/000321800			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	750OJ	WOS:000289557500003	21160234				2022-02-06	
J	Zaitsev, OS				Zaitsev, O. S.			Selection of neuromethabolic drug in severe brain injury	ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA			Russian	Article						traumatic brain injury; therapy; neurometabolic drugs			Russian Acad Med Sci, Sci Res Inst Neurosurg, Moscow, Russia		Zaitsev, OS (corresponding author), Russian Acad Med Sci, Sci Res Inst Neurosurg, Moscow, Russia.						Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; DOBROKHOTOVA TA, 2003, MEDICAL NOVA, V7, P1; GOGIDZE NV, 1990, DINAMIKA NEYROPSIKHI; URAKOV SV, 1999, AKTUAL PROBLEMY NEYR, P22; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; ZAYTSEV OS, 2005, SYEZD PSIKHIATROV RO, P267; ZAYTSEV OS, 2009, DOKTOR RU, V4, P59; ZAYTSEV OS, 2005, REGRESS PSIKHOPATOLO, P45; ZAYTSEV OS, 1994, 0PRINTSYPY SRAVNENIY, P25; ZAYTSEV OS, 2002, PSIKHIATR REABILITAT, V3, P499	11	3	5	0	0	IZDATELSTVO MEDITSINA	MOSCOW	PETROVERIGSKII PER 6-8, K-142 MOSCOW, RUSSIA	1997-7298			ZH NEVROL PSIKHIATR	Z. Nevrol. Psikhiatrii Im S S Korsakova		2010	110	9					66	69					8	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	686WW	WOS:000284729600013	21246892				2022-02-06	
J	Moutaouakil, F; El Otmani, H; Fadel, H; Slassi, I				Moutaouakil, F.; El Otmani, H.; Fadel, H.; Slassi, I.			Severe apathy following head injury: Improvement with Selegiline (R) treatment	NEUROCHIRURGIE			French	Article						Apathy; Head injury; Selegiline (R); Dopamine	TRAUMATIC BRAIN-INJURY	Apathy is defined as reduced goal-directed behavior due to lack of motivation Traumatic brain injury is a frequent cause. Drugs activating the dopaminergic system provide variable benefit A 30-year-old patient was the victim of a severe dead injury with frontal bruise at the age of 15 At the request of his family, lie consulted for a 7-year history that included a lack of initiative and the inability to generate behavior spontaneously, contrasting with the ability to execute behaviors on command He also presented indifference, major emotional disruption without sadness, pessimism, and other depressive. signs The examination found a severe apathetic syndrome confirmed by specific scales with a mild impairment of executive functions and without depressive syndrome Encephalic MRI showed atrophy of the whole prefrontal cerebral cortex The patient was treated with bromocriptine, which lie did not tolerate, then with Selegiline (R) at 15 mg per duly, which dramatically improved his symptoms. Apathy occurs frequently after traumatic brain injury, in 23-71% of patients according to the :authors The pathophysiology of apathy has beets described its anatomical terms as related to disruption of-frontal-subcortical pathways. The biochemical hypothesis postulates a disruption tit dopaminergic activity The use of dopaminergic agents usually improves cases similar to our patient Apathy is frequent Following head injury. warranting a search for systematic causes Since it increases dopaminergic activity. Selegiline (R) is well worth trying in these patients (C) 2008 Elsevier Masson SAS. All rights reserved.	[Moutaouakil, F.; El Otmani, H.; Fadel, H.] Hop Al Kortobi, Serv Neurol, Tanget 90000, Morocco; [Slassi, I.] CHU Ibn Rochd, Serv Neurol, Casablanca 20000, Morocco		Moutaouakil, F (corresponding author), 24,Ave Essalam,Appartement7,Residence Abou Adnane, Tanget 90000, Morocco.						Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; Dujardin K, 2007, REV NEUROL-FRANCE, V163, P513, DOI 10.1016/S0035-3787(07)90458-0; Falo MC, 2008, J NEUROTRAUM, V25, P769, DOI 10.1089/neu.2008.0511; Glenn MB, 2002, BRAIN INJURY, V16, P509, DOI 10.1080/02699050110119132; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Muller U, 2006, BRAIN INJURY, V20, P157, DOI 10.1080/02699050500443467; Newburn G, 2005, BRAIN INJURY, V19, P149, DOI 10.1080/02699050410001719989; Robert PH, 2002, INT J GERIATR PSYCH, V17, P1099, DOI 10.1002/gps.755; Roth Robert M, 2007, Curr Treat Options Neurol, V9, P363, DOI 10.1007/s11940-007-0022-5; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21	12	3	4	0	4	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0028-3770			NEUROCHIRURGIE	Neurochirurgie	DEC	2009	55	6					551	554		10.1016/j.neuchi.2008.10.009			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	532NA	WOS:000272754400002	19084243				2022-02-06	
J	Sawyer, JR; Kapoor, M; Gonzales, MH; Warner, WC; Canale, ST; Beaty, JH				Sawyer, Jeffrey R.; Kapoor, Mukesh; Gonzales, Mark H.; Warner, William C., Jr.; Canale, S. Terry; Beaty, James H.			Heterotopic Ossification of the Hip After Non-accidental Injury in a Child: Case Report	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						heterotopic ossification; nonaccidental injury; child	TRAUMATIC BRAIN INJURY; CEREBRAL-PALSY; RISK-FACTORS; ABUSE; FRACTURES; ADOLESCENTS; BURNS	Heterotopic ossification is bone formation that occurs in an abnormal soft tissue location, most commonly after trauma, head injury, and surgical procedures such as joint arthroplasty. We report a rare case of severe heterotopic ossification caused by nonaccidental injury in a 3-year-old child. To our knowledge, heterotopic ossification as a result of nonaccidental injury in children has been reported in only 2 other patients. Physicians should be aware of this rare presentation of nonaccidental injury, and nonaccidental injury should be considered in the differential diagnosis in children who present with heterotopic ossification.	[Sawyer, Jeffrey R.; Warner, William C., Jr.; Canale, S. Terry; Beaty, James H.] Univ Tennessee, Dept Orthopaed Surg, Campbell Clin, Memphis, TN 38104 USA; [Kapoor, Mukesh] Univ Illinois, Lutheran Gen Hosp, Dept Family Med, Chicago, IL USA; [Gonzales, Mark H.] Univ Illinois, Dept Orthopaed Surg, Chicago, IL USA		Sawyer, JR (corresponding author), Univ Tennessee, Dept Orthopaed Surg, Campbell Clin, 1211 Union Ave,Suite 510, Memphis, TN 38104 USA.	jsawyer@campbellclinic.com					ABLIN DS, 1992, PEDIATR RADIOL, V22, P454, DOI 10.1007/BF02013511; Arkader A, 2007, J PEDIATR ORTHOPED, V27, P751, DOI 10.1097/BPO.0b013e3181558b13; BENYOUSSEF L, 1983, J PEDIATR ORTHOPED, V3, P392, DOI 10.1097/01241398-198307000-00023; *CDC, 2006, MMWR-MORBID MORTAL W, V57, P336; CITTAPIETROLUNGO TJ, 1992, ARCH PHYS MED REHAB, V73, P258; GALLENO H, 1982, CLIN ORTHOP RELAT R, P11; GARLAND DE, 1989, CLIN ORTHOP RELAT R, P303; Gaur A, 2003, J BONE JOINT SURG AM, V85A, P1538, DOI 10.2106/00004623-200308000-00016; HURVITZ EA, 1992, ARCH PHYS MED REHAB, V73, P459; Inan M, 2006, J PEDIATR ORTHOPED, V26, P551, DOI 10.1097/01.bpo.0000217725.16417.af; Jarvis J, 2006, J TRAUMA, V60, P613, DOI 10.1097/01.ta.0000197606.63124.9e; Kaplan FS, 2008, BEST PRACT RES CL RH, V22, P191, DOI 10.1016/j.berh.2007.11.007; Kluger G, 2000, J CHILD NEUROL, V15, P406, DOI 10.1177/088307380001500610; KOCH BM, 1992, ARCH PHYS MED REHAB, V73, P1104; KRUM SD, 1993, J PEDIATR ORTHOPED, V13, P739, DOI 10.1097/01241398-199311000-00009; LEE M, 1992, ARCH PHYS MED REHAB, V73, P289; Loder R T, 1991, J Orthop Trauma, V5, P428, DOI 10.1097/00005131-199112000-00007; MCMAHON P, 1995, J BONE JOINT SURG AM, V77A, P1179, DOI 10.2106/00004623-199508000-00006; MERTEN DF, 1983, RADIOLOGY, V146, P377, DOI 10.1148/radiology.146.2.6849085; PAYNE LZ, 1993, J PEDIATR ORTHOPED, V13, P733, DOI 10.1097/01241398-199311000-00008; Riklin C, 2003, SPINAL CORD, V41, P192, DOI 10.1038/sj.sc.3101421; Sferopoulos NK, 1997, INT ORTHOP, V21, P412; THOMAS SA, 1991, PEDIATRICS, V88, P471	23	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-6798			J PEDIATR ORTHOPED	J. Pediatr. Orthop.	DEC	2009	29	8					865	867		10.1097/BPO.0b013e3181c1e2ce			3	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	526SN	WOS:000272313900007	19934700				2022-02-06	
J	Blizzard, CA; King, AE; Haas, MA; O'Toole, DA; Vickeys, JC; Dickson, TC				Blizzard, Catherine A.; King, Anna E.; Haas, Matilda A.; O'Toole, David A.; Vickeys, James C.; Dickson, Tracey C.			Axonal shearing in mature cortical neurons induces attempted regeneration and the reestablishment of neurite polarity	BRAIN RESEARCH			English	Article						Axonal injury; Regeneration; Plasticity; Growth cone	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; GROWTH CONE; IN-VITRO; CEREBRAL-CORTEX; ALZHEIMERS-DISEASE; PURKINJE-CELLS; STEM-CELLS; GLIAL SCAR	While functional recovery after injury is limited, it has become evident that the mature central nervous system does retain some ability to regenerate. This study investigated the intrinsic capacity of relatively mature cortical neurons (21 days in vitro) to respond to axonal loss. Neurons, growing as clusters on poly-L-lysine, were completely sheared of axons through chemical and mechanical disruption and transferred to either an intact astrocyte monolayer or a substrate of poly-L-lysine. injured neurons exhibited a regenerative sprouting response that was independent of neuronal cell division or neural progenitors, as demonstrated by negative bromodeoxyuridine (BrdU) and the neuronal precursor intermediate filament nestin, labeling. At 24 h after injury, neurons had extended appropriately polarized neurites, demonstrated by compartmentalized microtubule-associated proteins MAP2 and tau immunolabeling. Newly sprouting axons were tipped by growth cones; however, growth cones on the tips of sprouting axons (mean area, 26.32 +/- 2.20 mu m) were significantly (p < 0.05) smaller than their developmental counterparts (mean area, 48.64 +/- 5.9 mu m), independent of substrate. Furthermore, live imaging indicated that regenerating neurons exhibited distinct axonal dynamics, with a significant (p < 0.05) reduction (76%) in pausing, considered vital for interstitial branching and pathfinding, relative to developmental growth cones. This study indicates that mature cultured cortical pyramidal and interneurons have the intrinsic potential to survive, extend processes, and reestablish neurite polarity following significant physical damage. These results may aid in defining the cellular basis of neuronal structural plasticity and defining the role of astrocyte reactivity in the response to trauma. (C) 2009 Elsevier B.V. All rights reserved.	[Dickson, Tracey C.] Univ Tasmania, Wicking Dementia Res & Educ Ctr, Hobart, Tas 7000, Australia; Univ Tasmania, NeuroRepair Grp, Menzies Res Inst, Hobart, Tas 7000, Australia		Dickson, TC (corresponding author), Univ Tasmania, Wicking Dementia Res & Educ Ctr, Private Bag 29, Hobart, Tas 7000, Australia.	Tracey.Dickson@utas.edu.au	King, Anna/J-7927-2014; Vickers, James/J-7464-2014	King, Anna/0000-0003-1792-0965; Dickson, Tracey/0000-0002-9196-1661; Vickers, James/0000-0001-5671-4879; Blizzard, Catherine/0000-0002-8683-2937; Haas, Matilda/0000-0002-5149-0471	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Tasmanian Masonic Centenary Research Foundation; Wicking d Dementia Research and Education Centre	The National Health and Medical Research Council, the Tasmanian Masonic Centenary Research Foundation, and the Wicking d Dementia Research and Education Centre supported this research.	Arimura N, 2005, NEURON, V48, P881, DOI 10.1016/j.neuron.2005.11.007; BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; BERNHARDT R, 1984, J COMP NEUROL, V226, P203, DOI 10.1002/cne.902260205; BERRY M, 1994, EYE, V8, P245, DOI 10.1038/eye.1994.53; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BLACK MM, 1986, J CELL BIOL, V103, P545, DOI 10.1083/jcb.103.2.545; Blackmore M, 2006, J NEUROBIOL, V66, P348, DOI 10.1002/neu.20224; Blizzard CA, 2007, EUR J NEUROSCI, V26, P1100, DOI 10.1111/j.1460-9568.2007.05750.x; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Braun H, 2002, J NEUROTRAUM, V19, P975, DOI 10.1089/089771502320317122; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carmichael ST, 2003, CURR OPIN NEUROL, V16, P699, DOI 10.1097/00019052-200312000-00009; Carulli D, 2004, PROG NEUROBIOL, V72, P373, DOI 10.1016/j.pneurobio.2004.03.007; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Chierzi S, 2001, RESTOR NEUROL NEUROS, V19, P109; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; Chuckowree JA, 2004, NEUROSCIENTIST, V10, P280, DOI 10.1177/1073858404263511; Chuckowree JA, 2003, J NEUROSCI, V23, P3715; Chung RS, 2004, J NEUROCHEM, V88, P454, DOI 10.1046/j.1471-4159.2003.02193.x; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; de Ruiter GCW, 2008, EXP NEUROL, V211, P339, DOI 10.1016/j.expneurol.2007.12.023; Deller T, 1997, PROG NEUROBIOL, V53, P687, DOI 10.1016/S0301-0082(97)00044-0; Dent EW, 2003, NEUROSCIENTIST, V9, P343, DOI 10.1177/1073858403252683; Dickson TC, 2000, J NEUROTRAUM, V17, P1095, DOI 10.1089/neu.2000.17.1095; Dickson TC, 2005, NEUROBIOL DIS, V18, P286, DOI 10.1016/j.nbd.2004.10.001; Dickson TC, 2007, NEUROREPORT, V18, P283, DOI 10.1097/WNR.0b013e3280143cdb; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Fawcett JW, 1997, CELL TISSUE RES, V290, P371, DOI 10.1007/s004410050943; Gallyas F, 2006, ACTA NEUROPATHOL, V111, P229, DOI 10.1007/s00401-006-0034-3; Galtrey CM, 2007, BRAIN, V130, P926, DOI 10.1093/brain/awl372; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; GOSLIN K, 1988, NATURE, V336, P672, DOI 10.1038/336672a0; GOSLIN K, 1990, J NEUROSCI, V10, P588; Haas MA, 2004, EUR J NEUROSCI, V20, P1436, DOI 10.1111/j.1460-9568.2004.03620.x; HALLORAN MC, 1994, J NEUROSCI, V14, P2161; Holmin S, 1997, EUR J NEUROSCI, V9, P65, DOI 10.1111/j.1460-9568.1997.tb01354.x; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Kalil K, 1996, PROG BRAIN RES, V108, P31, DOI 10.1016/S0079-6123(08)62530-3; King AE, 2006, J COMP NEUROL, V498, P277, DOI 10.1002/cne.21053; King CE, 2001, NEUROPATH APPL NEURO, V27, P115, DOI 10.1046/j.1365-2990.2001.00317.x; Kwon BK, 2002, P NATL ACAD SCI USA, V99, P3246, DOI 10.1073/pnas.052308899; Lee KJ, 2005, CEREBELLUM, V4, P97, DOI 10.1080/14734220510007842; LI D, 1995, EUR J NEUROSCI, V7, P1164, DOI 10.1111/j.1460-9568.1995.tb01106.x; MASLIAH E, 1993, AM J PATHOL, V142, P871; MAXWELL WL, 1990, PHILOS T R SOC B, V328, P479, DOI 10.1098/rstb.1990.0121; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; Michalczyk K, 2005, HISTOL HISTOPATHOL, V20, P665, DOI 10.14670/HH-20.665; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; O'Toole DA, 2007, CELL MOL LIFE SCI, V64, P1303, DOI 10.1007/s00018-007-7106-y; Pak CW, 2008, NAT REV NEUROSCI, V9, P136, DOI 10.1038/nrn2236; Pappas IS, 1998, EUR J NEUROSCI, V10, P1436, DOI 10.1046/j.1460-9568.1998.00147.x; POVLISHOCK JT, 1985, LAB INVEST, V52, P540; Qiu J, 2000, GLIA, V29, P166, DOI 10.1002/(SICI)1098-1136(20000115)29:2<166::AID-GLIA10>3.3.CO;2-7; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Rossi F, 2001, RESTOR NEUROL NEUROS, V19, P85; Salin P, 1995, J NEUROSCI, V15, P8234; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Skaliora I, 2000, J NEUROSCI, V20, P3650, DOI 10.1523/JNEUROSCI.20-10-03650.2000; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.0.CO;2-U; Szebenyi G, 1998, J NEUROSCI, V18, P7930; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004; Yoshimura T, 2006, J NEUROSCI, V26, P10626, DOI 10.1523/JNEUROSCI.3824-06.2006	75	3	3	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 10	2009	1300						24	36		10.1016/j.brainres.2009.08.059			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	520DC	WOS:000271819200003	19715682				2022-02-06	
J	Kuroiwa, M; Kitano, Y; Takasuna, K; Manabe, S; Saito, T				Kuroiwa, Miho; Kitano, Yutaka; Takasuna, Kiyoshi; Manabe, Sunao; Saito, Takao			Muscle relaxant and neurotoxic activities of intrathecal baclofen in rats	PHARMACOLOGICAL RESEARCH			English	Article						Baclofen; Intrathecal; Spasticity; Muscle relaxant; Decerebrate rigidity; Electroencephalogram	AMINOBUTYRIC ACID(B) RECEPTORS; DECEREBRATE RIGIDITY; SPINAL-CORD; PHARMACOLOGICAL-PROPERTIES; INTRACTABLE SPASTICITY; HYDROCHLORIDE; OVERDOSE; LIORESAL; EPILEPSY; SYSTEMS	Intrathecal baclofen therapy by the continuous intrathecal infusion of baclofen has been shown to be an effective treatment for spasticity in patients with spinal cord injury, cerebral palsy, traumatic brain injury, multiple sclerosis and other disorders. To demonstrate the efficacy and safety of intrathecal baclofen therapy, we investigated the muscle relaxant and neurotoxic activities of intrathecal baclofen in rats, compared with intravenous baclofen. Intrathecal and intravenous administration of baclofen dose-dependently inhibited the anemic clecerebrate rigidity with ED50 values of 0.31 mu g/animal (=1.1-1.3 mu g/kg) and 0.43 mg/kg, respectively. Intrathecal administration of baclofen induced no noticeable changes in a spontaneous electroencephalogram at 30 mu g/animal. Intravenous administration of baclofen induced an abnormal electroencephalogram with flat waves in all the animals and the no-observed-effect level was estimated to be 5 mg/kg. In some animals, intravenous administration of baclofen induced sporadic spikes or sharp waves with background flat waves, indicating inhibitory and excitatory effects on the central nervous system. In conclusion, intrathecal administration of baclofen dose-dependently inhibited anemic decerebrate rigidity in rats and the effective dose was more than 300 times lower than that of intravenous baclofen. The safety margin of intrathecal baclofen was greater than that of intravenous baclofen (>= 97 versus 12). These results suggest that intrathecal baclofen therapy is superior to systemic baclofen therapy in both efficacy and safety. (C) 2009 Elsevier Ltd. All rights reserved.	[Kuroiwa, Miho; Kitano, Yutaka; Takasuna, Kiyoshi; Manabe, Sunao] Daiichi Sankyo Co Ltd, Med Safety Res Labs, Edogawa Ku, Tokyo 1348630, Japan; [Saito, Takao] Daiichi Sankyo Co Ltd, Prod Mkt Dept, Chuo Ku, Tokyo 1038234, Japan		Kitano, Y (corresponding author), Daiichi Sankyo Co Ltd, Med Safety Res Labs, Edogawa Ku, 1-16-13 Kita Kasai, Tokyo 1348630, Japan.	kitano.yutaka.yi@daiichisankyo.co.jp					BISHOP B, 1977, PHYS THER, V57, P371, DOI 10.1093/ptj/57.4.371; Bowery NG, 2000, J PHARMACOL EXP THER, V292, P2; Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247; COFFEY RJ, 1993, J NEUROSURG, V78, P226, DOI 10.3171/jns.1993.78.2.0226; Darbari FP, 2005, PEDIATR NEUROL, V33, P373, DOI 10.1016/j.pediatrneurol.2005.05.017; DAVIS RA, 1981, NEUROSURGERY, V9, P79, DOI 10.1227/00006123-198107000-00015; FEHR HU, 1974, J INT MED RES, V2, P36, DOI 10.1177/030006057400200107; FUKUDA H, 1974, JPN J PHARMACOL, V24, P810, DOI 10.1254/jjp.24.810; Fukuda H, 1979, Nihon Yakurigaku Zasshi, V75, P535; GOTO M, 1983, JPN J PHARMACOL, V33, P1241, DOI 10.1254/jjp.33.1241; GOTO M, 1982, J PHARMACOBIO-DYNAM, V5, P643; Guillaume D, 2005, ARCH PHYS MED REHAB, V86, P2165, DOI 10.1016/j.apmr.2005.05.018; HORMES JT, 1988, ARCH NEUROL-CHICAGO, V45, P814, DOI 10.1001/archneur.1988.00520310132033; ITO T, 1985, ARCH INT PHARMACOD T, V275, P105; Kakinohana O, 2006, NEUROSCIENCE, V141, P1569, DOI 10.1016/j.neuroscience.2006.04.083; KAWAJIRI S, 1984, FOLIA PHARMACOL JPN, V83, P263, DOI 10.1254/fpj.83.263; KLOCKGETHER T, 1989, NEUROSCI LETT, V97, P221, DOI 10.1016/0304-3940(89)90167-5; LEMBECK F, 1977, N-S ARCH PHARMACOL, V297, P47, DOI 10.1007/BF00508809; Malcangio M, 1996, TRENDS PHARMACOL SCI, V17, P457; MCDOWELL FH, 1981, DRUGS, V22, P401, DOI 10.2165/00003495-198122050-00003; MELDRUM B, 1984, NEUROSCI LETT, V47, P345, DOI 10.1016/0304-3940(84)90537-8; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P155, DOI 10.1053/apmr.2001.19246; MORIKAWA K, 1987, ARZNEIMITTEL-FORSCH, V37, P331; OCHIAI T, 1982, JPN J PHARMACOL, V32, P427, DOI 10.1254/jjp.32.427; ONO H, 1990, ARZNEIMITTEL-FORSCH, V40-2, P730; ONO H, 1986, GEN PHARMACOL, V17, P137, DOI 10.1016/0306-3623(86)90130-8; Otsu T, 1997, ARZNEIMITTEL-FORSCH, V47, P706; PAULSON GW, 1976, NEUROLOGY, V26, P1105, DOI 10.1212/WNL.26.11.1105; PENN RD, 1985, LANCET, V2, P125; PENN RD, 1992, J NEUROSURG, V77, P236, DOI 10.3171/jns.1992.77.2.0236; PENN RD, 1984, LANCET, V1, P1078; PENN RD, 1989, NEW ENGL J MED, V320, P1517, DOI 10.1056/NEJM198906083202303; Sadiq SA, 2006, J NEUROL, V253, P563, DOI 10.1007/s00415-005-0060-4; SAKITAMA K, 1995, EUR J PHARMACOL, V273, P47, DOI 10.1016/0014-2999(94)00666-U; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TOGARI A, 1978, Journal of Pharmacobio-Dynamics, V1, P332; VANRIJN CM, 1987, EPILEPSY RES, V1, P321, DOI 10.1016/0920-1211(87)90056-8; WAINAPEL SF, 1986, PARAPLEGIA, V24, P123, DOI 10.1038/sc.1986.16; WEISSENBORN K, 1991, CLIN NEUROL NEUROSUR, V93, P77, DOI 10.1016/0303-8467(91)90015-H; Yamamoto H., 1977, OYO YAKURI, V14, P97; YOKOI I, 1992, J NEURAL TRANSM-GEN, V87, P37, DOI 10.1007/BF01253109	41	3	3	0	2	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-6618			PHARMACOL RES	Pharmacol. Res.	NOV	2009	60	5					392	396		10.1016/j.phrs.2009.06.010			5	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	502NY	WOS:000270468400005	19577646				2022-02-06	
J	Galindo, LM; Delgado, RP; Lopez-Pison, J; Olloqui-Escalona, A; Iniguez, JPG; Izuzquiza, IRD; Pena-Segura, JL				Monge Galindo, L.; Perez Delgado, R.; Lopez-Pison, J.; Olloqui-Escalona, A.; Garcia Iniguez, J. P.; del Olmo Izuzquiza, I. Ruiz; Pena-Segura, J. L.			Benign intracranial hypertension: Experience over 18 years	ANALES DE PEDIATRIA			Spanish	Article						Headache; Fontanelle; Benign intracranial hypertension; Idiopathic intracranial hypertension; Children; Papilloedema; Pseudotumour cerebri	NERVE SHEATH DECOMPRESSION; PSEUDOTUMOR-CEREBRI; NEUROPAEDIATRIC ATTENTION; ATYPICAL PRESENTATION; PEDIATRIC-PATIENTS; CASE SERIES; CHILDHOOD; PRESSURE; DEMAND; MENINGITIS	Introduction: There are transient intracranial hypertension cases, recognizable by bulging fontanelle in infants and by papilloedema in children. We present our experience in benign intracranial hypertension (BIH) cases, excluding traumatic brain injuries, encephalitis and meningitis. Results: Among the entire neuropaediatric database, with 10,720 children in 18 years, 31 cases had the diagnosis of BIH. Sixteen aged between 2.3 and 8.9 months (75% mates), all of them with transient bulging fontanelle, and 15 aged between 4.4 and 13.7 years (73.3% females), all of them with papilloedema which was Subsequently resolved. A total of 75% of infants had recently finished corticosteroid treatment for bronchitis. In the older children, there was 1 case associated with excessive vitamin A intake and 1 mastoiditis. Transfontanelle ultrasonography or CT was performed on all infants and CT or MRI in every child. Lumbar puncture was also performed on 7 infants and on 13 children. Infants developed favourably in a few days, and children did so between 1 week and 5 months, some with treatment. Discussion: BIH usually has a favourable outcome, although it may take longer in children than in infants, but it can have serious visual repercussions, even blindness, so ophthalmological control is necessary. It is normally diagnosed by exclusion of other intracranial hypertension causes. MRI and lumbar puncture must be done on all children or infants who do not progress favourably. Acetazolamide and furosemide, corticosteroids, repeated Lumbar punctures and optic nerve sheath fenestration should be considered in those who do not progress well. (c) 2009 Asociacion Espanola de Pediatria. Published by Elsevier Espana, S.L. All rights reserved.	[Monge Galindo, L.; Perez Delgado, R.; Lopez-Pison, J.; Olloqui-Escalona, A.; Garcia Iniguez, J. P.; del Olmo Izuzquiza, I. Ruiz; Pena-Segura, J. L.] Hosp Univ Miguel Servet, Unidad Neuropediat, Zaragoza, Spain		Lopez-Pison, J (corresponding author), Hosp Univ Miguel Servet, Unidad Neuropediat, Zaragoza, Spain.	jlopezpi@salud.aragon.es		Monge-Galindo, Lorena/0000-0002-2985-3651; Lopez Pison, Francisco Javier/0000-0002-1876-1495; PENA SEGURA, JOSE LUIS/0000-0002-9336-780X; Garcia-Iniguez, Juan Pablo/0000-0003-2740-5385; RUIZ DEL OLMO IZUZQUIZA, IGNACIO/0000-0002-9993-035X			Abenia Uson P, 1999, An Esp Pediatr, V50, P610; Acheson JF, 2006, BRIT MED BULL, V79-80, P233, DOI 10.1093/bmb/ldl019; Agid R, 2006, Minerva Med, V97, P365; Ashwin PT, 2006, POSTGRAD MED J, V82, P580, DOI 10.1136/pgmj.2006.046508; BAKER RS, 1989, PEDIATR NEUROL, V5, P5, DOI 10.1016/0887-8994(89)90002-7; Balasubramanian S, 2005, Indian J Pediatr, V72, P994, DOI 10.1007/BF02731682; Cardinale A, 1991, Minerva Pediatr, V43, P457; Celebisoy N, 2007, ACTA NEUROL SCAND, V116, P322, DOI 10.1111/j.1600-0404.2007.00905.x; Cinciripini GS, 1999, AM J OPHTHALMOL, V127, P178, DOI 10.1016/S0002-9394(98)00386-9; CORBETT JJ, 1989, ARCH NEUROL-CHICAGO, V46, P1049, DOI 10.1001/archneur.1989.00520460025008; de Diago RC, 2005, REV NEUROLOGIA, V40, P598, DOI 10.33588/rn.4010.2004462; de Rivera FJR, 2003, REV NEUROLOGIA, V37, P801, DOI 10.33588/rn.3709.2003282; DHIRAVIBULYA K, 1991, J PAEDIATR CHILD H, V27, P304, DOI 10.1111/j.1440-1754.1991.tb02544.x; Digre K, 2005, NEUROLOGY, V64, P1827; Digre KB, 2003, BRIT MED J, V326, P613, DOI 10.1136/bmj.326.7390.613; Distelmaier F, 2007, CEPHALALGIA, V27, P1261, DOI 10.1111/j.1468-2982.2007.01442.x; Duggal HS, 2005, J NEUROPSYCH CLIN N, V17, P426, DOI 10.1176/appi.neuropsych.17.3.426; Fontana AJ, 2000, CEREAL FOOD WORLD, V45, P7; FOURIE DT, 1977, S AFR MED J, V52, P301; Freedman SB, 2005, J PEDIATR-US, V147, P640, DOI 10.1016/j.jpeds.2005.06.009; Friedman DI, 2005, AM J CLIN DERMATOL, V6, P29, DOI 10.2165/00128071-200506010-00004; Friedman DI, 2002, NEUROLOGY, V59, P1492, DOI 10.1212/01.WNL.0000029570.69134.1B; Gimeno-Pita P, 2002, REV NEUROLOGIA, V34, P109, DOI 10.33588/rn.3402.2001296; Gordon NS, 2006, EUR J PAEDIATR NEURO, V10, P1, DOI 10.1016/j.ejpn.2005.10.005; GRANT DN, 1971, ARCH DIS CHILD, V46, P651, DOI 10.1136/adc.46.249.651; Green JP, 1996, J NEURO-OPHTHALMOL, V16, P241; Higgins JNP, 2003, J NEUROL NEUROSUR PS, V74, P1662, DOI 10.1136/jnnp.74.12.1662; JENNINGS MT, 1993, J CHILD NEUROL, V8, P306, DOI 10.1177/088307389300800403; Kesler A, 2005, ISRAEL MED ASSOC J, V7, P627; Kesler A, 2004, NEUROLOGY, V63, P1737, DOI 10.1212/01.WNL.0000143067.40281.16; Kleinschmidt JJ, 2000, NEUROLOGY, V54, P319, DOI 10.1212/WNL.54.2.319; Lee AG, 1998, OPHTHALMIC SURG LAS, V29, P514; Levine A, 2001, J CHILD NEUROL, V16, P458, DOI 10.1177/088307380101600617; LO S, 1991, J ROY SOC MED, V84, P201, DOI 10.1177/014107689108400406; Lopez-Pison J, 1997, REV NEUROLOGIA, V25, P1896; Lopez-Pison J, 1997, REV NEUROLOGIA, V25, P1905; Lopez-Pison J, 1998, REV NEUROLOGIA, V26, P208, DOI 10.33588/rn.26150.981059; Lopez-Pison J, 2004, REV NEUROLOGIA, V38, P405; LopezPison J, 1997, REV NEUROLOGIA, V25, P1685; LopezPison J, 1997, REV NEUROLOGIA, V25, P1535; LUECK C, 2008, BIBLIOTECA COCHRANE; Matthews YY, 2008, ARCH DIS CHILDHOOD-E, V93, P19, DOI 10.1136/adc.2006.107326; MINNS RA, 1984, ARCH DIS CHILD, V59, P486, DOI 10.1136/adc.59.5.486; Neville L, 2005, CAN J OPHTHALMOL, V40, P775, DOI 10.1016/S0008-4182(05)80100-0; NICOLAIDES P, 1995, PEDIATR NEUROL, V12, P172, DOI 10.1016/0887-8994(94)00155-U; Orssaud C, 2001, J FR OPHTALMOL, V24, P54; PISON JL, 2006, REV NEUROL, V42, P123; Rangwala LM, 2007, SURV OPHTHALMOL, V52, P597, DOI 10.1016/j.survophthal.2007.08.018; Ray WZ, 2008, J NEUROSURG-PEDIATR, V1, P88, DOI 10.3171/PED-08/01/088; Salman MS, 2001, J CHILD NEUROL, V16, P465, DOI 10.1177/088307380101600701; Sanchez-Agreda J, 2003, REV NEUROLOGIA, V36, P351, DOI 10.33588/rn.3604.2002288; Santos S, 2001, REV NEUROLOGIA, V33, P1106, DOI 10.33588/rn.3312.2001346; SCHOEMAN JF, 1994, J CHILD NEUROL, V9, P130, DOI 10.1177/088307389400900205; Soler D, 1998, ARCH DIS CHILD, V78, P89, DOI 10.1136/adc.78.1.89; Thuente DD, 2005, OPHTHALMOLOGY, V112, P724, DOI 10.1016/j.ophtha.2004.11.049; Velazquez-Fragua R, 2008, REV NEUROLOGIA, V46, P766, DOI 10.33588/rn.4612.2008241; Vollbracht R, 1976, Can J Neurol Sci, V3, P59; Youroukos S, 2000, J CHILD NEUROL, V15, P453, DOI 10.1177/088307380001500706; ZEUMER H, 1981, KLIN PADIATR, V193, P325, DOI 10.1055/s-2008-1034487	59	3	4	0	0	EDICIONES DOYMA S A	BARCELONA	TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN	1695-4033	1696-4608		AN PEDIATR	An. Pediatr.	NOV	2009	71	5					400	406		10.1016/j.anpedi.2009.05.023			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	523HP	WOS:000272063500004	19782013				2022-02-06	
J	Saito, T; Sato, N; Kimoto, M; Asano, T; Aoki, A; Ikoma, A; Toyoshima, H; Kawakami, M; Ishikawa, S				Saito, Tomoyuki; Sato, Nobuaki; Kimoto, Mizuho; Asano, Tomoko; Aoki, Atsushi; Ikoma, Aki; Toyoshima, Hideo; Kawakami, Masanobu; Ishikawa, San-e			Incomplete Deficiency of Hypothalamic Hormones in Hypothalamic Hypopituitarism Associated with an Old Traumatic Brain Injury	ENDOCRINE JOURNAL			English	Article						Hypothalamic hypopituitarism; Traumatic brain injury; Hypoglycemia; Hypogonadism	NEUROENDOCRINE DYSFUNCTION; SUBARACHNOID HEMORRHAGE	A 62 year-old man was admitted to determine the pathogenesis of his hypoglycemia. He was unconscious and his plasma glucose level was 26 mg/dL. When he was 31 years old, he had a traffic accident and was unconscious for several days. Physical findings on admittance showed that the patient's BMI was 17.8 and blood pressure, 114/70 mmHg. He was alert. He had a hypogonadal face with a lack of beard, and he had an atrophic testis with a volume of I to 2 mL. Laboratory findings showed that his fasting plasma glucose was 73 mg/dL; serum sodium, 133 mmol/L; potassium, 4.1 mmol/L; serum insulin, less than 1.0 mu U/mL; plasma ACTH, 45.8 pg/mL; serum cortisol, 5.2 mu g/dL; and free cortisol urinary excretion, less than 4.5 mu g/day; serum LH, 0.8 mIU/mL; serum testosterone, less than 0.05 ng/mL; serum TSH, 2.0 mu IU/mL; free T-4, 0.7 ng/dL; free T-3, 1.5 pg/mL; and serum prolactin, 29.0 ng/mL. The levels of all the pituitary hormones were elevated in response to a mixture of exogenous corticotrophin-releasing hormone (CRH), luteinizing hormone-releasing hormone (LH-RH), thyrotropin-releasing hormone (TRH), and growth hormone-releasing hormone (GRH). However, there was no increased secretion of adrenocorticotropic hormone (ACTH) in response to hypoglycemia (induced by the administration of insulin) and there was no increased secretion of luteinizing hormone (LH) and follicle stimulating hormone (FSH) in response to the administration of clomiphene. Magnetic resonance imaging revealed an atrophied pituitary gland with an empty sella, but there were no abnormal findings of the hypothalamus. Hydrocortisone replacement at a dosage of 20 mg/day increased the patient's plasma glucose from 73 to 100 mg/dL and his serum sodium from 133 to 138 mmol/L. These findings therefore indicate a partial impairment in hypothalamic hormone release, resulting from a traumatic brain injury that the patient had received 31 years ago.	[Saito, Tomoyuki; Sato, Nobuaki; Kimoto, Mizuho; Asano, Tomoko; Aoki, Atsushi; Ikoma, Aki; Toyoshima, Hideo; Kawakami, Masanobu; Ishikawa, San-e] Jichi Med Univ, Saitama Med Ctr, Dept Med, Omiya Ku, Saitama 3308503, Japan		Ishikawa, S (corresponding author), Jichi Med Univ, Saitama Med Ctr, Dept Med, Omiya Ku, 1-847 Amanuma, Saitama 3308503, Japan.	saneiskw@jichi.ac.jp					Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Giordano Giulio, 2005, Pituitary, V8, P227, DOI 10.1007/s11102-006-6045-1; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287	11	3	3	0	1	JAPAN ENDOCRINE SOC	KYOTO	75  YANAGINOBANBA NISHIIRU-MASUYA-CHO, SANJOU-DORI, NAKAGYOU-KU, KYOTO, 604-8111, JAPAN	0918-8959	1348-4540		ENDOCR J	Endocr. J.	NOV	2009	56	8					945	950		10.1507/endocrj.K09E-202			6	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	551SU	WOS:000274231000004	19638713	Bronze			2022-02-06	
J	Wijesurendra, RS; Bernard, F; Outtrim, J; Maiya, B; Joshi, S; Hutchinson, PJ; Halsall, DJ; Menon, DK				Wijesurendra, R. S.; Bernard, F.; Outtrim, J.; Maiya, B.; Joshi, S.; Hutchinson, P. J.; Halsall, D. J.; Menon, D. K.			Low-Dose and High-Dose Synacthen Tests and the Hemodynamic Response to Hydrocortisone in Acute Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Tetracosactide; Synacthen; Low-dose; Adrenal insufficiency	PITUITARY-ADRENAL AXIS; SEPTIC SHOCK; STIMULATION TESTS; INSUFFICIENCY; DISEASE	In order to identify whether low-dose (1 mu g) tetracosactide (Synacthen(A (R))) testing may be preferable to high-dose (250 mu g) testing in the diagnosis of adrenal insufficiency in traumatic brain injury (TBI), as suggested by studies in other forms of critical illness. We retrospectively reviewed the results of modified tetracosactide tests (involving administration of both low-dose and high-dose tetracosactide) conducted for clinical indications in patients in a neurocritical care unit within 10 days of TBI. Sixty-three modified tests were included and cortisol concentrations before and after administration of tetracosactide were extracted from the hospital records. Data were also extracted regarding hemodynamic response to empirical corticosteroid therapy, based on rapid weaning from vasoactive drugs. Cortisol increments at 30 and 60 min following tetracosactide correlated well in the low-dose test (r (2) = 0.875, P < 0.0001). The mean cortisol concentration was 581 nmol/l at 30 min and 556 nmol/l at 60 min in the low-dose test. Cortisol increments following low-dose and high-dose testing correlated well overall (r (2) = 0.839, P < 0.0001), but results were discordant in 27 of 63 cases (43%) when the same diagnostic threshold was used. ROC curve analysis showed that both tests performed poorly in identifying hemodynamic steroid responsiveness (AUC 0.553 and 0.502, respectively). In the low-dose tetracosactide test, it is sufficient to determine cortisol concentrations at baseline and at 30 min. Low-dose and high-dose tests give discordant results in a significant proportion of cases when using the same diagnostic threshold. Neither test can be used to guide the initiation of corticosteroid therapy in acute TBI.	[Wijesurendra, R. S.; Bernard, F.; Outtrim, J.; Maiya, B.; Menon, D. K.] Univ Cambridge, Addenbrookes Hosp, Univ Div Anaesthesia, Hosp NHS Fdn Trust, Cambridge CB2 2QQ, England; [Joshi, S.; Halsall, D. J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Hosp NHS Fdn Trust, Cambridge CB2 2QQ, England; [Hutchinson, P. J.] Univ Cambridge, Addenbrookes Hosp, Univ Dept Neurosurg, Hosp NHS Fdn Trust, Cambridge CB2 2QQ, England; [Bernard, F.] Hop Sacre Coeur, Univ Dept Crit Care Med & Gen Internal Med, Montreal, PQ H4J 1C5, Canada		Wijesurendra, RS (corresponding author), Univ Cambridge, Addenbrookes Hosp, Univ Div Anaesthesia, Hosp NHS Fdn Trust, Box 93,Hills Rd, Cambridge CB2 2QQ, England.	rohansw@hotmail.com		Outtrim, Joanne/0000-0001-8118-6430	Intensive Care Society, UK; NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); Academy of Medical Sciences Health Foundation Senior Surgical Scientist Fellowship; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390, G0600986, G0601025] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986, G0601025, G9439390] Funding Source: UKRI	All patients were treated in the Neurosciences Critical Care Unit at Addenbrooke's Hospital (part of Cambridge University Hospitals NHS Foundation Trust), Cambridge, England. These studies were supported, in part, by a research grant from the Intensive Care Society, UK. We also acknowledge the NIHR Cambridge Biomedical Research Centre. PJ Hutchinson is supported by an Academy of Medical Sciences Health Foundation Senior Surgical Scientist Fellowship.	Abdu TAM, 1999, J CLIN ENDOCR METAB, V84, P838, DOI 10.1210/jc.84.3.838; Arafah BM, 2006, J CLIN ENDOCR METAB, V91, P3725, DOI 10.1210/jc.2006-0674; Bellissant E, 2000, CLIN PHARMACOL THER, V68, P293, DOI 10.1067/mcp.2000.109354; Benvenga Salvatore, 2005, Pituitary, V8, P193, DOI 10.1007/s11102-006-6040-6; Bernard F, 2006, BRIT J ANAESTH, V96, P72, DOI 10.1093/bja/aei277; Bernard F, 2006, NEUROCRIT CARE, V5, P176, DOI 10.1385/NCC:5:3:176; Darmon P, 1999, EUR J ENDOCRINOL, V140, P51, DOI 10.1530/eje.0.1400051; Magnotti Michael, 2008, Endocr Pract, V14, P233; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; Marik PE, 2003, CRIT CARE MED, V31, P141, DOI 10.1097/00003246-200301000-00022; Marik PE, 2002, CHEST, V122, P1784, DOI 10.1378/chest.122.5.1784; Mayenknecht J, 1998, J CLIN ENDOCR METAB, V83, P1558, DOI 10.1210/jc.83.5.1558; Nye EJ, 2001, CLIN ENDOCRINOL, V55, P625, DOI 10.1046/j.1365-2265.2001.01389.x; Reimondo G, 2008, PITUITARY, V11, P147, DOI 10.1007/s11102-008-0108-4; SAITO T, 1995, INTENS CARE MED, V21, P204, DOI 10.1007/BF01701473; Salgado DR, 2006, CRIT CARE, V10, DOI 10.1186/cc5077; Siraux V, 2005, CRIT CARE MED, V33, P2479, DOI 10.1097/01.CCM.0000185641.87051.7C; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366	18	3	4	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2009	11	2					158	164		10.1007/s12028-009-9217-9			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	495OG	WOS:000269902300005	19404783				2022-02-06	
J	Zhang, S; Liu, XZ; Liu, ZL; Shang, CZ; Hu, QL				Zhang Sai; Liu Xiao-zhi; Liu Zhen-lin; Shang Chong-Zhi; Hu Qun-liang			Tropism mechanism of stem cells targeting injured brain tissues by stromal cell-derived factor-1	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Stromal cell-derived factor; Stem cells; Chemotactic factor; Traumatic brain injury		Objective: To explore the role and function of stromal cell-derived factor-1 (SDF-1) in stem cells migrating into injured brain area. Methods: Rat-derived nerve stem cells (NSCs) were isolated and cultured routinely. Transwell system was used to observe the migration ability of NSCs into injured nerve cells. Immunocytochemistry was used to explore the expression of chemotactic factor receptor-4 (CXCR-4) in NSCs. In vivo, we applied immunofluorescence technique to observe themigration of NSCs into injured brain area. Immunofluorescence technique and Western blotting were used to test expression level of SDF-1. After AMD3100 (a special chemical blocker) blocking CXCR-4, themigration ability of NSCs was tested in vivo and in vitro, respectively. Results: NSCs displayed specific tropism for injured nerve cells or traumatic brain area in vivo and in vitro. The expression level of SDF-1 in traumatic brain area increased remarkably and the expression level of CXCR-4 in the NSCs increased simultaneously. After AMD3100 blocking the expression of CXCR-4, the migration ability of NSCs decreased significantly both in vivo and in vitro. Conclusions: SDF-1 may play a key role in stem cells migrating into injured brain area through specially combining with CXCR-4.	[Zhang Sai; Liu Xiao-zhi; Liu Zhen-lin; Shang Chong-Zhi; Hu Qun-liang] Chinese Peoples Armed Police Force, Affiliated Hosp, Med Coll, Dept Neurosurg, Tianjin 300162, Peoples R China		Liu, XZ (corresponding author), Chinese Peoples Armed Police Force, Affiliated Hosp, Med Coll, Dept Neurosurg, Tianjin 300162, Peoples R China.	lxz0907@yahoo.com.cn			Project of Science and Technology Funds of Tianjin [06YFSZSF01200]	This study was supported by the Project of Science and Technology Funds of Tianjin (No. 06YFSZSF01200).	Chen H Isaac, 2007, Curr Stem Cell Res Ther, V2, P13; Cullen DK, 2007, J NEUROSCI RES, V85, P3642, DOI 10.1002/jnr.21434; Einstein O, 2008, ARCH NEUROL-CHICAGO, V65, P452, DOI 10.1001/archneur.65.4.452; Fricker SP, 2008, EXPERT OPIN INV DRUG, V17, P1749, DOI 10.1517/13543784.17.11.1749 ; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Itoh T, 2009, NEUROL RES, V31, P90, DOI 10.1179/174313208X332995; Ni HT, 2004, DEV BRAIN RES, V152, P159, DOI 10.1016/j.devbrainres.2004.06.015; Schonemeier B, 2008, J COMP NEUROL, V510, P207, DOI 10.1002/cne.21780; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Yoshinaga T, 2007, J NEURAL TRANSM-SUPP, P331; Zagzag D, 2006, LAB INVEST, V86, P1221, DOI 10.1038/labinvest.3700482; Zhang S, 2008, CHIN J NERV MED, V7, P325; [张赛 ZHANG Sai], 2008, [中华创伤杂志, Chinese Journal of Trauma], V24, P425; [只达石 Zhi Dashi], 2005, [中华创伤杂志, Chinese Journal of Traumatology], V21, P50	14	3	4	1	2	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	OCT	2009	12	5					263	268		10.3760/cma.j.issn.1008-1275.2009.05.002			6	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VF0YF	WOS:000441890500002	19788842				2022-02-06	
J	Falk, AC; Von Wendt, L; Soderkvist, BK				Falk, Ann-Charlotte; Von Wendt, Lennart; Soderkvist, Birgitta Klang			The specificity of post-concussive symptoms in the pediatric population	JOURNAL OF CHILD HEALTH CARE			English	Article						accident and emergency; acute care; child health; childhood illness	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; CHILDREN; MILD	The study compared patterns of reported symptoms between a mild head injury group and a group of children with abdominal complaints visiting an emergency department. Children (0-15 years) admitted to an emergency department during a three-month period with a history of head injury and a comparison group of children were included. Medical records at the time of injury were reviewed and follow-up questionnaires focused on presumed symptoms related to concussion at three months post-visit. The comparison group reported significantly more change in behaviour than the head injury group. However, for the older children, higher intensity of symptoms was reported by the comparison group compared to the head injury group. Initial differences in the amount and presence of symptoms between the two groups did not reflect the findings at three months; both groups reported symptoms or changes at three months after the event. Evaluating children aged under five, their symptoms and recovery patterns after a head injury is recommended.	[Falk, Ann-Charlotte] Karolinska Inst, Dept Woman & Child Hlth, Neuropediat Res Unit, Stockholm, Sweden; [Von Wendt, Lennart] Univ Helsinki, Dept Child Neurol, Univ Hosp Children & Adolescents, FIN-00014 Helsinki, Finland; [Soderkvist, Birgitta Klang] Karolinska Univ, Red Cross Univ, Hosp Solna, Stockholm, Sweden		Falk, AC (corresponding author), Astrid Lindgren Childrens Hosp, Dept Woman & Child Hlth, Neuropediat Res Unit, Karolinska Inst, Q2-07, SE-17176 Stockholm, Sweden.	ann-charlotte.falk@karolinska.se	Falk, Ann-Charlotte/ABA-1730-2020	Falk, Ann-Charlotte/0000-0003-2246-7894			Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Bergman DA, 1999, PEDIATRICS, V104, P1407; CASEY R, 1986, PEDIATRICS, V78, P497; ELKIND D, 1976, BARNS UTVECKLING UPP; Falk Ann-Charlotte, 2007, Dev Neurorehabil, V10, P49, DOI 10.1080/13638490600864066; Falk AC, 2006, ACTA PAEDIATR, V95, P1533, DOI 10.1080/08035250600731957; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; KRAUS JF, 1987, PEDIATRICS, V79, P501; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P165; Leathem JM, 2000, J HEAD TRAUMA REHAB, V15, P1246, DOI 10.1097/00001199-200012000-00005; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Necajauskaite Olga, 2005, Medicina (Kaunas), V41, P457; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5	21	3	3	0	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1367-4935	1741-2889		J CHILD HEALTH CARE	J. Child Health Care	SEP	2009	13	3					227	238		10.1177/1367493509336691			12	Nursing; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Pediatrics	645YY	WOS:000281503300005	19713406				2022-02-06	
J	Forde, JC; Khan, KS; Awan, N				Forde, James C.; Khan, Khalid S.; Awan, Nasir			Traumatic Posterior Dislocation of the Hip in a 3-Year-Old Child	PEDIATRIC EMERGENCY CARE			English	Article						traumatic; posterior dislocation; orthopedic emergency; avascular necrosis; closed reduction; premature osteoarthritis		We report the case of a traumatic posterior dislocation of the hip in a 3-year-old boy. After a fall in the garden, the boy was brought to our emergency department where an x-ray confirmed a posterior dislocation of his right hip. A successful prompt reduction was performed in the operating room under general anesthesia. This uncommon injury represents an orthopedic emergency and requires prompt reduction to lessen the risk of complications including avascular necrosis of the femoral head.	[Forde, James C.; Khan, Khalid S.; Awan, Nasir] Our Lady Lourdes Hosp, Dept Trauma & Orthopaed, Drogheda, Louth, Ireland		Forde, JC (corresponding author), Our Lady Lourdes Hosp, Dept Trauma & Orthopaed, Drogheda, Louth, Ireland.	fordejames@yahoo.com					BARQUET A, 1982, ACTA ORTHOP SCAND, V53, P815, DOI 10.3109/17453678208992299; GARTLAND JJ, 1976, ORTHOP CLIN N AM, V7, P687; Hamilton PR, 1998, J PEDIATR ORTHOPED, V18, P691; Kutty S, 2001, PEDIATR EMERG CARE, V17, P32, DOI 10.1097/00006565-200102000-00009; MACNICOL MF, J PEDIAT ORTHOP, V9, P122; Mehlman CT, 2000, CLIN ORTHOP RELAT R, P68; OLSSON O, 1994, ACTA ORTHOP SCAND, V65, P476, DOI 10.3109/17453679408995496; Vemulapalli KK, 2005, ARCH ORTHOP TRAUM SU, V125, P490, DOI 10.1007/s00402-005-0029-x; Vialle R, 2004, PEDIATR RADIOL, V34, P970, DOI 10.1007/s00247-004-1299-0	9	3	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	SEP	2009	25	9					584	585		10.1097/PEC.0b013e3181b4f7bd			2	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	495DZ	WOS:000269872000011	19755894				2022-02-06	
J	Hosalkar, H; Pandya, NK; Hsu, J; Keenan, MA				Hosalkar, Harish; Pandya, Nirav K.; Hsu, Jason; Keenan, Mary Ann			What's New in Orthopedic Rehabilitation	JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME			English	Article							SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; PRESSURE WOUND THERAPY; DIABETIC FOOT ULCERS; TERM-CARE RESIDENTS; HETEROTOPIC OSSIFICATION; LIFE SATISFACTION; PHYSICAL CAPACITY; BONE; IMPACT		[Hosalkar, Harish] UCSD San Diego, Rady Childrens Hosp, San Diego, CA 92123 USA; [Pandya, Nirav K.; Hsu, Jason; Keenan, Mary Ann] Hosp Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA		Hosalkar, H (corresponding author), UCSD San Diego, Rady Childrens Hosp, 3030 Childrens Way,Suite 410, San Diego, CA 92123 USA.	HHosalkar@rchsd.org; maryann.keenan@uphs.upenn.edu	Keenan, Mary Ann/ABB-1551-2020				Anderson KD, 2009, SPINAL CORD, V47, P334, DOI 10.1038/sc.2008.148; Axelrad TW, 2008, J BONE JOINT SURG BR, V90B, P1617, DOI 10.1302/0301-620X.90B12.20975; Bao F, 2009, EXP NEUROL, V215, P308, DOI 10.1016/j.expneurol.2008.10.022; Bek D, 2009, J ARTHROPLASTY, V24, P226, DOI 10.1016/j.arth.2007.11.008; Bell AL, 2009, PHYS THER, V89, P103, DOI 10.2522/ptj.20080009.cx; Berendt AR, 2008, DIABETES-METAB RES, V24, pS145, DOI 10.1002/dmrr.836; Blokhuis TJ, 2009, CLIN ORTHOP RELAT R, V467, P526, DOI 10.1007/s11999-008-0532-9; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS77, DOI 10.1016/j.apmr.2008.07.008; Brower RS, 2008, SPINE, V33, pE653, DOI 10.1097/BRS.0b013e31817c4f1c; Bus SA, 2008, DIABETES-METAB RES, V24, pS162, DOI 10.1002/dmrr.850; Butalia S, 2008, JAMA-J AM MED ASSOC, V299, P806, DOI 10.1001/jama.299.7.806; Campagnolo DI, 2008, SPINAL CORD, V46, P477, DOI 10.1038/sc.2008.4; Chen YY, 2008, ARCH PHYS MED REHAB, V89, P2285, DOI 10.1016/j.apmr.2008.06.008; Curt A, 2008, J NEUROTRAUM, V25, P677, DOI 10.1089/neu.2007.0468; Dallolio L, 2008, ARCH PHYS MED REHAB, V89, P2332, DOI 10.1016/j.apmr.2008.06.012; Dedmond BT, 2007, J ORTHOP TRAUMA, V21, P11, DOI 10.1097/BOT.0b013e31802cbc54; Dinh MT, 2008, CLIN INFECT DIS, V47, P519, DOI 10.1086/590011; Dunsky A, 2008, ARCH PHYS MED REHAB, V89, P2223, DOI 10.1016/j.apmr.2008.08.206; Ertl J, 1949, CHIRURG, V20, P218; FURLAN J, 2008, SPINE J, V8, pS99; Ganguly S, 2008, J INDIAN MED ASSOC, V106, P244; Ganguly Suparno, 2008, J Indian Med Assoc, V106, P237; Goodman N, 2008, ARCH PHYS MED REHAB, V89, P1492, DOI 10.1016/j.apmr.2007.12.038; Gorton GE, 2009, GAIT POSTURE, V29, P398, DOI 10.1016/j.gaitpost.2008.10.060; Gough M, 2008, J BONE JOINT SURG BR, V90B, P946, DOI 10.1302/0301-620X.90B7.20577; Hinchliffe RJ, 2008, DIABETES-METAB RES, V24, pS119, DOI 10.1002/dmrr.825; Johannesson A, 2008, ACTA ORTHOP, V79, P361, DOI 10.1080/17453670710015265; Kan LX, 2009, STEM CELLS, V27, P150, DOI 10.1634/stemcells.2008-0576; Kavros Steven J, 2007, Adv Skin Wound Care, V20, P221, DOI 10.1097/01.ASW.0000266660.88900.38; Kavros Steven J, 2008, Adv Skin Wound Care, V21, P416, DOI 10.1097/01.ASW.0000323546.04734.31; Kawai M, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-62; Kontakis G, 2008, J BONE JOINT SURG BR, V90B, P1407, DOI 10.1302/0301-620X.90B11.21070; Lafleur MF, 2002, NEUROIMAGE, V16, P142, DOI 10.1006/nimg.2001.1048; Lipsky BA, 2008, CLIN INFECT DIS, V47, P1537, DOI 10.1086/593185; Lo SF, 2008, J CLIN NURS, V17, P1973, DOI 10.1111/j.1365-2702.2007.02264.x; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Macfarlane RJ, 2008, EXPERT OPIN PHARMACO, V9, P767, DOI 10.1517/14656566.9.5.767; Mehrholz Jan, 2008, Spine (Phila Pa 1976), V33, pE768, DOI 10.1097/BRS.0b013e3181849747; MITSIONIS GI, 2008, INT ORTHOP      0619; Moore Rusty A, 2008, Adv Skin Wound Care, V21, P517, DOI 10.1097/01.ASW.0000323579.87700.ec; Pinzur MS, 2008, J BONE JOINT SURG AM, V90A, P2682, DOI 10.2106/JBJS.G.01593; Powell ET, 2008, J ORTHOP TRAUMA, V22, pS138, DOI 10.1097/BOT.0b013e318188e27d; Rama KRBS, 2009, J ARTHROPLASTY, V24, P256, DOI 10.1016/j.arth.2007.12.004; Reinbolt JA, 2008, J BIOMECH, V41, P2362, DOI 10.1016/j.jbiomech.2008.05.030; Riegger T, 2009, NEUROSCIENCE, V158, P1194, DOI 10.1016/j.neuroscience.2008.08.021; Riegger T, 2007, EUR J NEUROSCI, V25, P1743, DOI 10.1111/j.1460-9568.2007.05447.x; Rintala DH, 2008, ARCH PHYS MED REHAB, V89, P1429, DOI 10.1016/j.apmr.2008.01.015; Rozzanigo U, 2009, RADIOL MED, V114, P121, DOI 10.1007/s11547-008-0337-7; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Schley MT, 2008, J TRAUMA, V65, P858, DOI 10.1097/TA.0b013e31812eed9e; Serena T, 2009, OSTOMY WOUND MANAG, V55, P22; Shilt JS, 2008, J PEDIATR ORTHOPED, V28, P684, DOI 10.1097/BPO.0b013e318183d591; Shore EM, 2007, NAT GENET, V39, P276, DOI 10.1038/ng0207-276b; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Singh R, 2007, CLIN REHABIL, V21, P754, DOI 10.1177/0269215507077361; Smith BM, 2008, AM J PHYS MED REHAB, V87, P750, DOI 10.1097/PHM.0b013e3181837a50; Smith PA, 2009, J BONE JOINT SURG AM, V91A, P356, DOI 10.2106/JBJS.G.01369; STAMMERS A, 2008, SPINE J, V8, pS98; Stewart C, 2008, GAIT POSTURE, V28, P372, DOI 10.1016/j.gaitpost.2008.05.007; Takahashi PY, 2008, INT WOUND J, V5, P625, DOI 10.1111/j.1742-481X.2008.00542.x; Takahashi PY, 2009, OSTOMY WOUND MANAG, V55, P32; Toffoli AM, 2008, BRAIN INJURY, V22, P511, DOI 10.1080/02699050802158235; Valent L, 2007, CLIN REHABIL, V21, P315, DOI 10.1177/0269215507073385; Valent LJ, 2008, ARCH PHYS MED REHAB, V89, P1016, DOI 10.1016/j.apmr.2007.10.034; van Koppenhagen CF, 2008, ARCH PHYS MED REHAB, V89, P1733, DOI 10.1016/j.apmr.2007.12.042; Vega SR, 2008, NEUROSCIENCE, V153, P1064, DOI 10.1016/j.neuroscience.2008.03.037; Webb LX, 2008, J ORTHOP TRAUMA, V22, pS135, DOI 10.1097/BOT.0b013e31818956ce; Werdin F, 2008, LANCET, V372, P1860, DOI 10.1016/S0140-6736(08)61793-6; Wierks C, 2009, CLIN ORTHOP RELAT R, V467, P225, DOI 10.1007/s11999-008-0406-1; Wilson JA, 2008, PAIN, V135, P108, DOI 10.1016/j.pain.2007.05.011; Wu SC, 2008, DIABETES CARE, V31, P2118, DOI 10.2337/dc08-0771; Wukich DK, 2008, J BONE JOINT SURG AM, V90A, P1570, DOI 10.2106/JBJS.G.01673; Wysocki RW, 2007, J HAND SURG-AM, V32A, P647, DOI 10.1016/j.jhsa.2007.03.001; Yaguchi M, 2008, J NEUROSCI RES, V86, P1972, DOI 10.1002/jnr.21658; Yang EJ, 2008, ARCH PHYS MED REHAB, V89, P2108, DOI 10.1016/j.apmr.2008.04.019; Yu PB, 2009, NAT MED, V15, P117, DOI 10.1038/nm0109-117a; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888	78	3	3	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0021-9355	1535-1386		J BONE JOINT SURG AM	J. Bone Joint Surg.-Am. Vol.	SEP	2009	91A	9					2296	2310		10.2106/JBJS.I.00319			15	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	489XS	WOS:000269460400029	19724009				2022-02-06	
J	Thomas, M; Dufour, L				Thomas, Margaret; Dufour, Linda			Challenges of Diffuse Axonal Injury Diagnosis	REHABILITATION NURSING			English	Article						diagnostic challenges; diffuse axonal injury; traumatic brain injury	TENSOR	"This can't be right. Jay is in a vegetative state following a severe traumatic brain injury (TBI), but his computed tomography scan is essentially normal. How am I going to explain this to his mom?" This is a conversation I overhear among my rehabilitation nurse colleagues from time to time. Jay has a type of brain trauma called diffuse axonal injury (DAI). Recent statistics from the National Centers for Injury Prevention and Control (NCIPC, 2006) indicate 1.4 million people sustain a TBI each year in the United States. The leading causes of TBI are falls (28%), motor vehicle accidents (20%, being struck by or against an object (19%), and assaults (11%; NCIPC). DAI, one of the most important causes of cognitive dysfunction after TBI (Sugiyama et al., 2007), occurs in a more widespread pattern in certain regions of the brain than the localized zone of focal injuries. It is one of the most devastating forms of TBI and a common cause of vegetative state and severe disability. DAI occurs in 40%-50% of all patients who are hospitalized from TBI (Meythaler Peduzzi, Eleftheriou, & Novack, 2001).	[Thomas, Margaret; Dufour, Linda] Shepherd Ctr, Atlanta, GA USA		Thomas, M (corresponding author), Shepherd Ctr, Atlanta, GA USA.	margaret_thomas@shepherd.org					Mao H, 2007, J NEUROIMAGING, V17, P292, DOI 10.1111/j.1552-6569.2007.00146.x; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; *NAT CTR INJ PREV, 2006, HEADS BRAIN INJ YOUR; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Okamoto T, 2007, EUR J NEUROL, V14, P540, DOI 10.1111/j.1468-1331.2007.01742.x; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Sugiyama K, 2007, BRAIN INJURY, V21, P413, DOI 10.1080/02699050701311042; Wasserman J, 2007, DIFFUSE AXONAL INJUR; Zheng WB, 2007, NEURORADIOLOGY, V49, P271, DOI 10.1007/s00234-006-0187-8	9	3	8	1	5	ASSOC REHABILITATION NURSES	GLENVIEW	4700 W LAKE AVE, GLENVIEW, IL 60025-1485 USA	0278-4807			REHABIL NURS	Rehabil. Nurs.	SEP-OCT	2009	34	5					179	180		10.1002/j.2048-7940.2009.tb00276.x			2	Nursing; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Rehabilitation	497IK	WOS:000270052200002	19772114				2022-02-06	
J	Gezici, AR; Karakas, A; Ergun, R; Gunduz, B				Gezici, Ali Riza; Karakas, Alper; Ergun, Ruchan; Gunduz, Bulent			Serum cortisol levels following acute experimental spinal cord injury	NEUROLOGIA I NEUROCHIRURGIA POLSKA			English	Article						cortisol; neuroprotection; spinal cord injury; ELISA	MELATONIN; SYNTHETASE; TRAUMA; SYSTEM; CELLS	Background and purpose: Cortisol has neuroprotective effects. We monitored the serum cortisol levels after cervical and thoracic spinal cord injury (SCI) in four groups of rats. Materials and methods: Forty male Sprague-Dawley rats were randomized to four groups. The control group received neither laminectomy nor SCI. The sham group received laminectomy without SCT. The cervical spinal trauma group received a C5-C6 laminectomy and spinal trauma at this level. The thoracic spinal trauma group received a T6-T7 laminectomy and spinal trauma. Blood samples were drawn 2, 6, 12 and 24 hours after surgeries and assayed immediately. Results: The level of cortisol in the cervical spinal trauma group was highest at the second hour of the experiment and the lowest in control and sham-operated groups at the same time. At the sixth hour, cortisol levels increased in control and sham operated groups decreased, but increased in thoracic and cervical groups decreased, but increased in thoracic and cervical groups. After the 24(th) hour, serum cortisol levels in thoracic and cervical groups decreased but did not change significantly in control and sham-operated animals. Conclusion: Activation of endogen cortisol secretion of the organism starts immediately after the SCI injury and throughout the experiment the serum cortisol levels in neurotrauma groups remained high compared with the control and sham-operated groups. At the beginning, the level of neurological lesion (cervical or thoracic) affected differently the level of serum cortisol at a statistically significant level but this difference disappeared at the 6(th) hour.	[Gezici, Ali Riza; Ergun, Ruchan] Abant Izzet Baysal Univ, Dept Neurosurg, Fac Med, Bolu, Turkey; [Karakas, Alper] Abant Izzet Baysal Univ, Dept Biol, Fac Arts & Sci, Bolu, Turkey; [Gunduz, Bulent] Canakkale Onsekiz Mart Univ, Dept Biol, Fac Arts & Sci, Canakkale, Turkey		Gezici, AR (corresponding author), Beskavaklar Mahallesi,Oznur Apt 16-8, TR-14300 Bolu, Turkey.		Gunduz, Bulent/AAA-5763-2019				ANDERSON DK, 1993, ANN EMERG MED, V22, P987, DOI 10.1016/S0196-0644(05)82739-8; BECKMAN JS, 1993, BIOCHEM SOC T, V21, P330, DOI 10.1042/bst0210330; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; Cuzzocrea S, 1998, IMMUNOLOGY, V93, P96; DeRiu PL, 1997, PHYSIOL BEHAV, V62, P1, DOI 10.1016/S0031-9384(97)00099-1; Desborough JP, 1993, ANAESTHESIA REV, V10, P131; Drew PD, 2000, BRAIN RES BULL, V52, P391, DOI 10.1016/S0361-9230(00)00275-6; FANTONE JC, 1982, AM J PATHOL, V107, P397; Fujimoto T, 2000, SPINE, V25, P769, DOI 10.1097/00007632-200004010-00003; Genovese T, 2005, J PINEAL RES, V38, P198, DOI 10.1111/j.1600-079X.2004.00194.x; Gerendai I, 2000, J AUTONOM NERV SYST, V80, P40, DOI 10.1016/S0165-1838(00)00071-0; Gorovits R, 1997, P NATL ACAD SCI USA, V94, P7024, DOI 10.1073/pnas.94.13.7024; Heiduschka P, 2006, GRAEF ARCH CLIN EXP, V244, P1512, DOI 10.1007/s00417-005-0164-7; Huang TS, 1998, AM J PHYS MED REHAB, V77, P108, DOI 10.1097/00002060-199803000-00004; Liu JB, 2004, CHINESE MED J-PEKING, V117, P571; Nagai K, 1996, PROG BRAIN RES, V111, P253, DOI 10.1016/S0079-6123(08)60413-6; RIVLIN AS, 1978, SURG NEUROL, V10, P39; SCARBOROUGH DE, 1990, ANN NY ACAD SCI, V594, P169; Tanaka J, 1997, GLIA, V20, P23, DOI 10.1002/(SICI)1098-1136(199705)20:1<23::AID-GLIA3>3.3.CO;2-U; Topsakal C, 2003, SPINE, V28, P1643, DOI 10.1097/00007632-200308010-00004; Yoo KY, 2006, ANESTH ANALG, V102, P1223, DOI 10.1213/01.ane.0000198429.09694.d3; Zeitzer JM, 2000, J CLIN ENDOCR METAB, V85, P2189, DOI 10.1210/jc.85.6.2189	22	3	3	1	3	ELSEVIER URBAN & PARTNER SP Z O O	WROCLAW	UL MIGDALOWA 4, LOK 59, WROCLAW, 02-796, POLAND	0028-3843			NEUROL NEUROCHIR POL	Neurol. Neurochir. Pol.	JUL-AUG	2009	43	4					352	357					6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	515EY	WOS:000271451600005	19742394				2022-02-06	
J	McNett, M				McNett, Molly			Intensive Care Unit Nurse Characteristics Impacting Judgments About Secondary Brain Injury	DIMENSIONS OF CRITICAL CARE NURSING			English	Article						Neurologic injury; Secondary brain injury; Traumatic brain injury		Although intensive care unit nurses have an integral role in preventing secondary brain injury when caring for critically ill traumatic brain injury patients, nursing practice varies and little research has examined if individual nurse characteristics affect judgments about secondary brain injury. The purpose of this study was to investigate how intensive care unit nurse characteristics influence judgments when managing secondary brain injury. A factorial survey research design was used to administer surveys to intensive care nurses from 2 level I trauma centers. Nursing shift and number of years in the intensive care unit were significant predictors of judgments. Understanding the role of nurse characteristics is important in future educational and research efforts aimed at evidence-based management of secondary brain injury.	[McNett, Molly] MetroHlth Med Ctr, Dept Nursing, Cleveland, OH 44116 USA		McNett, M (corresponding author), MetroHlth Med Ctr, Dept Nursing, Nursing Business Off, 2500 MetroHlth Dr, Cleveland, OH 44116 USA.	mmcnett@metrohealth.org					Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Bakalis N, 2003, INT J NURS STUD, V40, P749, DOI 10.1016/S0020-7489(03)00014-2; BENNER P, 1999, CLIN WISDOM INTERVEN; Bucknall TK, 2000, J CLIN NURS, V9, P25, DOI 10.1046/j.1365-2702.2000.00333.x; Centers for Disease Control and Prevention Division of Injury and Disability Outcomes and Progress, TRAUMATIC BRAIN INJU; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, TRAUM BRAIN INJ US; Chamberlain D J, 1998, Aust Crit Care, V11, P123, DOI 10.1016/S1036-7314(98)70499-0; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Corcoran-Perry S A, 1999, Nurs Health Sci, V1, P49, DOI 10.1046/j.1442-2018.1999.00008.x; Currey J, 2006, J CLIN NURS, V15, P1081, DOI 10.1111/j.1365-2702.2006.01392.x; Davis A E, 2000, Crit Care Nurs Q, V23, P1; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; FONTEYN ME, 1994, NURSING INFORMATICS: AN INTERNATIONAL OVERVIEW FOR NURSING IN A TECHNOLOGICAL ERA, P481; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; HENRY SB, 1991, HEART LUNG, V20, P478; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hickey J, 2003, CLIN PRACTICE NEUROL; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lauri S, 1998, HEART LUNG, V27, P133, DOI 10.1016/S0147-9563(98)90021-8; Ludwick R, 2004, ADV NURS SCI, V27, P224, DOI 10.1097/00012272-200407000-00007; Ludwick R, 2001, NURS RES, V50, P129, DOI 10.1097/00006199-200103000-00009; McNair ND, 1999, NURS CLIN N AM, V34, P637; McNett M, AM I CRIT C IN PRESS; Minick P, 1995, Sch Inq Nurs Pract, V9, P303; Peden-McAlpine Cynthia, 2002, Dimens Crit Care Nurs, V21, P144, DOI 10.1097/00003465-200207000-00006; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Tanner CA, 2006, J NURS EDUC, V45, P204, DOI 10.3928/01484834-20060601-04; The Brain Trauma Foundation, GUID MAN SEV TRAUM B; Tierney N, 1992, THESIS; Villanueva N E, 1999, J Neurosci Nurs, V31, P216	31	3	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0730-4625	1538-8646		DIMENS CRIT CARE NUR	Dimens. Crit. Care Nurs.	JUL-AUG	2009	28	4					182	188		10.1097/DCC.0b013e3181a473d7			7	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	V2J9V	WOS:000217649000007	19546729				2022-02-06	
J	Rios, A; Casado-Flores, J; Porto, R; Jimenez, AB; Jimenez, R; Serrano, A				Rios, A.; Casado-Flores, J.; Porto, R.; Jimenez, A. B.; Jimenez, R.; Serrano, A.			Severe child abuse admitted to paediatric ICU	ANALES DE PEDIATRIA			Spanish	Article						Child abuse; Subdural haematomas; Inflicted traumatic brain injury	YOUNG-CHILDREN; HEAD-INJURY	Objective: To describe cases of severe child abuse admitted to PICU. Methods and patients: It is a retrospective study (2000-2008) in which patients diagnosed with physical child abuse admitted to PICU were included. Other abuse patterns were excluded (severe negligence, sexual abuse or scalding). Results: There were 8 patients included (3 boys and 5 girls). The median age was 5.2 months, with 6 patients were less than 7 months old. The most frequent sign was neurological symptoms: seizures (4 patients), subdural haematoma (2 patients), traumatic brain injury (1 patient). Other: haemothorax (1 patient) and cardiac arrest of no known aetiology (1 patient). The CT showed a subdural haematoma in 5 patients, 3 of which needed surgical drainage. Child abuse was confirmed using the social history and the presence of inflicted injuries. There were Long bones fractures (tibia, ulna and radius, bilateral rib fractures) in 3 patients and 4 patients had retinal haemorrhages. There was one death and 3 had severe neurological after effects. Conclusion: Severely abused children can be falsely diagnosed with a casual neurological disease. The most frequent injury is subdural haematoma with or without another injury associated to child abuse. It very important to diagnose child abuse in order to prevent recurrent injuries. (C) 2009 Asociacion Espanola de Pediatria. Published by Elsevier Espana, S.L. All rights reserved.	[Rios, A.; Casado-Flores, J.; Porto, R.; Jimenez, A. B.; Jimenez, R.; Serrano, A.] Hosp Univ Nino Jesus, Dept Cuidados Intens, Madrid, Spain		Rios, A (corresponding author), Hosp Univ Nino Jesus, Dept Cuidados Intens, Madrid, Spain.	arantxarios@hotmail.com					Diaz Huertas J A, 2000, An Esp Pediatr, V52, P548; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Trenchs V, 2007, PEDIATR NEUROSURG, V43, P352, DOI 10.1159/000106382; Tung GA, 2006, PEDIATRICS, V118, P626, DOI 10.1542/peds.2006-0130; Wells RG, 2002, ARCH PEDIAT ADOL MED, V156, P252, DOI 10.1001/archpedi.156.3.252	9	3	4	0	0	EDICIONES DOYMA S A	BARCELONA	TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN	1695-4033	1696-4608		AN PEDIATR	An. Pediatr.	JUL	2009	71	1					64	67		10.1016/j.anpedi.2009.03.018			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	472OQ	WOS:000268141800011	19481991				2022-02-06	
J	Adeyanju, K; Krizova, A; Gilbert, PA; Dekaban, GA; Rieder, M				Adeyanju, Kemi; Krizova, Adriana; Gilbert, Philippe A.; Dekaban, Gregory A.; Rieder, Michael			HIV Tat potentiates cell toxicity in a T cell model for sulphamethoxazole-induced adverse drug reactions	VIRUS GENES			English	Article						Hypersensitivity adverse drug reactions; HIV-1 Tat; Sulphamethoxazole; Sulphamethaxazole-hydroxylamine	HUMAN-IMMUNODEFICIENCY-VIRUS; TRAUMATIC BRAIN INJURY; NF-KAPPA-B; EPIDERMAL NECROLYSIS; TRIMETHOPRIM-SULFAMETHOXAZOLE; CASPASE ACTIVATION; INFECTED PATIENTS; OXIDATIVE STRESS; GENE-EXPRESSION; CYTOCHROME-C	HIV infection results in severe immune dysfunction with ensuing sequelae that includes characteristic opportunistic infections. Pneumocystis pneumonia (PCP) is one of the most common of these infections and is routinely treated with sulphamethaxazole (SMX). Although this drug is known to cause hypersensitivity adverse drug reactions (ADRs) in 0.1% of the general population, the incidence of these ADRs increases tenfold in the HIV-positive population. The HIV-1 trans-activator of transcription (HIV-1 Tat) together with the drug metabolite sulphamethaxazole-hydroxylamine (SMX-HA) have both been reported to be factors in these hypersensitivity ADRs. In this study, we use an inducible, Tat-expressing vector system to show that the level of Tat expression contributes to the cellular sensitivity of Jurkat T cells to SMX-HA. We further demonstrated that apoptosis is the likely mechanism by which this occurs. Thus, our data provide insight into the significant increase of SMX-related ADRs during the transition between HIV-1 infection and AIDS.	[Adeyanju, Kemi; Krizova, Adriana; Gilbert, Philippe A.; Dekaban, Gregory A.; Rieder, Michael] Robarts Res Inst, Biotherapeut Res Grp, London, ON N6A 5K8, Canada; [Adeyanju, Kemi; Gilbert, Philippe A.; Dekaban, Gregory A.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5K8, Canada; [Krizova, Adriana; Rieder, Michael] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5K8, Canada		Dekaban, GA (corresponding author), Robarts Res Inst, Biotherapeut Res Grp, 100 Perth Dr, London, ON N6A 5K8, Canada.	dekaban@robarts.ca; mrieder@uwo.ca	Dekaban, Gregory/L-1987-2013; Rieder, Michael J/L-2397-2013	Dekaban, Gregory/0000-0002-3087-4660; 	Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR); CIHR-GSKCanadian Institutes of Health Research (CIHR); CHIR Canada Graduate Scholarships Doctoral AwardCanadian Institutes of Health Research (CIHR)	This work was supported by grants from the Canadian Institutes for Health Research (CIHR) and the CIHR-GSK Chair in Paediatric Clinical Pharmacology (to M. J. R.) and a CHIR Canada Graduate Scholarships Doctoral Award (to K. A.).	Abe R, 2003, AM J PATHOL, V162, P1515, DOI 10.1016/S0002-9440(10)64284-8; Ambrosino C, 1997, J BIOL CHEM, V272, P14883, DOI 10.1074/jbc.272.23.14883; Arp J, 2005, J PHARMACOL EXP THER, V314, P1218, DOI 10.1124/jpet.105.085050; Bartz SR, 1999, J VIROL, V73, P1956, DOI 10.1128/JVI.73.3.1956-1963.1999; BLUM RN, 1992, J ACQ IMMUN DEF SYND, V5, P341; Brigati C, 2003, FEMS MICROBIOL LETT, V220, P57, DOI 10.1016/S0378-1097(03)00067-3; BUHL R, 1989, LANCET, V2, P1294; Calista Donato, 2002, Am J Clin Dermatol, V3, P59, DOI 10.2165/00128071-200203010-00006; CARR A, 1993, CLIN EXP IMMUNOL, V94, P21; CARR A, 1993, AIDS, V7, P1532; Choi J, 2000, J BIOL CHEM, V275, P3693, DOI 10.1074/jbc.275.5.3693; Davis CM, 2008, J ALLERGY CLIN IMMUN, V121, P826, DOI 10.1016/j.jaci.2007.10.021; de la Fuente C, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-14; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; FLORES SC, 1993, P NATL ACAD SCI USA, V90, P7632, DOI 10.1073/pnas.90.16.7632; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Hess DA, 1999, FASEB J, V13, P1688, DOI 10.1096/fasebj.13.13.1688; Huigen MCDG, 2004, EUR J CLIN INVEST, V34, P57, DOI 10.1111/j.1365-2362.2004.01282.x; Jaattela M, 2004, ONCOGENE, V23, P2746, DOI 10.1038/sj.onc.1207513; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P914, DOI 10.1097/00004647-200108000-00003; LI CJ, 1995, SCIENCE, V268, P429, DOI 10.1126/science.7716549; LI CJ, 1995, P NATL ACAD SCI USA, V92, P5461, DOI 10.1073/pnas.92.12.5461; Li-Weber M, 2000, EUR J IMMUNOL, V30, P661, DOI 10.1002/1521-4141(200002)30:2<661::AID-IMMU661>3.0.CO;2-L; Lin D, 2006, ANN PHARMACOTHER, V40, P1594, DOI 10.1345/aph.1G525; Liu CC, 2004, CURR DIRECT AUTOIMMU, V7, P49; MALIM MH, 1988, NATURE, V335, P181, DOI 10.1038/335181a0; Masters PA, 2003, ARCH INTERN MED, V163, P402, DOI 10.1001/archinte.163.4.402; Morris A, 2004, EMERG INFECT DIS, V10, P1713, DOI 10.3201/eid1010.030985; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muthumani K, 2003, BIOCHEM BIOPH RES CO, V304, P583, DOI 10.1016/S0006-291X(03)00631-4; Paquet P, 2002, INT J MOL MED, V10, P145; Park IW, 2001, J IMMUNOL, V167, P2766, DOI 10.4049/jimmunol.167.5.2766; Paul C, 1996, BRIT J DERMATOL, V134, P710, DOI 10.1111/j.1365-2133.1996.tb06976.x; Pugliese A, 2005, CELL BIOCHEM FUNCT, V23, P223, DOI 10.1002/cbf.1147; Raidel SM, 2002, AM J PHYSIOL-HEART C, V282, pH1672, DOI 10.1152/ajpheart.00955.2001; Rego AC, 2003, NEUROCHEM RES, V28, P1563, DOI 10.1023/A:1025682611389; RIEDER MJ, 1988, J PHARMACOL EXP THER, V244, P724; RIEDER MJ, 1995, J ACQ IMMUN DEF SYND, V8, P134, DOI 10.1097/00042560-199502000-00004; Rieder MJ, 2000, ANN PHARMACOTHER, V34, P940; ROUJEAU JC, 1994, NEW ENGL J MED, V331, P1272, DOI 10.1056/NEJM199411103311906; SASTRY KJ, 1990, J BIOL CHEM, V265, P20091; STAAL FJT, 1992, AIDS RES HUM RETROV, V8, P305, DOI 10.1089/aid.1992.8.305; Strathdee CA, 1999, GENE, V229, P21, DOI 10.1016/S0378-1119(99)00045-1; Sullivan JR, 2001, ARCH DERMATOL, V137, P357; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Walmsley SL, 1997, AIDS, V11, P1689, DOI 10.1097/00002030-199714000-00005; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; WESTENDORP MO, 1995, EMBO J, V14, P546, DOI 10.1002/j.1460-2075.1995.tb07030.x; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yang YD, 2003, J VIROL, V77, P6700, DOI 10.1128/JVI.77.12.6700-6708.2003; Yedavalli VSRK, 2005, J VIROL, V79, P13735, DOI 10.1128/JVI.79.21.13735-13746.2005	52	3	3	1	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0920-8569	1572-994X		VIRUS GENES	Virus Genes	JUN	2009	38	3					372	382		10.1007/s11262-009-0344-3			11	Genetics & Heredity; Virology	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity; Virology	434AP	WOS:000265247900003	19277857				2022-02-06	
J	Fidopiastis, C; Hughes, CE; Smith, E				Fidopiastis, Cali; Hughes, Charles E.; Smith, Eileen			Mixed Reality for PTSD/TBI Assessment	ANNUAL REVIEW OF CYBERTHERAPY AND TELEMEDICINE			English	Article						Mixed reality; post-traumatic stress disorder; psychophysical metrics; traumatic brain injury		Mixed Reality (MR) refers to the blending of virtual content into the real world. Using MR, we create contextually meaningful scenarios in which users carry out tasks encountered in the presence of visual and aural distracters. Visual distracters can include subtle ones - people walking; and more abrupt ones cartons falling. Aural distracters can include gentle ones - fans whirring; and more aggressive ones - automobiles backfiring. The intensity of these distracters can be dynamically controlled by a therapist or software that takes into account the patient's perceived level of stress. Intensity can also be controlled between experiences. For example, one may increase the stress level in a subsequent session, attempting to improve a person's tolerance. Assessment of progress includes psychophysical metrics (stress indicators) and the performance of tasks (accuracy and adherence to time constraints). By accurately capturing a patient's interaction with the environment in the context of simulation events, we can use MR as a tool for assessment and rehabilitation planning for individuals with stress-related injuries. This paper reports on the MR environment we have developed and its efficacy (realized and potential) for the assessment of post-traumatic stress disorder (PTSD) with or without traumatic brain injury (TBI).	[Fidopiastis, Cali; Hughes, Charles E.; Smith, Eileen] Univ Cent Florida, Inst Simulat & Training, Orlando, FL 32816 USA; [Hughes, Charles E.] Univ Cent Florida, Sch EECS, Orlando, FL 32816 USA		Hughes, CE (corresponding author), Univ Cent Florida, Sch EECS, Orlando, FL 32816 USA.	ceh@eecs.ucf.edu		Hughes, Charles/0000-0002-2528-3380			Fidopiastis CM, 2006, CYBERPSYCHOL BEHAV, V9, P183, DOI 10.1089/cpb.2006.9.183; FIDOPIASTIS CM, 2007, VIRTUAL REHABILITATI; Holden MK, 2005, CYBERPSYCHOL BEHAV, V8, P187, DOI 10.1089/cpb.2005.8.187; MacIntyre B, 2005, IEEE COMPUT GRAPH, V25, P22, DOI 10.1109/MCG.2005.132; Rose FD, 2005, CYBERPSYCHOL BEHAV, V8, P241, DOI 10.1089/cpb.2005.8.241; Tarr MJ, 2002, NAT NEUROSCI, V5, P1089, DOI 10.1038/nn948; Uchiyama S, 2002, INTERNATIONAL SYMPOSIUM ON MIXED AND AUGMENTED REALITY, PROCEEDINGS, P246, DOI 10.1109/ISMAR.2002.1115095; Wilson PN, 1997, DISABIL REHABIL, V19, P213, DOI 10.3109/09638289709166530	8	3	3	0	0	INTERACTIVE MEDIA INST	SAN DIEGO	9565 WAPLES ST, STE 200, SAN DIEGO, CA 92121 USA	1554-8716	2352-927X		ANN REV CYBERTHERAPY	Ann. Rev. CyberTherapy Telemed.	SUM	2009	7						216	220					5	Computer Science, Cybernetics	Emerging Sources Citation Index (ESCI)	Computer Science	V1H5D	WOS:000216908800049					2022-02-06	
J	Fodor, L; Ullmann, Y; Soudry, M; Lerner, A				Fodor, Lucian; Ullmann, Yehuda; Soudry, Michael; Lerner, Alexander			Long-Term Results After Ilizarov Treatment for Severe High-Energy Injuries of the Elbow	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Ilizarov; High-energy injuries; Elbow	HINGED EXTERNAL FIXATOR; RADIAL HEAD FRACTURES; OPERATIVE TREATMENT; DISLOCATIONS; NONUNION; INSTABILITY; MANAGEMENT	Background: Clinical aspects, such as the long-term results after circular external fixation and functional rehabilitation after high-energy injuries of the elbow joint, have not received sufficient attention in the literature. Methods: Fourteen patients with high-energy elbow injuries were treated in our hospital over the last 15 years with a circular external fixation frame. The mechanism of injury was blast in eight patients, gunshot wounds in two, motor vehicle crash in two, and fall from height in two. Twelve patients had high-energy open periarticular fractures, nine had Gustillo-Anderson 3B fractures, and three had Gustillo-Anderson 3C fractures. Two patients suffered from closed high-energy periarticular elbow injuries. Seven patients had associated peripheral neurologic injuries and three had vascular injuries. Average Ilizarov fixation time was 20 weeks (range, 6-47 weeks). Results. The follow-up period varied from 1.5 years to 11 years. The average are of elbow flexion was 110.4 degrees and extension was 19.6 degrees. The average arc of forearm rotation was of 63.5 degrees for pronation (range, 5-90 degrees) and 63.2 degrees for supination (range, 5-90 degrees). The average Mayo Elbow Performance Index score was 84 points (range, 60-100) and the average Khalfayan functional score was 83.4 (range, 68.7-100). Conclusion: Long-term follow-up proved that the hinged Mzarov/hybrid frame represents a useful instrument to provide stabilization of the elbow joint while facilitating early movements and physiotherapy. The main indication is patients who suffered from open high-energy contaminated fractures with extensive soft-tissue damage (e.g., blast, war injuries) and combined bone and ligaments injuries.	[Soudry, Michael; Lerner, Alexander] Technion Israel Inst Technol, Dept Orthopaed Surg A, IL-35254 Haifa, Israel; [Fodor, Lucian; Ullmann, Yehuda] Technion Israel Inst Technol, Dept Plast & Reconstruct Surg, IL-35254 Haifa, Israel; Technion Israel Inst Technol, Fac Med, IL-35254 Haifa, Israel		Lerner, A (corresponding author), Technion Israel Inst Technol, Dept Orthopaed Surg A, Rambam Hlth Care Campus,8 HaAliya St, IL-35254 Haifa, Israel.	alex_lerner@yahoo.com					Barker KL, 2004, J BONE JOINT SURG BR, V86B, P81, DOI 10.1302/0301-620X.86B1.14347; Bilic R, 2005, MIL MED, V170, P164; BROBERG MA, 1987, CLIN ORTHOP RELAT R, P109; Buckwalter J A, 1999, J Am Acad Orthop Surg, V7, P291; Gugenheim JJ, 2000, J PEDIATR ORTHOPED, V20, P177, DOI 10.1097/00004694-200003000-00009; Hall J, 2000, J ORTHOP TRAUMA, V14, P442, DOI 10.1097/00005131-200008000-00012; Keppler P, 2005, J PEDIATR ORTHOPED, V25, P314, DOI 10.1097/01.bpo.0000153879.05314.d8; Khalfayan E E, 1992, J Orthop Trauma, V6, P283, DOI 10.1097/00005131-199209000-00003; Kolb Werner, 2006, Oper Orthop Traumatol, V18, P34, DOI 10.1007/s00064-006-1161-7; Labeeu F, 1996, J TRAUMA, V40, pS223, DOI 10.1097/00005373-199603001-00048; Lerner A, 2000, J TRAUMA, V49, P1017, DOI 10.1097/00005373-200012000-00007; Lerner A, 2004, ORTHOPEDICS, V27, P59; LERNER RK, 1993, CLIN ORTHOP RELAT R, P28; Lill H, 2001, ARCH ORTHOP TRAUM SU, V121, P31, DOI 10.1007/s004020000180; Liow RYL, 2002, INJURY, V33, P801, DOI 10.1016/S0020-1383(02)00164-X; Maini L, 2000, INJURY, V31, P509, DOI 10.1016/S0020-1383(00)00036-X; McKee MD, 1998, J BONE JOINT SURG BR, V80B, P1031, DOI 10.1302/0301-620X.80B6.8536; MEHNE D, 1992, SKELETAL TRAUMA; MORREY BF, 1990, J BONE JOINT SURG AM, V72A, P601, DOI 10.2106/00004623-199072040-00019; Morrey BF., 1993, ELBOW ITS DISORDERS; Nikolic D, 1999, INJURY, V30, P129, DOI 10.1016/S0020-1383(98)00239-3; O'Driscoll SW, 2005, J SHOULDER ELB SURG, V14, p186S, DOI 10.1016/j.jse.2004.09.033; ODRISCOLL SW, 1993, ELBOW ITS DISORDERS; Pennig D, 2000, INJURY, V31, P35, DOI 10.1016/S0020-1383(99)00261-2; Ring D, 1999, CLIN ORTHOP RELAT R, P203, DOI 10.1097/00003086-199902000-00022; Ring D, 1999, INJURY, V30, pS5; Ring David, 2005, Oper Orthop Traumatol, V17, P143, DOI 10.1007/s00064-005-1126-2; Rornmens PM, 2004, INJURY, V35, P1149, DOI 10.1016/j.injury.2003.12.002; Sekiya H, 2005, J SHOULDER ELB SURG, V14, P429, DOI 10.1016/j.jse.2004.09.012; Skaggs DL, 1998, J ORTHOP TRAUMA, V12, P439, DOI 10.1097/00005131-199808000-00015; UNSWORTHWHITE J, 1994, INJURY, V25, P165, DOI 10.1016/0020-1383(94)90154-6; Wilson RH, 2003, CLIN ORTHOP RELAT R, P133, DOI 10.1097/01.blo.0000052642.74302.bd	32	3	3	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	2009	66	6					1647	1652		10.1097/TA.0b013e3181a5970b			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	457PN	WOS:000266944500020	19509627				2022-02-06	
J	Perez-Barcena, J; Ibanez, J; Brell, M; Llinas, P; Abadal, JM; Llompart-Pou, JA				Perez-Barcena, Jon; Ibanez, Javier; Brell, Marta; Llinas, Pedro; Maria Abadal, Josep; Antonio Llompart-Pou, Juan			STUDY OF A BRAIN MICROCIRCULATION IN CRANIOENCEPHALIC TRAUMA USING THE SIDE STREAM FIELD (SDF) SYSTEM	MEDICINA INTENSIVA			Spanish	Article						Traumatic brain injury; Ischemia; Microcirculation	CEREBRAL BLOOD-FLOW; HEAD-INJURY; DAMAGE; DELIVERY; SURGERY	Posttraumatic tissular hypoxia can be due to multiple causes, including microcirculation disturbances, which can be studied with the SDF (Side Stream Dark Field) system. This system is based on a small hand-held microscope that eliminates directly reflected green polarised light from an organ surface using an orthogonal analyser. It offers clear images of red and white blood cells flow through microcirculation. Specific software is later used to determine the lenght and density of microvessels. We present a case of a TBI patient who required surgical evacuation of a brain contusion. Images of the microcirculatory bed were recorded with the SDI: microscope and compared with a normal pattern obtained from another patient who was operated on for an unruptured cerebral aneurysm. Both imaging and quantitative analyses showed significant differences in the cerebral microcirculatory status in these patients. Total length and density of vessels were markedly reduced in the TBI patient. SDF imaging allows direct and non-invasive in vivo observation of cerebral microcirculation, and may allow us to deepen our knowledge of the pathophysiology of posttraumatic brain ischemia.	[Perez-Barcena, Jon; Maria Abadal, Josep; Antonio Llompart-Pou, Juan] Hosp Univ Son Dureta, Serv Med Intens, Palma De Mallorca 07014, Illes Balears, Spain; [Ibanez, Javier; Brell, Marta; Llinas, Pedro] Hosp Univ Son Dureta, Serv Neurocirug, Palma De Mallorca 07014, Illes Balears, Spain		Perez-Barcena, J (corresponding author), Hosp Univ Son Dureta, Serv Med Intens, Andrea Doria 55, Palma De Mallorca 07014, Illes Balears, Spain.	jperez@hsd.es		Ibanez, Javier/0000-0003-3735-8332			Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; De Backer D, 2002, AM J RESP CRIT CARE, V166, P98, DOI 10.1164/rccm.200109-016OC; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Groner W, 1999, NAT MED, V5, P1209, DOI 10.1038/13529; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; Marin-Caballos AJ, 2008, MED INTENSIVA, V32, P81, DOI 10.1016/S0210-5691(08)70912-4; Mathura KR, 2001, LANCET, V358, P1698, DOI 10.1016/S0140-6736(01)06722-8; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Metz C, 2000, ANAESTHESIST, V49, P332, DOI 10.1007/s001010050838; Pennings FA, 2004, STROKE, V35, P1284, DOI 10.1161/01.STR.0000126039.91400.cb; Rodriguez-Baeza A, 2000, REV NEUROLOGIA, V31, P911, DOI 10.33588/rn.3110.2000346; SAHUQUILLO J, 1996, TRAUMATISMO CRANEOEN, P14; SIGGAARDANDERSEN O, 1995, CRIT CARE MED, V23, P1284, DOI 10.1097/00003246-199507000-00020; Zauner A, 1996, ACT NEUR S, V67, P40	15	3	4	0	3	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	0210-5691	1578-6749		MED INTENSIVA	Med. Intensiv.	JUN-JUL	2009	33	5					256	259		10.1016/S0210-5691(09)71761-9			4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642GF	WOS:000281192100007	19625001	Green Submitted			2022-02-06	
J	Sapir, S; Polczynska, M; Tobin, Y				Sapir, Shimon; Polczynska, Monika; Tobin, Yishai			WHY DOES THE VOWEL SPACE AREA AS AN ACOUSTIC METRIC FAIL TO DIFFERENTIATE DYSARTHRIC FROM NORMAL VOWEL ARTICULATION AND WHAT CAN BE DONE ABOUT IT?	POZNAN STUDIES IN CONTEMPORARY LINGUISTICS			English	Article						Traumatic Brain Injury; speech acoustics; formant centralization; vowel space area	INTENSIVE VOICE TREATMENT; CEREBRAL-PALSY; TREATMENT LSVT; INTELLIGIBILITY; PERCEPTION; SPEECH; SPEAKERS; CHILDREN; CLEAR	Background. The vowel space area (VSA) has been used as an acoustic metric of dysarthric vowel articulation, but with varying degrees of success. Here we test the hypothesis that the failure of the VSA to differentiate dysarthric from normal vowel articulation has to do in part with statistical "noise" that is introduced by insensitivity of Euclidean distances that define the VSA to vowel centralisation. Methods. Differences in vowel production between 5 dysarthric young men post traumatic brain injury (TBI) and 5 young men who served as healthy controls (HC) were tested with four acoustic metrics: the triangular VSA, constructed with the first (F1) and second (F2) formants of the vowels /i/, /u/, /a/, and the Euclidean distances (EDs) between the vowels /i/ and /u (EDiu), /i/ and /a/ (EDia), and /a/ and /u/ (EDau) that define the VSA. The formant frequencies of these metrics were logarithmically scaled to reduce irrelevant interspeaker variability. Results. The VSA failed to differentiate between the TBI and HC groups, as did the the EDia, and EDau. In contrast, the EDiu effectively differentiated between groups, both statistically (unpaired t-test, p=0.0174) and in terms effect size (1.88, large). The significant difference was in the expected direction, indicating vowel centralisation and articulatory undershoot in the TBI speakers. Conclusion. The VSA is likely to perform poorly as an acoustic metric of dysarthric speech because of "noise" introduced by Euclidian distances (EDs) metrics that are not sensitive to the articulatory abnormality (in this study, the EDia and EDau). Thus, rather than using the VSA, it might be more beneficial to use only those EDs that are likely to be sensitive to vowel centralisation, as might be the case with the EDiu.	[Sapir, Shimon] Univ Haifa, Fac Social Welf & Hlth Sci, Dept Commun Sci & Disorders, IL-39105 Haifa, Mount Carmel, Israel; [Polczynska, Monika] Adam Mickiewicz Univ, Poznan, Poland; [Tobin, Yishai] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel		Sapir, S (corresponding author), Univ Haifa, Fac Social Welf & Hlth Sci, Dept Commun Sci & Disorders, IL-39105 Haifa, Mount Carmel, Israel.	sapir@research.haifa.ac.il; plmonik@ifa.amu.edu.pl; yishai@bgu.ac.il	Polczynska, Monika/AAR-1321-2020				ANSEL BM, 1992, J SPEECH HEAR RES, V35, P296, DOI 10.1044/jshr.3502.296; Blomgren B, 1998, J SPEECH LANG HEAR R, V41, P1042, DOI 10.1044/jslhr.4105.1042; Boersma P, 2005, PRAAT DOING PHONETIC; Bunton K, 2001, J SPEECH LANG HEAR R, V44, P1215, DOI 10.1044/1092-4388(2001/095); Cohen J, 1988, STAT POWER ANLYSIS B; Ferguson SH, 2007, J SPEECH LANG HEAR R, V50, P1241, DOI 10.1044/1092-4388(2007/087); Higgins CM, 2002, J MED SPEECH-LANG PA, V10, P271; Liu HM, 2005, J ACOUST SOC AM, V117, P3879, DOI 10.1121/1.1898623; McHenry M, 2000, LARYNGOSCOPE, V110, P1157, DOI 10.1097/00005537-200007000-00017; Moura CP, 2008, J VOICE, V22, P34, DOI 10.1016/j.jvoice.2006.08.011; NEAREY TM, 1989, J ACOUST SOC AM, V85, P2088, DOI 10.1121/1.397861; PERKELL JS, 1985, J ACOUST SOC AM, V77, P1889, DOI 10.1121/1.391940; PISONI DB, 1980, PHONETICA, V37, P285, DOI 10.1159/000259999; Polczynska-Fiszer M., 2006, ACTA NEUROPSYCHOLOGI, V4, P257; POLCZYNSKAFISZE.M, 2006, THESIS A MICKIEWICZ; Sapir S, 2003, AM J SPEECH-LANG PAT, V12, P387, DOI 10.1044/1058-0360(2003/085); Sapir S, 2007, J SPEECH LANG HEAR R, V50, P899, DOI 10.1044/1092-4388(2007/064); Smiljanic R, 2005, J ACOUST SOC AM, V118, P1677, DOI 10.1121/1.2000788; STRANGE W, 1989, J ACOUST SOC AM, V85, P2081, DOI 10.1121/1.397860; Wang YT, 2005, FOLIA PHONIATR LOGO, V57, P59, DOI 10.1159/000083569; Weismer G, 2001, FOLIA PHONIATR LOGO, V53, P1, DOI 10.1159/000052649; Yunusova Y, 2008, J SPEECH LANG HEAR R, V51, P596, DOI 10.1044/1092-4388(2008/043)	22	3	3	0	1	DE GRUYTER MOUTON	BERLIN	GENTHINER STRASSE 13, 10785 BERLIN, GERMANY	1897-7499			POZ STUD CONTEMP LIN	Poznan Stud. Contemp. Linguist.	JUN	2009	45	2					301	311		10.2478/v10010-009-0018-2			11	Linguistics; Language & Linguistics	Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Linguistics	481AU	WOS:000268779500007					2022-02-06	
J	Guzel, A; Ceylan, A; Tatli, M; Basogul, M; Ozer, N; Kahraman, R; Salcan, T; Satici, O; Kurt, ME; Ilicin, E; Tokgoz, P				Guzel, Aslan; Ceylan, Ali; Tatli, Mehmet; Basogul, Mehmet; Ozer, Nuri; Kahraman, Recep; Salcan, Tarik; Satici, Oemer; Kurt, Mehmet Emin; Ilicin, Ersen; Tokgoz, Perran			Falls from height in childhood in Diyarbakir province: a questionnaire study combined with clinical data	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			Turkish	Article						Questionnaire; children; roof; epidemiology; head trauma; residence features; cost; fall height	TRAUMATIC BRAIN-INJURY; PEDIATRIC TRAUMA; CHILDREN; POPULATION; WINDOWS; EPIDEMIOLOGY; MORTALITY; PREVENTION; MORBIDITY; BALCONIES	BACKGROUND In Diyarbakir, the rate of falls from height increases during summer months since people sleep on the unprotected balconies and roofs of their houses. We aimed to determine the frequency of falls from height and the related risk factors. METHODS We used questionnaire method and clinical data in this study. The questionnaire was administered in 1445 residences. Clinical data were obtained from files of patients hospitalized due to trauma in the Neurosurgery Clinic of Dicle University over the last six years. RESULTS In this questionnaire study, it was determined that 246 people had fallen, their average age was 15.4 years, 98% of them had fallen accidentally (mostly from 3.6 m height in summer months), mortality was 6.9%, and the prevalence of falls from height over the previous six years was 472/100,000. Of 464 patients who were hospitalized during the last six years, 326 were cases of fall from height and 59% of these patients were falls from a roof. The average age of these patients was 8.9 years, and average height of the fall was 4.2 m. CONCLUSION Falls from height, particularly from roofs in Diyarbakir, remain a serious problem in terms of public health.	[Ceylan, Ali; Kurt, Mehmet Emin; Ilicin, Ersen; Tokgoz, Perran] Dicle Univ, Fac Med, Dept Publ Hlth, Diyarbakir, Turkey; [Guzel, Aslan; Tatli, Mehmet; Basogul, Mehmet] Dicle Univ, Fac Med, Dept Neurosurg, Diyarbakir, Turkey; [Satici, Oemer] Dicle Univ, Fac Med, Dept Biostat, Diyarbakir, Turkey; [Kahraman, Recep; Salcan, Tarik] Dicle Univ, Fac Med, Dept Med Student Res Club, Diyarbakir, Turkey		Guzel, A (corresponding author), Dicle Univ, Fac Med, Beyin & Sinir Cerrahisi Anabilim Dali, Diyarbakir, Turkey.	aslang@dicle.edu.tr	KURT, MEHMET EMIN/X-1387-2018				Abantanga FA, 1998, PEDIATR SURG INT, V13, P515, DOI 10.1007/s003830050387; Agalar F, 1999, INT SURG, V84, P271; Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; ARITURK E, 1992, PEDIAT CERRAHI DERGI, V6, P81; Beale JP, 2000, INJURY, V31, P503, DOI 10.1016/S0020-1383(00)00034-6; Bener A, 1998, EUR J EPIDEMIOL, V14, P175, DOI 10.1023/A:1007444109260; Benoit R, 2000, J TRAUMA, V49, P477, DOI 10.1097/00005373-200009000-00015; BERG J, 2004, EUR J HLTH EC S, V1, P84; Brener I, 2004, J HEAD TRAUMA REHAB, V19, P405, DOI 10.1097/00001199-200409000-00005; Bull MJ, 2001, PEDIATRICS, V107, P1188, DOI 10.1542/peds.107.5.1188; Bulut M, 2006, EMERG MED J, V23, P540, DOI 10.1136/emj.2005.029439; Dahl E, 2006, INJURY, V37, P402, DOI 10.1016/j.injury.2005.09.008; Durkin MS, 1998, NEUROSURGERY, V42, P300, DOI 10.1097/00006123-199802000-00052; Istre GR, 2003, INJURY PREV, V9, P349, DOI 10.1136/ip.9.4.349; Ittai S, 2000, EUR J EPIDEMIOL, V16, P47, DOI 10.1023/A:1007683020026; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Lallier M, 1999, J PEDIATR SURG, V34, P1060, DOI 10.1016/S0022-3468(99)90564-X; Lapostolle F, 2004, ANN FR ANESTH, V23, P689, DOI 10.1016/j.annfar.2004.05.018; LEHMAN D, 1993, PEDIATRICS, V92, P121; Marcin JP, 2003, AM J PUBLIC HEALTH, V93, P461, DOI 10.2105/AJPH.93.3.461; Mayer L, 2006, PEDIATR SURG INT, V22, P743, DOI 10.1007/s00383-006-1731-7; Mirzai Hasan, 2005, Ulus Travma Acil Cerrahi Derg, V11, P146; MOSENTHAL AC, 1995, J TRAUMA, V38, P753, DOI 10.1097/00005373-199505000-00013; O'Sullivan J, 2004, INJURY, V35, P429, DOI 10.1016/S0020-1383(03)00265-1; OKTEN AI, 1997, TURK ARCH ORL, V35, P118; Osmond MH, 2002, J TRAUMA, V52, P8, DOI 10.1097/00005373-200201000-00004; Park SH, 2004, YONSEI MED J, V45, P229, DOI 10.3349/ymj.2004.45.2.229; Stone KE, 2000, J URBAN HEALTH, V77, P26, DOI 10.1007/BF02350960; Velmahos GC, 1997, WORLD J SURG, V21, P816, DOI 10.1007/s002689900312; Wang MY, 2001, J PEDIATR SURG, V36, P1528, DOI 10.1053/jpsu.2001.27037; Weir E, 2001, CAN MED ASSOC J, V165, P468; Yagmur Y, 2004, INJURY, V35, P425, DOI 10.1016/S0020-1383(03)00198-0	32	3	3	2	8	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	MAY	2009	15	3					277	284					8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	438NL	WOS:000265562100015	19562552				2022-02-06	
J	Bruder, N; Velly, L; Codaccioni, JL				Bruder, N.; Velly, L.; Codaccioni, J. -L.			Hypothermia for intracranial hypertension	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article						Hypothermia; Intracranial hypertension	TRAUMATIC BRAIN-INJURY; MILD PERIOPERATIVE HYPOTHERMIA; WHOLE-BODY HYPOTHERMIA; MODERATE HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; HEAD-INJURY; BLOOD-LOSS; TEMPERATURE; ISCHEMIA; ENCEPHALOPATHY	There is a large body of experimental evidence showing benefits of deliberate mild hypothermia (33-35 degrees C) on the injured brain as well as an improvement of neurological outcome after cardiac arrest in humans. However. the clinical evidence of any benefit of hypothermia following stroke, brain and neonatal asphyxia is still lacking. Controversial results have been published in patients with brain trauma or neonatal asphyxia. Hypothermia can reduce the elevation of intracranial pressure, through mechanisms not completely understood. Hypothermia-induced hypocapnia should have a role on the reduction of intracranial pressure. The temperature target is unknown but no additional benefit was found below 34 degrees C. The duration of deliberate hypothermia for the treatment of elevated intracranial Pressure might be at least 48 hours, and the subsequent rewarming period must be very slow to prevent adverse effects. (C) 2009 Elsevier Masson SAS. All rights reserved.	[Bruder, N.; Velly, L.; Codaccioni, J. -L.] CHU Timone Adultes, Serv Anesthesie & Reanimat, F-13385 Marseille, France		Bruder, N (corresponding author), CHU Timone Adultes, Serv Anesthesie & Reanimat, 264 Rue St Pierre, F-13385 Marseille, France.	nicolas.bruder@ap-hm.fr					Anderson EG, 2006, MISS QUART, V60, P5; Azzopardi D, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-17; Bacher A, 1998, ANESTHESIOLOGY, V88, P403, DOI 10.1097/00000542-199802000-00019; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; Edwards AD, 2006, ARCH DIS CHILD-FETAL, V91, pF127, DOI 10.1136/adc.2005.071787; Frank SM, 1997, JAMA-J AM MED ASSOC, V277, P1127, DOI 10.1001/jama.277.14.1127; FRANK SM, 1993, ANESTHESIOLOGY, V78, P468, DOI 10.1097/00000542-199303000-00010; FRANK SM, 1995, ANESTHESIOLOGY, V82, P83, DOI 10.1097/00000542-199501000-00012; Frank SM, 1997, AM J PHYSIOL-REG I, V272, pR557, DOI 10.1152/ajpregu.1997.272.2.R557; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Gunn AJ, 1998, PEDIATRICS, V102, P885, DOI 10.1542/peds.102.4.885; Gupta AK, 2002, BRIT J ANAESTH, V88, P188, DOI 10.1093/bja/88.2.188; Hoehn T, 2008, RESUSCITATION, V78, P7, DOI 10.1016/j.resuscitation.2008.04.027; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Lavinio A, 2007, BRIT J ANAESTH, V99, P237, DOI 10.1093/bja/aem118; Maier CM, 1998, STROKE, V29, P2171, DOI 10.1161/01.STR.29.10.2171; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2001, J NEUROSURG, V94, P697, DOI 10.3171/jns.2001.94.5.0697; Rajagopalan S, 2008, ANESTHESIOLOGY, V108, P71, DOI 10.1097/01.anes.0000296719.73450.52; Samra SK, 2007, STROKE, V38, P1864, DOI 10.1161/STROKEAHA.106.477448; SANO T, 1992, ANESTHESIOLOGY, V76, P221, DOI 10.1097/00000542-199202000-00011; Schmied H, 1996, LANCET, V347, P289, DOI 10.1016/S0140-6736(96)90466-3; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; Schwab S, 2001, STROKE, V32, P2033, DOI 10.1161/hs0901.095394; Seck M, 1996, ANN FR ANESTH, V15, P204, DOI 10.1016/0750-7658(96)85046-5; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shiozaki T, 2003, J NEUROSURG, V99, P47, DOI 10.3171/jns.2003.99.1.0047; Soukup J, 2002, NEUROL RES, V24, P161, DOI 10.1179/016164102101199710; STEEN PA, 1983, ANESTHESIOLOGY, V58, P527, DOI 10.1097/00000542-198306000-00009; Tateishi A, 1998, NEUROSURGERY, V42, P1065, DOI 10.1097/00006123-199805000-00066; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083; Vigue B, 2006, ANN FR ANESTH, V25, P838, DOI 10.1016/j.annfar.2006.03.017; Vigue B, 2000, INTENS CARE MED, V26, P722, DOI 10.1007/s001340051238; Yanamoto H, 2001, STROKE, V32, P232, DOI 10.1161/01.STR.32.1.232; Zhang H, 2008, NEUROL RES, V30, P332, DOI 10.1179/174313208X300279; Zhao H, 2007, J CEREBR BLOOD F MET, V27, P1879, DOI 10.1038/sj.jcbfm.9600540	43	3	5	0	4	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0750-7658	1769-6623		ANN FR ANESTH	Ann. Fr. Anest. Reanim.	APR	2009	28	4					365	370		10.1016/j.annfar.2009.03.001			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	444YT	WOS:000266017500013	19346097				2022-02-06	
J	Daly, PR				Daly, Patrick R.			A theory of health science and the healing arts based on the philosophy of Bernard Lonergan	THEORETICAL MEDICINE AND BIOETHICS			English	Article						Diagnosis; Disease; Health; Philosophy, Medical; Injury		This paper represents a preliminary investigation relating Bernard Lonergan's thought to health science and the healing arts. First, I provide background for basic elements of Lonergan's theoretical terminology that I employ. As inquiry is the engine of Lonergan's method, next I specify two questions that underlie medical insights and define several terms, including health, disease, and illness, in relation to these questions. Then I expand the frame of reference to include all disciplines involved in the cycle of clinical interaction under the heading health science and the healing arts. Finally, I analyze the cycle of clinical interaction in terms of Lonergan's cognitive theory. I compare and contrast my analysis, based on Lonergan, with that of Pellegrino, Thomasma and Sulmasy as I proceed. In closing, I comment briefly on the next stage of this project regarding Lonergan's theory of the human good in relation to the practice of the healing arts.	1 VA Ctr, Togus VAMC, Augusta, ME 04330 USA		Daly, PR (corresponding author), 1 VA Ctr, Togus VAMC, Augusta, ME 04330 USA.	patrick.daly@med.va.gov					Cronin B., 2001, FDN PHILOS LONERGANS; Flanagan Joseph, 1997, QUEST SELF KNOWLEDGE; Gadamer H.G., 1996, ENIGMA HLTH; KERSHAW S, 2008, NY TIMES        0330; LANDRO L, 2008, WALL STREET J   0402; LONERGAN B, 1972, METHOD THEOLOGY; Lonergan B., 1985, 3 COLLECTION, P129; LONERGAN B, 1990, COLLECTED WORKS B LO, V5; Lonergan B. J. F., 1992, COLLECTED WORKS B LO, V3; Lonergan Bernard, 1997, COLLECTED WORKS B LO, V2; PEAR R, 2008, NY TIMES        1006; Pellegrino Edmund, 1981, PHILOS BASIS MED PRA; Sulmasy DP, 2005, THEOR MED BIOETH, V26, P487, DOI 10.1007/s11017-005-2206-x; Thomasma DC, 1997, THEOR MED, V18, P127, DOI 10.1023/A:1005726024062; Vickers AJ, 2008, ANN INTERN MED, V149, P200, DOI 10.7326/0003-4819-149-3-200808050-00010; [No title captured]	16	3	3	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1386-7415	1573-1200		THEOR MED BIOETH	Theor. Med. Bioeth.	APR	2009	30	2					147	160		10.1007/s11017-009-9101-9			14	Ethics; Social Issues; Social Sciences, Biomedical	Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Social Sciences - Other Topics; Social Issues; Biomedical Social Sciences	428WB	WOS:000264881100004	19283513				2022-02-06	
J	Engrand, N; Demeret, S; Savary, D; Clair, B				Engrand, N.; Demeret, S.; Savary, D.; Clair, B.			Non specific treatment of status epilepticus	REVUE NEUROLOGIQUE			French	Article						Status epilepticus; Respiratory failure; Hemodynamics; Blood glucose; Temperature	CONVULSIVE STATUS EPILEPTICUS; TRAUMATIC BRAIN-INJURY; DAMAGE; MANAGEMENT; SEIZURES; TEMPERATURE; EPILEPSY; RATS; PATHOPHYSIOLOGY; NEUROPROTECTION	The systemic consequences of status epilepticus occur in two stages: the first stage is a hyperadrenergic period (high blood pressure, tachycardia, arrhythmia, hyperventilation, hypermetabolism, hyperthermia), the second stage a collapsus period, sometimes with acute circulatory failure, and hypoxemia. Symptomatic resuscitation aimed at restoring vital functions should be under-taken. Resuscitation must be started immediately before hospital transfer, by a trained emergency team. Respiratory care includes at least oxygen intake, but it can also require oral intubation (crash induction) and mechanical ventilation. The arterial blood gas objectives are SaO(2) >= 95%, and 35 mmHg <= PaCO(2) <= 40 mmHg. Fluid and electrolyte care includes intravenous infusion of nor-Mal saline, with control of sodium and calcium levels as well as blood pH within normal limits. Heart rate and blood pressure must be monitored. Mean blood pressure must be kept between 70 and 90 mmHg, first by means of plasma volume expansion, and then norepinephrine if necessary. Hyperthermia must be corrected to prevent further neuronal damage. Cerebromeningeal sepsis should be ruled out. Capillary glucose (most often elevated) must be corrected using a pre-established insulin infusion algorithm. Rhabdomyolysis is rare, but can result in hyperkaliemia, acidosis, and acute renal failure. in case of associated intracranial hypertension (traumatic, vascular or infectious injury), status epilepticus is considered as a secondary insult for the brain, that can worsen neuronal damage. Numerous compounds have experimental neuroprotective properties, but none have proven significant efficacy in clinical conditions. Nevertheless, convulsion cessation is considered as a neuroprotective measure. (C) 2008 Elsevier Masson SAS. All rights reserved.	[Engrand, N.] Fdn Ophtalmol Rothschild, Dept Anesthesie Reanimat, F-75019 Paris, France; [Demeret, S.] Hop La Pitie Salpetriere, Unite Reanimat Neurol, Serv Neurol 1, Paris, France; [Savary, D.] Ctr Hosp Annecy, Serv Aide Med Urgente, Annecy, France; [Clair, B.] Hop Raymond Poincare, Serv Reanimat Medicochirurg, Garches, France		Engrand, N (corresponding author), Fdn Ophtalmol Rothschild, Dept Anesthesie Reanimat, 25-29 Rue Manin, F-75019 Paris, France.	nengrand@fo-rothschild.fr					Adams BD, 2006, J EMERG MED, V30, P75, DOI 10.1016/j.jemermed.2005.01.034; Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; Auer RN, 2004, METAB BRAIN DIS, V19, P169, DOI 10.1023/B:MEBR.0000043967.78763.5b; Baldy-Moulinier M, 2001, ANN FR ANESTH, V20, P97; BETTER OS, 1990, NEW ENGL J MED, V322, P825; Bleck TP, 2007, EPILEPSIA, V48, P59, DOI 10.1111/j.1528-1167.2007.01352.x; Boggs JG, 1998, EPILEPSY RES, V31, P199, DOI 10.1016/S0920-1211(98)00031-X; BOGGS JG, 1993, EPILEPSY RES, V14, P87, DOI 10.1016/0920-1211(93)90077-K; Brandt C, 2003, NEUROSCIENCE, V118, P727, DOI 10.1016/S0306-4522(03)00027-7; Brandt C, 2006, NEUROPHARMACOLOGY, V51, P789, DOI 10.1016/j.neuropharm.2006.05.021; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Chapman MG, 2001, ANAESTHESIA, V56, P648, DOI 10.1046/j.1365-2044.2001.02115.x; Chen JWY, 2006, LANCET NEUROL, V5, P246, DOI 10.1016/S1474-4422(06)70374-X; Chin RFM, 2005, ARCH DIS CHILD, V90, P66, DOI 10.1136/adc.2003.038844; Clair B, 2009, REV NEUROL-FRANCE, V165, P366, DOI 10.1016/j.neurol.2009.01.033; ENGRAND N, REV NEUROL IN PRESS; Huerta-Alardin AL, 2005, CRIT CARE, V9, P158, DOI 10.1186/cc2978; Johnson D, 1997, EDN, V42, P94; Jolkkonen J, 1996, NEUROREPORT, V7, P2031, DOI 10.1097/00001756-199608120-00036; Kline C A, 1998, J Emerg Med, V16, P715, DOI 10.1016/S0736-4679(98)00089-4; KREISMAN NR, 1993, BRAIN RES, V626, P295, DOI 10.1016/0006-8993(93)90590-J; Kudin AP, 2004, EPILEPSIA, V45, P1478, DOI 10.1111/j.0013-9580.2004.13504.x; LIU Z, 1993, BRAIN RES, V631, P51, DOI 10.1016/0006-8993(93)91185-U; LOWENSTEIN DH, 1993, NEUROLOGY, V43, P483, DOI 10.1212/WNL.43.3_Part_1.483; LUNDGREN J, 1994, EXP BRAIN RES, V99, P43; Manno EM, 2005, ANN NEUROL, V58, P954, DOI 10.1002/ana.20677; Mullner M, 1997, J CEREBR BLOOD F MET, V17, P430; Nadam J, 2007, NEUROBIOL DIS, V25, P412, DOI 10.1016/j.nbd.2006.10.009; Parviainen I, 2007, NEUROL RES, V29, P667, DOI 10.1179/016164107X240044; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Roppolo LP, 2004, NEUROCRIT CARE, V1, P405, DOI 10.1385/NCC:1:4:405; Rossetti AO, 2007, EUR J NEUROL, V14, P586, DOI 10.1111/j.1468-1331.2007.01724.x; Rossetti AO, 2009, REV NEUROL-FRANCE, V165, P373, DOI 10.1016/j.neurol.2008.12.003; Schmitt FC, 2005, EPILEPSIA, V46, P188, DOI 10.1111/j.0013-9580.2005.44204.x; TOMLINSON FH, 1993, EPILEPSY RES, V14, P123, DOI 10.1016/0920-1211(93)90017-2; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Vigue B, 2000, INTENS CARE MED, V26, P722, DOI 10.1007/s001340051238; Vinclair M, 2008, INTENS CARE MED, V34, P714, DOI 10.1007/s00134-007-0970-y; WAGNER RL, 1984, NEW ENGL J MED, V310, P1415, DOI 10.1056/NEJM198405313102202; Walker M, 2007, EPILEPSIA, V48, P66, DOI 10.1111/j.1528-1167.2007.01354.x; WALTON NY, 1993, EPILEPSIA, V34, pS54, DOI 10.1111/j.1528-1157.1993.tb05906.x; Wasterlain C.G., 1993, EPILEPSIA S1, pS37; WIJDICKS EFM, 1994, MAYO CLIN PROC, V69, P1044, DOI 10.1016/S0025-6196(12)61370-6	43	3	3	1	2	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0035-3787			REV NEUROL-FRANCE	Rev. Neurol.	APR	2009	165	4					348	354		10.1016/j.neurol.2008.11.007			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	443CI	WOS:000265887400010	19246065				2022-02-06	
J	Fischer, BR; Speckmann, EJ; Greiner, C; Gorji, A; Wolfer, J; Wassmann, H				Fischer, B. R.; Speckmann, E. J.; Greiner, C.; Gorji, A.; Woelfer, J.; Wassmann, H.			Hyperbaric oxygen in neurosurgery	ACTA NEUROCHIRURGICA			English	Article						Hyperbaric oxygenation; Stroke; Traumatic brain injury; History	NITRIC-OXIDE; THERAPY; MANAGEMENT; STROKE	The therapeutic use of pure oxygen, even under hyperbaric conditions, has been well established for about 50 years, whereas the discovery of oxygen occurred 250 years earlier. Many neurosurgical patients suffer from brain tissue damage, due to reduced blood flow, obstructive vessel disease, or as a result of traumatic brain injury. The application of pure oxygen in these patients is the only method of increasing the O-2 concentration in tissue with impaired blood supply and can minimize secondary impairment of brain tissue. In this brief historical overview we focus on the development and evidence of hyperbaric oxygenation in this specific field of insufficient oxygen supply to the central neural tissue. With the use of modern biological methods and new study designs, HBO has a place in evidence-based treatment of patients with neural tissue damage.	[Fischer, B. R.; Greiner, C.; Woelfer, J.; Wassmann, H.] UKM, Univ Hosp Munster, Dept Neurosurg, D-48129 Munster, Germany; [Speckmann, E. J.; Gorji, A.] Univ Hosp Munster, Inst Physiol 1, D-48149 Munster, Germany		Wassmann, H (corresponding author), UKM, Univ Hosp Munster, Dept Neurosurg, Albert Schweitzer Str 33, D-48129 Munster, Germany.	wasnch@uni-muenster.de					Acott C., 1999, SPUMS J, V29, P98; Al-Waili NS, 2007, MED HYPOTHESES, V68, P528, DOI 10.1016/j.mehy.2005.12.054; Behnke AR, 1936, AM J PHYSIOL, V114, P526; BOEREMA I, 1960, Ned Tijdschr Geneeskd, V104, P949; Carmichael S Thomas, 2005, NeuroRx, V2, P396; Demchenko IT, 2003, NEUROSCI LETT, V344, P53, DOI 10.1016/S0304-3940(03)00432-4; FASANO VA, 1963, CLIN APPL HYPERBARIC, P168; FISCHER BR, 2009, CURR VASC P IN PRESS; HALDANE JS, 1917, BMJ-BRIT MED J, V2, P181; Harch PG, 2004, TXB HYPERBARIC MED, P223; HAUX GFK, 2000, HIST HYPERBARIC CHAM, P1; Henninger N, 2006, EXP NEUROL, V201, P316, DOI 10.1016/j.expneurol.2006.04.011; HOLBACH KH, 1977, SURG NEUROL, V7, P325; HOLBACH KH, 1974, ACTA NEUROCHIR, V30, P247, DOI 10.1007/BF01405583; INGVAR DH, 1965, ACTA NEUROL SCAND, V41, P92, DOI 10.1111/j.1600-0404.1965.tb04282.x; JACOBSON I, 1963, LANCET, V2, P549; JAIN KK, 2004, TXB HYPERBARIC MED, P196; James PB, 2002, LANCET, V359, P1436, DOI 10.1016/S0140-6736(02)08377-0; Kocaogullar Y, 2004, INTENS CARE MED, V30, P141, DOI 10.1007/s00134-003-1916-7; Krebs HA, 1937, BIOCHEM J, V31, P645, DOI 10.1042/bj0310645; Kurschel S, 2006, CHILD NERV SYST, V22, P38, DOI 10.1007/s00381-005-1147-z; Kutlay M, 2008, NEUROSURGERY, V62, P540, DOI [10.1227/01.NEU.0000186012.95462.E5, 10.1227/01.neu.0000316257.21478.5b]; Lahiri S, 2000, J APPL PHYSIOL, V88, P1467, DOI 10.1152/jappl.2000.88.4.1467; MORRISON DS, 2001, HYPERBARIC MED BRIEF; Mulkey DK, 2001, J APPL PHYSIOL, V90, P1887, DOI 10.1152/jappl.2001.90.5.1887; NEUBAUER RA, 1980, STROKE, V11, P297, DOI 10.1161/01.STR.11.3.297; Neubauer RA, 1998, NEUROL RES, V20, pS33; PFLUGER E, 1875, ARCHIV GESAMTE PHYSL, V10, P251; Rockswold SB, 2007, NEUROL RES, V29, P162, DOI 10.1179/016164107X181798; SALTZMAN HA, 1965, 3 INT C HYP MED 1965; Scheele CW, 1777, CHEM ABHANDLUNG LUFT; Singhal AB, 2007, NEUROL RES, V29, P173, DOI 10.1179/016164107X181815; Spallanzani L, 1805, MEMOIRS RESP; STRATLING M, 2003, ANASTH INTENSIVMED, V37, P712, DOI DOI 10.1055/S-2002-35914; WASSMANN H, 2004, BULG NEUROSURG, V9, P6; Zhang John H, 2005, Pathophysiology, V12, P63, DOI 10.1016/j.pathophys.2005.01.003	36	3	7	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	APR	2009	151	4					415	418		10.1007/s00701-009-0228-2			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	437OS	WOS:000265497400021	19277461				2022-02-06	
J	Geeraerts, T; Vigue, B				Geeraerts, T.; Vigue, B.			Cellular metabolism, temperature and brain injury	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article						Brain; Energy metabolism; Temperature; Traumatic brain injury; Subarachnoid haemorrhage	CEREBRAL-BLOOD-FLOW; INTRACRANIAL-PRESSURE; SYSTEMIC TEMPERATURE; HEAD-INJURY; CONSCIOUSNESS; HYPOTHERMIA; ACTIVATION; ANESTHESIA; ACCURACY; ENERGY	Brain temperature is strongly linked to brain metabolic rate. In the brain, energy metabolism is mainly oxidative. The oxidative metabolism and heat production are therefore strongly related. In normal conditions, heat production consecutive to brain energy metabolism is counterbalanced by heat loss, by using a complex heat exchange system. After major cerebral injuries as subarachnoid haemorrhage or traumatic brain injury, cerebral temperature can often exceed systemic temperature. Moreover, brain temperature can vary independently to systemic temperature, making difficult the prediction of brain temperature from other central temperatures.. Mitochondrial dysfunction is probably the corner stone of these post-injury perturbations of brain temperature. Understanding of this phenomenon remains however not complete. (C) 2009 Elsevier Masson SAS. All rights reserved.	[Geeraerts, T.] Addenbrookes Hosp, Univ Dept Anaesthesia, Cambridge CB2 2QQ, England; [Geeraerts, T.] Univ Cambridge, Cambridge CB2 2QQ, England; [Geeraerts, T.; Vigue, B.] Univ Paris Sud, Hop Bicetre, AP HP, Dept Anesthesie Reanimat, F-94275 Le Kremlin Bicetre, France		Geeraerts, T (corresponding author), Addenbrookes Hosp, Univ Dept Anaesthesia, Hills Rd, Cambridge CB2 2QQ, England.	thgeeraerts@hotmail.com					Alessandri B, 2004, J NEUROSCI METH, V139, P161, DOI 10.1016/j.jneumeth.2004.04.021; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; BAKER MA, 1979, SCI AM, V240, P130, DOI 10.1038/scientificamerican0579-130; BAKER MA, 1979, SCIENCE, V21, P83; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; CORK RC, 1983, ANESTH ANALG, V62, P211; Corrard F, 1999, ARCH PEDIATRIE, V6, P87, DOI 10.1016/S0929-693X(99)80080-3; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Fountas KN, 2003, J NEUROSURG ANESTH, V15, P87, DOI 10.1097/00008506-200304000-00004; GEERAERTS T, 2006, TRAITE PHYSL HUMAINE; Geeraerts T, 2006, J NEUROTRAUM, V23, P1059, DOI 10.1089/neu.2006.23.1059; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; Kiyatkin EA, 2002, EUR J NEUROSCI, V16, P164, DOI 10.1046/j.1460-9568.2002.02066.x; Kiyatkin EA, 2005, PHYSIOL BEHAV, V84, P563, DOI 10.1016/j.physbeh.2005.02.002; KREBS HA, 1970, PERSPECT BIOL MED, V14, P154; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; MELLERGARD P, 1995, SURG NEUROL, V43, P91, DOI 10.1016/0090-3019(95)80049-M; Otawara Y, 2003, SURG NEUROL, V60, P159, DOI 10.1016/S0090-3019(03)00083-1; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Saper CB, 2005, TRENDS NEUROSCI, V28, P152, DOI 10.1016/j.tins.2004.12.009; Sessler DI, 2000, ANESTHESIOLOGY, V92, P578, DOI 10.1097/00000542-200002000-00042; Sokoloff L, 1999, NEUROCHEM RES, V24, P321, DOI 10.1023/A:1022534709672; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Steiner AA, 2001, AM J PHYSIOL-REG I, V280, pR448, DOI 10.1152/ajpregu.2001.280.2.R448; STONE JG, 1995, ANESTHESIOLOGY, V82, P344, DOI 10.1097/00000542-199502000-00004; Stone JG, 1997, NEUROSURGERY, V41, P20, DOI 10.1097/00006123-199707000-00007; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812; Zhu MM, 2004, J THERM BIOL, V29, P599, DOI 10.1016/j.jtherbio.2004.08.029	35	3	3	2	10	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0750-7658	1769-6623		ANN FR ANESTH	Ann. Fr. Anest. Reanim.	APR	2009	28	4					339	344		10.1016/j.annfar.2009.02.016			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	444YT	WOS:000266017500009	19303246				2022-02-06	
J	Rival, T; Mayeur, N; Minville, V; Fourcade, O				Rival, T.; Mayeur, N.; Minville, V.; Fourcade, O.			Practical means of temperature control	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article						Internal/external cooling; Shivering inhibition; Endovascular catheters	HOSPITAL CARDIAC-ARREST; TRAUMATIC BRAIN-INJURY; HEART ASSIST ECLHA; MILD THERAPEUTIC HYPOTHERMIA; WHOLE-BODY HYPOTHERMIA; INTENSIVE-CARE-UNIT; EXTRACORPOREAL LUNG; NEONATAL ENCEPHALOPATHY; CEREBRAL HYPOTHERMIA; SHIVERING THRESHOLD	Mild therapeutic hypothermia can provide neuroprotection in some clinical situations (postanoxic cardiac arrest, neonatal anoxia). Techniques to induce hypothermia are based on thermal exchanges, in particular conduction and convection. There are several external cooling techniques: application of ice packs, cold moistened towel, ice-cold devices, ventilation of cooled air, water- or air-cooled circulating mattresses or devices. These techniques are frequently used because of their reduced cost. Internal cooling techniques are more limited and more expensive: ice-cold perfusion, endovascular catheters. extracorporeal circulation. but they offer more efficiency (high speed to reach and to maintain the temperature target). Drugs can also induce hypothermia, either by decreasing body temperature, e.g. paracetamol and aspirin, or by blocking shivering, e.g neuromuscular blocking agents, opioids and alpha2-agonist. (C) 2009 Elsevier Masson SAS. All rights reserved.	[Rival, T.; Mayeur, N.; Minville, V.; Fourcade, O.] Univ Toulouse 3, CHU Toulouse, Hop Purpan, Unite Anesthesie Neurochirurg,GRCB 48, F-31059 Toulouse, France		Rival, T (corresponding author), Univ Toulouse 3, CHU Toulouse, Hop Purpan, Unite Anesthesie Neurochirurg,GRCB 48, Pl Docteur Baylac, F-31059 Toulouse, France.	rival.t@chu-toulouse.fr	Minville, Vincent/ABE-4286-2020	Minville, Vincent/0000-0003-0516-4939			Al-Senani FM, 2004, RESUSCITATION, V62, P143, DOI 10.1016/j.resuscitation.2004.02.016; Alyagari V, 2007, J NEUROL SCI, V261, P39, DOI 10.1016/j.jns.2007.04.030; Ao H, 2001, RESUSCITATION, V48, P163, DOI 10.1016/S0300-9572(00)00252-5; Armstrong LE, 1996, AM J EMERG MED, V14, P355, DOI 10.1016/S0735-6757(96)90048-0; Arrich J, 2007, CRIT CARE MED, V35, P1041, DOI 10.1097/01.CCM.0000259383.48324.35; Bernard S, 2003, RESUSCITATION, V56, P9, DOI 10.1016/S0300-9572(02)00276-9; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BRACCO D, 2002, TRAITE ANESTHESIE GE, P305; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Covaciu L, 2008, RESUSCITATION, V76, P83, DOI 10.1016/j.resuscitation.2007.07.002; Dae MW, 2002, AM J PHYSIOL-HEART C, V282, pH1584, DOI 10.1152/ajpheart.00980.2001; Doufas AG, 2003, STROKE, V34, P1218, DOI 10.1161/01.STR.0000068787.76670.A4; Eicher DJ, 2005, PEDIATR NEUROL, V32, P11, DOI 10.1016/j.pediatrneurol.2004.06.014; Gadkary C. S., 2002, COCHRANE DB SYST REV; Gal R, 2008, BRATISL MED J, V109, P144; Gal R, 2008, BRATISL MED J, V109, P66; Ginsberg MD, 1998, STROKE, V29, P529, DOI 10.1161/01.STR.29.2.529; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Guluma KZ, 2006, ACAD EMERG MED, V13, P820, DOI 10.1197/j.aem.2006.03.559; Hachimi-Idrissi S, 2001, RESUSCITATION, V51, P275, DOI 10.1016/S0300-9572(01)00412-9; Hajat C, 2000, STROKE, V31, P410, DOI 10.1161/01.STR.31.2.410; Haugk M, 2007, RESUSCITATION, V75, P76, DOI 10.1016/j.resuscitation.2007.03.001; Hoedemaekers CW, 2007, CRIT CARE, V11, DOI 10.1186/cc6104; Holzer M, 2002, NEW ENGL J MED, V346, P549; Holzer M, 2006, STROKE, V37, P1792, DOI 10.1161/01.STR.0000227265.52763.16; Ichinose K, 2006, RESUSCITATION, V70, P275, DOI 10.1016/j.resuscitation.2005.12.011; Ichinose K, 2006, RESUSCITATION, V69, P311, DOI 10.1016/j.resuscitation.2005.07.027; Irazuzta JE, 2002, CRIT CARE MED, V30, P2553, DOI 10.1097/00003246-200211000-00025; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Kammersgaard LP, 2000, STROKE, V31, P2251, DOI 10.1161/01.STR.31.9.2251; Kandzari DE, 2004, AM J CARDIOL, V93, P636, DOI 10.1016/j.amjcard.2003.11.038; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Kim F, 2007, CIRCULATION, V115, P3064, DOI 10.1161/CIRCULATIONAHA.106.655480; Kliegel A, 2007, RESUSCITATION, V73, P46, DOI 10.1016/j.resuscitation.2006.08.023; KOCIAN R, 2007, REANIMATION NEUROCHI, P407; Komatsu R, 2006, BRIT J ANAESTH, V96, P732, DOI 10.1093/bja/ael101; Kranke P, 2004, ANESTH ANALG, V99, P718, DOI 10.1213/01.ANE.0000130589.00098.CD; Leira R, 2004, NEUROLOGY, V63, P461, DOI 10.1212/01.WNL.0000133204.81153.AC; Ly HQ, 2005, AM HEART J, V150, DOI 10.1016/j.ahj.200502.049; Mahmood MA, 2007, J NEUROL SCI, V261, P47, DOI 10.1016/j.jns.2007.04.038; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Mokhtarani M, 2001, ANESTH ANALG, V93, P1233, DOI 10.1097/00000539-200111000-00038; Nagao S, 2003, J CLIN NEUROSCI, V10, P208, DOI 10.1016/S0967-5868(02)00322-3; Ning XH, 2008, RESUSCITATION, V76, P443, DOI 10.1016/j.resuscitation.2007.08.020; Nolan JP, 2003, RESUSCITATION, V57, P231, DOI 10.1016/S0300-9572(03)00184-9; Oliveira J, 2001, NEUROLOGY, V56, P1299, DOI 10.1212/WNL.56.10.1299; Pichon N, 2007, CRIT CARE, V11, DOI 10.1186/cc5956; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Proulx CI, 2003, J APPL PHYSIOL, V94, P1317, DOI 10.1152/japplphysiol.00541.2002; Rajek A, 2000, ANESTHESIOLOGY, V93, P629, DOI 10.1097/00000542-200009000-00010; Schwartz AE, 1996, NEUROSURGERY, V39, P577; Shankaran S, 2002, PEDIATRICS, V110, P377, DOI 10.1542/peds.110.2.377; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Sterz Fritz, 2006, Acute Card Care, V8, P25, DOI 10.1080/14628840600621371; Takasu A, 2003, RESUSCITATION, V56, P319, DOI 10.1016/S0300-9572(02)00405-7; Tanimoto H, 2007, RESUSCITATION, V72, P128, DOI 10.1016/j.resuscitation.2006.05.023; Tateishi A, 1998, NEUROSURGERY, V42, P1065, DOI 10.1097/00006123-199805000-00066; Thome C, 2005, NEUROL RES, V27, P229, DOI 10.1179/016164105X25252; Uray T, 2008, RESUSCITATION, V77, P331, DOI 10.1016/j.resuscitation.2008.01.005; Vigue B, 2006, ANN FR ANESTH, V25, P838, DOI 10.1016/j.annfar.2006.03.017; Wang H, 2004, J NEUROSURG, V100, P272, DOI 10.3171/jns.2004.100.2.0272; Wen YS, 2004, CRIT CARE MED, V32, P1391, DOI 10.1097/01.CCM.0000128568.99705.2A; Wu XR, 2005, J TRAUMA, V59, P291, DOI 10.1097/01.ta.0000179445.76729.2c; XIAO F, 1995, RESUSCITATION, V30, P51, DOI 10.1016/0300-9572(94)00858-D; Zeiner A, 2001, ARCH INTERN MED, V161, P2007, DOI 10.1001/archinte.161.16.2007; Zweifler Richard M, 2003, J Stroke Cerebrovasc Dis, V12, P237, DOI 10.1016/j.jstrokecerebrovasdis.2003.09.006	68	3	4	0	11	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0750-7658	1769-6623		ANN FR ANESTH	Ann. Fr. Anest. Reanim.	APR	2009	28	4					358	364		10.1016/j.annfar.2009.02.024			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	444YT	WOS:000266017500012	19328644				2022-02-06	
J	Aragao, MDV; Law, M; Netto, JP; Valenca, MM; Naidich, T				Vasco Aragao, Maria de Fatima; Law, Meng; Netto, Joao Prola; Valenca, Marcelo Moraes; Naidich, Thomas			PROGNOSTIC VALUE OF PROTON MAGNETIC RESONANCE SPECTROSCOPY FINDINGS IN NEAR DROWNING PATIENTS	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						hypoxia; near drowning; magnetic resonance spectroscopy	TRAUMATIC BRAIN-INJURY; HYPOXIC ENCEPHALOPATHY; CHILDREN	In two children with near drowning hypoxic encephalopathy and normal-appearing structural MRI, acute proton magnetic resonance spectroscopy (H-1 MRS) showed biochemical alterations that correctly indicated prognosis and helped to guide management decisions. Elevation of the lipid-lactate and glutamine-glutamate peaks, on the early (72 hour) H-1 MRS, predicts a poor prognosis. Absence of lipid-lactate and glutamine-glutamate peaks on the early H-1 MRS and reversibility of early mild metabolite abnormalities on follow up examination relates with good outcome.	[Vasco Aragao, Maria de Fatima; Law, Meng; Netto, Joao Prola; Naidich, Thomas] Mt Sinai Sch Med, Dept Radiol, New York, NY USA; [Vasco Aragao, Maria de Fatima] Hosp Alberta Sabin, Recife, PE, Brazil; [Vasco Aragao, Maria de Fatima; Valenca, Marcelo Moraes] Univ Fed Pernambuco, Dept Neuropsychiat & Behav Studies, Recife, PE, Brazil		Aragao, MDV (corresponding author), Estrada Ubaias 332-1201, BR-52061080 Recife, PE, Brazil.	aragao@truenet.com	Valenca, Marcelo/A-4302-2013	Valenca, Marcelo/0000-0003-0678-3782			Ashwal S, 2004, PEDIATR RES, V56, P630, DOI 10.1203/01.PDR.0000139928.60530.7D; DANIELSEN ER, 1999, MAGNETIC RESONANCE S; Dubowitz DJ, 1998, AM J NEURORADIOL, V19, P1617; Holshouser BA, 2006, J MAGN RESON IMAGING, V24, P33, DOI 10.1002/jmri.20607; Kreis R, 1996, J CLIN INVEST, V97, P1142, DOI 10.1172/JCI118528; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; TAYLOR SB, 1985, RADIOLOGY, V156, P641, DOI 10.1148/radiology.156.3.4023222; Tiberio M, 2006, J NEUROL, V253, P224, DOI 10.1007/s00415-005-0964-z	8	3	3	0	1	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	MAR	2009	67	1					55	57					3	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	426FR	WOS:000264693900014	19330212	gold, Green Submitted			2022-02-06	
J	Wilson, JP; Burgess, G; Winfield, RD; Lottenberg, L				Wilson, Jason P.; Burgess, George; Winfield, Robert D.; Lottenberg, Lawrence			Sturgeons Versus Surgeons: Leaping Fish Injuries at a Level I Trauma Center	AMERICAN SURGEON			English	Article; Proceedings Paper	Annual Scientific Meeting and Postgraduate Course Program of the Southeastern-Surgical-Congress	FEB 09-12, 2008	Birmingham, AL	SE Surg Congress			FLORIDA	We have recently noted an increase in patients injured by an unusual mechanism and source: leaping sturgeon. We present our experience with eight cases of sturgeon related injuries. Between January 2006 and June 2007, there were eight patients evaluated at our Level I trauma center for sturgeon related injuries. Injuries included isolated fractures, liver lacerations, severe facial trauma, and a closed head injury. The overall length of stay was 6 days (range 0-20) and 50 per cent of patients required an intensive care unit stay. For comparative purposes, injuries were classified as primary sturgeon injuries (injuries where the sturgeon directly impacted the patient) and secondary sturgeon injuries (injuries related to the sturgeon but not resultant from direct impact). There were five primary injuries and three secondary injuries in our series. Patients with secondary injuries had a longer length of stay (12 days vs 3, days) and a higher intensive care unit utilization (100 % vs 20%) when compared with patients having primary injuries. This is the first report of sturgeon-related injuries in the medical literature. These peculiar insults seem to have increased in recent years. Public awareness and proper boat safety are vital in reducing the number and severity of these incidents.	[Lottenberg, Lawrence] Univ Florida, Florida Museum Nat Hist, Dept Surg, Div Acute Care Surg, Gainesville, FL 32610 USA; [Burgess, George] Univ Florida, Florida Museum Nat Hist, Florida Program Shark Res, Gainesville, FL 32610 USA		Lottenberg, L (corresponding author), Univ Florida, Florida Museum Nat Hist, Dept Surg, Div Acute Care Surg, 1600 SW Archer Rd,POB 100286, Gainesville, FL 32610 USA.	Lawrence.lottenberg@surgery.ufl.edu					Ash RJ, 2002, EMERG INFECT DIS, V8, P713, DOI 10.3201/eid0807.010264; Burgess G H, 1997, J Fla Med Assoc, V84, P428; Chen M, 1995, CONT SURG U FLORIDA, V46, P252; Doherty Sean D, 2006, Dermatol Online J, V12, P6; Harding BE, 2006, J FORENSIC SCI, V51, P674, DOI 10.1111/j.1556-4029.2006.00135.x; Harris JE, 2005, T AM FISH SOC, V134, P975, DOI 10.1577/T04-100.1; HOWARD RJ, 1993, AM J SURG, V166, P563, DOI 10.1016/S0002-9610(05)81154-7; Nelson JS, 1994, FISHES WORLD, V3rd; Noonburg GE, 2005, J AM ACAD ORTHOP SUR, V13, P243, DOI 10.5435/00124635-200507000-00004; Varnagy D, 2006, J TRAUMA, V61, P766, DOI 10.1097/01.ta.0000224154.90023.5a	10	3	3	0	4	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	MAR	2009	75	3					220	222					3	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	416DD	WOS:000263984500006	19350856				2022-02-06	
J	Bouzat, P; Francony, G; Declety, P; Brun, J; Kaddour, A; Renversez, JC; Jacquot, C; Payen, JF				Bouzat, P.; Francony, G.; Declety, P.; Brun, J.; Kaddour, A.; Renversez, J. -C.; Jacquot, C.; Payen, J. -F.			Can serum protein S100 beta predict neurological deterioration after moderate or minor traumatic brain injury?	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article						Traumatic brain injury; Protein S-100; Neurological aggravation	MILD HEAD-INJURY; COMPUTERIZED-TOMOGRAPHY; OUTCOME PREDICTION; S-100B PROTEIN; S100B LEVELS; TALK	Introduction. - Patients with moderate traumatic brain injury (TBI) (Glasgow Coma Scale, GCS, 9-13) or minor TBI (GCS 14-15) are at risk for subsequent neurological deterioration. Serum protein S-100 is believed to reflect brain damage following TBI. In patients with normal or minor CT scan abnormalities on admission, we tested whether the determination of serum protein S-100 beta could predict secondary neurological deterioration. Methods. - Sixty-seven patients with moderate or minor TBI were prospectively studied. Serum samples were collected on admission within 12 hours post injury to measure serum protein S-100 levels. Neurological Outcome was assessed up to seven days after trauma. Secondary neurological deterioration was defined as two points or more decrease from the initial GCS, or any treatment for neurological deterioration. Results. - Nine patients had a secondary neurological deterioration after trauma. No differences in serum levels of protein S-100 were found between these patients and those without neurological aggravation (n = 58 patients): 0.93 mu g/l (0.14-4.85) vs 0.39 mu g/l (0.04-6.40), respectively. The proportion of patients with abnormal levels of serum protein S-100 at admission according to two admitted cut-off levels (> 0.1 and > 0.5 mu g/l) was comparable between the two groups of patients. Elevated serum levels of protein S-100 were found in patients with Injury Severity Score (ISS) of more than 16 (n = 23 patients): 1.26 mu g/l (0.14-6.40) vs 0.22 mu g/l (0.04-6.20) in patients with ISS less than 16 (n = 44 patients). Discussion. - The dosage of serum protein S-100 on admission failed to predict patients at risk for neurological deterioration after minor or moderate TBL. Extracranial injuries can increase serum protein S-100 levels, then limiting the usefulness of this dosage in this clinical setting. (C) 2009 Elsevier Masson SAS. All fights reserved.	[Kaddour, A.; Payen, J. -F.] Hop Albert Michallon, Serv Urgences Chirurg, F-38043 Grenoble, France; [Renversez, J. -C.] Hop Albert Michallon, Dept Biol Integree, F-38043 Grenoble, France		Payen, JF (corresponding author), Hop Albert Michallon, Serv Urgences Chirurg, BP 217, F-38043 Grenoble, France.	jfpayen@ujf-grenoble.fr	Bouzat, Pierre/AAC-4105-2019; Bouzat, Pierre/L-6881-2014; Payen, Jean-Francois/L-6667-2014	Bouzat, Pierre/0000-0003-4667-6738; 			Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Davis DP, 2007, J TRAUMA, V62, P277, DOI 10.1097/TA.0b013e31802ef4a3; de Boussard CN, 2005, J REHABIL MED, V37, P53, DOI 10.1080/16501970410015587; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Jaffres P, 2005, INTENS CARE MED, V31, P785, DOI 10.1007/s00134-005-2630-4; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; KORLIAS S, 2007, INTENS CARE MED, V33, P255; KORTIAS S, 2006, CURR MED CHEM, V13, P3719; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Nash DL, 2008, NEUROCRIT CARE, V8, P301, DOI 10.1007/s12028-007-9019-x; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Routsi C, 2006, SHOCK, V26, P20, DOI 10.1097/01.shk.0000209546.06801.d7; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Sen J, 2007, J NEUROSCI RES, V85, P1373, DOI 10.1002/jnr.21211; Stapert S, 2005, EUR NEUROL, V53, P22, DOI 10.1159/000083678; Stranjalis G, 2004, J NEUROTRAUM, V21, P1070, DOI 10.1089/0897715041651088; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Townend W, 2006, INJURY, V37, P1098, DOI 10.1016/j.injury.2006.07.014; Townend WJ, 2002, J NEUROL NEUROSUR PS, V73, P542, DOI 10.1136/jnnp.73.5.542; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75	27	3	4	0	7	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0750-7658	1769-6623		ANN FR ANESTH	Ann. Fr. Anest. Reanim.	FEB	2009	28	2					135	139		10.1016/j.annfar.2008.12.019			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	422IG	WOS:000264420300006	19211218				2022-02-06	
J	Foley, K; Kast, RE; Altschulerc, EL				Foley, Kevin; Kast, Richard E.; Altschulerc, Eric L.			Ritonavir and disulfiram have potential to inhibit caspase-1 mediated inflammation and reduce neurological sequelae after minor blast exposure	MEDICAL HYPOTHESES			English	Article							TRAUMATIC BRAIN-INJURY; DNA FRAGMENTATION; SHELL SHOCK; HEAD-INJURY; CELL-DEATH; IN-VITRO; T-CELLS; APOPTOSIS; PROTEASES; FAMILY	Caspase-1 triggers cytokine release following acceleration-induced concussive head injury. Minor blast injury in which no physical tissue injury occurs, results in the release of cytokines in a similar fashion. Ritonavir, a generically available protease inhibitor with a benign short-term side-effect profile, has been shown to inhibit expression of caspase-1. We review the relevant literature and propose that ritonavir may be of benefit in reducing adverse neuropsychiatric outcomes and hastening recovery following mild blast injury. Further research in animal models of blast injury followed by clinical studies would determine whether this therapy is effective. (C) 2008 Elsevier Ltd. All rights reserved.	[Kast, Richard E.] Univ Vermont, Coll Med, Dept Psychiat, Burlington, VT 05401 USA; [Foley, Kevin] No Michigan Univ, Clin Sci Lab, Marquette, MI 49855 USA; [Altschulerc, Eric L.] Univ Med & Dent New Jersey, Univ Hosp, Dept Phys Med & Rehabil, Newark, NJ 07103 USA		Kast, RE (corresponding author), Univ Vermont, Coll Med, Dept Psychiat, 2 Church St, Burlington, VT 05401 USA.	rekast@email.com					Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Faubel S., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P269, DOI 10.2174/1568008054863754; Felderhoff-Mueser U, 2005, TRENDS NEUROSCI, V28, P487, DOI 10.1016/j.tins.2005.06.008; Felderhoff-Mueser U, 2005, ANN NEUROL, V57, P50, DOI 10.1002/ana.20322; Fink KB, 1999, NEUROSCIENCE, V94, P1213, DOI 10.1016/S0306-4522(99)00345-0; GARTH RJN, 1995, INJURY, V26, P363, DOI 10.1016/0020-1383(95)00042-8; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Harada J, 1998, BRAIN RES, V793, P231, DOI 10.1016/S0006-8993(98)00156-5; Heitger MH, 2007, J NEUROL SCI, V253, P34, DOI 10.1016/j.jns.2006.11.007; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kim NG, 2003, MOL BRAIN RES, V114, P107, DOI 10.1016/S0169-328X(03)00135-9; Marchionini DM, 2004, CELL TRANSPLANT, V13, P273, DOI 10.3727/000000004783983972; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Masliah E, 1998, J NEUROPATH EXP NEUR, V57, P1041, DOI 10.1097/00005072-199811000-00007; Morita-Fujimura Y, 1999, J CEREBR BLOOD F MET, V19, P634, DOI 10.1097/00004647-199906000-00006; Nobel CSI, 1997, CHEM RES TOXICOL, V10, P1319, DOI 10.1021/tx970131m; O'Shea E, 2005, NEUROSCIENCE, V135, P1095, DOI 10.1016/j.neuroscience.2005.06.084; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Ross J, 2007, NEUROPHARMACOLOGY, V53, P638, DOI 10.1016/j.neuropharm.2007.07.015; Sifringer M, 2007, NEUROBIOL DIS, V25, P614, DOI 10.1016/j.nbd.2006.11.003; Sloand EM, 2000, BLOOD, V96, P2735; Sloand EM, 1999, BLOOD, V94, P1021, DOI 10.1182/blood.V94.3.1021.415k29_1021_1027; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Vlahakis SR, 2007, APOPTOSIS, V12, P969, DOI 10.1007/s10495-007-0755-3; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weichold FF, 1999, J HUMAN VIROL, V2, P261; Yakovlev AG, 1997, J NEUROSCI, V17, P7415	32	3	3	0	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	FEB	2009	72	2					150	152		10.1016/j.mehy.2008.08.024			3	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	398KH	WOS:000262730500011	19004566				2022-02-06	
J	Taupin, P				Taupin, Phillipe			Brevetoxin derivative compounds for stimulating neuronal growth	EXPERT OPINION ON THERAPEUTIC PATENTS			English	Article						CaMKK; ion channel; neurodegenerative diseases; neuron; NMDA	HIPPOCAMPAL-NEURONS; SODIUM-CHANNELS; CULTURE; ESTABLISHMENT; POLARITY; RECEPTOR	The application is in the field of neuronal growth and the activity of brevetoxins and their derivatives. It aims to characterize the activity of four generic formulae of brevetoxin derivatives - formulae I, II, III, and IV - and their compounds on the growth of neurites. The activity of the brevetoxin derivative compounds was tested on primary cultures of neocortical neurons. It was assayed in the presence and absence of antagonists of receptors and second-messenger signaling pathways, particulary NMDA receptors and the calmodulin-dependent protein-kinase kinase pathway. Brevetoxin derivatives stimulate neurite growth, particularly the growth of minor processes from which the axons form, on neurons in primary cultures. The activity is mediated by voltage-gated sodium channels and the N-methyl-D-aspartate-mediated intracellular Ca(2+) pathway. The application claims the use of the four generic formulae of brevetoxin derivatives (I, II, III, and IV) and their compounds for enhancing neuronal growth and for the treatment of neurodegenerative diseases and neurological disorders and injuries, such as Alzheimer's disease, amyotrophic lateral sclerosis, cerebral strokes, traumatic brain, and spinal cord injuries.	Dublin City Univ, Sch Biotechnol, Dublin 9, Ireland		Taupin, P (corresponding author), Dublin City Univ, Sch Biotechnol, Dublin 9, Ireland.	philippe.taupin@dcu.ie					Baden DG, 2005, ENVIRON HEALTH PERSP, V113, P621, DOI 10.1289/ehp.7499; Chahine M, 2008, CNS NEUROL DISORD-DR, V7, P144, DOI 10.2174/187152708784083830; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Dravid SM, 2005, BRAIN RES, V1031, P30, DOI 10.1016/j.brainres.2004.10.018; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FLETCHER TL, 1989, DEV BIOL, V136, P446, DOI 10.1016/0012-1606(89)90269-8; Fuwa H, 2007, CURR OPIN DRUG DISC, V10, P784; LePage KT, 2003, BRAIN RES, V959, P120, DOI 10.1016/S0006-8993(02)03737-X; Lesuisse C, 2002, J NEUROBIOL, V51, P9, DOI 10.1002/neu.10037; Narahashi T, 2008, P JPN ACAD B-PHYS, V84, P147, DOI 10.2183/pjab.84.147; TRAINER VL, 1991, MOL PHARMACOL, V40, P988; U N CAROLINA WILMING, 2005, Patent No. 2005028482; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021	13	3	3	0	5	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1354-3776			EXPERT OPIN THER PAT	Expert Opin. Ther. Patents	FEB	2009	19	2					269	274		10.1517/13543770802665725			6	Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	411QC	WOS:000263663400010	19441922				2022-02-06	
J	Thomas, G; Genest, P; Walter, M; Cozic, JY				Thomas, G.; Genest, P.; Walter, M.; Cozic, J. -Y.			Can concepts of neurodevelopment and neuroplasticity explain post-traumatic psychoses?	NEUROCHIRURGIE			French	Article						Brain injury; Neuronal plasticity; Neurodevelopment; Schizophrenia	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; SCHIZOPHRENIA; RISK; DISORDER	Cases of psychoses emerging after a brain injury, included in the diagnostic category "Pychotic disorder due to traumatic bra m injury," are not rare in psychiatry. The authors suggest hypotheses aimed at furthering the understanding of the pathogenic mechanisms relating traumatic brain injuries to psychotic disorders. These hypotheses find their starting point in two concepts: neuronal plasticity and the neurodevelopmental theory of schizophrenia. Neuroplasticity is the ability of nerve cells to alter after internal or external changes. The neurodevelopmental theory of schizophrenia is based on the idea that early impairments in cerebral development could later lead to a schizophrenic disorder; this theory has been integrated into the concept of vulnerability to schizophrenia. The authors hypothesize that traumatic brain injuries lead to neuronal reshaping and that this reshaping could cause impairments in subjects vulnerable to schizophrenia. (C) 2008 Elsevier Masson SAS. All rights reserved.	[Thomas, G.] Pole Hosp Univ Psychiat, F-29820 Bohars, France; Univ Brest, CHU Brest, F-29820 Bohars, France		Thomas, G (corresponding author), Pole Hosp Univ Psychiat, BP 17,JE 2535, F-29820 Bohars, France.	gregory.thomas@chu-brest.fr					AbdelMalik P, 2003, ARCH GEN PSYCHIAT, V60, P231, DOI 10.1001/archpsyc.60.3.231; Ahmed I, 1998, Semin Clin Neuropsychiatry, V3, P23; Bonnot O., 2006, NEUROPSYCHIAT ENFAN, V54, P92; BOTBOL M, 2005, EMC PSYCHIAT, V2, P195; Cannon M, 2005, SCHIZOPHR RES, V79, P5, DOI 10.1016/j.schres.2005.05.027; DAMATO T, 2003, C CONS 2003 SCH DEB, P211; David AS, 2005, J NEUROL NEUROSUR PS, V76, pI53, DOI 10.1136/jnnp.2004.060475; De Mol J, 1987, J ARCH PSYCHOL NEURO, V48, P336; DONE DJ, 1994, BRIT MED J, V309, P699, DOI 10.1136/bmj.309.6956.699; Fujii D, 2004, J NEUROPSYCH CLIN N, V16, P306, DOI 10.1176/appi.neuropsych.16.3.306; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Gourion D, 2003, SCHIZOPHR RES, V63, P181, DOI 10.1016/S0920-9964(02)00333-X; GRALL C, 2006, DIAGNOSTIC PRECOCE S; Harrison G, 2006, SCHIZOPHR RES, V88, P119, DOI 10.1016/j.schres.2006.07.001; Henriksson KM, 2004, SCHIZOPHR RES, V70, P39, DOI 10.1016/j.schres.2003.11.003; Isohanni M, 2001, SCHIZOPHR RES, V52, P1, DOI 10.1016/S0920-9964(00)00179-1; KENDLER KS, 1995, AM J PSYCHIAT, V152, P749; LACOUR M, 2004, NEUROPLASTICITE CERE, P25; Nielsen AS, 2002, SCHIZOPHR RES, V55, P93, DOI 10.1016/S0920-9964(01)00205-5; SARFATI Y, 2003, C CONS 2003 SCH DEB, P199; SCHURHOFF F, 2001, NOTION VULNERABILITE, P61; Speranza M., 2006, NEUROPSYCHIATRIE ENF, V54, P45; THIBAUT F, 2004, HYPOTHESE NEURODEVEL, P71; Verdoux H, 1996, ENCEPHALE, V22, P85	24	3	4	0	2	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0028-3770	1773-0619		NEUROCHIRURGIE	Neurochirurgie	FEB	2009	55	1					36	39		10.1016/j.neuchi.2008.09.002			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	410CA	WOS:000263552300005	19059615				2022-02-06	
J	Gu, JW; Zhou, HT; Yang, T; Cheng, JM; Qu, Y; Li, CY; Li, QJ; Lu, JY; Cheng, SL; Liu, JJ; Kuang, YQ; Huang, HD; Yang, LB; He, WQ; Zhao, K; Song, LX; Zheng, XD; Liu, SX; Sun, Y; He, HL; Wu, J; Liu, XS; Lu, M				Gu Jian-wen; Zhou Hu-tian; Yang Tao; Cheng Jing-min; Qu Yan; Li Cui-ying; Li Qing-jie; Lue Ji-yun; Cheng Shou-long; Liu Jian-jun; Kuang Yong-qin; Huang Hai-dong; Yang Li-bin; He Wei-qi; Zhao Kai; Song Li-xin; Zheng Xiao-dong; Liu Shu-xin; Sun Yan; He Hong-lian; Wu Jiang; Liu Xu-sheng; Lu Min			Ultimate treatment for a patient with severe traumatic brain injury without intake for 192 hours after Wenchuan massive earthquake	CHINESE MEDICAL JOURNAL			English	Article						earthquake; brain injury; shock			[Gu Jian-wen; Zhou Hu-tian; Yang Tao; Cheng Jing-min; Qu Yan; Kuang Yong-qin; Huang Hai-dong; Yang Li-bin; He Wei-qi; Zhao Kai; Lu Min] Gen Hosp Peoples Liberat Army Chengdu Mil Reg, Dept Neurosurg, Chengdu 610083, Sichuan, Peoples R China; [Li Qing-jie; Lue Ji-yun; Cheng Shou-long] Peoples Liberat Army Gen Logist Dept, Minist Hlth, Beijing 100842, Peoples R China; [Liu Jian-jun; Song Li-xin; Zheng Xiao-dong; Liu Shu-xin; Sun Yan; He Hong-lian; Wu Jiang; Liu Xu-sheng] 255 Hosp Peoples Liberat Army, Dept Emergency, Tangshan 063000, Hebei, Peoples R China; [Li Cui-ying] Gen Hosp Peoples Liberat Army Chengdu Mil Reg, Dept Blood Transfus, Chengdu 610083, Sichuan, Peoples R China		Gu, JW (corresponding author), Gen Hosp Peoples Liberat Army Chengdu Mil Reg, Dept Neurosurg, Chengdu 610083, Sichuan, Peoples R China.	gujianwen2000@yahoo.com.cn					Barbera Joseph A., 1996, Emergency Medicine Clinics of North America, V14, P399, DOI 10.1016/S0733-8627(05)70258-3; Mannucci PM, 2007, NEW ENGL J MED, V356, P2301, DOI 10.1056/NEJMra067742; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Pocan S, 2002, MIL MED, V167, P516, DOI 10.1093/milmed/167.6.516; Sever MS, 2002, CRIT CARE MED, V30, P2443, DOI 10.1097/00003246-200211000-00007; Shiga T, 2006, EUR J NUCL MED MOL I, V33, P817, DOI 10.1007/s00259-005-0033-y; Verbalis JG, 2006, ADV EXP MED BIOL, V576, P113	7	3	4	1	3	CHINESE MEDICAL ASSOC	BEIJING	42 DONGSI XIDAJIE, BEIJING 100710, PEOPLES R CHINA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	JAN 5	2009	122	1					113	116		10.3760/cma.j.issn.0366-6999.2009.01.022			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397WN	WOS:000262693100022	19187629				2022-02-06	
B	Campbell, JN; Kurz, JE; Churn, SB		Baylog, LR		Campbell, John N.; Kurz, Jonathon E.; Churn, Severn B.			Pathological Remodeling of Dendritic Spines	DENDRITIC SPINES: BIOCHEMISTRY, MODELING AND PROPERTIES			English	Article; Book Chapter							PROTEIN-KINASE-C; TRAUMATIC BRAIN-INJURY; MICROTUBULE-ASSOCIATED PROTEINS; MAXIMAL CALCINEURIN ACTIVITY; FLUID PERCUSSION INJURY; RAT PILOCARPINE MODEL; ACTIN CYTOSKELETON; SUBCELLULAR-DISTRIBUTION; HIPPOCAMPAL-NEURONS; KAINIC ACID	As highly plastic structures that receive most of the excitatory signaling in the brain, dendritic spines are particularly vulnerable to excitotoxic injury. Excessive stimulation of the dendritic spine can dramatically and persistently restructure the post-synapse. There appear to be multiple, complementary mechanisms which ultimately remodel and potentially destabilize the dendritic spine. Activation of these mechanisms is linked to the excitotoxic influx of calcium through post-synaptic receptor- and/or voltage-gated ion channels. The calcium-activated phosphatase, calcineurin, mediates at least two spine-destabilizing mechanisms: activation of the actin regulatory protein, cofilin, which binds and disrupts cytoskeletal actin; and a downstream increase in mRNA expression of Snk (serum induced kinase), which targets for destruction a cytoskeletal-stabilizing protein, SPAR (spine-associated Rap guanosine triphosphatase activating protein). The excitotoxic influx of calcium also triggers proteolysis of another cytoskeletal-stabilizing protein, MARCKS (myristoylated alanine-rich C-kinase substrate). The remodeling accomplished by these mechanisms has multiple functional consequences from acute protective effects to pathological re-wiring of neuronal circuitry. Injury-induced alterations of neural circuitry are thought to explain the development of post-injury neurological pathologies such as epilepsy. Therefore, stabilizing dendritic spines and other components of neural circuitry against injury-induced alterations may be a novel approach to preventing post-injury neurologic pathology.	[Campbell, John N.; Kurz, Jonathon E.; Churn, Severn B.] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA 23298 USA; [Campbell, John N.; Kurz, Jonathon E.; Churn, Severn B.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Churn, Severn B.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23298 USA; [Churn, Severn B.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA		Churn, SB (corresponding author), Virginia Commonwealth Univ, Dept Neurol, POB 980599, Richmond, VA 23298 USA.	SCHURN@VCU.EDU		Kurz, Jonathan/0000-0002-2259-4263			Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; Al-Noori S, 2000, NEUROSCIENCE, V101, P337, DOI 10.1016/S0306-4522(00)00384-5; Allison DW, 1998, J NEUROSCI, V18, P2423; Andrew RD, 2007, CEREB CORTEX, V17, P787, DOI 10.1093/cercor/bhk032; Ang XL, 2008, J BIOL CHEM, V283, P29424, DOI 10.1074/jbc.M802475200; Aramburu J, 2000, CURR TOP CELL REGUL, V36, P237; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Arias C, 1997, EXP BRAIN RES, V116, P467, DOI 10.1007/PL00005774; BAMBURG JR, 1980, FEBS LETT, V121, P178, DOI 10.1016/0014-5793(80)81292-0; Bardo S, 2006, TRENDS PHARMACOL SCI, V27, P78, DOI 10.1016/j.tips.2005.12.008; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; BINDOKAS VP, 1995, J NEUROSCI, V15, P6999; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Blackstone C, 2002, FRONT BIOSCI, V7, pD872, DOI 10.2741/blacksto; Bloodgood BL, 2007, CURR OPIN NEUROBIOL, V17, P345, DOI 10.1016/j.conb.2007.04.003; Bobkov AA, 2006, J MOL BIOL, V356, P325, DOI 10.1016/j.jmb.2005.11.072; Bragin A, 2000, EPILEPSIA, V41, pS144, DOI 10.1111/j.1528-1157.2000.tb01573.x; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; Cavazzini M, 2005, CELL CALCIUM, V38, P355, DOI 10.1016/j.ceca.2005.06.013; Chakravarthy B, 1999, TRENDS NEUROSCI, V22, P12, DOI 10.1016/S0166-2236(98)01288-0; CHANG FLF, 1984, BRAIN RES, V309, P35, DOI 10.1016/0006-8993(84)91008-4; Chen LS, 1996, EXP NEUROL, V141, P25, DOI 10.1006/exnr.1996.0135; CHOI DW, 1987, J NEUROSCI, V7, P369; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; COHEN RS, 1985, CELL MOL NEUROBIOL, V5, P271, DOI 10.1007/BF00711012; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Dehmelt L, 2005, GENOME BIOL, V6; DeLorenzo RJ, 2007, INT REV NEUROBIOL, V81, P59, DOI 10.1016/S0074-7742(06)81005-6; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Dubreuil CI, 2006, EXP NEUROL, V198, P361, DOI 10.1016/j.expneurol.2005.12.002; Durkin JP, 1996, J NEUROCHEM, V66, P951; EMERY DG, 1995, BRAIN RES, V692, P161, DOI 10.1016/0006-8993(95)00726-7; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; Fu ZY, 2007, J NEUROCHEM, V100, P118, DOI 10.1111/j.1471-4159.2006.04195.x; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gong CX, 2000, BRAIN RES, V853, P299, DOI 10.1016/S0006-8993(99)02294-5; Graber S, 2004, NEUROPHARMACOLOGY, V47, P706, DOI 10.1016/j.neuropharm.2004.08.004; Greenwood SM, 2007, NEUROPHARMACOLOGY, V53, P891, DOI 10.1016/j.neuropharm.2007.10.003; Greenwood SM, 2007, J BIOL CHEM, V282, P26235, DOI 10.1074/jbc.M704488200; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; Halpain S, 1998, J NEUROSCI, V18, P9835; HALPAIN S, 1990, NEURON, V5, P237, DOI 10.1016/0896-6273(90)90161-8; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; Hasbani MJ, 2001, NEUROREPORT, V12, P2731, DOI 10.1097/00001756-200108280-00028; Hasbani MJ, 1998, EXP NEUROL, V154, P241, DOI 10.1006/exnr.1998.6929; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; HORI N, 1994, EXP NEUROL, V129, P279, DOI 10.1006/exnr.1994.1170; Hoskison MM, 2007, NEUROSCIENCE, V145, P66, DOI 10.1016/j.neuroscience.2006.11.034; Hoskison MM, 2006, EXP NEUROL, V202, P302, DOI 10.1016/j.expneurol.2006.06.010; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Hussain RJ, 2006, HIPPOCAMPUS, V16, P495, DOI 10.1002/hipo.20177; Ikegaya Y, 2001, J CELL SCI, V114, P4083; IKONOMIDOU C, 1989, J NEUROSCI, V9, P1693; Inoue H, 2007, J NEUROSCI, V27, P1445, DOI 10.1523/JNEUROSCI.4694-06.2007; Isokawa M, 1998, NEUROSCI LETT, V258, P73, DOI 10.1016/S0304-3940(98)00848-9; Isomura Y, 2008, NEUROSCI RES, V61, P227, DOI 10.1016/j.neures.2008.04.002; KATAYAMA Y, 1990, ACT NEUR S, V51, P271; Kirov SA, 1999, NAT NEUROSCI, V2, P878, DOI 10.1038/13178; Kirov SA, 2004, NEUROSCIENCE, V127, P69, DOI 10.1016/j.neuroscience.2004.04.053; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; KURITA S, 2008, J BIOL CHEM; Kurz JE, 2005, BRAIN RES, V1048, P153, DOI 10.1016/j.brainres.2005.04.062; Kurz JE, 2005, J NEUROTRAUM, V22, P476, DOI 10.1089/neu.2005.22.476; Kurz JE, 2003, NEUROBIOL DIS, V14, P483, DOI 10.1016/j.nbd.2003.08.018; Kurz JE, 2001, J NEUROCHEM, V78, P304, DOI 10.1046/j.1471-4159.2001.00426.x; Kurz JE, 2008, EPILEPSIA, V49, P1696, DOI 10.1111/j.1528-1167.2008.01616.x; Kurz JE, 2006, EPILEPSIA, V47, P222; Leite JP, 2005, EPILEPSIA, V46, P134, DOI 10.1111/j.1528-1167.2005.01021.x; Lopachin RM, 2001, NEUROSCIENCE, V103, P971, DOI 10.1016/S0306-4522(01)00035-5; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McNamara J. M., 2006, SCI STKE, P59, DOI DOI 10.1126/STKE.3562006RE12; McNeil RS, 1999, CELL MOTIL CYTOSKEL, V43, P99, DOI 10.1002/(SICI)1097-0169(1999)43:2<99::AID-CM2>3.0.CO;2-W; Meller R, 2008, J NEUROSCI, V28, P50, DOI 10.1523/JNEUROSCI.3474-07.2008; Meng YH, 2004, NEUROPHARMACOLOGY, V47, P746, DOI 10.1016/j.neuropharm.2004.06.030; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Meng YH, 2003, REV NEUROSCIENCE, V14, P233; MIZUNO K, 1994, ONCOGENE, V9, P1605; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; NISHIDA E, 1984, BIOCHEMISTRY-US, V23, P5307, DOI 10.1021/bi00317a032; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Oertner TG, 2005, CELL CALCIUM, V37, P477, DOI 10.1016/j.ceca.2005.01.016; OHASHI K, 1994, J BIOCHEM, V116, P636, DOI 10.1093/oxfordjournals.jbchem.a124573; Ohmitsu M, 1999, J BIOL CHEM, V274, P408, DOI 10.1074/jbc.274.1.408; Ohta Y, 2003, GENES CELLS, V8, P811, DOI 10.1046/j.1365-2443.2003.00678.x; Oliva AA, 2002, J NEUROSCI, V22, P8052; Olney J W, 1986, Adv Neurol, V44, P857; OLNEY JW, 1979, BRAIN RES, V176, P91, DOI 10.1016/0006-8993(79)90872-2; OLNEY JW, 1989, J NEUROSCI, V9, P1701; OUIMET CC, 1990, J NEUROSCI, V10, P1683; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Park JS, 1996, NEUROBIOL DIS, V3, P215, DOI 10.1006/nbdi.1996.0022; Petrak LJ, 2005, J COMP NEUROL, V484, P183, DOI 10.1002/cne.20468; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Ponimaskin E, 2007, MOL NEUROBIOL, V35, P278, DOI 10.1007/s12035-007-0023-0; Quinlan EM, 1996, NEURON, V16, P357, DOI 10.1016/S0896-6273(00)80053-7; Quinlan EM, 1996, J NEUROSCI, V16, P7627; Racz B, 2006, NEUROSCIENCE, V138, P447, DOI 10.1016/j.neuroscience.2005.11.025; ROTHMAN SM, 1985, J NEUROSCI, V5, P1483; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Sarmiere PD, 2004, J NEUROBIOL, V58, P103, DOI 10.1002/neu.10267; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; SCHOLZ WK, 1991, J NEUROSCI, V11, P2422; Schubert V, 2006, J CELL BIOL, V172, P453, DOI 10.1083/jcb.200506136; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Slemmer JE, 2005, PROG BRAIN RES, V148, P367, DOI 10.1016/S0079-6123(04)48029-7; Solomonia RO, 2008, EXP BRAIN RES, V188, P323, DOI 10.1007/s00221-008-1428-3; Spizz G, 1997, J BIOL CHEM, V272, P23833, DOI 10.1074/jbc.272.38.23833; Swann JW, 2000, HIPPOCAMPUS, V10, P617, DOI 10.1002/1098-1063(2000)10:5<617::AID-HIPO13>3.0.CO;2-R; Takeuchi H, 2005, J BIOL CHEM, V280, P10444, DOI 10.1074/jbc.M413863200; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Velazquez JLP, 1999, EUR J NEUROSCI, V11, P4110, DOI 10.1046/j.1460-9568.1999.00837.x; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; Wong Michael, 2008, Expert Rev Neurother, V8, P907, DOI 10.1586/14737175.8.6.907; Wu LX, 2007, BRAIN RES, V1168, P38, DOI 10.1016/j.brainres.2007.06.082; Zeng LH, 2007, J NEUROSCI, V27, P11604, DOI 10.1523/JNEUROSCI.0983-07.2007; Zhang SX, 2005, J NEUROSCI, V25, P5333, DOI 10.1523/JNEUROSCI.1085-05.2005; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	131	3	3	0	0	NOVA SCIENCE PUBLISHERS, INC	HAUPPAUGE	400 OSER AVE, STE 1600, HAUPPAUGE, NY 11788-3635 USA			978-1-60741-460-5				2009							45	65					21	Neurosciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BMT39	WOS:000273536800003					2022-02-06	
B	Clark, E; Pompa, JL		FletcherJanzen, E		Clark, Elaine; Pompa, Janiece L.			Women and Traumatic Brain Injury	NEUROPSYCHOLOGY OF WOMEN	Issues of Diversity in Clinical Neuropsychology		English	Article; Book Chapter							POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; GENDER-DIFFERENCES; SEX-DIFFERENCES; HEAD-INJURY; MENSTRUAL-CYCLE; OUTCOMES; HEMORRHAGE; ESTROGEN; STROKE		[Clark, Elaine; Pompa, Janiece L.] Univ Utah, Dept Educ Psychol, Salt Lake City, UT 84112 USA		Clark, E (corresponding author), Univ Utah, Dept Educ Psychol, 1705 Campus Ctr Dr 327, Salt Lake City, UT 84112 USA.	clark@ed.utah.edu					Alkayed NJ, 1998, STROKE, V29, P159, DOI 10.1161/01.STR.29.1.159; Angele MK, 1998, J TRAUMA, V44, P78, DOI 10.1097/00005373-199801000-00007; BENEDICT T, 2007, PRIVATE WAR WOMEN SO; Bounds TA, 2003, NEUROREHABILITATION, V18, P189; Bremner JD, 2004, ANN NY ACAD SCI, V1032, P154, DOI 10.1196/annals.1314.012; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bryant RA, 2003, AUST NZ J PSYCHIAT, V37, P226, DOI 10.1046/j.1440-1614.2003.01130.x; Centers for Disease Control Prevention [CDC], 2007, TRAUM BRAIN INJ; Cerghet M, 2006, J NEUROSCI, V26, P1439, DOI 10.1523/JNEUROSCI.2219-05.2006; Choudhry MA, 2005, SHOCK, V24, P101, DOI 10.1097/01.shk.0000191341.31530.5e; CLARK AS, 1989, BEHAV NEUROSCI, V103, P1287, DOI 10.1037/0735-7044.103.6.1287; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; Conejo NM, 2003, NEUROSCI LETT, V339, P119, DOI 10.1016/S0304-3940(02)01484-2; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Croce MA, 2002, J TRAUMA, V53, P889, DOI 10.1097/00005373-200211000-00013; Czlonkowska A, 2005, CURR PHARM DESIGN, V11, P1017, DOI 10.2174/1381612053381693; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; DeGraba TJ, 2000, NEUROL CLIN, V18, P475, DOI 10.1016/S0733-8619(05)70203-6; Diodato MD, 2001, CYTOKINE, V14, P162, DOI 10.1006/cyto.2001.0861; Donders J, 2003, J HEAD TRAUMA REHAB, V18, P106, DOI 10.1097/00001199-200303000-00002; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Farace E, 2000, Neurosurg Focus, V8, pe6; Farin A, 2003, J NEUROSURG, V98, P32, DOI 10.3171/jns.2003.98.1.0032; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Groswasser Z, 1999, NEUROPSYCHOL REHABIL, V9, P493, DOI 10.1080/096020199389545; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; Hindmarsh GJ, 2000, EARLY HUM DEV, V60, P115, DOI 10.1016/S0378-3782(00)00105-5; Holbrook TL, 2004, J TRAUMA, V56, P284, DOI 10.1097/01.TA.0000109758.75406.F8; HULST LK, 1994, CLIN PHARMACOL THER, V55, P378, DOI 10.1038/clpt.1994.45; Hurn PD, 2003, STROKE, V34, P338, DOI 10.1161/01.STR.0000054051.88378.25; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; KAPLAN J, 2000, WORKING PREVENT CONT; Kirkness Catherine J, 2004, Biol Res Nurs, V5, P299, DOI 10.1177/1099800404263050; KOLB B, 2003, FUNDAMENTALS HUMAN N; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Lacreuse A, 2001, PSYCHONEUROENDOCRINO, V26, P623, DOI 10.1016/S0306-4530(01)00017-8; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Markham JA, 2005, HIPPOCAMPUS, V15, P97, DOI 10.1002/hipo.20034; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Miller JW, 2005, NEUROLOGY, V65, P1974, DOI 10.1212/01.wnl.0000188900.91741.ea; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; Mostafa G, 2002, J TRAUMA, V53, P430, DOI 10.1097/00005373-200209000-00006; Napolitano LM, 2001, J TRAUMA, V50, P274, DOI 10.1097/00005373-200102000-00013; Ng I, 2006, BRIT J NEUROSURG, V20, P73, DOI 10.1080/02688690600682259; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; *NIH, 1999, REH PERS TRAUM BRAIN; OKIE S, 2007, IRAQ VETS FALLING ME; Rabinowicz T, 2002, J NEUROPATH EXP NEUR, V61, P46, DOI 10.1093/jnen/61.1.46; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; RAZ S, 1995, DEV PSYCHOL, V31, P958, DOI 10.1037/0012-1649.31.6.958; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Seibert PS, 2002, BRAIN INJURY, V16, P837, DOI 10.1080/02699050210131939; Silberstein SD, 2000, CEPHALALGIA, V20, P148, DOI 10.1046/j.1468-2982.2000.00034.x; Smith MJ, 2002, ANN NEUROL, V51, P599, DOI 10.1002/ana.10180; Stein DG, 2007, PROG BRAIN RES, V161, P339, DOI 10.1016/S0079-6123(06)61024-8; Taupin P, 2006, CURR OPIN MOL THER, V8, P345; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Woodward H, 1999, J HEAD TRAUMA REHAB, V14, P351, DOI 10.1097/00001199-199908000-00004; Zoroya G, 2007, US TODAY, p8a	66	3	3	0	1	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-0-387-76907-3	ISSUES DIVERS CLIN N			2009							69	86		10.1007/978-0-387-76908-0_4			18	Clinical Neurology; Neurosciences; Psychiatry; Psychology; Women's Studies	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Psychiatry; Psychology; Women's Studies	BKG99	WOS:000268051300004					2022-02-06	
J	Eagleman, DM				Eagleman, David M.			Using Time Perception to Measure Fitness for Duty	MILITARY PSYCHOLOGY			English	Article							FLICKER-FUSION THRESHOLD; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; DURATION; DISCRIMINATION; SCHIZOPHRENIA; RECALIBRATION; ILLUSIONS	Assessing fitness for duty (FFD) typically requires expensive equipment and large time windows. Here we capitalize on basic principles of human time perception to build a portable software package that can quickly and efficiently test for excessive fatigue or traumatic brain injury. Time perception involves a collaboration of many brain areas, and we hypothesize that generalized damage to the brain can be rapidly assessed by subtle disorders in simple timing tasks. We aim to produce an inexpensive, portable device for rapid detection of fatigue or brain injury both in the clinic and on the field.	Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA		Eagleman, DM (corresponding author), Baylor Coll Med, Dept Neurosci, 1 Baylor Plaza, Houston, TX 77030 USA.	eagleman@bcm.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS053960, R01 NS053960-02, R01 NS053960-03] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS053960] Funding Source: NIH RePORTER		ARTIEDA J, 1992, BRAIN, V115, P199, DOI 10.1093/brain/115.1.199; BLACK S, 1975, NEW ZEAL MED J, V81, P244; Caldwell JA, 2003, CLIN NEUROPHYSIOL, V114, P23, DOI 10.1016/S1388-2457(02)00283-3; Curran S, 2004, INT J GERIATR PSYCH, V19, P575, DOI 10.1002/gps.1134; Curran S, 2000, HUM PSYCHOPHARM CLIN, V15, P103, DOI 10.1002/(SICI)1099-1077(200003)15:2<103::AID-HUP149>3.0.CO;2-7; DILOLLO V, 1977, NATURE, V267, P241, DOI 10.1038/267241a0; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; Eagleman DM, 2005, J NEUROSCI, V25, P10369, DOI 10.1523/JNEUROSCI.3487-05.2005; Eagleman DM, 2001, NAT REV NEUROSCI, V2, P920, DOI 10.1038/35104092; EFRON R, 1970, NEUROPSYCHOLOGIA, V8, P57, DOI 10.1016/0028-3932(70)90025-4; Elvevag B, 2003, PSYCHOL MED, V33, P1249, DOI 10.1017/S0033291703008122; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; GANDHI SK, 2007, SOC NEUR ANN M SAN D; Kanai R, 2006, J VISION, V6, P1421, DOI 10.1167/16.12.8; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; Pariyadath V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001264; Pariyadath V, 2008, J VISION, V8, DOI 10.1167/8.16.11; Riesen JM, 2001, J NEUROL, V248, P27, DOI 10.1007/s004150170266; RIGAUD MC, 1995, PSYCHIAT ANN, V25, P246, DOI 10.3928/0048-5713-19950401-13; Stetson C, 2006, NEURON, V51, P651, DOI 10.1016/j.neuron.2006.08.006; Stetson C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001295; Tse PU, 2004, PERCEPT PSYCHOPHYS, V66, P1171, DOI 10.3758/BF03196844; Ulrich R, 2006, PSYCHOL RES-PSYCH FO, V70, P77, DOI 10.1007/S00426-004-0195-4	24	3	3	0	10	LAWRENCE ERLBAUM ASSOC INC-TAYLOR & FRANCIS	PHILADELPHIA	325 CHESTNUT STREET, STE 800, PHILADELPHIA, PA 19106 USA	0899-5605			MIL PSYCHOL	Milit. Psychol.		2009	21						123	129	PII 908213059	10.1080/08995600802554789			7	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	400IC	WOS:000262860300013	20454542	Green Accepted			2022-02-06	
B	Hopewell, CA		Schultheis, MT; DeLuca, J; Chute, DL		Hopewell, C. Alan			DRIVING AND TRAUMATIC BRAIN INJURY	HANDBOOK FOR THE ASSESSMENT OF DRIVING CAPACITY			English	Article; Book Chapter							PSYCHIATRIC ASPECTS; CEREBRAL INJURY; PREDICTION; ACCIDENT; PERFORMANCE; VEHICLE; DAMAGE; ATTENTION; FITNESS; ISSUES										Bijkerk M., 1986, CONTUSIO CEREBRI JAR; Boake C., 1998, J INT NEUROPSYCH SOC, V4, P75; Brouwer WH, 1997, NEUROPSYCHOL REHABIL, V7, P177, DOI 10.1080/713755536; Brouwer WH, 2002, J HEAD TRAUMA REHAB, V17, P1, DOI 10.1097/00001199-200202000-00003; Chute D., 1996, B C POWER LAB; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; CREMONA A, 1986, BRIT J HOSP MED, V35, P193; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; De La Cancela V., 1999, AM J PSYCHOPHARMACOL, V2, P454; Delis DC, 2002, DELIS KAPLAN EXECUTI; Devani Serio C., 1994, NEUROREHABILITATION, V4, P53; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; Engum E. S., 1988, COGNITIVE REHABILITA, V6, P34; ENGUM ES, 1988, COGNITIVE REHABILITA, V6, P12; Engum ES, 1990, COGNITIVE REHABILITA, V8, P20; ERCULEI F, 1969, LATE EFFECTS HEAD IN; Ernest Overall J, 1972, APPL MULTIVARIATE AN; Evans L., 1985, HUMAN BEHAV TRAFFIC, P485; Fisk GD, 2002, J HEAD TRAUMA REHAB, V17, P16, DOI 10.1097/00001199-200202000-00004; Fisk GD, 1998, BRAIN INJURY, V12, P683; Formisano R, 2005, BRAIN INJURY, V19, P159, DOI 10.1080/02699050400017163; Fox G K, 1992, Disabil Rehabil, V14, P140; GALSKI T, 1993, AM J OCCUP THER, V47, P391, DOI 10.5014/ajot.47.5.391; Galski T, 2000, J HEAD TRAUMA REHAB, V15, P895, DOI 10.1097/00001199-200006000-00004; Galski T, 1997, AM J OCCUP THER, V51, P352, DOI 10.5014/ajot.51.5.352; GARRETSON M, 1982, Journal of Safety Research, V13, P141, DOI 10.1016/0022-4375(82)90030-5; GIANUTSOS R, 1994, BEHAV RES METH INSTR, V26, P183, DOI 10.3758/BF03204615; GOUVIER WD, 1989, ARCH PHYS MED REHAB, V70, P745; GREENSHIELDS BD, 1967, J APPL PSYCHOL, V51, P205, DOI 10.1037/h0024690; Hale Jr P. N., 1986, ANN REPORT CTR REHAB; HALE PN, 1987, ARCH PHYS MED REHAB, V68, P741; HARANO RM, 1975, J SAFETY RES, V7, P16; Harris GT, 1997, PSYCHIAT SERV, V48, P1168; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; HEATON RK, 1981, J CONSULT CLIN PSYCH, V49, P807, DOI 10.1037/0022-006X.49.6.807; Hopewell C. A., 1997, DRIVERS NEUROPSYCHOL; Hopewell CA, 2002, J HEAD TRAUMA REHAB, V17, P48, DOI 10.1097/00001199-200202000-00007; HOPEWELL CA, 1985, J CLIN EXP NEUROPSYC, V7, P148; HOPEWELL CA, 1990, NEUROPSYCHOLOGY EVER; JACKSON H F, 1992, Brain Injury, V6, P109, DOI 10.3109/02699059209029650; JENNETT B, 1975, LANCET, V1, P480; JONES R, 1983, AM J OCCUP THER, V37, P754, DOI 10.5014/ajot.37.11.754; KEWMAN DG, 1985, REHABIL PSYCHOL, V30, P11; KLAVORA P, 1995, AM J OCCUP THER, V49, P534, DOI 10.5014/ajot.49.6.534; Koops D., 1981, HE LEVEN ONUSIO EREB; Lemoine P, 1996, ENCEPHALE, V22, P1; Lengenfelder J, 2002, J HEAD TRAUMA REHAB, V17, P26, DOI 10.1097/00001199-200202000-00005; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; Marottoli RA, 1997, J AM GERIATR SOC, V45, P202, DOI 10.1111/j.1532-5415.1997.tb04508.x; MCFARLAND RA, 1954, HUMAN VARIABLES MOTO; Michon J. A., 1979, DEALING DANGER UNPUB; MIHAL WL, 1976, J APPL PSYCHOL, V61, P229, DOI 10.1037/0021-9010.61.2.229; MILLER TM, 1983, ACCIDENT ANAL PREV, V15, P11, DOI 10.1016/0001-4575(83)90003-9; Monahan J, 1996, CRIM JUSTICE BEHAV, V23, P107, DOI 10.1177/0093854896023001008; Monahan J., 1994, VIOLENCE MENTAL DISO; NOYES R, 1985, PSYCHOSOMATICS, V26, P569, DOI 10.1016/S0033-3182(85)72820-4; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; Parasuraman R, 1993, Clin Geriatr Med, V9, P377; PECK RC, 1983, ACCIDENT ANAL PREV, V15, P371, DOI 10.1016/0001-4575(83)90015-5; Pettis R W, 1992, Bull Am Acad Psychiatry Law, V20, P427; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Schultheis M. T., 1998, THESIS DREXEL U PHIL; Schultheis Maria T, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P4921; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; Schultheis MT, 2001, PRESENCE-TELEOP VIRT, V10, P431, DOI 10.1162/1054746011470271; SCHULTHEIS MT, 2004, ARCH CLIN NEUROPSYCH, V19, P905; SELZER ML, 1968, AM J PSYCHIAT, V124, P1028, DOI 10.1176/ajp.124.8.1028; SIVAK M, 1984, INT J REHABIL RES, V7, P389, DOI 10.1097/00004356-198412000-00002; Stahl S., 1996, J AFFECT DISORDERS, V51, P215; STOKX LC, 1986, J CLIN EXP NEUROPSYC, V8, P421, DOI 10.1080/01688638608401332; Texas Department of Public Safety, 1985, MOT VEH TRAFF ACC; Timm H, 1994, Rehabilitation (Stuttg), V33, P237; TSUANG MT, 1985, AM J PSYCHIAT, V142, P538; Wallace J. E., 1971, BEHAV RES HIGHWAY SA, V2, P53; [No title captured]	77	3	3	0	0	ELSEVIER ACADEMIC PRESS INC	SAN DIEGO	525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA			978-0-08-092565-3; 978-0-12-631255-3				2009							71	94		10.1016/B978-0-12-631255-3.00005-9			24	Clinical Neurology; Neurosciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BEN89	WOS:000317497300008					2022-02-06	
B	Kharatishvili, I; Pitkanen, A		Schwartzkroin, PA		Kharatishvili, I.; Pitkanen, A.			Posttraumatic Models	ENCYCLOPEDIA OF BASIC EPILEPSY RESEARCH, VOLS 1-3			English	Article; Book Chapter							PARTIAL CORTICAL DEAFFERENTATION; TRAUMATIC BRAIN-INJURY; HEAD TRAUMA; EPILEPSY; HIPPOCAMPUS; HYPEREXCITABILITY; EPILEPTOGENESIS; PREVENTION; INJECTION; SEIZURES		[Kharatishvili, I.; Pitkanen, A.] Univ Kuopio, FIN-70211 Kuopio, Finland		Kharatishvili, I (corresponding author), Univ Kuopio, FIN-70211 Kuopio, Finland.						Benardo LS, 2003, EPILEPSIA, V44, P27, DOI 10.1046/j.1528-1157.44.s10.2.x; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; Graber KD, 2004, ANN NEUROL, V55, P860, DOI 10.1002/ana.20124; Hernandez TD, 1997, NEUROLOGY, V48, P803, DOI 10.1212/WNL.48.4.803; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Nita DA, 2007, CEREB CORTEX, V17, P272, DOI 10.1093/cercor/bhj145; Pitkanen A, 2006, MODELS OF SEIZURES AND EPILEPSY, P1; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Topolnik L, 2003, CEREB CORTEX, V13, P883, DOI 10.1093/cercor/13.8.883; Ueda Y, 1998, EXP NEUROL, V153, P123, DOI 10.1006/exnr.1998.6869; WILLMORE LJ, 1978, SCIENCE, V200, P1501, DOI 10.1126/science.96527; Willmore LJ, 1995, PSYCHIAT CLIN NEUROS, V49, P171	15	3	3	0	0	ELSEVIER ACADEMIC PRESS INC	SAN DIEGO	525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA			978-0-12-373961-2				2009							1229	1238					10	Medicine, Research & Experimental; Clinical Neurology	Book Citation Index – Science (BKCI-S)	Research & Experimental Medicine; Neurosciences & Neurology	BFJ85	WOS:000320162800211					2022-02-06	
J	Kneebone, I; Hull, S				Kneebone, Ian I.; Hull, Samantha L.			Cognitive behaviour therapy for post-traumatic stress symptoms in the context of hydrocephalus: A single case	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							NORMAL-PRESSURE HYDROCEPHALUS; TRAUMATIC BRAIN-INJURY; PROCESSING THERAPY; DISORDER; DEFICITS	There is limited information about anxiety disorders occurring in the context of the challenging condition of hydrocephalus. This paper describes the treatment, via trauma-focused cognitive behaviour therapy (TFCBT), of post-traumatic stress symptoms arising on account of hydrocephalus in a 23-year-old man. Specific components of the intervention included exposure, cognitive disputation, and relaxation training. The 20-session intervention appeared effective with decreases in anxiety (on the Hospital Anxiety and Depression Scale) and event impact (on the Impact of Events Scale) from clinical to sub-clinical levels. The main contributor to change appeared to be the exposure element of the treatment. The benefits of the intervention were maintained at one-, three-, and six-month follow-up.	[Kneebone, Ian I.; Hull, Samantha L.] Surrey NHS Primary Care Trust, Surrey, England; [Kneebone, Ian I.] Univ Surrey, Guildford GU2 5XH, Surrey, England		Kneebone, I (corresponding author), Haslemere Hosp, Godwin Unit, Church Lane, Surrey GU27 2BJ, England.	i.kneebone@nhs.net		Kneebone, Ian/0000-0003-3324-7264			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Aschoff A, 1999, NEUROSURG REV, V22, P67, DOI 10.1007/s101430050035; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Bergsneider M, 2006, J NEUROSURG, V104, P157, DOI 10.3171/ped.2006.104.3.157; Bisson J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003388.pub3; BLACK PM, 1980, J NEUROSURG, V52, P371, DOI 10.3171/jns.1980.52.3.0371; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Bret P, 1995, CHILD NERV SYST, V11, P687, DOI 10.1007/BF00262232; Cowan JA, 2005, NEUROL RES, V27, P540, DOI 10.1179/016164105X17242; DEVILLY GJ, 2005, IMPACT EVENTS SCALE; FOA EB, 2007, WORLD C BEH COGN PSY; Harvey AG, 2003, CLIN PSYCHOL REV, V23, P501, DOI 10.1016/S0272-7358(03)00035-7; Horner MD, 2002, NEUROPSYCHOL REV, V12, P15, DOI 10.1023/A:1015439106231; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Kanagaratnam P, 2007, J ANXIETY DISORD, V21, P510, DOI 10.1016/j.janxdis.2006.06.008; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; Lewinsohn PM., 1974, PSYCHOL DEPRESSION C, P157; McMillan TM, 2003, NEUROPSYCHOL REHABIL, V13, P149, DOI 10.1080/09602010244000453; Paschall MJ, 2002, AGGRESS VIOLENT BEH, V7, P215, DOI 10.1016/S1359-1789(00)00044-6; Rattray JE, 2005, ANAESTHESIA, V60, P1085, DOI 10.1111/j.1365-2044.2005.04336.x; Resick PA, 2002, J CONSULT CLIN PSYCH, V70, P867, DOI 10.1037//0022-006X.70.4.867; RESICK PA, 1992, J CONSULT CLIN PSYCH, V60, P748, DOI 10.1037/0022-006X.60.5.748; RUSTARD RA, 1993, COGNITIVE ASSESSMENT; Schelling G, 1998, CRIT CARE MED, V26, P651, DOI 10.1097/00003246-199804000-00011; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Tedstone JE, 2003, CLIN PSYCHOL REV, V23, P409, DOI 10.1016/S0272-7358(03)00031-X; Turner S., 1998, MEASURES POSTTRAUMAT; Tyerman R., 1986, CHESSINGTON OCCUPATI; VAUGHAN K, 1992, BRIT J PSYCHIAT, V161, P658, DOI 10.1192/bjp.161.5.658; WINKLER R, 1982, MIGRAINE TENSION HEA; Zhou L, 2006, J NEUROCHEM, V96, P396, DOI 10.1111/j.1471-4159.2005.03562.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	33	3	3	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2009	19	1					86	97	PII 793085537	10.1080/09602010802009623			12	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	386HX	WOS:000261874300005	18609019				2022-02-06	
S	Kobeissy, FH; Zhang, ZQ; Sadasivan, S; Gold, MS; Wang, KKW		Ottens, AK; Wang, KKW		Kobeissy, Firas H.; Zhang, Zhiqun; Sadasivan, Shankar; Gold, Mark S.; Wang, Kevin K. W.			Methods in Drug Abuse Neuroproteomics: Methamphetamine Psychoproteome	NEUROPROTEOMICS: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Neurotoxicity; Methamphetamine; Proteomics; Drug of abuse; Proteolysis; Autophagy; Posttranslational modification	TRAUMATIC BRAIN-INJURY; NEURONAL APOPTOSIS; RAT-BRAIN; EXPOSURE; CORTEX; DEGENERATION; PROTEOLYSIS; AUTOPHAGY; SPECTRIN; DEATH	Methamphetamine (METH) is recognized as one of the most abused psychostimulants in the USA. METH is an illicit drug that is known to exert neurotoxic effects on both dopaminergic and serotonergic neural systems. Our laboratory has been Studying the biochemical mechanisms underlying MDMA and METH-induced neurotoxic effects both in vivo and in vitro. Our Substance abuse research focuses on the global alteration of cortical protein expression in rats treated with acute METH. Altered protein expression was identified using a multistep protein separation/proteomic platform. Differential changes of the selected proteins were further confirmed by quantitative immunoblotting. Our study identified 82 differentially expressed proteins, 40 of which were downregulated and 42 of which were upregulated post acute METH treatment. Proteins that were shown to be downregulated included collapsin response mediator protein-2 (CRMP-2), Superoxide dismutase I (SOD 1), and phosphatidylethanolamine-binding protein-1 (PEBP-1). Proteins that were shown to be upregulated included authophagy-linked microtuble-associated protein light chain 3 (LC3), synapsin-1, and Parkinsonism-linked ubiquitin carboxy-terminal hydroxylase-L1 (UCH-L1). This differential protein expression highlights on the neurotoxic mechanism involved in METH exposure as well as to discover potential markets for METH-induced neurotoxicity In this chapter, we describe the current protocols for the in vivo rat model of acute METH treatment (40 mg/kg) coupled with the description of the multistep separation platform applied. These methods and protocols arc discussed in the paradigm of acute model of methamphetamine drug abuse and can be applied to other models of substance abuse Such as to MDMA or cocaine.	[Kobeissy, Firas H.; Zhang, Zhiqun; Sadasivan, Shankar; Wang, Kevin K. W.] Univ Florida, McKnight Brain Inst, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, Gainesville, FL 32610 USA; [Gold, Mark S.] Univ Florida, McKnight Brain Inst, Dept Neurosci, Gainesville, FL USA; [Gold, Mark S.] Univ Florida, McKnight Brain Inst, Dept Community Hlth & Family Med, Gainesville, FL USA; [Wang, Kevin K. W.] Banyan Biomarkers Inc, Ctr Innovat Res, Alachua, FL USA		Kobeissy, FH (corresponding author), Univ Florida, McKnight Brain Inst, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, Gainesville, FL 32610 USA.		Kobeissy, Firas/E-7042-2017	Kobeissy, Firas/0000-0002-5008-6944			Bowyer JF, 2007, NEUROSCIENCE, V144, P66, DOI 10.1016/j.neuroscience.2006.08.076; Cadet JL, 1997, SYNAPSE, V25, P176; Cadet JL, 2003, FASEB J, V17, P1775, DOI 10.1096/fj.03-0073rev; Jayanthi S, 2004, FASEB J, V18, P238, DOI 10.1096/fj.03-0295com; Jimenez A, 2004, TOXICOL APPL PHARM, V196, P223, DOI 10.1016/j.taap.2003.12.017; Kanthasamy A, 2006, ANN NY ACAD SCI, V1074, P234, DOI 10.1196/annals.1369.022; Kobeissy FH, 2008, EXPERT REV PROTEOMIC, V5, P293, DOI 10.1586/14789450.5.2.293; Kobeissy FH, 2008, J PROTEOME RES, V7, P1971, DOI 10.1021/pr800029h; Lan KC, 1998, J FORMOS MED ASSOC, V97, P528; Larsen KE, 2002, J NEUROSCI, V22, P8951; *NSDUH, 2006, METH US AB DEP 2002; Ottens AK, 2005, ANAL CHEM, V77, P4836, DOI 10.1021/ac050478r; Perez JA, 1999, J EMERG MED, V17, P469, DOI 10.1016/S0736-4679(99)00009-8; Pu CF, 1996, SYNAPSE, V23, P328, DOI 10.1002/(SICI)1098-2396(199608)23:4<328::AID-SYN11>3.0.CO;2-T; Sokolov BP, 2006, NEUROPSYCHOPHARMACOL, V31, P956, DOI 10.1038/sj.npp.1300891; Staszewski RD, 2006, J NEUROCHEM, V96, P1267, DOI 10.1111/j.1471-4159.2005.03618.x; Wallace TL, 2003, NEUROSCIENCE, V116, P1063, DOI 10.1016/S0306-4522(02)00795-9; Warren M, 2006, INT J NEUROPSYCHOPH, V9, pS168; Warren MW, 2006, J ADDICT DIS, V25, P115, DOI 10.1300/J069v25n04_11; Warren MW, 2005, LIFE SCI, V78, P301, DOI 10.1016/j.lfs.2005.04.058	20	3	3	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-934115-84-8	METHODS MOL BIOL	Methods Mol. Biol.		2009	566						217	228		10.1007/978-1-59745-562-6_15	10.1007/978-1-59745-562-6		12	Biochemical Research Methods; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BLU16	WOS:000271018600015					2022-02-06	
J	Murphy, RKJ; McEvoy, L; Kelleher, MO; Bolger, C; Phillips, J				Murphy, R. K. J.; McEvoy, L.; Kelleher, M. O.; Bolger, C.; Phillips, J.			The burden of motorcycle-related neuro-trauma in Ireland and associated helmet usage	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Neurotrauma; motorcycle; helmet	RISK; INJURY	Motorcycles represent less than 2% of the licensed vehicles but motorcyclists account for 12% of road deaths in Ireland. The British Road Safety Authority has introduced the Sharp programme, which hopes to save 50 lives in the U.K. each year alone by helping riders to choose the best-fitting and safest helmets. We evaluated the pattern of head injuries sustained by motorcyclists referred to the two neurosurgical centres Beaumont Hospital and Cork University Hospital in Ireland and ascertained if the new SHARP guidelines could be of benefit in reducing the burden of motorcycle related neurotrauma and disability in Ireland. Despite Ireland having mandatory helmet laws almost a quarter of our motorcyclists with traumatic brain injury were unhelmeted. A significant reduction in mortality and morbidity is predicted if all motorcyclists in Ireland were to wear helmets that satisfied the SHARP criteria.	[Murphy, R. K. J.; McEvoy, L.; Kelleher, M. O.; Bolger, C.; Phillips, J.] Beaumont Hosp, Neurosurg Res & Dev Unit, Dublin 9, Ireland		Murphy, RKJ (corresponding author), Beaumont Hosp, Neurosurg Res & Dev Unit, Dublin 9, Ireland.	roryfromcork@hotmail.com					BACHULIS BL, 1988, AM J SURG, V155, P708, DOI 10.1016/S0002-9610(88)80151-X; Deutermann W., 2004, MOTORCYCLE HELMET EF; Elliott MA, 2007, ACCIDENT ANAL PREV, V39, P491, DOI 10.1016/j.aap.2006.08.012; Horswill MS, 2003, ACCIDENT ANAL PREV, V35, P589, DOI 10.1016/S0001-4575(02)00039-8; Lardelli-Claret P, 2005, INJURY PREV, V11, P225, DOI 10.1136/ip.2004.006957; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Maartens NF, 2002, NEUROSURGERY, V50, P176; *NAT ROADS AUTH, ROAD COLL FACTS 2002; Pileggi C, 2006, J PEDIATR-US, V148, P527, DOI 10.1016/j.jpeds.2005.11.017; Richter M, 2001, J TRAUMA, V51, P949, DOI 10.1097/00005373-200111000-00021; *ROAD SAF AUTH IR, 2007, CONS DOC COMP BAS TR; *ROAD SAF AUTH IR, MOT REP 1997 2006; Rutter DR, 1996, ACCIDENT ANAL PREV, V28, P15, DOI 10.1016/0001-4575(95)00037-2; Rutter DR, 1998, BRIT J PSYCHOL, V89, P681, DOI 10.1111/j.2044-8295.1998.tb02710.x; Servadei F, 2003, INJURY PREV, V9, P257, DOI 10.1136/ip.9.3.257; Stella Julian, 2002, Emerg Med (Fremantle), V14, P58, DOI 10.1046/j.1442-2026.2002.00287.x; Turner C, 2004, ACCIDENT ANAL PREV, V36, P383, DOI 10.1016/S0001-4575(03)00031-9; 1999, 2 EUR ROAD RES C; 1989, DIEMATH HE NEUROS S1, V12, P458; 2008, SHARP WORLD FOR HARM	20	3	3	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.		2009	23	2					162	164	PII 909741566	10.1080/02688690902759078			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	423XU	WOS:000264530900008	19306171				2022-02-06	
S	Oli, MW; Hayes, RL; Robinson, G; Wang, KKW		Ottens, AK; Wang, KKW		Oli, Monika W.; Hayes, Ronald L.; Robinson, Gillian; Wang, Kevin K. W.			Traumatic Brain Injury Biomarkers: From Pipeline to Diagnostic Assay Development	NEUROPROTEOMICS: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Biomarkers; Brain injury; Assay development; Clinical trials; ELISA	SPECTRIN BREAKDOWN PRODUCTS; ALPHA-II-SPECTRIN; CEREBROSPINAL-FLUID; INTERFERENCE; ANTIBODY; PROTEOME; RATS; PCR	In recent years, the term proteomics is often mentioned together with biomarker discovery, as proteomic studies have the capability of identifying unique and unobvious protein biomarkers from tissues or biofluids derived from animal models or human clinical samples inflicted with various diseases. Proteomics has yielded hundreds of potential biomarker candidates. However, biomarker discovery is only the beginning of a long road for generating a validated, clinically relevant, and FDA-approved biomarker assay. Many technical, financial, legal, and regulatory hurdles have to be overcome before the components can be commercially produced (1, 2). This chapter outlines in a condensed version the steps to successfully develop clinically acceptable biomarkers, given the marker of choice withstands the rigor of developmental challenges along the road.	[Oli, Monika W.] Banyan Biomarkers Inc, Dept Res & Dev, Alachua, FL USA; [Hayes, Ronald L.] Banyan Biomarkers Inc, Clin Dept, Ctr Innovat Res, Alachua, FL USA; [Wang, Kevin K. W.] Univ Florida, McKnight Brain Inst, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, Gainesville, FL USA		Oli, MW (corresponding author), Banyan Biomarkers Inc, Dept Res & Dev, Alachua, FL USA.						Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Goldmann BU, 2001, CURR CONTR TRIALS C, V2, P75, DOI 10.1186/CVM-2-2-075; Grebenchtchikov N, 2002, J IMMUNOL METHODS, V268, P219, DOI 10.1016/S0022-1759(02)00213-2; Katz Russell, 2004, NeuroRx, V1, P189, DOI 10.1007/BF03206602; Kobeissy FH, 2008, PROTEOM CLIN APPL, V2, P1467, DOI 10.1002/prca.200800011; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kricka LJ, 1999, CLIN CHEM, V45, P942; KRICKA LJ, 1990, CLIN CHEM, V36, P892; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; Niemeyer CM, 2007, NAT PROTOC, V2, P1918, DOI 10.1038/nprot.2007.267; Niemeyer CM, 2005, TRENDS BIOTECHNOL, V23, P208, DOI 10.1016/j.tibtech.2005.02.006; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; Romeo MJ, 2005, EXPERT REV PROTEOMIC, V2, P57, DOI 10.1586/14789450.2.1.57; Vitzthum F, 2005, J PROTEOME RES, V4, P1086, DOI 10.1021/pr050080b	17	3	3	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-934115-84-8	METHODS MOL BIOL	Methods Mol. Biol.		2009	566						293	302		10.1007/978-1-59745-562-6_19	10.1007/978-1-59745-562-6		10	Biochemical Research Methods; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BLU16	WOS:000271018600019					2022-02-06	
B	Reeves, RR; Brister, JC		Sher, L; Vilens, A		Reeves, Roy R.; Brister, James C.			TRAUMATIC BRAIN INJURY AND SUICIDE	TERROR AND SUICIDE	Terrorism Hot Spots and Conflict-Related Issues		English	Article; Book Chapter							MAJOR DEPRESSION; PEOPLE; RISK; ASSOCIATION; POPULATION; POSTINJURY; DISORDER; BEHAVIOR; ADULTS; DEATH	Traumatic brain injury (TBI) is a serious health problem that impacts many aspects of neurological, cognitive, and behavioral and psychological domains and is often associated with comorbid psychiatric disorders. Mood and anxiety disorders, including major depression, frequently occur among persons who have a TBI. Of particular concern is a body of evidence that suggests that people with TBI may be at increased risk for suicide, although the relationship between TBI and suicide is not entirely clear. This chapter will provide an overview of current literature on TBI and the risk of suicidality and discuss treatment approaches to the TBI patient who may be at risk for suicide.	[Reeves, Roy R.] VA Med Ctr, Jackson, MS USA; Univ Mississippi, Sch Med, Jackson, MS 39216 USA		Reeves, RR (corresponding author), VA Med Ctr, Jackson, MS USA.						ACHTE KA, 1971, ACTA PSYCHIAT SCAN S, V225, P1; ANTSEY KJ, 2004, J CLIN EPIDEMIOL, V57, P1202; Ben-Ya'acov Y, 2004, PERS INDIV DIFFER, V36, P1257, DOI 10.1016/S0191-8869(03)00003-5; Bennett T L, 1997, Appl Neuropsychol, V4, P55, DOI 10.1207/s15324826an0401_7; Dittmar C, 1997, Appl Neuropsychol, V4, P50, DOI 10.1207/s15324826an0401_6; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Gualtari CT, 1991, BRAIN INJURY, V5, P219; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Kuipers P, 2000, J HEAD TRAUMA REHAB, V15, P1275, DOI 10.1097/00001199-200012000-00007; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; MAINIO A, 2004, BRAIN INJURY, V21, P851; MAX W, 1991, J HEAD TRAUMA REHAB, V6, P436; Mrazek PB, 1994, REDUCING RISKS MENTA; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Oquendo MA, 2003, AM J PSYCHIAT, V160, P580, DOI 10.1176/appi.ajp.160.3.580; Satz P, 1998, BRAIN INJURY, V12, P555, DOI 10.1080/026990598122322; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2003, J HEAD TRAUMA REHAB, V18, P445, DOI 10.1097/00001199-200309000-00006; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Simpson GK, 2007, MED J AUSTRALIA, V187, P229, DOI 10.5694/j.1326-5377.2007.tb01206.x; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Thibault JM, 2004, AM FAM PHYSICIAN, V70, P1101; TREVENA L, 2004, CLIN PRACTICE GUIDEL; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246	30	3	3	0	1	NOVA SCIENCE PUBLISHERS, INC	HAUPPAUGE	400 OSER AVE, STE 1600, HAUPPAUGE, NY 11788-3635 USA			978-1-60876-103-6	TERROR HOT SPOTS CON			2009							105	114					10	Psychiatry; Psychology, Multidisciplinary	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Psychiatry; Psychology	BPH79	WOS:000278871700009					2022-02-06	
J	Reyes-Alva, HJ; Franco-Bourland, RE; Martinez-Cruz, A; Grijalva, I; Fuchs, B; Madrazo, I; Guizar-Sahagun, G				Reyes-Alva, Horacio J.; Franco-Bourland, Rebecca E.; Martinez-Cruz, Angelina; Grijalva, Israel; Fuchs, Bruno; Madrazo, Ignacio; Guizar-Sahagun, Gabriel			Thalidomide fails to be therapeutic following contusive spinal cord injury in rats	ACTA NEUROBIOLOGIAE EXPERIMENTALIS			English	Article						acute inflammatory reaction; vasogenic edema; neuroprotective drugs; secondary injury; TNF; VEGF	FUNCTIONAL RECOVERY; SECONDARY DAMAGE; EDEMA; MECHANISMS; MODEL; MICE; METHYLPREDNISOLONE; INDUCTION; TRAUMA; BRAIN	Mechanical damage to the spinal cord (SC) generates self-destructive processes that contribute to post-traumatic neurodegeneration. Because thalidomide apparently counteracts these effects its use clinically has been proposed enthusiastically. Nonetheless, we tested its action as a neuroprotectant in a clinically relevant model of SC injury in rats. We administered thalidomide intraperitoneally to rats subjected to thoracic SC contusion as single or repeated doses within the first 24 h after injury. Edema, neutrophil infiltration, and cord tissue preservation/destruction were assessed in the SC 24 h after injury and motor function for 7 weeks. Rats treated with thalidomide showed significant increase in SC water compared with naive rats, but not vehicle-treated rats; their neutrophil infiltration and amount of spared/destroyed cord tissue was not different from vehicle-treated rats; and in no case was motor performance improved after thalidomide. In conclusion, thalidomide failed here to be therapeutic, discouraging its use clinically for SC trauma.	[Reyes-Alva, Horacio J.; Grijalva, Israel; Madrazo, Ignacio; Guizar-Sahagun, Gabriel] Mexican Social Secur Inst, Med Ctr Century 21, Res Unit Neurol Dis, Mexico City, DF, Mexico; [Franco-Bourland, Rebecca E.; Martinez-Cruz, Angelina; Grijalva, Israel; Fuchs, Bruno; Madrazo, Ignacio; Guizar-Sahagun, Gabriel] Camina Project AC, Dept Expt Surg, Mexico City, DF, Mexico; [Franco-Bourland, Rebecca E.] Natl Inst Rehabil, Dept Biochem, Mexico City, DF, Mexico; [Reyes-Alva, Horacio J.] Autonomous Univ State Mexico, Sch Vet Med, Dept Surg, Toluca, Mexico		Guizar-Sahagun, G (corresponding author), Mexican Social Secur Inst, Med Ctr Century 21, Res Unit Neurol Dis, Mexico City, DF, Mexico.	guizarg@gmail.com		Martinez-Cruz, Angelina/0000-0002-1216-3427; Guizar-Sahagun, Gabriel/0000-0002-2722-5758; REYES-ALVA, HORACIO J/0000-0002-6678-8588	Instituto Mexicano del Seguro Social [2005/1/I/043]	This work was supported by the fund for health research (FIS) from the Instituto Mexicano del Seguro Social, grant 2005/1/I/043. We thank Francisco Marquez and Joel Mendez-Heredia for their invaluable technical assistance.	Akiyama C, 2004, J NEUROTRAUM, V21, P923, DOI 10.1089/0897715041526230; Baptiste DC, 2007, PROG BRAIN RES, V161, P217, DOI 10.1016/S0079-6123(06)61015-7; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Daruwalla J, 2005, J SURG ONCOL, V91, P134, DOI 10.1002/jso.20289; Ding Q, 2002, CANCER CHEMOTH PHARM, V50, P186, DOI 10.1007/s00280-002-0482-y; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Eter N, 2002, BRIT J OPHTHALMOL, V86, P1303, DOI 10.1136/bjo.86.11.1303; Garcia-Lopez P, 2007, SPINAL CORD, V45, P603, DOI 10.1038/sj.sc.3102001; GarciaLopez P, 1997, BIOPHARM DRUG DISPOS, V18, P203, DOI 10.1002/(SICI)1099-081X(199704)18:3<203::AID-BDD11>3.0.CO;2-F; Genovese T, 2008, SHOCK, V30, P231, DOI 10.1097/shk.0b013e318162d290; Greig NH, 2004, ACTA NEUROBIOL EXP, V64, P1; Guizar-Sahagun G, 1998, P W PHARMACOL SOC, V41, P237; Guizar-Sahagun G, 2005, NEUROSCIENCE, V130, P639, DOI 10.1016/j.neuroscience.2004.09.056; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hermann GE, 2001, NEUROBIOL DIS, V8, P590, DOI 10.1006/nbdi.2001.0414; Herrera JJ, 2009, J NEUROTRAUM, V26, P995, DOI [10.1089/neu.2008.0779, 10.1089/neu.2008-0779]; Huang YJ, 2005, BIOMED CHROMATOGR, V19, P488, DOI 10.1002/bmc.466; Hurlbert RJ, 2008, CAN J NEUROL SCI, V35, P41, DOI 10.1017/S031716710000754X; Josephson A, 2001, NEUROSURGERY, V48, P636, DOI 10.1097/00006123-200103000-00039; Kaicker S, 2003, INT J ONCOL, V23, P1651; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; Koopmans GC, 2009, EXP NEUROL, V216, P490, DOI 10.1016/j.expneurol.2009.01.005; Kotoh T, 1999, SURGERY, V125, P536, DOI 10.1067/msy.1999.97743; Kraus KH, 1996, SEMIN VET MED SURG, V11, P201; Leppert ER, 2006, CURR DRUG METAB, V7, P677, DOI 10.2174/138920006778017777; Lin YY, 2005, INFECT IMMUN, V73, P7946, DOI 10.1128/IAI.73.12.7946-7952.2005; Melchert M, 2007, INT J BIOCHEM CELL B, V39, P1489, DOI 10.1016/j.biocel.2007.01.022; NEMECEK S, 1977, ACTA NEUROCHIR, V37, P7, DOI 10.1007/BF01401922; Oliver S J, 2000, Curr Rheumatol Rep, V2, P486, DOI 10.1007/s11926-000-0025-7; Pan JZ, 2002, J NEUROSCI RES, V68, P315, DOI 10.1002/jnr.10215; Paravar T, 2008, INT REV IMMUNOL, V27, P111, DOI 10.1080/08830180801911339; Skold M, 2000, EUR J NEUROSCI, V12, P3675, DOI 10.1046/j.1460-9568.2000.00263.x; Suberviola B, 2008, INJURY, V39, P748, DOI 10.1016/j.injury.2007.12.005; Tei R, 2005, NEUROL RES, V27, P403, DOI 10.1179/016164105X25180; Tseng S, 1996, J AM ACAD DERMATOL, V35, P969, DOI 10.1016/S0190-9622(96)90122-X; Turan NN, 2008, ANN VASC SURG, V22, P98, DOI 10.1016/j.avsg.2007.07.023; van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218; WAGNER FC, 1981, J NEUROSURG, V54, P802, DOI 10.3171/jns.1981.54.6.0802; Yune TY, 2003, J NEUROTRAUM, V20, P207, DOI 10.1089/08977150360547116	39	3	3	0	1	NENCKI INST EXPERIMENTAL BIOLOGY	WARSAW	UL PASTEURA 3, 02-093 WARSAW, POLAND	0065-1400	1689-0035		ACTA NEUROBIOL EXP	Acta Neurobiol. Exp.		2009	69	4					494	503					10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	544JC	WOS:000273651000007	20048765				2022-02-06	
J	Shimia, M; Sayyahmelli, S				Shimia, Mohammad; Sayyahmelli, Sima			Traumatic Displacement of the Globe into Brain	RAWAL MEDICAL JOURNAL			English	Article						Head injury; orbit; orbital fracture		We report a case where globe was dislocated into the brain following orbital wall fracture. Traumatic dislocation of the eye into the brain is rare and urgent management and surgical repair is indicated. To our knowledge, this is the first case of traumatic displacement of the globe into the brain with satisfactory removal of the globe and orbital wall repair.	[Shimia, Mohammad; Sayyahmelli, Sima] Tabriz Univ Med Sci, Emam Reza Hosp, Tabriz, Iran		Sayyahmelli, S (corresponding author), Tabriz Univ Med Sci, Neurol Surg Dept, Tabriz, Iran.	sima_sayyah@yahoo.com					Abrishami M, 2007, OPHTHAL PLAST RECONS, V23, P156, DOI 10.1097/IOP.0b013e31802f2470; He DM, 2007, J ORAL MAXIL SURG, V65, P713, DOI 10.1016/j.joms.2006.09.006; Kim S, 2005, GRAEF ARCH CLIN EXP, V243, P1280, DOI 10.1007/s00417-004-1111-8; Kohlhof JK, 2007, KLIN MONATSBL AUGENH, V224, P867, DOI 10.1055/s-2007-963646; Muller-Richter UDA, 2007, INT J ORAL MAX SURG, V36, P1207, DOI 10.1016/j.ijom.2007.05.017; Ramstead C, 2008, CAN J OPHTHALMOL, V43, P364, DOI 10.3129/i08-045; Sargent L A, 1999, J Craniomaxillofac Trauma, V5, P19; Tranfa F, 2000, AM J OPHTHALMOL, V130, P253, DOI 10.1016/S0002-9394(00)00505-5	8	3	3	0	0	PAKISTAN MEDICAL ASSOC	KARACHI	PMA HOUSE, AGA KHAN III RD, KARACHI, 00000, PAKISTAN	0303-5212			RAWAL MED J	Rawal Med. J.		2009	34	2											6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V8Q3B	WOS:000421869400034					2022-02-06	
J	Svestkova, O; Angerova, Y; Sladkova, P				Svestkova, O.; Angerova, Y.; Sladkova, P.			The International Classification of Functioning, Disability and Health (ICF) - Quantitative Measurement of Capacity and Performance	CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE			Czech	Article						International Classification of Functioning, Disability and Health; activities; participation; environmental factors; rehabilitation	REHABILITATION	As part of the sixth framework EUMHADIE (Measuring Health and Disability in Europe: supporting policy development), the International Classification of Functioning, Disability and Health (ICF) was employed by 12 EU facilities (among them six clinical settings). A cross-sectional study of patients (n = 1,019) with eight different chronic conditions (musculoskeletal conditions rheumatoid arthritis, osteoporosis, osteoarthritis, low back pain, multiple sclerosis, Parkinson's disease, migraine, stroke, depression, bipolar disorder, and traumatic brain injury) was conducted. The Department of Rehabilitation Medicine of the First Faculty of Medicine and General Teaching Hospital in Prague participated in this project with 100 patients after TBI (traumatic brain injury) and 100 patients with MS (multiple sclerosis). Patient evaluation was performed by qualified health-professionals (trained on ICF courses) who completed a checklist composed according to ICF categories. Every patient then answered socio-demographic questions common to all centres and marked specific scales assessing the details of the disease. With the help of health professionals or students, the patients filled in the WHODAS II standardized quality of life questionnaires (WHO Disability Assessment Scale) and SF-36 (Short Form Measure of Generic Health Status) compiled along ICF guidelines. The study analyzed the structure of causal factors in terms of Activities (Capacity) and Participation (Performance). The authors would like to draw attention to the importance of ICF as a classification and, further, they would like to suggest the use of ICF in clinical and epidemiological studies.	[Svestkova, O.] Klin Rehabilitacniho Lekarstvi 1 LF UK, Prague 12800 2, Czech Republic; VFN Praze, Prague 12800 2, Czech Republic		Svestkova, O (corresponding author), Klin Rehabilitacniho Lekarstvi 1 LF UK, Albertov 7, Prague 12800 2, Czech Republic.	olga.svestkova@lf1.cuni.cz	Angerova, Yvona/AAL-8925-2021; Svetkova, Olga/O-1062-2017	Svetkova, Olga/0000-0002-4271-4795			Angelova K, 2008, MOL ENDOCRINOL, V22, P126, DOI 10.1210/me.2007-0352; Eldar R, 2008, DISABIL REHABIL, V30, P134, DOI 10.1080/09638280701191776; Ewert T, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410015362; Flora DB, 2004, PSYCHOL METHODS, V9, P466, DOI 10.1037/1082-989X.9.4.466; Hendl J., 2004, PREHLED STAT METOD Z, P696; Leonardi M, 2006, LANCET, V368, P1219, DOI 10.1016/S0140-6736(06)69498-1; Mont D, 2007, LANCET, V369, P1658, DOI 10.1016/S0140-6736(07)60752-1; PFEIFFER J, 2008, PREKLAD ANGLICKEHO O, P19; RODERICK P, 1991, FAKTOROVA ANAL PRIBU; Svestkova O, 2007, INT J REHABIL RES, V30, P33; Svestkova O, 2002, DISABIL REHABIL, V24, P798, DOI 10.1080/09638280210126435; SVESTKOVA O, 2008, PRAKT LEK, V88, P161; SVESTKOVA O, 2008, BRAIN INJURY S, V22, P113; SVESTKOVA O, 2006, EUROREHAB, V16, P117; SVESTKVOA O, 2008, J REHABIL MED S, V7, P286; World Health Organization, 2004, ICD 10 INT STAT CLAS; World Health Organization, 2007, INT CLASS FUNCT DIS; World Health Organization (WHO), 1999, HIST TYP LUNG PLEUR, P1; 1984, REHABILITACIA S, V28, P1; [No title captured]	20	3	3	0	4	CZECH MEDICAL SOC	PRAGUE 2	SOKOLSKA 31, PRAGUE 2 120 26, CZECH REPUBLIC	1210-7859	1802-4041		CESK SLOV NEUROL N	Cesk. Slov. Neurol. Neurochir.		2009	72	6					580	586					7	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	529LW	WOS:000272519700014					2022-02-06	
B	Thatcher, RW		Budzynski, TH; Budzynski, HK; Evans, JR; Abarbanel, A		Thatcher, Robert W.			EEG Evaluation of traumatic brain injury and EEG biofeedback treatment	INTRODUCTION TO QUANTITATIVE EEG AND NEUROFEEDBACK: ADVANCED THEORY AND APPLICATIONS, 2ND EDITION			English	Article; Book Chapter							TEST-RETEST RELIABILITY; MINOR HEAD-INJURY; RESOLUTION ELECTROMAGNETIC TOMOGRAPHY; CLINICAL NEUROPHYSIOLOGY SOCIETY; QUANTITATIVE EEG; AMERICAN ACADEMY; BIOPHYSICAL LINKAGE; SPECTRAL PARAMETERS; JUDGE RELIABILITY; MILD		[Thatcher, Robert W.] Appl Neurosci Inc, EEG & NeuroImaging Lab, St Petersburg, FL USA; [Thatcher, Robert W.] Univ S Florida, Dept Neurol, Tampa, FL 33620 USA		Thatcher, RW (corresponding author), Appl Neurosci Inc, EEG & NeuroImaging Lab, St Petersburg, FL USA.						Arruda JE, 1996, INT J PSYCHOPHYSIOL, V23, P63, DOI 10.1016/0167-8760(96)00032-3; AYERS ME, 1987, NATL HEAD INJURY SYL, P380; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Berger H, 1934, ARCH PSYCHIAT NERVEN, V102, P538, DOI 10.1007/BF01813827; Berger H, 1932, ARCH PSYCHIAT NERVEN, V97, P6, DOI 10.1007/BF01815532; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; BLACK AH, 1973, PSYCHOPHYSIOLOGY THI, P35; Bounias M., 2002, Journal of Neurotherapy, V6, P23, DOI 10.1300/J184v06n01_03; Bounias M., 2001, Journal of Neurotherapy, V5, P23, DOI 10.1300/J184v05n04_03; BURGESS A, 1993, ELECTROEN CLIN NEURO, V86, P219, DOI 10.1016/0013-4694(93)90101-Z; Byers AP., 1995, J NEUROTHERAPY, V1, P22; Carmines E.G., 1979, RELIABILITY VALIDITY; COOPER R, 1974, EEG TECHNOLOGY; CorsiCabrera M, 1997, ELECTROEN CLIN NEURO, V102, P248, DOI 10.1016/S0013-4694(96)95179-6; Duff J, 2004, CLIN EEG NEUROSCI, V35, P198, DOI 10.1177/155005940403500410; DUFFY FH, 1994, CLIN ELECTROENCEPHAL, V25, pR6, DOI 10.1177/155005949402500403; FOX SS, 1968, SCIENCE, V162, P1299, DOI 10.1126/science.162.3859.1299; GASSER T, 1985, ELECTROEN CLIN NEURO, V60, P312, DOI 10.1016/0013-4694(85)90005-7; Gillies RF, 1994, NMR PHYSL BIOMEDICIN; GLOOR P, 1968, BRAIN, V91, P779, DOI 10.1093/brain/91.4.779; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; Ham LP, 1996, BIOFEEDBACK SELF-REG, V21, P93, DOI 10.1007/BF02284689; Hamilton-Bruce M A, 1991, Clin Exp Neurol, V28, P219; Harmony T, 1993, Int J Neurosci, V68, P263, DOI 10.3109/00207459308994281; Hellstrom-Westas L, 2005, EARLY HUM DEV, V81, P255, DOI 10.1016/j.earlhumdev.2005.01.006; HETZLER BE, 1977, PHYSIOL BEHAV, V19, P527, DOI 10.1016/0031-9384(77)90229-3; Hoffman D. A., 1995, J NEUROTHERAPY, V1, P14, DOI [10.1300/ J184v01n01_03, DOI 10.1300/J184V01N01_03]; Hoffman DA, 1999, J NEUROPSYCH CLIN N, V11, P401, DOI 10.1176/jnp.11.3.401; HOFFMAN DA, 1996, CLIN ELECTROENCEPHAL, V27, P6; Hughes JR, 1999, J NEUROPSYCH CLIN N, V11, P190, DOI 10.1176/jnp.11.2.190; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Laibow R. E., 2001, Journal of Neurotherapy, V5, P45, DOI 10.1300/J184v05n04_04; LUBAR JO, 1984, BIOFEEDBACK SELF-REG, V9, P1, DOI 10.1007/BF00998842; LUND TR, 1995, PSYCHOPHYSIOLOGY, V32, P66, DOI 10.1111/j.1469-8986.1995.tb03407.x; MALMIVUO J, 1995, BIOELETROMAGNETISM P; MAS F, 1993, CLIN ELECTROENCEPHAL, V24, P118, DOI 10.1177/155005949302400309; MCLEAN AJ, 1995, J NEUROTRAUM, V12, P621, DOI 10.1089/neu.1995.12.621; Niedermeyer E., 2005, ELECTROENCEPHALOGRAP, pxxx; Niedermeyer E., 1995, ELECTROENCEPHALOGRAP; Nunez P, 1981, ELECT FIELDS BRAIN; Nunez P.L., 1995, NEOCORTICAL DYNAMICS; Nunnally JC., 1978, PSYCHOMETRIC THEORY, V2; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1995, J NEUROTRAUM, V12, P527, DOI 10.1089/neu.1995.12.527; Ommaya AK, 1968, J BIOMECH; PACKARD RC, 1994, SEMIN NEUROL, V14, P74, DOI 10.1055/s-2008-1041062; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Peniston EG., 1993, ADV MED PSYCHOTHER, V6, P37; POLLOCK VE, 1991, ELECTROEN CLIN NEURO, V79, P20, DOI 10.1016/0013-4694(91)90152-T; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Roche RAP, 2004, NEUROSCI LETT, V362, P1, DOI 10.1016/j.neulet.2003.11.064; RUIJS MBM, 1994, NEUROPEDIATRICS, V25, P73, DOI 10.1055/s-2008-1071589; SALINSKY MC, 1991, ELECTROEN CLIN NEURO, V79, P382, DOI 10.1016/0013-4694(91)90203-G; Sano K, 1967, Neurol Med Chir (Tokyo), V9, P21, DOI 10.2176/nmc.9.21; Schoenberger N. E., J HEAD TRAUMA REHABI, V16, P260; Slewa-Younan S, 2002, CLIN NEUROPHYSIOL, V113, P1640, DOI 10.1016/S1388-2457(02)00239-0; Slobounov S, 2002, CLIN NEUROPHYSIOL, V113, P185, DOI 10.1016/S1388-2457(01)00737-4; Slobounov S, 2006, FDN SPORT RELATED BR; Sterman MB, 1996, BIOFEEDBACK SELF-REG, V21, P3, DOI 10.1007/BF02214147; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; Thatcher RW, 2005, CLIN EEG NEUROSCI, V36, P116, DOI 10.1177/155005940503600211; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; Thatcher R W, 1995, J Neuroimaging, V5, P35; Thatcher R. W., 1999, BRAIN INJURY, V12, P13; Thatcher R.W., 1998, DATABASES NEUROTHER, V2, P8, DOI [10.1300/j184v02n04_02, DOI 10.1300/J184V02N04_02]; Thatcher R. W., 1989, ELECTROENCEPHALOGR C, V73, DOI [10.1016/0013-4694(89)90188-0, DOI 10.1016/0013-4694(89)90188-0, https://doi.org/10.1016/0013-4694(89)90188-0]; Thatcher R. W., 2000, 8 ANN ISNR C ST PAUL; Thatcher RW, 1998, NEUROIMAGE, V7, P352, DOI 10.1006/nimg.1998.0330; Thatcher RW, 1997, J NEUROTRAUM, V14, P1, DOI 10.1089/neu.1997.14.1; Thatcher RW, 2005, CLIN NEUROPHYSIOL, V116, P2129, DOI 10.1016/j.clinph.2005.04.026; Thatcher RW, 2005, CLIN EEG NEUROSCI, V36, P1, DOI 10.1177/155005940503600103; Thatcher RW, 2003, CLIN ELECTROENCEPHAL, V34, P39, DOI 10.1177/155005940303400203; THATCHER RW, 1986, ELECTROEN CLIN NEURO, V64, P123, DOI 10.1016/0013-4694(86)90107-0; Thatcher RW, 1998, NEUROIMAGE, V8, P307, DOI 10.1006/nimg.1998.0365; Thatcher RW, 2000, CLIN ELECTROENCEPHAL, V31, P38, DOI 10.1177/155005940003100110; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Thatcher RW, 2001, CLIN NEUROPHYSIOL, V112, P1729, DOI 10.1016/S1388-2457(01)00609-5; Thatcher RW, 1999, CLIN ELECTROENCEPHAL, V30, P94, DOI 10.1177/155005949903000304; THATCHER RW, 1999, INTRO QUANTITATIVE E; Thompson J, 2005, NEUROSCI LETT, V377, P158, DOI 10.1016/j.neulet.2004.11.090; Thorndike, 1971, ED MEASUREMENT, P443, DOI DOI 10.1037/14353-009; Thornton K, 2003, ARCH CLIN NEUROPSYCH, V18, P363, DOI 10.1016/S0887-6177(02)00139-7; Thornton KE, 2005, CHILD ADOL PSYCH CL, V14, P137, DOI 10.1016/j.chc.2004.07.001; Thornton KE, 1999, BRAIN INJURY, V13, P477, DOI 10.1080/026990599121395; Tinius T. P., 2000, J NEUROTHER, V4, P27, DOI [DOI 10.1300/J184v04n02_05, 10.1300/J184v04n02_05]; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; TRYER L, 1988, BIOCHEMISTRY; Van Egren L., 1996, CLIN ELECTROENCEPHAL, V27, P164; von Bierbrauer A., 1993, EEG EMG Z ELEKTROENZ, V23, P151; Wing K, 2001, Top Stroke Rehabil, V8, P45; WOODY RH, 1968, J CLIN PSYCHOL, V24, P251, DOI 10.1002/1097-4679(196804)24:2<251::AID-JCLP2270240241>3.0.CO;2-X; WOODY RH, 1966, J CLIN PSYCHOL, V22, P150, DOI 10.1002/1097-4679(196604)22:2<150::AID-JCLP2270220206>3.0.CO;2-5; [No title captured]	95	3	3	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS			978-0-08-092315-4				2009							269	294		10.1016/B978-0-12-374534-7.00011-3			26	Neurosciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BEO09	WOS:000317520800013					2022-02-06	
J	Yattoo, GH; Tabish, SA; Afzal, WM; Kirmani, A				Yattoo, G. H.; Tabish, S. A.; Afzal, Wani M.; Kirmani, Altaf			Factors Influencing Outcome of Head Injury Patients at A Tertiary Care Teaching Hospital in India	INTERNATIONAL JOURNAL OF HEALTH SCIENCES-IJHS			English	Article								Background: Trauma is the most common cause of morbidity and mortality in people younger than 45 years and head injury is mostly highly weighted predictor of outcome in trauma population, anything than can improve the outcome from severe head injury has the potential of improving the lives of many accident victims. Objective: A study regarding factors influencing outcome of traumatic brain injury patients was conducted at a tertiary care hospital of Srinagar (India). The basic predictors in this study included age, sex, rural/urban, time taken from site of trauma to arrival at hospital, mode of transportation, referral from other hospitals, referral to other hospitals, and Glasgow Coma Scale. Methods: Traumatic Brain Injury (TBI) patients (n 547) were taken prospectively by simple random sampling method for a period of one year (2004) for this study. Results: Majority of patients belonged to age group 0 to 10 years (25.5%) and a maximum death (8) were seen in age group 51 to 60 years. Maximum number of patients were males (75.9%) and (71.1%) TBI patients were from rural areas. (26.7%) reached this hospital within a period of one hour. (66%) were shifted through ambulance service. 6.4% expired after treatment. Conclusion: Factors responsible for improved outcome in severe head injury patients are improvement in early recognition, resuscitation and triage, coupled with prompt computed tomography (CT) scanning and aggressive surgical management.	[Yattoo, G. H.; Tabish, S. A.; Afzal, Wani M.; Kirmani, Altaf] Sheri Kashmir Inst Med Sci, Dept Accid & Emergency, Srinagar, Jammu & Kashmir, India; [Yattoo, G. H.; Tabish, S. A.; Afzal, Wani M.; Kirmani, Altaf] Sheri Kashmir Inst Med Sci, Dept Neurosurg, Srinagar, Jammu & Kashmir, India		Yattoo, GH (corresponding author), SK Inst Med Sci, Dept Hosp Adm, Srinagar 190011, Jammu & Kashmir, India.						Gabella B, 1999, YB EMERGENCY MED, P9; Gerberding JL, 2002, MMWR MORBIDITY MORTA, V51; Hans Feickert J, 1999, CRITICAL CARE, V47, P33; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; KENNEDY F, 1993, J TRAUMA, V35, P75, DOI 10.1097/00005373-199307000-00013; Kraus J, 2000, HEAD INJURY, P1; Mir MY, 2004, JIMSA, V13, P247; Peral PA, 2008, BMG, DOI 10.1136/bmj.3946; TABADDOR K, 1984, NEUROSURGERY, V14, P701, DOI 10.1227/00006123-198406000-00010; Wegner, 1983, YB EMERGENCY MED, P50; Yattoo Gh, 2008, J Trauma Manag Outcomes, V2, P5, DOI 10.1186/1752-2897-2-5	11	3	3	0	0	ACAD PUBLISHING & TRANSLATION	BURAIDAH	COLL MEDICINE, QASSIM UNIV, PO BOX 6655, BURAIDAH, 51432, SAUDI ARABIA	1658-3639			INT J HEALTH SCI-IJH	Int. J. Health Sci.-IJHS	JAN	2009	3	1					59	62					4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V6C5N	WOS:000420159800010	21475512				2022-02-06	
J	Beck, L; Heusinger, A; Boecker, M; Niemann, H; Gauggel, S				Beck, Lydia; Heusinger, Anne; Boecker, Maren; Niemann, Hendrik; Gauggel, Siegfried			Convergent and predictive validity of two computerized attention tests in brain-damaged patients	ZEITSCHRIFT FUR NEUROPSYCHOLOGIE			English	Article						brain injury; attention; proxy ratings; test validity	COGNITIVE IMPAIRMENTS; SUSTAINED ATTENTION; DIFFERENCE SCORES; HEAD-INJURY; PERFORMANCE; AWARENESS; FITNESS	Although computerized attention tests are used frequently, our knowledge about the convergent and predictive validity of these tests is limited. In the present study, 47 stroke and traumatic brain injury patients performed the Attention Network Test (ANT) and corresponding subtests of the Test for Attentional Performance (TAP). In addition, patients and staff completed the Attention Deficits Questionnaire (ADQ). Considering corresponding ANT and TAP subtests, significant correlations (r=.55 - .71) were found for alerting and orienting subtests and overall reaction time. Comparison of subtests of the two attention tests with staff reported deficits in the ADQ revealed moderate to high correlations for ANT (r=.62-.70) and TAP (r=.36-.86). The predictive validity of different subtests varies only sightly. The overall reaction time seems to be the best predictor of rated attention deficits. Findings support the convergent and predictive validity of both computerized attention tests.	[Beck, Lydia; Heusinger, Anne; Boecker, Maren; Gauggel, Siegfried] Rhein Westfal TH Aachen, Univ Hosp, Dept Med Psychol & Med Sociol, D-52074 Aachen, Germany; [Niemann, Hendrik] Neurol Rehabil Ctr Leipzig, Leipzig, Germany		Beck, L (corresponding author), Rhein Westfal TH Aachen, Univ Hosp, Dept Med Psychol & Med Sociol, Pauwelsstr 30, D-52074 Aachen, Germany.	lbeck@ukaachen.de					[Anonymous], 2008, Z NEUROPSYCHOL, V19, P59, DOI 10.1024/1016-264X.19.2.59; Bate AJ, 2001, CLIN NEUROPSYCHOL, V15, P405, DOI 10.1076/clin.15.3.405.10279; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Bowman ML, 1996, CLIN NEUROPSYCHOL, V10, P382, DOI 10.1080/13854049608406699; BROOKE MM, 1992, AM J PHYS MED REHAB, V71, P177, DOI 10.1097/00002060-199206000-00009; CRONBACH LJ, 1970, PSYCHOL BULL, V74, P68, DOI 10.1037/h0029382; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Farmer J E, 1995, Appl Neuropsychol, V2, P107, DOI 10.1207/s15324826an0203&4_2; Feldstein SN, 1999, CLIN NEUROPSYCHOL, V13, P303, DOI 10.1076/clin.13.3.303.1744; Fischer S, 2004, J INT NEUROPSYCH SOC, V10, P190, DOI 10.1017/S1355617704102051; FOldenyi M., 2000, Z NEUROPSYCHOL, V11, P154, DOI DOI 10.1024/1016-264X.11.3.154; Gasquoine P., 1992, NEUROPSYCHOLOGY, V6, P187, DOI [10.1037/0894-4105.6.3.187., DOI 10.1037/0894-4105.6.3.187, https://doi.org/10.1037/0894-4105.6.3.187]; Gauggel S, 2000, J HEAD TRAUMA REHAB, V15, P710, DOI 10.1097/00001199-200002000-00009; GAUGGEL S, 2004, KURZANLEITUNG AUFMER; GAUGGEL S, 1994, Z NEUROPSYCHOL, V5, P172; Goldstein G., 1995, INT J REHABILITATION, V1, DOI [10.1007/BF02214959, DOI 10.1007/BF02214959]; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Jancke L, 2008, Z NEUROPSYCHOL, V19, P91, DOI 10.1024/1016-264X.19.2.91; Kinsella GJ, 1998, NEUROPSYCHOL REHABIL, V8, P351, DOI 10.1080/713755576; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; LORD FM, 1967, PSYCHOL BULL, V68, P304, DOI 10.1037/h0025105; Lundqvist A, 1997, APPL NEUROPSYCHOL, V4, P220, DOI 10.1207/s15324826an0404_3; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; McPherson K, 1997, NEUROPSYCHOL REHABIL, V7, P241, DOI 10.1080/713755530; Nadolne MJ, 2001, J INT NEUROPSYCH SOC, V7, P675, DOI 10.1017/S1355617701766039; PETER JP, 1993, J CONSUM RES, V19, P655, DOI 10.1086/209329; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Ponsford JL, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Reddon JR, 2005, CURR PSYCHOL, V24, P60, DOI 10.1007/s12144-005-1004-y; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Robertson IH, 1997, NEUROPSYCHOLOGY, V11, P290, DOI 10.1037/0894-4105.11.2.290; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rosenthal R., 1994, HDB RES SYNTHESIS; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sturm W, 2008, Z NEUROPSYCHOL, V19, P83, DOI 10.1024/1016-264X.19.2.83; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Volz-Sidiropoulou E., 2007, Z NEUROPSYCHOL, V18, P299, DOI DOI 10.1024/1016-264X.18.4.299; *WHO, 2002, ICF INT CLASS FUNCT; Withaar FK, 2000, J INT NEUROPSYCH SOC, V6, P480, DOI 10.1017/S1355617700644065; Zimmermann, 1997, TEST ATTENTIONAL PER; Zimmermann P, 2002, TESTBATTERIE AUFMERK; Zoccolotti P, 2000, CORTEX, V36, P93, DOI 10.1016/S0010-9452(08)70839-6	46	3	3	0	5	VERLAG HANS HUBER	BERN 9	LANGGASS-STRASSE 76, CH-3000 BERN 9, SWITZERLAND	1016-264X	1664-2902		Z NEUROPSYCHOL	Z. Neuropsychol.	DEC	2008	19	4					213	222		10.1024/1016-264X.19.4.213			10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	385OP	WOS:000261823800002					2022-02-06	
J	Lannin, NA; McCluskey, A				Lannin, Natasha A.; McCluskey, Annie			A Systematic Review of Upper Limb Rehabilitation for Adults With Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						occupational therapy; motor training; upper extremity; arm	ELECTRICAL-STIMULATION; UPPER EXTREMITY; STROKE; THERAPY; OUTCOMES; QUALITY; IMPACT; ARM	Objective function in adults with traumatic brain injury. Data sources: Databases were last searched on August 2, 2008. Sources included the Cochrane Central Register of Controlled Trials (CENTRAL); Cochrane Database of Systematic Reviews, the Database of Effectiveness Reviews; MEDLINE, EMBASE, CINAHL, Physiotherapy Evidence Database (PEDro), Occupational Therapy Systematic Evaluation of Evidence database (OTseeker); Google Scholar; and reference lists of included studies. Review methods:Two reviewers determined whether retrieved abstracts met the inclusion criteria: systematic reviews and randomised controlled trials (RCTs); English language; adult participants; >= 50% of study participants with a brain injury; interventions designed to improve upper limb motor function. Included papers were appraised for. study design, participants, therapy approach, therapy protocol (indications, contra-indications, intensity and duration), safety and adverse events, and outcomes. The methodological quality of RCTs was rated using the PEDro scale (1-10 highest). Methodology of systematic reviews was rated using the QUOROM criteria. Results: Of the 333 references identified, six were appraised: three systematic reviews and three RCTs. Methodological quality was high for two RCTs, and moderate for one, based on the PEDro scale score. Interventions included upper limb casting, electrical stimulation, and coordination training using meal preparation tasks (making a sandwich and hot drink). In the latter trial, practice of functional kitchen tasks improved fine motor coordination speed on one of four Jebsen-Taylor hand function subtests by 9.38 seconds (95% Cl, 1.1 to 177). Remaining trials reported non-significant effects for hand function. Small sample sizes and limited reporting of results reduce the interpretability of two RCTs. Conclusion: No conclusive evidence was found on which to base upper limb motor rehabilitation after brain injury, however, lack of evidence does not equate to evidence of no effect.	[Lannin, Natasha A.; McCluskey, Annie] Univ Sydney, Rehabil Studies Unit, Ryde, NSW 1680, Australia		Lannin, NA (corresponding author), Univ Sydney, Rehabil Studies Unit, POB 6, Ryde, NSW 1680, Australia.	nlannin@mail.usyd.edu.au	Lannin, Natasha A/A-4195-2013	Lannin, Natasha A/0000-0002-2066-8345			Barreca S, 2003, NEUROREHAB NEURAL RE, V17, P220, DOI 10.1177/0888439003259415; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Braun SM, 2006, ARCH PHYS MED REHAB, V87, P842, DOI 10.1016/j.apmr.2006.02.034; de Kroon JR, 2005, J REHABIL MED, V37, P65, DOI 10.1080/16501970410024190; Domholdt E., 2000, PHYS THERAPY RES PRI, V2; Hakkennes S, 2005, AUST J PHYSIOTHER, V51, P221, DOI 10.1016/S0004-9514(05)70003-9; Harvey Lisa, 2002, Physiother Res Int, V7, P1, DOI 10.1002/pri.236; Keech AC, 2004, MED J AUSTRALIA, V181, P215, DOI 10.5694/j.1326-5377.2004.tb06241.x; Kushwaha V P, 1998, J Am Acad Orthop Surg, V6, P298; Kwakkel G, 2006, DISABIL REHABIL, V28, P823, DOI 10.1080/09638280500534861; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maher CG, 2003, PHYS THER REHABIL J, V83, P713, DOI 10.1093/ptj/83.8.713; Marshall S, 2007, BRAIN INJURY, V21, P133, DOI 10.1080/02699050701201383; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moseley AM, 2008, CLIN REHABIL, V22, P406, DOI 10.1177/0269215507083795; NEISTADT ME, 1994, AM J OCCUP THER, V48, P877, DOI 10.5014/ajot.48.10.877; Peri CV, 2001, BRAIN INJURY, V15, P903, DOI 10.1080/02699050110065709; PHILLIPS B, 2000, OXFORD CTR EVIDENCE; Pomeroy VM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003241.pub2; Prange GB, 2006, J REHABIL RES DEV, V43, P171, DOI 10.1682/JRRD.2005.04.0076; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V274, P1456; Tate R.L., 2006, BRAIN IMPAIR, V7, P1, DOI DOI 10.1375/brim.7.1.1; van der Lee JH, 2001, CLIN REHABIL, V15, P20, DOI 10.1191/026921501677557755; van Dijk H, 2005, J REHABIL MED, V37, P202, DOI 10.1080/16501970510030165; Van Peppen RPS, 2004, CLIN REHABIL, V18, P833, DOI 10.1191/0269215504cr843oa; WATSON MJ, 2001, PHYS THER REV, V6, P233; World Health Organization, 2007, INT CLASS FUNCT DIS	27	3	4	0	17	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	DEC	2008	9	3					237	246		10.1375/brim.9.3.237			10	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	390UT	WOS:000262189900001					2022-02-06	
J	Lindh, C; Wennersten, A; Arnberg, F; Holmin, S; Mathiesen, T				Lindh, Claes; Wennersten, Andre; Arnberg, Fabian; Holmin, Staffan; Mathiesen, Tiit			Differences in cell death between high and low energy brain injury in adult rats	ACTA NEUROCHIRURGICA			English	Article						Brain injury; Experimental contusion; Energy transfer; Cell death	SEVERE HEAD-INJURY; CEREBRAL-CORTEX; TRAUMA; APOPTOSIS; EXPRESSION; RESPONSES; GENE; COMA	Traumatic brain damage is dependent on energy transfer to the brain at impact. Different injury mechanisms may cause different types of brain injury. It is, however, unknown if the relative distribution between apoptotic cell-death and necrotic cell- death in different populations of brain cells varies depending on energy transfer. Experimental contusions were produced with a modified weight drop onto the exposed dura of rats. Animals were divided into two groups. They received a weight drop from two different heights to vary energy transfer to be higher or lower. Animals were sacrificed at 24 hours post injury (1 DPI) or 6 days (6 DPI); brains were frozen and processed for TUNEL (TdT mediated dUTP nick end labelling), light microscopy and immunochemistry. The total number of TUNEL positive cells was higher in the higher energy group on the first day after the injury. At the same time point, relatively fewer cells were apoptotic than necrotic, while relatively more glial cells than neurons were TUNEL-positive in higher energy trauma. At 6 day after the injury fewer cells were TUNEL positive and there were no longer significant differences between the high and low energy groups. Increasing energy transfer in a model for brain contusion demonstrated qualitative and quantitative changes in the pattern of cell death. This complexity must be considered when evaluating brain-protection as treatment results may vary depending on which cellular population and which mechanism of cell death is treated under the exact experimental and clinical conditions.	[Lindh, Claes; Wennersten, Andre; Arnberg, Fabian; Holmin, Staffan; Mathiesen, Tiit] Karolinska Inst, Dept Clin Neurosci, Sect Clin CNS Res, Stockholm 17176, Sweden		Arnberg, F (corresponding author), Karolinska Inst, Dept Clin Neurosci, Sect Clin CNS Res, Stockholm 17176, Sweden.	fabian.arnberg.162@student.karolinska.se	mathiesen, tiit/ABC-3627-2021	Mathiesen, Tiit/0000-0001-9463-1919; Holmin, Staffan/0000-0002-1628-1615	Trygg-Hansas Forskningsfonder.	This study was supported by grants from Trygg-Hansas Forskningsfonder.	Conti AC, 1998, J NEUROSCI, V18, P5663; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Eriskat J, 2003, ACTA NEUROCHIR SUPPL, V86, P265; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Hicks RR, 1999, J NEUROTRAUM, V16, P501, DOI 10.1089/neu.1999.16.501; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; JENNETT B, 1977, LANCET, V1, P878; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Matsushita Y, 2000, J NEUROTRAUM, V17, P143, DOI 10.1089/neu.2000.17.143; NEELY W A, 1962, Surg Forum, V13, P413; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Ringger NC, 2004, J NEUROTRAUM, V21, P829, DOI 10.1089/0897715041526177; RINK A, 1995, AM J PATHOL, V147, P1575; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; TEASDALE G, 1974, LANCET, V2, P81; Vink R, 1988, J NEUROTRAUM, V5, P315, DOI 10.1089/neu.1988.5.315; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y; Yang SY, 1998, J NEUROSURG, V89, P297, DOI 10.3171/jns.1998.89.2.0297; Yoles E, 2001, J NEUROSCI, V21, P3740, DOI 10.1523/JNEUROSCI.21-11-03740.2001; Zhou F, 2001, J CLIN NEUROSCI, V8, P561, DOI 10.1054/jocn.2001.0980; Zhu Tao, 2004, Chin J Traumatol, V7, P32	28	3	4	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	DEC	2008	150	12					1269	1275		10.1007/s00701-008-0147-7			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	382FF	WOS:000261590000008	19015811				2022-02-06	
J	Liu, ZL; Liu, L; Fan, ZB; Chen, XR; Zhao, XH; Zhang, LL; Rao, GX; Li, HX				Liu, Zilong; Liu, Liang; Fan, Zebing; Chen, Xiaorui; Zhao, Xiaohong; Zhang, Lingli; Rao, Guangxun; Li, Haixia			Correlations between Event-related Potentials with Pictures Recognition and WMS-RC Scores in Patients with Memory Disorder Caused by Severe Traumatic Brain Injury	JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES			English	Article						picture recognition; event-related potentials; memory disorder; severe traumatic brain injury	VISUAL WORKING-MEMORY; P300	This study explored the possibility of using event-related potentials (ERP) for the measurement of picture-recognition memory and examined its correlation with the Chinese Wechsler Memory Scale-revised (WMS-RC) in patients with memory disorder caused by severe traumatic brain injury (sTBI). The subjects included 20 sTBI patients with memory disorder and 22 healthy individuals. Memory function was measured by using WMS-RC. Behavioral and ERP responses were recorded on-line during performance on a battery of picture recognition and the responses were analyzed off-line for recognition memory effects. Mean memory quotient (MQ) of patients with sTBI was significantly lower than that of the control group. Mean reaction time (RT) was significantly longer and the mean correctness rate (CR) of picture recognition was significantly lower in sTBI group than that of the controls. In controls, the main components of average ERP of picture recognition includes two positive-going waves, designated as P-170 and P-500, that appear 170 ms and 500 ms after stimulation when the subject could later successfully recall and recognize the pictures. P-500 amplitude of target stimulus was significantly higher than that of non-target stimulus. Compared to controls, P-500 responses of sTBI group were significantly delayed in latency (P<0.001) and lower in amplitude (P<0.001). P-500 latency showed significant negative correlation with MQ and the scores of "addition", "visual recognition", "picture recall", "visual reproduction" and "tactile memory" in WMS-RC. ERP of picture recognition provides a neurophysiological approach to directly assess memory impairment, and P-500 may serve as a helpful index for memory disorder caused by sTBI in forensic practice.	[Liu, Zilong; Liu, Liang; Fan, Zebing; Chen, Xiaorui; Zhao, Xiaohong; Zhang, Lingli; Rao, Guangxun] Huazhong Univ Sci & Technol, Tongji Med Coll, Fac Forens Med, Wuhan 430030, Peoples R China; [Li, Haixia] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Pediat, Wuhan 430030, Peoples R China		Liu, L (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Fac Forens Med, Wuhan 430030, Peoples R China.	lzlong7678@yahoo.com.cn					Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Connolly JF, 2000, INT J PSYCHOPHYSIOL, V37, P31, DOI 10.1016/S0167-8760(00)00093-3; Drew TW, 2006, CLIN EEG NEUROSCI, V37, P286, DOI 10.1177/155005940603700405; Gaetz M, 2001, J HEAD TRAUMA REHAB, V16, P386, DOI 10.1097/00001199-200108000-00008; Gong Y., 1989, WECHSLER MEMORY SCAL, P2; GRANACHER RP, 2003, TRAUMATIC BRAIN INJU, P26; Harker KT, 2007, CLIN NEUROPHYSIOL, V118, P2479, DOI 10.1016/j.clinph.2007.07.026; Kotchoubey B, 2003, NEUROSCI LETT, V352, P129, DOI 10.1016/j.neulet.2003.08.045; Kotchoubey B, 2001, NEUROSCI LETT, V301, P37, DOI 10.1016/S0304-3940(01)01600-7; Liu Yu-Qing, 2007, Fa Yi Xue Za Zhi, V23, P108; MORSE PA, 1992, CLIN SYNDROMES ADULT; Naito Yasuo, 2005, Kobe Journal of Medical Sciences, V51, P95; Nittono H, 1999, PSYCHOPHYSIOLOGY, V36, P745; Reza F, 2006, J CLIN NEUROSCI, V13, P917, DOI 10.1016/j.jocn.2004.11.026; Song Wei-qun, 2004, Space Med Med Eng (Beijing), V17, P377	15	3	6	1	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1672-0733	1993-1352		J HUAZHONG U SCI-MED	J. Huazhong Univ. Sci. Tech.-Med.	DEC	2008	28	6					700	705		10.1007/s11596-008-0620-9			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387RW	WOS:000261970300020	19107371				2022-02-06	
J	Hosalkar, H; Hsu, J; Pandya, NK; Keenan, MA				Hosalkar, Harish; Hsu, Jason; Pandya, Nirav K.; Keenan, Mary Ann			What's New in Orthopaedic Rehabilitation	JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME			English	Article							TRAUMATIC BRAIN-INJURY; HETEROTOPIC OSSIFICATION; SPINAL-CORD; LONG-TERM; GUIDELINES; PREVENTION; AMPUTATIONS; ISCHEMIA; RISK; TRANSMISSION		[Hosalkar, Harish; Hsu, Jason; Pandya, Nirav K.; Keenan, Mary Ann] Hosp Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA		Hosalkar, H (corresponding author), Hosp Univ Penn, Dept Orthopaed Surg, 3400 Spruce St,2 Silverstein, Philadelphia, PA 19104 USA.	maryann.keenan@uphs.upenn.edu	Keenan, Mary Ann/ABB-1551-2020				Adderson JA, 2007, PROSTHET ORTHOT INT, V31, P384, DOI 10.1080/03093640701254018; ALEKNA V, 2008, SPINAL CORD     0429; Baum BS, 2008, INJURY, V39, P728, DOI 10.1016/j.injury.2007.11.021; Bevan WPC, 2008, FOOT ANKLE INT, V29, P568, DOI 10.3113/FAI.2008.0568; Canadian Agency for Drugs and Technologies in Health, 2010, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD005486.PUB.2; Canavan RJ, 2008, DIABETES CARE, V31, P459, DOI 10.2337/dc07-1159; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; Coleman KL, 1999, J REHABIL RES DEV, V36, P8; de Souza LJ, 2008, J BONE JOINT SURG AM, V90A, P754, DOI 10.2106/JBJS.F.01523; Elisa B, 2008, INT J LOW EXTR WOUND, V7, P82, DOI [10.11-7/1834734608318138, DOI 10.1177/1534734608318138]; Frigg A, 2007, FOOT ANKLE INT, V28, P64, DOI 10.3113/FAI.2007.0012; GRIFFIN L, 2008, J ELECTROMYOGR  0425; Hagberg K, 2008, PROSTHET ORTHOT INT, V32, P29, DOI 10.1080/03093640701553922; Hannallah D, 2004, J BONE JOINT SURG AM, V86A, P80, DOI 10.2106/00004623-200401000-00013; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; Hopf HW, 2008, WOUND REPAIR REGEN, V16, P175, DOI 10.1111/j.1524-475X.2008.00358.x; Hopf HW, 2006, WOUND REPAIR REGEN, V14, P693, DOI 10.1111/j.1524-475X.2006.00177.x; Hurlbert RJ, 2008, CAN J NEUROL SCI, V35, P41, DOI 10.1017/S031716710000754X; Kaplan FS, 2007, ANN NY ACAD SCI, V1116, P113, DOI 10.1196/annals.1402.039; Kaplan FS, 2007, J BONE JOINT SURG AM, V89A, P347, DOI 10.2106/JBJS.F.00472; Klein MB, 2007, J BURN CARE RES, V28, P447, DOI 10.1097/BCR.0B013E318053D378; KWON BK, 2008, SPINE J         0307; LAI PP, 2008, CLIN BIOMECH BR 0326; Lindenhovius ALC, 2007, J SHOULDER ELB SURG, V16, P621, DOI 10.1016/j.jse.2007.01.005; Malmstedt J, 2008, DIABETES CARE, V31, P887, DOI 10.2337/dc07-2424; Mehrholz J, 2008, COCHRANE DB SYST REV, V2; MIKI R, 2008, 75 ANN M AM AC ORTH; Morochovic R, 2008, INT J NEUROSCI, V118, P555, DOI 10.1080/00207450601123456; Nishi H, 2007, SPINE, V32, pE741, DOI 10.1097/BRS.0b013e31815b654b; Nohda K, 2007, SPINE, V32, P1060, DOI 10.1097/01.brs.0000261560.53428.90; NOISEUX NO, 2008, ANN M ORTH REH ASS S; Potter BK, 2007, J BONE JOINT SURG AM, V89A, P476, DOI 10.2106/JBJS.F.00412; Rerkasem Kittipan, 2008, Int J Low Extrem Wounds, V7, P88, DOI 10.1177/1534734608317939; Riley PO, 2008, MED SCI SPORT EXER, V40, P1093, DOI 10.1249/MSS.0b013e3181677530; Robson MC, 2008, WOUND REPAIR REGEN, V16, P147, DOI 10.1111/j.1524-475X.2008.00355.x; Robson MC, 2006, WOUND REPAIR REGEN, V14, P649, DOI 10.1111/j.1524-475X.2006.00174.x; Senneville E, 2008, DIABETES CARE, V31, P637, DOI 10.2337/dc07-1744; Simonsen LL, 2007, INJURY, V38, P1146, DOI 10.1016/j.injury.2007.03.019; SINGHAL B, 2008, SPINAL CORD     0513; Stechmiller JK, 2008, WOUND REPAIR REGEN, V16, P151, DOI 10.1111/j.1524-475X.2008.00356.x; Steed DL, 2008, WOUND REPAIR REGEN, V16, P169, DOI 10.1111/j.1524-475X.2008.00357.x; Steed DL, 2006, WOUND REPAIR REGEN, V14, P680, DOI 10.1111/j.1524-475X.2006.00176.x; Stepien JM, 2007, ARCH PHYS MED REHAB, V88, P896, DOI 10.1016/j.apmr.2007.03.016; Stoquart G, 2008, NEUROPHYSIOL CLIN, V38, P105, DOI 10.1016/j.neucli.2008.02.002; Sturnieks DL, 2008, MED SCI SPORT EXER, V40, P991, DOI 10.1249/MSS.0b013e318167812a; Thackham JA, 2008, WOUND REPAIR REGEN, V16, P321, DOI 10.1111/j.1524-475X.2008.00372.x; Trautner C, 2007, DIABETES CARE, V30, P2633, DOI 10.2337/dc07-0876; Ubbink DT, 2008, BRIT J SURG, V95, P685, DOI 10.1002/bjs.6238; Vaccaro AR, 1997, SPINE, V22, P2609, DOI 10.1097/00007632-199711150-00006; Whitney J, 2006, WOUND REPAIR REGEN, V14, P663, DOI 10.1111/j.1524-475X.2006.00175.x	50	3	3	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0021-9355	1535-1386		J BONE JOINT SURG AM	J. Bone Joint Surg.-Am. Vol.	OCT	2008	90A	10					2301	2311		10.2106/JBJS.H.00943			11	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	357UV	WOS:000259873300029	18829929				2022-02-06	
J	Perez-Orribo, L; Perez-Lorensu, PJ; Roldan-Delgado, H; Garcia-Conde, M; Spreafico, M; Garcia-Marin, V				Perez-Orribo, L.; Perez-Lorensu, P. J.; Roldan-Delgado, H.; Garcia-Conde, M.; Spreafico, M.; Garcia-Marin, V.			Intraoperative neurophysiological monitoring of the spinal cord: Our experience	REVISTA DE NEUROLOGIA			Spanish	Article						electromyography; intraoperative neurophysiological monitoring; motor evoked potentials; somatosensory evoked potentials	MOTOR-EVOKED-POTENTIALS; SCOLIOSIS SURGERY; COST-EFFECTIVENESS; STIMULATION; MANAGEMENT; INJURY; TUMORS; BRAIN	Introduction. The main objective of intraoperative monitoring of the spinal cord is to detect any neurological damage that may occur (and which would otherwise go unnoticed) while it is still reversible. Aim. To retrospectively evaluate the effectiveness of neurophysiological monitoring in spine and spinal cord surgery since the time such procedures were first implemented within our centre. Patients and methods. The patients were divided into three groups, according to their pathologies. They were clinically, evaluated with the McCormick scale before surgery, on discharge from hospital and at six months after the operation. Neurophysiological monitoring was performed with motor evoked potentials, somatosensory potentials and screw stimulation, when appropriate. Results. The sample finally consisted of 49 subjects, with a mean age of 51 +/- 19.4 years. Distribution by groups was 53.1% spinal cord tumours, 22.4% traumatic injuries to the spinal cold and 24.5% bone/disc pathologies. During surgery potentials improved in 4.08% of patients, in 63.26% they remained intact, 20.41% were alerted by the neurophysiologist with intact potentials, 10.2% suffered a transitory decline and in one case there was permanent loss. All the patients who were submitted to a follow-up, (it six months displayed a clinical status that was the same or better than the one before their operation. Conclusions. Neurophysiological monitoring is a valuable tool that prevented, in 30.61% of our patients, damage that could otherwise have occurred. Front the clinical point of view, its high predictive value is also worth highlighting.	[Perez-Orribo, L.; Roldan-Delgado, H.; Garcia-Conde, M.; Spreafico, M.; Garcia-Marin, V.] Hosp Univ Canarias, Serv Neurocirugia, E-38320 Tenerife, Spain; [Perez-Lorensu, P. J.] Hosp Univ Canarias, Serv Neurofisiol, E-38320 Tenerife, Spain		Perez-Orribo, L (corresponding author), Hosp Univ Canarias, Serv Neurocirugia, Ofra S-N, E-38320 Tenerife, Spain.	luisporribo@hotmail.com					Avellanal-Salas S, 2004, REV NEUROLOGIA, V38, P879, DOI 10.33588/rn.3809.2003515; BURKE D, 1992, ELECTROEN CLIN NEURO, V85, P388, DOI 10.1016/0168-5597(92)90052-D; BURKE D, 1999, RECOMMENDATIONS PRAC, P133; Cortes V, 2004, REV NEUROLOGIA, V38, P75, DOI 10.33588/rn.3801.2003518; Costa P, 2007, SPINAL CORD, V45, P86, DOI 10.1038/sj.sc.3101934; de Blas-Beorlegui G, 2004, REV NEUROLOGIA, V38, P68, DOI 10.33588/rn.3801.2003516; de Haan P, 2001, Anesthesiol Clin North Am, V19, P923; Delank KS, 2005, ARCH ORTHOP TRAUM SU, V125, P33, DOI 10.1007/s00402-004-0763-5; Deletis V, 2005, ACTA NEUROCHIR, V147, P1015, DOI 10.1007/s00701-005-0573-8; DELETIS V, 1997, NEUROSURGERY, V24, P1352; Devlin Vincent J, 2006, Spine J, V6, p212S, DOI 10.1016/j.spinee.2006.04.022; Franco-Carcedo C, 1999, REV NEUROLOGIA, V28, P583, DOI 10.33588/rn.2806.98484; Gunnarsson T, 2004, SPINE, V29, P677, DOI 10.1097/01.BRS.0000115144.30607.E9; Haghighi Siavash S, 2004, J Clin Monit Comput, V18, P1; Herdmann J, 1996, SPINE, V21, P879, DOI 10.1097/00007632-199604010-00023; Holland NR, 1998, SPINE, V23, P1915, DOI 10.1097/00007632-199809010-00023; Holland NR, 1997, SPINE, V22, P2547, DOI 10.1097/00007632-199711010-00016; Isley MR, 2007, J SPINAL DISORD TECH, V20, P104, DOI 10.1097/01.bsd.0000211280.60777.bd; Jameson Leslie C, 2006, Anesthesiol Clin, V24, P777, DOI 10.1016/j.atc.2006.08.002; Kelleher MO, 2008, J NEUROSURG-SPINE, V8, P215, DOI 10.3171/SPI/2008/8/3/215; Kombos T, 2002, ZBL NEUROCHIR, V63, P141, DOI 10.1055/s-2002-36434; Kothbauer KF, 2007, PEDIATR NEUROSURG, V43, P222, DOI 10.1159/000098835; Kothbauer KF, 1998, NEUROSURG FOCUS, V4, P1; Krassioukov AV, 2004, J NEUROSURG-SPINE, V1, P243, DOI 10.3171/spi.2004.1.3.0243; Lang EW, 1996, ANESTH ANALG, V83, P1337, DOI 10.1097/00000539-199612000-00038; Langeloo DD, 2003, SPINE, V28, P1043, DOI 10.1097/00007632-200305150-00017; Legatt Alan D, 2004, Am J Electroneurodiagnostic Technol, V44, P223; Leppanen Ronald E, 2006, J Clin Monit Comput, V20, P267, DOI 10.1007/s10877-006-9036-x; MCCORMICK PC, 1990, J NEUROSURG, V72, P523, DOI 10.3171/jns.1990.72.4.0523; Nagle KJ, 1996, NEUROLOGY, V47, P999, DOI 10.1212/WNL.47.4.999; Ofiram E, 2006, SPINE, V31, pE464, DOI 10.1097/01.brs.0000222122.37415.4d; Padberg AM, 2006, NEUROSURG CLIN N AM, V17, P205, DOI 10.1016/j.nec.2006.05.008; Pascual-Leone A, 2008, Rev Neurol, V46 Suppl 1, pS3; Pelosi L, 2002, CLIN NEUROPHYSIOL, V113, P1082, DOI 10.1016/S1388-2457(02)00027-5; Quinones-Hinojosa A, 2004, NEUROSURG CLIN N AM, V15, P537, DOI 10.1016/j.nec.2004.04.019; Sala F, 2004, ADV TECH STAND NEUR, V29, P133; Sala F, 2002, CHILD NERV SYST, V18, P264, DOI 10.1007/s00381-002-0582-3; Sala F, 2007, EUR SPINE J, V16, pS229; Schwartz DM, 2007, J BONE JOINT SURG AM, V89A, P2440, DOI 10.2106/Jl3JS.F01476; Smith PN, 2007, SPINE J, V7, P83, DOI 10.1016/j.spinee.2006.04.008; Terao Y, 2002, J CLIN NEUROPHYSIOL, V19, P322, DOI 10.1097/00004691-200208000-00006; Valverde Junguito J L, 2007, Rev Esp Anestesiol Reanim, V54, P231; Watanabe K, 2004, J NEUROSURG, V100, P155, DOI 10.3171/jns.2004.100.1.0155; Wiedemayer H, 2002, J NEUROSURG, V96, P255, DOI 10.3171/jns.2002.96.2.0255; Wilson L, 2003, LARYNGOSCOPE, V113, P1736, DOI 10.1097/00005537-200310000-00015	45	3	3	0	1	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	SEP 1	2008	47	5					236	241		10.33588/rn.4705.2008262			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	350AK	WOS:000259324600003	18780268				2022-02-06	
J	Melo, JRT; Reis, RC; Lemos, LP; Azevedo-Neto, A; Oliveira, DWS; Garcia, FRFC; Ribeiro, JO; Santos-Neto, MD; Oliveira-Filho, J				Tude Melo, Jose Roberto; Reis, Rodolfo Casimiro; Lemos-Junior, Laudenor Pereira; Azevedo-Neto, Assuero; Santos Oliveira, Dalton Willy; Cruz Garcia, Felipe Rene F.; Ribeiro, Joelson Oliveira; Santos-Neto, Muryllo de Brito; Oliveira-Filho, Jamary			SKULL RADIOGRAPHS AND COMPUTED TOMOGRAPHY SCANS IN CHILDREN AND ADOLESCENTS WITH MILD HEAD TRAUMA	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						tomography; radiography; traumatic injury brain; child; adolescent	INJURY; MANAGEMENT; RULE	Objective: To identify which pediatric patients with mild head trauma are candidates for skull radiographs or cranial computed tomography (CCT) scans. Method: Patients with mild head trauma aged from 0 to 19 years presenting to the Emergency Department of a trauma centre from Salvador City, Brazil, between May 2007 and May 2008. Results: A total of 1888 mild head trauma patients were admitted; mean age was 7.4 (+/- 5.5) years. A total of 1956 skull radiographs and 734 CCT scans were performed. About 44.4% patients with Glasgow coma score (GCS) 13 and 55.4% with GCS 14 had abnormal CCT scans. In patients with multiple traumas, 16% had abnormal findings on CCT scans. Conclusion: We strongly recommend routine CCT studies to patients with GCS of 13 and 14 or to multiple trauma victims, independently of score. Routine screening skull radiographs were not useful in the evaluation of mild head trauma patients in this study.	[Tude Melo, Jose Roberto] Univ Fed Bahia, Postgrad Program Med & Hlth, Salvador, BA, Brazil; [Reis, Rodolfo Casimiro; Lemos-Junior, Laudenor Pereira; Azevedo-Neto, Assuero; Santos Oliveira, Dalton Willy; Cruz Garcia, Felipe Rene F.; Ribeiro, Joelson Oliveira; Santos-Neto, Muryllo de Brito] Univ Fed Bahia, Head Trauma Res Grp, Salvador, BA, Brazil; [Oliveira-Filho, Jamary] Univ Sao Paulo, Sao Paulo, Brazil		Melo, JRT (corresponding author), Hosp Sao Rafael 2152, BR-41253900 Salvador, BA, Brazil.	robertotude@gmail.com	Oliveira-Filho, Jamary/B-6441-2016; Solebo, Colette N/B-6615-2008	Oliveira-Filho, Jamary/0000-0003-1915-0423; Solebo, Colette N/0000-0001-9764-2541			Aitken ME, 1998, ARCH PEDIAT ADOL MED, V152, P1176; *AM AC PED, MIN HEAD INJ CHILDR; American College of Surgeons Committee on Trauma, 1994, ADV TRAUM LIF SUPP R, P17; Bergman DA, 1999, PEDIATRICS, V104, P1407; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; *BRAZ SOC NEUR, 2001, DIAGN MAN PAT MILD H; *BRAZ SOC NEUR, 2001, DIAGN MAN PANT MOD H; Glauser J, 2004, CLEV CLIN J MED, V71, P353, DOI 10.3949/ccjm.71.4.353; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hofman PAM, 2000, J NEUROL NEUROSUR PS, V68, P416, DOI 10.1136/jnnp.68.4.416; Homer CJ, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e78; Lee Bruce, 2005, NeuroRx, V2, P372; LEONIDAS JC, 1982, PEDIATRICS, V69, P139; Lloyd DA, 1997, LANCET, V349, P821, DOI 10.1016/S0140-6736(96)09356-7; MACEDO K, 2006, THESIS FEDERAL U MIN; Melo JRT, 2006, ARQ NEURO-PSIQUIAT, V64, P994, DOI 10.1590/S0004-282X2006000600020; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TEASDALE G, 1974, LANCET, V2, P81; Hernandez AV, 2005, REV MEX NEUROCIENC, V6, P120	21	3	3	0	0	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	SEP	2008	66	3B					708	710		10.1590/S0004-282X2008000500019			3	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	365DV	WOS:000260387000019	18949267	gold, Green Published, Green Submitted			2022-02-06	
J	Nguyen, J; Kaplan, AM				Nguyen, Jimmy; Kaplan, Allen M.			Golf ball-related head injuries in children	PEDIATRIC NEUROLOGY			English	Article								Golf has become one of the most popular sports in the world. Golf-related head injuries are well-documented and include golf club, golf cart, and more recently golf ball trauma. We report on 2 cases of golf ball-associated traumatic brain injuries. The unique biomechanics of golf ball head trauma are reviewed. Initially golf injuries may cause minor clinical signs, with absence of skull fractures. However, the association of significant underlying intracranial hemorrhage should prompt a thorough neurologic evaluation. (C) 2008 by Elsevier Inc. All rights reserved.	[Nguyen, Jimmy] Phoenix Childrens Hosp, Div Child Neurol, Phoenix, AZ 85016 USA; [Kaplan, Allen M.] Univ Arizona, Hlth Sci Ctr, Div Neurol, Tucson, AZ USA		Kaplan, AM (corresponding author), Phoenix Childrens Hosp, Div Child Neurol, 1919 E Thomas Rd, Phoenix, AZ 85016 USA.	akaplan@phoenixchildrens.com					Burnstine MA, 1996, AM J OPHTHALMOL, V121, P437, DOI 10.1016/S0002-9394(14)70441-6; Chadwick D, 2000, J NEUROL NEUROSUR PS, V68, P251, DOI 10.1136/jnnp.68.2.251; Fountas KN, 2006, CHILD NERV SYST, V22, P1282, DOI 10.1007/s00381-006-0077-8; Fradkin Andrea J, 2005, Int J Inj Contr Saf Promot, V12, P201, DOI 10.1080/17457300500088972; Fradkin Andrea J, 2006, Int J Inj Contr Saf Promot, V13, P46, DOI 10.1080/17457300500167693; Gurdjian E S, 1972, Clin Neurosurg, V19, P43; Macgregor DM, 2002, EMERG MED J, V19, P576, DOI 10.1136/emj.19.6.576; McGuffie AC, 1998, SCOT MED J, V43, P139, DOI 10.1177/003693309804300504; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Passaro K T, 1996, Inj Prev, V2, P124, DOI 10.1136/ip.2.2.124; Rahimi SY, 2005, J NEUROSURG, V102, P163, DOI 10.3171/jns.2005.102.2.0163; Ridenour MV, 1998, PERCEPT MOTOR SKILL, V86, P747, DOI 10.2466/pms.1998.86.3.747; SCHULENBURG CAR, 1976, PRACTITIONER, V217, P625; SMITH RA, 1991, BRIT MED J, V302, P1505, DOI 10.1136/bmj.302.6791.1505; Wilks J, 1996, Aust J Sci Med Sport, V28, P43; YOUL BD, 1988, MED J AUSTRALIA, V148, P412, DOI 10.5694/j.1326-5377.1988.tb115972.x	16	3	3	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0887-8994			PEDIATR NEUROL	Pediatr. Neurol.	AUG	2008	39	2					126	128		10.1016/j.pediatrneurol.2008.05.007			3	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	336LO	WOS:000258365500012	18639759				2022-02-06	
J	de Pablo-Fernandez, E; Dominguez-Gonzalez, C; Correas-Callero, E; Sierra-Hidalgo, F; Hernandez-Gallego, J				de Pablo-Fernandez, E.; Dominguez-Gonzalez, C.; Correas-Callero, E.; Sierra-Hidalgo, F.; Hernandez-Gallego, J.			Reversal of vision metamorphopsia as a manifestation of cerebellar infarct	REVISTA DE NEUROLOGIA			Spanish	Article						cerebellum; inverted perception; reversal of vision metamorphopsia; tilt illusion; vertebrobasilar stroke; visual reversal	ROOM TILT ILLUSION; VERTEBRAL ARTERY; INVERTED VISION; UPSIDE; DISSECTION; PERCEPTION	Introduction. Reversal of vision metamorphopsia is a disorder affecting the visuospatial perception of objects, without any changes in their shape, size or colour. It generally involves a full 180 degrees rotation of the visual field in the coronal plane. Its chief causation is vertebrobasilar ischaemia, although the phenomenon has also been linked to many other conditions, such as multiple sclerosis, epilepsy, migraine or traumatic head and neck injuries. Some notable features of reversal of vision metamorphopsia are the wide topographic variety of the lesions responsible for the condition, the transient nature of the symptom and its improvement or resolution in the presence of certain stimuli. Case report. A 35-year-old male with a sudden episode of instability that prevented him from walking, together with vomiting and reversal of vision metamorphopsia that lasted for an hour. A magnetic resonance scan enabled us to identify an acute ischaemic cerebellar lension as the cause of the condition. Conclusions. The variety of locations of the lesions that give rise to reversal of vision metamorphopsia would be mainly due to the multisensory nature of the neurons in the posterior parietal cortex, the area of the brain where the visuospatial integration of images is performed. These neurons receive visual, proprioceptive and vestibular differences, which means that any lesions that occur in these three systems or in the central integrator itself could cause the phenomenon of reversal of vision metamorphopsia.	[de Pablo-Fernandez, E.; Dominguez-Gonzalez, C.; Correas-Callero, E.; Sierra-Hidalgo, F.; Hernandez-Gallego, J.] Hosp Univ 12 Octubre, Serv Neurol, E-28041 Madrid, Spain		de Pablo-Fernandez, E (corresponding author), Hosp Univ 12 Octubre, Serv Neurol, Ctra Andalucia,Km 5-400, E-28041 Madrid, Spain.	edudepablo@hotmail.com		HERNANDEZ-GALLEGO, JESUS/0000-0002-9410-1720; Sierra-Hidalgo, Fernando/0000-0003-4044-8304			Aldridge AJ, 2003, J NEURO-OPHTHALMOL, V23, P145, DOI 10.1097/00041327-200306000-00008; Arias M, 2001, NEUROLOGIA, V16, P149; Arjona A, 2002, NEUROLOGIA, V17, P338; CHARLES N, 1992, J NEUROL NEUROSUR PS, V55, P188, DOI 10.1136/jnnp.55.3.188; COHEN L, 1991, REV NEUROL, V147, P389; Dominguez JML, 2007, NEUROLOGIA, V22, P58; Franco E, 2000, Neurologia, V15, P418; Gonzalo-Fonrodona I, 2007, REV NEUROLOGIA, V44, P157, DOI 10.33588/rn.4403.2006526; Hernandez AH, 2006, J NEUROL, V253, P953, DOI 10.1007/s00415-006-0124-0; HICKS PA, 1994, OPHTHALMOLOGY, V101, P1786; Malis DD, 2003, ANN OTO RHINOL LARYN, V112, P600, DOI 10.1177/000348940311200705; Okuyucu EE, 2008, MULT SCLER, V14, P266, DOI 10.1177/1352458507082045; PAMIR MN, 1990, J CLIN NEURO-OPHTHAL, V10, P271; River Y, 1998, ARCH NEUROL-CHICAGO, V55, P1362, DOI 10.1001/archneur.55.10.1362; SOLMS M, 1988, CORTEX, V24, P499, DOI 10.1016/S0010-9452(88)80044-3; Tiliket C, 1996, ARCH NEUROL-CHICAGO, V53, P1259, DOI 10.1001/archneur.1996.00550120071018; Tilikete C, 2001, REV NEUROL-FRANCE, V157, P198; Unal A, 2006, EPILEPSY BEHAV, V8, P308, DOI 10.1016/j.yebeh.2005.08.012; Zeidman LA, 2004, NEUROLOGY, V63, P591, DOI 10.1212/01.WNL.0000133407.47811.B2	19	3	3	0	2	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	JUN 16	2008	46	12					724	726		10.33588/rn.4612.2008121			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	354IZ	WOS:000259634200005	18543198				2022-02-06	
J	Jobke, S; Kasten, E; Sabel, BA				Jobke, S.; Kasten, E.; Sabel, B. A.			Do patients undergo changes of their personality due to visual field defects? An investigation with FPI-R and NEI-VQ	KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE			German	Article						visual field defect; FPI-R; NEI-VFQ; personality traits	TRAUMATIC BRAIN-INJURY; DISORDER	Background: Visual restrictions can lead to anxiety and possibly to social retirement. Therefore it makes sense to assess the patients' degree of handicap. The goal of the present study was to investigate if patients show changes in their personality or a reduced quality of life as a result of their visual field defect. Methods: 15 patients with visual field defects were asked to fill out the revised version of the Freiburger Personlichkeitsinventar (FPI-R) and the National Eye Institute Visual Function Questionnaire (NEI-VFQ). The FPI-R encompasses the standardised recording of many personality traits whereas the NEI-VFQ addresses the visual quality of life. Results: In the total sample all FPI-R scales were appropriate for the study in the inconspicuous standard range. Slight shifts resulted toward increased willingness to make contacts (scale 4, ST 4.2), reduced physical strain (scale 7, ST4.3) and lower physical discomfort (scale 8, ST3.7). The size of the visual field defect does not correlate with the satisfaction with life, with the physical discomfort and with the state of health but with the dependency on others (p = 0.047) and with the exertion of their social roles (p=0.043). The scale "satisfaction with life" of the FPI-R correlated with the scale "psychic condition" of the NEI-VFQ(p = 0.028) and the physical discomfort showed a significant correlation with the scale "eye strain" (p=0.006) in the NEI-VFQ. Discussion: Contrary to our presumptions, patients with visual field defects did not show any changes in their personality. It is supposed that they have learned to compensate for their reduced visual functions.	[Kasten, E.] Univ Klinikum Schleswig Holstein, Inst Med Psychol, D-23538 Lubeck, Germany; [Jobke, S.; Sabel, B. A.] Otto Von Guericke Univ, Inst Med, Magdeburg, Germany		Kasten, E (corresponding author), Univ Klinikum Schleswig Holstein, Inst Med Psychol, Ratzeburger Allee 160, D-23538 Lubeck, Germany.	EriKasten@aol.com	Sabel, Bernhard A./E-6579-2013	Sabel, Bernhard/0000-0002-4472-5543			APPLE LE, 1976, B PROSTHETIC RES, V3, P102; BALLINGER BR, 1987, BRIT J PSYCHIAT, V150, P108, DOI 10.1192/bjp.150.1.108; Golden Z, 2003, INT J NEUROSCI, V113, P733, DOI 10.1080/00207450390200044; Handel SF, 2007, PSYCHOSOMATICS, V48, P67, DOI 10.1176/appi.psy.48.1.67; Huang ES, 2007, DIABETES CARE, V30, P2478, DOI 10.2337/dc07-0499; Jampel HD, 2007, AM J OPHTHALMOL, V144, P238, DOI 10.1016/j.ajo.2007.04.048; Janz NK, 2007, OPHTHALMOLOGY, V114, P2213, DOI 10.1016/j.ophtha.2007.02.014; KASTEN E, 1995, RESTOR NEUROL NEUROS, V8, P113, DOI 10.3233/RNN-1995-8302; KASTEN E, 1995, PRAXIS ERGOTHERAPIE, V8, P267; KASTEN E, 1997, Z VERKEHRSSICHERHEIT, V3, P116; KASTEN E, 2007, EINFUHRUNG NEUROPSYC; KASTEN E, 2008, S DT GES VE IN PRESS; KASTEN E, 2003, PSYCHOMED, V15, P214; LEE BS, 2008, OPHTHALMOLO IN PRESS; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P1496, DOI 10.1001/archopht.116.11.1496; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Obonsawin MC, 2007, J NEUROL NEUROSUR PS, V78, P1416, DOI 10.1136/jnnp.2004.052654corr1; ROSNER DE, 2005, THESIS UNIVERSITATSK; Schulte T, 1999, AM J PHYS MED REHAB, V78, P136, DOI 10.1097/00002060-199903000-00010; SCHULTE T, 1996, FORTSCHRITTE VERKEHR, P89; SCHULTE T, 1997, VERKEHRSPSYCHOLOGEN, P26; Selg H, 1994, FREIBURGER PERSONLIC; SOUBRANE G, 2007, ARCH OPHTHALMOL-CHIC, V125, P1266; ZIHL J, 1986, CEREBRALE SEHSTORUNG	24	3	3	0	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0023-2165			KLIN MONATSBL AUGENH	Klinische Monatsblat. Augenheilkunde	JUN	2008	225	6					570	+		10.1055/s-2008-1027417			7	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	318EU	WOS:000257075200009	18516778				2022-02-06	
J	Maegele, M; Lefering, R; Fach, H; Engel, D; Raum, M; Buchheister, B; Hoffgen, A; Doll, H; Klug, N; Weber, F; Neugebauer, E; Bouillon, B				Maegele, M.; Lefering, R.; Fach, H.; Engel, D.; Raum, M.; Buchheister, B.; Hoeffgen, A.; Doll, H.; Klug, N.; Weber, F.; Neugebauer, E.; Bouillon, B.			The incidence and outcome after relevant traumatic brain injury	NOTFALL & RETTUNGSMEDIZIN			German	Article						traumatic brain injury; incidence; outcome; urban center; cologne	SEVERE HEAD-INJURY; PRACTICAL SCALE; RISK-FACTORS; EPIDEMIOLOGY; MORTALITY; SCORE; COMA; ADMISSION; COMMUNITY; DEATHS	Background. Valid epidemiological data on the incidence and outcome of traumatic brain injury (TBI) show great variability. A 10-year study on the incidence, severity and outcome of relevant TBI was conducted in an urban area of one million inhabitants in western Germany, the city of Cologne. Patients and methods. A total of 130,000 prehospital emergencies carried out at the city of Cologne emergency medical service between 1st January 1990 and 31st December, 1999 were screened for TBI. Inclusion criteria were a GCS (Glasgow Coma Scale)<= 8 and/or AIS(head) (Abbreviated injury scale for the head)>= 2 with confirmed TBI via appropriate diagnostic procedures. Results. The annual incidence of relevant TBI was 7.3/100,000. The overall mortality rate was 45.8%, pre-hospital deaths totaled 182 (28%), 116 patients (17.8%) died in hospital. Of the surviving patients 214 out of 352 (60.8%) were sufficiently rehabilitated at discharge (GOS=1), but 138 patients (39.2%) survived with persisting deficits. GOS was correlated to initial GCS and AIS(head) values. Conclusions. The incidence of TBI was lower compared to the figures in the literature but the overall mortality was high, especially in the pre- and early in-hospital periods.	[Maegele, M.; Engel, D.; Raum, M.; Bouillon, B.] Univ Witten Herdecke gGmbH, Klin Unfallchirurg & Orthopadie, Klinikum Koln Merheim, Kliniken Stadt Koln, D-51109 Cologne, Germany; [Maegele, M.; Lefering, R.; Fach, H.; Hoeffgen, A.; Doll, H.; Neugebauer, E.] Univ Witten Herdecke gGmbH, Inst Forschung Operativen Med, D-51109 Cologne, Germany; [Engel, D.] Erasmus Sch Ctr, Dept Neurosurg, Rotterdam, Netherlands; [Buchheister, B.] Univ Cologne, Inst Med Stat Informat & Epidemiol, D-5000 Cologne 41, Germany; [Klug, N.] Univ Cologne, Neurochirurg Klin, D-5000 Cologne 41, Germany; [Weber, F.] Kliniken Stadt Koln, Klinikum Koln Merheim, Neurochirurg Klin, Cologne, Germany		Maegele, M (corresponding author), Univ Witten Herdecke gGmbH, Klin Unfallchirurg & Orthopadie, Klinikum Koln Merheim, Kliniken Stadt Koln, Ostmerheimerstr 200, D-51109 Cologne, Germany.	Marc.Maegele@t-online.de					BOUILLON B, 1990, THEOR SURG, V5, P36; Bouillon B, 1997, J TRAUMA, V42, P652, DOI 10.1097/00005373-199704000-00012; Bouillon B, 1999, RESTOR NEUROL NEUROS, V14, P85; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; *BTF, 2000, J NEUROTRAUM, V17, P457; Bundesarztekammer, IND NOT; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Chen JCT, 2000, NEUROSURG CLIN N AM, V11, P399, DOI 10.1016/S1042-3680(18)30101-3; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; DEMETRIADES D, 1964, J AM COLL SURGEONS, V199, P216; *DGNC, 2007, 008001 DGNC AWMF LEI; Farin A, 2003, J NEUROSURG, V98, P32, DOI 10.3171/jns.2003.98.1.0032; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; HARTWIG E, 1993, UNFALLCHIRURG, V96, P564; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; JENNETT B, 1975, LANCET, V1, P480; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; KRAUS JF, 1992, HEAD INJURY, P25; Lehr D, 1997, J TRAUMA, V42, pS71, DOI 10.1097/00005373-199705001-00015; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; Meixensberger J, 1998, LANGENBECK ARCH SURG, V383, P214, DOI 10.1007/s004230050121; MOECKE H, 1994, ANASTH INTENSIVMED, V31, P96; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Sambasivan M, 1997, SURG NEUROL, V47, P379, DOI 10.1016/S0090-3019(97)80728-8; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; *STADT KOLN AMT, 2006, ZAHL STAT VERK; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; TEASDALE G, 1974, LANCET, V2, P81; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170; Watts Dorraine D, 2004, Prehosp Emerg Care, V8, P254	38	3	3	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1434-6222	1436-0578		NOTFALL RETTUNGSMED	Notfall Rettungsmed.	JUN	2008	11	4					266	272		10.1007/s10049-008-1060-6			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	307OO	WOS:000256328400009					2022-02-06	
J	Petersen, C; Scherwath, A; Fink, J; Koch, U				Petersen, C.; Scherwath, A.; Fink, J.; Koch, U.			Health care needs of children and adolescents with a traumatic brain injury	BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ			German	Article						traumatic brain injury; children; adolescents; health care; utilisation	MILD HEAD-INJURY; QUALITY-OF-LIFE; INTERVENTION; EPIDEMIOLOGY	Traumatic brain injury is a leading cause of acquired disability in childhood. Within a project to improve out-patient rehabilitation and aftercare advice, centres for families affected by traumatic brain injuries were implemented in four German cities. the results of two sub-studies are described which aimed on the one hand at a process analysis of the network operation and on the other hand at a prospective analysis of the network interaction. The process analysis was based on a database which was developed for this study. Within a prospective longitudinal study, 103 families could be included. At four project sites, families were questioned with an interview and questionnaire at three different time points. Health-related quality of life, utilisation and health care satisfaction were assessed. In addition, a neuropsychological assessment was conducted with a portion of the sample. Overall, quality of life of the children and adolescents can be described as good. Health care services were scarcely utilised. A child-centred health care was predictive for the health care satisfaction of the parents. The short assessment proved to be a feasible method for identifying children and adolescents with special health care need.	[Petersen, C.] Univ Klinikum Hamburg Eppendorf, Inst & Poliklin Med Psychol, D-20246 Hamburg, Germany		Petersen, C (corresponding author), Univ Klinikum Hamburg Eppendorf, Inst & Poliklin Med Psychol, Martinistr 52-S 35, D-20246 Hamburg, Germany.	copeters@uke.uni-hamburg.de	Koch, Uwe/A-5825-2009; Scherwath, Angela/Q-4197-2016	Scherwath, Angela/0000-0002-7338-5218			Adams J, 2001, J PEDIATR SURG, V36, P119, DOI 10.1053/jpsu.2001.20026; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Astrand R, 2006, ACTA NEUROL SCAND, V113, P262, DOI 10.1111/j.1600-0404.2005.00573.x; BEERS SR, 1992, NEUROPSYCHOL REV, V3, P281, DOI 10.1007/BF01108414; Bock W, 2006, SCHADEL HIRN VERLETZ; BOLL TJ, 1983, PSYCHIAT DEV, V1, P263; Gillett J, 2004, NEUROREHABILITATION, V19, P207; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Helmstaedter C., 2001, VLMT VERBALER LERN M; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ravens-Sieberer U, 2007, BUNDESGESUNDHEITSBLA, V50, P810, DOI 10.1007/s00103-007-0244-4; Ravens-Sieberer U, 1998, QUAL LIFE RES, V7, P399, DOI 10.1023/A:1008853819715; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; Roddy SP, 1998, PEDIATRICS, V101, P575, DOI 10.1542/peds.101.4.575; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Schmidt S, 2007, AMBUL PEDIATR, V7, P374, DOI 10.1016/j.ambp.2007.04.007; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEWES U, 2001, HDB TESTANWEISUNG; TEWES U, 2001, DRITTE AUFLAGE MANUA; Thompson Matthew D, 2003, Semin Pediatr Neurol, V10, P130, DOI 10.1016/S1071-9091(03)00021-4; TULLOUS M, 1992, PEDIAT CRITICAL CARE; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; WEGMAN ME, 1982, PEDIATRICS, V70, P835	29	3	3	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-9990	1437-1588		BUNDESGESUNDHEITSBLA	Bundesgesundheitsblatt-Gesund.	JUN	2008	51	6					629	636		10.1007/s00103-008-0536-3			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	316WO	WOS:000256980600007	18458851				2022-02-06	
J	Ruff, RM; Jamora, CW				Ruff, Ronald M.; Jamora, Christina Weyer			Forensic Neuropsychology and Mild Traumatic Brain Injury	PSYCHOLOGICAL INJURY & LAW			English	Article						Traumatic Brain Injury; Neuropsychology; Forensics	GLASGOW COMA SCALE; COGNIFORM CONDITION; PROPOSED DIAGNOSES; HEAD-INJURY; CLINICAL NEUROPSYCHOLOGISTS; UNITED-STATES; CONCUSSION; SYMPTOMS; DISORDER; ISSUES	Over the last 20 years, the Courts and the legal community have increasingly relied on neuropsychologists to provide opinions, guidance, and expertise in the area of brain-behavior relationships. The purpose of this article is to review issues neuropsychologists commonly face when asked to evaluate cases with suspected mild traumatic brain injuries (TBI) in the civil or criminal legal context. In particular, we will discuss: (a) the neuropsychologist's role in TBI forensic cases, (b) the attorney's role in forensic TBI cases, (c) a neuropsychological framework to approach forensic mild TBI cases, (d) establishing working relationships with attorneys, (e) the Daubert and Frye standards, (f) symptom validity, (g) ethical issues, and (h) recommendations to improve the ecological validity of our tests and encourage test developers to provide alternate forms of tests.	[Ruff, Ronald M.] Univ Calif San Francisco, San Francisco Clin Neurosci, 909 Hyde St,Suite 620, San Francisco, CA 94109 USA; [Jamora, Christina Weyer] Univ Calif San Francisco, San Francisco Gen Hosp, San Francisco Clin Neurosci, San Francisco, CA 94109 USA		Ruff, RM (corresponding author), Univ Calif San Francisco, San Francisco Clin Neurosci, 909 Hyde St,Suite 620, San Francisco, CA 94109 USA.	ronruff@mindspring.com					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychological Association, 2017, ETH PRINC PSYCH COD; Axelrod B, 2000, ARCH CLIN NEUROPSYCH, V15, P383, DOI 10.1093/arclin/15.5.383; Baron R. S., 1986, ADV EXP SOC PSYCHOL, P1, DOI [DOI 10.1016/S0065-2601(08)60211-7, 10.1016/S0065-2601(08)60211-7]; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bigler ED, 2007, ARCH CLIN NEUROPSYCH, V22, P45, DOI 10.1016/j.acn.2006.06.019; Binder LM, 2007, ARCH CLIN NEUROPSYCH, V22, P681, DOI 10.1016/j.acn.2007.07.006; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P675, DOI 10.1016/j.acn.2007.07.005; Bos G. Vanden, 2007, APA DICT PSYCHOL; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Butcher J. N., 2001, MMPI 2 MINNESOTA MU; Canning N, 2005, HANDBOOK OF COMPLEX OCCUPATIONAL DISABILITY CLAIMS: EARLY RISK IDENTIFICATIONS, INTERVENTION, AND PREVENTION, P273, DOI 10.1007/0-387-28919-4_15; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Centers for Disease Control and Prevention, 2006, TRAUMATIC BRAIN INJU; Constantinou M., 2004, THESIS; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Dikmen S, 1992, Brain Inj, V6, P477, DOI 10.3109/02699059209008143; Evered L, 2003, ASSESSMENT, V10, P420, DOI 10.1177/1073191103259539; Faigman DL, 2005, ANNU REV PSYCHOL, V56, P631, DOI 10.1146/annurev.psych.56.091103.070316; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; GEEN RG, 1973, J EXP PSYCHOL, V100, P395, DOI 10.1037/h0035494; GREIFFENSTEIN MF, 2005, FORENSIC NEUROPSYCHO, P29; Grote C., 2005, ETHICAL PRACTICE FOR, P92; Heaton R. K., 2004, REVISED COMPREHENSIV; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Heyer EJ, 2000, J CLIN EXP NEUROPSYC, V22, P633; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Hom J, 2003, ARCH CLIN NEUROPSYCH, V18, P827, DOI 10.1016/S0887-6177(03)00076-3; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Iverson GL, 2006, APPL NEUROPSYCHOL, V13, P77, DOI 10.1207/s15324826an1302_3; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Kreutzer JS, 1990, NEUROPSYCHOLOGY, V4, P249, DOI 10.1037/0894-4105.4.4.249; Larrabee, 2005, FORENSIC NEUROPSYCHO, P209; Larrabee, 2007, ASSESSMENT MALINGERE, P334; Lees-Haley PR, 1999, STUD NEUROPSYCHOL DE, P443; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MALINA AC, 2005, J FORENS NEUROPSYCHO, V4, P21, DOI DOI 10.1300/J151V04N03_; Manly J., 2003, CLIN INTERPRETATION, P181, DOI DOI 10.1016/B978-012703570-3/50010-9; Marshall LF, 1989, MILD HEAD INJURY, P276; Martelli MF, 1999, J HEAD TRAUMA REHAB, V14, P49, DOI 10.1097/00001199-199902000-00007; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McCaffrey R. J., 2005, J FORENSIC NEUROPSYC, V4, P1, DOI [10.1300/J151v04n02_01, DOI 10.1300/J151V04N02_01, 10.1300/j151v04n02_01]; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M., 2008, MILD TRAUMATIC BRAIN; McLearen A., 2004, EVALUATION PSYCHOL D, P267; MILLER L, 1992, INT J LAW PSYCHIAT, V15, P303, DOI 10.1016/0160-2527(92)90005-L; Millon T., 1994, MILLON CLIN INVENTOR; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Morgan J. E., 2005, J FORENSIC NEUROPSYC, V4, P11, DOI DOI 10.1300/J151V04N03_02; National Academy of Neuropsychology, 2003, TEST SEC UPD; National Academy of Neuropsychology, 1999, 6 PART OBS; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; Parry John W, 2004, Ment Phys Disabil Law Rep, V28, P136; PROKOP CK, 1986, J CONSULT CLIN PSYCH, V54, P558, DOI 10.1037/0022-006X.54.4.558; Putnam S., 1989, CLIN NEUROPSYCHOL, V3, P97; PUTZ VR, 1975, BRIT J PSYCHOL, V66, P157, DOI 10.1111/j.2044-8295.1975.tb01449.x; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Reed J., 1999, J FORENSIC NEUROPSYC, V1, P49; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff R. M., 1999, MILD HEAD INJURY CAU, P99; Ruff RM, 1999, STUD NEUROPSYCHOL DE, P315; Ruff RM, 1999, BRAIN INJURY, V13, P943; Ruff RM, 1996, NEUROREHABILITATION, V7, P39, DOI 10.3233/NRE-1996-7105; RUFF RM, 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199309000-00008; Russell EW, 2005, ARCH CLIN NEUROPSYCH, V20, P785, DOI 10.1016/j.acn.2005.05.001; SANDOVAL J, 1998, TEST INTERPRETATION; Sbordone RJ, 2001, NEUROREHABILITATION, V16, P199; Seretny M L, 1986, Arch Clin Neuropsychol, V1, P5, DOI 10.1016/0887-6177(86)90021-1; SETA CE, 1988, PERS SOC PSYCHOL B, V14, P604, DOI 10.1177/0146167288143020; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Sosnoff JJ, 2007, NEUROPSYCHOLOGY, V21, P796, DOI 10.1037/0894-4105.21.6.796; STAMBROOK M, 1993, ARCH CLIN NEUROPSYCH, V8, P95; Sweet JJ, 2006, CLIN NEUROPSYCHOL, V20, P325, DOI 10.1080/13854040600760488; Sweet JJ, 2000, CLIN NEUROPSYCHOL, V14, P479, DOI 10.1076/clin.14.4.479.7201; Taylor J.S., 1991, NEUROPSYCHOLOGY, V5, P293, DOI [10.1037/0894-4105.5.4.293, DOI 10.1037/0894-4105.5.4.293]; Taylor JS, 1999, STUD NEUROPSYCHOL DE, P419; TEASDALE G, 1983, LANCET, V2, P678; TEASDALE G, 1974, LANCET, V2, P81; TOMBAUGH TN, 2003, J FORENSIC NEUROPSYC, V2, P69, DOI DOI 10.1300/J151V02N03_04; vanGorp WG, 1997, CLIN NEUROPSYCHOL, V11, P180, DOI 10.1080/13854049708407048; Varney NR, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P115; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wettstein RM, 2005, J AM ACAD PSYCHIATRY, V33, P158; *WHO, 1997, MULT PRES ICD 10 US; WICKLUND RA, 1971, J EXP SOC PSYCHOL, V7, P319, DOI 10.1016/0022-1031(71)90032-1; Wolfson, 1993, HALSTEAD REITAN NEUR; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014; Young G., 2007, CAUSALITY PSYCHOL IN; ZAJONC RB, 1965, SCIENCE, V149, P269, DOI 10.1126/science.149.3681.269	100	3	3	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	JUN	2008	1	2					122	137		10.1007/s12207-008-9010-7			16	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	VB3UT	WOS:000415439700005					2022-02-06	
J	Stocchetti, N; Zanier, ER; Magnoni, S; Canavesi, K; Ghisoni, L; Longhi, L				Stocchetti, N.; Zanier, E. R.; Magnoni, S.; Canavesi, K.; Ghisoni, L.; Longhi, L.			Hypothermia for brain protection in the non-cardiac arrest patient	MINERVA ANESTESIOLOGICA			English	Article; Proceedings Paper	19th Smart Congress	MAY 28-30, 2008	Milan, ITALY			hypothermia; intracranial pressure; brain injuries	THERAPEUTIC HYPOTHERMIA; INTRACRANIAL-PRESSURE; MODERATE HYPOTHERMIA; CLINICAL-TRIALS; INJURY; NEUROPROTECTION; MANAGEMENT; ISCHEMIA; AGENTS	This review focuses on the potential application of hypothermia in adults suffering traumatic brain injury (TBI). Hypothermia is neuroprotective, reducing the damaging effects of trauma to the brain in a variety of experimental situations, such as brain ischemia and brain injury, but it has failed to demonstrate outcome improvement in a major controlled, randomized trial. The evidence for the use of hypothermia as a protective procedure is scarce and contradictory. However, evidence does suggest that hypothermia is effective in reducing intracranial hypertension after head injury Since hypothermia has important side effects, further work is necessary before introducing this procedure into clinical practice for TBI.	[Stocchetti, N.; Zanier, E. R.; Magnoni, S.; Canavesi, K.; Ghisoni, L.; Longhi, L.] Univ Milan, Polyclin Hosp Mangiagalli & Regina Elena IRCCS, Dept Anesthesia & Crit Care Med, Neurosci ICU,Padiglione Beretta Neuro, I-20122 Milan, Italy		Stocchetti, N (corresponding author), Univ Milan, Polyclin Hosp Mangiagalli & Regina Elena IRCCS, Dept Anesthesia & Crit Care Med, Neurosci ICU,Padiglione Beretta Neuro, Via F Sforza 35, I-20122 Milan, Italy.	stocchet@policlinico.mi.it	Longhi, Luca/AAF-9903-2021; Zanier, Elisa/AAA-8095-2020; Magnoni, Sandra/AAC-7479-2022; Stocchetti, Nino/O-7444-2017	Longhi, Luca/0000-0001-9894-8788; Zanier, Elisa/0000-0002-3011-8718; Magnoni, Sandra/0000-0002-1723-0844; Stocchetti, Nino/0000-0003-3250-6834			Alderson P, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001048.pub2, DOI 10.1002/14651858.CD001048.PUB2]; Bayir H, 2003, CRIT CARE MED, V31, pS112, DOI 10.1097/01.CCM.0000042464.46603.0E; BOHN DJ, 1986, CRIT CARE MED, V14, P529, DOI 10.1097/00003246-198606000-00002; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS21; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Citerio G, 2004, Minerva Anestesiol, V70, P213; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Georgiadis D, 2002, STROKE, V33, P1584, DOI 10.1161/01.STR.0000016970.51004.D9; Ginsberg MD, 2003, STROKE, V34, P214, DOI 10.1161/01.STR.0000048846.09677.62; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; HOFF JT, 1986, J NEUROSURG, V65, P579, DOI 10.3171/jns.1986.65.5.0579; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Kochanek PA, 2003, JAMA-J AM MED ASSOC, V289, P3007, DOI 10.1001/jama.289.22.3007; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Narayan RK, 2001, NEW ENGL J MED, V344, P602, DOI 10.1056/NEJM200102223440810; Polderman KH, 2004, INTENS CARE MED, V30, P1860, DOI 10.1007/s00134-004-2383-5; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Sakoh M, 2003, AM J PHYSIOL-HEART C, V285, pH17, DOI 10.1152/ajpheart.01112.2002; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; SPETZLER RF, 1988, J NEUROSURG, V68, P868, DOI 10.3171/jns.1988.68.6.0868; Takeda Y, 2003, CRIT CARE MED, V31, P255, DOI 10.1097/00003246-200301000-00040; ZAGER EL, 1988, J NEUROSURG, V69, P568, DOI 10.3171/jns.1988.69.4.0568	32	3	3	0	3	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	JUN	2008	74	6					315	318					4	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Anesthesiology; General & Internal Medicine	306EE	WOS:000256230300017	18500206				2022-02-06	
J	Suzuki, K; Kole, H; Matsumoto, T; Asano, R				Suzuki, K.; Kole, H.; Matsumoto, T.; Asano, R.			The effect of hypertonic saline solution on vasodilatation of the superior sagittal sinus using magnetic resonance imaging in normovolemic dogs	RESEARCH IN VETERINARY SCIENCE			English	Article						cerebrospinal fluid; dextran; dog; hypertonic saline; magnetic resonance imaging; sagittal sinus	POSTTRAUMATIC INTRACRANIAL HYPERTENSION; TRAUMATIC BRAIN-INJURY; HEMORRHAGIC-SHOCK; HEAD-INJURY; CEREBRAL EDEMA; RESUSCITATION; PRESSURE; INFUSION; FLUID; MANNITOL	Several animal studies have demonstrated the beneficial effects of hypertonic saline (HSS) on cerebral blood flow, intracranial pressure and brain water content. This study aimed to investigate, using magnetic resonance imaging, whether a small volume of HSS is superior to dextran in vasodilatation of cerebral vessels and reduction of cerebrospinal fluids in dogs. HSS induced a significant expansion of the cross-section of the superior sagittal sinus in the axial transverse section of the pituitary and a decrease in cerebrospinal fluid area in the axial transverse section of the epencephalon more than dextran 40 did (p < 0.001, respectively). However, the relative plasma volume in the dog which received dextran 40 was significantly higher after t = 30 min than in the HSS group (p < 0.001). Therefore, it is suggested that HSS might be superior to colloid solutions in improving cerebral circulation, whereas dextran 40 is superior to HSS in enhancing systemic circulation in dogs. (c) 2007 Elsevier Ltd. All rights reserved.	[Suzuki, K.; Kole, H.; Matsumoto, T.; Asano, R.] Nihon Univ, Coll Bioresourse Sci, Dept Vet Med, Kanagawa 2528510, Japan		Suzuki, K (corresponding author), Nihon Univ, Coll Bioresourse Sci, Dept Vet Med, 1866 Kameino, Kanagawa 2528510, Japan.	kazuyuki@rgu-lavmth.jp		Suzuki, Kazuyuki/0000-0002-8179-6607			Bacher A, 1998, CRIT CARE MED, V26, P108, DOI 10.1097/00003246-199801000-00024; Chiara O, 2003, CRIT CARE MED, V31, P1915, DOI 10.1097/01.CCM.0000074725.62991.42; Deliganis AV, 2001, RADIOLOGY, V218, P152, DOI 10.1148/radiology.218.1.r01ja43152; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; GREENLEAF JE, 1979, J APPL PHYSIOL, V47, P1031, DOI 10.1152/jappl.1979.47.5.1031; GUNNAR W, 1988, SURGERY, V103, P398; Holbeck S, 2002, CRIT CARE MED, V30, P212, DOI 10.1097/00003246-200201000-00030; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kramer GC, 2003, J TRAUMA, V54, pS89, DOI 10.1097/01.TA.0000065609.82142.F1; Krausz MM, 2003, J TRAUMA, V55, P62, DOI 10.1097/01.TA.0000074110.77122.46; KRISTENSEN J, 1990, CRIT CARE MED, V18, P1261, DOI 10.1097/00003246-199011000-00016; Liu LM, 2003, J TRAUMA, V54, pS159, DOI 10.1097/01.TA.0000054649.46525.A5; Nagasawa K, 2006, J CELL PHYSIOL, V208, P123, DOI 10.1002/jcp.20647; OSTENSEN J, 1989, ACTA PHYSIOL SCAND, V137, P117; PASCUAL JMS, 1992, CRIT CARE MED, V20, P200, DOI 10.1097/00003246-199202000-00009; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Rozanski E, 2002, J AM ANIM HOSP ASSOC, V38, P499, DOI 10.5326/0380499; Schwarz S, 1998, STROKE, V29, P1550, DOI 10.1161/01.STR.29.8.1550; Sheikh AA, 1996, CRIT CARE MED, V24, P1226, DOI 10.1097/00003246-199607000-00027; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Smallwood I.M, 1996, HDB ORGANIC SOLVENT, P1; Somell A, 2005, ACTA ANAESTH SCAND, V49, P1124, DOI 10.1111/j.1399-6576.2005.00807.x; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Suzuki K, 1998, AM J VET RES, V59, P452; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; ZHUANG J, 1995, CRIT CARE MED, V23, P140, DOI 10.1097/00003246-199501000-00023	27	3	3	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0034-5288	1532-2661		RES VET SCI	Res. Vet. Sci.	JUN	2008	84	3					465	470		10.1016/j.rvsc.2007.05.016			6	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	300OD	WOS:000255832900024	17662319				2022-02-06	
J	Pahys, JM; Chicorelli, AM; Asghar, J; Betz, RR; Samdani, AF				Pahys, Joshua M.; Chicorelli, Anne Marie; Asghar, Jahangir; Betz, Randal R.; Samdani, Amer F.			Cervical pseudomeningocele due to occult hydrocephalus	SPINE			English	Article						hydrocephalus; pediatric traumatic brain injury; pseudomeningocele; spinal cord injury	POSTLAMINECTOMY PSEUDOMENINGOCELE; POSTTRAUMATIC HYDROCEPHALUS; NERVE ROOT; LUMBAR; FRACTURE; SURGERY	Study Design. Case report with a brief review of the literature. Objective. To describe a rare clinical presentation of post-traumatic hydrocephalus (PTH) in a child who sustained a complete cervical spinal cord injury (SCI). Summary of Background Data. The incidence of PTH can be as high as 30% in cases of pediatric SCI and traumatic brain injury. Presentation may include gait disturbance, altered mental status, or incontinence. To our knowledge, this is the first documentation of PTH presenting as a postsurgical pseudomeningocele. Methods. An 8-year-old girl involved in a motor vehicle accident sustained a C2-C3 fracture dislocation resulting in a complete SCI. She was initially treated with C2-C3 sublaminar wiring and halo placement. At postoperative week 6, the patient underwent drainage of a posterior cervical pseudomeningocele and repair of a small dural leak at C2-C3. She subsequently exhibited signs of altered mental status, and computed tomography scan revealed a significant hydrocephalus. Results. Emergent ventriculostomy was performed, and was converted to a ventriculo-peritoneal shunt 2 days later. The patient's neurologic status markedly improved, and she continues to do well at 2 months after surgery. Conclusion. PTH presenting as a pseudomeningocele is extremely rare. In a patient with polytrauma and concomitant traumatic brain injury, the spine surgeon should consider hydrocephalus as a potential cause for a postsurgical pseudomeningocele, even several months after initial injury.	[Asghar, Jahangir; Betz, Randal R.; Samdani, Amer F.] Shriners Hosp Children, Philadelphia, PA USA; [Pahys, Joshua M.] Albert Einstein Med Ctr, Philadelphia, PA 19141 USA; [Chicorelli, Anne Marie] Philadelphia Coll Osteopath Med, Philadelphia, PA USA		Samdani, AF (corresponding author), 3551 N Broad St, Philadelphia, PA 19140 USA.	amersamdani@yahoo.com	Pahys, Joshua/AAL-3630-2020				ALDRETE JA, 1995, REGION ANESTH, V20, P75; BURRES KP, 1978, J NEUROSURG, V48, P289, DOI 10.3171/jns.1978.48.2.0289; COOK DA, 1989, CLIN ORTHOP RELAT R, P74; Dandy WE, 1914, AM J DIS CHILD, V8, P406; EISMONT FJ, 1981, J BONE JOINT SURG AM, V63, P1132, DOI 10.2106/00004623-198163070-00010; HADANI M, 1986, NEUROSURGERY, V19, P405, DOI 10.1227/00006123-198609000-00011; HANAKITA J, 1985, NEUROSURGERY, V17, P317, DOI 10.1227/00006123-198508000-00012; HOFF JT, 1993, BRAIN SURG COMPLICAT, P108; Kayaoglu CR, 2003, J INT MED RES, V31, P318, DOI 10.1177/147323000303100410; Lau K K, 1992, Australas Radiol, V36, P262, DOI 10.1111/j.1440-1673.1992.tb03166.x; LEE KS, 1992, NEUROSURGERY, V30, P111, DOI 10.1227/00006123-199201000-00020; Licata C, 2001, J Neurosurg Sci, V45, P141; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Miki T, 2006, J TRAUMA, V61, P985, DOI 10.1097/01.ta.0000239665.39237.8c; Nairus JG, 1996, SPINE, V21, P1090, DOI 10.1097/00007632-199605010-00020; Natale M, 2004, ACTA NEUROCHIR, V146, P735, DOI 10.1007/s00701-004-0272-x; O'Connor D, 1998, SPINE, V23, P1501, DOI 10.1097/00007632-199807010-00014; Paoletti P, 1983, J Neurosurg Sci, V27, P171; Paolini S, 2003, EUR SPINE J, V12, P325, DOI 10.1007/s00586-002-0482-y; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007	20	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0362-2436			SPINE	SPINE	MAY 20	2008	33	12					E394	E396		10.1097/BRS.0b013e31817343f3			3	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	304NH	WOS:000256115700021	18496335				2022-02-06	
J	Rios-Lago, M; Alonso, R; Perianez, JA; Paul, N; Oliva, P; Alvarez-Linera, J				Rios-Lago, M.; Alonso, R.; Perianez, J. A.; Paul, N.; Oliva, P.; Alvarez-Linera, J.			Tensor diffusion by MRI and speed processing of the white matter after brain injuries	TRAUMA-SPAIN			Spanish	Article						Attention; diffusion tensor; traumatic brain injury; diffuse axonal injury		Objetives: The present work studies the possible ties among white matter, slowness of information processing and the deficits on attentional control, frequently impaired after TBI. Method: Fractional anisotropy (FA) values were measured in 15 TBI patients and 15 healthy controls. All subjects were also assessed using the Stroop Test and the Trail Making Test. Results: The analyses revealed impairments in the scores influenced by the speed of processing, and in the TMT-B/A. The analyses of the images showed a correlation between anisotropy and speed of processing. On the other hand, there were no significant correlations between the axonal integrity and the scores free of information processing speed. Conclusion: Part of the difficulties showed by TBI patients in attentional control tasks rely on a slowed information processing speed. The results DTI of analyses reveal for the first time that these deficits are directly related to the injuries caused in cerebral white matter.	[Rios-Lago, M.] UNED, Dpto Psicol Basica 2, Juan del Rosal 10, Madrid 28040, Spain; [Rios-Lago, M.; Paul, N.; Oliva, P.] Hosp Beata Maria Ana, Unidad Dano Cerebral, Madrid, Spain; [Rios-Lago, M.; Alvarez-Linera, J.] Fdn CIEN Fdn Reina Sofia, UIPA, Madrid, Spain; [Alonso, R.; Alvarez-Linera, J.] Hosp Ruber Int, Secc Neurorradiol, Madrid, Spain; [Perianez, J. A.] Univ Islas Balerares, Dpto Psicol, Palma de Mallorca, Spain		Rios-Lago, M (corresponding author), UNED, Dpto Psicol Basica 2, Juan del Rosal 10, Madrid 28040, Spain.	mrios@psi.uned.es	Rios-Lago, Marcos/P-6930-2019; Rios-Lago, Marcos/C-9568-2012; Perianez, Jose Antonio/AAI-3988-2021	Rios-Lago, Marcos/0000-0003-0187-5047; Rios-Lago, Marcos/0000-0003-0187-5047; Perianez, Jose Antonio/0000-0003-4310-4021; Paul, Nuria/0000-0001-5462-6138			ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Bagley LJ, 2000, J MAGN RESON IMAGING, V11, P1, DOI 10.1002/(SICI)1522-2586(200001)11:1<1::AID-JMRI1>3.0.CO;2-H; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Cappa SF, 2005, EUR J NEUROL, V12, P665; Chan JHM, 2003, NEURORADIOLOGY, V45, P34, DOI 10.1007/s00234-002-0891-y; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Felts PA, 1997, J NEUROSCI, V17, P7267; Ferraro FR, 1996, BRAIN COGNITION, V32, P429, DOI 10.1006/brcg.1996.0075; Garnett MR, 2001, CURR OPIN NEUROL, V14, P753, DOI 10.1097/00019052-200112000-00012; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kinsella GJ, 1998, NEUROPSYCHOL REHABIL, V8, P351, DOI 10.1080/713755576; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Liptak G S, 1996, Pediatr Rev, V17, P203, DOI 10.1542/pir.17-6-203; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mori S, 2005, MRI ATLAS HUMAN WHIT; Moseley M, 2002, BRAIN COGNITION, V50, P396, DOI 10.1016/S0278-2626(02)00524-9; Nakahara M, 2001, ACTA RADIOL, V42, P365, DOI 10.1080/028418501127346990; O'Sullivan M, 2004, J NEUROL NEUROSUR PS, V75, P441, DOI 10.1136/jnnp.2003.014910; Perianez JA, 2007, ARCH CLIN NEUROPSYCH; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Rios M, 2006, INT NEUROPSYCHOLOGIC, P64; RIOSLAGO M, 2004, ATENCION CONTROL EJE; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Spikman JM, 2001, BRAIN COGNITION, V47, P446, DOI 10.1006/brcg.2001.1320; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Spikman JM, 2000, J CLIN EXP NEUROPSYC, V22, P325, DOI 10.1076/1380-3395(200006)22:3;1-V;FT325; Spikman JM, 2006, EFFECTIVENESS REHABI, P71; Staines WR, 2002, STROKE, V33, P2642, DOI 10.1161/01.STR.0000032552.40405.40; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1961, LANCET, V2, P443; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; VAZQUEZBARQUERO A, 1992, EUR J EPIDEMIOL, V8, P832, DOI 10.1007/BF00145328	48	3	6	0	0	FUNDACION MAPFRE	MADRID	PASEO DE RECOLETOS, 23, MADRID, 28004, SPAIN	1888-6116			TRAUMA-SPAIN	Trauma-Spain	APR-JUN	2008	19	2					102	112					11	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V6F8Q	WOS:000420245900006					2022-02-06	
J	Rutland-Brown, W; Langlois, JA; Bazarian, JJ; Warden, D				Rutland-Brown, Wesley; Langlois, Jean A.; Bazarian, Jefftey J.; Warden, Deborah			Improving identification of traumatic brain injury after nonmilitary bomb blasts	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						blasts; brain injuiy; craniocerebral trauma; concussion; diagnosis; disaster response; traumatic brain injuiy	POSTTRAUMATIC-STRESS-DISORDER; GLASGOW COMA SCALE; MISSED INJURIES; TERRORIST BOMBINGS; CASUALTY INCIDENTS; EARLY INTERVENTION; HEAD-INJURY; AFGHANISTAN; EXPLOSIONS; MANAGEMENT	Objective: To improve identification of traumatic brain injury (TBI) in survivors of nonmilitary bomb blasts during the acute care phase. Methods: The Centers for Disease Control and Prevention convened a meeting of experts in TBI, emergency medicine, and disaster response to review the recent literature and make recommendations. Results: Seven key recommendations were proposed: (1) increase TBI awareness among medical professionals; (2) encourage use of standard definitions and consistent terminology; (3) improve screening methods for TBI in the acute care setting; (4) clarify the distinction between TBI and acute stress disorder; (5) encourage routine screening of hospitalized trauma patients for TBI; (6) improve identification of nonhospitalized TBI patients; and (7) integrate the appropriate level of TBI identification into all-hazards mass casualty preparedness. Conclusions: By adopting these recommendations, the United States could be better prepared to identify and respond to TBI following future bombing events.	[Rutland-Brown, Wesley; Langlois, Jean A.] Ctr Dis Control & Prevent, Div Injury Response, Natl Ctr Injury Prevent & Control, Atlanta, GA 30341 USA; [Bazarian, Jefftey J.] Univ Rochester, Sch Med, Dept Emergency Med, Rochester, NY USA; [Warden, Deborah] Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC 20307 USA		Langlois, JA (corresponding author), Ctr Dis Control & Prevent, Div Injury Response, Natl Ctr Injury Prevent & Control, 4770 Buford Hwy,NE MS F-41, Atlanta, GA 30341 USA.	jal7@cdc.gov					Aharonson-Daniel L, 2003, PEDIATRICS, V112, pE280, DOI 10.1542/peds.112.4.e280; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; *AM AC NEUR, PRACT PAR MAN CONC S; American College of Surgeons Committee on Trauma, 2004, ADV TRAUM LIF SUPP D; American Psychiatric Association , 2000, DSM 4 TR DIAGN STAT, Vtext revision; Arnold Jeffrey L, 2003, Prehosp Disaster Med, V18, P220; Arnold JL, 2004, ANN EMERG MED, V43, P263, DOI 10.1016/S0196-0644(03)00723-6; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Biffl WL, 2003, J TRAUMA, V54, P38, DOI 10.1097/00005373-200301000-00005; Brooks A, 2004, INJURY, V35, P407, DOI 10.1016/S0020-1383(03)00219-5; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Buduhan G, 2000, J TRAUMA, V49, P600, DOI 10.1097/00005373-200010000-00005; Burkle FM, 1996, ANN EMERG MED, V28, P119, DOI 10.1016/S0196-0644(96)70051-3; *CDCP, BLAST LUNG INJ WHAT; *CDCP, 2007, HEADS  PREV BRAIN IN; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; CERNAK A, 2005, NEUROTHERAPEUTICS, V2, P410; Chambers J, 1996, J TRAUMA, V41, P976, DOI 10.1097/00005373-199612000-00006; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; CHESNUT RM, 1999, 2 AG HEALTHC POL RES; Clements AD, 1997, J REHABIL, V63, P3; Committee on Trauma American College of Surgeons, 2006, RES OPT CAR INJ PAT; COOPER GJ, 1983, J TRAUMA, V23, P955, DOI 10.1097/00005373-198311000-00001; de Ceballos JPG, 2005, CRIT CARE, V9, P104, DOI 10.1186/cc2995; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Drazen JM, 2005, NEW ENGL J MED, V352, P2121, DOI 10.1056/NEJMe048332; Dutton RP, 2002, J TRAUMA, V53, P857, DOI 10.1097/00005373-200211000-00009; ENDERSON BL, 1991, SURG CLIN N AM, V71, P399; ENDERSON BL, 1990, J TRAUMA, V30, P666, DOI 10.1097/00005373-199006000-00002; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; *FED EM MAN AG, 1996, STAT LOC GUID SLG, V101; FRYKBERG ER, 1988, ANN SURG, V208, P569, DOI 10.1097/00000658-198811000-00005; Frykberg ER, 2002, J TRAUMA, V53, P201, DOI 10.1097/00005373-200208000-00001; GUHA-SAPIR D, 1991, World Health Statistics Quarterly, V44, P171; Halpern Pinchas, 2003, Prehosp Disaster Med, V18, P235; Hirshberg A, 1999, J TRAUMA, V47, P545, DOI 10.1097/00005373-199909000-00020; Hirshberg A, 2001, ANN EMERG MED, V37, P647, DOI 10.1067/mem.2001.115650; Houshian S, 2002, J TRAUMA, V52, P715, DOI 10.1097/00005373-200204000-00018; Janjua KJ, 1998, J TRAUMA, V44, P1000, DOI 10.1097/00005373-199806000-00012; Kapur GB, 2005, J TRAUMA, V59, P1436, DOI 10.1097/01.ta.0000197853.49084.3c; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kluger Y, 2004, J AM COLL SURGEONS, V199, P875, DOI 10.1016/j.jamcollsurg.2004.09.003; LINDSTROM AM, 2006, J EMERG MED SERV, V31, P26; Mallonee S, 1996, JAMA-J AM MED ASSOC, V276, P382, DOI 10.1001/jama.276.5.382; MARR AL, 2004, CENTR NERV SYST INJ; Mayo Ami, 2006, World J Emerg Surg, V1, P33, DOI 10.1186/1749-7922-1-33; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrea M., 1997, STANDARDIZED ASSESSM; McMillan TM, 2001, BRAIN INJURY, V15, P39, DOI 10.1080/02699050118030; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; *MOUNT SIN SCH MED, TRAUM BRAIN INJ CENT; MUSSER J, 2006, SURG ROUNDS, V12, P1; *NAT COUNT CTR, NCTC FACT SHEET OBS; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Peleg K, 2003, AM J EMERG MED, V21, P258, DOI 10.1016/S0735-6757(03)00043-3; Peleg K, 2004, ANN SURG, V239, P311, DOI 10.1097/01.sla.0000114012.84732.be; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; RIZOLI SB, 1994, ACCIDENT ANAL PREV, V26, P681, DOI 10.1016/0001-4575(94)90030-2; Rodoplu Ulkumen, 2004, Prehosp Disaster Med, V19, P133; Rutland-Brown W, 2007, PREHOSP DISASTER MED, V22, P157, DOI 10.1017/S1049023X00004593; Sasser SM, 2006, PREHOSP EMERG CARE, V10, P165, DOI 10.1080/10903120500540912; Schwab KA, 2006, NEUROLOGY, V66, pA235; SCOTT BA, 1986, NEUROSURGERY, V18, P107, DOI 10.1227/00006123-198601000-00020; SCOTT SG, 2005, FEDERAL PRACT, V22, P66; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Soundappan SVS, 2004, J TRAUMA, V57, P114, DOI 10.1097/01.TA.0000108992.51091.F7; Sumpter RE, 2005, BRIT J PSYCHIAT, V186, P423, DOI 10.1192/bjp.186.5.423; The Defense and Veterans Brain Injury Center, 2006, MIL AC CONC EV MACE; Thompson D, 2004, J TRAUMA, V57, P208, DOI 10.1097/01.TA.0000142672.99660.80; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; WALLACE GL, 2006, ASHA LEADER, V11, P26; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906	77	3	3	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2008	23	2					84	91		10.1097/01.HTR.0000314527.78134.70			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	280KW	WOS:000254426700003	18362762				2022-02-06	
J	Valle, GD; Puerta-Cuestas, MV; Renau-Hernandez, O; Noguera-Escalera, P; Garcia-Blazquez, MC; Ferri-Salvador, N; Chirivella-Garrido, J; Ferri-Campos, J; Noe-Sebastian, E				del Valle-del Valle, G.; Puerta-Cuestas, M. V.; Renau-Hernandez, O.; Noguera-Escalera, P.; Garcia-Blazquez, M. C.; Ferri-Salvador, N.; Chirivella-Garrido, J.; Ferri-Campos, J.; Noe-Sebastian, E.			Clinical utility of the 64-card version of the Wisconsin Card Sorting Test in patients with traumatic brain injury	REVISTA DE NEUROLOGIA			Spanish	Article						convergent validity; temporal stability; traumatic brain injury; WCST-64; WCST-128; Wisconsin Card Sorting Test	WCST-64; VALIDITY; FORM	Aims. To analyze the validity of the single deck 64-card Wisconsin Card Sorting Test (WCST-64) compared to the standard version (WCST-128), and to study the sensibility of both versions to identify changes over time in patients with traumatic brain injury (TBI). Patients and methods. The WCST was administered twice across a 6-month period to a sample of 50 patients with TBI. Pearson correlation coefficients were calculated to examine bivariate associations between WCST-128 scores and the corresponding WCST-64 scores at inclusion and at follow-up. Agreement in classification of impairment (z = -1) or normal performance was calculated for the two tests (kappa). Significant change over time was also analyzed for both versions of the test (paired-samples t test). Results. The results revealed positive and significant correlations between both measures as well as a significant agreement in the classification of patients as having deficits or not. Moreover the WCST-128 and the WCST-64 showed similar ability to identify changes over time. Conclusions. Our findings showed strong associations between scores derived from the two test and support the comparability of both versions when analyzing cross-sectional or longitudinal data. The findings support the use of the WCST-64 in evaluations of executive deficits of patients with moderate and severe TBI.	[del Valle-del Valle, G.; Puerta-Cuestas, M. V.; Renau-Hernandez, O.; Noguera-Escalera, P.; Garcia-Blazquez, M. C.; Ferri-Salvador, N.; Chirivella-Garrido, J.; Ferri-Campos, J.; Noe-Sebastian, E.] Hosp NISA, Fdn Inst Valenciano Neurorehabil, Serv Dano Cerebral, Valencia, Spain		Noe-Sebastian, E (corresponding author), Hosp Valencia Mar, Serv Dano Cerebral, Rio Tajo 1, E-46011 Valencia, Spain.	enoe@comv.es		Noe Sebastian, Enrique/0000-0002-2547-8727			Axelrod BN, 2002, CLIN NEUROPSYCHOL, V16, P7, DOI 10.1076/clin.16.1.7.8331; Basso MR, 2001, CLIN NEUROPSYCHOL, V15, P471, DOI 10.1076/clin.15.4.471.1883; Basso MR, 1999, CLIN NEUROPSYCHOL, V13, P283, DOI 10.1076/clin.13.3.283.1743; Donders J, 2004, CLIN NEUROPSYCHOL, V18, P521, DOI 10.1080/11385404049052411; Ferland MB, 1998, J CLIN EXP NEUROPSYC, V20, P473, DOI 10.1076/jcen.20.4.473.1475; Greve KW, 1997, BRIT J CLIN PSYCHOL, V36, P283, DOI 10.1111/j.2044-8260.1997.tb01414.x; Greve KW, 2002, ASSESSMENT, V9, P271, DOI 10.1177/1073191102009003006; Greve KW, 2001, CLIN NEUROPSYCHOL, V15, P228, DOI 10.1076/clin.15.2.228.1901; Heaton R.K., 1996, TEST CLASIFICACION C; Kongs S. K., 2000, WCST 64 WISCONSIN CA; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Love JM, 2003, APPL NEUROPSYCHOL, V10, P246, DOI 10.1207/s15324826an1004_7; Merrick EE, 2003, CLIN NEUROPSYCHOL, V17, P153, DOI 10.1076/clin.17.2.153.16512; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Robinson L J, 1991, Arch Clin Neuropsychol, V6, P27, DOI 10.1016/0887-6177(91)90019-6; Sherer M, 2003, J CLIN EXP NEUROPSYC, V25, P512, DOI 10.1076/jcen.25.4.512.13877; Vayalakkara J, 2000, INT J NEUROSCI, V103, P131, DOI 10.3109/00207450009003259	17	3	4	0	1	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	FEB 1	2008	46	3					142	146		10.33588/rn.4603.2007236			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	273QA	WOS:000253945600004	18297620				2022-02-06	
J	Zweckberger, K; Sakowitz, OW; Unterberg, AW; Kiening, KL				Zweckberger, K.; Sakowitz, O. W.; Unterberg, A. W.; Kiening, K. L.			Classification and therapy of craniocerebral injury (CCI)	LARYNGO-RHINO-OTOLOGIE			German	Article						traumatic brain injury; frontobasal injury; division of intracranial bleedings and operative as well as intensive care medicine	SEVERE HEAD-INJURY; CEREBRAL-BLOOD-FLOW; BRAIN; SYSTEM; VALIDATION; MANAGEMENT; NUTRITION; MORTALITY; BAVARIA; SUPPORT	In spite of great success in research severe traumatic brain injury (TBI) remains the most frequent cause for morbidity and mortality in the age < 45 years. The primary lesion emerges at the moment of trauma. Due to several pathophysiological mechanisms secondary lesions occur that enlarge size of contusions significantly. As a consequence of intracranial bleedings and brain edema intracranial pressure (ICP) increases and threaten the patient. Extent of severity (declared in Glasgow Coma Scale Score [GCS]), expansion and type of bleedings (acute and chronic subdural hemorrhage, epidural bleeding, contusion bleedings and intracerebral hemorrhage) determinate operative and conservative therapy as well as intensive care medicine. A specific feature represents frontobasal lesions that, apart of penetrating injuries, are treated interdisciplinary not before ICP is stable, brain edema declining and coagulation sufficient several days after trauma. A persisting rhinoliquorrhoe cause meningitis up to 85 % within 10 years. Patient with GCS < 8 have to be intubated and controlled ventilated. Basic monitoring does not differ from those of other patients treated at the intensive care ward (sufficient breathing [pO(2), pCO(2)], arterial blood pressure, CBC and coagulation parameters, fluid monitoring and nutrition). Additionally, ICP have to be measured and be treated corresponding to the algorithm of ICP treatment. Complementary, oxygen saturation of brain tissue (ptiO(2)), local cerebral blood flow (r-CBF) and cerebral metabolism (micro dialysis) can be measured. just the combination of the single monitoring parameters gives evidence of the functional condition of the injured brain and relieved planning and performing of the appropriate therapy.	[Zweckberger, K.; Sakowitz, O. W.; Unterberg, A. W.; Kiening, K. L.] Univ Klinikum Heidelberg, Neurochirurg Klin, Heidelberg, Germany		Zweckberger, K (corresponding author), Heidelberg Univ, Neurochirurg Klin, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	klaus.zweckberger@med.uni-heidelberg.de		Sakowitz, Oliver/0000-0003-3248-6335			ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ALLISON SP, 1992, CLIN NUTR, V11, P165, DOI 10.1016/0261-5614(92)90024-K; *ARB INT NEUR, 1997, ZENTRALBL NEUROCHIR, V58, P13; BAETHMANN A, 1988, CRIT CARE MED, V16, P972, DOI 10.1097/00003246-198810000-00008; Baethmann A, 2002, EUR SURG RES, V34, P42, DOI 10.1159/000048886; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bochicchio GV, 2006, JPEN-PARENTER ENTER, V30, P503, DOI 10.1177/0148607106030006503; Bouma GJ, 1998, ACT NEUR S, V71, P272; BRAAKMAN R, 1983, J NEUROSURG, V58, P326, DOI 10.3171/jns.1983.58.3.0326; BULLOCK R, 1993, SCHWEIZ MED WSCHR, V123, P449; Caricato A, 2005, J TRAUMA, V58, P571, DOI 10.1097/01.TA.0000152806.19198.DB; COOPER DJ, 2004, JAMA-J AM MED ASSOC, V17, P1350; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Heyland DK, 2004, CRIT CARE MED, V32, P2260, DOI 10.1097/01.CCM.0000145581.54571.32; Huynh T, 2002, J TRAUMA, V53, P488, DOI 10.1097/00005373-200209000-00016; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; KIENING K, 2007, CLIN NEUROSURG, V54, P1; KIMELBERG HK, 1992, J NEUROTRAUM, V9, pS71; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; Marion DW, 2006, NEUROSURGERY, V58, P655; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; POVLISHOCK JT, 2007, J NEUROTRAUMA S1, V24, P1; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; RUDEHILL A, 2003, J NEUROSCI METH, V19, P855; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Vajkoczy P, 2000, J NEUROSURG, V93, P265, DOI 10.3171/jns.2000.93.2.0265; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; von Wild KRH, 2005, ACTA NEUROCHIR SUPPL, V93, P15; Wirth A, 2004, ACT NEUR S, V89, P119; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	34	3	3	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0935-8943	1438-8685		LARYNGO RHINO OTOL	Laryngo-Rhino-Otol.	FEB	2008	87	2					121	132		10.1055/s-2007-995478			12	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	266RS	WOS:000253455300010	18224608				2022-02-06	
J	Ince, NF; Min, CH; Tewfik, A; Vanderpool, D				Ince, Nuri Firat; Min, Cheol-Hong; Tewfik, Ahmed; Vanderpool, David			Detection of early morning daily activities with static home and wearable wireless sensors	EURASIP JOURNAL ON ADVANCES IN SIGNAL PROCESSING			English	Article								This paper describes a flexible, cost-effective, wireless in-home activity monitoring system for assisting patients with cognitive impairments due to traumatic brain injury (TBI). The system locates the subject with fixed home sensors and classifies early morning bathroom activities of daily living with a wearable wireless accelerometer. The system extracts time- and frequency-domain features from the accelerometer data and classifies these features with a hybrid classifier that combines Gaussian mixture models and a finite state machine. In particular, the paper establishes that despite similarities between early morning bathroom activities of daily living, it is possible to detect and classify these activities with high accuracy. It also discusses system training and provides data to show that with proper feature selection, accurate detection and classification are possible for any subject with no subject specific training. Copyright (C) 2008.	[Ince, Nuri Firat; Min, Cheol-Hong; Tewfik, Ahmed; Vanderpool, David] Univ Minnesota, Dept Elect & Comp Engn, Minneapolis, MN 55455 USA; [Ince, Nuri Firat] Vet Adm Med Ctr, Dept Vet Affairs, Minneapolis, MN 55417 USA		Tewfik, A (corresponding author), Univ Minnesota, Dept Elect & Comp Engn, Minneapolis, MN 55455 USA.	tewfik@umn.edu					Bao L, 2004, LECT NOTES COMPUT SC, V3001, P1, DOI 10.1007/978-3-540-24646-6_1; FINKELSTEIN EA, 2006, INCIDENCE EC BURDEN, P3; Huang YH, 2005, IEEE T BIO-MED ENG, V52, P1801, DOI 10.1109/TBME.2005.856295; INCE NF, 2007, P 32 IEEE INT C AC S, V2, P565; INCE NF, 2006, P 3 INT SUMM SCH S M; LEE SW, 2002, IEEE PERVAS COMPUT, V1, P24; Lester J, 2005, 19TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-05), P766; Levinson R, 1997, J HEAD TRAUMA REHAB, V12, P85, DOI 10.1097/00001199-199704000-00010; MIN CH, 2007, P 15 EUR SIGN P C EU; Mynatt ED, 2000, CUU 2000 CONFERENCE PROCEEDINGS, P65; Ogawa M, 2000, 1ST ANNUAL INTERNATIONAL IEEE-EMBS SPECIAL TOPIC CONFERENCE ON MICROTECHNOLOGIES IN MEDICINE & BIOLOGY, PROCEEDINGS, P611, DOI 10.1109/MMB.2000.893858; Pollack M., 2002, P 6 INT C ART INT PL, P322; REYNOLDS DA, 1995, IEEE T SPEECH AUDI P, V3, P72, DOI 10.1109/89.365379; ROY N, 2000, P WORKSH INT ROB ENT; Tamura T, 1998, MED ENG PHYS, V20, P573, DOI 10.1016/S1350-4533(98)00064-2	15	3	3	0	2	SPRINGEROPEN	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	1687-6180			EURASIP J ADV SIG PR	EURASIP J. Adv. Signal Process.		2008									273130	10.1155/2008/273130			11	Engineering, Electrical & Electronic	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	278XE	WOS:000254318800001		gold, Green Submitted			2022-02-06	
J	Kadas, I; Szita, J; Zadravecz, G; Hangody, L; Doczi, J				Kadas, Istvan; Szita, Janos; Zadravecz, Goeyrgy; Hangody, Laszl; Doczi, Jozsef			Stabilization of calcaneus fractures in a closed manner with a distraction screw	EKLEM HASTALIKLARI VE CERRAHISI-JOINT DISEASES AND RELATED SURGERY			English	Article						bone screws; calcaneus/injuries; fracture fixation, internal/methods; manipulation, orthopedic/methods	DISPLACED INTRAARTICULAR FRACTURES; OPERATIVE TREATMENT	Calcaneus fractures with joint crunches need surgical treatment. This treatment can be closed reposition and overstitching, or open reposition with osteosynthesis using an H plate. There is also a minimal invasive technique, whereby the fracture is reduced with a distraction device in a closed manner and stabilized with three supporting screws. This method became widespread with Zadravecz's endeavors and has become the most popular and most frequent way of stabilization for calcaneus fractures in our institute. To further improve the Zadravecz's technique, we developed a new headless distraction screw. There are threads on both ends of the screw, which turn in the same direction. The size of the threads on the side of the screw head is greater in diameter and pitch compared to those on the other end, exerting and maintaining a distancing effect. The repositioning tool has undergone changes, as well. A desirable ligamentotaxis is achieved by a newly designed distraction-reposition apparatus. We currently use two half-arcs, on which three Kirschner wires can be used. For accurate repositioning, we rely upon the ligamentotaxis effect of the reposition tool, and the inner synergetic effect of the distraction screw. The technique described here was used in 56 patients (mean age 46 years; range 28 to 67 years) with calcaneus fractures. The patients were followed-up for a mean of 18.3 months (range 10 to 36 months) and were evaluated by the American Orthopaedic Foot and Ankle Society (AOFAS) score for the ankle and hindfoot. The mean AOFAS score was 76.5 (range 54 to 98), and the mean pain score was 22 (range 22 to 32). The authors believe that this minimally invasive technique will arose even more interest among orthopedic surgeons.	[Kadas, Istvan; Szita, Janos; Zadravecz, Goeyrgy; Doczi, Jozsef] Natl Inst Traumatol & Emergency, Budapest, Hungary; [Hangody, Laszl] Uzsoki Hosp, Dept Orthoped & Traumatol, Budapest, Hungary		Kadas, I (corresponding author), Laborc Utca 67, H-1037 Budapest, Hungary.	drkados@freemail.hu					Barei DP, 2002, ORTHOP CLIN N AM, V33, P263, DOI 10.1016/S0030-5898(03)00084-1; Crosby LA, 1996, FOOT ANKLE INT, V17, P253, DOI 10.1177/107110079601700503; CROSBY LA, 1993, CLIN ORTHOP RELAT R, P47; KITAOKA HB, 1994, FOOT ANKLE INT, V15, P349, DOI 10.1177/107110079401500701; Laughlin RT, 1996, FOOT ANKLE INT, V17, P71, DOI 10.1177/107110079601700203; LEUNG KS, 1993, J BONE JOINT SURG BR, V75, P196, DOI 10.1302/0301-620X.75B2.8444936; Macey, 1994, J Am Acad Orthop Surg, V2, P36; MELCHER G, 1995, J TRAUMA, V38, P713, DOI 10.1097/00005373-199505000-00006; Sanders R, 1992, J Orthop Trauma, V6, P252, DOI 10.1097/00005131-199206000-00022; SANDERS R, 1993, CLIN ORTHOP RELAT R, P87; Zadravecz G, 1989, Magy Traumatol Orthop Helyreallito Seb, V32, P201; Zadravecz G, 1984, Aktuelle Traumatol, V14, P218; ZWIPP H, 1993, CLIN ORTHOP RELAT R, P76	13	3	3	0	0	TURKISH JOINT DISEASES FOUNDATION	KAVAKLIDERE	BUGDAY SOKAK 6-27, KAVAKLIDERE, ANKARA 06700, TURKEY	1305-8282	1309-0313		EKLEM HAST CERRAHISI	Eklem Hast. Cerrahisi		2008	19	1					45	49					5	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	294ZE	WOS:000255444000010					2022-02-06	
J	Olsson, KA; Le Brocque, RM; Kenardy, JA; Anderson, V; Spence, SH				Olsson, Katherine A.; Le Brocque, Robyne M.; Kenardy, Justin A.; Anderson, Vicki; Spence, Susan H.			The influence of pre-injury behaviour on children's type of accident, type of injury and severity of injury	BRAIN INJURY			English	Article						children; behaviour; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; UNINTENTIONAL INJURY; OUTCOMES; MILD; ADOLESCENTS; PREDICTORS; RECOVERY; DISORDER; COHORT	Primary objective: To investigate the relationship between children's pre-injury behaviour and accident type (high vs. low risk), injury type (traumatic brain injury (TBI), fractures/dislocations and other injuries) and TBI severity. Research design: Cross-sectional comparison of 205 children with TBI aged 6-14 years, with 101 children aged 7-14 years with non-TBI injuries. Methods and procedures: Pre-injury behavioural data were collected via parental report with the Child Behaviour Checklist. Information on children's accident type and TBI severity was obtained from medical records. Main outcomes and results: The pre-injury behaviour of children involved in high or low risk accidents did not differ. Pre-injury behavioural differences were observed among children with TBI, fractures/dislocations, other injuries and normative samples. The involvement of children in high and low risk accidents differed depending on the severity of TBI. Pre-injury behaviour of children with mild or moderate/severe TBI was similar. Conclusions: Pre-injury behaviour does not appear to influence children's involvement in high vs. low risk accidents or the severity of their TBI. However pre-injury behaviour increases children's differential risk for types of accidental injuries.	[Olsson, Katherine A.; Le Brocque, Robyne M.; Kenardy, Justin A.] Univ Queensland, Ctr Natl Res Disabil & Rehabil Med, Brisbane, Qld 4072, Australia; [Kenardy, Justin A.] Univ Queensland, Sch Psychol, Brisbane, Qld 4072, Australia; [Anderson, Vicki] Murdoch Childrens Res Inst, Murdoch, WA, Australia; [Spence, Susan H.] Griffith Univ, Nathan, Qld 4111, Australia		Kenardy, JA (corresponding author), Mayne Med Sch, CONROD, Level 3,Herston Rd, Herston, Qld 4006, Australia.	j.kenardy@uq.edu.au	Olsson, Katherine A/K-9957-2016; Le Brocque, Robyne/F-4848-2010; Kenardy, Justin/F-2085-2010; Kenardy, Justin A/H-6603-2014	Le Brocque, Robyne/0000-0002-4574-1254; Kenardy, Justin A/0000-0001-9475-8450; Spence, Susan/0000-0002-7022-6676			ABS, 2006, YB AUSTR; Achenbach TM, 1991, MANUAL CHILD BEHAV C; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; Brehaut JC, 2003, PEDIATRICS, V111, P262, DOI 10.1542/peds.111.2.262; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Clancy TA, 2006, J CLIN CHILD ADOLESC, V35, P203, DOI 10.1207/s15374424jccp3502_4; DONDERS J, 1992, J ABNORM CHILD PSYCH, V20, P233, DOI 10.1007/BF00916690; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FORTUNE N, 1999, DEFINITION INCIDENCE; Howell DC., 1997, STAT METHODS PSYCHOL, V4th ed; Jennett B., 1974, LANCET, V2, P8; Kenardy JA, 2006, PEDIATRICS, V118, P1002, DOI 10.1542/peds.2006-0406; Lalloo R, 2003, ACCIDENT ANAL PREV, V35, P661, DOI 10.1016/S0001-4575(02)00044-1; Lee WE, 2006, PSYCHOL MED, V36, P345, DOI 10.1017/S0033291705006847; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; MATHENY AP, 1984, ADV BEHAV PEDIATR, V5, P221; PELCO L, 1992, Brain Injury, V6, P29, DOI 10.3109/02699059209008119; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Rowe R, 2004, J PEDIATR PSYCHOL, V29, P119, DOI 10.1093/jpepsy/jsh015; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Schwebel DC, 2004, J PEDIATR PSYCHOL, V29, P93, DOI 10.1093/jpepsy/jsh013; Schwebel DC, 2002, J PEDIATR PSYCHOL, V27, P727, DOI 10.1093/jpepsy/27.8.727; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	27	3	3	1	9	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2008	22	7-8					595	602		10.1080/02699050802132453			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	318MG	WOS:000257095300011	18568713				2022-02-06	
J	Salgado, DR; Rocco, JR; Verdeal, JCR				Salgado, D. R.; Rocco, J. R.; Verdeal, J. C. Rosso			Adrenal function in different subgroups of septic shock patients	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article						septic shock; relative adrenal insufficiency; cortisol; ACTH test; ICU	TRAUMATIC BRAIN-INJURY; CORTISOL RESPONSE; SEVERE SEPSIS; INSUFFICIENCY; CORTICOTROPIN; HYDROCORTISONE; CLASSIFICATION; DEFINITIONS; STIMULATION; THERAPY	Background: Relative adrenal insufficiency (RAI) is a common complication during septic shock and may be more frequent in specific subgroups. The main objectives of this study were to determine the adrenal function and the RAI incidence in different subgroups of septic shock patients considering: main admission categories (medical, elective or emergency surgery); source of infection; nosocomial or community-acquired infections; gender, age < 65 years or > 65 years; and the presence or absence of neurological diseases, acute respiratory distress syndrome (ARDS) and bacteremia. Methods: Prospective study in a medical-surgical ICU, including adults with septic shock, from May 2002 to May 2005. All patients had total serum cortisol measured at baseline and 60 min after a high-dose ACTH test within the first 96 h of shock onset. RAI was defined as a serum cortisol increment after ACTH test (Delta max(249)) < 90 mu g/l. Results: One hundred and two subjects were enrolled, and the overall RAI incidence was 22.5%. Patients with ARDS before ACTH test or bacteremia showed lower Delta max(249) values than patients with ARDS after ACTH test (96 vs. 153 mu g/l, P=0.02) or without bacteremia (140 vs. 175 mu g/l, P = 0.04). Multivariate regression analysis revealed that female gender, development of ARDS before ACTH test, and bacteremia were associated with greater RAI incidence. There was no difference in RAI incidence considering neurological diseases, age, type and source of infection and the main admission categories. Conclusions; Female gender, bacteremia and early-onset ARDS were variables independently associated with greater RAI incidence in septic shock patients. There was no difference in the RAI incidence concerning other subgroups.	[Salgado, D. R.; Verdeal, J. C. Rosso] Hosp Avenida Ayrton Senna, Intens Care Unit, Barra Dor Hosp, BR-22775001 Rio De Janeiro, RJ, Brazil; [Salgado, D. R.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Dept Internal Med, Rio De Janeiro, Brazil; [Rocco, J. R.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Intens Care Unit, Rio De Janeiro, Brazil		Salgado, DR (corresponding author), Hosp Avenida Ayrton Senna, Intens Care Unit, Barra Dor Hosp, 2541 Barra Tijuca, BR-22775001 Rio De Janeiro, RJ, Brazil.	d.salgado@globo.com					Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2006, CRIT CARE MED, V34, P22, DOI 10.1097/01.CCM.0000194723.78632.62; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Arafah BM, 2006, J CLIN ENDOCR METAB, V91, P3725, DOI 10.1210/jc.2006-0674; Beishuizen Albertus, 2004, Curr Opin Crit Care, V10, P461, DOI 10.1097/01.ccx.0000142748.40422.c8; Bernard F, 2006, BRIT J ANAESTH, V96, P72, DOI 10.1093/bja/aei277; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; *BLOOD I ARDS, 2006, NEW ENGL J MED, V354, P1671; Bollaert PE, 1998, CRIT CARE MED, V26, P645, DOI 10.1097/00003246-199804000-00010; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Confalonieri M, 2005, AM J RESP CRIT CARE, V171, P242, DOI 10.1164/rccm.200406-808OC; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; Dimopoulou L, 2004, CRIT CARE MED, V32, P404, DOI 10.1097/01.CCM.0000108885.37811.CA; Ely EW, 2003, CLIN INFECT DIS, V37, P187, DOI 10.1086/375775; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Hoen S, 2002, ANESTHESIOLOGY, V97, P807, DOI 10.1097/00000542-200210000-00010; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Loisa P, 2005, ANESTH ANALG, V101, P1792, DOI 10.1213/01.ANE.0000184042.91452.48; Loisa P, 2002, ACTA ANAESTH SCAND, V46, P145, DOI 10.1034/j.1399-6576.2002.460204.x; Manglik S, 2003, CRIT CARE MED, V31, P1668, DOI 10.1097/01.CCM.0000063447.37342.A9; Marik P, 2006, INTENS CARE MED, V32, P275, DOI 10.1007/s00134-005-0005-5; Meduri GU, 1998, JAMA-J AM MED ASSOC, V280, P159, DOI 10.1001/jama.280.2.159; Morel J, 2006, INTENS CARE MED, V32, P1184, DOI 10.1007/s00134-006-0233-3; Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931; ROTHWELL PM, 1991, LANCET, V337, P582, DOI 10.1016/0140-6736(91)91641-7; Salgado DR, 2006, CRIT CARE, V10, DOI 10.1186/cc5077; Salluh J, 2006, INTENS CARE MED, V32, P595, DOI 10.1007/s00134-005-0046-9; Schroeder S, 2001, CRIT CARE MED, V29, P310, DOI 10.1097/00003246-200102000-00017; Silva E, 2004, CRIT CARE, V8, pR251, DOI 10.1186/cc2892; Siraux V, 2005, CRIT CARE MED, V33, P2479, DOI 10.1097/01.CCM.0000185641.87051.7C; TAYEK JA, 1995, ENDOCRINE, V3, P315, DOI 10.1007/BF03021412; Thompson BT, 2003, CRIT CARE MED, V31, pS253, DOI 10.1097/01.CCM.0000057900.19201.55; van Eijk LT, 2007, CRIT CARE MED, V35, P1464, DOI 10.1097/01.CCM.0000266534.14262.E8; Yeager MP, 2004, ACTA ANAESTH SCAND, V48, P799, DOI 10.1111/j.1399-6576.2004.00434.x; Yildiz O, 2002, CRIT CARE, V6, P251, DOI 10.1186/cc1498; Zaloga GP, 2001, CRIT CARE MED, V29, P688, DOI 10.1097/00003246-200103000-00051	40	3	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	JAN	2008	52	1					36	44		10.1111/j.1399-6576.2007.01492.x			9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	242ZD	WOS:000251763800006	17999714				2022-02-06	
J	Shibuya, H; Hannerz, H; Mikkelsen, KL; Cleal, B; Gubba, L				Shibuya, Hitomi; Hannerz, Harald; Mikkelsen, Kim Lyngby; Cleal, Bryan; Gubba, Lotte			Hospital contacts due to injuries among male drivers working for road goods-transport contractors in Denmark	INTERNATIONAL JOURNAL OF OCCUPATIONAL MEDICINE AND ENVIRONMENTAL HEALTH			English	Article						professional drivers; road transport contractors; hospital contacts; work injury	SLEEP; RISK; ACCIDENTS; FATIGUE	Objectives: To establish a detailed picture of injury pattern among professional goods-transport drivers in Denmark. Methods: For each calendar year over the period of 1995-2003, the age-standardized hospital contact ratios (SHRs) for injury were calculated for male drivers working for road goods-transport contractors in Denmark. The reference population was the male skilled/semiskilled subpopulation of the general workforce in Denmark. Results: No differences in the rate of injury-related hospital contact could be found between male goods-transport drivers and the reference population between 1995 and 1999. However, in the following period of 2000-2003, elevated rates of injury-related hospital contact were noted among goods-transport drivers, compared with the reference population. Furthermore, the injury-related SHR of goods-transport drivers showed a significant increase throughout the period of 1995-2003. Injuries to ankles/feet/toes were prominent among goods-transport drivers. Compared with the reference population, male goods-transport drivers had elevated rates of superficial injuries, dislocations/sprains/strains, fractures, and concussion. The superficial injuries were sustained most frequently in the ankles/feet/toes, open wounds in head/neck, dislocations/sprains/strains in ankles/feet/toes, and fractures in wrists/hands/fingers and ankles/feet/toes. Conclusion: There is a clear need for efforts to prevent work injuries among goods-transport drivers. Special attention should be paid to preventing fractures in wrists/hands/fingers and ankles/feet/toes, dislocations/sprains/strains in ankles/feet/toes, open wounds in head/neck, and concussion.	[Shibuya, Hitomi; Hannerz, Harald; Mikkelsen, Kim Lyngby; Cleal, Bryan] Natl Res Ctr Working Environm, DK-2100 Copenhagen O, Denmark; [Gubba, Lotte] Herning Hosp, Dept Occupat Med, Herning, Denmark		Shibuya, H (corresponding author), Natl Res Ctr Working Environm, Lerso Parkalle 105, DK-2100 Copenhagen O, Denmark.	his@nrcwe.dk	cleal, bryan/AAJ-5464-2021	Cleal, Bryan/0000-0003-3065-7364; Mikkelsen, Kim Lyngby/0000-0001-7325-7040	Danish Work Environment Research Fund [2-2004-03]	The present study was supported by Danish Work Environment Research Fund (2-2004-03).	Charlton SG, 2001, NEW ZEAL J PSYCHOL, V30, P32; Crum MR, 2002, TRANSPORT J, V42, P20; Crum MR, 2001, TRANSPORT RES REC, P125; Hannerz H, 2001, OCCUP ENVIRON MED, V58, P253, DOI 10.1136/oem.58.4.253; Hannerz H, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-215; Lal SKL, 2001, BIOL PSYCHOL, V55, P173, DOI 10.1016/S0301-0511(00)00085-5; Maldonado CC, 2002, S AFR J SCI, V98, P319; MIKKELSEN KL, 2003, MALING FREMDRIFTEN V; Moore-Ede M, 2004, AVIAT SPACE ENVIR MD, V75, pA107; Radun I, 2004, SLEEP, V27, P224, DOI 10.1093/sleep/27.2.224; SHIBUYA H, 2008, AM J IND MED, DOI DOI 10.1002/AJIM_20568; Soll-Johanning H, 2004, DAN MED BULL, V51, P207; *STAT DENM, 1996, DISCO88 STAT DENM; Statistics Denmark, 1995, DAN IND CLASS ALL EC; Taylor AH, 2006, ANNU REV PUBL HEALTH, V27, P371, DOI 10.1146/annurev.publhealth.27.021405.102117; van den Berg J, 2006, TRANSPORT RES F-TRAF, V9, P207, DOI 10.1016/j.trf.2006.01.001	16	3	3	0	2	NOFER INST OCCUPATIONAL MEDICINE, SW	LODZ	TERESY 8, LODZ, 91-348, POLAND	1232-1087	1896-494X		INT J OCCUP MED ENV	Int. J. Occup. Med. Environ. Health		2008	21	1					59	66		10.2478/v10001-008-0005-0			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	348ZG	WOS:000259248000005	18482902				2022-02-06	
J	Toomela, A				Toomela, Aaro			Word meaning structure as a predictor of depression in Estonian defense forces	MILITARY PSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SELF-ESTEEM; PERSONALITY; INVENTORY; DISORDER; RISK; AGGRESSION; SYMPTOMS; SUICIDE; COPE	This study examined psychological factors that predict the level of depression and the role of the dominant type of word meaning structure in the prediction of the level of depression. Native-born Estonian male recruits (N = 687), 18-28 years old, completed psychological tests assessing depression, dominant type of word meaning structure, cognitive ability, personality, self-esteem, coping style, and aggressiveness during the first month of their compulsory military service. The level of depression was assessed a second time about 4-5 months later. The study found that the level of depression could be predicted by a set of psychological factors. Both the accuracy of prediction and the list of psychological factors related to the prediction of depression depended on the dominant type of word meaning structure.	Univ Tartu, Dept Special Educ, EE-50103 Tartu, Estonia		Toomela, A (corresponding author), Univ Tartu, Dept Special Educ, EE-50103 Tartu, Estonia.	aaro.toomela@ut.ee	Toomela, Aaro/H-6033-2018	Toomela, Aaro/0000-0002-8520-9676			ANDREASEN NC, 1977, COMPR PSYCHIAT, V18, P456; Bain GH, 2003, SOC PSYCH PSYCH EPID, V38, P632, DOI 10.1007/s00127-003-0685-5; Beck A.T., 1967, DEPRESSION CLIN; Booth-Kewley S, 2002, MIL MED, V167, P760, DOI 10.1093/milmed/167.9.760; BRAFF DL, 1983, COMPR PSYCHIAT, V24, P57, DOI 10.1016/0010-440X(83)90050-0; BRAFF DL, 1974, ARCH GEN PSYCHIAT, V31, P456; BRATTEMO CE, 1961, ACTA PSYCHOL, V18, P342, DOI 10.1016/0001-6918(61)90024-5; BROWN RG, 1994, PSYCHOL MED, V24, P829, DOI 10.1017/S0033291700028932; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Cheng H, 2003, PERS INDIV DIFFER, V34, P921, DOI 10.1016/S0191-8869(02)00078-8; Costa P. T., 1992, REVISED NEO PERSONAL; David AS, 2002, PSYCHOL MED, V32, P1357, DOI 10.1017/S0033291702006359; Davies S, 2001, BRIT MED J, V322, P1500, DOI 10.1136/bmj.322.7301.1500; Emerson CS, 2005, ARCH CLIN NEUROPSYCH, V20, P539, DOI 10.1016/j.acn.2004.10.003; Finch JF, 2001, J PERS, V69, P27, DOI 10.1111/1467-6494.00135; Funnell E, 2001, COGNITIVE NEUROPSYCH, V18, P323, DOI 10.1080/02643290042000134; Holden RR, 2002, CAN J BEHAV SCI, V34, P104, DOI 10.1037/h0087160; Kallasmaa T, 2000, EUR J PERSONALITY, V14, P265, DOI 10.1002/1099-0984(200005/06)14:3<265::AID-PER376>3.3.CO;2-2; Kallasmaa T, 2000, PERS INDIV DIFFER, V29, P881, DOI 10.1016/S0191-8869(99)00240-8; Kraaij V, 2002, ANXIETY STRESS COPIN, V15, P163, DOI 10.1080/10615800290028468; Leon-Carrion J, 2001, BRAIN INJURY, V15, P175, DOI 10.1080/026990501458407; Lonnqvist JK, 2000, INT HDB SUICIDE ATTE, P107; Lubin B, 1999, J CLIN PSYCHOL, V55, P71, DOI 10.1002/(SICI)1097-4679(199901)55:1<71::AID-JCLP7>3.3.CO;2-9; LURIA AR, 1979, JAZYK SOZNANIJE; Miner RC., 1996, COUNS PSYCHOL Q, V9, P163, DOI [10.1080/09515079608256361, DOI 10.1080/09515079608256361]; MUUG K, 1997, THESIS U TARTU ESTON; Nelson K., 1996, LANGUAGE COGNITIVE D; OU H, 2001, CHINESE MENTAL HLTH, V15, P340; Pullmann H, 2000, PERS INDIV DIFFER, V28, P701, DOI 10.1016/S0191-8869(99)00132-4; PULVER A, 1995, EUR J PERSONALITY, V9, P109, DOI 10.1002/per.2410090205; PULVER A, 1999, VAIMSETE VOIMETE SKA; Rosenberg, 1985, DEV SELF, V1, P205; ROSENBERG M, 1989, AM SOCIOL REV, V54, P1004, DOI 10.2307/2095720; Rosenberg M., 1965, SOC ADOLESCENT SELF; Toomela A, 1996, CULT PSYCHOL, V2, P285, DOI 10.1177/1354067X9600200305; Toomela A, 2003, J PERS SOC PSYCHOL, V85, P723, DOI 10.1037/0022-3514.85.4.723; Toomela A, 1999, BRAIN COGNITION, V39, P187, DOI 10.1006/brcg.1999.1077; TOOMELA A, 2003, CULTURAL GUIDANCE DE, P163; TOOMELA A, 2003, DIALOGICALITY DEV, P129; Vygotsky, 1996, MYSHLENIJE RECH; Vygotsky Lev Semionovich, 1994, VYGOTSKY READER, P99; Wolfersdorf M, 1999, PSYCHOTHERAPEUT, V44, P94, DOI 10.1007/s002780050152; Zammit S, 2004, ARCH GEN PSYCHIAT, V61, P354, DOI 10.1001/archpsyc.61.4.354; [No title captured]	45	3	3	0	4	LAWRENCE ERLBAUM ASSOC INC-TAYLOR & FRANCIS	PHILADELPHIA	325 CHESTNUT STREET, STE 800, PHILADELPHIA, PA 19106 USA	0899-5605			MIL PSYCHOL	Milit. Psychol.		2008	20	2					103	114		10.1080/08995600701869551			12	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	295JG	WOS:000255470200004					2022-02-06	
J	Weant, KA; Cook, AM				Weant, Kyle A.; Cook, Aaron M.			Pharmacologic Strategies for the Treatment of Elevated Intracranial Pressure Focus on Osmotherapy	ADVANCED EMERGENCY NURSING JOURNAL			English	Article						brain injury; hypertonic saline; intracranial hypertension; intracranial pressure; mannitol	7.5-PERCENT SODIUM-CHLORIDE; HYPERTONIC SALINE SOLUTION; HEAD-INJURED PATIENTS; CEREBRAL EDEMA; BRAIN-INJURY; BLOOD-FLOW; MANNITOL; RESUSCITATION; TRAUMA; INFUSION	Cerebral edema is a significant cause of elevated intracranial pressure and a consequence of secondary injury following traumatic brain injury. The use of hyperosmolar agents has been theorized to reduce intracranial pressure through osmotic effects on the water content of the injured brain. The most commonly used agents for this purpose are mannitol and hypertonic saline. While these agents have demonstrated efficacy, prospective, randomized clinical data are somewhat limited. This article reviews the available data concerning the safety, efficacy, and monitoring of osmotic agents when used to treat elevated intracranial pressure.	[Weant, Kyle A.] Univ North Carolina Hosp, Chapel Hill, NC USA; [Weant, Kyle A.] Univ N Carolina, Sch Pharm, Chapel Hill, NC USA; [Cook, Aaron M.] Univ Kentucky, Coll Pharm, Lexington, KY 40506 USA		Weant, KA (corresponding author), 101 Manning Dr, Chapel Hill, NC 27514 USA.	kweant@unch.unc.edu		Cook, Aaron/0000-0001-8539-902X			BARRY KG, 1961, NEW ENGL J MED, V264, P1085, DOI 10.1056/NEJM196105252642105; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; BAXT WG, 1987, J TRAUMA, V27, P602, DOI 10.1097/00005373-198706000-00003; Bhardwaj Anish, 2004, Curr Opin Crit Care, V10, P126, DOI 10.1097/00075198-200404000-00009; Biestro A, 1997, ACTA NEUROCHIR, V139, P725, DOI 10.1007/BF01420045; BOLDT J, 1991, BRIT J ANAESTH, V67, P595, DOI 10.1093/bja/67.5.595; BOURGOUIN PM, 1995, AM J NEURORADIOL, V16, P1495; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; BURKE AM, 1981, J NEUROSURG, V55, P550, DOI 10.3171/jns.1981.55.4.0550; Clausen T, 2001, BRAIN RES, V908, P35, DOI 10.1016/S0006-8993(01)02566-5; CONSTABLE PD, 1995, AM J VET RES, V56, P1513; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; FEIG PU, 1977, NEW ENGL J MED, V297, P1444, DOI 10.1056/NEJM197712292972608; FENSTERMACHER JD, 1966, AM J PHYSIOL, V211, P341, DOI 10.1152/ajplegacy.1966.211.2.341; FRASER PA, 1990, J PHYSIOL-LONDON, V423, P343, DOI 10.1113/jphysiol.1990.sp018026; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Hartl R, 1997, J TRAUMA, V42, pS41, DOI 10.1097/00005373-199705001-00008; Harukuni Izumi, 2002, J Anesth, V16, P229, DOI 10.1007/s005400200030; Holcroft J W, 1989, Prog Clin Biol Res, V299, P331; HOLCROFT JW, 1987, ANN SURG, V206, P279, DOI 10.1097/00000658-198709000-00006; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; HUANG PP, 1995, ANN SURG, V221, P543, DOI 10.1097/00000658-199505000-00012; Huang SJ, 2006, SURG NEUROL, V65, P539, DOI 10.1016/j.surneu.2005.11.019; JAFAR JJ, 1986, J NEUROSURG, V64, P754, DOI 10.3171/jns.1986.64.5.0754; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; KIEN ND, 1991, CIRC SHOCK, V35, P109; Kramer GC, 2003, J TRAUMA, V54, pS89, DOI 10.1097/01.TA.0000065609.82142.F1; LIEN YHH, 1995, J CLIN INVEST, V95, P1579, DOI 10.1172/JCI117831; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; Mazzoni MC, 1995, INT J MICROCIRC, V15, P265, DOI 10.1159/000179028; MENDELOW AD, 1985, J NEUROSURG, V63, P43, DOI 10.3171/jns.1985.63.1.0043; MOON PF, 1991, AM J VET RES, V52, P1611; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ogden AT, 2005, NEUROSURGERY, V57, P207, DOI 10.1227/01.NEU.0000166533.79031.D8; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Poli de Figueiredo L F, 1995, Cardiovasc Surg, V3, P679; Prough DS, 1998, CRIT CARE MED, V26, P421, DOI 10.1097/00003246-199803000-00002; Qureshi AI, 1999, J TRAUMA, V47, P659, DOI 10.1097/00005373-199910000-00009; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; RAPOPORT SI, 1979, BRAIN RES, V172, P354, DOI 10.1016/0006-8993(79)90546-8; Sayre MR, 1996, ACAD EMERG MED, V3, P840, DOI 10.1111/j.1553-2712.1996.tb03528.x; Schell RM, 1996, J NEUROSURG ANESTH, V8, P178, DOI 10.1097/00008506-199604000-00022; SCHWARTZ ML, 1984, CAN J NEUROL SCI, V11, P434, DOI 10.1017/S0317167100045960; Schwarz S, 1998, STROKE, V29, P1550, DOI 10.1161/01.STR.29.8.1550; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; SHACKFORD SR, 1994, J TRAUMA, V37, P899, DOI 10.1097/00005373-199412000-00005; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; SMERLING A, 1992, J NEUROSURG ANESTH, V4, P1, DOI 10.1097/00008506-199201000-00001; SMITH HP, 1986, J NEUROSURG, V65, P820, DOI 10.3171/jns.1986.65.6.0820; Suarez JI, 1999, J NEUROSURG ANESTH, V11, P178, DOI 10.1097/00008506-199907000-00004; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Suarez Jose I, 2004, Cleve Clin J Med, V71 Suppl 1, pS9; The Joint Commission, 2005, 2005 HOSP NAT PAT SA; VASSAR MJ, 1990, ARCH SURG-CHICAGO, V125, P1309; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Vincent JL, 2005, CRIT CARE MED, V33, P1392, DOI 10.1097/01.CCM.0000166890.93559.2D; Wade CE, 1997, SURGERY, V122, P609, DOI 10.1016/S0039-6060(97)90135-5; Wakai A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub4; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; WORTHLEY LIG, 1988, J NEUROSURG, V68, P478, DOI 10.3171/jns.1988.68.3.0478; Zornow MH, 1996, J NEUROSURG ANESTH, V8, P175, DOI 10.1097/00008506-199604000-00021	66	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1931-4485	1931-4493		ADV EMERG NURS J	Adv. Emerg. Nurs. J.	JAN-MAR	2008	30	1					17	26		10.1097/01.TME.0000311542.95656.92			10	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	V93MA	WOS:000213064300004					2022-02-06	
J	Wilbur, R; Wilk, C; Silver, R; Parente, R				Wilbur, Rebecca; Wilk, Chris; Silver, Rebecca; Parente, Rick			Validity and reliability of self-monitoring indices	BRAIN INJURY			English	Article						self-monitoring; intelligence; executive control	ACQUIRED BRAIN-INJURY; AWARENESS; REHABILITATION; PERFORMANCE; STUDENTS	Primary objective: This research concerns the measurement of self-monitoring in people who were diagnosed with traumatic brain injury (TBI), learning disability (LD) and emotional disorder (ED). Two measures of self-monitoring were evaluated: (1) the correlation between participants' self-predicted and observed standardized sub-test scores (R) on 17 WAIS-III 1 sub-tests and (2) the average difference between the participants' predicted and observed sub-tests scores (B). It was then determined if these measures could discriminate the three diagnostic groups. Research design: Canonical analysis assessed the relationship between the self-monitoring measures and four WAIS-III IQ measures. This study also evaluated if the R and B measures could discriminate the diagnostic groups. Methods and procedures: One hundred and twenty-four participants, 42 with TBI, 42 with LD and 40 with ED predicted their performance on 17 WAIS-III sub-tests. Main outcomes and results: Canonical analysis demonstrated a significant relationship between the R and B measures and four WAIS-III IQ measures. Results of a MANOVA showed that the R and B measures differed significantly among the diagnostic groups. Conclusions: The R and B measures are two valid and reliable indices of self-monitoring that can be conveniently estimated from the WAIS-III.	[Parente, Rick] Towson Univ, Dept Psychol, Towson, MD 21252 USA		Parente, R (corresponding author), Towson Univ, Dept Psychol, Towson, MD 21252 USA.	rparente07@yahoo.com	Parente, Frederick/W-2570-2019	Parente, Frederick/0000-0002-2784-3433			Ackerman PL, 2007, J EXP PSYCHOL-APPL, V13, P57, DOI 10.1037/1076-898X.13.2.57; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Cohen RJ, 2002, PSYCHOL TESTING ASSE; Dugbartey A T, 1999, Semin Clin Neuropsychiatry, V4, P5; FINGERMAN KL, 1994, INT J AGING HUM DEV, V36, P363; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; HALLAHAN DP, 1979, LEARN DISABILITY Q, V2, P24, DOI 10.2307/1511021; Holliday F, 1949, OCCUP PSYCHOL, V23, P112; KRATOCHWILL TR, 1976, J CONSULT CLIN PSYCH, V44, P879, DOI 10.1037/0022-006X.44.5.879; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Ownsworth T, 2006, REHABIL PSYCHOL, V51, P50, DOI 10.1037/0090-5550.51.1.50; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; RIM Y, 1982, PERS INDIV DIFFER, V3, P219, DOI 10.1016/0191-8869(82)90038-1; Rock ML, 2005, J POSIT BEHAV INTERV, V7, P3, DOI 10.1177/10983007050070010201; ROONEY K, 1985, J LEARN DISABIL, V18, P384, DOI 10.1177/002221948501800703; Stankov L, 1996, PERS INDIV DIFFER, V21, P971, DOI 10.1016/S0191-8869(96)00130-4; STANKOV L, 2000, PSYCHOL BEITR, V42, P213; WESCHLER D, 1981, WESCHLER ADULT INTEL	19	3	3	0	4	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2008	22	9					685	690		10.1080/02699050802270014			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	336NS	WOS:000258371600005	18698518				2022-02-06	
J	Carter, BG; Buttt, W; Taylor, A				Carter, B. G.; Buttt, W.; Taylor, A.			Bilaterally absent pupillary responses: not always a bad sign	ANAESTHESIA AND INTENSIVE CARE			English	Article; Proceedings Paper	Congress of the European-Society-of-Intensive-Care-Medicine	2006	Amsterdam, NETHERLANDS	European Soc Intens Care Med		pupillary response; brain injury; traumatic brain injury; false positive; outcome prediction	SEVERE HEAD-INJURY; SOMATOSENSORY-EVOKED POTENTIALS; BRAIN-STEM REFLEXES; CARDIAC-ARREST; CARDIOPULMONARY-RESUSCITATION; COMATOSE SURVIVORS; EARLY PREDICTION; TRAUMATIC COMA; ISCHEMIC COMA; PROGNOSIS	Pupillary responses are a simple test commonly used as a predictor of outcome after severe brain injury. It is also common for clinicians to associate bilaterally absent pupillary responses with very poor prognosis. We report a series of cases of severely brain injured children with bilaterally absent pupillary responses who had favourable outcomes. From a group of 89 patients with brain injury, 32 had bilaterally absent pupillary responses and AV (four with traumatic brain injury and two with infective brain injury) subsequently had favourable outcomes. This represents 18.8% of patients and should be a reminder to clinicians that the clinical sign of bilaterally absent pupillary responses is not always associated with a hopeless outcome.	[Carter, B. G.; Buttt, W.; Taylor, A.] Royal Childrens Hosp, Intens Care Unit, Melbourne, Vic, Australia		Carter, BG (corresponding author), Royal Childrens Hosp, Intens Care Unit, Melbourne, Vic, Australia.						Attia J, 1998, CRIT CARE CLIN, V14, P497, DOI 10.1016/S0749-0704(05)70013-0; Bassetti C, 1996, J NEUROL NEUROSUR PS, V61, P610, DOI 10.1136/jnnp.61.6.610; Booth CM, 2004, JAMA-J AM MED ASSOC, V291, P870, DOI 10.1001/jama.291.7.870; BORN JD, 1988, ACTA NEUROCHIR, V91, P1, DOI 10.1007/BF01400520; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; Carter BG, 2005, INTENS CARE MED, V31, P840, DOI 10.1007/s00134-005-2634-0; Chen R, 1996, CRIT CARE MED, V24, P672, DOI 10.1097/00003246-199604000-00020; Claassen J, 2001, CRIT CARE MED, V29, P494, DOI 10.1097/00003246-200103000-00005; EDGREN E, 1994, LANCET, V343, P1055, DOI 10.1016/S0140-6736(94)90179-1; EDGREN E, 1987, CRIT CARE MED, V15, P820, DOI 10.1097/00003246-198709000-00004; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; HAHN YS, 1988, CHILD NERV SYST, V4, P34; JENNETT B, 1976, LANCET, V1, P1031; Jorgensen EO, 1998, RESUSCITATION, V36, P111, DOI 10.1016/S0300-9572(97)00094-4; JORGENSEN EO, 1981, RESUSCITATION, V9, P133, DOI 10.1016/0300-9572(81)90023-X; KAISER G, 1984, NEUROPEDIATRICS, V15, P68, DOI 10.1055/s-2008-1052344; LEVY DE, 1981, ANN INTERN MED, V94, P293, DOI 10.7326/0003-4819-94-3-293; LEVY DE, 1985, JAMA-J AM MED ASSOC, V253, P1420, DOI 10.1001/jama.253.10.1420; MARSHALL LF, 1991, J NEUROSURG S, V75, P28; Meeker Michele, 2005, J Neurosci Nurs, V37, P34; MONASTERIO F, 1997, CLIN INTENSIVE CARE, V8, P126; MYBURGH JA, 1997, INTENSIVE CARE MANUA, P376; PFENNINGER J, 1984, Z KINDERCHIR, V39, P223; Plum F., 1985, DIAGNOSIS STUPOR COM; SIESJO BK, 1988, CRIT CARE MED, V16, P954, DOI 10.1097/00003246-198810000-00006; SNYDER BD, 1981, NEUROLOGY, V31, P1092, DOI 10.1212/WNL.31.9.1092; TORRANCE GW, 1982, OPER RES, V30, P1043, DOI 10.1287/opre.30.6.1043; Zandbergen EGJ, 2006, NEUROLOGY, V66, P62, DOI 10.1212/01.wnl.0000191308.22233.88; Zandbergen EGJ, 1998, LANCET, V352, P1808, DOI 10.1016/S0140-6736(98)04076-8	29	3	3	0	2	AUSTRALIAN SOC ANAESTHETISTS	EDGECLIFF	P O BOX 600, EDGECLIFF, NSW 2027, AUSTRALIA	0310-057X			ANAESTH INTENS CARE	Anaesth. Intensive Care	DEC	2007	35	6					984	987		10.1177/0310057X0703500623			4	Anesthesiology; Critical Care Medicine	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	245QM	WOS:000251950500023	18084996	Bronze			2022-02-06	
J	Rozet, I; Domino, KB				Rozet, Irene; Domino, Karen B.			Respiratory care	BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY			English	Article						brain injury; subarachnoid haemorrhage; hyperventilation; lung-protective strategy of ventilation; PEEP; weaning; extubation; tracheostomy	CEREBRAL PERFUSION-PRESSURE; CRITICAL ILLNESS POLYNEUROPATHY; VENTILATOR-ASSOCIATED PNEUMONIA; BRAIN NATRIURETIC PEPTIDE; END-EXPIRATORY PRESSURE; ANEURYSMAL SUBARACHNOID HEMORRHAGE; MULTIPLE TRAUMA PATIENTS; CRITICALLY-ILL PATIENTS; ACUTE LUNG INJURY; INTENSIVE-CARE	Purpose of the review: Neurosurgical patients frequently develop respiratory complications, adversely affecting neurologic outcome and survival. The review summarizes current literature and management of respiratory complications associated with brain injury. Major findings: Respiratory complications are commonly associated with traumatic brain injury and subarachnoid haemorrhage. Lung-protective ventilation with reduced tidal volumes improves outcome in acute lung injury, and should be applied to neurosurgical patients in the absence of increased intracranial pressure. Weaning from the mechanical ventilation should be initiated as soon as possible, although the role of neurological status in the weaning process is not clear. Prevention of pneumonia and aspiration improves survival. In patients with difficult weaning, early bedside percutaneous tracheostomy should be considered. Further Investigations: Further studies are warranted to elucidate an optimal oxygenation and ventilation in brain-injured patients, weaning strategies, predictors of the failed weaning and extubation, respiratory support in patients with difficulties to wean, and early tracheostomy.	[Domino, Karen B.] Univ Washington, Sch Med, Dept Anesthesiol, 1959 NE Pacific St,Box 356540, Seattle, WA 98195 USA		Domino, KB (corresponding author), Univ Washington, Sch Med, Dept Anesthesiol, 1959 NE Pacific St,Box 356540, Seattle, WA 98195 USA.	irozet@u.washington.edu; kdomino@u.washington.edu					Bein T, 2005, J TRAUMA, V58, P1294, DOI 10.1097/01.TA.0000173275.06947.5C; BELLAMY R, 1973, J NEUROSURG, V39, P596, DOI 10.3171/jns.1973.39.5.0596; Bercker S, 2005, CRIT CARE MED, V33, P711, DOI 10.1097/01.CCM.0000157969.46388.A2; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; BOLTON CF, 1984, J NEUROL NEUROSUR PS, V47, P1223, DOI 10.1136/jnnp.47.11.1223; Boyce JM, 2002, AM J INFECT CONTROL, V30, pS1, DOI 10.1067/mic.2002.130391; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P471; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; BROCHARD L, 1994, AM J RESP CRIT CARE, V150, P896, DOI 10.1164/ajrccm.150.4.7921460; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Bruder N, 1999, ANESTH ANALG, V89, P674, DOI 10.1097/00000539-199909000-00027; Caricato A, 2005, J TRAUMA, V58, P571, DOI 10.1097/01.TA.0000152806.19198.DB; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Coplin WM, 2000, AM J RESP CRIT CARE, V161, P1530, DOI 10.1164/ajrccm.161.5.9905102; D'Amico R, 1998, BMJ-BRIT MED J, V316, P1275, DOI 10.1136/bmj.316.7140.1275; David M, 2005, ACTA ANAESTH SCAND, V49, P209, DOI 10.1111/j.1399-6576.2004.00570.x; de Jonge E, 2003, LANCET, V362, P1011, DOI 10.1016/S0140-6736(03)14409-1; De Jonghe B, 1998, INTENS CARE MED, V24, P1242, DOI 10.1007/s001340050757; De Jonghe B, 2004, INTENS CARE MED, V30, P1117, DOI 10.1007/s00134-004-2174-z; DEVIVO MJ, 1993, ARCH PHYS MED REHAB, V74, P248; DOMINO KB, 1993, ANESTHESIOLOGY, V78, P91, DOI 10.1097/00000542-199301000-00014; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Epstein SK, 1998, AM J RESP CRIT CARE, V158, P489, DOI 10.1164/ajrccm.158.2.9711045; Esteban A, 1999, AM J RESP CRIT CARE, V159, P512, DOI 10.1164/ajrccm.159.2.9803106; Farias JA, 2001, INTENS CARE MED, V27, P1649, DOI 10.1007/s001340101035; FISHBURN MJ, 1990, ARCH PHYS MED REHAB, V71, P197; Francois B, 2007, LANCET, V369, P1083, DOI 10.1016/S0140-6736(07)60526-1; Friedman JA, 2003, NEUROSURGERY, V52, P1025, DOI 10.1227/01.NEU.0000058222.59289.F1; Garnacho-Montero J, 2005, CRIT CARE MED, V33, P349, DOI 10.1097/01.CCM.0000153521.41848.7E; Garnacho-Montero J, 2001, INTENS CARE MED, V27, P1288, DOI 10.1007/s001340101009; Georgiadis D, 2001, STROKE, V32, P2088, DOI 10.1161/hs0901.095406; Girou E, 2002, BRIT MED J, V325, P362, DOI 10.1136/bmj.325.7360.362; Gruber A, 1999, CRIT CARE MED, V27, P505, DOI 10.1097/00003246-199903000-00026; Heyland DK, 1999, CRIT CARE MED, V27, P2399, DOI 10.1097/00003246-199911000-00013; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Huynh T, 2002, J TRAUMA, V53, P488, DOI 10.1097/00005373-200209000-00016; Huynh T, 2002, J TRAUMA, V53, P92; Imberti R, 2002, J NEUROSURG, V96, P97, DOI 10.3171/jns.2002.96.1.0097; JACKSON AB, 1994, ARCH PHYS MED REHAB, V75, P270, DOI 10.1016/0003-9993(94)90027-2; Kluger Y, 1996, Eur J Emerg Med, V3, P95, DOI 10.1097/00063110-199606000-00007; Koh WY, 1997, ANAESTH INTENS CARE, V25, P365, DOI 10.1177/0310057X9702500407; Kollef MH, 2004, CRIT CARE MED, V32, P1396, DOI 10.1097/01.CCM.0000128569.09113.FB; Kollef MH, 2003, CHEST, V123, p464S, DOI 10.1378/chest.123.5_suppl.464S; Kollef MH, 1997, CHEST, V112, P765, DOI 10.1378/chest.112.3.765; Kostadima E, 2005, EUR RESPIR J, V26, P106, DOI 10.1183/09031936.05.00096104; Leal-Noval SR, 2000, CRIT CARE MED, V28, P935, DOI 10.1097/00003246-200004000-00004; Lee VH, 2006, J NEUROSURG, V105, P264, DOI 10.3171/jns.2006.105.2.264; LEMAIRE F, 1988, ANESTHESIOLOGY, V69, P171, DOI 10.1097/00000542-198808000-00004; Leone M, 2002, CRIT CARE MED, V30, P1741, DOI 10.1097/00003246-200208000-00011; Lopez-Aguilar J, 2005, CRIT CARE MED, V33, P1077, DOI 10.1097/01.CCM.0000162913.72479.F7; Lowe GJ, 2006, CURR OPIN CRIT CARE, V12, P3, DOI 10.1097/01.ccx.0000198055.29600.4b; Magnoni S, 2003, J NEUROSURG, V98, P952, DOI 10.3171/jns.2003.98.5.0952; MAHUL P, 1992, INTENS CARE MED, V18, P20, DOI 10.1007/BF01706421; MALIK AB, 1985, CIRC RES, V57, P1; Martinez-Perez M, 2004, INTENS CARE MED, V30, P2021, DOI 10.1007/s00134-004-2439-6; Mascia L, 2005, INTENS CARE MED, V31, P373, DOI 10.1007/s00134-004-2491-2; McClelland RL, 2003, NEUROSURGERY, V52, P31; McGirt MJ, 2004, NEUROSURGERY, V55, P473, DOI 10.1227/00006123-200408000-00100; McGirt MJ, 2004, NEUROSURGERY, V54, P1369, DOI 10.1227/01.NEU.0000125016.37332.50; Mekontso-Dessap A, 2006, INTENS CARE MED, V32, P1529, DOI 10.1007/s00134-006-0339-7; Muench E, 2005, CRIT CARE MED, V33, P2367, DOI 10.1097/01.CCM.0000181732.37319.DF; Namen AM, 2001, AM J RESP CRIT CARE, V163, P658, DOI 10.1164/ajrccm.163.3.2003060; Nathens AB, 1999, ARCH SURG-CHICAGO, V134, P170, DOI 10.1001/archsurg.134.2.170; Nekludov M, 2006, ACTA ANAESTH SCAND, V50, P932, DOI 10.1111/j.1399-6576.2006.01099.x; Pelosi P, 2005, CURR OPIN CRIT CARE, V11, P37, DOI 10.1097/00075198-200502000-00006; Petrucci N, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD003844.PUB2; Pinsky MR, 2000, INTENS CARE MED, V26, P1164, DOI 10.1007/s001340000619; PINSKY MR, 1983, J APPL PHYSIOL, V54, P950, DOI 10.1152/jappl.1983.54.4.950; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Quinio B, 1996, CHEST, V109, P765, DOI 10.1378/chest.109.3.765; Qureshi AI, 2000, CRIT CARE MED, V28, P1383, DOI 10.1097/00003246-200005000-00020; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Reinert M, 2003, ACTA NEUROCHIR WIEN, V145, P9; Reinprecht A, 2003, CRIT CARE MED, V31, P1831, DOI 10.1097/01.CCM.0000063453.93855.0A; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Salam A, 2004, INTENS CARE MED, V30, P1334, DOI 10.1007/s00134-004-2231-7; Salim A, 2004, J TRAUMA, V57, P542, DOI 10.1097/01.TA.0000135159.94744.5F; SCHUMACKER PT, 1979, AM REV RESPIR DIS, V119, P33; SOLENSKI NJ, 1995, CRIT CARE MED, V23, P1007, DOI 10.1097/00003246-199506000-00004; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; Stocchetti N, 2000, INTENS CARE MED, V26, P1101, DOI 10.1007/s001340051324; Stocchetti N, 2000, J NEUROSURG ANESTH, V12, P307, DOI 10.1097/00008506-200010000-00002; Sugerman HJ, 1997, J TRAUMA, V43, P741, DOI 10.1097/00005373-199711000-00002; Sviri GE, 2006, ACTA NEUROCHIR, V148, P529, DOI 10.1007/s00701-005-0666-4; Teramoto S, 2004, CHEST, V125, P801, DOI 10.1378/chest.125.2.801; Teramoto S, 2003, LANCET, V362, P493, DOI 10.1016/S0140-6736(03)14080-9; Thelandersson A, 2006, ACTA ANAESTH SCAND, V50, P937, DOI 10.1111/j.1399-6576.2006.01037.x; TORRES A, 1995, AM J RESP CRIT CARE, V152, P137, DOI 10.1164/ajrccm.152.1.7599812; Tsubokawa T, 2004, NEUROL RES, V26, P893, DOI 10.1179/016164104225017776; Tung PP, 2005, STROKE, V36, P1567, DOI 10.1161/01.STR.0000170699.59783.d6; VALLES J, 1995, ANN INTERN MED, V122, P179, DOI 10.7326/0003-4819-122-3-199502010-00004; Vallverdu I, 1998, AM J RESP CRIT CARE, V158, P1855, DOI 10.1164/ajrccm.158.6.9712135; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Vonberg RP, 2006, INTENS CARE MED, V32, P1329, DOI 10.1007/s00134-006-0241-3; WITT NJ, 1991, CHEST, V99, P176, DOI 10.1378/chest.99.1.176; YANG KL, 1991, NEW ENGL J MED, V324, P1445, DOI 10.1056/NEJM199105233242101; Yarlagadda S, 2006, NEUROCRIT CARE, V5, P102, DOI 10.1385/NCC:5:2:102; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	105	3	3	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1521-6896	1878-1608		BEST PRACT RES-CLIN	Best Pract. Res.-Clin Anaesth.	DEC	2007	21	4					465	482		10.1016/j.bpa.2007.07.001			18	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	V27TF	WOS:000215381400004	18286832				2022-02-06	
J	Bishnoi, M; Chopra, K; Kulkarni, SK				Bishnoi, M.; Chopra, K.; Kulkarni, S. K.			U-74500A (Lazaroid), a 21-aminosteroid attenuates neuroleptic-induced orofacial dyskinesia	METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY			English	Article						haloperidol; MDA; Orofacial dyskinesia; U-74500A	POSSIBLE ANTIOXIDANT; OXIDATIVE STRESS; MECHANISMS; PATHOPHYSIOLOGY; INVOLVEMENT; INHIBITORS; RESERPINE; MODEL	21-Ammosteroid, or lazaroid, is one of a novel class of antioxidant drugs designed to inhibit iron-dependent lipid peroxidation in biological lipid environments. They have shown promising results in several animal models of traumatic, ischemic and hemorrhagic injury of the central nervous system. Neuroleptic-induced orofacial dyskinesio is an animal model of tardive dyskinesia whose pathophysiology has been related to oxidative stress in the basal ganglia. In this study, we have examined the protective role of U-74500A [pregna-1,4,9(11)-triene-3,20-dione, 21-(4-(5,6-bis(diethylamino) -2-pyridinyl)-1-piperazinyl)-16-ethyl-HCl (16-alpha)], a 21-aminosteroid having antioxidant property in attenuating the behavioral and biochemical effects of chronic haloperidol and chlorpromazine administration. Haloperidol (1 mg/kg/day i.p.) and chlorpromazine (5 mglkglday i.p.) administered for 21 days caused a significant increase in vacuous chewing movements (VCMs), tongue protrusion (TP) and the number of facial twitchings (FT) observed on day 22. U-74500A (1, 2 and 5 mg/kg i.p.), administered every day, along with haloperidol (I mglkglday i.p.) and chlorpromazine (5 mglkglday), attenuated the increase of VCMs and related behaviors on day 22. Haloperidol and chlorpromazine significantly increased lipid peroxidation in various brain areas such as the cortex, striatum and subcortical parts characterized by an increase in MDA levels. The coadministration of U-74500A limited the effect of haloperidol and chlorpromazine on MDA levels in the cortex and striatum but not in the subcortical parts. U-74500A, an ammosteroid, may have therapeutic use in typical neuroleptic-induced tardive dyskinesia-like effects. (C) 2007 Prous Science. All rights reserved.	[Bishnoi, M.; Kulkarni, S. K.] Panjab Univ, CPEBS, Chandigarh 160014, India; [Chopra, K.; Kulkarni, S. K.] Panjab Univ, Div Pharmacol, Univ Inst Pharmaceut Sci, Chandigarh 160014, India		Kulkarni, SK (corresponding author), Panjab Univ, CPEBS, Chandigarh 160014, India.	skpu@yahoo.com					Baldessarini R. J., 2001, GOODMAN GILMANS PHAR, P485; Bishnoi M, 2007, PROG NEURO-PSYCHOPH, V31, P1130, DOI 10.1016/j.pnpbp.2007.04.007; Bishnoi M, 2007, PHARMACOLOGY, V79, P171, DOI 10.1159/000100924; Bishnoi M, 2006, EUR J PHARMACOL, V552, P55, DOI 10.1016/j.ejphar.2006.09.010; BRAUGHLER J M, 1989, Drugs of the Future, V14, P143; BRAUGHLER JM, 1987, J BIOL CHEM, V262, P10438; BRAUGHLER JM, 1988, J PHARMACOL EXP THER, V244, P423; Burger M, 2004, BRAIN RES BULL, V64, P339, DOI 10.1016/j.brainresbull.2004.09.006; Burger ME, 2005, PHARMACOL BIOCHEM BE, V81, P608, DOI 10.1016/j.pbb.2005.05.002; Burger ME, 2005, BRAIN RES, V1031, P202, DOI 10.1016/j.brainres.2004.10.038; Casey DE, 2004, J CLIN PSYCHIAT, V65, P25; FISHER M, 1990, STROKE, V21, P1435, DOI 10.1161/01.STR.21.10.1435; HALL ED, 1989, EFFECTS 21 AMINOSTER; Lohr JB, 2003, CNS DRUGS, V17, P47, DOI 10.2165/00023210-200317010-00004; LOHR JB, 1991, ARCH GEN PSYCHIAT, V48, P1097; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Naidu PS, 2003, NEUROPHARMACOLOGY, V44, P1100, DOI 10.1016/S0028-3908(03)00101-1; Naidu PS, 2002, BRIT J PHARMACOL, V136, P193, DOI 10.1038/sj.bjp.0704717; Naidu PS, 2001, BEHAV PHARMACOL, V12, P209, DOI 10.1097/00008877-200105000-00006; Tsai GC, 1998, AM J PSYCHIAT, V155, P1207, DOI 10.1176/ajp.155.9.1207; WADDINGTON JL, 1990, PSYCHOPHARMACOLOGY, V101, P431, DOI 10.1007/BF02244220; WILLS ED, 1966, BIOCHEM J, V99, P667, DOI 10.1042/bj0990667; WOLFARTH S, 1989, PROG NEURO-PSYCHOPH, V13, P799, DOI 10.1016/0278-5846(89)90036-5; YOUNG W, 1988, STROKE, V19, P1013, DOI 10.1161/01.STR.19.8.1013	24	3	3	0	1	PROUS SCIENCE, SAU-THOMSON REUTERS	BARCELONA	398 PROVENCA, 08025 BARCELONA, SPAIN	0379-0355	2013-0155		METHOD FIND EXP CLIN	Methods Find. Exp. Clin. Pharmacol.	NOV	2007	29	9					601	605		10.1358/mf.2007.29.9.1161006			5	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	253EX	WOS:000252502600003	18193111				2022-02-06	
J	Hsieh, CT; Lin, EY; Tsai, TH; Chiang, YH; Ju, DT				Hsieh, Cheng-Ta; Lin, En-Yuan; Tsai, Tung-Han; Chiang, Yung-Hsiao; Ju, Da-Tong			Delayed rupture of pre-existing cerebral aneurysm in a young patient with minor head trauma	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						head injury; pre-existing aneurysm; subarachnoid hemorrhage	SUBARACHNOID HEMORRHAGE	An intracranial saccular aneurysm is not commonly diagnosed in a patient with head injury. We present a patient with a history of minor head trauma and a CT scan of the brain revealing minimal subarachnoid hemorrhage 17 days prior to admission, complaining of severe headache, dysarthria and focal right limb seizures 3 hours prior to admission. A traumatic aneurysm was suspected based on clinical history and radiological findings including hematoma in the falx region on a CT scan of the brain and an aneurysm of the pericallosal artery on magnetic resonance angiography and four-vessel cerebral angiography. However, at craniotomy, an intracranial non-traumatic saccular aneurysm at the bifurcation of the pericallosal artery was found. The patient recovered fully after successful clipping the aneurysm. (C) 2006 Elsevier Ltd. All rights reserved.	Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Neurol Surg, Taipei 114, Taiwan		Ju, DT (corresponding author), Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Neurol Surg, 325 Cheng Kung Rd Sect 2, Taipei 114, Taiwan.	nogor@mail2000.com.tw		Ju, Da-Tong/0000-0003-1055-1597			Cairns CJS, 2003, ANAESTH INTENS CARE, V31, P87, DOI 10.1177/0310057X0303100117; Cummings TJ, 2000, NEUROL RES, V22, P165, DOI 10.1080/01616412.2000.11741055; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fainardi E, 2004, ACTA NEUROCHIR, V146, P257, DOI 10.1007/s00701-003-0207-y; Kakarieka A, 1997, NEUROL RES, V19, P230, DOI 10.1080/01616412.1997.11740804; Ogungbo B, 2003, J NEUROSURG, V98, P43, DOI 10.3171/jns.2003.98.1.0043; SENEGOR M, 1991, J NEUROSURG, V75, P475, DOI 10.3171/jns.1991.75.3.0475; Suzuki H, 2001, STROKE, V32, P2203; Tan TC, 2001, BRIT J NEUROSURG, V15, P137; TATSUNO Y, 1974, ARCH PATHOL, V97, P211	10	3	3	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2007	14	11					1120	1122		10.1016/j.jocn.2006.03.014			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	236CW	WOS:000251281600014	17954376				2022-02-06	
J	Bruder, N				Bruder, N.			Transfer of emergency neurosurgical patients: When and how?	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article						neurosurgery; head injury; emergency; teleradiology	SEVERE HEAD-INJURY; TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE-UNIT; MANAGEMENT; MORTALITY; IMPACT; TELERADIOLOGY; OUTCOMES; TOMOGRAPHY; HEMORRHAGE	The annual incidence of severe head injury lies between 9 and 25/100 000 inhabitants, depending on the criteria used for its definition. In most countries, the shortage in neurosurgical ICU beds makes it impossible to take in charge all patients with a severe brain injury. But the beneficial effect of a specialized neurosurgical ICU on outcome after brain injury has been demonstrated in several retrospective studies. Ideally, the best strategy is to admit the patients with a severe head injury directly in a neurosurgical centre. When this is not possible, the appropriate decision of a secondary transfer relies on the quality of the relationships between physicians in the community and the neurosurgical hospitals. Teleradiology is the best method to avoid unnecessary transportation or deleterious delays before transfer. In an era of decreasing medical budgets, technical improvements to enhance medical cooperation should be encouraged. (C) 2007 Elsevier Masson SAS. Tons droits reserves.	CHU Timone Adultes, F-13385 Marseille, France		Bruder, N (corresponding author), CHU Timone Adultes, 264 Rue St Pierre, F-13385 Marseille, France.	nicolas.bruder@ap-hm.fr					*AN, 2003, ET LIEUX TEL MED FRA; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Crimmins DW, 2000, J NEUROL NEUROSUR PS, V68, P8, DOI 10.1136/jnnp.68.1.8; Diringer MN, 2001, CRIT CARE MED, V29, P635, DOI 10.1097/00003246-200103000-00031; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Goh KYC, 1997, BRIT J NEUROSURG, V11, P52; Goh KYC, 1997, CAN J NEUROL SCI, V24, P235, DOI 10.1017/S0317167100021867; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Kirkpatrick AW, 1999, J TRAUMA, V46, P1017, DOI 10.1097/00005373-199906000-00006; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; Martin DK, 2003, J NEUROL NEUROSUR PS, V74, P1299, DOI 10.1136/jnnp.74.9.1299; Masson F, 2000, ANN FR ANESTH, V19, P261; McKeating EG, 1998, BRIT J NEUROSURG, V12, P7; Mirski MA, 2001, J NEUROSURG ANESTH, V13, P83, DOI 10.1097/00008506-200104000-00004; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Nathens AB, 2000, JAMA-J AM MED ASSOC, V283, P1990, DOI 10.1001/jama.283.15.1990; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Pierrot M, 2003, ANN FR ANESTH, V22, P12, DOI 10.1016/S0750-7658(02)00003-5; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; Sampalis JS, 1997, J TRAUMA, V43, P288, DOI 10.1097/00005373-199708000-00014; Schuhmann MU, 2001, J NEUROL NEUROSUR PS, V71, P182, DOI 10.1136/jnnp.71.2.182; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Stevenson MD, 2001, INJURY, V32, P267, DOI 10.1016/S0020-1383(00)00191-1; Yamada M, 2003, NEUROSURGERY, V52, P986, DOI 10.1227/01.NEU.0000053152.45258.74; Zimmerman JE, 1998, NEUROSURGERY, V42, P91, DOI 10.1097/00006123-199801000-00019	29	3	3	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0750-7658			ANN FR ANESTH	Ann. Fr. Anest. Reanim.	OCT	2007	26	10					873	877		10.1016/j.annfar.2007.06.011			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	224FG	WOS:000250432300011	17692495				2022-02-06	
J	Kreipke, CW; Morgan, RL; Petrov, T; Rafols, JA				Kreipke, Christian W.; Morgan, Randy L.; Petrov, Theodor; Rafols, Jose A.			Subcellular redistribution of calponin underlies sustained vascular contractility following traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						contractile protein; microvascular control; acceleration impact model	ENDOTHELIAL GROWTH-FACTOR; PORCINE CORONARY-ARTERY; NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE-C; SMOOTH-MUSCLE; EXPRESSION; PHOSPHORYLATION; CALDESMON; MODEL; RAT	Objectives: The purpose of this study was to observe temporal changes in calponin (Cp), a contractile protein, in response to traumatic brain injury (TBI). Methods: Double immunocytochemistry in conjunction with morphometric methods was used to study Cp temporal migration in smooth muscle cells (SM) of reacting microvessels following TBI, as induced using a weight-drop, acceleration impact method. Results: Quantification of migrated Cp in the SM wall after TBI was carried out on three-dimensional orthographic reconstructions of serial, digitally acquired images and optical densitometry. Color shifts in Cp intensity were measured in three arbitrary longitudinal compartments, luminal (lu), middle (m) and abluminal (ablu), of SM cytoplasm with respect to proximity to the vessel's lumen. By 24 and 48 hours after TBI, most Cp had migrated from the SM compartment closest to the lu to that farthest away or ablu. In addition, a qualitative increase in Cp was detected closest to the ablu compartment in those segments of the vessel severely constricted. Discussion: Cp migration from cytoskeletal to contractile regions of SM supports its role both in the initiation of vessel contractility and its interaction with cytoskeletal structures subjacent to the cell membrane in SM's contracted state.	Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA		Rafols, JA (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 E Canfield, Detroit, MI 48201 USA.	jrafols@med.wayne.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS039860] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039860] Funding Source: NIH RePORTER		Abu-Judeh HH, 1999, NUCL MED COMMUN, V20, P505, DOI 10.1097/00006231-199906000-00003; ALTURA BM, 1977, FED PROC, V36, P1853; ARBUSTINI E, 1993, AM J CARDIOL, V71, P1382, DOI 10.1016/0002-9149(93)90597-6; CATT KJ, 1984, J CARDIOVASC PHARM S, V6, P575; Fee DB, 2004, BRAIN RES, V1012, P52, DOI 10.1016/j.brainres.2004.03.028; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; Gimona M, 1996, BIOCH SMOOTH MUSCLE, P91; Graceffa P, 1996, J BIOL CHEM, V271, P30336, DOI 10.1074/jbc.271.48.30336; Kayali F, 2005, NEUROSCIENCE, V134, P1223, DOI 10.1016/j.neuroscience.2005.05.047; Kreipke CW, 2006, MICROVASC RES, V71, P197, DOI 10.1016/j.mvr.2006.02.002; LIN Y, 1993, J BIOCHEM-TOKYO, V113, P643, DOI 10.1093/oxfordjournals.jbchem.a124096; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSTON SB, 1991, BIOCHEM J, V279, P1; McBeth BD, 2005, ACAD EMERG MED, V12, P483, DOI 10.1197/j.aem.2004.11.028; Millatt LJ, 1999, REGUL PEPTIDES, V81, P1, DOI 10.1016/S0167-0115(99)00027-0; MINO T, 1995, BIOCHEM BIOPH RES CO, V208, P397, DOI 10.1006/bbrc.1995.1351; Mirzapoiazova T, 2005, J CELL PHYSIOL, V203, P520, DOI 10.1002/jcp.20244; Nag S, 2002, J NEUROPATH EXP NEUR, V61, P778, DOI 10.1093/jnen/61.9.778; Parker CA, 1998, J PHYSIOL-LONDON, V508, P187, DOI 10.1111/j.1469-7793.1998.187br.x; Petrov T, 2002, NEUROSCIENCE, V115, P275, DOI 10.1016/S0306-4522(02)00345-7; Petrov T, 2001, NEUROL RES, V23, P139, DOI 10.1179/016164101101198479; Petrov T, 2000, ACTA NEUROPATHOL, V100, P196, DOI 10.1007/s004019900167; Pohl J, 1997, AM J PHYSIOL-LUNG C, V272, pL115, DOI 10.1152/ajplung.1997.272.1.L115; Rafols D, 2004, NEUROSCI LETT, V362, P154, DOI 10.1016/j.neulet.2004.03.021; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Steiner J, 2004, NITRIC OXIDE-BIOL CH, V10, P162, DOI 10.1016/j.niox.2004.03.005; Suzuki R, 2003, ACTA NEUROCHIR SUPPL, V86, P277; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; Takahashi A, 1997, ACTA NEUROPATHOL, V93, P354, DOI 10.1007/s004010050627; Walsh MP, 1996, BIOCHEM CELL BIOL, V74, P485, DOI 10.1139/o96-053; WINDER SJ, 1993, BIOCHEM J, V296, P827, DOI 10.1042/bj2960827; Worth NF, 2001, CELL MOTIL CYTOSKEL, V49, P130, DOI 10.1002/cm.1027; Yang JX, 2004, ACTA BIOCH BIOPH SIN, V36, P529, DOI 10.1093/abbs/36.8.529; Yuasa U, 1999, J MOL CELL CARDIOL, V31, P1281, DOI 10.1006/jmcc.1999.0960	35	3	3	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412			NEUROL RES	Neurol. Res.	SEP	2007	29	6					604	609		10.1179/016164107X166317			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	218GY	WOS:000250005200014	17535561				2022-02-06	
J	Meixensberger, J; Renner, C				Meixensberger, J.; Renner, C.			Therapeutic hypothermia in the intensive care unit	ANAESTHESIST			German	Article						hypothermia; traumatic brain injury; subarachnoid hemorrhage; stroke; cardiac arrest; resuscitation	SEVERE HEAD-INJURY; CEREBRAL-ARTERY INFARCTION; TRAUMATIC BRAIN-INJURY; MILD HYPOTHERMIA; MODERATE HYPOTHERMIA; INTRACRANIAL-PRESSURE; CARDIAC-ARREST; SYSTEMIC HYPOTHERMIA; HYPERTENSION; FEASIBILITY	Experimental studies have demonstrated the neuroprotective effects of induced hypothermia in prevention of secondary insults following acute brain injury. Therefore, therapeutic hypothermia could be effective in the clinical setting of intensive care therapy. In this paper pathophysiological aspects of induced hypothermia are discussed and clinically relevant study results of hypothermia therapy are given in respect to evidence-based medicine.	Univ Leipzig, Klin & Poliklin Neurochirurg, D-04103 Leipzig, Germany		Meixensberger, J (corresponding author), Univ Leipzig, Klin & Poliklin Neurochirurg, D-04103 Leipzig, Germany.	meix@medizin.uni-leipzig.de					Adachi M, 2001, PEDIATR RES, V50, P590, DOI 10.1203/00006450-200111000-00010; Bernard S, 1996, ANAESTH INTENS CARE, V24, P382, DOI 10.1177/0310057X9602400315; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Berrouschot J, 1998, INTENS CARE MED, V24, P620, DOI 10.1007/s001340050625; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Hayashi S, 2002, ACT NEUR S, V81, P83; HIMMELSEHER S, 2004, INTENSIVMED NOTFAL S, V41, P147; Holzer M, 2002, NEW ENGL J MED, V346, P549; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; Nagao S, 2003, J CLIN NEUROSCI, V10, P208, DOI 10.1016/S0967-5868(02)00322-3; Nagao S, 2000, ACT NEUR S, V76, P547; OKU K, 1994, RESUSCITATION, V27, P141, DOI 10.1016/0300-9572(94)90007-8; Park CK, 1998, ACT NEUR S, V71, P225; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; Schwab S, 1998, ACT NEUR S, V71, P131; Schwab S, 2001, STROKE, V32, P2033, DOI 10.1161/hs0901.095394; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Sterz F, 1996, J NEUROSURG ANESTH, V8, P88, DOI 10.1097/00008506-199601000-00028; Tateishi A, 1998, NEUROSURGERY, V42, P1065, DOI 10.1097/00006123-199805000-00066; Thome C, 2005, NEUROL RES, V27, P229, DOI 10.1179/016164105X25252; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Winfree CJ, 1996, NEUROSURGERY, V38, P1216, DOI 10.1097/00006123-199606000-00034; Xu LJ, 2002, J CEREBR BLOOD F MET, V22, P21, DOI 10.1097/00004647-200201000-00003; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4	31	3	3	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	SEP	2007	56	9					945	948		10.1007/s00101-007-1225-6			4	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	212UG	WOS:000249621700017	17594066				2022-02-06	
J	Storozhuk, VM; Zinyuk, LE				Storozhuk, Viktor M.; Zinyuk, Larissa E.			Specific features of sensorimotor cerebral cortex activity modulation by dopamine releaser amantadine	EXPERIMENTAL BRAIN RESEARCH			English	Article						sensorimotor cortex; electrophysiology; conditioning; cat	POSITRON-EMISSION-TOMOGRAPHY; TRAUMATIC BRAIN-INJURY; PREFRONTAL CORTEX; CHANNEL BLOCK; MOTOR CORTEX; IN-VITRO; RECEPTOR; NEURONS; MEMANTINE; MEMORY	The modulatory effects of amantadine (1-adamantanamine) on the activity of sensorimotor cerebral cortex neurones during microiontophoretic application of agonists of glutamatergic and GABA-ergic (gamma-aminobutyric acid) transmission were studied. In non-anaesthetised cats, dopamine (DA) released by amantadine application in a small area of the neocortex increased baseline and evoked neuronal activity, providing stabilization and optimum course of both the neuronal and the conditioned responses of the animal. Amantadine eliminates a decrease in the level of neuronal baseline and evoked activity and marked increase in the latency of neuronal activation and conditioned movement mediated by D2 receptor antagonist sulpiride ((S)-5-aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl) methyl]-2-methoamantadineybenzamide) or GABA. This is reflected by a proportionate decrease in the onset of neuronal impulse reaction and latency of conditioned movement. Combined NMDA (N-methyl-D-aspartate) and amantadine application also caused a considerable increase in baseline and evoked activity, but produced a slightly weaker effect than that evoked by NMDA application alone. A decrease in the baseline and evoked neuronal activity after NMDA withdrawn lasted during next control session (up to 40 min). The ability of DA releaser amantadine to alleviate significant increase in the latency of neuronal responses and conditioned movement induced by sulpiride or GABA suggests that dopamine modulates the activity of GABA-ergic inhibitory fast spike interneurons in the cat sensorimotor cortex during conditioning.	Univ Bristol, MRC Ctr Synapt Plast, Dept Anat, Bristol BS8 1TD, Avon, England; Ukrainian Acad Sci, AA Bogomoletz Inst Physiol, UA-010024 Kiev, Ukraine		Zinyuk, LE (corresponding author), Univ Bristol, MRC Ctr Synapt Plast, Dept Anat, Univ Walk, Bristol BS8 1TD, Avon, England.	l.e.zynyuk@bris.ac.uk					AOKI FY, 1988, CLIN PHARMACOKINET, V14, P35, DOI 10.2165/00003088-198814010-00003; Awenowicz PW, 2002, J NEUROPHYSIOL, V88, P3439, DOI 10.1152/jn.00078.2002; Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; Blanchet PJ, 2003, ADV NEUROL, V91, P251; Blanpied TA, 2005, J NEUROSCI, V25, P3312, DOI 10.1523/JNEUROSCI.4262-04.2005; Blanpied TA, 1997, J NEUROPHYSIOL, V77, P309, DOI 10.1152/jn.1997.77.1.309; Chen GJ, 2004, P NATL ACAD SCI USA, V101, P2596, DOI 10.1073/pnas.0308618100; CHUGANI HT, 1991, J NUCL MED, V32, P23; DAVIES WL, 1964, SCIENCE, V144, P862, DOI 10.1126/science.144.3620.862; Deep P, 1999, SYNAPSE, V34, P313, DOI 10.1002/(SICI)1098-2396(19991215)34:4<313::AID-SYN7>3.0.CO;2-1; Floresco SB, 2001, BEHAV NEUROSCI, V115, P934, DOI 10.1037/0735-7044.115.4.934; GIANUTSOS G, 1985, EUR J PHARMACOL, V110, P357, DOI 10.1016/0014-2999(85)90564-3; GOLDMAN PS, 1971, EXP NEUROL, V32, P366, DOI 10.1016/0014-4886(71)90005-7; Gorelova N, 2002, J NEUROPHYSIOL, V88, P3150, DOI 10.1152/jn.00335.2002; Greene R, 2001, HIPPOCAMPUS, V11, P569, DOI 10.1002/hipo.1072.abs; HEIKKILA RE, 1972, EUR J PHARMACOL, V20, P156, DOI 10.1016/0014-2999(72)90144-6; Hesselink MB, 1999, J NEURAL TRANSM, V106, P803, DOI 10.1007/s007020050201; Kegeles LS, 2002, SYNAPSE, V43, P19, DOI 10.1002/syn.10010; Kraus MF, 2005, BRAIN INJURY, V19, P471, DOI 10.1080/02699050400025059; LIDOW MS, 1992, CEREB CORTEX, V2, P401, DOI 10.1093/cercor/2.5.401; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Moresco RM, 2002, J NEURAL TRANSM, V109, P1265, DOI 10.1007/s00702-002-0694-7; Mrzljak L, 1996, NATURE, V381, P245, DOI 10.1038/381245a0; Muly EC, 1998, J NEUROSCI, V18, P10553; PACKARD MG, 1991, BEHAV NEUROSCI, V105, P295, DOI 10.1037/0735-7044.105.2.295; PHILLIPS C. G., 1959, QUART JOUR EXPTL PHYSIOL, V44, P1; RICHFIELD EK, 1987, NEUROSCI LETT, V73, P203, DOI 10.1016/0304-3940(87)90245-X; Sawaguchi T, 2001, NEUROSCI RES, V41, P115, DOI 10.1016/S0168-0102(01)00270-X; SCHWAB RS, 1969, J AMER MED ASSOC, V208, P1168, DOI 10.1001/jama.208.7.1168; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seamans JK, 2001, J NEUROSCI, V21, P3628, DOI 10.1523/JNEUROSCI.21-10-03628.2001; Storozhuk V M, 2005, Neurosci Behav Physiol, V35, P655; Storozhuk VM, 2004, NEUROSCI LETT, V356, P127, DOI 10.1016/j.neulet.2003.11.039; Storozhuk VM, 2002, NEUROSCI LETT, V330, P171, DOI 10.1016/S0304-3940(02)00775-9; Von Voigtlander P F, 1971, Science, V174, P408, DOI 10.1126/science.174.4007.408; Winblad B, 1999, INT J GERIATR PSYCH, V14, P135, DOI 10.1002/(SICI)1099-1166(199902)14:2<135::AID-GPS906>3.0.CO;2-0	36	3	3	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	SEP	2007	182	2					157	167		10.1007/s00221-007-0976-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	208JE	WOS:000249314800002	17522851				2022-02-06	
J	Dheen, ST; Hao, AJ; Fu, J; Gopalakrishnakone, P; Ling, EA				Dheen, S. T.; Hao, A. J.; Fu, J.; Gopalakrishnakone, P.; Ling, E.-A.			Identification of differentially expressed genes in fetal rat forebrain exposed to a teratogen by cDNA microarray analysis	HISTOLOGY AND HISTOPATHOLOGY			English	Article						amoeboid microglia/brain macrophages; inflammation genes; fetal forebrain; teratogen; microarray	NEURAL-TUBE DEFECTS; NITRIC-OXIDE SYNTHASE; TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; CEREBRAL-ISCHEMIA; CATHEPSIN-B; IN-VITRO; MICROGLIA; ACID; EMBRYOS	In an attempt to understand the molecular basis underlying the neural tube defects induced by the teratogen, cyclophosphamide (CP), cDNA microarray analysis was carried out in neural tubes of embryos derived from normal and CP-treated rats. Genes found to have altered expression levels in CP-treated group were clustered into groups on the basis of their biological functions. The expression profile of different genes involved in transcription of molecules related to cell adhesion, inflammation, metabolism and neurotrophic factors pathways as well as in still undefined processes was differentially affected by the teratogen treatment. The most remarkable change was the up-regulation of genes related to an inflammatory process dominated by the fetal brain macrophages viz. amoeboid microglia. Amoeboid microglia/brain macrophage expansion, based on gene expression and histological analysis, was found to be vigorous at the subventricular region. The present results suggest that a vigorous inflammatory response involving amoeboid microglia/brain macrophages primarily is an important component in CP-induced prenatal development disorder.	Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Mol Neurobiol Lab, Singapore 117597, Singapore		Dheen, ST (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Mol Neurobiol Lab, Blk MD10,4 Med Dr, Singapore 117597, Singapore.	antstd@nus.edu.sg	Dheen, S. Thameem/AAU-8627-2020	Dheen, S. Thameem/0000-0001-9600-6789			Aguan K, 1998, DEV BRAIN RES, V111, P271, DOI 10.1016/S0165-3806(98)00145-X; Al Deeb S, 2000, NEUROSCI LETT, V292, P179, DOI 10.1016/S0304-3940(00)01457-9; Alizadeh AA, 2000, CURR OPIN IMMUNOL, V12, P219, DOI 10.1016/S0952-7915(99)00078-3; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Anthony D C, 2001, Prog Brain Res, V132, P507; Bacon KB, 2000, J NEUROIMMUNOL, V104, P92, DOI 10.1016/S0165-5728(99)00266-0; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Bannerman DD, 1998, J BIOL CHEM, V273, P35371, DOI 10.1074/jbc.273.52.35371; Bennett GD, 2000, REPROD TOXICOL, V14, P1, DOI 10.1016/S0890-6238(99)00064-7; Benveniste EN, 1997, J MOL MED-JMM, V75, P165, DOI 10.1007/s001090050101; BENVENISTE EN, 1992, AM J PHYSIOL, V263, P1; Bona E, 1999, PEDIATR RES, V45, P500, DOI 10.1203/00006450-199904010-00008; Bredt DS, 1999, FREE RADICAL RES, V31, P577, DOI 10.1080/10715769900301161; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Cobbs CS, 1997, BRAIN RES, V751, P336, DOI 10.1016/S0006-8993(96)01429-1; Craig JC, 2000, TERATOLOGY, V61, P305, DOI 10.1002/(SICI)1096-9926(200004)61:4<305::AID-TERA10>3.0.CO;2-8; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; De Groot C J, 2001, Prog Brain Res, V132, P533; DeSesso JM, 1999, AM J MED GENET, V87, P143, DOI 10.1002/(SICI)1096-8628(19991119)87:2<143::AID-AJMG6>3.0.CO;2-J; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FERM VH, 1986, PEDIATR RES, V20, P761, DOI 10.1203/00006450-198608000-00012; Galasso JM, 2000, EXP NEUROL, V165, P295, DOI 10.1006/exnr.2000.7466; Gebicke-Haerter P J, 2001, Prog Brain Res, V132, P525; Gebicke-Haerter PJ, 2001, MICROSC RES TECHNIQ, V54, P47, DOI 10.1002/jemt.1120; Grunblatt E, 2001, J NEUROCHEM, V78, P1, DOI 10.1046/j.1471-4159.2001.00397.x; Hansen DK, 2001, REPROD TOXICOL, V15, P21, DOI 10.1016/S0890-6238(00)00117-9; Hao AJ, 2001, J NEUROSCI RES, V64, P79, DOI 10.1002/jnr.1056; Ivnitsky I, 1998, AM J REPROD IMMUNOL, V40, P431, DOI 10.1111/j.1600-0897.1998.tb00430.x; Jin KL, 2001, ANN NEUROL, V50, P93, DOI 10.1002/ana.1073; Kingham PJ, 2001, J NEUROCHEM, V76, P1475, DOI 10.1046/j.1471-4159.2001.00146.x; Kiss JZ, 2001, BRAIN RES REV, V36, P175, DOI 10.1016/S0165-0173(01)00093-5; Lee SJ, 1999, J NEUROIMMUNOL, V98, P77, DOI 10.1016/S0165-5728(99)00084-3; McManus CM, 1998, J IMMUNOL, V160, P1449; MILLIGAN CE, 1995, NEURON, V15, P385, DOI 10.1016/0896-6273(95)90042-X; Mirnics K, 2001, NAT REV NEUROSCI, V2, P444, DOI 10.1038/35077587; Mody M, 2001, P NATL ACAD SCI USA, V98, P8862, DOI 10.1073/pnas.141244998; NAKAJIMA K, 1992, J NEUROCHEM, V58, P1401, DOI 10.1111/j.1471-4159.1992.tb11356.x; PADMANABHAN R, 1990, ACTA ANAT, V137, P5; PADMANABHAN R, 1988, TERATOLOGY, V37, P29, DOI 10.1002/tera.1420370106; Pasinetti GM, 2001, J NEUROSCI RES, V65, P471, DOI 10.1002/jnr.1176; Planas AM, 2001, NEUROBIOL DIS, V8, P834, DOI 10.1006/nbdi.2001.0435; Possel H, 2000, GLIA, V32, P51, DOI 10.1002/1098-1136(200010)32:1<51::AID-GLIA50>3.0.CO;2-4; Qiu WQ, 1997, J BIOL CHEM, V272, P6641, DOI 10.1074/jbc.272.10.6641; REDDY VY, 1995, P NATL ACAD SCI USA, V92, P3849, DOI 10.1073/pnas.92.9.3849; Saliba E, 2001, BIOL NEONATE, V79, P224; SELLER MJ, 1995, REPROD TOXICOL, V9, P449, DOI 10.1016/0890-6238(95)00037-B; Sun D, 2000, J NEUROPATH EXP NEUR, V59, P1031, DOI 10.1093/jnen/59.12.1031; Takami S, 2001, J CEREBR BLOOD F MET, V21, P1430, DOI 10.1097/00004647-200112000-00007; Whitney LW, 1999, ANN NEUROL, V46, P425	50	3	3	0	1	F HERNANDEZ	MURCIA	PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN	0213-3911	1699-5848		HISTOL HISTOPATHOL	Histol. Histopath.	JUL	2007	22	7					729	742					14	Cell Biology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Pathology	159XX	WOS:000245902300004	17455147				2022-02-06	
J	Arivazhagan, A; Garg, N; Devi, BI; Dawn, BR; Pandey, P				Arivazhagan, A.; Garg, N.; Devi, B. Indira; Dawn, B. Rose; Pandey, P.			Complete ophthalmoplegia associated with clival fracture following trauma: Case report and clinico-anatomical correlation	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						Clivus fracture; post-traumatic ophthalmoplegia; post-traumatic cranial nerve palsy; midbrain injury; post-traumatic cortical infarcts		Fractures of clivus occur following high energy trauma and are rare. There are a few reports of associated vascular and brainstem injury in literature. We report a patient with transverse clivus fracture and complete ophthalmoplegia and bilateral multiple cranial nerve palsies. A young boy was admitted in altered sensorium following RTA. Initial imaging revealed diffuse pneumocephalus, subarachnoid hemorrhage and diffuse cerebral edema. He was treated conservatively. Clinical review after improvement in sensorium showed that he had visual loss in left eye, bilateral ptosis, complete ophthalmoplegia in horizontal as well as vertical gaze, bilateral trigeminal paresis, right facial weakness and dysarthria. There was right CSF otorrhea. A spiral CT scan revealed transverse clivus fracture extending into bilateral middle cranial base. The fracture line was involving facial canal and mastoid on the right side. An MRI brain demonstrated periaqueductal infarcts and multiple cortical infarcts. He was managed conservatively. In the presence of clinical suspicion of skull base injuries, a spiral CT scan and MRI brain and MR angiography are essential for accurate assessment of bony and neurological involvement. The diagnosis of clivus fracture should prompt the clinician to look for associated brainstem or basilar artery injury.	[Arivazhagan, A.; Garg, N.; Devi, B. Indira; Dawn, B. Rose; Pandey, P.] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India		Devi, BI (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India.	bindira@nimhans.kar.nic.in		Bharath, Rose Dawn/0000-0002-7464-4250			ANTHONY DC, 1987, J NEUROSURG, V66, P929, DOI 10.3171/jns.1987.66.6.0929; Bonilha L, 2002, ARQ NEURO-PSIQUIAT, V60, P636, DOI 10.1590/S0004-282X2002000400023; Corradino G, FRACTURES CLIVUS CLA; Khan N, 2000, SURG NEUROL, V54, P171, DOI 10.1016/S0090-3019(00)00284-6; Paterakis KN, 2005, CLIN NEUROL NEUROSUR, V108, P67, DOI 10.1016/j.clineuro.2004.11.010; RUSSELL WR, 1949, J NEUROL NEUROSUR PS, V12, P52, DOI 10.1136/jnnp.12.1.52; SHARMA BS, 1994, CLIN NEUROL NEUROSUR, V96, P197, DOI 10.1016/0303-8467(94)90063-9; Suliman HM, 2001, J NEUROTRAUM, V18, P1289, DOI 10.1089/089771501317095322	8	3	3	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	JUN	2007	4	1					49	52		10.1016/S0973-0508(07)80012-8			4	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3L8O	WOS:000218373700011					2022-02-06	
J	Marshall, RC; McGurk, SR; Karow, CM; Kairy, TJ				Marshall, Robert C.; McGurk, Susan R.; Karow, Colleen M.; Kairy, Tamar J.			Problem-solving abilities of participants with and without diffuse neurologic involvement	APHASIOLOGY			English	Article; Proceedings Paper	36th Annual Clinical Aphasiology Conference	2006	Ghent, BELGIUM				INDIVIDUALS; DEFICITS	Background: Impaired problem solving is a frequent consequence of brain trauma and other conditions that result in diffuse neurologic involvement. Information about how individuals with diffuse neurologic involvement solve problems is important to the development of strategies designed to help them achieve the highest degree of independent living despite neuropsychological compromise, and may aid clinical decision making in general. Aims: To examine and compare problem-solving abilities of participants with and without diffuse neurologic involvement. Methods & Procedures: We used the Rapid Assessment of Problem Solving test (RAPS; Marshall, Karow, Morelli, Iden, & Dixon, 2003a), a modification of Mosher and Hornsby's (1966) 20 Question task, to examine the problem-solving abilities of two groups of neurologically intact (NI) participants and three groups of participants with diffuse neurologic involvement (DNf). The RAPS is a clinical test of problem-solving abilities in which the client asks yes/no questions to identify a "target picture" in a 32-item array. The DNI groups included individuals with recent and chronic acquired traumatic brain injuries, and a third group of participants with severe mental illness. It was hypothesised that participants with DNI would perform less well on the RAPS than the NI participants, and that these differences would be reflected in lower scores on the RAPS and differences in the frequency with which certain types of questions were used to solve problems. Outcomes & Results: Findings revealed significant differences between NI groups and two of the three DNI groups on objective scores, types of questions asked, and the strategies used to solve problems on the RAPS. The NI participants used a more systematic, organised approach to solving problems, whereas participants with DNI were less organised, inconsistent, and sometimes inflexible in their use of problemsolving strategies. Conclusions: Findings suggest the problem-solving abilities of participants with and without DN1 are distinguishable in terms of selected components of Scholnick and Friedman's (1993) developmental theory of planning. These include a decision to plan, strategy choice and execution, and monitoring effects of prior actions.	Univ Kentucky, Lexington, KY 40536 USA; Dartmouth Med Sch, Hanover, NH USA; Univ Tennessee, Knoxville, TN USA; Hofstra Univ, Hempstead, NJ USA		Marshall, RC (corresponding author), Univ Kentucky, Room 120F,CTW Bldg,900 S Limestone, Lexington, KY 40536 USA.	remarsh@uky.edu					Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Brookshire R. H., 2003, INTRO NEUROGENIC COM; CHEN RC, 2004, EUROPEAN ARCHIVES PS, V254, P236; Cummings J. L., 1983, DEMENTIA CLIN APPROA; DENNEY DR, 1973, DEV PSYCHOL, V9, P275, DOI 10.1037/h0035092; DENNEY NW, 1985, INT J AGING HUM DEV, V21, P161, DOI 10.2190/A3J2-75L4-01C3-W81W; DENNEY NW, 1981, J GERONTOL, V36, P323, DOI 10.1093/geronj/36.3.323; GLOSSER G, 1990, J CLIN EXP NEUROPSYC, V12, P485, DOI 10.1080/01688639008400995; GOLD JM, 1993, PSYCHIAT CLIN N AM, V16, P295; GOLDSTEIN FC, 1991, BRAIN COGNITION, V17, P23, DOI 10.1016/0278-2626(91)90063-E; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; HAGAN C, 1979, ANN CONV AM SPEECH L; Hochberg Y., 1987, MULTIPLE COMP PROCED; Keil K, 2002, APHASIOLOGY, V16, P305, DOI 10.1080/02687030143000654; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; LAPOINTE LL, 1995, J MED SPEECH-LANG PA, V3, P95; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Marshall RC, 2006, SCHIZOPHR RES, V84, P331, DOI 10.1016/j.schres.2006.01.025; Marshall RC, 2004, APHASIOLOGY, V18, P659, DOI 10.1080/02687030444000237; Marshall RC, 2003, AM J SPEECH-LANG PAT, V12, P333, DOI 10.1044/1058-0360(2003/079); Marshall RC, 2003, BRAIN INJURY, V17, P589, DOI 10.1080/0269905031000088496; MARSHALL RC, 1996, CLIN APHASIOLOGY, V24, P181; MARSHALL RC, 1999, CONV AM SPEECH LANG; Marshall RC, 2007, APHASIOLOGY, V21, P235, DOI 10.1080/02687030600624400; Mosher F.A., 1966, STUDIES COGNITIVE GR, P86; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Porteus S.D., 1965, PORTEUS MAZE TEST 50; Rath JF, 2004, ARCH CLIN NEUROPSYCH, V19, P613, DOI 10.1016/j.acn.2003.08.006; Rath JF, 2000, J HEAD TRAUMA REHAB, V15, P724, DOI 10.1097/00001199-200002000-00010; Raven J.C., 1984, COLOURED PROGR MATRI; SCHOLNICK EK, 1993, INT J BEHAV DEV, V16, P145, DOI 10.1177/016502549301600204; Wilkinson GS., 1984, WIDE RANGE ACHIEVEME; Willis SL, 1998, GERONTOLOGIST, V38, P569, DOI 10.1093/geront/38.5.569	33	3	3	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology	JUN-AUG	2007	21	6-8					750	762		10.1080/02687030601154076			13	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	179XN	WOS:000247323900018					2022-02-06	
J	Zaaroor, M; Mahamid, E; Shik, V; Soustiel, JF				Zaaroor, Menashe; Mahamid, Eugenia; Shik, Venyamin; Soustiel, Jean F.			Course of cerebral blood flow and metabolism following severe brain injury. Correlation with neurological function and outcome	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						cerebral blood flow; cerebral metabolism; head injury		This study was carried out investigate the course of cerebral blood flow and metabolism in fifty five head-injured patients and to specifically characterize the changes in oxidative and glucose indices in the acute post-traumatic period with regard to neurological condition and functional outcome. Blood flow volume (BFV) measurements were obtained from the extracranial internal carotid artery using a dual-beam angle-independent digital Doppler ultrasound. Cerebral metabolism was studied using blood sample, blood gas, blood saturation, hemoglobin, hematocrit, pH and glucose plasma concentrations. Arterial jugular differences were then calculated and used to determine global cerebral metabolic rates of oxygen (gCMRO2) and glucose (gCMRGlc). In patients with good outcome, CBF remained stable within the normal range whereas in patients with poor outcome, the course of CBF was characterized by a triphasic pattern defined by a secondary decrease on the third day. CMRO2 showed a significant and progressive correlation with level of consciousness expressed by means of GCS. Lower CBF values were significantly associated with poorer outcome.	[Zaaroor, Menashe; Soustiel, Jean F.] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Acute Brain Injury Res Lab, Haifa, Israel; [Mahamid, Eugenia; Shik, Venyamin] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Rambam Med Ctr, Dept Neurosurg, Haifa, Israel		Zaaroor, M (corresponding author), Rambam Med Ctr, Dept Neurosurg & Intens Care, Haifa, Israel.						Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Hattori N, 2003, J NUCL MED, V44, P1709; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Soustiel JF, 2003, STROKE, V34, P1876, DOI 10.1161/01.STR.0000080942.32331.39; Soustiel JF, 2002, J ULTRAS MED, V21, P1405, DOI 10.7863/jum.2002.21.12.1405; Vink R, 1990, J NEUROTRAUM, V7, P21, DOI 10.1089/neu.1990.7.21	11	3	3	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	JUN	2007	4	1					25	29		10.1016/S0973-0508(07)80007-4			5	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3L8O	WOS:000218373700006					2022-02-06	
J	Reinhard, MJ; Satz, P; Scaglione, CA; D'Elia, LF; Rassovsky, Y; Arita, AA; Hinkin, CH; Thrasher, D; Ordog, G				Reinhard, Matthew J.; Satz, Paul; Scaglione, Cris A.; D'Elia, Louis F.; Rassovsky, Yuri; Arita, Anthony A.; Hinkin, Charles H.; Thrasher, Delaney; Ordog, Gary			Neuropsychological exploration of alleged mold neurotoxicity	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						mold; cognition; neurotoxicity; litigation; MMPI; Stachybotrys	FAKE BAD SCALE; WATER-DAMAGED BUILDINGS; TRAUMATIC BRAIN-INJURY; SYMPTOM EXAGGERATION; FUNGAL EXPOSURE; HIV-1 INFECTION; MMPI-2; PERFORMANCE; DEPRESSION; LITIGANTS	Cognitive and emotional correlates of toxic mold exposure and potential dose-response effects for both outcomes were investigated. Self-reported length of exposure, time since last exposure, and serum immunoglobulin (IgG) levels were assessed. Despite CNS complaints often seen with mold exposed individuals, overall results did not uncover concomitant cognitive deficits suggested in previous studies or a significant reduction in intellectual functioning. Fewer subjects were excluded as result of failing effort/motivation assessment than expected. Correlations of IgG and cognitive function are discussed. A dose-effect for self-reported length of exposure and cognitive outcome was not seen. The sample's overall Minnesota Multiphasic Personality Inventory 11 (MMPI-2) profile indicated elevations on scales 1, 2, 3, 7 and 8. MMPI-2 clinical scales I and 3 were significantly correlated with length of exposure. The MMPI-2 may be sensitive to increasing physical and emotional sequelae as length of exposure increases. A potential subgroup of cognitively impaired outliers within mold exposure litigants is explored. Limitations of self-reported and objective measurements for mold exposure and exploratory statistical methodology are discussed. (c) 2007 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; Med Toxicol, Santa Clarita, SC USA		Reinhard, MJ (corresponding author), Vet Affairs Med Ctr, Trauma Serv, 50 Irving St NW,3D201, Washington, DC 20422 USA.	matthew.reinhard@va.gov	ordog, gary/AAB-8399-2019	ordog, gary/0000-0002-6394-6317; Rassovsky, Yuri/0000-0002-6362-9944			Baldo Juliana V, 2002, Appl Neuropsychol, V9, P193, DOI 10.1207/S15324826AN0904_1; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; *CADHS, 2000, STACHYBOTRYS CHARTAR; Castellon SA, 2006, J CLIN EXP NEUROPSYC, V28, P420, DOI 10.1080/13803390590935444; Castellon SA, 1998, J NEUROPSYCH CLIN N, V10, P320, DOI 10.1176/jnp.10.3.320; *CDCP, 2002, STAT SCI MOLDS HUM H; CRAGO RB, 2003, ARCH ENVIRON HEALTH, V58, P436; Gordon WA, 2004, APPL NEUROPSYCHOL, V11, P65, DOI 10.1207/s15324826an1102_1; GORDON WA, 1999, BIOAEROSOLS FUNGI MY, P94; Gray MR, 2003, ARCH ENVIRON HEALTH, V58, P410; Greiffenstein MF, 2002, J CLIN PSYCHOL, V58, P1591, DOI 10.1002/jclp.10077; Heaton R K, 1995, J Int Neuropsychol Soc, V1, P231; HINKIN CH, 1992, J CLIN EXP NEUROPSYC, V14, P289, DOI 10.1080/01688639208402829; HUNTER CA, 1988, INT BIODETERIOR, V24, P81, DOI 10.1016/0265-3036(88)90052-8; IOM (Institute of Medicine), 2004, DAMP IND SPAC HLTH; Johanning E, 1999, ENVIRON HEALTH PERSP, V107, P489, DOI 10.1289/ehp.99107s3489; Kaemmer, 1989, MINNESOTA MULTIPHASI; Kuhn DM, 2003, CLIN MICROBIOL REV, V16, P144, DOI 10.1128/CMR.16.1.144-172.2003; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P54, DOI 10.1076/clin.17.1.54.15627; Lees-Haley PR, 2003, PSYCHOL REP, V93, P561, DOI 10.2466/PR0.93.6.561-584; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Morey, 1991, PERSONALITY ASSESSME; Nelson NW, 2006, J CLIN EXP NEUROPSYC, V28, P1, DOI 10.1080/13803390490919272; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rippeth JD, 2004, J INT NEUROPSYCH SOC, V10, P1, DOI 10.1017/S1355617704101021; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; STONE D, 2006, ANN M INT NEUR SOC; Tombaugh T. N., 1997, TEST MEMORY MALINGER; Tsushima WT, 2001, ASSESSMENT, V8, P205, DOI 10.1177/107319110100800208; Tuomi T, 2000, APPL ENVIRON MICROB, V66, P1899, DOI 10.1128/AEM.66.5.1899-1904.2000; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wechsler D., 1997, WAIS 3 WMS 3 TECHNIC	36	3	3	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2007	22	4					533	543		10.1016/j.acn.2007.03.006			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	182OP	WOS:000247514200011	17521866	Bronze			2022-02-06	
J	Amo, C; Boyajian, RA; Romine, JS; Otis, SM				Amo, Carlos; Boyajian, Robert A.; Romine, John S.; Otis, Shirley M.			High-resolution magnetoencephalographic functional mapping of the cortical network mediating intentional movement	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						magnetoencephalography; MEG; brain mapping; cortical activation; neurophysiology	SUPPLEMENTARY MOTOR AREA; VOLUNTARY MOVEMENTS; FINGER MOVEMENT; RECOVERY; CORTEX; BRAIN; POTENTIALS; STROKE; EEG	Magnetoencephalography (MEG) is a sensitive technique that can detect and map cortical electrophysiologic activations with high spatial (mm) and temporal (msecs) resolutions. We used 148-channel whole-head MEG to record the activation sequence for the somatosensory and motor cortical network during cued hand movements in a healthy 39-yr-old subject. The complex sequence and topography of cortical activations were superimposed onto the subject's brain magnetic resonance images. Frontal premotor and supplementary motor and cingulate areas activated well before the primary motor area and again repetitively from 200 msecs onward with activations alternating repeatedly between frontal and parietal areas. The network's very close functional integration of supplementary motor areas suggests how brain injury that is localized to these regions, but not to the primary motor area itself, can disrupt integrity of movement, and why preservation of functional integrity of some areas traditionally viewed as extramotor may be necessary for recovery from neurologic disability.	Scripps Clin, Brain Res & Treatment Ctr, Div Neurol, Dept Med, La Jolla, CA 92037 USA		Boyajian, RA (corresponding author), Scripps Clin, Brain Res & Treatment Ctr, Div Neurol, Dept Med, MS-313,10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.						Amo C, 2006, ARQ NEURO-PSIQUIAT, V64, P394, DOI 10.1590/S0004-282X2006000300008; Atlas SW, 1996, NEUROSURGERY, V38, P329, DOI 10.1097/00006123-199602000-00019; Babiloni F, 2001, HUM BRAIN MAPP, V14, P197, DOI 10.1002/hbm.1052; Carey LM, 2005, STROKE, V36, P625, DOI 10.1161/01.STR.0000155720.47711.83; Castillo EM, 2004, NEUROIMAGE, V21, P973, DOI 10.1016/j.neuroimage.2003.10.020; Dick J P, 1986, Mov Disord, V1, P255, DOI 10.1002/mds.870010405; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; Erdler M, 2000, NEUROIMAGE, V11, P697, DOI 10.1006/nimg.2000.0579; FORSS N, 1995, BRAIN RES, V685, P68, DOI 10.1016/0006-8993(95)00424-O; Forss N, 2001, REV NEUROL-FRANCE, V157, P816; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hoshiyama M, 1997, EXP BRAIN RES, V115, P6, DOI 10.1007/PL00005685; Huang M, 2004, CLIN NEUROPHYSIOL, V115, P820, DOI 10.1016/j.clinph.2003.11.022; Huang MX, 2004, HUM BRAIN MAPP, V23, P26, DOI 10.1002/hbm.20038; IKEDA A, 1992, BRAIN, V115, P1017, DOI 10.1093/brain/115.4.1017; Krainik A, 2004, NEUROLOGY, V62, P1323, DOI 10.1212/01.WNL.0000120547.83482.B1; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; REKTOR I, 1994, ELECTROEN CLIN NEURO, V90, P273, DOI 10.1016/0013-4694(94)90145-7; Schwartz DP, 1999, BRAIN TOPOGR, V11, P279, DOI 10.1023/A:1022206603596; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a	21	3	3	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	APR	2007	86	4					304	309		10.1097/PHM.0b013e3180383c0d			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	150QV	WOS:000245232200009	17413544				2022-02-06	
J	Chandrashekar, R; Benshoff, JJ				Chandrashekar, Rupa; Benshoff, John J.			Increasing quality of life and awareness of deficits in persons with traumatic brain injury: A pilot study	JOURNAL OF REHABILITATION			English	Article							SELF-AWARENESS; INDIVIDUALS	Thirty-six people participated to examine how persons with traumatic brain injury differ in their quality of life and awareness of deficits. ANOVA results indicated a significant difference exists in perceptions of Physiological needs on the Wisconsin HSS Quality of Life Inventory between the control and experimental groups. Results on the other subscales on the Wisconsin HSS Quality of Life Inventory and Awareness Questionnaire were not statistically significant. The results could be used to develop specific rehabilitation counseling programs utilizing the group model. Independent living centers can use results to encourage persons with traumatic brain injury to participate in groups around the community. Rehabilitation educators can provide training in group counseling techniques specific to the traumatic brain injury population and provide internships and practicums in centers serving persons with traumatic brain injury.	So Illinois Univ, Inst Rehabil, Carbondale, IL 62901 USA		Chandrashekar, R (corresponding author), So Illinois Univ, Inst Rehabil, Mailcode 4609, Carbondale, IL 62901 USA.	dr_rupac@yahoo.com					*BRAIN INJ RES FDN, 2006, RISK HIGH BRAIN INJ; BROOKS N, 1984, CLOSED HEAD INJURY P; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Brown M, 2000, BRAIN INJURY, V14, P5, DOI 10.1080/026990500120899; *CDC, 2002, TRAUM BRAIN INJ US R; Collins R, 2000, J HEAD TRAUMA REHAB, V15, P1139, DOI 10.1097/00001199-200010000-00007; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; Farmer JE, 2003, J HEAD TRAUMA REHAB, V18, P116, DOI 10.1097/00001199-200303000-00003; Giacino JT, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199810000-00003; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; McColl MA, 1999, BRAIN INJURY, V13, P311, DOI 10.1080/026990599121511; Newman AC, 2000, BRAIN INJURY, V14, P333; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; Patrick DL, 1993, HLTH STATUS HLTH POL; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Rauch RJ, 2001, NEUROREHABILITATION, V16, P11; Riketta M, 2004, PSYCHOL REP, V94, P1232, DOI 10.2466/PR0.94.3.1232-1234; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Torkelson Lynch R., 1995, J SPEC GROUP WORK, V20, P108, DOI [10.1080/01933929508411333, DOI 10.1080/01933929508411333]; TOSI DJ, 1975, J PERS ASSESS, V39, P215, DOI 10.1207/s15327752jpa3903_1; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Wallace CA, 2000, BRAIN INJURY, V14, P549	25	3	4	0	2	NATL REHABILITATION ASSOC-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109 USA	0022-4154			J REHABIL	J. Rehabil.	APR-JUN	2007	73	2					50	56					7	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	172BF	WOS:000246778400006					2022-02-06	
J	Muller, C; Herberth, H; Cosquer, B; Kelche, C; Cassel, JC; Schimchowitsch, S				Muller, Christophe; Herberth, Heike; Cosquer, Brigitte; Kelche, Christian; Cassel, Jean-Christophe; Schimchowitsch, Sarah			Structural and functional recovery elicited by combined putrescine and aminoguanidine treatment after aspirative lesion of the fimbria-fornix and overlying cortex in the adult rat	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						brain injury; cAMP cascade; iNOS inhibitor; mammalian central nervous system; neuroprotection	NERVE GROWTH-FACTOR; POLYAMINE STRESS-RESPONSE; BLOOD-BRAIN-BARRIER; SPINAL-CORD-INJURY; NUCLEUS-ACCUMBENS; CHOLINERGIC REINNERVATION; SEROTONERGIC NEURONS; AXONAL GROWTH; REGENERATION; ISCHEMIA	Damage to the adult CNS often causes permanent deficits. Based on a lesion model of septohippocampal pathway aspiration in the rat, we attempted to promote neuronal cell survival and post-traumatic recovery by using a pharmalogical treatment combining aminoguanidine and putrescine (AGP). The functional recovery was followed over 15 weeks before morphological analysis. AGP treatment produced a persistent attenuation (similar to 50%) of the lesion-induced hyperactivity, a reduction (similar to 60%) in the sensorimotor impairments and an improved performance in the water-maze task which did not, however, rely upon improved memory capabilities. AGP weakened the lesion-induced decrease in ChAT-positive neurons in the medial septum and the extent of thalamic retrograde necrosis (by similar to 30% in each case) and resulted in a partial cholinergic reinnervation of the dentate gyrus. These promising results support the idea that coadministration of putrescine and aminoguanidine might become a potent way to foster structural and functional recovery (or compensation) in the adult mammalian CNS after injury.	CNRS, IFR 37, LINC UMR 7191, Lab Neurosci Comportementales & Cognit, F-67000 Strasbourg, France		Schimchowitsch, S (corresponding author), LN2C,12 Rue Goethe, F-67000 Strasbourg, France.	schim@neurochem.u-strasbg.fr					Aizenman CD, 2002, NEURON, V34, P623, DOI 10.1016/S0896-6273(02)00674-8; Bannerman DM, 2001, BEHAV BRAIN RES, V120, P1, DOI 10.1016/S0166-4328(00)00354-5; BEAVEN MA, 1969, J PHARMACOL EXP THER, V165, P14; BJORKLUND A, 1981, BRAIN RES, V229, P403, DOI 10.1016/0006-8993(81)91004-0; Brodal A, 1981, NEUROLOGICAL ANATOMY; BRUNTON VG, 1991, BIOCHEM J, V280, P193, DOI 10.1042/bj2800193; Cai DM, 2002, NEURON, V35, P711, DOI 10.1016/S0896-6273(02)00826-7; Casanova C, 1999, M S-MED SCI, V15, P1302, DOI 10.4267/10608/1263; CASSEL JC, 1993, BRAIN RES, V604, P53, DOI 10.1016/0006-8993(93)90351-M; CASSEL JC, 1992, NEUROSCI LETT, V138, P32, DOI 10.1016/0304-3940(92)90465-J; Cassel JC, 1997, PROG NEUROBIOL, V51, P663, DOI 10.1016/S0301-0082(97)00009-9; Chatzipanteli K, 2002, J NEUROTRAUM, V19, P639, DOI 10.1089/089771502753754109; CHU PJ, 1995, BRAIN RES, V673, P233, DOI 10.1016/0006-8993(94)01419-I; Cockroft KM, 1996, STROKE, V27, P1393, DOI 10.1161/01.STR.27.8.1393; CRUTCHER KA, 1981, TRENDS NEUROSCI, V4, P70, DOI 10.1016/0166-2236(81)90024-2; CRUTCHER KA, 1987, BRAIN RES REV, V12, P203, DOI 10.1016/0165-0173(87)90013-0; DIETRICH WD, 1991, ACTA NEUROPATHOL, V81, P615, DOI 10.1007/BF00296371; Dogan A, 1999, J NEUROSURG, V90, P1078, DOI 10.3171/jns.1999.90.6.1078; DORNAY M, 1986, EXP NEUROL, V92, P665, DOI 10.1016/0014-4886(86)90307-9; DRAVID AR, 1984, BRAIN RES, V324, P119, DOI 10.1016/0006-8993(84)90628-0; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Ellezam B, 2002, PROG BRAIN RES, V137, P371; Faull RLM, 1985, RAT NERVOUS SYSTEM, V1, P129; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Gage F.H., 1986, HIPPOCAMPUS, V3, P33; GAGE FH, 1984, NEUROSCI LETT, V44, P211, DOI 10.1016/0304-3940(84)90083-1; GAGE FH, 1983, BRAIN RES, V268, P39, DOI 10.1016/0006-8993(83)90388-8; Giardino I, 1998, DIABETES, V47, P1114, DOI 10.2337/diabetes.47.7.1114; Gilad GM, 1999, J PHARMACOL EXP THER, V291, P39; GILAD GM, 1983, BRAIN RES, V273, P191, DOI 10.1016/0006-8993(83)91113-7; Gilad GM, 2002, BRAIN RES, V943, P23, DOI 10.1016/S0006-8993(02)02479-4; GILAD GM, 1992, BIOCHEM PHARMACOL, V44, P401, DOI 10.1016/0006-2952(92)90428-L; GILAD GM, 1991, EXP NEUROL, V111, P349, DOI 10.1016/0014-4886(91)90102-I; Gilad GM, 1996, J NEUROCHEM, V67, P1992; GILAD GM, 1993, MOL CHEM NEUROPATHOL, V18, P197, DOI 10.1007/BF03160034; Gilad VH, 2001, BIOCHEM PHARMACOL, V61, P207, DOI 10.1016/S0006-2952(00)00517-7; Gilad VH, 1996, BRAIN RES, V724, P141, DOI 10.1016/0006-8993(96)00287-9; GLICK SD, 1971, J COMP PHYSIOL PSYCH, V76, P454, DOI 10.1037/h0031373; GRAY JA, 1983, NEUROSCI BIOBEHAV R, V7, P119, DOI 10.1016/0149-7634(83)90014-3; Haas CA, 1998, INT J DEV NEUROSCI, V16, P691, DOI 10.1016/S0736-5748(98)00079-3; HECKERS S, 1994, J NEUROSCI, V14, P1271, DOI 10.1523/JNEUROSCI.14-03-01271.1994; Hofferer E, 1996, BEHAV BRAIN RES, V74, P175, DOI 10.1016/0166-4328(95)00158-1; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; IIZUKA H, 1990, STROKE, V21, P790, DOI 10.1161/01.STR.21.5.790; Ivanova S, 1998, J EXP MED, V188, P327, DOI 10.1084/jem.188.2.327; JELTSCH H, 1994, NEUROSCIENCE, V63, P41, DOI 10.1016/0306-4522(94)90005-1; JELTSCH H, 1994, BEHAV NEURAL BIOL, V62, P121, DOI 10.1016/S0163-1047(05)80033-0; JENSEN JR, 1987, J NEUROCHEM, V48, P765, DOI 10.1111/j.1471-4159.1987.tb05583.x; KOELLE GB, 1954, J COMP NEUROL, V100, P211, DOI 10.1002/cne.901000108; LANDIS SC, 1983, DEV BIOL, V98, P349, DOI 10.1016/0012-1606(83)90365-2; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Lehmann O, 2000, EUR J NEUROSCI, V12, P67, DOI 10.1046/j.1460-9568.2000.00881.x; LOY R, 1980, SCIENCE, V208, P1282, DOI 10.1126/science.7375941; Lu J, 2003, NEUROPHARMACOLOGY, V44, P253, DOI 10.1016/S0028-3908(02)00380-5; Madziar B, 2005, J NEUROCHEM, V92, P767, DOI 10.1111/j.1471-4159.2004.02908.x; Malaterre J, 2004, EUR J NEUROSCI, V20, P317, DOI 10.1111/j.1460-9568.2004.03498.x; Merabet L, 1998, NATURE, V396, P265, DOI 10.1038/24382; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Mori K, 2001, BEHAV BRAIN RES, V120, P159, DOI 10.1016/S0166-4328(00)00371-5; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; NAUMANN T, 1994, NEUROSCI LETT, V173, P213, DOI 10.1016/0304-3940(94)90186-4; Nilsson BO, 1999, INFLAMM RES, V48, P509, DOI 10.1007/s000110050495; O'Connor CA, 2006, ACTA NEUROCHIR SUPPL, V96, P121; ODONNELL P, 1995, J NEUROSCI, V15, P3622; ORITA T, 1989, ACTA NEUROPATHOL, V77, P397, DOI 10.1007/BF00687374; PASCHEN W, 1992, MOL CHEM NEUROPATHOL, V16, P241, DOI 10.1007/BF03159973; Paxinos G, 1997, RAT BRAIN STEREOTAXI; Pereira PM, 2005, BRAIN RES BULL, V64, P381, DOI 10.1016/j.brainresbull.2004.09.007; PETERSON GM, 1992, NEUROSCI LETT, V138, P81, DOI 10.1016/0304-3940(92)90477-O; Pluta R, 2005, CHEMOTHERAPY, V51, P223, DOI 10.1159/000086924; Scheiderer CL, 2006, J NEUROSCI, V26, P3745, DOI 10.1523/JNEUROSCI.5507-05.2006; Schimchowitsch S, 2006, J PHYSIOL-PARIS, V99, P221, DOI 10.1016/j.jphysparis.2005.12.015; Schulz D, 2002, EUR J NEUROSCI, V16, P2175, DOI 10.1046/j.1460-9568.2002.02282.x; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Seiler N, 2004, AMINO ACIDS, V26, P217, DOI 10.1007/s00726-004-0070-z; SEILER N, 1990, INT J BIOCHEM, V22, P211, DOI 10.1016/0020-711X(90)90332-W; Seiler N, 2000, NEUROCHEM RES, V25, P471, DOI 10.1023/A:1007508008731; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; SHIN WW, 1985, J NEUROCHEM, V44, P1056, DOI 10.1111/j.1471-4159.1985.tb08724.x; Shirhan M, 2004, LIFE SCI, V76, P661, DOI 10.1016/j.lfs.2004.07.015; Shirhan M, 2004, NEUROSCIENCE, V124, P299, DOI 10.1016/j.neuroscience.2003.10.050; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Silvers JM, 2003, BRAIN RES REV, V43, P275, DOI 10.1016/j.brainresrev.2003.09.002; Soulet D, 2003, J CELL BIOL, V162, P257, DOI 10.1083/jcb.200301097; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Walker A. E., 1966, THALAMUS, P1; Weiner I, 1996, BEHAV BRAIN RES, V81, P123, DOI 10.1016/S0166-4328(96)00051-4; WILKINSON LS, 1993, BEHAV BRAIN RES, V55, P143, DOI 10.1016/0166-4328(93)90110-C; WILL B, 1985, BEHAV BRAIN RES, V17, P17, DOI 10.1016/0166-4328(85)90004-X; Williams K, 1997, BIOCHEM J, V325, P289, DOI 10.1042/bj3250289; Winer B.J., 1971, STAT PRINCIPLES EXPT; Winton MJ, 2002, J BIOL CHEM, V277, P32820, DOI 10.1074/jbc.M201195200; ZHANG CH, 2000, J HUAZHONG U SCI TEC, V28, P60; ZIMMERMAN GA, 1995, P NATL ACAD SCI USA, V92, P3744, DOI 10.1073/pnas.92.9.3744	95	3	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	APR	2007	25	7					1949	1960		10.1111/j.1460-9568.2007.05474.x			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	155UP	WOS:000245604200005	17439484				2022-02-06	
J	Fischer, B; Wit, J				Fischer, B.; Wit, J.			Emergency ward management of traumatic head injury in children	UNFALLCHIRURG			German	Article						traumatic head injury in children; intracranial lesion; risk factors; radiological methods; management plan	INTRACRANIAL INJURY; BRAIN INJURY; CONSCIOUSNESS; PREDICTORS; YOUNGER; SCALE; SCANS; COMA	Background. The controversial situation relating to assessment and management of the traumatic head injury (THI) in children inspired us to study our own patient pool. The aims were to find a significant correlation between skull fracture or clinical symptom and intracranial lesion as well as to determine the importance of each radiological diagnostic method in the initial management of the pediatric THI. Patients and methods. In 1 year 1,637 children had been treated in the emergency room of pediatric surgery with the diagnosis of THI. Age, sex, injury pattern, symptoms, radiological diagnostic methods, diagnosis, and clinical follow-up had been registered. Results. A significant correlation between skull fracture or clinical symptom and the intracranial injury in children could not be found, but risk factors exist. Cranial computed tomography is the imaging method of choice. X-ray, ultrasound, and MRI of the head are reserved for a few indications. Conclusion. A management plan for pediatric head and brain injury in the emergency room based on our own and published international results is introduced.	Univ Med Berlin, Charite, Kinderchirurg Klin, D-13353 Berlin, Germany		Fischer, B (corresponding author), Univ Med Berlin, Charite, Kinderchirurg Klin, Campus Virchow Klinikum,Augustenburger Pl 1, D-13353 Berlin, Germany.	b.fischer@charite.de					Bergman DA, 1999, PEDIATRICS, V104, P1407; DAVIS RL, 1994, ANN EMERG MED, V24, P640, DOI 10.1016/S0196-0644(94)70273-X; FENDEL H, 1987, AUSWIRKUNG EFFICACY; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; JACOBI G, 1997, PADIATR PRAX, V52, P621; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Lloyd DA, 1997, LANCET, V349, P821, DOI 10.1016/S0140-6736(96)09356-7; LOCHBIHLER H, 2002, KINDER JUGENDMEDIZIN, V2, P211; Maier B, 2003, UNFALLCHIRURG, V106, P220, DOI 10.1007/s00113-002-0546-9; MITCHELL KA, 1994, J PEDIATR SURG, V29, P851, DOI 10.1016/0022-3468(94)90001-9; Murgio A, 1999, CHILD NERV SYST, V15, P318, DOI 10.1007/s003810050401; Murgio A, 2001, CHILD NERV SYST, V17, P257, DOI 10.1007/s003810000403; RAMUNDO ML, 1995, PEDIATR EMERG CARE, V11, P1, DOI 10.1097/00006565-199502000-00001; Reither M, 2001, RADIOLOGE, V41, P434, DOI 10.1007/s001170051039; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Simon B, 2001, J TRAUMA, V51, P231, DOI 10.1097/00005373-200108000-00004; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; TEASDALE G, 1974, LANCET, V2, P81; TONNIS W, 1953, ARZTLICHE PRAXIS, V36; TURIAL S, 1999, SCHADELHIRNVERLETZTE; Wang MY, 2000, NEUROSURGERY, V46, P1093, DOI 10.1097/00006123-200005000-00014	24	3	3	0	2	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0177-5537			UNFALLCHIRURG	Unfallchirurg	MAR	2007	110	3					226	232		10.1007/s00113-006-1209-z			7	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	151DH	WOS:000245268600005	17123040				2022-02-06	
J	Alvarez-Caldas, C; Quesada, A; Roman, JLS; Olmeda, E				Alvarez-Caldas, Carolina; Quesada, Alejandro; Roman, Jose Luis San; Olmeda, Ester			Head injury criterion: the best way to evaluate head damage?	INTERNATIONAL JOURNAL OF VEHICLE DESIGN			English	Article						head injury criterion; HIC; safety; vehicle design	DIFFUSE AXONAL INJURY; BIOMECHANICS; TRAUMA; CONCUSSION; INDEX; MODEL	During the design and construction of a new car model, there are a lot of important aspects that have to be taken into account. The car's designers look for a beautiful appearance, for a car as light as possible, try to reduce the manufacture costs and times and, of course, want to guarantee that their car is as safe as it can be. There are several criteria that allow to quantify the safety of a car. One of them, the Head Injury Criterion (also known as HIC) gives a measure of the damage that the head can suffer in case of collision. This paper presents a review of some works related to this criterion. It will be proved that the HIC has several limitations that allow to say that this criterion is clearly improvable.	Univ Carlos III Madrid, Dept Mech Engn, E-28911 Leganes, Spain		Alvarez-Caldas, C (corresponding author), Univ Carlos III Madrid, Dept Mech Engn, Avda Univ,No 30, E-28911 Leganes, Spain.	calvarez@ing.uc3m.es; alejandro@ing.uc3m.es; jlsanro@ing.uc3m.es; eolmeda@ing.uc3m.es	Alvarez-Caldas, Carolina/L-9145-2014; Quesada, Alejandro/L-9328-2014; San Roman, Jose Luis/L-9187-2014	Alvarez-Caldas, Carolina/0000-0003-0681-8826; Quesada, Alejandro/0000-0002-2662-0959; San Roman, Jose Luis/0000-0002-1698-4900; OLMEDA, ESTER/0000-0002-1982-0290			ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Bronzino J. D., 1995, BIOMEDICAL ENG HDB; Chan M., 1980, P 24 STAPP CAR CRASH, P347; Cory CZ, 2001, FORENSIC SCI INT, V123, P89, DOI 10.1016/S0379-0738(01)00523-0; Eppinger R., 2000, DEV IMPROVED INJUR S; EPPINGER RH, 1981, HEAD NECK INJURY CRI; Gadd C, 1961, NATL RES COUNCIL PUB, P141; Gadd C. W., 1966, P 10 STAPP CAR CRASH; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GOLDSMITH W, 1981, J BIOMECH, V14, P883, DOI 10.1016/0021-9290(81)90016-6; Got C., 1978, P 22 STAPP CAR CRASH; GROSS AG, 1958, J NEUROSURG, V15, P548, DOI 10.3171/jns.1958.15.5.0548; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; GURDJIAN ES, 1953, NEUROLOGY, V3, P417, DOI 10.1212/WNL.3.6.417; GURDJIAN ES, 1961, J NEUROSURG, V18, P58, DOI 10.3171/jns.1961.18.1.0058; Gurdjian ES, 1975, IMPACT HEAD INJURY M; GURDJIAN ES, 1964, J TRAUMA, V4, P273; HARDY WN, 1994, INT J IMPACT ENG, V15, P561, DOI 10.1016/0734-743X(94)80034-7; HIRSCH AE, 1970, P 14 STAPP CAR CRASH, P144; HODGSON VR, 1977, DOTHS1462230 WAYN ST; HODGSON VR, 1973, P 17 STAPP CAR CRASH; Hutchinson J, 1998, APPL MATH COMPUT, V96, P1, DOI 10.1016/S0096-3003(97)10106-0; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; LAU IV, 1986, P 30 STAPP CAR CRASH, P123; LOCKETT FJ, 1985, J BIOMECH, V18, P217, DOI 10.1016/0021-9290(85)90207-6; MCHENRY BG, 2004, ATB US C 2004 SALT L; Nahum A, 1976, P 20 STAPP CAR CRASH; NAHUM AM, 1979, P 23 STAPP CAR CRASH; Nahum AM, 1977, P 21 STAPP CAR CRASH, P337; *NAT SAF COUNC, 1974, ACC FACTS; NEWMAN JA, 1980, P 24 STAPP CAR CRASH; NEWMAN S, 2001, STAPP CAR CRASH J, V44, P215; Nishimoto T, 2000, JSAE REV, V21, P117, DOI 10.1016/S0389-4304(99)00079-X; NUSHOLTZ GS, 1984, P 28 STAPP CAR CRASH; OMMAYA AK, 1964, J NEUROSURG, V21, P249, DOI 10.3171/jns.1964.21.4.0249; ONUSIC H, 1995, INT J VEHICLE DES, V16, P194; PEDDER JB, 1979, P 4 INT C IMP TRAUM; PRASAD P, 1985, 851246 SAE; RUAN JS, 1993, P 37 STAPP CAR CRASH; Stalnaker RL., 1973, HUMAN IMPACT RESPONS, P85; STURTZ G, 1980, P 24 STAPP CAR CRASH; TARRIERE C, 1982, 22SC12GT6 ISOTC 118; THIBAULT L, 1994, INT J IMPACT ENG, V4, P535; THOMAS DJ, 1983, IMPACT INJURY HEAD S, P177; Versace J, 1971, SAE TECHNICAL PAPER, DOI [10.4271/710881, DOI 10.4271/710881]; VIANO DC, 1989, J BIOMECH, V22, P403, DOI 10.1016/0021-9290(89)90201-7; VIANO DC, 1988, P 32 STAPP CAR CRASH, V97, P1; WALKER AE, 1944, J NEUROSURG, V1, P102; WARD CC, 1978, P NATO ADV GROUP AER; Watanabe I, 2001, JSAE REV, V22, P189, DOI 10.1016/S0389-4304(01)00092-3	50	3	3	1	8	INDERSCIENCE ENTERPRISES LTD	GENEVA	WORLD TRADE CENTER BLDG, 29 ROUTE DE PRE-BOIS, CASE POSTALE 856, CH-1215 GENEVA, SWITZERLAND	0143-3369	1741-5314		INT J VEHICLE DES	Int. J. Veh. Des.		2007	45	3					411	425					15	Engineering, Mechanical; Transportation Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Transportation	218AM	WOS:000249988400009					2022-02-06	
J	Arushanyan, EB; Beier, EV				Arushanyan, E. B.; Beier, E. V.			Hyppocampus and cognitive disturbances	ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA			Russian	Article							LONG-TERM POTENTIATION; TRANSIENT FOREBRAIN ISCHEMIA; GLOBAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; RAT HIPPOCAMPUS; AGED RATS; ACETYLCHOLINE-RECEPTORS; SYNAPTIC-TRANSMISSION; GLUTAMATE RELEASE		Stavropol State Med Acad, Stavropol, Russia		Arushanyan, EB (corresponding author), Stavropol State Med Acad, Stavropol, Russia.						Alvarez XA, 1999, METHOD FIND EXP CLIN, V21, P535, DOI 10.1358/mf.1999.21.8.794835; Arai N, 2001, NEUROSCI LETT, V299, P213, DOI 10.1016/S0304-3940(01)01520-8; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; ARUSHANYAN EB, 2004, LEKARSTVENNOYE ULUCH; Bastianetto S, 2002, CELL MOL BIOL, V48, P693; Baydas G, 2005, J PINEAL RES, V39, P346, DOI 10.1111/j.1600-079X.2005.00257.x; Becker JT, 2006, ARCH NEUROL-CHICAGO, V63, P97, DOI 10.1001/archneur.63.1.97; BLISS TVP, 1983, J PHYSIOL-LONDON, V334, P475, DOI 10.1113/jphysiol.1983.sp014507; Bramham CR, 1996, J COMP NEUROL, V368, P371; BURGARD EC, 1990, NEUROSCI LETT, V116, P34, DOI 10.1016/0304-3940(90)90382-J; Chen KB, 2003, J PINEAL RES, V35, P109, DOI 10.1034/j.1600-079X.2003.00063.x; Crottaz-Herbette S, 2005, HIPPOCAMPUS, V15, P132, DOI 10.1002/hipo.20039; Cuzzocrea S, 2000, J PINEAL RES, V29, P217, DOI 10.1034/j.1600-0633.2002.290404.x; Daumas S, 2005, LEARN MEMORY, V12, P375, DOI 10.1101/lm.81905; De Butte M, 2002, NEUROBIOL AGING, V23, P309, DOI 10.1016/S0197-4580(01)00277-9; DEMPSEY RJ, 2003, J NEUROSURG, V8, P67; den Heijer T, 2006, ARCH GEN PSYCHIAT, V63, P57, DOI 10.1001/archpsyc.63.1.57; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Dore S, 1999, ANN NY ACAD SCI, V890, P356, DOI 10.1111/j.1749-6632.1999.tb08015.x; Eder P, 2001, HISTOCHEM J, V33, P605, DOI 10.1023/A:1016394031947; El-Sherif Y, 2002, BRAIN RES, V945, P191, DOI 10.1016/S0006-8993(02)02752-X; El-Sokkary GH, 2003, CELL MOL BIOL LETT, V8, P461; ENGELSEN B, 1986, ACTA NEUROL SCAND, V74, P337; ESPARZA YL, 2006, J PINEAL RES, V35, P32; Feng Z, 2004, J PINEAL RES, V37, P129, DOI 10.1111/j.1600-079X.2004.00144.x; FOSTER AC, 1987, NEUROSCI LETT, V76, P307, DOI 10.1016/0304-3940(87)90420-4; FREY U, 1991, NEUROSCI LETT, V129, P111, DOI 10.1016/0304-3940(91)90732-9; Frick KM, 2002, NEUROSCIENCE, V115, P547, DOI 10.1016/S0306-4522(02)00377-9; Fukui K, 2005, J ALZHEIMERS DIS, V8, P299, DOI 10.3233/jad-2005-8309; Galeotti N, 2003, N-S ARCH PHARMACOL, V368, P538, DOI 10.1007/s00210-003-0812-6; GAMBARYAN LS, 1973, GIPPOKAMP; Giovannini MG, 2001, NEUROSCIENCE, V106, P43, DOI 10.1016/S0306-4522(01)00266-4; Gomazkov OA, 2002, ZH NEVROPATOL PSIKH, P17; Gottschalk WA, 1999, LEARN MEMORY, V6, P243; Gunten A., 2006, NEUROBIOL AGING, V27, P270; GUSEV YI, 2002, USPEKHI FIZIOL NAUK, V33, P80; Hartman RE, 2005, BRAIN RES, V1043, P48, DOI 10.1016/j.brainres.2005.02.030; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; HOLMAN BL, 1995, YAMA, V254, P3063; Hortnagl H, 1994, J Neural Transm Suppl, V44, P245; Koizumi S, 1999, NEURON, V22, P125, DOI 10.1016/S0896-6273(00)80684-4; Letechipia-Vallejo G, 2001, ARCH MED RES, V32, P186, DOI 10.1016/S0188-4409(01)00268-5; LURIYA AR, 2000, VYSSHIYE KORKOVYE FU; MACLEAN PD, 1958, AM J MED, V25, P611, DOI 10.1016/0002-9343(58)90050-0; Maurizi CP, 1997, MED HYPOTHESES, V49, P153, DOI 10.1016/S0306-9877(97)90220-6; McCann SM, 1997, EXP GERONTOL, V32, P431, DOI 10.1016/S0531-5565(96)00154-4; Mennerick S, 1998, J NEUROSCI, V18, P9716; MOKRUSHIN AA, 2004, USPEKHI FIZIOL NAUK, V32, P16; MULLER WE, 1994, LIFE SCI, V55, P2147, DOI 10.1016/0024-3205(94)00395-5; Nitta A, 1997, BEHAV BRAIN RES, V83, P201, DOI 10.1016/S0166-4328(97)86069-X; OLNEY YW, 1987, EXCITATORY AMINOACID, P217; Ongur D, 2005, PSYCHIAT RES-NEUROIM, V139, P191, DOI 10.1016/j.pscychresns.2005.05.006; OTTERSEN OP, 1991, EXCITALARY AMINO ACI, P24; POPOVA EN, 1986, ZH NEVROPATOL PSIKH, V86, P1860; PULSINELLI WA, 1985, PROG BRAIN RES, V63, P29; RAYEVSKY KS, 2000, VESTN RAMN, V4, P11; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; SCHEFF SW, 2005, NEUROBIOL AGING, V26, P150; Schwyzer L, 2002, EUR J NEUROSCI, V16, P1939, DOI 10.1046/j.1460-9568.2002.02259.x; SHEN JX, 2001, ACTA PHARM SIN, V20, P797; Shen YX, 2002, J PINEAL RES, V32, P85, DOI 10.1034/j.1600-079x.2002.1819.x; Shen YX, 2002, J PINEAL RES, V32, P173, DOI 10.1034/j.1600-079x.2002.1o850.x; SHERMAN KA, 1990, INT J DEV NEUROSCI, V8, P689, DOI 10.1016/0736-5748(90)90063-8; Shiozaki K, 2001, J NEUROL SCI, V193, P23, DOI 10.1016/S0022-510X(01)00638-4; Simic G, 2000, EXP NEUROL, V165, P12, DOI 10.1006/exnr.2000.7448; Skrebitsky V. G., 1999, Uspekhi Fiziologicheskikh Nauk, V30, P3; SOININEN HS, 1994, NEUROLOGY, V44, P1660, DOI 10.1212/WNL.44.9.1660; Szot P, 2006, J NEUROSCI, V26, P467, DOI 10.1523/JNEUROSCI.4265-05.2006; Tanaka H, 2002, J NEUROSCI RES, V67, P11, DOI 10.1002/jnr.10004.abs; Tang F, 2002, LIFE SCI, V71, P2625, DOI 10.1016/S0024-3205(02)02105-7; Tang YP, 2000, MOL BRAIN RES, V80, P188, DOI 10.1016/S0169-328X(00)00158-3; Telushkin P. K., 1999, Uspekhi Fiziologicheskikh Nauk, V30, P14; Trofimov S. S., 1992, Eksperimental'naya i Klinicheskaya Farmakologiya, V55, P18; Uchida K, 2004, J PINEAL RES, V37, P215, DOI 10.1111/j.1600-079X.2004.00159.x; van de Pol LA, 2006, NEUROLOGY, V66, P236, DOI 10.1212/01.wnl.0000194240.47892.4d; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Vinogradova O.S., 1975, GIPPOKAMP PAMYAT; Vogt KE, 2001, J NEUROSCI, V21, P75, DOI 10.1523/JNEUROSCI.21-01-00075.2001; Willson CA, 1997, NEUROSCI LETT, V229, P149, DOI 10.1016/S0304-3940(97)00441-2; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wu M, 2003, EUR J NEUROSCI, V18, P1155, DOI 10.1046/j.1460-9568.2003.02847.x; Yamashita K, 2000, CELL MOL NEUROBIOL, V20, P541, DOI 10.1023/A:1007007710703; Yen CLE, 2001, FASEB J, V15, P1704, DOI 10.1096/fj.00-0800com; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhang Jing, 2002, Yaoxue Xuebao, V37, P329; Zhang Zhang, 2002, Yaoxue Xuebao, V37, P682; Zhao LR, 2001, NEUROSCI LETT, V305, P169, DOI 10.1016/S0304-3940(01)01837-7; Zhu Y, 2001, NEUROSCIENCE, V107, P593, DOI 10.1016/S0306-4522(01)00357-8	88	3	8	0	2	IZDATELSTVO MEDITSINA	MOSCOW	PETROVERIGSKII PER 6-8, K-142 MOSCOW, RUSSIA	1997-7298			ZH NEVROL PSIKHIATR	Z. Nevrol. Psikhiatrii Im S S Korsakova		2007	107	7					72	77					6	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	197AQ	WOS:000248525700014	18689020				2022-02-06	
B	Caswell, SV; Gould, TE; Wiggins, JS		Subic, A		Caswell, S. V.; Gould, T. E.; Wiggins, J. S.			Protective helmets in sports	MATERIALS IN SPORTS EQUIPMENT, VOL 2			English	Article; Book Chapter							FEMALE SOCCER PLAYERS; ZEALAND RUGBY INJURY; ICE HOCKEY; UNITED-STATES; BRAIN-INJURY; PROFESSIONAL FOOTBALL; PERFORMANCE PROJECT; HEAD-INJURIES; IMPACT FORCES; CONCUSSION		[Caswell, S. V.] George Mason Univ, Sch Recreat Hlth & Tourism, Manassas, VA 20109 USA; [Gould, T. E.; Wiggins, J. S.] Univ So Mississippi, Sch Human Performance & Recreat, Sport & High Performance Mat Program, Hattiesburg, MS 39406 USA		Caswell, SV (corresponding author), George Mason Univ, Sch Recreat Hlth & Tourism, 208D Bull Run Hall,PW MS 4E5,10900 Univ Blvd, Manassas, VA 20109 USA.	scaswell@gmu.edu; Trent.Gould@usm.edu; Jeffrey.Wiggins@usm.edu					Al-Saidi LF, 2003, POLYM DEGRAD STABIL, V82, P451, DOI 10.1016/S0141-3910(03)00199-X; [Anonymous], 2006, D25606A ASTM INT; *ASTM INT, 2006, D611006 ASTM INT; *ASTM INT, 2006, F243906 ASTM INT; *ASTM INT, 2006, D182206 ASTM INT; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Barth JT, 2001, J ATHL TRAINING, V36, P253; Bauer JA, 2001, J SPORT SCI, V19, P171, DOI 10.1080/026404101750095312; *BAYER CORP PROD L, 1995, INJ MOLD GUID; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Biasca N, 2002, BRIT J SPORT MED, V36, P410, DOI 10.1136/bjsm.36.6.410; Bird YN, 1998, BRIT J SPORT MED, V32, P319, DOI 10.1136/bjsm.32.4.319; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; BRAY C, 2004, 1982 2001 NCAA SPORT; Broglio SP, 2003, J ATHL TRAINING, V38, P220; Caputo P, 2005, J SPORT SCI MED, V4, P58; Caswell SV, 2002, J ATHL TRAINING, V37, P164; *CONS, 2006, BIC HELM CONS REP; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Delaney JS, 2004, CLIN J SPORT MED, V14, P80, DOI 10.1097/00042752-200403000-00005; Di Landro L, 2002, POLYM TEST, V21, P217, DOI 10.1016/S0142-9418(01)00073-3; Finch CF, 2001, BRIT J SPORT MED, V35, P89, DOI 10.1136/bjsm.35.2.89; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; GERRARD DF, 1994, BRIT J SPORT MED, V28, P229, DOI 10.1136/bjsm.28.4.229; Gordon KE, 2006, PEDIATR NEUROL, V34, P376, DOI 10.1016/j.pediatrneurol.2005.09.007; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Inberg JPF, 2002, POLYMER, V43, P4197, DOI 10.1016/S0032-3861(02)00220-3; ISO, 2003, 102562003 ISO; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Knouse CL, 2003, J ATHL TRAINING, V38, P330; Lynch JM, 1996, US SOCCER SPORTS MED, P81; Marshall SW, 2001, J ATHL TRAINING, V36, P334; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory PR, 2003, BRIT MED J, V327, P351, DOI 10.1136/bmj.327.7411.351; McIntosh Andrew S, 2005, Med Sport Sci, V49, P120, DOI 10.1159/000085394; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; McIntosh AS, 2001, BRIT J SPORT MED, V35, P167, DOI 10.1136/bjsm.35.3.167; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1197/aemj.10.1.85; *NCAA, 2004, NAT COLL ATHL ASS NC; *NCIPC, 2003, C MILD TRAUM BRAIN I; *NFHS, 2004, NFHS 2003 04 HIGH SC; Parkinson GW, 2003, PEDIATRICS, V112, P320, DOI 10.1542/peds.112.2.320; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rivara F P, 1999, Inj Prev, V5, P194; SORTLAND O, 1989, NEURORADIOLOGY, V31, P44; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; TYSVAER AT, 1989, AM J SPORT MED, V17, P573, DOI 10.1177/036354658901700421; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Wilson BD, 1998, SPORTS MED, V25, P333, DOI 10.2165/00007256-199825050-00005; Withnall C, 2005, BRIT J SPORT MED, V39, pI40, DOI 10.1136/bjsm.2005.019174; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8	62	3	3	0	0	WOODHEAD PUBL LTD	CAMBRIDGE	ABINGTON HALL ABINGTON, CAMBRIDGE CB1 6AH, CAMBS, ENGLAND			978-1-84569-366-4; 978-1-84569-131-8				2007							87	126		10.1533/9781845693664.1.87			40	Materials Science, Multidisciplinary; Materials Science, Textiles	Book Citation Index – Science (BKCI-S)	Materials Science	BSI66	WOS:000284577600006					2022-02-06	
J	Corcoran, C; Malaspina, D				Corcoran, Cheryl; Malaspina, Dolores			Traumatic Brain Injury as a Risk Factor for Schizophrenia	CURRENT PSYCHIATRY REVIEWS			English	Article						Traumatic brain injury; schizophrenia; prevention; gene-environment interaction; risk	UNITED-STATES; CHILDHOOD ABUSE; HEAD TRAUMA; PSYCHOSIS; CONCUSSION; NEUROTRANSMISSION; ABNORMALITIES; EPIDEMIOLOGY; DYSFUNCTION; SECONDARY	Traumatic brain injury (TBI) is associated with schizophrenia, but the causal nature of this relationship is not clear. Three models for their association exist: 1) TBI causes a phenocopy of schizophrenia (parallelism); 2) TBI is a marker of schizophrenia vulnerability (spurious association); and 3) TBI interacts with genetic vulnerability to cause schizophrenia (interaction or effect modification). We found that TBI is a causal component of some cases of schizophrenia, specifically those with enhanced genetic vulnerability. This has biological plausibility. Prevention of 50% of these cases could lead to a savings of $313 million annually in the United States. Further research on critical windows for traumatic brain injury in vulnerable individuals could shed light on the developmental pathophysiology of schizophrenia.	[Corcoran, Cheryl] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Corcoran, Cheryl] Columbia Univ, Dept Psychiat, 1051 Riverside Dr, New York, NY 10032 USA; [Malaspina, Dolores] NYU, Dept Psychiat, New York, NY 10003 USA		Corcoran, C (corresponding author), Columbia Univ, Dept Psychiat, 1051 Riverside Dr, New York, NY 10032 USA.	cc788@columbia.edu	Corcoran, Cheryl/M-1397-2016	Corcoran, Cheryl/0000-0002-8902-4353			Ahmed I, 1998, Semin Clin Neuropsychiatry, V3, P23; Benes FM, 1999, BIOL PSYCHIAT, V46, P589, DOI 10.1016/S0006-3223(99)00136-5; Bigler ED, 1996, BRAIN INJURY, V10, P197, DOI 10.1080/026990596124511; Brown AS, 2002, MENT RETARD DEV D R, V8, P51, DOI 10.1002/mrdd.10004; BUCKLEY P, 1993, AM J PSYCHIAT, V150, P146; Carlsson A, 2001, ANNU REV PHARMACOL, V41, P237, DOI 10.1146/annurev.pharmtox.41.1.237; CLONINGER CR, 1994, AM J MED GENET, V54, P83, DOI 10.1002/ajmg.1320540202; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Corcoran C, 2003, SCHIZOPHRENIA BULL, V29, P671, DOI 10.1093/oxfordjournals.schbul.a007038; CORCORAN C, 2005, TXB TRAUMATIC BRAIN, P213; Corcoran C, 2001, INT J MENT HLTH, V30, P17; Dalman C, 2001, BRIT J PSYCHIAT, V179, P403, DOI 10.1192/bjp.179.5.403; Darroch J, 1997, AM J EPIDEMIOL, V145, P661; David AS, 2005, J NEUROL NEUROSUR PS, V76, pI53, DOI 10.1136/jnnp.2004.060475; DAVISON K, 1969, CURRENT PROBLEMS NEU; Eaton DK, 2006, J SCHOOL HEALTH, V76, P353, DOI 10.1111/j.1746-1561.2006.00127.x; FISH B, 1987, SCHIZOPHRENIA BULL, V13, P395, DOI 10.1093/schbul/13.3.395; Fujii Daryl, 2002, Cogn Neuropsychiatry, V7, P41, DOI 10.1080/135468000143000131; Fujii DE, 2001, J NEUROPSYCH CLIN N, V13, P61, DOI 10.1176/appi.neuropsych.13.1.61; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GOFF DC, 1991, PSYCHIAT RES, V37, P73, DOI 10.1016/0165-1781(91)90107-Z; GREENFIELD SF, 1994, BRIT J PSYCHIAT, V164, P831, DOI 10.1192/bjp.164.6.831; Heresco-Levy U, 1998, EUR NEUROPSYCHOPHARM, V8, P141, DOI 10.1016/S0924-977X(97)00050-3; HILLBOM E, 1960, Acta Psychiatr Scand Suppl, V35, P1; Hoek HW, 1998, SOC PSYCH PSYCH EPID, V33, P373, DOI 10.1007/s001270050068; Ismail B, 1998, AM J PSYCHIAT, V155, P84, DOI 10.1176/ajp.155.1.84; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Joashi UC, 1999, EUR J NEUROSCI, V11, P91, DOI 10.1046/j.1460-9568.1999.00409.x; KARAYIORGOU M, 1994, AM J MED GENET, V54, P345, DOI 10.1002/ajmg.1320540413; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kendler KS, 1996, AM J MED GENET, V67, P343, DOI 10.1002/(SICI)1096-8628(19960726)67:4<343::AID-AJMG5>3.0.CO;2-N; Keshavan MS, 1999, DEV PSYCHOPATHOL, V11, P525, DOI 10.1017/S0954579499002199; KORNILOV AA, 1980, ZH NEVROPATOL PSIKH, V80, P1687; Kraepelin E., 1919, DEMENTIA PRAECOX PAR; Kubicki M, 2005, CURR OPIN PSYCHIATR, V18, P121, DOI 10.1097/00001504-200503000-00004; Lewis DA, 1999, BIOL PSYCHIAT, V46, P616, DOI 10.1016/S0006-3223(99)00061-X; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; Malik AS, 2003, J NEUROTRAUM, V20, P463, DOI 10.1089/089771503765355531; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; Nielsen AS, 2002, SCHIZOPHR RES, V55, P93, DOI 10.1016/S0920-9964(01)00205-5; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; O'Shanick GJ, 2005, TXB TRAUMATIC BRAIN, P245; ONSTAD S, 1991, ACTA PSYCHIAT SCAND, V83, P395, DOI 10.1111/j.1600-0447.1991.tb05563.x; Park MJ, 2006, J ADOLESCENT HEALTH, V39, P305, DOI 10.1016/j.jadohealth.2006.04.017; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Reiss JP, 2006, J CLIN NEUROSCI, V13, P282, DOI 10.1016/j.jocn.2005.02.017; Robinson RG, 2005, TXB TRAUMATIC BRAIN, P201; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; Tsauo JY, 1999, ACCIDENT ANAL PREV, V31, P253, DOI 10.1016/S0001-4575(98)00078-5; Vakis AF, 2006, BRIT J NEUROSURG, V20, P156, DOI 10.1080/02688690600776986; Van Hoesen GW, 1999, ANN NY ACAD SCI, V877, P575; von Krafft-Ebing R, 1868, UEBER DURCH GEHIRNER; WILCOX JA, 1987, PSYCHIAT RES, V21, P303, DOI 10.1016/0165-1781(87)90013-8; Williams AF, 2006, J SAFETY RES, V37, P123, DOI 10.1016/j.jsr.2006.01.001; Winqvist S, 2006, J ADOLESCENT HEALTH, V39; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Wu EQ, 2005, J CLIN PSYCHIAT, V66, P1122, DOI 10.4088/JCP.v66n0906; Yao JK, 2001, CNS DRUGS, V15, P287, DOI 10.2165/00023210-200115040-00004; Yudofsky S.C., 2005, TXB TRAUMATIC BRAIN, P27	65	3	4	0	1	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1573-4005	1875-6441		CURR PSYCHIATRY REV	Curr. Psychiatry Rev.		2007	3	1					25	32		10.2174/157340007779815646			8	Psychiatry	Emerging Sources Citation Index (ESCI)	Psychiatry	V95QI	WOS:000213210700004					2022-02-06	
J	Giles, GM				Giles, Gordon Muir			Assessing adaptive behaviour in the post-acute setting following traumatic brain injury: Initial reliability and validity of the Adaptive Behaviour and Community Competency Scale (ABCCS)	BRAIN INJURY			English	Article						traumatic brain injury; Adaptive Behaviour and Community Competency Scale; direct-care staff	OUTCOMES; PARTICIPATION; DISABILITY; PROGRAM; COMA	Primary objective: Present the rationale for adaptive behavior rating and introduce the Adaptive Behaviour and Community Competency Scale ( ABCCS), a comprehensive and detailed measure of adaptive behaviour, for use with persons with traumatic brain injury ( TBI) in the post-acute period. Methods and procedures: Direct-care staff with limited exposure to the ABCCS, completed it twice, two weeks apart, about persons with TBI who were resident in diverse community settings. Other measures to assess validity were administered concurrently. Results: Intraclass Correlation Coefficients ( ICC) for interrater and test-retest reliability of the ABCCS were excellent ( ICC = 0.9681 and 0.9860 respectively). Evidence for convergent and divergent validity with comparison measures was strong with highly significant correlations with scales measuring similar content ( Rho = 0.613-0.919) and weak correlations for scales measuring dissimilar content ( Rho = 0.318-0.397). Conclusions: The ABCCS is a reliable and a valid indicator of functioning post-acute TBI and is straightforward enough to be used by direct-care staff.	Samuel Merritt Coll, Oakland, CA 94609 USA; Crestwood Behav Hlth Inc, Idylwood Care Ctr, Sunnyvale, CA USA		Giles, GM (corresponding author), Samuel Merritt Coll, 450,30th St, Oakland, CA 94609 USA.	ggiles@samuelmerritt.edu					ACKER MB, 1990, NEUROPSYCHOLOGY EVER; Bohac DL, 1997, BRAIN INJURY, V11, P469, DOI 10.1080/713802185; BORENSTEIN M, 1990, POWER; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FRICK T, 1978, REV EDUC RES, V48, P157, DOI 10.2307/1169913; Giles G. M., 1999, REHABILITATION SEVER, P81; Giles GM, 2005, BRAIN INJURY, V19, P753, DOI 10.1080/02699050500110108; Giles GM, 2001, BRAIN DAM B, P231; GILES GM, 1999, REHABILITATION SEVER; Gurka JA, 1999, J HEAD TRAUMA REHAB, V14, P247, DOI 10.1097/00001199-199906000-00005; Haffey W. J., 1990, NEUROPSYCHOLOGY EVER, P99; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; HARRICK L, 1994, BRAIN INJURY, V8, P439, DOI 10.3109/02699059409150995; HEATON RK, 1981, J CONSULT CLIN PSYCH, V49, P807, DOI 10.1037/0022-006X.49.6.807; JACOBSON JW, 1996, MANUAL DIAGNOSIS PRO; JENNETT B, 1975, LANCET, V1, P480; JOHNSTON M V, 1991, Brain Injury, V5, P155, DOI 10.3109/02699059109008086; Johnston MV, 2006, BRAIN INJURY, V20, P391, DOI 10.1080/02699050500487795; KILGORE KM, 1995, ARCH PHYS MED REHAB, V76, pSC21; MALEC J, 1990, J HEAD TRAUMA REHAB, V5, P60; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; MALEC JF, 1993, BRAIN INJURY, V7, P383, DOI 10.3109/02699059309029682; McPherson KM, 1996, DISABIL REHABIL, V18, P341, DOI 10.3109/09638289609165892; Minnes P, 1998, BRAIN INJURY, V12, P987, DOI 10.1080/026990598122034; NIHIRA K, 1993, AAMD ADAPTIVE BEHAV; Nunnally JC., 1978, PSYCHOMETRIC THEORY, V2; O'Brien G, 2001, DEV MED CHILD NEUROL, V43, P1; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Pollock N, 1998, CANADIAN OCCUPATIONA; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Robson C., 1993, REAL WORLD RES RESOU; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; SPREAT S, 1999, ADAPTIVE BEHAV ITS M; *SPSS, 2005, SPSS MAC 11 04; TEASDALE G, 1974, LANCET, V2, P81; THOMPSON JR, 1999, ADAPTIVE BEHAV ITS M; Walker N, 2003, AM J PHYS MED REHAB, V82, P936, DOI 10.1097/01.PHM.0000098041.42394.9A; WIDAMAN KF, 1996, MANUAL DIAGNOSIS PRO; Willer B, 1994, BRAIN INJURY REHABIL, P355; Wood RL, 1999, BRAIN INJURY, V13, P69, DOI 10.1080/026990599121746; World Health Organization, 2007, INT CLASS FUNCT DIS; Worthington AD, 2006, BRAIN INJURY, V20, P947, DOI 10.1080/02699050600888314; [No title captured]	44	3	3	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	5					521	529		10.1080/02699050701311067			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	175FI	WOS:000246998000009	17522992				2022-02-06	
J	Heydebrand, G				Heydebrand, Gitry			Issues in Rehabilitation of Cognitive Deficits in Schizophrenia: A Critical Review	CURRENT PSYCHIATRY REVIEWS			English	Article						Review; cognitive rehabilitation; schizophrenia		Over the past 20 years, researchers have begun to examine whether remediation of cognitive deficits could improve cognitive performance in individuals with schizophrenia, using rehabilitation medicine models for traumatic brain injury. A number of recent meta-analyses have demonstrated that this type of intervention is of benefit, but numerous questions remain, including the crucial issue of whether improvement on cognitive measures corresponds to improvements on other tasks or to real-world functioning. Further, there has been little analysis of individual differences in response to cognitive remediation, despite increasing evidence for considerable heterogeneity of cognitive function in schizophrenia, ranging from near-normal cognitive function to global impairment. This article will provide a summary of the research in this area to date, and address many of the methodological issues that are relevant in studies on cognitive rehabilitation in schizophrenia, including a critical review of treatment and outcome variables.	[Heydebrand, Gitry] Washington Univ, Sch Med, Dept Psychiat, POB 8134,660 S Euclid, St Louis, MO 63110 USA		Heydebrand, G (corresponding author), Washington Univ, Sch Med, Dept Psychiat, POB 8134,660 S Euclid, St Louis, MO 63110 USA.	Heydebrg@wustl.edu					Allen DN, 2000, J NERV MENT DIS, V188, P381, DOI 10.1097/00005053-200006000-00010; Anthony WA, 1987, PSYCHOSOC REHABIL, V11, P5, DOI DOI 10.1037/H0099582; APA/ CAPP Task Force on Serious Mental Illness and Severe Emotional Disturbance, TRAIN GRID OUTL BEST; Bark N, 2003, SCHIZOPHR RES, V63, P229, DOI 10.1016/S0920-9964(02)00374-2; Bell M, 2001, ARCH GEN PSYCHIAT, V58, P763, DOI 10.1001/archpsyc.58.8.763; Bell MD, 2001, SCHIZOPHRENIA BULL, V27, P269, DOI 10.1093/oxfordjournals.schbul.a006873; Bell MD, 2003, ACTA PSYCHIAT SCAND, V207, P1; Bellack AS, 1999, SCHIZOPHRENIA BULL, V25, P257, DOI 10.1093/oxfordjournals.schbul.a033377; Bellucci DM, 2003, SCHIZOPHR RES, V59, P225, DOI 10.1016/S0920-9964(01)00402-9; BENEDICT RHB, 1994, SCHIZOPHRENIA BULL, V20, P537, DOI 10.1093/schbul/20.3.537; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Blashfield R.K., 1984, CLUSTER ANAL; BRENNER HD, 1992, SCHIZOPHRENIA BULL, V18, P21, DOI 10.1093/schbul/18.1.21; Browne S, 1996, ACTA PSYCHIAT SCAND, V94, P118, DOI 10.1111/j.1600-0447.1996.tb09835.x; Brune M, 2003, SCHIZOPHR RES, V60, P57, DOI 10.1016/s0920-9964(02)00162-7; BUCHANAN RW, 1994, ARCH GEN PSYCHIAT, V51, P804; BURDA PC, 1994, COMPUT HUM BEHAV, V10, P359, DOI 10.1016/0747-5632(94)90061-2; Censits DM, 1997, SCHIZOPHR RES, V24, P289, DOI 10.1016/S0920-9964(96)00091-6; CHUA SE, 1995, BRIT J PSYCHIAT, V166, P563, DOI 10.1192/bjp.166.5.563; COHEN BD, 1956, J ABNORM SOC PSYCH, V52, P186, DOI 10.1037/h0048262; Cohen J., 2013, STAT POWER ANAL BEHA; Curtis VA, 1999, SCHIZOPHR RES, V37, P35, DOI 10.1016/S0920-9964(98)00141-8; Danion JM, 2001, AM J PSYCHIAT, V158, P944, DOI 10.1176/appi.ajp.158.6.944; Fiszdon J, 2006, PSYCHIAT RES; Fiszdon JM, 2005, ACTA PSYCHIAT SCAND, V112, P187, DOI 10.1111/j.1600-0447.2005.00565.x; Fiszdon JM, 2004, PSYCHIAT RES, V125, P1, DOI 10.1016/j.psychres.2003.10.004; GOLDMANRAKIC PS, 1991, AM PSYCHOP, P1; Goldstein G, 1990, Arch Clin Neuropsychol, V5, P251, DOI 10.1016/0887-6177(90)90024-J; Goldstein G, 1998, J INT NEUROPSYCH SOC, V4, P353, DOI 10.1017/S1355617798003531; Goldstein G, 1998, AM J PSYCHIAT, V155, P1117, DOI 10.1176/ajp.155.8.1117; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Green MF, 1996, AM J PSYCHIAT, V153, P321; GUR RC, 1995, LANCET, V345, P1383, DOI 10.1016/S0140-6736(95)92591-0; Harvey PD, 2001, AM J PSYCHIAT, V158, P176, DOI 10.1176/appi.ajp.158.2.176; Heaton RK, 2001, ARCH GEN PSYCHIAT, V58, P24, DOI 10.1001/archpsyc.58.1.24; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; HEINRICHS RW, 1993, SCHIZOPHR RES, V9, P49, DOI 10.1016/0920-9964(93)90009-8; HERMANUTZ M, 1991, EUR ARCH PSY CLIN N, V240, P282, DOI 10.1007/BF02189541; Hill SK, 2002, J CLIN EXP NEUROPSYC, V24, P765, DOI 10.1076/jcen.24.6.765.8402; Hogarty GE, 2004, ARCH GEN PSYCHIAT, V61, P866, DOI 10.1001/archpsyc.61.9.866; Hogarty GE, 1999, SCHIZOPHRENIA BULL, V25, P693, DOI 10.1093/oxfordjournals.schbul.a033411; Jaeger J, 2003, SCHIZOPHRENIA BULL, V29, P153, DOI 10.1093/oxfordjournals.schbul.a006987; Journal Jaeger, 1993, SCHIZOPHR RES, V9, P179; Kayser N, 2006, NEUROPSYCHOL REHABIL, V16, P83, DOI 10.1080/09602010443000236; Keefe RSE, 1999, SCHIZOPHRENIA BULL, V25, P201, DOI 10.1093/oxfordjournals.schbul.a033374; Kern RS, 2005, AM J PSYCHIAT, V162, P513, DOI 10.1176/appi.ajp.162.3.513; KERN RS, 1995, J ABNORM PSYCHOL, V104, P385, DOI 10.1037/0021-843X.104.2.385; Kindermann SS, 1997, SCHIZOPHR RES, V27, P143, DOI 10.1016/S0920-9964(97)00063-7; Krabbendam L, 2003, PSYCHOPHARMACOLOGY, V169, P376, DOI 10.1007/s00213-002-1326-5; Kurtz MM, 2001, NEUROPSYCHOL REV, V11, P197, DOI 10.1023/A:1012953108158; Kurtz MM, 2001, NEUROREHAB NEURAL RE, V15, P75, DOI 10.1177/154596830101500110; KURTZ MM, 2006, SCHIZOPHR RES; LEVIN S, 1984, J PSYCHIATR RES, V18, P27, DOI 10.1016/0022-3956(84)90046-3; LIDDLE PF, 1990, BRIT J PSYCHIAT, V157, P558, DOI 10.1192/bjp.157.4.558; Lopez-Luengo B, 2003, PSYCHIAT RES, V119, P41, DOI 10.1016/S0165-1781(03)00102-1; Mattson DT, 1997, J GENET PSYCHOL, V158, P487, DOI 10.1080/00221329709596685; McGurk SR, 2000, SCHIZOPHR RES, V45, P175, DOI 10.1016/S0920-9964(99)00198-X; McGurk SR, 2005, SCHIZOPHRENIA BULL, V31, P898, DOI 10.1093/schbul/sbi037; Medalia A, 2005, SCHIZOPHRENIA BULL, V31, P942, DOI 10.1093/schbul/sbi045; Medalia A, 1998, SCHIZOPHRENIA BULL, V24, P147, DOI 10.1093/oxfordjournals.schbul.a033306; Medalia A, 2002, REMEDIATION COGNITIV; Meichenbaum D, 1973, BEHAV THER, V4, P447; Meltzer HY, SCHIZOPHR B, V199, P233; Mieselman KC, 1973, J CONSULT CLIN PSYCH, V41, P447; Milev P, 2005, AM J PSYCHIAT, V162, P495, DOI 10.1176/appi.ajp.162.3.495; Mishara AL, 2004, BIOL PSYCHIAT, V55, P1013, DOI 10.1016/j.biopsych.2004.01.027; Muller BW, 2004, EUR PSYCHOL, V9, P96, DOI 10.1027/1016-9040.9.2.96; NUECHTERLEIN KH, 1992, SCHIZOPHRENIA BULL, V18, P387, DOI 10.1093/schbul/18.3.387; OLBRICH R, 1990, EUR ARCH PSY CLIN N, V239, P366, DOI 10.1007/BF01734543; Palmer BW, 1997, NEUROPSYCHOLOGY, V11, P437, DOI 10.1037/0894-4105.11.3.437; Patel A, 2006, SCHIZOPHRENIA BULL, V32, P776, DOI 10.1093/schbul/sbl013; Patterson TL, 2001, SCHIZOPHRENIA BULL, V27, P235, DOI 10.1093/oxfordjournals.schbul.a006870; Penades R, 2000, PSYCHIAT RES-NEUROIM, V98, P127, DOI 10.1016/S0925-4927(99)00050-5; Penades R, 2002, ACTA PSYCHIAT SCAND, V105, P202, DOI 10.1034/j.1600-0447.2002.1o421.x; Pfammatter M, 2006, SCHIZOPHRENIA BULL, V32, pS64, DOI 10.1093/schbul/sbl030; Pilling S, 2002, PSYCHOL MED, V32, P783, DOI 10.1017/S0033291702005640; Purdon SE, 1999, SCHIZOPHR RES, V35, pS51, DOI 10.1016/S0920-9964(98)00166-2; Purdon SE, 2000, J PSYCHIATR NEUROSCI, V25, P108; Rempfer MV, 2003, PSYCHIAT RES, V117, P103, DOI 10.1016/S0165-1781(02)00318-9; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Roder V, 2006, SCHIZOPHR B; RUBIN P, 1994, ACTA PSYCHIAT SCAND, V90, P281, DOI 10.1111/j.1600-0447.1994.tb01594.x; Rund BR, 1999, ACTA PSYCHIAT SCAND, V100, P85, DOI 10.1111/j.1600-0447.1999.tb10829.x; Satory G, 2005, SCHIZOPHR RES, V75, P219; SAYKIN AJ, 1994, ARCH GEN PSYCHIAT, V51, P124; SCHMAND B, 1994, PSYCHOL MED, V24, P869, DOI 10.1017/S0033291700028968; Seaton BE, 1999, J NERV MENT DIS, V187, P414, DOI 10.1097/00005053-199907000-00004; Seaton BE, 2001, NEUROPSYCHOL REV, V11, P45, DOI 10.1023/A:1009013718684; Seidman LJ, 2003, PSYCHIAT SERV, V54, P905, DOI 10.1176/appi.ps.54.6.905; Semkovska M, 2004, SCHIZOPHR RES, V69, P289, DOI 10.1016/j.schres.2003.07.005; SILVERSTEIN ML, 1985, J CONSULT CLIN PSYCH, V53, P267, DOI 10.1037/0022-006X.53.2.267; Silverstein SM, 2004, SCHIZOPHRENIA BULL, V30, P679, DOI 10.1093/oxfordjournals.schbul.a007122; Silverstein SM, 2001, SCHIZOPHRENIA BULL, V27, P247, DOI 10.1093/oxfordjournals.schbul.a006871; Silverstein SM, 2000, APPL PREV PSYCHOL, V9, P227, DOI 10.1016/S0962-1849(00)80002-5; Smith TE, 2002, SCHIZOPHR RES, V55, P229, DOI 10.1016/S0920-9964(01)00231-6; Smith TE, 1999, AM J PSYCHIAT, V156, P1817; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Spaulding WE, 1999, SCHIZOPHR B, P657; Sturm W, 1997, NEUROPSYCHOL REHABIL, V7, P81, DOI 10.1080/713755526; Suslow T, 2001, ACTA PSYCHIAT SCAND, V103, P15, DOI 10.1034/j.1600-0447.2001.00016.x; Terrell S., 1996, Journal of Research on Computing in Education, V28, P403; Turetsky BI, 2002, NEUROPSYCHOLOGY, V16, P481, DOI 10.1037//0894-4105.16.4.481; Twamley EW, 2003, SCHIZOPHRENIA BULL, V29, P359, DOI 10.1093/oxfordjournals.schbul.a007011; Ueland T, 1999, SCHIZOPHR B, V25, P291; Van der Gaag M, 2002, SCHIZOPHR B, V167, P166; Vauth R, 2005, SCHIZOPHRENIA BULL, V31, P55, DOI 10.1093/schbul/sbi013; Vauth R, 2001, Z FUER KLIN PSYCHOL, V31, P251; Velligan DI, 1999, J CLIN PSYCHIAT, V60, P25; Velligan DI, 2000, AM J PSYCHIAT, V157, P1317, DOI 10.1176/appi.ajp.157.8.1317; Weickert TW, 2000, ARCH GEN PSYCHIAT, V57, P907, DOI 10.1001/archpsyc.57.9.907; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; Wexler BE, 2005, SCHIZOPHRENIA BULL, V31, P931, DOI 10.1093/schbul/sbi038; Wexler BE, 2000, AM J PSYCHIAT, V157, P1694, DOI 10.1176/appi.ajp.157.10.1694; Wiedl KH, 1999, INT J REHABIL RES, V22, P55, DOI 10.1097/00004356-199903000-00007; Woonings FMJ, 2003, SCHIZOPHR RES, V59, P287, DOI 10.1016/S0920-9964(02)00163-9; Wykes T, 2003, SCHIZOPHR RES, V61, P163, DOI 10.1016/S0920-9964(02)00239-6; Wykes T, 1998, SCHIZOPHR RES, V34, P77, DOI 10.1016/S0920-9964(98)00076-0; Wykes T, 1999, SCHIZOPHRENIA BULL, V25, P291, DOI 10.1093/oxfordjournals.schbul.a033379; Wykes T, 2002, BRIT J PSYCHIAT, V181, P144	119	3	3	0	0	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1573-4005	1875-6441		CURR PSYCHIATRY REV	Curr. Psychiatry Rev.		2007	3	3					186	195		10.2174/157340007781369676			10	Psychiatry	Emerging Sources Citation Index (ESCI)	Psychiatry	V95RP	WOS:000213214000004					2022-02-06	
J	Martin-Rodriguez, A; Gregorio, MAPS				Martin-Rodriguez, Agustin; Perez-San Gregorio, Maria Angeles			Influence of Intensive Care Unit in relatives of patients with bad quality of life	INTERNATIONAL JOURNAL OF CLINICAL AND HEALTH PSYCHOLOGY			Spanish	Article						Intensive Care Unit; quality of life; relative; Ex post facto study	RHEUMATOID-ARTHRITIS; FAMILY NEEDS; PSYCHOLOGY; CAREGIVERS; CHILDREN; MOTHERS; BURDEN; HEALTH	In this ex post facto study, we have analysed if relatives of patients with bad quality of life show differences in the variables "clinical of personality" and "family relations" depending on the fact that the patient has been hospitalized or not in the Intensive Care Unit. We have selected two groups: (1) 29 relatives of severely traumatized patients after four years of being hospitalized in a Traumatology ICU and with bad quality of life (due to physical and/or psychological sequelae of the hospitalization such as traumatic brain injuries, politraumatisms and traumatic quadriplegics) and (2) 32 relatives of patients with bad quality of life with a four-year evolution of their physical medical condition (hypertension, diabetes, rheumatoid arthritis and irritable bowel syndrome) who have never been hospitalized in the ICU. In order to achieve our goal we have used a Psychosocial Survey and the following tools: Clinical Analysis Questionnaire, Family Environment Scale and Psychosocial Adjustment to Illness Scale. The results indicated that relatives with patients with bad quality of life who were in the ICU four years ago show significant differences in the variables agitation and expression compared to relatives of patients with bad quality of life who have not been in the ICU.	Univ Seville, Seville, Spain		Martin-Rodriguez, A (corresponding author), Fac Psicol, Dept Personalidad Evaluac & Tratamiento Psicol, C Camilo Jose Cela S-N, Seville 41018, Spain.	amartinr@us.es					AFFLECK G, 1990, INF MENTAL HLTH J, V11, P12, DOI 10.1002/1097-0355(199021)11:1<12::AID-IMHJ2280110103>3.0.CO;2-P; Ahrens T, 2003, AM J CRIT CARE, V12, P317, DOI 10.4037/ajcc2003.12.4.317; ANGUERA B, 1978, ANUARIO PSICOLOGIA, V19, P5; AVERBACH M, 2005, AM J CRITICAL J, V3, P202; BENNUN I, 1999, J FAM THER, V1, P96; Boling W, 2005, FAM COMMUNITY HEALTH, V28, P176, DOI 10.1097/00003727-200504000-00009; BRESLAU N, 1982, AM J DIS CHILD, V136, P682, DOI 10.1001/archpedi.1982.03970440026007; Brooks R, 1997, INTENS CARE MED, V23, P581, DOI 10.1007/s001340050376; CRESPO MD, 1992, PSIQUIS, V13, P260; Deeken JF, 2003, J PAIN SYMPTOM MANAG, V26, P922, DOI 10.1016/S0885-3924(03)00327-0; DORRZEGER O, 1988, ACTAS LUSO-ESP NEUR, V4, P246; FERRARI M, 1983, FAM PROCESS, V22, P53, DOI 10.1111/j.1545-5300.1983.00053.x; FIFE B, 1987, SOC SCI MED, V24, P159, DOI 10.1016/0277-9536(87)90248-6; FLOREZ JA, 2001, ASPECTOS PSICOCOAFEC; FORRESTER DA, 1990, HEART LUNG, V19, P655; Foster M, 2003, SCAND J CARING SCI, V17, P205, DOI 10.1046/j.1471-6712.2003.00230.x; FULLERJONAP F, 1995, J AGING HEALTH, V7, P99, DOI 10.1177/089826439500700105; KORNBLIT A, 1984, SOMATICA FAMILIAR EN; KRUGG SS, 1987, CUEESTIONARIO ANAL C; MARTIN A, 2005, J PSYCHOSOM RES, V58, P447; Montero I, 2005, INT J CLIN HLTH PSYC, V5, P115; MOOS RH, 1989, ESCALAS CLIMA SOC FA; Perez F.J, 1999, EMOCIONES SALUD, P301; PEREZ MA, 1994, PSICOTERAPIA MODELOS, P661; Power W. E., 2004, FAMILIES LIVING CHRO; PRICE DM, 1991, HEART LUNG, V20, P183; Ramos-Alvarez MM, 2006, INT J CLIN HLTH PSYC, V6, P773; REVENSON TA, 1990, J SOC PERS RELAT, V7, P575, DOI 10.1177/0265407590074013; Riveros A, 2005, INT J CLIN HLTH PSYC, V5, P445; SCHULZ R, 1995, GERONTOLOGIST, V35, P771, DOI 10.1093/geront/35.6.771; SMITH I, 1990, J BEHAV MED, V6, P561; Vinaccia S, 2005, INT J CLIN HLTH PSYC, V5, P129; Walsh JD, 1999, BEHAV RES THER, V37, P259, DOI 10.1016/S0005-7967(98)00128-4	33	3	3	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1697-2600	1576-7329		INT J CLIN HLTH PSYC	Int. J. Clin. Health Psychol.	JAN	2007	7	1					71	82					12	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	126AH	WOS:000243484100005					2022-02-06	
J	Matschke, J; Laas, R; Schulz, F				Matschke, J.; Laas, R.; Schulz, F.			Cerebellar atrophy following mild head injury in a 4-year-old girl	PEDIATRIC NEUROSURGERY			English	Article						head injury; traumatic brain injury; cerebellar atrophy; forensic neuropathology	TRAUMATIC BRAIN INJURY; CENTRAL-NERVOUS-SYSTEM; SUPERFICIAL SIDEROSIS; RAT; VULNERABILITY; INDUCTION; DAMAGE; CELLS	Cerebellar atrophy following severe head injury in infants has been described in imaging studies. We report the case of a 4-year-old girl who died of accidental hypothermia. Three weeks before, she had sustained head injury after falling on the back of her head with linear fracture of the occipital bone. Neuropathological examination of the girl's brain revealed cerebellar atrophy with specific loss of Purkinje cells. We present findings of detailed neuropathological studies and discuss possible mechanisms of posttraumatic cerebellar atrophy. To the best of our knowledge, cerebellar atrophy following mild head injury in man has not been described morphologically so far. Copyright (C) 2007 S. Karger AG, Basel.	Univ Hamburg, Ctr Med, Inst Neuropathol, DE-20246 Hamburg, Germany; Univ Hamburg, Ctr Med, Inst Legal Med, DE-20246 Hamburg, Germany		Matschke, J (corresponding author), Univ Hamburg, Ctr Med, Inst Neuropathol, Martinistr 52, DE-20246 Hamburg, Germany.	matschke@uke.uni-hamburg.de	Matschke, Jakob/F-6641-2013	Matschke, Jakob/0000-0001-6080-0198			Ai JL, 2002, NEUROSCI LETT, V332, P155, DOI 10.1016/S0304-3940(02)00945-X; Benavidez DA, 1999, PRINCIPLES AND PRACTICE OF PEDIATRIC NEUROSURGERY, P915; CAJAL SR, 1991, CAJALS DEGENERATION, P91; CAMMERMEYER J, 1947, J NEUROPATH EXP NEUR, V6, P111, DOI 10.1097/00005072-194704000-00001; Cavanagh JB, 1997, NEUROPATH APPL NEURO, V23, P355; FEARNLEY JM, 1995, BRAIN, V118, P1051, DOI 10.1093/brain/118.4.1051; FIEZ JA, 1992, BRAIN, V115, P155, DOI 10.1093/brain/115.1.155; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; FUKUDA K, 1995, NEUROSCI LETT, V199, P127, DOI 10.1016/0304-3940(95)12042-3; GRAFMAN J, 1992, NEUROLOGY, V42, P1493, DOI 10.1212/WNL.42.8.1493; GRAHAM DI, 2002, GREENFIELDS NEUROPAT, V1, P823; Ivry R B, 1992, Curr Opin Neurobiol, V2, P212, DOI 10.1016/0959-4388(92)90015-D; KOEPPEN AH, 1991, J NEUROPATH EXP NEUR, V50, P579, DOI 10.1097/00005072-199109000-00005; KOEPPEN AH, 1993, ANN NEUROL, V34, P646, DOI 10.1002/ana.410340505; Mautes AEM, 1996, NEUROSCI LETT, V214, P95, DOI 10.1016/0304-3940(96)12916-5; OHEARN E, 1995, NEUROREPORT, V6, P1611, DOI 10.1097/00001756-199508000-00006; OZAWA H, 1994, BRAIN RES, V651, P345, DOI 10.1016/0006-8993(94)90717-X; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; Slemmer JE, 2004, NEUROBIOL DIS, V15, P563, DOI 10.1016/j.nbd.2003.11.027; Soto-Ares G, 2001, CHILD NERV SYST, V17, P263, DOI 10.1007/s003810000411; Townsend J, 1999, J NEUROSCI, V19, P5632	21	3	3	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291			PEDIATR NEUROSURG	Pediatr. Neurosurg.		2007	43	4					330	333		10.1159/000103317			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	190PQ	WOS:000248071700014	17627153				2022-02-06	
J	Navratil, L				Navratil, L.			Decompressive craniotomy in craniocerebral injury - Evaluation of outcome one year after trauma	CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE			Czech	Article						cerebral injury; decompressive craniotomy; age; outcome; GOS	SEVERE BRAIN-INJURY; SEVERE HEAD-INJURY; POSTTRAUMATIC INTRACRANIAL HYPERTENSION; PRACTICAL SCALE; CRANIECTOMY; MANAGEMENT; CHILDREN; AGE; EDEMA; COMA	Aim: The aim of this study is to evaluate the outcome of patiens treated for craniocerebral trauma by means of decompressive craniotomy. Material and methods: In the group of 110 patients (83 males, 27 females, age 6-82 years, mean 47 18,27) the influence of different factors to the outcome of patient one year after injury was evaluated. Among the factors in view we included age, clinical status and its worsenig after admission, CT exam, accompanying injuries, time period between injury and operation, finding during operation, intracranial pressure and post-oparative complications, Results: Age is an independent and very significant factor which influences the outcome of patients treated with decompressive craniotomy (p < 0.0001). Level of consciousness during admission (GCS) is in strong relation to the outcome in non-sedated patients (p = 0.0141). When the reactivity and width of pupils were evaluated together, a strong correlation to the outcome was detected (p = 0.0111). In the preoperative CT the significance of midline shift or narrowing of cinsterns to the outcome of all patients was not found. The perioperative measurement of dural gap before the duroplasty is the speciality of this work. The dural gap was significantly bigger in patients with closed cisterns in the CT (p < 0.0001). It was a strong correlation between the dural gap and the outcome in the soubgroup of patients with closed cisterns on CT (p = 0.0021). After decompressive craniotomy was noted lowering of ICP and increase of CPP in monitored patiens. Conclussion: Our results indicate, that active approach of the neurosurgeon and the early indication of decompressive craniotomy are helpfull especially for younger patients.	Neurochirurg Oddeleni, Fak Nemocnice, Plzen 30460, Czech Republic		Navratil, L (corresponding author), Neurochirurg Oddeleni, Fak Nemocnice, Alej Svobody 80, Plzen 30460, Czech Republic.	navratil@fnplzen.cz					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; *BRAIN TRAUM FDN A, 1996, J NEUROTRAUM, V13, P641; Choc M, 1980, Rozhl Chir, V59, P747; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; Csokay A, 2002, NEUROL RES, V24, P157, DOI 10.1179/016164102101199701; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; De Luca GP, 2000, ACTA NEUROCHIR SUPPL, V76, P401; Dickerman RD, 2005, CHILD NERV SYST, V21, P1014, DOI 10.1007/s00381-005-1257-7; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hejazi N, 2002, EUR J PEDIATR, V161, P99, DOI 10.1007/s00431-001-0864-x; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hutchinson P J, 2004, Curr Opin Crit Care, V10, P101, DOI 10.1097/00075198-200404000-00004; Hutchinson PJ, 2005, ACTA NEUROCHIR, V147, P1, DOI 10.1007/s00701-004-0400-7; JENNETT B, 1975, LANCET, V1, P480; KERR ME, 2001, NEUROSURG FOCUS, V11, P1; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; LEVIN HS, 1990, HEAD INJURY HDB CLIN, V13, P367; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Meier U, 2003, ACTA NEUROCHIR SUPPL, V86, P367; Messing-Junger AM, 2003, ZBL NEUROCHIR, V64, P171; Miller KJ, 2005, J NEUROSURG, V103, P239, DOI 10.3171/jns.2005.103.2.0239; Mracek Z, 1977, Rozhl Chir, V56, P597; Mracek Z., 1996, PLZEN LEK SBORN S, V70, P147; Mracek Z, 2000, PLZEN LEK SBORN S, V74, P195; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Reithmeier T, 2005, ACTA NEUROCHIR, V147, P947, DOI 10.1007/s00701-005-0543-1; Reithmeier T, 2005, CHILD NERV SYST, V21, P249, DOI 10.1007/s00381-004-1044-x; SAHUQUILLO J, 2006, COCHRANE DB SYST REV, P2; Schneider GH, 2002, ACT NEUR S, V81, P77; Soukiasian HJ, 2002, AM SURGEON, V68, P1066; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P140; TEASDALE G, 1974, LANCET, V2, P81; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; WEIWEI H, CESK SLOV NEUROL N; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110	43	3	3	0	1	CZECH MEDICAL SOC	PRAGUE 2	SOKOLSKA 31, PRAGUE 2 120 26, CZECH REPUBLIC	1210-7859			CESK SLOV NEUROL N	Cesk. Slov. Neurol. Neurochir.		2007	70	3					294	301					8	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	292KE	WOS:000255264100011					2022-02-06	
J	Papageorgiou, KI; Mathew, RG; Ghazi-Nouri, SMS; Andreou, PS; Sinha, AJ				Papageorgiou, K. I.; Mathew, R. G.; Ghazi-Nouri, S. M. S.; Andreou, P. S.; Sinha, A. J.			Optochiasmal Avulsion Secondary to Minor Occipital Trauma	ORBIT-AN INTERNATIONAL JOURNAL ON ORBITAL DISORDERS AND FACIAL RECONSTRUCTIVE SURGERY			English	Article						Optic nerve avulsion; occipital trauma; chiasmal ischemia; retrobulbar hemorrhage; globe expulsion		Background: Optic nerve avulsion is an extremely rare occurrence and usually arises in the setting of severe fronto-orbital fractures or penetrating orbital injuries. However, a few cases have been associated with minor injury. Objective: To overview the pathophysiology of delayed optochiasmal avulsion following minor ocipital trauma and discuss management options. Methods: Report of a unique case of a 79-year-old woman who presented with delayed partial expulsion of the right globe and complete optic nerve avulsion following closed head injury to the occiput. Conclusion: Antero-posterior distortion of the skull following such a deceleration injury can cause laceration and thrombosis of the pre-chiasmal and pial arteries supplying the optic chiasm. The ensuing ischaemic changes subsequently caused delayed softening of the chiasm and its avulsion. The concomitant retrobulbar haemorrhage and mass effect within the orbit consequently led to the partial expulsion of the globe.	[Papageorgiou, K. I.; Mathew, R. G.; Ghazi-Nouri, S. M. S.; Andreou, P. S.; Sinha, A. J.] Broomfield Hosp, Ophthalmol Dept, Chelmsford, Essex, England		Papageorgiou, KI (corresponding author), Midlessex NHS Trust, Broomfield Hosp, Ophthalmol Dept, Court Rd, Chelmsford CM1 7ET, Essex, England.	papageorgiouk@doctors.org.uk					ANDERSON DL, 1964, CAN MED ASSOC J, V90, P110; Elder Duke, 1972, SYSTEM OPHTHALMOLOGY, V14, P187; HOOPER RS, 1951, BRIT J SURG, V39, P126, DOI 10.1002/bjs.18003915406; HUGHES B, 1962, B JOHNS HOPKINS HOSP, V111, P98; HYKIN PG, 1990, BRIT J OPHTHALMOL, V74, P499, DOI 10.1136/bjo.74.8.499; KLINE LB, 1984, NEUROSURGERY, V14, P756, DOI 10.1227/00006123-198406000-00021; LESSELL S, 1989, ARCH OPHTHALMOL-CHIC, V107, P382, DOI 10.1001/archopht.1989.01070010392031; LOWENSTEIN A, 1943, BR J OPHTHALMOL, V27, P208; PILLAI S, 1987, BRIT J OPHTHALMOL, V71, P69, DOI 10.1136/bjo.71.1.69; Traquair HM, 1935, BRAIN, V58, P398, DOI 10.1093/brain/58.3.398; WALSH FB, 1969, CLIN NEUROOPHTHALMOL, P2375; Wolter J R, 1988, J Pediatr Ophthalmol Strabismus, V25, P55	12	3	3	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0167-6830	1744-5108		ORBIT	Orbit		2007	26	1					71	74		10.1080/01676830600675350			4	Ophthalmology	Emerging Sources Citation Index (ESCI)	Ophthalmology	VB4FZ	WOS:000415469200016	17510878				2022-02-06	
B	Prigatano, GP; Naar-King, S		Hunter, SJ; Donders, J		Prigatano, George P.; Naar-King, Sylvie			Neuropsychological rehabilitation of school-age children: an integrated team approach to individualized interventions	PEDIATRIC NEUROPSYCHOLOGICAL INTERVENTION: A CRITICAL REVIEW OF SCIENCE AND PRACTICE			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; PEDIATRIC HOME CARE; MENTAL-HEALTH; FAMILY; PROGRAM; PARENTS; SUPPORT		[Prigatano, George P.] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Naar-King, Sylvie] Wayne State Univ, Childrens Hosp Michigan, Dept Pediat, Detroit, MI USA		Prigatano, GP (corresponding author), Barrow Neurol Inst, Phoenix, AZ 85013 USA.						Aitken ME, 2005, ARCH PHYS MED REHAB, V86, P175, DOI 10.1016/j.apmr.2004.02.026; Andrews K, 2005, NEUROPSYCHOL REHABIL, V15, P461, DOI 10.1080/09602010443000326; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Braga LW, 2005, CHILD TRAUMATIC BRAI; Carrigan Natalie, 2001, Physical and Occupational Therapy in Pediatrics, V21, P51, DOI 10.1300/J006v21n01_05; DECHILLO N, 1994, AM J ORTHOPSYCHIAT, V64, P564, DOI 10.1037/h0079572; Drotar D, 1995, CONSULTING PEDIAT PS; Glang A., 1997, STUDENTS ACQUIRED BR; Haas D L, 1992, Issues Compr Pediatr Nurs, V15, P39, DOI 10.3109/01460869209078239; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; King G, 1999, J PEDIATR PSYCHOL, V24, P41, DOI 10.1093/jpepsy/24.1.41; King SM, 1996, DEV MED CHILD NEUROL, V38, P757, DOI 10.1111/j.1469-8749.1996.tb15110.x; King Susanne, 2004, Semin Pediatr Neurol, V11, P78, DOI 10.1016/j.spen.2004.01.009; MICHAUD LJ, 1999, REHABILITATION ADULT; Naar-King S, 2003, CHILD HEALTH CARE, V32, P233, DOI 10.1207/S15326888CHC3203_4; NAARKING S, 2006, TREATING NEURODEVELO, P149; NAARKING S, 2002, CHILDRENS SERVICES S, V5, P189; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; PRIGATANO GP, 2004, COMMUNITY SCH REINTE; STEIN REK, 1984, PEDIATRICS, V73, P845; STEIN REK, 1991, PEDIATRICS, V88, P490; Wade SL, 2005, J PEDIATR PSYCHOL, V30, P437, DOI 10.1093/jpepsy/jsi067; WALDERS N, 1999, CHILDRENS SERVICES S, V2, P117; WILLIAMS J, 1995, CHILD HEALTH CARE, V24, P235, DOI 10.1207/s15326888chc2404_3; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009	27	3	3	0	1	CAMBRIDGE UNIV PRESS	CAMBRIDGE	THE PITT BUILDING, TRUMPINGTON ST, CAMBRIDGE CB2 1RP, CAMBS, ENGLAND			978-0-521-87550-9				2007							465	473					9	Clinical Neurology; Psychology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Psychology	BXM34	WOS:000296371600021					2022-02-06	
J	Vajtr, D; Prusa, R; Kukacka, J; Houstava, L; Samal, F; Pachl, J; Pazout, J				Vajtr, D.; Prusa, R.; Kukacka, J.; Houstava, L.; Samal, F.; Pachl, J.; Pazout, J.			Dynamics of the GCS, NSE and S100B serum levels and the morphology of the expansive contussion in head injury patients	CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE			Czech	Article						contusion; glasgow coma Score (GCS); neuron specific enolasis; S100B protein; electron microscopy; immunohistochemistry	TRAUMATIC BRAIN-INJURY; NEURON-SPECIFIC ENOLASE; CEREBRAL-CORTEX; RELEASE; MARKERS; PROFILE; DAMAGE	Introduction. Laboratory management of brain contussions is based on monitoring of proteins released to circulation (neuron specific enolasis (NSE) and S100B protein) from affected tissues. Morphological investigation of biopsy speciments proved focal changes of brain. Methods. The group (n = 20) of patients with focal traumatic brain injury was investigated. In 9 patients was found improvement of Glasgow coma score (GCS) up to 13-15 points during 10 days after admission (group I) and 11 patients had value of GCS less than 13 (groupII). Results. We found the decrease of value of NSE and S100 b protein in group of all patients with focal brain injury during 10 days of hospitalisation. 5 patients died, we observed increase of NSE and S100B protein values on the high 2(nd)-3(rd) day. Patients with improvement of clinical status and GCS up to 15 points during 10 days of hospitalization (group 1) had lower value of NSE (33.53 vs 61.76 mu g/l, p < 0.05) and S100B protein (0.61 vs 4.45 mu g/l, p < 0.05) 1-3 days after admission compared to values of group II. A morphological investigation demonstrated no damage of nucleolus of glial and ganglial cells, pericytes digested the foregin proteins. Immuno-histochemical investigation proved diffuse positivite reaction of anti-NSE, and CD68 antibody reacted around vessels microenvironment. Conclusion. Monitoring of serum levels of NSE and S100B is convenient and investigation for monitoring of patients with TBI.	[Vajtr, D.; Prusa, R.; Kukacka, J.] LF UK & FN Motol, Ustav Klin Biochem & Patobiochem 2, Prague 15006 5, Czech Republic; [Houstava, L.; Samal, F.] LF UK & FNKV, Neurochirurg Klin 3, Prague, Czech Republic; [Vajtr, D.] LF UK & VFN, Ustav Soudniho Lekarstvi & Toxikol 1, Prague, Czech Republic; [Pachl, J.; Pazout, J.] LF UK & FNKV, Klin Anesteziol & Resuscitace 3, Prague, Czech Republic		Vajtr, D (corresponding author), LF UK & FN Motol, Ustav Klin Biochem & Patobiochem 2, Uvalu 84, Prague 15006 5, Czech Republic.	vajtr777@seznam.cz	Kukacka, Jiri/C-4770-2013				Castejon O. J., 2004, Journal of Submicroscopic Cytology and Pathology, V36, P273; Castejon O. J., 2004, Journal of Submicroscopic Cytology and Pathology, V36, P285; Castejon OJ, 2004, BRAIN INJURY, V18, P1107, DOI 10.1080/02699050410001672332; Castejon OJ, 1999, BRAIN INJURY, V13, P291, DOI 10.1080/026990599121665; GENNARELLI TA, 1993, J EMERG MED, V1, P5; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Huang FP, 2002, J NEUROSURG, V96, P287, DOI 10.3171/jns.2002.96.2.0287; Kukacka J, 2006, NEUROENDOCRINOL LETT, V27, P116; Oehmichen M, 1999, ACTA NEUROPATHOL, V97, P491, DOI 10.1007/s004010051018; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; PRUSA R, 2006, MOL BIOL CELL S, V17; ROYDS JA, 1983, J NEUROL NEUROSUR PS, V46, P1031, DOI 10.1136/jnnp.46.11.1031; SIESJPO B K, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P165; Unden J, 2004, BRIT J NEUROSURG, V18, P277, DOI 10.1080/02688690410001732742; Vajtr D, 2006, Soud Lek, V51, P36; Vaz R, 1997, ACTA NEUROCHIR, V139, P215, DOI 10.1007/BF01844754; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Woertgen C, 2000, ACT NEUR S, V76, P371; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6	22	3	3	0	4	CZECH MEDICAL SOC	PRAGUE 2	SOKOLSKA 31, PRAGUE 2 120 26, CZECH REPUBLIC	1210-7859	1802-4041		CESK SLOV NEUROL N	Cesk. Slov. Neurol. Neurochir.		2007	70	5					515	520					6	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	292KG	WOS:000255264300006					2022-02-06	
J	Claudet, I; Federici, S; Debuisson, C; Laporte-Turpin, E; Micheau, P; Pajot, C; Grouteau, E; Serignac, C; Huguenin, M				Claudet, I.; Federici, S.; Debuisson, C.; Laporte-Turpin, E.; Micheau, P.; Pajot, C.; Grouteau, E.; Serignac, C.; Huguenin, M.			Babywalker use (baby-trot, youpala): an unsafe practice	ARCHIVES DE PEDIATRIE			French	Article						babywalker; home accidents; infant	RANDOMIZED CONTROLLED-TRIAL; WALKER-RELATED INJURIES; CHILD SAFETY; PREVENTION; ACCIDENTS; RISK	Aim. - Epidemiological analysis of accidents related to babywalker use admitted to a pediatric emergency department. Methods. - Retrospective, descriptive study of injuries related to babywalkers admitted to the pediatric emergency department between January 1st, 2003 and December 31 st, 2005. Results. - One hundred and seventy-eight children were admitted due to an accident related to babywalker use. The sex ratio was 1.7 with a male prevalence. Mean age was 11 +/- 4 months. Seventy-eight percent of babywalker-related injuries were attributable to fall down a flight of stairs. The mean number of steps that a child fell down was 7 (range 1-20 steps). The repartition of accidents was bimodal: during the year, I peak in May and I in October; during the week: 54% of the cases occurred on Thursday or on the weekend; during the day (I peak between 10 a.m. and I p.m. and I peak between 4 p.m. and 7 p.m.). Non-severe head traumas represented the most frequent injury (72%). Twenty-one children were hospitalised for concussion (N = 15), cranial fractures (N = 3), forearm fracture (N = 1), dental subluxation (N - 1) and extradural hematoma (N = 1). A social problem (families with unsafe domestic practices) was identified in 26 children (15%), 16 of these situations were recognized due to the retrospective character of the study and the analysis of hospital admissions after the first accident. Conclusion. - Stairway related falls associated with babywalker use and fall down in the stairs are very frequent in children less than I year-old. This resulted in babywalkers being prohibited in Canada since 2004. In several countries, advocates are working to ban babywalkers. Active or passive prevention methods have shown their limits. This unsafe and dangerous practice should be banned in France. (c) 2006 Publie par Elsevier Masson SAS.	CHU Toulouse, POSU Pediat, Hop Enfants, F-31059 Toulouse 09, France		Claudet, I (corresponding author), CHU Toulouse, POSU Pediat, Hop Enfants, 330 Ave Grande Bretagne,TSA 70034, F-31059 Toulouse 09, France.	claudet.i@ichu-toulouse.fr	CLAUDET, ISABELLE/N-4195-2019; Claudet, Isabelle/G-9457-2016	CLAUDET, ISABELLE/0000-0002-3868-8483; Claudet, Isabelle/0000-0002-3868-8483			Al-Nouri L, 2006, ANN TROP PAEDIATR, V26, P67, DOI 10.1179/146532806X90637; *AM AC PED, 2001, POLICY STATEMENT, P790, DOI 10.1542/peds.108.3.790; BOYLE WE, 1995, PEDIATRICS, V95, P778; Cassell OCS, 1997, BURNS, V23, P451, DOI 10.1016/S0305-4179(97)89768-9; CHIAVIELLO CT, 1994, PEDIATRICS, V93, P974; Conners GP, 1999, J EMERG MED, V17, P269, DOI 10.1016/S0736-4679(98)00190-5; CROUCHMAN M, 1986, DEV MED CHILD NEUROL, V28, P757; Dedoukou X, 2004, ARCH PEDIAT ADOL MED, V158, P1002, DOI 10.1001/archpedi.158.10.1002; DiLillo D, 2001, Inj Prev, V7, P223, DOI 10.1136/ip.7.3.223; JOHNSON C F, 1990, Pediatric Emergency Care, V6, P58, DOI 10.1097/00006565-199003000-00017; Kendrick D, 2005, BRIT J GEN PRACT, V55, P582; Kendrick D, 1998, Inj Prev, V4, P295; Kendrick D, 2001, ARCH DIS CHILD, V85, P366, DOI 10.1136/adc.85.5.366; Laffoy M, 1995, Inj Prev, V1, P109, DOI 10.1136/ip.1.2.109; LANGRUNTZ H, 1983, CAN MED ASSOC J, V129, P482; Macgregor DM, 2003, EMERG MED J, V20, P21, DOI 10.1136/emj.20.1.21; MAYR J, 1994, EUR J PEDIATR, V153, P531, DOI 10.1007/s004310050186; Mroz LS, 2000, VET HUM TOXICOL, V42, P39; PARTINGTON MD, 1991, ANN EMERG MED, V20, P652, DOI 10.1016/S0196-0644(05)82386-8; Petridou E, 1996, Inj Prev, V2, P118, DOI 10.1136/ip.2.2.118; Powell EC, 2002, PEDIATRICS, V110, P792, DOI 10.1542/peds.110.4.792; RIEDER MJ, 1986, PEDIATRICS, V78, P488; Rodgers GB, 2005, J SAFETY RES, V36, P327, DOI 10.1016/j.jsr.2005.06.010; Santos Serrano L, 1996, AN ESP PEDIATR, V44, P337; SCHEIDT PC, 2006, INJURY PREV, V6, P51; Shields BJ, 2006, PEDIATRICS, V117, pE452, DOI 10.1542/peds.2005-1916; Siegel AC, 1999, J DEV BEHAV PEDIATR, V20, P355, DOI 10.1097/00004703-199910000-00010; Smith GA, 1997, PEDIATRICS, V100, DOI 10.1542/peds.100.2.e1; Suprano I, 2003, C ACTUALISATION 45 C, P705; TRINKOFF A, 1993, PUBLIC HEALTH REP, V108, P784; *VS, ENQ PERM ACC VIE COU; Warrington SA, 2001, ARCH DIS CHILD, V85, P104, DOI 10.1136/adc.85.2.104; Watson M, 2005, BMJ-BRIT MED J, V330, P178, DOI 10.1136/bmj.38309.664444.8F	33	3	3	1	9	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0929-693X	1769-664X		ARCH PEDIATRIE	Arch. Pediatr.	DEC	2006	13	12					1481	1485		10.1016/j.arcped.2006.08.017			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	123JA	WOS:000243291000001	17029935				2022-02-06	
J	Antonio-Arce, VS; Fernandez-Mayoralas, AM; Munoz-Jareno, N; Fresneda-Machado, C; Saiz-Ayala, A; Campos-Castello, J				Antonio-Arce, V. San; Fernandez-Mayoralas, A. Martin; Munoz-Jareno, N.; Fresneda-Machado, C.; Saiz-Ayala, A.; Campos-Castello, J.			Leukoencephalopathy with vanishing white matter: A case report	REVISTA DE NEUROLOGIA			Spanish	Article						cerebellar ataxia; eukaryotic initiation factor-2B; hereditary central nervous system demyelinating diseases; magnetic resonance imaging; magnetic resonance spectroscopy; muscle spasticity	ADULT-ONSET LEUKOENCEPHALOPATHY; INITIATION-FACTOR EIF2B; CHILDHOOD ATAXIA; CEREBROSPINAL-FLUID; SEVERE VARIANT; LEUKODYSTROPHY; MUTATIONS; SUBUNITS; DISEASE	Introduction. Leukoencephalopathy with vanishing white matter is an autosomal recessive hereditary disease that was first reported in 1997. Some time later the genetic anomalies responsible for the disease were identified, these being different mutations in any of the five genes that code for the five subunits of the translation initiation factor eIF2B. Since then, the clinical spectrum of this condition has proved to be much broader and far more frequent than was initially believed. We report on a case of the classical clinical form, which is to our knowledge the first to be published in Spain to date. Case report. A 5-year-old female who presented gait instability that recently got worse following a mild traumatic head injury. The examination revealed overall cerebellar ataxia and generalised spasticity. Magnetic resonance imaging (MRI) showed diffuse and symmetrical involvement of the white matter of the brain with the presence of cavities in which the signal intensity and the proton spectrum were similar to those of cerebrospinal fluid. The genetic study revealed a mutation of the gene that codes for eIF2B-epsilon. Conclusions. A suggestive MRI scan, even in an atypical presentation, would be enough to rule out a mutation of the genes that code for eIF2B. This would make it possible to reach an early diagnosis of this disease, which is probably more prevalent than is currently thought. This would allow genetic counselling to be conducted and would help to establish a genotype-phenotype correlate that would also make it possible to offer an estimated prognosis.	Hosp Clin San Carlos, Dept Neuropediat, E-28040 Madrid, Spain; Hosp Clin San Carlos, Serv Radiodiagnot, E-28040 Madrid, Spain; Hosp Virgen Altagracia, Serv Pediat, Ciudad Real, Spain		Campos-Castello, J (corresponding author), Hosp Clin San Carlos, Dept Neuropediat, Prof Martin Lagos,S-N, E-28040 Madrid, Spain.	jcampos.hcsc@salud.madrid.org	Saiz, Albert/K-8236-2014	Saiz, Albert/0000-0002-5793-8791; Saiz, Antonio/0000-0002-7352-1486			Biancheri R, 2003, NEUROLOGY, V61, P1818, DOI 10.1212/01.WNL.0000098994.35677.3C; BLACK DN, 1988, ANN NEUROL, V24, P490, DOI 10.1002/ana.410240403; Boltshauser E, 2002, NEUROPEDIATRICS, V33, P57, DOI 10.1055/s-2002-32363; DREHAKULACZEWSK.S, 2005, EUR J PAEDIATR NEURO, V9, P129; Fogli A, 2004, NEUROLOGY, V62, P1509, DOI 10.1212/01.WNL.0000123259.67815.DB; Fogli A, 2003, AM J HUM GENET, V72, P1544, DOI 10.1086/375404; Fogli A, 2002, NEUROLOGY, V59, P1966, DOI 10.1212/01.WNL.0000041666.76863.47; Fogli A, 2002, ANN NEUROL, V52, P506, DOI 10.1002/ana.10339; Francalanci P, 2001, NEUROLOGY, V57, P265, DOI 10.1212/WNL.57.2.265; Gallo A, 2004, NEUROLOGY, V62, P323, DOI 10.1212/01.WNL.0000103292.72400.B7; HANEFELD F, 1993, NEUROPEDIATRICS, V24, P244, DOI 10.1055/s-2008-1071551; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Leegwater PAJ, 2001, NAT GENET, V29, P383, DOI 10.1038/ng764; Li W, 2004, MOL CELL BIOL, V24, P3295, DOI 10.1128/MCB.24.8.3295-3306.2004; Ohtake H, 2004, NEUROLOGY, V62, P1601, DOI 10.1212/01.WNL.0000123117.11264.0E; Prass K, 2001, ANN NEUROL, V50, P665, DOI 10.1002/ana.1259; Rosemberg S, 2002, BRAIN DEV-JPN, V24, P250, DOI 10.1016/S0387-7604(02)00034-7; SCHIFFMANN R, 1994, ANN NEUROL, V35, P331, DOI 10.1002/ana.410350314; Schiffmann R, 1997, ANN NEUROL, V41, P654, DOI 10.1002/ana.410410515; Senol U, 2000, AM J ROENTGENOL, V175, P826; Sugiura C, 2001, BRAIN DEV-JPN, V23, P58, DOI 10.1016/S0387-7604(00)00198-4; TEDESCHI G, 1995, NEUROLOGY, V45, P1526, DOI 10.1212/WNL.45.8.1526; Topcu M, 2000, NEUROPEDIATRICS, V31, P100, DOI 10.1055/s-2000-7481; van der Knaap MS, 2002, ANN NEUROL, V51, P264, DOI 10.1002/ana.10112; van der Knaap MS, 2004, NEUROLOGY, V62, P1598, DOI 10.1212/01.WNL.0000123118.86746.FC; van der Knaap MS, 1998, NEUROLOGY, V51, P540, DOI 10.1212/WNL.51.2.540; van der Knaap MS, 2003, AM J HUM GENET, V73, P1199, DOI 10.1086/379524; van der Knaap MS, 1999, J CHILD NEUROL, V14, P728, DOI 10.1177/088307389901401108; vanderKnaap MS, 1997, NEUROLOGY, V48, P845, DOI 10.1212/WNL.48.4.845; Vanderver A, 2005, CLIN CHEM, V51, P2031, DOI 10.1373/clinchem.2005.055053; Verghese J, 2002, EUR J NEUROL, V9, P663, DOI 10.1046/j.1468-1331.2002.00469.x	31	3	3	0	2	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	NOV 1	2006	43	9					535	540		10.33588/rn.4309.2005762			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	104PZ	WOS:000241972100005	17072809				2022-02-06	
J	Cerovski, B; Vidovic, T; Papa, J; Cerovski, J; Bojic, L				Cerovski, Branimir; Vidovic, Tomislav; Papa, Jurica; Cerovski, Jasenka; Bojic, Lovro			Minor head trauma and isolated unilateral internuclear ophthalmoplegia	JOURNAL OF EMERGENCY MEDICINE			English	Article						internuclear ophthalmoplegia; magnetic resonance imaging; minor head trauma	INJURY	Internuclear ophthalmoplegia is a syndrome that develops due to a lesion of the medial longitudinal fasciculus. This lesion is mostly caused by multiple sclerosis (usually bilaterally), and only rarely by head injury. A case is presented of unilateral internuclear ophthalmoplegia as an isolated sequel of minor head trauma, which eventually resolved. A 40-year-old woman with isolated internuclear ophthalmoplegia secondary to closed head trauma with anatomical lesions of the mesencephalon in the region of medial longitudinal fasciculus is described. A minor contusion was detected by magnetic resonance imaging. Diplopia resolved in 5 months. In conclusion, internuclear ophthalmoplegia should be considered in the differential diagnosis in patients with recent head injuries showing adduction impairment. The connection between the clinical picture and anatomical lesions is visualized by magnetic resonance imaging. (C) 2006 Elsevier Inc.	Univ Zagreb Hosp Ctr, Univ Dept Ophthalmol, HR-10000 Zagreb, Croatia; Univ Zagreb Hosp Ctr, Univ Dept Radiol, HR-10000 Zagreb, Croatia; Split Univ Hosp Ctr, Univ Dept Ophthalmol, Split, Croatia		Cerovski, B (corresponding author), Univ Zagreb Hosp Ctr, Univ Dept Ophthalmol, Kispaticeva 12, HR-10000 Zagreb, Croatia.						Chan JW, 2001, J NEURO-OPHTHALMOL, V21, P212, DOI 10.1097/00041327-200109000-00011; HALLER KA, 1990, OPHTHALMOLOGY, V97, P1162; Hsu HC, 2001, ACTA OPHTHALMOL SCAN, V79, P57, DOI 10.1034/j.1600-0420.2001.079001057.x; JAMMES JL, 1989, J CLIN NEURO-OPHTHAL, V9, P112; Kataoka S, 1997, STROKE, V28, P809, DOI 10.1161/01.STR.28.4.809; Lagreze WDA, 1996, ARCH OPHTHALMOL-CHIC, V114, P429, DOI 10.1001/archopht.1996.01100130425012; Masai H, 1996, AM J OPHTHALMOL, V122, P897, DOI 10.1016/S0002-9394(14)70393-9; MUELLER C, 1993, DEV MED CHILD NEUROL, V35, P163; PERENIN MT, 1977, OPHTHALMOLOGICA, V175, P206, DOI 10.1159/000308659; RICH JR, 1974, ARCH OPHTHALMOL-CHIC, V92, P66; STRAUSS C, 1995, NEURO-OPHTHALMOLOGY, V15, P15, DOI 10.3109/01658109509044589; STROMINGER MB, 1986, J CLIN NEURO-OPHTHAL, V6, P57; Von Noorden G., 1996, BINOCULAR VISION OCU; Walsh WP, 2003, J EMERG MED, V24, P19, DOI 10.1016/S0736-4679(02)00662-5	14	3	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679			J EMERG MED	J. Emerg. Med.	AUG	2006	31	2					165	167		10.1016/j.jemermed.2005.09.013			3	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	067UL	WOS:000239328000006	17044578				2022-02-06	
J	Petit, L; Masson, F; Cottenceau, V; Sztark, F				Petit, L.; Masson, F.; Cottenceau, V.; Sztark, F.			Controlled hypernatremia	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article; Proceedings Paper	27th Conference of the Association-de-Neuroanesthesie-Reanimation-de-Langue-Francaise	NOV 17-18, 2005	Toulouse, FRANCE	Assoc Neuroanesthesie Reanimat Langue Francaise		brain osmolarity; hypertonic saline; blood brain barrier; intracranial pressure; traumatic brain injury; mannitol	TRAUMATIC BRAIN-INJURY; ELEVATED INTRACRANIAL-PRESSURE; HYPERTONIC SALINE RESUSCITATION; CEREBRAL WATER-CONTENT; LACTATED RINGERS SOLUTION; CLOSED-HEAD-INJURY; HEMORRHAGIC-SHOCK; CELL-VOLUME; MICROVASCULAR PERMEABILITY; 20-PERCENT MANNITOL	Hypernatremia exerts its main effect on the brain through the osmotic gradient it creates on either side of the blood brain barrier, which is impermeable to sodium. This generates a transfer of water from the intracellular to the vascular sector leading to temporary cell shrinkage. Osmoregulation permits cerebral cells to accumulate osmoactive molecules in order to restore their initial volume. It has been demonstrated in animals with brain injury that intracellular dehydration occurs essentially in the nonlesioned hemisphere. In most experimental studies, the reduction in cerebral volume obtained by hypertonic saline (HS) perfusion is accompanied by an intracranial pressure decrease, even under hemorrhagic shock conditions. Initially, clinical studies successfully used HS, as an alternative to mannitol, in the treatment of acute and refractory intracranial hypertension. Then continuous infusion of HS, with the objective of inducing hypernatremia, had produced encouraging effects on intracranial pressure control. However, these results were limited to non-randomized studies, without control groups and mainly in pediatric patients. Nevertheless, the use of HS on intracranial hypertension, refractory to conventional treatments, could be reasonable under strict monitoring of natremia as well as its adverse effects. (c) 2006 Elsevier SAS. Tous droits reserves.	CHU Pellegrin, Dept Anesthesie Reanimat, Unite Reanimat Chirurg & Traumatol, F-33076 Bordeaux, France		Sztark, F (corresponding author), CHU Pellegrin, Dept Anesthesie Reanimat, Unite Reanimat Chirurg & Traumatol, 1 Pl Amelie Raba Leon, F-33076 Bordeaux, France.	francois.sztark@chu-bordeaux.fr		LAURENT, PETIT/0000-0003-1530-5678			ADAMS RD, 1959, ARCH NEURO PSYCHIATR, V81, P154, DOI 10.1001/archneurpsyc.1959.02340140020004; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS40; Anderson AW, 2000, MAGN RESON IMAGING, V18, P689, DOI 10.1016/S0730-725X(00)00147-8; ARIEFF AI, 1972, J LAB CLIN MED, V79, P334; ARIEFF AI, 1986, NEW ENGL J MED, V314, P1529, DOI 10.1056/NEJM198606123142401; ATLAS M, 1984, J MOL CELL CARDIOL, V16, P311, DOI 10.1016/S0022-2828(84)80602-1; Ayus JC, 1996, J PHYSIOL-LONDON, V492, P243, DOI 10.1113/jphysiol.1996.sp021305; Bacher A, 1998, CRIT CARE MED, V26, P108, DOI 10.1097/00003246-199801000-00024; BAETHMANN A, 1988, CRIT CARE MED, V16, P972, DOI 10.1097/00003246-198810000-00008; BARRACLOUGH MA, 1970, CLIN SCI, V39, P517, DOI 10.1042/cs0390517; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Beetsch JW, 1998, AM J PHYSIOL-CELL PH, V274, pC866, DOI 10.1152/ajpcell.1998.274.4.C866; BERGER S, 1995, NEUROSURGERY, V37, P98, DOI 10.1227/00006123-199507000-00015; BERGER S, 1994, ACT NEUR S, V60, P494; Boulard G, 2001, ANN FR ANESTH, V20, P196; BURG MB, 1995, AM J PHYSIOL, V268, P983; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; CLARK BA, 1991, AM J PHYSIOL, V261, pE252, DOI 10.1152/ajpendo.1991.261.2.E252; CLUITMANS FHM, 1990, AM J MED, V88, P161, DOI 10.1016/0002-9343(90)90467-R; Coats TJ, 2004, RESUSCITATION, V60, P101, DOI 10.1016/j.resuscitation.2003.08.001; COTE CJ, 1979, ANESTHESIOLOGY, V50, P30, DOI 10.1097/00000542-197901000-00007; CSERR HF, 1991, J PHYSIOL-LONDON, V442, P277, DOI 10.1113/jphysiol.1991.sp018793; CSERR HF, 1987, AM J PHYSIOL, V253, P522; CSERR HF, 1987, AM J PHYSIOL, V253, P530; DEPASQUALE M, 1989, AM J PHYSIOL, V256, pF1059, DOI 10.1152/ajprenal.1989.256.6.F1059; Dominguez TE, 2004, CRIT CARE MED, V32, P1438, DOI 10.1097/01.CCM.0000124860.91886.C2; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; Eilig I, 2001, ANESTH ANALG, V92, P669, DOI 10.1213/00000539-200103000-00023; FINBERG L, 1967, PEDIATRICS, V40, P1031; Fujimura M, 1999, BRAIN RES, V842, P92, DOI 10.1016/S0006-8993(99)01843-0; GROSS D, 1988, J TRAUMA, V28, P751, DOI 10.1097/00005373-198806000-00005; GULLANS SR, 1993, ANNU REV MED, V44, P289, DOI 10.1146/annurev.med.44.1.289; GUNNAR W, 1988, SURGERY, V103, P398; Hartl R, 1997, J TRAUMA, V42, pS41, DOI 10.1097/00005373-199705001-00008; Hartl R, 1996, J CEREBR BLOOD F MET, V16, P1108; Heermann R, 2004, CURR OPIN MICROBIOL, V7, P168, DOI 10.1016/j.mib.2004.02.008; HEILIG CW, 1989, AM J PHYSIOL, V257, pF1108, DOI 10.1152/ajprenal.1989.257.6.F1108; Heimann A, 2003, CRIT CARE MED, V31, P2495, DOI 10.1097/01.CCM.0000084893.44650.CB; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; HUANG R, 1995, BRAIN RES, V702, P181, DOI 10.1016/0006-8993(95)01042-0; Ibsen L, 1996, AM J PHYSIOL-RENAL, V271, pF877, DOI 10.1152/ajprenal.1996.271.4.F877; ICHAI C, 1994, ANN FR ANESTH, V13, P68, DOI 10.1016/S0750-7658(94)80189-4; Isaacks RE, 1999, J NEUROSCI RES, V57, P866, DOI 10.1002/(SICI)1097-4547(19990915)57:6<866::AID-JNR12>3.0.CO;2-K; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; KIEN ND, 1991, ANESTH ANALG, V73, P597; Kimelberg HK, 2004, NEUROSCIENCE, V129, P851, DOI 10.1016/j.neuroscience.2004.07.033; KUBO S, 1978, JPN HEART J, V19, P852; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lenzlinger PM, 2001, J NEUROTRAUM, V18, P479, DOI 10.1089/089771501300227288; LIEN YHH, 1990, J CLIN INVEST, V85, P1427, DOI 10.1172/JCI114587; LOCKWOOD AH, 1975, ARCH NEUROL-CHICAGO, V32, P62, DOI 10.1001/archneur.1975.00490430084018; LOHR JW, 1988, LIFE SCI, V43, P271, DOI 10.1016/0024-3205(88)90317-7; Luh EH, 1996, J SURG RES, V60, P122, DOI 10.1006/jsre.1996.0020; Marmarou A, 2000, ACT NEUR S, V76, P349; MARSDEN PA, 1985, AM J NEPHROL, V5, P229, DOI 10.1159/000166940; Mirski MA, 2000, J NEUROSURG ANESTH, V12, P334, DOI 10.1097/00008506-200010000-00006; MOREL N, 2004, REANIMATION, V13, P484; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; NAKAYAMA SI, 1985, J SURG RES, V38, P180, DOI 10.1016/0022-4804(85)90025-3; Ng KFJ, 2002, BRIT J ANAESTH, V88, P475, DOI 10.1093/bja/88.4.475; Papadopoulos MC, 2002, MT SINAI J MED, V69, P242; Payen JF, 2003, ANN FR ANESTH, V22, P220, DOI 10.1016/S0750-7658(03)00010-8; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; POLLOCK AS, 1980, AM J PHYSIOL, V239, pF195, DOI 10.1152/ajprenal.1980.239.3.F195; Prough DS, 1999, J NEUROSURG ANESTH, V11, P102, DOI 10.1097/00008506-199904000-00006; PULLEN RGL, 1987, AM J PHYSIOL, V253, pF538, DOI 10.1152/ajprenal.1987.253.3.F538; Qureshi AI, 1999, J TRAUMA, V47, P659, DOI 10.1097/00005373-199910000-00009; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Qureshi AI, 2002, CRIT CARE MED, V30, P435, DOI 10.1097/00003246-200202000-00028; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; RAMMING S, 1994, J TRAUMA, V37, P705, DOI 10.1097/00005373-199411000-00003; REED RL, 1991, J TRAUMA, V31, P8, DOI 10.1097/00005373-199101000-00002; SATO K, 1993, ACTA ENDOCRINOL-COP, V129, P65, DOI 10.1530/acta.0.1290065; Schatzmann C, 1998, ACT NEUR S, V71, P31; Scheingraber S, 1999, ANESTHESIOLOGY, V90, P1265, DOI 10.1097/00000542-199905000-00007; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; SOMERO GN, 1986, AM J PHYSIOL, V251, pR197, DOI 10.1152/ajpregu.1986.251.2.R197; Soupart A, 1996, J NEUROPATH EXP NEUR, V55, P106, DOI 10.1097/00005072-199601000-00011; Stanimirovic D, 2000, BRAIN PATHOL, V10, P113; STERNS RH, 1986, NEW ENGL J MED, V314, P1535, DOI 10.1056/NEJM198606123142402; STRANGE K, 1994, GLIA, V12, P35, DOI 10.1002/glia.440120105; STRANGE K, 1991, AM J PHYSIOL, V260, pC784, DOI 10.1152/ajpcell.1991.260.4.C784; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Svensen CH, 2003, J SURG RES, V113, P6, DOI 10.1016/S0022-4804(03)00128-8; Sztark F, 1997, ANN FR ANESTH, V16, P282, DOI 10.1016/S0750-7658(97)86412-X; Taylor G, 1996, J PEDIATR SURG, V31, P65, DOI 10.1016/S0022-3468(96)90321-8; TORNHEIM PA, 1981, J NEUROSURG, V55, P407, DOI 10.3171/jns.1981.55.3.0407; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; Victorino GP, 2003, J SURG RES, V112, P79, DOI 10.1016/S0022-4804(03)00132-X; Victorino GP, 2002, J SURG RES, V104, P101, DOI 10.1006/jsre.2002.6419; Weed LH, 1919, AM J PHYSIOL, V48, P531, DOI 10.1152/ajplegacy.1919.48.4.531; Wilder DM, 2002, THROMB RES, V107, P255, DOI 10.1016/S0049-3848(02)00335-3; WINER A, 1998, ANN FR ANESTH, V17, P923; WISNER DH, 1990, J TRAUMA, V30, P75, DOI 10.1097/00005373-199001000-00011; WORTHLEY LIG, 1988, J NEUROSURG, V68, P478, DOI 10.3171/jns.1988.68.3.0478; WRIGHT DG, 1979, BRAIN, V102, P361, DOI 10.1093/brain/102.2.361; Yamashita T, 1997, MOL BRAIN RES, V46, P236, DOI 10.1016/S0169-328X(97)00020-X; ZHUANG J, 1993, J TRAUMA, V35, P415, DOI 10.1097/00005373-199309000-00014; ZORNOW MH, 1989, J TRAUMA, V29, P484, DOI 10.1097/00005373-198904000-00011; ZORNOW MH, 1990, ACT NEUR S, V51, P324; Zornow MH, 1996, J NEUROSURG ANESTH, V8, P175, DOI 10.1097/00008506-199604000-00021; ZUBIAUR M, 1987, MINER ELECTROL METAB, V13, P13	106	3	4	0	4	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0750-7658			ANN FR ANESTH	Ann. Fr. Anest. Reanim.	AUG	2006	25	8					828	837		10.1016/j.annfar.2006.04.005			10	Anesthesiology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	087OH	WOS:000240751200008	16860968				2022-02-06	
J	Vella, AE; Wang, VJ; McElderry, C				Vella, Adam E.; Wang, Vincent J.; McElderry, Craig			Predictors of fluid resuscitation in pediatric trauma patients	JOURNAL OF EMERGENCY MEDICINE			English	Article; Proceedings Paper	Western Regional Meeting of the Ambulatory-Pediatric-Association	FEB   01, 2003	Carmel, CA	Ambulatory Pediat Assoc, Western Reg		intravenous; trauma; ATLS; fluid; pediatric	INTRAVENOUS ACCESS; SEVERITY; INJURY; SCORE; CARE	Advanced Trauma Life Support (ATLS) is accepted as the standard for the first hours of trauma care. However, ATLS is designed primarily for adults. In children, vascular access can be difficult and time-consuming. Due to the differences in the epidemiology of children suffering traumatic injury, they may not require aggressive fluid resuscitation. The objective of the study was to establish predictors of fluid resuscitation, and to determine whether all pediatric Level I Trauma victims require two intravenous catheters. Medical charts of all patients aged < 18 years meeting Level I Trauma criteria who presented to Childrens Hospital Los Angeles (CHLA) between January I and December 31, 1999 were retrospectively reviewed. There were 152 patients reviewed with a median age of 6 years (range 4 months to 17 years); 64% were boys. The mechanism of injury was motor vehicle crash 49%, fall 37%, crush 8%, gunshot 5%, and knife 1%. Injuries included closed head 88%, penetrating abdomen/chest 6%, and other 6%. Vital signs over time showed no change in 59%, got better in 34%, and got worse in 7%. Fluid resuscitation included no bolus in 70%, 1 bolus in 20%, 2 boluses in 7%, > 2 boluses in 3%. The ICU admitted 23%, 12% were intubated, survival was 95%, and 59% received a prehospital i.v. The i.v. #1 site: antecubital 51%, hand 41%, foot 5%, femoral 1%. The i.v. #2 site: hand 30%, antecubital 20%, foot 2%, none 48%. T test showed no statistically significant differences in fluid resuscitation or second i.v. placement based on the mechanism of injury. T test for unequal variances showed a statistically significant difference in means with p < 0.001 for second i.v. placement as compared with only i.v. fluid amount, age, and Injury Severity Score (ISS). Revised Trauma Score was the only predictor of worsening of vital signs (logistic regression [LR], p < 0.001). Age was the only predictor of second i.v. placement (LR, p < 0.03). ISS was the only predictor of a bolus being given (LR, p < 0.01). In our study, blunt trauma occurred in 90% of children, with 10% requiring > I fluid bolus. ISS was the only predictor of the need for fluid resuscitation and is not likely to be helpful in the clinical setting. In our population, nearly 50% had no second i.v. This preliminary review of the nature of pediatric trauma suggests that ATLS guidelines may not always be appropriate for the management of pediatric trauma. (C) 2006 Elsevier Inc.	Mt Sinai Hosp, Dept Emergency Med, New York, NY 10029 USA; Childrens Hosp Los Angeles, Div Emergency & Transport Med, Los Angeles, CA 90027 USA		Vella, AE (corresponding author), Mt Sinai Hosp, Dept Emergency Med, 1 Gustave L Levy Pl,Box 1149, New York, NY 10029 USA.						*AM ASS AUT MED, 1990, ABBR INJ SCAL AIS; *AM COLL SURG COMM, 1994, ADV TRAUM LIF SUPP R; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BAKER SP, 1996, INJURY CHILDREN TEEN; Bell RM, 1999, ANN EMERG MED, V34, P233, DOI 10.1016/S0196-0644(99)70238-6; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; *I MED, 1993, RED BURD INJ; JONES SE, 1989, ANN EMERG MED, V18, P244, DOI 10.1016/S0196-0644(89)80405-6; KANTER RK, 1986, AM J DIS CHILD, V140, P132, DOI 10.1001/archpedi.1986.02140160050030; LILLIS KA, 1992, ANN EMERG MED, V21, P1430, DOI 10.1016/S0196-0644(05)80054-X; Newgard CD, 2002, ANN EMERG MED, V39, P481, DOI 10.1067/mem.2002.123549; OWENS TM, 1995, J TRAUMA, V39, P200, DOI 10.1097/00005373-199508000-00004; Paul TR, 1999, J TRAUMA, V47, P455, DOI 10.1097/00005373-199909000-00004; Rosetti V, 1984, ANN EMERG MED, V13, P406; *SPSS INC, 1968, STAT PACK SOC SCI; MERCK MANUAL DIAGNOS, pCH200	16	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679			J EMERG MED	J. Emerg. Med.	AUG	2006	31	2					151	155		10.1016/j.jemermed.2005.12.018			5	Emergency Medicine	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	067UL	WOS:000239328000004	17044576				2022-02-06	
J	Frencham, KAR; Maybery, MT; Fox, AM				Frencham, Katherine A. R.; Maybery, Murray T.; Fox, Allison M.			Hand movement span after mild traumatic brain injury: A longitudinal study	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						mild head injury; neuropsychology; recovery; immediate memory; memory span; interference; practice effect	MINOR HEAD-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT; RECOVERY; MEMORY	This study examined whether memory span was impaired during the acute and post-acute phases following mild traumatic brain injury (mTBI). Twenty-two adults with mTBI were compared with 22 controls on computerized tasks of immediate memory for verbal, spatial, and hand movement sequences under no interference (baseline) and articulatory suppression conditions. Groups were assessed within a month and followed up 3-12 months post-injury. In the acute phase, there were no group differences across tasks under either condition. At follow-up, all spatial and verbal span scores and associated practice effects were equivalent across groups. Yet for the hand movement task, baseline movement span was worse for the mTBI group suggesting that they failed to benefit from practice to the same extent as controls. Furthermore, the fact that this group difference in span scores disappeared when articulatory suppression was imposed indicates that successful hand movement task performance involves verbal recoding.	Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia		Frencham, KAR (corresponding author), 4 Westgarth St, Northcote, Vic 3070, Australia.	katef@graduate.uwa.edu.au	Maybery, Murray/H-5390-2014; Fox, Allison M/H-9218-2014	Fox, Allison M/0000-0001-5189-6271; Maybery, Murray/0000-0002-3760-1382			Baddeley A., 1992, SPEED CAPACITY LANGU; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bruce JM, 2003, NEUROPSYCHOLOGY, V17, P622, DOI 10.1037/0894-4105.17.4.622; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; FOX G, 2001, BRAIN IMPAIR, V2, P140; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Frencham KAR, 2004, J INT NEUROPSYCH SOC, V10, P355, DOI 10.1017/S1355617704103032; Frencham KAR, 2003, J INT NEUROPSYCH SOC, V9, P633, DOI 10.1017/S1355617703940033; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MILLER WR, 1991, BRIT J ADDICT, V86, P43; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Potter DD, 1999, J PSYCHOPHYSIOL, V13, P173, DOI 10.1027//0269-8803.13.3.173; Raskin SA, 1998, CLIN NEUROPSYCHOL, V12, P21, DOI 10.1076/clin.12.1.21.1724; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874	20	3	3	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2006	12	4					580	584		10.1017/S1355617706060711			5	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	063DU	WOS:000238997300017	16981612				2022-02-06	
J	Lange, RT; Schoenberg, MR; Saklofske, DH; Woodward, TS; Brickell, TA				Lange, RT; Schoenberg, MR; Saklofske, DH; Woodward, TS; Brickell, TA			Expanding the WAIS-III estimate of premorbid ability for Canadians (EPAC)	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	33rd Annual Meeting of the International-Neuropsychological-Society	FEB   03, 2005	St Louis, MO	Int Neuropsychol Soc			TRAUMATIC BRAIN INJURY; CLINICAL UTILITY; INTELLIGENCE; INDEX; PERFORMANCE; SAMPLES; OPIE-3	Since the release of the Canadian WAIS-III normative data in 2001 (Wechsler, 2001), the clinical application of these norms has been limited by the absence of a method to estimate premorbid functioning. However, Lange, Schoenberg, Woodward, and Brickell (2005) recently developed regression algorithms that estimate premorbid FSIQ, VIQ and PIQ scores for use with the Canadian WAIS-III norms. The purpose of this study was to expand work by Lange and colleagues by developing regression algorithms to estimate premorbid GAI (Saklofske et al., 2005), VCI, and POI scores. Participants were the Canadian WAIS-III standardization sample (n = 1,105). The sample was randomly divided into two groups (Development and Validation group). Using the Development group, a total of 14 regression algorithms were generated to estimate GAI, VCI, and POI scores by combining subtest performance (i.e., Vocabulary, Information, Matrix Reasoning, and Picture Completion) with demographic variables (i.e., age, education, ethnicity, region of the country, and gender). The algorithms accounted for a maximum of 77% of the variance in GAI, 78% of the variance in VCI, and 63% of the variance in POI. In the Validation Group, correlations between predicted and obtained scores were high (GAI = .70 to .88; VCI = .87 to .88; POI = .71 to .80). Evaluation of prediction errors revealed that the majority of estimated GAI, VCI, and POI scores fell within a 95% CI band (93.5% to 97.0%) and within 10 points of obtained index scores (72.3% to 85.6%) depending on the subtests used. These algorithms provide a promising means for estimating premorbid GAI, VCI, and POI scores using the Canadian WAIS-III norms.	Riverview Hosp, Dept Res, Coquitlam, BC, Canada; Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Univ Calgary, Calgary, AB T2N 1N4, Canada; Back Mot Rehabil, Richmond, BC, Canada		Lange, RT (corresponding author), Riverview Hosp, Dept Res, Room 124 Admin Bldg,2601 Lougheed Highway, Coquitlam, BC, Canada.	rlange@bcmhs.bc.ca	Schoenberg, Mike R/J-9018-2012	Woodward, Todd/0000-0001-8083-0079; Schoenberg, Mike/0000-0003-1355-3651			Axelrod BN, 1999, ARCH CLIN NEUROPSYCH, V14, P341, DOI 10.1016/S0887-6177(98)00028-6; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Krul K, 1995, CAP Today, V9, P18; Lange RT, 2005, ARCH CLIN NEUROPSYCH, V20, P1009, DOI 10.1016/j.acn.2005.06.004; Lange RT, 2005, CLIN NEUROPSYCHOL, V19, P73, DOI 10.1080/13854040490888549; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; Prifitera A., 1998, WISC 3 CLIN USE INTE, P1, DOI [10.1016/B978-012564930-8/50002-4, DOI 10.1016/B978-012564930-8/50002-4]; *PSYCH CORP, 1997, WAIS 3 WMS 3 TECHN M; Psychological Corporation, 2001, MAN WECHSL TEST AD R; Saklofske DH, 2005, CAN J BEHAV SCI, V37, P44, DOI 10.1037/h0087244; SCHOENBERG M, 2004, J INT NEUROPSYCH SOC, V10, P104; Schoenberg MR, 2003, CLIN NEUROPSYCHOL, V17, P308, DOI 10.1076/clin.17.3.308.18088; Schoenberg MR, 2002, CLIN NEUROPSYCHOL, V16, P426, DOI 10.1076/clin.16.4.426.13913; SCHOENBERG MR, IN PRESS ARCH CLIN N; Scott JG, 1997, CLIN NEUROPSYCHOL, V11, P146, DOI 10.1080/13854049708407043; *STAT CAN, 1991, CENS CAN 1991 SURV; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; Tulsky DS, 2001, PSYCHOL ASSESSMENT, V13, P566, DOI 10.1037/1040-3590.13.4.566; VANDERPLOEG RD, 1995, ARCH CLIN NEUROPSYCH, V10, P225, DOI 10.1016/0887-6177(94)00042-O; Veiel HOF, 2001, PSYCHOL ASSESSMENT, V13, P356, DOI 10.1037/1040-3590.13.3.356; Wechsler D., 2001, WECHSLER ADULT INTEL; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Weiss L. G., 1999, CANADIAN J SCH PSYCH, V14, P1, DOI [10.1177/082957359901400202, DOI 10.1177/082957359901400202]	27	3	3	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUL	2006	28	5					773	789		10.1080/13803390591000981			17	Psychology, Clinical; Clinical Neurology; Psychology	Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	046AS	WOS:000237784400012	16723324				2022-02-06	
J	Lescot, T; Marchand-Verrecchia, C; Puybasset, L				Lescot, T.; Marchand-Verrecchia, C.; Puybasset, L.			Anti-inflammatory modulators in traumatic brain injury	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article; Proceedings Paper	27th Conference of the Association-de-Neuroanesthesie-Reanimation-de-Langue-Francaise	NOV 17-18, 2005	Toulouse, FRANCE	Assoc Neuroanesthesie Reanimat Langue Francaise		traumatic brain injury; inflammation; neuroprotection	NITRIC-OXIDE SYNTHASE; SEVERE HEAD-INJURY; IMPROVES NEUROLOGICAL RECOVERY; TUMOR-NECROSIS-FACTOR; CLINICAL-TRIALS; CEREBRAL EDEMA; NONCOMPETITIVE BLOCKADE; OXIDATIVE STRESS; RAT; MICE	Traumatic brain injury leads to primary and secondary brain injuries. Primary brain injury results from mechanical forces applied to the head at the time of impact. Secondary brain injury occurs at some time after the primary impact. Numerous pathophysiological mechanisms have been postulated to explain the progressive tissue damage produced by secondary injuries. The endogenous neuroinflammatory response after traumatic brain injury contributes to the development of blood-brain barrier breakdown, cerebral oedema and neuronal cell death and this has led to various pharmacological therapies to try to limit this type of damage. Studies employing glutamate receptor antagonist for cerebral protection have yielded promising results in laboratory animals but failed to produce clinically significant improvements. The present review will summarize the mechanisms of post traumatic cerebral inflammation with a special focus on the anti-inflammatory drug targets. (c) 2006 Elsevier SAS. Tous droits reserves.	Univ Paris 06, Dept Anesthesie Reanimat, CHU Pitie Salpetriere, APHP, F-75651 Paris 13, France; Univ Paris Descartes, Lab Pharmacol Circulat Cerebrale, Fac Sci Pharmaceut & Biol, Lab Pharmacol Circulat,UPRES EA 2510, F-75006 Paris, France		Puybasset, L (corresponding author), Univ Paris 06, Dept Anesthesie Reanimat, CHU Pitie Salpetriere, APHP, 47-83,Blvd Hop, F-75651 Paris 13, France.	louis.puybasset@psl.ap-hop-paris.fr	MARCHAND-LEROUX, Catherine/L-7453-2017	MARCHAND-LEROUX, Catherine/0000-0003-0113-5348			Alderson P, 1997, BRIT MED J, V314, P1855, DOI 10.1136/bmj.314.7098.1855; Allen JW, 1999, J PHARMACOL EXP THER, V290, P112; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; GOLDING EM, 1995, MOL CHEM NEUROPATHOL, V24, P137, DOI 10.1007/BF02962139; Gorlach C, 2000, PFLUG ARCH EUR J PHY, V440, P309; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HALL ED, 1994, SECONDARY TISSUE DAM; Hamm RJ, 1996, J NEUROTRAUM, V13, P325, DOI 10.1089/neu.1996.13.325; Hatton J, 2001, CNS DRUGS, V15, P553, DOI 10.2165/00023210-200115070-00005; Hlatky R, 2002, ACT NEUR S, V81, P331; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Jafarian-Tehrani M, 2005, NITRIC OXIDE-BIOL CH, V12, P61, DOI 10.1016/j.niox.2004.12.001; Jones NC, 2004, J NEUROPATH EXP NEUR, V63, P708, DOI 10.1093/jnen/63.7.708; Lavine SD, 1998, J CEREBR BLOOD F MET, V18, P52, DOI 10.1097/00004647-199801000-00005; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; LIU TH, 1989, AM J PHYSIOL, V256, P589; Lu J, 2003, NEUROPHARMACOLOGY, V44, P253, DOI 10.1016/S0028-3908(02)00380-5; Lu YC, 1997, MOL CHEM NEUROPATHOL, V30, P125, DOI 10.1007/BF02815154; Maas AIR, 2000, CNS DRUGS, V13, P139, DOI 10.2165/00023210-200013020-00007; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; MCINTOSH TK, 1992, J NEUROTRAUM, V9, P33, DOI 10.1089/neu.1992.9.33; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; McIntosh TK, 1996, J NEUROTRAUM, V13, P767, DOI 10.1089/neu.1996.13.767; McIntosh TK, 1996, LAB INVEST, V74, P315; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Mesenge C, 1998, J PINEAL RES, V25, P41, DOI 10.1111/j.1600-079X.1998.tb00384.x; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Okiyama K, 1997, J NEUROTRAUM, V14, P211, DOI 10.1089/neu.1997.14.211; Petty MA, 1996, EUR J PHARMACOL, V307, P149, DOI 10.1016/0014-2999(96)00235-X; Reinert MM, 1999, NEUROL RES, V21, P330, DOI 10.1080/01616412.1999.11740940; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; TOULMOND S, 1993, BRAIN RES, V620, P32, DOI 10.1016/0006-8993(93)90267-Q; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538	50	3	3	0	1	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0750-7658			ANN FR ANESTH	Ann. Fr. Anest. Reanim.	JUL	2006	25	7					755	760		10.1016/j.annfar.2006.03.014			6	Anesthesiology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	077FQ	WOS:000240014000015	16675184				2022-02-06	
J	Wang, YT; Kent, RD; Duffy, JR; Thomas, JE; Fredericks, GV				Wang, Yu-Tsai; Kent, Ray D.; Duffy, Joseph R.; Thomas, Jack E.; Fredericks, Geoffrey V.			Dysarthria following cerebellar mutism secondary to resection of a fourth ventricle medulloblastoma: A case study	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article							POSTERIOR-FOSSA SURGERY; TRAUMATIC BRAIN-INJURY; OF-THE-LITERATURE; ATAXIC DYSARTHRIA; CHILDREN; SPEECH; TUMORS; CHILDHOOD; SINGAPORE; NETWORKS	A case study is presented of an 11-year-old boy who developed severe cerebellar ataxia following resection of a fourth ventricle meduloblastoma. Dysarthria is a frequent sequela to resolution of the cerebellar mutism syndrome associated with posterior fossa surgery in children, but the speech disorder has not been well characterized by quantitative means. An acoustic analysis of the boy's speech was performed for a variety of speaking tasks, including sustained phonation, syllable repetition, sentence recitation, and conversation. His dysarthria was notable for its scanning pattern, which co-occurred with a number of other abnormalities, including explosive consonants, dysphonia, and irregular articulatory breakdowns. The dysarthria was highly similar to classic descriptions of ataxic dysarthria in adults. It is shown that the measure, pair-wise variability index, is sensitive to the scanning pattern of his dysarthria. Implications of this syndrome for understanding the role of the cerebellum in speech are discussed in terms of recent models of cerebellar function.	Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; Natl Yang Ming Univ, Taipei 112, Taiwan; Mayo Clin, Rochester, MN USA; Radford Univ, Radford, VA 24142 USA		Kent, RD (corresponding author), Univ Wisconsin, Waisman Ctr, Rm 435,1500 Highland Ave, Madison, WI 53705 USA.	kent@waisman.wisc.edu	Kent, Raymond D/AAI-1928-2020				Aarsen FK, 2004, NEUROLOGY, V62, P1311, DOI 10.1212/01.WNL.0000120549.77188.36; Auzou P, 2000, CLIN LINGUIST PHONET, V14, P131; Brown J.R., 1975, MOTOR SPEECH DISORDE; Bullock D, 2004, TRENDS COGN SCI, V8, P426, DOI 10.1016/j.tics.2004.07.003; Chen SHA, 2005, NEUROIMAGE, V24, P332, DOI 10.1016/j.neuroimage.2004.08.032; Cornwell PL, 2004, FOLIA PHONIATR LOGO, V56, P93, DOI 10.1159/000076061; Cornwell PL, 2003, CLIN LINGUIST PHONET, V17, P597, DOI 10.1080/0269920031000111339; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P462, DOI 10.1044/jshr.1203.462; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246, DOI 10.1044/jshr.1202.246; Deterding D, 2001, J PHONETICS, V29, P217, DOI 10.1006/jpho.2001.0138; Duffy, 2005, MOTOR SPEECH DISORDE; Ersahin Y, 2002, CHILD NERV SYST, V18, P318, DOI 10.1007/s00381-002-0614-z; FUJISAWA H, IN PRESS CHILDS NERV; Gelabert-Gonzalez M, 2001, CLIN NEUROL NEUROSUR, V103, P111, DOI 10.1016/S0303-8467(01)00125-1; Grill J, 2004, J NEUROSURG, V101, P152, DOI 10.3171/ped.2004.101.2.0152; HUBER JF, IN PRESS CHILDS NERV; Ildan F, 2002, ACTA NEUROCHIR, V144, P463, DOI 10.1007/s007010200067; Kassardjian CD, 2005, J NEUROSCI, V25, P7979, DOI 10.1523/JNEUROSCI.2215-05.2005; *KAY EL, 1993, MULT VOIC PROGR COMP; KENT RD, 1987, J SPEECH HEAR DISORD, V52, P367, DOI 10.1044/jshd.5204.367; Kent RD, 2000, J SPEECH LANG HEAR R, V43, P1275, DOI 10.1044/jslhr.4305.1275; Ling LE, 2000, LANG SPEECH, V43, P377, DOI 10.1177/00238309000430040301; Mewasingh LD, 2003, PEDIATR NEUROL, V28, P59, DOI 10.1016/S0887-8994(02)00503-9; MILENKOVIC P, 2001, TF32 COMP PROGR; MURDOCH BE, 1991, J SPEECH HEAR RES, V34, P768, DOI 10.1044/jshr.3404.768; MURDOCH BE, 1994, EUR J DISORDER COMM, V29, P379; Ozawa Y, 2001, FOLIA PHONIATR LOGO, V53, P67, DOI 10.1159/000052656; Ozimek A, 2004, J NEUROL, V251, P963, DOI 10.1007/s00415-004-0472-6; Paquier P, 2003, REV NEUROL-FRANCE, V159, P1017; POLLACK IF, 1995, NEUROSURGERY, V37, P885, DOI 10.1227/00006123-199511000-00006; RAKATE HL, 1985, ARCH NEUROL-CHICAGO, V43, P697; Richter S, 2005, BRAIN LANG, V92, P153, DOI 10.1016/j.bandl.2004.06.015; Riecker A, 2005, NEUROLOGY, V64, P700, DOI 10.1212/01.WNL.0000152156.90779.89; Riva D, 1998, CORTEX, V34, P279, DOI 10.1016/S0010-9452(08)70755-X; Riva D, 2000, BRAIN, V123, P1051, DOI 10.1093/brain/123.5.1051; SALVATI M, 1991, CLIN NEUROL NEUROSUR, V93, P313, DOI 10.1016/0303-8467(91)90096-8; Sherman JH, 2005, SURG NEUROL, V63, P476, DOI 10.1016/j.surneu.2004.06.015; Siffert J, 2000, J NEURO-ONCOL, V48, P75, DOI 10.1023/A:1006483531811; Steinbok P, 2003, PEDIATR NEUROSURG, V39, P179, DOI 10.1159/000072468; STUNTEBECK SK, UNPUB ACOUSTIC ANAL; SWINNY JD, 2005, NEURAL PLAST, V12, P263; VANCALENBERGH F, 1995, NEUROSURGERY, V37, P894, DOI 10.1227/00006123-199511000-00007; vanMourik M, 1996, PEDIATR NEUROL, V15, P352, DOI 10.1016/S0887-8994(96)00226-3; Wang YT, 2005, FOLIA PHONIATR LOGO, V57, P59, DOI 10.1159/000083569; Wang YT, 2005, J COMMUN DISORD, V38, P231, DOI 10.1016/j.jcomdis.2004.12.001; Wang YT, 2004, CLIN LINGUIST PHONET, V18, P57, DOI 10.1080/02699200310001596160; Yonemasu Y, 1985, 13 ANN M JAP SOC PED	47	3	3	0	2	DELMAR CENGAGE LEARNING	FLORENCE	PO BOX 6904, FLORENCE, KY 41022-6904 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	JUN	2006	14	2					109	122					14	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	047ME	WOS:000237882600009					2022-02-06	
J	Mashiyama, S; Fukawa, O; Kawase, M; Noshita, N; Takada, S				Mashiyama, Shoji; Fukawa, Osamu; Kawase, Makoto; Noshita, Norio; Takada, Shihomi			Stab injury of the brain by kitchen knife	NEUROLOGICAL SURGERY			Japanese	Article						stab injury; kitchen knife; operation	PENETRATING INJURY; WOUNDS	A 32-year-old male attempted suicide by stabbing his forehead with a kitchen knife, and was sent to our hospital. On admission, he was confused (20-30/JCS), but was able to move his both extremities. Skull X-p, CT scan indicated that the kitchen knife penetrated the frontal bone, reached the cerebrum by way of the frontal sinus. Cerebral angiography was performed, and showed no vascular lesions. Emergent craniotomy was performed and the kitchen knife was removed with minimum movement. Traumatic intracerebral hematoma was removed, and injured frontal sinus, dura mater and frontal bone were repaired. Postoperative course was excellent and he was discharged with the wounds well healded, no neurological deficits on the 17th day after the operation. There are several reported cases of such stab injury. Stab injury of the brain was discussed in the literature.	Iwaki Municipal Sogo Iwaki Kyotitsu Hosp, Dept Neurosurg, Iwaki, Fukushima 9738555, Japan		Mashiyama, S (corresponding author), Iwaki Municipal Sogo Iwaki Kyotitsu Hosp, Dept Neurosurg, 16 Kusehara, Iwaki, Fukushima 9738555, Japan.	noge@iwaki-kyoritsu.iwaki.fukushima.jp					ALMEFTY O, 1986, AM J NEURORADIOL, V7, P164; ASARI S, 1977, J NEUROSURG, V46, P795, DOI 10.3171/jns.1977.46.6.0795; DETREVOU MD, 1992, NEUROSURGERY, V31, P905; HAWORTH CS, 1988, NEUROSURGERY, V23, P431, DOI 10.1227/00006123-198810000-00004; HERRING CJ, 1988, NEUROSURGERY, V23, P658, DOI 10.1227/00006123-198811000-00022; Iwakura M, 2005, NEUROL MED-CHIR, V45, P172, DOI 10.2176/nmc.45.172; KHALIL N, 1991, SURG NEUROL, V35, P294, DOI 10.1016/0090-3019(91)90008-W; KIECK CF, 1984, J NEUROSURG, V60, P42, DOI 10.3171/jns.1984.60.1.0042; MILLER P, 1987, NEUROSURGERY, V21, P92, DOI 10.1227/00006123-198707000-00021; Nathoo N, 2000, NEUROSURGERY, V47, P1117, DOI 10.1097/00006123-200011000-00018; Taylor AG, 1997, J NEUROSURG, V87, P512, DOI 10.3171/jns.1997.87.4.0512; VANDELLEN JR, 1978, SURG NEUROL, V10, P110; WU JJ, 1982, SURG NEUROL, V17, P43, DOI 10.1016/0090-3019(82)90041-6	13	3	3	0	0	IGAKU-SHOIN LTD	TOKYO	1-28-23 HONGO, BUNKYO-KU, TOKYO, 113-8719, JAPAN	0301-2603			NEUROL SURG TOKYO	Neurol. Surg.	MAY	2006	34	5					497	502					6	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	050JG	WOS:000238082900006	16689393				2022-02-06	
J	Rao, V; Spiro, J; Degoankar, M; Horska, A; Rosenberg, PB; Yousem, DM; Barker, PB; Phil, D				Rao, Vani; Spiro, Jennifer; Degoankar, Mahaveer; Horska, Alena; Rosenberg, Paul B.; Yousem, David M.; Barker, Peter B.; Phil, D.			Lesion location in depression post aumatic brain injury using magnetic resonance spectroscopy: Preliminary results from a pilot study	EUROPEAN JOURNAL OF PSYCHIATRY			English	Article						magnetic resonance spectroscopy; traumatic brain injury; depression	MAJOR DEPRESSION; H-1-MR SPECTROSCOPY; ALZHEIMERS-DISEASE; FRONTAL-LOBE; DISORDER; ABNORMALITIES; ONSET	Objective: To determine the metabolic status of the brain in post traumatic brain injury(TBI) depression using proton magnetic resonance spectroscopy (MRS). Design: Case-control study including 5 TBI depressed subjects and 5 age matched non-TBI non-depressed controls. Methods: Metabolic status was assessed using proton MRS. Ratios of N-acetylaspartate (NAA), choline (Cho) and total creatine (Cr) were calculated in frontal cortex, basal ganglia and thalamus. Results: NAA/Cho or NAA/Cr ratios were significantly reduced in the TBI depressed group compared to controls in frontal cortex, basal ganglia and thalamus. Conclusion: Reduced levels of NAA in frontal regions, basal ganglia and thalamus in TBI depression suggest neuronal damage or dysfunction which may be a associated with the primary brain injury or with depressed mood.	Johns Hopkins Sch Med, Dept Psychiat, Div Geriatr Psychiat & Neuropsychiat, Baltimore, MD 21287 USA; Johns Hopkins Sch Med, Div Neuroradiol, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA		Rao, V (corresponding author), Johns Hopkins Sch Med, Dept Psychiat, Div Geriatr Psychiat & Neuropsychiat, Baltimore, MD 21287 USA.	vrao@jhmi.edu					Auer DP, 2000, BIOL PSYCHIAT, V47, P305, DOI 10.1016/S0006-3223(99)00159-6; BACHELARD H, 1993, J NEUROCHEM, V61, P412; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Condon B, 1998, J NEUROTRAUM, V15, P563, DOI 10.1089/neu.1998.15.563; Coupland NJ, 2005, BIOL PSYCHIAT, V57, P1526, DOI 10.1016/j.biopsych.2005.02.027; Deb S, 1999, AM J PSYCHIAT, V156, P374; DUYN JH, 1993, RADIOLOGY, V188, P277, DOI 10.1148/radiology.188.1.8511313; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Kumar A, 2002, AM J PSYCHIAT, V159, P630, DOI 10.1176/appi.ajp.159.4.630; Lyketsos CG, 2001, INT J GERIATR PSYCH, V16, P1043, DOI 10.1002/gps.448; Lyoo IK, 2002, BIOL PSYCHIAT, V51, P195, DOI 10.1016/S0006-3223(01)01313-0; MAYBERG HS, 1994, J NEUROPSYCH CLIN N, V6, P428; MAYBERG HS, 1990, ANN NEUROL, V28, P57, DOI 10.1002/ana.410280111; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; Moore Gregory J, 2002, Psychopharmacol Bull, V36, P5; Murata T, 2001, INT J GERIATR PSYCH, V16, P1129, DOI 10.1002/gps.501; Rosenberg PB, 2005, INT J GERIATR PSYCH, V20, P119, DOI 10.1002/gps.1261; Soher BJ, 1996, MAGNET RESON MED, V35, P356, DOI 10.1002/mrm.1910350313; Umile EM, 1998, BRAIN INJURY, V12, P577; Videbech P, 2000, ACTA PSYCHIAT SCAND, V101, P11, DOI 10.1034/j.1600-0447.2000.101001011.x; Vythilingam M, 2003, BIOL PSYCHIAT, V54, P744, DOI 10.1016/S0006-3223(02)01908-X; Yoon SJ, 2005, CLIN REHABIL, V19, P209, DOI 10.1191/0269215505cr813oa	26	3	3	0	1	EUROPEAN JOURNAL OF PSYCHIATRY	SARAGOOSE	PO BOX 6029, 50080 SARAGOOSE, SPAIN	0213-6163			EUR J PSYCHIAT	Eur. J. Psychiat.	APR-JUN	2006	20	2					65	73					9	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	070HY	WOS:000239513700002		Green Submitted, gold			2022-02-06	
J	Volpe, AG; Davis, AS; Dean, RS				Volpe, AG; Davis, AS; Dean, RS			Predicting global and specific neurological impairment with sensory-motor functioning	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						neurological impairment; sensory-motor functioning	NEUROPSYCHOLOGICAL BATTERY; BRAIN-DAMAGE; CHILDREN; TESTS	The present study assessed the ability of the Dean-Woodcock Sensory-Motor Battery (DWSMB) to distinguish between normal subjects and neurologically impaired individuals. Scores from the subtests of the DWSMB for 250 normal and 250 neurologically impaired individuals were randomly assigned to two equal groups to allow for cross-validation. The DWSMB was able to correctly identify 92.8% of the cases, identifying 94.4% of the normal population and 91.2% of the neurologically impaired subjects. The cross-validation correctly identified 87.2% of the total cases, identifying 91.2% of the normal subjects and 83.2% of the neurologically impaired subjects. An additional discriminant analysis indicated that the DWSMB correctly identified the following cases: 44.9% cardio-vascular accidents, 66.7% multiple sclerosis, 40% seizures, 42% traumatic brain injuries, 62.7% dementia, and 54.5% Parkinson's disease. The results add to the validity of the DWSMB by providing evidence of its ability to differentiate between neurologically impaired and normal individuals. (c) 2006 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	Ball State Univ, Teachers Coll, Dept Educ Psychol, Muncie, IN 47306 USA		Davis, AS (corresponding author), Ball State Univ, Teachers Coll, Dept Educ Psychol, Room 515, Muncie, IN 47306 USA.	davis@bsu.edu					Adams R. D., 1993, PRINCIPLES NEUROLOGY; *AM MED ASS, 2000, INT CLASS DIS; *AM PSYCH ASS, 2004, ETH PRINC PSYCH COD; DAVIS AS, 2005, UNPUB EVALUATING CON; Dean R. S., 2003, DEAN WOODCOCK SENSOR; Dean R. S., 1999, WJ R BATERIA R NEURO; Gaddes W.H., 1994, LEARNING DISABILITIE; GLICK TH, 1993, NEUROLOGIC SKILLS EX; GOLDEN CJ, 1976, J CLIN PSYCHOL, V32, P821, DOI 10.1002/1097-4679(197610)32:4<821::AID-JCLP2270320419>3.0.CO;2-W; GOLDEN CJ, 1978, J CONSULT CLIN PSYCH, V46, P1258, DOI 10.1037/0022-006X.46.6.1258; GOLDEN CJ, 1981, J CONSULT CLIN PSYCH, V49, P491, DOI 10.1037/0022-006X.49.4.491; Lang D, 2001, INT J NEUROSCI, V111, P211, DOI 10.3109/00207450108994232; MALLOY PF, 1986, NEUROPSYCHOLOGY HDB, P115; Martella R. C., 1999, RES METHODS; MURPHY LL, 1994, TESTS PRINT 4 INDEX, V1; Reitan RM, 2003, ARCH CLIN NEUROPSYCH, V18, P11, DOI 10.1016/S0887-6177(01)00177-9; Reitan RM, 2001, ARCH CLIN NEUROPSYCH, V16, P215; SNOW JH, 1993, ARCH CLIN NEUROPSYCH, V8, P55, DOI 10.1016/0887-6177(93)90043-Z; Wolfson, 1993, HALSTEAD REITAN NEUR; Woodward HR, 2002, INT J NEUROSCI, V112, P1115, DOI 10.1080/00207450290026094	20	3	3	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	APR	2006	21	3					203	210		10.1016/j.acn.2005.12.005			8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	039RP	WOS:000237324800001	16517117	Bronze			2022-02-06	
J	Snell, D; Surgenor, L				Snell, Deborah; Surgenor, Lois			An analysis of referees and referrals to a specialist concussion clinic in New Zealand	NEW ZEALAND MEDICAL JOURNAL			English	Article								Aim. This study reviews the characteristics of referrals to a specialist concussion clinic (Burwood Hospital Concussion Clinic, Christchurch, New Zealand) in its first two years of operation. Method. Information regarding referral source, demographic and clinical features, time since mild traumatic brain injury (MTBI), assessment and treatment provided, service follow-up, and outcome at discharge were collected from a file search of all referrals received in the two years ending in October 2004. Results. Cases reflected the clinical and demographic diversity expected of those incurring an MTBI. Age and referral source were associated with failing to keep initial appointments. Assessments typically resulted in ongoing treatment from the service, although many were 'one-off' assessments. One-in-five cases resulted in ongoing treatment for more than 7 months. Gender, cause of MTBI, and time delay between injury and assessment were significantly associated with receiving long-term follow-up. Most cases had a good clinical outcome at discharge. Conclusions. While the Concussion Clinic services the intended clinical population, referrals for assault-related MTBIs were greater than expected, and men may be under-referred. The disproportional number of non-attending patients referred from Christchurch Hospital Emergency Department along with the unanticipated proportion of cases receiving long-term follow-up, suggest a need for review of the referral response systems and the scope of service provision.	[Snell, Deborah] Burwood Hosp, Canterbury Dist Hlth Board, Brain Injury Rehabil Serv, POB 4708, Christchurch, New Zealand; [Surgenor, Lois] Univ Otago, Christchurch Sch Med, Dept Psychol Med, Christchurch, New Zealand		Snell, D (corresponding author), Burwood Hosp, Canterbury Dist Hlth Board, Brain Injury Rehabil Serv, POB 4708, Christchurch, New Zealand.	deborah.snell@cdhb.govt.nz					Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Hamilton W, 2002, BRIT J GEN PRACT, V52, P317; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; MITTENBERG W, 1994, BRAIN INJURY, V8, P429, DOI 10.3109/02699059409150994; Moore C, 2004, NZ MED J, V117; Murray MJ, 1996, ANN EMERG MED, V27, P56, DOI 10.1016/S0196-0644(96)70297-4; Peloso PM, 2004, J REHABIL MED, V36, P106, DOI 10.1080/16501960410023868; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Simmons AV, 1997, J ROY COLL PHYS LOND, V31, P70; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stanway A, 2004, NZ MED J, V117; TEASDALE G, 1974, LANCET, V2, P81; Turner-Stokes L, 2004, CLIN MED, V4, P61, DOI 10.7861/clinmedicine.4-1-61; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478; Wrightson P, 2000, J CLIN NEUROSCI, V7, P384, DOI 10.1054/jocn.1999.0678	24	3	3	0	0	NEW ZEALAND MEDICAL ASSOC	CHRISTCHURCH	C/O BRENNAN EDWARDES, DEPT SURGERY, CHRISTCHURCH HOSPITAL, PO BOX 4345, CHRISTCHURCH, 00000, NEW ZEALAND	0028-8446	1175-8716		NEW ZEAL MED J	N. Z. Med. J.	MAR 31	2006	119	1231					66	74					9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V7O4H	WOS:000421144600007					2022-02-06	
J	Lemaire, ED; Deforge, D; Marshall, S; Curran, D				Lemaire, ED; Deforge, D; Marshall, S; Curran, D			A secure web-based approach for accessing transitional health information for people with traumatic brain injury	COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE			English	Article						electronic health record; physical rehabilitation; brain injury; Internet	PATIENT RECORD; COMMUNITY INTEGRATION; MEDICAL-RECORD; SYSTEM; MODEL; CARE	A web-based transitional health record was created to provide regional healthcare professionals with ubiquitous access to information on people with brain injuries as they move through the healthcare system. Participants included public, private, and community healthcare organizations/providers in Eastern Ontario (Canada). One hundred and nineteen service providers and 39 brain injury survivors registered over 6 months. Fifty-eight percent received English and 42% received bilingual services (English-French). Public health providers contacted the regional service coordinator more than private providers (52% urban centres, 26% rural service providers, and 22% both areas). Thirty-five percent of contacts were for technical difficulties, 32% registration inquiries, 21% forms and processes, 6% resources, and 6% education. Seventeen technical enquiries required action by technical support personnel: 41% digital certificates, 29% web forms, and 12% log-in. This web-based approach to clinical information sharing provided access to relevant data as clients moved through or re-entered the health system. improvements include automated digital certificate management, institutional health records system integration, and more referral tracking tools. More sensitive test data could be accessed on-line with increasing consumer/clinician confidence. In addition to a strong technical infrastructure, human resource issues are a major information security component and require continuing attention to ensure a viable on-line information environment. (c) 2006 Elsevier Ireland Ltd. All rights reserved.	Inst Rehabil Res & Dev, Rehabil Ctr, Ottawa, ON K1H 8M2, Canada		Lemaire, ED (corresponding author), Inst Rehabil Res & Dev, Rehabil Ctr, 505 Smyth Rd, Ottawa, ON K1H 8M2, Canada.	elemaire@ottawahospital.on.ca		Lemaire, Edward/0000-0003-4693-2623			ADAMS T, 2004, BMJ-BRIT MED J, V6, P871; BRIGGS JS, 1997, IEE C TECHN SUPP REM, P1; BUELL MK, 1994, J DEV DISABILITIES, V3, P94; Burton LC, 2004, MILBANK Q, V82, P457, DOI 10.1111/j.0887-378X.2004.00318.x; Dalley A, 2005, IEEE T INF TECHNOL B, V9, P289, DOI 10.1109/TITB.2005.847143; Delpierre C, 2004, INT J QUAL HEALTH C, V16, P407, DOI 10.1093/intqhc/mzh064; Fraser HSF, 2004, BMJ-BRIT MED J, V329, P1142, DOI 10.1136/bmj.329.7475.1142; Fyffe C, 1996, Aust J Rural Health, V4, P232, DOI 10.1111/j.1440-1584.1996.tb00216.x; Heitmann KU, 2003, INT J MED INFORM, V70, P195, DOI 10.1016/S1386-5056(03)00036-4; Henrard S, 2004, 17TH IEEE SYMPOSIUM ON COMPUTER-BASED MEDICAL SYSTEMS, PROCEEDINGS, P10, DOI 10.1109/CBMS.2004.1311683; Kohane IS, 1996, J AM MED INFORM ASSN, V3, P191, DOI 10.1136/jamia.1996.96310633; Labreze L, 1998, MED INFORM, V23, P75, DOI 10.3109/14639239809001393; Liu CT, 2001, INT J MED INFORM, V61, P189, DOI 10.1016/S1386-5056(01)00141-1; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; Minnes P, 2001, NEUROREHABILITATION, V16, P3; Minnes P, 2000, BRAIN INJURY, V14, P737; Person DA, 1998, PACIFIC MEDICAL TECHNOLOGY SYMPOSIUM, PROCEEDINGS, P132, DOI 10.1109/PACMED.1998.767946; Pinciroli F, 2004, STUD HEALTH TECHNOL, V98, P301; Reponen J, 2004, J TELEMED TELECARE, V10, pS81; Safran C, 2000, INT J MED INFORM, V60, P77, DOI 10.1016/S1386-5056(00)00106-4; van Ginneken AM, 2002, INT J MED INFORM, V65, P97, DOI 10.1016/S1386-5056(02)00007-2; Wang MS, 2004, IEEE T INF TECHNOL B, V8, P287, DOI 10.1109/TITB.2004.834397; WILLER B, 1994, BRAIN INJURY, V8, P647, DOI 10.3109/02699059409151017; Woolman PS, 2001, INT J MED INFORM, V64, P379, DOI 10.1016/S1386-5056(01)00199-X	24	3	3	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-2607	1872-7565		COMPUT METH PROG BIO	Comput. Meth. Programs Biomed.	MAR	2006	81	3					213	219		10.1016/j.cmpb.2005.11.011			7	Computer Science, Interdisciplinary Applications; Computer Science, Theory & Methods; Engineering, Biomedical; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Computer Science; Engineering; Medical Informatics	028CL	WOS:000236463600004	16469409				2022-02-06	
J	Srinivasan, US				Srinivasan, U. S.			A mathematical model for predicting the outcome in moderate head injury	NEUROLOGY INDIA			English	Article						moderate head injury; traumatic brain injury; computed tomographic data; glasgow coma scale; neurological signs	TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; MILD; CLASSIFICATION; PROGNOSIS; SYMPTOMS; LESION; SYSTEM	Background: Virtually all the literature on head injury has focused on the outcome prediction of severe and mild head injuries and very few studies have been dedicated to patients sustaining moderate head injuries. Aim: To identify the patient following moderate head injury who may die, develop severe disability or significant cognitive and behavioral problems on the first day of injury itself. Setting: Tertiary teaching hospital. Design: Prospective study divided into two groups. Materials and Methods: The study included 85 patients whose Glasgow coma scale score were 9-12 and who had isolated moderate head injury. Among the above patients a preliminary prospective study was conducted in first group of 64 patients using 7 clinical factors, 18 neuro-behavioral sequel and CT brain data in prediction of outcome with moderate head injury. From the results obtained in the above study three statistically significant factors were identified and a mathematica model was developed and used prospectively in the next 21 patients and its accuracy was evaluated. Statistical I Methods Used: Multiple regression analysis and Kendall's, tau non- parametric test using statistical package for social sciences (SPSS 11-5-version) were used to find out the predictive factors. Results: Results of these patients showed combination of CT scan brain data, verbal response and neurological signs could provide a reliable prediction in moderate head injury. Conclusion: Based upon the above results a mathematical model was developed giving a value for the above-mentioned factors. The mathematical model was "CT brain data x (Verbal response + Neurological Signs)". Its overall accuracy when used on the day of admission was around 80%.	PSG Inst Med Sci, Dept Neurosurg, Coimbatore, Tamil Nadu, India; MIOT Hosp, Madras, Tamil Nadu, India		Srinivasan, US (corresponding author), 2B E Wood,Fairmont Gardens,66 MT Poonamalle Rd, Madras 600089, Tamil Nadu, India.	ussrini@vsnl.net					CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Fearnside M, 1998, AUST NZ J SURG, V68, P58, DOI 10.1111/j.1445-2197.1998.tb04638.x; FEUERMAN T, 1988, NEUROSURGERY, V22, P449, DOI 10.1227/00006123-198803000-00001; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; HSIANG J, 1998, OUTCOMES NEUROLOGICA, P157; JENNETT B, 1975, LANCET, V1, P480; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; LEVIN HS, 1992, MILD MODERATE HEAD I, P52; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; MARSHALL LF, 1996, NEUROSURGERY, P2717; Mataro M, 2001, J NEUROTRAUM, V18, P869, DOI 10.1089/089771501750451794; Mukherjee K, 2000, NEUROL INDIA, V48, P43; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Srinivasan US, 1999, ICRAN 99: INTERNATIONAL CONFERENCE ON RECENT ADVANCES IN NEUROTRAUMATOLOGY, P281; SRINIVASAN US, 1993, NEUROL INDIA, V41, P51; SWEET RC, 1978, NEUROSURGERY, V3, P16, DOI 10.1227/00006123-197807000-00003; TABBADOR K, 1984, NEUROSURGERY, V14, P701; TEASDALE G, 1974, LANCET, V2, pS1; TEASDALE G, 1992, MILD MODERATE HEAD I, P226; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188	30	3	3	0	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	MAR	2006	54	1					28	32		10.4103/0028-3886.24698			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045VG	WOS:000237770100005	16679639	Green Submitted			2022-02-06	
J	Akdur, O; Ikizceli, B; Sozuer, EM; Avsarogullari, L; Kilic, S; Taymus, E				Akdur, Okhan; Ikizceli, Brahim; Sozuer, Erdogan M.; Avsarogullari, Levent; Kilic, Sebnem; Taymus, Esengul			Evaluation of pediatric head traumas in preschool age period	TURKISH JOURNAL OF EMERGENCY MEDICINE			Turkish	Article						Accidents/statistics & numerical data; child; child; preschool; head injury; hospitalization		Objectives: Head injuries compose an important part of childhood traumas. Traumatic head injuries in this age group are still important despite all efforts. Aim of this study was to determine causes, results, prevalence and other properties of head injury patients in preschool period in our region. Materials and Methods: This study was performed retrospectively in preschool age trauma patients presented to Erciyes University Faculty of Medicine, Emergency Department between the dates of 1 January 2004 and 30 June 2004. From the patient files of head injury patients; demographic features, mechanism of trauma, clinical status and duration of treatment were evaluated. Results: Eighty-five cases were detected in preschool age group (0-6 years). Fifty-three of the cases (62.3%) were male. The most common mechanism of actions were falls (n=52, 61%) and traffic accidents out of vehicle (n=13, 15.2%). Seventy of the cases (82.3%) were mild head injury, 10 (11.8%) were moderate and 5 (5.9%) were severe. Twelve cases (14.1%) also had concomitant trauma of other systems. Brain surgeons consultated 49 cases (57.6%). Fifty- three of the cases (62.3%) were discharged after emergency department follow-up. The most common hospitalization was made to neurochirurgia department (n=25, 29.4%). The mean follow-up period in the emergency department was 6.7 +/- 5.43 hours. Mortality was seen in 4 cases (4.4%). Mechanism of injury in all of these cases was out of vehicle traffic accident. Conclusion: In the preschool childhood, the most common cause of traumas was falls. Most of these cases can be treated and followed-up in the emergency department and then discharged. But, the most common mechanism of trauma causing death is out of vehicle traffic accidents. These traumas can be decreased by preventive measures.	[Akdur, Okhan; Ikizceli, Brahim; Sozuer, Erdogan M.; Avsarogullari, Levent; Kilic, Sebnem; Taymus, Esengul] Erciyes Univ, Tip Fak, Acil Tip Anabilim Dali, TR-38039 Kayseri, Turkey		Akdur, O (corresponding author), Erciyes Univ, Tip Fak, Acil Tip Anabilim Dali, TR-38039 Kayseri, Turkey.	oakdur@hotmail.com	Kilic, Sara Sebnem/AAH-1658-2021				Berger RP, 2005, CLIN PEDIATR EMERG M, V6, P8, DOI 10.1016/j.cpem.2004.12.005; Bergman DA, 1999, PEDIATRICS, V104, P1407; Brook U, 2003, PATIENT EDUC COUNS, V51, P177, DOI 10.1016/S0738-3991(02)00192-1; Chiaretti A, 2003, Pediatr Med Chir, V25, P432; Garzon Dawn Lee, 2005, J Pediatr Nurs, V20, P441, DOI 10.1016/j.pedn.2005.03.014; Gedeit R, 2001, Pediatr Rev, V22, P118, DOI 10.1542/pir.22-4-118; Goodwin V, 2001, CURR PEDIAT, V11, P420; HAUDA WE, 2004, EMERGENCY MED COMPRE, P1542; Hoyt DB, 2001, SURG SCI PRINCIPLES, P269; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Johnson K, 2005, CLIN RADIOL, V60, P464, DOI 10.1016/j.crad.2004.09.013; Meier R, 2005, CLIN ORTHOP RELAT R, P127, DOI 10.1097/01.blo.0000156005.01503.0a; Ozsarac M, 2003, AKAD ACIL TIP DERGIS, V2, P19; Pediatric trauma, 2004, ADVENCED TRAUM LIF S, P243; Sahin S, 2002, ULUDAG U TIP FAKULTE, V28, P45; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; SMITH GS, 1991, EPIDEMIOL REV, V13, P228, DOI 10.1093/oxfordjournals.epirev.a036070; Tabish A, 2006, INJURY, V37, P410, DOI 10.1016/j.injury.2006.01.039; Wang MY, 2001, J PEDIATR SURG, V36, P1528, DOI 10.1053/jpsu.2001.27037; Woodcock RJ, 2001, SEMIN ULTRASOUND CT, V22, P162, DOI 10.1016/S0887-2171(01)90043-5	20	3	3	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2452-2473			TURK J EMERG MED	Turk. J. Emerg. Med.		2006	6	4					158	162					5	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V7I5W	WOS:000420992700003					2022-02-06	
J	Alverzo, JP				Alverzo, Joan P.			A review of the literature on orientation as an indicator of level of consciousness	JOURNAL OF NURSING SCHOLARSHIP			English	Article						orientation; consciousness; temporal orientation; levels of consciousness; cognition; awareness; neurological assessment	CLOSED-HEAD-INJURY; GLASGOW COMA SCALE; TEMPORAL ORIENTATION; AMNESIA; MEMORY; DISORIENTATION; COGNITION; DELIRIUM; MODEL	Purpose: To review and compare the concepts of orientation and level of consciousness. Methods: Literature review, including studies of orientation as an indicator of level of consciousness, in the domains of nursing, medicine, and neuropsychology. Findings: Orientation to time, place, and person as a measure of level of consciousness is poorly understood. The nursing practice of assessing orientation is common in many practice settings, yet little research has been done to validate whether it is meaningful. Conclusions: This review lays important groundwork for future evidence-based research into the use of orientation as an indicator of level of consciousness.	Kesser Rehabil Corp, W Orange, NJ 07052 USA		Alverzo, JP (corresponding author), Kesser Rehabil Corp, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	jalverzo@kessler-rehab.com					Alverzo J P, 1999, Rehabil Nurs, V24, P7; Alverzo Joan P, 2005, Rehabil Nurs, V30, P230; Benner P, 1984, NOVICE EXPERT; BENTON AL, 1964, J NERV MENT DIS, V139, P110, DOI 10.1097/00005053-196408000-00003; Boring E. G., 1933, PHYS DIMENSIONS CONS; CORRIGAN JD, 1985, ARCH PHYS MED REHAB, V66, P626; CROSBY L, 1989, HEART LUNG, V18, P121; DANIEL WF, 1987, CORTEX, V23, P169, DOI 10.1016/S0010-9452(87)80030-8; DESMOND DW, 1994, J NEUROL, V241, P585, DOI 10.1007/BF00920621; DEVINSKY O, 1988, CONT NEUROLOGY SERIE, V29, P321; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; ESLINGER PJ, 1984, JAMA-J AM MED ASSOC, V253, P670; GRANT JS, 1990, RES NURS HEALTH, V13, P403, DOI 10.1002/nur.4770130608; INGRAM N, 1994, J ADV NURS, V20, P881, DOI 10.1046/j.1365-2648.1994.20050881.x; Inouye SK, 1996, JAMA-J AM MED ASSOC, V275, P852, DOI 10.1001/jama.275.11.852; INOUYE SK, 1994, AM J MED, V97, P278, DOI 10.1016/0002-9343(94)90011-6; Ishizaki J, 1998, J GERONTOL B-PSYCHOL, V53, pP359, DOI 10.1093/geronb/53B.6.P359; JACKSON RD, 1989, ARCH PHYS MED REHAB, V70, P33; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Le N, 1994, Rehabil Nurs, V19, P293; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lusardi PT, 1996, J ADV NURS, V23, P896, DOI 10.1046/j.1365-2648.1996.01036.x; NATELSON BH, 1979, ARCH NEUROL-CHICAGO, V36, P444, DOI 10.1001/archneur.1979.00500430074014; Posner JB., 1980, DIAGNOSIS STUPOR COM, V3; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; Schnider A, 1996, BRAIN, V119, P1627, DOI 10.1093/brain/119.5.1627; SCHORR JA, 1983, ADV NURS SCI, P26; SEGATORE M, 1992, HEART LUNG, V21, P548; SMITH MJ, 1995, J PAIN SYMPTOM MANAG, V10, P35, DOI 10.1016/0885-3924(94)00066-T; Sweet JJ, 1999, CLIN NEUROPSYCHOL, V13, P495, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT495; TEASDALE G, 1974, LANCET, V2, P81; Tosch P, 1988, J Neurosci Nurs, V20, P223; VARNEY NR, 1991, NEUROPSYCHOLOGY, V5, P13; Way C, 1994, J Neurosci Nurs, V26, P278; Wechsler D, 1987, MEMORY SCALE REVISED; Williams M A, 1988, J Gerontol Nurs, V14, P25; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0; 1995, STEDMANS MED DICT	40	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1527-6546	1547-5069		J NURS SCHOLARSHIP	J. Nurs. Scholarsh.		2006	38	2					159	164		10.1111/j.1547-5069.2006.00094.x			6	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	040QQ	WOS:000237395900020	16773920				2022-02-06	
J	Dowson, JH				Dowson, Jonathan H.			Pharmacological Treatments for Attention-Deficit/Hyperactivity Disorder (ADHD) in Adults	CURRENT PSYCHIATRY REVIEWS			English	Article						Attention-deficit; hyperactivity; impulsivity; adult; treatment	DEFICIT HYPERACTIVITY DISORDER; SUBSTANCE USE DISORDERS; DISRUPTIVE BEHAVIOR DISORDERS; RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; CONDUCT DISORDER; DOUBLE-BLIND; BIPOLAR DISORDER; METHYLPHENIDATE TREATMENT; STIMULANT MEDICATION	Attention-Deficit/Hyperactivity Disorder (ADHD), as defined by DSM-IV, is a heterogeneous syndrome affecting an estimated 7% of children. Many will continue to have clinically-significant features of ADHD as adults, although some patients referred to adult psychiatrists have previously-unrecognised ADHD. Studies involving neurocognitive assessments or brain imaging have indicated ADHD-associated brain dysfunctions. An important therapeutic role for drugs such as methylphenidate has been clearly established in children and the benefits of medication for ADHD in adults are being increasingly recognised. The present review is aimed at adult psychiatrists who are considering or managing drug treatments for ADHD in adult patients. The focus is on medication regimes, but relevant 'background' literature is also reviewed, as an awareness of a range of published evidence is necessary when assessing ADHD in adult patients and advising on possible drug treatments.	[Dowson, Jonathan H.] Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 2QQ, England		Dowson, JH (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Box 189, Cambridge CB2 2QQ, England.	jhd1000@cam.ac.uk					Adler L, 2004, PSYCHIAT CLIN N AM, V27, P187, DOI 10.1016/j.psc.2003.12.003; Adler LA, 2005, J CLIN PSYCHIAT, V66, P294, DOI 10.4088/JCP.v66n0304; Adler LA, 2002, J CLIN PSYCHIAT, V63, P29; Aman MG, 2004, J CHILD ADOL PSYCHOP, V14, P243, DOI 10.1089/1044546041649020; Aman MG, 2003, J CHILD ADOL PSYCHOP, V13, P29, DOI 10.1089/104454603321666171; American Psychiatric Association (APA), DIAGN STAT MAN MENT, V5th; American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT, VIV; [Anonymous], 2005, BRIT NATL FORMULARY, P206; Arnold LE, 1997, ARCH GEN PSYCHIAT, V54, P865; Aron AR, 2003, BIOL PSYCHIAT, V54, P1465, DOI 10.1016/S0006-3223(03)00609-7; Barbaresi WJ, 2002, ARCH PAEDIAT ADOLESC, V156, P209; Barkley R, ATTENTION DEFICIT HY; Barkley R. A., 1998, ATTENTION DEFICIT HY, P139; Barkley RA, 2003, PEDIATRICS, V111, P97, DOI 10.1542/peds.111.1.97; Bazire S., 1999, PSYCHOTROPIC DRUG DI, P17; Biederman J, 2000, AM J PSYCHIAT, V157, P816, DOI 10.1176/appi.ajp.157.5.816; BIEDERMAN J, 1995, AM J PSYCHIAT, V152, P1652; Biederman J, 2003, J CLIN PSYCHIAT, V64, P3; Bostic JQ, J CHILD ADOLESC PSYC, V10; Bradley C, 1937, AM J PSYCHIAT, V94, P577, DOI 10.1176/ajp.94.3.577; Brown TE, 2004, J CHILD ADOL PSYCHOP, V14, P129, DOI 10.1089/104454604773840571; Brown TE, 1996, BROWN ATTENTION DEFI; Burd L, 2003, NEUROTOXICOL TERATOL, V25, P681, DOI 10.1016/j.ntt.2003.07.020; Caballero J, 2003, CLIN THER, V25, P3065, DOI 10.1016/S0149-2918(03)90092-0; Carlson GA, 2003, J CHILD ADOL PSYCHOP, V13, P137, DOI 10.1089/104454603322163853; CARTER CM, 1993, ARCH DIS CHILD, V69, P564, DOI 10.1136/adc.69.5.564; Castaneda Ricardo, 1999, Subst Abus, V20, P59, DOI 10.1023/A:1021300907111; Challman TD, 2000, MAYO CLIN PROC, V75, P711; Chalon SA, 2003, CLIN PHARMACOL THER, V73, P3; Christman AK, 2004, PHARMACOTHERAPY, V24, P1020, DOI 10.1592/phco.24.11.1020.36146; Clark DB, 2004, AM J PSYCHIAT, V161, P685, DOI 10.1176/appi.ajp.161.4.685; Coetzee Martha, 2002, Subst Abus, V23, P165, DOI 10.1023/A:1019804806658; Conners CK, 2002, J ATTEN DISORD S1, V6, P517; Cox DJ, 2000, J NERV MENT DIS, V188, P230, DOI 10.1097/00005053-200004000-00006; Daviss WB, 2001, J AM ACAD CHILD PSY, V40, P307, DOI 10.1097/00004583-200103000-00010; Diamond A, 2005, DEV PSYCHOPATHOL, V17, P807, DOI 10.1017/S0954579405050388; Disney ER, 1999, AM J PSYCHIAT, V156, P1515, DOI 10.1176/ajp.156.10.1515; Dopfner M, 2004, EUR CHILD ADOLESC S1, V13, P193; Dorrego MF, 2002, J NEUROPSYCH CLIN N, V14, P289, DOI 10.1176/appi.neuropsych.14.3.289; Elliott R, 1997, PSYCHOPHARMACOLOGY, V131, P196, DOI 10.1007/s002130050284; Faraone S V, 2002, J Atten Disord, V6, P69, DOI 10.1177/108705470200600203; Faraone SV, 2000, BIOL PSYCHIAT, V48, P21, DOI 10.1016/S0006-3223(00)00230-4; Faraone SV, 2005, J CHILD ADOL PSYCHOP, V15, P664, DOI 10.1089/cap.2005.15.664; Faraone SV, 2004, J CLIN PSYCHOPHARM, V24, P24, DOI 10.1097/01.jcp.0000108984.11879.95; Faraone SV, 2003, J CLIN PSYCHIAT, V64, P9; Faraone SV, 1998, J AM ACAD CHILD PSY, V37, P459, DOI 10.1097/00004583-199805000-00002; Faraone SV, 2002, INT J NEUROPSYCHOPH, V5, P121, DOI 10.1017/S1461145702002845; Faraone SV, 2002, J CLIN PSYCHOPHARM, V22, P468, DOI 10.1097/00004714-200210000-00005; Faraone SV, 2001, J CHILD ADOL PSYCHOP, V11, P171, DOI 10.1089/104454601750284081; Feinberg SS, 2004, J CLIN PSYCHIAT, V65, P1520, DOI 10.4088/JCP.v65n1113; FELDMAN H, 1989, AM J DIS CHILD, V143, P1081, DOI 10.1001/archpedi.1989.02150210117030; Findling RL, 1996, J CLIN PSYCHIAT, V57, P184; Findling RL, 2001, J AM ACAD CHILD PSY, V40, P525, DOI 10.1097/00004583-200105000-00011; Fischer M, 2002, J ABNORM CHILD PSYCH, V30, P463, DOI 10.1023/A:1019864813776; FLEMINGER S, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003299; Flory K, 2003, CLIN CHILD FAM PSYCH, V6, P1, DOI 10.1023/A:1022260221570; Flory K, 2003, PSYCHOL ADDICT BEHAV, V17, P151, DOI 10.1037/0893-164X.17.2.151; Flory K, CLIN CHILD FAM PSYCH; Fone KCF, 2005, CURR OPIN PHARMACOL, V5, P87, DOI 10.1016/j.coph.2004.10.001; Galanter CA, 2003, J CHILD ADOL PSYCHOP, V13, P123, DOI 10.1089/104454603322163844; Gershon J, 2002, J Atten Disord, V5, P143, DOI 10.1177/108705470200500302; GITTELMAN R, 1985, ARCH GEN PSYCHIAT, V42, P937; Glaser PEA, 2005, PSYCHOPHARMACOLOGY, V178, P250, DOI 10.1007/s00213-004-2012-6; Grcevich S, 2001, EXPERT OPIN INV DRUG, V10, P2003, DOI 10.1517/13543784.10.11.2003; Grcevich S, 2001, J CHILD ADOL PSYCHOP, V11, P35, DOI 10.1089/104454601750143401; Greenwood TA, 2005, MOL PSYCHIAT; Gross-Tsur V, 2002, J CHILD NEUROL, V17, P863, DOI 10.1177/08830738020170121401; GUALTIERI CT, 1982, J AM ACAD CHILD PSY, V21, P19, DOI 10.1097/00004583-198201000-00005; Harrington R, 2003, BIOL PSYCHIAT, V53, P961, DOI 10.1016/S0006-3223(03)00315-9; Hauser P, 1997, PSYCHONEUROENDOCRINO, V22, P107, DOI 10.1016/S0306-4530(96)00043-1; Hauser P, 1998, TOXICOL IND HEALTH, V14, P85, DOI 10.1177/074823379801400108; Hazell P, 2005, EXPERT OPIN PHARMACO, V6, P1989, DOI 10.1517/14656566.6.12.1989; Hazell Philip, 2004, Australas Psychiatry, V12, P369; Hazell PL, 2003, J AM ACAD CHILD PSY, V42, P886, DOI 10.1097/01.CHI.0000046908.27264.00; Hazell PL, 2003, J AM ACAD CHILD PSY, V42, P552, DOI 10.1097/01.CHI.0000046830.95464.33; Hechtman L, 2000, CHILD ADOL PSYCH CL, V9, P481; Hechtman Lily, 2003, Paediatr Drugs, V5, P787, DOI 10.2165/00148581-200305120-00002; Horrigan JP, 2000, J CLIN PSYCHIAT, V61, P414, DOI 10.4088/JCP.v61n0604; Jensen P, 2002, J ATTEN DISORD S1, V6, P545; Jensen PS, 2004, PEDIATRICS, V113, P754; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Jensen PS, 2001, J AM ACAD CHILD PSY, V40, P147, DOI 10.1097/00004583-200102000-00009; Jick H, 2004, BRIT J GEN PRACT, V54, P345; Jin C, 2004, CNS SPECTRUMS, V9, P217, DOI 10.1017/S1092852900009019; Johann M, 2003, ALCOHOL CLIN EXP RES, V27, P1527, DOI 10.1097/01.ALC.0000090143.00703.07; Kent L, 2003, J AFFECT DISORDERS, V73, P211, DOI 10.1016/S0165-0327(02)00092-7; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Klein RG, 1997, ARCH GEN PSYCHIAT, V54, P1073; Kooij JJS, 2004, PSYCHOL MED, V34, P973, DOI 10.1017/S0033291703001776; Kratochvil CJ, 2005, J AM ACAD CHILD PSY, V44, P915, DOI 10.1097/01.chi.0000169012.81536.38; Kratochvil CJ, 2003, EXPERT OPIN PHARMACO, V4, P1165, DOI 10.1517/14656566.4.7.1165; Kuperman S, 2001, Ann Clin Psychiatry, V13, P129, DOI 10.3109/10401230109148958; Kurlan Roger, 2003, Curr Neurol Neurosci Rep, V3, P285, DOI 10.1007/s11910-003-0004-2; Lage M, 2004, J CHILD ADOL PSYCHOP, V14, P575, DOI 10.1089/cap.2004.14.575; Leonhard C, 2005, INT J NEUROPSYCHOPHA; Levin FR, 1998, DRUG ALCOHOL DEPEN, V52, P15, DOI 10.1016/S0376-8716(98)00049-0; Levin FR, 1998, J CLIN PSYCHIAT, V59, P300, DOI 10.4088/JCP.v59n0605; Levin FR, 2002, J ADDICT DIS, V21, P1, DOI 10.1300/J069v21n02_01; Levy F, 1997, J AM ACAD CHILD PSY, V36, P737, DOI 10.1097/00004583-199706000-00009; Lynskey MT, 2001, ADDICTION, V96, P815, DOI 10.1046/j.1360-0443.2001.9668153.x; Maidment ID, 2003, ANN PHARMACOTHER, V37, P1884, DOI 10.1345/aph.1D028; Maidment ID, 2003, J PSYCHOPHARMACOL, V17, P332, DOI 10.1177/02698811030173016; Mannuzza S, 1998, AM J PSYCHIAT, V155, P493, DOI 10.1176/ajp.155.4.493; Mannuzza S, 2000, CHILD ADOL PSYCH CL, V9, P711; Manos MJ, 1999, J AM ACAD CHILD PSY, V38, P813, DOI 10.1097/00004583-199907000-00010; Markowitz JS, 2001, CLIN PHARMACOKINET, V40, P753, DOI 10.2165/00003088-200140100-00004; Martins S, 2004, J CHILD ADOL PSYCHOP, V14, P195, DOI 10.1089/1044546041649066; MATTES JA, 1986, J CLIN PSYCHOPHARM, V6, P299; Michelson D, 2002, AM J PSYCHIAT, V159, P1896, DOI 10.1176/appi.ajp.159.11.1896; Michelson D, 2003, BIOL PSYCHIAT, V53, P112, DOI 10.1016/S0006-3223(02)01671-2; Milberger S, 1996, AM J PSYCHIAT, V153, P1138; MILBERGER S, 1995, AM J PSYCHIAT, V152, P1793; Mill J, 2003, NEUROREPORT, V14, P1463, DOI 10.1097/00001756-200308060-00011; Morgan JC, 2004, MOVEMENT DISORD, V19, P840, DOI 10.1002/mds.20081; Murphy P, 2000, AM J PSYCHIAT, V157, P1156, DOI 10.1176/appi.ajp.157.7.1156; Nierenberg AA, 2005, BIOL PSYCHIAT, V57, P1467, DOI 10.1016/j.biopsych.2005.01.036; Olfson M, 2004, AM J MANAG CARE, V10, pS117; Pataki Caroly S, 2004, Expert Opin Emerg Drugs, V9, P293, DOI 10.1517/14728214.9.2.293; Paterson R, 2000, AUST NZ J PSYCHIAT, V34, P874; Pelham WE, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e105; Pliszka SR, 2005, BIOL PSYCHIAT, V57, P1385, DOI 10.1016/j.biopsych.2004.08.026; Pliszka SR, 1998, J CLIN PSYCHIAT, V59, P50; Popper CW, 2000, CHILD ADOLESC PSYCHI, V9; Prince JB, 2000, J CHILD ADOL PSYCHOP, V10, P193, DOI 10.1089/10445460050167304; Quinn PO, 2005, J CLIN PSYCHOL, V61, P579, DOI 10.1002/jclp.20121; QUINTANA H, 1995, J AUTISM DEV DISORD, V25, P283, DOI 10.1007/BF02179289; RAPOPORT JL, 1978, SCIENCE, V199, P560, DOI 10.1126/science.341313; RAPOPORT JL, 1980, ARCH GEN PSYCHIAT, V37, P933; Rapport MD, 2002, CLIN PSYCHOL REV, V22, P1107, DOI 10.1016/S0272-7358(02)00129-0; Reich W, 2005, TWIN RES HUM GENET, V8, P459, DOI 10.1375/twin.8.5.459; Reimherr FW, 2005, BIOL PSYCHIAT, V58, P125, DOI 10.1016/j.biopsych.2005.04.040; Rey JM, 2002, BRIT J PSYCHIAT, V183, P173; Ricaurte GA, 2005, J PHARMACOL EXP THER, V315, P91, DOI 10.1124/jpet.105.087916; Riggs PD, 1998, J AM ACAD CHILD PSY, V37, P1271, DOI 10.1097/00004583-199812000-00010; Riggs PD, 2004, J AM ACAD CHILD PSY, V43, P420, DOI 10.1097/00004583-200404000-00008; Riordan HJ, 1999, ARCH CLIN NEUROPSYCH, V14, P217, DOI 10.1016/S0887-6177(98)00015-8; Roman Tatiana, 2004, Am J Pharmacogenomics, V4, P83, DOI 10.2165/00129785-200404020-00003; Rosler M, 2004, EUR ARCH PSY CLIN N, V254, P365, DOI 10.1007/S00406-004-0516-Z; Rugino TA, 2003, PEDIATR NEUROL, V29, P136, DOI 10.1016/S0887-8994(03)00148-6; Rugino TA, 2001, J AM ACAD CHILD PSY, V40, P230, DOI 10.1097/00004583-200102000-00018; RYBACK R, 1995, AM J PSYCHIAT, V152, P1399; Sachdev P, 1999, PSYCHOL MED, V29, P507, DOI 10.1017/S003329179800720X; Sachdev PS, 2000, AUST NZ J PSYCHIAT, V34, P645; Sachs GS, 2000, AM J PSYCHIAT, V157, P466, DOI 10.1176/appi.ajp.157.3.466; Sadeghian H, 2004, CAN J NEUROL SCI, V31, P109, DOI 10.1017/S0317167100002924; Safren SA, 2004, PSYCHIAT CLIN N AM, V27, P349, DOI 10.1016/S0193-953X(03)00089-3; SATEL S, 1988, J NERV MENT DIS, V176, P305, DOI 10.1097/00005053-198805000-00010; Schteinschnaider A, 2000, J CHILD NEUROL, V15, P265, DOI 10.1177/088307380001500414; Schubiner H, 2000, J CLIN PSYCHIAT, V61, P244, DOI 10.4088/JCP.v61n0402; Schubiner H, 2002, EXP CLIN PSYCHOPHARM, V10, P286, DOI 10.1037//1064-1297.10.3.286; Schwartz RH, 2004, J PEDIATR-US, V144, P675, DOI 10.1016/j.jpeds.2003.12.039; Senecky Y, 2002, PEDIATR NEUROL, V27, P224, DOI 10.1016/S0887-8994(02)00429-0; Serra-Pinheiro MA, 2004, ARQ NEURO-PSIQUIAT, V62, P399, DOI 10.1590/S0004-282X2004000300005; Simpson D, 2004, DRUGS, V64, P205, DOI 10.2165/00003495-200464020-00005; Sokol MS, 1999, INT J EAT DISORDER, V25, P233, DOI 10.1002/(SICI)1098-108X(199903)25:2<233::AID-EAT14>3.0.CO;2-2; Solanto MV, 2001, STIMULANT DRUGS ADHD, P355; Solhkhah R, 1998, ALCOHOL HEALTH RES W, V22, P122; Somoza EC, 2004, J ADDICT DIS, V23, P77, DOI 10.1300/J069v23n01_07; Sonuga-Barke EJS, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-28; Sparrow E, 1999, CONNERS ADULT ADHD R; Spencer T, 2000, CHILD ADOL PSYCH CL, V9, P77; Spencer T, 2001, ARCH GEN PSYCHIAT, V58, P775, DOI 10.1001/archpsyc.58.8.775; Spencer T, 1998, J CLIN PSYCHIAT, V59, P59; Spencer T, 2004, PSYCHIAT CLIN N AM, V27, P373, DOI 10.1016/j.psc.2003.12.001; SPENCER T, 1995, ARCH GEN PSYCHIAT, V52, P434; Spencer TJ, 2004, J CLIN PSYCHIAT, V65, P22; Spencer TJ, 2001, BIOL PSYCHIAT, V49, P1062, DOI 10.1016/S0006-3223(01)01155-6; Steinhausen H-C, 2003, ACTA PSYCHIAT SCAND, V107, P592; Stevenson CS, 2002, AUST NZ J PSYCHIAT, V36, P610, DOI 10.1046/j.1440-1614.2002.01052.x; STRINGER AY, 1983, AM J PSYCHIAT, V140, P1365; Sullivan MA, 2001, ANN NY ACAD SCI, V931, P251, DOI 10.1111/j.1749-6632.2001.tb05783.x; Taylor FB, 2001, J CLIN PSYCHOPHARM, V21, P223, DOI 10.1097/00004714-200104000-00015; Taylor FB, 2000, J CHILD ADOL PSYCHOP, V10, P311, DOI 10.1089/cap.2000.10.311; Thapar A, 1999, BRIT J PSYCHIAT, V174, P105, DOI 10.1192/bjp.174.2.105; Timimi S, 2004, BRIT J PSYCHIAT, V184, P8, DOI 10.1192/bjp.184.1.8; Todd RD, 2001, AM J PSYCHIAT, V158, P1891, DOI 10.1176/appi.ajp.158.11.1891; Triolo SJ, 1996, MANUAL SCORING INTER; Turner DC, 2005, PSYCHOPHARMACOLOGY, V178, P286, DOI 10.1007/s00213-004-1993-5; Turner DC, 2004, BIOL PSYCHIAT, V55, P1031, DOI 10.1016/j.biopsych.2004.02.008; Turner DC, 2003, PSYCHOPHARMACOLOGY, V165, P260, DOI 10.1007/s00213-002-1250-8; Varley CK, 2001, COMPR PSYCHIAT, V42, P228, DOI 10.1053/comp.2001.23145; Vitiello B, 2001, J AM ACAD CHILD PSY, V40, P188, DOI 10.1097/00004583-200102000-00013; Volkow ND, 2002, J ATTEN DISORD S1, V6, P531; Wagner KD, 2004, J CLIN PSYCHIAT, V65, P30; Waldman I. D., 2001, ATTENTION GENES ADHD, P115; Weiss G, HYPERACTIVE CHILDREN; Weiss MD, 2004, J CLIN PSYCHIAT, V65, P27; Weller EB, 1999, J CLIN PSYCHIAT, V60, P5; Wender PH, 2001, ANN NY ACAD SCI, V931, P1; WENDER PH, 1985, AM J PSYCHIAT, V142, P547; Wernicke JF, 2002, J CLIN PSYCHIAT, V63, P50; Wernicke JF, J CLIN PSYCHOPHARMAC; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; WILENS TE, 1995, HARVARD REV PSYCHIAT, V3, P160, DOI 10.3109/10673229509017182; Wilens TE, 2000, J CHILD ADOL PSYCHOP, V10, P217, DOI 10.1089/10445460050167322; Wilens TE, 2003, PEDIATRICS, V111, P179, DOI 10.1542/peds.111.1.179; Wilens TE, 1996, AM J PSYCHIAT, V153, P1147; Wilens TE, 2005, J CLIN PSYCHIAT, V66, P253, DOI 10.4088/JCP.v66n0215; Wilens TE, 2004, J CLIN PSYCHIAT, V65, P38; Wilens TE, 2003, BIOL PSYCHIAT, V54, P9, DOI 10.1016/S0006-3223(02)01664-5; Wilens TE, 2003, DRUGS, V63, P2395, DOI 10.2165/00003495-200363220-00002; Wilens TE, 2003, BIOL PSYCHIAT, V54, P1, DOI 10.1016/S0006-3223(02)01666-9; Wilens TE, 2001, AM J PSYCHIAT, V158, P282, DOI 10.1176/appi.ajp.158.2.282; Wilens TE, 2005, BIOL PSYCHIAT, V57, P793, DOI 10.1016/j.biopsych.2005.01.027; WILENS TE, 1998, ATTENTION DEFICIT HY, P592; Wilens Timothy E, 2002, J Atten Disord, V5, P189; Willoughby MT, 2000, J AM ACAD CHILD PSY, V39, P1512, DOI 10.1097/00004583-200012000-00013; Winsberg BG, 1999, J AM ACAD CHILD PSY, V38, P1474, DOI 10.1097/00004583-199912000-00006; Witcher JW, 2003, J CHILD ADOL PSYCHOP, V13, P53, DOI 10.1089/104454603321666199; Wolraich ML, 2004, CNS DRUGS, V18, P243, DOI 10.2165/00023210-200418040-00004; WOOD DR, 1976, ARCH GEN PSYCHIAT, V33, P1453; Zwi M, 2000, BRIT MED J, V321, P975, DOI 10.1136/bmj.321.7267.975	212	3	3	0	0	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1573-4005	1875-6441		CURR PSYCHIATRY REV	Curr. Psychiatry Rev.		2006	2	3					317	331		10.2174/157340006778018157			15	Psychiatry	Emerging Sources Citation Index (ESCI)	Psychiatry	VA9YO	WOS:000411477400003					2022-02-06	
J	Goryunova, AV; Bazarnaya, NA; Sorokina, EG; Semenova, NY; Globa, OV; Semenova, JB; Pinelis, VG; Roshal, LM; Maslova, OI				Goryunova, A. V.; Bazarnaya, N. A.; Sorokina, E. G.; Semenova, N. Yu.; Globa, O. V.; Semenova, J. B.; Pinelis, V. G.; Roshal, L. M.; Maslova, O. I.			Autoantibodies to glutamate receptors in children with chronic posttraumatic headache	ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA			Russian	Article						glutamate receptor; autoantibodies; chronic posttraumatic headache		Autoantibodies (aAB) to AMPA (Glu R1 subunit) and NMDA (NR 2A subunit) glutamate receptors were studied in blood serum of 60 children, aged 7-16 years, with chronic posttraumatic headache after mild skull injury. All the children were divided into 2 groups: group 1 included 48 children with concussion of the brain, group 2 - 12 children with brain contusion. Group 1 was divided into 2 subgroups: subgroup la comprised 34 children with single concussion and subgroup 1b - 14 children with repeated concussion. The aAB level was determined 6 months and 1 year after skull injury. The aAB concentration was expressed in percents to the control level being considered significant if the increase was higher than 120%. The increased NMDA aAB level was observed during the first year after skull injury. In the la subgroup, the NR2 aAB level in blood serum was 145 +/- 12,6%, in the 1b one - 108 +/- 12,4%, in group 2 - 165 +/- 34%. The content of aAB to AMPA receptors was elevated only in children of 1b subgroup and group 2 (150 +/- 16,8% and 167 +/- 31,3%, respectively). The EEG examination of this group revealed the nonspecific paroxysmal discharges in 18% of cases and epileptiform activity in 6% of children. The results obtained suggest that children with posttraumatic headache have elevated levels of aAB to glutamate receptors, hyperstimulation of which reflects hypoxic processes in the brain, and are in need of metabolic therapy.	Sci Ctr Childrens Hlth, Pediat Res Inst, Moscow, Russia		Goryunova, AV (corresponding author), Sci Ctr Childrens Hlth, Pediat Res Inst, Moscow, Russia.		Pinelis, Vsevolod G/K-5564-2017	Pinelis, Vsevolod G/0000-0001-8579-605X			BAZARNAYA NA, 2003, NEYROIMMUNOLOGIYA, V1, P15; BAZARNAYA NA, 2003, SOVREMENNYE PREDSTAV, V6, P222; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Dambinova SA, 1997, ZH VYSSH NERV DEYAT+, V47, P439; Dambinova SA, 2001, ZH NEVROPATOL PSIKH, V101, P58; DAMBINOVA SA, 1989, NEYRORETSEPTORY GLUT; GAPPOYEVA MU, 2003, THESIS ST PETERSBURG; GLOBA OV, 2004, 7 EHF C HEAD ROTT, P34; Gong QZ, 1999, J NEUROTRAUM, V16, P893, DOI 10.1089/neu.1999.16.893; GREENAMYRE JT, 1994, NEUROLOGY, V44, P7; GUSEV YI, 2001, ISHEMIYA GOLOVNOGO M; MELDRUM B, 1982, NEIROTRANSMITTERNYE, P164; MELDRUM BS, 1989, EXCITOTOXICITY ISCHE, P47; OBRENOVITCH TP, 1995, FR HEAD RES, V5, P113; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; PALMER AM, 1999, J HEAD TRAUMA REHAB, V14, P54; RANDALL A, 2001, J HEAD TRAUMA REHAB, V14, P24; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Skoromets AA, 1997, ZH NEVROPATOL PSIKH, V97, P53; Sorokina EG, 1999, BIOL MEMBRANY, V16, P318; SOROKINA YG, 2005, NAUCHN KONF NEYR FUN; SOROKINA YG, 2003, NEYROIMMUNOLOGIYA, V1, P137	22	3	5	0	3	IZDATELSTVO MEDITSINA	MOSCOW	PETROVERIGSKII PER 6-8, K-142 MOSCOW, RUSSIA	1997-7298			ZH NEVROL PSIKHIATR	Z. Nevrol. Psikhiatrii Im S S Korsakova		2006	106	8					50	53					4	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	142HM	WOS:000244640100008	16972597				2022-02-06	
J	Hutchinson, PJ; Gimson, A; Al-Rawi, PG; O'Connell, MT; Czosnyka, M; Menon, DK				Hutchinson, P. J.; Gimson, A.; Al-Rawi, P. G.; O'Connell, M. T.; Czosnyka, M.; Menon, D. K.			Microdialysis in the management of hepatic encephalopathy	NEUROCRITICAL CARE			English	Article						microdialysis; hepatic encephalopathy; glucose metabolism; fulminant hepatic failure	TRAUMATIC BRAIN-INJURY; INTRACRANIAL HYPERTENSION; CEREBRAL MICRODIALYSIS; EXTRACELLULAR LACTATE; FULMINANT; PRESSURE; METABOLISM; PERFUSION; FAILURE	Introduction: Fulminant hepatic encephalopathy has a high mortality. Methods: This case report describes the role of cerebral microdialysis as an adjunct to the management of a 49-year-old woman with hepatic encephalopathy secondary to a paracetamol overdose. Results: The application of the microdialysis technique, by detecting a very low cerebral glucose concentration in the presence of a normal plasma glucose, assisted in clinical decision making. Conclusions: Cerebral microdialysis, by enabling continuous on-line monitoring of substrate delivery and metabolism, may have a role in the management of patients with fulminant hepatic failure.	Univ Cambridge, Addenbrookes Hosp, Acad Dept Neurosurg, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Acad Dept Anaesthesia, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Hepatol, Cambridge CB2 2QQ, England		Hutchinson, PJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Neurosurg, Box 167, Cambridge CB2 2QQ, England.	pjah2@cam.ac.uk		O'Connell, Mark/0000-0001-6272-8767	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390] Funding Source: UKRI		AGGARWAL S, 1994, HEPATOLOGY, V19, P80, DOI 10.1002/hep.1840190114; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Desjardins P, 2001, J NEUROSCI RES, V66, P967, DOI 10.1002/jnr.10045; Gimson AES, 1996, BRIT J ANAESTH, V77, P90, DOI 10.1093/bja/77.1.90; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Hazell AS, 1999, P SOC EXP BIOL MED, V222, P99, DOI 10.1046/j.1525-1373.1999.d01-120.x; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Hutchinson PJA, 2000, BRIT J NEUROSURG, V14, P46; Hutchinson PJA, 2000, ACT NEUR S, V76, P431; Jalan R, 1999, LANCET, V354, P1164, DOI 10.1016/S0140-6736(98)12440-6; Larsen FS, 2004, HEPATOLOGY, V39, P299, DOI 10.1002/hep.20071; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Murphy N, 2004, HEPATOLOGY, V39, P464, DOI 10.1002/hep.20056; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Richardson D, 2002, NEPHROL DIAL TRANSPL, V17, P23, DOI 10.1093/ndt/17.1.23; Tofteng F, 2006, J CEREBR BLOOD F MET, V26, P21, DOI 10.1038/sj.jcbfm.9600168; Tofteng F, 2004, J CEREBR BLOOD F MET, V24, P798, DOI 10.1097/01.WCB.0000125648.03213.1D; Tofteng F, 2002, HEPATOLOGY, V36, P1333, DOI 10.1053/jhep.2002.36944; Ungerstedt U, 2004, CURR PHARM DESIGN, V10, P2145, DOI 10.2174/1381612043384105; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; WENDON JA, 1994, HEPATOLOGY, V19, P1407, DOI 10.1002/hep.1840190614	25	3	3	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care		2006	5	3					202	205		10.1385/NCC:5:3:202			4	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	132AD	WOS:000243913200007	17290089				2022-02-06	
J	Johnstone, B; Martin, TA; Bounds, TA; Brown, E; Rupright, J; Sherman, A				Johnstone, Brick; Martin, Thomas; Bounds, Thomas; Brown, Earl; Rupright, Jon; Sherman, Ashley			The impact of concomitant disabilities on employment outcomes for state vocational rehabilitation clients with traumatic brain injury	JOURNAL OF VOCATIONAL REHABILITATION			English	Article						Traumatic brain injury; concomitant disability; vocational rehabilitation		Objective: To investigate the effect of traumatic brain injury (TBI) and concomitant disabilities on vocational outcomes. Design: Non-experimental, prospective analysis of adults who qualified for services with the Missouri Division of Vocational Rehabilitation (MDVR) based on a history of TBI. Participants: 139 MDVR clients with non-acute TBI, followed from enrollment until case closure, who were divided into 5 groups (TBI only; TBI + orthopedic injury; TBI + seizure; TBI + psychological disorder; TBI + learning disability). Main outcome measures: Demographic characteristics; injury severity; neuropsychological functioning; and employment status at case closure. Analyses: Multivariate analysis of variance and non-parametric methods were used to evaluate differences in outcome variables between the TBI Only and other 4 groups. Results: Statistically non-significant trends between the groups suggested less successful employment outcomes for persons with TBI and concomitant psychological disorders (11%) and learning disabilities (8%) vs. persons with orthopedic injuries (23%), seizure disorders (32%), or TBI only (26%). Conclusions: Concomitant psychological and learning disabilities, compared to concomitant physical disabilities, are associated with greater employment difficulties for persons with TBI. VR clients with psychological and learning disorders may require additional services/ interventions to enhance their vocational outcomes.	[Johnstone, Brick; Martin, Thomas] Univ Missouri Columbia, Sch Hlth Profess, Dept Hlth Psychol, 1 Hosp Dr, Columbia, MO 65212 USA; [Bounds, Thomas] Louisiana Dept Hlth & Hosp, Off Citizens Dev Disabil, Baton Rouge, LA 70821 USA; [Brown, Earl] Dept Elementary & Secondary Educ, Jefferson City, AR 65101 USA; [Rupright, Jon] Univ Missouri Columbia, Sch Med, Dept Phys Med & Rehabil, Columbia, MO 65211 USA; [Sherman, Ashley] Univ Missouri Columbia, Hlth Sci Ctr, Dept Biostat, Columbia, MO 65211 USA		Johnstone, B (corresponding author), Univ Missouri Columbia, Sch Hlth Profess, Dept Hlth Psychol, 1 Hosp Dr, Columbia, MO 65212 USA.	johnstoneg@health.missouri.edu		Johnstone, Brick/0000-0001-8845-9649	National Institute on Disability and Rehabilitation Research [H133A980008]	This study was completed as part of the Missouri Model Brain Injury System, a grant funded by the National Institute on Disability and Rehabilitation Research (#H133A980008).	Blalock J., 1982, J APPLIED REHABILITA, V13, P9; Bounds TA, 2003, NEUROREHABILITATION, V18, P189; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; CUMMINGS RW, 1987, EXCEPT CHILDREN, V54, P167, DOI 10.1177/001440298705400210; DEFILIPPIS NA, 1991, MANUAL BOOKLET CATEG; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dunham MD, 1996, J REHABIL, V62, P42; ELLERD DA, 1992, J APPL REHABILITATIO, V23, P48; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Fleming J, 1999, BRAIN INJURY, V13, P417; FRASER R, 1988, REHABIL COUNS BULL, V31, P276; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; HARING KA, 1990, J LEARN DISABIL, V23, P108, DOI 10.1177/002221949002300206; HUMPHREY M, 1980, INJURY, V12, P107, DOI 10.1016/0020-1383(80)90133-3; Johnstone B, 2003, NEUROREHABILITATION, V18, P197; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P161, DOI 10.1053/apmr.2003.50098; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Johnstone B, 2003, BRAIN INJURY, V17, P95, DOI 10.1080/0269905021000010212; Johnstone B, 1999, J HEAD TRAUMA REHAB, V14, P220, DOI 10.1097/00001199-199906000-00003; KAITARO T, 1995, BRAIN INJURY, V9, P713, DOI 10.3109/02699059509008227; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KlOve H, 1963, MED CLIN N AM; Kowalske K, 2000, J HEAD TRAUMA REHAB, V15, P989, DOI 10.1097/00001199-200008000-00003; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Levin HS., 1982, NEUROBEHAVIORAL CONS; Lewis DR, 2003, J INTELLECT DEV DIS, V28, P24, DOI 10.1080/1366825031000086876; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Patton J., 1982, TOPICS LEARNING LEAR, V2, P91; Reitan R, 1985, HALSTEAD REITAN NEUR; Reitan RM, 1992, TRAIL MAKING TEST MA; Rosenthal M, 1999, REHABILITATION ADULT; Sander AM, 1997, J HEAD TRAUMA REHAB, V12, P28, DOI 10.1097/00001199-199710000-00004; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; SCHUMAKER JB, 1984, J LEARN DISABIL, V17, P422, DOI 10.1177/002221948401700708; Scuccimarra D., 1990, J LEARN DISABIL, V23, P518; Skeel RL, 2003, REHABIL PSYCHOL, V48, P145, DOI 10.1037/0090-5550.48.3.145; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; U.S. Department of Education, 2005, RSA PROGR DAT STAT O; Wechsler D, 1997, WMS 3 ADM SCORING MA; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; WEHMAN P, 1989, J APPL BEHAV ANAL, V22, P395, DOI 10.1901/jaba.1989.22-395; WEHMAN PH, 1995, J HEAD TRAUMA REHAB, V10, P27; Woodcock R.W., 1989, WOODCOCK JOHNSON TES; 1998, NIH CONSENSUS STATEM, V16, P1	50	3	3	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1052-2263	1878-6316		J VOCAT REHABIL	J. Vocat. Rehabil.		2006	25	2					97	105					9	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V71ON	WOS:000211583600004					2022-02-06	
S	Nemoto, EM; Rao, G; Robinson, T; Saunders, T; Kirkman, J; Davis, D; Kuwabara, H; Dixon, CE		Cicco, G; Bruley, DF; Ferrari, M; Harrison, DK		Nemoto, Edwin M.; Rao, Gutti; Robinson, Timothy; Saunders, Todd; Kirkman, John; Davis, Denise; Kuwabara, Hiroto; Dixon, C. Edward			Effect of local cooling (15 degrees C for 24 hours) with the Chillerpad (TM) after traumatic brain injury in the nonhuman primate	OXYGEN TRANSPORT TO TISSUE XXVII	ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY		English	Article; Proceedings Paper	32nd Annual Meeting of the International-Society-on-Oxygen-Transport-to-Tissue	AUG 21-26, 2004	Bari, ITALY	Int Soc Oxygen Transport Tissue			HYPOTHERMIA		Univ Pittsburgh, Pittsburgh, PA 15213 USA; Seacoast Technol Inc, Portsmouth, NH 03801 USA; Johns Hopkins Univ, Baltimore, MD 21287 USA		Nemoto, EM (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15213 USA.						Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13	3	3	4	0	0	SPRINGER	DORDRECHT	PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS	0065-2598		0-387-29543-7	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2006	578						311	315					5	Biochemistry & Molecular Biology; Medicine, Research & Experimental; Physiology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Research & Experimental Medicine; Physiology	BEX48	WOS:000239998000049	16927710				2022-02-06	
J	Young, P; Finn, BC; Pellegrin, D; Soloaga, ED; Bruetman, JE				Young, Pablo; Finn, Barbara C.; Pellegrin, Debora; Soloaga, Elias D.; Bruetman, Julio E.			Paroxysmal sympathetic storm after diffuse axonal head injury	MEDICINA-BUENOS AIRES			Spanish	Article						paroxysmal sympathetic storms; autonomic abnormalities; diffuse axonal head injury	TRAUMATIC BRAIN-INJURY; DIENCEPHALIC SEIZURES; BROMOCRIPTINE; SYSTEM	Paroxysmal sympathetic storm after diffuse axonal head injury. The term paroxysmal sympathetic storms is used to define episodic alterations in body temperature, blood pressure, heart and respiratory rate, size of pupil, and level of consciousness coinciding with hyperhidrosis, excessive salivation and extensor posturing. All the cases were presented after severe diffuse axonal head injury. We present two young patients with diffuse axonal head injury that develop in their evolution hypertension, tachycardia and fever without evidence during the episodes of epileptiform activity and without any infectious cause with excellent answer to the treatment with beta-blockers and morphine. We consider that the correct diagnosis of this entity minimizes the application of unnecessary studies allowing an appropriate treatment.	Hosp Britan, Serv Clin Med, RA-1280 Buenos Aires, DF, Argentina		Finn, BC (corresponding author), Hosp Britan, Serv Clin Med, Perdriel 74, RA-1280 Buenos Aires, DF, Argentina.	barbarafinn73@hotmail.com		Young, Pablo/0000-0002-2857-6541			Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; Do D, 2000, J NEUROL NEUROSUR PS, V69, P832, DOI 10.1136/jnnp.69.6.832; Horntagl H, 1980, INTENS CARE MED, V6, P169; KLOOS RT, 1995, MEDICINE, V74, P268, DOI 10.1097/00005792-199509000-00004; Lemke Denise M, 2004, J Neurosci Nurs, V36, P4; Penfield W, 1929, ARCH NEURO PSYCHIATR, V22, P358, DOI 10.1001/archneurpsyc.1929.02220020174010; Russo RN, 2000, J PAEDIATR CHILD H, V36, P283, DOI 10.1046/j.1440-1754.2000.00485.x; SIMON HB, 1993, NEW ENGL J MED, V329, P483; SIREN AL, 1992, NEWS PHYSIOL SCI, V7, P26; STURM S, 2003, POST HEAD INJURY AUT; TALMAN WT, 1985, ANN NEUROL, V18, P1, DOI 10.1002/ana.410180102; TALMAN WT, 1988, ARCH NEUROL-CHICAGO, V45, P1037, DOI 10.1001/archneur.1988.00520330129022; WILSON SAK, 1923, BRAIN, V43, P220; YOUNG WF, 1995, MAYO CLIN P, V7, P57	16	3	4	1	2	MEDICINA (BUENOS AIRES)	BUENOS AIRES	DONATO ALVAREZ 3150, 1427 BUENOS AIRES, ARGENTINA	0025-7680			MEDICINA-BUENOS AIRE	Med.-Buenos Aires		2006	66	5					439	442					4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	102GW	WOS:000241800000009	17137174				2022-02-06	
J	Kortepeter, MG; Lemmon, JW; Moran, KA				Kortepeter, MG; Lemmon, JW; Moran, KA			A soldier with traumatic brain injury and meningitis	CLINICAL INFECTIOUS DISEASES			English	Article							ACINETOBACTER; IMIPENEM		Walter Reed Army Med Ctr, Dept Pathol, Washington, DC USA; Walter Reed Army Med Ctr, Infect Dis Serv, Dept Med, Washington, DC USA		Kortepeter, MG (corresponding author), Walter Reed Army Med Ctr, Infect Dis Serv, 1114 Churchview Pl, Potomac, MD 20854 USA.	Mark.Kortepeter@na.amedd.army.mil					Benifla M, 2004, J ANTIMICROB CHEMOTH, V54, P290, DOI 10.1093/jac/dkh289; Bernabeu-Wittel M, 2004, CLIN MICROBIOL INFEC, V10, P931, DOI 10.1111/j.1469-0691.2004.00944.x; EWELL A, 2004, 44 INT C ANT AG CHEM, P391; HARRINGTON BJ, 1997, CLIN MICROBIOL NEWSL, V19, P191; Jain R, 2004, ANN PHARMACOTHER, V38, P1449, DOI 10.1345/aph.1D592; KONEMAN EW, 1997, COLAR ATLAS TXB DIAG; Lee SO, 2004, ANTIMICROB AGENTS CH, V48, P224, DOI 10.1128/AAC.48.1.224-228.2004; PETERSEN K, 2003, ACINETOBACTER DRUG R; SCHRECKENBERGER PC, 2003, MANUAL CLIN MICROBIO, P750; Scott P. T., 2004, Morbidity and Mortality Weekly Report, V53, P1063	10	3	3	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1058-4838	1537-6591		CLIN INFECT DIS	Clin. Infect. Dis.	DEC 1	2005	41	11					1604	+					4	Immunology; Infectious Diseases; Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Infectious Diseases; Microbiology	980KY	WOS:000233018600009	16273662	Bronze			2022-02-06	
J	Wada, T; Kuroda, K; Yoshida, Y; Ogawa, A; Endo, S				Wada, T; Kuroda, K; Yoshida, Y; Ogawa, A; Endo, S			Recovery process of immediate prolonged posttraumatic coma following severe head injury without mass lesions	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						diffuse axonal injury; posttraumatic coma; magnetic resonance imaging	DIFFUSE AXONAL INJURY; BRAIN-STEM; VEGETATIVE STATE; TRAUMATIC COMA	The recovery process of immediate posttraumatic coma was investigated in 24 patients with severe head injury. The correlation between poor outcome in the recovery process and magnetic resonance (MR) imaging findings was analyzed. MR imaging was performed within the first 7 days for all patients. The recovery process was classified into phase 1 for recovery to moderately disabled and phase 2 to good recovery (GR) according to the Glasgow Outcome Scale. The median of phase 1 was 21.0 days. Four patients did not recover to GR and had poor outcome. Twenty patients recovered to GR. Thirteen patients had short phase 2 of under 10 days and seven patients had long phase 2 of over 60 days. All patients had abnormal lesions on MR imaging considered to be diffuse axonal injury. The number of lesions ranged from two to 10, with a mean of five. Lesions in the dorsal upper brainstem were significantly associated with poor outcome (p < 0.05). The combination of focal lesions in the callosal splenium and dorsal upper brainstem was most common in patients with poor outcome. Patients with long phase 2 had significantly more lesions than patients with short phase 2.	Iwate Med Univ, Dept Neurosurg, Morioka, Iwate 0208505, Japan; Iwate Med Univ, Dept Crit Care Med, Morioka, Iwate 0208505, Japan		Wada, T (corresponding author), Iwate Med Univ, Dept Neurosurg, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	twada@iwate-med.ac.jp					ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Bhatoe HS, 1999, ACTA NEUROCHIR, V141, P515, DOI 10.1007/s007010050333; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; Gennarelli T A, 1984, Emerg Med Clin North Am, V2, P749; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Hardman J M, 1979, Adv Neurol, V22, P15; Hoelper BM, 2000, ACT NEUR S, V76, P265; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; Keren O, 1998, J HEAD TRAUMA REHAB, V13, P15; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; LINDENBERG R, 1970, ARCH PATHOL, V90, P509; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG S, V75, P28; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; SCHOENHUBER R, 1986, NEUROSURGERY, V19, P532, DOI 10.1227/00006123-198610000-00006; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Tomei G, 1991, J Neurosurg Sci, V35, P61; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630	24	3	4	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	C/O AKAMON-MAE IWATA BLDG, 5-27-8 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105			NEUROL MED-CHIR	Neurol. Med.-Chir.	DEC	2005	45	12					614	619		10.2176/nmc.45.614			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	995PT	WOS:000234117000004	16377948	Bronze			2022-02-06	
J	Wilhelm, J; von Ahsen, N; Frieling, H; Hillemacher, T; Bayerlein, K; Bonsch, D; Ziegenbein, M; Kornhuber, J; Bleich, S				Wilhelm, Julia; von Ahsen, Nicolas; Frieling, Helge; Hillemacher, Thomas; Bayerlein, Kristina; Boensch, Dominikus; Ziegenbein, Marc; Kornhuber, Johannes; Bleich, Stefan			Apolipoprotein E4 genotype is not associated with short-term cognition deficits during alcohol withdrawal	ALCOHOL			English	Article						apolipoprotein E4; alcohol withdrawal; alcoholism; cognition; cognitive decline	EPSILON-4 ALLELE DISTRIBUTION; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; E POLYMORPHISM; HOMOCYSTEINE; DEMENTIA; RISK; DIFFERENTIATION; PERFORMANCE; MODULATION	Aim of this prospective study was to investigate a possible association between the apolipoprotein E4 (ApoE4) genotype and clinically well-known cognition deficits during alcohol withdrawal, We examined 172 patients with alcohol dependence (137 men, 35 women) during withdrawal treatment. The ApoE genotype was determined in all patients using polymerase chain reaction. Cognitive function was assessed applying the c.I.-Test on day 0 (admission) and on day 7 of withdrawal treatment. Using Pearson's chi(2) test we found no significant association between the ApoE4 genotype and cognition deficits for both dates (day 0: p = .463; day 7: p = .760). Moreover, multivariate logistic regression analyses revealed no significant association between presence of the ApoE4 allele and cognitive dysfunction. Even though ApoE4 plays an important role in alcoholism-related brain atrophy and cognition deficits in demented as well as in nondemented healthy elderly people, this study provides no evidence for an association with short-term cognition deficits during alcohol withdrawal. (c) 2005 Elsevier Inc. All rights reserved.	Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany; Univ Gottingen, Dept Clin Chem, Gottingen, Germany; Hannover Med Sch, Dept Social Psychiat & Psychotherapy, Hannover, Germany		Wilhelm, J (corresponding author), Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Schwabachanlage 6, D-91054 Erlangen, Germany.	juli.wilhelm@web.de	Hillemacher, Thomas/E-4596-2012; Frieling, Helge/C-5299-2015; Bleich, Stefan/ABC-1796-2020; Kornhuber, Johannes/B-9613-2014	Hillemacher, Thomas/0000-0002-3362-7868; Frieling, Helge/0000-0001-5146-9720; Kornhuber, Johannes/0000-0002-8096-3987			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257; Bartres-Faz D, 2002, ADDICT BIOL, V7, P227, DOI 10.1080/135562102200120451; Bayerlein K, 2005, BIOL PSYCHIAT, V57, P1590, DOI 10.1016/j.biopsych.2005.01.046; BELLOSTA S, 1995, J BIOL CHEM, V270, P27063, DOI 10.1074/jbc.270.45.27063; Bleich S, 2005, ALCOHOL CLIN EXP RES, V29, P334, DOI 10.1097/01.ALC.0000156083.91214.59; Bleich S, 2003, NEW ENGL J MED, V349, P609; Bleich S, 2003, J NEURAL TRANSM, V110, P401, DOI 10.1007/s00702-002-0789-1; Bockelmann I, 2002, DISABIL REHABIL, V24, P455, DOI 10.1080/09638280110102126; BUTTERWORTH RF, 1995, METAB BRAIN DIS, V10, P1, DOI 10.1007/BF01991777; Christie LA, 2005, NEUROSCI LETT, V373, P119, DOI 10.1016/j.neulet.2004.09.072; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Goudet J, 1996, GENETICS, V144, P1933; HANDELMANN GE, 1992, J LIPID RES, V33, P1677; HENDERSON AS, 1995, LANCET, V346, P1387, DOI 10.1016/S0140-6736(95)92405-1; Hillemacher T, 2004, ALCOHOL, V34, P211, DOI 10.1016/j.alcohol.2004.09.004; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kalman J, 2000, NEUROBIOL AGING, V21, P555, DOI 10.1016/S0197-4580(00)00150-0; Laws SM, 2002, MOL PSYCHIATR, V7, P768, DOI 10.1038/sj.mp.4001083; Lehfeld H, 1997, Int Psychogeriatr, V9 Suppl 1, P115; Lehfeld H, 1997, Int Psychogeriatr, V9, P139, DOI 10.1017/S1041610297004304; LEHRL S, 1992, CL TEST FRUHDIAGNOST; LOUIS EJ, 1987, BIOMETRICS, V43, P805, DOI 10.2307/2531534; Luchsinger JA, 2004, J AM GERIATR SOC, V52, P540, DOI 10.1111/j.1532-5415.2004.52159.x; Lutz MT, 2004, EPILEPSIA, V45, P809, DOI 10.1111/j.0013-9580.2004.54003.x; Mann K, 1999, ALCOHOL ALCOHOLISM, V34, P567, DOI 10.1093/alcalc/34.4.567; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; MOLLENHAUER B, IN PRESS DEMENT GERI; MOTULSKY HJ, 1996, INTUITIVE BIOSTATIST; Muramatsu T, 1997, J NEURAL TRANSM, V104, P913, DOI 10.1007/BF01285559; MURAMATSU T, 1994, ANN NEUROL, V36, P797, DOI 10.1002/ana.410360519; NOGUCHI S, 1993, LANCET, V342, P737, DOI 10.1016/0140-6736(93)91728-5; PAYAMI H, 1993, LANCET, V342, P738; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Riemenschneider M, 2002, J NEUROL NEUROSUR PS, V72, P639, DOI 10.1136/jnnp.72.5.639; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHNEIDER JA, 1995, ANN NEUROL, V38, P131, DOI 10.1002/ana.410380122; Schulte T, 2003, J NEURAL TRANSM, V110, P749, DOI 10.1007/s00702-003-0832-x; Seifert J, 2003, ADDICT BIOL, V8, P75, DOI 10.1080/1355621031000069918; Wetterling T, 1999, ALCOHOL ALCOHOLISM, V34, P330, DOI 10.1093/alcalc/34.3.330; Wilhelm J, 2006, J NEURAL TRANSM, V113, P357, DOI 10.1007/s00702-005-0333-1	44	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0741-8329	1873-6823		ALCOHOL	Alcohol	NOV	2005	37	3					151	156		10.1016/j.alcohol.2006.01.002			6	Substance Abuse; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Substance Abuse; Pharmacology & Pharmacy; Toxicology	047GS	WOS:000237868400004	16713503				2022-02-06	
J	Mussack, T; Buhmann, S; Kirchhoff, C; Wanger, A; Biberthaler, P; Reiser, M; Mutschler, W				Mussack, T; Buhmann, S; Kirchhoff, C; Wanger, A; Biberthaler, P; Reiser, M; Mutschler, W			Cerebral perfusion pressure for prediction of recurrent intracranial hypertension after primary decompressive craniectomy	EUROPEAN JOURNAL OF MEDICAL RESEARCH			English	Article						traumatic brain injury; decompressive craniectomy; brain oedema; ICP; CPP; outcome	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; INTENSIVE-CARE; MANAGEMENT; MECHANISMS; EDEMA	Background: Decompressive craniectomy (DC) with dural grafting may be performed in patients with moderate (Glasgow-Coma-Scale [GCS] score 9-12 points) or severe traumatic brain injury (TBI; GCS score <= 8 points) and threatening herniation. However, its effectiveness especially after primary craniectomy is still discussed due to missing evidence of improved outcome. The objectives of this study were to show the incidence of recurrent intracranial hypertension after primary DC, to identify predictive parameters for secondary DC, and to evaluate the long-term neurological performance 12 months after TBI. Methods: Between 01/1997 and 06/2001 all consecutive patients admitted with moderate or severe isolated TBI were enrolled in this study. The), were treated according to the guidelines of the European Brain Injury Consortium, and the American Association of Neurosurgical Surgeons (AANS) for the management of severe TBI. Process and clinical data as well as every intervention were registered prospectively The long-term neurological status was reassessed using the Glasgow Outcome Score (GOS) 12 months after TBI. Statistical comparison was performed using Mann-Whitney-U test, and multivariate testing by means of logistic regression analysis. Results: Fifty-one (43 males, 8 females; median age 51.4 years) of 119 isolated TBI patients were included. Ten patients (8 males, 2 females; median age 38.4 years) underwent secondary extended or contralateral DC in their clinical course. Three of them (30%) died at a median of 1 day after revision respectively 6 days after TBI. According to univariate analysis, secondary DC significantly correlated with arterial hypotension (p = 0.020) an otorrhagia at admission (p = 0.041), skull base fracture (p = 0.011) and decreased maximum cerebral perfusion pressure (CPP; p = 0.006) after primary surgery. Multivariate analysis identified decreased maximum CPP as the only independent predictive parameter (p = 0.036) for secondary DC and unfavourable GOS after 12-months follow-up. Conclusion: Arterial hypotension, otorrhagia at admission and skull base fractures are negatively influencing the mortality and morbidity of patients with isolated moderate or severe TBI. However, only decreased maximum CPP may independently indicate secondary DC after primary craniectomy in case of recurrent intractanial hypertension.	Univ Munich, Klinikum Innenstadt, Dept Surg, D-80336 Munich, Germany; Klinikum Univ Munchen, Inst Clin Radiol, Munich, Germany		Mussack, T (corresponding author), Univ Munich, Klinikum Innenstadt, Dept Surg, Nussbaumstr 20, D-80336 Munich, Germany.	Thomas.Mussack@med.uni-muenchen.de		Wanger, Anke/0000-0003-3581-1797			BRITT RH, 1978, NEUROSURGERY, V2, P195, DOI 10.1227/00006123-197805000-00001; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Burkert W, 1989, Zentralbl Neurochir, V50, P106; BUXTON RL, 1970, LANCET, V2, P498; Chesnut Randall M., 1993, P203; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLIFTON GL, 1993, NEUROSURGERY, V33, P34; Cooper P R, 1976, Surg Neurol, V5, P25; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Dearden NM, 1998, CLIN NEUROPATHOL, V17, P221; GAAB MR, 1990, ACT NEUR S, V51, P326; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; HATASHITA S, 1987, J NEUROSURG, V67, P573, DOI 10.3171/jns.1987.67.4.0573; Hatashita Shizuo, 1993, Neurologia Medico-Chirurgica, V33, P13, DOI 10.2176/nmc.33.13; Hieu PD, 1996, CHILD NERV SYST, V12, P270; JAMIESON KG, 1972, J NEUROSURG, V37, P137, DOI 10.3171/jns.1972.37.2.0137; JOURDAN C, 1993, NEUROCHIRURGIE, V39, P304; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marion DW, 1998, NEUROL CLIN, V16, P485, DOI 10.1016/S0733-8619(05)70073-6; MOODY RA, 1968, J NEUROSURG, V29, P586, DOI 10.3171/jns.1968.29.6.0586; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Parzhuber A, 1996, UNFALLCHIRURG, V99, P541; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Prat R, 1998, ACTA NEUROCHIR, V140, P1257, DOI 10.1007/s007010050247; REILLY P, 1997, HEAD INJURY, P385; RINALDI A, 1990, ACT NEUR S, V51, P394; ROSNER MJ, 1986, J NEUROSURG, V65, P636, DOI 10.3171/jns.1986.65.5.0636; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; Ruchholtz S, 1998, J TRAUMA, V45, P505, DOI 10.1097/00005373-199809000-00013; Ruchholtz S, 2000, UNFALLCHIRURG, V103, P30, DOI 10.1007/s001130050005; Samii M, 2002, NEUROL RES, V24, P147, DOI 10.1179/016164102101199693; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; Silvestri S, 1997, MT SINAI J MED, V64, P329; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009	37	3	4	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0949-2321	2047-783X		EUR J MED RES	Eur. J. Med. Res.	OCT 18	2005	10	10					426	433					8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	976JU	WOS:000232730500003	16287604				2022-02-06	
J	Shah, M; Vavilala, MS; Feldman, KW; Hallam, DK				Shah, M; Vavilala, MS; Feldman, KW; Hallam, DK			Motor vehicle crash brain injury in infants and toddlers: A suitable model for inflicted head injury?	CHILD ABUSE & NEGLECT			English	Article						motor vehicle crash; head injury; infants and toddlers; child abuse; subdural hemorrhage; concussion	SHAKEN-BABY SYNDROME; YOUNG-CHILDREN; SUBDURAL HEMATOMAS; HEMORRHAGE; ABUSE; AGE	Objective: Children involved in motor vehicle crash (MVC) events might experience angular accelerations similar to those experienced by children with inflicted traumatic brain injury (iTBI). This is a pilot study to determine whether the progression of signs and symptoms and radiographic findings of MVC brain injury (mvcTBI) in children of the age at greatest risk of iTBI could be evaluated with retrospective data. The ultimate goal was to examine the association of subdural hematoma (SDH) with initial loss of consciousness (LOC) and outcome. Methods: Retrospective review of records was conducted of 51 patients involved in a MVC, between birth and 36 months, admitted to Harborview Medical Center between January 1996 and December 2001. Radiographs were reviewed. Simple descriptive statistics and Fisher's exact test were used. Results: Ambulance reports were available for 57% of the patients, while Glasgow Coma Scale (GCS) scores (from any source) were only available for 76% of patients. Thirty-nine percent of patients sustained skull fractures, 8% long bone fractures, 20% thoracic injuries, and 8% intra-abdominal injuries. Twenty-four percent of the patients had SDHs; half of these experienced LOC. SDH patients without initial LOC had computed tomography findings and clinical courses indicative of focal impact injury, not angular acceleration. Conclusions: Initial LOC and subsequent evolution of GCS scores are inconsistently documented in retrospective records. Seven of the 12 patients with SDHs had simple contact injuries, while 5 exhibited diffuse brain injury. Initial LOC was associated with diffuse brain injury and poor outcome. Due to the high rate of simple contact injury, mvcTBI may be a difficult model for iTBI. (c) 2005 Elsevier Ltd. All rights reserved.	Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Radiol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Anesthesiol, Seattle, WA 98195 USA; Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA USA; Childrens Hosp, Seattle, WA USA; Reg Med Ctr, Seattle, WA USA		Feldman, KW (corresponding author), Odessa Brown Childrens Clin, 2101 E Yesler Way, Seattle, WA 98122 USA.						BILLMIRE ME, 1985, PEDIATRICS, V75, P340; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Duhaime AC, 1996, PEDIATR NEUROSURG, V25, P116, DOI 10.1159/000121108; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Gilles EE, 1998, PEDIATR NEUROL, V19, P119, DOI 10.1016/S0887-8994(98)00038-1; Gilliland MGF, 1998, J FORENSIC SCI, V43, P723; HAHN YS, 1993, PEDIATR NEUROSURG, V19, P135, DOI 10.1159/000120718; HUMPHREYS RP, 1990, CHILD NERV SYST, V6, P139, DOI 10.1007/BF00308490; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; Plunkett J, 1999, AM J FOREN MED PATH, V20, P17, DOI 10.1097/00000433-199903000-00005; RIVARA FP, 1988, PEDIATRICS, V81, P93; SCHUTZMAN SA, 1993, ANN EMERG MED, V22, P535, DOI 10.1016/S0196-0644(05)81938-9; Shugerman RP, 1996, PEDIATRICS, V97, P664; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; TULLOUS M, 1992, PEDIAT CRITICAL CARE, P1165; Vinchon M, 2002, PEDIATR NEUROSURG, V37, P245, DOI 10.1159/000066216; Willman KY, 1997, CHILD ABUSE NEGLECT, V21, P929, DOI 10.1016/S0145-2134(97)00054-9; Winston, 1998, CHILD MALTREATMENT, V3, P116, DOI [DOI 10.1177/1077559598003002006, 10.1177/1077559598003002006]	25	3	3	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134			CHILD ABUSE NEGLECT	Child Abuse Negl.	SEP	2005	29	9					953	967		10.1016/j.chiabu.2004.08.011			15	Family Studies; Psychology, Social; Social Work	Social Science Citation Index (SSCI)	Family Studies; Psychology; Social Work	971CJ	WOS:000232358400003	16159663				2022-02-06	
J	Rieck, B				Rieck, B			Dog bite injuries in children. Treatment and aftercare	MONATSSCHRIFT KINDERHEILKUNDE			German	Article						dog bite injury; child; wound treatment; flap coverage; antibiotic treatment	ANIMAL BITES; MANAGEMENT; HEAD; NECK; FACE	Following a review of the literature, dog bite injuries are analyzed in terms of their hazards and risk profile. The infection risk is especially high in bite wounds of hands and feet, close to joints, and in older injuries. Meticulous surgical debridement, early defect coverage including flap techniques, and regular early antibiotic therapy are recommended. Wound irrigation under high pressure is discouraged. Patients with bite injuries of the face or hands should be transferred to a specialized unit of plastic surgery or hand surgery.	Klinikum Hildesheim, Klin Plast Chirurgie & Handchirurgie, D-31134 Hildesheim, Germany		Rieck, B (corresponding author), Klinikum Hildesheim, Klin Plast Chirurgie & Handchirurgie, Weinberg 1, D-31134 Hildesheim, Germany.	b.rieck@stk-hildesheim.de					ANDERSON CR, 1992, POSTGRAD MED, V92, P134; AXMANN HD, 1993, DTSCH ARZTEBL, V90, pA1432; Blackman J R, 1998, J Am Board Fam Pract, V11, P167; CALLAHAM M, 1980, JAMA-J AM MED ASSOC, V244, P2327, DOI 10.1001/jama.244.20.2327; CALLAHAM ML, 1978, JACEP-J AM COLL EMER, V7, P83, DOI 10.1016/S0361-1124(78)80063-X; Cornwell JM, 1997, J AM VET MED ASSOC, V210, P1147; Gandhi RR, 1999, AM SURGEON, V65, P863; GAWENDA M, 1996, DTSCH ARZTEBL, V93, P1959; GNEHM HE, 1986, THER UMSCH, V43, P546; GOLDSTEIN EJC, 1992, CLIN INFECT DIS, V14, P633, DOI 10.1093/clinids/14.3.633; GRIEGO RD, 1995, J AM ACAD DERMATOL, V33, P1019, DOI 10.1016/0190-9622(95)90296-1; HERBERT I, 1986, LARYNGO RHINO OTOL, V65, P92, DOI 10.1055/s-2007-998790; Horch RE, 1997, PLAST RECONSTR SURG, V100, P1073, DOI 10.1097/00006534-199709001-00043; Javaid M, 1998, J ROY SOC MED, V91, P414, DOI 10.1177/014107689809100804; KUNERT P, 1988, Handchirurgie Mikrochirurgie Plastische Chirurgie, V20, P66; Kuntz P, 1996, DTSCH ARZTEBL, V93, pA969; LACKMANN GM, 1990, MONATSSCHR KINDERH, V138, P742; Mitchell RB, 2003, LARYNGOSCOPE, V113, P492, DOI 10.1097/00005537-200303000-00018; MORGAN JP, 1995, J ORAL MAXIL SURG, V53, P435, DOI 10.1016/0278-2391(95)90720-3; OBERASCHER G, 1985, HNO, V33, P443; PINCKNEY LE, 1982, PEDIATRICS, V69, P193; RETTINGER G, 1995, HNO, V43, P159; RIECK B, 2001, KLEINTIERMED, V4, P160; Rothe M, 2002, Handchir Mikrochir Plast Chir, V34, P22, DOI 10.1055/s-2002-22103; SACKS JJ, 1989, JAMA-J AM MED ASSOC, V262, P1489, DOI 10.1001/jama.262.11.1489; Scheithauer MO, 1997, HNO, V45, P891, DOI 10.1007/s001060050170; SCHMIDBAUER U, 2004, PADIATR HAUTNAH, V16, P86; STUCKER FJ, 1990, ARCH OTOLARYNGOL, V116, P789; THOMSON HG, 1973, J TRAUMA, V13, P20, DOI 10.1097/00005373-197301000-00004; Wolff KD, 1998, J ORAL MAXIL SURG, V56, P838, DOI 10.1016/S0278-2391(98)90009-X	30	3	3	1	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0026-9298	1433-0474		MONATSSCHR KINDERH	Mon.schr. Kinderheilkd.	AUG	2005	153	8					789	794		10.1007/s00112-005-1177-3			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	961HR	WOS:000231653100014					2022-02-06	
J	Song, KS; Kim, HKW				Song, KS; Kim, HKW			Femoral neck fracture in a child with autosomal-dominant osteopetrosis: Failure of spica cast treatment and successful outcome by internal fixation	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						autosomal-dominant osteopetrosis; femoral neck fracture; spica cast	COMPLICATION; EPIPHYSIS; RATS	A case report of a 6-year-old child with autosomal dominant osteopetrosis who sustained a closed femoral neck fracture initially treated with a spica cast with subsequent fracture displacement is presented. Further treatment included closed reduction and operative fixation, first, with a guide pin placement for a cannulated screw insertion that was abandoned because of the hardness of the bone. Three Kirschner wires were then inserted to maintain the closed reduction, followed by immobilization in a spica cast. At the 2-year follow-up, the child was completely free of any complications resulting from her injury and treatment. Radiographs showed no evidence of avascular necrosis in the affected femoral head. Review of the literature supports evidence for early operative fixation of such cases, whether or not the femoral neck fracture is nondisplaced or displaced.	Keimyung Univ, Sch Med, Dept Orthoped Surg, Taegu, South Korea; Shriners Hosp Children, Tampa, FL USA		Song, KS (corresponding author), Keimyung Univ, Sch Med, Dept Orthoped Surg, 194 Dong San Dong, Taegu, South Korea.	skspos@dsmc.or.kr		Song, Kwang Soon/0000-0001-6029-1901			Armstrong DG, 1999, J PEDIATR ORTHOPED, V19, P122, DOI 10.1097/00004694-199901000-00026; BAYNHAM GC, 1991, J PEDIATR ORTHOPED, V11, P187, DOI 10.1097/01241398-199103000-00009; BEIGHTON P, 1980, S AFR MED J, V58, P600; CANALE ST, 1994, J PEDIATR ORTHOPED, V14, P623, DOI 10.1097/01241398-199409000-00014; DEPALMA L, 1994, CLIN ORTHOP RELAT R, P85; ENTICKNAP JB, 1954, J BONE JOINT SURG BR, V36, P123, DOI 10.1302/0301-620X.36B1.123; GREENE WB, 1985, J PEDIATR ORTHOPED, V5, P483, DOI 10.1097/01241398-198507000-00020; JOHNSTON CC, 1968, MEDICINE, V47, P149, DOI 10.1097/00005792-196803000-00004; MARKS SC, 1978, CLIN ORTHOP RELAT R, P259; MAZUR J, 1982, CLIN ORTHOP RELAT R, P202; MILGRAM JW, 1982, J BONE JOINT SURG AM, V64, P912, DOI 10.2106/00004623-198264060-00016; RATILIFF AC, 1962, J BONE JOINT SURG BR, V44, P528; SCHMIDT CJ, 1977, RADIOLOGY, V122, P517, DOI 10.1148/122.2.517; SHAPIRO F, 1980, J BONE JOINT SURG AM, V62, P384, DOI 10.2106/00004623-198062030-00008; SHAPIRO F, 1993, CLIN ORTHOP RELAT R, P34; STEINWENDER G, 1995, J PEDIATR ORTHOP B, V4, P213, DOI 10.1097/01202412-199504020-00016	16	3	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	AUG	2005	19	7					494	497		10.1097/01.bot.0000145971.56642.12			4	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	954EG	WOS:000231136300013	16056085				2022-02-06	
J	Teramoto, S; Uchiyama, M; Higurashi, N; Wada, Y; Kubo, M; Eto, Y				Teramoto, S; Uchiyama, M; Higurashi, N; Wada, Y; Kubo, M; Eto, Y			A case of isolated retrograde amnesia following brain concussion	PEDIATRICS INTERNATIONAL			English	Article						anterograde amnesia; brain concussion; retrograde amnesia; single photon emission computed tomography	HERPES-SIMPLEX ENCEPHALITIS		Jikei Univ, Sch Med, Dept Pediat, Kashiwa, Chiba 2778567, Japan; Jikei Univ, Sch Med, Dept Radiol, Kashiwa, Chiba 2778567, Japan		Teramoto, S (corresponding author), Jikei Univ, Sch Med, Dept Pediat, 163-1 Kashiwashita, Kashiwa, Chiba 2778567, Japan.	rndth@jikei.ac.jp					Butters N., 1986, AUTOBIOGRAPHICAL MEM, P253, DOI [10.1017/CBO9780511558313.021, DOI 10.1017/CBO9780511558313.021]; Evans JJ, 1996, NEUROCASE, V2, P1; Fujii T, 1999, CORTEX, V35, P599, DOI 10.1016/S0010-9452(08)70822-0; HIRASAWA N, 1992, INT ARCH ALLERGY IMM, V99, P107, DOI 10.1159/000236342; Kopelman M D, 1994, Memory, V2, P211, DOI 10.1080/09658219408258945; MIZUTA H, 1998, JPN J NEUROPSYCHOL, V14, P26; Nakamura H, 2002, CORTEX, V38, P613, DOI 10.1016/S0010-9452(08)70025-X; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Tanaka Y, 1999, NEUROLOGY, V53, P344, DOI 10.1212/WNL.53.2.344; TULVING E, 1995, COGNITIVE NEUROSCIEN, P825; Yamadori A, 2001, TOHOKU J EXP MED, V193, P57, DOI 10.1620/tjem.193.57; YONEDA Y, 1994, EUR NEUROL, V34, P243, DOI 10.1159/000117051	12	3	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	AUG	2005	47	4					469	472		10.1111/j.1442-200x.2005.02095.x			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	950WC	WOS:000230888400022	16118897				2022-02-06	
J	Suh, CM; Kim, SH; Oh, SY				Suh, CM; Kim, SH; Oh, SY			Analysis of traumatic brain injury using a finite element model	JOURNAL OF MECHANICAL SCIENCE AND TECHNOLOGY			English	Article						traumatic brain injury (TBI); finite element model; head injury criterion (HIC); brain damage; skull & brain	HUMAN HEAD	In this study, head injury by impact force was evaluated by numerical analysis with 3-dimensional finite element (FE) model. Brain deformation by frontal head impact was analyzed to evaluate traumatic brain injury (TBI). The variations of head acceleration and intra-cranial pressure (ICP) during the impact were analyzed. Relative displacement between the skull and the brain due to head impact was investigated from this simulation. In addition, pathological severity was evaluated according to head injury criterion (HIC) from simulation with FE model. The analytic result of brain damage was accorded with that of the cadaver test performed by Nahum et al. (1977) and many medical reports. The main emphasis of this study is that our FE model was valid to simulate the traumatic brain injury by head impact and the variation of the HIC value was evaluated according to various impact conditions using the FE model.	Kyungpook Natl Univ, Sch Mech Engn, Taegu 702701, South Korea; Korean Intellectual Property Off, Gen Machinery Examinat Div, Taejon 302701, South Korea; Catholic Sangji Coll, Automot Div, Andong 760711, Kyungpook, South Korea		Suh, CM (corresponding author), Kyungpook Natl Univ, Sch Mech Engn, 1370 Sankyuk Dong, Taegu 702701, South Korea.	cmsuh@knu.ac.kr					Al-Bsharat AS, 1999, P 43 STAPP CAR CRASH; Holbourn AHS, 1943, LANCET, V2, P438; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; LEE MC, 1989, J BIOMECH, V22, P537, DOI 10.1016/0021-9290(89)90005-5; LUCHTER S, 1996, TRAUMATIC BRAIN INJU, P9; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Miller R. T., 1998, 983154 SAE; NAHUM S, 1977, P 21 STAPP CAR CRASH, P339; SHUCK L, 1972, T ASME, P905; SUH CM, 2001, J KSME, V25, P800; Thibault L., 1971, P 15 STAPP CAR CRASH; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165	12	3	3	1	4	KOREAN SOC MECHANICAL ENGINEERS	SEOUL	KSTC NEW BLD. 7TH FLOOR, 635-4 YEOKSAM-DONG KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	1738-494X			J MECH SCI TECHNOL	J. Mech. Sci. Technol.	JUL	2005	19	7					1424	1431		10.1007/BF03023901			8	Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	953DP	WOS:000231056900004					2022-02-06	
J	Bauman, RA; Widholm, J; Long, JB				Bauman, RA; Widholm, J; Long, JB			Secondary hypoxia exacerbates acute disruptions of energy metabolism in rats resulting from fluid percussion injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						head injury; hypoxia; food intake; body weight; exercise	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; CEREBRAL BLOOD-FLOW; HEAD-INJURY; CELL-DEATH; BEHAVIOR; MILD; SCOPOLAMINE; HYPOXEMIA; RESPONSES	The purpose of these experiments was to determine whether secondary hypoxia exacerbates the metabolic consequences of fluid percussion injury (FPI). In Experiment I, rats were trained to press a lever for their entire daily ration of food at any time during a 12-h light/dark cycle and run in an activity wheel. After food intake and body weight stabilized, rats were surgically prepared, assigned to one of four groups [FPI + Hypoxia (IH), FPI + Normoxia (IN), Sham Injury + Hypoxia (SH), Sham Injury + Normoxia (SN)] and, after recovery from surgery, anesthetized with halothane delivered by a 21% O-2 source. Immediately after injury or sham injury, the O-2 source was switched to 13% for rats in Groups IH and SH for 30 min. Post-traumatic hypoxemia exacerbated the ensuing FPI-induced reductions of food intake and body weight, but did not change FPI-induced reduction in wheel running. In Experiment II, rats were assigned to one of three groups (SH, IN, or IH) and subjected to sham injury and 13% 02 or FPI and either 13 or 21% O-2. Immediately after 30 min of hypoxia or normoxia, rats were confined to metabolism cages that were used to quantify rates of oxygen consumption (VO2), carbon dioxide production (VCO2), and heat production (H). Post-traumatic hypoxia exacerbated the FPI-induced increases in VO2, VCO2, and H. The results of Experiments I and II provide convergent confirmation that secondary hypoxemia exacerbates the FPI-induced hypermetabolic state in rats and therefore might significantly exacerbate the brain injury-induced disruptions of energy metabolism in humans. (c) 2004 Elsevier B.V. All rights reserved.	Walter Reed Army Inst Res, Div Neurosci, Silver Spring, MD 20910 USA; Coll Charleston, Dept Psychol, Charleston, SC 29424 USA; Walter Reed Army Inst Res, Div Mil Casualty Res, Silver Spring, MD 20910 USA		Bauman, RA (corresponding author), Walter Reed Army Inst Res, Div Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	richard.bauman@na.amedd.army.mil					Bauman RA, 2000, J NEUROTRAUM, V17, P679, DOI 10.1089/089771500415427; Bentzer P, 2000, J NEUROTRAUM, V17, P441, DOI 10.1089/neu.2000.17.441; Blaxter KL., 1989, ENERGY METABOLISM AN, P336; Bramlett HM, 1999, J NEUROTRAUM, V16, P1035, DOI 10.1089/neu.1999.16.1035; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; BRAND MD, 1994, BBA-BIOENERGETICS, V1187, P132, DOI 10.1016/0005-2728(94)90099-X; BROWN GC, 1992, FASEB J, V6, P2961, DOI 10.1096/fasebj.6.11.1644259; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; CHESNUT RM, 1997, NEUROL EMERG, V15, P581; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ENTERS EK, 1992, BRAIN RES, V576, P271; GORDON CJ, 1993, TEMPERATURE REGULATI, P276; Greene JG, 1996, PROG NEUROBIOL, V48, P613, DOI 10.1016/0301-0082(96)00006-8; HARIRI RJ, 1993, J NEUROSURG, V79, P421, DOI 10.3171/jns.1993.79.3.0421; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; KITA H, 1994, ACTA NEUROCHIR, P452; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; LYETH BG, 1993, BRAIN RES, V617, P69, DOI 10.1016/0006-8993(93)90614-S; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MCLEAN JA, 1990, ANIMAL HUMAN CALORIM, P338; NAWASHIRO H, 1995, NEUROL RES, V17, P455, DOI 10.1080/01616412.1995.11740363; OTT L, 1991, J NEUROSURG, V74, P738, DOI 10.3171/jns.1991.74.5.0738; Pieper AA, 1999, TRENDS PHARMACOL SCI, V20, P171, DOI 10.1016/S0165-6147(99)01292-4; ROBERTSON CS, 1984, NEUROSURGERY, V15, P307, DOI 10.1227/00006123-198409000-00003; ROBINSON SE, 1990, BRAIN RES, V511, P141, DOI 10.1016/0006-8993(90)90233-2; ROBINSON SE, 1990, BRAIN RES, V509, P41, DOI 10.1016/0006-8993(90)90306-V; Roe SY, 1997, J NEUROTRAUM, V14, P399, DOI 10.1089/neu.1997.14.399; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong Y, 2001, NEUROL RES, V23, P129, DOI 10.1179/016164101101198460; YOUNG B, 1985, NEUROSURGERY, V17, P784, DOI 10.1227/00006123-198511000-00010	41	3	4	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAY 7	2005	160	1					25	33		10.1016/j.bbr.2004.11.031			9	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	923DE	WOS:000228888400003	15836897				2022-02-06	
J	Arnold, MP				Arnold, MP			Mountain biking. Cool way to enjoy nature with side effects	ORTHOPADE			German	Article						mountain bike; off-road biking; mountain bike injuries; concussion; prevention	HEAD-INJURIES; ICE HOCKEY; FOOTBALL PLAYERS; BRAIN-INJURY; CONCUSSION; PERFORMANCE; COLLEGIATE; CHILDREN; SPORTS; TRAUMA	Mountain biking grew from a trend to a serious branch of sport. This article presents the different subspecialties within the sport, the injury rates and the types of injuries among high-class and recreational bikers. The experiences made during several years as a team physician of top athletes as well as the statistics from the Swiss accident insurance company SUVA are the basis for the data presented. The issue of mountain bike-related concussions is particularly discussed since this type of injury is a point of increasing concern in the recent sports traumatology literature.	Univ Groningen, Orthopaed Dept, Med Ctr, Groningen, Netherlands		Arnold, MP (corresponding author), Univ Groningen, Orthopaed Dept, Med Ctr, Groningen, Netherlands.	m.arnold@orth.umcg.nl					Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; ARNOLD MP, 1999, SPORTORTHOP TRAUMAT, V15, P3; ARNOLD MP, 2000, MED PRAX, P2; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailes JE, 2001, J ATHL TRAINING, V36, P236; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Biasca N, 2002, BRIT J SPORT MED, V36, P410, DOI 10.1136/bjsm.36.6.410; BIASCA N, 1993, UNFALLCHIRURG, V96, P259; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Brolinson P Gunnar, 2004, Clin J Sport Med, V14, P253, DOI 10.1097/00042752-200407000-00015; *BUND UNF BFU, 2004, B BUND UNF BFU; Cobb Sarah, 2004, J Sch Nurs, V20, P262; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Delmonico RL, 2005, J HEAD TRAUMA REHAB, V20, P112, DOI 10.1097/00001199-200501000-00011; Durkin MS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e74; Gaulrapp H, 2001, KNEE SURG SPORT TR A, V9, P48, DOI 10.1007/s001670000145; GLUSKIN E, 2000, CYCLING CONSUMER NEW; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; HAYMAN F, 2005, BIKE, V3, P68; Honey CR, 1998, CLIN J SPORT MED, V8, P43, DOI 10.1097/00042752-199801000-00010; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; Kronisch RL, 1996, AM J SPORT MED, V24, P88, DOI 10.1177/036354659602400116; Kronisch RL, 2002, SPORTS MED, V32, P523, DOI 10.2165/00007256-200232080-00004; KRONISCH RL, 1994, CLIN J SPORT MED, V4, P240; Leblanc Kim Edward, 1999, Comprehensive Therapy, V25, P39, DOI 10.1007/BF02889833; McIntosh A, 2004, BRIT J SPORT MED, V38, P46, DOI 10.1136/bjsm.2002.003103; PFEIFFER RP, 1994, CLIN SPORT MED, V13, P207; REQUA RK, 1993, AM J SPORT MED, V21, P461, DOI 10.1177/036354659302100323; Shafi S, 1998, J PEDIATR SURG, V33, P317, DOI 10.1016/S0022-3468(98)90454-7; *SPORT SLSOCI, 2004, BRIT J SPORT MED, V38, P654; *SUVA, 2002, SUVA UNF UVG 1998 20; Wesson D, 2000, J PEDIATR SURG, V35, P688, DOI 10.1053/jpsu.2000.5944; WILLIAMS M, 1991, ACCIDENT ANAL PREV, V23, P119, DOI 10.1016/0001-4575(91)90043-5	38	3	3	1	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0085-4530	1433-0431		ORTHOPADE	Orthopade	MAY	2005	34	5					405	410		10.1007/s00132-005-0791-z			6	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	938QD	WOS:000230017000004	15856164				2022-02-06	
J	Giugni, E; Sabatini, U; Hagberg, GE; Formisano, R; Castriota-Scanderbeg, A				Giugni, E; Sabatini, U; Hagberg, GE; Formisano, R; Castriota-Scanderbeg, A			Turbo-Proton Echo Planar Spectroscopic Imaging (t-PEPSI) MR technique in the detection of diffuse axonal damage in brain injury. Comparison with Gradient-Recalled Echo (GRE) sequence	RADIOLOGIA MEDICA			English	Article						MRI; traumatic brain injury; diffuse axonal injury; Gradient Recalled Echo Imaging	INTRACEREBRAL HEMORRHAGE; PRACTICAL SCALE; HEAD-INJURY; SEVERITY; LESIONS; TRAUMA; COMA	Purpose. Diffuse axonal injury (DAI) is a common type of primary neuronal injury in patients with severe traumatic brain injury, and is frequently accompanied by tissue tear haemorrhage. The T2*-weighted gradient-recalled echo (GRE) sequences are more sensitive than T2-weighted spin-echo images for detection of haemorrhage. This study was undertaken to determine whether turbo-PEPSI, an extremely fast multi-echo-planar-imaging sequence, can be used as an alternative to the GREsequence for detection of DAI. Materials and methods. Nineteen patients (mean age 24,5 year) with severe traumatic brain injury (TBI), occurred at least 3 months earlier, underwent a brain MRI study on a 1.5-Tesla scanner. A qualitative evaluation of the turbo-PEPSI sequences was performed by identifying the optimal echo time and in-plane resolution. The number and size of DAI lesions, as well as the signal intensity contrast ratio (SI CR), were computed for each set of GRE and turbo-PEPSI images, and divided according to their anatomic location into lobar and/or deep brain. Results. There was no significant difference between GRE and turbo-PEPSI sequences in the total number of DAI lesions detected (283 vs 225 lesions, respectively). The GRE sequence identified a greater number of hypointense lesions in the temporal lobe compared to the t-PEPS1 sequence (72 vs 35, p < 0.003), while no significant differences were found for the other brain regions. The SI CR was significantly better (i.e. lower) for the turbo-PEPSI than for the GRE sequence (p < 0.00001). Conclusions. Owing to its very short scan time and high sensitivity to the haemorrhage foci, the turbo-PEPSI sequence can be used as an alternative to the GRE to assess brain DAI in severe TBI patients, especially if uncooperative and medically unstable.	Fdn IRCCS S Lucia, I-00179 Rome, Italy		Giugni, E (corresponding author), Fdn IRCCS S Lucia, Via Ardeatina 306, I-00179 Rome, Italy.	eligiugni@yahoo.it	Sabatini, Umberto/A-8484-2010; Sabatini, Umberto/K-4659-2016; Hagberg, Gisela E/A-2134-2010	Sabatini, Umberto/0000-0001-5321-8626; Hagberg, Gisela E/0000-0003-2176-7086; Bastianello, Stefano/0000-0002-8414-9077			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Besenski N, 2002, EUR RADIOL, V12, P1237, DOI 10.1007/s00330-002-1355-9; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; DELAPAZ RL, 1994, RADIOGRAPHICS, V14, P1045, DOI 10.1148/radiographics.14.5.7991813; DORIS LDM, 2001, AJNR, V22, P1275; EDELMAN RR, 1994, RADIOLOGY, V192, P600, DOI 10.1148/radiology.192.3.8058920; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Garnett MR, 2001, CURR OPIN NEUROL, V14, P753, DOI 10.1097/00019052-200112000-00012; GEAN AD, 1994, IMAGING HEAD TRAUMA, P207; GENTRY LR, 1994, RADIOLOGY, V297, P1; Graham D.I., 1996, NEUROTRAUMA, P43; Hagberg GE, 2002, MAGNET RESON MED, V48, P877, DOI 10.1002/mrm.10283; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 1990, HDB CLIN NEUROLOGY, V13, P1; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Kinoshita T, 2000, STROKE, V31, P1646, DOI 10.1161/01.STR.31.7.1646; Kuzma BB, 2000, SURG NEUROL, V53, P400; LAMPFL A, 1998, J NEUROSURG, V88, P809; Liang LX, 1999, AM J NEURORADIOL, V20, P1527; MCLELLAN DR, 1990, COMA EMERGING PATIEN, P389; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Patel MR, 1999, AM J ROENTGENOL, V173, P479, DOI 10.2214/ajr.173.2.10430158; Patel MR, 1996, STROKE, V27, P2321, DOI 10.1161/01.STR.27.12.2321; Posse S, 1999, MAGN RESON MED, V42, P87, DOI 10.1002/(SICI)1522-2594(199907)42:1<87::AID-MRM13>3.0.CO;2-O; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Reichenbach JR, 1998, MAGN RESON MATER PHY, V6, P62, DOI 10.1016/S1352-8661(98)00011-8; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Takaoka M, 2002, J NEUROL NEUROSUR PS, V73, P289, DOI 10.1136/jnnp.73.3.289; TEASDALE G, 1974, LANCET, V2, P81; Wardlaw JM, 2000, NEURORADIOLOGY, V42, P81, DOI 10.1007/s002340050019; Wolansky LJ, 2000, J NEUROIMAGING, V10, P131, DOI 10.1111/jon2000103131; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013	35	3	3	0	1	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0033-8362			RADIOL MED	Radiol. Med.	MAY-JUN	2005	109	5-6					563	572					10	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	982LU	WOS:000233160700013	15973231				2022-02-06	
J	Payen, JF; Francony, G; Fauvage, B; Le Bas, JF				Payen, JF; Francony, G; Fauvage, B; Le Bas, JF			Interest of magnetic resonance spectroscopy in predicting severity and outcome in traumatic brain injury	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article						nuclear magnetic resonance; magnetic resonance spectroscopy; brain metabolism; traumatic brain injury	AXONAL INJURY; HEAD-INJURY; PHOSPHATE-METABOLISM; PH; RATS; H-1; MRS	Nuclear magnetic spectroscopy (MRS) is a useful method for noninvasively studying intracerebral metabolism. Proton MRS can identify markers of the neuronal viability (N-acetyl-aspartate, NAA), of the metabolism of cellular membranes (choline), of the cellular energy metabolism (creatine, lactate). In Phosphorus MRS, the peaks most readily identified are involved in the high-energy cellular metabolism (ATP, phosphocreatine, inorganic phosphate), and intracellular pH (pHi) can be determined using this method. MRS has been used in experimental models of traumatic brain injury (TBI), primarily to study the cellular metabolism and the relation between biochemical and histological changes after trauma. In trauma patients, significant changes in NAA, choline and pHi were found in both grey and white matter comparing with controls, and these alterations correlated with injury severity. Correlations have been reported between these biochimical changes (reduction in NAA, increase in choline) measured at 1 to 6 months after TBI and the clinical outcome of the patients. However, there are methodological issues which still impede to recommend MRS as a tool for predicting neurological outcome in the clinical setting. (c) 2005 Elsevier SAS. Tous droits reserves.	Hop Michallon, Dept Anesthesie Reanimat 1, F-38043 Grenoble, France; Hop Michallon, Serv Neuroradiol, F-38043 Grenoble, France		Payen, JF (corresponding author), Hop Michallon, Dept Anesthesie Reanimat 1, BP 217, F-38043 Grenoble, France.	jfpayen@ujf-grenoble.fr	Payen, Jean-Francois/L-6667-2014				Ariza M, 2004, ARCH NEUROL-CHICAGO, V61, P541, DOI 10.1001/archneur.61.4.541; Brenner T, 2003, PEDIATR NEUROL, V28, P104, DOI 10.1016/S0887-8994(02)00491-5; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Cecil KM, 1998, J NEUROCHEM, V70, P2038; Claassen J, 2001, CRIT CARE MED, V29, P494, DOI 10.1097/00003246-200103000-00005; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2001, CURR OPIN NEUROL, V14, P753, DOI 10.1097/00019052-200112000-00012; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; MARMAROU A, 1994, ACTA NEUROCHIR, P421; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; MOON RB, 1973, J BIOL CHEM, V248, P7276; RANGO M, 1990, ANN NEUROL, V28, P661, DOI 10.1002/ana.410280510; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Vink R, 1988, J NEUROTRAUM, V5, P315, DOI 10.1089/neu.1988.5.315	25	3	3	0	2	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0750-7658	1769-6623		ANN FR ANESTH	Ann. Fr. Anest. Reanim.	MAY	2005	24	5					522	527		10.1016/j.annfar.2005.03.005			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	930XZ	WOS:000229451700011	15904731				2022-02-06	
J	Sanders, AK; Boggess, BR; Koenig, SJ; Toth, AP				Sanders, AK; Boggess, BR; Koenig, SJ; Toth, AP			Medicolegal issues in sports medicine	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							CERVICAL SPINAL STENOSIS; HYPERTROPHIC CARDIOMYOPATHY; CARDIOVASCULAR-DISEASE; ATHLETIC-TRAINERS; ARTERIAL INJURY; SUDDEN-DEATH; MANAGEMENT; FOOTBALL; DISLOCATION; CONCUSSION	This article reviews medicolegal issues in sports medicine. Nonmusculoskeletal medical conditions discussed include cardiac abnormalities, heat illness, and concussion in the athlete. Musculoskeletal injuries with the greatest potential for litigation, knee dislocation, and cervical spine trauma, are also reviewed. We provide legal case examples and discuss evaluation and treatment strategies to assist the medical team in the care of athletes.	Duke Sports Med, Durham, NC 27708 USA		Toth, AP (corresponding author), Duke Sports Med, 317 Finch Yeager Bldg, Durham, NC 27708 USA.	toth0001@mc.duke.edu					Allen CR, 2002, CLIN SPORT MED, V21, P15, DOI 10.1016/S0278-5919(03)00054-1; [Anonymous], 2000, Am J Sports Med, V28, P440; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailes JE, 2001, J ATHL TRAINING, V36, P236; Balady GJ, 1998, MED SCI SPORT EXER, V30, P1009; Barnes CJ, 2002, J TRAUMA, V53, P1109, DOI 10.1097/00005373-200212000-00013; Barrow MW, 1998, AM FAM PHYSICIAN, V58, P749; Basilico FC, 1999, AM J SPORT MED, V27, P108, DOI 10.1177/03635465990270010601; Binkley HM, 2002, J ATHL TRAINING, V37, P329; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Breslow M J, 2000, Bull Hosp Jt Dis, V59, P201; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; Cantu RC, 1997, MED SCI SPORT EXER, V29, pS233; Castro FP, 2003, CLIN SPORT MED, V22, P483, DOI 10.1016/S0278-5919(02)00094-7; Castro FP, 1997, AM J SPORT MED, V25, P603, DOI 10.1177/036354659702500503; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; FAHRENBACH M C, 1992, Cardiology Clinics, V10, P319; FANANAPAZIR L, 1995, CIRCULATION, V92, P700, DOI 10.1161/01.CIR.92.4.700; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Ghiselli G, 2003, CLIN SPORT MED, V22, P445, DOI 10.1016/S0278-5919(02)00109-6; Good, 1995, J Am Acad Orthop Surg, V3, P284; GREEN NE, 1977, J BONE JOINT SURG AM, V59, P236, DOI 10.2106/00004623-197759020-00017; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Hansen RD, 1996, INT J SPORTS MED, V17, P66, DOI 10.1055/s-2007-972810; Harmon KG, 1999, AM FAM PHYSICIAN, V60, P887; Harner CD, 2004, J BONE JOINT SURG AM, V86A, P262, DOI 10.2106/00004623-200402000-00008; HASSANEIN T, 1992, AM J GASTROENTEROL, V87, P1382; HERBERT DL, 1995, LEGAL ASPECTS SPORTS; HERBERT DL, 1990, SPORTS MED STAND MAL, V2, P45; Hett HA, 1998, POSTGRAD MED, V103, P107, DOI 10.3810/pgm.1998.06.507; Hoffman JL., 2001, CLIN PEDIAT EMERGENC, V2, P203, DOI [10.1016/S1522-8401(01)90006-0, DOI 10.1016/S1522-8401(01)90006-0]; HOOVER NW, 1961, SURG CLIN N AM, V41, P1099; Huang FS, 2000, ARTHROSCOPY, V16, P323, DOI 10.1016/S0749-8063(00)90057-4; JACKSON DW, 1986, CLIN SPORT MED, V5, P373; Jordan BD, 1999, NEUROLOGY, V53, P892, DOI 10.1212/WNL.53.4.892; Kelly JP, 1997, NEUROLOGY, V48, P581; KENNEDY JC, 1963, J BONE JOINT SURG AM, V45, P889, DOI 10.2106/00004623-196345050-00001; Kim DH, 2003, CLIN SPORT MED, V22, P501, DOI 10.1016/S0278-5919(02)00105-9; Kovacic JC, 2003, INTERN MED J, V33, P521, DOI 10.1046/j.1445-5994.2003.00475.x; Kushner DS, 2001, AM FAM PHYSICIAN, V64, P1007; LEECHIONG TL, 1995, POSTGRAD MED, V98, P26, DOI 10.1080/00325481.1995.11946015; MARON BJ, 1994, MED SCI SPORT EXER, V26, pS261; Maron BJ, 1998, J AM COLL CARDIOL, V32, P1881, DOI 10.1016/S0735-1097(98)00491-4; MARON BJ, 1986, J AM COLL CARDIOL, V7, P204, DOI 10.1016/S0735-1097(86)80283-2; Maron BJ, 1996, CIRCULATION, V94, P850, DOI 10.1161/01.CIR.94.4.850; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Maron BJ, 1997, LANCET, V350, P127, DOI 10.1016/S0140-6736(97)01282-8; McCrory P, 2001, BRIT J SPORT MED, V35, P380, DOI 10.1136/bjsm.35.6.380; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; Mellion M. B., 1997, TEAM PHYS HDB; MEYER SA, 1994, AM J SPORT MED, V22, P158, DOI 10.1177/036354659402200202; MEYERS MH, 1971, J BONE JOINT SURG AM, VA 53, P16, DOI 10.2106/00004623-197153010-00002; Mitten MJ, 2001, CLIN J SPORT MED, V11, P199, DOI 10.1097/00042752-200107000-00012; Nissen SJ, 1996, PHYSICIAN SPORTSMED, V24, P57, DOI 10.3810/psm.1996.06.1378; ODOR JM, 1990, AM J SPORT MED, V18, P507, DOI 10.1177/036354659001800510; Osborne B, 2001, J ATHL TRAINING, V36, P316; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Riebe D, 1997, MED SCI SPORT EXER, V29, P117, DOI 10.1097/00005768-199701000-00017; Roman P D, 1987, Orthop Rev, V16, P917; SANDOR RP, 1997, AM FAM PHYSICIAN, P746; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schnirring L, 2004, PHYSICIAN SPORTSMED, V32, P8, DOI 10.1080/00913847.2004.11440728; SHEKELLE P, 2003, AHRQ PUBLICATION, P81; THOMPSON PD, 1982, JAMA-J AM MED ASSOC, V247, P2535, DOI 10.1001/jama.247.18.2535; TORG JS, 1985, JAMA-J AM MED ASSOC, V254, P3439, DOI 10.1001/jama.254.24.3439; TORG JS, 1986, J BONE JOINT SURG AM, V68A, P1354, DOI 10.2106/00004623-198668090-00008; Torg JS, 1996, J BONE JOINT SURG AM, V78A, P1308, DOI 10.2106/00004623-199609000-00003; Torg JS, 1997, PHYSICIAN SPORTSMED, V25, P60, DOI 10.3810/psm.1997.07.1487; TORG JS, 1993, AM J SPORT MED, V21, P640, DOI 10.1177/036354659302100502; VARNELL RM, 1989, AM SURGEON, V55, P699; WILLIAMS C, 2003, CHICAGO SUN TIMES; Wojtys EM, 1999, AM J SPORT MED, V27, P676, DOI 10.1177/03635465990270052401; 2002, MED SCI SPORTS EXERC, V34, P239	73	3	3	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	APR	2005		433					38	49		10.1097/01.blo.0000159764.03919.33			12	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	913RF	WOS:000228170000007	15805935				2022-02-06	
J	Bianco, M; Colella, F; Pannozzo, A; Oradei, A; Bucari, S; Palmieri, V; Zuppi, C; Zeppilli, P				Bianco, M; Colella, F; Pannozzo, A; Oradei, A; Bucari, S; Palmieri, V; Zuppi, C; Zeppilli, P			Boxing and "commotio cordis": ECG and humoral study	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						sport; heart; cardiac concussion; sudden death; myocardiurn; fight	SUDDEN-DEATH; MYOCARDIAL CONTUSION; EXPERIMENTAL-MODEL; SPORTS ACTIVITIES; CARDIAC-ARREST; CHEST; IMPACT; EXERCISE; YOUNG; HEART	The objective of the study was to analyze the presence of myocardial damage in relation to official boxing matches. Low-energy chest wall impact could be responsible for sudden cardiac death, i.e. commotio cordis. As boxing is a traumatic sport in which thoracic hits usually occur, it seems interesting to know if there are any significant cardiac changes during official bouts. Fifteen amateur boxers, participating in the semifinals of the Italian Championship were investigated. A standard ECG before, immediately after, 1 hour and 12 hours after the match were obtained from each athlete to analyze atrio-ventricular conduction, QRS axis and duration, and ventricular repolarization. A blood sample was also obtained before and 12 hours after the match for analysis of total-creatin-phosphokinase, myoglobin, and T-troponin. After the fight, the following significant changes were encountered: higher QRS voltages, lowering of J-point and ST segment in lateral leads, higher ST-slope, lower T-wave amplitude, shorter T-wave peak time, and shorter QT interval. When the last 2 parameters were corrected for heart rate, no differences were observed for QTc, while T-wave peak time significantly increased. All these changes persisted until one hour after the match. Moreover, 3/15 boxers (20%) showed marked ventricular repolarization anomalies in lateral leads after the contest, persisting for 12 hours in one case. However, no athlete had clinical and humoral signs of myocardial damage following the match. It was concluded that no clinical and humoral signs of myocardial damage were found after amateur boxing matches, although ventricular repolarization abnormalities can be found on ECG in 20% of boxers, probably due to sympathetic hyper-activity related to the agonistic event.	Univ Cattolica Sacro Cuore, Ist Med Interna & Geriatria, Ctr Sports Med, I-00168 Rome, Italy; Catholic Univ, Inst Clin Chem, Rome, Italy; Italian Boxing Federat, Med Committee, Rome, Italy		Zeppilli, P (corresponding author), Univ Cattolica Sacro Cuore, Ist Med Interna & Geriatria, Ctr Sports Med, Lgo F Vito 1, I-00168 Rome, Italy.	massibianco@tin.it	Bianco, Massimiliano/M-9907-2019; Zeppilli, Paolo/AAA-8877-2019	Bianco, Massimiliano/0000-0002-0587-5899; Zeppilli, Paolo/0000-0002-5228-3634; Palmieri, Vincenzo/0000-0002-4478-4033			BELLOTTI P, 1992, AM J CARDIOL, V69, P709, DOI 10.1016/0002-9149(92)90175-X; Bright EF, 1935, AM HEART J, V10, P293, DOI 10.1016/S0002-8703(35)90312-X; Dickman Gerald L, 1978, Phys Sportsmed, V6, P85, DOI 10.1080/00913847.1978.11948393; FURLAN R, 1993, CARDIOVASC RES, V27, P482, DOI 10.1093/cvr/27.3.482; GREEN ED, 1980, ANN EMERG MED, V9, P155, DOI 10.1016/S0196-0644(80)80272-1; JOKL E, 1947, VOLKSKRAGTE MANPOWER, V1, P39; KAPLAN JA, 1993, J TRAUMA, V34, P151, DOI 10.1097/00005373-199301000-00030; Langley P, 2002, PACE, V25, P1230, DOI 10.1046/j.1460-9592.2002.01230.x; Link MS, 2003, J AM COLL CARDIOL, V41, P99, DOI 10.1016/S0735-1097(02)02669-4; Link MS, 1998, NEW ENGL J MED, V338, P1805, DOI 10.1056/NEJM199806183382504; Link MS, 2001, J AM COLL CARDIOL, V37, P649, DOI 10.1016/S0735-1097(00)01142-6; Maron BJ, 1997, AM J CARDIOL, V79, P840, DOI 10.1016/S0002-9149(96)00887-9; MARON BJ, 1995, NEW ENGL J MED, V333, P337, DOI 10.1056/NEJM199508103330602; Maron BJ, 1999, J CARDIOVASC ELECTR, V10, P114, DOI 10.1111/j.1540-8167.1999.tb00648.x; MARON BJ, 2000, CIRCULATION, V102; Meola F, 1879, GIORNALE INT SCI MED, V1, P923; RIEDINGER F, 1903, HDB PRAKTISCHEN CHIR, P373; TENZER ML, 1985, J TRAUMA, V25, P620, DOI 10.1097/00005373-198507000-00008; VIANO DC, 1992, CLIN J SPORT MED, V2, P161; YOUNG F A, 1949, Manit Med Rev, V29, P9; ZEPPILLI P, 2001, CESI, P189; ZEPPILLI P, 2001, CARDIOLOGIA SPORT, P778; 1982, SERIE GEN, V63, P1715	23	3	3	0	4	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	MAR	2005	26	2					151	157		10.1055/s-2004-817916			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	905VT	WOS:000227599600013	15726492				2022-02-06	
J	Floccare, DJ; Cushman, JT				Floccare, DJ; Cushman, JT			Endotracheal intubation in the field: pro position	HOSPITAL MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; CLINICAL-TRIAL; HYPERVENTILATION; SURVIVAL		Maryland Inst Emergency Med Serv Syst, Div Emergency Med, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Div Emergency Med, Baltimore, MD 20742 USA		Floccare, DJ (corresponding author), Maryland Inst Emergency Med Serv Syst, Div Emergency Med, Baltimore, MD 21201 USA.			Cushman, Jeremy/0000-0003-4767-3731			Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Dunham CM, 2004, J TRAUMA, V56, P482, DOI 10.1097/01.TA.0000114537.52540.95; Dunham CM, 2003, J TRAUMA, V55, P162, DOI 10.1097/01.ta.0000083335.93868.2c; Frankel H, 1997, AM J EMERG MED, V15, P630, DOI 10.1016/S0735-6757(97)90174-1; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Pitts S, 2004, LANCET, V364, P313, DOI 10.1016/S0140-6736(04)16740-8; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008	11	3	3	0	0	MARK ALLEN PUBLISHING LTD	LONDON	CROXTED MEWS, 286A-288 CROXTED ROAD, LONDON SE24 9BY, ENGLAND	1462-3935			HOSP MED	Hosp. Med	FEB	2005	66	2					89	91					3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	899DV	WOS:000227126000010	15739702				2022-02-06	
J	Pannen, BHJ; Loop, T				Pannen, BHJ; Loop, T			Evidence-based intensive care treatment of intracranial hypertension after traumatic brain injury	ANAESTHESIST			German	Article						traumatic brain injury; evidence-based medicine; intracranial pressure; conservative treatment; intensive care medicine	SEVERE HEAD-INJURY; RESPIRATORY-DISTRESS-SYNDROME; FACTOR-KAPPA-B; NUCLEAR-FACTOR; BARBITURATE COMA; HYPOTHERMIA; MANNITOL; MANAGEMENT; MEDICINE; TRIAL	Traumatic brain injury (TBI) occurs frequently and is associated with a poor prognosis. Severe TBI results in substantial disability or death in more than 40% of cases. The major aim of treatment of these patients is to minimize secondary brain injury and in this respect, the prevention of intracranial hypertension plays a key role. In addition to surgical approaches, various conservative treatment options exist, such as the use of osmodiuretics, barbiturates, or corticosteroids, hyperventilation as well as induced therapeutic hypothermia. This review analyzes these treatment options and the therapeutic goals of lowering intracranial pressure (ICP) in patients after TBI using evidence-based criteria, and provides recommendations for clinical practice.	Univ Freiburg Klinikum, Anasthesiol Klin, D-79106 Freiburg, Germany		Pannen, BHJ (corresponding author), Univ Freiburg Klinikum, Anasthesiol Klin, Hugstetter Str 55, D-79106 Freiburg, Germany.	pannen@ana1.ukl.uni-freiburg.de					ALDERSON P, 2003, CORTICOSTEROIDS ACUT; Bazarian JJ, 2002, ANN EMERG MED, V40, P515, DOI 10.1067/mem.2002.128780; Bernard SA, 2003, CRIT CARE MED, V31, P2041, DOI 10.1097/01.CCM.0000069731.18472.61; BLOCH M, 1964, BRAIN, V40, P769; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P450; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cruz J, 2002, NEUROSURGERY, V51, P628, DOI 10.1097/00006123-200209000-00006; Cruz J, 2001, NEUROSURGERY, V49, P864; *DIVI, 1997, ANASTH INTENSIVMED, V38, P433; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Firsching R, 2001, WORLD J SURG, V25, P1221; GADKARY CS, 2004, THERAPEUTIC HYPOTHER; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Himmelseher S, 2004, ANASTH INTENSIVMED, V45, P262; Humar M, 2004, MOL PHARMACOL, V65, P350, DOI 10.1124/mol.65.2.350; Kopp R, 2003, ANAESTHESIST, V52, P195, DOI 10.1007/s00101-003-0469-z; Laffey JG, 2002, NEW ENGL J MED, V347, P43, DOI 10.1056/NEJMra012457; Loop T, 2003, ANESTHESIOLOGY, V99, P360, DOI 10.1097/00000542-200308000-00017; Loop T, 2002, ANESTHESIOLOGY, V96, P1202, DOI 10.1097/00000542-200205000-00025; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Pannen B H J, 2002, Anaesthesiol Reanim, V27, P4; *PULM ART CATH CON, 1997, CRIT CARE MEDE, V26, P910; Rhodes Jonathan K J, 2003, Curr Opin Crit Care, V9, P86; Roberts I, 2001, CRIT CARE, V5, P292, DOI 10.1186/cc1051; ROBERTS I, 2003, MANNITOL ACUTE TRAUM; ROBERTS I, 2003, HYPERVENTILATION THE; ROBERTS I, 2003, BARBITURATES ACUTE T; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SCHWARTZ ML, 1984, CAN J NEUROL SCI, V11, P434, DOI 10.1017/S0317167100045960; SMITH HP, 1986, J NEUROSURG, V65, P820, DOI 10.3171/jns.1986.65.6.0820; Stover JF, 1998, EUR J CLIN PHARMACOL, V54, P529, DOI 10.1007/s002280050508; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383	39	3	3	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	FEB	2005	54	2					127	+		10.1007/s00101-004-0785-y			9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	903EZ	WOS:000227409700006	15565388				2022-02-06	
J	Mussack, T; Briegel, J; Schelling, G; Jochum, M				Mussack, T; Briegel, J; Schelling, G; Jochum, M			Hemofiltrastion does not influence early S-100B serum levels in septic shock patients receiving stress doses of hydrocortisone or placebo	EUROPEAN JOURNAL OF MEDICAL RESEARCH			English	Article						septic shock; sepsis; hemofiltration; hydrocortisone; S-100B; brain damage	SYSTEMIC INFLAMMATORY RESPONSE; CRITICALLY-ILL PATIENTS; BRAIN-DAMAGE; NEUROLOGICAL COMPLICATIONS; NEUROBIOCHEMICAL MARKERS; CARDIOPULMONARY BYPASS; CARDIAC-SURGERY; ORGAN FAILURE; HEAD TRAUMA; SEPSIS	Background: The prognosis in patients with hyperdynamic septic shock correlates with the presence and the severity of septic encephalopathy However, the neurological evaluation is considerably influenced by the use of analgesia sedation during mechanical ventilation. An early concentration peak of the neuroprotein S-100B in serum reflects both cellular damage at an increased permeability of the blood-brain-barrier and a delayed renal elimination. Thus, the objective of this study was to analyze the effect of continuous veno-venous hemofiltration (CVVH) on early S-100B serum levels in septic shock patients, who were treated with either stress doses of hydrocortisone or placebo. Methods: Twenty-four consecutive patients, who met the ACCP / SCCM criteria for septic shock, were enrolled in this prospective, randomised, double-blind, single-center trial. The severity of illness at recruitment was graded using the APACHE II and SAPS II scoring systems; the MODS was described by the SOFA score. All patients were prospectively randomised to receive either stress doses of hydrocortisone or placebo. Hydrocortisone was started in 12 patients with a loading dose of 100 mg and followed by a continuous infusion of 0.18 mg/kg/h for 6 days. Results: Median S-100B serum levels of the hydrocortisone group decreased from 0.32 ng/ml (0.19-3.60) at study entry to 0.07 ng/ml (0.04-0.32) 6 days later without significant differences compared to the placebo group. Patients undergoing CVVH showed significantly higher S-100B serum values compared to patients without CVVH (p<0.001). However, initial median S-100B serum levels of the CVVH group even increased from 0.92 ng/ml (0.16 - 4.63) to 2.33 ng/ml (0.59 - 2.44) 30 hours after stud), entry, reaching data ranges already known in patients with out-of-hospital cardiac arrest or severe traumatic brain injury Conclusion: Early S-100B serum levels in septic shock patients receiving either stress doses of hydrocortisone or placebo were not influenced by CVVH. For the first time, we observed a similar extent of S-100B serum increase in CVVH patients, who had significantly higher S-100B serum values compared to those without CVVH, as reported for out-of-hospital cardiac arrest or severe traumatic brain injury; Hypercortisolemia induced by the infusion of stress doses of hydrocortisone did not significantly reduce early S100B serum concentrations with time.	Univ Munich, Klinikum Innenstadt, Dept Surg, D-80336 Munich, Germany; Klinikum Univ Munchen, Dept Clin Chem & Clin Biochem, D-80336 Munich, Germany; Klinikum Univ Munchen, Klinikum Grosshadern, Dept Anaesthesiol, D-80336 Munich, Germany		Mussack, T (corresponding author), Univ Munich, Klinikum Innenstadt, Dept Surg, Nussbaumstr 20, D-80336 Munich, Germany.	Thomas.Mussack@med.uni-muenchen.de	Josef, Briegel/ABF-3522-2021; Schelling, Gustav/U-2603-2018; Briegel, Josef/AAG-3774-2019	Schelling, Gustav/0000-0002-6538-0652; 			Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Astudillo R, 1996, Eur J Cardiothorac Surg, V10, P1107, DOI 10.1016/S1010-7940(96)80358-7; Barie PS, 1998, J TRAUMA, V44, P1108, DOI 10.1097/00005373-199806000-00032; BARIE PS, 1994, J TRAUMA, V37, P660, DOI 10.1097/00005373-199410000-00022; BASTOS PG, 1993, CRIT CARE MED, V21, P1459, DOI 10.1097/00003246-199310000-00012; Bertsch T, 2001, CLIN CHEM LAB MED, V39, P319, DOI 10.1515/CCLM.2001.050; Blomquist S, 1997, J CARDIOTHOR VASC AN, V11, P699, DOI 10.1016/S1053-0770(97)90160-9; Bollaert PE, 1998, CRIT CARE MED, V26, P645, DOI 10.1097/00003246-199804000-00010; BOLTON CF, 1993, ANN NEUROL, V33, P94, DOI 10.1002/ana.410330115; Bolton CF, 1996, CRIT CARE MED, V24, P1408, DOI 10.1097/00003246-199608000-00022; BRIEGEL J, 1994, CLIN INVESTIGATOR, V72, P782; Briegel J, 1999, CRIT CARE MED, V27, P723, DOI 10.1097/00003246-199904000-00025; Briegel J, 2001, J AM SOC NEPHROL, V12, pS70; Cole L, 2002, CRIT CARE MED, V30, P100, DOI 10.1097/00003246-200201000-00016; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Eidelman LA, 1996, JAMA-J AM MED ASSOC, V275, P470, DOI 10.1001/jama.275.6.470; GROENEVELD ABJ, 1990, INTENS CARE MED, V16, P489, DOI 10.1007/BF01709397; HAIMOTO H, 1987, LAB INVEST, V57, P489; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Hoffmann JN, 1996, INTENS CARE MED, V22, P1360, DOI 10.1007/BF01709552; Hund E, 2001, J NEUROL, V248, P929, DOI 10.1007/s004150170043; Hund E, 1999, CRIT CARE MED, V27, P2544, DOI 10.1097/00003246-199911000-00036; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Lindner A, 1998, INTERNIST, V39, P485, DOI 10.1007/s001080050200; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Mussack T, 2000, ACT NEUR S, V76, P393; Mussack T, 2001, RESUSCITATION, V49, P193, DOI 10.1016/S0300-9572(00)00346-4; Rosen H, 1998, STROKE, V29, P473, DOI 10.1161/01.STR.29.2.473; Schwarz S, 1997, NERVENARZT, V68, P292, DOI 10.1007/s001150050127; USUI A, 1989, CLIN CHEM, V35, P1942; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Westaby S, 1996, ANN THORAC SURG, V61, P88, DOI 10.1016/0003-4975(95)00904-3; Wheeler AP, 1999, NEW ENGL J MED, V340, P207, DOI 10.1056/NEJM199901213400307; Wiesmann M, 1997, ACTA NEUROCHIR, V139, P1155, DOI 10.1007/BF01410976; Wunderlich MT, 1999, STROKE, V30, P1190, DOI 10.1161/01.STR.30.6.1190; YOUNG GB, 1990, CLIN INVEST MED, V13, P297	38	3	3	0	0	I HOLZAPFEL VERLAG GMBH	MUNICH	RAUCHSTR 8, D-81679 MUNICH, GERMANY	0949-2321			EUR J MED RES	Eur. J. Med. Res.	JAN 28	2005	10	1					11	17					7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	898QN	WOS:000227091400003	15737948				2022-02-06	
J	Cagavi, F; Tekkok, IH; Akpinar, G				Cagavi, F; Tekkok, IH; Akpinar, G			Malignant cerebral infarction secondary to internal carotid injury in closed head trauma: Good outcome with aggressive treatment - A case report	ANGIOLOGY			English	Article							ARTERY INJURY; FRACTURE; THROMBOSIS; SKULL	A 25-year-old male patient in whom occlusion of the internal carotid artery developed secondary to a skull base fracture is presented. The diagnosis of internal carotid artery occlusion was reached 12 hours after the admission and 17 hours after the injury. The patient was initially treated for ischemic edema and when the patient showed signs of cerebral herniation, decompressive craniectomy was necessary. The outcome was good. The clinical and radiologic characteristics of internal carotid artery occlusion in closed head injury are highlighted and treatment options are reviewed in light of pertinent literature.	Mersin Univ, Sch Med, TR-33079 Mersin, Turkey; Bayindir Med Ctr, Ankara, Turkey		Tekkok, IH (corresponding author), Mersin Univ Tip Fak, Beyin Ve Sinir Cerrahisi AD, TR-33079 Mersin, Turkey.	tekkokih@hotmail.com					AARABI B, 1978, SURG NEUROL, V10, P233; ARSENI C, 1980, NEUROCHIRURGIA, V23, P25; Berlot G, 1996, Eur J Emerg Med, V3, P36, DOI 10.1097/00063110-199603000-00007; Bouthillier A, 1996, NEUROSURGERY, V38, P425, DOI 10.1097/00006123-199603000-00001; Carter DA, 1998, J TRAUMA, V44, P230, DOI 10.1097/00005373-199801000-00039; Erikson S, 1943, ACTA RADIOL, V24, P392, DOI 10.3109/00016924309137646; FABIAN TC, 1990, J TRAUMA, V30, P953, DOI 10.1097/00005373-199008000-00003; GOODWIN JR, 1994, J TRAUMA, V37, P119, DOI 10.1097/00005373-199407000-00021; MORGAN MK, 1987, J NEUROSURG, V66, P192, DOI 10.3171/jns.1987.66.2.0192; Pedraza S, 2000, REV NEUROLOGIA, V31, P1007, DOI 10.33588/rn.3111.2000371; Resnick DK, 1997, NEUROSURGERY, V40, P1177, DOI 10.1097/00006123-199706000-00012; Rommel O, 1999, CEREBROVASC DIS, V9, P202, DOI 10.1159/000015956; SHIRAI S, 1976, SHINKEI GEKA, V4, P605; Tartara F, 2000, J Neurosurg Sci, V44, P103; UNGER JM, 1990, RADIOLOGY, V175, P175, DOI 10.1148/radiology.175.1.2315477; VIGOUROUX R, 1962, NEURO-CHIR, V8, P115; WEST OC, 1993, RADIOLOGY, V188, P329, DOI 10.1148/radiology.188.2.8327674	17	3	4	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-3197	1940-1574		ANGIOLOGY	Angiology	JAN-FEB	2005	56	1					107	114		10.1177/000331970505600116			8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	891BT	WOS:000226557000016	15678265				2022-02-06	
J	Gongora, EL; McKenney, A; Godinez, C				Gongora, Elizabeth L.; McKenney, Alexis; Godinez, Caroline			A Multidisciplinary Approach to Teaching Anger Coping After Sustaining a Traumatic Brain Injury: A Case Report	THERAPEUTIC RECREATION JOURNAL			English	Article						Anger; Coping; Therapeutic Recreation; Traumatic Brain Injury		This case report describes an anger coping program that was used with an individual who sustained a traumatic brain injury as a result of an automobile accident. A certified therapeutic recreation specialist and a neuro-psychologist implemented the program to teach coping skills as part of the client's treatment in an outpatient brain injury program. Skills taught throughout the program included: (a) identifying anger, (b) reacting to anger, (c) recognizing the boiling point, (d) coping with stress and anger, (e) discussing assertive reactions, (f) modeling assertive behavior, (g) role-playing assertive behavior, and (h) processing feelings. A review of the program indicated that the participant demonstrated an improved ability to cope with, and respond to, anger as a result of participating in the anger coping program.	[Gongora, Elizabeth L.] Miami Jewish Home & Hosp Aged, Miami, FL USA; [McKenney, Alexis] Florida Int Univ, Therapeut Recreat, Miami, FL 33199 USA; [Godinez, Caroline] Baptist Hosp Miami, Miami, FL USA; [Godinez, Caroline] Baptist Hosp Miami, Brain Injury Program, Miami, FL USA		McKenney, A (corresponding author), Florida Int Univ, Miami, FL 33199 USA.						Austin D. R., 2000, THERAPEUTIC RECREATI; Beck J.S., 1995, COGNITIVE THERAPY BA; Brophy J. E., 1990, ED PSYCHOL REALISTIC, V4th; Brown Timothy A., 1993, P137; Campbell M., 2000, REHABILITATION THERA; CARTER M, 1995, THERAPEUTIC RECREATI; Center for Outcome Measurement in Brain Injury (COMBI, 2003, FUNCT IND MEAS FIM; Centers for Disease Control, 2004, TRAUM BRAIN INJ FACT; Demark J, 2002, BRAIN INJURY, V16, P91, DOI 10.1080/02699050110102059; Golant M, 1987, SOMETIMES ITS OK BE; Hal KM, 1997, J REHABILITATION OUT, V1, P63; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Hart J. H., 1993, COGNITIVE BEHAV PROC, P1; LOCHMAN JE, 1986, J CLIN CHILD PSYCHOL, V15, P159, DOI 10.1207/s15374424jccp1502_8; Mateer C. A., 1999, REHABILITATION ADULT, P254; McKenney A., 2000, FACILITATION TECHNIQ, P41; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; PETERSON CA, 2000, THERAPEUTIC RECREATI; Reilly P.M, 2002, ANGER MANAGEMENT SUB, DOI [12-4210/SMA12-4210.PDF., DOI 12-4210/SMA12-4210.PDF]; Seligman M. E. P., 1993, WHAT YOU CAN CHANGE; Smith S. W., 1993, BEHAV DISORDERS, V19, P126; Spielberger CD., 1988, STATE TRAIT ANGER EX; SUNY@Buffalo, 1997, GUID UN DAT SET MED	23	3	3	0	0	SAGAMORE PUBL LLC	URBANA	1807 N FEDERAL DR, URBANA, IL 61801 USA	0040-5914	2159-6433		THER RECREAT J	Ther. Recreat. J.		2005	39	3					229	240					12	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	VF4KZ	WOS:000442875700004					2022-02-06	
J	Maksymiuk, G; Szlakowska, M; Stepien, A; Modrzewski, A				Maksymiuk, G; Szlakowska, M; Stepien, A; Modrzewski, A			Changes in regional cerebral blood flow, cognitive functions and emotional status in patients after mild traumatic brain injury - Retrospective evaluation	BIOLOGY OF SPORT			English	Article						postconcussion syndrome; regional cerebral blood flow; mild traumatic brain injury; cognitive disturbances	HEAD-INJURY; COMPUTED-TOMOGRAPHY; CONCUSSION; SYMPTOMS; MORBIDITY; DISORDER; HISTORY	The aim of the study was to estimate rCBF in patients after mild traumatic brain injury (mTBI) and to compare the results of neuropsychological examinations. The study was conducted in a group of 17 males aged 19-25 years (average age 22.1) after mTBI. The SPECT examination carried out early after the trauma, showed in 16 patients numerous foci of the decreased perfusion mostly in the frontal and temporal areas and, less frequently, in the parietal areas of brain; the foci were localised predominantly in the left hemisphere. One year after the injury, both the magnitude and the intensity of rCBF alterations were in 7 patients less pronounced than shortly after the trauma, and in 3 patients reduction of changes was very significant. Abnormal concentration and attention divisibility level was found in 9 (52.9%) patients in early period after mTBI. In five of them, and another one (35.3%) with previous normal result of Couve test, abnormalities were found a year after TBI as well. Short-term memory was weak directly after mTBI in 11 (64.7%) subjects. High anxiety level coexisted in patients with abnormalities described above in early period and a year after trauma. Depression was diagnosed in 5 patients a year after TBI. It was consistent with their complaints found in other psychological examinations. All above-mentioned abnormal results were found in patients with high level of neuroticism. Multifocal rCBF changes revealed in acute phase and a year after trauma did not correlated with psychological patient status. Our survey did not revealed any relationship between the results of SPECT examination and the development or sort of posttraumatic cognitive abnormalities found in neuropsychological tests.	Polish Air Force, Inst Aviat Med, Neurol Clin, PL-01755 Warsaw, Poland		Maksymiuk, G (corresponding author), Polish Air Force, Inst Aviat Med, Neurol Clin, Krasinskiego 54, PL-01755 Warsaw, Poland.	gmaksymiuk@poczta.onet.pl					Abu-Judeh HH, 1999, NUCL MED COMMUN, V20, P505, DOI 10.1097/00006231-199906000-00003; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; CASEY R, 1986, PEDIATRICS, V78, P497; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; GRABOWSKA A, 1997, BRAIN BEHAV, P147; GRAHAM DI, 1996, NEUROLOGY TRAUMA, P53; GRAY BG, 1992, J NUCL MED, V33, P52; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; KOWALSKA DM, 1997, BRAIN BEHAV, P298; KRAUS JF, 1996, NEUROLOGY TRAUMA, P3; Leclerc S, 2001, SPORTS MED, V31, P629, DOI 10.2165/00007256-200131080-00007; Levin HS., 1982, NEUROBEHAVIORAL CONS; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; MCMORDIE WR, 1988, CLIN NEUROPSYCHOL, V2, P198; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mrazik M, 2000, BRAIN INJURY, V14, P921, DOI 10.1080/026990500445736; POLLIN RS, 1996, NEUROLOGY TRAUMA, P166; POVLISHOCK JT, 1979, ACTA NEUROPATHOL, V47, P1, DOI 10.1007/BF00698266; POVLISHOK JT, 1986, J NEUROPATHOL EXP NE, V42, P225; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; World Health Organization, 1978, MENT DIS GLOSS GUID; YOKOTA H, 1991, J TRAUMA, V31, P351, DOI 10.1097/00005373-199103000-00007	28	3	3	0	3	INST SPORT	WARSAW 45	TRYLOGII 2, POB 30,, 01-892 WARSAW 45, POLAND	0860-021X			BIOL SPORT	Biol. Sport		2005	22	3					281	291					11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	969RA	WOS:000232251200008					2022-02-06	
J	Owacki, MG; Czernicki, Z; Jurkiewicz, J; Walasek, N				Owacki, Mariusz G.; Czernicki, Zbigniew; Jurkiewicz, Jerzy; Walasek, Nestor			Teleradiology in neurosurgery, based on the experience of the Department of Neurosurgery, Polish Academy of Sciences	POLISH JOURNAL OF RADIOLOGY			English	Article						teleradiology; computed tomography; teleconsulting; neurosurgery		Background: The aim of the study was to analyze experience with the teleconsulting system applied at the Department of Neurosurgery, Polish Academy of Sciences (PAN) and to establish the best medical and economic conditions for teleradiological networks. Material/Methods: The presented system is based on frame-grabbing technology and is operated by MultiView T 2.0D (eMeD, Tech.) software. Computed tomography (CT) examinations performed in the hospitals in Ciechanow or Ostroleka are transmitted to the teleconsulting center in the Department of Neurosurgery, PAN. Regular telephone lines with a transmission speed of 56 kbps are utilized. One whole CT examination is transmitted in 5 to 7 minutes. All clinical information is reported during telephone conversation optimized by a specific questionnaire which helps improve arrangements for neurosurgical intervention and to document consultations. The usefulness of mobile phones and email in teleradiology was also evaluated. Results: The period from December 1996 to April 2002 was studied. During this time, 931 transmission were performed. The most common were control examinations (26%), followed by neurotrauma (19%), spontaneous intracerebral hemorrhage (18%), neurooncology (13%), subarachnoidal hemorrhage (7%), hydrocephalus (5%), cerebral ischemia (3%), and those without any intracranial pathologies (4%). Disturbances were observed in 4% of transmissions. Seventy percent of the consulted patients were treated conservatively in remote hospitals. Thirty percent of the cases were admitted to our department, of whom 86% were operated. Mobile phones were found to be a useful tool in urgent neurosurgical consultations. Sending compressed CT images via email provided sufficient quality, but requires a particular technical background. Conclusions: The system allows for: 1) proper qualification for neurosurgical treatment, 2) fast and easy access to consultations with specialists, 3) patient follow-up (repeated consultations), 4) avoidance of unnecessary transportation, and 5) transportation cost reductions. These results indicate the usefulness of applying the presented system in different medical fields and the necessity of developing regional and national multidisciplinary teleconsulting networks.	[Owacki, Mariusz G.; Czernicki, Zbigniew; Jurkiewicz, Jerzy; Walasek, Nestor] Zakad Neurochirurgii IMDiK PAN, Ul. Ceg.owska 80, PL-01809 Warsaw, Poland; [Czernicki, Zbigniew; Jurkiewicz, Jerzy] Akad Medyczna, Klin Neurochirurgii wydzia lekarski 2, Warsaw, Poland		Owacki, MG (corresponding author), Zakad Neurochirurgii IMDiK PAN, Ul. Ceg.owska 80, PL-01809 Warsaw, Poland.	mgwaw@bielanski.med.pl					Aarnio P, 2000, J TELEMED TELECARE, V6, P237, DOI 10.1258/1357633001935301; AGGARWAL A, 2000, J TELEMEDICINE TE S1, V6, P217; *AM COLL RAD, 1998, ACR STAND TEL; American College of Radiology, 2000, ACR STAND GEN RAD; American College of Radiology, 1999, ACR STAND COMM DIAGN; Anogianakis G, 1997, Stud Health Technol Inform, V39, P264; Apple SL, 2000, SURG NEUROL, V53, P411, DOI 10.1016/S0090-3019(00)00194-4; Bailes J E, 1997, Telemed Today, V5, P26; BAILES JE, 1994, NEUROSURGERY, V35, P732, DOI 10.1227/00006123-199410000-00021; Beach M, 2000, J TELEMED TELECARE, V6, P90, DOI 10.1258/1357633001934276; BIDGOOD WD, 1992, RADIOGRAPHICS, V12, P345, DOI 10.1148/radiographics.12.2.1561424; Bonnin A, 1999, B ACAD NAT MED PARIS, V183, P1123; BRILEY MS, 1994, BRIT J RADIOL, V67, P453, DOI 10.1259/0007-1285-67-797-453; Buravkov SV, 1999, J TELEMED TELECARE, V5, P31, DOI 10.1258/1357633991932450; Cannavo M J, 1996, Health Manag Technol, V17, P44; Chen HS, 2001, INT J MED INFORM, V61, P117, DOI 10.1016/S1386-5056(01)00134-4; Coutino JC, 1999, J TELEMED TELECARE, V5, P131, DOI 10.1258/1357633991933332; Czernicki Z., 2000, RESTORIATIVE NEUROLO, V16, P347; Darkins A, 1996, J Telemed Telecare, V2 Suppl 1, P82, DOI 10.1258/1357633961929385; Filip M, 2001, LEKAR TECHNIKA, V32, P158; Filip M., 2000, LEKAR TECHNIKA, V31, P162; Gale ME, 1997, J DIGIT IMAGING, V10, P47, DOI 10.1007/BF03168555; Gelber H, 1999, J TELEMED TELECARE, V5, P21, DOI 10.1258/1357633991933297; Glowacki M., 2002, ACTA NEUROCHIRUGICA, V144, pA12; Glowacki M., 2002, NEUROL NEUROCHIR POL, P363; Goh KYC, 1997, BRIT J NEUROSURG, V11, P52; Gray W.P., 1995, EUR RADIOL, V5, pS296; Gray W.P., 1996, J TELEMEDICINE TE S1, V3, P36; Gray WP, 1998, NEUROSURGERY, V42, P103, DOI 10.1097/00006123-199801000-00020; Houkin K, 1999, NEUROL MED-CHIR, V39, P773, DOI 10.2176/nmc.39.773; HUANG HK, 1993, COMPUT MED IMAG GRAP, V17, P1, DOI 10.1016/0895-6111(93)90069-Y; Hynes D.M, 1997, LANCET, V30, P350; Kehler M, 1997, ACTA RADIOL, V38, P338; Klutke PJ, 1999, MED INFORM INTERNET, V24, P135, DOI 10.1080/146392399298474; Lee JKT, 1998, ACAD RADIOL, V5, P533, DOI 10.1016/S1076-6332(98)80204-3; LOU SL, 1992, AM J ROENTGENOL, V159, P1321, DOI 10.2214/ajr.159.6.1442409; Mattioli P, 1999, COMPUT METH PROG BIO, V60, P143, DOI 10.1016/S0169-2607(99)00029-2; Newcombe R, 1999, J CLIN NEUROSCI, V6, P85, DOI 10.1016/S0967-5868(99)90619-7; ROBERGE FA, 1982, CAN MED ASSOC J, V127, P707; Rosser JC, 1999, J AM COLL SURGEONS, V189, P397, DOI 10.1016/S1072-7515(99)00185-4; Samiotakis Y, 2000, Stud Health Technol Inform, V57, P91; Sebera W, 1994, Adm Radiol, V13, P53; SIMON R, 1995, COMPUTER, V28, P65, DOI 10.1109/2.384119; SPENCER JA, 1991, CLIN RADIOL, V44, P342, DOI 10.1016/S0009-9260(05)81273-5; Tachakra S, 2000, J TELEMED TELECARE, V6, P178, DOI 10.1258/1357633001934591; Urban V, 1996, Eur J Emerg Med, V3, P5, DOI 10.1097/00063110-199603000-00001; Wysoki MG, 1998, RADIOLOGY, V208, P125, DOI 10.1148/radiology.208.1.9646802	47	3	3	0	0	INT SCIENTIFIC INFORMATION INC	SMITHTOWN	361 FOREST LN, SMITHTOWN, NY 11787 USA	0137-7183	1899-0967		POL J RADIOL	Pol. J. Radiol.		2005	70	4					27	34					8	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	V6J1E	WOS:000420330500004					2022-02-06	
J	Platt, S				Platt, S			Evaluation and treatment of the head trauma patient	IN PRACTICE			English	Article								SEVERE head trauma is associated with high mortality, with death often resulting from progressive increases in intracranial pressure. Brain injury in dogs and cats is most frequently caused by road traffic accidents, but can also be due to falls, kicks, gunshot wounds and animal bites. Appropriate management of patients with head trauma remains a controversial area in veterinary medicine because of a lack of retrospective studies evaluating treatment approaches for dogs and cats with similar injuries. Notwithstanding, management of affected cases must be immediate if the animal is to recover to a level that is both functional and acceptable to the owner. The first veterinary surgeon to deal with an animal suffering from brain injuries following an inciting traumatic event will dictate that patients fate! It is important to be aware of the optimal way to assess head trauma cases before making treatment decisions. Many dogs and cats can indeed recover from severe brain injuries if treatable systemic and neurological abnormalities are identified promptly. This article discusses current recommendations for optimising the chances of success for such patients.	Anim Hlth Trust, Neurol Unit, Newmarket CB8 7DW, Suffolk, England		Platt, S (corresponding author), Anim Hlth Trust, Neurol Unit, Newmarket CB8 7DW, Suffolk, England.						Dewey CW, 2000, VET CLIN N AM-SMALL, V30, P207, DOI 10.1016/S0195-5616(00)50010-2; Platt SR, 2001, J VET INTERN MED, V15, P581, DOI 10.1892/0891-6640(2001)015&lt;0581:TPVOTM&gt;2.3.CO;2	2	3	3	2	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0263-841X	2042-7689		IN PRACTICE	In Practice	JAN	2005	27	1					31	35		10.1136/inpract.27.1.31			5	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	890DL	WOS:000226491800003					2022-02-06	
J	Gonzalez, MA; Benito, RP; Grabulosa, JMS				Ariza Gonzalez, Mar; Pueyo Benito, Roser; Serra Grabulosa, Josep Maria			Neuropsychological sequelae of traumatic brain injury.	ANALES DE PSICOLOGIA			Spanish	Article						Traumatic brain injury; neuropsychology; sequelae; neuroimage; assessment	CLOSED-HEAD-INJURY; DIFFUSE AXONAL INJURY; MAGNETIC-RESONANCE SPECTROSCOPY; COGNITIVE SEQUELAE; VENTRICULAR ENLARGEMENT; BEHAVIORAL SEQUELAE; PROCEDURAL MEMORY; EARLY INDEXES; DAMAGE; RECOVERY	Nowadays, the clinical neuropsychologist faces a great number of patients surviving to a Traumatic Brain Injury (TBI) with neurological sequelae, partially due to the improvement of the therapeutic techniques. TBI neuropsychological impairment is directly related to underlying physiopathological mechanisms and biological and demographic variables. The knowledge of the physiopathology and the execution of neuroimaging studies, which provide structural and functional data, are necessary for the judgment of TBI effects. The prototype to moderate to severe TBI lesion prototype is probably generalized, non-specific damage, but with greater involvement of the frontal and temporal lobe regions. Brain damage is reflected on the impaired neuropsychological functions after a TBI, which are mainly attention, memory, frontal functions, emotion and behaviour.	[Ariza Gonzalez, Mar] Univ Barcelona, Fac Psicol, Dept Psiquiatria & Psicobiol Clin, Barcelona 08035, Spain		Gonzalez, MA (corresponding author), Univ Barcelona, Fac Psicol, Dept Psiquiatria & Psicobiol Clin, Passeig Vall Hebron 171, Barcelona 08035, Spain.	mariza@psi.ub.es	Benito, Roser Pueyo/G-3433-2011; Serra-Grabulosa, Josep M/S-8371-2019	Benito, Roser Pueyo/0000-0002-8230-8409; Serra-Grabulosa, Josep M/0000-0002-4291-9432			Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ALEXANDRE A, 1983, J NEUROSURG, V59, P751, DOI 10.3171/jns.1983.59.5.0751; Almli CR, 1992, J HEAD TRAUMA REHAB, V7, P70; ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; Anderson CV, 1996, J NEUROTRAUM, V13, P35, DOI 10.1089/neu.1996.13.35; Ariza M, 2004, ARCH NEUROL-CHICAGO, V61, P541, DOI 10.1001/archneur.61.4.541; Ariza M., J NEUROTRAU IN PRESS; Benavidez DA, 1999, CORTEX, V35, P315, DOI 10.1016/S0010-9452(08)70803-7; BENNETTLEVY JM, 1984, ACTA NEUROL SCAND, V70, P285; Bentivoglio M, 1999, BRAIN RES BULL, V50, P383, DOI 10.1016/S0361-9230(99)00115-X; Bigler E, 1990, TRAUMATIC BRAIN INJU, P13; BIGLER ED, 1992, BRAIN RES BULL, V28, P651, DOI 10.1016/0361-9230(92)90119-I; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Bigler ED, 1996, J LEARN DISABIL-US, V29, P515, DOI 10.1177/002221949602900507; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; Blumer D., 1975, PSYCHIAT ASPECTS NEU; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; Brooks D.N., 1988, ACTA NEUROCHIRURGI S, V44, P59; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Brooks N, 1984, CLOSED HEAD INJURY P, P123; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; BROUWER WH, 1989, CORTEX, V25, P219, DOI 10.1016/S0010-9452(89)80038-3; BROWN DSO, 1992, ARCH PHYS MED REHAB, V73, P758; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; Eames P. G., 1990, NEUROBEHAVIOURAL SEQ; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Gennarelli T. A., 1987, HEAD INJURY, P108; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA, 1997, NEUROSCIENTIST, V3, P73, DOI 10.1177/107385849700300117; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Gil M, 1996, BRAIN INJURY, V10, P39, DOI 10.1080/026990596124700; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Gronwall D, 1974, PSYCHOL EFFECTS CONC; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; GROSWASSER Z, 1977, SCAND J REHABIL MED, V9, P147; Halstead W.C., 1947, BRAIN INTELLIGENCE; Hamsher K., 1989, MULTILINGUAL APHASIA; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Heaton RK, 1981, MANUAL WISCONSIN CAR; HECAEN H, 1976, BRAIN LANG, V3, P114, DOI 10.1016/0093-934X(76)90009-2; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; HOGARTY GE, 1971, ARCH GEN PSYCHIAT, V25, P470; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 1981, MANAGEMENT HEAD INJU; JUNQUE C, 1998, TRAUMATISMOS CRANEOE; KAPLAN E, 1986, TEST VOCABULARIO BOS; Katoh H, 1997, BRAIN RES, V758, P153, DOI 10.1016/S0006-8993(97)00213-8; KERR C, 1995, BRAIN INJURY, V9, P777, DOI 10.3109/02699059509008234; KlOve H, 1963, MED CLIN N AM; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; LEES J, 1989, CHILDRENS HEAD INJUR, P80; LEVIN HS, 1990, J NEUROSURG, V73, P77, DOI 10.3171/jns.1990.73.1.0077; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; LUYTEN PR, 1986, RADIOLOGY, V161, P795, DOI 10.1148/radiology.161.3.3786735; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; MCLELLAN DR, 1990, COMA EMERGING PATIEN, P389; MEYERS CA, 1983, J NEUROL NEUROSUR PS, V46, P1092, DOI 10.1136/jnnp.46.12.1092; MILLER E, 1980, J NEUROL NEUROSUR PS, V43, P525, DOI 10.1136/jnnp.43.6.525; MUNOZCESPEDES JM, 1997, MAPFRE MED, V8, P41; Murdoch G. E, 1990, ACQUIRED SPEECH LANG; Nakano K, 2000, J NEUROL, V247, P1; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Ponsford JL, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; POWELL GE, 1981, BRAIN FUNCTION THERA; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; Prigatano GP, 1985, NEUROPSYCHOLOGICAL R; Primus EA, 1997, BRAIN INJURY, V11, P577; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; REIDERGROSWASSER I, 1993, AM J ROENTGENOL, V160, P147, DOI 10.2214/ajr.160.1.8416613; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A, 1959, TEST COPIE REPRODUCT; Rey A., 1964, EXAMEN CLIN PSYCHOL; Ricci B, 1997, NEURORADIOLOGY, V39, P313, DOI 10.1007/s002340050415; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; ROSS BL, 1994, AM J PHYS MED REHAB, V73, P341, DOI 10.1097/00002060-199409000-00007; SCHOENFELD TA, 1977, PHYSIOL BEHAV, V18, P951, DOI 10.1016/0031-9384(77)90206-2; Serra-Grabulosa J . M., J NEUROLOGY IN PRESS; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SIMON HA, 1975, COGNITIVE PSYCHOL, V7, P268, DOI 10.1016/0010-0285(75)90012-2; Smith A., 1991, SYMBOL DIGIT MODALIT; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Sohlberg M. M, 1990, COMMUNITY INTEGRATIO; Stuss D.T, 1987, NEUROBEHAVIOURAL REC; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; TABADDOR K, 1984, NEUROSURGERY, V14, P701, DOI 10.1227/00006123-198406000-00010; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; TEASDALE G, 1982, BRIT MED J, V285, P1695, DOI 10.1136/bmj.285.6356.1695; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Timmerman ME, 1999, NEUROPSYCHOLOGIA, V37, P467, DOI 10.1016/S0028-3932(98)00085-2; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630; UZZELL BP, 1987, NEUROSURGERY, V20, P396, DOI 10.1227/00006123-198703000-00007; Van Zomeren A.H, 1990, TRAUMATIC BRAIN INJU; Van Zomeren A. H, 1990, PRINCIPLES PRATTLE N; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Verger K, 2000, BRAIN INJURY, V14, P495; Verger K, 2001, REV NEUROLOGIA, V33, P30, DOI 10.33588/rn.3301.2001103; VILKKI J, 1988, J NEUROL NEUROSUR PS, V51, P1452, DOI 10.1136/jnnp.51.11.1452; Walsh K. W., 1985, UNDERSTANDING BRAIN; Warrington E, 1984, RECOGNITION MEMORY T, V1; Whyte J, 1993, REHABILITATION MED P, P825; WILLER B, 1990, NEUROBEHAVIORAL SEQU; WILSON B, 1991, Brain Injury, V5, P189, DOI 10.3109/02699059109008089; Wilson B. A., 1992, NEUROPSYCHOLOGY MEMO, P315; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; YLVISAKER M, 1993, NEUROPSYCHOL REHABIL, V3, P367, DOI 10.1080/09602019308401447	138	3	10	1	4	UNIV MURCIA	MURCIA	SOC ESPANOLA HISTORIA AGRARIA, CAMPUS ESPINARDO, MURCIA, 30100, SPAIN	0212-9728	1695-2294		AN PSICOL-SPAIN	An. Psicol.	DEC	2004	20	2			SI		303	316					14	Psychology; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	V22DY	WOS:000208257100010					2022-02-06	
J	Mandelcorn, J; Cullen, NK; Bayley, MT				Mandelcorn, J; Cullen, NK; Bayley, MT			A preliminary study of the efficacy of ondansetron in the treatment of ataxia, poor balance and incoordination from brain injury	BRAIN INJURY			English	Article							BLIND DRUG-PLACEBO; ANTAGONIST ONDANSETRON; CEREBELLAR-ATAXIA; BUSPIRONE; DELIRIUM; STROKE; SCALE	Background: Ataxia is caused by a variety of conditions leading to imbalance, incoordination and other disabilities. Current treatment is largely symptomatic. Ondansetron (a 5-HT3 antagonist) has been established as an anti-emetic in cancer patients, but has recently been shown to improve vertigo and cerebellar tremor in some patients. Hypothesis: Ondansetron can improve symptoms of ataxia, imbalance and incoordination in four brain-injured patients. Design: Placebo-controlled, double blind, crossover, 'n of 1' study, A-B-A design. Subjects: Four patients with ataxia from traumatic brain injury. Methods: Four patients underwent five separate tests of ataxia under three different conditions in a double blind fashion. Results: For all subjects, there was little difference in scores in the five areas tested, with some improvement in tests of lower limb ataxia (10.4% for 4 mg and 10.7% for 8 mg ondansetron vs baseline). Conclusion: Ondansetron use showed a trend towards improvement in tests of lower extremity ataxia but did not consistently improve scores in four patients.	Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada		Cullen, NK (corresponding author), Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	cullen.nora@torontorehab.on.ca		Cullen, Nora/0000-0001-6359-9418; Bayley, Mark/0000-0001-7860-9463			*AM GUID SERV INC, 1969, MINN RAT MAN TESTS E; Backman CL, 1997, ARCH PHYS MED REHAB, V78, P1145, DOI 10.1016/S0003-9993(97)90142-8; Bayindir O, 2000, J CARDIOTHOR VASC AN, V14, P288, DOI 10.1016/S1053-0770(00)90127-7; Bayindir O, 2001, J THORAC CARDIOV SUR, V121, P176, DOI 10.1067/mtc.2001.108726; BERG K, 1995, SCAND J REHABIL MED, V27, P27; BERG K, 1989, Physiotherapy Canada, V41, P304; BERG KO, 1992, ARCH PHYS MED REHAB, V73, P1073; BERGER AW, 1992, J DISCRETE EVENT DYN, V2, P7; Broocks A, 1998, PSYCHIAT RES, V79, P11, DOI 10.1016/S0165-1781(98)00029-8; Charuluxananan S, 2000, REGION ANESTH PAIN M, V25, P535, DOI 10.1053/rapm.2000.7809; FREEMAN AM, 1998, DEPRESS ANXIETY, V79, P11; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; LOU JS, 1995, ARCH NEUROL-CHICAGO, V52, P982, DOI 10.1001/archneur.1995.00540340074015; PLAITAKIS A, 1978, J NEUROCHEM, V3, P1087; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; REPCHINSKY C, 2000, COMEPNDIUM PHARM SPE, P1797; Rice GPA, 1997, J NEUROL NEUROSUR PS, V62, P282, DOI 10.1136/jnnp.62.3.282; RICE GPA, 1995, LANCET, V345, P1182, DOI 10.1016/S0140-6736(95)91015-8; Sirota P, 2000, AM J PSYCHIAT, V157, P287, DOI 10.1176/appi.ajp.157.2.287; Tiffin J., 1948, PURDUE PEGBOARD EXAM; Trouillas P, 1997, ARCH NEUROL-CHICAGO, V54, P749, DOI 10.1001/archneur.1997.00550180059013; TROUILLAS P, 1995, ARCH NEUROL-CHICAGO, V52, P456, DOI 10.1001/archneur.1995.00540290042016; VANWOERT MH, 1979, BRAIN RES, V138, P103; Wilde MI, 1996, DRUGS, V52, P773, DOI 10.2165/00003495-199652050-00010; Wood-Dauphine S, 1997, CAN J REHABIL, V10, P35	27	3	3	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2004	18	10					1025	1039		10.1080/02699050410001672297			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	845LQ	WOS:000223244600006	15370901				2022-02-06	
J	Ortega-Martinez, M; Fernandez-Portales, I; Perals, LFG; Cabezudo, JM				Ortega-Martinez, M; Fernandez-Portales, I; Perals, LFG; Cabezudo, JM			Contralateral extradural hematoma during evacuation of a previous one	NEUROCIRUGIA			Spanish	Article						contralateral epidural hematoma; intraoperative epidural hematoma; brain herniation; head injury	EPIDURAL HEMATOMA	The development of an extradural hematoma during the evacuation of a traumatic extracerebral hematoma is a very rare event. it occurs in patients with a severe head injury that present with both an extraaxial hematoma and a contralAteral skull fracture. Recognition of the significance of a sudden increase in the cerebral tension after hematoma evacuation is the key for a pront diagnosis of the development of a contralateral lesion. We present the case of a patient with a severe head trauma and an extradural hematoma who developed a contralateral extradural hematoma during evacuation of the initial one. The development of a contralateral lesion was suspected by a sudden and unexpected increase in cerebral tension during evacuation of the first hematoma and confirmed by emergency CT scan. We think that the most important pathogenetic mechanisms involved in the development of a contralateral extradural hematoma are the rapid fall of intracranial pressure, the loss of tamponade effect achieved by the energetic use of antiedema measures and the evacuation of the ipsilateral hematoma.	Hosp Reg Univ Infanta Cristina, Serv Neurocirugia, Badajoz 06080, Spain		Ortega-Martinez, M (corresponding author), Hosp Infanta Cristina, Serv Neurocirugia, Avda Elvas S-N, Badajoz 06080, Spain.						BALASUBRAMANIAM V, 1991, SURG NEUROL, V36, P462, DOI 10.1016/0090-3019(91)90161-2; BOROVICH B, 1985, J NEUROSURG, V63, P30, DOI 10.3171/jns.1985.63.1.0030; BUCCI MN, 1986, NEUROSURGERY, V19, P65, DOI 10.1227/00006123-198607000-00009; BULLOCK R, 1990, J NEUROSURG, V72, P9, DOI 10.3171/jns.1990.72.1.0009; FEUERMAN T, 1988, NEUROSURGERY, V23, P480, DOI 10.1227/00006123-198810000-00013; KOGA H, 1985, SURG NEUROL, V24, P272, DOI 10.1016/0090-3019(85)90037-0; KOULOURIS S, 1980, NEUROSURGERY, V7, P608, DOI 10.1227/00006123-198012000-00014; LESOIN F, 1984, NEURORADIOLOGY, V26, P515, DOI 10.1007/BF00342691; MEGURO K, 1987, NEUROSURGERY, V20, P326, DOI 10.1227/00006123-198702000-00023; Ortega-Martinez M, 2004, NEUROCIRUGIA, V15, P468; PIEPMEIER JM, 1982, J TRAUMA, V22, P455, DOI 10.1097/00005373-198206000-00003; PIEPMEIER JM, 1988, NEUROSURGERY, V23, P483; REALE F, 1985, SURG NEUROL, V24, P260, DOI 10.1016/0090-3019(85)90034-5; THIBODEAU M, 1987, J CAN ASSOC RADIOL, V38, P52; Yague L G, 1991, J Neurosurg Sci, V35, P107	15	3	3	0	1	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	1130-1473			NEUROCIRUGIA	Neurocirugia	OCT	2004	15	5					468	471					4	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	872CP	WOS:000225183900005	15558204				2022-02-06	
J	Roig, RL; Worsowicz, GM; Stewart, DG; Cifu, DX				Roig, RL; Worsowicz, GM; Stewart, DG; Cifu, DX			Geriatric rehabilitation. 3. Physical medicine and rehabilitation interventions for common disabling disorders	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						disabled persons; geriatrics; rehabilitation	RANDOMIZED CONTROLLED TRIAL; OF-THE-LITERATURE; RHEUMATOID-ARTHRITIS; OLDER-ADULTS; CARDIOPULMONARY REHABILITATION; PULMONARY REHABILITATION; VENOUS THROMBOEMBOLISM; CARDIAC REHABILITATION; STROKE REHABILITATION; PERIPHERAL NEUROPATHY	This self-directed learning module highlights physical medicine and rehabilitation (PM&R) interventions for common disorders that cause disability in older adults. It is part of the study guide on geriatric rehabilitation in the Self-Directed Physiatric Education Program for practitioners and trainees in PM&R and geriatric medicine. This article specifically focuses on PM&R interventions for arthritides, fractures, cardiovascular disorders, peripheral vascular disease, amputations, pulmonary disorders, cancer, stroke, traumatic brain injury, Parkinson's disease, spinal cord injury, peripheral neuropathies, an diabetic complications. Overall Article Objective: To summarize the physical medicine and rehabilitation interventions for commonly disabling conditions of older adults.	Northlake Rehabil Profess, Dept Phys Med & Rehabil, Hammond, LA 70403 USA; Univ Missouri, Dept Phys Med & Rehabil, Columbia, MO USA; Brooks Hlth Syst Adm, Jacksonville, FL USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Phys Med & Rehabil, Richmond, VA 23298 USA		Roig, RL (corresponding author), Northlake Rehabil Profess, Dept Phys Med & Rehabil, 2101 Robin Ave,Ste 3, Hammond, LA 70403 USA.	rroig@aol.com	YAMAMOTO, MASAHIRO/F-9094-2011	YAMAMOTO, MASAHIRO/0000-0003-3859-0125; Cifu, David/0000-0003-1600-9387			Aggarwal Atul, 2001, Cardiology Clinics, V19, P525, DOI 10.1016/S0733-8651(05)70234-4; ALBA AS, 2000, PHYS MED REHABILITAT, P687; ANDERSON FA, 1991, ANN INTERN MED, V115, P591, DOI 10.7326/0003-4819-591; BACH JR, 1998, REHABILITATION MED, P1359; Braddom, 2000, PHYS MED REHABILITAT, P1024; Christmas C, 2000, J AM GERIATR SOC, V48, P318, DOI 10.1111/j.1532-5415.2000.tb02654.x; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P733, DOI 10.1016/S0003-9993(99)90219-8; CIFU DX, 2000, PHYS MED REHABILITAT, P1534; de Goede CJT, 2001, ARCH PHYS MED REHAB, V82, P509, DOI 10.1053/apmr.2001.22352; Ephraim PL, 2003, ARCH PHYS MED REHAB, V84, P747, DOI 10.1016/S0003-9993(03)04932-8; *FED INT FOR AG RE, 2000, OLD AM 2000 KEY IND; Flick CL, 1999, ARCH PHYS MED REHAB, V80, pS21, DOI 10.1016/S0003-9993(99)90098-9; Flores AM, 1998, REHABILITATION MED P, P1337; Geerts WH, 2001, CHEST, V119, p132S, DOI 10.1378/chest.119.1_suppl.132S; Gillis TA, 2001, ARCH PHYS MED REHAB, V82, pS63, DOI 10.1016/S0003-9993(01)80042-3; GILLIS TA, 2000, PHYS MED REHABILITAT, P1305; Gold DT, 2001, RHEUM DIS CLIN N AM, V27, P255, DOI 10.1016/S0889-857X(05)70197-6; GUTMAN MB, 1991, J TRAUMA, V31, P974, DOI 10.1097/00005373-199107000-00016; Harvey RL, 1998, ARCH PHYS MED REHAB, V79, P1349, DOI 10.1016/S0003-9993(98)90226-X; Jorgensen HS, 1997, STROKE, V28, P1138, DOI 10.1161/01.STR.28.6.1138; Kanj LF, 1998, J AM ACAD DERMATOL, V38, P517, DOI 10.1016/S0190-9622(98)70113-6; Katz P, 2001, J AM GERIATR SOC, V49, P808; Kavanagh T, 2002, CIRCULATION, V106, P666, DOI 10.1161/01.CIR.0000024413.15949.ED; Komatireddy GR, 1997, J RHEUMATOL, V24, P1531; Kowalske KJ, 2000, ARCH PHYS MED REHAB, V81, pS20; Levy R, 2001, J AM GERIATR SOC, V49, P1400; Lieberman DV, 2002, AM J PHYS MED REHAB, V81, P745, DOI 10.1097/00002060-200210000-00005; Lin JL, 2004, ARCH PHYS MED REHAB, V85, pS76, DOI 10.1016/j.apmr.2004.04.015; Liu MG, 1999, AM J PHYS MED REHAB, V78, P416, DOI 10.1097/00002060-199909000-00004; Loeser RF, 2000, RHEUM DIS CLIN N AM, V26, P547, DOI 10.1016/S0889-857X(05)70156-3; *MCKESSON HLTH SOL, 2003, INTERQUAL REH CRIT; McKinley W, 2003, NEUROREHABILITATION, V18, P83; MINOR MA, 1989, ARTHRITIS RHEUM, V32, P1396, DOI 10.1002/anr.1780321108; Mitchell SL, 2001, CLIN REHABIL, V15, P282, DOI 10.1191/026921501676849095; MOLDOVER JR, 2000, PHYS MED REHABILITAT, P665; O'Grady M, 2000, RHEUM DIS CLIN N AM, V26, P617, DOI 10.1016/S0889-857X(05)70159-9; Ostir GV, 2002, J AM GERIATR SOC, V50, P713, DOI 10.1046/j.1532-5415.2002.50167.x; Pandian G, 2001, ARCH PHYS MED REHAB, V82, pS9, DOI 10.1053/apmr.2001.22227; Pandian G., 1998, REHABILITATION MED P, P1517; Penninx BWJH, 2001, ARCH INTERN MED, V161, P2309, DOI 10.1001/archinte.161.19.2309; Rall LC, 1996, ARTHRITIS RHEUM-US, V39, P415, DOI 10.1002/art.1780390309; Richardson JK, 2002, ARCH PHYS MED REHAB, V83, P1553, DOI 10.1053/apmr.2002.35656; Rozzini R, 2002, AGE AGEING, V31, P277, DOI 10.1093/ageing/31.4.277; Rubenstein LZ, 2002, CLIN GERIATR MED, V18, P141, DOI 10.1016/S0749-0690(02)00002-2; Schulz GM, 2000, J COMMUN DISORD, V33, P59, DOI 10.1016/S0021-9924(99)00025-8; Seel R T, 2001, J Spinal Cord Med, V24, P241; Seto CK, 2003, CLIN SPORT MED, V22, P23, DOI 10.1016/S0278-5919(02)00040-6; Sherrington C, 1997, ARCH PHYS MED REHAB, V78, P208, DOI 10.1016/S0003-9993(97)90265-3; Singh MAF, 2002, CLIN GERIATR MED, V18, P431; Stewart DG, 2001, ARCH PHYS MED REHAB, V82, P347, DOI 10.1053/apmr.2001.20838; TODD CJ, 1995, BRIT MED J, V310, P904, DOI 10.1136/bmj.310.6984.904; Walker WC, 2001, ARCH PHYS MED REHAB, V82, pS56, DOI 10.1053/apmr.2001.22443; Weatherall M, 2001, NEW ZEAL MED J, V114, P547; Womack L, 2003, CLIN SPORT MED, V22, P135, DOI 10.1016/S0278-5919(02)00039-X	55	3	3	1	5	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUL	2004	85	7		3			S12	S17		10.1016/j.apmr.2004.03.007			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	837ZG	WOS:000222679600004	15221717				2022-02-06	
J	Stuart, M				Stuart, M			Fighting the silent epidemic - The Florida brain and spinal cord injury program	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						chronic care; community reintegration; healthcare; Medicaid; TBI	SUBSTANCE-ABUSE; MANAGED CARE; MEDICAID; ALCOHOL; OUTCOMES; MODEL; CONSUMPTION; DISABILITY; HEMORRHAGE; LESSONS	This article describes a statewide model program that provides a range of services for individuals with traumatic brain injury in Florida. The article answers questions regarding the organization, delivery, and financing of a system that includes surveillance data, case management, health services, a network of contractors, and a Medicaid waiver. With an annual budget of more than $15 million, the primary source of financing is a trust fund established through state statute with revenues from fines levied for driving while intoxicated. Lessons from Florida that will be useful to states as they respond to Olmstead and develop Medicaid waivers include (a) how a data registry laid the foundation for a service delivery system, (b) how early and aggressive case management has the potential for Medicaid savings, and (c) how a statewide system, critical mass of patients, and standards for providers can improve the quality of services for persons with traumatic brain injury.	Univ Maryland Baltimore Cty, Dept Sociol & Anthropol, Baltimore, MD 21250 USA		Stuart, M (corresponding author), Univ Maryland Baltimore Cty, Dept Sociol & Anthropol, 1000 Hilltop Circle, Baltimore, MD 21250 USA.	stuart@umbc.edu			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [200-2002-M-00815] Funding Source: Medline		ALECXIH LM, 1996, ESTIMATED SAVINGS US; Anderson G, 2001, HEALTH AFFAIR, V20, P146, DOI 10.1377/hlthaff.20.6.146; Bardach NS, 2002, STROKE, V33, P1851, DOI 10.1161/01.STR.0000019126.43079.7B; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; *BRAIN INJ ASS AM, 2001, TBI INC; *BRAIN INJ ASS FLO, 2003, CONS SAT SURV REP SU; CALLAHAN JJ, 1995, HEALTH AFFAIR, V14, P173, DOI 10.1377/hlthaff.14.3.173; Centers for Disease Control and Prevention, 2001, TRAUM BRAIN INJ US R; Chaloupka FJ, 2002, ALCOHOL RES HEALTH, V26, P22; Cohen DA, 2002, PREV MED, V34, P187, DOI 10.1006/pmed.2001.0970; Cook PJ, 2002, HEALTH AFFAIR, V21, P120, DOI 10.1377/hlthaff.21.2.120; *CTR HLTH PROGR DE, 1996, MAR MED HIGH COST US; Day S., 2001, OLMSTEAD SUPPORTIVE, P1; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Farrell S, 2003, J HEALTH ECON, V22, P117, DOI 10.1016/S0167-6296(02)00099-1; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; *FLOR DEP HLTH, 2002, STAB TIM CHANG BRAIN; *FLOR DEP HLTH, 2002, STAB TIM CHANG BRAIN, P12; *FLOR DEP HLTH, 2002, STAB TIM CHANG BRAIN, P7; *FLOR DEP HLTH, 2002, STAB TIM CHANG BRAIN, P42; FREUND DA, 1995, ANNU REV PUBL HEALTH, V16, P473; Frye R, 1997, Health Care Strateg Manage, V15, P16; Glasgow RE, 2001, MILBANK Q, V79, P579, DOI 10.1111/1468-0009.00222; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P161, DOI 10.1053/apmr.2003.50098; Kingdon J., 1995, AGENDAS ALTERNATIVES; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; Lehman AF, 1997, ARCH GEN PSYCHIAT, V54, P1038; Leutz W, 1999, GERONTOLOGIST, V39, P86, DOI 10.1093/geront/39.1.86; LoBianco MS, 1996, NURS ECON, V14, P303; MAGUIRE NP, 1996, J GEN INTERNAL MED S, V11, P79; Master R, 1996, Manag Care Q, V4, P26; *NAT HEAD INJ FDN, 1986, DEF TRAUM HEAD INJ; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; SALVAS R, 2002, REQUIREMENT REPORT T, P1; SALVAS R, 2002, REQ REP TRAUM BRAIN, P2; SHIELDS K, 2003, OVERVIEW FLORIDA BRA; SHIELDS K, 2002, FLORIDA STATE STATE; SOMERS SA, 1997, HLTH STRATEG Q, P2; Stuart M, 2004, CHEST, V125, P695, DOI 10.1378/chest.125.2.695; Stuart M, 2001, J Aging Soc Policy, V12, P81, DOI 10.1300/J031v12n04_05; Stuart M, 2001, NEUROREHAB NEURAL RE, V15, P159, DOI 10.1177/154596830101500302; Stuart M, 2001, GERONTOLOGIST, V41, P474, DOI 10.1093/geront/41.4.474; STUART ME, 1994, MILBANK Q, V72, P679, DOI 10.2307/3350360; Stuart ME, 1998, MILBANK Q, V76, P251, DOI 10.1111/1468-0009.00088; Tu JV, 2001, J VASC SURG, V33, P447, DOI 10.1067/mva.2001.113487; Wu AW, 2001, ARCH INTERN MED, V161, P2554, DOI 10.1001/archinte.161.21.2554; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	49	3	3	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2004	19	4					329	340		10.1097/00001199-200407000-00007			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	839CB	WOS:000222759800007	15263860	Green Published			2022-02-06	
J	Joly, LM; Raggueneau, JL				Joly, LM; Raggueneau, JL			When and how to start sedation in a neuro-intensive care patient?	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article; Proceedings Paper	25th French Language Conference on Neuro-Anesthesia and Resuscitation	NOV 19-20, 2003	Paris, FRANCE			sedation; intracranial hypertension; neuro-intensive care unit	BLOOD-FLOW VELOCITY; CEREBRAL PERFUSION-PRESSURE; CEREBROSPINAL-FLUID PRESSURE; END-EXPIRATORY PRESSURE; TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; TRACHEAL INTUBATION; OXYGEN EXTRACTION; OXIDE ANESTHESIA; HEAD-INJURY	Sedatives drugs are part of the everyday care in the neuro-ICU. Reasons to sedate patients in neuro-ICU are as usual to ensure the comfort and to secure the patients, to permit nursing as well as to permit adaptation to the ventilator. But some objectives are specific in neuro-ICU as optimisation of cerebral haemodynamics and oxygenation, and to avoid a convulsive state or a dysautonomic syndrome. Starting the sedation usually necessitate a tracheal intubation and mechanical ventilation. Patients presenting with intracranial hypertension are at risk of developing cerebral ischaemia in case of cerebral haemodynamics alteration associated with anaesthetic drugs injection. Morphinomimetics increase intracranial pressure (ICP), but cerebral perfusion pressure and oxygenation (CPP) remain usually unaltered. Injection of an intravenous bolus of thiopental or propofol lowers ICP and CPP, but also the cerebral tissular oxygen consumption: the cerebral oxygenation seems therefore protected. The succinylcholine used for emergency tracheal intubation has no effect on the cerebral haemodynamic. Some more studies are needed to better understand the cerebral oxygenation at the local level when sedative drugs are injected or perfused in patients with intracranial hypertension. (C) 2004 Elsevier SAS. Tous droits reserves.	Ctr Hosp St Anne, Dept Anesthesie Reanimat, F-75674 Paris 14, France		Joly, LM (corresponding author), Ctr Hosp St Anne, Dept Anesthesie Reanimat, Rue Cabanis, F-75674 Paris 14, France.	Luc-Marie.joly@chu.rouen..fr					ALBANESE J, 1993, ANESTHESIOLOGY, V79, P493, DOI 10.1097/00000542-199309000-00012; Albanese J, 1999, CRIT CARE MED, V27, P407, DOI 10.1097/00003246-199902000-00050; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Bazin JE, 1997, ANN FR ANESTH, V16, P445, DOI 10.1016/S0750-7658(97)81477-3; BEDFORD RF, 1980, ANESTH ANALG, V59, P435; Brown MM, 1996, EUR J ANAESTH, V13, P474, DOI 10.1046/j.1365-2346.1996.00973.x; Brucia J, 1996, HEART LUNG, V25, P295, DOI 10.1016/S0147-9563(96)80065-3; Bruder N, 2003, ANN FR ANESTH, V22, P226, DOI 10.1016/S0750-7658(03)00011-X; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; de Nadal M, 1998, ACT NEUR S, V71, P10; de Nadal M, 2000, ANESTHESIOLOGY, V92, P11, DOI 10.1097/00000542-200001000-00008; Ederberg S, 1998, ANESTH ANALG, V86, P1201, DOI 10.1097/00000539-199806000-00011; FORSTER A, 1983, J CEREBR BLOOD F MET, V3, P246, DOI 10.1038/jcbfm.1983.33; Georgiadis D, 2001, STROKE, V32, P2088, DOI 10.1161/hs0901.095406; HANOWELL LH, 1993, J NEUROSURG ANESTH, V5, P31; Huynh T, 2002, J TRAUMA, V53, P488, DOI 10.1097/00005373-200209000-00016; Jamali S, 1996, ANESTH ANALG, V82, P600, DOI 10.1097/00000539-199603000-00030; Jansen GFA, 1999, ANESTH ANALG, V89, P358, DOI 10.1097/00000539-199908000-00021; JUNG R, 1990, ANESTH ANALG, V71, P419; KOVARIK WD, 1994, ANESTH ANALG, V78, P469; Ludbrook GL, 2002, ANESTHESIOLOGY, V97, P1363, DOI 10.1097/00000542-200212000-00006; MAYBERG TS, 1995, ANESTH ANALG, V81, P84, DOI 10.1097/00000539-199507000-00017; McGuire G, 1997, CRIT CARE MED, V25, P1059, DOI 10.1097/00003246-199706000-00025; MILDE LN, 1985, ANESTHESIOLOGY, V63, P371, DOI 10.1097/00000542-198510000-00005; MODICA PA, 1992, CAN J ANAESTH, V39, P236, DOI 10.1007/BF03008783; Mortier E, 2000, ACTA NEUROL BELG, V100, P225; MOSS E, 1978, BRIT J ANAESTH, V50, P353, DOI 10.1093/bja/50.4.353; Nemoto EM, 1996, J NEUROSURG ANESTH, V8, P52, DOI 10.1097/00008506-199601000-00012; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; PAPAZIAN L, 1993, BRIT J ANAESTH, V71, P267, DOI 10.1093/bja/71.2.267; PINAUD M, 1990, ANESTHESIOLOGY, V73, P404, DOI 10.1097/00000542-199009000-00007; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; Ravussin P, 1988, Anaesthesia, V43 Suppl, P37, DOI 10.1111/j.1365-2044.1988.tb09066.x; SCHREGEL W, 1993, J NEUROSURG ANESTH, V5, P86; Schulte am Esch J, 1978, ACTA NEUROCHIR, V45, P15; SPERRY RJ, 1992, ANESTHESIOLOGY, V77, P416, DOI 10.1097/00000542-199209000-00002; STEEN PA, 1983, ANESTHESIOLOGY, V58, P527, DOI 10.1097/00000542-198306000-00009; THORSEN T, 1980, ACTA ANAESTH SCAND, V24, P1, DOI 10.1111/j.1399-6576.1980.tb01494.x; UNNI VKN, 1984, BRIT J ANAESTH, V56, P1219, DOI 10.1093/bja/56.11.1219; Van Hemelrijck J, 1989, Acta Anaesthesiol Belg, V40, P95; Vandesteene A, 1988, Anaesthesia, V43 Suppl, P42, DOI 10.1111/j.1365-2044.1988.tb09067.x; Warner DS, 1996, ANESTH ANALG, V83, P348, DOI 10.1097/00000539-199608000-00025; WEINSTABL C, 1992, EUR J ANAESTH, V9, P481; WERNER C, 1995, ANESTHESIOLOGY, V83, P721, DOI 10.1097/00000542-199510000-00011	44	3	3	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0750-7658	1769-6623		ANN FR ANESTH	Ann. Fr. Anest. Reanim.	MAY	2004	23	5					522	527		10.1016/j.annfar.2004.01.004			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Anesthesiology	832GK	WOS:000222255100014	15158247				2022-02-06	
J	Nishio, S; Takemura, N; Ikai, Y; Baba, T				Nishio, S; Takemura, N; Ikai, Y; Baba, T			Sensory aphasia after closed head injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						closed head injury; post-traumatic aphasia; sensory aphasia; Wernicke's aphasia; clinical course	REHABILITATION; TRAUMA	A 51-year-old, right-handed male injured his head when drunk. After an initial mute state lasting for several hours, he exhibited fluent aphasia, impaired word finding, some verbal paraphasia and impaired verbal comprehension. A CT scan revealed a contusion in the left anterior temporal lobe. He was treated conservatively, and at the follow-up 6 months later, his sensory aphasia had recovered well. The relationship between closed head trauma and aphasia is reviewed with special attention to its nature and clinical course. (C) 2004 Elsevier Ltd. All rights reserved.	Baba Mem Hosp, Dept Rehabil, Speech Therapy Unit, Sakai, Osaka, Japan; Baba Mem Hosp, Dept Neurosurg, Sakai, Osaka, Japan		Nishio, S (corresponding author), 4-244 Higashi,Hamaderafunao Cho, Sakai, Osaka 5928555, Japan.	shunishio-nsu@umin.ac.jp					ALAJOUANINE T, 1957, Encephale, V46, P1; BOND MR, 1976, SCAND J REHABIL MED, V8, P127; Glaser MA, 1932, J AMER MED ASSOC, V98, P271, DOI 10.1001/jama.1932.02730300001001; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; LISHMAN WA, 1966, P ROY SOC MED, V59, P261, DOI 10.1177/003591576605900328; NAJENSON T, 1974, SCAND J REHABIL MED, V6, P5; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; STONE JL, 1978, SURG NEUROL, V9, P27; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P2160; 1975, NIR C STAND LANG TES	12	3	3	0	2	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	MAY	2004	11	4					442	444		10.1016/j.jocn.2003.04.006			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	818DW	WOS:000221226800027	15080970				2022-02-06	
J	Powell, JM; Hunt, E; Pepping, M				Powell, JM; Hunt, E; Pepping, M			Collaboration between cognitive science and cognitive rehabilitation - A call for action	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; cognition; cognitive disorders; cognitive psychology; cognitive rehabilitation; cognitive science; health science education; interdisciplinary education; interdisciplinary research; professional education	TRAUMATIC BRAIN-INJURY; MEMORY	The fields of cognitive science and cognitive rehabilitation share a fundamental interest in the nature of cognition. Both groups address questions that are critical to our understanding of human thought. Researchers in basic cognitive science address these questions from a theoretical perspective. Clinicians in cognitive rehabilitation address them from an applied perspective for individuals with brain injuries. Collaborative efforts and cross-fertilization of theory and practice have been less than what might be expected given the underlying commonality of the two fields. Here, we explore the complex nature of the relationship between cognitive rehabilitation and cognitive science, discuss barriers to collaboration, and suggest ways of overcoming those barriers.	Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA; Univ Washington, Dept Psychol, Seattle, WA 98195 USA		Powell, JM (corresponding author), Univ Washington, Sch Med, Dept Rehabil Med, 1959 NE Pacific St,Box 356490, Seattle, WA 98195 USA.	jmpowell@u.washington.edu					Anderson J. R., 1993, RULES MIND; BADDELEY A, 1993, NEUROPSYCHOL REHABIL, V3, P235, DOI 10.1080/09602019308401438; Baddeley AD, 2001, AM PSYCHOL, V56, P851, DOI 10.1037/0003-066X.56.11.851; BENTON A, 1992, J CLIN EXP NEUROPSYC, V14, P407, DOI 10.1080/01688639208407616; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; BENYISHAY Y, 1990, REHABILITATION ADULT, P393; Caramazza A., 1989, COGNITIVE APPROACHES, P383; Card SK, 1983, PSYCHOL HUMAN COMPUT; *CARE, 1999, MED REH STAND MAN; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Chipman SF, 2000, EXP RES APPL, P3; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Eysenck M. W., 1991, BLACKWELL DICT COGNI; GILLIS R, 1996, TRAUMATIC BRAIN INJU; Greenwald AG, 2002, PSYCHOL REV, V109, P3, DOI 10.1037/0033-295X.109.1.3; Hilgard E.R., 1986, DIVIDED CONSCIOUSNES, VExpanded; Kihlstrom JF, 1998, PSYCHOL BULL, V123, P186, DOI 10.1037/0033-2909.123.2.186; KOLB B, 1996, FUNDAMENTALS HUMAN N; LAMPORT NK, 2001, ACTIVITY ANAL APPL; Mesulam M., 1985, PRINCIPLES BEHAV NEU; Meyer DE, 1997, PSYCHOL REV, V104, P3, DOI 10.1037/0033-295X.104.1.3; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P215, DOI 10.1016/0028-3932(68)90021-3; NAVON D, 1984, PSYCHOL REV, V91, P216, DOI 10.1037/0033-295X.91.2.216; OSCARBERMAN M, 1989, J CLIN EXP NEUROPSYC, V11, P571, DOI 10.1080/01688638908400915; Paller KA, 2003, NEURON, V38, P507, DOI 10.1016/S0896-6273(03)00198-3; PARENTE R., 1996, RETRAINING COGNITION; PEPPING M, 1991, NEUROPSYCHOLOGY EVER, V3; PETERSON K, 2003, SEATTLE TIMES   0729, pC1; Prigatano G. P., 2003, CLIN NEUROPSYCHOLOGY; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Robertson IH, 1999, CURR OPIN NEUROL, V12, P703, DOI 10.1097/00019052-199912000-00008; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Schaafstal A, 2000, EXP RES APPL, P57; Sohlberg M., 2001, COGNITIVE REHABILITA; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Wieser S, 2003, CLIN NEUROPHYSIOL, V114, P1144, DOI 10.1016/S1388-2457(03)00044-0; WILSON B, 1990, APPL COGNITIVE PSYCH, V4, P247, DOI 10.1002/acp.2350040403; Wilson BA, 1997, J INT NEUROPSYCH SOC, V3, P487, DOI 10.1017/S1355617797004876; Wilson P, 2002, AUST J PSYCHOL, V54, P64	39	3	3	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2004	19	3					266	276		10.1097/00001199-200405000-00007			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	826JB	WOS:000221824300007	15247848				2022-02-06	
J	Drake, DF; Nadler, SF; Chou, LH; Toledo, SD; Akuthota, V				Drake, DF; Nadler, SF; Chou, LH; Toledo, SD; Akuthota, V			Sports and performing arts medicine. 4. Traumatic injuries in sports	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain concussion; cardiac; pain; rehabilitation; sports; trauma	PHYSICAL-EXAMINATION; PRIMARY-CARE; SHOULDER; PNEUMOTHORAX; MANAGEMENT; 1ST-TIME; LIGAMENT; COLLEGE; IMPACT; KNEE	This self-directed learning module focuses on injuries often seen in contact sports. It includes information on trauma to the cervical spine, wrist, shoulder, knee, ankle, foot, and chest and also discusses concussion in sport. It is part of the study guide on sports and performing arts medicine in the Self-Directed Physiatric Education Program for practitioners and trainees in physical medicine and rehabilitation. This article specifically focuses on the etiology, differential diagnoses, treatment, and return-to-play criteria for traumatic sports injuries. Overall Article Objective: To summarize the approach to common traumatic sports injuries.	Virginia Commonwealth Univ, Dept PM&R, Med Coll Virginia, Richmond, VA 23298 USA; Univ Med & Dent New Jersey, Dept Phys Med & Rehabil, Newark, NJ USA; Univ Penn, Dept Rehabil, Philadelphia, PA USA; Rehabil Inst Chicago, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; Univ Colorado, Dept Rehabil Med, Denver, CO USA		Drake, DF (corresponding author), Virginia Commonwealth Univ, Dept PM&R, Med Coll Virginia, POB 980677 MCV Stn, Richmond, VA 23298 USA.	dfdrake42@hotmail.com					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Baumann MH, 2001, CHEST, V119, P590, DOI 10.1378/chest.119.2.590; BODEN SD, 1992, CLIN ORTHOP RELAT R, P177; Bottoni CR, 2002, AM J SPORT MED, V30, P576, DOI 10.1177/03635465020300041801; BOYTIM MJ, 1991, AM J SPORT MED, V19, P294, DOI 10.1177/036354659101900315; Cantu RC, 2000, SEMIN NEUROL, V20, P173, DOI 10.1055/s-2000-9825; Clanton TO, 1997, CLIN SPORT MED, V16, P435, DOI 10.1016/S0278-5919(05)70034-X; Coss HS, 1998, FOOT ANKLE INT, V19, P537; Curtin SM, 2000, PHYSICIAN SPORTSMED, V28, P23, DOI 10.3810/psm.2000.08.1153; FAM AG, 1985, CAN MED ASSOC J, V133, P379; Feinberg J H, 2000, Phys Med Rehabil Clin N Am, V11, P771; HOVELIUS L, 1987, J BONE JOINT SURG AM, V69A, P393; KONRADSEN L, 1991, FOOT ANKLE, V12, P69, DOI 10.1177/107110079101200202; Leddy JJ, 1998, AM J SPORT MED, V26, P158, DOI 10.1177/03635465980260020201; Lewis DM, 2001, CLIN SPORT MED, V20, P131, DOI 10.1016/S0278-5919(05)70251-9; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Malanga GA, 2003, ARCH PHYS MED REHAB, V84, P592, DOI 10.1053/apmr.2003.50026; MANTAS JP, 1994, CLIN SPORT MED, V13, P719; MARON BJ, 1995, NEW ENGL J MED, V333, P337, DOI 10.1056/NEJM199508103330602; Mastey RD, 1997, CLIN SPORT MED, V16, P705, DOI 10.1016/S0278-5919(05)70049-1; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McIntosh AS, 2001, BRIT J SPORT MED, V35, P167, DOI 10.1136/bjsm.35.3.167; Morganti C, 2001, SPINE, V26, P1131, DOI 10.1097/00007632-200105150-00007; Ronning R, 2001, AM J SPORT MED, V29, P581, DOI 10.1177/03635465010290051001; Solomon DH, 2001, JAMA-J AM MED ASSOC, V286, P1610, DOI 10.1001/jama.286.13.1610; Taylor DC, 1997, AM J SPORT MED, V25, P306, DOI 10.1177/036354659702500306; Weinstein SM, 1998, CLIN SPORT MED, V17, P127, DOI 10.1016/S0278-5919(05)70067-3	28	3	3	1	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2004	85	3		1			S67	S71		10.1053/j.apmr.2003.11.008			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	802DE	WOS:000220143400012	15034858				2022-02-06	
J	Karlsson, AK; Krassioukov, AV				Karlsson, AK; Krassioukov, AV			Hyponatremia-induced transient visual disturbances in acute spinal cord injury	SPINAL CORD			English	Article						spinal cord injury; acute management; hyponatremia; blindness	BLINDNESS	Study design: Case report and literature review. Objective: To report an unusual case of prolonged hyponatremia in acute cervical spinal cord injury complicated by visual disturbances and to review the literature regarding the issue. Settings: Spinal Cord Injury Unit in Goteborg, Sweden. Methods: Retrospective analysis of clinical charts of an individual with traumatic spinal cord injury. Results: A previously healthy 28-year-old man sustained a C7 injury in a motor vehicle accident. His injury was managed surgically and he was overhydrated during the acute management and postoperatively. When weaned off the respirator he was confused and anxious and showed a S-Na of 127 mmol/1 and complained of visual disturbances. The hyponatremia was treated by extra sodium and fluid restriction but fell to a lowest value of 121 mmol/l ( Day 14 post injury). Visual acuity was 0.2 on right eye and 0.06 on left eye and the eye examination revealed signs of fundus hypertonicus. CT scans and MRI revealed no signs of brain edema. The patient was further treated by mineral corticoids and fluid restriction for 4 months and his vision improved slightly, but on a final examination 125 days post injury he was found to have an afferent pupillary defect on his left eye, and bilateral atrophy of the visual nerves. The hyponatremia resolved and 6 months post injury he showed a normal S-Na. Conclusions: SCI individuals are at increased risk of developing hyponatremia. The reported complication of visual disturbances further stresses the importance of prevention of overhydration and of timely management of hyponatremia in this group of patients.	Sahlgrenska Acad, Inst Clin Neurosci, Spinal Cord Injury Unit, S-41345 Gothenburg, Sweden; Univ British Columbia, ICORD, Div Phys Med & Rehabil, Vancouver, BC V5Z 1M9, Canada		Karlsson, AK (corresponding author), Sahlgrenska Acad, Inst Clin Neurosci, Spinal Cord Injury Unit, S-41345 Gothenburg, Sweden.		Karlsson, Ann-Katrin/ABG-5529-2021; Krassioukov, Andrei V/K-3131-2017				BARLETTA JP, 1994, J NEURO-OPHTHALMOL, V14, P6; Bertholini DM, 2000, ANAESTH INTENS CARE, V28, P199, DOI 10.1177/0310057X0002800214; BIYANI A, 1993, INJURY, V24, P671, DOI 10.1016/0020-1383(93)90318-Z; Giordano M, 2000, CLIN NEPHROL, V53, P222; Lebl J, 2001, EUR J PEDIATR, V160, P159, DOI 10.1007/s004310000686; LEVI L, 1993, NEUROSURGERY, V33, P1007, DOI 10.1097/00006123-199312000-00008; PERUZZI WT, 1994, CRIT CARE MED, V22, P252, DOI 10.1097/00003246-199402000-00016; SICA DA, 1989, AM J MED SCI, V298, P331, DOI 10.1097/00000441-198911000-00011	8	3	10	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393			SPINAL CORD	Spinal Cord	MAR	2004	42	3					204	207		10.1038/sj.sc.3101577			4	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	804EE	WOS:000220281200010	15001983	Bronze			2022-02-06	
J	Lang, CJG; Heidenreich, SP; Fahlbusch, R; Neundorfer, B				Lang, CJG; Heidenreich, SP; Fahlbusch, R; Neundorfer, B			Primary loss of consciousness and amnesia in subarachnoid hemorrhage - A quantitative study	ZENTRALBLATT FUR NEUROCHIRURGIE			German	Article						subarachnoid hemorrhage; amnesia; anterograde; retrograde; loss of consciousness	ANTERIOR COMMUNICATING ARTERY; ANEURYSM; COGNITION; MEMORY; IMPAIRMENT; QUALITY; RUPTURE; SURGERY; REPAIR; LIFE	Subarachnoid hemorrhages (SAH) being sudden events affecting the brain in a rather wide-spread fashion are apt to induce loss of consciousness (LOC) and amnesia. The aim of the present study was to collect data on their frequency and extent. To this end we examined 48 patients at a mean of one year post-onset. Two thirds of them reported anterograde and an additional 17% retrograde amnesias; in 40% LOC (median 6 minutes) was observed. The durations were extremely skewed towards shorter times with a median of 2.7 days for anterograde and 1.3 days for retrograde amnesias who - with a single exception - were markedly shorter than anterograde amnesias. Summing up, a significant proportion of all SAH suffered LOC and amnesias occurred in the majority of cases. SAH therefore are events which with respect to LOC and amnesia bear some resemblance with closed head injuries. Exact observation and history taking may disclose important data on their severity and possible sequelae.	Univ Erlangen Nurnberg, Neurol Klin Piliklin, Erlangen, Germany		Lang, CJG (corresponding author), Neurol Universitatsklin, Schwabachanlage 6, D-91054 Erlangen, Germany.	christoph.lang@neuro.imed.uni-erlangen.de					Abe K, 1998, J NEUROL NEUROSUR PS, V65, P126, DOI 10.1136/jnnp.65.1.126; Babinsky R, 1997, INT J NEUROSCI, V91, P265, DOI 10.3109/00207459708986382; D'Esposito M, 1996, J Int Neuropsychol Soc, V2, P565; Eslinger PJ, 1996, CEREB CORTEX, V6, P530, DOI 10.1093/cercor/6.3.530; Fasanaro A M, 1989, Acta Neurol (Napoli), V11, P272; GADE A, 1982, SURG NEUROL, V18, P46, DOI 10.1016/0090-3019(82)90013-1; Germano A, 1998, ACTA NEUROCHIR, V140, P805, DOI 10.1007/s007010050182; Hackett ML, 2000, NEUROLOGY, V55, P658, DOI 10.1212/WNL.55.5.658; Harting C, 2000, WMS R WECHSLER GEDAC; Hillis AE, 2000, J NEUROL NEUROSUR PS, V69, P608, DOI 10.1136/jnnp.69.5.608; Hop JW, 1999, STROKE, V30, P2268, DOI 10.1161/01.STR.30.11.2268; HUTTER BO, 1995, BRIT J NEUROSURG, V9, P465, DOI 10.1080/02688699550041106; Hutter BO, 1999, ACT NEUR S, V72, P157; MAURICEWILLIAMS RS, 1991, J NEUROL NEUROSUR PS, V54, P335, DOI 10.1136/jnnp.54.4.335; Mavaddat N, 1999, J NEUROSURG, V91, P402, DOI 10.3171/jns.1999.91.3.0402; MCKENNA P, 1989, NEUROSURGERY, V24, P361, DOI 10.1227/00006123-198903000-00009; Mielke U, 1996, NERVENARZT, V67, P781, DOI 10.1007/s001150050053; ODER W, 1991, J NEUROSURG, V74, P601, DOI 10.3171/jns.1991.74.4.0601; OGDEN JA, 1993, NEUROSURGERY, V33, P572, DOI 10.1227/00006123-199310000-00004; RICHARDSON JTE, CLIN NEUROPSYCHOLOGI; SONESSON B, 1987, NEUROSURGERY, V21, P279, DOI 10.1227/00006123-198709000-00001; SONESSON B, 1989, ACTA NEUROL SCAND, V80, P400, DOI 10.1111/j.1600-0404.1989.tb03901.x; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; VOLPE BT, 1983, J NEUROL NEUROSUR PS, V46, P704, DOI 10.1136/jnnp.46.8.704; Wheatley J, 1997, CORTEX, V33, P711, DOI 10.1016/S0010-9452(08)70728-7	25	3	3	0	4	JOHANN AMBROSIUS BARTH VERLAG MEDIZINVERLAGE HEIDELBERG GMBH	STUTTGART	RUEDIGERSTR 14, D-70469 STUTTGART, GERMANY	0044-4251			ZBL NEUROCHIR	Zent.bl. Neurochir.	FEB	2004	65	1					18	24		10.1055/s-2004-44884			7	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	800ER	WOS:000220012200004	14981572				2022-02-06	
J	Simo-Guerrero, M; Chirivella-Garrido, J; Ferri-Campos, J; Ramirez, RM; Caballero, MC; Noe-Sebastian, E				Simo-Guerrero, M; Chirivella-Garrido, J; Ferri-Campos, J; Ramirez, RM; Caballero, MC; Noe-Sebastian, E			Anoxic encephalopathy. Clinical description, prognosis and neuroimaging	REVISTA DE NEUROLOGIA			Spanish	Article						anoxic encephalopathy; functional neuroimaging; rehabilitation	TRAUMATIC BRAIN-INJURY; CARDIAC-ARREST; SELF-AWARENESS; BASAL GANGLIA; REHABILITATION; SURVIVORS; SEQUELAE; AMNESIA; MEMORY	Objectives. To describe the clinical profile (neuropsychological, psychopatological, functional and neuroimaging), as well as the evolution of patients with anoxic encephalopathy. Patients and methods. Nine patients with anoxic encephalopathy attending our Service were included in the study. All patients were assessed with abroad range of neuropsychological tests, checklists of psychopathological symptoms, and several functional scales. A CT/MRI or a positron emission tomography (PET) were performed in five patients. Five patients were admitted to a multidisciplinary rehabilitation program. Results. All patients showed problems in orientation, executive functions, verbal learning an immediate and long-term verbal memory, in association with diffuse cognitive changes in other functions. Psychopathologically, all patients showed apathy-indifference, and eight subjects showed anosognosia. All subjects have an important dependence in daily activities. CT/MRI were normal or showed subcortical changes whereas the PET showed a predominantly cortical hypometabolism with specifical patterns. There were no significance improvements after rehabilitation in treated patients. Conclusion. In the absence of a unique clinical profile, our patients with anoxic encephalopathy showed similarities in their symptoms (diffuse cognitive deficits with predominance of mnesic and executive impairments; presence of apathy and anosognosia; complete functional dependence; and poor response to the rehabilitation). Functional neuroimaging could be a useful tool for a better understanding of these encephalopaties.	Hosp NISA Valencia Mar, Serv Dano Cerebral, E-46011 Valencia, Spain		Noe-Sebastian, E (corresponding author), Hosp NISA Valencia Mar, Serv Dano Cerebral, E-46011 Valencia, Spain.	enoe@comv.es		Noe Sebastian, Enrique/0000-0002-2547-8727			ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Armengol CG, 2000, BRAIN INJURY, V14, P237, DOI 10.1080/026990500120718; BENEDET MJ, 1999, TEST APRENDIZAJE VER; Caine D, 2000, J INT NEUROPSYCH SOC, V6, P86, DOI 10.1017/S1355617700611116; CORKIN S, 1985, ANN NY ACAD SCI, V444, P10, DOI 10.1111/j.1749-6632.1985.tb37577.x; De Reuck J, 2003, EUR NEUROL, V49, P131, DOI 10.1159/000069075; DEELIA LF, 1996, COLOR TRAILS TESTS; DEVOLDER AG, 1990, ARCH NEUROL-CHICAGO, V47, P197, DOI 10.1001/archneur.1990.00530020103022; Fleming JM, 1996, BRAIN INJURY, V10, P1; FLETCHER DE, 1945, J NERV MENT DIS, V102, P392, DOI 10.1097/00005053-194510000-00010; GARCIAALBEA J, 1998, TEST BOSTON DIAGNOST; GRANT DA, 1996, TEST CLASIFICACION T; Hopkins R O, 1995, J Int Neuropsychol Soc, V1, P501; HOWARD R, 1987, ARCH NEUROL-CHICAGO, V44, P934, DOI 10.1001/archneur.1987.00520210036016; Kapur N., 1988, MEMORY DISORDERS CLI; KJOS BO, 1983, AM J ROENTGENOL, V141, P1227, DOI 10.2214/ajr.141.6.1227; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Pentland B, 1999, CLIN REHABIL, V13, P498, DOI 10.1191/026921599676188597; REICH P, 1983, AM J PSYCHIAT, V140, P1194; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; ROINE RO, 1993, JAMA-J AM MED ASSOC, V269, P237, DOI 10.1001/jama.269.2.237; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; SIGNORETT JL, 1985, MEMORY AMNESIAS PRIC, P169; Singhal AB, 2002, J NEUROL SCI, V196, P37, DOI 10.1016/S0022-510X(02)00019-9; STEEGMANN AT, 1951, NEUROLOGY, V1, P261, DOI 10.1212/WNL.1.7-8.261; Takahashi W, 1998, CLIN IMAG, V22, P188, DOI 10.1016/S0899-7071(97)00120-4; Vilalta-Franch J, 1999, REV NEUROLOGIA, V29, P15, DOI 10.33588/rn.2901.99226; VOLPE BT, 1986, NEUROLOGY, V36, P408, DOI 10.1212/WNL.36.3.408; VOLPE BT, 1983, ARCH NEUROL-CHICAGO, V40, P436, DOI 10.1001/archneur.1983.04050070066017; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1999, WAIS 3 ESCALA INTELI; Wilson BA, 1996, BRAIN INJURY, V10, P863, DOI 10.1080/026990596123846	34	3	3	0	5	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	JAN 16	2004	38	2					111	117		10.33588/rn.3802.2003530			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	774VF	WOS:000189005600003	14752707				2022-02-06	
J	Matsushige, T; Kiya, K; Satoh, H; Mizoue, T; Kagawa, K; Araki, H				Matsushige, T; Kiya, K; Satoh, H; Mizoue, T; Kagawa, K; Araki, H			Cerebral venous congestion following closed head injury in a child	PEDIATRIC NEUROSURGERY			English	Article						diffusion-weighted image; perfusion-weighted image; magnetic resonance imaging; hemispheric low density; venous congestion	TRAUMATIC BRAIN-INJURY; VASOGENIC EDEMA; DIFFUSION; THROMBOSIS; PERFUSION	In pediatric patients with head injury, progressive hemispheric low density (HLD) on CT is a specific phenomenon although the underlying mechanism remains controversial. We used CT, MRI, diffusion weighted imaging (DWI), and perfusion weighted imaging (PWI) studies to identify pathophysiological patterns in a child. A 6-year-old boy sustained a left temporal head injury in a car accident. Although the initial CT was normal, serial CT demonstrated progressive left HLD; an extensive heterogeneous high-intensity lesion was noted on fluid-attenuated imaging recovery ( FLAIR) and DWI studies. On PWI, the regional cerebral blood volume was increased and the mean transit time was markedly prolonged. After the conservative treatment, despite the widespread abnormal imaging on CT and DWI, the final brain damage located in isolated left temporal cortical brain damage. The lesion coincided with the area on PWI where increased rCBV and MTT prolongation were noted. Based on these findings, we posit that the extensive but reversible brain changes seen on neuroimaging studies were the result of venous congestion. Our result stresses the importance of functional neuroimaging such as DWI and PWI in order to elucidate the pathophysiology of HLD. Copyright (C) 2004 S. Karger AG, Basel.	Hiroshima Prefectural Hosp, Dept Neurosurg, Hiroshima, Japan		Matsushige, T (corresponding author), Matsue Red Cross Hosp, Dept Neurosurg, 200 Horo Machi, Matsue, Shimane 6908506, Japan.	h-k1122@m3.dion.ne.jp					Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Doege CA, 2001, J NEUROL, V248, P564, DOI 10.1007/s004150170133; Ducreux D, 2001, AM J NEURORADIOL, V22, P261; GOTOH M, 1993, ACTA NEUROCHIR, V124, P120, DOI 10.1007/BF01401133; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Keller E, 1999, STROKE, V30, P1144, DOI 10.1161/01.STR.30.5.1144; LANKSCH W, 1981, BRAIN EDEMA, P67; Loubinoux I, 1997, STROKE, V28, P419, DOI 10.1161/01.STR.28.2.419; Lovblad KO, 2000, NEURORADIOLOGY, V42, P728, DOI 10.1007/s002340000395; ONUMA T, 1995, J NEUROSURG, V82, P995, DOI 10.3171/jns.1995.82.6.0995; Rother J, 1996, J CEREBR BLOOD F MET, V16, P1353; Sarabia R, 1988, Acta Neurochir Suppl (Wien), V42, P40; Schaefer PW, 1997, STROKE, V28, P1082, DOI 10.1161/01.STR.28.5.1082; SEVICK RJ, 1992, RADIOLOGY, V185, P687, DOI 10.1148/radiology.185.3.1438745; VILLRINGER A, 1994, J NEURORADIOLOGY, V21, P72	16	3	3	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2004	40	5					241	244		10.1159/000082300			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	894LN	WOS:000226793400008	15689643				2022-02-06	
J	Kegler, SR; Coronado, VG; Annest, JL; Thurman, DJ				Kegler, SR; Coronado, VG; Annest, JL; Thurman, DJ			Estimating nonfatal traumatic brain injury hospitalizations using an urban/rural index	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						negative binomial regression; traumatic brain injury		Objective: To develop state-level estimates of the annual number of nonfatal cases of traumatic brain injury (TBI) resulting in hospitalization. Methods: The estimation process incorporates annual nonfatal TBI hospitalization case counts from 15 states funded by the Centers for Disease Control and Prevention to conduct TBI surveillance; annual fatal TBI case counts based on National Center for Health Statistics data for all 50 states; and an index reflecting the urban/rural character of each state. These data are used to develop a negative binomial regression model that yields estimates of the annual number of nonfatal TBI hospitalization cases for each state not funded to conduct TBI surveillance. Results: Sensitivity analysis suggests that on average the estimates fall within +/-15% of the case counts that would be obtained directly from surveillance. Conclusion: In combination, the TBI case count data and the urban/rural index support effective modeling and estimation of annual nonfatal TBI hospitalization case counts at the state level.	Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30341 USA; Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA		Kegler, SR (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Highway NE,MS-K59, Atlanta, GA 30341 USA.			Thurman, David/0000-0002-0533-7062			Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Agresti A., 2019, INTRO CATEGORICAL DA; *AR DEP TRANSP, 2001 MOT VEH CRASH F; Butler MA, 1994, 9425 USDA EC RES SER; Cameron A., 1998, REGRESSION ANAL COUN; *CDC NAT CTR INJ P, 1999, TRAUM BRAIN INJ US R; Eberhardt M., 2001, URBAN RURAL HLTH CHA; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; *MINN DEP PUBL SAF, 2001, MINN MOT VEH CRASH F; *OKL DEP PUBL SAF, 2000 OKL CRASH FACTS; SAS, 1999, SAS STAT US GUID VER, V10th; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ., 1995, GUIDELINES SURVEILLA; *US CENS BUR, HOUS HOUS EC STAT DI; *US CENS BUR POP D, 2000, TIM SER INT EST COUN; *USDA EC RES SERV, 1993, RUR URB CONT COD; *UT DEP PUBL SAF, 2001 UT CRASH SUMM	17	3	3	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2003	18	6					469	478		10.1097/00001199-200311000-00001			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	747MX	WOS:000186809200001	14707877				2022-02-06	
J	Soto-Ares, G; Denes, M; Noule, N; Vinchon, M; Pruvo, JP; Gosset, D				Soto-Ares, G; Denes, M; Noule, N; Vinchon, M; Pruvo, JP; Gosset, D			Subdural hematomas in children: Role of cerebral and spinal MRI in the diagnosis of child abuse	JOURNAL DE RADIOLOGIE			French	Article						child abuse; head injury, closed; shaken baby syndrome; battered child syndrome; hematoma, subdural; magnetic resonance imaging	NONACCIDENTAL HEAD-INJURY; SUBARACHNOID SPACE ENLARGEMENT; SHAKEN-BABY SYNDROME; BRAIN-INJURY; YOUNG-CHILDREN; CRANIAL MRI; INFANTS; TRAUMA; NEUROPATHOLOGY; PATTERNS	Purpose. To determine if the presence of multiple subdural hematomas (SH) of varying signal intensities at MRI was suggestive of repeated injuries allowing a diagnosis of non accidental head injury (NAHI). Material and Methods. We included 13 patients (9 boys/4 girls; mean age 15,3 weeks) with suspected NAHI and bilateral SH. Six patients had MRI during acute admission (first week) and seven patients between 10 and 30 days after head trauma (mean 12,6 days). A total of 8/13 patients had spinal MRI. We assessed the distribution and signal intensity of SH, brain, epidural and spinal cord abnormalities. Our findings were compared to medico-legal investigations in 7/13 patients to evaluate the correlation between the age of SH on MRI and the date of injuries. Result. Lesions detected included cerebral edema, ischemia, contusions and cranio-cervical axonal injury and 2/8 patient had spinal epidural hematomas. Multiple SH with varying signal intensities were seen. The commonest location was the frontoparietal areas (100%) and suboccipital region (77%). In 5/6 cases, MRI during the acute admission revealed multiple and small SH having the same signal intensity. When MRI was performed later multiple SH of varying signal intensity were found in 54% of cases. We found a good correlation between the age of the SH and the date of suspected injuries in all cases. Nevertheless, in 5 patients, other SH of various ages were present suggesting rebleeding. Conclusion. Our findings confirm the value of MRI in the detection of brain and spinal cord lesions and SH of varying signal intensities in non accidental head injury. MRI is not able to predict whether different signal intensities correspond to spontaneous repeated bleedings or repeated injuries. The presence of these lesions without clinical evidence of accidental trauma justifies a medico-legal evaluation to confirm the diagnosis of child abuse and to protect these patients.	CHRU Lille, Serv Neuroradiol, F-59037 Lille, France; CHRU Lille, Serv Med Legale, F-59037 Lille, France; CHRU Lille, Serv Neurochirurg Infantile, F-59037 Lille, France		Soto-Ares, G (corresponding author), CHRU Lille, Serv Neuroradiol, F-59037 Lille, France.			Vinchon, Matthieu/0000-0002-9122-6165			AOKI N, 1994, J NEUROSURG, V81, P20, DOI 10.3171/jns.1994.81.1.0020; BALL WS, 1989, RADIOLOGY, V173, P609, DOI 10.1148/radiology.173.3.2813759; Barlow KM, 1999, ACTA PAEDIATR, V88, P734; Barnes PD, 2000, PEDIATR RADIOL, V30, P74, DOI 10.1007/s002470050018; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; BROWN JK, 1993, DEV MED CHILD NEUROL, V35, P849; Carty H, 1997, EUR RADIOL, V7, P1365, DOI 10.1007/s003300050303; Chabrol B, 1999, CHILD ABUSE NEGLECT, V23, P217, DOI 10.1016/S0145-2134(98)00128-8; Chateil JF, 1999, J RADIOL, V80, P553; Conway EE, 1998, PEDIATR ANN, V27, P677, DOI 10.3928/0090-4481-19981001-11; Dashti SR, 1999, PEDIATR NEUROSURG, V31, P302, DOI 10.1159/000028880; Dias MS, 1998, PEDIATR NEUROSURG, V29, P77, DOI 10.1159/000028694; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; El Quessar A, 1999, J RADIOL, V80, P913; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; FOBBEN ES, 1989, AM J ROENTGENOL, V153, P589, DOI 10.2214/ajr.153.3.589; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Gout A, 1997, ARCH PEDIATRIE, V4, P983, DOI 10.1016/S0929-693X(97)86096-4; HADLEY MN, 1989, NEUROSURGERY, V24, P536, DOI 10.1227/00006123-198904000-00008; Hart BL, 1996, AM J FOREN MED PATH, V17, P217, DOI 10.1097/00000433-199609000-00008; HARWOODNASH DC, 1992, AM J NEURORADIOL, V13, P569; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Kleinman PK, 1998, DIAGNOSTIC IMAGING C, P285; PARENT AD, 1992, PEDIATR NEUROSURG, V18, P266, DOI 10.1159/000120674; Prasad R, 2000, AIRL BUS, V16, P25; Sane SM, 2000, PEDIATRICS, V105, P1345; SATO Y, 1989, RADIOLOGY, V173, P653, DOI 10.1148/radiology.173.3.2813768; Swift DM, 2000, NEUROSURG CLIN N AM, V11, P439, DOI 10.1016/S1042-3680(18)30106-2; Tzioumi D, 1998, CHILD ABUSE NEGLECT, V22, P1105, DOI 10.1016/S0145-2134(98)00093-3; Williams VL, 2000, NEUROSURG CLIN N AM, V11, P491, DOI 10.1016/S1042-3680(18)30112-8	33	3	3	0	3	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0221-0363			J RADIOL	J. Radiol.	NOV	2003	84	11	1				1757	1765					9	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	756FP	WOS:000187455400008	15022989				2022-02-06	
J	Struffert, T; Axmann, C; Reith, W				Struffert, T; Axmann, C; Reith, W			Brain and head injury. Part 2: intra-axonal injuries and secondary injuries to the brain	RADIOLOGE			German	Article						head trauma; CT; MRI; diagnostic work-up	DESCENDING TRANSTENTORIAL HERNIATION; COMPUTED TOMOGRAPHY; CERVICAL-SPINE; KERNOHAN NOTCH; TRAUMA; MR; HEMORRHAGE; FEATURES; LESIONS; DAMAGE	This article describes the imaging tools for efficient diagnostic management of head trauma victims. The basic mechanisms of brain injuries are explained and the imaging features are described. Computed tomography, remains the most important method for the initial screening and follow-up investigation. Though magnetic resonance imaging has higher sensitivity to most traumatic lesions, it does not play an important role in the acute phase of head trauma patients. In the first part of. this paper clinical classifications, imaging modalities, extra-axial injuries, and contusions are described. in the second part of this paper intra-axial and secondary discussed.	Univ Saarland, Abt Neuroradiol, Radiol Klin, D-66421 Homburg, Germany		Struffert, T (corresponding author), Univ Saarland, Abt Neuroradiol, Radiol Klin, D-66421 Homburg, Germany.	tobias.struffert@uniklinik-saarland.de					ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Adams JH, 1991, NEUROIMAG CLIN N AM, V1, P397; ADAMS JH, 1984, GREENFIELDS NEUROPAT, P85; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; BRAUN IF, 1983, SOUTHERN MED J, V76, P1507, DOI 10.1097/00007611-198312000-00014; CHAN KH, 1993, NEUROSURGERY, V32, P547, DOI 10.1227/00006123-199304000-00009; DAVIS JM, 1983, NEURORADIOLOGY, V25, P55, DOI 10.1007/BF00333294; DIGRE KB, 1992, AM J NEURORADIOL, V13, P223; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; HAHN FJ, 1985, AM J NEURORADIOL, V6, P844; Holbourn AHS, 1943, LANCET, V2, P438; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; IWAMA T, 1992, NEURORADIOLOGY, V34, P225, DOI 10.1007/BF00596342; JONES KM, 1991, AM J NEURORADIOL, V12, P1238; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Kernohan JW, 1929, ARCH NEURO PSYCHIATR, V21, P274, DOI 10.1001/archneurpsyc.1929.02210200030004; Kuker W, 1996, CHIRURG, V67, P1098, DOI 10.1007/s001040050110; LEE JP, 1991, ACTA NEUROL SCAND, V84, P85, DOI 10.1111/j.1600-0404.1991.tb04913.x; LEROUX PD, 1992, NEUROSURGERY, V31, P678, DOI 10.1227/00006123-199210000-00010; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; OSBORN AG, 1977, RADIOLOGY, V123, P93, DOI 10.1148/123.1.93; PARENT AD, 1992, NEUROSURGERY, V31, P501, DOI 10.1227/00006123-199209000-00012; Parizel PM, 2002, INTENS CARE MED, V28, P85, DOI 10.1007/s00134-001-1160-y; Reissberg S, 2003, KLIN NEURORADIOL, V13, P27; SANDE GM, 1980, SCOT MED J, V25, P227, DOI 10.1177/003693308002500308; SCHIRMER M, 1994, NEUROCHIRURGIE; SUNDERLAND S, 1958, BRIT J SURG, V45, P422, DOI 10.1002/bjs.18004519306; VERGOTE G, 1992, NEURORADIOLOGY, V34, P215, DOI 10.1007/BF00596339; Wiesmann M, 1998, RADIOLOGE, V38, P645, DOI 10.1007/s001170050405; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393	38	3	5	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0033-832X	1432-2102		RADIOLOGE	Radiologe	NOV	2003	43	11					1001	1016		10.1007/s00117-003-0962-z			16	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	754LP	WOS:000187318900009	15174469				2022-02-06	
J	Hanten, G; Stallings-Roberson, G; Song, JX; Bradshaw, M; Levin, HS				Hanten, G; Stallings-Roberson, G; Song, JX; Bradshaw, M; Levin, HS			Subject ordered pointing task performance following severe traumatic brain injury in adults	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; WORKING-MEMORY CAPACITY; PRACTICAL SCALE; FRONTAL-LOBE; DEFICITS; COMPREHENSION; AMNESIA; CORTEX	The utility of a non-verbal, untimed subject ordered pointing task for identifying memory deficit in adult patients with TBI was tested. Using a cross-sectional design, the working memory performance of 70 adults with severe traumatic brain injury ( TBI) and 45 uninjured adults was investigated on a computerized, self-paced, non-verbal subject ordered pointing task. Persons with severe TBI were impaired on measures of working memory relative to the control subjects. In addition, the task appeared to be sensitive to severity of injury as measured by the Glasgow Coma Scale, even within a truncated range of severity (GCS scores 3 - 8). It was concluded that the subject ordered pointing task is useful in identifying memory deficits in persons with brain injury.	Baylor Coll Med, Dept Phys Med & Rehabil, Cognit Neurosci Lab, Houston, TX 77030 USA		Hanten, G (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, Cognit Neurosci Lab, 6560 Fannin St,Box 67, Houston, TX 77030 USA.	ghanten@bcm.tmc.edu					Adams JH, 1975, HDB CLIN NEUROLOGY, V23, P35; Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; Bigler E, 1990, TRAUMATIC BRAIN INJU, P13; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; EHRLICH MF, 1994, PSYCHOL RES-PSYCH FO, V56, P110, DOI 10.1007/BF00419718; Gabrieli JDE, 1996, NEUROPSYCHOLOGY, V10, P322, DOI 10.1037/0894-4105.10.3.321; GEARY DC, 1993, PSYCHOL BULL, V114, P345, DOI 10.1037/0033-2909.114.2.345; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Hanten G, 1999, DEV NEUROPSYCHOL, V16, P393, DOI 10.1207/S15326942DN1603_23; Haut M W, 1990, Arch Clin Neuropsychol, V5, P299, DOI 10.1016/0887-6177(90)90028-N; HAUT MW, 1991, BRAIN COGNITION, V17, P31, DOI 10.1016/0278-2626(91)90064-F; JANOWSKY JS, 1989, BEHAV NEUROSCI, V103, P548, DOI 10.1037/0735-7044.103.3.548; KESSLER HR, 1992, INT J NEUROSCI, V62, P17, DOI 10.3109/00207459108999754; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; Lehto JH, 1996, Q J EXP PSYCHOL-A, V49, P29, DOI 10.1080/027249896392793; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEVIN HS, 1988, SCANDINAVIAN J REH S, V20, P33; MARTIN A, 1995, J CLIN EXP NEUROPSYC, V17, P786, DOI 10.1080/01688639508405167; Martin R., 1994, NEUROPSYCHOLOGY, V8, P506, DOI [10.1037/0894-4105.8.4.506, DOI 10.1037/0894-4105.8.4.506]; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; MILLER EK, 1970, CORTEX, V6, P212; MYERS JE, 1997, APPL NEUROPSYCHOLOGY, V3, P89; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; SCHMITTEREDGECOMBE ME, 1992, J CLIN EXP NEUROPSYC, V14, P717, DOI 10.1080/01688639208402858; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; TEASDALE G, 1974, LANCET, V2, P81; WIEGERSMA S, 1990, NEUROPSYCHOLOGIA, V28, P95, DOI 10.1016/0028-3932(90)90089-7	32	3	3	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2003	17	10					871	882		10.1080/02699050210147220			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	719CR	WOS:000185186500005	12963553				2022-02-06	
J	Okada, PJ; Young, KD; Baren, JM; Raroque, SS; Huff, KR; Wiebe, JB; Stavinoha, PL; Lewis, RJ				Okada, PJ; Young, KD; Baren, JM; Raroque, SS; Huff, KR; Wiebe, JB; Stavinoha, PL; Lewis, RJ			Neurologic outcome score for infants and children	ACADEMIC EMERGENCY MEDICINE			English	Article						neurologic outcome; brain injury; neurologic assessment; child; infant	TRAUMATIC BRAIN INJURY; SEVERE HEAD-INJURY; SCALE; ADOLESCENTS; DISABILITY; RECOVERY	Objectives: To develop and validate a practical outcome instrument applicable to a broad range of neurologic deficits in children. Methods: Reliability testing of a draft version of the Neurologic Outcome Scale for Infants and Children (NOSIC) in 100 children with a wide range of ages and levels of neurologic function was performed. After review of the reliability data by a panel of experts, the NOSIC was revised. Validity and reliability testing of the final NOSIC was performed in a new population of 157 children, 52 with cerebral palsy, motor delay, or language delay. Interrater reliability was assessed using Spearman rank correlation coefficients of two investigators' scores. NOSIC scores were correlated with scores on criterion-standard neuropsychological tests to assess validity. Results: The median NOSIC score for normal children was 98, interquartile range 96-100; the median score for abnormal children was 87, interquartile range 58-96. Interrater reliability of the NOSIC scores of 84 patients rated by both raters demonstrated excellent reliability (rho = 0.77, 95% confidence interval [CI] = 0.62 to 0.88). Correlation of the NOSIC scores of the 127 patients who had neuropsychological testing with applicable criterion standards was rho = 0.63, 95% CI = 0.50 to 0.74. Conclusions: The NOSIC is a practical, reliable, valid, instrument applicable to infants and children with a broad range of neurologic deficits. It should be a useful research tool when neurologic function is an important outcome measure.	Univ Texas, SW Med Ctr, Div Emergency Med, Dept Pediat, Dallas, TX 75216 USA; Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA; Harbor UCLA Med Ctr, Dept Pediat, Torrance, CA 90509 USA; Harbor UCLA Res & Educ Inst, Torrance, CA USA; Univ Penn, Sch Med, Dept Emergency Med, Philadelphia, PA 19104 USA; Childrens Hosp Cent Calif, Dept Pediat, Fresno, CA USA; Harbor UCLA Med Ctr, Dept Pediat, Div Neurol, Torrance, CA 90509 USA; Denton Reg Med Ctr, Denton, TX USA; Childrens Med Ctr Dallas, Dept Psychiat, Div Psychol, Dallas, TX USA; Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX USA		Okada, PJ (corresponding author), Univ Texas, SW Med Ctr, Div Emergency Med, Dept Pediat, 5323 Harry Hines Blvd, Dallas, TX 75216 USA.			Stavinoha, Peter L/0000-0002-3955-9579	AHRQ HHSUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [5 F32 HS00091] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [F32HS000091] Funding Source: NIH RePORTER		Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Bayley N., 2006, BAYLEY SCALES INFANT, V3rd; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; DONDERSJ, 1992, J CLIN PSYCHOL, V48, P364; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Fuchs S, 2003, ACAD EMERG MED, V10, P368, DOI 10.1197/aemj.10.4.368; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Koelfen W, 1997, EUR J PEDIATR, V156, P230, DOI 10.1007/s004310050590; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Langlois J. A., 2000, TRAUMATIC BRAIN INJU; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; *SAS I INC, 2003, JACKN BOOTSTR AN; WECHSLER D, 1991, MANUAL WECHSLER PRES; Winogron H W, 1984, J Clin Neuropsychol, V6, P267	19	3	3	0	1	HANLEY & BELFUS INC	PHILADELPHIA	210 S 13TH ST, PHILADELPHIA, PA 19107 USA	1069-6563			ACAD EMERG MED	Acad. Emerg. Med.	OCT	2003	10	10					1034	1039		10.1197/S1069-6563(03)00364-6			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	729MB	WOS:000185776500004	14525734				2022-02-06	
J	Rooker, S; Van Reempts, J; Van Deuren, B; Borgers, M; Jorens, PG; Paelinck, BP; Verlooy, J				Rooker, S; Van Reempts, J; Van Deuren, B; Borgers, M; Jorens, PG; Paelinck, BP; Verlooy, J			Ultrasound agents may open the blood-brain barrier in rats and aggravate pathologic consequences of experimental head trauma	NEUROPATHOLOGY			English	Article						blood-brain barrier; experimental head injury; rats; ultrasound contrast agent; vasogenic edema	OPTISON; DAMAGE; FS069; EDEMA; MODEL	Unilateral intracarotid injection of contrast agents may considerably destabilize the blood - brain barrier in rats. This leads to vasogenic edema in the ipsilateral hemisphere. Mortality and extravasation increased significantly when administration of these ultrasound contrast agents was followed by mild traumatic brain injury. Direct administration to the cerebral circulation is, therefore, indicative for edema-related pathology and may amplify the consequences of experimental neurotrauma.	Univ Antwerp Hosp, Dept Neurosurg, B-2650 Edegem, Belgium; Janssen Res Fdn, Dept Life Sci, Neuropathol Lab, B-2340 Beerse, Belgium; Univ Antwerp Hosp, Dept Intens Care, Antwerp, Belgium; Univ Antwerp Hosp, Dept Cardiol, Antwerp, Belgium		Rooker, S (corresponding author), Univ Antwerp Hosp, Dept Neurosurg, Wilrijkstr 10, B-2650 Edegem, Belgium.	servanrooker@belgacom.net	Rooker, Servan/AAD-4316-2020				Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; BROWN AW, 1968, BRIT J EXP PATHOL, V49, P87; Cohen JL, 1998, J AM COLL CARDIOL, V32, P746, DOI 10.1016/S0735-1097(98)00311-8; De Mulder G, 2000, ACT NEUR S, V76, P409; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; Killam AL, 1998, J ULTRAS MED, V17, P349, DOI 10.7863/jum.1998.17.6.349; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; MARMAROU A, 1994, ACTA NEUROCHIR, P421; Miller DL, 1998, ULTRASOUND MED BIOL, V24, P285, DOI 10.1016/S0301-5629(97)00267-6; Mychaskiw G, 1999, CIRCULATION, V100, P444; Paelinck BP, 1999, ACTA CARDIOL, V54, P195; ROOKER S, 2000, 11 INT S INTR PRESS; SZTRIHA L, 1991, BRAIN RES, V550, P257, DOI 10.1016/0006-8993(91)91326-V; Toshima Y, 2000, STROKE, V31, P2245, DOI 10.1161/01.STR.31.9.2245; Van Reempts J, 2000, NEUROSCI RES COMMUN, V26, P161, DOI 10.1002/1520-6769(200005/06)26:3<161::AID-NRC4>3.0.CO;2-N; VANREEMPTS J, 1994, HISTOL HISTOPATHOL, V9, P185; VANREEMPTS J, 1990, CEREBRAL ISCHEMIA RE, P235	17	3	3	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	SEP	2003	23	3					210	213		10.1046/j.1440-1789.2003.00505.x			4	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	719ER	WOS:000185191100009	14570289				2022-02-06	
J	Dawes, H; Cockburn, J; Roach, NK; Wade, DT; Bateman, A; Scott, O				Dawes, H; Cockburn, J; Roach, NK; Wade, DT; Bateman, A; Scott, O			The effect of a perceptual cognitive task on exercise performance: the dual-task condition after brain injury	CLINICAL REHABILITATION			English	Article							INTERFERENCE	Objective: To examine the effect of additional cognitive demand on cycling performance in individuals with acquired brain injury (ABI). Design: Prospective observational study. Setting: Rivermead Rehabilitation Centre. Participants: Ten individuals with ABI ( 7 men, 3 women) ( traumatic brain injury 7, tumour 1, stroke 2) and 10 healthy controls ( 6 men, 4 women). Intervention: Individuals were asked to maintain a set cadence during a three-stage incremental cycling test in both single-task ( no additional task) and dual-task ( whilst performing an additional cognitive task) conditions. Results: The ABI group showed a slight slowing in cadence in stages 1 and 3 of the graded exercise test from the single-to the dual-task condition, although this was not significant ( p less than or equal to 0.05). The control group showed no slowing of cadence at any incremental stage. When directly comparing the ABI with the control group, the change in cadence observed in dual-task conditions was only significantly different in stage 3 ( p less than or equal to 0.05). Conclusions: Clinicians should be aware of the possibility that giving additional cognitive tasks ( such as monitoring exercise intensity) while individuals with acquired brain injury are performing exercises may detrimentally affect performance. The effect may be more marked when the individuals are performing exercise at higher intensities.	Oxford Brookes Univ, Sch Biol & Mol Sci, Oxford OX3 0BP, England; Rivermead Rehabil Ctr, Oxford OX1 4XD, England; Univ Reading, Dept Psychol, Reading RG6 2AH, Berks, England; Manchester Metropolitan Univ, Dept Exercise & Sport Sci, Manchester M15 6BH, Lancs, England; Univ E London, London E15 4LZ, England		Dawes, H (corresponding author), Oxford Brookes Univ, Sch Biol & Mol Sci, Gipsy Lane Campus, Oxford OX3 0BP, England.			Dawes, Helen/0000-0002-2933-5213; Bateman, Andrew/0000-0002-2547-5921; Wade, Derick/0000-0002-1188-8442			*ACSM, 1995, GUID GRAD EX TEST TR, P35; Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; BROADBENT DE, 1958, PRECEPTION COMMUNICA; DAWES H, 2001, PERCEPTION FATIGUE E, P360; GUERTS ACH, 1996, ARCH PHYSICAL MED RE, V77, P639; Haggard P, 2000, J NEUROL NEUROSUR PS, V69, P479, DOI 10.1136/jnnp.69.4.479; LAJOIE Y, 1993, EXP BRAIN RES, V97, P139; Marshall SC, 1997, ARCH PHYS MED REHAB, V78, P7, DOI 10.1016/S0003-9993(97)90002-2; Noble B, 1996, PERCEIVED EXERTION, P77; NOBLE BJ, 1983, MED SCI SPORT EXER, V15, P523; PAAS FGWC, 1991, ERGONOMICS, V34, P1385, DOI 10.1080/00140139108964879; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; SHALLICE T, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P125; VANZOMEREN AH, 1994, CLIN NEUROPHYSIOLOGY; [No title captured]	15	3	3	0	10	ARNOLD, HODDER HEADLINE PLC	LONDON	338 EUSTON ROAD, LONDON NW1 3BH, ENGLAND	0269-2155			CLIN REHABIL	Clin. Rehabil.	AUG	2003	17	5					535	539		10.1191/0269215503cr623oa			5	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	704YG	WOS:000184369000011	12952160				2022-02-06	
J	Ahmed, Z; Baker, D; Cuzner, ML				Ahmed, Z; Baker, D; Cuzner, ML			Interleukin-12 induces mild experimental allergic encephalomyelitis following local central nervous system injury in the Lewis rat	JOURNAL OF NEUROIMMUNOLOGY			English	Article						experimental allergic encephalomyelitis; T cells; interleukin-12; inflammation; central nervous system	NITRIC-OXIDE SYNTHASE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ANTIADHESION MOLECULE THERAPY; MULTIPLE-SCLEROSIS; SPINAL-CORD; PERIPHERAL BENZODIAZEPINE; ADOPTIVE TRANSFER; CEREBRAL-CORTEX; T-CELLS; BRAIN	The major pathological feature in the central nervous system (CNS) following traumatic brain injury is activation of microglia both around and distant from the injury site. intraperitoneal administration of interleukin-12 (IL-12) after brain injury resulted in a 7% weight loss, clinical signs of mild EAE and significant myelin basic protein (MBP)-specific splenic cell proliferation. The extent of pathology, in terms of the number of inflammatory perivascular cuffs and activation of microglia was greatest if IL-12 was administered immediately compared to a week following brain injury, whether at one or two sites. Specifically immunostaining for MHC class II and iNOS on macrophages and microglia, ICAM-1 on endothelial cells and macrophages was observed around the site of injury. A degree of myelin processing was apparent from immunostaining of MBP in inflammatory cells distant from the lesion. Inflammatory cuffs comprising macrophages, activated microglia, CD4(+) T cells and iNOS(+) cells were also detected distant to the injury site in the medulla and spinal cord of animals treated with IL-12. These results suggest that immune-mediated events in which IL-12 production is stimulated as for example viral infection, superimposed on a brain injury, could provide a trigger for a MS-like pathology. (C) 2003 Elsevier B.V. All rights reserved.	UCL, Inst Neurol, Dept Neuroinflammat, London WC1N 3BG, England		Ahmed, Z (corresponding author), Univ Birmingham, Queen Elizabeth Med Ctr, Wolfson Res Labs, Dept Med, 3rd Floor, Birmingham B15 2TH, W Midlands, England.	z.ahmed.1@bham.ac.uk	Ahmed, Zubair/AAN-1869-2021		Multiple Sclerosis SocietyNational Multiple Sclerosis Society [541] Funding Source: Medline		AFONSO LCC, 1994, SCIENCE, V263, P235, DOI 10.1126/science.7904381; Ahmed Z, 2001, AM J PATHOL, V158, P2127, DOI 10.1016/S0002-9440(10)64684-6; ALLEN I, 1993, J NEUROPATH EXP NEUR, V52, P95, DOI 10.1097/00005072-199303000-00001; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Banati RB, 1997, J NEUROCYTOL, V26, P77, DOI 10.1023/A:1018567510105; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; Bo L, 1996, J NEUROPATH EXP NEUR, V55, P1060, DOI 10.1097/00005072-199655100-00006; BO L, 1994, ANN NEUROL, V36, P778, DOI 10.1002/ana.410360515; BOULLERNE AI, 1995, J NEUROIMMUNOL, V60, P117, DOI 10.1016/0165-5728(95)00061-6; CANNELLA B, 1993, J NEUROIMMUNOL, V46, P43, DOI 10.1016/0165-5728(93)90232-N; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; DAWSON VL, 1993, J NEUROSCI, V13, P2651; DAWSON VL, 1994, NEUROPHARMACOLOGY, V33, P1425, DOI 10.1016/0028-3908(94)90045-0; DoreDuffy P, 1996, J NEUROSCI RES, V44, P223, DOI 10.1002/(SICI)1097-4547(19960501)44:3<223::AID-JNR3>3.0.CO;2-I; Du CG, 2001, J IMMUNOL, V167, P7094, DOI 10.4049/jimmunol.167.12.7094; Fujita T, 1998, ACTA NEUROCHIR, V140, P275, DOI 10.1007/s007010050095; GAY FW, 1997, BRAIN, V120, P83; GEHRMANN J, 1993, GLIA, V7, P50, DOI 10.1002/glia.440070110; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; GEHRMANN J, 1993, BRAIN PATHOL, V3, P11, DOI 10.1111/j.1750-3639.1993.tb00720.x; HENDRZAK JA, 1995, LAB INVEST, V72, P619; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Kanwar JR, 2000, J NEUROIMMUNOL, V103, P146, DOI 10.1016/S0165-5728(99)00245-3; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lake J, 1999, J PATHOL, V187, P259, DOI 10.1002/(SICI)1096-9896(199901)187:2<259::AID-PATH212>3.0.CO;2-H; Lee SJ, 1999, J NEUROIMMUNOL, V98, P77, DOI 10.1016/S0165-5728(99)00084-3; Li H, 1996, NEUROPATH APPL NEURO, V22, P207; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; MERRILL JE, 1992, P NATL ACAD SCI USA, V89, P574, DOI 10.1073/pnas.89.2.574; Murphy P, 2002, J NEUROSCI RES, V67, P461, DOI 10.1002/jnr.10139; PANITCH HS, 1994, ANN NEUROL, V36, P25; PERRY VH, 1993, TRENDS NEUROSCI, V16, P268, DOI 10.1016/0166-2236(93)90180-T; PHILLIPS MJ, 1995, NEUROPATH APPL NEURO, V21, P189, DOI 10.1111/j.1365-2990.1995.tb01050.x; Phillips MJ, 1997, J PATHOL, V182, P457; Popovich PG, 1996, J NEUROSCI RES, V45, P349, DOI 10.1002/(SICI)1097-4547(19960815)45:4<349::AID-JNR4>3.0.CO;2-9; POSER CM, 1993, J NEUROL SCI S, V115, P3; RAINE CS, 1990, LAB INVEST, V63, P476; Rose JW, 1999, J NEUROIMMUNOL, V97, P110, DOI 10.1016/S0165-5728(99)00064-8; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; SCHIJNS VECJ, 1995, J IMMUNOL, V155, P2525; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Scott GS, 2001, NEUROSCI LETT, V311, P125, DOI 10.1016/S0304-3940(01)02160-7; Segal BM, 1998, J EXP MED, V187, P537, DOI 10.1084/jem.187.4.537; Smith KJ, 1999, BRAIN PATHOL, V9, P69; Smith T, 1997, AM J PATHOL, V150, P1909; SOBEL RA, 1990, AM J PATHOL, V136, P1309; Stahel PF, 1998, NEUROSCI LETT, V249, P123, DOI 10.1016/S0304-3940(98)00410-8; Tamatani M, 1998, J NEUROCHEM, V71, P1588; Trinchieri G, 1995, RES IMMUNOL, V146, P423, DOI 10.1016/0923-2494(96)83011-2; TRINCHIERI G, 1994, IMMUNOL TODAY, V15, P460, DOI 10.1016/0167-5699(94)90189-9; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V132, P51; van der Veen RC, 2001, INT IMMUNOPHARMACOL, V1, P1491, DOI 10.1016/S1567-5769(01)00093-5; Waldburger KE, 1996, AM J PATHOL, V148, P375; Weller RO, 1996, BRAIN PATHOL, V6, P275, DOI 10.1111/j.1750-3639.1996.tb00855.x; Willenborg DO, 1999, J NEUROIMMUNOL, V100, P21, DOI 10.1016/S0165-5728(99)00212-X; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S	57	3	4	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-5728			J NEUROIMMUNOL	J. Neuroimmunol.	JUL	2003	140	1-2					109	117		10.1016/S0165-5728(03)00180-2			9	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	709DZ	WOS:000184610600012	12864978				2022-02-06	
J	Asa, I; Ivashkova, Y; Artru, AA; Lifshitz, M; Gavrilov, V; Azab, AN; Kapuler, V; Alouchin, A; Rachinsky, M; Pruneau, D; Shapira, Y; Kaplanski, J				Asa, I; Ivashkova, Y; Artru, AA; Lifshitz, M; Gavrilov, V; Azab, AN; Kapuler, V; Alouchin, A; Rachinsky, M; Pruneau, D; Shapira, Y; Kaplanski, J			LF 16-0687 Ms, a new bradykinin B-2 receptor antagonist, improves neurologic outcome but not brain tissue prostaglandin E-2 release in a rat model of closed head trauma combined with ethanol intoxication	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						bradykinin B (2) antagonist; cerebral edema; ethanol; head injury; neurologic outcome; prostaglandin; rat	KALLIKREIN-KININ SYSTEM; NITRIC-OXIDE; N1E-115 NEUROBLASTOMA; ALCOHOL-INTOXICATION; PHOSPHOLIPASE-C; EDEMA; EXPOSURE; INJURY; MEDIATOR; CELLS	Background:. LF 16-0687 Ms previously was reported to improve Neurological Severity Score (NSS) and decrease cerebral edema and prostaglandin E-2 (PGE(2)) release after closed head trauma (CHT) in rats. Here, we examined whether these beneficial effects of LF 160687 Ms are altered when CHT is accompanied by acute ethanol administration. Methods. six groups of rats (n = 8 per group) were examined during combination of the following experimental conditions: CHT versus sham operation, LF 16-0687 Ms 3 mg/kg subcutaneously versus saline, and ethanol 2 g/kg versus saline. Results: After CHT, brain water content decreased and NSS improved with ethanol + LF 16-0687 Ms as compared with values after saline or ethanol. PGE2 release decreased with ethanol (147 +/- 59 pg/mg tissue) but not with ethanol + LF 16-0687 Ms (286 194 pg/mg tissue). Conclusions:. Ethanol does not affect the improvement of NSS and the decrease of cerebral edema seen with LF 16-0687 Ms after CHT, but does reverse the ability of LF 16-0687 Ms to minimize the increase of PGE(2) release. In intoxicated patients, bradykinin antagonist therapy may improve post-CHT outcome without altering PGE(2) release.	Univ Washington, Sch Med, Dept Anesthesiol, Seattle, WA 98195 USA; Ben Gurion Univ Negev, Soroka Med Ctr, Div Anesthesiol, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Dept Pediat, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Dept Pharmacol, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Toxicol Lab, IL-84105 Beer Sheva, Israel; Ctr Rech, Labs Fournier, Daix, France		Artru, AA (corresponding author), Univ Washington, Sch Med, Dept Anesthesiol, Box 356540,1959 NE Pacific St, Seattle, WA 98195 USA.		GAVRILOV, VLADIMIR/F-2326-2012				ALBIN MS, 1986, CRIT CARE MED, V14, P841, DOI 10.1097/00003246-198610000-00001; Alling C, 1993, Alcohol Alcohol Suppl, V2, P295; BAUGHMAN VL, 1990, J NEUROSURG ANESTH, V2, P290, DOI 10.1097/00008506-199012000-00007; Bokkala S, 1999, ALCOHOL CLIN EXP RES, V23, P1875, DOI 10.1111/j.1530-0277.1999.tb04086.x; Chorny I, 1999, J NEUROSURG ANESTH, V11, P273, DOI 10.1097/00008506-199910000-00008; DAVDA RK, 1993, HYPERTENSION, V21, P939, DOI 10.1161/01.HYP.21.6.939; Deaciuc IV, 1996, ALCOHOL CLIN EXP RES, V20, P293, DOI 10.1111/j.1530-0277.1996.tb01642.x; DEMOPOULOS HB, 1972, STEROIDS BRAIN EDEMA, P29; ELLIS EF, 1989, J NEUROSURG, V61, P97; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; Feldman Z, 1997, J TRAUMA, V43, P667, DOI 10.1097/00005373-199710000-00017; FELETOU M, 1994, BRIT J PHARMACOL, V112, P683, DOI 10.1111/j.1476-5381.1994.tb13130.x; FLAMM ES, 1977, J NEUROSURG, V46, P328, DOI 10.3171/jns.1977.46.3.0328; GAMACHE DA, 1986, J NEUROSURG, V65, P686, DOI 10.3171/jns.1986.65.5.0686; Gecse A, 1989, Adv Exp Med Biol, V247A, P249; Gorlach C, 1996, PEPTIDES, V17, P1373, DOI 10.1016/S0196-9781(96)00223-9; GREENBERG SS, 1993, ALCOHOL, V10, P21, DOI 10.1016/0741-8329(93)90049-T; Gurevich B, 1998, J NEUROSURG, V88, P1066, DOI 10.3171/jns.1998.88.6.1066; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; Jeftinija SD, 1996, J NEUROCHEM, V66, P676; Kaplanski J, 2003, RESUSCITATION, V56, P207, DOI 10.1016/S0300-9572(02)00371-4; KATUSIC ZS, 1993, STROKE, V24, P392, DOI 10.1161/01.STR.24.3.392; Kennedy CRJ, 1996, AM J PHYSIOL-CELL PH, V271, pC1064, DOI 10.1152/ajpcell.1996.271.4.C1064; KIM WK, 1993, MOL PHARMACOL, V44, P405; Koyfman L, 2000, J NEUROSURG ANESTH, V12, P44, DOI 10.1097/00008506-200001000-00009; Lang CH, 2000, AM J PHYSIOL-ENDOC M, V279, pE1029, DOI 10.1152/ajpendo.2000.279.5.E1029; LE AD, 1994, PHARMACOL BIOCHEM BE, V48, P229, DOI 10.1016/0091-3057(94)90521-5; Levine GH, 2000, ALCOHOL CLIN EXP RES, V24, P93, DOI 10.1111/j.1530-0277.2000.tb04558.x; Lorber A, 2000, J NEUROSURG ANESTH, V12, P345, DOI 10.1097/00008506-200010000-00007; MAIERHAUFF K, 1984, J NEUROSURG, V61, P97, DOI 10.3171/jns.1984.61.1.0097; Marie J, 2001, J BIOL CHEM, V276, P41100, DOI 10.1074/jbc.M104875200; MOURSI MM, 1983, STROKE, V14, P791, DOI 10.1161/01.STR.14.5.791; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pruneau D, 1999, J NEUROTRAUM, V16, P1057, DOI 10.1089/neu.1999.16.1057; Pruneau D, 1999, IMMUNOPHARMACOLOGY, V43, P187, DOI 10.1016/S0162-3109(99)00128-9; RODRIGUEZ FD, 1992, NEUROPHARMACOLOGY, V31, P1157, DOI 10.1016/0028-3908(92)90012-E; Shapira Y, 1997, J NEUROSURG ANESTH, V9, P118, DOI 10.1097/00008506-199704000-00003; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHAPIRA Y, 1989, PROSTAG LEUKOTR ESS, V36, P49, DOI 10.1016/0952-3278(89)90162-2; SHAPIRA Y, 1992, ANESTH ANALG, V75, P238; SHAPIRA Y, 1988, J CEREBR BLOOD F MET, V8, P395, DOI 10.1038/jcbfm.1988.75; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; SIMONSSON P, 1989, BIOCHEM PHARMACOL, V38, P2801, DOI 10.1016/0006-2952(89)90434-6; SMITH TL, 1991, J PHARMACOL EXP THER, V258, P410; SMITH TL, 1993, ALCOHOL, V10, P83, DOI 10.1016/0741-8329(93)90057-U; Sobey CG, 1997, STROKE, V28, P2290, DOI 10.1161/01.STR.28.11.2290; UNTERBERG A, 1986, J NEUROSURG, V64, P269, DOI 10.3171/jns.1986.64.2.0269; UNTERBERG A, 1984, J CEREBR BLOOD F MET, V4, P574, DOI 10.1038/jcbfm.1984.82; UNTERBERG A, 1984, J NEUROSURG, V61, P87, DOI 10.3171/jns.1984.61.1.0087; Vasta V, 1998, BBA-LIPID LIPID MET, V1391, P280, DOI 10.1016/S0005-2760(98)00013-7; WAHL M, 1983, J CEREBR BLOOD F MET, V3, P231, DOI 10.1038/jcbfm.1983.31; XIE CI, 1994, ALCOHOL CLIN EXP RES, V18, P1443, DOI 10.1111/j.1530-0277.1994.tb01448.x	53	3	4	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2003	54	5					881	887		10.1097/01.TA.0000046700.45106.4B			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	687BN	WOS:000183356100015	12777900				2022-02-06	
J	Grechenig, W; Peicha, G; Boldin, C; Mayr, J				Grechenig, W; Peicha, G; Boldin, C; Mayr, J			Ipsilateral femoral fracture and anterior hip dislocation in a 15-year-old girl: case report	UNFALLCHIRURG			German	Article						combination of injuries; femoral shaft fracture; anterior hip dislocation; adolescent	CHILDREN	Operative management of concomitant ipsilateral femur fracture and anterior hip dislocation has not been previously described in the literature. We report the case of a 15-years-old girl who was injured in a motorcycle accident and presented with a femoral shaft fracture and a concomitant ipsilateral anterior hip dislocation. Operative management consisted of an attempted closed reduction of the femoral fracture, which was unsuccessful; thus, an external fixator was temporarily applied. Subsequently, the hip dislocation was treated by open reduction through an anterolateral approach. Finally, the femoral fracture was securely stabilized using an unreamed femoral intramedullary nail. The postoperative course was uneventful. MRI follow-up after 6 weeks did not reveal any sign of mangled vascularization of the femoral head and radiographs demonstrated normal bony healing of the shaft fracture. Due to the fact that there is no definitive surgical strategy for this rare combination of injuries, concomitant ipsilateral femoral fracture and anterior hip dislocation is an interesting and challenging situation for the trauma surgeon which requires a subtle and exact surgical technique in order to achieve satisfying results.	Graz Univ, Unfallchirurg Klin, A-8036 Graz, Austria; Graz Univ, Klin Kinderchirurg, A-8036 Graz, Austria		Grechenig, W (corresponding author), Graz Univ, Unfallchirurg Klin, Auenbruggerpl 7A, A-8036 Graz, Austria.						BEATY JH, 2001, ROCKWOOD WILKENS FRA; CRAIG CL, 1980, ORTHOP CLIN N AM, V11, P743; FRANKE K, 1980, TRAUMATOLOGIE SPORTS; HENDERSON RS, 1951, J BONE JOINT SURG BR, V33, P602, DOI 10.1302/0301-620X.33B4.602; INGRAM AJ, 1954, J BONE JOINT SURG AM, V36-A, P1249, DOI 10.2106/00004623-195436060-00014; Jonasch E., 1981, VERLETZUNGEN BEI KIN, V14; LITTON LO, 1958, J BONE JOINT SURG AM, V40, P1419, DOI 10.2106/00004623-195840060-00017; NERUBAY J, 1976, CLIN ORTHOP RELAT R, P129; OGDEN JA, 2000, SKELETAL INJURY CHIL; SAUER H, 1984, VERLETZTE KIND; von Laer L, 1996, FRAKTUREN LUXATIONEN; WADSWORTH TG, 1961, J BONE JOINT SURG BR, V43, P47	12	3	3	0	0	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0177-5537			UNFALLCHIRURG	Unfallchirurg	MAY	2003	106	5					412	415		10.1007/s00113-003-0583-z			4	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	689XL	WOS:000183518200008	12750814				2022-02-06	
J	Koskinen, LOD; Koch, ML				Koskinen, LOD; Koch, ML			Nitric oxide inhibition by L-NAME but not 7-NI induces a transient increase in cortical cerebral blood flow and affects the cerebrovasodilation induced by TRH	PEPTIDES			English	Article						nitric oxide; L-NAME; 7-NI; TRH; cerebral blood flow; peptides	THYROTROPIN-RELEASING-HORMONE; TRAUMATIC BRAIN INJURY; CARDIOVASCULAR-SYSTEM; ANESTHETIZED RABBIT; VASCULAR-DISEASE; RAT; MICROCIRCULATION; VASODILATORS; RESPONSES; ISCHEMIA	The tripeptide thyrotropin releasing hormone (TRH) has multiple interesting and complex physiological effects. One of these is the cerebrovasodilating effect, which has been described under several different conditions. The final mechanism for this effect is unknown. In the present study, we found an initial atropine-resistant cerebral vasodilation (24%) elicited by the NOS inhibitor L-NAME in the rat. D-NAME and 7-NI did not produce this effect. TRH (300 mug kg(-1), i.v.) induced an increase in cerebral blood flow by 62%. L-NAME reduced this effect significantly. The cerebrovasodilating mechanism of TRH, at least in part, is endothelial NO dependent as the neuronal 7-NI NOS inhibitor does not affect the TRH response. (C) 2003 Elsevier Science Inc. All rights reserved.	Univ Umea Hosp, Dept Pharmacol & Clin Neurosci, Div Neurosurg, SE-90185 Umea, Sweden; Swedish Def Res Agcy, Inst Threat Assessment, Div NBC Def, Umea, Sweden		Koskinen, LOD (corresponding author), Univ Umea Hosp, Dept Pharmacol & Clin Neurosci, Div Neurosurg, SE-90185 Umea, Sweden.	lars-owe.koskinen@neuro.umu.se	Koskinen, Lars-Owe/AAQ-8957-2020	Koskinen, Lars-Owe/0000-0003-3528-8502			Chiueh CC, 1999, ANN NY ACAD SCI, V890, P301, DOI 10.1111/j.1749-6632.1999.tb08007.x; CICARDI C, 1994, ITAL J NEUROL SCI, V15, P395; Cooke JP, 1997, ANNU REV MED, V48, P489, DOI 10.1146/annurev.med.48.1.489; DeWitt DS, 1997, J NEUROTRAUM, V14, P931, DOI 10.1089/neu.1997.14.931; ENGEL WK, 1989, ANN NY ACAD SCI, V553, P462; EYRE JA, 1988, CLIN PHYS PHYSIOL M, V9, P65, DOI 10.1088/0143-0815/9/1/006; FADEN AI, 1989, ANN NY ACAD SCI, V553, P380; FARACI FM, 1994, STROKE, V25, P692, DOI 10.1161/01.STR.25.3.692; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Heuer H, 1999, ACTA MED AUST, V26, P119; Horita A, 1998, LIFE SCI, V62, P1443, DOI 10.1016/S0024-3205(98)00087-3; HUGOSONSELIGSOHN EE, 1989, BRIT J PHARMACOL, V97, P190, DOI 10.1111/j.1476-5381.1989.tb11941.x; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; INANAMI O, 1992, NEUROSCI LETT, V143, P151, DOI 10.1016/0304-3940(92)90254-5; INANAMI O, 1988, NEUROSCI LETT, V88, P184, DOI 10.1016/0304-3940(88)90123-1; KONDOH Y, 1989, J CEREBR BLOOD F MET, V9, P196, DOI 10.1038/jcbfm.1989.29; KOSKINEN LO, 1984, ACTA PHYSIOL SCAND, V122, P127, DOI 10.1111/j.1748-1716.1984.tb07490.x; KOSKINEN LOD, 1986, ACTA PHYSIOL SCAND, V128, P277, DOI 10.1111/j.1748-1716.1986.tb07976.x; KOSKINEN LOD, 1994, ACTA PHYSIOL SCAND, V152, P399, DOI 10.1111/j.1748-1716.1994.tb09822.x; KOSKINEN LOD, 1985, BRIT J PHARMACOL, V85, P489, DOI 10.1111/j.1476-5381.1985.tb08886.x; KOSKINEN LOD, 1991, PEPTIDES, V12, P1273, DOI 10.1016/0196-9781(91)90206-5; KOSKINEN LOD, 1989, PEPTIDES, V10, P933, DOI 10.1016/0196-9781(89)90171-X; Koskinen LOD, 2000, UPSALA J MED SCI, V105, P73, DOI 10.1517/03009734000000049; Li HG, 2000, J PATHOL, V190, P244, DOI 10.1002/(SICI)1096-9896(200002)190:3<244::AID-PATH575>3.0.CO;2-8; Maejima S, 2001, WORLD J SURG, V25, P1205, DOI 10.1007/s00268-001-0083-7; Magnusson BM, 2001, PEPTIDES, V22, P73, DOI 10.1016/S0196-9781(00)00358-2; MORITATSUZUKI Y, 1992, ACTA PHYSIOL SCAND, V146, P431, DOI 10.1111/j.1748-1716.1992.tb09444.x; OSHAUGHNESSY CT, 1989, CAN J PHYSIOL PHARM, V67, P1345, DOI 10.1139/y89-214; SANO K, 1979, ADV NEUROL SCI, V23, P184; SELIGSOHN EE, 1993, BRIT J PHARMACOL, V109, P1219, DOI 10.1111/j.1476-5381.1993.tb13752.x; SELIGSOHN EE, 1991, ACTA PHYSIOL SCAND, V143, P187, DOI 10.1111/j.1748-1716.1991.tb09220.x; TODA N, 1988, JPN J PHARMACOL, V76, P349; Tzeng AC, 2000, AM J PHYS MED REHAB, V79, P435, DOI 10.1097/00002060-200009000-00005; YARBROUGH GG, 1979, PROG NEUROBIOL, V12, P291, DOI 10.1016/0301-0082(79)90012-1	34	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	APR	2003	24	4					579	583		10.1016/S0196-9781(03)00107-4			5	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	704FZ	WOS:000184329600011	12860202				2022-02-06	
J	Watanabe, Y; Araki, S; Kurihara, M				Watanabe, Y; Araki, S; Kurihara, M			Health-related quality of life of stroke patients' families during the patients' hospitalization: a pilot study in Japan	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						health-related quality of life; stroke; family members	TRAUMATIC BRAIN-INJURY; SURVEY QUESTIONNAIRE; OUTCOME MEASURE; VALIDATION; SPOUSES; MEMBERS; STRAIN		Repatriat Gen Hosp, Dept Rehabil & Aged Care, Daw Pk, SA 5041, Australia		Watanabe, Y (corresponding author), Repatriat Gen Hosp, Dept Rehabil & Aged Care, Daws Rd, Daw Pk, SA 5041, Australia.	yuriko50@hotmail.com					Bethoux F, 1996, INT J REHABIL RES, V19, P291, DOI 10.1097/00004356-199612000-00001; Blake H, 2000, CLIN REHABIL, V14, P307, DOI 10.1191/026921500667530134; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Canam C, 1999, Rehabil Nurs, V24, P192; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Fukuhara SSY., 2001, MANUAL SF 36 JAPANES; GARRATT AM, 1993, BRIT MED J, V306, P1440, DOI 10.1136/bmj.306.6890.1440; GREVESON GC, 1991, AGE AGEING, V20, P337, DOI 10.1093/ageing/20.5.337; Hanger HC, 1998, CLIN REHABIL, V12, P45, DOI 10.1191/026921598668677675; Kimura A., 1994, JPN J REHABIL MED, V31, P119, DOI DOI 10.2490/JJRM1963.31.119; O'Mahony PG, 1998, AGE AGEING, V27, P19, DOI 10.1093/ageing/27.1.19; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; TAKAI Y, 2000, SOGO REHABIRITESHON, V28, P11; TYMAN RV, 1994, CLIN REHABIL, V8, P341; Watanabe Y, 2001, DISABIL REHABIL, V23, P370; Watanabe Y, 2000, CLIN REHABIL, V14, P172, DOI 10.1191/026921500666833742; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; [No title captured], DOI DOI 10.1177/026921559601000413	18	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	MAR	2003	26	1					43	45		10.1097/00004356-200303000-00005			3	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	652LD	WOS:000181379900005	12601266				2022-02-06	
J	Dumas, HM; Haley, SM; Carey, TM; Ludlow, LH; Rabin, JP				Dumas, HM; Haley, SM; Carey, TM; Ludlow, LH; Rabin, JP			Lower extremity spasticity as an early marker of ambulatory recovery following traumatic brain injury	CHILDS NERVOUS SYSTEM			English	Article						muscle spasticity; walking; brain injuries; child; sensitivity and specificity	CLOSED HEAD TRAUMA; PROLONGED UNCONSCIOUSNESS; CHILDREN; SEVERITY	Methods: A consecutive series of 107 children and young persons with traumatic brain injury (TBI) admitted to a hospital-based inpatient rehabilitation program was assessed to determine whether lower extremity spasticity could be utilized as an early clinical marker for recovery of ambulation. Presence of spasticity was determined by clinical examination at admission, and the ability to ambulate safely indoors (15.24 m) was evaluated at discharge. Sensitivity, specificity and positive and negative predictive values for spasticity were calculated. Results: Lower extremity spasticity is a sensitive (71.4%) and specific (81.5%) predictor of the inability to ambulate at discharge. The absence of lower extremity spasticity, however, was a better predictor of ambulation recovery than the presence of spasticity was a predictor of nonambulatory status at hospital discharge. Discussion: Implications for spasticity assessment and prognosis in terms of ambulation and recovery are discussed.	Franciscan Childrens Hosp & Rehabil Ctr, Res Ctr Children Special Hlth Care Needs, Boston, MA 02135 USA; Boston Univ, Ctr Rehabil Effectiveness, Sargent Coll Hlth & Rehabil Sci, Boston, MA 02115 USA; Boston Coll, Lynch Coll Educ, Chestnut Hill, MA 02467 USA; Franciscan Childrens Hosp & Rehabil Ctr, Phys Rehabil Program, Boston, MA 02135 USA		Dumas, HM (corresponding author), Franciscan Childrens Hosp & Rehabil Ctr, Res Ctr Children Special Hlth Care Needs, 30 Warren St, Boston, MA 02135 USA.	hdumas@fchrc.org					BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; Damiano DL, 2002, DEV MED CHILD NEUROL, V44, P112, DOI 10.1017/S0012162201001761; Emanuelson I, 1996, CHILD NERV SYST, V12, P460, DOI 10.1007/BF00261625; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; Haley S, 1992, PEDIAT EVALUATION DI; HOFFER MM, 1986, LOVELL WINTERS PEDIA, P611; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; KRIEL RL, 1993, PEDIATR NEUROL, V9, P362, DOI 10.1016/0887-8994(93)90104-K; KRIEL RL, 1988, ARCH PHYS MED REHAB, V69, P678; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; MAYER NH, 1997, MUSCLE NERVE       S, V6, P21; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; RAO N, 1988, ARCH PHYS MED REHAB, V69, P179; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; WESSON DE, 1989, J TRAUMA, V29, P589, DOI 10.1097/00005373-198905000-00008; 1999, STAT PACKAGE SOCIAL	19	3	4	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	FEB	2003	19	2					114	118		10.1007/s00381-002-0696-7			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	657GX	WOS:000181659000009	12607031				2022-02-06	
J	Weber, RK; Kaftan, H; Draf, W; Keerl, R				Weber, RK; Kaftan, H; Draf, W; Keerl, R			First experiences in endonasal duraplasty without antibiotics	LARYNGO-RHINO-OTOLOGIE			German	Article						CSF leak; endonasal duraplasty; antibiotics	ENDOSCOPIC SINUS SURGERY; BASILAR SKULL FRACTURE; ANTIMICROBIAL PROPHYLAXIS; HEAD-INJURY; MENINGITIS; MANAGEMENT; COMPLICATIONS; NEUROSURGERY; REPAIR; LEAKS	Background: Available evidence does not support the use of prophylactic antibiotics in patients with CSF fistulae. The question arises whether an antibiotic prophylaxis or therapy is mandatory planning an operative closure of frontobasal dural lesions. Patients: In a retrospective survey a consecutive sample of 7 patients who had undergone endonasal ENT-department of two universities and an university teaching hospital was taken. The hospital course was evaluated and all patients were interviewed after a postoperative period between 6 and 36 months. Endonasal duraplasty by underlay or onlay technique without pre- or intraoperative application of antibiotics was performed. Hospital course, development of meningitis, need for antibiotic therapy later on, subjective complaints, history of meningitis, cerebrospinal fluid rhinorrhea, fluoresceine test (intrathecal administration of fluoresceine sodium and subsequent nasal endoscopy) were evaluated. Results: 6 patients had an uneventful postoperative hospital course without any sign of inflammatory complications. In one patient with a larger resection of dura antibiotics were administered at the second postoperative day because of recurrent fever. There occured no meningitis in any patient. All duraplasties were successfully closed. 5 patients showed a negative fluoresceine test, 2 patients denied it having no special problems. Conclusions: Duraplasty can be performed satisfactorily by endonasal approach. In small lesions and in the absence of special risk factors (diabetes, acute sinusitis, immunoincompetent patients) endonasal duraplasty don't seem to inevitably need an antibiotic cover. A larger patient population is necessary to confirm these results.	Marien Hosp, Klin Hals Nasen Ohren Heilkunde Kopf & Halschirur, D-70199 Stuttgart, Germany; Univ Greifswald, Klin & Poliklin Hals Nasen Ohren Krankheiten Kopf, Greifswald, Germany; Klinikum Fulda, Klin Hals Nasen Ohren Heilkunde Kopf Hals & Plast, Fulda, Germany; Klinikum St Elisabeth, Klin Hals Nasen Ohren Heilkunde Kopf Hals & Plast, Straubing, Germany		Weber, RK (corresponding author), Marien Hosp, Klin Hals Nasen Ohren Heilkunde Kopf & Halschirur, Boheimstr 37, D-70199 Stuttgart, Germany.						BROWN EM, 1994, LANCET, V344, P1547; BROWN EM, 1993, J ANTIMICROB CHEMOTH, V31, P49, DOI 10.1093/jac/31.suppl_B.49; DODSON EE, 1994, OTOLARYNG HEAD NECK, V111, P600, DOI 10.1016/S0194-5998(94)70527-5; FRAZEE RC, 1988, POSTGRAD MED, V83, P267, DOI 10.1080/00325481.1988.11700238; Hosemann W., 1999, Rhinology (Utrecht), V37, P108; HOSEMANN W, 2000, MINIMALLY INVASIVE E; IGNELZI RJ, 1975, J NEUROSURG, V43, P721, DOI 10.3171/jns.1975.43.6.0721; LEECH PJ, 1973, LANCET, V1, P1013; LEVINE HL, 1991, OPERATIVE TECH OTOLA, V2, P282; MATTOX DE, 1990, LARYNGOSCOPE, V100, P857; PAPAY FA, 1989, LARYNGOSCOPE, V99, P1195; RATHORE MH, 1991, PEDIATR INFECT DIS J, V10, P87, DOI 10.1097/00006454-199102000-00001; SIEGMANIGRA Y, 1993, CLIN INFECT DIS, V17, P843, DOI 10.1093/clinids/17.5.843; Stammberger H, 1993, Eur Arch Otorhinolaryngol Suppl, V1, P61; STANKIEWICZ JA, 1991, LARYNGOSCOPE, V101, P250; VLEMING M, 1992, ARCH OTOLARYNGOL, V118, P617; Weber R, 1996, ARCH OTOLARYNGOL, V122, P732; WEBER R, 1992, HNO, V40, P170; Wigand ME, 1990, ENDOSCOPIC SURG PARA; Wolf G, 1997, LARYNGO RHINO OTOL, V76, P588	20	3	3	0	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	1615-0007			LARYNGO RHINO OTOL	Laryngo-Rhino-Otol.	FEB	2003	82	2					114	117		10.1055/s-2003-37729			4	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	648PA	WOS:000181158700007	12624840				2022-02-06	
